PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Mildner, A; Chapnik, E; Varol, D; Aychek, T; Lampl, N; Rivkin, N; Bringmann, A; Paul, F; Boura-Halfon, S; Hayoun, YS; Barnett-Itzhaki, Z; Amit, I; Hornstein, E; Jung, S				Mildner, Alexander; Chapnik, Elik; Varol, Diana; Aychek, Tegest; Lampl, Nardi; Rivkin, Natalia; Bringmann, Anita; Paul, Franziska; Boura-Halfon, Sigalit; Hayoun, Yifat Segal; Barnett-Itzhaki, Zohar; Amit, Ido; Hornstein, Eran; Jung, Steffen			MicroRNA-142 controls thymocyte proliferation	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						microRNAs; Posttranscriptional control; Thymocyte development	T-CELL DIFFERENTIATION; TARGET RECOGNITION; DOWN-REGULATION; MICE; EXPRESSION; P27(KIP1); HOMEOSTASIS; RECEPTOR; MIR-142; ABSENCE	T-cell development is a spatially and temporally regulated process, orchestrated by well-defined contributions of transcription factors and cytokines. Here, we identify the noncoding RNA miR-142 as an additional regulatory layer within murine thymocyte development and proliferation. MiR-142 deficiency impairs the expression of cell cycle-promoting genes in mature mouse thymocytes and early progenitors, accompanied with increased levels of cyclin-dependent kinase inhibitor 1B (Cdkn1b, also known as p27(Kip1)). By using CRISPR/Cas9 technology to delete the miR-142-3p recognition element in the 3'UTR of cdkn1b, we confirm that this gene is a novel target of miR-142-3p in vivo. Increased Cdkn1b protein expression alone however was insufficient to cause proliferation defects in thymocytes, indicating the existence of additional critical miR-142 targets. Collectively, we establish a key role for miR-142 in the control of early and mature thymocyte proliferation, demonstrating the multifaceted role of a single miRNA on several target genes.	[Mildner, Alexander; Varol, Diana; Aychek, Tegest; Lampl, Nardi; Bringmann, Anita; Paul, Franziska; Boura-Halfon, Sigalit; Hayoun, Yifat Segal; Barnett-Itzhaki, Zohar; Amit, Ido; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Chapnik, Elik; Rivkin, Natalia; Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-ISRAEL Rehovot, Israel	Jung, S (reprint author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.; Hornstein, E (reprint author), Weizmann Inst Sci, Dept Mol Genet, IL-ISRAEL Rehovot, Israel.	eran.hornstein@weizmann.ac.il; s.jung@weizmann.ac.il		Paul, Franziska/0000-0003-0344-6764; mildner, alexander/0000-0002-2019-8427	Israeli Science Foundation; Kekst Family Institute for Medical Genetics; Deutsche Forschungsgemeinschaft Research Unit 1336; ERC consolidator program (FP7); Minerva program	We would like to thank Rita Krauthgamer for technical assistance, the staff members of the Weizmann sorting facility, in particular Eitan Ariel and Ayala Sharp for excellent technical support. We are also grateful to Ofira Higfa and Yehuda Melamed for animal welfare. Thank to the University of Utah, Mutation Generation and Detection Core for Crispr reagents. We would like to thank members of the Jung laboratory and Klaus Rajewsky for stimulating discussions. AM was a fellow of the Minerva foundation. This study was supported by funding of the Israeli Science Foundation, the Kekst Family Institute for Medical Genetics and the Deutsche Forschungsgemeinschaft Research Unit 1336. E. H. was supported by the ERC consolidator program (FP7) and Minerva program.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x                                                ; Cao XC, 2016, CELL PROLIFERAT, V49, P58, DOI 10.1111/cpr.12235; Carraro G, 2014, DEVELOPMENT, V141, P1272, DOI 10.1242/dev.105908; Chapnik E, 2014, ELIFE, V3, DOI 10.7554/eLife.01964; Chassot AA, 2008, CELL CYCLE, V7, P2038, DOI 10.4161/cc.7.13.6233                                                            ; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Dou LP, 2013, MOL BIOL REP, V40, P6811, DOI 10.1007/s11033-013-2798-6; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6                                                   ; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Qi X., CELL PHYSL BIOCH, V36, P1743; Regelin M, 2015, J IMMUNOL, V195, P4832, DOI 10.4049/jimmunol.1402248; Rivkin N, 2017, HAEMATOLOGICA, V102, P676, DOI 10.3324/haematol.2016.156109; Seok H, 2016, MOL CELLS, V39, P375, DOI 10.14348/molcells.2016.0013; Shrestha A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136913; Sun YP, 2015, J CLIN INVEST, V125, P2825, DOI 10.1172/JCI78753; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304                                                      ; vonsFreeden-Jeffry U, 1995, J EXP MED, V181, P1519	33	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	JUL	2017	47	7					1142	1152		10.1002/eji.201746987				11	Immunology	Immunology	FA2CM	WOS:000405248300007	28471480				2018-01-05	
J	Jensen, KT; Floe, L; Petersen, TS; Huang, JR; Xu, FP; Bolund, L; Luo, YL; Lin, L				Jensen, Kristopher Torp; Floe, Lasse; Petersen, Trine Skov; Huang, Jinrong; Xu, Fengping; Bolund, Lars; Luo, Yonglun; Lin, Lin			Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency	FEBS LETTERS			English	Article						chromatin accessibility; CRISPR; efficiency; gRNA	MAMMALIAN-CELLS; GENOME; NUCLEASES; SYSTEMS; CAS9; ENDONUCLEASE; SPECIFICITY; PARAMETERS; ENRICHMENT; MUTATIONS	Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (CRISPR-Cas9) systems have emerged as the method of choice for genome editing, but large variations in on-target efficiencies continue to limit their applicability. Here, we investigate the effect of chromatin accessibility on Cas9-mediated gene editing efficiency for 20 gRNAs targeting 10 genomic loci in HEK293T cells using both SpCas9 and the eSpCas9(1.1) variant. Our study indicates that gene editing is more efficient in euchromatin than in heterochromatin, and we validate this finding in HeLa cells and in human fibroblasts. Furthermore, we investigate the gRNA sequence determinants of CRISPR-Cas9 activity using a surrogate reporter system and find that the efficiency of Cas9-mediated gene editing is dependent on guide sequence secondary structure formation. This knowledge can aid in the further improvement of tools for gRNA design.	[Jensen, Kristopher Torp; Floe, Lasse; Petersen, Trine Skov; Bolund, Lars; Luo, Yonglun; Lin, Lin] Aarhus Univ, Dept Biomed, Wilhelm Meyer 4, DK-8000 Aarhus C, Denmark; [Jensen, Kristopher Torp] Univ Cambridge, Cambridge, England; [Huang, Jinrong; Xu, Fengping; Bolund, Lars] BGI Shenzhen, Shenzhen, Peoples R China; [Huang, Jinrong; Xu, Fengping; Bolund, Lars] BGI Shenzhen, China Natl GeneBank Shenzhen, Shenzhen, Peoples R China; [Xu, Fengping] Univ Copenhagen, Biol Dept, Copenhagen, Denmark	Luo, YL; Lin, L (reprint author), Aarhus Univ, Dept Biomed, Wilhelm Meyer 4, DK-8000 Aarhus C, Denmark.	alun@biomed.au.dk; lin.lin@biomed.au.dk	Luo, Yonglun/C-4708-2013	Luo, Yonglun/0000-0002-0007-7759	Danish Research Council for Independent Research [DFF-1337-00128]; Sapere Aude Young Research Talent Prize [DFF-1335-00763A]; Innovation Fund Denmark (BrainStem); Lundbeck Foundation [R173-2014-1105, R219-2016-1375]; Lundbeck Foundation through the DREAM [R151-2013-14439]; Shenzhen Municipal Government of China [CXZZ20150330171838997]	We thank Prof. Jacob Giehm Mikkelsen for the critical reading and comments, and the FACS Core Facility of Aarhus University for technical help with all FCM analysis. This work was funded by grants from the Danish Research Council for Independent Research (DFF-1337-00128), the Sapere Aude Young Research Talent Prize (DFF-1335-00763A), the Innovation Fund Denmark (BrainStem) and the Lundbeck Foundation (R173-2014-1105) to YL. The Lundbeck Foundation (R151-2013-14439) supported LB through the DREAM project and YL through the Casmere project. LL is supported by the Lundbeck Foundation (R219-2016-1375). JH, and FX are supported by a grant from the Shenzhen Municipal Government of China (NO.CXZZ20150330171838997).	Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daer RM, 2017, ACS SYNTH BIOL, V6, P428, DOI 10.1021/acssynbio.5b00299; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Horlbeck MA, 2016, ELIFE; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren CH, 2015, CELL MOL LIFE SCI, V72, P2763, DOI 10.1007/s00018-015-1874-6; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501                                                          ; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Wolfsheimer S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021902; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhou Y, 2016, CELL MOL LIFE SCI, V73, P2543, DOI 10.1007/s00018-015-2128-3	25	2	2	18	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1873-3468			FEBS LETT	FEBS Lett.	JUL	2017	591	13					1892	1901		10.1002/1873-3468.12707				10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FA1KC	WOS:000405197200007	28580607				2018-01-05	
J	Huang, Z; Tomitaka, A; Raymond, A; Nair, M				Huang, Z.; Tomitaka, A.; Raymond, A.; Nair, M.			Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS	GENE THERAPY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; COMBINATION ANTIRETROVIRAL THERAPY; INHIBIT HIV-1 REPLICATION; POST-INTEGRATION LATENCY; IN-VIVO; INFECTED PATIENTS; VIRAL LOAD; NEUROCOGNITIVE DISORDERS	Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) remains a major health hazard despite significant advances in prevention and treatment of HIV infection. The major reason for the persistence of HIV/AIDS is the inability of existing treatments to clear or eradicate the multiple HIV reservoirs that exist in the human body. To suppress the virus replication and rebound, HIV/AIDS patients must take life-long antiviral medications. The clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated nuclease 9 (Cas9) system is an emerging gene-editing technique with the potential to eliminate or disrupt HIV-integrated genomes or HIV-infected cells from multiple HIV reservoirs, which could result in the complete cure of HIV/AIDS. Encouraging progress has already been reported for the application of the CRISPR/Cas9 technique to HIV/AIDS treatment and prevention, both in vitro in human patient cells and in vivo in animal model experiments. In this review, we will summarize the most recent progress in the application of the CRISPR/Cas9 gene-editing technique to HIV/AIDS therapy and elimination. Future directions and trends of such applications are also discussed.	[Huang, Z.; Tomitaka, A.; Raymond, A.; Nair, M.] Florida Int Univ, Dept Immunol, Inst NeuroImmune Pharmacol, Ctr Personalized Nanomed,Herbert Wertheim Coll Me, Miami, FL 33199 USA	Huang, Z; Nair, M (reprint author), Florida Int Univ, Dept Immunol, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, 11200 SW 8th St, Miami, FL 33199 USA.	zahuan@fiu.edu; nairm@fiu.edu			National Institutes of Health, US [R01DA037838, R01DA034547]	This work was supported by grants (R01DA037838 and R01DA034547) from National Institutes of Health, US. We also thank Maureen Pelham and Courtney Myhr for their help in English editing.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BICKEL U, 1994, J HISTOCHEM CYTOCHEM, V42, P1493, DOI 10.1177/42.11.7930531                                                           ; Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Clark AJ, 2015, P NATL ACAD SCI USA, V112, P12486, DOI 10.1073/pnas.1517048112; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cu-Uvin S, 2010, AIDS, V24, P2486, DOI 10.1097/QAD.0b013e32833e5043; Dampier W., 2014, MOJ IMMUNOL, V1; De Luca MA, 2015, INT J PHARMACEUT, V479, P129, DOI 10.1016/j.ijpharm.2014.12.057; Delagreverie HM, 2016, INFECT DIS, V3; Ding H, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/5/055101; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Fornaguera C, 2015, J CONTROL RELEASE, V211, P134, DOI 10.1016/j.jconrel.2015.06.002; Gallastegui E, 2011, J VIROL, V85, P3187, DOI 10.1128/JVI.01920-10; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2015, CLIN INFECT DIS, V60, P473, DOI 10.1093/cid/ciu862; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huang YP, 2016, ACS APPL MATER INTER, V8, P11336, DOI 10.1021/acsami.6b02838; Jayant RD, 2015, INT J NANOMED, V10, P1077, DOI 10.2147/IJN.S76517; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaminski R, 2016, GENE THER, V23, P696, DOI 10.1038/gt.2016.45; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kaushik A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25309; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lambert-Niclot S, 2010, ANTIMICROB AGENTS CH, V54, P4910, DOI 10.1128/AAC.00725-10; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansouri M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11529; MCELRATH MJ, 1991, J CLIN INVEST, V87, P27, DOI 10.1172/JCI114981; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nair M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2717; Narasipura SD, 2014, J VIROL, V88, P3031, DOI 10.1128/JVI.03333-13; Nath A, 2015, J NEUROVIROL, V21, P227, DOI 10.1007/s13365-014-0291-1; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Patel P, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0108-6; Petito CK, 1999, J NEUROVIROL, V5, P670, DOI 10.3109/13550289909021295                                                       ; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Qazi S, 2016, MOL PHARMACEUT, V13, P1191, DOI 10.1021/acs.molpharmaceut.5b00822; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ruelas DS, 2015, J BIOL CHEM, V290, P13736, DOI 10.1074/jbc.M115.641837; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Sagar V, 2015, J BIOMED NANOTECHNOL, V11, P1722, DOI 10.1166/jbn.2015.2108; Schneider M, 2015, AIDS, V29, P1147, DOI 10.1097/QAD.0000000000000691; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shi B, 2016, J ACQUIR IMMUNE DEFI; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; Solas C, 2003, ANTIMICROB AGENTS CH, V47, P238, DOI 10.1128/AAC.47.1.238-243.2003; Stanley SK, 1996, NEW ENGL J MED, V334, P1222, DOI 10.1056/NEJM199605093341903; Strong CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125652; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Sunshine S, 2016, J VIROL, V90, P4511, DOI 10.1128/JVI.01617-15; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tomitaka A, 2015, NANOSCALE, V7, P16890, DOI 10.1039/c5nr02831k; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang L, 2015, J DRUG TARGET, V23, P832, DOI 10.3109/1061186X.2015.1025077; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; YOSHIKAWA T, 1992, J PHARMACOL EXP THER, V263, P897; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang Y, 2003, J GENE MED, V5, P1039, DOI 10.1002/jgm.449; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	100	2	2	26	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	JUL	2017	24	7					377	384		10.1038/gt.2017.35				8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FA2WC	WOS:000405300900001	28471431				2018-01-05	
J	Chattong, S; Ruangwattanasuk, O; Yindeedej, W; Setpakdee, A; Manotham, K				Chattong, S.; Ruangwattanasuk, O.; Yindeedej, W.; Setpakdee, A.; Manotham, K.			CD34+cells from dental pulp stem cells with a ZFN-mediated and homology-driven repair-mediated locus-specific knock-in of an artificial beta-globin gene	GENE THERAPY			English	Article							BONE-MARROW-TRANSPLANTATION; ZINC-FINGER NUCLEASES; HEMATOPOIETIC STEM; PROGENITOR CELLS; HUMAN FIBROBLASTS; POINT MUTATION; DE-NOVO; THALASSEMIA; DISEASE; CRISPR/CAS9	In humans, mutations in the beta-globin gene (HBB) have two important clinical manifestations: beta-thalassemia and sickle cell disease. The progress in genome editing and stem cell research may be relevant to the treatment of beta-globin-related diseases. In this work, we employed zinc-finger nuclease (ZFN)-mediated gene integration of synthetic beta-globin cDNA into HBB loci, thus correcting almost all beta-globin mutations. The integration was achieved in both HEK 293 cells and isolated dental pulp stem cell (DPSCs). We also showed that DPSCs with an artificial gene knock-in were capable of generating stable six-cell clones and were expandable at least 10(8)-fold; therefore, they may serve as a personalized stem cell factory. In addition, transfection with non-integrated pCAG-hOct4 and culturing in a conditioned medium converted the genome-edited DPSCs to CD34(+) HSC-like cells. We believe that this approach may be useful for the treatment of beta-globin-related diseases, especially the severe form of beta-thalassemia.	[Chattong, S.; Yindeedej, W.; Setpakdee, A.; Manotham, K.] Lerdsin Gen Hosp, Dept Med, Mol & Cell Biol Unit, 190 Silom, Bang Rak Bangkok 10500, Thailand; [Chattong, S.; Ruangwattanasuk, O.] SS Mfg Co Ltd, 114-7 Moo2 Mahasawadi, Nonthaburi, Thailand	Manotham, K (reprint author), Lerdsin Gen Hosp, Dept Med, Mol & Cell Biol Unit, 190 Silom, Bang Rak Bangkok 10500, Thailand.	kmanotham@hotmail.com			Lerdsin Foundation and SS Manufacturing	We thank Prof. Reiko Inagi (University of Tokyo, Tokyo) and Prof. Kanya Suphapeetiporn (Chulalongkorn Universty, Bangkok) for their helpful advice. We are grateful to Dr. Ryoji Sassa (Okasaki, Nagoya) for his generous support. This work was supported Lerdsin Foundation and SS Manufacturing.	Bottardi S, 2003, BLOOD, V102, P3989, DOI 10.1182/blood-2003-05-1540; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107                                                     ; Cao A, 2010, GENET MED, V12, P61, DOI 10.1097/GIM.0b013e3181cd68ed; Capellera-Garcia S, 2016, CELL REP, V15, P2550, DOI 10.1016/j.celrep.2016.05.027; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chang KH, 2010, BLOOD, V115, P2553, DOI 10.1182/blood-2009-11-252650; Chattong S, 2014, ASIAN BIOMED, V8, P333, DOI 10.5372/1905-7415.0803.297; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daniel MG, 2016, ANN NY ACAD SCI, V1370, P24, DOI 10.1111/nyas.12989; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Huang X, 2016, LEUKEMIA, V30, P144, DOI 10.1038/leu.2015.189; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Ketterer N, 1998, BLOOD, V91, P3148; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Li W, 2012, P NATL ACAD SCI USA, V109, P20853, DOI 10.1073/pnas.1219181110; Liu H, 2002, GENE THER, V9, P118, DOI 10.1038/sj/gt/3301610; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701                                                     ; Ma N, 2015, J BIOL CHEM, V290, P12079, DOI 10.1074/jbc.M114.624999; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Manotham K, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0130-6; Mansilla-Soto J, 2016, HUM GENE THER, V27, P295, DOI 10.1089/hum.2016.037; Mitchell R, 2014, STEM CELLS, V32, P2178, DOI 10.1002/stem.1721; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Molete JM, 2002, GENE, V283, P185, DOI 10.1016/S0378-1119(01)00858-7; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Niu XH, 2016, J BIOL CHEM, V291, P16576, DOI 10.1074/jbc.M116.719237; Pasi CE, 2011, CELL DEATH DIFFER, V18, P745, DOI 10.1038/cdd.2011.9; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pisciotta A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0065-x; Porteus MH, 2016, BLOOD, V127, P2507, DOI 10.1182/blood-2016-03-703181; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Romero Z, 2013, J CLIN INVEST, V123, P3317, DOI 10.1172/JCI67930; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tsai SQ, 2014, CELL STEM CELL, V15, P3, DOI 10.1016/j.stem.2014.06.017; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vo LT, 2015, BLOOD, V125, P2641, DOI 10.1182/blood-2014-10-570234; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Walters MC, 1996, NEW ENGL J MED, V335, P369, DOI 10.1056/NEJM199608083350601; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	50	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	JUL	2017	24	7					425	432		10.1038/gt.2017.42				8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FA2WC	WOS:000405300900007	28530652				2018-01-05	
J	Fuller, MS; Majumder, K; Pintel, DJ				Fuller, Matthew S.; Majumder, Kinjal; Pintel, David J.			Minute Virus of Mice Inhibits Transcription of the Cyclin B1 Gene during Infection	JOURNAL OF VIROLOGY			English	Article						DNA damage checkpoints; minute virus of mice; parvovirus; virology	CELL-CYCLE; MESSENGER-RNA; VPR ARRESTS; IN-VIVO; C-MYC; EXPRESSION; PROTEIN; FOXM1; G(2); P53	Replication of minute virus of mice (MVM) induces a sustained cellular DNA damage response (DDR) which the virus then exploits to prepare the nuclear environment for effective parvovirus takeover. An essential aspect of the MVMinduced DDR is the establishment of a potent premitotic block, which we previously found to be independent of activated p21 and ATR/Chk1 signaling. This arrest, unlike others reported previously, depends upon a significant, specific depletion of cyclin B1 and its encoding RNA, which precludes cyclin B1/CDK1 complex function, thus preventing mitotic entry. We show here that while the stability of cyclin B1 RNA was not affected by MVM infection, the production of nascent cyclin B1 RNA was substantially diminished at late times postinfection. Ectopic expression of NS1 alone did not reduce cyclin B1 expression. MVM infection also reduced the levels of cyclin B1 protein, and RNA levels normally increased in response to DNA-damaging reagents. We demonstrated that at times of reduced cyclin B1 expression during infection, there was a significantly reduced occupancy of RNA polymerase II and the essential mitotic transcription factor FoxM1 on the cyclin B1 gene promoter. Additionally, while total FoxM1 levels remained constant, there was a significant decrease of the phosphorylated, likely active, forms of FoxM1. Targeting of a constitutively active FoxM1 construct or the activation domain of FoxM1 to the cyclin B1 gene promoter via clustered regularly interspaced short palindromic repeats (CRISPR)-enzymatically inactive Cas9 in MVM-infected cells increased both cyclin B1 protein and RNA levels, implicating FoxM1 as a critical target for cyclin B1 inhibition during MVM infection. IMPORTANCE Replication of the parvovirus minute virus of mice (MVM) induces a sustained cellular DNA damage response (DDR) which the virus exploits to prepare the nuclear environment for effective takeover. An essential aspect of the MVM-induced DDR is establishment of a potent premitotic block. This block depends upon a significant, specific depletion of cyclin B1 and its encoding RNA that precludes cyclin B1/CDK1 complex functions necessary for mitotic entry. We show that reduced cyclin B1 expression is controlled primarily at the level of transcription initiation. Additionally, the essential mitotic transcription factor FoxM1 and RNA polymerase II were found to occupy the cyclin B1 gene promoter at reduced levels during infection. Recruiting a constitutively active FoxM1 construct or the activation domain of FoxM1 to the cyclin B1 gene promoter via CRISPR-catalytically inactive Cas9 (dCas9) in MVM-infected cells increased expression of both cyclin B1 protein and RNA, implicating FoxM1 as a critical target mediating MVM-induced cyclin B1 inhibition.	[Fuller, Matthew S.; Majumder, Kinjal; Pintel, David J.] Univ Missouri Columbia, Sch Med, Dept Mol Microbiol & Immunol, Bond Life Sci Ctr, Columbia, MO 65211 USA	Pintel, DJ (reprint author), Univ Missouri Columbia, Sch Med, Dept Mol Microbiol & Immunol, Bond Life Sci Ctr, Columbia, MO 65211 USA.	pinteld@missouri.edu					Adeyemi RO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004055; Adeyemi RO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003891; Adeyemi RO, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001141; Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Bashir T, 2001, J VIROL, V75, P4394, DOI 10.1128/JVI.75.9.4394-4398.2001; CATER JE, 1992, J GEN VIROL, V73, P1839, DOI 10.1099/0022-1317-73-7-1839; Chae HD, 2011, BMB REP, V44, P553, DOI 10.5483/BMBRep.2011.44.8.553; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; Darbinyan A, 2002, ONCOGENE, V21, P5574, DOI 10.1038/sj.onc.1205744; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Fasina OO, 2016, J VIROL, V90, P1718, DOI 10.1128/JVI.02618-15; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Goh WC, 2004, VIROLOGY, V318, P337, DOI 10.1016/j.virol.2003.10.007; HE JL, 1995, J VIROL, V69, P6705; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Knight GL, 2006, J VIROL, V80, P7416, DOI 10.1128/JVI.00196-06; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Lipski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042615; MAITY A, 1995, EMBO J, V14, P603; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Muller GA, 2012, NUCLEIC ACIDS RES, V40, P1561, DOI 10.1093/nar/gkr793; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Poggioli GJ, 2001, J VIROL, V75, P7429, DOI 10.1128/JVI.75.16.7429-7434.2001; RE F, 1995, J VIROL, V69, P6859; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; SCARANO FJ, 1994, J VIROL, V68, P2355; SCHOBORG RV, 1991, VIROLOGY, V181, P22, DOI 10.1016/0042-6822(91)90466-O; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394                                                      ; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wasner M, 2003, FEBS LETT, V536, P66, DOI 10.1016/S0014-5793(03)00028-0; Yin XY, 2001, CANCER RES, V61, P6487; Zhang SM, 2010, FASEB J, V24, P495, DOI 10.1096/fj.09-143925	48	1	1	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JUL	2017	91	14							UNSP e00428-17	10.1128/JVI.00428-17				14	Virology	Virology	FA5EP	WOS:000405465700027					2018-01-05	
J	Zhu, B; Chen, SB; Hu, XD; Jin, XF; Le, YC; Cao, LH; Yuan, ZH; Lin, Z; Jiang, SM; Sun, LC; Yu, L				Zhu, Bo; Chen, Shaobo; Hu, Xiaoding; Jin, Xiaofeng; Le, Yichen; Cao, Lihuan; Yuan, Zhonghua; Lin, Zhen; Jiang, Songmin; Sun, Lichun; Yu, Long			Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma	NEOPLASIA			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CERVICAL-CANCER CELLS; LIVER-CANCER; ENDOPLASMIC-RETICULUM; NEURITE OUTGROWTH; SIGNALING PATHWAY; STAT3; ACTIVATION; INFLAMMATION; RECEPTOR	Human hepatocellular carcinoma (HCC) is a malignant cancer. It is a challenge to develop anti-HCC drugs due to HCC's extreme aggressiveness and with the sensitivity of the liver to show severe adverse effects. More importantly, the precise mechanisms causing HCC pathogenicity are not known. Our previous study disclosed Nogo-B as a reticulon 4 (Rtn4) family member. In the present study, we first identified that Nogo-B played a critical role in HCC progression. We found, via in vitro and in vivo assays, that Nogo-B was expressed aberrantly in primary HCC tumor tissues and immortal HCC cells but was relatively scarce in the normal liver tissues or cells. Nogo-B knockout, via the CRISPR-Cas9 technique, resulted in significant suppression of HCC cell proliferation and tumor growth. Next-generation sequencing analysis showed that Nogo-B knockout have effects on interleukin-6 (IL-6) signaling pathway. Furthermore, we observed that IL-6 induced phosphorylation of STAT3 (pSTAT3) in wild-type HCC cells, but Nogo-B knockout could reduce IL-6-induced increase of pSTAT3, supporting that Nogo-B affects HCC tumor progression possibly via regulating the IL-6/STAT3 signaling pathway. In conclusion, Nogo-B is expressed aberrantly in HCCs and plays an oncogenic role. These findings support that Nogo-B may be a novel anti-HCC therapeutic target.	[Zhu, Bo; Chen, Shaobo; Hu, Xiaoding; Jin, Xiaofeng; Le, Yichen; Cao, Lihuan; Jiang, Songmin; Sun, Lichun; Yu, Long] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, 2005 Songhu Rd, Shanghai 200433, Peoples R China; [Sun, Lichun] Univ South China, Inst Pharm & Pharmacol, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang 421001, Peoples R China; [Yuan, Zhonghua] Univ South China, Key Lab Arteriosclerol Human, Inst Cardiovasc Dis, Hengyang 421001, Peoples R China; [Sun, Lichun] Tulane Hlth Sci Ctr, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Lin, Zhen] Tulane Hlth Sci Ctr, Sch Med, Dept Pathol, New Orleans, LA 70112 USA	Jiang, SM; Sun, LC; Yu, L (reprint author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, 2005 Songhu Rd, Shanghai 200433, Peoples R China.	smjiang@fudan.edu.cn			National Basic Research Program of China (973 Program) [2013CB910504]; National Key Sci-Tech Special Project of China [2013ZX10002010]	This work was supported by the National Basic Research Program of China (973 Program; 2013CB910504) and the National Key Sci-Tech Special Project of China (2013ZX10002010).	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Anding BI, 2000, CHINESE SCI BULL, V45, P1862; Barre B, 2007, TRENDS MOL MED, V13, P4, DOI 10.1016/j.molmed.2006.11.001; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Cao F, 2016, PHACTR4 REGULATES PR; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219                                                                ; Choudhari SR, 2007, MOL CANCER THER, V6, P112, DOI 10.1156/1535-7163.MCT-06-0561; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fang YQ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0522-x; Fang YQ, 2015, J BIOL CHEM, V290, P28901, DOI 10.1074/jbc.M115.678326; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072                                                                ; Gao LL, 2013, HEPATOLOGY, V57, P1992, DOI 10.1002/hep.26235; Gao Yuqi, 2009, J HIGH ALTITUDE MED, V19, P3; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226                                                                ; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Howlader N, 2014, SEER CANC STAT REV; In LS, 2015, KOREAN J PHYSIOL PHA, V19, P105; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; Kao JT, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0283-5; Lee S, 2016, BIOCHEM BIOPH RES CO, V473, P1247, DOI 10.1016/j.bbrc.2016.04.049; Liu X, 2014, INT J CLIN EXP PATHO, V7, P2044; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G                ; Lu ZY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-783; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; Marin EP, 2010, AM J PATHOL, V177, P2765, DOI 10.2353/ajpath.2010.100199; McGlynn KA, 2012, CANCER EPIDEM BIOMAR, V21, P384, DOI 10.1158/1055-9965.EPI-11-1102; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Paszkowiak JJ, 2007, VASC PHARMACOL, V46, P293, DOI 10.1016/j.vph.2006.11.003; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287                                                                ; Rabinovich A, 2007, ANTICANCER RES, V27, P267; Santer FR, 2009, CELLS, V17, P241; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Sun GC, 2015, J CANCER, V6, P996, DOI 10.7150/jca.12135; Sun L, 2014, CURR DRUG TARGETS, V16; Sun L, 2015, ANTICANCER AGENTS ME, V15; Sun LC, 2016, J CANCER, V7, P1388, DOI 10.7150/jca.15274; Tashiro K, 2013, AM J PATHOL, V182, P786, DOI 10.1016/j.ajpath.2012.11.032; Teng FYH, 2008, J CELL PHYSIOL, V216, P303, DOI 10.1002/jcp.21434; Thompson EW, 2005, EXPER OPIN THER TAR, V6, P217; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wright PL, 2010, J EXP MED, V207, P2595, DOI 10.1084/jem.20100786; Xiao W, 2013, ONCOL REP, V29, P109, DOI 10.3892/or.2012.2069; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xu WJ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-14; Yang J, 2000, CYTOGENET CELL GENET, V88, P101, DOI 10.1159/000015499; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Zhang DH, 2011, HEPATOLOGY, V53, P1306, DOI 10.1002/hep.24200; Zhou SM, 2010, BIOCHEM BIOPH RES CO, V398, P247, DOI 10.1016/j.bbrc.2010.06.068	59	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1476-5586			NEOPLASIA	Neoplasia	JUL	2017	19	7					583	593		10.1016/j.neo.2017.02.007				11	Oncology	Oncology	FA5CO	WOS:000405460400007	28628795	gold			2018-01-05	
J	Sharma, K; Verma, R; Advani, J; Chatterjee, O; Solanki, HS; Sharma, A; Varma, S; Modi, M; Ray, P; Mukherjee, KK; Sharma, M; Dhillion, MS; Suar, M; Chatterjee, A; Pandey, A; Prasad, TSK; Gowda, H				Sharma, Kusum; Verma, Renu; Advani, Jayshree; Chatterjee, Oishi; Solanki, Hitendra S.; Sharma, Aman; Varma, Subhash; Modi, Manish; Ray, Pallab; Mukherjee, Kanchan K.; Sharma, Megha; Dhillion, Mandeed Singh; Suar, Mrutyunjay; Chatterjee, Aditi; Pandey, Akhilesh; Prasad, Thottethodi Subrahmanya Keshava; Gowda, Harsha			Whole Genome Sequencing of Mycobacterium tuberculosis Isolates From Extrapulmonary Sites	OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY			English	Article						coding DNA sequence; lineage; lymphadenitis; nonsynonymous; octal code	MULTIDRUG-RESISTANT TUBERCULOSIS; EXTRA-PULMONARY TUBERCULOSIS; COMPENSATORY MUTATIONS; RIFAMPICIN RESISTANCE; DRUG-RESISTANCE; COMPLEX STRAINS; VIRULENCE; TOOL; EVOLUTION; GENE	Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide. Extrapulmonary tuberculosis (EPTB) constitutes around 15-20% of TB cases in immunocompetent individuals. Extrapulmonary sites that are affected by TB include bones, lymph nodes, meningitis, pleura, and genitourinary tract. Whole genome sequencing has emerged as a powerful tool to map genetic diversity among Mycobacterium tuberculosis (MTB) isolates and identify the genomic signatures associated with drug resistance, pathogenesis, and disease transmission. Several pulmonary isolates of MTB have been sequenced over the years. However, availability of whole genome sequences of MTB isolates from extrapulmonary sites is limited. Some studies suggest that genetic variations in MTB might contribute to disease presentation in extrapulmonary sites. This can be addressed if whole genome sequence data from large number of extrapulmonary isolates becomes available. In this study, we have performed whole genome sequencing of five MTB clinical isolates derived from EPTB sites using next generation sequencing platform. We identified 1434 nonsynonymous single nucleotide variations (SNVs), 143 insertions and 105 deletions. This includes 279 SNVs that were not reported before in publicly available datasets. We found several mutations that are known to confer resistance to drugs. All the five isolates belonged to EastAfrican-Indian lineage (lineage 3). We identified 9 putative prophage DNA integrations and 14 predicted clustered regularly interspaced short palindromic repeats (CRISPR) in MTB genome. Our analysis indicates that more work is needed to map the genetic diversity of MTB. Whole genome sequencing in conjunction with comprehensive drug susceptibility testing can reveal clinically relevant mutations associated with drug resistance.	[Sharma, Kusum; Ray, Pallab; Sharma, Megha] PGIMER, Dept Med Microbiol, Sect 12, Chandigarh 160012, India; [Verma, Renu; Advani, Jayshree; Chatterjee, Oishi; Solanki, Hitendra S.; Chatterjee, Aditi; Pandey, Akhilesh; Prasad, Thottethodi Subrahmanya Keshava; Gowda, Harsha] Inst Bioinformat, 7th Floor,Discoverer Bldg,Int Technol Pk, Bangalore 560066, Karnataka, India; [Verma, Renu; Solanki, Hitendra S.] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Advani, Jayshree] Manipal Univ, Manipal, India; [Chatterjee, Oishi] Amrita Vishwa Vidyapeetham, Sch Biotechnol, Kollam, India; [Sharma, Aman; Varma, Subhash] PGIMER, Dept Internal Med, Chandigarh, India; [Modi, Manish] PGIMER, Dept Neurol, Chandigarh, India; [Mukherjee, Kanchan K.] PGIMER, Dept Neurosurg, Chandigarh, India; [Dhillion, Mandeed Singh] PGIMER, Dept Orthoped, Chandigarh, India; [Chatterjee, Aditi; Prasad, Thottethodi Subrahmanya Keshava; Gowda, Harsha] YU IOB Ctr Syst Biol & Mol Med, Mangalore, India; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Prasad, Thottethodi Subrahmanya Keshava] Natl Inst Mental Hlth & Neurosci, Neurobiol Res Ctr, NIMHANS IOB Prote & Bioinformat Lab, Bangalore, Karnataka, India	Sharma, K (reprint author), PGIMER, Dept Med Microbiol, Sect 12, Chandigarh 160012, India.; Prasad, TSK (reprint author), Inst Bioinformat, 7th Floor,Discoverer Bldg,Int Technol Pk, Bangalore 560066, Karnataka, India.; Gowda, H (reprint author), Inst Bioinformat, 7th Floor,Discoverer Bldg,Int Tech Pk, Bangalore 560066, Karnataka, India.	sharmakusum9@yahoo.co.in; keshav@ibioinformatics.org; harsha@ibioinformatics.org		Verma, Renu/0000-0003-1277-8824	Department of Science and Technology (DST)-IDP research grant "Development of epitope based diagnostic gadget for detection of MTB in the Indian population'' from the DST, Government of India; HRTP-NIH (HIV Research Training Program); New York University's School of Medicine, New York University under HRTP-NIH; Infosys Foundation; University Grants Commission (UGC), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India; DST, Government of India	T.S.K.P. is the recipient of the Department of Science and Technology (DST)-IDP research grant "Development of epitope based diagnostic gadget for detection of MTB in the Indian population'' from the DST, Government of India. K.S. is thankful to HRTP-NIH (HIV Research Training Program) for financial support in the form of 3 months fellowship for learning the analysis of whole genome sequencing (WGS) at Johns Hopkins University. K.S. acknowledges the financial support to New York University's School of Medicine, New York University under HRTP-NIH for 3 months fellowship.; We thank the Infosys Foundation for research support to the Institute of Bioinformatics. R.V. is a recipient of Senior Research Fellowship from University Grants Commission (UGC), Government of India. J.A. is a recipient of Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), Government of India. O.C. is a recipient of INSPIRE Fellowship from the DST, Government of India.	Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117771; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Banuls AL, 2015, J MED MICROBIOL, V64, P1261, DOI 10.1099/jmm.0.000171; Bhuwan M, 2016, MBIO, V7, DOI 10.1128/mBio.02259-15; Brandis G, 2013, J ANTIMICROB CHEMOTH, V68, P2493, DOI 10.1093/jac/dkt224; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chernyaeva EN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-308; Choo SW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04061; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159                                                                   ; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Das S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-404; David S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140625; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; Lorenzo G, 2005, J INFECT DIS, V192, P2059, DOI DOI 10.1086/498245.PUBMED:16288368; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507                                                          ; Faksri K, 2011, TUBERCULOSIS, V91, P594, DOI 10.1016/j.tube.2011.08.005; Fanning A, 1999, CAN MED ASSOC J, V160, P1597; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963.1970.2003; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Friedman CR, 1997, J INFECT DIS, V176, P478, DOI 10.1086/514067                                                                  ; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6                                                   ; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; GOREN MB, 1978, AM REV RESPIR DIS, V118, P151; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784; Kansal RG, 1998, MICROB PATHOGENESIS, V25, P203, DOI 10.1006/mpat.1998.0227; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martinez A, 1999, J BACTERIOL, V181, P7331; Massi MN, 2017, J ORTHOP, V14, P189, DOI 10.1016/j.jor.2016.12.003; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meghdadi H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00675; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miotto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051950; NATHAVITHARANA RR, 2017, EUR RESP J, V49; Oki Noffisat O, 2011, BMC Res Notes, V4, P28, DOI 10.1186/1756-0500-4-28; Peng LX, 2014, J IND MICROBIOL BIOT, V41, P1677, DOI 10.1007/s10295-014-1507-3; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saeed M, 2017, J PAK MED ASSOC, V67, P270; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Shemyakin IG, 2004, INT J TUBERC LUNG D, V8, P1194; Song TY, 2009, RNA BIOL, V6, P254, DOI 10.4161/rna.6.3.8371                                                            ; Srilohasin P, 2014, J CLIN MICROBIOL, V52, P4267, DOI 10.1128/JCM.01467-14; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; Tso HW, 2005, GENES IMMUN, V6, P358, DOI 10.1038/sj.gene.6364189; van Soolingen Dick, 2016, Int J Mycobacteriol, V5 Suppl 1, pS60, DOI 10.1016/j.ijmyco.2016.10.036; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6                                                   ; Wong KC, 2007, CLIN VACCINE IMMUNOL, V14, P1279, DOI 10.1128/CVI.00190-07; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	66	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1536-2310	1557-8100		OMICS	OMICS	JUL	2017	21	7					413	425		10.1089/omi.2017.0070				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FA0BW	WOS:000405096900007	28692415				2018-01-05	
J	Xu, Y; Liu, SS; Liu, YQ; Ling, S; Chen, CS; Yao, JL				Xu, Ya; Liu, Shasha; Liu, Yaqin; Ling, Sheng; Chen, Caisheng; Yao, Jialing			HOTHEAD-Like HTH1 is Involved in Anther Cutin Biosynthesis and is Required for Pollen Fertility in Rice	PLANT AND CELL PHYSIOLOGY			English	Article						Anther development; Cuticle; Cutin; HOTHEAD; Pollen fertility	FATTY-ACIDS; SHOOT DEVELOPMENT; EXINE FORMATION; ORGAN FUSION; ARABIDOPSIS; ENCODES; TRANSPORTER; GENE; WALL; CYTOCHROME-P450	The cuticle covering the outer surface of anthers is essential for male reproductive development in plants. However, the mechanism underlying the synthesis of these lipidic polymers remains unclear. HOTHEAD (HTH) in Arabidopsis thaliana is a presumptive glucose-methanol-choline (GMC) oxidoreductase involved in the biosynthesis of long-chain alpha-, omega-dicarboxylic fatty acids. In this study, we characterized the function of an anther-specific gene HTH1 in rice. HTH1 contains a conserved GMC oxidoreductase-like domain, and the sequence of HTH1 was highly similar to that of HTH in A. thaliana. Quantitative real-time PCR (qRT-PCR) and in situ hybridization analyses showed that HTH1 was highly expressed in epidermal cells of anthers. Rice plants with HTH1 suppression through CRISPR (clustered regularly interspaced short palindromic repeats) and RNA interference (RNAi) displayed defective anther wall and aborted pollen. Disorganized cuticle layers in anthers and shriveled pollen grains were observed in HTH1-RNAi lines. The total amounts of long-chain fatty acids and cutin monomers in anthers of HTH1-RNAi lines were significantly reduced compared with the wild type. Our results suggested that HTH1 is involved in cutin biosynthesis and is required for anther development and pollen fertility in rice.	[Xu, Ya; Liu, Shasha; Liu, Yaqin; Ling, Sheng; Chen, Caisheng; Yao, Jialing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Yao, JL (reprint author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	yaojlmy@mail.hzau.edu.cn			National Natural Science Foundation of China [31570321]	This research was supported by the National Natural Science Foundation of China [grant No. 31570321]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115; Akiba T, 2014, PLANT CELL PHYSIOL, V55, P42, DOI 10.1093/pcp/pct154; Bonaventure G, 2004, PLANT J, V40, P920, DOI 10.1111/j.1365-313X.2004.02258.x; Cavener D. R., 1992, MOL BIOL, V223, P811; de Halac IN, 2003, BIOCELL, V27, P11; Dominguez E, 2015, TRENDS PLANT SCI, V20, P551, DOI 10.1016/j.tplants.2015.05.009; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6                                                   ; Fang YX, 2015, J INTEGR PLANT BIOL, V57, P151, DOI 10.1111/jipb.12230; Franke R, 2005, PHYTOCHEMISTRY, V66, P2643, DOI 10.1016/j.phytochem.2005.09.027; Heredia A, 2003, BBA-GEN SUBJECTS, V1620, P1, DOI 10.1016/S0304-4165(02)00510-X; HOLMQUIST B, 1991, BIOCHEM BIOPH RES CO, V178, P1371, DOI 10.1016/0006-291X(91)91045-E; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; Krolikowski KA, 2003, PLANT J, V35, P501, DOI 10.1046/j.1365-313X.2003.01824.x; Kurdyukov S, 2006, PLANTA, V224, P315, DOI 10.1007/s00425-005-0215-7; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; Le Bouquin R, 2001, EUR J BIOCHEM, V268, P3083, DOI 10.1046/j.1432-1327.2001.02207.x; Li H, 2010, PLANT SIGNAL BEHAV, V5, P1121, DOI 10.4161/psb.5.9.12562; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Li YH, 2007, P NATL ACAD SCI USA, V104, P18339, DOI 10.1073/pnas.0706984104; Lopez-Casado G, 2007, J EXP BOT, V58, P3875, DOI 10.1093/jxb/erm233; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Moon S, 2013, PLANT PHYSIOL, V161, P663, DOI 10.1104/pp.112.210948; Morant M, 2003, CURR OPIN BIOTECH, V14, P355, DOI 10.1016/S0958-1669(03)00072-7; Muller C, 2005, J CHEM ECOL, V31, P2621, DOI 10.1007/s10886-005-7617-7; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; Niu BX, 2013, J INTEGR PLANT BIOL, V55, P710, DOI 10.1111/jipb.12053; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Qin P, 2013, PLANT CELL PHYSIOL, V54, P138, DOI 10.1093/pcp/pcs162; Samuels L, 2005, PLANT BIOSYST, V139, P65, DOI 10.1080/11263500500059868; Shi JX, 2015, TRENDS PLANT SCI, V20, P741, DOI 10.1016/j.tplants.2015.07.010; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Twell D, 2006, NAT CELL BIOL, V8, P14, DOI 10.1038/ncb0106-14; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wu LN, 2014, PLANT CELL REP, V33, P1881, DOI 10.1007/s00299-014-1666-8; Xu DW, 2017, PLANT PHYSIOL, V173, P240, DOI 10.1104/pp.16.00095; Yang XJ, 2014, J INTEGR PLANT BIOL, V56, P979, DOI 10.1111/jipb.12212; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Zhang DB, 2011, J GENET GENOMICS, V38, P379, DOI 10.1016/j.jgg.2011.08.001; Zhao GC, 2015, PLANT PHYSIOL, V169, P2064, DOI 10.1104/pp.15.00262; Zhu L, 2013, J PLANT BIOL, V56, P59, DOI 10.1007/s12374-013-0902-z	44	0	0	10	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	JUL	2017	58	7			SI		1238	1248		10.1093/pcp/pcx063				11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	FA4QX	WOS:000405429400011	28838125				2018-01-05	
J	Aznar-Moreno, JA; Durrett, TP				Aznar-Moreno, J. A.; Durrett, T. P.			Simultaneous Targeting of Multiple Gene Homeologs to Alter Seed Oil Production in Camelina sativa	PLANT AND CELL PHYSIOLOGY			English	Article						Camelina; CRISPR/Cas; Diacylglycerol acyltransferase (DGAT1); Oil seeds; Phospholipid:diacylglycerol acyltransferase (PDAT1); Triacylglycerol (TAG)	FATTY-ACID ACCUMULATION; DIACYLGLYCEROL ACYLTRANSFERASE; ARABIDOPSIS-THALIANA; TRIACYLGLYCEROL BIOSYNTHESIS; REDUCED-VISCOSITY; FIELD PRODUCTION; OILSEED CROPS; GENOME; PLANTS; IDENTIFICATION	The ability to transform Camelina sativa easily with biosynthetic enzymes derived from other plants has made this oil seed crop an ideal platform for the production of unusual lipids valuable for different applications. However, in addition to expressing transgenic enzymes, the suppression of endogenous enzyme activity to reduce competition for common substrates or cofactors is also required to enhance the production of target compounds. As camelina possesses a relatively undifferentiated hexaploid genome, up to three gene homeologs can code for any particular enzymatic activity, complicating efforts to alter endogenous biosynthetic pathways. New genome editing technologies, such as that offered by the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein) system, offer the capability to introduce mutations into specifically targeted genomic sites. Here, by using a carefully designed guide RNA identical to all three homeologs, we demonstrate the ability of the CRISPR/Cas genome editing system to introduce mutations in all three CsDGAT1 or CsPDAT1 homeologous genes important for triacylglycerol (TAG) synthesis in developing seeds. Sequence analysis from transgenic T-1 plants revealed that each CsDGAT1 or each CsPDAT1 homeolog was altered by multiple mutations, resulting in a genetic mosaic in the plants. Interestingly, seed harvested from both CsDGAT1- and CsPDAT1-targeted lines was often shrunken and wrinkled. Further, lipid analysis revealed that many lines produced seed with reduced oil content and altered fatty acid composition, consistent with the role of the targeted genes in seed oil biosynthesis. The CRISPR/Cas system therefore represents a useful method to alter endogenous biosynthetic pathways efficiently in polyploid species such as camelina.	[Aznar-Moreno, J. A.; Durrett, T. P.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Durrett, TP (reprint author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	tdurrett@ksu.edu	Aznar-Moreno, Jose/F-9815-2016	Aznar-Moreno, Jose/0000-0002-4474-8710	U.S. Department of Agriculture [2015-67013-22815]	This work was supported by the U.S. Department of Agriculture [under Award Number 2015-67013-22815].	Badami R C, 1980, Prog Lipid Res, V19, P119, DOI 10.1016/0163-7827(80)90002-8; Bansal S, 2016, BIOCHIMIE, V120, P9, DOI 10.1016/j.biochi.2015.06.009; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fan JL, 2013, PLANT J, V76, P930, DOI 10.1111/tpj.12343; Herridge RP, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-3; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; Nguyen HT, 2015, PLANT BIOTECHNOL J, V13, P38, DOI 10.1111/pbi.12233; Iven T, 2016, PLANT BIOTECHNOL J, V14, P252, DOI 10.1111/pbi.12379; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kagale S, 2016, PLANT J, V88, P879, DOI 10.1111/tpj.13302; Kagale S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4706; Kang JL, 2011, PLANT PHYSIOL BIOCH, V49, P223, DOI 10.1016/j.plaphy.2010.12.004; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; Kim HJ, 2015, PLANT J, V84, P1021, DOI 10.1111/tpj.13063; Kim HJ, 2015, J EXP BOT, V66, P4251, DOI 10.1093/jxb/erv225; KLEIMAN R, 1967, LIPIDS, V2, P473, DOI 10.1007/BF02533174                                                              ; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Liu J, 2015, PLANT BIOTECHNOL J, V13, P858, DOI 10.1111/pbi.12325; Liu JJ, 2015, IND CROP PROD, V65, P259, DOI 10.1016/j.indcrop.2014.11.019; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Lu LZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0652-y; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Mhaske V, 2005, PLANT PHYSIOL BIOCH, V43, P413, DOI 10.1016/j.plaphy.2005.01.013; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Nguyen HT, 2013, PLANT BIOTECHNOL J, V11, P759, DOI 10.1111/pbi.12068; Pan X, 2013, J BIOL CHEM, V288, P24173, DOI 10.1074/jbc.M113.475699; Podevin N, 2013, TRENDS BIOTECHNOL, V31, P375, DOI 10.1016/j.tibtech.2013.03.004; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schaeffer SM, 2015, PLANT SCI, V240, P130, DOI 10.1016/j.plantsci.2015.09.011; Snapp AR, 2014, PLANTA, V240, P599, DOI 10.1007/s00425-014-2122-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Erp H, 2015, PLANT PHYSIOL, V168, P36, DOI 10.1104/pp.114.254110; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu P, 2006, PLANT PHYSIOL, V142, P429, DOI 10.1104/pp.106.083295; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhu LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22181; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	47	2	2	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	JUL	2017	58	7			SI		1260	1267		10.1093/pcp/pcx058				8	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	FA4QX	WOS:000405429400013	28444368				2018-01-05	
J	Janga, MR; Campbell, LM; Rathore, KS				Janga, Madhusudhana R.; Campbell, LeAnne M.; Rathore, Keerti S.			CRISPR/Cas9-mediated targeted mutagenesis in upland cotton (Gossypium hirsutum L.)	PLANT MOLECULAR BIOLOGY			English	Article						CRISPR/Cas9; Gene knockout; GFP; Gossypium hirsutum; sgRNAs; Targeted mutagenesis	RNA-GUIDED ENDONUCLEASE; LATER GENERATIONS; GENOME; SYSTEM; PLANTS; CAS9; DNA; MULTIPLEX; EFFICIENT; TOMATO	The clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR associated (Cas)9 protein system has emerged as a simple and efficient tool for genome editing in eukaryotic cells. It has been shown to be functional in several crop species, yet there are no reports on the application of this or any other genome editing technologies in the cotton plant. Cotton is an important crop that is grown mainly for its fiber, but its seed also serves as a useful source of edible oil and feed protein. Most of the commercially-grown cotton is tetraploid, thus making it much more difficult to target both sets of homeologous alleles. Therefore, in order to understand the efficacy of the CRISPR/Cas9 system to target a gene within the genome of cotton, we made use of a transgenic cotton line previously generated in our laboratory that had a single copy of the green fluorescent protein (GFP) gene integrated into its genome. We demonstrate, for the first time, the use of this powerful new tool in targeted knockout of a gene residing in the cotton genome. By following the loss of GFP fluorescence, we were able to observe the cells that had undergone targeted mutations as a result of CRISPR/Cas9 activity. In addition, we provide examples of the different types of indels obtained by Cas9-mediated cleavage of the GFP gene, guided by three independent sgRNAs. The results provide useful information that will help us target important native genes in the cotton plant in future.	[Janga, Madhusudhana R.; Campbell, LeAnne M.; Rathore, Keerti S.] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Rathore, Keerti S.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Rathore, KS (reprint author), Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA.; Rathore, KS (reprint author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	rathore@tamu.edu		Janga, Madhusudhana/0000-0002-3743-6006	Texas A&M AgriLife Research	This research was supported by funding from Texas A&M AgriLife Research.	Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Baysal C, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0533-4; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brazelton VA, 2015, QUICK GUIDE CRISPR S, V6, P266, DOI DOI 10.1080/21645698; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cermak T, 2015, METHODS MOL BIOL, V1239, P133, DOI 10.1007/978-1-4939-1862-1_7; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chaudhry B, 1999, PLANT MOL BIOL REP, V17, P280, DOI 10.1023/A:1007629715971                                                         ; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koonin Eugene V, 2009, F1000 Biol Rep, V1, P95; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li JF, 2015, METHODS MOL BIOL, V1284, P239, DOI 10.1007/978-1-4939-2444-8_12; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21451; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Rathore KS, 2015, METHODS MOL BIOL, V1224, P11, DOI 10.1007/978-1-4939-1658-0_2; Seth K, 2016, BIOCHEM BIOPH RES CO, V480, P499, DOI 10.1016/j.bbrc.2016.10.130; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sunilkumar G, 2002, PLANT MOL BIOL, V50, P463, DOI 10.1023/A:1019832123444; Sunilkumar G, 2001, MOL BREEDING, V8, P37, DOI 10.1023/A:1011906701925; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tang W, 2017, J FORESTRY RES, V28, P15, DOI 10.1007/s11676-016-0281-7; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang W, 2016, BIORXIV, DOI [10.1101/051342, DOI 10.1101/051342]; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Yan R, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0534-3; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617	55	4	4	24	24	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	JUL	2017	94	4-5					349	360		10.1007/s11103-017-0599-3				12	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	FA2SW	WOS:000405292100001	28258551				2018-01-05	
J	Moreno, AM; Mali, P				Moreno, Ana M.; Mali, Prashant			Therapeutic genome engineering via CRISPR-Cas systems	WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE			English	Review							RNA-GUIDED ENDONUCLEASE; ZINC-FINGER NUCLEASES; OFF-TARGET SITES; CELLS IN-VIVO; GENE-THERAPY; LENTIVIRAL VECTORS; MUSCULAR-DYSTROPHY; STREPTOCOCCUS-THERMOPHILUS; HOMOLOGOUS RECOMBINATION; CELLULAR-IMMUNITY	Differences in genomes underlie most organismal diversity, and aberrations in genomes underlie many disease states. With the growing knowledge of the genetic and pathogenic basis of human disease, development of safe and efficient platforms for genome and epigenome engineering will transform our ability to therapeutically target human diseases and also potentially engineer disease resistance. In this regard, the recent advent of clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) RNA-guided nuclease systems have transformed our ability to target nucleic acids. Here we review therapeutic genome engineering applications with a specific focus on the CRISPR-Cas toolsets. We summarize past and current work, and also outline key challenges and future directions. (C) 2017 Wiley Periodicals, Inc.	[Moreno, Ana M.; Mali, Prashant] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA	Mali, P (reprint author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.	pmali@ucsd.edu			UCSD; Burroughs Wellcome Fund; March of Dimes Foundation; Kimmel Foundation; CONACYT; University of California Institute for Mexico; United States	PM acknowledges UCSD startup funds, the Burroughs Wellcome Fund, the March of Dimes Foundation, and the Kimmel Foundation for generous support of this work. AM acknowledges a graduate fellowship from CONACYT and the University of California Institute for Mexico and the United States.	Anson D.S., 2004, GENET VACCINES THER, V2, P9, DOI DOI 10.1186/1479-0556-2-9; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898                                                          ; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715; KATSUMI A, 1994, HUM GENE THER, V5, P1335, DOI 10.1089/hum.1994.5.11-1335; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P193, DOI 10.1016/j.nano.2005.06.004; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Miyoshi H, 1998, J VIROL, V72, P8150; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Persons DA, 2010, MOL THER, V18, P861, DOI 10.1038/mt.2010.70; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; PICKERING JG, 1994, CIRCULATION, V89, P13; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rothe M, 2013, CURR GENE THER, V13, P453; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; White MK, 2015, DISCOV MED, V19, P255; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183                                                ; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407                                                         ; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	116	2	2	17	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-5094	1939-005X		WIRES SYST BIOL MED	Wiley Interdiscip. Rev.-Syst. Biol	JUL-AUG	2017	9	4							UNSP e1380	10.1002/wsbm.1380				14	Medicine, Research & Experimental	Research & Experimental Medicine	FA0DO	WOS:000405101500003					2018-01-05	
J	Gray, BN; Spruill, WM				Gray, Benjamin N.; Spruill, W. Murray			CRISPR-Cas9 claim sets and the potential to stifle innovation	NATURE BIOTECHNOLOGY			English	Article							SYSTEMS; CAS9		[Gray, Benjamin N.; Spruill, W. Murray] Benson Hill Biosyst, Durham, NC 27713 USA	Spruill, WM (reprint author), Benson Hill Biosyst, Durham, NC 27713 USA.	mspruill@bensonhillbio.com					Broad, 2016, Reply 5, Patent Interference No, Patent No. [106,048, 106048]; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Levine HW, 1998, NAT BIOTECHNOL, V16, P87, DOI 10.1038/nbt0198-87; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Noman A., 2016, FRONT PLANT SCI, P1740; Pollack A., 2017, NY TIMES, pB3; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sanders R., 2017, BERKELEY NEWS; Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007; [Anonymous], 2015, US Patent Application No, Patent No. [13/ 842,859, 13842859]; [Anonymous], 2015, MANUAL PATENT EXAMIN; [Anonymous], US Patent No, Patent No. [8,697,359, 8697359]; [Anonymous], 2017, Judgment, Patent Interference No, Patent No. [106,048, 106048]	18	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2017	35	7					630	+						5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FA2ZJ	WOS:000405310300011	28700549				2018-01-05	
J	Ajjawi, I; Verruto, J; Aqui, M; Soriaga, LB; Coppersmith, J; Kwok, K; Peach, L; Orchard, E; Kalb, R; Xu, WD; Carlson, TJ; Francis, K; Konigsfeld, K; Bartalis, J; Schultz, A; Lambert, W; Schwartz, AS; Brown, R; Moellering, ER				Ajjawi, Imad; Verruto, John; Aqui, Moena; Soriaga, Leah B.; Coppersmith, Jennifer; Kwok, Kathleen; Peach, Luke; Orchard, Elizabeth; Kalb, Ryan; Xu, Weidong; Carlson, Tom J.; Francis, Kristie; Konigsfeld, Katie; Bartalis, Judit; Schultz, Andrew; Lambert, William; Schwartz, Ariel S.; Brown, Robert; Moellering, Eric R.			Lipid production in Nannochloropsis gaditana is doubled by decreasing expression of a single transcriptional regulator	NATURE BIOTECHNOLOGY			English	Article							RNA-SEQ; CHLAMYDOMONAS-REINHARDTII; YARROWIA-LIPOLYTICA; GENOME; MICROALGAE; OIL; ACCUMULATION; METABOLISM; PERFORMANCE; MECHANISMS	Lipid production in the industrial microalga Nannochloropsis gaditana exceeds that of model algal species and can be maximized by nutrient starvation in batch culture. However, starvation halts growth, thereby decreasing productivity. Efforts to engineer N. gaditana strains that can accumulate biomass and overproduce lipids have previously met with little success. We identified 20 transcription factors as putative negative regulators of lipid production by using RNA-seq analysis of N. gaditana during nitrogen deprivation. Application of a CRISPR-Cas9 reverse-genetics pipeline enabled insertional mutagenesis of 18 of these 20 transcription factors. Knocking out a homolog of fungal Zn(II)(2)Cys(6)-encoding genes improved partitioning of total carbon to lipids from 20% (wild type) to 40-55% (mutant) in nutrient-replete conditions. Knockout mutants grew poorly, but attenuation of Zn(II)(2)Cys(6) expression yielded strains producing twice as much lipid (similar to 5.0 g m(-2) d(-1)) as that in the wild type (similar to 2.5 g m(-2) d(-1)) under semicontinuous growth conditions and had little effect on growth.	[Ajjawi, Imad; Verruto, John; Aqui, Moena; Soriaga, Leah B.; Coppersmith, Jennifer; Kwok, Kathleen; Peach, Luke; Orchard, Elizabeth; Kalb, Ryan; Xu, Weidong; Carlson, Tom J.; Francis, Kristie; Konigsfeld, Katie; Bartalis, Judit; Schultz, Andrew; Lambert, William; Schwartz, Ariel S.; Brown, Robert; Moellering, Eric R.] Synthet Genom Inc, La Jolla, CA 92037 USA	Ajjawi, I (reprint author), Synthet Genom Inc, La Jolla, CA 92037 USA.	iajjawi@syntheticgenomics.com; emoeller@syntheticgenomics.com			ExxonMobil; Synthetic Genomics, Inc.	This work was funded by ExxonMobil and Synthetic Genomics, Inc. We thank A. Withrow (Center for Advanced Microscopy at Michigan State University) for producing the TEM images and C. Packard, B. Scherer, E. Wang and the rest of the analytical team at SGI for processing FAME and TOC samples. This work is dedicated to our colleague Tom Carlson, who passed away during the preparation of this manuscript.	Biddy MJ, 2016, ACS SUSTAIN CHEM ENG, V4, P3196, DOI 10.1021/acssuschemeng.6b00243; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUSSIBA S, 1987, BIOMASS, V12, P37, DOI 10.1016/0144-4565(87)90006-0                                                    ; Cerutti H, 2011, EUKARYOT CELL, V10, P1164, DOI 10.1128/EC.05106-11; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Corteggiani C.E., 2014, MOL PLANT, V7, P323; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; Friedlander J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0492-3; Gargouri M, 2015, J EXP BOT, V66, P4551, DOI 10.1093/jxb/erv217; Goncalves EC, 2016, PLANT BIOTECHNOL J, V14, P1649, DOI 10.1111/pbi.12523; Goold HD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25209; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Hu Jianqiang, 2014, Scientific Reports, V4, P5454; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kaspar H, 2009, THESIS; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531                                                                   ; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Levitan O, 2015, PLANT J, V84, P963, DOI 10.1111/tpj.13052; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Littler MM, 1985, HDB PHYCOLOGICAL MET, P349; Ma XN, 2016, MAR DRUGS, V14, DOI 10.3390/md14040061; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngan CY, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.107, 10.1038/NPLANTS.2015.107]; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Ruiz-Matute AI, 2011, J CHROMATOGR B, V879, P1226, DOI 10.1016/j.jchromb.2010.11.013; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Schulz-Raffelt M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0469-2; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sukenik A, 2009, AQUAT MICROB ECOL, V56, P297, DOI 10.3354/ame01309; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Vasudevan V, 2012, ENVIRON SCI TECHNOL, V46, P2451, DOI 10.1021/es2026399; Vieler A, 2012, PLANT PHYSIOL, V158, P1562, DOI 10.1104/pp.111.193029; Wang QT, 2016, PLANT J, V88, P1071, DOI 10.1111/tpj.13307; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Xiao Y, 2013, BIORESOURCE TECHNOL, V130, P731, DOI 10.1016/j.biortech.2012.11.116; Xu P, 2016, P NATL ACAD SCI USA, V113, P10848, DOI 10.1073/pnas.1607295113; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zienkiewicz K, 2016, BBA-MOL CELL BIOL L, V1861, P1269, DOI 10.1016/j.bbalip.2016.02.008	46	4	4	31	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2017	35	7					647	+		10.1038/nbt.3865				9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FA2ZJ	WOS:000405310300016	28628130				2018-01-05	
J	Sun, YZ; Law, YS; Cheng, SF; Lim, BL				Sun, Yuzhe; Law, Yee-Song; Cheng, Shifeng; Lim, Boon Leong			RNA editing of cytochrome c maturation transcripts is responsive to the energy status of leaf cells in Arabidopsis thaliana	MITOCHONDRION			English	Article						AtPAP2; MORF; Ccm; RNA editing; Cytochrome c	PENTATRICOPEPTIDE REPEAT PROTEIN; PPR PROTEIN; APOCYTOCHROME-C; MESSENGER-RNA; DYW DOMAIN; MITOCHONDRIA; CHLOROPLASTS; COMPLEX; METABOLISM; SEQUENCES	Overexpression of AtPAP2, a phosphatase located on the outer membranes of chloroplasts and mitochondria, leads to higher energy outputs from these organelles. AtPAP2 interacts with seven MORF proteins of the editosome complex. RNA-sequencing analysis showed that the editing degrees of most sites did not differ significantly between OE and WT, except some sites on the transcripts of several cytochrome c maturation (Ccm) genes. Western blotting of 2D BN-PAGE showed that the patterns of CcmF(N1) polypeptides were different between the lines. We proposed that AtPAP2 may influence cytochrome c biogenesis by modulating RNA editing through its interaction with MORF proteins.	[Sun, Yuzhe; Law, Yee-Song; Cheng, Shifeng; Lim, Boon Leong] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Lim, Boon Leong] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Lim, BL (reprint author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	bllim@hku.hk		Law, Yee-Song/0000-0002-5078-5374	Strategic Research Theme on Clean Energy; Seed Fund for Basic Research of the University of Hong Kong [20161119042]; General Research Fund [HKU 772012M]; Innovation and Technology Fund	This work was supported by the Strategic Research Theme on Clean Energy and the Seed Fund for Basic Research (20161119042) of the University of Hong Kong; the General Research Fund (HKU 772012M); and the Innovation and Technology Fund (Funding Support to Partner State Key Laboratories in Hong Kong) of the HKSAR, China.	Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Brehme N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140680; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Carrie C, 2009, FEBS J, V276, P1187, DOI 10.1111/j.1742-4658.2009.06876.x; Chaudhuri S, 1996, EMBO J, V15, P5958; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; Germain A, 2015, PLANT J, V83, P546, DOI 10.1111/tpj.12892; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Glass F, 2015, MOL PLANT, V8, P1466, DOI 10.1016/j.molp.2015.05.008; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Hartel B, 2013, PLANT MOL BIOL, V81, P337, DOI 10.1007/s11103-012-0003-2; Haili N, 2016, PLANT PHYSIOL, V170, P354, DOI 10.1104/pp.15.01591; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2015, J BIOL CHEM, V290, P10136, DOI 10.1074/jbc.M114.631630; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370                                                          ; Hsieh WY, 2015, PLANT PHYSIOL, V168, P490, DOI 10.1104/pp.15.00354; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Law YS, 2015, PLANT PHYSIOL, V169, P1344, DOI 10.1104/pp.15.01115; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang C, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0726-3; Liang C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00922; Liang C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-116; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; Rayapuram N, 2007, J BIOL CHEM, V282, P21015, DOI 10.1074/jbc.M704091200; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Richard-Fogal C, 2010, J MOL BIOL, V401, P350, DOI 10.1016/j.jmb.2010.06.041; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schweiger R., 2014, J VIS EXP; Sechet J, 2015, MOL PLANT, V8, P644, DOI 10.1016/j.molp.2014.12.005; Springer N. M., 2010, COLD SPRING HARB PRO; Sun F, 2015, PLANT J, V84, P283, DOI 10.1111/tpj.12993; Sun F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-752; Sun F, 2012, PLANT SIGNAL BEHAV, V7, P927, DOI 10.4161/psb.20769; Sun F, 2012, NEW PHYTOL, V194, P206, DOI 10.1111/j.1469-8137.2011.04026.x; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Sung TY, 2010, PLANT J, V63, P499, DOI 10.1111/j.1365-313X.2010.04258.x; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Travaglini-Allocatelli C., 2013, SCIENTIFICA, V2013, DOI [10.1155/2013/505714, DOI 10.1155/2013/505714]; Verissimo AF, 2013, J BIOL CHEM, V288, P6272, DOI 10.1074/jbc.M112.440024; Voon C. P., EFFICIENT COOP UNPUB; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Weigel D., 2006, COLD SPRING HARB PRO; WINTZ H, 1991, CURR GENET, V19, P61, DOI 10.1007/BF00362089; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yap A, 2015, PLANT J, V81, P661, DOI 10.1111/tpj.12756; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Zehrmann A, 2015, J BIOL CHEM, V290, P6445, DOI 10.1074/jbc.M114.602086; Zhang HD, 2015, PHOTOSYNTH RES, V126, P311, DOI 10.1007/s11120-015-0171-4; Zhang RS, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1239687; Zhu Q, 2014, MOL PLANT, V7, P290, DOI 10.1093/mp/sst102; Zhu Q, 2012, PLANT J, V71, P836, DOI 10.1111/j.1365-313X.2012.05036.x	67	0	0	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	JUL	2017	35						23	34		10.1016/j.mito.2017.04.006				12	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	EZ9QK	WOS:000405064700004	28478183	gold			2018-01-05	
J	Alcon, P; Montoya, G; Stella, S				Alcon, Pablo; Montoya, Guillermo; Stella, Stefano			Assembly of Francisella novicida Cpf1 endonuclease in complex with guide RNA and target DNA	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						crystallization; protein-DNA interaction; protein-RNA interaction; data collection; genome editing; CRISPR-Cas	CRISPR RNA; NUCLEASES; IMMUNITY; TOOLBOX; SYSTEMS	Bacteria and archaea use the CRISPR-Cas system as an adaptive response against infection by foreign nucleic acids. Owing to its remarkable flexibility, this mechanism has been harnessed and adopted as a powerful tool for genome editing. The CRISPR-Cas system includes two classes that are subdivided into six types and 19 subtypes according to conservation of the cas gene and loci organization. Recently, a new protein with endonuclease activity belonging to class 2 type V has been identified. This endonuclease, termed Cpf1, in complex with a single CRISPR RNA (crRNA) is able to recognize and cleave a target DNA preceded by a 50-TTN-3' protospacer-adjacent motif (PAM) complementary to the RNA guide. To obtain structural insight into the inner workings of Cpf1, the crystallization of an active complex containing the full extent of the crRNA and a 31-nucleotide dsDNA target was attempted. The gene encoding Cpf1 from Francisella novicida was cloned, overexpressed and purified. The crRNA was transcribed and purified in vitro. Finally, the ternary FnCpf1-crRNA-DNA complex was assembled and purified by preparative electrophoresis before crystallization. Crystals belonging to space group C2221, with unit-cell parameters a = 85.2, b = 137.6, c = 320.5 angstrom, were obtained and subjected to preliminary diffraction experiments.	[Alcon, Pablo; Montoya, Guillermo; Stella, Stefano] Univ Copenhagen, Fac Hlth & Med Sci, Prot Struct & Funct Programme, Novo Nordisk Fdn,Ctr Prot Res, Blegdamsvej 3b, DK-2200 Copenhagen, Denmark	Montoya, G; Stella, S (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Prot Struct & Funct Programme, Novo Nordisk Fdn,Ctr Prot Res, Blegdamsvej 3b, DK-2200 Copenhagen, Denmark.	guillermo.montoya@cpr.ku.dk; stefano.stella@cpr.ku.dk			Novo Nordisk Foundation [NNF14CC0001]	The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (Grant NNF14CC0001).	Cunningham L, 1996, NUCLEIC ACIDS RES, V24, P3647, DOI 10.1093/nar/24.18.3647; Dauter Z, 1999, ACTA CRYSTALLOGR D, V55, P1703, DOI 10.1107/S0907444999008367; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	21	1	1	5	5	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	JUL	2017	73		7				409	415		10.1107/S2053230X1700838X				7	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	EZ8FJ	WOS:000404959800007	28695850	gold			2018-01-05	
J	Giuliano, AE; Connolly, JL; Edge, SB; Mittendorf, EA; Rugo, HS; Solin, LJ; Weaver, DL; Winchester, DJ; Hortobagyi, GN				Giuliano, Armando E.; Connolly, James L.; Edge, Stephen B.; Mittendorf, Elizabeth A.; Rugo, Hope S.; Solin, Lawrence J.; Weaver, Donald L.; Winchester, David J.; Hortobagyi, Gabriel N.			Breast Cancer-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual	CA-A CANCER JOURNAL FOR CLINICIANS			English	Article						biomarkers; distant metastases; ductal carcinoma in situ; estrogen receptor; human epidermal growth receptor 1 (HER2); infiltrating ductal carcinoma; infiltrating lobular carcinoma; lobular carcinoma in situ; lymph node metastases; neoadjuvant chemotherapy	LYMPH-NODE RATIO; TERM-FOLLOW-UP; 70-GENE SIGNATURE; CONCORDANCE; PROGNOSIS; DECISIONS; SURVIVAL; SOCIETY; ASSAY	The revision of the eighth edition of the primary tumor, lymph node, and metastasis (TNM) classification of the American Joint Commission of Cancer (AJCC) for breast cancer was determined by a multidisciplinary team of breast cancer experts. The panel recognized the need to incorporate biologic factors, such as tumor grade, proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression prognostic panels into the staging system. AJCC levels of evidence and guidelines for all tumor types were followed as much as possible. The panel felt that, to maintain worldwide value, the tumor staging system should remain based on TNM anatomic factors. However, the recognition of the prognostic influence of grade, hormone receptor expression, and HER2 amplification mandated their inclusion into the staging system. The value of commercially available, gene-based assays was acknowledged and prognostic input added. Tumor biomarkers and low Oncotype DX recurrence scores can alter prognosis and stage. These updates are expected to provide additional precision and flexibility to the staging system and were based on the extent of published information and analysis of large, as yet unpublished databases. The eighth edition of the AJCC TNM staging system, thus, provides a flexible platform for prognostic classification based on traditional anatomic factors, which can be modified and enhanced using patient biomarkers and multifactorial prognostic panel data. The eighth edition remains the worldwide basis for breast cancer staging and will incorporate future online updates to remain timely and relevant. (C) 2017 American Cancer Society.	[Giuliano, Armando E.] Cedars Sinai Med Ctr, Surg, 310 N San Vicente Blvd,Third Floor, Los Angeles, CA 90048 USA; [Giuliano, Armando E.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, 310 N San Vicente Blvd,Third Floor, Los Angeles, CA 90048 USA; [Connolly, James L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Pathol, Boston, MA USA; [Edge, Stephen B.] Roswell Pk Canc Inst, Healthcare Outcomes & Policy, Buffalo, NY 14263 USA; [Mittendorf, Elizabeth A.] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA; [Rugo, Hope S.] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA; [Rugo, Hope S.] Univ Calif San Francisco, Breast Oncol & Clin Trials Educ, San Francisco, CA 94143 USA; [Solin, Lawrence J.] Albert Einstein Healthcare Network, Dept Radiat Oncol, Philadelphia, PA USA; [Weaver, Donald L.] Univ Vermont, Pathol, Burlington, VT USA; [Winchester, David J.] NorthShore Univ HealthSyst, Kellogg Canc Surg Serv, Evanston, IL USA; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Breast Canc Res Program, Houston, TX 77030 USA	Giuliano, AE (reprint author), Cedars Sinai Med Ctr, Surg, 310 N San Vicente Blvd,Third Floor, Los Angeles, CA 90048 USA.; Giuliano, AE (reprint author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, 310 N San Vicente Blvd,Third Floor, Los Angeles, CA 90048 USA.	armando.giuliano@cshs.org			GlaxoSmithKline; Genetech/Roche; Novartis Pharmaceuticals Corporation; Lilly USA LLC; Macrogenics; OBI; Pfizer Inc; Merck Company; Eisai; Amgen; Plexxikon	Hope S. Rugo reports being on the Speakers Bureau for Genomic Health, and reports grants from GlaxoSmithKline; Genetech/Roche; Novartis Pharmaceuticals Corporation; Lilly USA LLC; Macrogenics; OBI; Pfizer Inc; Merck & Company; Eisai; Amgen; and Plexxikon for funding to the University of California Regents. Lawrence J. Solin is a member of the Genomic Health Inc advisory board but is unpaid for his services. Gabriel N. Hortobagyi reports personal fees from Agendia; F. Hoffman-La Roche, Ltd; Lilly USA, LLC; Peregrine Pharmaceuticals, Inc; Merck & Company; Novartis Pharmaceuticals Corporation; Bayer HealthCare Pharmaceuticals; Metastat; Celgene Corporation; Pfizer Inc; and Antigen Express, outside the submitted work. Dr. Hortobagyi also chairs the Agendia Scientific Advisory Board. The remaining authors report no conflicts of interest.	Ahn SH, 2011, BREAST CANCER RES TR, V130, P507, DOI 10.1007/s10549-011-1730-9; AJCC, 2017, AJCC CANC STAGING MA; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Bagaria SP, 2014, JAMA SURG, V149, P125, DOI 10.1001/jamasurg.2013.3181; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Chagpar AB, 2011, ANN SURG ONCOL, V18, P3143, DOI 10.1245/s10434-011-2012-9; Danko ME, 2010, J AM COLL SURGEONS, V210, P797, DOI 10.1016/j.jamcollsurg.2010.02.045; Drukker CA, 2014, BREAST CANCER RES TR, V145, P697, DOI 10.1007/s10549-014-2954-2; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Duraker N, 2013, WORLD J SURG, V37, P1241, DOI 10.1007/s00268-013-1965-1; Duraker N, 2011, BREAST J, V17, P47, DOI 10.1111/j.1524-4741.2010.01032.x; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x                                              ; Gluz O, 2016, J CLIN ONCOL, V34, P2341, DOI 10.1200/JCO.2015.63.5383; Greene F, 2010, J AM COLL SURGEONS, V210, P805; Harris LN, 2016, J CLIN ONCOL, V34, P1134, DOI 10.1200/JCO.2015.65.2289; National Comprehensive Cancer Network, 2016, NCCN CLIN PRACT GUID; Polley MYC, 2015, MODERN PATHOL, V28, P778, DOI 10.1038/modpathol.2015.38; Rezo A, 2011, BREAST, V20, P259, DOI 10.1016/j.breast.2011.01.005; Shak S, 2015, 2015 SAN ANT BREAST; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Stemmer S, 2015, 2015 EUR CANC C SEPT; Stemmer SM, 2015, 2015 SAN ANT BREAST; Yi M, 2011, J CLIN ONCOL, V29, P4654, DOI 10.1200/JCO.2011.38.3174	25	12	12	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-9235	1542-4863		CA-CANCER J CLIN	CA-Cancer J. Clin.	JUL-AUG	2017	67	4					291	303		10.3322/caac.21393				13	Oncology	Oncology	EZ8KD	WOS:000404973500005	28294295				2018-01-05	
J	Chen, J; Crutchley, J; Zhang, DD; Owzar, K; Kastan, MB				Chen, Jing; Crutchley, John; Zhang, Dadong; Owzar, Kouros; Kastan, Michael B.			Identification of a DNA Damage-Induced Alternative Splicing Pathway That Regulates p53 and Cellular Senescence Markers	CANCER DISCOVERY			English	Article							MESSENGER-RNA TRANSLATION; RIBOSOMAL-PROTEIN L26; ATM KINASE; IONIZING-RADIATION; CHILDHOOD-CANCER; GENE-EXPRESSION; ADULT SURVIVORS; PROBE LEVEL; P53-BETA; ISOFORMS	Cellular responses to DNA damage are critical determinants of cancer development and aging-associated pathogenesis. Here, we identify and characterize a DNA-damage response (DDR) pathway that regulates alternative splicing of numerous gene products, including the human tumor suppressor TP53, and controls DNA damage-induced cellular senescence. In brief, ionizing radiation (IR) inhibits the activity of SMG1, a phosphoinositide-3-kinase-like kinase family member, reducing the binding of SMG1 to a specific region near exon 9 of p53 precursor mRNA and promoting the binding of ribosomal protein L26 (RPL26) to p53 pre-mRNA. RPL26, in turn, is required for the recruitment of the serine/arginine-rich splicing factor SRSF7 to p53 pre-mRNA and generation of alternatively spliced p53 beta RNA. Disruption of this pathway via selective knockout of p53 beta by CRISPR/Cas9 or downregulation of pathway constituents significantly reduces IR-induced senescence markers, and cells lacking p53 beta expression fail to transcriptionally repress negative regulators of cellular senescence and aging. SIGNIFICANCE: We identified a new component of the DDR pathway that regulates alternative splicing of messenger RNAs, including human TP53 mRNA. Modulation of this regulatory pathway affects DNA-damage induction of cellular senescence markers. (C) 2017 AACR.	[Chen, Jing; Crutchley, John; Kastan, Michael B.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Chen, Jing; Crutchley, John; Zhang, Dadong; Owzar, Kouros; Kastan, Michael B.] Duke Univ, Duke Canc Inst, Durham, NC USA; [Owzar, Kouros] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA	Kastan, MB (reprint author), Duke Univ, Sch Med, Mail Box 3917,10 Bryan Searle Dr, Durham, NC 27710 USA.	michael.kastan@duke.edu			NIH [R01ES005777, P30CA014236]	This work was supported by grants R01ES005777 and P30CA014236 from the NIH.	Abraham RT, 2004, DNA REPAIR, V3, P919, DOI 10.1016/j.dnarep.2004.04.003; Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bourdon JC, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.969136; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carlson M., GO DB SET ANNOTATION; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Graupner V, 2009, CELL CYCLE, V8, P1238, DOI 10.4161/cc.8.8.8251                                                             ; Guo KX, 2014, J BIOMOL SCREEN, V19, P538, DOI 10.1177/1087057113520325; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249                                                   ; Joruiz SM, 2016, COLD SPRING HARB PER, V6, P1; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764                                                         ; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lopez-Diaz FJ, 2013, MOL CELL, V50, P552, DOI 10.1016/j.molcel.2013.04.029; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Marcel V, 2014, CELL DEATH DIFFER, V21, P1377, DOI 10.1038/cdd.2014.73; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Margalit O, 2006, BLOOD, V107, P1599, DOI 10.1182/blood-2005-04-1629; Mills AA, 2005, GENE DEV, V19, P2091, DOI 10.1101/gad.1362905; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Muller-McNicoll M, 2016, GENE DEV, V30, P553, DOI 10.1101/gad.276477.115; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; O'Sullivan B, 2003, SEMIN RADIAT ONCOL, V13, P274, DOI 10.1016/S1053-4296(03)00037-7; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; R Core Team, 2016, R LANG ENV STAT COMP; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Tejedor JR, 2015, MOL CELL, V57, P23, DOI 10.1016/j.molcel.2014.10.029; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Silverman IM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r3; Simeonova I, 2013, CELL REP, V3, P2046, DOI 10.1016/j.celrep.2013.05.028; [Anonymous], AFF US GUID ALT SPLI, P20; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	57	1	1	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2159-8274	2159-8290		CANCER DISCOV	Cancer Discov.	JUL	2017	7	7					766	781		10.1158/2159-8290.CD-16-0908				16	Oncology	Oncology	EZ8JH	WOS:000404970800027	28288992				2018-01-05	
J	Luo, L; Tong, SJ; Wall, AA; Khromykh, T; Sweet, MJ; Stow, JL				Luo, Lin; Tong, Samuel J.; Wall, Adam A.; Khromykh, Tatiana; Sweet, Matthew J.; Stow, Jennifer L.			Development of SH2 probes and pull-down assays to detect pathogen-induced, site-specific tyrosine phosphorylation of the TLR adaptor SCIMP	IMMUNOLOGY AND CELL BIOLOGY			English	Article							PHOSPHOTYROSINE RECOGNITION; HIGH-AFFINITY; SRC KINASE; PROTEIN; DOMAIN; RECEPTOR; COMPLEX; MACROPHAGES; ACTIVATION; BLNK	Protein tyrosine phosphorylation guides many molecular interactions for cellular functions. SCIMP is a transmembrane adaptor protein (TRAP) family member that mediates selective proinflammatory cytokine responses generated by pathogen-activated Toll-like receptor (TLR) pathways in macrophages. TLR activation triggers SCIMP phosphorylation and selective phosphorylation of distinct tyrosine residues on this adaptor offers the potential for regulating or biasing inflammatory responses. To analyze site-specific phosphorylation events, we developed three probes based on the SH2 domains of known SCIMP effectors, and used them for pull-downs from macrophage extracts. CRISPR-mediated SCIMP-deficient RAW264.7 macrophage-like cells were reconstituted with various phosphorylation-deficient (Y58F, Y96F, Y120F) SCIMPs, and used to demonstrate the specificity of LPS/TLR4-induced, site-specific phosphorylation of SCIMP for the temporal recruitment of the effectors Grb2, Csk and SLP65. Our findings reveal potential for differential SCIMP phosphorylation and specific effectors to influence TLR signaling and inflammatory programs. Furthermore, the use of Csk-SH2 pull-downs to identify additional known and new Csk targets in LPS-activated macrophages reveals the wider utility of our SH2 probes.	[Luo, Lin; Tong, Samuel J.; Wall, Adam A.; Khromykh, Tatiana; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB, Brisbane, Qld, Australia; [Luo, Lin; Tong, Samuel J.; Wall, Adam A.; Khromykh, Tatiana; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld, Australia	Luo, L; Stow, JL (reprint author), Univ Queensland, IMB, Brisbane, Qld, Australia.; Luo, L; Stow, JL (reprint author), Univ Queensland, IMB Ctr Inflammat & Dis Res, Queensland Biosci Precinct, Bldg 80,Serv Rd, Brisbane, Qld 4072, Australia.	l.luo@imb.uq.edu.au; j.stow@imb.uq.edu.au			NHMRC [APP1101072]; ARC [DP130101431];  [APP1003021];  [APP1107914]	We acknowledge IMB Mass Spectrometry Facility. This work was funded by NHMRC project grant (APP1101072) and fellowships (APP1003021, APP1107914) to JLS and MJS, and an ARC grant (DP130101431) to MJS.	Ackermann JA, 2011, EMBO J, V30, P1621, DOI 10.1038/emboj.2011.74; Aki D, 2005, GENES CELLS, V10, P357, DOI 10.1111/j.1365-2443.2005.00839.x; ARKINSTALL S, 1995, MOL CELL BIOL, V15, P1431; Bradshaw JM, 1999, BIOCHEMISTRY-US, V38, P5147, DOI 10.1021/bi982974y; Bradshaw JM, 1999, J MOL BIOL, V293, P971, DOI 10.1006/jmbi.1999.3190; Draber P, 2011, MOL CELL BIOL, V31, P4550, DOI 10.1128/MCB.05817-11; Drobek A, 2015, J IMMUNOL, V195, P3416, DOI 10.4049/jimmunol.1401494; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fusaki N, 2000, EUR J IMMUNOL, V30, P1326, DOI 10.1002/(SICI)1521-4141(200005)30:5<1326::AID-IMMU1326>3.0.CO;2-Q; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hu JJ, 2005, J BIOL CHEM, V280, P18943, DOI 10.1074/jbc.M414157200; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; JOHNSON LN, 1993, ANNU REV BIOPH BIOM, V22, P199, DOI 10.1146/annurev.bb.22.060193.001215                                             ; Kralova J, 2016, J BIOL CHEM, V291, P16530, DOI 10.1074/jbc.M116.717157; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Luo L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14133; Luo L, 2014, PROTEOMICS, V14, P19, DOI 10.1002/pmic.201300315; Mandell JW, 2003, AM J PATHOL, V163, P1687, DOI 10.1016/S0002-9440(10)63525-0; MAYER BJ, 1991, P NATL ACAD SCI USA, V88, P627, DOI 10.1073/pnas.88.2.627; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8                                                   ; Sawyers CL, 2002, CURR OPIN GENET DEV, V12, P111, DOI 10.1016/S0959-437X(01)00273-8; Silverman SK, 1998, BIOPHYS J, V75, P1330, DOI 10.1016/S0006-3495(98)74051-2                                                   ; Songyang Z, 1993, Cell, V72, P767; Walker F, 1998, MOL CELL BIOL, V18, P7192, DOI 10.1128/MCB.18.12.7192                                                          ; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791                                                           	27	0	0	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0818-9641	1440-1711		IMMUNOL CELL BIOL	Immunol. Cell Biol.	JUL	2017	95	6					564	570		10.1038/icb.2017.10				7	Cell Biology; Immunology	Cell Biology; Immunology	EZ8EU	WOS:000404958100011	28290451				2018-01-05	
J	Liu, Q; Liu, W; Zeng, BS; Wang, GR; Hao, DJ; Huang, YP				Liu, Qun; Liu, Wei; Zeng, Baosheng; Wang, Guirong; Hao, Dejun; Huang, Yongping			Deletion of the Bombyx mori odorant receptor co-receptor (BmOrco) impairs olfactory sensitivity in silkworms	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Odorant-receptor co-receptor (Orco); Transgene; CRISPR/Cas9; Bombyx mori	GERM-LINE TRANSFORMATION; SEX-PHEROMONE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; DROSOPHILA-MELANOGASTER; SPODOPTERA-LITURA; MEMBRANE TOPOLOGY; BINDING-PROTEINS; FRUIT-FLY; IN-VIVO; GENE	Olfaction plays an essential role in many important insect behaviors such as feeding and reproduction. To detect olfactory stimuli, an odorant receptor co-receptor (Orco) is required. In this study, we deleted the Orco gene in the Lepidopteran model insect, Bombyx mori, using a binary transgene-based clustered regulatory interspaced short palindromic repeats (CRISPR)/Cas9 system. We initially generated somatic mutations in two targeted sites, from which we obtained homozygous mutants with deletion of a 866 base pair sequence. Because of the flight inability of B. mori, we developed a novel method to examine the adult mating behavior. Considering the specialization in larval feeding, we examined food selection behavior in Orco somatic mutants by the walking trail analysis of silkworm position over time. Single sensillum recordings indicated that the antenna of the homozygous mutant was unable to respond to either of the two sex pheromones, bombykol or bombykal. An adult mating behavior assay revealed that the Orco mutant displayed a significantly impaired mating selection behavior in response to natural pheromone released by a wild-type female moth as well as an 11:1 mixture of bombykol/bombykal. The mutants also exhibited a decreased response to bombykol and, similar to wild-type moths, they displayed no response to bombykal. A larval feeding behavior assay revealed that the Orco mutant displayed defective selection for mulberry leaves and different concentrations of the volatile compound cis-jasmane found in mulberry leaves. Deletion of BmOrco severely disrupts the olfactory system, suggesting that BmOrco is indispensable in the olfactory pathway. The approach used for generating somatic and homozygous mutations also highlights a novel method for mutagenesis. This study on BmOrco function provides insights into the insect olfactory system and also provides a paradigm for agroforestry pest control. (C) 2017 Elsevier Ltd. All rights reserved.	[Liu, Qun; Hao, Dejun] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern Chin, Nanjing 210037, Jiangsu, Peoples R China; [Liu, Qun; Hao, Dejun] Nanjing Forestry Univ, Coll Forestry, Nanjing 210037, Jiangsu, Peoples R China; [Liu, Qun; Zeng, Baosheng; Huang, Yongping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolut Biol, Shanghai 200032, Peoples R China; [Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Hao, DJ (reprint author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern Chin, Nanjing 210037, Jiangsu, Peoples R China.; Huang, YP (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolut Biol, Shanghai 200032, Peoples R China.	djhao@njfu.edu.cn; yphuang@sibs.ac.cn		wei, liu/0000-0001-5852-2336	National Science Foundation [31372257]; National research program of China [2015CB755703]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB11010600]; Priority Academic Program Development of Jiangsu Province, China (PAPD)	The work was supported by the National Science Foundation (31372257), National research program of China (2015CB755703), Strategic Priority Research Program of Chinese Academy of Sciences (XDB11010600) and a grant from Priority Academic Program Development of Jiangsu Province, China (PAPD).	Badeke E, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00143; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, ANN NY ACAD SCI, V1170, P478, DOI 10.1111/j.1749-6632.2009.03880.x; Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341; BIESSMANN H, 1985, P NATL ACAD SCI USA, V82, P7369, DOI 10.1073/pnas.82.21.7369; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Chang HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13093; Condon KC, 2007, INSECT MOL BIOL, V16, P573, DOI 10.1111/j.1365-2583.2007.00752.x                                                ; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fan J, 2015, INSECT BIOCHEM MOLEC, V64, P16, DOI 10.1016/j.ibmb.2015.07.006; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Fujii T, 2010, INSECT MOL BIOL, V19, P659, DOI 10.1111/j.1365-2583.2010.01020.x; Fujii T, 2011, P NATL ACAD SCI USA, V108, P18038, DOI 10.1073/pnas.1107282108; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garside EL, 2014, NAT BIOTECHNOL, V32, P338, DOI 10.1038/nbt.2872; Guidobaldi F, 2014, J PHYSIOL-PARIS, V108, P96, DOI 10.1016/j.jphysparis.2014.04.006; Handler AM, 1998, P NATL ACAD SCI USA, V95, P7520, DOI 10.1073/pnas.95.13.7520; Heinrich JC, 2002, INSECT MOL BIOL, V11, P1, DOI 10.1046/j.0962-1075.2001.00301.x; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang YP, 2016, J GENET GENOMICS, V43, P263, DOI 10.1016/j.jgg.2016.04.007; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Joseph RM, 2015, TRENDS GENET, V31, P683, DOI 10.1016/j.tig.2015.09.005; KAISSLING KE, 1978, NATURWISSENSCHAFTEN, V65, P382, DOI 10.1007/BF00439702; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Kuwayama H, 2006, INSECT MOL BIOL, V15, P507, DOI 10.1111/j.1365-2583.2006.00665.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; LEGAY JM, 1958, ANNU REV ENTOMOL, V3, P75, DOI 10.1146/annurev.en.03.010158.000451; Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; Li ZQ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0513; Ling L, 2014, INSECT BIOCHEM MOLEC, V53, P13, DOI 10.1016/j.ibmb.2014.06.011; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4                                                   ; Martins S, 2012, INSECT MOL BIOL, V21, P414, DOI 10.1111/j.1365-2583.2012.01146.x; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sakurai T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11001; Sampson TR, 2014, BIOESSAYS, V36, P34, DOI 10.1002/bies.201300135; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006; Tan AJ, 2013, P NATL ACAD SCI USA, V110, P6766, DOI 10.1073/pnas.1221700110; Tanaka H, 2009, MOL BIOTECHNOL, V41, P173, DOI 10.1007/s12033-008-9108-x; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Xu J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006576; Yan P, 2012, ANAL BIOCHEM, V430, P65, DOI 10.1016/j.ab.2012.07.029; Yang B, 2016, INSECT BIOCHEM MOLEC, V70, P53, DOI 10.1016/j.ibmb.2015.12.003; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhang ZJ, 2015, J INSECT PHYSIOL, V79, P73, DOI 10.1016/j.jinsphys.2015.06.004; Zhu GH, 2016, INSECT BIOCHEM MOLEC, V75, P1, DOI 10.1016/j.ibmb.2016.05.006	61	1	1	36	36	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	JUL	2017	86						58	67		10.1016/j.ibmb.2017.05.007				10	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	EZ9MS	WOS:000405055100007	28577927				2018-01-05	
J	Steele, EJ; Lindley, RA				Steele, Edward J.; Lindley, Robyn A.			ADAR deaminase A-to-I editing of DNA and RNA moieties of RNA:DNA hybrids has implications for the mechanism of Ig somatic hypermutation	DNA REPAIR			English	Article						Somatic hypermutation; Strand-biased mutations; DNA polymerase-eta; A-to-I RNA and DNA editing; Codon-context mutations; AID/APOBEC-deaminase oncogenesis	IMMUNOGLOBULIN GENE HYPERMUTATION; POLYMERASE-ETA; MUTATION SIGNATURES; MOLECULAR-MECHANISM; SWITCH REGIONS; CODON-CONTEXT; BASE-PAIRS; TRANSCRIPTION; STRAND; REPAIR	The implications are discussed of recently published biochemical studies on ADAR-mediated A-to-I DNA and RNA deamination at RNA:DNA hybrids. The significance of these data are related to previous work on strand-biased and codon-context mutation signatures in B lymphocytes and cancer genomes. Those studies have established that there are two significant strand biases at A:T and G:C base pairs, A-site mutations exceed T-site mutations (A > > T) by 2.9 fold and G-site mutations exceed C-site mutations (G > > C) by 1.7 fold. Both these strand biases are inconsistent with alternative "DNA Deamination" mechanisms, yet are expected consequences of the RNA/RT-based "Reverse Transcriptase" mechanism of immunoglobulin (Ig) somatic hypermutation (SHM). The A-to-I DNA editing component at RNA:DNA hybrids that is likely to occur in Transcription Bubbles, while important, is of far lower A-to-I editing efficiency than in dsRNA substrates. The RNA moiety of RNA:DNA hybrids is also edited at similar lower frequencies relative to the editing rate at dsRNA substrates. Further, if the A-to-I DNA editing at RNA:DNA hybrids were the sole cause of A-to-I (read as A-to-G) mutation events for Ig SHM in vivo then the exact opposite strand biases at A:T base pairs (T > > A) of what is actually observed (A > > T) would be predicted. It is concluded that the strand-biased somatic mutation patterns at both A:T and G:C base pairs in vivo are best interpreted by the sequential steps of the RNA/RT-based mechanism. Further, the direct DNA A-to-I deamination at Transcription Bubbles is expected to contribute to the T-to-C component of the strand-biased Ig SHM spectrum.	[Steele, Edward J.] CYO Connor ERADE Village Fdn Inc, 24 Genom Rise, Piara Waters, WA 6112, Australia; [Lindley, Robyn A.] GMDxCo Pty Ltd, Hawthorn, Vic, Australia; [Lindley, Robyn A.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Pathol, Melbourne, Vic, Australia	Steele, EJ (reprint author), CYO Connor ERADE Village Fdn Inc, 24 Genom Rise, Piara Waters, WA 6112, Australia.	ejsteele@cyo.edu.au					Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Franklin A, 2006, TRENDS BIOCHEM SCI, V31, P252, DOI 10.1016/j.tibs.2006.03.008; Franklin A, 2005, IMMUNOL CELL BIOL, V83, P383, DOI 10.1111/j.1440-1711.2005.01327.x; Franklin A, 2004, IMMUNOL CELL BIOL, V82, P557, DOI 10.1111/j.1440-1711.2004.01289.x; Franklin A, 2004, IMMUNOL CELL BIOL, V82, P219, DOI 10.1046/j.0818-9641.2004.01221.x; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Guo H., 2014, MICROBIOL SPECTR, V2; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindley R.A., 2013, GENOMICS; Lindley RA, 2016, CANCER MED-US, V5, P2629, DOI 10.1002/cam4.825; Lindley RA, 2013, CANCER GENET-NY, V206, P222, DOI 10.1016/j.cancergen.2013.05.016; Longerich S, 2007, DNA REPAIR, V6, P1764, DOI 10.1016/j.dnarep.2007.06.012; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Mayorov VI, 2005, J IMMUNOL, V174, P7781, DOI 10.4049/jimmunol.174.12.7781                                                    ; Mooney RA, 1998, J BACTERIOL, V180, P3265; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Steele EJ, 2008, MOL IMMUNOL, V45, P2723, DOI 10.1016/j.molimm.2008.02.002; Steele EJ, 2006, DNA REPAIR, V5, P1346, DOI 10.1016/j.dnarep.2006.06.002; Steele EJ, 2016, DNA REPAIR, V45, P1, DOI 10.1016/j.dnarep.2016.07.001; Steele EJ, 2010, DNA REPAIR, V9, P600, DOI 10.1016/j.dnarep.2010.03.007; Steele EJ, 2009, MOL IMMUNOL, V46, P305, DOI 10.1016/j.molimm.2008.10.021; Steele EJ, 1997, IMMUNOL CELL BIOL, V75, P82, DOI 10.1038/icb.1997.12                                                             ; Steele E.J., 2004, IMMUNOL CELL BIOL, V82, P208; Tsuruoka N, 2013, J BIOL CHEM, V288, P826, DOI 10.1074/jbc.M112.365718; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Winter DB, 2003, J IMMUNOL, V170, P5558, DOI 10.4049/jimmunol.170.11.5558                                                    ; Wright BE, 2008, MOL IMMUNOL, V45, P3600, DOI 10.1016/j.molimm.2008.05.012; Wright BE, 2008, MOL IMMUNOL, V45, P3589, DOI 10.1016/j.molimm.2008.02.030; Wright BE, 2004, GENES IMMUN, V5, P176, DOI 10.1038/sj.gene.6364053; Wu JH, 2008, BIOCHEM BIOPH RES CO, V372, P288, DOI 10.1016/j.bbrc.2008.05.058; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zeng XM, 2004, J EXP MED, V199, P917, DOI 10.1084/jem.2003022; Zheng YX, 2017, NUCLEIC ACIDS RES, V45, P3369, DOI 10.1093/nar/gkx050; Zubani GG, 2017, J EXP MED, V214, P1169, DOI 10.1084/jem.20161576	50	1	1	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	JUL	2017	55						1	6		10.1016/j.dnarep.2017.04.004				6	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	EZ6FY	WOS:000404815000002	28482199				2018-01-05	
J	Grinberg, M; Djureinovic, D; Brunnstrom, HRR; Mattsson, JSM; Edlund, K; Hengstler, JG; La Fleur, L; Ekman, S; Koyi, H; Branden, E; Stahle, E; Jirstrom, K; Tracy, DK; Ponten, F; Botling, J; Rahnenfuhrer, J; Micke, P				Grinberg, Marianna; Djureinovic, Dijana; Brunnstrom, Hans R. R.; Mattsson, Johanna S. M.; Edlund, Karolina; Hengstler, Jan G.; La Fleur, Linnea; Ekman, Simon; Koyi, Hirsh; Branden, Eva; Stahle, Elisabeth; Jirstrom, Karin; Tracy, Derek K.; Ponten, Fredrik; Botling, Johan; Rahnenfuehrer, Joerg; Micke, Patrick			Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters	MODERN PATHOLOGY			English	Article							PROTEIN EXPRESSION; ADJUVANT CHEMOTHERAPY; TNM CLASSIFICATION; MALIGNANT-TUMORS; PREDICT SURVIVAL; GENE SIGNATURE; 7TH EDITION; EARLY-STAGE; RISK MODEL; ADENOCARCINOMA	Numerous protein biomarkers have been analyzed to improve prognostication in non-small cell lung cancer, but have not yet demonstrated sufficient value to be introduced into clinical practice. Here, we aimed to develop and validate a prognostic model for surgically resected non-small cell lung cancer. A biomarker panel was selected based on (1) prognostic association in published literature, (2) prognostic association in gene expression data sets, (3) availability of reliable antibodies, and (4) representation of diverse biological processes. The five selected proteins (MKI67, EZH2, SLC2A1, CADM1, and NKX2-1 alias TTF1) were analyzed by immunohistochemistry on tissue microarrays including tissue from 326 non-small cell lung cancer patients. One score was obtained for each tumor and each protein. The scores were combined, with or without the inclusion of clinical parameters, and the best prognostic model was defined according to the corresponding concordance index (C-index). The best-performing model was subsequently validated in an independent cohort consisting of tissue from 345 non-small cell lung cancer patients. The model based only on protein expression did not perform better compared to clinicopathological parameters, whereas combining protein expression with clinicopathological data resulted in a slightly better prognostic performance (C-index: all non-small cell lung cancer 0.63 vs 0.64; adenocarcinoma: 0.66 vs 0.70, squamous cell carcinoma: 0.57 vs 0.56). However, this modest effect did not translate into a significantly improved accuracy of survival prediction. The combination of a prognostic biomarker panel with clinicopathological parameters did not improve survival prediction in non-small cell lung cancer, questioning the potential of immunohistochemistry-based assessment of protein biomarkers for prognostication in clinical practice.	[Grinberg, Marianna; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Djureinovic, Dijana; Mattsson, Johanna S. M.; La Fleur, Linnea; Ekman, Simon; Ponten, Fredrik; Botling, Johan; Micke, Patrick] Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Brunnstrom, Hans R. R.; Jirstrom, Karin] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Edlund, Karolina; Hengstler, Jan G.] TU Dortmund Univ, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Koyi, Hirsh; Branden, Eva] Gavle Cent Hosp, Dept Resp Med, Gavle, Sweden; [Koyi, Hirsh; Branden, Eva] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Gavle, Sweden; [Stahle, Elisabeth] Uppsala Univ, Dept Clin Sci, Uppsala, Sweden; [Tracy, Derek K.] Oxleas NHS Fdn Trust, London, England; [Tracy, Derek K.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Cognit Schizophrenia & Imaging Lab, London, England	Micke, P (reprint author), Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden.	patrick.micke@igp.uu.se		Tracy, Derek/0000-0002-3609-9407; Djureinovic, Dijana/0000-0002-1852-5409; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Swedish Cancer Society; Lions Cancer Foundation, Uppsala, Sweden; Regional Research Foundation of the Uppsala Orebro region [RFR 556381]	We acknowledge the Human Protein Atlas team for the support of tissue microarray construction and immunohistochemical staining. We thank the Clinical Pathology at the Uppsala University Hospital and Simin Tahmasebpoor for assistance with tissue samples and sample preparations. This study was supported by the Swedish Cancer Society and Lions Cancer Foundation, Uppsala, Sweden, and the Regional Research Foundation of the Uppsala Orebro region (RFR 556381).	Barlesi F, 2005, BRIT J CANCER, V93, P450, DOI 10.1038/sj.bjc.6602717; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Behrens C, 2013, CLIN CANCER RES, V19, P6556, DOI 10.1158/1078-0432.CCR-12-3946; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Burdett S, 2015, COCHRANE DB SYST REV, V2; D'Amico TA, 1999, J THORAC CARDIOV SUR, V117, P736, DOI 10.1016/S0022-5223(99)70294-1; Demarchi LMMF, 2000, MODERN PATHOL, V13, P511, DOI 10.1038/modpathol.3880089                                                       ; Der SD, 2014, J THORAC ONCOL, V9, P59, DOI 10.1097/JTO.0000000000000042; Djureinovic D, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86837; Edlund K, 2012, INT J CANCER, V131, P2264, DOI 10.1002/ijc.27518; Gold KA, 2014, CLIN CANCER RES, V20, P1946, DOI 10.1158/1078-0432.CCR-13-1959; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goto A, 2005, CANCER SCI, V96, P480, DOI 10.1111/j.1349-7006.2005.00075.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Jakobsen JN, 2013, LUNG CANCER, V79, P1, DOI 10.1016/j.lungcan.2012.10.008; Jiang T, 2016, ONCOTARGET, V7, P4584, DOI 10.18632/oncotarget.6612; Kern SE, 2012, CANCER RES, V72, P6097, DOI 10.1158/0008-5472.CAN-12-3232; Kloppel G, 2009, NEUROENDOCRINOLOGY, V90, P162, DOI 10.1159/000182196; Ko E, 2013, CLIN CANCER RES, V19, P1204, DOI 10.1158/1078-0432.CCR-12-2848; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Lindskog C, 2015, EXPERT REV MOL DIAGN, V15, P471, DOI 10.1586/14737159.2015.1002772; Masuda K, 2011, CLIN CANCER RES, V17, P7712, DOI 10.1158/1078-0432.CCR-11-0619; Micke P, 2016, J THORAC ONCOL, V11, P862, DOI 10.1016/j.jtho.2016.01.020; Micke P, 2011, J THORAC ONCOL, V6, P1833, DOI 10.1097/JTO.0b013e3182295917; Nakagawa T, 2016, INTERACT CARDIOV TH, V23, P560, DOI 10.1093/icvts/ivw175; Nakamura N, 2002, MODERN PATHOL, V15, P1058, DOI 10.1097/01.MP.0000028572.44247.CF; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Ooi AT, 2015, CLIN CANCER RES, V21, P2440, DOI 10.1158/1078-0432.CCR-14-1209; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Rousseaux S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005723; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9                   ; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sheppard MN, 2000, HISTOPATHOLOGY, V36, P273; Shiba M, 2000, CANCER, V89, P1457, DOI 10.1002/1097-0142(20001001)89:7<1457::AID-CNCR7>3.0.CO;2-L; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Tran L, 2016, APPL IMMUNOHISTO M M, V24, P648, DOI 10.1097/PAI.0000000000000235                                                    ; Travis WD, 2004, PATHOLOGY GENETICS T, P25; Uchino K, 2003, CANCER, V98, P1002, DOI 10.1002/cncr.11599; Wen J, 2011, MODERN PATHOL, V24, P932, DOI 10.1038/modpathol.2011.46; Wistuba II, 2013, CLIN CANCER RES, V19, P6261, DOI 10.1158/1078-0432.CCR-13-0596; Xie Y, 2011, CLIN CANCER RES, V17, P5705, DOI 10.1158/1078-0432.CCR-11-0196; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yotsukura M, 2016, J THORAC ONCOL, V11, P1311, DOI 10.1016/j.jtho.2016.04.029; Younes M, 1997, CANCER, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Zeng D, 2016, GASTROENT RES PRACT, V2016; Zhang JF, 2012, J MOL HISTOL, V43, P715, DOI 10.1007/s10735-012-9438-7; Zhu CQ, 2006, J CLIN PATHOL, V59, P790, DOI 10.1136/jcp.2005.031351; Zhu CQ, 2014, TRANSL LUNG CANCER R, V3, P149, DOI 10.3978/j.issn.2218-6751.2014.06.09; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	61	4	4	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	JUL	2017	30	7					964	977		10.1038/modpathol.2017.14				14	Pathology	Pathology	EZ4YJ	WOS:000404718100006	28281552				2018-01-05	
J	Drezen, JM; Gauthier, J; Josse, T; Bezier, A; Herniou, E; Huguet, E				Drezen, J. -M.; Gauthier, J.; Josse, T.; Bezier, A.; Herniou, E.; Huguet, E.			Foreign DNA acquisition by invertebrate genomes	JOURNAL OF INVERTEBRATE PATHOLOGY			English	Review						Horizontal gene transfer; Endogenous viruses; Transposable elements; Gene domestication; Baculovirus; Polydnavirus	HORIZONTAL GENE-TRANSFER; MICROPLITIS-DEMOLITOR BRACOVIRUS; WASP COTESIA-CONGREGATA; LARGE DSDNA VIRUSES; TRANSPOSABLE ELEMENTS; DROSOPHILA-MELANOGASTER; POPULATION GENOMICS; GERMLINE TRANSFORMATION; ENDOGENOUS RETROVIRUS; EVOLUTIONARY INSIGHTS	Recent studies have highlighted that the accidental acquisition of DNA from other species by invertebrate genomes is much more common than originally thought. The transferred DNAs are of bacterial or eukaryote origin and in both cases the receiver species may end up utilising the transferred genes for its own benefit. Frequent contact with prokaryotic DNA from symbiotic endocellular bacteria may predispose invertebrates to incorporate this genetic material into their genomes. Increasing evidence also points to viruses as major players in transferring genes and mobile elements between the species they infect. Unexpectedly a gene flux between Hymenoptera and Lepidoptera mediated by endogenous viruses of parasitic wasps has been recently unravelled, suggesting we are probably just seeing the tip of the iceberg concerning horizontal gene transfers in invertebrates. In the context of insect for feed and food, if the new technology of insect genome editing (such as CrisperiCas9) were used to modify the genome of reared insects it is important to take into account the risk that an introduced gene can be transferred. More generally, although insects are traditionally consumed in Asia and Africa, knowledge on insect viruses is still limited rendering it difficult to predict the impact they might have in the context of insect rearing at an industrial scale. (C) 2016 Elsevier Inc. All rights reserved.	[Drezen, J. -M.; Gauthier, J.; Josse, T.; Bezier, A.; Herniou, E.; Huguet, E.] Univ Tours, UFR Sci & Tech, UMR CNRS 7261, Inst Rech Biol Insecte, Tours, France	Drezen, JM (reprint author), Univ Tours, UFR Sci & Tech, UMR CNRS 7261, Inst Rech Biol Insecte, Tours, France.	drezen@univ-tours.fr; jeremy.gauthier@etu.univ-tours.fr; thibautjosse@univ-tours.fr; annie.bezier@univ-tours.fr; elisabeth.herniou@univ-tours.fr; elisabeth.huguet@univ-tours.fr	Herniou, Elisabeth/B-3786-2016	Herniou, Elisabeth/0000-0001-5362-6056	CNRS; Universite Francois Rabelais (Tours); ANR Bioadapt grant (ABC Papogen project)	This work was performed thanks to CNRS and Universite Francois Rabelais (Tours) recurrent funding and the ANR Bioadapt grant (ABC Papogen project).	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Abhiman S, 2008, BIOINFORMATICS, V24, P458, DOI 10.1093/bioinformatics/btn007; Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Aikawa T, 2009, P R SOC B, V276, P3791, DOI 10.1098/rspb.2009.1022; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Barron MG, 2014, ANNU REV GENET, V48, P561, DOI 10.1146/annurev-genet-120213-092359; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beck MH, 2011, J VIROL, V85, P11685, DOI 10.1128/JVI.05726-11; Beckage NE, 2002, J INVERTEBR PATHOL, V81, P49, DOI 10.1016/S0022-2011(02)00112-X; Beliveau C, 2015, J VIROL, V89, P8909, DOI 10.1128/JVI.01001-15; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2008, ARCH INSECT BIOCHEM, V67, P172, DOI 10.1002/arch.20219; Bezier A, 2015, J VIROL, V89, P3008, DOI 10.1128/JVI.02884-14; Bezier A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0047; Bezier A, 2009, J INVERTEBR PATHOL, V101, P194, DOI 10.1016/j.jip.2009.04.006; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Brelsfoard C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002728; Burke GR, 2015, J VIROL, V89, P9511, DOI 10.1128/JVI.01388-15; Burke GR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004660; Burke GR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003348; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Chateigner A, 2015, VIRUSES-BASEL, V7, P3625, DOI 10.3390/v7072788; Cheng RL, 2014, J VIROL, V88, P5310, DOI 10.1128/JVI.03166-13; Chevignon G, 2014, J VIROL, V88, P8795, DOI 10.1128/JVI.00209-14; Choi JY, 2015, GENOME BIOL EVOL, V7, P2362, DOI 10.1093/gbe/evv158; Chou S, 2015, NATURE, V518, P98, DOI 10.1038/nature13965; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3; Dai Q, 2013, GENE DEV, V27, P602, DOI 10.1101/gad.213314.113; Daimon T, 2008, J BIOL CHEM, V283, P15271, DOI 10.1074/jbc.M709350200; Danchin EGJ, 2016, MOL BIOL EVOL, V33, P1571, DOI 10.1093/molbev/msw041; Danchin EGJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00027; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; DANIELS SB, 1990, GENETICS, V124, P339; DAVIES DH, 1987, DEV COMP IMMUNOL, V11, P353, DOI 10.1016/0145-305X(87)90079-6; Delaroque N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-110; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Doolittle WE, 1998, TRENDS GENET, V14, P307; Dotto BR, 2015, BIOINFORMATICS, V31, P2915, DOI 10.1093/bioinformatics/btv281; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; Drezen JM, 2014, CURR OPIN INSECT SCI, V6, P35, DOI 10.1016/j.cois.2014.09.008; Dupuy C., 2011, TRANSFER CHROMOSOMAL; DUSHAY MS, 1993, J INSECT PHYSIOL, V39, P1029, DOI 10.1016/0022-1910(93)90127-D; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Eyres I, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0202-9; Favery B, 2016, J INSECT PHYSIOL, V84, P60, DOI 10.1016/j.jinsphys.2015.07.013; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; FRASER MJ, 1983, J VIROL, V47, P287; Friedli M, 2015, ANNU REV CELL DEV BI, V31, P429, DOI 10.1146/annurev-cellbio-100814-125514; Gasmi L, 2016, DEV COMP IMMUNOL, V56, P37, DOI 10.1016/j.dci.2015.11.014; Gasmi L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005470; Gayral P, 2008, J VIROL, V82, P6697, DOI 10.1128/JVI.00212-08; Gilbert C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005838; Gilbert C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4348; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Gundersen-Rindal D, 2013, BIOCONTROL SCI TECHN, V23, P1, DOI 10.1080/09583157.2012.731497; Habibi L, 2015, DNA CELL BIOL, V34, P597, DOI 10.1089/dna.2015.2938; Hadfield SJ, 1999, NATURE, V402, P482, DOI 10.1038/45002; Hall CB, 2010, J INFECT DIS, V201, P505, DOI 10.1086/650495; Harwood SH, 1998, J INVERTEBR PATHOL, V71, P271, DOI 10.1006/jipa.1997.4745                                                          ; Herniou EA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0051; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; HOUCK MA, 1991, SCIENCE, V253, P1125, DOI 10.1126/science.1653453; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Jehle JA, 1998, J MOL EVOL, V46, P215, DOI 10.1007/PL00006296; Jordan IK, 1999, P NATL ACAD SCI USA, V96, P12621, DOI 10.1073/pnas.96.22.12621; JUCHAULT P, 1993, J EVOLUTION BIOL, V6, P511, DOI 10.1046/j.1420-9101.1993.6040511.x; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Katzourakis A, 2009, SCIENCE, V325, P1512, DOI 10.1126/science.1174149; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kirsch R, 2016, INSECT BIOCHEM MOLEC, V71, P72, DOI 10.1016/j.ibmb.2016.02.007; Kirsch R, 2014, INSECT BIOCHEM MOLEC, V52, P33, DOI 10.1016/j.ibmb.2014.06.008; Klasson L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1097; Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Krupovic M, 2016, CURR OPIN MICROBIOL, V31, P25, DOI 10.1016/j.mib.2016.01.006; Krupovic M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-6; Kumar Nikhil, 2012, BMC Res Notes, V5, P230, DOI 10.1186/1756-0500-5-230; Kyndt T, 2015, P NATL ACAD SCI USA, V112, P5844, DOI 10.1073/pnas.1419685112; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lee S, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev002; Lin CL, 1999, J VIROL, V73, P128; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; Louis F, 2013, J VIROL, V87, P9649, DOI 10.1128/JVI.00886-13; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; MILLER DW, 1982, NATURE, V299, P562, DOI 10.1038/299562a0; MIZROKHI LJ, 1990, P NATL ACAD SCI USA, V87, P9216, DOI 10.1073/pnas.87.23.9216; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Ortiz MF, 2015, MOL GENET GENOMICS, V290, P67, DOI 10.1007/s00438-014-0900-y; Owens L, 2011, J FISH DIS, V34, P509, DOI 10.1111/j.1365-2761.2011.01263.x; Pardue ML, 1999, GENETICA, V107, P189, DOI 10.1023/A:1003905210770; Pauchet Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1021; Petrov DA, 2011, MOL BIOL EVOL, V28, P1633, DOI 10.1093/molbev/msq337; Pichon A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501150; Piegu B, 2013, J GEN VIROL, V94, P2112, DOI 10.1099/vir.0.054213-0; Piskurek O, 2007, P NATL ACAD SCI USA, V104, P12046, DOI 10.1073/pnas.0700531104; Qin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131365; Richards EH, 1999, J INSECT PHYSIOL, V45, P1073, DOI 10.1016/S0022-1910(99)00091-8; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rohrmann GF, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-1; RONSSERAY S, 1989, GENET RES, V54, P13, DOI 10.1017/S0016672300028329                                                       ; ROTHERAM S, 1967, NATURE, V214, P700, DOI 10.1038/214700a0; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Routh A, 2012, P NATL ACAD SCI USA, V109, P1907, DOI 10.1073/pnas.1116168109; RoyBurman P, 1995, VIRUS GENES, V11, P147, DOI 10.1007/BF01728655; Ryabov EV, 2017, J INVERTEBR PATHOL, V147, P37, DOI 10.1016/j.jip.2016.10.002; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schneider SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109446; Serbielle C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-253; Silva JC, 2004, CURR ISSUES MOL BIOL, V6, P57; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Strand MR, 2013, CURR OPIN VIROL, V3, P587, DOI 10.1016/j.coviro.2013.06.004; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; Sun BF, 2013, INSECT MOL BIOL, V22, P72, DOI 10.1111/imb.12004; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Terzian C, 2000, MOL BIOL EVOL, V17, P908, DOI 10.1093/oxfordjournals.molbev.a026371                                           ; Theze J, 2015, VIRUSES-BASEL, V7, P1960, DOI 10.3390/v7041960; Theze J, 2014, GENOME BIOL EVOL, V6, P2129, DOI 10.1093/gbe/evu163; Theze J, 2011, P NATL ACAD SCI USA, V108, P15931, DOI 10.1073/pnas.1105580108; Touret F, 2014, VIRUSES-BASEL, V6, P4914, DOI 10.3390/v6124914; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Van Leeuwen T, 2016, ANNU REV ENTOMOL, V61, P475, DOI 10.1146/annurev-ento-010715-023907; van't Hof AE, 2016, NATURE, V534, P102, DOI 10.1038/nature17951; Vega FE, 2015, SCI REP-UK, V5, DOI 10.1038/srep12525; Volkoff AN, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P33, DOI 10.1016/B978-0-12-384858-1.00003-5; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Wallau GL, 2016, MOL BIOL EVOL, V33, P1094, DOI 10.1093/molbev/msv341; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Williams S., 2017, J INVERTEBR PATHOL, V147, P4; Wybouw N, 2014, ELIFE, V3, DOI 10.7554/eLife.02365; Wyder S, 2003, J INSECT PHYSIOL, V49, P491, DOI 10.1016/S0022-1910(03)00056-8; Zhao CY, 2015, CURR BIOL, V25, P613, DOI 10.1016/j.cub.2014.12.057; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	156	5	5	26	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2011	1096-0805		J INVERTEBR PATHOL	J. Invertebr. Pathol.	JUL	2017	147						157	168		10.1016/j.jip.2016.09.004				12	Zoology	Zoology	EZ6AT	WOS:000404801500013	27642089				2018-01-05	
J	Fu, LB; Jin, YQ; Jia, C; Zhang, J; Tai, J; Li, HB; Chen, F; Shi, J; Guo, YL; Ni, X; He, LJ				Fu, Libing; Jin, Yaqiong; Jia, Chao; Zhang, Jie; Tai, Jun; Li, Hongbin; Chen, Feng; Shi, Jin; Guo, Yongli; Ni, Xin; He, Lejian			Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma	SCIENCE CHINA-LIFE SCIENCES			English	Article						atypical alveolar rhabdomyosarcoma; FOXO1; fluorescence in situ hybridization	CHILDRENS ONCOLOGY GROUP; TISSUE SARCOMA COMMITTEE; EMBRYONAL RHABDOMYOSARCOMA; PEDIATRIC RHABDOMYOSARCOMA; MYOGENIN EXPRESSION; GENE FUSIONS; CLASSIFICATION; TUMORS; CHILDHOOD; PROGNOSIS	The morphologies of alveolar rhabdomyosarcoma (ARMS) are various. Some cases entirely lack an alveolar pattern and instead display a histological pattern that overlaps with embryonal rhabdomyosarcoma (ERMS). The method of pathological diagnosis of ARMS and ERMS has been updated in the 4th edition of the World Health Organization's guidelines for classification of skeletal muscle tumors. Under the new guidelines, there is still no molecular test to distinguish between these two subtypes of rhabdomyosarcoma (RMS). In the present study, we applied fluorescent in situ hybridization (FISH) and found that the Forkhead box O1 (FOXO1) gene broke apart, amplified, and displayed an aneuploid signal that was related to the RMS pathological subtype. Aside from the fact that FOXO1 break-apart and its amplification were correlated with atypical ARMS, aneuploidies were usually found in atypical ERMS. In conclusion, our results detail a potential biomarker to improve the accuracy of pathological diagnosis by discriminating between atypical ARMS and atypical ERMS.	[Fu, Libing; Jia, Chao; He, Lejian] Capital Med Univ, Beijing Childrens Hosp, Dept Pathol, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China; [Jin, Yaqiong; Shi, Jin; Guo, Yongli; Ni, Xin] Capital Med Univ, Beijing Key Lab Pediat Dis Otolaryngol Head & Nec, MOE Key Lab Major Dis Children, Beijing Pediat Res Inst,Beijing Childrens Hosp,Na, Beijing 100045, Peoples R China; [Jin, Yaqiong; Guo, Yongli; Ni, Xin] Capital Med Univ, Biobank Clin Data & Samples Pediat, Beijing Pediat Res Inst, Beijing Childrens Hosp,Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China; [Zhang, Jie; Tai, Jun; Li, Hongbin; Chen, Feng; Ni, Xin] Capital Med Univ, Beijing Childrens Hosp, Dept Otolaryngol Head & Neck Surg, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China	He, LJ (reprint author), Capital Med Univ, Beijing Childrens Hosp, Dept Pathol, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China.; Ni, X (reprint author), Capital Med Univ, Beijing Key Lab Pediat Dis Otolaryngol Head & Nec, MOE Key Lab Major Dis Children, Beijing Pediat Res Inst,Beijing Childrens Hosp,Na, Beijing 100045, Peoples R China.; Ni, X (reprint author), Capital Med Univ, Biobank Clin Data & Samples Pediat, Beijing Pediat Res Inst, Beijing Childrens Hosp,Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China.; Ni, X (reprint author), Capital Med Univ, Beijing Childrens Hosp, Dept Otolaryngol Head & Neck Surg, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China.	nixin@bch.com.cn; lejianhe@sina.com			Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201508]; Beijing Health System Top Level Health Technical Personnel Training Plan [20153079]; Beijing Talents Fund [2015000021469G210]	This work was supported in part by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201508), Beijing Health System Top Level Health Technical Personnel Training Plan (20153079), and the Beijing Talents Fund (2015000021469G210).	Cerveira N, 2005, CANCER GENET CYTOGEN, V163, P138, DOI 10.1016/j.cancergencyto.2005.06.020; Dasgupta R, 2016, SEMIN PEDIATR SURG, V25, P276, DOI 10.1053/j.sempedsurg.2016.09.011; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Dias P, 2000, AM J PATHOL, V156, P399, DOI 10.1016/S0002-9440(10)64743-8; Donaldson SS, 2001, INT J RADIAT ONCOL, V51, P718, DOI 10.1016/S0360-3016(01)01709-6; Ferrari A, 2005, EXPERT REV ANTICANC, V5, P283, DOI 10.1586/14737140.5.2.283; Heerema-McKenney A, 2008, AM J SURG PATHOL, V32, P1513, DOI 10.1097/PAS.0b013e31817a909a; Hostein I, 2004, CANCER, V101, P2817, DOI 10.1002/cncr.20711; Jo VY, 2014, PATHOLOGY, V46, P95, DOI 10.1097/PAT.0000000000000050; Karunamurthy A, 2016, CYTOGENET GENOME RES, V150, P253, DOI 10.1159/000458167; Kelly KM, 1997, J CLIN ONCOL, V15, P1831, DOI 10.1200/JCO.1997.15.5.1831                                                      ; Mehra S, 2008, DIAGN MOL PATHOL, V17, P14, DOI 10.1097/PDM.0b013e3181255e62; Morgenstern DA, 2008, PATHOL ONCOL RES, V14, P233, DOI 10.1007/s12253-008-9012-5; Ognjanovic S, 2009, CANCER, V115, P4218, DOI 10.1002/cncr.24465; Parham DM, 2001, MODERN PATHOL, V14, P506, DOI 10.1038/modpathol.3880339                                                       ; Raney RB, 2001, J PEDIAT HEMATOL ONC, V23, P215, DOI 10.1097/00043426-200105000-00008                                                ; Rudzinski ER, 2015, ARCH PATHOL LAB MED, V139, P1281, DOI 10.5858/arpa.2014-0475-OA; Rudzinski ER, 2014, AM J SURG PATHOL, V38, P654, DOI 10.1097/PAS.0000000000000195; Rudzinski ER, 2013, AM J CLIN PATHOL, V140, P82, DOI 10.1309/AJCPA1WN7ARPCMKQ; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Stevens MCG, 2005, J CLIN ONCOL, V23, P2618, DOI 10.1200/JCO.2005.08.130; TSOKOS M, 1992, ARCH PATHOL LAB MED, V116, P847; Wang C, 2012, J DENT RES, V91, P341, DOI 10.1177/0022034511421490; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814	24	1	1	3	3	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	JUL	2017	60	7					721	728		10.1007/s11427-017-9082-9				8	Biology	Life Sciences & Biomedicine - Other Topics	EZ5RT	WOS:000404776100007	28646473				2018-01-05	
J	Sarkar, T; Mogili, T; Sivaprasad, V				Sarkar, Tanmoy; Mogili, Thallapally; Sivaprasad, Vankadara			Improvement of abiotic stress adaptive traits in mulberry (Morus spp.): an update on biotechnological interventions	3 BIOTECH			English	Review						Transgenic mulberry; Marker-assisted; selection; Functional genomics; Climate resilience; Genomic tool	INDICA CV K2; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; COMPARATIVE TRANSCRIPTOMICS; PLANT-REGENERATION; SP. GENOTYPES; MATURE TREES; AFLP MARKERS; ISSR MARKERS; HVA1 GENE	Mulberry (Morus spp.), being an economically important tree, is cultivated in China, India, Thailand, Brazil, Uzbekistan and other Countries across the globe, for its leaves to feed monophagous mulberry silkworm (Bombyx mori). The sustainability of silk industry is directly correlated with the production and continuous supply of high-quality mulberry leaves. In India, it is cultivated on large scale in tropical, sub-tropical and temperate regions under irrigated conditions for silkworm rearing. Drought, low temperature, high salinity and alkalinity, being experienced in widespread areas, are the major abiotic stresses, causing reduction in its potential foliage yield and quality. Further, climate change effects may worsen the productivity of mulberry in near future, not only in India but also across the globe. Although traditional breeding methods contributed immensely towards the development of abiotic stress-tolerant mulberry varieties, still there is lot of scope for implementation of modern genomic and molecular biology tools for accelerating mulberry genetic improvement programmes. This review discusses omics approaches, molecular breeding, plant tissue culture and genetic engineering techniques exploited for mulberry genetic improvement for abiotic stress tolerance. However, high-throughput biotechnological tools such as RNA interference, virus-induced gene silencing, epigenomics and genome editing tools need to be utilized in mulberry to accelerate the progress of functional genomics. The application of genomic tools such as genetic engineering, marker-assisted selection and genomic selection in breeding programmes can hasten the development of climate resilient and productive mulberry varieties leading to the vertical and horizontal expansion for quality silk production.	[Sarkar, Tanmoy; Mogili, Thallapally; Sivaprasad, Vankadara] CSRTI, Mysuru 570008, Karnataka, India	Sarkar, T (reprint author), CSRTI, Mysuru 570008, Karnataka, India.	tanmoy.dgr@gmail.com		SARKAR, TANMOY/0000-0002-1885-2864			Aggarwal RK, 2004, MOL ECOL NOTES, V4, P477, DOI 10.1111/j.1471-8286.2004.00718.x; Ahmad P, 2007, HORTIC SCI, V34, P114; Akram M, 2012, PAK J BOT, V44, P285; Anis M., 2003, PLANT TISSUE CULT, V13, P47; Anuradha HJ, 2013, EMIR J FOOD AGR, V25, P124, DOI 10.9755/ejfa.v25i2.11660; Arora V, 2014, INT J GENET ENG BIOT, V52, P191; Awasthi AK, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-1; Balakrishnan V., 2009, BOT RES INT, V2, P42; Baranwal VK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30794; Bhatnagar S, 2003, PLANT CELL REP, V21, P669, DOI 10.1007/s00299-003-0572-2; Bhatnagar S., 2001, PLANT BIOTECHNOL-NAR, V18, P61; Bhattacharya E, 2001, BMC Plant Biol, V1, P3, DOI 10.1186/1471-2229-1-3; Bhau BS, 2003, BIOL PLANTARUM, V46, P349, DOI 10.1023/A:1024313832737; Bhau BS, 2001, PLANT CELL TISS ORG, V66, P25, DOI 10.1023/A:1010617212237; Central Silk Board, 2015, CENTR SILK BOARD ANN; Chattopadhyay S, 2011, AFR J BIOTECHNOL, V10, P18153, DOI 10.5897/AJB10.1474; Checker VG, 2013, PLANT CELL REP, V32, P1729, DOI 10.1007/s00299-013-1483-5; Checker VG, 2012, TREE GENET GENOMES, V8, P1437, DOI 10.1007/s11295-012-0531-6; Checker VG, 2012, TRANSGENIC RES, V21, P939, DOI 10.1007/s11248-011-9577-8; Chen C, 2015, J DNA MAPP SEQ ANAL, DOI [10.3109/19401736.2015.1053127, DOI 10.3109/19401736.2015.1053127]; Chikkaswamy B. K, 2012, INT J MOL BIOL, V3, P2; Chikkaswamy B. K., 2012, NATURE SCI, V10, P45; Chitra D. S. V., 2014, American Journal of Plant Sciences, V5, P1, DOI 10.4236/ajps.2014.51001; Chitra DSV, 2005, SCI HORTIC-AMSTERDAM, V106, P593, DOI 10.1016/j.scienta.2005.05.008; Chitra DSV, 2002, SCI HORTIC-AMSTERDAM, V92, P55, DOI 10.1016/S0304-4238(01)00279-5; Dai FW, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0851-4; Das M, 2013, SERICOLOGIA, V53, P1; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; Dhanyalakshmi KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151323; Doss SG, 2012, EUPHYTICA, V185, P215, DOI 10.1007/s10681-011-0523-x; Feng L. C., 1996, ACTA SERICOL SIN, V22, P135; Gulyani V, 2011, TREE GENET GENOMES, V7, P725, DOI 10.1007/s11295-011-0369-3; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; HOSSAIN M, 1992, PLANT CELL REP, V11, P522, DOI 10.1007/BF00236269; Hossain M, 1991, B SERIC RES, V2, P67; Huang R. Z, 2009, SCI SERIC, V35, P837; Ipek M, 2012, J SCI FOOD AGR, V92, P1633, DOI 10.1002/jsfa.4749; Jain AK, 1996, PLANT CELL TISS ORG, V44, P143, DOI 10.1007/BF00048192; Jianzhong T, 2001, J AGR BIOTECHNOL, V9, P400; Kafkas S, 2008, J AM SOC HORTIC SCI, V133, P593; Bhatnagar S., 2001, SERICOLOGIA, V41, P207; Kar PK, 2008, TREE GENET GENOMES, V4, P75, DOI 10.1007/s11295-007-0089-x; Kavyashree R., 2007, Indian Journal of Biotechnology, V6, P385; Khurana P, 2011, PLANT CELL REP, V30, P825, DOI 10.1007/s00299-011-1059-1; KIM HR, 1985, BOT GAZ, V146, P335, DOI 10.1086/337533; Krishnan RR, 2014, TREES-STRUCT FUNCT, V28, P1793, DOI 10.1007/s00468-014-1086-y; Krishnan RR, 2014, PLANT GENET RESOUR-C, V12, P129, DOI 10.1017/S1479262113000415; Krishnan RR Guruprasad, 2014, TREES-STRUCT FUNCT, V28, P723; Kumar HVAnil, 2012, SCHOL J BIOTECH, V1, P1; Kunjupillai Vijayan, 2011, Tree and Forestry Science and Biotechnology, V5, P1; Lal S, 2008, TRANSGENIC RES, V17, P651, DOI 10.1007/s11248-007-9145-4; Lal S, 2009, TREE GENET GENOMES, V5, P359, DOI 10.1007/s11295-008-0192-7; Lalitha N., 2013, INT J ADG RES, V1, P22; Li T., 2014, DATABASE, DOI [10.1093/database/bau05424923822, DOI 10.1093/DATABASE/BAU054]; Lin Z, 2011, AFR J BIOTECHNOL, V10, P7756; Liu XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145619; Lou C. F., 1998, SERICOLOGIA, V38, P437; Lu MC, 2002, SCI HORTIC-AMSTERDAM, V96, P329, DOI 10.1016/S0304-4238(02)00120-6; Machii M, 1996, J SERIC SCI JPN, V65, P503; Machii M, 1990, J SERIC SCI JPN, V59, P105; Mamrutha HM, 2017, CURR SCI INDIA, V112, P759, DOI 10.18520/cs/v112/i04/759-766; Mehbooba Zaki, 2011, World Journal of Agricultural Sciences, V7, P496; Mishra GP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00360; Mishra S., 2014, THESIS; Mishra S, 2013, INDIAN J GENET PL BR, V73, P405, DOI 10.5958/j.0975-6906.73.4.061; Mishra Sidhartha, 2010, Indian Journal of Sericulture, V49, P50; Mogili T., 2008, Advances in Plant Sciences, V21, P621; Naik V. G., 2013, Indian Journal of Sericulture, V52, P34; Naik VG, 2015, INDIAN J BIOTECHNOL, V14, P334; Naik V. Girish, 2002, Indian Journal of Genetics and Plant Breeding, V62, P193; Naik VG, 2014, SERICOLOGIA, V54, P221; NARAYAN P, 1989, Proceedings of the Indian National Science Academy Part B Biological Sciences, V55, P469; OHNISHI T, 1989, Journal of Sericultural Science of Japan, V58, P353; OHNISHI T, 1987, Journal of Sericultural Science of Japan, V56, P418; Ohyama K, 1976, J SERIC SCI JPN, V45, P115; Oka Seibi, 2000, Journal of Sericultural Science of Japan, V69, P13; Orhan E, 2007, PLANT SYST EVOL, V265, P251, DOI 10.1007/s00606-007-0525-2; Ozrenk K, 2010, AFR J BIOTECHNOL, V9, P1; Ping Lu Xiao, 2003, Journal of Insect Biotechnology and Sericology, V72, P177; Pinto MV, 2012, J SERICULT TECHNOL, V3, P38; Raghunath M. K., 2013, American Journal of Plant Sciences, V4, P2001, DOI 10.4236/ajps.2013.410249; Raghunath MK, 2008, BANGLADESH J SERIC, V2-3, P31; Rani R, 2016, BIOTECHNOL LETT, V38, P1991, DOI 10.1007/s10529-016-2195-z; Rao P. J. S. V. V. N. H., 2010, EURO J BIOL SCI, V2, P80; Rao P. J. S. V. V. N. H., 2010, CURR BIOT, V3, P555; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Ravi V, 2007, TREE GENET GENOMES, V3, P49, DOI 10.1007/s11295-006-0051-3; Ravish Choudhary, 2013, African Journal of Biotechnology, V12, P5983; Rita Banerjee, 2016, Journal of Crop Improvement, V30, P478, DOI 10.1080/15427528.2016.1177803; Saeed B, 2017, PLANT PHYSIOL BIOCH, V111, P174, DOI 10.1016/j.plaphy.2016.11.020; Saeed B, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.10.0107; Saeed B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2417-8; Saeed B, 2015, PLANT CELL TISS ORG, V120, P1003, DOI 10.1007/s11240-014-0654-6; Saha S, 2016, META GENE, V7, P7, DOI 10.1016/j.mgene.2015.10.004; Sajeevan RS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00418; Sajeevan R. S., 2011, INT RES J PLANT SCI, V2, P254; Sajeevan R.S., 2016, PLANT GENE, V5, P109; Sarkar T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00935; Sarkar T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110507; Schmitz RJ, 2011, CURR OPIN PLANT BIOL, V14, P130, DOI 10.1016/j.pbi.2011.03.010; Sharma A, 2000, THEOR APPL GENET, V101, P1049, DOI 10.1007/s001220051579; Shoukang L., 1987, SCI SINICA, V30, P853; SITA GL, 1991, CURR PLANT SCI BIOT, V12, P225; Sugimura Yukio, 1999, Journal of Sericultural Science of Japan, V68, P49; Susheelamma BN, 1996, EUPHYTICA, V90, P25; Susheelamma BN, 1992, SERICOLOGY, V32, P609; Tewary PK, 2000, PLANT GROWTH REGUL, V30, P17, DOI 10.1023/A:1006297830318; Thomas TD, 1999, EUPHYTICA, V110, P169, DOI 10.1023/A:1003797328246; Thomas TD, 2000, PLANT CELL REP, V19, P395, DOI 10.1007/s002990050746; Thomas TD, 2003, BIOL PLANTARUM, V46, P529, DOI 10.1023/A:1024807426591; Thumilan BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162909; Thumilan BM, 2013, BMC PLANT BIOL, V13, P194, DOI [10.1186/1471-2229-13-194, DOI 10.1186/1471-2229-13-194]; Tikader A., 2008, GEOBIOS, V35, P113; Umate P, 2005, PLANT CELL TISS ORG, V82, P289, DOI 10.1007/s11240-005-1541-y; Umate P, 2010, PLANT SIGNAL BEHAV, V5, P785, DOI 10.4161/psb.5.7.12035; Venkateswarlu M, 2007, TREE GENET GENOMES, V3, P15, DOI 10.1007/s11295-006-0048-y; Vijayan K., 2004, Indian Journal of Biotechnology, V3, P47, DOI 10.1177/1534734604263455; Vijayan K, 2006, PLANT BREEDING, V125, P298, DOI 10.1111/j.1439-0523.2006.01212.x; Vijayan K., 2000, Indian Journal of Experimental Biology, V38, P504; Vijayan K, 2004, GENOME, V47, P439, DOI [10.1139/g03-147, 10.1139/G03-147]; Vijayan K, 2014, EMIR J FOOD AGR, V26, P472, DOI 10.9755/ejfa.v26i6.18019; Vijayan K, 2003, PLANT CELL REP, V22, P350, DOI 10.1007/s00299-003-0695-5; Vijayan K., 2009, Caspian Journal of Environmental Sciences, V7, P23; Vijayan K, 2009, EUPHYTICA, V169, P403, DOI 10.1007/s10681-009-9972-x; Vijayan K, 2010, TREE GENET GENOMES, V6, P613, DOI 10.1007/s11295-010-0276-z; Wang H, 2014, RUSS J BIOORG CHEM+, V40, P423, DOI 10.1134/S1068162014040037; Wang XL, 2015, PLANT CELL TISS ORG, V121, P301, DOI 10.1007/s11240-014-0701-3; Wang ZuoWei, 2001, Acta Sericologica Sinica, V27, P170; Wangari N. P., 2013, International Journal for Biotechnology and Molecular Biology Research, V4, P38; Weigu Z., 2007, BIODIVERS CONSERV, V16, P275, DOI DOI 10.1007/S10531-005-6973-5; Xiang ZH, 1995, SERIC SCI, V21, P203; Zhao W, 2007, SCI HORTIC-AMSTERDAM, V115, P47, DOI 10.1016/j.scienta.2007.07.017; Zhao WG, 2007, BIODIVERS CONSERV, V16, P275, DOI 10.1007/s10531-005-6973-5; Zhao WG, 2006, CAN J PLANT SCI, V86, P251; Zhao WG, 2009, AFR J BIOTECHNOL, V8, P2604; [赵卫国 ZHAO WeiGuo], 2008, [蚕业科学, Acta Sericologica Sinica], V34, P1; Zhao WG, 2005, PLANT SCI, V168, P519, DOI 10.1016/j.plantsci.2004.09.020; Zhao W. G, 2002, ACTA SERICOL SIN, V26, P1	138	0	0	7	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-572X	2190-5738		3 BIOTECH	3 Biotech	JUL 1	2017	7									10.1007/s13205-017-0829-z				14	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EZ4KA	WOS:000404680800004	28669073				2018-01-05	
J	Kan, YN; Ruis, B; Takasugi, T; Hendrickson, EA				Kan, Yinan; Ruis, Brian; Takasugi, Taylor; Hendrickson, Eric A.			Mechanisms of precise genome editing using oligonucleotide donors	GENOME RESEARCH			English	Article							DOUBLE-STRAND BREAK; TARGETED GENE MODIFICATION; HOMOLOGY-DIRECTED REPAIR; HUMAN-CELLS; MAMMALIAN-CELLS; CROSSING-OVER; INDUCED REPLICATION; RECOMBINATION; DNA; YEAST	The use of programmable meganucleases is transforming genome editing and functional genomics. CRISPR/Cas9 was developed such that targeted genomic lesions could be introduced in vivo with unprecedented ease. In the presence of homology donors, these lesions facilitate high-efficiency precise genome editing (PGE) via homology-directed repair (HDR) pathways. However, the identity and hierarchy of the HDR (sub) pathways leading to the formation of PGE products remain elusive. Here, we established a green to blue fluorescent protein conversion system to systematically characterize oligodeoxynucleotide (ODN)-mediated PGE using Cas9 and its nickase variants in human cells. We demonstrate that, unlike double-stranded DNA (dsDNA) donors with central heterologies, ODNs generated short conversion tracts with Gaussian-like distributions. Interestingly, single-nick-induced PGE using ODN donors produced conversion tracts biased either mostly uni-or bidirectional depending on the relative strandedness of the ODNs and the nick. Moreover, the ODNs were physically incorporated into the genome only in the bidirectional, but not in the unidirectional, conversion pathway. In the presence of double-stranded genomic lesions, the unidirectional conversion pathway was preferentially utilized even though the knock-in mutation could theoretically have been converted by both pathways. Collectively, our results suggest that ODN-mediated PGE utilizes synthesis-dependent strand annealing and single-stranded DNA incorporation pathways. Both of these pathways generate short conversion tracts with Gaussian-like distributions. Although synthesis-dependent strand annealing is preferentially utilized, our work unequivocally establishes the existence of a single-stranded DNA incorporation pathway in human cells. This work extends the paradigms of HDR-mediated gene conversion and establishes guidelines for PGE in human cells.	[Kan, Yinan; Ruis, Brian; Takasugi, Taylor; Hendrickson, Eric A.] Univ Minnesota, Med Sch, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Kan, Yinan] Dept Genet, New Res Bldg, Boston, MA 02115 USA; [Takasugi, Taylor] Yale Univ, Med Sch, Dept Med, New Haven, CT 06510 USA	Hendrickson, EA (reprint author), Univ Minnesota, Med Sch, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	hendr064@umn.edu			National Institutes of Health: the National Institutes of General Medical Sciences [GM088351]; National Cancer Institute [CA154461, CA190492]	We thank Drs. Feng Zhang, Keith Joung, and George Church for sharing plasmids through Addgene. We thank Jason Motl and Nisha Shah at the University of Minnesota Flow Cytometry Core for cell sorting. This work was supported by grants from the National Institutes of Health: the National Institutes of General Medical Sciences (GM088351) and the National Cancer Institute (CA154461 and CA190492).	Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bizard AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016477; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; Byrne SM, 2014, METHOD ENZYMOL, V546, P119, DOI 10.1016/B978-0-12-801185-0.00006-4; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen FQ, 2015, METHODS MOL BIOL, V1239, P251, DOI 10.1007/978-1-4939-1862-1_14; CHEN TR, 1983, CANCER GENET CYTOGEN, V10, P351, DOI 10.1016/0165-4608(83)90092-4; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Davis L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023981; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; Ferrara L, 2004, NUCLEIC ACIDS RES, V32, P5239, DOI 10.1093/nar/gkh822; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI [10.1146/annurev.biochern.77.061306.125255, 10.1146/annurev.biochem.77.061306.125255]; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; HASTINGS PJ, 1988, BIOESSAYS, V9, P61, DOI 10.1002/bies.950090206; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jensen NM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; Karnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047389; Katada H, 2008, NUCL ACIDS S SER OXF, V52, P483; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Kuan Jean Y, 2004, Methods Mol Biol, V262, P173; Langston LD, 2004, P NATL ACAD SCI USA, V101, P15392, DOI 10.1073/pnas.0403748101; LaRocque JR, 2010, MOL CELL BIOL, V30, P1887, DOI 10.1128/MCB.01553-09; Li JL, 2000, GENETICS, V156, P809; Li JL, 2001, MOL CELL BIOL, V21, P501, DOI 10.1128/MCB.21.2.501-510.2001; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu PP, 2014, CELL RES, V24, P886, DOI 10.1038/cr.2014.73; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613                                                             ; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679                                                            ; Murayama Y, 2008, NATURE, V451, P1018, DOI 10.1038/nature06609; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reardon S, 2016, NATURE, V531, P160, DOI 10.1038/531160a; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Siehler SY, 2009, DNA REPAIR, V8, P242, DOI 10.1016/j.dnarep.2008.10.011; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Suzuki T, 2008, FRONT BIOSCI-LANDMRK, V13, P737, DOI 10.2741/2715; Swuec P, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-36; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Wolt JD, 2016, PLANT BIOTECHNOL J, V14, P510, DOI 10.1111/pbi.12444; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu XS, 2005, P NATL ACAD SCI USA, V102, P2508, DOI 10.1073/pnas.0406991102; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134	69	1	1	8	8	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2017	27	7					1099	1111		10.1101/gr.214775.116				13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	EZ5EM	WOS:000404735500001	28356322	gold			2018-01-05	
J	Wang, YM; Xu, XY; Yu, SX; Jeong, KJ; Zhou, ZC; Han, L; Tsang, YH; Li, J; Chen, H; Mangala, LS; Yuan, Y; Eterovic, AK; Lu, YL; Sood, AK; Scott, KL; Mills, GB; Liang, H				Wang, Yumeng; Xu, Xiaoyan; Yu, Shuangxing; Jeong, Kang Jin; Zhou, Zhicheng; Han, Leng; Tsang, Yiu Huen; Li, Jun; Chen, Hu; Mangala, Lingegowda S.; Yuan, Yuan; Eterovic, A. Karina; Lu, Yiling; Sood, Anil K.; Scott, Kenneth L.; Mills, Gordon B.; Liang, Han			Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers	GENOME RESEARCH			English	Article							DEEP SEQUENCING DATA; BREAST-CANCER; STEM-CELLS; DIFFERENTIAL EXPRESSION; MESENCHYMAL TRANSITION; PROGNOSTIC MARKER; MIR-200 FAMILY; GENOME ATLAS; HUMAN BRAIN; IDENTIFICATION	RNA editing, a widespread post-transcriptional mechanism, has emerged as a new player in cancer biology. Recent studies have reported key roles for individual miRNA editing events, but a comprehensive picture of miRNA editing in human cancers remains largely unexplored. Here, we systematically characterized the miRNA editing profiles of 8595 samples across 20 cancer types from miRNA sequencing data of The Cancer Genome Atlas and identified 19 adenosine-to-inosine (A-to-I) RNA editing hotspots. We independently validated 15 of them by perturbation experiments in several cancer cell lines. These miRNA editing events show extensive correlations with key clinical variables (e.g., tumor subtype, disease stage, and patient survival time) and other molecular drivers. Focusing on the RNA editing hotspot in miR-200b, a key tumor metastasis suppressor, we found that the miR-200b editing level correlates with patient prognosis opposite to the pattern observed for the wild-type miR-200b expression. We further experimentally showed that, in contrast to wild-type miRNA, the edited miR-200b can promote cell invasion and migration through its impaired ability to inhibit ZEB1/ZEB2 and acquired concomitant ability to repress new targets, including LIFR, a well-characterized metastasis suppressor. Our study highlights the importance of miRNA editing in gene regulation and suggests its potential as a biomarker for cancer prognosis and therapy.	[Wang, Yumeng; Chen, Hu; Liang, Han] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Wang, Yumeng; Xu, Xiaoyan; Zhou, Zhicheng; Li, Jun; Chen, Hu; Yuan, Yuan; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Xu, Xiaoyan] China Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Shenyang 110122, Liaoning Provin, Peoples R China; [Yu, Shuangxing; Jeong, Kang Jin; Zhou, Zhicheng; Eterovic, A. Karina; Lu, Yiling; Mills, Gordon B.; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Han, Leng] Univ Texas Hlth Sci Ctr Houston, Houston McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Tsang, Yiu Huen] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mangala, Lingegowda S.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Mangala, Lingegowda S.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Liang, H (reprint author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.; Liang, H (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.; Liang, H (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	hliang1@mdanderson.org			National Institutes of Health, National Cancer Institute [CA168394, CA098258, U24CA143883, R01CA175486, U24CA209851, CA016672]; R. Lee Clark Fellow Award from The Jeanne F. Shelby Scholarship Fund; Cancer Prevention and Research Institute of Texas [RP140462]; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine	We acknowledge contributions from the TCGA Research Network and TCGA Pan-Cancer Analysis Working Group. This study was supported by the National Institutes of Health, National Cancer Institute (CA168394, CA098258, and U24CA143883 to G.B.M.; R01CA175486 and U24CA209851 to H.L.; and CCSG grant CA016672); the R. Lee Clark Fellow Award from The Jeanne F. Shelby Scholarship Fund; a grant from the Cancer Prevention and Research Institute of Texas (RP140462 to H.L.); and the Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine (to H.L.). We thank the MD Anderson high-performance computing core facility for computing and LeeAnn Chastain for editorial assistance.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Alon S, 2015, BIOINFORMATICS, V31, P2568, DOI 10.1093/bioinformatics/btv187; Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Cox DR, 1992, BREAKTHROUGHS STAT M, VII, P527; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Eisenberg E, 2010, RNA BIOL, V7, P248, DOI 10.4161/rna.7.2.11565                                                           ; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fumagalli D., 2015, GASTROENTEROLOGY, V13, P277; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gong J, 2017, NUCLEIC ACIDS RES, V45, pD79, DOI 10.1093/nar/gkw835; Gong J, 2014, RNA BIOL, V11, P1375, DOI 10.1080/15476286.2014.996465; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B., 2010, CURR PROTOC BIOINFOR, V11, P7, DOI DOI 10.1002/0471250953.BI1107S32; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nandy SB, 2015, ONCOTARGET, V6, P17366, DOI 10.18632/oncotarget.3953                                                        ; Negi V, 2015, NUCLEIC ACIDS RES, V43, P8057, DOI 10.1093/nar/gkv752; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paz-Yaacov N., 2015, GASTROENTEROLOGY, V13, P267; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saiselet M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2082-3; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Tomaselli S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0575-z; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Warnefors M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r83; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	62	2	2	2	2	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2017	27	7					1112	1125		10.1101/gr.219741.116				14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	EZ5EM	WOS:000404735500002	28411194				2018-01-05	
J	Lu, HY; Villafane, N; Dogruluk, T; Grzeskowiak, CL; Kong, K; Tsang, YH; Zagorodna, O; Pantazi, A; Yang, LX; Neill, NJ; Kim, YW; Creighton, CJ; Verhaak, RG; Mills, GB; Park, PJ; Kucherlapati, R; Scott, KL				Lu, Hengyu; Villafane, Nicole; Dogruluk, Turgut; Grzeskowiak, Caitlin L.; Kong, Kathleen; Tsang, Yiu Huen; Zagorodna, Oksana; Pantazi, Angeliki; Yang, Lixing; Neill, Nicholas J.; Kim, Young Won; Creighton, Chad J.; Verhaak, Roel G.; Mills, Gordon B.; Park, Peter J.; Kucherlapati, Raju; Scott, Kenneth L.			Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer	CANCER RESEARCH			English	Article							CHRONIC MYELOID-LEUKEMIA; IN-VIVO; CHROMOSOMAL TRANSLOCATIONS; CRISPR/CAS TECHNOLOGY; LUNG-CANCER; C-MET; REARRANGEMENTS; INHIBITOR; KINASE; GENERATION	Oncogenic gene fusions drive many human cancers, but tools to more quickly unravel their functional contributions are needed. Here we describe methodology permitting fusion gene construction for functional evaluation. Using this strategy, we engineered the known fusion oncogenes, BCR-ABL1, EML4-ALK, and ETV6-NTRK3, as well as 20 previously uncharacterized fusion genes identified in The Cancer Genome Atlas datasets. In addition to confirming oncogenic activity of the known fusion oncogenes engineered by our construction strategy, we validated five novel fusion genes involving MET, NTRK2, and BRAF kinases that exhibited potent transforming activity and conferred sensitivity to FDA-approved kinase inhibitors. Our fusion construction strategy also enabled domain-function studies of BRAF fusion genes. Our results confirmed other reports that the transforming activity of BRAF fusions results from truncation-mediated loss of inhibitory domains within the N-terminus of the BRAF protein. BRAF mutations residing within this inhibitory region may provide a means for BRAF activation in cancer, therefore we leveraged the modular design of our fusion gene construction methodology to screen N-terminal domain mutations discovered in tumors that are wild-type at the BRAF mutation hotspot, V600. We identified an oncogenic mutation, F247L, whose expression robustly activated the MAPK pathway and sensitized cells to BRAF and MEK inhibitors. When applied broadly, these tools will facilitate rapid fusion gene construction for subsequent functional characterization and translation into personalized treatment strategies. (C) 2017 AACR.	[Lu, Hengyu; Villafane, Nicole; Dogruluk, Turgut; Grzeskowiak, Caitlin L.; Kong, Kathleen; Tsang, Yiu Huen; Zagorodna, Oksana; Neill, Nicholas J.; Kim, Young Won; Scott, Kenneth L.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,BCM225, Houston, TX 77030 USA; [Villafane, Nicole] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Pantazi, Angeliki; Park, Peter J.; Kucherlapati, Raju] Brigham & Womens Hosp, Dept Genet, 75 Francis St, Boston, MA 02115 USA; [Yang, Lixing; Park, Peter J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [Creighton, Chad J.; Scott, Kenneth L.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Verhaak, Roel G.] Jackson Lab, Genom Med, Farmington, CT USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Kucherlapati, Raju] Harvard Med Sch, Dept Genet, Boston, MA USA	Scott, KL (reprint author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,BCM225, Houston, TX 77030 USA.	kls1@bcm.edu		Dogruluk, Turgut/0000-0002-9212-9471	Cancer Prevention and Research Institute of Texas (CPRIT) [RP120046]; NIH [R21CA198320, U01CA168394]; CPRIT [RP140102]; Medical Resident Training Grant [RP14010]; NIH (University of Texas MD Anderson Cancer Center, Houston, TX) [P30CA016672]; NIH (Baylor College of Medicine, Houston, TX) [P30CA125123]	This work was supported by the Cancer Prevention and Research Institute of Texas (CPRIT) RP120046 (to K.L. Scott), R21CA198320 from NIH (to K.L. Scott), U01CA168394 from NIH (to G.B. Mills and K.L. Scott), P30CA016672 from NIH (University of Texas MD Anderson Cancer Center, Houston, TX), and P30CA125123 from NIH (Baylor College of Medicine, Houston, TX). H. Lu and N. Villafane were supported by the CPRIT Pre-Doctoral Fellowship (RP140102) and Medical Resident Training Grant (RP14010), respectively.	Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Botton Thomas, 2013, Pigment Cell Melanoma Res, V26, P845, DOI 10.1111/pcmr.12148; Cancer Genome Atlas Network, 2015, CELL, V161, P1681, DOI DOI 10.1016/J.CELL.2015.05.044; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung LWT, 2014, CANCER CELL, V26, P479, DOI [10.1016/j.cce11.2014.08.017, 10.1016/j.ccell.2014.08.017]; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Cin H, 2011, ACTA NEUROPATHOL, V121, P763, DOI 10.1007/s00401-011-0817-z; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dogruluk T, 2015, CANCER RES, V75, P5341, DOI 10.1158/0008-5472.CAN-15-1654; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401                                                     ; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901                                                              ; Falchi L, 2014, LEUKEMIA, V28, P2090, DOI 10.1038/leu.2014.168; Furlan A, 2014, CANCER RES, V74, P6737, DOI 10.1158/0008-5472.CAN-14-1932; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grubbs EG, 2015, J CLIN ENDOCR METAB, V100, P788, DOI 10.1210/jc.2014-4153; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hutchinson KE, 2013, CLIN CANCER RES, V19, P6696, DOI 10.1158/1078-0432.CCR-13-1746; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lekomtsev S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3084-5; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Rolfo C, 2015, EXPERT OPIN INV DRUG, V24, P1493, DOI 10.1517/13543784.2015.1096344; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604                                                              ; Schwaab J, 2015, ANN HEMATOL, V94, P233, DOI 10.1007/s00277-014-2221-y; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI 10.1056/NEJMoa1311107; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shin Clifford H, 2015, Genes Cancer, V6, P9; SOULE HD, 1990, CANCER RES, V50, P6075; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639                                                             ; STANTON VP, 1987, MOL CELL BIOL, V7, P1171, DOI 10.1128/MCB.7.3.1171                                                            ; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tsang YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10500; Wardwell-Ozgo J, 2014, ONCOGENE, V33, P1017, DOI 10.1038/onc.2013.30; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f                                                    ; Yang LX, 2016, AM J HUM GENET, V98, P843, DOI 10.1016/j.ajhg.2016.03.017; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	49	0	0	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	JUL 1	2017	77	13					3502	3512		10.1158/0008-5472.CAN-16-2745				11	Oncology	Oncology	EZ4YM	WOS:000404718400012	28512244				2018-01-05	
J	Peng, RC; Xu, Y; Zhu, TF; Li, NN; Qi, JX; Chai, Y; Wu, M; Zhang, XZ; Shi, Y; Wang, PY; Wang, JW; Gao, N; Gao, GF				Peng, Ruchao; Xu, Ying; Zhu, Tengfei; Li, Ningning; Qi, Jianxun; Chai, Yan; Wu, Min; Zhang, Xinzheng; Shi, Yi; Wang, Peiyi; Wang, Jiawei; Gao, Ning; Gao, George Fu			Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures	CELL RESEARCH			English	Article						CRISPR/Cas system; anti-CRISPR proteins; phage; immune evasion; cryo-EM	BACTERIAL IMMUNE-SYSTEM; VIBRIO-PARAHAEMOLYTICUS; BACTERIOPHAGE THERAPY; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; CAS SYSTEMS; DNA; MECHANISMS; CASCADE; CRYSTALLOGRAPHY	Bacterioph ages encode anti-CRISPR suppressors to counteract the CRISPR/Cas immunity of their bacterial hosts, thus facilitating their survival and replication. Previous studies have shown that two phage-encoded anti-CRISPR proteins, AcrF1 and AcrF2, suppress the type I-F CRISPR/Cas system of Pseudomonas aeruginosa by preventing target DNA recognition by the Csy surveillance complex, but the precise underlying mechanism was unknown. Here we present the structure of AcrF1/2 bound to the Csy complex determined by cryo-EM single-particle reconstruction. By structural analysis, we found that AcrF1 inhibits target DNA recognition of the Csy complex by interfering with base pairing between the DNA target strand and crRNA spacer. In addition, multiple copies of AcrF1 bind to the Csy complex with different modes when working individually or cooperating with AcrF2, which might exclude target DNA binding through different mechanisms. Together with previous reports, we provide a comprehensive working scenario for the two anti-CRISPR suppressors, AcrF1 and AcrF2, which silence CRISPR/Cas immunity by targeting the Csy surveillance complex.	[Peng, Ruchao; Xu, Ying; Qi, Jianxun; Chai, Yan; Shi, Yi; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Peng, Ruchao; Zhu, Tengfei; Qi, Jianxun; Shi, Yi; Gao, George Fu] Univ Chinese Acad Sci, Beijing 101408, Peoples R China; [Xu, Ying] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhu, Tengfei; Gao, George Fu] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China; [Li, Ningning; Gao, Ning] Peking Univ, Sch Life Sci, Peking Tsinghua Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Wu, Min] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58203 USA; [Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Shi, Yi; Gao, George Fu] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Guangdong, Peoples R China; [Shi, Yi; Gao, George Fu] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China; [Wang, Peiyi] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Wang, Jiawei] Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Gao, George Fu] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Gao, GF (reprint author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Gao, GF (reprint author), Univ Chinese Acad Sci, Beijing 101408, Peoples R China.; Gao, GF (reprint author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.; Gao, N (reprint author), Peking Univ, Sch Life Sci, Peking Tsinghua Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.; Gao, GF (reprint author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Guangdong, Peoples R China.; Gao, GF (reprint author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.; Wang, PY (reprint author), Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.; Wang, JW (reprint author), Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.; Gao, GF (reprint author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.	fbspw@leeds.ac.uk; jwwang@tsinghua.edu.cn; gaon@pku.edu.cn; gaof@im.ac.cn		Gao, Ning/0000-0003-3067-9993	CAS [XDB08020100]; Ministry of Science and Technology of China (973 Project) [2013CB531502, 2014CB542503]; National Natural Science Foundation of China (NSFC) [81622031]; Excellent Young Scientist Program of CAS; Youth Innovation Promotion Association CAS [2015078]	We thank all staffs at the National Center for Protein Science Shanghai (NCPSS) cryo-EM department and Xiaojun Huang, Gang Ji and other staffs at the Center of Biological Imaging (IBP, Chinese Academy of Sciences (CAS)) for assistance with data collection. We are grateful to Dr Guopeng Wang (The Core Facilities at School of Life Sciences, Peking University) and Dr Tie Yang (The State Key Laboratory of Membrane Biology, Institute of Zoology, CAS, Beijing) for technical support in electron microscope operation. This study was supported by the Strategic Priority Research Program of CAS (XDB08020100), the Ministry of Science and Technology of China (973 Project; 2013CB531502 and 2014CB542503). YS is supported by the Excellent Young Scientist Program from the National Natural Science Foundation of China (NSFC; 81622031), the Excellent Young Scientist Program of CAS and the Youth Innovation Promotion Association CAS (2015078). GFG is supported partly as a leading principal investigator of the NSFC Innovative Research Group (81621091).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Chaudhary K, 2017, J CELL PHYSL, DOI [10.1002/jcp.25877, DOI 10.1002/JCP.25877]; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Grant T, 2015, J STRUCT BIOL, V192, P204, DOI 10.1016/j.jsb.2015.08.006; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jore MM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003657; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Jun JW, 2014, INT J FOOD MICROBIOL, V188, P31, DOI 10.1016/j.ijfoodmicro.2014.07.007; Jun JW, 2014, J INFECT DIS, V210, P72, DOI 10.1093/infdis/jiu059; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Maxwell KL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005282; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Skurnik Mikael, 2016, Duodecim, V132, P712; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Wang JY, 2016, CELL RES, V26, P1165, DOI 10.1038/cr.2016.103; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Xu YQ, 2015, VIROL SIN, V30, P11, DOI 10.1007/s12250-014-3543-6; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	43	1	1	10	10	INST BIOCHEMISTRY & CELL BIOLOGY	SHANGHAI	SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA	1001-0602	1748-7838		CELL RES	Cell Res.	JUL	2017	27	7					853	864		10.1038/cr.2017.79				12	Cell Biology	Cell Biology	EZ3NU	WOS:000404618500005	28574055				2018-01-05	
J	Zuo, EW; Cai, YJ; Li, K; Wei, Y; Wang, BA; Sun, YD; Liu, Z; Liu, JW; Hu, XD; Wei, W; Huo, XN; Shi, LY; Tang, C; Liang, D; Wang, Y; Nie, YH; Zhang, CC; Yao, X; Wang, X; Zhou, CY; Ying, WQ; Wang, QF; Chen, RC; Shen, Q; Xu, GL; Li, JS; Sun, Q; Xiong, ZQ; Yang, H				Zuo, Erwei; Cai, Yi-Jun; Li, Kui; Wei, Yu; Wang, Bang-An; Sun, Yidi; Liu, Zhen; Liu, Jiwei; Hu, Xinde; Wei, Wei; Huo, Xiaona; Shi, Linyu; Tang, Cheng; Liang, Dan; Wang, Yan; Nie, Yan-Hong; Zhang, Chen-Chen; Yao, Xuan; Wang, Xing; Zhou, Changyang; Ying, Wenqin; Wang, Qifang; Chen, Ren-Chao; Shen, Qi; Xu, Guo-Liang; Li, Jinsong; Sun, Qiang; Xiong, Zhi-Qi; Yang, Hui			One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs	CELL RESEARCH			English	Article						complete gene knockout; CRISPR/Cas9; multiple sgRNAs	RNA-GUIDED ENDONUCLEASES; OFF-TARGET MUTATIONS; CYNOMOLGUS MONKEY; MOUSE; CAS9; CELLS; TALEN; CRISPR-CAS9; SPECIFICITY; DISRUPTION	The CRISPR/Cas9 system is an efficient gene-editing method, but the majority of gene-edited animals showed mosaicism, with editing occurring only in a portion of cells. Here we show that single gene or multiple genes can be completely knocked out in mouse and monkey embryos by zygotic injection of Cas9 mRNA and multiple adjacent single-guide RNAs (spaced 10-200 bp apart) that target only a single key exon of each gene. Phenotypic analysis of F0 mice following targeted deletion of eight genes on the Y chromosome individually demonstrated the robustness of this approach in generating knockout mice. Importantly, this approach delivers complete gene knockout at high efficiencies (100% on Arntl and 91% on Prrt2) in monkey embryos. Finally, we could generate a complete Prrt2 knockout monkey in a single step, demonstrating the usefulness of this approach in rapidly establishing gene-edited monkey models.	[Zuo, Erwei; Cai, Yi-Jun; Li, Kui; Wang, Bang-An; Liu, Zhen; Liu, Jiwei; Hu, Xinde; Wei, Wei; Huo, Xiaona; Shi, Linyu; Tang, Cheng; Wang, Yan; Nie, Yan-Hong; Zhang, Chen-Chen; Yao, Xuan; Wang, Xing; Zhou, Changyang; Ying, Wenqin; Wang, Qifang; Chen, Ren-Chao; Shen, Qi; Sun, Qiang; Xiong, Zhi-Qi; Yang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Institute Neurosci,State Key Lab Neurosci,Key Lab, CAS Ctr Excellence Brain Sci & Intelligence Techn, Shanghai 200031, Peoples R China; [Wei, Yu; Liang, Dan; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,Shanghai Key Lab Mol And, CAS Ctr Excellence Mol Cell Sci,State Key Lab Cel, Shanghai 200031, Peoples R China; [Wang, Bang-An; Xu, Guo-Liang] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci,State Key Lab Mol Biol, CAS Ctr Excellence Mol Cell Sci,Inst Biochem & Ce, Shanghai 200031, Peoples R China; [Wei, Yu] Shanghai Univ, Shanghai 200444, Peoples R China; [Wei, Wei] Guangxi Univ, Coll Anim Sci & Technol, Nanning 530004, Guangxi, Peoples R China; [Sun, Yidi] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Shi, Linyu] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China; [Liu, Zhen; Tang, Cheng; Yao, Xuan; Wang, Xing; Zhou, Changyang] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Sun, Q; Xiong, ZQ; Yang, H (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Institute Neurosci,State Key Lab Neurosci,Key Lab, CAS Ctr Excellence Brain Sci & Intelligence Techn, Shanghai 200031, Peoples R China.	qsun@ion.ac.cn; xiongzhiqi@ion.ac.cn; huiyang@ion.ac.cn		yang, hui/0000-0003-3590-722X; Li, Kui/0000-0003-4187-4276	CAS [XDB02050007, XDA01010409]; National High-tech R&D Program (863 Program) [2015AA020307]; National Natural Science Foundation of China [31522037, 31500825]; China Youth Thousand Talents Program; Break-through project of Chinese Academy of Sciences; Shanghai Sailing Plan for the Young Scientific Talents [15YF1414700]; National Key Technology R&D Program of China [2014BAI03B00]; Shanghai City Committee of science and technology project [16JC1420202, 14140900100]; CAS Hundreds of Talents Program of China	We thank Drs Mu-ming Poo and Dangsheng Li for comments on the manuscript. This work was supported by CAS Strategic Priority Research Program (XDB02050007, XDA01010409), the National High-tech R&D Program (863 Program; 2015AA020307), the National Natural Science Foundation of China grants (31522037, 31500825), China Youth Thousand Talents Program (to HY), Break-through project of Chinese Academy of Sciences, Shanghai Sailing Plan for the Young Scientific Talents (15YF1414700), The National Key Technology R&D Program of China (2014BAI03B00, QS), Shanghai City Committee of science and technology project (16JC1420202, HY; 14140900100, Q.S.), CAS Hundreds of Talents Program of China (QS).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Dai HQ, 2016, NATURE, V538, P528, DOI 10.1038/nature20095; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Goyal HO, 2001, BIOL REPROD, V64, P927, DOI 10.1095/biolreprod64.3.927; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Izpisua BJC, 2015, NEURON, V86, P617; Jennings C, 2016, NAT NEUROSCI, V19, P1123, DOI 10.1038/nn.4362; Kang J, 2015, P NATL ACAD SCI USA, V112, pE4236, DOI 10.1073/pnas.1510510112; Kato T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03136; Kotani H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128319; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Matsubara Y, 2015, STEM CELLS DEV, V24, P1164, DOI 10.1089/scd.2014.0466; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Sato M, 2015, INT J MOL SCI, V16, P17838, DOI 10.3390/ijms160817838; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Sun Q, 2008, P NATL ACAD SCI USA, V105, P12956, DOI 10.1073/pnas.0805639105; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tang L, 2015, ANIM REPROD, V12, P93; Tu ZC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42081; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	37	0	0	13	13	INST BIOCHEMISTRY & CELL BIOLOGY	SHANGHAI	SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA	1001-0602	1748-7838		CELL RES	Cell Res.	JUL	2017	27	7					933	945		10.1038/cr.2017.81				13	Cell Biology	Cell Biology	EZ3NU	WOS:000404618500010	28585534	gold			2018-01-05	
J	Chadwick, AC; Musunuru, K				Chadwick, Alexandra C.; Musunuru, Kiran			Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing	CURRENT ATHEROSCLEROSIS REPORTS			English	Review						Genome editing; Dyslipidemia; CRISPR/Cas9; PCSK9; Cardiovascular disease	INNATE IMMUNE-RESPONSE; GUIDED CAS9 NUCLEASES; ONE-STEP GENERATION; CRISPR-CAS9 NUCLEASES; MAMMALIAN-CELLS; HEART-DISEASE; DNA CLEAVAGE; SPECIFICITY; PCSK9; ADENOVIRUS	Purpose of Review Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) has recently emerged as a top genome editing technology and has afforded investigators the ability to more easily study a number of diseases. This review discusses CRISPR/Cas9's advantages and limitations and highlights a few recent reports on genome editing applications for alleviating dyslipidemia through disruption of proprotein convertase subtilisin/kexin type 9 (PCSK9). Recent Findings Targeting of mouse Pcsk9 using CRISPR/Cas9 technology has yielded promising results for lowering total cholesterol levels, and several recent findings are highlighted in this review. Reported on-target mutagenesis efficiency is as high as 90% with a subsequent 40% reduction of blood cholesterol levels in mice, highlighting the potential for use as a therapeutic in human patients. Summary The ability to characterize and treat diseases is becoming easier with the recent advances in genome editing technologies. In this review, we discuss how genome editing strategies can be of use for potential therapeutic applications.	[Chadwick, Alexandra C.; Musunuru, Kiran] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Dept Med, Philadelphia, PA 19104 USA; [Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Cardiovasc Inst, Dept Med, Philadelphia, PA 19104 USA.; Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kiranmusunuru@gmail.com					Cayo MA, 2017, CELL STEM CELL, V20, P478, DOI 10.1016/j.stem.2017.01.011; Chadwick AC, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0830-5; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Gupta RM, 2016, ARTERIOSCL THROM VAS, V36, P15, DOI 10.1161/ATVBAHA.115.305956; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Ji DN, 2015, TRANSGENIC RES, V24, P227, DOI 10.1007/s11248-014-9834-8; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Li J, 2015, CIRC RES, V116, P1655, DOI 10.1161/CIRCRESAHA.116.306287; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Niimi M, 2016, ATHEROSCLEROSIS, V245, P187, DOI 10.1016/j.atherosclerosis.2015.12.002; Nishida K, 2016, SCIENCE, V16, P353; Pashos EE, 2017, CELL STEM CELL, V20, P558, DOI 10.1016/j.stem.2017.03.017; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI 10.1056/NEJMoa1615664; Seeger T, 2017, CIRC RES, V120, P778, DOI 10.1161/CIRCRESAHA.116.310197; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Strong A, 2017, NAT REV CARDIOL, V14, P11, DOI 10.1038/nrcardio.2016.139; Termglinchan V, 2016, GENOME EDITING, P107; Umeyama K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24413; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Warren CR, 2017, CELL STEM CELL, V20, P547, DOI 10.1016/j.stem.2017.01.010; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhu X, 2015, HYPERTENSION; Zou J, 2015, ELIFE, V4, DOI 10.7554/eLife.09406	52	0	0	12	12	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1523-3804	1534-6242		CURR ATHEROSCLER REP	Curr. Atheroscleros. Rep.	JUL	2017	19	7							32	10.1007/s11883-017-0668-8				6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	EZ2KG	WOS:000404537600003	28550381				2018-01-05	
J	Fish, JE; Gutierrez, MC; Dang, LT; Khyzha, N; Chen, ZQ; Veitch, S; Cheng, HS; Khor, M; Antounians, L; Njock, MS; Boudreau, E; Herman, AM; Rhyner, AM; Ruiz, OE; Eisenhoffer, GT; Medina-Rivera, A; Wilson, MD; Wythe, JD				Fish, Jason E.; Gutierrez, Manuel Cantu; Dang, Lan T.; Khyzha, Nadiya; Chen, Zhiqi; Veitch, Shawn; Cheng, Henry S.; Khor, Melvin; Antounians, Lina; Njock, Makon-Sebastien; Boudreau, Emilie; Herman, Alexander M.; Rhyner, Alexander M.; Ruiz, Oscar E.; Eisenhoffer, George T.; Medina-Rivera, Alejandra; Wilson, Michael D.; Wythe, Joshua D.			Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network	DEVELOPMENT			English	Article						Endothelial cell; Transcription; Enhancer; Angiogenesis; Genome editing; ETS factor; Zebrafish; Mouse; Human	FACTOR ERG; INDUCED ANGIOGENESIS; ENDOTHELIAL-CELLS; ETS FAMILY; ZEBRAFISH; NOTCH; DIFFERENTIATION; EXPRESSION; LYMPHANGIOGENESIS; MORPHOGENESIS	The transcriptional pathways activated downstream of vascular endothelial growth factor (VEGF) signaling during angiogenesis remain incompletely characterized. By assessing the signals responsible for induction of the Notch ligand delta-like 4 (DLL4) in endothelial cells, we find that activation of the MAPK/ERK pathway mirrors the rapid and dynamic induction of DLL4 transcription and that this pathway is required for DLL4 expression. Furthermore, VEGF/ERK signaling induces phosphorylation and activation of the ETS transcription factor ERG, a prerequisite for DLL4 induction. Transcription of DLL4 coincides with dynamic ERG-dependent recruitment of the transcriptional co-activator p300. Genome-wide gene expression profiling identified a network of VEGF-responsive and ERG-dependent genes, and ERG chromatin immunoprecipitation (ChIP)-seq revealed the presence of conserved ERG-bound putative enhancer elements near these target genes. Functional experiments performed in vitro and in vivo confirm that this network of genes requires ERK, ERG and p300 activity. Finally, genome-editing and transgenic approaches demonstrate that a highly conserved ERG-bound enhancer located upstream of HLX (which encodes a transcription factor implicated in sprouting angiogenesis) is required for its VEGF-mediated induction. Collectively, these findings elucidate a novel transcriptional pathway contributing to VEGF-dependent angiogenesis.	[Fish, Jason E.; Dang, Lan T.; Khyzha, Nadiya; Chen, Zhiqi; Veitch, Shawn; Cheng, Henry S.; Khor, Melvin; Njock, Makon-Sebastien; Boudreau, Emilie] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada; [Fish, Jason E.; Dang, Lan T.; Khyzha, Nadiya; Chen, Zhiqi; Veitch, Shawn; Cheng, Henry S.; Khor, Melvin; Njock, Makon-Sebastien; Boudreau, Emilie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Fish, Jason E.; Dang, Lan T.; Khyzha, Nadiya; Chen, Zhiqi; Veitch, Shawn; Cheng, Henry S.; Khor, Melvin; Njock, Makon-Sebastien; Boudreau, Emilie; Wilson, Michael D.] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5S 3H2, Canada; [Gutierrez, Manuel Cantu; Herman, Alexander M.; Rhyner, Alexander M.; Wythe, Joshua D.] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA; [Gutierrez, Manuel Cantu; Herman, Alexander M.; Rhyner, Alexander M.; Wythe, Joshua D.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Gutierrez, Manuel Cantu; Eisenhoffer, George T.; Wythe, Joshua D.] Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; [Antounians, Lina; Medina-Rivera, Alejandra; Wilson, Michael D.] Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Antounians, Lina; Wilson, Michael D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ruiz, Oscar E.; Eisenhoffer, George T.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Eisenhoffer, George T.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Medina-Rivera, Alejandra] Univ Nacl Autonoma Mexico, Lab Int Invest Genoma Humano, Queretaro 76230, Mexico	Fish, JE (reprint author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada.; Fish, JE (reprint author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.; Fish, JE (reprint author), Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5S 3H2, Canada.; Wythe, JD (reprint author), Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA.; Wythe, JD (reprint author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.; Wythe, JD (reprint author), Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA.	jason.fish@utoronto.ca; wythe@bcm.edu	Wilson, Michael/K-6294-2014	Wilson, Michael/0000-0002-4015-3066; Dang, Lan Thi Hoang/0000-0002-5704-4552	Canadian Institutes of Health Research (CIHR) [MOP-119506]; Leaders Opportunity Fund/Canada Foundation for Innovation [26422]; Ontario Ministry of Research and Innovation; University of Toronto's Medicine by Design initiative; Canada First Research Excellence Fund; Toronto General Hospital Research Institute; Natural Sciences and Engineering Research Council of Canada; Vascular Network Scholar Award (CIHR); Ontario Graduate Student award; Natural Sciences and Engineering Research Council of Canada (NSERC) [4361942013]; Alexander Graham Bell Canada Graduate Scholarship; CONACYT [269449, 203853]; Programa de Apoyo a Proyectos de investigacion e innovacion tecnologica - Universidad Nacional Autonoma de Mexico (PAPII-TUNAM) [IA206517]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR140077]; Cytometry and Cell Sorting Core at Baylor College of Medicine; CVRI at Baylor College of Medicine; Caroline Wiess Law Fund; Curtis Hankamer Basic Research Fund; ARCO Foundation Young Teacher-Investigator; American Heart Association [16GRNT31330023]; CIHR; CIHR STAGE; National Institutes of Health [CA125123, RR024574]; Molecular Physiology of the Cardiovascular System Training Grant, National Institutes of Health [T32HL07676]	J.E.F. was funded by an operating grant from the Canadian Institutes of Health Research (CIHR) (MOP-119506), and a Leaders Opportunity Fund/Canada Foundation for Innovation equipment grant (26422). J.E.F. and M.D.W. were supported by Early Researcher Awards from the Ontario Ministry of Research and Innovation, Canada Research Chairs from CIHR, and a Team Project Award from the University of Toronto's Medicine by Design initiative, which receives funding from the Canada First Research Excellence Fund. L.T.D. was supported by a postdoctoral fellowship from the Toronto General Hospital Research Institute, N.K. was supported by a Canada Graduate Studentship from the Natural Sciences and Engineering Research Council of Canada. M.S.N. was supported by a Vascular Network Scholar Award (CIHR funded). H.S.C. was supported by an Ontario Graduate Student award. ChIP-seq and bioinformatics work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (4361942013 to M.D.W.). L.A. was supported by an Alexander Graham Bell Canada Graduate Scholarship; and A.M.-R. was supported by a CONACYT fellowship (203853) and a CIHR STAGE fellowship. A.M.-R.'s laboratory is supported by a CONACYT grant (269449) and a Programa de Apoyo a Proyectos de investigacion e innovacion tecnologica - Universidad Nacional Autonoma de Mexico (PAPII-TUNAM) grant (IA206517). G.T.E. was supported by a Cancer Prevention and Research Institute of Texas (CPRIT) First-Time Tenure-Track Faculty Recruitment Award (RR140077). This project was supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the National Institutes of Health (CA125123 and RR024574). A.M.H. was supported by a Molecular Physiology of the Cardiovascular System Training Grant, The National Institutes of Health (T32HL07676). J.D.W. was supported by institutional startup funds from the CVRI at Baylor College of Medicine, the Caroline Wiess Law Fund, the Curtis Hankamer Basic Research Fund, and the ARCO Foundation Young Teacher-Investigator Award. Work within the Wythe lab is supported by the American Heart Association (16GRNT31330023). Deposited in PMC for release after 12 months.	Adamo P, 2016, ONCOGENE, V35, P403, DOI 10.1038/onc.2015.109; Al-Greene NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069660; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Ballester B, 2014, ELIFE, V3, DOI 10.7554/eLife.02626; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Birdsey GM, 2012, BLOOD, V119, P894, DOI 10.1182/blood-2011-04-350025; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0                                                                ; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; Costa G, 2016, NAT CELL BIOL, V18, P1292, DOI 10.1038/ncb3443; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750                                                         ; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herbert SP, 2012, CURR BIOL, V22, P1789, DOI 10.1016/j.cub.2012.07.037; Herbert SP, 2011, EXP CELL RES, V12, P551, DOI DOI 10.1038/NRM3176; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iaccarino G, 2005, CIRC RES, V97, P1182, DOI 10.1161/01.RES.0000191541.06788.bb; Inoue D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019713; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0                                                                ; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Le Guen L, 2014, DEVELOPMENT, V141, P1239, DOI 10.1242/dev.100495; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mirza MA, 2013, BRAIN RES BULL, V98, P111, DOI 10.1016/j.brainresbull.2013.07.011; Moehler TM, 2008, J CELL PHYSIOL, V215, P27, DOI 10.1002/jcp.21285; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Pin AL, 2012, ANGIOGENESIS, V15, P593, DOI 10.1007/s10456-012-9283-z; Prahst C, 2014, ARTERIOSCL THROM VAS, V34, P1468, DOI 10.1161/ATVBAHA.114.303626; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Randi AM, 2009, BIOCHEM SOC T, V37, P1248, DOI 10.1042/BST0371248; Rodriguez CI, 2000, NAT GENET, V25, P139; Roman BL, 2002, DEVELOPMENT, V129, P3009; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Sacilotto N, 2016, GENE DEV, V30, P2297, DOI 10.1101/gad.290619.116; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Schultz H, 1997, J CELL PHYSIOL, V173, P310, DOI 10.1002/(SICI)1097-4652(199712)173:3<310::AID-JCP2>3.0.CO;2-Q; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902                                                              ; Selvaraj N, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0089-7; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shin M, 2016, DEVELOPMENT, V143, P3796, DOI 10.1242/dev.137919; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Testori J, 2011, BLOOD, V117, P2735, DOI 10.1182/blood-2010-07-293209; Toffoli S, 2009, ANGIOGENESIS, V12, P339, DOI 10.1007/s10456-009-9156-2; Ubezio B, 2016, ELIFE, V5, DOI 10.7554/eLife.12167; Vijayaraj P, 2012, DEVELOPMENT, V139, P3973, DOI 10.1242/dev.081596; Wang J, 2016, DEVELOPMENT, V143, P504, DOI 10.1242/dev.126920; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wythe JD, 2013, DEV CELL, V26, P45, DOI 10.1016/j.devcel.2013.06.007; Wythe JD, 2011, DIS MODEL MECH, V4, P607, DOI 10.1242/dmm.002204; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yuan L, 2012, J BIOL CHEM, V287, P6582, DOI 10.1074/jbc.M111.300236; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zhang B, 2013, GENOME RES, V23, P917, DOI 10.1101/gr.149674.112; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	78	0	0	6	6	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	JUL 1	2017	144	13					2428	2444		10.1242/dev.146050				17	Developmental Biology	Developmental Biology	EZ3SP	WOS:000404631000012	28536097				2018-01-05	
J	Cortina, C; Turon, G; Stork, D; Hernando-Momblona, X; Sevillano, M; Aguilera, M; Tosi, S; Merlos-Suarez, A; Attolini, CSO; Sancho, E; Batlle, E				Cortina, Carme; Turon, Gemma; Stork, Diana; Hernando-Momblona, Xavier; Sevillano, Marta; Aguilera, Monica; Tosi, Sebastien; Merlos-Suarez, Anna; Stephan-Otto Attolini, Camille; Sancho, Elena; Batlle, Eduard			A genome editing approach to study cancer stem cells in human tumors	EMBO MOLECULAR MEDICINE			English	Article						cancer stem cells; colorectal cancer; CRISPR/ Cas9; LGR5	COLORECTAL-CANCER; SMALL-INTESTINE; COLON; CRYPT; REVEALS; ADENOMAS	The analysis of stem cell hierarchies in human cancers has been hampered by the impossibility of identifying or tracking tumor cell populations in an intact environment. To overcome this limitation, we devised a strategy based on editing the genomes of patientderived tumor organoids using CRISPR/ Cas9 technology to integrate reporter cassettes at desired marker genes. As proof of concept, we engineered human colorectal cancer (CRC) organoids that carry EGFP and lineage-tracing cassettes knocked in the LGR5 locus. Analysis of LGR5-EGFP(+) cells isolated from organoid-derived xenografts demonstrated that these cells express a gene program similar to that of normal intestinal stem cells and that they propagate the disease to recipient mice very efficiently. Lineage-tracing experiments showed that LGR5(+) CRC cells self-renew and generate progeny over long time periods that undergo differentiation toward mucosecreting-and absorptive-like phenotypes. These genetic experiments confirm that human CRCs adopt a hierarchical organization reminiscent of that of the normal colonic epithelium. The strategy described herein may have broad applications to study cell heterogeneity in human tumors.	[Cortina, Carme; Turon, Gemma; Stork, Diana; Hernando-Momblona, Xavier; Sevillano, Marta; Aguilera, Monica; Tosi, Sebastien; Merlos-Suarez, Anna; Stephan-Otto Attolini, Camille; Sancho, Elena; Batlle, Eduard] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Batlle, Eduard] ICREA, Barcelona, Spain; [Batlle, Eduard] CIBER ONC, Barcelona, Spain	Batlle, E (reprint author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Batlle, E (reprint author), ICREA, Barcelona, Spain.; Batlle, E (reprint author), CIBER ONC, Barcelona, Spain.	eduard.batlle@irbbarcelona.org	Batlle, Eduard/K-8080-2014	Batlle, Eduard/0000-0003-2422-0326	European Research Council (ERC) [340176]; Fundacion Botin; Banco Santander, through Santander Universities; Severo Ochoa Award of Excellence from the MINECO	We thank all members of the Batlle laboratory for support and discussions. We are grateful for the excellent assistance by IRB Barcelona core facilities for histology, functional genomics, biostatistics/bioinformatics, and advanced digital microscopy, as well as the flow cytometry and animal facilities of the UB/PCB. This work has been financed by the European Research Council (ERC advanced grant 340176). Work in the laboratory of EB is also supported by Fundacion Botin and Banco Santander, through Santander Universities. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from the MINECO.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basak O, 2014, EMBO J, V33, P2057, DOI 10.15252/embj.201488017; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9                   ; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0                                                   ; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zeuner A, 2014, CELL STEM CELL, V15, P692, DOI 10.1016/j.stem.2014.11.012	29	2	2	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-4676	1757-4684		EMBO MOL MED	EMBO Mol. Med.	JUL	2017	9	7					869	879		10.15252/emmm.201707550				11	Medicine, Research & Experimental	Research & Experimental Medicine	EZ2PO	WOS:000404552000004	28468934	gold			2018-01-05	
J	Lamborn, IT; Jing, H; Zhang, Y; Drutman, SB; Abbott, JK; Munir, S; Bade, S; Murdock, HM; Santos, CP; Brock, LG; Masutani, E; Fordjour, EY; McElwee, JJ; Hughes, JD; Nichols, DP; Belkadi, A; Oler, AJ; Happel, CS; Matthews, HF; Abel, L; Collins, PL; Subbarao, K; Gelfand, EW; Ciancanelli, MJ; Casanova, JL; Su, HC				Lamborn, Ian T.; Jing, Huie; Zhang, Yu; Drutman, Scott B.; Abbott, Jordan K.; Munir, Shirin; Bade, Sangeeta; Murdock, Heardley M.; Santos, Celia P.; Brock, Linda G.; Masutani, Evan; Fordjour, Emmanuel Y.; McElwee, Joshua J.; Hughes, Jason D.; Nichols, Dave P.; Belkadi, Aziz; Oler, Andrew J.; Happel, Corinne S.; Matthews, Helen F.; Abel, Laurent; Collins, Peter L.; Subbarao, Kanta; Gelfand, Erwin W.; Ciancanelli, Michael J.; Casanova, Jean-Laurent; Su, Helen C.			Recurrent rhinovirus infections in a child with inherited MDA5 deficiency	JOURNAL OF EXPERIMENTAL MEDICINE			English	Article							INFLUENZA-A VIRUS; AICARDI-GOUTIERES SYNDROME; PARTICLE MESH EWALD; I INTERFERON; RIG-I; INNATE IMMUNITY; RESPIRATORY VIRUSES; EXPLICIT SOLVENT; DENDRITIC CELLS; RNA VIRUSES	MDA5 is a cytosolic sensor of double-stranded RNA (ds)RNA including viral byproducts and intermediates. We studied a child with life-threatening, recurrent respiratory tract infections, caused by viruses including human rhinovirus (HRV), influenza virus, and respiratory syncytial virus (RSV). We identified in her a homozygous missense mutation in IFIH1 that encodes MDA5. Mutant MDA5 was expressed but did not recognize the synthetic MDA5 agonist/(ds)RNA mimic polyinosinic-polycytidylic acid. When overexpressed, mutant MDA5 failed to drive luciferase activity from the IFNB1 promoter or promoters containing ISRE or NF-kappa B sequence motifs. In respiratory epithelial cells or fibroblasts, wild-type but not knockdown of MDA5 restricted HRV infection while increasing IFN-stimulated gene expression and IFN-beta/lambda. However, wild-type MDA5 did not restrict influenza virus or RSV replication. Moreover, nasal epithelial cells from the patient, or fibroblasts gene-edited to express mutant MDA5, showed increased replication of HRV but not influenza or RSV. Thus, human MDA5 deficiency is a novel inborn error of innate and/or intrinsic immunity that causes impaired (ds) RNA sensing, reduced IFN induction, and susceptibility to the common cold virus.	[Lamborn, Ian T.; Jing, Huie; Zhang, Yu; Murdock, Heardley M.; Fordjour, Emmanuel Y.; Happel, Corinne S.; Su, Helen C.] NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Munir, Shirin; Santos, Celia P.; Brock, Linda G.; Collins, Peter L.; Subbarao, Kanta] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Masutani, Evan; Matthews, Helen F.] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Oler, Andrew J.] NIAID, Bioinformat & Computat Biosci Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lamborn, Ian T.; Su, Helen C.] Univ Penn, Dept Pathol & Lab Med, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Abbott, Jordan K.; Gelfand, Erwin W.] Natl Jewish Hlth, Immunodeficiency Diag & Treatment Program, Div Allergy & Immunol, Denver, CO USA; [Nichols, Dave P.] Natl Jewish Hlth, Div Pediat Pulm Med, Dept Pediat, Denver, CO USA; [Drutman, Scott B.; Abel, Laurent; Ciancanelli, Michael J.; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA; [Drutman, Scott B.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Bade, Sangeeta] Med Sci & Comp LLC, Rockville, MD USA; [McElwee, Joshua J.; Hughes, Jason D.] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Belkadi, Aziz; Abel, Laurent; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Necker Hosp Sick Children, INSERM,UMR1163,Lab Human Genet Infect Dis,Necker, Paris, France; [Belkadi, Aziz; Abel, Laurent; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Necker Hosp Sick Children, Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Immunohematol Unit, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA	Su, HC (reprint author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Su, HC (reprint author), Univ Penn, Dept Pathol & Lab Med, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	hsu@niaid.nih.gov	Su, Helen/H-9541-2015	Su, Helen/0000-0002-5582-9110	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Center for Research Resources; National Center for Advancing Sciences of the National Institutes of Health [8UL1TR000043]; St. Giles Foundation; Rockefeller University; National Jewish Health; CSL Behring;  [T32CA009207]	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, the National Center for Research Resources, and the National Center for Advancing Sciences of the National Institutes of Health (grant 8UL1TR000043), the St. Giles Foundation, the Rockefeller University, and National Jewish Health. S.B. Drutman is supported by T32CA009207, and J.K. Abbot was supported by a fellowship from CSL Behring. I.T. Lamborn is a Medical Scientist Training Program student in the Graduate Program in Immunology at the University of Pennsylvania. The authors declare no competing financial interests.	Arora R, 2011, ANN ALLERG ASTHMA IM, V106, P544, DOI 10.1016/j.anai.2011.03.007; Balish A.L., 2013, CURR PROTOC MICROB G, V15G, P11, DOI DOI 10.1002/9780471729259.MC15G01S29; Banos-Lara MD, 2013, J VIROL, V87, P1242, DOI 10.1128/JVI.01213-12; Benitez AA, 2015, CELL REP, V11, P1714, DOI 10.1016/j.celrep.2015.05.032; Bochkov YA, 2014, J CLIN MICROBIOL, V52, P2461, DOI 10.1128/JCM.00075-14; Byington CL, 2015, CLIN INFECT DIS, V61, P1217, DOI 10.1093/cid/civ486; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Case DA, 2015, AMBER 2015; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078                                                     ; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; DECHASSEVAL R, 1992, NUCLEIC ACIDS RES, V20, P245, DOI 10.1093/nar/20.2.245                                                            ; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040; Eilertson KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002806; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Galama JMD, 2000, CLIN MICROBIOL INFEC, V6, P630, DOI 10.1046/j.1469-0691.2000.00173.x                                                ; Gaunt ER, 2011, J CLIN VIROL, V52, P215, DOI 10.1016/j.jcv.2011.07.017; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Grandvaux N, 2014, J INNATE IMMUN, V6, P650, DOI 10.1159/000360764; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hasegawa K, 2014, EXPERT REV ANTI-INFE, V12, P817, DOI 10.1586/14787210.2014.906901; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Israel L, 2017, CELL, V168, P789, DOI 10.1016/j.cell.2017.01.039; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Jaidane H, 2010, REV MED VIROL, V20, P265, DOI 10.1002/rmv.647; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jin YH, 2012, J VIROL, V86, P1531, DOI 10.1128/JVI.06457-11; Jing H, 2014, J ALLERGY CLIN IMMUN, V133, P1667, DOI 10.1016/j.jaci.2014.03.025; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim WK, 2014, AM J RESP CRIT CARE, V189, P437, DOI 10.1164/rccm.201307-1338OC; Kingston R. E., 2003, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB2003S19; Lee WM, 2015, METHODS MOL BIOL, V1221, P25, DOI 10.1007/978-1-4939-1571-2_3; Lee WM, 2015, METHODS MOL BIOL, V1221, P71, DOI 10.1007/978-1-4939-1571-2_7; Lee WM, 2015, METHODS MOL BIOL, V1221, P49, DOI 10.1007/978-1-4939-1571-2_5; Li JF, 2010, J VIROL, V84, P6472, DOI 10.1128/JVI.00016-10; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000                                                ; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Reynolds SD, 2016, AM J RESP CELL MOL, V55, P323, DOI 10.1165/rcmb.2015-0274MA; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Rodriguez-Calvo T, 2015, DIABETES, V64, P1503, DOI 10.2337/db14-1931; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123                                                     ; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Triantafilou K, 2011, VIRULENCE, V2, P22, DOI 10.4161/viru.2.1.13807; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wiszniewski W, 2013, AM J HUM GENET, V93, P197, DOI 10.1016/j.ajhg.2013.05.027; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	82	4	4	4	4	ROCKEFELLER UNIV PRESS	NEW YORK	950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA	0022-1007	1540-9538		J EXP MED	J. Exp. Med.	JUL	2017	214	7					1949	1972		10.1084/jem.20161759				24	Immunology; Medicine, Research & Experimental	Immunology; Research & Experimental Medicine	EZ2SZ	WOS:000404561900009	28606988				2018-01-05	
J	Kuscu, C; Parlak, M; Tufan, T; Yang, JK; Szlachta, K; Wei, XL; Mammadov, R; Adli, M				Kuscu, Cem; Parlak, Mahmut; Tufan, Turan; Yang, Jiekun; Szlachta, Karol; Wei, Xiaolong; Mammadov, Rashad; Adli, Mazhar			CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations	NATURE METHODS			English	Article							MAMMALIAN-CELLS; HUMAN GENOME; HYPERMUTATION; SCREENS; ENABLES; TOOL	CRISPR-Cas9-induced DNA damage may have deleterious effects at high-copy-number genomic regions. Here, we use CRISPR base editors to knock out genes by changing single nucleotides to create stop codons. We show that the CRISPR-STOP method is an efficient and less deleterious alternative to wild-type Cas9 for gene-knockout studies. Early stop codons can be introduced in similar to 17,000 human genes. CRISPR-STOP-mediated targeted screening demonstrates comparable efficiency to WT Cas9, which indicates the suitability of our approach for genome-wide functional screenings.	[Kuscu, Cem; Parlak, Mahmut; Tufan, Turan; Yang, Jiekun; Szlachta, Karol; Wei, Xiaolong; Mammadov, Rashad; Adli, Mazhar] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Adli, M (reprint author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	adli@virginia.edu		Mammadov, Rashad/0000-0003-0945-540X	V Cancer Research Foundation; UVA Cancer Center pilot project awards; NIDDK [P50 DK096373]	This research was funded through a pilot project (NIDDK P50 DK096373), V Scholar award to M.A. from V Cancer Research Foundation, and UVA Cancer Center pilot project awards to M.A. We would like to thank S. Shang for his constructive feedback and critical reading of the manuscript.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Chen ZG, 2010, RNA, V16, P1040, DOI 10.1261/rna.1863010; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kuscu C., 2017, PROTOCOL EXCHANGE; Kuscu C, 2016, NAT METHODS, V13, P983, DOI 10.1038/nmeth.4076; Liao SR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv675; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nishida K, 2016, SCIENCE, V353, P919, DOI 10.1126/science.aaf7573; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	21	6	6	17	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUL	2017	14	7					710	+		10.1038/nmeth.4327				5	Biochemical Research Methods	Biochemistry & Molecular Biology	EZ0MK	WOS:000404399500027	28581493				2018-01-05	
J	Rogers, ZN; McFarland, CD; Winters, IP; Naranjo, S; Chuang, CH; Petrov, D; Winslow, MM				Rogers, Zoe N.; McFarland, Christopher D.; Winters, Ian P.; Naranjo, Santiago; Chuang, Chen-Hua; Petrov, Dmitri; Winslow, Monte M.			A quantitative and multiplexed approach to uncover the fitness Landscape of tumor suppression in vivo	NATURE METHODS			English	Article							CONDITIONAL MOUSE MODEL; CELL LUNG-CANCER; ONCOGENIC K-RAS; CLONAL DYNAMICS; MUTATIONAL LANDSCAPE; BREAST-CANCER; ADENOCARCINOMA; P53; PROGRESSION; GENES	Cancer growth is a multistage, stochastic evolutionary process. While cancer genome sequencing has been instrumental in identifying the genomic alterations that occur in human tumors, the consequences of these alterations on tumor growth remain largely unexplored. Conventional genetically engineered mouse models enable the study of tumor growth in vivo, but they are neither readily scalable nor sufficiently quantitative to unravel the magnitude and mode of action of many tumor-suppressor genes. Here, we present a method that integrates tumor barcoding with ultradeep barcode sequencing (Tuba-seq) to interrogate tumor-suppressor function in mouse models of human cancer. Tuba-seq uncovers genotype dependent distributions of tumor sizes. By combining Tuba-seq with multiplexed CRISPR-Cas9-mediated genome editing, we quantified the effects of 11 tumor-suppressor pathways that are frequently altered in human lung adenocarcinoma. Tuba-seq enables the broad quantification of the function of tumor-suppressor genes with unprecedented resolution, parallelization, and precision.	[Rogers, Zoe N.; Winters, Ian P.; Naranjo, Santiago; Chuang, Chen-Hua; Winslow, Monte M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [McFarland, Christopher D.; Petrov, Dmitri] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Winslow, Monte M.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Winslow, Monte M.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Winslow, Monte M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA	Winslow, MM (reprint author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Winslow, MM (reprint author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Winslow, MM (reprint author), Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.; Winslow, MM (reprint author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.	mwinslow@stanford.edu		Winters, Ian/0000-0002-3497-3228	National Science Foundation; Stanford Graduate Fellowship; NIH [E25CA180993, R01CA175336, R21CA194910, R01CA207133]; Stanford Cancer Institute support grant (NIH) [P30CA124435]	We thank P. Chu and R. Ma for technical support; A. Orantes for administrative support; C. Murray, C. Kim-Kiselak, J. Lipsick, B. Callahan, 5 Sage, and members of the Petrov and Winslow Laboratories for helpful comments; J. Xuhuai and the Stanford Functional Genomics Facility (S100D018220) for advice and technical assistance; and S. Chan for sequencing expertise. I.P.W. and Z.N.R. were supported by the National Science Foundation Graduate Research Fellowship Program (GRFP). Z.N.R. was also supported by a Stanford Graduate Fellowship. C.D.M. was supported by NIH grant no. E25CA180993. D.P. is the Michelle and Kevin Douglas Professor of Biology. This work was supported by NIH grant nos. R01CA175336 and R21CA194910 (to M.M.W.), R01CA207133 (to D.P. and M.M.W.), and in part by the Stanford Cancer Institute support grant (NIH grant no. P30CA124435).	Annunziato S, 2016, GENE DEV, V30, P1470, DOI 10.1101/gad.279190.116; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cancer Genome Atlas Research Network, 2014, NATURE, V511, P543, DOI DOI 10.1038/NATURE13385; Caswell DR, 2014, CANCER DISCOV, V4, P781, DOI 10.1158/2159-8290.CD-13-0862; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Chuang CH, 2017, NAT MED, V23, P291, DOI 10.1038/nm.4285; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Efeyan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005475; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gruner BM, 2016, NAT METHODS, V13, P883, DOI 10.1038/nmeth.3992; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hernandez J, 2016, RNA BIOL, V13, P466, DOI 10.1080/15476286.2016.1144004; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4                                                   ; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nguyen LV, 2015, NATURE, V528, P267, DOI 10.1038/nature15742; NORTON L, 1988, CANCER RES, V48, P7067; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rogers Z., 2017, PROTOCOL EXCHANGE; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schuster K, 2014, MOL CANCER RES, V12, P912, DOI 10.1158/1541-7786.MCR-13-0620-T; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9                                                   ; Venkataram S, 2016, CELL, V166, P1585, DOI 10.1016/j.cell.2016.08.002; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Welford SM, 2011, MOL CANCER RES, V9, P538, DOI 10.1158/1541-7786.MCR-11-0065; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008	56	2	2	20	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUL	2017	14	7					737	+		10.1038/nmeth.4297				12	Biochemical Research Methods	Biochemistry & Molecular Biology	EZ0MK	WOS:000404399500032	28530655				2018-01-05	
J	Wang, SQ; Gao, D; Chen, Y				Wang, Shangqian; Gao, Dong; Chen, Yu			The potential of organoids in urological cancer research	NATURE REVIEWS UROLOGY			English	Review							PLURIPOTENT STEM-CELLS; RESISTANT PROSTATE-CANCER; LONG-TERM EXPANSION; ACUTE KIDNEY INJURY; IN-VITRO; JUVENILE POLYPOSIS; COLORECTAL-CANCER; EPITHELIAL-CELL; BASAL-CELLS; 3D CULTURE	Technical advances in the development of organoid systems enable cell lines, primary adult cells, or stem or progenitor cells to develop into diverse, multicellular entities, which can self-renew, self-organize, and differentiate. These 3D organoid cultures have proven to be of value in increasing our understanding of the biology of disease and offer the potential of regenerative and genetic therapies. The successful application of 3D organoids derived from adult tissue into urological cancer research can further our understanding of these diseases and could also provide preclinical cancer models to realize the precision medicine paradigm by therapeutic screening of individual patient samples ex vivo. Kidney organoids derived from induced pluripotent stem cells provide personalized biomarkers, which can be correlated with genetic and clinical information. Organoid models can also improve our comprehension of aspects of particular diseases; for example, in prostate cancer, 3D organoids can aid in the identification of tumour-initiating cells from an epithelial cell lineage. Furthermore, kidney organoid differentiation from human pluripotent stem cells enables gene editing to model disease in kidney tubular epithelial cells. State-of-the-art human organoid cultures have potential as tools in basic and clinical research in renal, bladder, and prostatic diseases.	[Wang, Shangqian; Gao, Dong; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Dept Med, 1275 York Ave, New York, NY 10065 USA; [Wang, Shangqian] Nanjing Med Univ, Affiliated Hosp 1, Urol Dept, Nanjing 210029, Jiangsu, Peoples R China; [Gao, Dong] Chinese Acad Sci, Univ Chinese Acad Sci, Key Lab Syst Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biochem, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Chen, Yu] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA; [Chen, Yu] Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA	Chen, Y (reprint author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Dept Med, 1275 York Ave, New York, NY 10065 USA.; Chen, Y (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA.; Chen, Y (reprint author), Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA.	cheny1@mskcc.org		Gao, Dong/0000-0003-1821-2741	US Department of Defense [W81XWH-10-1-0197]; Geoffrey Beene Cancer Center; STARR Cancer Consortium [I8-A722]; Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Research Grant [SU2CAACR-DT0712]; Prostate Cancer Foundation Movember Challenge Grant; National Institutes of Health [5K08CA140946]; National Institutes of Health (NIH Cancer Center Core Grant) [P30 CA008748]; National Institutes of Health (SPORE in Prostate Cancer) [5P50CA092629-15]	We thank Margaret McPartland for providing editorial input. Funding was providing by the National Institutes of Health (5K08CA140946 and NIH Cancer Center Core Grant P30 CA008748, and SPORE in Prostate Cancer (5P50CA092629-15)), US Department of Defense (W81XWH-10-1-0197), the Geoffrey Beene Cancer Center, the STARR Cancer Consortium (I8-A722), a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Research Grant (SU2CAACR-DT0712), and a Prostate Cancer Foundation Movember Challenge Grant.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Ader M, 2014, CURR OPIN CELL BIOL, V31, P23, DOI 10.1016/j.ceb.2014.06.013; Agarwal S, 2015, CELL REP, V13, P2147, DOI 10.1016/j.celrep.2015.10.077; Akerfelt M, 2015, ONCOTARGET, V6, P30035, DOI 10.18632/oncotarget.5046; Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Batchelder CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136758; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400                                                            ; Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Calderon-Gierszal EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133238; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Cancer Genome Atlas Research Network, 2014, NATURE, V507, P315, DOI DOI 10.1038/NATURE12965; Cancer Genome Atlas N, 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222]; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Chua CW, 2014, NAT CELL BIOL, V16, P951, DOI 10.1038/ncb3047; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Dayyani F, 2011, J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Deiss F, 2013, ANAL CHEM, V85, P8085, DOI 10.1021/ac400161j; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002                                                ; Drost J., NAT PROTOC, V11; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong ELS, 2016, BIOMATERIALS, V77, P164, DOI 10.1016/j.biomaterials.2015.10.059; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2003, PROSTATE, V55, P206, DOI 10.1002/pros.10244; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Hahn WC, 1999, NATURE, V400, P464; Hakanson M, 2011, INTEGR BIOL-UK, V3, P31, DOI 10.1039/c0ib00074d; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Harrison RG, 1907, ANAT REC, V1, P116, DOI 10.1002/ar.1090010503                                                           ; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086                                                   ; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Imberti B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08826; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073                                                            ; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kang M, 2014, INT J MOL SCI, V15, P7139, DOI 10.3390/ijms15057139; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; KONTUREK JW, 1989, GUT, V30, P1194, DOI 10.1136/gut.30.9.1194; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee SH, 2015, CURR OPIN CELL BIOL, V37, P35, DOI 10.1016/j.ceb.2015.10.002; Li ZW, 2016, CELL STEM CELL, V19, P516, DOI 10.1016/j.stem.2016.07.016; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Liu X, 2016, CELL REP, V17, P2596, DOI 10.1016/j.celrep.2016.11.010; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lobo NC, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2539-z; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Matulay JT, 2016, J UROLOGY, V195, pE926, DOI 10.1016/j.juro.2016.02.1487                                                     ; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831                                                             ; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; Ohishi T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010043; Osborn SL, 2014, STEM CELL TRANSL MED, V3, P610, DOI 10.5966/sctm.2013-0131; Park JW, 2016, P NATL ACAD SCI USA, V113, P4482, DOI 10.1073/pnas.1603645113; Pavlovich CP, 2004, NAT REV CANCER, V4, P381, DOI 10.1038/nrc1364; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Rinkevich Y, 2014, CELL REP, V7, P1270, DOI 10.1016/j.celrep.2014.04.018; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rookmaaker MB, 2015, NAT REV NEPHROL, V11, P546, DOI 10.1038/nrneph.2015.118; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scher HI, 2015, J CLIN ONCOL, V33, P1348, DOI 10.1200/JCO.2014.55.3487; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simon J., 1852, LANCET, Vii, P568; Sluka P, 2013, NAT REV UROL, V10, P441, DOI 10.1038/nrurol.2013.146; Smith YC, 2006, INFECT IMMUN, V74, P750, DOI 10.1128/IAI.74.1.750-757.2006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takasato M, 2016, NAT PROTOC, V11, P1681, DOI 10.1038/nprot.2016.098; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takasato M, 2015, DEVELOPMENT, V142, P1937, DOI 10.1242/dev.104802; Toyohara T, 2015, STEM CELL TRANSL MED, V4, P980, DOI 10.5966/sctm.2014-0219; Tyson DR, 2007, PROSTATE, V67, P1601, DOI 10.1002/pros.20628; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901                                                              ; Valta MP, 2008, INT J CANCER, V123, P22, DOI 10.1002/ijc.23422; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van Hemelrijck M, 2013, BJU INT, V112, P1113, DOI 10.1111/bju.12239; Varley CL, 2011, METHODS MOL BIOL, V695, P197, DOI 10.1007/978-1-60761-984-0_13; Wan X, 2014, SCI TRANSL MED, V6, P122; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Weigelt B., BREAST CANC RES TREA, V122; Wyatt AW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0426-y; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yagi S, 2012, EMBO REP, V13, P237, DOI 10.1038/embor.2011.249; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhu JJ, 2012, GENESIS, V50, P102, DOI 10.1002/dvg.20799	123	0	0	11	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4812	1759-4820		NAT REV UROL	Nat. Rev. Urol.	JUL	2017	14	7					401	414		10.1038/nrurol.2017.65				14	Urology & Nephrology	Urology & Nephrology	EZ2NY	WOS:000404547200015	28534535	green_accepted			2018-01-05	
J	Larsen, PA; Lutz, MW; Hunnicutt, KE; Mihovilovic, M; Saunders, AM; Yoder, AD; Roses, AD				Larsen, Peter A.; Lutz, Michael W.; Hunnicutt, Kelsie E.; Mihovilovic, Mirta; Saunders, Ann M.; Yoder, Anne D.; Roses, Allen D.			The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease	ALZHEIMERS & DEMENTIA			English	Article						Alternative splicing; Alzheimer's disease; Epigenetics; H3K9; Inflammation; LINE; Neuroepigenetics; Nonsensemediated decay; Parkinson's disease; Retrotransposon; SINE; Somatic mutation; Somatic mosaicism; Spliceosome; A-to-I editing	ALZHEIMERS-DISEASE; DNA METHYLATION; EPIGENETIC MECHANISMS; COGNITIVE PERFORMANCE; PROTEIN AGGREGATION; SUSCEPTIBILITY LOCI; NONHUMAN-PRIMATES; HUMAN BRAIN; TOMM40; ELEMENTS	It is hypothesized that retrotransposons have played a fundamental role in primate evolution and that enhanced neurologic retrotransposon activity in humans may underlie the origin of higher cognitive function. As a potential consequence of this enhanced activity, it is likely that neurons are susceptible to deleterious retrotransposon pathways that can disrupt mitochondrial function. An example is observed in the TOMM40 gene, encoding a beta-barrel protein critical for mitochondrial preprotein transport. Primate-specific Alu retrotransposons have repeatedly inserted into TOMM40 introns, and at least one variant associated with late-onset Alzheimer's disease originated from an Alu insertion event. We provide evidence of enriched Alu content in mitochondrial genes and postulate that Alus can disrupt mitochondrial populations in neurons, thereby setting the stage for progressive neurologic dysfunction. This Alu neurodegeneration hypothesis is compatible with decades of research and offers a plausible mechanism for the disruption of neuronal mitochondrial homeostasis, ultimately cascading into neurodegenerative disease. (C) 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.	[Larsen, Peter A.; Hunnicutt, Kelsie E.; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Lutz, Michael W.; Mihovilovic, Mirta; Saunders, Ann M.; Roses, Allen D.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Yoder, Anne D.] Duke Univ, Duke Lemur Ctr, Durham, NC USA; [Roses, Allen D.] Zinfandel Pharmaceut Inc, Durham, NC USA	Larsen, PA (reprint author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	peter.larsen@duke.edu			Duke Research Computing; Duke Data Commons (NIH) [1S10OD018164-01]	The authors thank W.K. Gottschalk, S.S. Sundeth, O. Chiba-Falek, B.A. Sullivan, A.D. Brown, C.R. Campbell, R.J. Larsen, and L. Pinto for comments and discussion that helped to improve this manuscript. We are grateful for the support of Duke Research Computing and the Duke Data Commons (NIH 1S10OD018164-01). This is Duke Lemur Center publication number 1340.	An HJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-97; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bakshi A, 2016, EPIGENETICS-US, V11, P163, DOI 10.1080/15592294.2015.1130518; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bender A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062277; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Caselli RJ, 2012, ALZHEIMERS DEMENT, V8, P490, DOI 10.1016/j.jalz.2011.11.006; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Crenshaw DG, 2013, CLIN PHARMACOL THER, V93, P177, DOI 10.1038/clpt.2012.222; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; de Andrade A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-617; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864                                                          ; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Evrony GD, 2016, SCIENCE, V354, P557, DOI 10.1126/science.aak9761; Finch CE, 2015, NEUROBIOL AGING, V36, P553, DOI 10.1016/j.neurobiolaging.2014.10.025; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Friedli M, 2015, ANNU REV CELL DEV BI, V31, P429, DOI 10.1146/annurev-cellbio-100814-125514; Gallus GN, 2010, MOL VIS, V16, P178; Ganapathi M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-126; Gearing M, 1997, NEUROBIOL AGING, V18, P139, DOI 10.1016/S0197-4580(97)00012-2                                                   ; Gianfrancesco O, 2016, NEUROPEPTIDES; Gottschalk WK, 2014, J PARKINSONS DIS ALZ, V1, P1; Greenbaum L, 2014, EUR NEUROPSYCHOPHARM, V24, P1492, DOI 10.1016/j.euroneuro.2014.06.002; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hayden KM, 2012, ALZHEIMERS DEMENT, V8, P381, DOI 10.1016/j.jalz.2011.10.005; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Heuer E, 2012, CURR PHARM DESIGN, V18, P1159, DOI 10.2174/138161212799315885                                                      ; Hirai K, 2001, J NEUROSCI, V21, P3017; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012; Jun G, 2012, ARCH NEUROL-CHICAGO, V69, P1270, DOI 10.1001/archneurol.2012.2052; Kuszak AJ, 2015, J BIOL CHEM, V290, P26204, DOI 10.1074/jbc.M115.642173; Kutsche K, 2002, HUM MUTAT, V19, P526, DOI 10.1002/humu.10072; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Lee J, 2015, GENE, V555, P208, DOI 10.1016/j.gene.2014.11.005; Leuner K, 2012, MOL NEUROBIOL, V46, P186, DOI 10.1007/s12035-012-8307-4; Lin L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0876-5; Linnertz C, 2014, ALZHEIMERS DEMENT, V10, P541, DOI 10.1016/j.jalz.2013.08.280; Liu XY, 2014, J NEUROL, V261, P1499, DOI 10.1007/s00415-014-7368-x; Lord J, 2014, NAT NEUROSCI, V17, P1138, DOI 10.1038/nn.3792; Lu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099580; Lutz MW, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0643-8; Mastroeni D, 2011, NEUROBIOL AGING, V32, P1161, DOI 10.1016/j.neurobiolaging.2010.08.017; McGuinness MC, 2003, MOL CELL BIOL, V23, P744, DOI 10.1128/MCB.23.2.744-753.2003; Mitsui J, 2014, BIOCHEM BIOPH RES CO, V452, P221, DOI 10.1016/j.bbrc.2014.07.098; Morais Sara, 2016, Neurol Genet, V2, pe73, DOI 10.1212/NXG.0000000000000073; Payton A, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.11.017; Perez SE, 2016, NEUROBIOL AGING, V39, P195, DOI 10.1016/j.neurobiolaging.2015.12.017; RAPOPORT SI, 1989, MED HYPOTHESES, V29, P147, DOI 10.1016/0306-9877(89)90185-0; Richards RI, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00193; Robbez-Masson L, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0173-5; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Roses AD, 2016, EXPERT OPIN DRUG MET, V12, P135, DOI 10.1517/17425255.2016.1133586; Roses AD, 2014, ALZHEIMERS DEMENT, V10, P592, DOI 10.1016/j.jalz.2014.06.009; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shiota T, 2015, SCIENCE, V349, P1544, DOI 10.1126/science.aac6428; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; Strittmatter WJ, 1994, EXP NEUROL, P72; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Takasugi M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-481; Trono Didier, 2015, Cold Spring Harb Symp Quant Biol, V80, P281, DOI 10.1101/sqb.2015.80.027573; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; Varanita T., 2015, ALZHEIMERS DEMENT, V21, P834; Varshney D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7569; Verdier JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00064; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Yu L, 2017, NEUROLOGY, V88, P661, DOI 10.1212/WNL.0000000000003614; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang Y, 2008, BMC BIOINFORMATICS, V9, P1, DOI DOI 10.1186/1471-2105-9-40	92	2	2	16	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUL	2017	13	7					828	838		10.1016/j.jalz.2017.01.017				11	Clinical Neurology	Neurosciences & Neurology	EZ2SC	WOS:000404559300011	28242298	gold			2018-01-05	
J	Qazi, MA; Vora, P; Venugopal, C; Sidhu, SS; Moffat, J; Swanton, C; Singh, SK				Qazi, M. A.; Vora, P.; Venugopal, C.; Sidhu, S. S.; Moffat, J.; Swanton, C.; Singh, S. K.			Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma	ANNALS OF ONCOLOGY			English	Review						glioblastoma; intratumoral heterogeneity; brain tumor initiating cells; recurrence; models of resistance; polytherapy	STEM-LIKE CELLS; TUMOR-INITIATING CELLS; CENTRAL-NERVOUS-SYSTEM; BRAIN-TUMORS; ADJUVANT TEMOZOLOMIDE; SELF-RENEWAL; CANCER; EVOLUTION; GLIOMA; REVEALS	Intratumoral heterogeneity (ITH) has increasingly being described for multiple cancers as the root cause of therapy resistance. Recent studies have started to explore the scope of ITH in glioblastoma (GBM), a highly aggressive and fatal form of brain tumor, to explain its inevitable therapy resistance and disease relapse. In this review, we detail the emerging data that explores the extensive genetic, cellular and functional ITH present in GBM. We discuss current experimental models of human GBM recurrence and suggest harnessing new technologies (CRISPR-Cas9 screening, CyTOF, cellular barcoding, single cell analysis) to delineate GBM ITH and identify treatment-refractory cell populations, thus opening new therapeutic windows. We will also explore why current therapeutics have failed in clinical trials and how ITH can inform us on developing empiric therapies for the treatment of recurrent GBM.	[Qazi, M. A.; Vora, P.; Venugopal, C.; Singh, S. K.] McMaster Univ, Stem Cell & Canc Res Inst, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Qazi, M. A.; Singh, S. K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Vora, P.; Venugopal, C.; Singh, S. K.] McMaster Univ, Dept Surg, Hamilton, ON, Canada; [Sidhu, S. S.; Moffat, J.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Sidhu, S. S.; Moffat, J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Swanton, C.] Univ Coll London Inst, Francis Crick Inst, London, England	Singh, SK (reprint author), McMaster Univ, Stem Cell & Canc Res Inst, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	ssingh@mcmaster.ca			Canadian Institute of Health Research Canada Graduate Scholarship; Terry Fox Research Institute Program Project Grant	M.A.Q. is funded by the Canadian Institute of Health Research Canada Graduate Scholarship. J.M., S.S.S. and S.K.S. are funded by the Terry Fox Research Institute Program Project Grant.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen L, 2013, BBA-REV CANCER, V1836, P158, DOI 10.1016/j.bbcan.2013.04.003; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chroscinski D, 2015, ELIFE, V4, DOI 10.7554/eLife.04363; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207                                                     ; Dunn-Pirio AM, 2017, CANCER-AM CANCER SOC, V123, P734, DOI 10.1002/cncr.30371; Ellis HP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00251; Eskilsson E, 2016, NEURO-ONCOLOGY, V18, P1644, DOI 10.1093/neuonc/now113; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Favero F, 2015, ANN ONCOL, V26, P880, DOI 10.1093/annonc/mdv127; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5                                                   ; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435                                                               ; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee J-K, 2017, NAT GENET, V54, P3988; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Manoranjan B, 2013, STEM CELLS, V31, P1266, DOI 10.1002/stem.1401; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Nguyen LV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6871; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Osuka S, 2017, J CLIN INVEST, V127, P415, DOI 10.1172/JCI89587; Parker NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22477; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Qazi MA, 2016, J NEURO-ONCOL, V126, P57, DOI 10.1007/s11060-015-1951-6; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Ramaswamy V, 2015, CANCER CELL, V28, P275, DOI 10.1016/j.ccell.2015.08.010; Reinartz R, 2017, CLIN CANCER RES, V23, P562, DOI 10.1158/1078-0432.CCR-15-2089; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Schuster J, 2015, NEURO-ONCOLOGY, V17, P854, DOI 10.1093/neuonc/nou348; Scorsetti M, 2015, BMC CANC; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Soeda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07979; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330                                                            ; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tamura K, 2013, J NEUROSURG, V119, P1145, DOI 10.3171/2013.7.JNS122417; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Venugopal C, 2015, CLIN CANCER RES, V21, P5324, DOI 10.1158/1078-0432.CCR-14-3147; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JG, 2016, NAT GENET, V48, P768, DOI 10.1038/ng.3590; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385                                                  ; Wei W, 2016, CANCER CELL, V29, P563, DOI 10.1016/j.ccell.2016.03.012; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	75	1	1	9	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	JUL	2017	28	7					1448	1456		10.1093/annonc/mdx169				9	Oncology	Oncology	EY6ZL	WOS:000404134100011	28407030	gold			2018-01-05	
J	Lai, FPL; Lau, ST; Wong, JKL; Gui, HS; Wang, RX; Zhou, TW; Lai, WH; Tse, HF; Tam, PKH; Garcia-Barcelo, MM; Ngan, ESW				Lai, Frank Pui-Ling; Lau, Sin-Ting; Wong, John Kwong-Leong; Gui, Hongsheng; Wang, Reeson Xu; Zhou, Tingwen; Lai, Wing Hon; Tse, Hung-Fat; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Mercedes; Ngan, Elly Sau-Wai			Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function	GASTROENTEROLOGY			English	Article						PSC-Based Model; Neural Development; Enteric Nervous System; Congenital	ENTERIC NERVOUS-SYSTEM; TYROSINE KINASE; IPS CELLS; RET; VINCULIN; DISEASE; INTEGRATION; DEFECTS; COMMON; MICE	BACKGROUND & AIMS: Hirschsprung disease is caused by failure of enteric neural crest cells (ENCCs) to fully colonize the bowel, leading to bowel obstruction and megacolon. Heterozygous mutations in the coding region of the RET gene cause a severe form of Hirschsprung disease (total colonic aganglionosis). However, 80% of HSCR patients have short-segment Hirschsprung disease (S-HSCR), which has not been associated with genetic factors. We sought to identify mutations associated with S-HSCR, and used the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene editing system to determine how mutations affect ENCC function. METHODS: We created induced pluripotent stem cell (iPSC) lines from 1 patient with total colonic aganglionosis (with the G731del mutation in RET) and from 2 patients with S-HSCR (without a RET mutation), as well as RET+/- and RET-/- iPSCs. IMR90-iPSC cells were used as the control cell line. Migration and differentiation capacities of iPSC-derived ENCCs were analyzed in differentiation and migration assays. We searched for mutation(s) associated with S-HSCR by combining genetic and transcriptome data from patient blood-and iPSC-derived ENCCs, respectively. Mutations in the iPSCs were corrected using the CRISPR/Cas9 system. RESULTS: ENCCs derived from all iPSC lines, but not control iPSCs, had defects in migration and neuronal lineage differentiation. RET mutations were associated with differentiation and migration defects of ENCCs in vitro. Genetic and transcriptome analyses associated a mutation in the vinculin gene (VCL M209L) with S-HSCR. CRISPR/Cas9 correction of the RET G731del and VCL M209L mutations in iPSCs restored the differentiation and migration capacities of ENCCs. CONCLUSIONS: We identified mutations in VCL associated with S-HSCR. Correction of this mutation in iPSC using CRISPR/Cas9 editing, as well as the RET G731del mutation that causes Hirschsprung disease with total colonic aganglionosis, restored ENCC function. Our study demonstrates how human iPSCs can be used to identify disease-associated mutations and determine how they affect cell functions and contribute to pathogenesis.	[Lai, Frank Pui-Ling; Lau, Sin-Ting; Wang, Reeson Xu; Zhou, Tingwen; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Mercedes; Ngan, Elly Sau-Wai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Wong, John Kwong-Leong; Gui, Hongsheng] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Lai, Wing Hon; Tse, Hung-Fat] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China	Ngan, ESW (reprint author), Univ Hong Kong, Dept Surg, Fac Med Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	engan@hku.hk			Health and Medical Research Fund grant [01121476]; Research Grants Council of Hong Kong Special Administrative Region, China Hong Kong [HKU17119514, T12C-714/14-R]	This work described was substantially supported by a Health and Medical Research Fund grant (project no. 01121476) to Elly Sau-Wai Ngan and research grants from the Research Grants Council of Hong Kong Special Administrative Region, China Hong Kong (HKU17119514, T12C-714/14-R).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Durbec PL, 1996, DEVELOPMENT, V122, P349; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JOCKUSCH BM, 1981, P NATL ACAD SCI-BIOL, V78, P3005, DOI 10.1073/pnas.78.5.3005; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011530; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Parisi MA., 2002, HIRSCHSPRUNG DIS OVE; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Taraviras S, 1999, DEVELOPMENT, V126, P2785; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; Zeltner N, 2014, J VIS EXP; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.0028-07	25	1	1	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JUL	2017	153	1					139	+		10.1053/j.gastro.2017.03.014				23	Gastroenterology & Hepatology	Gastroenterology & Hepatology	EY4AL	WOS:000403918300032	28342760				2018-01-05	
J	Hellmuth, M; Stadler, PF; Wieseke, N				Hellmuth, Marc; Stadler, Peter F.; Wieseke, Nicolas			The mathematics of xenology: di-cographs, symbolic ultrametrics, 2-structures and tree-representable systems of binary relations	JOURNAL OF MATHEMATICAL BIOLOGY			English	Article						Xenologs; Paralogs; Orthologs; Gene tree; 2-Structures; Uniformly non-prime decomposition; Di-cograph; Symbolic ultrametric; Recognition algorithm; NP-completeness; Integer Linear Program	HORIZONTAL GENE-TRANSFER; MODULAR DECOMPOSITION; GRAPHS; ALGORITHM; RECOGNITION; ORTHOLOGS; EVOLUTION; PARALOGS	The concepts of orthology, paralogy, and xenology play a key role in molecular evolution. Orthology and paralogy distinguish whether a pair of genes originated by speciation or duplication. The corresponding binary relations on a set of genes form complementary cographs. Allowing more than two types of ancestral event types leads to symmetric symbolic ultrametrics. Horizontal gene transfer, which leads to xenologous gene pairs, however, is inherent asymmetric since one offspring copy "jumps" into another genome, while the other continues to be inherited vertically. We therefore explore here the mathematical structure of the non-symmetric generalization of symbolic ultrametrics. Our main results tie non-symmetric ultrametrics together with di-cographs (the directed generalization of cographs), so-called uniformly non-prime () 2-structures, and hierarchical structures on the set of strong modules. This yields a characterization of relation structures that can be explained in terms of trees and types of ancestral events. This framework accommodates a horizontal-transfer relation in terms of an ancestral event and thus, is slightly different from the the most commonly used definition of xenology. As a first step towards a practical use, we present a simple polynomial-time recognition algorithm of 2-structures and investigate the computational complexity of several types of editing problems for 2-structures. We show, finally that these NP-complete problems can be solved exactly as Integer Linear Programs.	[Hellmuth, Marc] Ernst Moritz Arndt Univ Greifswald, Dept Math & Comp Sci, Walther Rathenau Str 47, D-17487 Greifswald, Germany; [Hellmuth, Marc] Univ Saarland, Ctr Bioinformat, Bldg E 2-1,POB 151150, D-66041 Saarbrucken, Germany; [Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Hartelstr 16-18, D-04107 Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Hartelstr 16-18, D-04107 Leipzig, Germany; [Stadler, Peter F.] Max Planck Inst Math Sci, Inselstr 22, D-04103 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, Wahringerstr 17, A-1090 Vienna, Austria; [Stadler, Peter F.] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA; [Wieseke, Nicolas] Univ Leipzig, Dept Comp Sci, Parallel Comp & Complex Syst Grp, Johannisgasse 26, D-04103 Leipzig, Germany; [Wieseke, Nicolas] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Johannisgasse 26, D-04103 Leipzig, Germany	Hellmuth, M (reprint author), Ernst Moritz Arndt Univ Greifswald, Dept Math & Comp Sci, Walther Rathenau Str 47, D-17487 Greifswald, Germany.; Hellmuth, M (reprint author), Univ Saarland, Ctr Bioinformat, Bldg E 2-1,POB 151150, D-66041 Saarbrucken, Germany.	mhellmuth@mailbox.org; studla@bioinf.uni-leipzig.de; wieseke@informatik.uni-leipzig.de			German Research Foundation (DFG) [MI439/14-1]	We thanks Maribel Hernandez-Rosales for discussions. This work was funded by the German Research Foundation (DFG) (Proj. Nos. MI439/14-1 to P.F.S. and N.W.).	Altenhoff AM, 2016, NAT METHODS, V13, P425, DOI [10.1038/NMETH.3830, 10.1038/nmeth.3830]; Bocker S, 1998, ADV MATH, V138, P105, DOI 10.1006/aima.1998.1743; Brandstadt A., 1999, GRAPH CLASSES SURVEY; CORNEIL DG, 1981, DISCRETE APPL MATH, V3, P163, DOI 10.1016/0166-218X(81)90013-5                                                    ; Crespelle C, 2006, DISCRETE APPL MATH, V154, P1722, DOI 10.1016/j.dam.2006.03.005; Dondi R., 2016, INT WORKSH ALG BIOIN, P121; EHRENFEUCHT A, 1990, THEOR COMPUT SCI, V70, P305, DOI 10.1016/0304-3975(90)90130-A; EHRENFEUCHT A, 1990, THEOR COMPUT SCI, V70, P277, DOI 10.1016/0304-3975(90)90129-6; EHRENFEUCHT A, 1990, THEOR COMPUT SCI, V70, P343, DOI 10.1016/0304-3975(90)90131-Z                                                    ; EHRENFEUCHT A, 1994, J ALGORITHM, V16, P283, DOI 10.1006/jagm.1994.1013                                                          ; Ehrenfeucht A, 1995, LECT NOTES COMPUT SC, V944, P1; Ehrenfeucht A., 1999, THEORY 2 STRUCTURES; Engelfriet J, 1996, THEOR COMPUT SCI, V154, P247, DOI 10.1016/0304-3975(94)00272-X; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9                                                   ; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; GRAY GS, 1983, MOL BIOL EVOL, V1, P57; Hellmuth M, 2016, ARXIV150905069; Hellmuth M, 2016, SEQUENCE DATA INCLUD; Hellmuth M, 2015, LECT NOTES COMPUT SC, V9198, P609, DOI 10.1007/978-3-319-21398-9_48; Hellmuth M, 2015, P NATL ACAD SCI USA, V112, P2058, DOI 10.1073/pnas.1412770112; Hellmuth M, 2013, J MATH BIOL, V66, P399, DOI 10.1007/s00285-012-0525-x; Hernandez-Rosales M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S6; Jensen RA, 2001, GENOME BIOL, V2, P8; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709                                                  ; Lafond M, 2015, INT WORKSH ALG BIOIN, P66; Lafond M, 2016, ALGORITHM MOL BIOL, V11, DOI 10.1186/s13015-016-0067-7; Lechner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105015; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; McConnell RM, 2005, DISCRETE APPL MATH, V145, P198, DOI 10.1016/j.dam.2004.02.017; MCCONNELL RM, 1995, ALGORITHMICA, V14, P229, DOI 10.1007/BF01206330; Mohring R. H., 1985, Annals of Operations Research, V4, P195, DOI 10.1007/BF02022041; Mohring R., 1984, ANN DISCRETE MATH, V19, P257; SCHMERL JH, 1993, DISCRETE MATH, V113, P191, DOI 10.1016/0012-365X(93)90516-V                                                    ; Semple C., 2003, OXFORD LECT SERIES M, V24; Sennblad B, 2009, SYST BIOL, V58, P411, DOI 10.1093/sysbio/syp046; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; VALDES J, 1982, SIAM J COMPUT, V11, P298, DOI 10.1137/0211023                                                                 	39	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0303-6812	1432-1416		J MATH BIOL	J. Math. Biol.	JUL	2017	75	1					199	237		10.1007/s00285-016-1084-3				39	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	EY7GS	WOS:000404158500007	27904954				2018-01-05	
J	Matsui, T; Lee, JT; Ehrenreich, IM				Matsui, Takeshi; Lee, Jonathan T.; Ehrenreich, Ian M.			Genetic suppression: Extending our knowledge from lab experiments to natural populations	BIOESSAYS			English	Article						complex traits; epistasis; genetic interaction; genotype-phenotype map; natural genetic variation; positive genetic interactions; suppressors	SEQUENCE-SPECIFIC CONTROL; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; INTERACTION NETWORKS; FITNESS LANDSCAPE; YEAST POPULATIONS; COMPLEX TRAITS; GENOME; EVOLUTION; CRISPR	Many mutations have deleterious phenotypic effects that can be alleviated by suppressor mutations elsewhere in the genome. High-throughput approaches have facilitated the large-scale identification of these suppressors and have helped shed light on core functional mechanisms that give rise to suppression. Following reports that suppression occurs naturally within species, it is important to determine how our understanding of this phenomenon based on lab experiments extends to genetically diverse natural populations. Although suppression is typically mediated by individual genetic changes in lab experiments, recent studies have shown that suppression in natural populations can involve combinations of genetic variants. This difference in complexity suggests that sets of variants can exhibit similar functional effects to individual suppressors found in lab experiments. In this review, we discuss how characterizing the way in which these variants jointly lead to suppression could provide important insights into the genotype-phenotype map that are relevant to evolution and health.	[Matsui, Takeshi; Lee, Jonathan T.; Ehrenreich, Ian M.] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	Ehrenreich, IM (reprint author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	ian.ehrenreich@usc.edu			National Institutes of Health [R01GM110255]; Alfred. P Sloan Foundation	This work was supported by a grant from the National Institutes of Health (R01GM110255) to IME, as well as fellowship from the Alfred. P Sloan Foundation to IME.	Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Botstein D., 2015, DECODING LANGUAGE GE; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bui DT, 2017, GENETICS, V205, P1459, DOI 10.1534/genetics.116.199513; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chandler CH, 2014, GENETICS, V196, P1321, DOI 10.1534/genetics.113.159426; Chandler CH, 2013, TRENDS GENET, V29, P358, DOI 10.1016/j.tig.2013.01.009; Chari S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003661; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Forsberg SKG, 2017, NAT GENET, V49, P497, DOI 10.1038/ng.3800; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; HODGKIN J, 1987, TRENDS GENET, V3, P325, DOI 10.1016/0168-9525(87)90281-2; Hodgkin Jonathan, 2005, WormBook, P1; Hou J, 2017, MOL BIOL EVOL, V34, P110, DOI 10.1093/molbev/msw225; Hou J, 2016, CELL REP, V16, P1106, DOI 10.1016/j.celrep.2016.06.048; Hou J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8214; Ip Camilla L C, 2015, F1000Res, V4, P1075, DOI 10.12688/f1000research.7201.1; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Jordan DM, 2015, NATURE, V524, P225, DOI 10.1038/nature14497; Julien P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11558; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee JT, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005929; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Li C, 2016, SCIENCE, V352, P837, DOI 10.1126/science.aae0568; Liu GW, 2015, CELL, V163, P1388, DOI 10.1016/j.cell.2015.10.069; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Matsui T, 2015, GENETICS, V201, P769, DOI 10.1534/genetics.115.180661; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Paaby AB, 2015, ELIFE, V4, DOI 10.7554/eLife.09178; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Prelich G, 1999, TRENDS GENET, V15, P261, DOI 10.1016/S0168-9525(99)01749-7                                                   ; Puchta O, 2016, SCIENCE, V352, P840, DOI 10.1126/science.aaf0965; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sandrock TM, 1997, GENETICS, V147, P1635; Sarkisyan KS, 2016, NATURE, V533, P397, DOI 10.1038/nature17995; Schell R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2001015; Siegal ML, 2014, ANNU REV ECOL EVOL S, V45, P495, DOI 10.1146/annurev-ecolsys-120213-091705; Skelly DA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2672; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Taylor MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11669; Taylor MB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005606; Taylor MB, 2015, TRENDS GENET, V31, P34, DOI 10.1016/j.tig.2014.09.001; Taylor MB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004324; Tischler J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r69; van Leeuwen J, 2016, SCIENCE, V354, DOI 10.1126/science.aag0839; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bias.20170; Wagner A, 2012, P ROY SOC B-BIOL SCI, V279, P1249, DOI 10.1098/rspb.2011.2293	71	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	JUL	2017	39	7							1700023	10.1002/bies.201700023				7	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	EY6XY	WOS:000404129100005					2018-01-05	
J	Lork, M; Verhelst, K; Beyaert, R				Lork, Marie; Verhelst, Kelly; Beyaert, Rudi			CYLD, A20 and OTULIN deubiquitinases in NF-kappa B signaling and cell death: so similar, yet so different	CELL DEATH AND DIFFERENTIATION			English	Review							TUMOR-SUPPRESSOR CYLD; EDITING ENZYME A20; ZINC-FINGER PROTEIN; ONSET AUTOINFLAMMATORY DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; LINEAR POLYUBIQUITIN CHAINS; ALPHA-INDUCED APOPTOSIS; INDUCED JNK ACTIVATION; SPATA2 LINKS CYLD; E3 LIGASE ITCH	Polyubiquitination of proteins has a pivotal role in the regulation of numerous cellular functions such as protein degradation, DNA repair and cell signaling. As deregulation of these processes can result in pathological conditions such as inflammatory diseases, neurodegeneration or cancer, tight regulation of the ubiquitin system is of tremendous importance. Ubiquitination by E3 ubiquitin ligases can be counteracted by the activity of several deubiquitinating enzymes (DUBs). CYLD, A20 and OTULIN have been implicated as key DUBs in the negative regulation of NF-kappa B transcription factor-mediated gene expression upon stimulation of cytokine receptors, antigen receptors and pattern recognition receptors, by removing distinct types of polyubiquitin chains from specific NF-kappa B signaling proteins. In addition, they control TNF-induced cell death signaling leading to apoptosis and necroptosis via similar mechanisms. In the case of A20, also catalytic-independent mechanisms of action have been demonstrated to have an important role. CYLD, A20 and OTULIN have largely overlapping substrates, suggesting at least partially redundant functions. However, mice deficient in one of the three DUBs show significant phenotypic differences, indicating also non-redundant functions. Here we discuss the activity and polyubiquitin chain-type specificity of CYLD, A20 and OTULIN, their specific role in NF-kappa B signaling and cell death, the molecular mechanisms that regulate their activity, their role in immune homeostasis and the association of defects in their activity with inflammation, autoimmunity and cancer.	[Lork, Marie; Verhelst, Kelly; Beyaert, Rudi] Univ Ghent VIB, VIB Ctr Inflammat Res, Unit Mol Signal Transduct Inflammat, Technol Pk 927, B-9052 Ghent, Belgium; [Lork, Marie; Verhelst, Kelly; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Beyaert, R (reprint author), Univ Ghent VIB, VIB Ctr Inflammat Res, Unit Mol Signal Transduct Inflammat, Technol Pk 927, B-9052 Ghent, Belgium.	rudi.beyaert@irc.vib-ugent.be	Beyaert, Rudi/B-2589-2009		Fund for Scientific Research Flanders (FWO); Belgian Foundation Against Cancer, Interuniversity Attraction Poles, Concerted Research Actions (GOA); Group-ID Multidisciplinary Research Partnership of Ghent University; predoctoral fellowship from the FWO	This work was supported by grants from the Fund for Scientific Research Flanders (FWO), the Belgian Foundation Against Cancer, Interuniversity Attraction Poles, Concerted Research Actions (GOA) and the Group-ID Multidisciplinary Research Partnership of Ghent University. ML is supported by a predoctoral fellowship from the FWO.	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Arora M, 2015, BLOOD CELL MOL DIS, V54, P132, DOI 10.1016/j.bcmd.2014.07.008; Balkhi MY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004177; Bignell GR, 2000, NAT GENET, V25, P160; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chanudet E, 2010, LEUKEMIA, V24, P483, DOI 10.1038/leu.2009.234; Chu YY, 2012, J IMMUNOL, V189, P4437, DOI 10.4049/jimmunol.1200396; Cleynen I, 2014, GUT, V63, P1265, DOI 10.1136/gutjnl-2012-303205; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Daniel S, 2006, TRANSPLANT P, V38, P3225, DOI 10.1016/j.transproceed.2006.10.167; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Drennan MB, 2016, J EXP MED, V213, P1973, DOI 10.1084/jem.20151065; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Elliott PR, 2016, MOL CELL, V63, P990, DOI 10.1016/j.molcel.2016.08.001; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Heideker J, 2015, BIOCHEM J, V467, P191, DOI 10.1042/bj4670191                                                               ; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hovelmeyer N, 2007, J EXP MED, V204, P2615, DOI 10.1084/jem.20070318; Hrdinka M, 2016, CELL REP, V14, P2846, DOI 10.1016/j.celrep.2016.02.062; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Jin YJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86548; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Karatzas DN, 2016, CELL ONCOL, V39, P287, DOI 10.1007/s13402-016-0279-3; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Klei LR, 2016, CELL REP, V17, P221, DOI 10.1016/j.celrep.2016.08.080; Kobayashi T, 2015, ONCOGENE, V34, P2251, DOI 10.1038/onc.2014.159; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Kulathu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2567; Kupka S, 2016, CELL REP, V16, P2271, DOI 10.1016/j.celrep.2016.07.086; Lee AJ, 2010, EMBO J, V29, P1600, DOI 10.1038/emboj.2010.31; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Legarda D, 2016, CELL REP, V15, P2449, DOI 10.1016/j.celrep.2016.05.032; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Maelfait J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005410; Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.06.041; Massoumi R, 2011, FUTURE ONCOL, V7, P285, DOI 10.2217/FON.10.187; Mathis BJ, 2015, CURR DRUG TARGETS, V16, P284, DOI 10.2174/1389450115666141024152421                                               ; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Mc Guire C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.55; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Reissig S, 2015, IMMUNOL CELL BIOL, V93, P558, DOI 10.1038/icb.2014.122; Reissig S, 2012, J IMMUNOL, V189, P4770, DOI 10.4049/jimmunol.1201993; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Rodriguez MS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.366; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Sato Y, 2015, NAT STRUCT MOL BIOL, V22, P222, DOI 10.1038/nsmb.2970; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Schlicher L, 2016, EMBO REP, V17, P1485, DOI 10.15252/embr.201642592; Schworer SA, 2014, J BIOL CHEM, V289, P14422, DOI 10.1074/jbc.M114.547547; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Srokowski CC, 2009, BLOOD, V113, P5891, DOI 10.1182/blood-2008-08-175489; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Takagi M, 2016, J ALLERGY CLIN IMMUN, VS0091-6749, P31286; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thein S, 2014, BIOCHEM BIOPH RES CO, V450, P550, DOI 10.1016/j.bbrc.2014.06.019; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Trompouki E, 2009, NEOPLASIA, V11, P469, DOI 10.1593/neo.81424; Vande W. L., 2014, NATURE, V512, P69, DOI DOI 10.1038/NATURE13322; Vereecke L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6103; Vereecke L, 2011, BIOCHEM SOC T, V39, P1086, DOI 10.1042/BST0391086; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Verhelst K, 2014, EMBO REP, V15, P734, DOI 10.15252/embr.201439014; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wagner SA, 2016, EMBO J, V35, P1868, DOI 10.15252/embj.201694300; Wang S, 2016, GENES IMMUN, V17, P165, DOI 10.1038/gene.2016.4; Wang X, 2013, ACTA NEUROPATHOL, V126, P711, DOI 10.1007/s00401-013-1183-9; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Wex Katharina, 2015, Front Immunol, V6, P650, DOI 10.3389/fimmu.2015.00650; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu XM, 2014, ONCOTARGET, V5, P4211, DOI 10.18632/oncotarget.1971                                                        ; Yamaguchi N, 2015, FEBS LETT, V589, P1369, DOI 10.1016/j.febslet.2015.04.022; Ye HS, 2012, NUCLEIC ACIDS RES, V40, P5201, DOI 10.1093/nar/gks175; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhang F, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-44; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P10127, DOI 10.1073/pnas.1612594113; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	135	8	8	17	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	JUL	2017	24	7			SI		1172	1183		10.1038/cdd.2017.46				12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EY5SM	WOS:000404039800008	28362430				2018-01-05	
J	Du, LJ; Zhou, A; Patel, A; Rao, M; Anderson, K; Roy, S				Du, Lijuan; Zhou, Amy; Patel, Akshay; Rao, Mishal; Anderson, Kelsey; Roy, Sougata			Unique patterns of organization and migration of FGF-expressing cells during Drosophila morphogenesis	DEVELOPMENTAL BIOLOGY			English	Article						Branchless; Breathless; CRISPR/Cas; LexA/lexO; Neurons; Tracheoblast	CENTRAL-NERVOUS-SYSTEM; ZINC-FINGER NUCLEASES; GENE-EXPRESSION; TRACHEAL; BRANCHLESS; NEUROBLASTS; HOMOLOG; NEURONS; MARKERS; BRAIN	Fibroblast growth factors (FGF) are essential signaling proteins that regulate diverse cellular functions in developmental and metabolic processes. In Drosophila, the FGF homolog, branchless (bnl) is expressed in a dynamic and spatiotemporally restricted pattern to induce branching morphogenesis of the trachea, which expresses the Bnl-receptor, breathless (btl). Here we have developed a new strategy to determine bnl-expressing cells and study their interactions with the btl-expressing cells in the range of tissue patterning during Drosophila development. To enable targeted gene expression specifically in the bnl expressing cells, a new LexA based bnl enhancer trap line was generated using CRISPR/Cas9 based genome editing. Analyses of the spatiotemporal expression of the reporter in various embryonic stages, larval or adult tissues and in metabolic hypoxia, confirmed its target specificity and versatility. With this tool, new bnl expressing cells, their unique organization and functional interactions with the btl-expressing cells were uncovered in a larval tracheoblast niche in the leg imaginal discs, in larval photoreceptors of the developing retina, and in the embryonic central nervous system. The targeted expression system also facilitated live imaging of simultaneously labeled Bnl sources and tracheal cells, which revealed a unique morphogenetic movement of the embryonic bnl-source. Migration of bnl-expressing cells may create a dynamic spatiotemporal pattern of the signal source necessary for the directional growth of the tracheal branch. The genetic tool and the comprehensive profile of expression, organization, and activity of various types of bnl-expressing cells described in this study provided us with an important foundation for future research investigating the mechanisms underlying Bnl signaling in tissue morphogenesis.	[Du, Lijuan; Zhou, Amy; Patel, Akshay; Rao, Mishal; Anderson, Kelsey; Roy, Sougata] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	Roy, S (reprint author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	sougata@umd.edu			NIH [R00HL114867]; University of Maryland Research and Scholarship Summer Award (RASA)	We thank Dr. T.B. Kornberg, Dr. L. Jiang, Dr. H. Bellen, Dr. H. Lacin, Dr. J. Skeath, Dr. L. Pick, Dr. I. Ando, Dr. W.F. Odenwald, Dr. C. Desplan, the Bloomington Stock Center, the Developmental Studies Hybridoma Bank, and the PACMAN resource center for reagents; Dr. A.E. Beaven and the UMD Imaging core facility for confocal imaging; Dr. H. Lacin and Dr. J. Skeath for discussions and reagents; Dr. L. Pick and Dr. N. Andrews for comments on the manuscript. Funding from: NIH R00HL114867 and University of Maryland Research and Scholarship Summer Award (RASA) to S.R.	Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4; Bae YK, 2012, CELL ADHES MIGR, V6, P397, DOI 10.4161/cam.21103; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Bibikova M, 2002, GENETICS, V161, P1169; Bodenstein D., 1965, POSTEMBRYONIC DEV DR, P275; Brewer JR, 2016, GENE DEV, V30, P751, DOI 10.1101/gad.277137.115; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Chen F, 2014, SCIENCE, V343, P186, DOI 10.1126/science.1241442; DOE CQ, 1992, DEVELOPMENT, V116, P855; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gonzalez M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00075; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Guha A, 2009, DEV BIOL, V335, P317, DOI 10.1016/j.ydbio.2009.09.005; Haack T, 2014, DEV BIOL, V396, P169, DOI 10.1016/j.ydbio.2014.08.033; Higashijima S, 1996, DEVELOPMENT, V122, P527; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kornberg TB, 2014, TRENDS CELL BIOL, V24, P370, DOI 10.1016/j.tcb.2014.01.003; Lacin H, 2016, ELIFE, V5, DOI 10.7554/eLife.13399; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Lin CC, 2016, GENETICS, V203, P1613, DOI 10.1534/genetics.116.191783; Macpherson LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10024; Manning Gerards, 1993, P609; Mukherjee T, 2012, G3-GENES GENOM GENET, V2, P23, DOI 10.1534/g3.111.001495; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Roy S, 2015, BIOESSAYS, V37, P25, DOI 10.1002/bies.201400122; Roy S, 2014, SCIENCE, V343, P852, DOI 10.1126/science.1244624; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Triantafyllou A, 2006, FREE RADICAL RES, V40, P847, DOI 10.1080/10715760600730810; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Yotnda P, 2011, J VIS EXP; Yu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4626; Zartman J, 2013, DEVELOPMENT, V140, P667, DOI 10.1242/dev.088872	42	0	0	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JUL 1	2017	427	1					35	48		10.1016/j.ydbio.2017.05.009				14	Developmental Biology	Developmental Biology	EY6JO	WOS:000404089200005	28502613				2018-01-05	
J	Tchasovnikarova, IA; Timms, RT; Douse, CH; Roberts, RC; Dougan, G; Kingston, RE; Modis, Y; Lehner, PJ				Tchasovnikarova, Iva A.; Timms, Richard T.; Douse, Christopher H.; Roberts, Rhys C.; Dougan, Gordon; Kingston, Robert E.; Modis, Yorgo; Lehner, Paul J.			Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2	NATURE GENETICS			English	Article							POSITION-EFFECT VARIEGATION; DOMAIN-CONTAINING PROTEINS; DNA-DAMAGE RESPONSE; HUMAN-CELLS; GENETIC SCREENS; CRISPR-CAS9 SYSTEM; CHROMATIN; GENOME; BINDING; FAMILY	Dominant mutations in the MORC2 gene have recently been shown to cause axonal Charcot-Marie-Tooth (CMT) disease, but the cellular function of MORC2 is poorly understood. Here, through a genome-wide CRISPR-Cas9-mediated forward genetic screen, we identified MORC2 as an essential gene required for epigenetic silencing by the HUSH complex. HUSH recruits MORC2 to target sites in heterochromatin. We exploited a new method, differential viral accessibility (DIVA), to show that loss of MORC2 results in chromatin decompaction at these target loci, which is concomitant with a loss of H3K9me3 deposition and transcriptional derepression. The ATPase activity of MORC2 is critical for HUSH-mediated silencing, and the most common alteration affecting the ATPase domain in CMT patients (p. Arg252Trp) hyperactivates HUSH-mediated repression in neuronal cells. These data define a critical role for MORC2 in epigenetic silencing by the HUSH complex and provide a mechanistic basis underpinning the role of MORC2 mutations in CMT disease.	[Tchasovnikarova, Iva A.; Timms, Richard T.; Lehner, Paul J.] Cambridge Inst Med Res, Dept Med, Cambridge, England; [Tchasovnikarova, Iva A.; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Tchasovnikarova, Iva A.; Kingston, Robert E.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Douse, Christopher H.; Modis, Yorgo] Univ Cambridge, Dept Med, MRC Lab Mol Biol, Cambridge, England; [Roberts, Rhys C.] Cambridge Inst Med Res, Dept Clin Neurosci, Cambridge, England; [Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England	Lehner, PJ (reprint author), Cambridge Inst Med Res, Dept Med, Cambridge, England.	pjl30@cam.ac.uk		Modis, Yorgo/0000-0002-6084-0429; Douse, Christopher/0000-0002-1604-8944; Tchasovnikarova, Iva/0000-0002-0477-0956	Wellcome Trust [101835/Z/13/Z, 101908/Z/13/Z]; Wellcome Trust through Sir Henry Wellcome Postdoctoral Fellowship [201387/Z/16/Z]; BBSRC through Future Leader Fellowship; Damon Runyon Cancer Research Foundation [DRG-2277-16]; Wellcome Trust	We are indebted to CIMR core facilities: R. Schulte and his team for FACS, and M. Gratian and M. Bowen for microscopy. We thank S. Andrews for assistance with data analysis with SeqMonk, and S. Kundu and M. Tolstorukov for helpful discussions. We thank B. Cochran (Tufts University), F. Randow (MRC-LMB), D. Rubinsztein (CIMR) and M. Brenner (Harvard Medical School) for providing materials. This work was supported by the Wellcome Trust, through a Principal Research Fellowship to P.J.L. (101835/Z/13/Z), a Senior Research Fellowship to Y.M. (101908/Z/13/Z), a Sir Henry Wellcome Postdoctoral Fellowship to R.T.T. (201387/Z/16/Z) and a PhD studentship to I.A.T., and by the BBSRC, through a Future Leader Fellowship to C.H.D.I.A.T. is supported as a Damon Runyon Fellow by the Damon Runyon Cancer Research Foundation (DRG-2277-16). The CIMR is in receipt of a Wellcome Trust strategic award.	Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Albulym OM, 2016, ANN NEUROL, V79, P419, DOI [10.1002/ana.4575, 10.1002/ana.24575]; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen KL, 2015, P NATL ACAD SCI USA, V112, pE3535, DOI 10.1073/pnas.1504232112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Harten SK, 2014, MAMM GENOME, V25, P293, DOI 10.1007/s00335-014-9516-0; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hyun YS, 2016, BRAIN, V139, DOI 10.1093/brain/aww082; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; Lassuthova P, 2016, BRAIN, V139, DOI 10.1093/brain/awv411; Lerdrup M, 2016, NAT STRUCT MOL BIOL, V23, P349, DOI 10.1038/nsmb.3180; Li DQ, 2013, EPIGENETICS-US, V8, P685, DOI 10.4161/epi.24976; Li DQ, 2012, CELL REP, V2, P1657, DOI 10.1016/j.celrep.2012.11.018; Li SS, 2016, P NATL ACAD SCI USA, V113, pE5108, DOI 10.1073/pnas.1609709113; Liu YL, 2016, CURR PROTEIN PEPT SC, V17, P497, DOI 10.2174/1389203717666160125115130; Liu YL, 2016, J BIOL CHEM, V291, P9000, DOI 10.1074/jbc.M116.718973; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Pastor WA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6795; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6                                                   ; Schottmann G, 2016, BRAIN, V139, DOI 10.1093/brain/aww252; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302                                                              ; Sevilla T, 2016, BRAIN, V139, P62, DOI 10.1093/brain/awv311; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Soehn AS, 2009, GENESIS, V47, P697, DOI 10.1002/dvg.20553; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2                                                   ; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Tchasovnikarova IA, 2015, SCIENCE, V348, P1481, DOI 10.1126/science.aaa7227; Timms RT, 2016, CELL REP, V17, P653, DOI 10.1016/j.celrep.2016.09.050; Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786; Wang JY, 2014, CELL MOL LIFE SCI, V71, P4841, DOI 10.1007/s00018-014-1725-x; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4                                                   ; Zhao X, 2016, BRAIN, V139, DOI 10.1093/brain/aww156	47	0	0	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1035	+		10.1038/ng.3878				13	Genetics & Heredity	Genetics & Heredity	EY8OB	WOS:000404253300012	28581500				2018-01-05	
J	Dao, LTM; Galindo-Albarran, AO; Castro-Mondragon, JA; Andrieu-Soler, C; Medina-Rivera, A; Souaid, C; Charbonnier, G; Griffon, A; Vanhille, L; Stephen, T; Alomairi, J; Martin, D; Torres, M; Fernandez, N; Soler, E; van Helden, J; Puthier, D; Spicuglia, S				Dao, Lan T. M.; Galindo-Albarran, Ariel O.; Castro-Mondragon, Jaime A.; Andrieu-Soler, Charlotte; Medina-Rivera, Alejandra; Souaid, Charbel; Charbonnier, Guillaume; Griffon, Aurelien; Vanhille, Laurent; Stephen, Tharshana; Alomairi, Jaafar; Martin, David; Torres, Magali; Fernandez, Nicolas; Soler, Eric; van Helden, Jacques; Puthier, Denis; Spicuglia, Salvatore			Genome-wide characterization of mammalian promoters with distal enhancer functions	NATURE GENETICS			English	Article							CHROMOSOME CONFORMATION CAPTURE; HIGH-THROUGHPUT; R/BIOCONDUCTOR PACKAGE; CHROMATIN INTERACTIONS; GENE-EXPRESSION; SEQUENCING DATA; TRANSCRIPTION; ARCHITECTURE; DISCOVERY; RNA	Gene expression in mammals is precisely regulated by the combination of promoters and gene-distal regulatory regions, known as enhancers. Several studies have suggested that some promoters might have enhancer functions. However, the extent of this type of promoters and whether they actually function to regulate the expression of distal genes have remained elusive. Here, by exploiting a high-throughput enhancer reporter assay, we unravel a set of mammalian promoters displaying enhancer activity. These promoters have distinct genomic and epigenomic features and frequently interact with other gene promoters. Extensive CRISPR-Cas9 genomic manipulation demonstrated the involvement of these promoters in the cis regulation of expression of distal genes in their natural loci. Our results have important implications for the understanding of complex gene regulation in normal development and disease.	[Dao, Lan T. M.; Galindo-Albarran, Ariel O.; Castro-Mondragon, Jaime A.; Souaid, Charbel; Charbonnier, Guillaume; Griffon, Aurelien; Vanhille, Laurent; Alomairi, Jaafar; Torres, Magali; Fernandez, Nicolas; van Helden, Jacques; Puthier, Denis; Spicuglia, Salvatore] Aix Marseille Univ, INSERM, TAGC, UMR 1090, Marseille, France; [Souaid, Charbel; Stephen, Tharshana; Soler, Eric] Univ Paris Saclay, Univ Paris Diderot, Lab Mol Hematopoiesis, INSERM,UMR 967,CEA,DRF,iRCM, Fontenay Aux Roses, France; [Andrieu-Soler, Charlotte; Soler, Eric] Univ Sorbonne Paris Cite, Labex GR Ex, Paris, France; [Andrieu-Soler, Charlotte; Stephen, Tharshana; Martin, David; Soler, Eric] Univ Montpellier, IGMM, CNRS, Montpellier, France; [Medina-Rivera, Alejandra] Univ Nacl Autonoma Mexico, Lab Int Invest Genoma Humano, Juriquilla, Mexico; [Dao, Lan T. M.] Vinmec Res Inst Stem Cell & Gene Technol, Hanoi, Vietnam	Spicuglia, S (reprint author), Aix Marseille Univ, INSERM, TAGC, UMR 1090, Marseille, France.	salvatore.spicuglia@inserm.fr		puthier, denis/0000-0002-7240-5280; Spicuglia, Salvatore/0000-0002-8101-7108; van Helden, Jacques/0000-0002-8799-8584	INSERM; Aix-Marseille University; European Union [282510-BLUEPRINT]; ARC [PJA 20151203149]; A*MIDEX [ANR-11-IDEX-0001-02]; Vietnam International Education Development [911]; CONACYT; FRM	We thank J.-C. Andrau and J. Imbert for critical reading of the manuscript. We thank the IBiSA 'Transcriptomics and Genomics Marseille-Luminy' (TGML) platform for sequencing of CapStarr-seq samples and the cell biology platform for management of cell culture. Work in the laboratory of S.S. was supported by recurrent funding from INSERM and Aix-Marseille University and by specific grants from the European Union's FP7 Programme (282510-BLUEPRINT), ARC (PJA 20151203149) and A*MIDEX (ANR-11-IDEX-0001-02). L.T.M.D., A.G. and G.C. were supported, respectively, by Vietnam International Education Development (911), CONACYT and FRM.	Andersson R, 2015, BIOESSAYS, V37, P314, DOI 10.1002/bies.201400162; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Benaglia T, 2009, J STAT SOFTW, V32, P1; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Dailey L, 2015, GENOMICS, V106, P151, DOI 10.1016/j.ygeno.2015.06.004; Dao L. T. M., 2015, PROTOCOL EXCHANGE; Duttke SHC, 2015, MOL CELL, V57, P674, DOI 10.1016/j.molcel.2014.12.029; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Feuerborn A, 2015, TRENDS GENET, V31, P483, DOI 10.1016/j.tig.2015.07.001; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Glusman G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077885; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kuznetsova T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0832-9; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; MOMBAERTS P, 1995, P NATL ACAD SCI USA, V92, P7420, DOI 10.1073/pnas.92.16.7420; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nejepinska J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043283; Nguyen TA, 2016, GENOME RES, V26, P1023, DOI 10.1101/gr.204834.116; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaffner W, 2015, BIOL CHEM, V396, P311, DOI 10.1515/hsz-2014-0303; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Stadhouders R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9893; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Thongjuea S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt373; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vanhille L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7905; Vieux-Rochas M, 2015, P NATL ACAD SCI USA, V112, P4672, DOI 10.1073/pnas.1504783112; Walter C, 2014, BIOINFORMATICS, V30, P3268, DOI 10.1093/bioinformatics/btu497; Whalen S, 2016, NAT GENET, V48, P488, DOI 10.1038/ng.3539; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994	51	5	5	21	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1073	+		10.1038/ng.3884				12	Genetics & Heredity	Genetics & Heredity	EY8OB	WOS:000404253300016	28581502				2018-01-05	
J	Liu, XQ; Yagi, H; Saeed, S; Bais, AS; Gabriel, GC; Chen, ZH; Peterson, KA; Li, Y; Schwartz, MC; Reynolds, WT; Saydmohammed, M; Gibbs, B; Wu, YJ; Devine, W; Chatterjee, B; Klena, NT; Kostka, D; Bentley, KLD; Ganapathiraju, MK; Dexheimer, P; Leatherbury, L; Khalifa, O; Bhagat, A; Zahid, M; Pu, W; Watkins, S; Grossfeld, P; Murray, SA; Porter, GA; Tsang, M; Martin, LJ; Benson, DW; Aronow, BJ; Lo, CW				Liu, Xiaoqin; Yagi, Hisato; Saeed, Shazina; Bais, Abha S.; Gabriel, George C.; Chen, Zhaohan; Peterson, Kevin A.; Li, You; Schwartz, Molly C.; Reynolds, William T.; Saydmohammed, Manush; Gibbs, Brian; Wu, Yijen; Devine, William; Chatterjee, Bishwanath; Klena, Nikolai T.; Kostka, Dennis; Bentley, Karen L. de Mesy; Ganapathiraju, Madhavi K.; Dexheimer, Phillip; Leatherbury, Linda; Khalifa, Omar; Bhagat, Anchit; Zahid, Maliha; Pu, William; Watkins, Simon; Grossfeld, Paul; Murray, Stephen A.; Porter, George A., Jr.; Tsang, Michael; Martin, Lisa J.; Benson, D. Woodrow; Aronow, Bruce J.; Lo, Cecilia W.			The complex genetics of hypoplastic left heart syndrome	NATURE GENETICS			English	Article							BICUSPID AORTIC-VALVE; EPIGENETIC REGULATION; FETAL ECHOCARDIOGRAPHY; TRANSCRIPTION FACTOR; EXPRESSION PROFILES; DISEASE; CELLS; MALFORMATIONS; MUTATIONS; DEFECTS	Congenital heart disease (CHD) affects up to 1% of live births(1). Although a genetic etiology is indicated by an increased recurrence risk(2,3), sporadic occurrence suggests that CHD genetics is complex(4). Here, we show that hypoplastic left heart syndrome (HLHS), a severe CHD, is multigenic and genetically heterogeneous. Using mouse forward genetics, we report what is, to our knowledge, the first isolation of HLHS mutant mice and identification of genes causing HLHS. Mutations from seven HLHS mouse lines showed multigenic enrichment in ten human chromosome regions linked to HLHS5-7. Mutations in Sap130 and Pcdha9, genes not previously associated with CHD, were validated by CRISPR-Cas9 genome editing in mice as being digenic causes of HLHS. We also identified one subject with HLHS with SAP130 and PCDHA13 mutations. Mouse and zebrafish modeling showed that Sap130 mediates left ventricular hypoplasia, whereas Pcdha9 increases penetrance of aortic valve abnormalities, both signature HLHS defects. These findings show that HLHS can arise genetically in a combinatorial fashion, thus providing a new paradigm for the complex genetics of CHD.	[Liu, Xiaoqin; Yagi, Hisato; Saeed, Shazina; Bais, Abha S.; Gabriel, George C.; Chen, Zhaohan; Li, You; Schwartz, Molly C.; Reynolds, William T.; Saydmohammed, Manush; Gibbs, Brian; Wu, Yijen; Devine, William; Chatterjee, Bishwanath; Klena, Nikolai T.; Kostka, Dennis; Bhagat, Anchit; Zahid, Maliha; Tsang, Michael; Lo, Cecilia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15213 USA; [Peterson, Kevin A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Bentley, Karen L. de Mesy] Univ Rochester, Sch Med & Dent, Pathol & Lab Med & Elect Microscope Res Core, Rochester, NY USA; [Ganapathiraju, Madhavi K.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15213 USA; [Dexheimer, Phillip; Aronow, Bruce J.] Cincinnati Childrens Hosp Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; [Leatherbury, Linda] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Pu, William] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Watkins, Simon] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Dept Cell Biol, Pittsburgh, PA USA; [Grossfeld, Paul] Univ San Diego, Sch Med, Div Cardiol, San Diego, CA 92110 USA; [Porter, George A., Jr.] Univ Rochester, Sch Med & Dent, Dept Pediat, Div Cardiol, Rochester, NY 14642 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Benson, D. Woodrow] Med Coll Wisconsin, Pediat Cardiol, Milwaukee, WI 53226 USA	Lo, CW (reprint author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15213 USA.	cel36@pitt.edu		Ganapathiraju, Madhavi/0000-0002-3825-0924	NIH [U01-HL098180, R01-HL132024, R01-GM104412, S10-OD010340, R01-MH094564, OD011185]; Children's Heart Foundation; Junior Cooperative Society	We thank T. Yagi (Osaka University) for providing plasmid for Pcdha9 in situ probes and A. Handen (University of Pittsburgh) for assisting with programming. We also thank C.G Burns (Harvard Medical School) for providing the transgene marker, Tg (5.7myl7: nDsRed2). This work was supported by funding from the NIH (U01-HL098180 (C.W.L.), R01-HL132024 (C.W.L.), R01-GM104412 (C.W.L.), S10-OD010340 (C.W.L.), R01-MH094564 (M.K.G.), and OD011185 (S.A.M.)), the Children's Heart Foundation (L.J.M. and D.W.B.), and the Junior Cooperative Society (D.W.B.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Benson DW, 2016, J PEDIATR-US, V173, P25, DOI 10.1016/j.jpeds.2016.02.052; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chakraborty S, 2008, PHYSIOL GENOMICS, V35, P75, DOI 10.1152/physiolgenomics.90212.2008; Chandra S, 2012, JACC-CARDIOVASC IMAG, V5, P981, DOI 10.1016/j.jcmg.2012.07.008; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Christofori G, 2010, EMBO J, V29, P1787, DOI 10.1038/emboj.2010.92; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Freud LR, 2014, CIRCULATION, V130, P638, DOI 10.1161/CIRCULATIONAHA.114.009032; Gaber N, 2013, AM J PATHOL, V183, P720, DOI 10.1016/j.ajpath.2013.05.022; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Ganapathiraju MK, 2016, NPJ SCHIZOPHR, V2, DOI 10.1038/npjschz.2016.12; Gill HK, 2003, J AM COLL CARDIOL, V42, P923, DOI 10.1016/S0735-1097(03)00853-2; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hinton RB, 2009, J AM COLL CARDIOL, V53, P1065, DOI 10.1016/j.jacc.2008.12.023; Hinton RB, 2007, J AM COLL CARDIOL, V50, P1590, DOI 10.1016/j.jacc.2007.07.021; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7                                                   ; Hom J, 2010, BBA-BIOENERGETICS, V1797, P913, DOI 10.1016/j.bbabio.2010.03.018; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Iascone M, 2012, CLIN GENET, V81, P542, DOI 10.1111/j.1399-0004.2011.01674.x; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Keshava Prasad T. S., 2009, NUCLEIC ACIDS RES, V37, pD767, DOI DOI 10.1093/NAR/GKN892; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Lin YW, 2014, CURR PHARM DESIGN, V20, P1698, DOI 10.2174/13816128113199990512                                                    ; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Liu XQ, 2014, CIRC-CARDIOVASC IMAG, V7, P31, DOI 10.1161/CIRCIMAGING.113.000451; Liu XQ, 2013, BIRTH DEFECTS RES C, V99, P93, DOI 10.1002/bdrc.21037; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; MacGrogan D, 2011, BIRTH DEFECTS RES A, V91, P449, DOI 10.1002/bdra.20815; Magarin M, 2016, GENOM DATA, V9, P145, DOI 10.1016/j.gdata.2016.08.009; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Manuylov NL, 2009, THESCIENTIFICWORLDJO, V9, P575, DOI 10.1100/tsw.2009.75; Mardin WA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-264; Martin LJ, 2007, HUM GENET, V121, P275, DOI 10.1007/s00439-006-0316-9; Martinez-Fernandez A, 2013, CIRC-CARDIOVASC GENE, V6, P462, DOI 10.1161/CIRCGENETICS.113.000045; McBride KL, 2009, EUR J HUM GENET, V17, P811, DOI 10.1038/ejhg.2008.255; McBride KL, 2005, AM J MED GENET A, V134A, P180, DOI 10.1002/ajmg.a.30602; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nakano H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2569; Noguchi Y, 2009, J BIOL CHEM, V284, P32002, DOI 10.1074/jbc.M109.046938; Noonan JP, 2003, AM J HUM GENET, V72, P621, DOI 10.1086/368060                                                                  ; Oliver D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129457; Oyen N, 2009, CIRCULATION, V120, P295, DOI 10.1161/CIRCULATIONAHA.109.857987; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Ricci M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029784; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Taketazu M, 2004, J AM COLL CARDIOL, V43, P1902, DOI 10.1016/j.jacc.2004.01.033; Theis JL, 2015, HUM GENET, V134, P1003, DOI 10.1007/s00439-015-1582-1; Tomoeda M, 2011, BIOCHEM BIOPH RES CO, V410, P798, DOI 10.1016/j.bbrc.2011.06.066; van Loo,PF, 2007, MOL CELL BIOL, V27, P8571, DOI 10.1128/MCB.01350-07; Vijaya M, 2013, GENE, V516, P218, DOI 10.1016/j.gene.2012.12.071; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu C, 2014, ADV EXP MED BIOL, V799, P69, DOI 10.1007/978-1-4614-8778-4_4	68	4	4	15	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1152	+		10.1038/ng.3870				11	Genetics & Heredity	Genetics & Heredity	EY8OB	WOS:000404253300028	28530678				2018-01-05	
J	Feng, YZ; Zhang, QY; Fu, MT; Zhang, ZF; Wei, M; Zhou, JY; Shi, R				Feng, Yu-Zhen; Zhang, Qing-Yan; Fu, Mei-Ting; Zhang, Zhen-Fei; Wei, Min; Zhou, Jue-Yu; Shi, Rong			Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer	ONCOLOGY REPORTS			English	Article						PinX1; basal-like breast cancer; malignant behavior; biomarker; molecular target	SQUAMOUS-CELL CARCINOMAS; BINDING-FACTOR PINX1; TELOMERASE ACTIVITY; PROGNOSIS; CLASSIFICATION; METASTASIS; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; HIGHLIGHTS; SUBTYPES	Human Pinx1 protein, associated with shelterin proteins, is widely revealed as a haploinsufficient tumor suppressor. Growing evidence has manifested the deregulation of PinX1 in distinct cancers. Nonetheless, the loss status of PinX1 and its diagnostic, prognostic and clinicopathological significance in Basal-like breast cancer are still unclear. In the present study, the PinX1 expression levels of breast cancer tissues were investigated by qRT-PCR and immunoblotting assays. Then immunohistochemistry (IHC) was performed to detect PinX1 expression on a tissue microarray. The optimal threshold for PinX1 positivity was determined by receiver operating characteristic (ROC) curve analysis. To clarify the probable role of PinX1 in BLBC, the PinX1 knockout and stably over-expressed MDA-MB-231 cell lines were constructed by the CRISPR-Cas9 system and gene transfection. The association of PinX1 expression with cell proliferation, migration and apoptosis of MDA-MB-231 cells were observed by CCK-8 assay, wound healing assay, Transwell assay, flow cytometric analysis and immunoblotting of the cleaved caspase-3 protein level. Our results showed that both PinX1 mRNA and protein expression were downregulated in breast cancer tissues (P<0.05). In IHC analysis, the optimal cut-off parameter for PinX1 positive expression was 62.5% (the AUC was 0.749, P<0.01). PinX1 positivity was 76.9% (10/14) in luminal subtypes, 50% (5/10) in Her2-enriched breast cancer and 27.3% (9/33) in basal-like subtypes. Besides, in 59 invasive ductal breast carcinomas, PinX1 expression was inversely related to histology grade (P<0.05) while it was positively associated with PR status (P<0.05) and ER status (P<0.05). These results indicated that low expression of PinX1 correlated with aggressive clinicopathological significance of breast cancer, especially in the basal-like subtype. Besides, we identified that overexpression of PinX1 inhibited the proliferation rates and migration ability and increased the apoptosis rates of BLBC. Our findings demonstrated that low expression of PinX1 was associated with malignant behaviors in basal-like subtype of breast cancer. PinX1 is likely a feasible biomarker and molecular target of BLBC.	[Feng, Yu-Zhen; Zhang, Zhen-Fei; Wei, Min; Zhou, Jue-Yu; Shi, Rong] Southern Med Univ, Sch Basic Med Sci, Inst Genet Engn, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Qing-Yan; Fu, Mei-Ting] Southern Med Univ, Clin Med Coll 1, Guangzhou 510515, Guangdong, Peoples R China	Zhou, JY; Shi, R (reprint author), Southern Med Univ, Sch Basic Med Sci, Inst Genet Engn, Guangzhou 510515, Guangdong, Peoples R China.	zhoujueyu@126.com; shirongphd@126.com			National Natural Science Foundation of China [81372154, 81672588]; Science and Technology Planning Project of Guangdong Province, China [2013B021800146]	The present study was supported by the National Natural Science Foundation of China (81372154, 81672588) and the Science and Technology Planning Project of Guangdong Province, China (2013B021800146).	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bartholomeusz C, 2015, MOL CANCER THER, V14, P2773, DOI 10.1158/1535-7163.MCT-15-0243; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Burnett JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15821; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; De Laurentiis M, 2010, CANCER TREAT REV, V36, pS80, DOI 10.1016/S0305-7372(10)70025-6; Deng WY, 2015, BIOMED PHARMACOTHER, V73, P1, DOI 10.1016/j.biopha.2015.04.011; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Esposito A, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.518; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gelmon K, 2012, ANN ONCOL, V23, P2223, DOI 10.1093/annonc/mds067; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Johnson FB, 2011, J CLIN INVEST, V121, P1242, DOI 10.1172/JCI57024; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lai XF, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-12; Lang JE, 2015, J SURG ONCOL, V111, P81, DOI 10.1002/jso.23732; Li HL, 2015, ONCOTARGET, V6, P21406, DOI 10.18632/oncotarget.4011                                                        ; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Liu JY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morris PG, 2012, BREAST J, V18, P345, DOI 10.1111/j.1524-4741.2012.01246.x; Nelson ER, 2016, ONCOTARGET, V7, P84030, DOI 10.18632/oncotarget.12767; Ogata H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001756; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Qian D, 2013, J PATHOL, V229, P765, DOI 10.1002/path.4163; Ramirez-Fort MK, 2014, AM J CLIN ONCOL-CANC, V37, P266, DOI 10.1097/COC.0b013e318277d62f; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodler ET, 2016, CLIN CANCER RES, V22, P2855, DOI 10.1158/1078-0432.CCR-15-2137; Shi R, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-46; Swanson PE, 2015, APPL IMMUNOHISTO M M, V23, P81, DOI 10.1097/PAI.0000000000000181; Taherian-Fard A, 2015, BRIEF BIOINFORM, V16, P461, DOI 10.1093/bib/bbu020; Tian XP, 2014, CANCER LETT, V353, P104, DOI 10.1016/j.canlet.2014.07.012; Toss A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0560-9; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; Wang HB, 2010, J GASTROINTEST SURG, V14, P1227, DOI 10.1007/s11605-010-1253-4; Wu JN, 2011, J CANCER RES CLIN, V137, P1505, DOI 10.1007/s00432-011-1029-6; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452; Zuo J, 2013, ONCOL REP, V30, P1823, DOI 10.3892/or.2013.2649	39	0	0	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUL	2017	38	1					109	119		10.3892/or.2017.5696				11	Oncology	Oncology	EY6JR	WOS:000404089500011	28586040	green_published			2018-01-05	
J	Bobik, K; McCray, TN; Ernest, B; Fernandez, JC; Howell, KA; Lane, T; Staton, M; Burch-Smith, TM				Bobik, Krzysztof; McCray, Tyra N.; Ernest, Ben; Fernandez, Jessica C.; Howell, Katharine A.; Lane, Thomas; Staton, Margaret; Burch-Smith, Tessa M.			The chloroplast RNA helicase ISE2 is required for multiple chloroplast RNA processing steps in Arabidopsis thaliana	PLANT JOURNAL			English	Article						RNA helicase; splicing; RNA editing; chloroplast; ribosome; Arabidopsis thaliana; ISE2; group II intron; plasmodesmata	PLASTID GENE-EXPRESSION; DEAD-BOX PROTEIN; RIBOSOME BIOGENESIS; ABSCISIC-ACID; PLASMODESMATA; PLANTS; MITOCHONDRIA; EVOLUTION; ENCODES; FAMILY	INCREASED SIZE EXCLUSION LIMIT2 (ISE2) is a chloroplast-localized RNA helicase that is indispensable for proper plant development. Chloroplasts in leaves with reduced ISE2 expression have previously been shown to exhibit reduced thylakoid contents and increased stromal volume, indicative of defective development. It has recently been reported that ISE2 is required for the splicing of group II introns from chloroplast transcripts. The current study extends these findings, and presents evidence for ISE2's role in multiple aspects of chloroplast RNA processing beyond group II intron splicing. Loss of ISE2 from Arabidopsis thaliana leaves resulted in defects in C-to-U RNA editing, altered accumulation of chloroplast transcripts and chloroplast-encoded proteins, and defective processing of chloroplast ribosomal RNAs. Potential ISE2 substrates were identified by RNA immunoprecipitation followed by next-generation sequencing (RIP-seq), and the diversity of RNA species identified supports ISE2's involvement in multiple aspects of chloroplast RNA metabolism. Comprehensive phylogenetic analyses revealed that ISE2 is a non-canonical Ski2-like RNA helicase that represents a separate sub-clade unique to green photosynthetic organisms, consistent with its function as an essential protein. Thus ISE2's evolutionary conservation may be explained by its numerous roles in regulating chloroplast gene expression.	[Bobik, Krzysztof; Fernandez, Jessica C.; Burch-Smith, Tessa M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [McCray, Tyra N.; Ernest, Ben; Staton, Margaret; Burch-Smith, Tessa M.] Univ Tennessee, Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Howell, Katharine A.] Univ Western Australia, ARC Ctr Excellence, Plant Energy Biol, Perth, WA, Australia; [Lane, Thomas; Staton, Margaret] Univ Tennessee, Inst Agr, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA	Burch-Smith, TM (reprint author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.; Burch-Smith, TM (reprint author), Univ Tennessee, Sch Genome Sci & Technol, Knoxville, TN 37996 USA.	tburchsm@utk.edu		Burch-Smith, Tessa/0000-0002-5994-4343; Howell, Katharine/0000-0002-5044-0034	National Science Foundation [1456761]; University of Tennessee; Australian Research Council [DE120101117]	The generous donation of antibodies by Drs. Zach Adam, Wataru Sakamoto and Masato Nakai is acknowledged. The contributions of the University of Rochester Genomics Resource Center (URGRC) are also acknowledged. We are grateful to Dr. Albrecht von Arnim, Dr. Beth Mullin and Emmanuel Perrodin-Njoku for critical reading of the manuscript and their thoughtful suggestions. This research was supported by National Science Foundation Award 1456761 and start-up funds from the University of Tennessee to T.B.S. and a Discovery Early Career Researcher Award (DE120101117) from the Australian Research Council to K.A.H.	Asakura Y, 2007, PLANT CELL, V19, P3864, DOI 10.1105/tpc.107.055160; Asakura Y, 2012, PLANT PHYSIOL, V159, P961, DOI 10.1104/pp.112.197525; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bobik K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00781; Branscheid A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1014; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.084624; Burch-Smith TM, 2011, P NATL ACAD SCI USA, V108, pE1451, DOI 10.1073/pnas.1117226108; Burch-Smith TM, 2011, PROTOPLASMA, V248, P61, DOI 10.1007/s00709-010-0252-3; Burch-Smith TM, 2010, CURR BIOL, V20, P989, DOI 10.1016/j.cub.2010.03.064; Carlotto N, 2016, PLANT CELL ENVIRON, V39, P165, DOI 10.1111/pce.12603; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chi W, 2012, PLANT PHYSIOL, V158, P693, DOI 10.1104/pp.111.186775; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; desLongevialle A. F., 2008, PLANT J, V56, P157; Dorcey E, 2012, PLOS GENET, V8, P395, DOI 10.1371/journal.pgen.1002652; Eisen A, 1998, BIOESSAYS, V20, P634, DOI 10.1002/(SICI)1521-1878(199808)20:8<634::AID-BIES6>3.3.CO;2-L; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fristedt R, 2014, PLANT PHYSIOL, V164, P201, DOI 10.1104/pp.113.228338; GoldschmidtClermont M, 1998, INT REV CYTOL, V177, P115; Gu L, 2014, PLANT PHYSIOL BIOCH, V82, P309, DOI 10.1016/j.plaphy.2014.07.006; Halbach F, 2013, CELL, V154, P814, DOI 10.1016/j.cell.2013.07.017; Han X, 2014, J EXP BOT, V65, P1737, DOI 10.1093/jxb/ert422; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kakizaki T, 2012, J EXP BOT, V63, P251, DOI 10.1093/jxb/err257; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kobayashi K, 2007, PLANT CELL, V19, P1885, DOI 10.1105/tpc.106.045666; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Li F, 2011, P NATL ACAD SCI USA, V108, P3542, DOI 10.1073/pnas.1014152108; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu XY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-287; Lucas WJ, 2004, NAT REV MOL CELL BIO, V5, P712, DOI 10.1038/nrm1470; Martin R, 2013, RNA BIOL, V10, P4, DOI 10.4161/rna.21879; Mingam A, 2004, PLANT BIOTECHNOL J, V2, P401, DOI 10.1111/j.1467-7652.2004.00084.x; Nakajima Y, 2005, J PLANT PHYSIOL, V162, P1347, DOI 10.1016/j.jplph.2005.02.009; Nishimura K, 2010, PLANT J, V63, P766, DOI 10.1111/j.1365-313X.2010.04276.x; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Pyo YJ, 2013, PLANT PHYSIOL, V163, P1844, DOI 10.1104/pp.113.227199; Rodriguez-Galan O, 2013, BBA-GENE REGUL MECH, V1829, P775, DOI 10.1016/j.bbagrm.2013.01.007; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stonebloom S, 2012, PLANT PHYSIOL, V158, P190, DOI 10.1104/pp.111.186130; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; Takenaka M, 2003, J BIOL CHEM, V278, P47526, DOI 10.1074/jbc.M305341200; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tiller N, 2014, MOL PLANT, V7, P1105, DOI 10.1093/mp/ssu022; Tiller N, 2012, PLANT J, V69, P302, DOI 10.1111/j.1365-313X.2011.04791.x; Tseng CC, 2013, PLANT MOL BIOL, V82, P375, DOI 10.1007/s11103-013-0069-5; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Umate P, 2010, PLANT MOL BIOL, V73, P449, DOI 10.1007/s11103-010-9632-5; Walter M, 2010, PLANT J, V64, P851, DOI 10.1111/j.1365-313X.2010.04377.x; Yagi Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00061	57	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	JUL	2017	91	1					114	131		10.1111/tpj.13550				18	Plant Sciences	Plant Sciences	EY3OP	WOS:000403882100009	28346704				2018-01-05	
J	Romero-Moya, D; Santos-Ocana, C; Castano, J; Garrabou, G; Rodriguez-Gomez, JA; Ruiz-Bonilla, V; Bueno, C; Gonzalez-Rodriguez, P; Giorgetti, A; Perdiguero, E; Prieto, C; Moren-Nunez, C; Fernandez-Ayala, DJ; Cascajo, MV; Velasco, I; Canals, JM; Montero, R; Yubero, D; Jou, C; Lopez-Barneo, J; Cardellach, F; Munoz-Canoves, P; Artuch, R; Navas, P; Menendez, P				Romero-Moya, Damia; Santos-Ocana, Carlos; Castano, Julio; Garrabou, Gloria; Rodriguez-Gomez, Jose A.; Ruiz-Bonilla, Vanesa; Bueno, Clara; Gonzalez-Rodriguez, Patricia; Giorgetti, Alessandra; Perdiguero, Eusebio; Prieto, Cristina; Moren-Nunez, Constanza; Fernandez-Ayala, Daniel J.; Victoria Cascajo, Maria; Velasco, Ivan; Maria Canals, Josep; Montero, Raquel; Yubero, Delia; Jou, Cristina; Lopez-Barneo, Jose; Cardellach, Francesc; Munoz-Canoves, Pura; Artuch, Rafael; Navas, Placido; Menendez, Pablo			Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q(10) Deficiency	STEM CELLS			English	Article						Coenzyme Q10; COQ4; Induced pluripotent stem cell; CRISPR-Cas9; Dopaminergic and motor neurons; Skeletal muscle	HUMAN B-CELLS; COQ(10) DEFICIENCY; Q BIOSYNTHESIS; UBIQUINONE DEFICIENCY; CEREBELLAR-ATAXIA; NEPHROTIC SYNDROME; OXIDATIVE STRESS; MUTATIONS CAUSE; MOTOR-NEURONS; HUMAN ES	Coenzyme Q(10) (CoQ(10)) plays a crucial role in mitochondria as an electron carrier within the mitochondrial respiratory chain (MRC) and is an essential antioxidant. Mutations in genes responsible for CoQ(10) biosynthesis (COQ genes) cause primary CoQ(10) deficiency, a rare and heterogeneous mitochondrial disorder with no clear genotype-phenotype association, mainly affecting tissues with high-energy demand including brain and skeletal muscle (SkM). Here, we report a four-year-old girl diagnosed with minor mental retardation and lethal rhabdomyolysis harboring a heterozygous mutation (c. 483G > C (E161D)) in COQ4. The patient's fibroblasts showed a decrease in [CoQ(10)], CoQ(10) biosynthesis, MRC activity affecting complexes I/II+III, and respiration defects. Bona fide induced pluripotent stem cell (iPSCs) lines carrying the COQ4 mutation (CQ4-iPSCs) were generated, characterized and genetically edited using the CRISPRCas9 system (CQ4 ed -iPSCs). Extensive differentiation and metabolic assays of control-iPSCs, CQ4iPSCs and CQ4 ed -iPSCs demonstrated a genotype association, reproducing the disease phenotype. The COQ4 mutation in iPSC was associated with CoQ(10) deficiency, metabolic dysfunction, and respiration defects. iPSC differentiation into SkM was compromised, and the resulting SkM also displayed respiration defects. Remarkably, iPSC differentiation in dopaminergic or motor neurons was unaffected. This study offers an unprecedented iPSC model recapitulating CoQ(10) deficiency-associated functional and metabolic phenotypes caused by COQ4 mutation. 0	[Romero-Moya, Damia; Castano, Julio; Ruiz-Bonilla, Vanesa; Gonzalez-Rodriguez, Patricia; Perdiguero, Eusebio; Navas, Placido] Univ Barcelona, Dept Biomed Sci, Fac Med & Hlth Sci, Josep Carreras Leukemia Res Inst, Barcelona, Spain; [Santos-Ocana, Carlos; Fernandez-Ayala, Daniel J.; Victoria Cascajo, Maria; Navas, Placido] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Santos-Ocana, Carlos; Garrabou, Gloria; Moren-Nunez, Constanza; Fernandez-Ayala, Daniel J.; Victoria Cascajo, Maria; Montero, Raquel; Jou, Cristina; Cardellach, Francesc; Artuch, Rafael; Navas, Placido] CIBERER, Valencia, Spain; [Garrabou, Gloria; Moren-Nunez, Constanza; Cardellach, Francesc] Univ Barcelona, Fac Med & Hlth Sci, Muscle Res & Mitochondrial Funct Lab, Cellex IDIBAPS, Barcelona, Spain; [Rodriguez-Gomez, Jose A.; Gonzalez-Rodriguez, Patricia; Lopez-Barneo, Jose] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Seville, Seville, Spain; [Ruiz-Bonilla, Vanesa; Gonzalez-Rodriguez, Patricia; Perdiguero, Eusebio; Maria Canals, Josep; Lopez-Barneo, Jose; Munoz-Canoves, Pura] CIBER Neurodegenerat Dis CIBERNED, Madrid, Spain; [Ruiz-Bonilla, Vanesa; Perdiguero, Eusebio; Munoz-Canoves, Pura] Pompeu Fabra Univ UPF, Barcelona, Spain; [Velasco, Ivan] Univ Nacl Autonoma Mexico, Insituto Fisiol Celular Neurociencias, Mexico City, DF, Mexico; [Velasco, Ivan] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, IFC, Lab Reprogramac Celular, Mexico City, DF, Mexico; [Maria Canals, Josep] Univ Barcelona, Dept Biomed Sci, Fac Med & Hlth Sci, Stem Cells & Regenerat Med Lab,Prod & Validat Ctr, Barcelona, Spain; [Maria Canals, Josep] Univ Barcelona, Neurosci Inst, Barcelona, Spain; [Maria Canals, Josep] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Montero, Raquel; Yubero, Delia; Jou, Cristina; Artuch, Rafael] Hosp San Juan Dios, Pediat Res Inst, Dept Clin Biochem, Barcelona, Spain; [Munoz-Canoves, Pura; Menendez, Pablo] Lluis Co 23, ICREA, Barcelona, Spain; [Munoz-Canoves, Pura] Spanish Natl Ctr Cardiovasc Res CNIC, Madrid, Spain; [Menendez, Pablo] ISCIII, Ctr Invest Biomedica Red Canc, Madrid, Spain	Menendez, P (reprint author), Univ Barcelona, Sch Med, Josep Carreras Leukemia Res Inst, Casanova 143, E-08036 Barcelona, Spain.	pmenendez@carrerasresearch.org	Velasco, Ivan/D-3593-2014	Velasco, Ivan/0000-0002-8953-6578; Canals, Josep M./0000-0001-6829-7670	ISCIII/FEDER [E-Rare-2 Call PI12/03112]; FIS/ISCIII/FEDER project [PI14/01962]; European Research Council [ERC-2014-CoG-646903]; PFIS [FI11/0511, FI12/00468]; Miguel Servet II contract [CPII13/00011]; Obra Social La Caixa-Fundacio Josep Carreras; Generalitat de Catalunya [SGR330]; Ramon y Cajal Program [RyC-2013-13221]	This work was supported by the ISCIII/FEDER (E-Rare-2 Call PI12/03112 to P.M.), FIS/ISCIII/FEDER project (PI14/01962 to P.N.) and the European Research Council (ERC-2014-CoG-646903 to P.M.). D.R.M. and C.P. are supported by PFIS scholarships (FI11/0511 and FI12/00468, respectively). C.B is supported by a Miguel Servet II contract (CPII13/00011). P.M. also acknowledges the financial support from The Obra Social La Caixa-Fundacio Josep Carreras and The Generalitat de Catalunya (SGR330). P.M. and J.L.-B. are investigators of the Spanish Cell Therapy cooperative network (TERCEL). A.G. is supported by Ramon y Cajal Program (RyC-2013-13221).	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Artuch R, 2006, J NEUROL SCI, V246, P153, DOI 10.1016/j.jns.2006.01.021; Artuch R, 2009, ADV EXP MED BIOL, V652, P117, DOI 10.1007/978-90-481-2813-6_8; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Brea-Calvo G, 2015, AM J HUM GENET, V96, P309, DOI 10.1016/j.ajhg.2014.12.023; Brito S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00254; Bueno C, 2016, LEUKEMIA, V30, P674, DOI 10.1038/leu.2015.294; Bujan N, 2014, J INHERIT METAB DIS, V37, P53, DOI 10.1007/s10545-013-9620-4; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chung WK, 2015, J MED GENET, V52, P627, DOI 10.1136/jmedgenet-2015-103140; Cui TZ, 2009, FEBS J, V276, P748, DOI 10.1111/j.1742-4658.2008.06821.x; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206; Freyer C, 2015, J MED GENET, V52, P779, DOI 10.1136/jmedgenet-2015-102986; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023                                                                  ; Lopez-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JC129089; Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007; Montero R, 2007, CEREBELLUM, V6, P118, DOI 10.1080/14734220601021700; Montes R, 2014, LEUKEMIA, V28, P666, DOI 10.1038/leu.2013.346; Munoz-Lopez A, 2016, STEM CELLS, V34, P581, DOI 10.1002/stem.2303; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Prieto C, 2016, CANCER RES, V76, P2478, DOI 10.1158/0008-5472.CAN-15-2769; Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155; Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728; Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108; Ramos-Mejia V, 2012, TRENDS MOL MED, V18, P245, DOI 10.1016/j.molmed.2012.04.001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romero-Moya D, 2013, HAEMATOLOGICA, V98, P1022, DOI 10.3324/haematol.2012.079244; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Rubio R, 2014, STEM CELLS, V32, P1136, DOI 10.1002/stem.1647; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Segales J, 2015, FEBS J, V282, P1571, DOI 10.1111/febs.13065; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yubero D, 2015, EXPERT REV MOL DIAGN, V15, P1049, DOI 10.1586/14737159.2015.1062727	63	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUL	2017	35	7					1687	1703		10.1002/stem.2634				17	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	EY5JA	WOS:000404011900004	28472853				2018-01-05	
J	Lee, JH				Lee, Je H.			De Novo Gene Expression Reconstruction in Space	TRENDS IN MOLECULAR MEDICINE			English	Review							CELL RNA-SEQ; IN-SITU HYBRIDIZATION; SINGLE CELLS; EXPANSION MICROSCOPY; GENOME; CRISPR-CAS9; TISSUE; TRANSCRIPTOMICS; PROBES; VISUALIZATION	The biological function of a gene often depends on spatial context, and an atlas of transcriptional regulation could be instrumental in defining functional elements across the genome. Despite recent advances in single-cell RNA sequencing and in situ RNA imaging, fundamental barriers limit the speed, genome-wide coverage, and resolution of de novo transcriptome assembly in space. Here, I discuss potential next-generation approaches for the de novo assembly of the transcriptome in space, and propose more efficient methods of detecting long-range spatial variations in gene expression. Finally, I discuss future in situ sequencing chemistries for visualizing biological pathways and processes in tissues so that genomics technologies might be more easily applied to conditions of human health and disease.	[Lee, Je H.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	Lee, JH (reprint author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	jlee@cshl.edu		Lee, Je/0000-0001-6947-7446	NIGMS NIH HHS [R35 GM119772]		Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cao J, 2017, BIORXIV, DOI 10.1101/104844; Chang J.-B.B., 2017, NAT METHODS, DOI 10.1038/nmeth.4261; Chen F, 2016, NAT METHODS, V13, P679, DOI 10.1038/nmeth.3899; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Coskun AF, 2016, NAT METHODS, V13, P657, DOI [10.1038/NMETH.3895, 10.1038/nmeth.3895]; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800                                                         ; Frank J, 2006, 3 DIMENSIONAL ELECT; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Hashimshony T, 2012, CELL REPORTS, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/NMETH.4108, 10.1038/nmeth.4108]; Kim JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9687; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; LANDER E S, 1988, Genomics, V2, P231, DOI 10.1016/0888-7543(88)90007-9; Lee H., 2016, BIORXIV, P48603; Lee JH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.191; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lee J.H., 2016, WILEY INTERDISCIP RE; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/nmeth.1329, 10.1038/NMETH.1329]; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P11046, DOI 10.1073/pnas.1612826113; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Moor AE, 2017, CURR OPIN BIOTECH, V46, P126, DOI 10.1016/j.copbio.2017.02.004; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507                                                      ; PORT E, 1995, GENOMICS, V26, P84, DOI 10.1016/0888-7543(95)80086-2; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Satija R., 2015, NAT BIOTECHNOL; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Shah S, 2016, DEVELOPMENT, V143, P2862, DOI 10.1242/dev.138560; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Svensson V, 2017, NAT METHODS, V14, P381, DOI 10.1038/nmeth.4220; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Venteicher AS, 2017, SCIENCE, V355, P1391, DOI 10.1126/science.aai8478; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Ziegenhain C, 2017, MOL CELL, V65, P631, DOI 10.1016/j.molcel.2017.01.023	65	0	0	8	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4914	1471-499X		TRENDS MOL MED	Trends Mol. Med	JUL	2017	23	7					583	593		10.1016/j.molmed.2017.05.004				11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EY3ZO	WOS:000403915500003	28571832				2018-01-05	
J	Schenk, H; Muller-Deile, J; Kinast, M; Schiffer, M				Schenk, Heiko; Mueller-Deile, Janina; Kinast, Mark; Schiffer, Mario			Disease modeling in genetic kidney diseases: zebrafish	CELL AND TISSUE RESEARCH			English	Review						Genetic kidney disease; Zebrafish; Morpholino; CRISPR/Cas; Podocytopathies	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ZINC-FINGER NUCLEASES; RESISTANT NEPHROTIC SYNDROME; TRANSGENIC ZEBRAFISH; IN-VITRO; GLOMERULAR-FILTRATION; FUNCTIONAL-ANALYSIS; LARVAL ZEBRAFISH; RENAL-FUNCTION; HUMAN GENOME	Growing numbers of translational genomics studies are based on the highly efficient and versatile zebrafish (Danio rerio) vertebrate model. The increasing types of zebrafish models have improved our understanding of inherited kidney diseases, since they not only display pathophysiological changes but also give us the opportunity to develop and test novel treatment options in a high-throughput manner. New paradigms in inherited kidney diseases have been developed on the basis of the distinct genome conservation of approximately 70 % between zebrafish and humans in terms of existing gene orthologs. Several options are available to determine the functional role of a specific gene or gene sets. Permanent genome editing can be induced via complete gene knockout by using the CRISPR/Cas-system, among others, or via transient modification by using various morpholino techniques. Cross-species rescues succeeding knockdown techniques are employed to determine the functional significance of a target gene or a specific mutation. This article summarizes the current techniques and discusses their perspectives.	[Schenk, Heiko; Mueller-Deile, Janina; Kinast, Mark; Schiffer, Mario] Hannover Med Sch, Dept Med Nephrol, Hannover, Germany; [Schenk, Heiko; Mueller-Deile, Janina; Kinast, Mark; Schiffer, Mario] Mt Desert Isl Biol Lab, Bar Harbor, ME 04609 USA	Schiffer, M (reprint author), Hannover Med Sch, Dept Med Nephrol, Hannover, Germany.; Schiffer, M (reprint author), Mt Desert Isl Biol Lab, Bar Harbor, ME 04609 USA.	Schiffer.Mario@mh-hannover.de					Anderson BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005349; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169X.2008.01044.x, 10.1111/j.1440-169x.2008.01044.x]; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Baek JI, 2016, J BIOL CHEM, V291, P8632, DOI 10.1074/jbc.M115.688663; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Blackburn PR, 2013, ZEBRAFISH, V10, P116, DOI 10.1089/zeb.2013.9999; Boute N, 2000, NAT GENET, V24, P349; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clark KJ, 2011, METHOD CELL BIOL, V104, P137, DOI 10.1016/B978-0-12-374814-0.00008-2; Dai SC, 2010, NEPHROL DIAL TRANSPL, V25, P824, DOI 10.1093/ndt/gfp394; Deiters A, 2010, J AM CHEM SOC, V132, P15644, DOI 10.1021/ja1053863; Drummond I, 2003, TRENDS CELL BIOL, V13, P357, DOI 10.1016/S0962-8924(03)00124-7; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Dweep H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053780; Ebarasi L, 2011, CURR OPIN NEPHROL HY, V20, P416, DOI 10.1097/MNH.0b013e3283477797; Endlich N, 2014, J AM SOC NEPHROL, V25, P681, DOI 10.1681/ASN.2013020178; The European Polycystic Kidney Disease Consortium, 1994, CELL, V77, P881; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gbadegesin RA, 2014, J AM SOC NEPHROL, V25, P1991, DOI 10.1681/ASN.2013090976; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; Gerety SS, 2013, DEVELOPMENT, V140, P2235, DOI 10.1242/dev.091520; Hanaoka K, 2000, NATURE, V408, P990; Hanke N, 2015, ZEBRAFISH, V12, P372, DOI 10.1089/zeb.2015.1093; Hanke N, 2013, BIOMED RES INT, DOI 10.1155/2013/658270; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Holder N, 1999, METH MOL B, V97, P487, DOI 10.1385/1-59259-270-8:487; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang JM, 2013, KIDNEY INT, V83, P1193, DOI 10.1038/ki.2013.6; HUANG LW, 2014, JOVE J VIS EXP DEC, DOI DOI 10.3791/52156; Huang P, 2016, METHODS MOL BIOL, V1338, P191, DOI 10.1007/978-1-4939-2932-0_15; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hudziak RM, 1996, ANTISENSE NUCLEIC A, V6, P267, DOI 10.1089/oli.1.1996.6.267; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; IbraghimovBeskrovnaya O, 1997, P NATL ACAD SCI USA, V94, P6397, DOI 10.1073/pnas.94.12.6397; Ichimura K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08993; The International Polycystic Kidney Disease Consortium, 1995, CELL, V81, P289; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068                                                         ; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kotb AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153768; Kotb AM, 2014, AM J PHYSIOL-RENAL, V307, pF1427, DOI 10.1152/ajprenal.00029.2014; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lakhia R, 2016, J AM SOC NEPHROL, V27, P2319, DOI 10.1681/ASN.2015060634; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Li Y, 2016, J AM SOC NEPHROL; Ma D, 2015, BIOINFORM, V13, P336; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072750; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Metelo AM, 2015, J CLIN INVEST, V125, P1987, DOI 10.1172/JCI73665; Miyagi A, 2016, J AM SOC NEPHROL, V27, P2940, DOI 10.1681/ASN.2016020146; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Moulton JD, 2016, J DRUG DISCOV DEV DE, V3, P1023; Muller T, 2011, KIDNEY INT, V80, P1055, DOI 10.1038/ki.2011.256; Muller-Deile J, 2016, CELL PHYSIOL BIOCHEM, V40, P819, DOI 10.1159/000453142; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishibori Y, 2011, J AM SOC NEPHROL, V22, P2037, DOI 10.1681/ASN.2010111147; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Olabisi O, 2016, CLIN NEPHROL, V86, pS114, DOI 10.5414/CNP86S116; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Pavel MA, 2016, P NATL ACAD SCI USA, V113, pE2363, DOI 10.1073/pnas.1517066113; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4                                                    ; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Ramachandran H, 2016, EUR J HUM GENET, V24, P774, DOI 10.1038/ejhg.2015.199; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen; Roxo-Rosa M, 2015, BIOL OPEN, V4, P1356, DOI 10.1242/bio.014076; Sanna-Cherchi S, 2011, KIDNEY INT, V80, P389, DOI 10.1038/ki.2011.148; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Sassen W. A., 2015, Advances in Genomics and Genetics, V5, P151; Shestopalov IA, 2007, NAT CHEM BIOL, V3, P650, DOI 10.1038/nchembio.2007.30; Siegerist F, 2016, ACTA PHYSL, DOI [10.1111/apha.12754, DOI 10.1111/APHA.12754]; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Sun H., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1007/S00704-013-1033-7; Sun H, 2013, J AM SOC NEPHROL, V24, P917, DOI 10.1681/ASN.2012080834; Sun H, 2011, P NATL ACAD SCI USA, V108, P2933, DOI 10.1073/pnas.1017010108; Ta MHT, 2013, NEPHROLOGY, V18, P317, DOI 10.1111/nep.12045; Tallafuss A, 2012, DEVELOPMENT, V139, P1691, DOI 10.1242/dev.072702; Teng B, 2016, DIABETES, V65, P3667, DOI 10.2337/db16-0081; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tobin JL, 2008, PEDIATR NEPHROL, V23, P2095, DOI 10.1007/s00467-008-0898-7; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; Weber T, 2013, METHODS, V62, P279, DOI 10.1016/j.ymeth.2013.07.028; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wu M, 2016, NEPHROL DIAL TRANSPL, V31, P1826, DOI 10.1093/ndt/gfw058; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zhang MQ, 2002, NAT REV GENET, V3, P698, DOI 10.1038/nrg890; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF1040, DOI 10.1152/ajprenal.00394.2010; Zhu XD, 2016, J MORPHOL, V277, P1104, DOI 10.1002/jmor.20560; Zoja C, 2015, NEPHRON, V129, P52, DOI 10.1159/000369149; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	124	1	1	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	JUL	2017	369	1					127	141		10.1007/s00441-017-2593-0				15	Cell Biology	Cell Biology	EY4GS	WOS:000403936100012	28331970				2018-01-05	
J	Getwan, M; Lienkamp, SS				Getwan, Maike; Lienkamp, Soeren S.			Toolbox in a tadpole: Xenopus for kidney research	CELL AND TISSUE RESEARCH			English	Review						Kidney disease; Renal development; Xenopus; Ciliopathies; Model organism	TARGETED GENE DISRUPTION; BEAUTY TRANSPOSON SYSTEM; I-SCEI MEGANUCLEASE; PRONEPHRIC KIDNEY; SLEEPING-BEAUTY; INTRAFLAGELLAR TRANSPORT; MEDIATED TRANSGENESIS; MOTILE CILIA; LAEVIS; EXPRESSION	Xenopus is a versatile model organism increasingly used to study organogenesis and genetic diseases. The rapid embryonic development, targeted injections, loss- and gain-of-function experiments and an increasing supply of tools for functional in vivo analysis are unique advantages of the Xenopus system. Here, we review the vast array of methods available that have facilitated its transition into a translational model. We will focus primarily on how these methods have been employed in the study of kidney development, renal function and kidney disease. Future advances in the fields of genome editing, imaging and quantitative 'omics approaches are likely to enable exciting and novel applications for Xenopus to deepen our understanding of core principles of renal development and molecular mechanisms of human kidney disease. Thus, using Xenopus in clinically relevant research diversifies the narrowing pool of "standard" model organisms and provides unique opportunities for translational research.	[Getwan, Maike; Lienkamp, Soeren S.] Univ Freiburg, Renal Div, Dept Med, Med Ctr,Fac Med, Hugstetter Str 55, D-79106 Freiburg, Germany; [Lienkamp, Soeren S.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany	Lienkamp, SS (reprint author), Univ Freiburg, Renal Div, Dept Med, Med Ctr,Fac Med, Hugstetter Str 55, D-79106 Freiburg, Germany.; Lienkamp, SS (reprint author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany.	soeren.lienkamp@uniklinik-freiburg.de		Lienkamp, Soeren/0000-0003-2963-6865	Emmy Noether Programme [LI1817/2-1]; collaborative research initiative [SFB 1140]; German Research Foundation (DFG)	This work was supported by the Emmy Noether Programme to SSL (LI1817/2-1) and Project B07 of the collaborative research initiative (SFB 1140) to SSL by the German Research Foundation (DFG).	Allen BG, 2006, NAT PROTOC, V1, P1248, DOI 10.1038/nprot.2006.183; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bhattacharya D, 2015, DEV BIOL, V408, P196, DOI 10.1016/j.ydbio.2015.11.003; Blitz IL, 2016, DEVELOPMENT, V143, P2868, DOI 10.1242/dev.138057; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Blum M, 2015, DEV CELL, V35, P145, DOI 10.1016/j.devcel.2015.09.017; Blum M, 2014, DEV BIOL, V393, P109, DOI 10.1016/j.ydbio.2014.06.014; BONHAM JR, 1985, CLIN CHIM ACTA, V145, P297, DOI 10.1016/0009-8981(85)90037-3; Bonnard C, 2012, NAT GENET, V44, P709, DOI 10.1038/ng.2259; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Braun DA, 2016, NAT GENET, V48, P457, DOI 10.1038/ng.3512; Brennan HC, 1998, MECH DEVELOP, V75, P127, DOI 10.1016/S0925-4773(98)00094-X; Brennan HC, 1999, DEVELOPMENT, V126, P5847; Brooks Eric R, 2013, Cilia, V2, P13, DOI 10.1186/2046-2530-2-13; Brooks ER, 2012, J CELL BIOL, V198, P37, DOI 10.1083/jcb.201204072; Caine ST, 2013, DEV DYNAM, V242, P219, DOI 10.1002/dvdy.23916; Campbell EP, 2016, DEVELOPMENT, V143, P4654, DOI 10.1242/dev.143859; Chan TC, 1999, NATURWISSENSCHAFTEN, V86, P224, DOI 10.1007/s001140050602; Christensen EI, 2008, PFLUG ARCH EUR J PHY, V456, P1163, DOI 10.1007/s00424-008-0488-3; DALE L, 1985, J EMBRYOL EXP MORPH, V89, P289; DALE L, 1987, DEVELOPMENT, V99, P527; del Viso F, 2016, DEV CELL, V38, P478, DOI 10.1016/j.devcel.2016.08.002; Desgrange Audrey, 2015, Cells, V4, P483, DOI 10.3390/cells4030483; Doherty JR, 2007, DEV DYNAM, V236, P2808, DOI 10.1002/dvdy.21321; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Elkan ER, 1938, BMJ-BRIT MED J, V2, P1252; Elliott KL, 2010, INT J DEV BIOL, V54, P1443, DOI 10.1387/ijdb.103061ke; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Futel M, 2015, J CELL SCI, V128, P888, DOI 10.1242/jcs.155499; Gilchrist MJ, 2009, DEV DYNAM, V238, P1379, DOI 10.1002/dvdy.21940; Gordon CT, 2017, NAT GENET, V49, P249, DOI 10.1038/ng.3765; GRAINGER RM, 1988, DEVELOPMENT, V102, P517; Greger R, 1996, PFLUG ARCH EUR J PHY, V432, P579, DOI 10.1007/s004240050173; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Higa MM, 2006, METHODS, V39, P284, DOI 10.1016/j.ymeth.2006.06.004; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Hoppler S., 2012, XENOPUS PROTOCOLS PO; Ishibashi Shoko, 2012, Methods Mol Biol, V917, P185, DOI 10.1007/978-1-61779-992-1_11; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jaffe KM, 2016, CELL REP, V14, P1841, DOI 10.1016/j.celrep.2016.01.069; Jevtic P, 2016, INT J DEV BIOL, V60, P277, DOI 10.1387/ijdb.160158dl; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Kelley Clair M, 2012, Methods Mol Biol, V917, P231, DOI 10.1007/978-1-61779-992-1_14; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Krogh A, 1929, SCIENCE, V70, P200, DOI 10.1126/science.70.1809.200                                                     ; Leclerc C, 2008, DEV BIOL, V321, P357, DOI 10.1016/j.ydbio.2008.06.029; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li You E, 2012, Methods Mol Biol, V917, P219, DOI 10.1007/978-1-61779-992-1_13; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Lienkamp SS, 2016, SEMIN CELL DEV BIOL, V51, P117, DOI 10.1016/j.semcdb.2016.02.002; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Loots GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068548; Love NR, 2011, DEVELOPMENT, V138, P5451, DOI 10.1242/dev.066498; Magalska A, 2014, DEV CELL, V31, P305, DOI 10.1016/j.devcel.2014.09.001; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Naert T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35264; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakayama T., 2016, DEV BIOL; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; NIEUWKOOP P D, 1969, Wilhelm Roux' Archiv fuer Entwicklungsmechanik der Organismen, V163, P298, DOI 10.1007/BF00577017; Ochi H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1851; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Osafune K, 2002, DEV GROWTH DIFFER, V44, P161; Pan FC, 2006, DEV DYNAM, V235, P247, DOI 10.1002/dvdy.20608; Papke RL, 2009, COMB CHEM HIGH T SCR, V12, P38, DOI 10.2174/138620709787047975                                                      ; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Reid C.D., 2016, DEV BIOL; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; SADAGHIANI B, 1987, DEV BIOL, V124, P91, DOI 10.1016/0012-1606(87)90463-5; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Schmitt SM, 2014, ADV DRUG DELIVER REV, V69, P225, DOI 10.1016/j.addr.2014.02.004; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Silva P, 1996, KIDNEY INT, V49, P1552, DOI 10.1038/ki.1996.223; Sinzelle L, 2006, TRANSGENIC RES, V15, P751, DOI 10.1007/s11248-006-9014-6; Sive H.L., 2000, EARLY DEV XENOPUS LA; Sive HL, 2007, CSH PROTOCOLS, V2007; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8                                                    ; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133                                                              ; Suzuki N, 2015, INT J DEV BIOL, V59, P241, DOI 10.1387/ijdb.140263ho; Tandon P., 2016, DEV BIOL; Toriyama M, 2016, NAT GENET, V48, P648, DOI 10.1038/ng.3558; Uochi T, 1998, GENE, V211, P245, DOI 10.1016/S0378-1119(98)00102-4                                                   ; VIZE PD, 1995, DEV BIOL, V171, P531, DOI 10.1006/dbio.1995.1302; Vize PD, 2009, NAT PROTOC, V4, P975, DOI 10.1038/nprot.2009.69; Vollmer B, 2015, DEV CELL, V33, P717, DOI 10.1016/j.devcel.2015.04.027; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Wessely O, 2011, PEDIATR NEPHROL, V26, P1545, DOI 10.1007/s00467-011-1881-2; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Yasunaga T, 2015, J CELL BIOL, V211, P963, DOI 10.1083/jcb.201502043; Young John J, 2012, Methods Mol Biol, V917, P129, DOI 10.1007/978-1-61779-992-1_7; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zhang Siwei, 2015, Cilia, V5, P2, DOI 10.1186/s13630-016-0024-6; Zhou XL, 2004, DEV BIOL, V271, P322, DOI 10.1016/j.ydbio.2004.03.036	108	1	1	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	JUL	2017	369	1					143	157		10.1007/s00441-017-2611-2				15	Cell Biology	Cell Biology	EY4GS	WOS:000403936100013	28401306				2018-01-05	
J	Hofmeister, AF; Komhoff, M; Weber, S; Grgic, I				Hofmeister, Andreas F.; Koemhoff, Martin; Weber, Stefanie; Grgic, Ivica			Disease modeling in genetic kidney diseases: mice	CELL AND TISSUE RESEARCH			English	Review						Genetic kidney diseases; Glomerulopathies; Inherited disorders of the renal tubule; Polycystic kidney disease; Genetic mouse models	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; RESISTANT NEPHROTIC SYNDROME; EPITHELIAL SODIUM-CHANNEL; DELAYS RENAL-FAILURE; ALPORT-SYNDROME; MOUSE MODEL; CYCLOOXYGENASE-2 EXPRESSION; CHLORIDE CHANNEL; BARTTER-SYNDROME; MACULA DENSA	The mouse still represents arguably the most important mammal organism in research for modeling human genetic kidney diseases in vivo. Compared with many other mammal species, the breeding and maintenance of mice in the laboratory is relatively simple and cheap and reproduction cycles are short. In addition to classic gene knockout mouse lines, new molecular biological technologies have led to the development of a plethora of other, more sophisticated, mouse models, allowing the targeting of genes or gene function in a cell-specific, tissue-specific and time-dependent fashion. With the refinement of more recently developed genome-editing technologies, including the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system and other engineered nucleases such as zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), our "tool set" of mouse models is expected to rapidly expand. These technological advances hold great promise and should enable us to study and hence understand the biology of inherited kidney diseases in greater detail. By analogy, we may be able to answer questions regarding the impact of individual proteins on the development of human kidney disorders, the underlying mechanisms governing the evolution of the disease and the predicted responsiveness to therapeutic interventions. Moreover, knockout and transgenic mouse models can be highly informative with respect to the effects of genetic variations on renal phenotypes. This review focuses on mouse models that have been devised primarily to study monogenic human kidney diseases, which are typically caused by a single abnormal gene and passed on in a Mendelian pattern. Despite the large number of human hereditary kidney disorders and the multitude of mouse models described in the literature, we attempt to give a balanced overview of several well-known renal pathologies, a few of which are addressed in some detail.	[Hofmeister, Andreas F.; Grgic, Ivica] Philipps Univ Marburg, Univ Hosp Giessen & Marburg, Dept Internal Med & Nephrol, Baldingerstr 1, D-35033 Marburg, Germany; [Koemhoff, Martin; Weber, Stefanie] Philipps Univ Marburg, Univ Childrens Hosp, Marburg, Germany	Grgic, I (reprint author), Philipps Univ Marburg, Univ Hosp Giessen & Marburg, Dept Internal Med & Nephrol, Baldingerstr 1, D-35033 Marburg, Germany.	grgic@med.uni-marburg.de			Deutsche Forschungsgemeinschaft [GR 3301/4-1]; University Medical Center Giessen and Marburg; Philipps-University Marburg Innovation Fund; Von Behring-Rontgen Foundation	I.G. was supported by a fellowship from the Deutsche Forschungsgemeinschaft (GR 3301/4-1) and grants from the University Medical Center Giessen and Marburg, Philipps-University Marburg Innovation Fund and the Von Behring-Rontgen Foundation.	Alport AC, 1927, BMJ-BRIT MED J, V1927, P504; Bartram MP, 2016, HUM MOL GENET, V25, P1152, DOI 10.1093/hmg/ddv638; Boute N, 2002, NEPHROLOGIE, V23, P35; Boyer O, 2011, J AM SOC NEPHROL, V22, P239, DOI 10.1681/ASN.2010050518; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Buscher AK, 2010, CLIN J AM SOC NEPHRO, V5, P2075, DOI 10.2215/CJN.01190210; Chen YM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0090-9; Cheng HF, 2000, J CLIN INVEST, V106, P681, DOI 10.1172/JCI10318; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; Ehrlicher AJ, 2015, P NATL ACAD SCI USA, V112, P6619, DOI 10.1073/pnas.1505652112; Farman N, 2002, J CLIN INVEST, V110, P1233, DOI 10.1172/JCI200217064; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344                                                          ; Fuchshuber A, 1996, LANCET, V347, P1050, DOI 10.1016/S0140-6736(96)90193-2                                                   ; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Grgic I, 2014, KIDNEY INT, V86, P1116, DOI 10.1038/ki.2014.204; Gross O, 2003, KIDNEY INT, V63, P438, DOI 10.1046/j.1523-1755.2003.00779.x; Gross O, 2012, KIDNEY INT, V81, P494, DOI 10.1038/ki.2011.407; Guay-Woodford LM, 2003, PEDIATRICS, V111, P1072, DOI 10.1542/peds.111.5.1072; Gurel PS, 2014, CURR BIOL, V24, P156, DOI 10.1016/j.cub.2013.12.018; Hamano Y, 2002, J BIOL CHEM, V277, P31154, DOI 10.1074/jbc.M204806200; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hennings JC, 2017, J AM SOC NEPHROL, V28, P209, DOI 10.1681/ASN.2016010085; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Hummler E, 2005, J AM SOC NEPHROL, V16, P3160, DOI 10.1681/ASN.2005040450; Jeck N, 2000, PEDIATR RES, V48, P754, DOI 10.1203/00006450-200012000-00009; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431                                                               ; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kashtan CE, 1999, MEDICINE, V78, P338, DOI 10.1097/00005792-199909000-00005                                                ; Katayama Kan, 2014, World J Nephrol, V3, P230, DOI 10.5527/wjn.v3.i4.230; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Knoers NVAM, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-22; Komhoff M, 2000, KIDNEY INT, V58, P2420, DOI 10.1046/j.1523-1755.2000.00425.x; Komhoff M, 2004, PEDIATR RES, V55, P261, DOI 10.1203/01.PDR.0000101747.09626.6B; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Laghmani K, 2016, NEW ENGL J MED, V374, P1853, DOI 10.1056/NEJMoa1507629; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lorenz JN, 2002, J BIOL CHEM, V277, P37871, DOI 10.1074/jbc.M205627200; Lu W, 1999, GENOMICS, V61, P113, DOI 10.1006/geno.1999.5943; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179                                                              ; Lu WN, 1999, NAT GENET, V21, P160; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Masyuk TV, 2003, GASTROENTEROLOGY, V125, P1303, DOI 10.1053/S0016-5085(03)01369-6; Michaud JLR, 2006, KIDNEY INT, V70, P1054, DOI 10.1038/sj.ki.5001665; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moser M, 2005, HEPATOLOGY, V41, P1113, DOI 10.1002/hep.20655; Nomura N, 2011, AM J PHYSIOL-RENAL, V301, pF297, DOI 10.1152/ajprenal.00604.2010; Philippe A, 2008, KIDNEY INT, V73, P1038, DOI 10.1038/ki.2008.27; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pradervand S, 1999, J AM SOC NEPHROL, V10, P2527; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190; Reinalter SC, 2002, KIDNEY INT, V62, P253, DOI 10.1046/j.1523-1755.2002.00435.x; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Riehle M, 2016, J AM SOC NEPHROL, V27, P2771, DOI 10.1681/ASN.2015030318; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Scheinman SJ, 1999, NEW ENGL J MED, V340, P1177, DOI 10.1056/NEJM199904153401507                                                     ; Seyberth HW, 2017, CURR OPIN PEDIATR, V29, P179, DOI 10.1097/MOP.0000000000000447; SEYBERTH HW, 1985, J PEDIATR-US, V107, P694, DOI 10.1016/S0022-3476(85)80395-4; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Subramanian B, 2016, KIDNEY INT, V90, P363, DOI 10.1016/j.kint.2016.04.020; Tabassum A, 2014, INTERDISCIP SCI, V6, P32, DOI 10.1007/s12539-014-0190-4; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Warnock DG, 1998, KIDNEY INT, V53, P18, DOI 10.1046/j.1523-1755.1998.00728.x                                                ; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562; Wilson PD, 2008, CURR TOP DEV BIOL, V84, P311, DOI 10.1016/S0070-2153(08)00606-6; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Woollard JR, 2007, KIDNEY INT, V72, P328, DOI 10.1038/sj.ki.5002294; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6                                                   ; Yang SS, 2010, HUM MUTAT, V31, P1304, DOI 10.1002/humu.21364; Yang TX, 2000, J BIOL CHEM, V275, P37922, DOI 10.1074/jbc.M006218200; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Zerres K, 1998, AM J MED GENET, V76, P137, DOI 10.1002/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.3.CO;2-O	87	1	1	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	JUL	2017	369	1					159	170		10.1007/s00441-017-2639-3				12	Cell Biology	Cell Biology	EY4GS	WOS:000403936100014	28601904				2018-01-05	
J	Hirschhorn, T; Levi-Hofman, M; Danziger, O; Smorodinsky, NI; Ehrlich, M				Hirschhorn, Tal; Levi-Hofman, Michal; Danziger, Oded; Smorodinsky, Nechama I.; Ehrlich, Marcelo			Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Bone morphogenetic protein; ER translocation; N-Glycosylation; Disulfide bond formation; Intracellular localization; Ovarian cancer	MORPHOGENETIC PROTEIN-RECEPTOR; ANTI-MULLERIAN HORMONE; SERINE/THREONINE KINASE RECEPTORS; N-LINKED GLYCOSYLATION; TGF-BETA SUPERFAMILY; ENDOPLASMIC-RETICULUM; NEGATIVE REGULATION; CANCER GENOMICS; LIGAND-BINDING; OVARIAN-CANCER	The Type-I bone morphogenetic protein receptors (BMPRs), BMPR1A and BMPR1B, present the highest sequence homology among BMPRs, suggestive of functional similitude. However, sequence elements within their extracellular domain, such as signal sequence or N-glycosylation motifs, may result in differential regulation of biosynthetic processing and trafficking and in alterations to receptor function. We show that (i) BMPR1A and the ubiquitous isoform of BMPR1B differed in mode of translocation into the endoplasmic reticulum; and (ii) BMPR1A was N-glycosylated while BMPR1B was not, resulting in greater efficiency of processing and plasma membrane expression of BMPR1A. We further demonstrated the importance of BMPR1A expression and glycosylation in ES-2 ovarian cancer cells, where (i) CRISPR/Cas9-mediated knockout of BMPR1A abrogated BMP2-induced Smad1/5/8 phosphorylation and reduced proliferation of ES-2 cells and (ii) inhibition of N-glycosylation by site-directed mutagenesis, or by tunicamycin or 2-deoxyd-glucose treatments, reduced biosynthetic processing and plasma membrane expression of BMPR1A and BMP2-induced Smad1/5/8 phosphorylation.	[Hirschhorn, Tal; Levi-Hofman, Michal; Danziger, Oded; Smorodinsky, Nechama I.; Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Tel Aviv, Israel	Ehrlich, M (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Tel Aviv, Israel.	marceloe@post.tau.ac.il					Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Ahadova A, 2015, IUBMB LIFE, V67, P218, DOI 10.1002/iub.1364; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Belville C, 2005, ONCOGENE, V24, P4984, DOI 10.1038/sj.onc.1208686; Belville C, 2009, HUM MOL GENET, V18, P3002, DOI 10.1093/hmg/ddp238; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chetrit D, 2011, J BIOL CHEM, V286, P5392, DOI 10.1074/jbc.M110.161851; Ehrlich M, 2016, CYTOKINE GROWTH F R, V27, P35, DOI 10.1016/j.cytogfr.2015.12.008; Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Frump AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080319; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023                                                           ; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0                                                   ; Gouedard L, 2000, J BIOL CHEM, V275, P27973; Guo M, 2014, CARCINOGENESIS, V35, P1698, DOI 10.1093/carcin/bgu030; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirschhorn T, 2015, J CELL SCI, V128, P1352, DOI 10.1242/jcs.160143; Hirschhorn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043459; Hover LD, 2016, NEURO-ONCOLOGY, V18, P928, DOI 10.1093/neuonc/nov310; Hover LD, 2015, CANCER LETT, V368, P79, DOI 10.1016/j.canlet.2015.07.032; Hume AN, 2013, MOL CELL BIOCHEM, V373, P247, DOI 10.1007/s11010-012-1496-3; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kida Y, 2005, EMBO J, V24, P3202, DOI 10.1038/sj.emboj.7600788; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423                                                         ; Kotzsch A, 2009, ACTA CRYSTALLOGR F, V65, P779, DOI 10.1107/S1744309109024142; Lai CW, 2010, MOL BIOL CELL, V21, P1909, DOI 10.1091/mbc.E09-12-1066; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lin HW, 2011, MATH PROBL ENG, DOI 10.1155/2011/402437; Liu S, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-52; Lowery JW, 2014, CELL MOL LIFE SCI, V71, P3165, DOI 10.1007/s00018-013-1541-8; Luga V, 2009, BIOCHEM J, V421, P119, DOI 10.1042/BJ20081131; Rodriguez JM, 2015, NUCLEIC ACIDS RES, V43, pW455, DOI 10.1093/nar/gkv512; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345                                                        ; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109                                                         ; Peng J, 2016, MOL CARCINOGEN, V55, P335, DOI 10.1002/mc.22283; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X                                                   ; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Viner R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002988; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wells RG, 1997, J BIOL CHEM, V272, P11444; Yi SE, 2000, DEVELOPMENT, V127, P621; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22	68	0	0	3	3	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUL	2017	74	14					2645	2662		10.1007/s00018-017-2488-y				18	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EY3QF	WOS:000403887100010	28357470				2018-01-05	
J	Hong, CH; Sohn, HJ; Lee, HJ; Cho, HI; Kim, TG				Hong, Cheol-Hwa; Sohn, Hyun-Jung; Lee, Hyun-Joo; Cho, Hyun-Il; Kim, Tai-Gyu			Antigen Presentation by Individually Transferred HLA Class I Genes in HLA-A, HLA-B, HLA-C Null Human Cell Line Generated Using the Multiplex CRISPR-Cas9 System	JOURNAL OF IMMUNOTHERAPY			English	Article						HLA class I; multiplex; CRISPR/Cas9; HLA class I null cell line; artificial antigen-presenting cell	CYTOTOXIC T-LYMPHOCYTES; STEM-CELLS; HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; PRESENTING CELLS; MAMMALIAN-CELLS; UNIVERSAL CELLS; HEK293 CELLS; EXPRESSION; CRISPR/CAS9	Human leukocyte antigens (HLAs) are essential immune molecules that affect transplantation and adoptive immunotherapy. When hematopoietic stem cells or organs are transplanted with HLA-mismatched recipients, graft-versus-host disease or graft rejection can be induced by allogeneic immune responses. The function of each HLA allele has been studied using HLA-deficient cells generated from mutant cell lines or by RNA interference, zinc finger nuclease, and the CRISPR/Cas9 system. To improve HLA gene editing, we attempted to generate an HLA class I null cell line using the multiplex CRISPR/Cas9 system by targeting exons 2 and 3 of HLA-A, HLA-B, and HLA-C genes simultaneously. Multiplex HLA editing could induce the complete elimination of HLA class I genes by bi-allelic gene disruption on target sites which was defined by flow cytometry and target-specific polymerase chain reaction. Furthermore, artificial antigen presenting cells were generated by transfer of a single HLA class I allele and co-stimulatory molecules into this novel HLA class I null cell line. Artificial antigen-presenting cells showed HLA-restricted antigen presentation following antigen processing and were successfully used for the efficient generation of tumor antigen-specific cytotoxic T cells in vitro. The efficient editing of HLA genes may provide a basis for universal cellular therapies and transplantation.	[Hong, Cheol-Hwa; Kim, Tai-Gyu] Catholic Univ Korea, Dept Microbiol, Seoul, South Korea; [Sohn, Hyun-Jung; Lee, Hyun-Joo; Cho, Hyun-Il; Kim, Tai-Gyu] Catholic Univ Korea, Catholic Hematopoiet Stem Cell Bank, Seoul, South Korea; [Cho, Hyun-Il] Catholic Univ Korea, Coll Med, Canc Res Inst, Seoul, South Korea	Kim, TG (reprint author), 222 Banpo Daero, Seoul 06591, South Korea.	kimtg@catholic.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIP) [2015M 3A9D9074278]	Supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIP) (No. 2015M 3A9D9074278).	Abrahimi P, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85293; Abrahimi P, 2015, CIRC RES, V117, P121, DOI 10.1161/CIRCRESAHA.117.306290; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BODMER WF, 1987, J CLIN PATHOL, V40, P948, DOI 10.1136/jcp.40.9.948; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deuse T, 2011, CIRCULATION, V124, pS3, DOI 10.1161/CIRCULATIONAHA.111.020727; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Figueiredo C, 2006, J MOL MED-JMM, V84, P425, DOI 10.1007/s00109-005-0024-2; Figueiredo C, 2015, TISSUE ANTIGENS, V85, P443, DOI 10.1111/tan.12564; Figueiredo C, 2010, TRANSFUSION, V50, P1690, DOI 10.1111/j.1537-2995.2010.02644.x; Gama-Norton L, 2011, HUM GENE THER, V22, P1269, DOI 10.1089/hum.2010.143; Gonzalez S, 2005, MOL THER, V11, P811, DOI 10.1016/j.ymthe.2004.12.023; Haga K, 2006, TRANSPLANT P, V38, P3184, DOI 10.1016/j.transproceed.2006.10.158; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim JV, 2004, NAT BIOTECHNOL, V22, P403, DOI 10.1038/nbt955; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Latouche JB, 2000, NAT BIOTECHNOL, V18, P405; Liu J, 2015, NAT PROTOC, V10, P1842, DOI 10.1038/nprot.2015.117; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Merten OW, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.17; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Pham PL, 2005, BIOTECHNOL BIOENG, V90, P332, DOI 10.1002/bit.20428; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schlaeger EJ, 1999, CYTOTECHNOLOGY, V30, P71, DOI 10.1023/A:1008000327766; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SHIMIZU Y, 1986, MOL CELL BIOL, V6, P1074, DOI 10.1128/MCB.6.4.1074                                                            ; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Torikai H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21757; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiegmann B, 2014, BIOMATERIALS, V35, P8123, DOI 10.1016/j.biomaterials.2014.06.007; Zeng WY, 2014, IMMUNOBIOLOGY, V219, P583, DOI 10.1016/j.imbio.2014.03.003	44	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1524-9557	1537-4513		J IMMUNOTHER	J. Immunother.	JUL-AUG	2017	40	6					201	210						10	Oncology; Immunology; Medicine, Research & Experimental	Oncology; Immunology; Research & Experimental Medicine	EY5ER	WOS:000404000500001	28604557				2018-01-05	
J	Huai, C; Jia, CQ; Sun, RL; Xu, PP; Min, TS; Wang, QH; Zheng, CD; Chen, HY; Lu, DR				Huai, Cong; Jia, Chenqiang; Sun, Ruilin; Xu, Peipei; Min, Taishan; Wang, Qihan; Zheng, Chengde; Chen, Hongyan; Lu, Daru			CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice	HUMAN GENETICS			English	Article							HYDRODYNAMICS-BASED TRANSFECTION; RNA-GUIDED ENDONUCLEASES; ONE-STEP GENERATION; FACTOR-IX; SKELETAL-MUSCLE; PLASMID DNA; THERAPY; EXPRESSION; MUTATION; LIVER	Hemophilia B (HB) is an X-linked disorder caused by defects of F9 encoded coagulation factor IX, which is an ideal model for gene therapy. Most existing HB gene therapies are based on viral mediated gene supplementation, which could increase immunoreaction. In this study, CRISPR/Cas9 system was used for gene correction in an F9 mutant HB mouse model in both adult mice (in vivo) and in germline cells (ex vivo). In vivo, naked Cas9-sgRNA plasmid and donor DNA were delivered to HB mice livers to recover the mutation via hydrodynamic tail vein (HTV) injection. 62.5% of the HTV-treated mice showed a detectable gene correction (> 1%) in the F9 alleles of hepatocytes, which was sufficient to remit the coagulation deficiency. Ex vivo, three different forms of Cas9 were microinjected into germline cells of HB mice to investigate their efficiency and safety in gene correction. Cas9 protein showed higher gene recovery rates, less embryo toxicity, and lower mosaic repair percentage, making it more suitable for germline gene therapy. Our study strongly supports that CRISPR/Cas9-mediated genome editing is feasible in gene therapy of genetic disorders.	[Huai, Cong; Jia, Chenqiang; Xu, Peipei; Min, Taishan; Wang, Qihan; Zheng, Chengde; Chen, Hongyan; Lu, Daru] Fudan Univ, Key Lab Genet Engn, MOE Key Lab Contemporary Anthropol, Room C613,Bldg Sch Life Sci,2005 Songhu Rd, Shanghai 200433, Peoples R China; [Sun, Ruilin] Shanghai Model Organisms Ctr, 3577 Jinke Rd, Shanghai 201203, Peoples R China	Chen, HY; Lu, DR (reprint author), Fudan Univ, Key Lab Genet Engn, MOE Key Lab Contemporary Anthropol, Room C613,Bldg Sch Life Sci,2005 Songhu Rd, Shanghai 200433, Peoples R China.	chenhy@fudan.edu.cn; darulu@hotmail.com			Natural Science Foundation of China [31571371]	We are grateful to Prof. Jihua Yao for her kindness gift of Cas9 expressing plasmid, to Dr. Huaxing Zhu and Mr. Yuanping Liao (Novoprotein Co., Ltd.) for their assistance in Cas9 protein expression and purification, to Dr. Xiao Song and Dr. Shingming Wang for their help in language polishing, to Dr. Kun Chen for providing technical assistance. This work was supported by the grants from the Natural Science Foundation of China (31571371).	ANDERSON W F, 1985, Recombinant DNA Technical Bulletin, V8, P55; Andrianaivo F, 2004, J GENE MED, V6, P877, DOI 10.1002/igm.574; Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Chen L, 2003, SCI CHINA SER C, V46, P422, DOI [10.1360/02yc0059, 10.1007/BF03192585]; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAY MA, 1993, SCIENCE, V262, P117, DOI 10.1126/science.8211118; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; LEBO RV, 1991, BAILLIERE CLIN OB GY, V5, P697, DOI 10.1016/S0950-3552(05)80265-2; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; LU DR, 1993, SCI CHINA SER B, V36, P1342; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Qihan W, 2015, YI CHUAN, V37, P1143, DOI 10.16288/j.yczz.15-117; Rallapalli PM, 2013, J THROMB HAEMOST, V11, P1329, DOI 10.1111/jth.12276; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; White GC, 2001, THROMB HAEMOSTASIS, V85, P560; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Yang JW, 2001, HEPATOLOGY, V33, P848, DOI 10.1053/jhep.2001.23438; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	40	0	0	12	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	JUL	2017	136	7					875	883		10.1007/s00439-017-1801-z				9	Genetics & Heredity	Genetics & Heredity	EX6QY	WOS:000403368400007	28508290				2018-01-05	
J	Tamburini, C; Li, M				Tamburini, Claudia; Li, Meng			Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons	BRAIN PATHOLOGY			English	Article						disease modeling; human pluripotent stem cells; neurodevelopment; neuronal differentiation; psychiatric disorders	SMALL-MOLECULE COMPOUNDS; ADULT HUMAN FIBROBLASTS; DIRECTED DIFFERENTIATION; DIRECT CONVERSION; BIPOLAR DISORDER; RETT-SYNDROME; NEUROPSYCHIATRIC DISORDERS; FUNCTIONAL MATURATION; TRANSCRIPTION FACTORS; DOPAMINERGIC-NEURONS	Research into psychiatric disorders has long been hindered by the lack of appropriate models. Induced pluripotent stem cells (iPSCs) offer an unlimited source of patient-specific cells, which in principle can be differentiated into all disease-relevant somatic cell types to create in vitro models of the disorder of interest. Here, neuronal differentiation protocols available for this purpose and the current progress on iPSCs-based models of schizophrenia, autism spectrum disorders and bipolar disorder were reviewed. We also discuss the impact of the recently developed CRISPR/Cas9 genome editing tool in the disease modeling field. Genetically engineered mutation of disease risk alleles in well characterized reference control hPSCs or correction of disease risk variants in patient iPSCs has been used as a powerful means to establish causality of the identified cellular pathology. Together, iPSC reprogramming and CRISPR/CAS9 genome editing technology have already significantly contributed to our understanding of the developmental origin of some major psychiatric disorders. The challenge ahead is the identification of shared mechanisms in their etiology, which will ultimately be relevant to the development of new treatments.	[Li, Meng] Cardiff Univ, Sch Med, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales; Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Li, M (reprint author), Cardiff Univ, Sch Med, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales.	Lim26@cardiff.ac.uk		Tamburini, Claudia/0000-0002-3778-1926			Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Amir RE, 1999, NAT GENET, V23, P185; Arber C, 2015, DEVELOPMENT, V142, P1375, DOI 10.1242/dev.117093; ARDHANAREESWARAN K, 2015, YALE J BIOL MED, V88, P5; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Beneyto M, 2011, INT J DEV NEUROSCI, V29, P295, DOI 10.1016/j.ijdevneu.2010.08.003; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742                                                      ; Boissart C, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.71; Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Colasante G, 2015, CELL STEM CELL, V17, P719, DOI 10.1016/j.stem.2015.09.002; Cong L., 2013, SCIENCE; Cristino AS, 2014, MOL PSYCHIATR, V19, P294, DOI 10.1038/mp.2013.16; Denham M, 2012, STEM CELLS, V30, P2400, DOI 10.1002/stem.1204; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Donegan JJ, 2016, BRAIN RES; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde                                                    ; Fuccillo MV, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00027; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Germain ND, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-44; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Griesi-Oliveira K, 2014, MOL PSYCHIATR, V20, P1; Guo X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129715; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Jaeger I, 2011, DEVELOPMENT, V138, P4363, DOI 10.1242/dev.066746; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kirov G, 2015, HUM MOL GENET, V24, pR45, DOI 10.1093/hmg/ddv253; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/nmeth.1972, 10.1038/NMETH.1972]; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Loh Y, 2009, HEMATOP STEM CELLS, V113, P1; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Montserrat N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168013; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nicoleau C, 2013, STEM CELLS, V31, P1763, DOI 10.1002/stem.1462; O'Shea KS, 2016, MOL CELL NEUROSCI, V73, P63, DOI 10.1016/j.mcn.2015.11.006; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Srikanth P, 2015, CELL REP, V12, P1414, DOI 10.1016/j.celrep.2015.07.061; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sun AX, 2016, CELL REP, V16, P1942, DOI 10.1016/j.celrep.2016.07.035; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Topol A, 2015, BIOL PSYCHIAT, V78, pE29, DOI 10.1016/j.biopsych.2014.12.028; Victor MB, 2014, NEURON, V84, P311, DOI 10.1016/j.neuron.2014.10.016; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; Xu Z, 2016, MOL PSYCHIATR, V21, P62, DOI 10.1038/mp.2015.101; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Ziats MN, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00065	103	0	0	16	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2017	27	4					508	517		10.1111/bpa.12517				10	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	EW9FF	WOS:000402821500009	28585386				2018-01-05	
J	Dolt, KS; Hammachi, F; Kunath, T				Dolt, Karamjit Singh; Hammachi, Fella; Kunath, Tilo			Modeling Parkinson's disease with induced pluripotent stem cells harboring alpha-synuclein mutations	BRAIN PATHOLOGY			English	Article						Parkinson's disease; alpha-synuclein; induced pluripotent stem cells; midbrain dopaminergic neurons; isogenic controls; gene triplication	THERAPEUTIC IMPLICATIONS; DOPAMINE NEURONS; IPS CELLS; HUMAN ES; GENE; DIFFERENTIATION; TRIPLICATION; TOXICITY; LOCUS; IDENTIFICATION	Parkinson's disease (PD) is a common neurodegenerative condition affecting more than 8 million people worldwide. Although, the majority of PD cases are sporadic in nature, there are a growing number of monogenic mutations identified to cause PD in a highly penetrant manner. Many of these familial mutations give rise to a condition that is clinically and neuropathologically similar, if not identical, to sporadic PD. Mutations in genes such as SNCA cause PD in an autosomal dominant manner and patients have motor and non-motor symptoms that are typical for sporadic PD. With the advent of reprogramming technology it is now possible to capture these mutations in induced pluripotent stem cells (iPSCs) to establish models of PD in a dish. There are multiple neuronal subtypes affected in PD including the midbrain dopaminergic (mDA) neurons of the substantia nigra. Robust neuronal differentiation into mDA or other relevant neural cell types are critical to accurately model the disease and ensure the findings are relevant to understanding the disease process. Another challenge for establishing accurate models of PD is being met by the generation of isogenic control iPSC lines with precise correction of mutations using advanced gene editing technology. The contributions of ageing and environmental factors present further challenges to this field, but significant progress is being made in these areas to establish highly relevant and robust models of PD. These human neuronal models, used in conjunction with other model systems, will vastly improve our understanding of the early stages of the PD, which will be key to identifying disease-modifying and preventative treatments.	[Dolt, Karamjit Singh; Kunath, Tilo] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, Edinburgh EH16 4UU, Midlothian, Scotland; [Hammachi, Fella] Univ Bristol, Sch Clin Sci, Bristol BS2 8DZ, Avon, England	Kunath, T (reprint author), Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, Edinburgh EH16 4UU, Midlothian, Scotland.	tilo.kunath@ed.ac.uk					Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bonifati Vincenzo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS4, DOI 10.1016/S1353-8020(11)70004-9; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Byers B, 2012, CURR NEUROL NEUROSCI, V12, P237, DOI 10.1007/s11910-012-0270-y; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1                                                   ; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Flierl A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112413; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gowers WR, 1886, MANUAL DIS NERVOUS S, VII; Howden SE, 2015, STEM CELL REP, V5, P1109, DOI [10.1016/j.stemer.2015.10.009, 10.1016/j.stemcr.2015.10.009]; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kouroupi G, 2017, P NATL ACAD SCI USA, V114, pE3679, DOI 10.1073/pnas.1617259114; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lin L, 2016, CELL REP, V15, P2411, DOI 10.1016/j.celrep.2016.05.022; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Oliveira LMA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.318; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023                                                    ; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045                                                   ; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Rudenko I, 2014, NEUROTHERAPEUTICS, V11, P738, DOI 10.1007/s13311-014-0284-z; Ruetz T, 2014, CURR OPIN GENET DEV, V28, P38, DOI [10.1016/j.gde.2014.08.001, 10.1016/j.gde.2014.08.006]; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278                                                         ; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wrasidlo W, 2016, BRAIN, V139, P3217, DOI 10.1093/brain/aww238; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	54	1	1	21	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2017	27	4					545	551		10.1111/bpa.12526				7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	EW9FF	WOS:000402821500013	28585381				2018-01-05	
J	Hamacher, R; Bauer, S				Hamacher, Rainer; Bauer, Sebastian			Preclinical models for translational sarcoma research	CURRENT OPINION IN ONCOLOGY			English	Review						cell lines; genetically engineered mouse model; preclinical; sarcoma; xenograft	GASTROINTESTINAL STROMAL TUMORS; SOFT-TISSUE SARCOMA; TYROSINE KINASE INHIBITOR; TRANSFORMING-GENE-PRODUCT; TRANSGENIC MOUSE MODEL; CELL-LINE; XENOGRAFT MODELS; THERAPEUTIC TARGETS; PHASE-III; PLEOMORPHIC RHABDOMYOSARCOMA	Purpose of reviewSarcoma is a basket term for mesenchymal tumors for which more than 75 genetically and histologically distinct subtypes are recognized. Therapeutic progress has largely been achieved with classical chemotherapeutic drugs that were tested in empirical clinical trials. However, outcome in metastatic patients remains poor and with few exceptions numerous trials have failed or only provided limited improvement in recent years.Recent findingsGiven the genomic heterogeneity, preclinical model systems will be indispensable to identify new molecular targets and to prioritize drugs and drug combinations. Cell culture is still widely used in preclinical sarcoma research to identify potential novel therapeutic approaches and resistance mechanisms. New and improved techniques in genome-wide and proteome-wide screens enable a better characterization. In addition to cell line xenograft mouse models, patient-derived xenografts crucially broadened and improved preclinical studies using primary human samples. Finally, novel strategies for genome editing, like CRISPR/Cas and sleeping beauty transposon, lead to development of novel genetically engineered cell lines and mouse models.SummaryThe present review gives a non-comprehensive overview on current model systems used in sarcoma research and discusses their translational relevance. Those include cell lines, subtype-specific patient-derived cell lines and xenografts as well as developments in genome editing and genetically engineered cell lines and mouse models.	[Hamacher, Rainer; Bauer, Sebastian] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr,Sarcoma Ctr, Essen, Germany; [Bauer, Sebastian] German Canc Consortium DKTK, Heidelberg, Germany	Bauer, S (reprint author), Univ Hosp Essen, West German Canc Ctr, Dept Med Oncol, Sarcoma Ctr, Hufelandstr 55, D-45122 Essen, Germany.	sebastian.bauer@uk-essen.de		Hamacher, Rainer/0000-0001-9655-1226	Sarkomtour	This work/S.B. is supported by the Sarkomtour (www.sarkomtour.de).	Arora S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-218; Bai CJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0175-0; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Barrott JJ, 2016, J EXP MED, V213, P2989, DOI 10.1084/jem.20160817; Barrott JJ, 2015, ONCOTARGET, V6, P22758, DOI 10.18632/oncotarget.4283; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bauer S, 2014, BRIT J CANCER, V110, P1155, DOI 10.1038/bjc.2013.826; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Bozzi F, 2013, LAB INVEST, V93, P1232, DOI 10.1038/labinvest.2013.107; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0                                                                ; Caramel J, 2008, CANCER RES, V68, P6154, DOI 10.1158/0008-5472.CAN-08-0115; Cassinelli G, 2016, ONCOTARGET, V7, P47848, DOI 10.18632/oncotarget.10292; Charytonowicz E, 2012, J CLIN INVEST, V122, P886, DOI 10.1172/JCI60015; Cioffi A, 2015, J CLIN ONCOL, V33, P1849, DOI 10.1200/JCO.2014.59.7344; Clark JCM, 2009, ANZ J SURG, V79, P327, DOI 10.1111/j.1445-2197.2009.04884.x; D'Arcy P, 2009, CANCER LETT, V275, P285, DOI 10.1016/j.canlet.2008.10.030; de Graaff MA, 2016, LAB INVEST, V96, P885, DOI 10.1038/labinvest.2016.64; Demetri GD, 2002, EUR J CANCER, V38, pS52, DOI 10.1016/S0959-8049(02)80603-7; Demetri GD, 2016, J CLIN ONCOL, V34, P786, DOI 10.1200/JCO.2015.62.4734; Demicco EG, 2012, ADV ANAT PATHOL, V19, P170, DOI 10.1097/PAP.0b013e318253462f; Dodd RD, 2010, DIS MODEL MECH, V3, P557, DOI 10.1242/dmm.005223; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; ERIKSON E, 1978, NATURE, V274, P919, DOI 10.1038/274919a0; Floris G, 2009, CLIN CANCER RES, V15, P4066, DOI 10.1158/1078-0432.CCR-08-2588; Forscher C, 2014, BIOL-TARGETS THER, V8, P91, DOI 10.2147/BTT.S26555; Garcia-Carbonero R, 2004, J CLIN ONCOL, V22, P1480, DOI 10.1200/JCO.2004.02.098; Gebreyohannes YK, 2016, MOL CANCER THER, V15, P2845, DOI 10.1158/1535-7163.MCT-16-0224; Goldstein SD, 2015, CLIN EXP METASTAS, V32, P703, DOI 10.1007/s10585-015-9738-x; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Guijarro MV, 2013, AM J PATHOL, V182, P2015, DOI 10.1016/j.ajpath.2013.02.035; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Haldar M, 2009, CANCER RES, V69, P3657, DOI 10.1158/0008-5472.CAN-08-4127; Hayashi T, 2002, CANCER RES, V62, P24; Hayashi Takuma, 2011, Sarcoma, P1, DOI 10.1155/2011/476498; Hayashi T, 2010, PROTEIN CELL, V1, P711, DOI 10.1007/s13238-010-0095-x; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Hernando E, 2007, NAT MED, V13, P748, DOI 10.1038/nm1560; Hiroshima Y, 2015, ANTICANCER RES, V35, P697; Hoffman-Luca CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128807; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Ishikawa T, 2009, LAB INVEST, V89, P1161, DOI 10.1038/labinvest.2009.78; Jamshidi F, 2016, J PATHOL, V238, P63, DOI 10.1002/path.4636; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Jones KB, 2016, ONCOGENE, V35, P5021, DOI 10.1038/onc.2016.38; Jung J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12609; Kabaroff L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094817; Kanojia D, 2015, ONCOTARGET, V6, P42429, DOI 10.18632/oncotarget.6464; Katsumi Y, 2011, BIOCHEM BIOPH RES CO, V413, P62, DOI 10.1016/j.bbrc.2011.08.047; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Kenney S, 2011, J PEDIAT HEMATOL ONC, V33, P360, DOI 10.1097/MPH.0b013e3182002f9f; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Kresse SH, 2012, CANCER-AM CANCER SOC, V118, P558, DOI 10.1002/cncr.26276; Krump-Konvalinkova V, 2003, ENDOTHELIUM-J ENDOTH, V10, P319, DOI 10.1080/10623320390272316; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Lagares-Tena L, 2016, ONCOTARGET, V7, P56889, DOI 10.18632/oncotarget.10872; Lagutina IV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004951; Lamhamedi-Cherradi SE, 2014, ADV DRUG DELIVER REV, V79-80, P155, DOI 10.1016/j.addr.2014.07.012; Le Cesne A, 2005, J CLIN ONCOL, V23, P576, DOI 10.1200/JCO.2005.01.180; Li HF, 2014, TRANSL ONCOL, V7, P665, DOI 10.1016/j.tranon.2014.09.007; Li LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133813; Li WW, 2001, CLIN CANCER RES, V7, P2908; Lin PP, 2008, CANCER RES, V68, P8968, DOI 10.1158/0008-5472.CAN-08-0573; Liu T, 2016, CANCER LETT, V373, P109, DOI 10.1016/j.canlet.2016.01.030; Lopez G, 2016, MOL CANCER RES, V14, P35, DOI 10.1158/1541-7786.MCR-15-0295; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mankin HJ, 2004, CLIN ORTHOP RELAT R, P225, DOI 10.1097/01.blo.0000119250.08614.82; Medjkane S, 2004, CANCER RES, V64, P3406, DOI 10.1158/0008-5472.CAN-03-3004; Minas TZ, 2016, ONCOTARGET; Molyneux SD, 2010, J CLIN INVEST, V120, P3310, DOI 10.1172/JCI42391; Moriarity BS, 2015, NAT GENET, V47, P615, DOI 10.1038/ng.3293; Morton JJ, 2016, CANCER RES, V76, P6153, DOI 10.1158/0008-5472.CAN-16-1260; Muhlenberg T, 2009, CANCER RES, V69, P6941, DOI 10.1158/0008-5472.CAN-08-4004; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Nakai N, 2008, J PATHOL, V214, P302, DOI 10.1002/path.2296; Nanni P, 2003, CANCER RES, V63, P2728; Ng AJM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-19; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Panagopoulos I, 2008, CANCER GENET CYTOGEN, V185, P74, DOI 10.1016/J.cancergencyto.2008.04.020; Patwardhan PP, 2016, ONCOTARGET, V7, P4093, DOI 10.18632/oncotarget.6547; Perez-Losada J, 2000, ONCOGENE, V19, P2413, DOI 10.1038/sj.onc.1203572; Post SM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-20; Rauch DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015755; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Sabin FR, 1932, J EXP MED, V56, P267, DOI 10.1084/jem.56.2.267; Sakharpe A, 2011, ONCOLOGIST, V16, P512, DOI 10.1634/theoncologist.2010-0174; Salawu A, 2016, BRIT J CANCER, V115, P1058, DOI 10.1038/bjc.2016.259; Sarlomo-Rikala M, 1998, MODERN PATHOL, V11, P728; Seitz G, 2010, ONCOL REP, V24, P1067, DOI 10.3892/or_00000956; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Sonobe H, 1997, CANCER GENET CYTOGEN, V96, P178; Stebbing J, 2014, CANCER-AM CANCER SOC, V120, P2006, DOI 10.1002/cncr.28696; Strizzi L, 2007, J PATHOL, V211, P36, DOI 10.1002/path.2083; TAKIGAWA M, 1991, INT J CANCER, V48, P717, DOI 10.1002/ijc.2910480515; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Teicher BA, 2015, MOL CANCER THER, V14, P2452, DOI 10.1158/1535-7163.MCT-15-0074; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Toro JR, 2006, INT J CANCER, V119, P2922, DOI 10.1002/ijc.22239; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Van Looy T, 2014, CLIN CANCER RES, V20, P6071, DOI 10.1158/1078-0432.CCR-14-1823; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543	117	1	1	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-8746	1531-703X		CURR OPIN ONCOL	Curr. Opin. Oncol.	JUL	2017	29	4					275	285		10.1097/CCO.0000000000000373				11	Oncology	Oncology	EX2WM	WOS:000403091400008	28445233				2018-01-05	
J	Lualdi, S; Del Zotto, G; Zegarra-Moran, O; Pedemonte, N; Corsolini, F; Bruschi, M; Tomati, V; Amico, G; Candiano, G; Dardis, A; Cooper, DN; Filocamo, M				Lualdi, Susanna; Del Zotto, Genny; Zegarra-Moran, Olga; Pedemonte, Nicoletta; Corsolini, Fabio; Bruschi, Maurizio; Tomati, Valeria; Amico, Giulia; Candiano, Giovanni; Dardis, Andrea; Cooper, David N.; Filocamo, Mirella			In vitro recapitulation of the site-specific editing (to wild-type) of mutant IDS mRNA transcripts, and the characterization of IDS protein translated from the edited mRNAs	HUMAN MUTATION			English	Article						confocal high-content analysis; confocal microscopy; edited IDS transcripts to wild-type; expression vectors; imaging flow cytometry; RNA editing conversion and deletion; SDS-PAGE; single nucleotide primer extension; variant correction; western blot	SEQ DATA; IDENTIFICATION; SEQUENCE; ROLES; GENE; MITOCHONDRIA; INFORMATION; DEAMINASES; LANDSCAPE; VARIANTS	The transfer of genomic information into the primary RNA sequence can be altered by RNA editing. We have previously shown that genomic variants can be RNA-edited to wild-type. The presence of distinct edited iduronate 2-sulfatase (IDS) mRNA transcripts ex vivo evidenced the correction of a nonsense and frameshift variant, respectively, in three unrelated Hunter syndrome patients. This phenomenon was confirmed in various patient samples by a variety of techniques, and was quantified by single-nucleotide primer extension. Western blotting also confirmed the presence of IDS protein similar in size to the wild-type. Since preliminary experimental evidence suggested that the corrected IDS proteins produced by the patients were similar in molecular weight and net charge to their wild-type counterparts, an in vitro system employing different cell types was established to recapitulate the site-specific editing of IDS RNA (uridine to cytidine conversion and uridine deletion), and to confirm the findings previously observed ex vivo in the three patients. In addition, confocal microscopy and flow cytometry analyses demonstrated the expression and lysosomal localization in HEK293 cells of GFP-labeled proteins translated from edited IDS mRNAs. Confocal high-content analysis of the two patients' cells expressing wild-type or mutated IDS confirmed lysosomal localization and showed no accumulation in the Golgi or early endosomes.	[Lualdi, Susanna; Corsolini, Fabio; Amico, Giulia; Filocamo, Mirella] Ist Giannina Gaslini, UOSD Ctr Diagnost Genet & Biochim Malattie Metab, Genoa, Italy; [Del Zotto, Genny] Ist Giannina Gaslini, Core Facil, Genoa, Italy; [Zegarra-Moran, Olga; Pedemonte, Nicoletta; Tomati, Valeria] Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy; [Bruschi, Maurizio; Candiano, Giovanni] Ist Giannina Gaslini, Lab Physiopathol Uremia, Genoa, Italy; [Dardis, Andrea] Univ Hosp Santa Maria Misericordia, Reg Coordinator Ctr Rare Dis, Udine, Italy; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff, S Glam, Wales	Filocamo, M (reprint author), Ist Giannina Gaslini, UOSD Ctr Diagnost Genet & Biochim Malattie Metab, Genoa, Italy.	mirellafilocamo@gaslini.org		Del Zotto, Genny/0000-0001-7272-7776	Istituto Giannina Gaslini; Telethon Network of Genetic Biobanks [GTB12001]; Cinque per mille e Ricerca Corrente, Ministero della Salute	Contract grant sponsors: Istituto Giannina Gaslini; Telethon Network of Genetic Biobanks (project no. GTB12001); Cinque per mille e Ricerca Corrente, Ministero della Salute.	Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizheva I, 2016, TRENDS PARASITOL, V32, P144, DOI 10.1016/j.pt.2015.10.004; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Behm M, 2016, TRENDS GENET, V32, P165, DOI 10.1016/j.tig.2015.12.005; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Bruschi M, 2005, J PROTEOME RES, V4, P1304, DOI 10.1021/pr050026v; Bruschi M, 2003, PROTEOMICS, V3, P821, DOI 10.1002/pmic.200300361; Chen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-616; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Chen L, 2013, P NATL ACAD SCI USA, V110, pE2741, DOI 10.1073/pnas.1218884110; Cruz-Reyes J, 2001, MOL CELL BIOL, V21, P884, DOI 10.1128/MCB.21.3.884-892.2001; Daniel C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r28; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Estevez AM, 1999, GENE, V240, P247, DOI 10.1016/S0378-1119(99)00437-0; Filocamo M, 2014, OPEN J BIORESOURCES, V1, pe2; Gott J. M., 2011, RNA EDITING HUMAN DI; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grohmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008956; Harjanto D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12145; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Inada T, 2017, TRENDS BIOCHEM SCI, V42, P5, DOI 10.1016/j.tibs.2016.09.005; Jobert L, 2014, CELL MOL LIFE SCI, V71, P2451, DOI 10.1007/s00018-014-1562-y; Kai M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030310; Kim M. S., 2016, BMC GENOMICS, V17, P1; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Lualdi S, 2010, HUM MUTAT, V31, pE1261, DOI 10.1002/humu.21208; Maas Stefan, 2006, RNA Biol, V3, P1; Mrowka C, 2000, J AM SOC NEPHROL, V11, pS106; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; Niavarani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120089; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Reautschnig P., 2016, RNA BIOL, V14, P1; Rieder LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3232; Savva YA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4157; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720                                                             ; Simms CL, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1366; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Velho RV, 2016, J HUM GENET, V61, P555, DOI 10.1038/jhg.2016.13; Villegas J, 2002, NUCLEIC ACIDS RES, V30, P1895, DOI 10.1093/nar/30.9.1895                                                           ; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Xu GX, 2014, P NATL ACAD SCI USA, V111, P3769, DOI 10.1073/pnas.1321745111; Zhu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043227; Zougman A, 2008, CURR BIOL, V18, P1760, DOI 10.1016/j.cub.2008.09.059	50	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	JUL	2017	38	7					849	862		10.1002/humu.23243				14	Genetics & Heredity	Genetics & Heredity	EX6KV	WOS:000403352100010	28477385				2018-01-05	
J	Jia, HG; Zhang, YZ; Orbovic, V; Xu, J; White, FF; Jones, JB; Wang, N				Jia, Hongge; Zhang, Yunzeng; Orbovic, Vladimir; Xu, Jin; White, Frank F.; Jones, Jeffrey B.; Wang, Nian			Genome editing of the disease susceptibility gene CsLOB1 in citrus confers resistance to citrus canker	PLANT BIOTECHNOLOGY JOURNAL			English	Article						Xanthomonas citri; Cas9; sgRNA; Citrus paradisi	FAMILY; EXPRESSION; RICE	Citrus is a highly valued tree crop worldwide, while, at the same time, citrus production faces many biotic challenges, including bacterial canker and Huanglongbing (HLB). Breeding for disease-resistant varieties is the most efficient and sustainable approach to control plant diseases. Traditional breeding of citrus varieties is challenging due to multiple limitations, including polyploidy, polyembryony, extended juvenility and long crossing cycles. Targeted genome editing technology has the potential to shorten varietal development for some traits, including disease resistance. Here, we used CRISPR/Cas9/sgRNA technology to modify the canker susceptibility gene CsLOB1 in Duncan grapefruit. Six independent lines, DLOB2, DLOB3, DLOB9, DLOB10, DLOB11 and DLOB12, were generated. Targeted next-generation sequencing of the six lines showed the mutation rate was 31.58%, 23.80%, 89.36%, 88.79%, 46.91% and 51.12% for DLOB2, DLOB3, DLOB9, DLOB10, DLOB11 and DLOB12, respectively, of the cells in each line. DLOB2 and DLOB3 showed canker symptoms similar to wild-type grapefruit, when inoculated with the pathogen Xanthomonas citri subsp. citri (Xcc). No canker symptoms were observed on DLOB9, DLOB10, DLOB11 and DLOB12 at 4 days postinoculation (DPI) with Xcc. Pustules caused by Xcc were observed on DLOB9, DLOB10, DLOB11 and DLOB12 in later stages, which were much reduced compared to that on wild-type grapefruit. The pustules on DLOB9 and DLOB10 did not develop into typical canker symptoms. No side effects and off-target mutations were detected in the mutated plants. This study indicates that genome editing using CRISPR technology will provide a promising pathway to generate disease-resistant citrus varieties.	[Jia, Hongge; Zhang, Yunzeng; Xu, Jin; Wang, Nian] Univ Florida, Inst Food & Agr Sci IFAS, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA; [Orbovic, Vladimir] Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL USA; [White, Frank F.; Jones, Jeffrey B.] Univ Florida, Dept Plant Pathol, IFAS, Gainesville, FL 32611 USA	Wang, N (reprint author), Univ Florida, Inst Food & Agr Sci IFAS, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.	nianwang@ufl.edu		xu, jin/0000-0003-2289-4896	Florida Citrus Research and Development Foundation	This study has been supported by Florida Citrus Research and Development Foundation. We thank Dr. Manjul Dutt for plasmid AtSUC2-NPR1.	Blanvillain-Baufume S, 2017, PLANT BIOTECHNOL J, V15, P306, DOI 10.1111/pbi.12613; Chen XH, 2013, PHYSIOL MOL PLANT P, V84, P115, DOI 10.1016/j.pmpp.2013.07.002; Davey MR, 2005, BIOTECHNOL ADV, V23, P131, DOI 10.1016/j.biotechadv.2004.09.008; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fass JN, 2011, G3-GENES GENOM GENET, V1, P515, DOI 10.1534/g3.111.000927; Fu XZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-55; Hu Y, 2014, P NATL ACAD SCI USA, V111, pE521, DOI 10.1073/pnas.1313271111; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Jia HG, 2014, PLANT CELL REP, V33, P1993, DOI 10.1007/s00299-014-1673-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Orbovic V, 2015, METHODS MOL BIOL, V1224, P245, DOI 10.1007/978-1-4939-1658-0_20; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Velasco R, 2014, NAT BIOTECHNOL, V32, P640, DOI 10.1038/nbt.2954; Waltz E, 2016, NAT BIOTECHNOL, V34, P582, DOI 10.1038/nbt0616-582; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Yordanov YS, 2010, PLANT CELL, V22, P3662, DOI 10.1105/tpc.110.078634; Zhang JL, 2017, MOL PLANT PATHOL, V18, P798, DOI 10.1111/mpp.12441; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838	22	7	7	35	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	JUL	2017	15	7					817	823		10.1111/pbi.12677				7	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	EX1SR	WOS:000403006800004	27936512	gold			2018-01-05	
J	Chen, LL; Yang, L				Chen, Ling-Ling; Yang, Li			ALUternative Regulation for Gene Expression	TRENDS IN CELL BIOLOGY			English	Review							MESSENGER-RNA DECAY; ALU ELEMENTS; NUCLEAR RETENTION; EXON CIRCULARIZATION; HUMAN MICRORNAS; EDITING SITES; HUMAN GENOME; TRANSPOSABLE ELEMENTS; HUMAN TRANSCRIPTOME; CIRCRNA BIOGENESIS	Alu elements belong to the primate-specific SINE family of retrotransposons and constitute almost 11% of the human genome. Alus are transcribed by RNA polymerase (Pol) III and are inserted back into the genome with the help of autonomous LINE retroelements. Since Alu elements are preferentially located near to or within gene-rich regions, they can affect gene expression by distinct mechanisms of action at both DNA and RNA levels. In this review we focus on recent advances of how Alu elements are pervasively involved in gene regulation. We discuss the impacts of Alu DNA sequences that are in close proximity to genes, Pol-III-transcribed free Alu RNAs, and Pol-II-transcribed Alu RNAs that are embedded within coding or noncoding RNA transcripts. The recent elucidation of Alu functions reveals previously underestimated roles of these selfish or junk DNA sequences in the human genome.	[Chen, Ling-Ling] Chinese Acad Sci, State Key Lab Mol Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai Key Lab Mol Androl,Shanghai Inst Biochem, Shanghai 200031, Peoples R China; [Yang, Li] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Chen, Ling-Ling; Yang, Li] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chen, LL (reprint author), Chinese Acad Sci, State Key Lab Mol Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai Key Lab Mol Androl,Shanghai Inst Biochem, Shanghai 200031, Peoples R China.; Yang, L (reprint author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.; Chen, LL; Yang, L (reprint author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China.	linglingchen@sibcb.ac.cn; liyang@picb.ac.cn			MOST [2016YFA0100701, 2014CB910601]; CAS [XDB19000000]; NSFC [91540115, 91440202]	We are grateful to Gordon Carmichael for critical reading of this manuscript. We apologize to authors whose work could not cite here owing to space/content limitations. Our work is supported by grants 2016YFA0100701 and 2014CB910601 from MOST, XDB19000000 from CAS, and 91540115 and 91440202 from NSFC.	An HJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-97; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1174; Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927                                                            ; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen T, 2015, CELL RES, V25, P459, DOI 10.1038/cr.2015.24; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58                                                             ; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Daniel C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r28; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; DeCerbo J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-216; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864                                                          ; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Du ZQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-98; Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247; Elbarbary RA, 2015, GENE DEV, V29, P687, DOI 10.1101/gad.261438.115; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Gleghorn ML, 2013, NAT STRUCT MOL BIOL, V20, P515, DOI 10.1038/nsmb.2528; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Goodyer CG, 2001, J MOL ENDOCRINOL, V27, P357, DOI 10.1677/jme.0.0270357; Gu TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-563; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hoffman Y, 2014, J MOL CELL BIOL, V6, P192, DOI 10.1093/jmcb/mju020; Hoffman Y, 2013, BIOINFORMATICS, V29, P894, DOI 10.1093/bioinformatics/btt044; Hormozdiari F, 2013, P NATL ACAD SCI USA, V110, P13457, DOI 10.1073/pnas.1310914110; Hormozdiari F, 2011, GENOME RES, V21, P840, DOI 10.1101/gr.115956.110; Hu SB, 2015, GENE DEV, V29, P630, DOI 10.1101/gad.257048.114; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Kelly S, 2015, J MOL BIOL, V427, P2414, DOI 10.1016/j.jmb.2015.02.018; KNEBELMANN B, 1995, HUM MOL GENET, V4, P675, DOI 10.1093/hmg/4.4.675; Kreahling J, 2004, TRENDS GENET, V20, P1, DOI 10.1016/j.tig.2003.11.001; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2001, GENOMICS, V76, P110, DOI 10.1006/geno.2001.6604; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Lei HX, 2005, MOL CELL BIOL, V25, P6912, DOI 10.1128/MCB.25.16.6912-6920.2005; Lei HX, 2005, NUCLEIC ACIDS RES, V33, P3897, DOI 10.1093/nar/gki707; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; ORGEL LE, 1980, NATURE, V288, P645, DOI 10.1038/288645a0                                                                ; Pagano A, 2007, PLOS GENET, V3, P174, DOI 10.1371/journal.pgen.0030001; Park E, 2013, P NATL ACAD SCI USA, V110, P405, DOI 10.1073/pnas.1213508110; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; QUENTIN Y, 1992, NUCLEIC ACIDS RES, V20, P487, DOI 10.1093/nar/20.3.487; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Roy-Engel AM, 2005, CYTOGENET GENOME RES, V110, P365, DOI 10.1159/000084968; Rubin CM, 2002, NUCLEIC ACIDS RES, V30, P3253, DOI 10.1093/nar/gkf419                                                              ; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Spengler RM, 2014, HUM MOL GENET, V23, P1783, DOI 10.1093/hmg/ddt569; Starke S, 2015, CELL REP, V10, P103, DOI 10.1016/j.celrep.2014.12.002; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Stuart JJ, 2000, BIOCHEM BIOPH RES CO, V274, P641, DOI 10.1006/bbrc.2000.3189; Su M, 2014, CELL REP, V7, P376, DOI 10.1016/j.celrep.2014.03.011; Tang RB, 2005, MOL CARCINOGEN, V42, P93, DOI 10.1002/mc.20057; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Xie HH, 2009, NUCLEIC ACIDS RES, V37, P4331, DOI 10.1093/nar/gkp393; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yang L, 2015, WIRES RNA, V6, P651, DOI 10.1002/wrna.1307; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2016, CELL REP, V15, P611, DOI 10.1016/j.celrep.2016.03.058; Zhu SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-206	91	1	1	7	7	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0962-8924	1879-3088		TRENDS CELL BIOL	Trends Cell Biol.	JUL	2017	27	7					480	490		10.1016/j.tcb.2017.01.002				11	Cell Biology	Cell Biology	EX6EX	WOS:000403336600003	28209295				2018-01-05	
J	Khalili, K; White, MK; Jacobson, JM				Khalili, Kamel; White, Martyn K.; Jacobson, Jeffrey M.			Novel AIDS therapies based on gene editing	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Gene editing; CRISPR/Cas9; HIV-1; AIDS	ZINC-FINGER NUCLEASE; HIV-1 PROVIRAL DNA; CD4(+) T-CELLS; HEMATOPOIETIC STEM-CELLS; CRISPR/CAS9 SYSTEM; ANTIRETROVIRAL THERAPY; VIRUS REACTIVATION; CORECEPTOR CCR5; CRE RECOMBINASE; TALE NUCLEASES	HIV/AIDS remains a major public health issue. In 2014, it was estimated that 36.9 million people are living with HIV worldwide, including 2.6 million children. Since the advent of combination antiretroviral therapy (cART), in the 1990s, treatment has been so successful that in many parts of the world, HIV has become a chronic condition in which progression to AIDS has become increasingly rare. However, while people with HIV can expect to live a normal life span with cART, lifelong medication is required and cardiovascular, renal, liver, and neurologic diseases are still possible, which continues to prompt research for a cure for HIV. Infected reservoir cells, such as CD4+T cells and myeloid cells, allow persistence of HIV as an integrated DNA provirus and serve as a potential source for the re-emergence of virus. Attempts to eradicate HIV from these cells have focused mainly on the so-called "shock and kill" approach, where cellular reactivation is induced so as to trigger the purging of virus-producing cells by cytolysis or immune attack. This approach has several limitations and its usefulness in clinical applications remains to be assessed. Recent advances in gene-editing technology have allowed the use of this approach for inactivating integrated proviral DNA in the genome of latently infected cells or knocking out HIV receptors. Here, we review this strategy and its potential to eliminate the latent HIV reservoir resulting in a sterile cure of AIDS.	[Khalili, Kamel; White, Martyn K.; Jacobson, Jeffrey M.] Temple Univ, Lewis Katz Sch Med, Dept Neurosci, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA; [Khalili, Kamel; White, Martyn K.; Jacobson, Jeffrey M.] Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA; [Khalili, Kamel; White, Martyn K.; Jacobson, Jeffrey M.] Temple Univ, Lewis Katz Sch Med, Comprehens NeuroAIDS Ctr, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA; [Khalili, Kamel; Jacobson, Jeffrey M.] Temple Univ, Lewis Katz Sch Med, Ctr Translat AIDS Res, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA; [Jacobson, Jeffrey M.] Temple Univ, Dept Med, Lewis Katz Sch Med, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA	Khalili, K (reprint author), Temple Univ, Lewis Katz Sch Med, Dept Neurosci, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.; Khalili, K (reprint author), Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.; Khalili, K (reprint author), Temple Univ, Lewis Katz Sch Med, Comprehens NeuroAIDS Ctr, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.; Khalili, K (reprint author), Temple Univ, Lewis Katz Sch Med, Ctr Translat AIDS Res, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.	kamel.khalili@temple.edu			NIMH NIH HHS [P30 MH092177]; NINDS NIH HHS [R01 NS087971]		Adair JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13173; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, J INFECT DIS, V210, P728, DOI 10.1093/infdis/jiu155; Benjamin R, 2016, HUM GENET, V135, P1059, DOI 10.1007/s00439-016-1678-2; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Buchholz F, 2013, ANTIVIR RES, V97, P211, DOI 10.1016/j.antiviral.2012.12.017; Buchholz F, 2011, METHODS, V53, P102, DOI 10.1016/j.ymeth.2010.06.014; Cannon P, 2011, CURR OPIN HIV AIDS, V6, P74, DOI 10.1097/COH.0b013e32834122d7; Cary DC, 2016, F1000RES, V5; Chen X, 2016, MOL THER, V24, P447, DOI 10.1038/mt.2015.164; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003                                                ; Conway JM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004677; Conway JM, 2015, P NATL ACAD SCI USA, V112, P5467, DOI 10.1073/pnas.1419162112; Datta PK, 2016, CURR HIV RES, V14, P431, DOI 10.2174/1570162X14666160324125536; de Silva E, 2004, FEMS MICROBIOL LETT, V241, P1, DOI 10.1016/j.femsle.2004.09.040; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ebina H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120047; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Feelixge HSD, 2016, ANTIVIR RES, V126, P90, DOI 10.1016/j.antiviral.2015.12.007; Finzi D, 1999, NAT MED, V5, P512; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Hearps AC, 2014, CURR HIV-AIDS REP, V11, P20, DOI 10.1007/s11904-013-0190-8; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Hill AL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005535; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Hofer U, 2013, J INFECT DIS, V208, pS160, DOI 10.1093/infdis/jit382; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kaminski R, 2016, GENE THER, V23, P696, DOI 10.1038/gt.2016.45; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Karpinski J, 2016, NAT BIOTECHNOL, V34, P401, DOI 10.1038/nbt.3467; Khalili K, 2015, J NEUROVIROL, V21, P310, DOI 10.1007/s13365-014-0308-9; KIM YG, 1994, J BIOL CHEM, V269, P31978; Kishida T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01001; Kulpa DA, 2015, J VIRUS ERAD, V1, P59; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Li L, 2013, ELECTRON J DIFFER EQ; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Liu L, 2015, J VIROL, V89, P6685, DOI 10.1128/JVI.00474-15; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mariyanna L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031576; Martin AR, 2016, ANNU REV MED, V67, P215, DOI 10.1146/annurev-med-011514-023043; Meinke G, 2016, CHEM REV, V116, P12785, DOI 10.1021/acs.chemrev.6b00077; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Mock U, 2014, SCI REP-UK, V4, DOI 10.1038/srep06409; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Ousterout DG, 2016, METHODS MOL BIOL, V1338, P27, DOI 10.1007/978-1-4939-2932-0_3; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Qu XY, 2014, MOL BIOL REP, V41, P5819, DOI 10.1007/s11033-014-3456-3; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Randhawa S, 2016, BRIT J HAEMATOL, V174, P425, DOI 10.1111/bjh.14075; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Ru Renli, 2013, Cell Regen (Lond), V2, P5, DOI 10.1186/2045-9769-2-5; Sahu GK, 2013, VIROLOGY, V446, P268, DOI 10.1016/j.virol.2013.08.002; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI 10.1038/nrneurol.2016.27; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Sedlak RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20064; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Strong CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125652; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Ueda S, 2016, MICROBIOL IMMUNOL, V60, P483, DOI 10.1111/1348-0421.12395; Urba WJ, 2011, NEW ENGL J MED, V365, P754, DOI 10.1056/NEJMe1106965; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Wang CX, 2016, BLOOD, V127, P2546, DOI 10.1182/blood-2016-01-678144; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; White MK, 2015, DISCOV MED, V19, P255; Woollard Shawna M, 2015, Drug Des Devel Ther, V9, P5447, DOI 10.2147/DDDT.S90580; Wright DA, 2014, BIOCHEM J, V462, P15, DOI 10.1042/BJ20140295; Yang YM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5564; Yao YC, 2012, HUM GENE THER, V23, P238, DOI 10.1089/hum.2011.126; Yi GH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.52; Yin CR, 2016, AIDS, V30, P1163, DOI 10.1097/QAD.0000000000001079; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277; Zhen A, 2016, J VIS EXP IN PRESS; Zhen AJ, 2015, MOL THER, V23, P1358, DOI 10.1038/mt.2015.102; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z	104	2	2	25	25	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUL	2017	74	13					2439	2450		10.1007/s00018-017-2479-z				12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EX6HV	WOS:000403344300007	28210784				2018-01-05	
J	Liu, Y; Zhu, ZY; Ho, IHT; Shi, YJ; Xie, YX; Li, JZ; Zhang, Y; Chan, MTV; Cheng, CHK				Liu, Yun; Zhu, Zeyao; Ho, Idy H. T.; Shi, Yujian; Xie, Yuxin; Li, Jianzhen; Zhang, Yong; Chan, Matthew T. V.; Cheng, Christopher H. K.			Germline-specific dgcr8 knockout in zebrafish using a BACK approach	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Crispr-cas9; Maternal-zygotic transition; Germ layer specification; Small regulatory RNAs	ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; GENOME; EFFICIENT; SYSTEM; XENOPUS; TALENS; CRISPR-CAS9; CRISPR/CAS9; MUTAGENESIS	Zebrafish is an important model to study developmental biology and human diseases. However, an effective approach to achieve spatial and temporal gene knockout in zebrafish has not been well established. In this study, we have developed a new approach, namely bacterial artificial chromosome-rescue-based knockout (BACK), to achieve conditional gene knockout in zebrafish using the Cre/loxP system. We have successfully deleted the DiGeorge syndrome critical region gene 8 (dgcr8) in zebrafish germ line and demonstrated that the maternal-zygotic dgcr8 (MZdgcr8) embryos exhibit MZdicer-like phenotypes with morphological defects which could be rescued by miR-430, indicating that canonical microRNAs play critical rol in early development. Our findings establish that Cre/loxPmediated tissue-specific gene knockout could be achieved using this BACK strategy and that canonical microRNAs play important roles in early embryonic development in zebrafish.	[Liu, Yun; Zhang, Yong] Sun Yat Sen Univ, State Key Lab Biocontrol, Inst Aquat Econ Anim, Guangzhou, Guangdong, Peoples R China; [Liu, Yun; Zhang, Yong] Sun Yat Sen Univ, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou, Guangdong, Peoples R China; [Liu, Yun; Zhu, Zeyao; Ho, Idy H. T.; Shi, Yujian; Xie, Yuxin; Li, Jianzhen; Zhang, Yong; Cheng, Christopher H. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Ho, Idy H. T.; Chan, Matthew T. V.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Zhu, Zeyao; Ho, Idy H. T.; Shi, Yujian; Xie, Yuxin; Li, Jianzhen; Cheng, Christopher H. K.] Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci Core Lab, Shenzhen, Peoples R China; [Zhang, Yong] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China	Cheng, CHK (reprint author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.; Cheng, CHK (reprint author), Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci Core Lab, Shenzhen, Peoples R China.	chkcheng@cuhk.edu.hk	Chan, Matthew/J-2884-2013	Chan, Matthew/0000-0002-3574-7855	Research Grant Council of Hong Kong [14119715]; Fundamental Research Funds for the Central Universities [151gzs102, 151gzs121]	This work was supported by the Research Grant Council of Hong Kong (Grant No. 14119715) and the Fundamental Research Funds for the Central Universities (Grant Nos. 151gzs102 and 151gzs121).	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bibikova M, 2002, GENETICS, V161, P1169; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li JW, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-48; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23864; Liu Y, 2016, METHODS MOL BIOL, V1338, P207, DOI 10.1007/978-1-4939-2932-0_16; Liu Y, 2014, METHODS, V69, P58, DOI 10.1016/j.ymeth.2014.02.011; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.3.CO;2-2; Ni TT, 2012, P NATL ACAD SCI USA, V109, P15389, DOI 10.1073/pnas.1206131109; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Boxtel AL, 2015, DEV CELL, V35, P175, DOI 10.1016/j.devcel.2015.09.014; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Xiong F, 2013, MAR BIOTECHNOL, V15, P526, DOI 10.1007/s10126-013-9505-4; Yang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064058; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	40	0	0	5	7	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUL	2017	74	13					2503	2511		10.1007/s00018-017-2471-7				9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EX6HV	WOS:000403344300011	28224202				2018-01-05	
J	Lin, GG; Zhang, K; Han, YX; Li, JM				Lin, Guigao; Zhang, Kuo; Han, Yanxi; Li, Jinming			Quality control materials for pharmacogenomic testing in the clinic	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Review						next-generation sequencing; pharmaco-geno-mic testing; quality control materials	CELL LUNG-CANCER; DNA REFERENCE MATERIALS; COLORECTAL-CANCER; BREAST-CANCER; COLLABORATIVE-PROJECT; LABORATORY STANDARDS; CRISPR/CAS9 SYSTEM; MOLECULAR ANALYSIS; 3 ROUNDS; GENERATION	Pharmacogenomics has significantly added to our understanding of drug responses in clinical pharmacology, changing the paradigm of treatment decisions. Interrogations of both inherited and somatic variations for therapeutic purposes are increasingly being adopted in clinics, where quality control (QC) materials are required. However, for many pharmacogenomic tests, the acquisition of well-characterized QC materials is often difficult or impossible. In this review, several sources of appropriate QC materials for therapy-associated genetic testing are discussed. Among them, the novel methods for producing renewable controls that resemble patient samples are highlighted. Owing to technological complexity, more efforts are needed to develop proper controls for next-generation sequencing-based assay.	[Lin, Guigao; Zhang, Kuo; Han, Yanxi; Li, Jinming] Beijing Hosp, Natl Ctr Gerontol, Natl Ctr Clin Labs, Beijing, Peoples R China; [Lin, Guigao; Zhang, Kuo; Han, Yanxi; Li, Jinming] Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China; [Li, Jinming] 1 DaHua Rd, Beijing 100730, Peoples R China	Li, JM (reprint author), Beijing Hosp, Natl Ctr Gerontol, Natl Ctr Clin Labs, Beijing, Peoples R China.; Li, JM (reprint author), Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China.; Li, JM (reprint author), 1 DaHua Rd, Beijing 100730, Peoples R China.	jmli@nccl.org.cn			Natural Science Foundation of Beijing Municipality [7164295]; National Natural Science Foundation of China [81601841]; Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P.R. China [201402018]	Natural Science Foundation of Beijing Municipality (Grant/Award Number: '7164295'). National Natural Science Foundation of China (Grant/Award Number: '81601841'). Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P.R. China (Grant/Award Number: '201402018').	Aziz N, 2015, ARCH PATHOL LAB MED, V139, P481, DOI 10.5858/arpa.2014-0250-CP; Bellon E, 2011, ONCOLOGIST, V16, P467, DOI 10.1634/theoncologist.2010-0429; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003                                                         ; Chen B, 2005, GENET MED, V7, P534, DOI 10.1097/01.GIM.0000183043.94406.81; Pantel K., 2016, ONCOTARGET, V10, P371; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Clinical and Laboratory Standards Institute, 2012, MM1A3 CLSI; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornish A, 2015, BIOMED RES INT, DOI 10.1155/2015/456479; Deans ZC, 2014, J CLIN PATHOL, V67, P120, DOI 10.1136/jclinpath-2013-201848; Deans ZC, 2013, J CLIN PATHOL, V66, P319, DOI 10.1136/jclinpath-2012-201227; Deans ZC, 2011, GENET TEST MOL BIOMA, V15, P777, DOI 10.1089/gtmb.2010.0239; Dequeker E, 2011, VIRCHOWS ARCH, V459, P155, DOI 10.1007/s00428-011-1094-x; Dequeker EMC, 2016, J MOL DIAGN, V18, P205, DOI 10.1016/j.jmoldx.2015.09.004; Der Straaten TV, 2008, PHARMACOGENOMICS, V9, P1261; Deveson IW, 2016, NAT METHODS, V13, P784, DOI [10.1038/NMETH.3957, 10.1038/nmeth.3957]; Dijkstra JR, 2012, J MOL DIAGN, V14, P187, DOI 10.1016/j.jmoldx.2012.01.002; Dumur CI, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0403-0; Fang H, 2014, PHARMACOGENOMICS J, V14, P564, DOI 10.1038/tpj.2014.27; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Li YL, 2016, J THORAC ONCOL, V11, P924, DOI 10.1016/j.jtho.2016.03.004; Lih CJ, 2016, J MOL DIAGN, V18, P51, DOI 10.1016/j.jmoldx.2015.07.006; Lin GG, 2015, J CARDIOVASC PHARM, V66, P129, DOI 10.1097/FJC.0000000000000254; Lin GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134174; Lutins E, 2015, GENET TEST MOL BIOMA, V19, P589, DOI 10.1089/gtmb.2015.29006.sjt; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Normanno N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0655-1; Patton S, 2014, BRIT J CANCER, V111, P413, DOI 10.1038/bjc.2014.353; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Pratt VM, 2016, J MOL DIAGN, V18, P109, DOI 10.1016/j.jmoldx.2015.08.005; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Qiao WQ, 2016, HUM MUTAT, V37, P315, DOI 10.1002/humu.22936; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rhodes A, 2002, AM J CLIN PATHOL, V117, P81; Riera J, 1999, AM J CLIN PATHOL, V111, P329; RUBY SG, 1995, AM J CLIN PATHOL, V104, P167; Tack V, 2015, ONCOLOGIST, V20, P257, DOI 10.1634/theoncologist.2014-0382; Thunnissen E, 2011, J CLIN PATHOL, V64, P884, DOI 10.1136/jclinpath-2011-200163; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang SR, 2016, J MOL DIAGN, V18, P416, DOI 10.1016/j.jmoldx.2016.01.006; Whittaker MH, 1999, AM J CLIN PATHOL, V111, P449; Wu AHB, 2013, ARCH PATHOL LAB MED, V137, P1232, DOI 10.5858/arpa.2012-0261-CP; Xiao Y, 2009, CLIN CHEM, V55, P1307, DOI 10.1373/clinchem.2008.120576; Yi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148081; Zhang R, 2016, ONCOTARGET; Zhang R, 2014, CLIN CHEM LAB MED, V52, P1851, DOI 10.1515/cclm-2014-0227; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25	50	0	0	3	3	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	JUL	2017	55	7					926	933		10.1515/cclm-2016-0755				8	Medical Laboratory Technology	Medical Laboratory Technology	EX2RV	WOS:000403075100012	27845879				2018-01-05	
J	Hwang, Y; Broxmeyer, HE; Lee, MR				Hwang, Yongsung; Broxmeyer, Hal E.; Lee, Man Ryul			Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors	CURRENT OPINION IN HEMATOLOGY			English	Review						CRISPR; Cas9; direct conversion; direct differentiation; hematopoietic stem cells; induced pluripotent stem cells	RED-BLOOD-CELLS; LARGE-SCALE PRODUCTION; HUMAN FIBROBLASTS; PROGENITOR CELLS; CRISPR/CAS9 SYSTEM; DIRECT CONVERSION; DIFFERENTIATION; INDUCTION; SPECIFICATION; CRISPR-CAS9	Purpose of reviewHematopoietic cell transplantation (HCT) is a successful treatment modality for patients with malignant and nonmalignant disorders, usually when no other treatment option is available. The cells supporting long-term reconstitution after HCT are the hematopoietic stem cells (HSCs), which can be limited in numbers. Moreover, finding an appropriate human leukocyte antigen-matched donor can be problematic. If HSCs can be stably produced in large numbers from autologous or allogeneic cell sources, it would benefit HCT. Induced pluripotent stem cells (iPSCs) established from patients' own somatic cells can be differentiated into hematopoietic cells in vitro. This review will highlight recent methods for regulating human (h) iPSC production of HSCs and more mature blood cells.Recent findingsAdvancements in transcription factor-mediated regulation of the developmental stages of in-vivo hematopoietic lineage commitment have begun to provide an understanding of the molecular mechanism of hematopoiesis. Such studies involve not only directed differentiation in which transcription factors, specifically expressed in hematopoietic lineage-specific cells, are overexpressed in iPSCs, but also direct conversion in which transcription factors are introduced into patient-derived somatic cells which are dedifferentiated to hematopoietic cells. As iPSCs derived from patients suffering from genetically mutated diseases would express the same mutated genetic information, CRISPR-Cas9 gene editing has been utilized to differentiate genetically corrected iPSCs into normal hematopoietic cells.SummaryIPSCs provide a model for molecular understanding of disease, and also may function as a cell population for therapy. Efficient differentiation of patient-specific iPSCs into HSCs and progenitor cells is a potential means to overcome limitations of such cells for HCT, as well as for providing in-vitro drug screening templates as tissue-on-a-chip models.	[Hwang, Yongsung; Lee, Man Ryul] Soon Chun Hyang Univ, SIMS, 25 Bongjeong Ro, Cheonan Si 31151, Chungcheongnam, South Korea; [Hwang, Yongsung; Lee, Man Ryul] Soon Chun Hyang Univ, Coll Med, Inst Tissue Regenerat, Cheonan Si, Chungcheongnam, South Korea; [Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Lee, MR (reprint author), Soon Chun Hyang Univ, SIMS, 25 Bongjeong Ro, Cheonan Si 31151, Chungcheongnam, South Korea.	leeman@sch.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1A6A1A03032522]; Soon Chun Hyang University Research Fund	M.R.L.'s studies are supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A1A03032522), and work supported by the Soon Chun Hyang University Research Fund.	Amabile G, 2013, BLOOD, V121, P1255, DOI 10.1182/blood-2012-06-434407; Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; BEYER J, 1995, J CLIN ONCOL, V13, P1328, DOI 10.1200/JCO.1995.13.6.1328                                                      ; Broxmeyer HE FS, 2016, THOMAS HEMATOPOIETIC, P437; Capellera-Garcia S, 2016, CELL REP, V15, P2550, DOI 10.1016/j.celrep.2016.05.027; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Easterbrook J, 2016, BRIT J HAEMATOL, V173, P671, DOI 10.1111/bjh.14010; Ebina W, 2015, EMBO J, V34, P694, DOI 10.15252/embj.201490804; Elcheva I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5372; Esposito MT, 2016, HAEMATOLOGICA, V101, P999, DOI 10.3324/haematol.2016.150755; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Ferrell PI, 2015, STEM CELLS, V33, P1130, DOI 10.1002/stem.1940; Hu XT, 2016, BLOOD CELL MOL DIS, V62, P6, DOI 10.1016/j.bcmd.2016.09.003; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Jackson M, 2016, STEM CELL TRANSL MED, V5, P981, DOI 10.5966/sctm.2015-0324; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598                                                          ; Kime C, 2015, CURR PROTOC HUM GENE, V87, P1; Lee MR, 2016, STEM CELL REP, V7, P1, DOI 10.1016/j.stemcr.2016.05.012; Lee MR, 2013, STEM CELLS, V31, P666, DOI 10.1002/stem.1302; Liakhovitskaia A, 2014, DEVELOPMENT, V141, P3319, DOI 10.1242/dev.110841; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Moreau T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11208; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Niu XH, 2016, J BIOL CHEM, V291, P16576, DOI 10.1074/jbc.M116.719237; Olivier EN, 2006, EXP HEMATOL, V34, P1635, DOI 10.1016/j.exphem.2006.07.003; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Pulecio J, 2016, CELL REP, V17, P671, DOI 10.1016/j.celrep.2016.09.036; Pulecio J, 2014, STEM CELLS, V32, P2923, DOI 10.1002/stem.1800; Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003; Ran D, 2013, BLOOD, V121, P2882, DOI 10.1182/blood-2012-08-451641; Real PJ, 2013, BLOOD, V121, P5250, DOI 10.1182/blood-2013-03-487587; Real PJ, 2012, MOL THER, V20, P1443, DOI 10.1038/mt.2012.49; Reardon S, 2014, NATURE, V513, P287, DOI 10.1038/513287a; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2004, EXP HEMATOL, V32, P1000, DOI 10.1016/j.exphem.2004.06.013; Toscano MG, 2015, MOL THER, V23, P158, DOI 10.1038/mt.2014.196; Vo LT, 2015, BLOOD, V125, P2641, DOI 10.1182/blood-2014-10-570234; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wahlster L, 2016, NAT CELL BIOL, V18, P1111, DOI 10.1038/ncb3419; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; Yang CT, 2017, STEM CELLS, V35, P886, DOI 10.1002/stem.2562; Yung S, 2011, HUM MOL GENET, V20, P4932, DOI 10.1093/hmg/ddr431; Zhang H, 2016, BRIT J HAEMATOL, V175, P208, DOI 10.1111/bjh.14297	52	1	1	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1065-6251	1531-7048		CURR OPIN HEMATOL	Curr. Opin. Hematol.	JUL	2017	24	4					283	288		10.1097/MOH.0000000000000343				6	Hematology	Hematology	EX2UH	WOS:000403082300001	28383341	gold			2018-01-05	
J	Fan, HH; Qiao, LH; Kang, KD; Fan, JF; Wei, WS; Luo, GX				Fan, Huahao; Qiao, Luhua; Kang, Kyung-Don; Fan, Junfen; Wei, Wensheng; Luo, Guangxiang			Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission	JOURNAL OF VIROLOGY			English	Article						hepatitis C virus; attachment receptor; postattachment receptor; infection; cell-to-cell transmission; cell-free infection	HEPARAN-SULFATE PROTEOGLYCANS; B TYPE-I; HUMAN APOLIPOPROTEIN-E; E2 GLYCOPROTEIN; ENTRY FACTOR; NEUTRALIZING ANTIBODIES; HEPATOMA-CELLS; HUMANIZED MICE; VIRAL ENTRY; EARLY STEPS	Hepatitis C virus (HCV) requires multiple receptors for its attachment to and entry into cells. Our previous studies found that human syndecan-1 (SDC-1), SDC-2, and T cell immunoglobulin and mucin domain-containing protein 1 (TIM-1) are HCV attachment receptors. Other cell surface molecules, such as CD81, Claudin-1 (CLDN1), Occludin (OCLN), SR-BI, and low-density lipoprotein receptor (LDLR), function mainly at postattachment steps and are considered postattachment receptors. The underlying molecular mechanisms of different receptors in HCV cell-free and cell-to-cell transmission remain elusive. In the present study, we used a clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 technology, gene-specific small interfering RNAs, and a newly developed luciferase-based reporter system to quantitatively determine the importance of individual receptors in HCV cell-free and cell-to-cell transmission. Knockouts of SDC-1 and SDC-2 resulted in remarkable reductions of HCV infection and cell attachment, whereas SDC-3 and SDC-4 knockouts did not affect HCV infection. Defective HCV attachment to SDC-1 and/or SDC-2 knockout cells was completely restored by SDC-1 and SDC-2 but not SDC-4 expression. Knockout of the attachment receptors SDC-1, SDC-2, and TIM-1 also modestly decreased HCV cell-to-cell transmission. In contrast, silencing and knockout of the postattachment receptors CD81, CLDN1, OCLN, SR-RI, and LDLR greatly impaired both HCV cell-free and cell-to-cell transmission. Additionally, apolipoprotein E was found to be important for HCV cell-to-cell spread, but very-low-density lipoprotein (VLDL)-containing mouse serum did not affect HCV cell-to-cell transmission, although it inhibited cell-free infection. These findings demonstrate that attachment receptors are essential for initial HCV binding and that postattachment receptors are important for both HCV cell-free and cell-to-cell transmission. IMPORTANCE The importance and underlying molecular mechanisms of cell surface receptors in HCV cell-free and cell-to-cell transmission are poorly understood. The role of some of the HCV attachment and postattachment receptors in HCV infection and cell-to-cell spread remains controversial. Using CRISPR-Cas9-mediated knockouts of specific cellular genes, we demonstrate that both SDC-1 and SDC-2, but not SDC-3 or SDC-4, are bona fide HCV attachment receptors. We also used a newly developed luciferase-based reporter system to quantitatively determine the importance of attachment and postattachment receptors in HCV cell-to-cell transmission. SDC-1, SDC-2, TIM-1, and SR-RI were found to modestly promote HCV cell-to-cell spread. CD81, CLDN1, OCLN, and LDLR play more important roles in HCV cell-to-cell transmission. Likewise, apolipoprotein E (apoE) is critically important for HCV cell-to-cell spread, unlike VLDL-containing mouse serum, which did not affect HCV cell-to-cell spread. These findings suggest that the mechanism(s) of HCV cell-to-cell spread differs from that of cell-free infection.	[Fan, Huahao; Qiao, Luhua; Luo, Guangxiang] Peking Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China; [Wei, Wensheng] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Fan, Huahao; Qiao, Luhua; Kang, Kyung-Don; Fan, Junfen; Luo, Guangxiang] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	Luo, GX (reprint author), Peking Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China.; Luo, GX (reprint author), Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA.	gluo@uab.edu			National Natural Science Foundation of China (NSFC) [81130082]; NIH [AI097318, AI091953]; University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR), an NIH [P30 AI027767]; UAB Comprehensive Cancer Center [P30 CA013148]; China Scholarship Council, China (CSC) [20143026]	This work was supported by the National Natural Science Foundation of China (NSFC) (grant 81130082), NIH grants AI097318 and AI091953, the University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR), an NIH-funded program (grant P30 AI027767), and the UAB Comprehensive Cancer Center (grant P30 CA013148). Huahao Fan and Junfen Fan are sponsored by the China Scholarship Council, China (CSC) (file no. 20143026).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Anjum S, 2013, J INFECT DIS, V208, P1888, DOI 10.1093/infdis/jit376; Barretto N, 2014, J VIROL, V88, P5050, DOI 10.1128/JVI.03241-13; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Basu A, 2004, J VIROL, V78, P4478, DOI 10.1128/JVI.78.9.4478-4486.2004; Basu A, 2007, J VIROL, V81, P3933, DOI 10.1128/JVI.02622-06; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Catanese MT, 2013, J VIROL, V87, P8282, DOI 10.1128/JVI.01102-13; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562                                                         ; Devhare PB, 2017, J VIROL; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fofana I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064221; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gondar V, 2015, J VIROL, V89, P9962, DOI 10.1128/JVI.00577-15; Grigorov B, 2016, CELL MICROBIOL; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Helenius A., 2013, FIELDS VIROLOGY, V1, P87; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067982; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lacek K, 2012, J HEPATOL, V57, P17, DOI 10.1016/j.jhep.2012.02.018; Lefevre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095550; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Liu Z, 2012, J BIOL CHEM, V287, P41922, DOI 10.1074/jbc.M112.414789; Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146; Liu ZQ, 2013, J VIROL, V87, P8545, DOI 10.1128/JVI.01062-13; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mailly L, 2015, NAT BIOTECHNOL, V33, P549, DOI 10.1038/nbt.3179; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Morikawa K, 2007, J MED VIROL, V79, P714, DOI 10.1002/jmv.20842; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Patman Gillian, 2014, Nat Rev Gastroenterol Hepatol, V11, P704, DOI 10.1038/nrgastro.2014.179; Pierce BG, 2016, P NATL ACAD SCI USA, V113, pE6946, DOI 10.1073/pnas.1614942113; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Pringle CR, 1999, ARCH VIROL, V144, P421, DOI 10.1007/s007050050515; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Ren QP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08865; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shi Q, 2013, J VIROL, V87, P6866, DOI 10.1128/JVI.03475-12; Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15; Sourisseau M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003244; Tao J, 2015, J VIROL, V89, P6782, DOI 10.1128/JVI.00194-15; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Wang J, 2017, J VIROL, V91, DOI 10.1128/JVI.01583-16; Wasilewski LN, 2016, J VIROL, V90, P3773, DOI 10.1128/JVI.02837-15; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI [10.1099/vir.0.006700-0, 10.1099/vir.0.2008/006700-0]; Wu XF, 2014, J VIROL, V88, P8433, DOI 10.1128/JVI.00081-14; Xu Y, 2015, J VIROL, V89, P3846, DOI 10.1128/JVI.03647-14; Zahid MN, 2013, HEPATOLOGY, V57, P492, DOI 10.1002/hep.26097; Zhang F, 2017, GASTROENTEROLOGY, V152, P257, DOI 10.1053/j.gastro.2016.09.033; Zhao FF, 2017, J VIROL, V91, DOI 10.1128/JVI.01720-16	79	0	0	11	11	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JUL	2017	91	13							UNSP e00280-17	10.1128/JVI.00280-17				20	Virology	Virology	EX3CC	WOS:000403108600008					2018-01-05	
J	Wang, LJ; Ran, LY; Hou, YS; Tian, QY; Li, CF; Liu, R; Fan, D; Luo, KM				Wang, Lijun; Ran, Lingyu; Hou, Yisu; Tian, Qiaoyan; Li, Chaofeng; Liu, Rui; Fan, Di; Luo, Keming			The transcription factor MYB115 contributes to the regulation of proanthocyanidin biosynthesis and enhances fungal resistance in poplar	NEW PHYTOLOGIST			English	Article						CRISPR/Cas9; fungal pathogen; Populus; proanthocyanidin; R2R3 MYB transcription factor	ASPEN POPULUS-TREMULOIDES; ARABIDOPSIS-THALIANA; FLAVONOID BIOSYNTHESIS; PHENYLPROPANOID BIOSYNTHESIS; ANTHOCYANIN BIOSYNTHESIS; MEDICAGO-TRUNCATULA; ECTOPIC EXPRESSION; MOLECULAR-CLONING; GENE ENCODES; LEUCOANTHOCYANIDIN REDUCTASE	Proanthocyanidins (PAs) are major defense phenolic compounds in the leaves of poplar (Populus spp.) in response to abiotic and biotic stresses. Transcriptional regulation of PA biosynthetic genes by the MYB-basic helix-loop-helix (bHLH)-WD40 complexes in poplar is not still fully understood. Here, an Arabidopsis TT2-like gene MYB115 was isolated from Populus tomentosa and characterized by various molecular, genetic and biochemical approaches. MYB115 restored PA productions in the seed coat of the Arabidopsis tt2 mutant. Overexpression of MYB115 in poplar activated expression of PA biosynthetic genes, resulting in a significant increase in PA concentrations. By contrast, the CRISPR/Cas9-generated myb115 mutant exhibited reduced PA content and decreased expression of PA biosynthetic genes. MYB115 directly activated the promoters of PA-specific structural genes. MYB115 interacted with poplar TT8. Coexpression of MYB115, TT8 and poplar TTG1 significantly enhanced the expression of ANR1 and LAR3. Additionally, transgenic plants overexpressing MYB115 had increased resistance to the fungal pathogen Dothiorella gregaria, whereas myb115 mutant exhibited greater sensitivity compared with wild-type plants. Our data provide insight into the regulatory mechanisms controlling PA biosynthesis by MYB115 in poplar, which could be effectively employed for metabolic engineering of PAs to improve resistance to fungal pathogens.	[Wang, Lijun; Ran, Lingyu; Hou, Yisu; Tian, Qiaoyan; Liu, Rui; Fan, Di; Luo, Keming] Southwest Univ, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ, Inst Resources Bot,Sch Life Sci, Chongqing 400715, Peoples R China; [Li, Chaofeng] Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, Northwest Inst Plateau Biol, Xining 810008, Peoples R China	Luo, KM (reprint author), Southwest Univ, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ, Inst Resources Bot,Sch Life Sci, Chongqing 400715, Peoples R China.	kemingl@swu.edu.cn			National Key Research and Development Program [2016YFD0600105]; National Natural Science Foundation of China [31370672, 31300990]; National Key Project for Research on Transgenic Plant [2016ZX08010-003]; Fundamental Research Funds for the Central Universities [XDJK2014a005, XDJK2013B032]	This work was supported by the National Key Research and Development Program (2016YFD0600105), the National Natural Science Foundation of China (31370672, 31300990), the National Key Project for Research on Transgenic Plant (2016ZX08010-003) and the Fundamental Research Funds for the Central Universities (XDJK2014a005, XDJK2013B032).	Abrahams S, 2003, PLANT J, V35, P624, DOI 10.1046/j.1365-313X.2003.01834.x; Akagi T, 2010, PLANTA, V232, P1045, DOI 10.1007/s00425-010-1241-7; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; Bhargava A, 2010, PLANT PHYSIOL, V154, P1428, DOI 10.1104/pp.110.162735; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059                                                           ; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cos P, 2004, CURR MED CHEM, V11, P1345, DOI 10.2174/0929867043365288                                                        ; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dixon RA, 1996, GENE, V179, P61, DOI 10.1016/S0378-1119(96)00327-7; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fan JY, 2008, BIOCHEM BIOPH RES CO, V367, P47, DOI 10.1016/j.bbrc.2007.12.101; FEUCHT W, 1990, ANN BOT-LONDON, V65, P225, DOI 10.1093/oxfordjournals.aob.a087928                                              ; Forkner RE, 2004, ECOL ENTOMOL, V29, P174, DOI 10.1111/j.1365-2311.2004.0590.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Hancock KR, 2012, PLANT PHYSIOL, V159, P1204, DOI 10.1104/pp.112.195420; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hemming JDC, 1999, J CHEM ECOL, V25, P1687, DOI 10.1023/A:1020805420160; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Hu L, 2005, TREE PHYSIOL, V25, P1273, DOI 10.1093/treephys/25.10.1273                                                     ; Huang WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070778; Huang Y, 2012, TREE PHYSIOL, V32, P1313, DOI 10.1093/treephys/tps079; Huang YF, 2014, NEW PHYTOL, V201, P795, DOI 10.1111/nph.12557; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jia ZC, 2010, TREE PHYSIOL, V30, P1599, DOI 10.1093/treephys/tpq093; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Koyama K, 2014, J EXP BOT, V65, P4433, DOI 10.1093/jxb/eru213; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li YG, 1996, J SCI FOOD AGR, V70, P89, DOI 10.1002/(SICI)1097-0010(199601)70:1<89::AID-JSFA470>3.0.CO;2-N; Liu CG, 2014, PLANT PHYSIOL, V165, P1424, DOI 10.1104/pp.114.241877; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd G, 1981, INT PLANT PROP SOC P, V30, P421; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; McMahon LR, 2000, CAN J PLANT SCI, V80, P469, DOI 10.4141/P99-050                                                                 ; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Middleton E, 2000, PHARMACOL REV, V52, P673; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Pang YZ, 2009, PLANT PHYSIOL, V151, P1114, DOI 10.1104/pp.109.144022; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3                                                   ; Quattrocchio F, 1999, PLANT CELL, V11, P1433; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Salminen JP, 2004, J CHEM ECOL, V30, P1693, DOI 10.1023/B:JOEC.0000042396.40756.b7; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Schaart JG, 2013, NEW PHYTOL, V197, P454, DOI 10.1111/nph.12017; Schimel JP, 1996, CAN J BOT, V74, P84, DOI 10.1139/b96-012                                                                 ; Sharma SB, 2005, PLANT J, V44, P62, DOI 10.1111/j.1365-313X.2005.02510.x; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Shim JS, 2013, PLANT J, V73, P483, DOI 10.1111/tpj.12051; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x                                             ; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stevens MT, 2005, OECOLOGIA, V145, P298, DOI 10.1007/s00442-005-0128-y; Tamagnone L, 1998, PLANT CELL, V10, P135; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064664; Wei YL, 2007, MOL BIOL REP, V34, P105, DOI 10.1007/s11033-006-9024-8; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257                                                         ; Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.026553.x; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Yang W, 1999, J BEIJING FORESTRY U, V21, P13; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Yoshida K, 2008, PLANT CELL PHYSIOL, V49, P157, DOI 10.1093/pcp/pcn009; Yoshida K, 2015, PLANT PHYSIOL, V167, P693, DOI 10.1104/pp.114.253674; Yuan L, 2012, J EXP BOT, V63, P2513, DOI 10.1093/jxb/err425; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	98	1	1	38	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	JUL	2017	215	1					351	367		10.1111/nph.14569				17	Plant Sciences	Plant Sciences	EW3PQ	WOS:000402413100030	28444797				2018-01-05	
J	Mezzanotte, L; van 't Root, M; Karatas, H; Goun, EA; Lowik, CWGM				Mezzanotte, Laura; van 't Root, Moniek; Karatas, Hacer; Goun, Elena A.; Lowik, Clemens W. G. M.			In Vivo Molecular Bioluminescence Imaging: New Tools and Applications	TRENDS IN BIOTECHNOLOGY			English	Review							EXTRACELLULAR VESICLES; LUCIFERASE BIOLUMINESCENCE; HYDROGEN-PEROXIDE; FIREFLY LUCIFERIN; GENE-EXPRESSION; LIVING SUBJECTS; REPORTER MICE; CANCER-CELLS; SINGLE-CELL; MOUSE MODEL	in vivo bioluminescence imaging (BLi) is an optical molecular imaging technique used to visualize molecular and cellular processes in health and diseases and to follow the fate of cells with high sensitivity using luciferase-based gene reporters. The high sensitivity of this technique arises from efficient photon production, followed by the reaction between luciferase enzymes and luciferin substrates. Novel discoveries and developments of luciferase reporters, substrates, and gene-editing techniques, and emerging fields of applications, promise a new era of deeper and more sensitive molecular imaging.	[Mezzanotte, Laura; van 't Root, Moniek; Lowik, Clemens W. G. M.] Erasmus MC, Opt Mol Imaging, Dept Radiol, Rotterdam, Netherlands; [Karatas, Hacer; Goun, Elena A.] Swiss Fed Inst Technol Lausanne EPFL, Inst Chem Sci & Engn ISIC, Lab Bioorgan Chem & Mol Imaging, CH-1015 Lausanne, Switzerland	Mezzanotte, L (reprint author), Erasmus MC, Opt Mol Imaging, Dept Radiol, Rotterdam, Netherlands.	l.mezzanotte@erasmusmc.nl		Mezzanotte, Laura/0000-0001-5592-8904	European H2020 MSCA grant [675743]	The authors acknowledge receipt of an European H2020 MSCA grant under proposal number 675743 (project acronym: ISPIC), which is currently supporting the work of LM, CL and EG as Principal Investigators of the ISPIC project.	Alam R, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/49/495606; Alam R, 2013, NANOSCALE, V5, P5303, DOI 10.1039/c3nr01842c; Ando Y, 2016, BIOMED OPT EXPRESS, V7, P963, DOI 10.1364/BOE.7.000963; Bakayan A, 2015, PFLUG ARCH EUR J PHY, V467, P2031, DOI 10.1007/s00424-014-1639-3; BALDWIN TO, 1984, BIOCHEMISTRY-US, V23, P3663, DOI 10.1021/bi00311a014; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Branchini BR, 2015, ANAL BIOCHEM, V484, P148, DOI 10.1016/j.ab.2015.05.020; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441                                                     ; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chan K, 2013, ANTIVIR RES, V98, P85, DOI 10.1016/j.antiviral.2013.01.005; Chang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108341; Chaudhari AJ, 2005, PHYS MED BIOL, V50, P5421, DOI 10.1088/0031-9155/50/23/001; Chen CH, 2013, DEVELOPMENT, V140, P4988, DOI 10.1242/dev.102053; Cho JS, 2011, J INVEST DERMATOL, V131, P907, DOI 10.1038/jid.2010.417; Chu J, 2016, NAT BIOTECHNOL, V34, P760, DOI 10.1038/nbt.3550; Coleman SM, 2015, FUTURE VIROL, V10, P169, DOI 10.2217/FVL.14.96; Conley NR, 2012, ANGEW CHEM INT EDIT, V51, P3350, DOI 10.1002/anie.201105653; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x                                              ; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; Daniel C, 2015, APPL ENVIRON MICROB, V81, P5344, DOI 10.1128/AEM.01042-15; Darne C, 2014, PHYS MED BIOL, V59, pR1, DOI 10.1088/0031-9155/59/1/R1; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Dragulescu-Andrasi A, 2011, P NATL ACAD SCI USA, V108, P12060, DOI 10.1073/pnas.1100923108; Dragulescu-Andrasi A, 2009, BIOCONJUGATE CHEM, V20, P1660, DOI 10.1021/bc9002508; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Evans MS, 2014, NAT METHODS, V11, P393, DOI [10.1038/NMETH.2839, 10.1038/nmeth.2839]; Galmozzi A, 2014, CELL REPORT, V9, P1; Gealageas R, 2014, ANAL BIOANAL CHEM, V406, P2695, DOI 10.1007/s00216-014-7656-4; Godinat A, 2013, ACS CHEM BIOL, V8, P987, DOI 10.1021/cb3007314; Gorman MW, 2007, CLIN CHEM, V53, P318, DOI 10.1373/clinchem.2006.076364; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Henkin AH, 2012, ACS CHEM BIOL, V7, P1884, DOI 10.1021/cb300194b; Hickson J, 2010, CELL DEATH DIFFER, V17, P1003, DOI 10.1038/cdd.2009.205; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; Jathoul AP, 2014, ANGEW CHEM INT EDIT, V53, P13059, DOI 10.1002/anie.201405955; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Karlsson EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7378; Kiyama M, 2016, CURR TOP MED CHEM, V16, P2648, DOI 10.2174/1568026616666160413135055; Kuchimaru T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11856; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Lee HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09865; Loening A. M., 2006, PROTEIN ENG DES SEL, V199, P91; Luker KE, 2010, ANTIVIR RES, V86, P93, DOI [10.1016/j.antiviral.2010.02.002, 10.1016/j.antivira1.2010.02.002]; Maguire CA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.25; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Matsuoka Hiroyuki, 2015, Tropical Medicine and Health, V43, P53, DOI 10.2149/tmh.2014-18; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Mezzanotte L, 2014, ANAL BIOANAL CHEM, V406, P5727, DOI 10.1007/s00216-014-7917-2; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Michelini E, 2005, CLIN CHEM, V51, P1995, DOI 10.1373/clinchem.2005.053017; Michelini E, 2008, ANAL CHEM, V80, P260, DOI 10.1021/ac7016579; Mofford DM, 2014, J AM CHEM SOC, V136, P13277, DOI 10.1021/ja505795s; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565                                                              ; Nakajima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010011; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Ozawa T, 2013, ANAL CHEM, V85, P590, DOI 10.1021/ac3031724; Patel MR, 2010, CANCER RES, V70, P10141, DOI 10.1158/0008-5472.CAN-10-1843; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Promega Corporation, 2015, CHROM LUC REP VECT T; Rojas-Fernandez A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09811; Rumyantsev KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep36588; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Schaub FX, 2015, CANCER RES, V75, P5023, DOI 10.1158/0008-5472.CAN-14-3538; Seruggia D, 2014, TRANSGENIC RES, V23, P707, DOI 10.1007/s11248-014-9823-y; Siciliano G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00391; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Takahashi Y, 2013, J BIOTECHNOL, V165, P77, DOI 10.1016/j.jbiotec.2013.03.013; Takai A, 2015, P NATL ACAD SCI USA, V112, P4352, DOI 10.1073/pnas.1418468112; TANAHASHI H, 1990, GENE, V96, P249, DOI 10.1016/0378-1119(90)90260-X; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; THOMPSON EM, 1995, P NATL ACAD SCI USA, V92, P1317, DOI 10.1073/pnas.92.5.1317                                                          ; THOMPSON EM, 1989, P NATL ACAD SCI USA, V86, P6567, DOI 10.1073/pnas.86.17.6567; Tian XD, 2015, ANAL CHEM, V87, P11325, DOI 10.1021/acs.analchem.5b03712; Van de Bittner GC, 2013, J AM CHEM SOC, V135, P1783, DOI 10.1021/ja309078t; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Van Reet N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003054; Vande Velde G, 2014, CELL MICROBIOL, V16, P115, DOI 10.1111/cmi.12184; Viviani VR, 2014, BIOCHEMISTRY-US, V53, P5208, DOI 10.1021/bi500160m; Vorobyeva AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131037; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Woodroofe CC, 2008, BIOCHEMISTRY-US, V47, P10383, DOI 10.1021/bi800505u; Yan XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073580; Yang YM, 2012, ANGEW CHEM INT EDIT, V51, P3125, DOI 10.1002/anie.201107919; Yao H, 2007, ANGEW CHEM INT EDIT, V46, P7031, DOI 10.1002/anie.200701931; Yoshioka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106367; Zagozdzon AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-209; Zhang N, 2009, CLIN CANCER RES, V15, P4915, DOI 10.1158/1078-0432.CCR-08-2256; Zhang WS, 1999, ADV EXP MED BIOL, V471, P775; Zhao H., 2005, J BIOMED OPT, V104, P41210	93	3	3	30	35	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0167-7799	1879-3096		TRENDS BIOTECHNOL	Trends Biotechnol.	JUL	2017	35	7					640	652		10.1016/j.tibtech.2017.03.012				13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EX4ZX	WOS:000403246400009	28501458				2018-01-05	
J	Pankowicz, FP; Jarrett, KE; Lagor, WR; Bissig, KD				Pankowicz, Francis P.; Jarrett, Kelsey E.; Lagor, William R.; Bissig, Karl-Dimiter			CRISPR/Cas9: at the cutting edge of hepatology	GUT			English	Article							HEPATITIS-B-VIRUS; RNA-GUIDED ENDONUCLEASE; TYROSINEMIA TYPE-I; FAMILIAL AMYLOID POLYNEUROPATHY; DIRECTED GENE-THERAPY; STRAND BREAK REPAIR; ONE-STEP GENERATION; HEREDITARY TYROSINEMIA; HUMAN HEPATOCYTES; HUMAN-CELLS	Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 genome engineering has revolutionised biomedical science and we are standing on the cusp of medical transformation. The therapeutic potential of this technology is tremendous, however, its translation to the clinic will be challenging. In this article, we review recent progress using this genome editing technology and explore its potential uses in studying and treating diseases of the liver. We discuss the development of new research tools and animal models as well as potential clinical applications, strategies and challenges.	[Pankowicz, Francis P.; Lagor, William R.; Bissig, Karl-Dimiter] Baylor Coll Med, Ctr Cell & Gene Therapy, Ctr Stem Cells & Regenerat Med, Houston, TX 77030 USA; [Pankowicz, Francis P.; Bissig, Karl-Dimiter] Baylor Coll Med, Dept Mol & Cellular Biol, Grad Program, Houston, TX 77030 USA; [Jarrett, Kelsey E.; Lagor, William R.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Jarrett, Kelsey E.; Lagor, William R.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Lagor, William R.; Bissig, Karl-Dimiter] Baylor Coll Med, Texas Med Ctr, Digest Dis Ctr, Houston, TX 77030 USA; [Bissig, Karl-Dimiter] Baylor Coll Med, Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bissig, Karl-Dimiter] Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Bissig, Karl-Dimiter] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Bissig, Karl-Dimiter] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Bissig, KD (reprint author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	bissig@bcm.edu			National Heart and Lung Institute [HL132840, R01HL134510, T32HL07676, T32HL092332]; Cancer Prevention and Research Institute of Texas [RP150587]	National Heart and Lung Institute (HL132840, R01HL134510, T32HL07676 and T32HL092332) and Cancer Prevention and Research Institute of Texas (RP150587).	Adams D, 2000, BRAIN, V123, P1495, DOI 10.1093/brain/123.7.1495; Arruda VR, 2016, J THROMB HAEMOST, V14, P1121, DOI 10.1111/jth.13331; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barzi M, 2017, NAT COMMUN IN PRESS; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Bissig KD, 2007, P NATL ACAD SCI USA, V104, P20507, DOI 10.1073/pnas.0710528105; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Bissig-Choisat B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8339; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, pR7, DOI 10.1093/hmg/ddr143; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; CRYSTAL RG, 1995, SCIENCE, V270, P404, DOI 10.1126/science.270.5235.404                                                    ; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Demers SI, 2003, HUM PATHOL, V34, P1313, DOI 10.1016/S0046-8177(03)00406-4; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Duell PB, 2016, J CLIN LIPIDOL, V10, P1011, DOI 10.1016/j.jacl.2016.04.013; Endo F, 1997, J BIOL CHEM, V272, P24426, DOI 10.1074/jbc.272.39.24426                                                        ; Fan YB, 2016, GASTROENTEROLOGY, V150, P1208, DOI 10.1053/j.gastro.2016.01.005; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Geutskens SB, 2000, GENE THER, V7, P1410, DOI 10.1038/sj.gt.3301251; Gil-Farina I, 2016, MOL THER, V24, P1100, DOI 10.1038/mt.2016.52; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721                                                           ; Holme E, 1998, J INHERIT METAB DIS, V21, P507, DOI 10.1023/A:1005410820201; Holme E, 2000, Clin Liver Dis, V4, P805, DOI 10.1016/S1089-3261(05)70142-2; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Hornsten R, 2004, TRANSPLANTATION, V78, P112, DOI 10.1097/01.TP.0000133517.20972.27; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Iwagami Y, 2016, HEPATOLOGY, V63, P1213, DOI 10.1002/hep.28411; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jarrett KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44624; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Jin C, 2017, ONCOTARGET, V8, P25977, DOI 10.18632/oncotarget.10774; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kleinstiver BP, 2016, NATURE; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x                                               ; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; KVITTINGEN EA, 1994, J CLIN INVEST, V94, P1657, DOI 10.1172/JCI117509; Lagor WR, 2014, ATHEROSCLEROSIS, V233, P234, DOI 10.1016/j.atherosclerosis.2013.12.043; Lee PC, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.98; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Li SL, 2015, STEM CELLS DEV, V24, P2925, DOI 10.1089/scd.2015.0131; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang WC, 2017, J CELL BIOCHEM, V118, P530, DOI 10.1002/jcb.25722; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Lu J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42922; Luizon MR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006449; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679                                                            ; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Michel M, 2016, P NATL ACAD SCI USA, V113, P3084, DOI 10.1073/pnas.1513212113; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27857; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; OSONO Y, 1995, J CLIN INVEST, V95, P1124, DOI 10.1172/JCI117760                                                               ; Pankowicz FP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12642; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090                                                        ; Pott LL, 2017, ONCOTARGET, V8, P11950, DOI 10.18632/oncotarget.14447; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Qi ZH, 2014, J VIROL, V88, P8045, DOI 10.1128/JVI.01024-14; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706.5715.2003; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Slijepcevic D, 2015, HEPATOLOGY, V62, P207, DOI 10.1002/hep.27694; Song CQ, 2017, GASTROENTEROLOGY, V152, P1161, DOI 10.1053/j.gastro.2016.12.002; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Stephen SL, 2010, J VIROL, V84, P9987, DOI 10.1128/JVI.00751-10; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tian LP, 2016, STEM CELL REV REP, V12, P500, DOI 10.1007/s12015-016-9657-5; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; van Til NP, 2005, MOL THER, V11, P26, DOI 10.1016/j.ymthe.2004.09.012                                                     ; Vartak SV, 2015, FEBS J, V282, P4289, DOI 10.1111/febs.13416; Vercauteren K, 2016, MOL THER, V24, P1042, DOI 10.1038/mt.2016.61; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang DX, 2015, HUM MOL GENET, V24, P1556, DOI 10.1093/hmg/ddu566; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang LL, 2015, MOL THER, V23, P1877, DOI 10.1038/mt.2015.179; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Wang X, 2016, BIOCHEM PHARMACOL, V105, P80, DOI 10.1016/j.bcp.2016.03.001; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; Wold WSM, 2013, CURR GENE THER, V13, P421; Xu XJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00180-1; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203; Ye J, 2017, P NATL ACAD SCI USA, V114, P292, DOI 10.1073/pnas.1618605114; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31460; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zhu PP, 2015, J CLIN INVEST, V125, P3795, DOI 10.1172/JCI81979; Zhu W, 2016, VIRUS RES, V217, P125, DOI 10.1016/j.virusres.2016.04.003; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	179	1	2	17	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	JUL	2017	66	7					1329	1340		10.1136/gutjnl-2016-313565				12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	EW7WZ	WOS:000402730000020	28487442	gold			2018-01-05	
J	Sieriebriennikov, B; Markov, GV; Witte, H; Sommer, RJ				Sieriebriennikov, Bogdan; Markov, Gabriel V.; Witte, Hanh; Sommer, Ralf J.			The Role of DAF-21/Hsp90 in Mouth-Form Plasticity in Pristionchus pacificus	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						plasticity; canalization; robustness; heat-shock proteins; Pristionchus pacificus	PHENOTYPIC PLASTICITY; MORPHOLOGICAL EVOLUTION; CAENORHABDITIS-ELEGANS; FEEDING PLASTICITY; NEMATODE; HSP90; CAPACITOR; COMPLEX; SWITCH; EVOLVABILITY	Phenotypic plasticity is increasingly recognized to facilitate adaptive change in plants and animals, including insects, nematodes, and vertebrates. Plasticity can occur as continuous or discrete (polyphenisms) variation. In social insects, for example, in ants, some species have workers of distinct size classes while in other closely related species variation in size may be continuous. Despite the abundance of examples in nature, how discrete morphs are specified remains currently unknown. In theory, polyphenisms might require robustness, whereby the distribution of morphologies would be limited by the same mechanisms that execute buffering from stochastic perturbations, a function attributed to heat-shock proteins of the Hsp90 family. However, this possibility has never been directly tested because plasticity and robustness are considered to represent opposite evolutionary principles. Here, we used a polyphenism of feeding structures in the nematode Pristionchus pacificus to test the relationship between robustness and plasticity using geometric morphometrics of 20 mouth-form landmarks. We show that reducing heat-shock protein activity, which reduces developmental robustness, increases the range of mouth-form morphologies. Specifically, elevated temperature led to a shift within morphospace, pharmacological inhibition of all Hsp90 genes using radicicol treatment increased shape variability in both mouth-forms, and CRISPR/Cas9-induced Ppa-daf-21/Hsp90 knockout had a combined effect. Thus, Hsp90 canalizes the morphologies of plastic traits resulting in discrete polyphenism of mouth-forms.	[Sieriebriennikov, Bogdan; Markov, Gabriel V.; Witte, Hanh; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany; [Markov, Gabriel V.] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Integrat Biol Marine Models,Stn Biol Roscoff,UMR, Roscoff, France	Sommer, RJ (reprint author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de			Max Planck Society	We thank Dr Vladislav Susoy for advice on experimental design and discussion of the results and Dr Natsumi Kanzaki for morphological expertise. We are also grateful to Dr Michael Werner and Dr James Lightfoot, Tess Renahan, and four anonymous reviewers for critical reading of the article. The work was funded by the Max Planck Society.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8                                                   ; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01834; Birnby DA, 2000, GENETICS, V155, P85; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Dryden I. L., 1998, STAT SHAPE ANAL; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/gentics.104.029173; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kanzaki N, 2012, ZOOL SCI, V29, P403, DOI 10.2108/zsj.29.403; Kieninger MR, 2016, CURR BIOL, V26, P2174, DOI 10.1016/j.cub.2016.06.018; Leaver M, 2016, BIOL OPEN, V5, P1111, DOI 10.1242/bio.018127; [Anonymous], 1998, GUID MUS, V5, P333; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Navarro N, 2003, COMPUT GEOSCI-UK, V29, P655, DOI 10.1016/S0098-3004(03)00043-8; Paaby AB, 2014, NAT REV GENET, V15, P247, DOI 10.1038/nrg3688; Pigliucci M, 2001, NEW PHYTOL, V152, P419, DOI 10.1046/j.0028-646X.2001.00275.x; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; R Development Core Team, 2016, R LANG ENV STAT COMP; Ragsdale EJ, 2013, CELL, V155, P922, DOI 10.1016/j.cell.2013.09.054; Ragsdale EJ, 2010, P ROY SOC B-BIOL SCI, V277, P1299, DOI 10.1098/rspb.2009.2195; Rodelsperger C, 2014, GENETICS, V196, P1153, DOI 10.1534/genetics.113.159855; Rohner N, 2013, SCIENCE, V342, P1372, DOI 10.1126/science.1240276; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Serobyan V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12337; Serobyan V, 2013, EVOL DEV, V15, P161, DOI 10.1111/ede.12030; Siegal ML, 2014, ANNU REV ECOL EVOL S, V45, P495, DOI 10.1146/annurev-ecolsys-120213-091705; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Sommer RJ, 2015, ANNU REV CELL DEV BI, V31, P453, DOI 10.1146/annurev-cellbio-102314-112451; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Sommer RJ., 2015, EVOLUTIONARY DEV BIO, P15; Stiernagle T., 2016, MAINTENANCE C ELEGAN; Susoy V., 2016, FRONT ECOL EVOL, V4, P23, DOI DOI 10.3389/FEV0.2016.00023); Susoy V, 2015, ELIFE, V4, DOI 10.7554/eLife.05463; THOMAS JH, 1993, GENETICS, V134, P1105; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; Wang XY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001110; West-Eberhard MJ., 2003, DEV PLASTICITY EVOLU; Wilecki M, 2015, J EXP BIOL, V218, P1306, DOI 10.1242/jeb.118620; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8	47	1	1	7	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	JUL	2017	34	7					1644	1653		10.1093/molbev/msx106				10	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	EW8FP	WOS:000402754400008	28333289	gold			2018-01-05	
J	Ulaganathan, K; Goud, S; Reddy, M; Kayalvili, U				Ulaganathan, Kandasamy; Goud, Sravanthi; Reddy, Madhavi; Kayalvili, Ulaganathan			Genome engineering for breaking barriers in lignocellulosic bioethanol production	RENEWABLE & SUSTAINABLE ENERGY REVIEWS			English	Review						Bioethanol; Lignocellulose; Genome engineering; CRISPR/Cas; TALEN; ZFN; Meganuclease; YOGE	ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; SITE-DIRECTED MUTAGENESIS; CINNAMYL-ALCOHOL-DEHYDROGENASE; CRISPR-CAS SYSTEMS; RECOMBINANT SACCHAROMYCES-CEREVISIAE; AMINO-ACID SUBSTITUTIONS; DNA-BINDING SPECIFICITY; BIOMASS ENZYMATIC SACCHARIFICATION; MEDIATED HOMOLOGOUS RECOMBINATION	Lignocellulosic biomass, though available in massive volumes, is not used for production of bioethanol due to existence of several barriers which escalate the cost of production. Microorganisms possess different proteins associated with different stages of lignocellulosic bioethanol production. Though a large number of such proteins have been identified, their specificities and expression levels are not suitable for lignocellulosic bioethanol production. Additionally, the host organism used for bioethanol production may not be tolerant to temperature, pH and ethanol stresses. Hence, the host organisms and the proteins used for bioethanol production needs to be engineered to suit the conditions for ethanol production. Engineering the host strain and altering specificities of proteins employed for bioethanol production can be achieved by genetic engineering techniques, where the gene of interest is isolated first, manipulated in vitro and introduced back into the host organism. Recently, a number of precision genome engineering techniques have been developed which facilitate modification of genes / genomic regions directly in the organism of interest without the need for isolating the genes/genomic regions. These techniques include (a). The bacterial immunity based CRISPR/Cas system, (b). Xanthomonas transcription-activator-like effector nuclease based TALEN system, (c). Zinc finger domain based ZFN system, (d). Long region recognizing-nuclease based meganuclease system and (e). Oligonucleotide based YOGE system. Protein engineering studies and whole genome sequencing of bioethanol producing strains have shown that alteration of one or more nucleotides can bring out large changes that facilitate increased, production of cellulosic bioethanol. These precision engineering techniques can supplement genetic engineering to bring out alteration in specificities of enzymes and change the host's tolerance to various stress levels by specific alteration of genomic regions. In this review, various methods of genome engineering available and their possible application for breaking barriers in lignocellulosic bioethanol production are discussed.	[Ulaganathan, Kandasamy; Goud, Sravanthi; Reddy, Madhavi; Kayalvili, Ulaganathan] Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Telangana, India	Ulaganathan, K (reprint author), Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Telangana, India.	kulaganathan123@gmail.com			University Grant's Commission (OU-UGC-UPE); University Grants Commission; Department of Biotechnology	Financial Assistance from University Grant's Commission (OU-UGC-UPE) under the University of Potential for Excellence programme is acknowledged. B. Sravanthi Goud thanks the University Grants Commission for the BSR-RFSMS Senior Research Fellowship. M. Madhavi Reddy is thankful to the Department of Biotechnology for the Junior Research Fellowship.	Abdel-Banat BMA, 2010, APPL MICROBIOL BIOT, V85, P861, DOI 10.1007/s00253-009-2248-5; Abedinifar S, 2009, BIOMASS BIOENERG, V33, P828, DOI 10.1016/j.biombioe.2009.01.003; Akao T, 2011, DNA RES, V18, P423, DOI 10.1093/dnares/dsr029; Akcapinar GB, 2015, PROTEIN ENG DES SEL, V28, P127, DOI 10.1093/protein/gzv012; Alexeeva V, 2016, STEM CELL RES, V17, P93, DOI 10.1016/j.scr.2016.05.010; Ali SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054701; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Anbar M, 2010, CHEMCATCHEM, V2, P997, DOI 10.1002/cctc.201000112; Aouida M, 2015, J BIOSCI BIOENG, V120, P364, DOI 10.1016/j.jbiosc.2015.02.017; Apel AR, 2016, SCI REP-UK, V6, DOI 10.1038/srep19512; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Ayadi DZ, 2015, INT J BIOL MACROMOL, V72, P163, DOI 10.1016/j.ijbiomac.2014.08.014; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Badhan A, 2016, CURR METABOL, V4, P49, DOI 10.2174/2213235X03666141226213656; Baker JO, 2005, APPL BIOCHEM BIOTECH, V121, P129, DOI 10.1385/ABAB:121:1-3:0129; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Barnett JA, 2011, YEAST RES HIST OVERV; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Basak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051179; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Baxter HL, 2014, PLANT BIOTECHNOL J, V12, P914, DOI 10.1111/pbi.12195; Baxter Sarah K, 2013, Methods Mol Biol, V978, P45, DOI 10.1007/978-1-62703-293-3_4; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bengtsson O, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-9; Bengtsson O, 2008, YEAST, V25, P835, DOI 10.1002/yea.1638; Benjaphokee S, 2012, NEW BIOTECHNOL, V29, P166, DOI 10.1016/j.nbt.2011.03.007; Bennetzen JL, 2003, CURR OPIN PLANT BIOL, V6, P128, DOI 10.1016/S1369-5266(03)00015-3; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P1717, DOI 10.1534/g3.113.007260; Beurdeley M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2782; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Binod P, 2011, BIOFUELS: ALTERNATIVE FEEDSTOCKS AND CONVERSION PROCESSES, P229; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Blin K., 2016, SYNTH SYST BIOTECHNO, V1, P118, DOI 10.1016/j.synbio.2016.01.003; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30330; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Bok JD, 1998, APPL ENVIRON MICROB, V64, P4774; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Borde V, 2013, CURR OPIN GENET DEV, V23, P147, DOI 10.1016/j.gde.2012.12.002; Brachman EE, 2003, GENETICS, V163, P527; Bradley P, 2012, PROTEIN SCI, V21, P471, DOI 10.1002/pro.2034; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brown SD, 2011, P NATL ACAD SCI USA, V108, P13752, DOI 10.1073/pnas.1102444108; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Cai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11989; Cakar ZP, 2012, FEMS YEAST RES, V12, P171, DOI 10.1111/j.1567-1364.2011.00775.x; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Carroll D, 2014, METHODS, V69, P137, DOI 10.1016/j.ymeth.2014.03.026; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; CASEY GP, 1986, CRIT REV MICROBIOL, V13, P219, DOI 10.3109/10408418609108739; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Castiglia D, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0569-z; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chames P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni175; Chang HK, 2016, MOL THER, V24, P1644, DOI 10.1038/mt.2016.120; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chapdelaine P, 2010, GENE THER, V17, P846, DOI 10.1038/gt.2010.26; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen K, 2016, J BIOL MET, V3, pa56; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Cheng YS, 2015, APPL MICROBIOL BIOT, V99, P9503, DOI 10.1007/s00253-015-6712-0; Cheng YS, 2012, APPL MICROBIOL BIOT, V95, P661, DOI 10.1007/s00253-011-3791-4; Chevalier B, 2003, J MOL BIOL, V329, P253, DOI 10.1016/S0022-2836(03)00447-9; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chin YW, 2016, J IND MICROBIOL BIOT, V43, P1517, DOI 10.1007/s10295-016-1831-x; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SY, 2008, BIOCHEM BIOPH RES CO, V369, P845, DOI 10.1016/j.bbrc.2008.02.106; Chokhawala HA, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0118-z; Chong HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057628; Chundawat SPS, 2007, BIOTECHNOL BIOENG, V96, P219, DOI 10.1002/bit.21132; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Couturier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079800; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-152; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; D'Halluin K, 2013, PLANT BIOTECHNOL J, V11, P933, DOI 10.1111/pbi.12085; d'Yvoire MB, 2013, PLANT J, V73, P496, DOI 10.1111/tpj.12053; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626                                                          ; David F, 2014, FEMS YEAST RES, P1; David K, 2010, ENERG ENVIRON SCI, V3, P1182, DOI 10.1039/b926617h; de Leon VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088146; Rocha GJD, 2011, BIOMASS BIOENERG, V35, P663, DOI 10.1016/j.biombioe.2010.10.018; Del Pozo MV, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-73; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; DESJARLAIS JR, 1993, P NATL ACAD SCI USA, V90, P2256, DOI 10.1073/pnas.90.6.2256; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diaz M, 2004, FEMS MICROBIOL LETT, V240, P237, DOI 10.1016/j.femsle.2004.09.032; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; DiCarlo JE, 2015, NAT BIOTECHNOL; Djukanovic V, 2013, PLANT J, V76, P888, DOI 10.1111/tpj.12335; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja0575191; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Dumon C, 2012, PROCESS BIOCHEM, V47, P346, DOI 10.1016/j.procbio.2011.06.017; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551                                                           ; EauClaire SF, 2016, J IND MICROBIOL BIOT, V43, P1001, DOI 10.1007/s10295-016-1776-0; Edgell DR, 2004, J MOL BIOL, V343, P1231, DOI 10.1016/j.jmb.2004.09.005; Ehrensberger AH, 2006, STRUCTURE, V14, P567, DOI 10.1016/j.str.2005.11.016; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Eriksen DT, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-61; Eriksson T, 2002, ENZYME MICROB TECH, V31, P353, DOI 10.1016/S0141-0229(02)00134-5; Escamilla-Trevino LL, 2012, BIOENERG RES, V5, P1, DOI 10.1007/s12155-011-9159-x; Escovar-Kousen JM, 2004, APPL BIOCHEM BIOTECH, V113, P287, DOI 10.1385/ABAB:113:1-3:287; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Fornale S, 2012, MOL PLANT, V5, P817, DOI 10.1093/mp/ssr097; Franden MA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-99; Friedberg EC, 2006, DNA REPAIR MUTAGENES; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Fujita K, 2006, FEMS YEAST RES, V6, P744, DOI 10.1111/j.1567-1364.2006.00040.x; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Gallego-Giraldo L, 2014, PLANT PHYSIOL, V164, P1139, DOI 10.1104/pp.113.232421; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gardonyi M, 2003, BIOTECHNOL BIOENG, V82, P818, DOI 10.1002/bit.10631; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gimble FS, 2003, J MOL BIOL, V334, P993, DOI 10.1016/j.jmb.2003.01.013; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gomes I, 2000, APPL MICROBIOL BIOT, V53, P461, DOI 10.1007/s002530051642; Gonzalez-Ramos D, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0583-1; GoodrichBlair H, 1996, CELL, V84, P211, DOI 10.1016/S0092-8674(00)80976-9; Gorthy S, 2013, MOL BREEDING, V31, P795, DOI 10.1007/s11032-012-9834-4; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Sravanthi Goud B, 2015, GENOME ANNOUNC, V3; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Gray KA, 2006, CURR OPIN CHEM BIOL, V10, P141, DOI 10.1016/j.cbpa.2006.02.035; Greenwald DL, 2010, INVEST OPHTH VIS SCI, V51, P6374, DOI 10.1167/iovs.10-5781; Greve Bo, 2004, Archaea, V1, P231, DOI 10.1155/2004/151926; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Guerriero G, 2015, PLANT SCI, V234, P180, DOI 10.1016/j.plantsci.2015.02.010; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guillaumie S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-71; Guo BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147301; Gupta P, 2012, INT J MICROBIOL, V2012, DOI DOI 10.1155/2012/578925; Ha SJ, 2013, APPL ENVIRON MICROB, V79, P1500, DOI 10.1128/AEM.03253-12; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hansen K, 2012, JOVE-J VIS EXP, V2012, pe3304, DOI DOI 10.3791/3304; Haq F, 2016, INT J GREEN ENERGY; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Hatefi Y, 1985, ENZYMES BIOL MEMBR, V4, P1; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hayashi T, 2012, APPL ENVIRON MICROB, V78, P5622, DOI 10.1128/AEM.00733-12; Hayashi T, 2011, J BIOSCI BIOENG, V111, P414, DOI 10.1016/j.jbiosc.2010.12.009; He MX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-75; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heigwer F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt789; Heinzelman P, 2009, J BIOL CHEM, V284, P26229, DOI 10.1074/jbc.C109.034058; Hemmati N, 2012, ATLAS J BIOL, V100; her CR, 2008, METAB ENG, V10, P295; Hilioti Z, 2016, PLANT CELL REP, V35, P2241, DOI 10.1007/s00299-016-2031-x; Hilton IB, 2015, GENOME RES, V25, P1442, DOI 10.1101/gr.190124.115; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hokanson CA, 2011, PROTEIN ENG DES SEL, V24, P597, DOI 10.1093/protein/gzr028; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang JW, 2012, APPL MICROBIOL BIOT, V94, P111, DOI 10.1007/s00253-011-3586-7; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; Huang J, 2014, J IMMUNOL, V193, P1496, DOI [10.4049/jimmuno1.1400915, 10.4049/jimmunol.1400915]; Huang Y, 2015, BIORESOURCE TECHNOL, V181, P224, DOI 10.1016/j.biortech.2015.01.020; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas2135381100; Igarashi K, 2013, NAT CHEM BIOL, V9, P350, DOI 10.1038/nchembio.1237; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Ito Y, 2013, PROTEIN ENG DES SEL, V26, P73, DOI 10.1093/protein/gzs072; Jackson LA, 2008, BIOENERG RES, V1, P180, DOI 10.1007/s12155-008-9020-z; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Jayakanthan M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-421; Jeffries TW, 2004, APPL MICROBIOL BIOT, V63, P495, DOI 10.1007/s00253-003-1450-0; Jeppsson M, 2006, BIOTECH BIOENG, V93; Jia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108449; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang X, 2016, BIOTECHNOL BIOTECHNO; Jin WX, 2016, APPL ENERG, V175, P82, DOI 10.1016/j.apenergy.2016.04.104; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; Juillerat A, 2014, NUCLEIC ACIDS RES, V42, P5390, DOI 10.1093/nar/gku155; Jung JH, 2013, PLANT BIOTECHNOL J, V11, P709, DOI 10.1111/pbi.12061; Jung JH, 2012, PLANT BIOTECHNOL J, V10, P1067, DOI 10.1111/j.1467-7652.2012.00734.x; Jurica NS, 1998, MOL CELL, V2, P469; Kalnenieks U, 2008, MICROBIOL-SGM, V154, P989, DOI 10.1099/mic.0.2007/012682-0; Kaper T, 2000, BIOCHEMISTRY-US, V39, P4963, DOI 10.1021/bi992463r; Karimi K, 2006, PROCESS BIOCHEM, V41, P653, DOI 10.1016/j.procbio.2005.08.014; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kaur K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30870; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; Ke Q, 2016, CELL RES, V26, P1048, DOI 10.1038/cr.2016.93; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim HS, 2012, APPL MICROBIOL BIOT, V95, P531, DOI 10.1007/s00253-012-4022-3; Kim HS, 2011, APPL MICROBIOL BIOT, V91, P1159, DOI 10.1007/s00253-011-3298-z; Kim JS, 2010, NAT METHODS, V7, P91, DOI 10.1038/nmeth0210-91a; Kim M, 2011, J IND MICROBIOL BIOT, V38, P803, DOI 10.1007/s10295-010-0812-8; Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; KIM YG, 1994, J BIOL CHEM, V269, P31978; Kime C, 2016, CURR PROTOC HUM GENE, V88; Klein-Marcuschamer D, 2008, P NATL ACAD SCI USA, V105, P2319, DOI 10.1073/pnas.0712177105; Kleinstiver BP, 2012, P NATL ACAD SCI USA, V109, P8061, DOI 10.1073/pnas.1117984109; Klose H, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0443-3; Koike M, 1998, BIOCHEM BIOPH RES CO, V252, P679, DOI 10.1006/bbrc.1998.9368; Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058; Kosaric N, 2001, BIOTECHNOLOGY ETHANO; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Kumar L, 2012, BIORESOURCE TECHNOL, V103, P201, DOI 10.1016/j.biortech.2011.09.091; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Laluce C, 2012, APPL BIOCHEM BIOTECH, V166, P1908, DOI 10.1007/s12010-012-9619-6; Lamb BM, 2013, NUCLEIC ACIDS RES, V41, P9779, DOI 10.1093/nar/gkt754; Laughery MF, 2015, YEAST, V32, P711, DOI 10.1002/yea.3098; Laughery MF, 2015, YEAST; Lee CY, 2010, J BIOSCI BIOENG, V109, P331, DOI 10.1016/j.jbiosc.2009.10.014; Lee D., 2007, COMPOSITION HERBACEO; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lee SM, 2012, APPL ENVIRON MICROB, V78, P5708, DOI 10.1128/AEM.01419-12; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Lewis JA, 2010, GENETICS, V186, P1197, DOI 10.1534/genetics.110.121871; Li FC, 2015, PLANT BIOTECHNOL J, V13, P514, DOI 10.1111/pbi.12276; Li G, 2014, J GENET GENOMICS, V41, P215, DOI 10.1016/j.jgg.2014.02.003; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; LI L, 1992, P NATL ACAD SCI USA, V89, P4275, DOI 10.1073/pnas.89.10.4275; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Li M, 2014, BIORESOURCE TECHNOL, V167, P14, DOI 10.1016/j.biortech.2014.04.086; Li SJ, 2010, MOL BIOSYST, V6, P2129, DOI 10.1039/c0mb00063a; Li T, 2016, J GENET GENOMICS, V43, P297, DOI 10.1016/j.jgg.2016.03.005; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li XY, 2015, GENET MOL RES, V14, P17519, DOI 10.4238/2015.December.21.24; Lian JZ, 2014, BIOTECHNOL BIOENG, V111, P1521, DOI 10.1002/bit.25214; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Liber MR, 2010, CELL, V142; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002; Liming Xia, 2004, Bioresource Technology, V91, P259, DOI 10.1016/S0960-8524(03)00195-0; Lin YN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1363; Lin YP, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0126-6; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindquist S, 1996, P NATL ACAD SCI USA, V93, P5301, DOI 10.1073/pnas.93.11.5301; Lindsey K, 2013, BIOMASS BIOENERG, V56, P29, DOI 10.1016/j.biombioe.2013.04.023; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Liu J, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.6; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Liu W, 2010, APPL ENVIRON MICROB, P4914; Liu WJ, 2009, BIOTECHNOL BIOENG, V103, P1087, DOI 10.1002/bit.22340; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Longo A, 2005, NAT STRUCT MOL BIOL, V12, P779, DOI 10.1038/nsmb976; Ma J, 2016, BIOINFORMATICS, V32, P3336, DOI 10.1093/bioinformatics/btw476; Ma MG, 2010, APPL MICROBIOL BIOT, V87, P829, DOI 10.1007/s00253-010-2594-3; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Magid J, 2004, PLANT SOIL, V258, P351, DOI 10.1023/B:PLSO.0000016565.14718.4b; Mahadevan SA, 2008, FEMS MICROBIOL LETT, V287, P205, DOI 10.1111/j.1574-6968.2008.01324.x; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marriott PE, 2014, P NATL ACAD SCI USA, V111, P14601, DOI 10.1073/pnas.1414020111; Martin-Ortigosa S, 2014, PLANT PHYSIOL, V164, P537, DOI 10.1104/pp.113.233650; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Mattanovich D, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-34; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Meineke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103580; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; METZGER MH, 1995, EUR J BIOCHEM, V228, P50, DOI 10.1111/j.1432-1033.1995.tb20227.x; MILLER J, 1985, EMBO J, V4, P1609; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miller OJ, 2006, NAT METHODS, V3, P561, DOI 10.1038/NMETH897; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; MOERSCHELL RP, 1988, P NATL ACAD SCI USA, V85, P524, DOI 10.1073/pnas.85.2.524; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Bhuvan Molparia, 2010, Genomics, Proteomics & Bioinformatics, V8, P122, DOI 10.1016/S1672-0229(10)60013-7; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Monte J. R., 2010, American Journal of Agricultural and Biological Sciences, V5, P468, DOI 10.3844/ajabssp.2010.468.476; Mooney CA, 1998, BIORESOURCE TECHNOL, V64, P113, DOI 10.1016/S0960-8524(97)00181-8; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murashima K, 2002, MOL MICROBIOL, V45, P617, DOI 10.1046/j.1365-2958.2002.03049.x                                                ; Murray PG, 2001, ENZYME MICROB TECH, V29, P90, DOI 10.1016/S0141-0229(01)00354-4; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakagame S, 2011, ACS SYM SER, P145; Nakamura A, 2013, J BIOL CHEM, V288, P13503, DOI 10.1074/jbc.M113.452623; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nasution O, 2015, ENVIRON MICROBIOL, V17, P2721, DOI 10.1111/1462-2920.12649; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Neff KL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-1; NEUHAUS D, 1992, J MOL BIOL, V228, P637, DOI 10.1016/0022-2836(92)90846-C; Nijkamp JF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-36; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Nuruddin M, 2011, CELL CHEM TECHNOL, V45, P347; Ochiai H, 2014, P NATL ACAD SCI USA, V111, P1461, DOI 10.1073/pnas.1317008111; Ogawa Y, 2000, J BIOSCI BIOENG, V90, P313, DOI 10.1016/S1389-1723(00)80087-0; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Osakabe K, 2010, P NATL ACAD SCI USA, V107, P12034, DOI 10.1073/pnas.1000234107; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000                                                    ; Ozawa T, 2001, PROTEIN ENG, V14, P501, DOI 10.1093/protein/14.7.501                                                        ; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; PAN T, 1990, Proceedings of the National Academy of Sciences of the United States of America, V87, P2077, DOI 10.1073/pnas.87.6.2077; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Parikh BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116484; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Park SH, 2016, PLANT BIOTECHNOL J, V14, P1329, DOI 10.1111/pbi.12505; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093560; Parry NJ, 2002, ARCH BIOCHEM BIOPHYS, V404, P243, DOI 10.1016/S0003-9861(02)00301-6; Pastwa E, 2003, ACTA BIOCHIM POL, V50, P891; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pei YJ, 2016, BIORESOURCE TECHNOL, V203, P325, DOI 10.1016/j.biortech.2015.12.072; Peng Y, 2014, DEVELOPMENT, V141, P4042, DOI 10.1242/dev.102186; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Perez-Quintero AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068464; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Petschacher B, 2005, APPL ENVIRON MICROB, V71, P6390, DOI 10.1128/AEM.71.10.6390-6393.2005; Petschacher B, 2005, BIOCHEM J, V385, P75, DOI 10.1042/BJ20040363; Pingoud A, 2007, NAT BIOTECHNOL, V25, P743, DOI 10.1038/nbt0707-743; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138634; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qian CL, 2015, ENZYME MICROB TECH, V70, P35, DOI 10.1016/j.enzmictec.2014.11.005; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rastogi A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1143-1; Rastogi S, 2006, BIOTECHNOL PROGR, V22, P609, DOI 10.1021/bp050206+; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2                                                   ; Ren XJ, 2014, G3-GENES GENOM GENET, V4, P1955, DOI 10.1534/g3.114.013821; Reyon D, 2012, CURRENT PROTOCOLS MO, P1; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rignall TR, 2002, APPL BIOCHEM BIOTECH, V98, P383, DOI 10.1385/ABAB:98-100:1-9:383; Rodriguez GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042905; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Ronald P, 2002, SCIENCE, V296, P58, DOI 10.1126/science.1071337; Ronda C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0288-3; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Roth N, 2012, PLANT J, V72, P781, DOI 10.1111/j.1365-313X.2012.05119.x; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Ruller R, 2008, PROTEINS, V70, P1280, DOI 10.1002/prot.21617; Runquist D, 2010, APPL ENVIRON MICROB, V76, P7796, DOI 10.1128/AEM.01505-10; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Ryan OW, 2014, METHOD ENZYMOL, V546, P473, DOI 10.1016/B978-0-12-801185-0.00023-4; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Sadie CJ, 2011, APPL MICROBIOL BIOT, V90, P1373, DOI 10.1007/s00253-011-3164-z; Saha BC, 2012, BIOENGINEERED, V3, P197, DOI 10.4161/bioe.19874; Sahara T, 2014, GENOME ANNOUNC, V16, P2; Sakai S, 2007, APPL ENVIRON MICROB, V73, P2349, DOI 10.1128/AEM.02880-06; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sandgren M, 2003, PROTEIN SCI, V12, P848, DOI 10.1110/ps.0237703; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sattler SE, 2012, BIOENERG RES, V5, P855, DOI 10.1007/s12155-012-9197-z; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Scharf ME, 2010, INSECT SCI, V17, P166, DOI 10.1111/j.1744-7917.2009.01309.x; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Schmidt D, 2004, MOL BIOL EVOL, V21, P2326, DOI 10.1093/molbev/msh246; Scully ED, 2016, J INTEGR PLANT BIOL, V58, P136, DOI 10.1111/jipb.12375; Segal DJ, 2003, BIOCHEMISTRY-US, V42, P2137, DOI 10.1021/bi026806o; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; She QX, 1998, EXTREMOPHILES, V2, P417, DOI 10.1007/s007920050087                                                           ; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Shi SB, 2016, METAB ENG, V33, P19, DOI 10.1016/j.ymben.2015.10.011; SHI YG, 1995, CHEM BIOL, V2, P83, DOI 10.1016/1074-5521(95)90280-5                                                    ; Shima J, 2003, APPL ENVIRON MICROB, V69, P715, DOI 10.1128/AEM.69.1.715-718.2003; Shulda V.K., 2009, NATURE, V459, P437; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Skotnicki M L, 1983, Biochem Soc Symp, V48, P53; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Smith RA, 2013, PLANT CELL, V25, P3988, DOI 10.1105/tpc.113.117176; Sonderegger M, 2003, APPL ENVIRON MICROB, V69, P1990, DOI 10.1128/AEM.69.4.1990-1998.2003; Song J, 2011, J PLANT RES, V124, P183, DOI 10.1007/s10265-010-0350-5; Song LT, 2015, BIOTECHNOL BIOENG, V112, P1081, DOI 10.1002/bit.25533; Song LT, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-3; Sriprang R, 2006, J BIOTECHNOL, V126, P454, DOI 10.1016/j.jbiotec.2006.04.031; Stephens DE, 2007, THESIS; Steuer S, 2004, CHEMBIOCHEM, V5, P206, DOI 10.1002/cbic.200300718; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Stoddard BL, 2007, PROGR GENE THER, V3, P135; Stovicek Vratislav, 2015, Metabolic Engineering Communications, V2, P13, DOI 10.1016/j.meteno.2015.03.001; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450; SUGISAKI H, 1981, GENE, V16, P73; Sun N, 2014, MOL BIOSYST, V10, P446, DOI 10.1039/c3mb70412b; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Svetlitchnyi VA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-31; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Takasu Y, 2016, INSECT BIOCHEM MOLEC, V78, P29, DOI 10.1016/j.ibmb.2016.08.006; Takeuchi R, 2014, P NATL ACAD SCI USA, V111, P4061, DOI 10.1073/pnas.1321030111; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Tan FR, 2015, APPL MICROBIOL BIOT, V99, P5363, DOI 10.1007/s00253-015-6577-2; Taylor GK, 2012, NUCLEIC ACIDS RES, V40, pW110, DOI 10.1093/nar/gks365; Garcia-Cubero MT, 2009, BIORESOURCE TECHNOL, V100, P1608, DOI 10.1016/j.biortech.2008.09.012; Tsai CS, 2015, BIOTECHNOL BIOENG, V112, P2406, DOI 10.1002/bit.25632; Tutt M., 2011, AGRONOMY RES BIOSYST, V1, P261; Ulaganathan K, 2015, GENOME ANNOUNC, V3, DOI DOI 10.1128/GENOMEA.01557-14; Ulaganathan K, 2015, CURR PROTEIN PEPT SC, V16, P100, DOI 10.2174/138920371602150215165718                                                ; Upadhyay SK, 2014, BIOMED RES INT, DOI 10.1155/2014/742482; U'Ren JM, 2015, GENOME ANNOUNC, V3; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Van Acker R, 2014, P NATL ACAD SCI USA, V111, P845, DOI 10.1073/pnas.1321673111; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Varnai A, 2010, ENZYME MICROB TECH, V46, P185, DOI 10.1016/j.enzmictec.2009.12.013; Vieira MC, 2002, CELLULOSE, V9, P203, DOI 10.1023/A:1020158128506; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Vilela LD, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0102-y; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Voutilainen SP, 2007, ENZYME MICROB TECH, V41, P234, DOI 10.1016/j.enzmictec.2007.01.015; Voutilainen SP, 2009, APPL MICROBIOL BIOT, V83, P261, DOI 10.1007/s00253-008-1848-9; Voytas DF, 2009, SCIENCE, V326, P1491, DOI 10.1126/science.1183604; Vuong TV, 2009, APPL ENVIRON MICROB, P6655; Wahlbom CF, 2003, FEMS YEAST RES, V3, P319, DOI 10.1016/S1567-1356(03)00206-4; WAKE CT, 1985, MOL CELL BIOL, V5, P2080, DOI 10.1128/MCB.5.8.2080                                                            ; Waldman AS, 2008, BIOESSAYS, V30, P1163, DOI 10.1002/bies.20845; Wang K, 2014, APPL ENVIRON MICROB, V80, P2158, DOI 10.1128/AEM.03458-13; Wang Z, 2012, ANGEW CHEM INT EDIT, V51, P8505, DOI 10.1002/anie.201203597; Wang FY, 2016, TRENDS CELL BIOL, V26, P875, DOI 10.1016/j.tcb.2016.08.004; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JS, 1998, J BIOL CHEM, V273, P31068, DOI 10.1074/jbc.273.47.31068                                                        ; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang T, 2005, BIOMOL ENG, V22, P89, DOI 10.1016/j.bioeng.2004.10.003                                                    ; WARD JF, 1985, RADIAT RES, V104, pS103, DOI 10.2307/3576637; Watanabe K, 2016, J EXP BOT, V67, P1433, DOI 10.1093/jxb/erv537; Watanabe S, 2005, J BIOL CHEM, V280, P10340, DOI 10.1074/jbc.M409443200; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P1365, DOI [10.1271/bbb.70104, 10.1271/bbb.701041]; WAUGH DS, 1993, P NATL ACAD SCI USA, V90, P9596, DOI 10.1073/pnas.90.20.9596; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wei N, 2013, APPL ENVIRON MICROB, V79, P3193, DOI 10.1128/AEM.00490-13; Wei XY, 2016, BIORESOURCES, V11, P2124; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Weyda I, 2014, J IND MICROBIOL BIOT, V41, P733, DOI 10.1007/s10295-014-1415-6; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wilson KA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.13; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183                                                ; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Wu I, 2013, BIOTECH BIOENG, V110; Wu ZL, 2014, BIOMASS BIOENERG, V70, P347, DOI 10.1016/j.biombioe.2014.08.025; Wyman C., 1996, HDB BIOETHANOL PRODU; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xiao A, 2013, NUCLEIC ACIDS RES, V41, pD415, DOI 10.1093/nar/gks1144; Xiao H, 2011, APPL ENVIRON MICROB, V77, P7886, DOI 10.1128/AEM.00644-11; Xiao Y, 2016, BIOENERG RES, P1; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing MN, 2012, BIOTECHNOL ADV, V30, P920, DOI 10.1016/j.biotechadv.2012.01.021; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Yang MZ, 2009, PLANT MOL BIOL, V70, P669, DOI 10.1007/s11103-009-9499-5; Yazawa H, 2007, YEAST, V24, P551, DOI 10.1002/yea.1492; Yin P, 2012, CELL REP, V2, P707, DOI 10.1016/j.celrep.2012.09.001; Yomano LP, 1998, J IND MICROBIOL BIOT, V20, P132, DOI 10.1038/sj.jim.2900496; Yoshida K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00383; Youn B, 2006, ORG BIOMOL CHEM, V4, P1687, DOI 10.1039/b601672c; Young EM, 2014, P NATL ACAD SCI USA, V111, P131, DOI 10.1073/pnas.1311970111; Yu S, 1995, APPL MICROBIOL BIOT, V44, P314, DOI 10.1007/s002530050560; Yu ZS, 2014, BIOL OPEN, V3, P271, DOI 10.1242/bio.20147682; Zeng Q, 2008, CHIN J BIOTECHNOL, V24, P1108; Zeng QK, 2009, BIOTECHNOL LETT, V31, P1025, DOI 10.1007/s10529-009-9980-x; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang GQ, 2015, ACS SYNTH BIOL, V4, P1101, DOI 10.1021/acssynbio.5b00074; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang HM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-3; Zhang J, 2015, PLANT SCI, V239, P84, DOI 10.1016/j.plantsci.2015.07.014; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047232; Zhang KW, 2006, PLANT PHYSIOL, V140, P972, DOI 10.1104/pp.105.073007; Zhang MJ, 2014, PROG BIOPHYS MOL BIO, V114, P25, DOI 10.1016/j.pbiomolbio.2013.11.006; Zhang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20910; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x                                                ; Zhang S, 1997, J BIOTECHNOL, V57, P101, DOI 10.1016/S0168-1656(97)00093-X; Zhang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087632; Zhang Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.318; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhang YHP, 2004, APPL ENVIRON MICROB, V70, P1563, DOI 10.1128/AEM.70.3.1563-1569.2004; Zhang ZG, 2010, BIORESOURCE TECHNOL, V101, P9272, DOI 10.1016/j.biortech.2010.07.060; Zhao XQ, 2012, ADV BIOCHEM ENG BIOT, V128, P25, DOI 10.1007/10_2011_129; Zheng TY, 2015, J BACTERIOL, V197, P2610, DOI 10.1128/JB.00232-15; Zheng YH, 2014, NEUROSCI BULL, V30, P379, DOI 10.1007/s12264-013-1436-6; Zhu HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep25516; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	568	1	1	25	27	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-0321			RENEW SUST ENERG REV	Renew. Sust. Energ. Rev.	JUL	2017	74						1080	1107		10.1016/j.rser.2017.01.028				28	GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels	Science & Technology - Other Topics; Energy & Fuels	EV1FU	WOS:000401492900076					2018-01-05	
J	Villate-Beitia, I; Zarate, J; Puras, G; Pedraz, JL				Villate-Beitia, Ilia; Zarate, Jon; Puras, Gustavo; Luis Pedraz, Jose			Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis	DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY			English	Review						Cystic fibrosis; cystic fibrosis transmembrane conductance regulator; gene therapy; genome edition; scale up	PLACEBO-CONTROLLED TRIAL; PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; ADENOASSOCIATED VIRUS; HIGHLY EFFICIENT; CFTR GENE; MEDICINAL PRODUCTS; LENTIVIRAL VECTORS; DNA NANOPARTICLES; CLINICAL-PRACTICE	Cystic fibrosis (CF) is a monogenic autosomal recessive disorder where the defective gene, the cystic fibrosis transmembrane conductance regulator (CFTR), is well identified. Moreover, the respiratory tract can be targeted through noninvasive aerosolized formulations for inhalation. Therefore, gene therapy is considered a plausible strategy to address this disease. Conventional gene therapy strategies rely on the addition of a correct copy of the CFTR gene into affected cells in order to restore the channel activity. In recent years, genome correction strategies have emerged, such as zinc-finger nucleases, transcription activator-like effector nucleases and clustered regularly interspaced short palindromic repeats associated to Cas9 nucleases. These gene editing tools aim to repair the mutated gene at its original genomic locus with high specificity. Besides, the success of gene therapy critically depends on the nucleic acids carriers. To date, several clinical studies have been carried out to add corrected copies of the CFTR gene into target cells using viral and non-viral vectors, some of them with encouraging results. Regarding genome editing systems, preliminary in vitro studies have been performed in order to repair the CFTR gene. In this review, after briefly introducing the basis of CF, we discuss the up-to-date gene therapy strategies to address the disease. The review focuses on the main factors to take into consideration when developing gene delivery strategies, such as the design of vectors and plasmid DNA, in vitro/in vivo tests, translation to human use, administration methods, manufacturing conditions and regulatory issues.	[Villate-Beitia, Ilia; Zarate, Jon; Puras, Gustavo; Luis Pedraz, Jose] Univ Basque Country UPV EHU, NanoBioCel Grp, Vitoria, Spain; [Villate-Beitia, Ilia; Zarate, Jon; Puras, Gustavo; Luis Pedraz, Jose] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain	Puras, G; Pedraz, JL (reprint author), Univ Basque Country, Sch Pharm, Lab Pharm & Pharmaceut Technol, Vitoria 01006, Spain.	gustavo.puras@ehu.eus; joseluis.pedraz@ehu.eus			University of the Basque Country UPV/EHU [UFI 11/32]; Basque Government (Department of Education, University and Research) [PRE_2015_2_0151]	This project was supported by the University of the Basque Country UPV/EHU (UFI 11/32) and the Basque Government (Department of Education, University and Research, predoctoral grant PRE_2015_2_0151).	Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y; Alton EWFW, 2015, LANCET RESP MED, V3, pE33; Alton EWFW, 1999, LANCET, V353, P947, DOI 10.1016/S0140-6736(98)06532-5; Belardelli F, 2011, ANN I SUPER SANITA, V47, P72, DOI 10.4415/ANN_11_01_15; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Cant N, 2014, INT J BIOCHEM CELL B, V52, P15, DOI [10.1016/j.bioce1.2014.02.004, 10.1016/j.biocel.2014.02.004]; Chamberlain K, 2016, HUM GENE THER METHOD, V27, P1, DOI 10.1089/hgtb.2015.140; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Cooney AL, 2015, CYSTIC FIBROSIS LIGH, P327; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; Davies JC, 2014, ARCH DIS CHILD, V99, P1033, DOI 10.1136/archdischild-2013-304400; Davies LA, 2010, BIOTECHNIQUES, V49, P666, DOI 10.2144/000113498; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Duan DS, 1998, J VIROL, V72, P8568; Eastman SJ, 1997, HUM GENE THER, V8, P765, DOI 10.1089/hum.1997.8.6-765; Edwards Jill, 2013, Chronic Illn, V9, P312, DOI 10.1177/1742395313479982; European Medicines Agency, 2016, OUTC MULT M EXP REG; European Medicines Agency, 2011, REGEN MED, V6, P90; Flory E, 2013, TRANSFUS MED HEMOTH, V40, P409, DOI 10.1159/000356364; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; Griesenbach U, 2015, HUM GENE THER, V26, P266, DOI 10.1089/hum.2015.027; Griesenbach U, 2013, HUM MOL GENET, V22, pR52, DOI 10.1093/hmg/ddt372; Griesenbach U, 2012, AM J RESP CRIT CARE, V186, P846, DOI 10.1164/rccm.201206-1056OC; Griesenbach U, 2009, ADV DRUG DELIVER REV, V61, P128, DOI 10.1016/j.addr.2008.09.010; Grosse S, 2004, J GENE MED, V6, P345, DOI 10.1002/jgm.515; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hattori Y, 2005, NON-VIRAL GENE THERAPY: GENE DESIGN AND DELIVERY, P293, DOI 10.1007/4-431-27879-6_22; Hirota S, 1999, BIOTECHNIQUES, V27, P286; Husain SR, 2015, CANCER GENE THER, V22, P554, DOI 10.1038/cgt.2015.58; Hyde SC, 2000, GENE THER, V7, P1156, DOI 10.1038/sj.gt.3301212                                                           ; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; Jaffe A, 2006, J MED ETHICS, V32, P361, DOI 10.1136/jme.2005.012740; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4                                                    ; Keles E, 2016, BIOMATER SCI-UK, V4, P1291, DOI 10.1039/c6bm00441e; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156; King M, 2002, ADV DRUG DELIVER REV, V54, P1475, DOI 10.1016/S0169-409X(02)00156-4                                                   ; Kinsey BM, 2005, CURR GENE THER, V5, P181, DOI 10.2174/1566523053544254; Konstan MW, 1997, PEDIATR PULM, V24, P137, DOI 10.1002/(SICI)1099-0496(199708)24:2<137::AID-PPUL13>3.3.CO;2-4; Kormann MSD., 2015, CYSTIC FIBROSIS LIGH, P358; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lane MA, 2014, CLIN MED, V14, P76, DOI 10.7861/clinmedicine.14-1-76; Lechardeur D, 2005, ADV DRUG DELIVER REV, V57, P755, DOI 10.1016/j.addr.2004.12.008; Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218; Lengsfeld CS, 2002, J PHARM SCI, V91, P1581, DOI 10.1002/jps.10140; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Li Y, 2015, EXPERT OPIN BIOL TH, V15, P437, DOI 10.1517/14712598.2015.990882; Liang M, 2012, CURR PHARM BIOTECHNO, V13, P1852, DOI 10.2174/138920112800958760                                                      ; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Lopes-Pacheco M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00275; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mastorakos P, 2015, P NATL ACAD SCI USA, V112, P8720, DOI 10.1073/pnas.1502281112; McKay T, 2006, GENE THER, V13, P715, DOI 10.1038/sj.gt.3302715; McLachlan G, 2011, GENE THER, V18, P996, DOI 10.1038/gt.2011.55; Mishra A, 2008, J PEDIATR, V153, P758, DOI 10.1016/j.jpeds.2008.04.067; Mitomo K, 2010, MOL THER, V18, P1173, DOI 10.1038/mt.2010.13; Mojica FJM, 2016, TRENDS MICROBIOL, V24, P811, DOI 10.1016/j.tim.2016.06.005; Moskowitz SM, 2008, GENET MED, V10, P851, DOI 10.1097/GIM.0b013e31818e55a2; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509                                                         ; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Nance ME, 2015, HUM GENE THER, V26, P786, DOI 10.1089/hum.2015.107; Patrick AE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00162; Pezzoli D, 2012, J APPL BIOMATER FUNC, V10, P82, DOI 10.5301/JABFM.2012.9707; Pol J, 2015, ONCOIMMUNOLOGY, V5; Pringle LA, 2009, EXPERT OPIN BIOL TH, V9, P991, DOI 10.1517/14712590903055029; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Schneider CK, 2010, NAT REV DRUG DISCOV, V9, P195, DOI 10.1038/nrd3052; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Sinn PL, 2008, J VIROL, V82, P10684, DOI 10.1128/JVI.00227-08; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Stocker AG, 2009, J GENE MED, V11, P861, DOI 10.1002/jgm.1368; Suk JS, 2011, MOL THER, V19, P1981, DOI 10.1038/mt.2011.160; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Camarasa MV, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0275-6; Villate-Beitia I, 2015, GENE THERAPY PRINCIP, P145, DOI [10. 5772/61060, DOI 10.5772/61060]; Wang YT, 2014, INT J BIOCHEM CELL B, V52, P47, DOI 10.1016/j.biocel.2014.04.001; Winter MC, 1997, NATURE, V389, P294; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Yuan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010525; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K	99	0	0	20	44	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0363-9045	1520-5762		DRUG DEV IND PHARM	Drug Dev. Ind. Pharm.	JUL	2017	43	7					1071	1081		10.1080/03639045.2017.1298122				11	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	ET7TB	WOS:000400500200003	28270008				2018-01-05	
J	Fei, X; He, X; Guo, RX; Yin, C; Geng, HP; Wu, KY; Yin, KQ; Geng, SZ; Pan, ZM; Li, QC; Jiao, XA				Fei, Xiao; He, Xiao; Guo, Rongxian; Yin, Chao; Geng, Haopeng; Wu, Kaiyue; Yin, Kequan; Geng, Shizhong; Pan, Zhiming; Li, Qiuchun; Jiao, Xinan			Analysis of prevalence and CRISPR typing reveals persistent antimicrobial-resistant Salmonella infection across chicken breeder farm production stages	FOOD CONTROL			English	Article						Salmonella; Prevalence; Antimicrobial resistance; CRISPR; Breeder farm	MEDIATED QUINOLONE RESISTANCE; ENTERICA SEROTYPE ENTERITIDIS; RETAIL RAW CHICKEN; NALIDIXIC-ACID; FOOD ANIMALS; SHELL EGGS; FLUOROQUINOLONE SUSCEPTIBILITY; HOUSING SYSTEMS; UNITED-STATES; HUMAN HEALTH	Salmonella is considered one of the most important foodborne pathogens, and is commonly associated with the consumption of poultry meat and eggs. Multidrug-resistant (MDR) Salmonella strains are highly adaptive and have been responsible for foodborne disease outbreaks with high mortality worldwide. Therefore, we investigated Salmonella prevalence and antimicrobial resistance at different production stages in a chicken breeder farm in Jiangsu Province, China. A total of 115 Salmonella isolates were recovered from 638 samples. Interestingly, serotyping revealed all of these to be Salmonella enterica subsp. enterica serovar Enteritidis (S. Enteritidis). Prevalence was highest at the laying stage, with 29.17% of samples containing Salmonella, followed by the hatching phase (21.56%). Tests of susceptibility to 16 antimicrobial agents using a disk diffusion assay showed that all isolates were resistant to at least one compound, and 31.30% exhibited MDR phenotypes, covering all five production stages. Of the Salmonella isolates recovered during the rearing and laying periods, a large proportion (>50%) were MDR (100 and 71.43%, respectively). Our results imply that the laying period constitutes a high-risk stage in breeder farms. Clustered regularly interspaced short palindromic repeat (CRISPR) sequence typing identified three CRISPR patterns among the isolates. Two of these were detected in samples from four of the five production stages, suggesting that certain genetically similar strains may have spread across the farm. Our study provides data concerning Salmonella epidemiology and antimicrobial resistance in breeder farms, which may aid the optimization of hazard analysis and critical control point strategies for such sites. (C) 2017 Elsevier Ltd. All rights reserved.	[Fei, Xiao; He, Xiao; Guo, Rongxian; Yin, Chao; Geng, Haopeng; Wu, Kaiyue; Yin, Kequan; Geng, Shizhong; Pan, Zhiming; Li, Qiuchun; Jiao, Xinan] Yangzhou Univ, Jiangsu Key Lab Zoonosis, Joint Int Res Lab Agr & Agri Prod Safety, Yangzhou 225009, Jiangsu, Peoples R China; [Fei, Xiao; He, Xiao; Guo, Rongxian; Yin, Chao; Geng, Haopeng; Wu, Kaiyue; Yin, Kequan; Geng, Shizhong; Pan, Zhiming; Li, Qiuchun; Jiao, Xinan] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China	Jiao, XA (reprint author), Yangzhou Univ, Jiangsu Key Lab Zoonosis, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China.	jiao@yzu.edu.cn			Special Fund for Agro-Scientific Research in the Public Interest [201403054]; National Natural Science Foundation of China [31320103907]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Special Fund for Agro-Scientific Research in the Public Interest (201403054), the National Natural Science Foundation of China (31320103907) and Priority Academic Program Development of Jiangsu Higher Education Institutions.	Aarestrup FM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0085; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Asna SMZH, 2003, JPN J INFECT DIS, V56, P32; Bai L, 2015, PLOS ONE, V10; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Boonmar S, 1998, J CLIN MICROBIOL, V36, P971; BULLIS KL, 1977, AVIAN DIS, V21, P422, DOI 10.2307/1589326                                                                 ; Cai YQ, 2016, INT J FOOD MICROBIOL, V222, P56, DOI 10.1016/j.ijfoodmicro.2016.01.020; CDC, 2016, NAT ANT RES MON SYST; Chai SJ, 2012, CLIN INFECT DIS, V54, pS488, DOI 10.1093/cid/cis231; Cheung TKM, 2005, J ANTIMICROB CHEMOTH, V56, P586, DOI 10.1093/jac/dki250; CLSI (Clinical and Laboratory Standards Institute), 2013, M100S23 CLSI; Cui MQ, 2016, FOOD CONTROL, V62, P270, DOI 10.1016/j.foodcont.2015.10.036; Davies RH, 1997, VET MICROBIOL, V58, P277, DOI 10.1016/S0378-1135(97)00157-0; DiMarzio M, 2013, ANTIMICROB AGENTS CH, V57, P4282, DOI 10.1128/AAC.00913-13; EFSA, 2015, EFSA J, V13, P7; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Feberwee A, 2001, AVIAN DIS, V45, P83, DOI 10.2307/1593015; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Galis AM, 2013, COMPR REV FOOD SCI F, V12, P155, DOI 10.1111/1541-4337.12007; Gantois I. D. I., 2006, ORAL IMMUNISATION TA; Gast RK, 2013, POULTRY SCI, V92, P468, DOI 10.3382/ps.2012-02811; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Grissa L, 2007, NUCLEIC ACIDS RES, V35, pW52 ; Hakanen A, 1999, J CLIN MICROBIOL, V37, P3572; Hakanen AJ, 2005, J CLIN MICROBIOL, V43, P5775, DOI 10.1128/JCM.43.11.5775-5778.2005; Hoelzer K, 2010, APPL ENVIRON MICROB, V76, P5947, DOI 10.1128/AEM.00377-10; Huang JL, 2016, FOOD CONTROL, V59, P68, DOI 10.1016/j.foodcont.2015.05.009; Hur J, 2012, FOOD RES INT, V45, P819, DOI 10.1016/j.foodres.2011.05.014; Jacoby G. A., 2014, MICROBIOLOGY SPECTRU, V2; Jie Z, 2007, EMERG INFECT DIS, V13, P1932; Johnston CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048195; Jones DR, 2016, POULTRY SCI, V95, P1116, DOI 10.3382/ps/pew036; KAPIL A, 2002, THE INDIAN JOURNAL O, V115, P49; Kim JH, 2013, AVIAN PATHOL, V42, P221, DOI 10.1080/03079457.2013.779636; Kirk MD, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001921; LEE LA, 1994, THE JOURNAL OF INFEC, V170, P128; Li RC, 2013, INT J FOOD MICROBIOL, V163, P14, DOI 10.1016/j.ijfoodmicro.2013.01.020; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Lostec Z. L, 1997, CLIN MICROBIOL INFEC, V3, P576; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Muhammad M, 2010, VET MICROBIOL, V140, P131, DOI 10.1016/j.vetmic.2009.07.009; National Committee for Clinical Laboratory Standards (NCCLS), 2000, M2A7 NCCLS; Nesbitt A, 2012, EPIDEMIOL INFECT, V140, P1757, DOI 10.1017/S0950268811002548; Oteo J, 2000, CLIN MICROBIOL INFEC, V6, P273, DOI 10.1046/j.1469-0691.2000.00058-3.x                                              ; Parisi MA, 2015, FOOD CONTROL, V47, P161, DOI 10.1016/j.foodcont.2014.06.038; Rabsch W, 2000, EMERG INFECT DIS, V6, P443, DOI 10.3201/eid0605.000501                                                          ; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; Scallan E., 2011, INFECT DIS, V17, P7, DOI DOI 10.3201/EID1701.P11101; Schroeder CM, 2006, FOODBORNE PATHOG DIS, V3, P403, DOI 10.1089/fpd.2006.3.403; Sivaramalingam T, 2013, CAN J VET RES, V77, P1; Thomas MK, 2015, FOODBORNE PATHOG DIS, V12, P820, DOI 10.1089/fpd.2015.1966; Veldman K, 2011, J ANTIMICROB CHEMOTH, V66, P1278, DOI 10.1093/jac/dkr084; Wang H, 2013, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2013-378; Wang JQ, 2013, J FOOD PROTECT, V76, P1958, DOI 10.4315/0362-028X.JFP-13-168; Wang YR, 2014, FOODBORNE PATHOG DIS, V11, P126, DOI 10.1089/fpd.2013.1586; Yang BW, 2014, J FOOD PROTECT, V77, P894, DOI 10.4315/0362-028X.JFP-13-439; Yin MY, 2016, FOOD CONTROL, V64, P165, DOI 10.1016/j.foodcont.2015.12.029; Zhu JH, 2014, FOOD CONTROL, V44, P198, DOI 10.1016/j.foodcont.2014.03.050	59	0	0	15	36	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-7135	1873-7129		FOOD CONTROL	Food Control	JUL	2017	77						102	109		10.1016/j.foodcont.2017.01.023				8	Food Science & Technology	Food Science & Technology	EP4PI	WOS:000397362000014					2018-01-05	
J	Kesavan, G; Chekuru, A; Machate, A; Brand, M				Kesavan, Gokul; Chekuru, Avinash; Machate, Anja; Brand, Michael			CRISPR/Cas9-Mediated Zebrafish Knock-in as a Novel Strategy to Study Midbrain-Hindbrain Boundary Development	FRONTIERS IN NEUROANATOMY			English	Article						CRISPR/Cas9; midbrain-hindbrain boundary (MHB); knock-in reporter; zebrafish and transgenesis	GOLDFISH OPTIC TECTUM; EXPRESSION PATTERN; GENES SUGGESTS; GENOME; ORGANIZER; EFFICIENT; NEUROGENESIS; BRAIN; FGF8; GBX2	The midbrain-hindbrain boundary (MHB) acts as an organizer and controls the fate of neighboring cells to develop into either mesencephalic (midbrain) or metencephalic (hindbrain) cells by secreting signaling molecules like Wnt1 and Fgf8. The zebrafish is an excellent vertebrate model for studying MHB development due to the ease of gene manipulation and the possibility of following cellular dynamics and morphogenetic processes using live imaging. Currently, only very few reporter and/or Cre-driver lines are available to study gene expression at the MHB, hampering the understanding of MHB development, and traditional transgenic technologies using promoter/enhancer fragments or bacterial artificial chromosome (BAC)-mediated transgenesis often do not faithfully recapitulate endogenous expression patterns. In contrast, CRISPR/Cas9-mediated genome editing technology now provides a great opportunity to efficiently knock-in or knock-out genes. We have generated four CRISPR/Cas9-based knock-in fluorescent reporter lines for two crucial genes involved in MHB development, namely otx2 and pax2a. The coding sequences of the reporters were knocked-in upstream of the corresponding ATG and are, thus, under the control of the endogenous promoter/enhancer elements. Interestingly, this strategy does not disturb endogenous gene expression. Using the fast maturing fluorescent protein reporter, Venus, enabled us to follow MHB development using cell tracking and live imaging. In addition, we show that these reporter lines label various neuronal and glial cell types in the adult zebrafish brain, making them highly suitable for investigating embryonic and adult midbrain, hindbrain, and MHB development.	[Brand, Michael] Tech Univ Dresden, Biotechnol Ctr, Dresden, Germany; Tech Univ Dresden, DFG Res Ctr Regenerat Therapies Dresden, Dresden, Germany	Brand, M (reprint author), Tech Univ Dresden, Biotechnol Ctr, Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Kesavan, Gokul/0000-0002-2828-1460	Swedish research council (Vetenskapsradet); EMBO [ALTF 350-2011]; ERC (Zf-BrainReg); German Research Foundation (Deutsche Forschungsgemeinschaft) [BR 1746/6-1]	GK was supported by post-doctoral fellowships from Swedish research council (Vetenskapsradet) and an EMBO long-term fellowship (ALTF 350-2011). This work was also supported by an ERC advanced grant (Zf-BrainReg) and project grant of the German Research Foundation (Deutsche Forschungsgemeinschaft, project number BR 1746/6-1) to MB.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Brand M, 1996, DEVELOPMENT, V123, P179; Brand Michael, 2002, P7; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai J, 2010, INT J BIOL SCI, V6, P756; Dworkin S, 2013, CELL MOL LIFE SCI, V70, P3365, DOI 10.1007/s00018-012-1240-x; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Hagmann M, 1998, BIOL CHEM, V379, P673, DOI 10.1515/bchm.1998.379.6.673; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Kurokawa D, 2006, P NATL ACAD SCI USA, V103, P19350, DOI 10.1073/pnas.0604686103; Langenberg T, 2005, DEVELOPMENT, V132, P3209, DOI 10.1242/dev.01862; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun K, 1998, DEVELOPMENT, V125, P3049; Macdonald R, 1999, METH MOL B, V127, P77, DOI 10.1385/1-59259-678-9:77; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; MEEK J, 1978, J COMP NEUROL, V182, P89, DOI 10.1002/cne.901820107; MEEK J, 1981, J COMP NEUROL, V199, P149, DOI 10.1002/cne.901990202; MERCIER P, 1995, INT J DEV BIOL, V39, P559; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Muto A, 2013, CURR BIOL, V23, P307, DOI 10.1016/j.cub.2012.12.040; Ota S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34991; Picker A, 2002, DEVELOPMENT, V129, P3227; Raible F, 2004, TRENDS NEUROSCI, V27, P727, DOI 10.1016/j.tins.2004.10.003; Reifers F, 1998, DEVELOPMENT, V125, P2381; Reim G, 2002, DEVELOPMENT, V129, P917; Rhinn M, 2006, CURR OPIN NEUROBIOL, V16, P5, DOI 10.1016/j.conb.2006.01.005; Rhinn M, 2003, MECH DEVELOP, V120, P919, DOI 10.1016/S0925-4773(03)00135-7; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9                                                   ; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Schier AF, 1996, DEVELOPMENT, V123, P165; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Sunmonu NA, 2011, DEVELOPMENT, V138, P725, DOI 10.1242/dev.055665; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tossell K, 2011, DEVELOPMENT, V138, P3745, DOI 10.1242/dev.070318; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Wullimann M. F., 1996, NEUROAN ZEBRAFISH BR, DOI [10.1007/978-3-0348-8979-7, DOI 10.1007/978-3-0348-8979-7]; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516                                                                ; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	47	0	0	9	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5129			FRONT NEUROANAT	Front. Neuroanat.	JUN 30	2017	11								52	10.3389/fnana.2017.00052				14	Anatomy & Morphology; Neurosciences	Anatomy & Morphology; Neurosciences & Neurology	FA1XW	WOS:000405236000001	28713249				2018-01-05	
J	Li, X; Baker, J; Cracknell, T; Haynes, AR; Blanco, G				Li, Xiang; Baker, Jane; Cracknell, Tobias; Haynes, Andrew R.; Blanco, Gonzalo			IGFN1_v1 is required for myoblast fusion and differentiation	PLOS ONE			English	Article							KY; PROTEIN; DROSOPHILA; MUTATION; MOUSE; RAC1; GENE; DEFICIENCY; EXPRESSION; MUSCLES	Igfn1 is a complex locus that codes for multiple splicing variants of Immunoglobulin-and Fibronectin-like domain containing proteins predominantly expressed in skeletal muscle. To reveal possible roles for Igfn1, we applied non-selective knock-down by shRNAs as well as specific targeting of Igfn1 exon 13 by CRISPR/Cas9 mutagenesis in C2C12 cells. Decreased expression of Igfn1 variants via shRNAs against the common 3'-UTR region caused a total blunting of myoblast fusion, but did not prevent expression of differentiation markers. Targeting of N-terminal domains by elimination of exon 13 via CRISPR/Cas9 mediated homologous recombination, also resulted in fusion defects as well as large multinucleated cells. Expression of IGFN1_v1 partially rescued fusion and myotube morphology in the Igfn1 exon 13 knock-out cell line, indicating a role for this variant in myoblast fusion and differentiation. However, in vivo overexpression of IGFN1_v1 or the Igfn1 Exon 13 CRISPR/Cas9 targeting vector did not result in significant size changes in transfected fibres.	[Li, Xiang; Cracknell, Tobias; Blanco, Gonzalo] Univ York, Dept Biol, York, N Yorkshire, England; [Baker, Jane; Haynes, Andrew R.] MRC Harwell Inst, Mammalian Genet Unit, Harwell, Berks, England	Blanco, G (reprint author), Univ York, Dept Biol, York, N Yorkshire, England.	gonzalo.blanco@york.ac.uk			Medical Research Council [MC_U142684168]; Biotechnology and Biological Sciences Research Council [BB/M011151/1]	Support was provided by the Medical Research Council (MC_U142684168 to Andy Haynes) and Biotechnology and Biological Sciences Research Council (BB/M011151/1 to Tobias Cracknell).	Baker J, 2010, EXP CELL RES, V316, P1856, DOI 10.1016/j.yexcr.2010.02.027; Beatham J, 2004, HUM MOL GENET, V13, P2863, DOI 10.1093/hmg/ddh308; Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9                                                              ; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Fernandes JJ, 2005, DEV BIOL, V285, P11, DOI 10.1016/j.ydbio.2005.05.040; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hedberg-Oldfors C, 2016, EUR J HUM GENET, V24, P1771, DOI 10.1038/ejhg.2016.98; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Otey CA, 2009, CELL MOTIL CYTOSKEL, V66, P618, DOI 10.1002/cm.20385; Pinotsis N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001261; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Straussberg R, 2016, ACTA NEUROPATHOL, V132, P475, DOI 10.1007/s00401-016-1602-9; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G                     ; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180217	10.1371/journal.pone.0180217                                                    				24	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ3KB	WOS:000404608700074	28665998				2018-01-05	
J	Roldan, MVG; Perilleux, C; Morin, H; Huerga-Fernandez, S; Latrasse, D; Benhamed, M; Bendahmane, A				Roldan, Maria Victoria Gomez; Perilleux, Claire; Morin, Halima; Huerga-Fernandez, Samuel; Latrasse, David; Benhamed, Moussa; Bendahmane, Abdelhafid			Natural and induced loss of function mutations in SlMBP21 MADS-box gene led to jointless-2 phenotype in tomato	SCIENTIFIC REPORTS			English	Article							ABSCISSION ZONE DEVELOPMENT; INFLORESCENCE DEVELOPMENT; SOLANUM-LYCOPERSICON; CENTROMERIC REGION; SYSTEM; MACROCALYX; FRUIT; SEQUENCE; PROVIDES; PEDICEL	Abscission is the mechanism by which plants disconnect unfertilized flowers, ripe fruits, senescent or diseased organs from the plant. In tomato, pedicel abscission is an important agronomic factor that controls yield and post-harvest fruit quality. Two non-allelic mutations, jointless (j) and jointless-2 (j-2), controlling pedicel abscission zone formation have been documented but only j-2 has been extensively used in breeding. J was shown to encode a MADS-box protein. Using a combination of physical mapping and gene expression analysis we identified a positional candidate, Solyc12g038510, associated with j-2 phenotype. Targeted knockout of Solyc12g038510, using CRISPR/Cas9 system, validated our hypothesis. Solyc12g038510 encodes the MADS-box protein SlMBP21. Molecular analysis of j-2 natural variation revealed two independent loss-of-function mutants. The first results of an insertion of a Rider retrotransposable element. The second results of a stop codon mutation that leads to a truncated protein form. To bring new insights into the role of J and J-2 in abscission zone formation, we phenotyped the single and the double mutants and the engineered alleles. We showed that J is epistatic to J-2 and that the branched inflorescences and the leafy sepals observed in accessions harboring j-2 alleles are likely the consequences of linkage drags.	[Roldan, Maria Victoria Gomez; Morin, Halima; Latrasse, David; Benhamed, Moussa; Bendahmane, Abdelhafid] Univ Paris Saclay, Univ Paris Diderot, Univ Paris Sud,Univ Evry,Sorbonne Paris Cite, Inst Plant Sci Paris Saclay IPS2,CNRS,INRA, F-91405 Orsay, France; [Perilleux, Claire; Huerga-Fernandez, Samuel] Univ Liege, InBioS, PhytoSYST, Lab Plant Physiol, Sart Tilman Campus Quartier Vallee 1, B-4000 Liege, Belgium	Bendahmane, A (reprint author), Univ Paris Saclay, Univ Paris Diderot, Univ Paris Sud,Univ Evry,Sorbonne Paris Cite, Inst Plant Sci Paris Saclay IPS2,CNRS,INRA, F-91405 Orsay, France.	abdelhafid.bendahmane@inra.fr					Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; BERRY SZ, 1991, HORTSCIENCE, V26, P1093; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Budiman MA, 2004, THEOR APPL GENET, V108, P190, DOI 10.1007/s00122-003-1429-3; Butenko MA, 2015, J EXP BOT, V66, P5194, DOI 10.1093/jxb/erv310; Butler L, 1936, J HERED, V27, P25; Gupta S, 2016, PLANT CELL TISS ORG, V127, P417, DOI 10.1007/s11240-016-1063-9; Ito Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00442; Joubert L. A. G., 1965, S AFR J AGR SCI, V8, P571; Kim J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01109; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu DM, 2014, PLANT J, V77, P284, DOI 10.1111/tpj.12387; Mao L, 2001, PLANT PHYSIOL, V126, P1331, DOI 10.1104/pp.126.3.1331; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; Nakano T, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-40; Nakano T, 2012, PLANT PHYSIOL, V158, P439, DOI 10.1104/pp.111.183731; van Nocker S., 2009, STEWART POSTHARVEST, V5; Perilleux C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00121; PHILOUZE J, 1978, ANN AMELIOR PLANT, V28, P431; Quinet M, 2006, NEW PHYTOL, V170, P701, DOI 10.1111/j.1469-8137.2006.01717.x; Quinet M., 2007, INT J PLANT DEV BIOL, V2007, P64; REYNARD GB, 1961, SCIENCE, V134, P2102, DOI 10.1126/science.134.3496.2102                                                   ; RICK CM, 1956, AM J BOT, V43, P687, DOI 10.2307/2438834; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Scott J. W., 1997, P FLA STATE HORTIC S, V110, P281; Szymkowiak EJ, 1999, PLANT CELL, V11, P159; Thouet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031096; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yang TJ, 2005, CHROMOSOMA, V114, P103, DOI 10.1007/s00412-005-0342-8; Yuste-Lisbona FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18796; Zdravkovic J, 2012, GENETIKA-BELGRADE, V44, P701, DOI 10.2298/GENSR1203701Z; Zhang HB, 2000, THEOR APPL GENET, V100, P1183, DOI 10.1007/s001220051422	36	0	0	18	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 30	2017	7								4402	10.1038/s41598-017-04556-1				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ1DX	WOS:000404451300008	28667273	gold			2018-01-05	
J	Van der Hoek, KH; Eyre, NS; Shue, B; Khantisitthiporn, O; Glab-Ampi, K; Carr, JM; Gartner, MJ; Jolly, LA; Thomas, PQ; Adikusuma, F; Jankovic-Karasoulos, T; Roberts, CT; Helbig, KJ; Beard, MR				Van der Hoek, Kylie H.; Eyre, Nicholas S.; Shue, Byron; Khantisitthiporn, Onruedee; Glab-Ampi, Kittirat; Carr, Jillian M.; Gartner, Matthew J.; Jolly, Lachlan A.; Thomas, Paul Q.; Adikusuma, Fatwa; Jankovic-Karasoulos, Tanja; Roberts, Claire T.; Helbig, Karla J.; Beard, Michael R.			Viperin is an important host restriction factor in control of Zika virus infection	SCIENTIFIC REPORTS			English	Article							INTERFERON-STIMULATED GENES; SEXUAL TRANSMISSION; NEURAL PROGENITORS; RNA VIRUSES; MOUSE MODEL; REPLICATION; DENGUE; PROTEIN; BRAIN; MACROPHAGES	XXX Zika virus (ZIKV) infection has emerged as a global health threat and infection of pregnant women causes intrauterine growth restriction, spontaneous abortion and microcephaly in newborns. Here we show using biologically relevant cells of neural and placental origin that following ZIKV infection, there is attenuation of the cellular innate response characterised by reduced expression of IFN-beta and associated interferon stimulated genes (ISGs). One such ISG is viperin that has well documented antiviral activity against a wide range of viruses. Expression of viperin in cultured cells resulted in significant impairment of ZIKV replication, while MEFs derived from CRISPR/Cas9 derived viperin(-/-) mice replicated ZIKV to higher titers compared to their WT counterparts. These results suggest that ZIKV can attenuate ISG expression to avoid the cellular antiviral innate response, thus allowing the virus to replicate unchecked. Moreover, we have identified that the ISG viperin has significant anti-ZIKV activity. Further understanding of how ZIKV perturbs the ISG response and the molecular mechanisms utilised by viperin to suppress ZIKV replication will aid in our understanding of ZIKV biology, pathogenesis and possible design of novel antiviral strategies.	[Van der Hoek, Kylie H.; Eyre, Nicholas S.; Shue, Byron; Khantisitthiporn, Onruedee; Glab-Ampi, Kittirat; Gartner, Matthew J.; Thomas, Paul Q.; Adikusuma, Fatwa; Beard, Michael R.] Univ Adelaide, Res Ctr Infect Dis, Mol & Cellular Biol, Adelaide, SA 5005, Australia; [Jolly, Lachlan A.; Jankovic-Karasoulos, Tanja; Roberts, Claire T.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia; [Jolly, Lachlan A.; Jankovic-Karasoulos, Tanja; Roberts, Claire T.] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia; [Van der Hoek, Kylie H.; Eyre, Nicholas S.; Shue, Byron; Khantisitthiporn, Onruedee; Glab-Ampi, Kittirat; Gartner, Matthew J.; Beard, Michael R.] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Carr, Jillian M.] Flinders Univ S Australia, Sch Med, Microbiol & Infect Dis, Bedford Pk, SA 5042, Australia; [Helbig, Karla J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia	Beard, MR (reprint author), Univ Adelaide, Res Ctr Infect Dis, Mol & Cellular Biol, Adelaide, SA 5005, Australia.; Beard, MR (reprint author), Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.	michael.beard@adelaide.edu.au			NHMRC of Australia [APP1053206]; Robinson Research Institute Innovation at The University of Adelaide	We would like to thank Sandy Piltz, Catherine Scougall and Ying Sun for technical assistance with generation of CRISPR/Cas9 viperin null mice, MEFS and neural progenitor cells respectively. This work was supported by grants from the NHMRC (APP1053206) of Australia and the Robinson Research Institute Innovation Seed Funding Program at The University of Adelaide.	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682; Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13; Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Eyre NS, 2016, VIROLOGY, V491, P27, DOI 10.1016/j.virol.2016.01.018; Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130; Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17; Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2009, J VIROL, V83, P836, DOI 10.1128/JVI.01388-08; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jolly LA, 2013, HUM MOL GENET, V22, P4673, DOI 10.1093/hmg/ddt315; Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Li C., 2016, CELL STEM CELL; Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017; Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wati S, 2007, J VIROL, V81, P10161, DOI 10.1128/JVI.00313-07; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004	55	2	2	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 30	2017	7								4475	10.1038/s41598-017-04138-1				14	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ1DX	WOS:000404451300081	28667332	gold			2018-01-05	
J	Wang, HW; Qin, F				Wang, Hongwei; Qin, Feng			Genome-Wide Association Study Reveals Natural Variations Contributing to Drought Resistance in Crops	FRONTIERS IN PLANT SCIENCE			English	Review						GWAS; drought tolerance; gene cloning; crops; natural variation	QUANTITATIVE TRAIT LOCI; SINGLE-NUCLEOTIDE POLYMORPHISMS; ANTHESIS-SILKING INTERVAL; VACUOLAR H+-PYROPHOSPHATASE; ABSCISIC-ACID CONCENTRATION; TROPICAL MAIZE POPULATIONS; MARKER-ASSISTED SELECTION; ABIOTIC STRESS RESPONSES; PCR-BASED MARKERS; ZEA-MAYS L.	Crops are often cultivated in regions where they will face environmental adversities; resulting in substantial yield loss which can ultimately lead to food and societal problems. Thus, significant efforts have been made to breed stress tolerant cultivars in an attempt to minimize these problems and to produce more stability with respect to crop yields across broad geographies. Since stress tolerance is a complex and multi-genic trait, advancements with classical breeding approaches have been challenging. On the other hand, molecular breeding, which is based on transgenics, marker-assisted selection and genome editing technologies; holds great promise to enable farmers to better cope with these challenges. However, identification of the key genetic components underlying the trait is critical and will serve as the foundation for future crop genetic improvement. Recently, genome-wide association studies have made significant contributions to facilitate the discovery of natural variation contributing to stress tolerance in crops. From these studies, the identified loci can serve as targets for genomic selection or editing to enable the molecular design of new cultivars. Here, we summarize research progress on this issue and focus on the genetic basis of drought tolerance as revealed by genomewide association studies and quantitative trait loci mapping. Although many favorable loci have been identified, elucidation of their molecular mechanisms contributing to increased stress tolerance still remains a challenge. Thus, continuous efforts are still required to functionally dissect this complex trait through comprehensive approaches, such as system biological studies. It is expected that proper application of the acquired knowledge will enable the development of stress tolerant cultivars; allowing agricultural production to become more sustainable under dynamic environmental conditions.	[Wang, Hongwei] Yangtze Univ, Coll Agr, Jingzhou, Peoples R China; [Wang, Hongwei] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China; [Qin, Feng] China Agr Univ, Coll Biol Sci, Beijing, Peoples R China	Qin, F (reprint author), China Agr Univ, Coll Biol Sci, Beijing, Peoples R China.	qinfeng@cau.edu.cn			National Key Research and Development Plan of China [2016YFD0100605]; National Natural Science Foundation of China [31625022]	This work is supported by National Key Research and Development Plan of China (2016YFD0100605) and the National Natural Science Foundation of China (31625022).	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698                                                                  ; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Agrama HAS, 1996, EUPHYTICA, V91, P89, DOI 10.1007/BF00035278; Almeida GD, 2013, THEOR APPL GENET, V126, P583, DOI 10.1007/s00122-012-2003-7; Altshuler D, 2000, NATURE, V407, P513; And J. I, 2003, ANNU REV PLANT BIOL, V47, P377, DOI [10.1146/annurev.arplant.47.1.377, DOI 10.1146/ANNUREV.ARPLANT.47.1.377]; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bao AK, 2009, PLANT SCI, V176, P232, DOI 10.1016/j.plantsci.2008.10.009; Barakat MN, 2015, BIOL PLANTARUM, V59, P291, DOI 10.1007/s10535-015-0499-9; Bartoli CG, 1999, J EXP BOT, V50, P375, DOI 10.1093/jxb/50.332.375                                                          ; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x                                       ; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Boyer JS, 2013, GLOB FOOD SECUR-AGR, V2, P139, DOI 10.1016/j.gfs.2013.03.002; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443                                                    ; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035                                                           ; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deschamps Stephane, 2012, Biology (Basel), V1, P460, DOI 10.3390/biology1030460; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Fu YB, 2014, GENET RESOUR CROP EV, V61, P579, DOI 10.1007/s10722-013-0058-1; Fu YB, 2011, PLANT GENOME-US, V4, P226, DOI 10.3835/plantgenome2011.08.0022; Gao CX, 2015, NATL SCI REV, V2, P13, DOI 10.1093/nsr/nwu054; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; GEBER MA, 1990, OECOLOGIA, V85, P153, DOI 10.1007/BF00319396; Gill Sarvajeet Singh, 2010, Plant Signal Behav, V5, P26, DOI 10.4161/psb.5.1.10291; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Guingo E, 1998, AGRONOMIE, V18, P225, DOI 10.1051/agro:19980305                                                           ; Hao ZF, 2008, ANN APPL BIOL, V153, P73, DOI 10.1111/j.1744-7348.2008.00239.x; Hao ZF, 2010, EUPHYTICA, V174, P165, DOI 10.1007/s10681-009-0091-5; HENDERSON CR, 1975, J ANIM SCI, V41, P760; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Huang XH, 2016, NATURE, V537, P629, DOI 10.1038/nature19760; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XQ, 2011, P NATL ACAD SCI USA, V108, P4488, DOI 10.1073/pnas.1100465108; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Iehisa JCM, 2014, J PLANT PHYSIOL, V171, P830, DOI 10.1016/j.jplph.2014.02.003; Izanloo A, 2008, J EXP BOT, V59, P3327, DOI 10.1093/jxb/ern199; Jackson RB, 2000, TRENDS PLANT SCI, V5, P482, DOI 10.1016/S1360-1385(00)01766-0; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kang Y, 2015, PLANT CELL ENVIRON, V38, P1997, DOI 10.1111/pce.12520; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Landi P, 2005, MOL BREEDING, V15, P291, DOI 10.1007/s11032-004-7604-7; LEBRETON C, 1995, J EXP BOT, V46, P853, DOI 10.1093/jxb/46.7.853                                                            ; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Liang CZ, 2014, P NATL ACAD SCI USA, V111, P10013, DOI 10.1073/pnas.1321568111; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; LITT M, 1989, AM J HUM GENET, V44, P397; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Lu GH, 2006, J INTEGR PLANT BIOL, V48, P1233, DOI 10.1111/j.1672-9072.2006.00289.x; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mace ES, 2012, THEOR APPL GENET, V124, P97, DOI 10.1007/s00122-011-1690-9; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Maherali H, 2010, AM NAT, V175, P211, DOI 10.1086/649598; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao HD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9326; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Merchuk-Ovnat L, 2016, PLANT SCI, V251, P23, DOI 10.1016/j.plantsci.2016.05.003; Messmer R, 2011, FIELD CROP RES, V124, P93, DOI 10.1016/j.fcr.2011.06.010; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Miedaner T, 2006, THEOR APPL GENET, V112, P562, DOI 10.1007/s00122-005-0163-4; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Pan QC, 2016, NEW PHYTOL, V210, P1083, DOI 10.1111/nph.13810; PARAN I, 1993, THEOR APPL GENET, V85, P985, DOI 10.1007/BF00215038; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; Pei LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043501; Poland JA, 2012, PLANT GENOME-US, V5, P92, DOI 10.3835/plantgenome2012.05.0005; POLLAK EJ, 1983, J DAIRY SCI, V66, P1503, DOI 10.3168/jds.S0022-0302(83)81965-1                                               ; Pritchard JK, 2000, GENETICS, V155, P945; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; QUAAS RL, 1980, J ANIM SCI, V51, P1277; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rahman H, 2011, GENET MOL RES, V10, P889, DOI 10.4238/vol10-2gmr1139; Rea A. P, 2003, ANNU REV PLANT BIOL, V44, P157, DOI [10.1146/annurev.pp.44.060193.001105, DOI 10.1146/ANNUREV.PP.44.060193.001105]; Ribaut JM, 1997, THEOR APPL GENET, V94, P887, DOI 10.1007/s001220050492; Ribaut JM, 1996, THEOR APPL GENET, V92, P905, DOI 10.1007/BF00221905; Richardson KL, 2006, THEOR APPL GENET, V113, P485, DOI 10.1007/s00122-006-0314-2; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sanguineti MC, 1999, J EXP BOT, V50, P1289, DOI 10.1093/jexbot/50.337.1289; Schilling RK, 2014, PLANT BIOTECHNOL J, V12, P378, DOI 10.1111/pbi.12145; SCHULZE ED, 1986, ANNU REV PLANT PHYS, V37, P247, DOI 10.1146/annurev.pp.37.060186.001335; Sebastian J, 2016, P NATL ACAD SCI USA, V113, P8861, DOI 10.1073/pnas.1604021113; Sebolt AM, 2000, CROP SCI, V40, P1438, DOI 10.2135/cropsci2000.4051438x                                                    ; Semagn K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-313; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherrard ME, 2009, EVOLUTION, V63, P702, DOI 10.1111/j.1558-5646.2008.00580.x; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Song L, 2016, SCIENCE, V354, DOI 10.1126/science.aag1550; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Sulpice R, 2010, PLANT CELL, V22, P2872, DOI 10.1105/tpc.110.076653; Tapp I, 2000, BIOTECHNIQUES, V28, P732; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thirunavukkarasu N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1182; THOMPSON R, 1979, BIOMETRICS, V35, P339, DOI 10.2307/2529955                                                                 ; Thudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096758; Thudi M, 2012, BRIEF FUNCT GENOMICS, V11, P3, DOI 10.1093/bfgp/elr045; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tuberosa R, 1998, THEOR APPL GENET, V97, P744, DOI 10.1007/s001220050951; Tuberosa R, 2002, PLANT MOL BIOL, V48, P697, DOI 10.1023/A:1014897607670; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Tuberosa Roberto, 2009, P501, DOI 10.1007/978-0-387-79418-1_26; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Verslues PE, 2014, PLANT PHYSIOL, V164, P144, DOI 10.1104/pp.113.224014; Vikram P, 2012, FIELD CROP RES, V134, P185, DOI 10.1016/j.fcr.2012.05.012; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wallace JG, 2016, CROP SCI, V56, P2365, DOI 10.2135/cropsci2015.10.0632; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077                                                   ; Wang X., 2016, ATMOS CHEM PHYS DISC, V2016, P1, DOI DOI 10.1038/NG.3636; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wehner GG, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0524-3; Welcker C, 2007, J EXP BOT, V58, P339, DOI 10.1093/jxb/erl227; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Xiang YL, 2017, MOL PLANT, V10, P456, DOI 10.1016/j.molp.2016.10.003; Xiao YJ, 2016, NEW PHYTOL, V210, P1095, DOI 10.1111/nph.13814; Xu ZZ, 2009, CROP SCI, V49, P1843, DOI 10.2135/cropsci2008.12.0725; Xue YD, 2013, THEOR APPL GENET, V126, P2587, DOI 10.1007/s00122-013-2158-x; Yadaw RB, 2013, FIELD CROP RES, V144, P281, DOI 10.1016/j.fcr.2013.01.019; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang YH, 2015, J EXP BOT, V66, P6311, DOI 10.1093/jxb/erv342; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096; Zhu YL, 2003, GENETICS, V163, P1123; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	163	0	0	25	25	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	JUN 30	2017	8								1110	10.3389/fpls.2017.01110				12	Plant Sciences	Plant Sciences	EZ2XX	WOS:000404575500001	28713401				2018-01-05	
J	Smith, LC; Lun, CM				Smith, L. Courtney; Lun, Cheng Man			The SpTransformer Gene Family (Formerly Sp185/333) in the Purple Sea Urchin and the Functional Diversity of the Anti-Pathogen rSpTransformer-E1 Protein	FRONTIERS IN IMMUNOLOGY			English	Review						Sp185/333; multitasking; anti-pathogen; purple sea urchin; Strongylocentrotus; echinoderm; invertebrate; intrinsically disordered proteins	SECONDARY STRUCTURE ANALYSES; IMMUNE-RESPONSE PROTEINS; STRONGYLOCENTROTUS-PURPURATUS; PHOSPHATIDIC-ACID; V(D)J RECOMBINATION; EXPRESSION; SEQUENCE; LOCALIZATION; CELOMOCYTES; EVOLUTION	The complex innate immune system of sea urchins is underpinned by several multigene families including the SpTransformer family (SpTrf; formerly Sp185/333) with estimates of similar to 50 members, although the family size is likely variable among individuals of Strongylocentrotus purpuratus. The genes are small with similar structure, are tightly clustered, and have several types of repeats in the second of two exons and that surround each gene. The density of repeats suggests that the genes are positioned within regions of genomic instability, which may be required to drive sequence diversification. The second exon encodes the mature protein and is composed of blocks of sequence called elements that are present in mosaics of defined element patterns and are the major source of sequence diversity. The SpTrf genes respond swiftly to immune challenge, but only a single gene is expressed per phagocyte. Many of the mRNAs appear to be edited and encode proteins with altered and/or missense sequence that are often truncated, of which some may be functional. The standard SpTrf protein structure is an N-terminal glycine-rich region, a central RGD motif, a histidine-rich region, and a C-terminal region. Function is predicted from a recombinant protein, rSpTransformer-E1 (rSpTrf-E1), which binds to Vibrio and Saccharomyces, but not to Bacillus, and binds tightly to lipopolysaccharide, beta-1,3-glucan, and flagellin, but not to peptidoglycan. rSpTrf-E1 is intrinsically disordered but transforms to a helical structure in the presence of binding targets including lipopolysaccharide, which may underpin the characteristics of binding to multiple targets. SpTrf proteins associate with coelomocyte membranes, and rSpTrf-E1 binds specifically to phosphatidic acid (PA). When rSpTrf-E1 is bound to PA in liposome membranes, it induces morphological changes in liposomes that correlate with PA clustering and leakage of luminal contents, and it extracts or removes PA from the bilayer. The multitasking activities of rSpTrf-E1 infer multiple and perhaps overlapping activities for the hundreds of native SpTrf proteins that are produced by individual sea urchins. This likely generates a flexible and highly protective immune system for the sea urchin in its marine habitat that it shares with broad arrays of microbes that may be pathogens and opportunists.	[Smith, L. Courtney; Lun, Cheng Man] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Lun, Cheng Man] NCI, HIV Dynam & Replicat Program, Virus Cell Interact Sect, Ctr Canc Res, Frederick, MD 21701 USA	Smith, LC (reprint author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	csmith@gwu.edu			National Science Foundation [IOS-1146124, IOS-1550474]	Support for research on sea urchin immunology and writing this review was awarded by the National Science Foundation (IOS-1146124 and IOS-1550474) to LCS.	Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Buckley KM, 2008, J MOL BIOL, V379, P912, DOI 10.1016/j.jmb.2008.04.037; Buckley KM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-68; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Buckley KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-318; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585                                                    ; Cameron RA, 2000, P NATL ACAD SCI USA, V97, P9514, DOI 10.1073/pnas.160261897; Carmona LM, 2016, GENE DEV, V30, P909, DOI 10.1101/gad.278432.116; Clow LA, 2000, IMMUNOGENETICS, V51, P1021, DOI 10.1007/s002510000233; Cross PS, 1999, DEV COMP IMMUNOL, V23, P429, DOI 10.1016/S0145-305X(99)00022-1                                                   ; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; de Latour FA, 2010, BIOCHEM BIOPH RES CO, V396, P825, DOI 10.1016/j.bbrc.2010.04.158; Dheilly NM, 2013, DEV COMP IMMUNOL, V40, P35, DOI 10.1016/j.dci.2013.01.007; Dheilly NM, 2011, IMMUNOL CELL BIOL, V89, P861, DOI 10.1038/icb.2011.3; Dheilly NM, 2009, J IMMUNOL, V182, P2203, DOI 10.4049/jimmunol.07012766; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Ghosh J, 2010, DEV COMP IMMUNOL, V34, P235, DOI 10.1016/j.dci.2009.10.008; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234                                                           ; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hencken CG, 2012, NAT STRUCT MOL BIOL, V19, P834, DOI 10.1038/nsmb.2338; Ho ECH, 2016, IMMUNOL CELL BIOL, V94, P861, DOI 10.1038/icb.2016.51; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; Kassas N, 2017, J BIOL CHEM, V292, P4266, DOI 10.1074/jbc.M116.742346; Kober KM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-88; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Lee YH, 2003, MOL BIOL EVOL, V20, P1211, DOI 10.1093/molbev/msg125; Liu Y, 2013, ADV EXP MED BIOL, V991, P159, DOI 10.1007/978-94-007-6331-9_9; Lun CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00481; Lun CM, 2017, J IMMUNOL, V198, P2957, DOI 10.4049/jimmunol.1601795; Lun CM, 2016, IMMUNOBIOLOGY, V221, P889, DOI 10.1016/j.imbio.2016.03.006; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Majeske AJ, 2014, J IMMUNOL, V193, P5678, DOI 10.4049/jimmunol.1401681; Majeske AJ, 2013, INNATE IMMUN-LONDON, V19, P569, DOI 10.1177/1753425912473850; Majeske AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061419; Miller CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-575; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mondragon-Palomino M, 2002, GENOME RES, V12, P1305, DOI 10.1101/gr.159402; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Olender Tsviya, 2008, Human Genomics, V3, P87; Oren M, 2016, EVOLUTION IMMUNE SYS, P295; Oren M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3241-x; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Rast JP, 2000, CURR TOP MICROBIOL, V248, P3; Roth MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0062079; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5                                                    ; Sherman LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138892; Smith LC, 2016, ISJ-INVERT SURVIV J, V13, P355; Smith L Courtney, 2012, Front Immunol, V3, P70, DOI 10.3389/fimmu.2012.00070; Smith LC, 2010, ADV EXP MED BIOL, V708, P260; Smith LC, 1996, J IMMUNOL, V156, P593; Smith LC, 2016, PATHOGEN INFECT DIS, V2, pe1394, DOI DOI 10.14800/PID.1394; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; TAMBOLINE CR, 1992, J EXP ZOOL, V262, P51, DOI 10.1002/jez.1402620108                                                          ; Tang H, 2007, CHEM REV, V107, P3391, DOI 10.1021/cr0683008; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Vieira-Pires RS, 2010, J GEN PHYSIOL, V136, P585, DOI 10.1085/jgp.201010508; Wang YN, 2016, J OCEAN U CHINA, V15, P163, DOI 10.1007/s11802-016-2707-4; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	70	2	2	7	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	JUN 30	2017	8								725	10.3389/fimmu.2017.00725				20	Immunology	Immunology	EZ3BF	WOS:000404584100002	28713368				2018-01-05	
J	Levin, RA; Voolstra, CR; Agrawal, S; Steinberg, PD; Suggett, DJ; van Oppen, MJH				Levin, Rachel A.; Voolstra, Christian R.; Agrawal, Shobhit; Steinberg, Peter D.; Suggett, David J.; van Oppen, Madeleine J. H.			Engineering Strategies to Decode and Enhance the Genomes of Coral Symbionts	FRONTIERS IN MICROBIOLOGY			English	Article						synthetic biology; genetic engineering; dinoflagellate; Symbiodinium; zooxanthellae; coral bleaching	DINOFLAGELLATE GENUS SYMBIODINIUM; CRISPR-CAS9 RIBONUCLEOPROTEINS; OCEAN ACIDIFICATION; EXPRESSION VECTORS; THERMAL TOLERANCES; HYDROGEN-PEROXIDE; HOST-SPECIFICITY; CLIMATE-CHANGE; REEF CORALS; COPY NUMBER	Elevated sea surface temperatures from a severe and prolonged El Nino event (2014-2016) fueled by climate change have resulted in mass coral bleaching (loss of dinoflagellate photosymbionts, Symbiodinium spp., from coral tissues) and subsequent coral mortality, devastating reefs worldwide. Genetic variation within and between Symbiodinium species strongly influences the bleaching tolerance of corals, thus recent papers have called for genetic engineering of Symbiodinium to elucidate the genetic basis of bleaching-relevant Symbiodinium traits. However, while Symbiodinium has been intensively studied for over 50 years, genetic transformation of Symbiodinium has seen little success likely due to the large evolutionary divergence between Symbiodinium and other model eukaryotes rendering standard transformation systems incompatible. Here, we integrate the growing wealth of Symbiodinium next-generation sequencing data to design tailored genetic engineering strategies. Specifically, we develop a testable expression construct model that incorporates endogenous Symbiodinium promoters, terminators, and genes of interest, as well as an internal ribosomal entry site from a Symbiodinium virus. Furthermore, we assess the potential for CRISPR/Cas9 genome editing through new analyses of the three currently available Symbiodinium genomes. Finally, we discuss how genetic engineering could be applied to enhance the stress tolerance of Symbiodinium, and in turn, coral reefs.	[Levin, Rachel A.; Steinberg, Peter D.] Univ New South Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Levin, Rachel A.; Steinberg, Peter D.] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Levin, Rachel A.; Suggett, David J.] Univ Technol Sydney, Climate Change Cluster, Ultimo, NSW, Australia; [Voolstra, Christian R.; Agrawal, Shobhit] KAUST, Red Sea Res Ctr, Div Biol & Environm Sci & Engn BESE, Thuwal, Saudi Arabia; [Steinberg, Peter D.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld, Australia; [van Oppen, Madeleine J. H.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia	Levin, RA (reprint author), Univ New South Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia.; Levin, RA (reprint author), Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.; Levin, RA (reprint author), Univ Technol Sydney, Climate Change Cluster, Ultimo, NSW, Australia.	rachylevin@gmail.com	van Oppen, Madeleine/C-3261-2008; Suggett, David/G-9212-2017	Suggett, David/0000-0001-5326-2520	University of New South Wales; King Abdullah University of Science and Technology (KAUST)	Funding from the University of New South Wales and King Abdullah University of Science and Technology (KAUST) supported the analyses presented here.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Alavi M, 2001, ENVIRON MICROBIOL, V3, P380, DOI 10.1046/j.1462-2920.2001.00207.x                                                ; Allera-Moreau C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-74; Aranda M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39734; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Barshis DJ, 2014, MOL BIOL EVOL, V31, P1343, DOI 10.1093/molbev/msu107; Baumgarten S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-704; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Berkelmans R, 2006, P R SOC B, V273, P2305, DOI 10.1098/rspb.2006.3567; Boulotte NM, 2016, ISME J, V10, P2693, DOI 10.1038/ismej.2016.54; Breyer D, 2014, CRIT REV PLANT SCI, V33, P286, DOI 10.1080/07352689.2013.870422; Byler KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059596; CABOCHE M, 1990, PHYSIOL PLANTARUM, V79, P173; Cesar H., 2003, EC WORLDWIDE CORAL R; Chi JY, 2014, J EUKARYOT MICROBIOL, V61, P322, DOI 10.1111/jeu.12110; Clarke BD, 2013, ZEBRAFISH, V10, P472, DOI 10.1089/zeb.2012.0782; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; COLANDUONI JA, 1986, BIOORG CHEM, V14, P163, DOI 10.1016/0045-2068(86)90026-X; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Correa AMS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00127; Correa AMS, 2013, ISME J, V7, P13, DOI 10.1038/ismej.2012.75; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Davey MR, 2005, ACTA PHYSIOL PLANT, V27, P117, DOI 10.1007/s11738-005-0044-0; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Edmunds PJ, 2014, MAR ECOL PROG SER, V506, P129, DOI 10.3354/meps10808; Ortiz-Matamoros MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132693; Ortiz-Matamoros MF, 2015, CIENC MAR, V41, P21, DOI 10.7773/cm.v41i1.2449; Figueroa RI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142667; Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7; Gierz SL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00271; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3                                                    ; GOOMER RS, 1992, NUCLEIC ACIDS RES, V20, P4903, DOI 10.1093/nar/20.18.4903                                                          ; Goyen S, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3073-5; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jacobs DF, 2013, NEW PHYTOL, V197, P378, DOI 10.1111/nph.12020; Jiang J, 2012, BBA-BIOENERGETICS, V1817, P983, DOI 10.1016/j.bbabio.2012.03.027; Jones A. M., 2011, J MARINE BIOL, V2011, P12, DOI [10.1371/journal.pone.0010437, DOI 10.1371/JOURNAL.PONE.0010437]; Karas B. J., 2015, NATURE COMMUNICATION, V6, P1, DOI DOI 10.1038/NC0MMS7925; Kirk NL, 2016, ADV ENV MICROBIOLOGY, V2, P269, DOI 10.1007/978-3-319-28068-4_10; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Krueger T, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0326-0; Ladner JT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-217; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Leggat W, 2011, J EXP MAR BIOL ECOL, V408, P120, DOI 10.1016/j.jembe.2011.07.032; Levin RA, 2017, J EUKARYOT MICROBIOL, V64, P588, DOI 10.1111/jeu.12393; Levin RA, 2016, MOL BIOL EVOL, V33, P2201, DOI 10.1093/molbev/msw119; Levin RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097415; Levin RA, 2017, ISME J, V11, P808, DOI 10.1038/ismej.2016.154; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; MARKELL DA, 1992, SYMBIOSIS, V12, P19; Martinez-Salas E, 1999, CURR OPIN BIOTECH, V10, P458, DOI 10.1016/S0958-1669(99)00010-5                                                   ; Mathur J, 1998, METH MOL B, V82, P267; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; Moldowan JM, 1998, SCIENCE, V281, P1168, DOI 10.1126/science.281.5380.1168                                                   ; Mora C, 2016, CORAL REEFS, V35, P1271, DOI 10.1007/s00338-016-1479-z; Murray S. A., 2016, PERSPECT PHYCOL, V3, P37, DOI DOI 10.1127/PIP/2016/0039; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Muscatine L, 1990, CORAL REEFS ECOSYSTE, P75; Nehlsen K, 2006, GENE THER MOL BIOL, V10B, P233; Nymark M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24951; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parkinson JE, 2016, GENOME BIOL EVOL, V8, P665, DOI 10.1093/gbe/evw019; Piaggio AJ, 2017, TRENDS ECOL EVOL, V32, P97, DOI 10.1016/j.tree.2016.10.016; Pline WA, 2001, PESTIC BIOCHEM PHYS, V71, P48, DOI 10.1006/pest.2001.2556; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Powell W, 2014, SCI AM, V310, P68, DOI 10.1038/scientificamerican0314-68                                               ; Quigley KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094297; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reaka-Kudla M. L., 1996, BIODIVERSITY; Rinkevich B, 2014, CURR OPIN ENV SUST, V7, P28, DOI 10.1016/j.cosust.2013.11.018; Ritchie K. B., 2012, BENEFICIAL MICROORGA, P139, DOI 10.1007/978-3-642-21680-0_9; Rosic N, 2015, ISME J, V9, P844, DOI 10.1038/ismej.2014.182; Santos SR, 2003, BIOL BULL-US, V204, P10, DOI 10.2307/1543491; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shoguchi E, 2015, GENOME BIOL EVOL, V7, P2237, DOI 10.1093/gbe/evv137; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Sole R, 2015, ECOL COMPLEX, V22, P40, DOI 10.1016/j.ecocom.2015.01.005; Stoykova P, 2011, PLANT CELL TISS ORG, V105, P141, DOI 10.1007/s11240-010-9858-6; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; ten Lohuis MR, 1998, PLANT J, V13, P427; Thacker D., 2016, DNA REPLICATION RECO, P131, DOI [10.1007/978-4-431-55873-6_6, DOI 10.1007/978-4-431-55873-6_6]; Thomas L, 2014, MOL ECOL, V23, P3113, DOI 10.1111/mec.12801; Toller WW, 2001, BIOL BULL, V201, P360, DOI 10.2307/1543614; Tonk L, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-7; TRENCH RK, 1987, J PHYCOL, V23, P469, DOI 10.1111/j.1529-8817.1987.tb02534.x; Van Oppen MJH, 2017, GLOBAL CHANGE BIOL, V23, P3437, DOI 10.1111/gcb.13647; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733                                                          ; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vicens Q, 2003, J MOL BIOL, V326, P1175, DOI 10.1016/S0022-2836(02)01435-3; Wakefield TS, 2000, BIOL BULL, V199, P76, DOI 10.2307/1542709; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007                                                         ; Watrin E, 2003, BIOL CELL, V95, P507, DOI 10.1016/j.biolcel.2003.08.003; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weynberg KD, 2017, CORAL REEFS, V36, P773, DOI 10.1007/s00338-017-1568-7; Weynberg KD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00206; Wilkinson SP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0325-1; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xiang TT, 2015, PLANT J, V82, P67, DOI 10.1111/tpj.12789; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004; Zhang H, 2013, PROTIST, V164, P510, DOI 10.1016/j.protis.2013.04.002; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	116	1	1	28	28	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUN 30	2017	8								1220	10.3389/fmicb.2017.01220				11	Microbiology	Microbiology	EZ1EV	WOS:000404453800003	28713348				2018-01-05	
J	Yang, S; Chang, RB; Yang, HM; Zhao, T; Hong, Y; Kong, HE; Sun, XB; Qin, ZH; Jin, P; Li, SH; Li, XJ				Yang, Su; Chang, Renbao; Yang, Huiming; Zhao, Ting; Hong, Yan; Kong, Ha Eun; Sun, Xiaobo; Qin, Zhaohui; Jin, Peng; Li, Shihua; Li, Xiao-Jiang			CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease	JOURNAL OF CLINICAL INVESTIGATION			English	Article							KNOCK-IN MICE; MUTANT HUNTINGTIN; EARLY MOTOR; BEHAVIORAL DEFICITS; RNA INTERFERENCE; NEUROPATHOLOGY; ABNORMALITIES; DYSFUNCTION; NEURONS; VIVO	Huntington's disease is a neurodegenerative disorder caused by a polyglutamine repeat in the Huntingtin gene (HTT). Although suppressing the expression of mutant HTT (mHTT) has been explored as a therapeutic strategy to treat Huntington's disease, considerable efforts have gone into developing allele-specific suppression of mHTT expression, given that loss of Htt in mice can lead to embryonic lethality. It remains unknown whether depletion of HTT in the adult brain, regardless of its allele, could be a safe therapy. Here, we report that permanent suppression of endogenous mHTT expression in the striatum of mHTT-expressing mice (HD140Q-knockin mice) using CRISPR/Cas9-mediated inactivation effectively depleted HTT aggregates and attenuated early neuropathology. The reduction of mHTT expression in striatal neuronal cells in adult HD140Q-knockin mice did not affect viability, but alleviated motor deficits. Our studies suggest that non-allele-specific CRISPR/Cas9-mediated gene editing could be used to efficiently and permanently eliminate polyglutamine expansion-mediated neuronal toxicity in the adult brain.	[Yang, Su; Chang, Renbao; Yang, Huiming; Zhao, Ting; Hong, Yan; Kong, Ha Eun; Jin, Peng; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Chang, Renbao] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Chang, Renbao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Xiaobo] Emory Univ, Dept Math & Comp Sci, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Qin, Zhaohui] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Li, Xiao-Jiang] Jinan Univ, Minist Educ CNS Regenerat Collaborat Joint Lab, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China	Li, SH; Li, XJ (reprint author), 347 Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	sli@emory.edu; xli2@emory.edu		Qin, Zhaohui/0000-0002-1583-146X	NIH [NS036232, NS101701, NS095279]; National Natural Science Foundation of China [91332206]	This work was supported by grants from the NIH (NS036232 and NS101701, to XJL, and NS095279, to SHL) and the National Natural Science Foundation of China (grant 91332206).	Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Drouet V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099341; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Iyer V, NAT METHODS; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Liu XD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006083; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2002, J NEUROSCI, V22, P8266; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Palfi S, 2007, MOL THER, V15, P1444, DOI 10.1038/sj.mt.6300185; Pepin J, 2016, NEUROIMAGE, V139, P53, DOI 10.1016/j.neuroimage.2016.06.023; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yu ZX, 2003, J NEUROSCI, V23, P2193	21	9	9	12	12	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	JUN 30	2017	127	7					2719	2724		10.1172/JCI92087				6	Medicine, Research & Experimental	Research & Experimental Medicine	EZ2RM	WOS:000404557400029	28628038	green_published			2018-01-05	
J	Facchinello, N; Skobo, T; Meneghetti, G; Colletti, E; Dinarello, A; Tiso, N; Costa, R; Gioacchini, G; Carnevali, O; Argenton, F; Colombo, L; Dalla Valle, L				Facchinello, N.; Skobo, T.; Meneghetti, G.; Colletti, E.; Dinarello, A.; Tiso, N.; Costa, R.; Gioacchini, G.; Carnevali, O.; Argenton, F.; Colombo, L.; Dalla Valle, L.			nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptor	SCIENTIFIC REPORTS			English	Article							CORTICOSTEROID STRESS AXIS; PITUITARY-INTERRENAL AXIS; GENE-EXPRESSION; DANIO-RERIO; TRANSLATIONAL ISOFORMS; BETA-ISOFORM; MECHANISMS; CORTISOL; CELLS; MODEL	Glucocorticoids (GCs) play important roles in developmental and physiological processes through the transcriptional activity of their cognate receptor (Gr). Using CRISPR/Cas9 technology, we established a zebrafish null Gr mutant line and compared its phenotypes with wild type and a zebrafish line with partially silenced gr (gr(s357/s357)). Homozygous gr(-/-) larvae are morphologically inconspicuous and, in contrast to GR(-/-) knockout mice, viable through adulthood, although with reduced fitness and early life survival. Mutants gr(-/-) are fertile, but their reproductive capabilities fall at around 10 months of age, when, together with cardiac and intestinal abnormalities already visible at earlier stages, increased fat deposits are also observed. Mutants show higher levels of whole-body cortisol associated with overstimulated basal levels of crh and pomca transcripts along the HPI axis, which is unresponsive to a mechanical stressor. Transcriptional activity linked to immune response is also hampered in the gr(-/-) line: after intestinal damage by dextran sodium sulphate exposure, there are neither inflammatory nor anti-inflammatory cytokine gene responses, substantiating the hypothesis of a dual-action of the GC-GR complex on the immune system. Hence, the zebrafish gr mutant line appears as a useful tool to investigate Gr functions in an integrated in vivo model.	[Facchinello, N.; Skobo, T.; Colletti, E.; Dinarello, A.; Tiso, N.; Argenton, F.; Colombo, L.; Dalla Valle, L.] Univ Padua, Dept Biol, Padua, Italy; [Meneghetti, G.; Costa, R.] Univ Padua, Dept Mol Med, Padua, Italy; [Gioacchini, G.; Carnevali, O.] Marche Polytech Univ, Dept Life & Environm Sci, Ancona, Italy	Dalla Valle, L (reprint author), Univ Padua, Dept Biol, Padua, Italy.	luisa.dallavalle@unipd.it		Tiso, Natascia/0000-0002-5444-9853	Progetti di Ricerca di Ateneo, University of Padova, Italy [CPDA134095]; PRIN from the Ministry of the University and Scientific and Technological Research of Italy [2010W87LBJ]	We would like to thank Prof. Herwig Baier (Max Planck Institute of Neurobiology, Germany) for sharing the gr<SUP>s357/s357</SUP> mutant line and Zebrafish Facility of Padova and the aquarium team (Drs Martina Milanetto and Luigi Pivotti) for excellent care of zebrafish. This work was supported by Progetti di Ricerca di Ateneo (CPDA134095), University of Padova, Italy (LDV) and from PRIN 2010-2011 (2010W87LBJ) from the Ministry of the University and Scientific and Technological Research of Italy (OC).	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P5988, DOI 10.1210/jc.86.12.5988; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Alsop D, 2009, COMP BIOCHEM PHYS A, V153, P49, DOI 10.1016/j.cbpa.2008.12.008; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Benato F, 2014, MOL CELL ENDOCRINOL, V392, P60, DOI 10.1016/j.mce.2014.04.015; Bertotto D, 2011, GEN COMP ENDOCR, V174, P44, DOI 10.1016/j.ygcen.2011.08.003; Bonga SEW, 1997, PHYSIOL REV, V77, P591; Bury NR, 2007, GEN COMP ENDOCR, V153, P47, DOI 10.1016/j.ygcen.2007.03.009; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chatzopoulou A, 2017, MOL CELL ENDOCRINOL, V447, P61, DOI 10.1016/j.mce.2017.02.036; Chatzopoulou A, 2016, ENDOCRINOLOGY, V157, P2772, DOI 10.1210/en.2015-2050; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Drouin J, 2016, J MOL ENDOCRINOL, V56, pT99, DOI 10.1530/JME-15-0289; Duque ED, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00078; Eberhardt W, 2002, MOL ENDOCRINOL, V16, P1752, DOI 10.1210/me2001-0278; Evans AN, 2013, MOL ENDOCRINOL, V27, P1796, DOI 10.1210/me.2013-1095; Facchinello N, 2016, METHODS MOL BIOL, V1481, P81, DOI 10.1007/978-1-4939-6393-5_9; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Griffiths BB, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00068; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Grzegorski SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108475; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Jamalzadeh HR, 2013, J APPL ANIM RES, V41, P133, DOI 10.1080/09712119.2012.738228; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kwong RWM, 2013, J COMP PHYSIOL B, V183, P203, DOI 10.1007/s00360-012-0700-9; Lefevre F, 2016, AQUACULTURE, V464, P654, DOI 10.1016/j.aquaculture.2016.07.039; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023689; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Milla S, 2009, COMP BIOCHEM PHYS A, V153, P242, DOI 10.1016/j.cbpa.2009.02.027; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nesan D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22582; Nesan D, 2012, ENDOCRINOLOGY, V153, P1288, DOI 10.1210/en.2011-1559; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Nicolaides NC, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-71; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Oehlers SH, 2012, DIS MODEL MECH, V5, P457, DOI 10.1242/dmm.009365; Pikulkaew S, 2011, DEV DYNAM, V240, P874, DOI 10.1002/dvdy.22586; Reichardt HM, 1998, J STEROID BIOCHEM, V65, P111, DOI 10.1016/S0960-0760(97)00181-7; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schaaf MJM, 2009, COMP BIOCHEM PHYS A, V153, P75, DOI 10.1016/j.cbpa.2008.12.014; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Stolte EH, 2006, J ENDOCRINOL, V190, P17, DOI 10.1677/joe.1.06703; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Wilson KS, 2015, MOL CELL ENDOCRINOL, V414, P120, DOI 10.1016/j.mce.2015.07.025; Wu I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.193; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	53	1	1	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 29	2017	7								4371	10.1038/s41598-017-04535-6				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EY9QC	WOS:000404332100009	28663543	gold			2018-01-05	
J	Jung, C; Hawkins, JA; Jones, SK; Xiao, YB; Rybarski, JR; Dillard, KE; Hussmann, J; Saifuddin, FA; Savran, CA; Ellington, AD; Ke, A; Press, WH; Finkelstein, IJ				Jung, Cheulhee; Hawkins, John A.; Jones, Stephen K., Jr.; Xiao, Yibei; Rybarski, James R.; Dillard, Kaylee E.; Hussmann, Jeffrey; Saifuddin, Fatema A.; Savran, Cagri A.; Ellington, Andrew D.; Ke, Ailong; Press, William H.; Finkelstein, Ilya J.			Massively Parallel Biophysical Analysis of CRISPR-Cas Complexes on Next Generation Sequencing Chips	CELL			English	Article							R-LOOP FORMATION; RNA-GUIDED CAS9; ESCHERICHIA-COLI; SURVEILLANCE COMPLEX; SPACER ACQUISITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA RECOGNITION; SEED SEQUENCE; IMMUNE-SYSTEM	CRISPR-Cas nucleoproteins target foreign DNA via base pairing with a crRNA. However, a quantitative description of protein binding and nuclease activation at off-target DNA sequences remains elusive. Here, we describe a chip-hybridized association-mapping platform (CHAMP) that repurposes next-generation sequencing chips to simultaneously measure the interactions between proteins and similar to 10(7) unique DNA sequences. Using CHAMP, we provide the first comprehensive survey of DNA recognition by a type I-E CRISPR-Cas (Cascade) complex and Cas3 nuclease. Analysis of mutated target sequences and human genomic DNA reveal that Cascade recognizes an extended protospacer adjacent motif (PAM). Cascade recognizes DNA with a surprising 3-nt periodicity. The identity of the PAM and the PAM-proximal nucleotides control Cas3 recruitment by releasing the Cse1 subunit. These findings are used to develop a model for the biophysical constraints governing off-target DNA binding. CHAMP provides a framework for high-throughput, quantitative analysis of protein-DNA interactions on synthetic and genomic DNA.	[Jung, Cheulhee; Jones, Stephen K., Jr.; Rybarski, James R.; Dillard, Kaylee E.; Saifuddin, Fatema A.; Ellington, Andrew D.; Finkelstein, Ilya J.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Jung, Cheulhee; Jones, Stephen K., Jr.; Rybarski, James R.; Dillard, Kaylee E.; Saifuddin, Fatema A.; Ellington, Andrew D.; Finkelstein, Ilya J.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hawkins, John A.; Hussmann, Jeffrey; Press, William H.] Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA; [Xiao, Yibei; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA; [Savran, Cagri A.] Purdue Univ, Birck Nanotechnol Ctr, Sch Mech Engn, 1205 West State St, W Lafayette, IN 47907 USA; [Ellington, Andrew D.; Finkelstein, Ilya J.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Press, William H.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Press, William H.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Finkelstein, IJ (reprint author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Finkelstein, IJ (reprint author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Finkelstein, IJ (reprint author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	ifinkelstein@cm.utexas.edu	Jung, Cheulhee/D-2726-2017		College of Natural Sciences Catalyst award; CPRIT [R1214]; Welch Foundation [F-1808]; National Science Foundation [1453358]; NIH [F32 AG053051, R01 GM120554]; John Templeton Foundation [UTA16-000194]	We are indebted to our colleague Scott Hunicke-Smith and members of the Genomic Sequencing and Analysis Facility for valuable insights. We are grateful to members of the Finkelstein laboratory for carefully reading the manuscript. This work was supported by a College of Natural Sciences Catalyst award, CPRIT (R1214 to I.J.F.), the Welch Foundation (F-1808 to I.J.F.), the National Science Foundation (1453358), and the NIH (F32 AG053051 to S.K.J. and R01 GM120554 to I.J.F.). This publication was also made possible through the support of a grant from the John Templeton Foundation (UTA16-000194 to A.D.E). The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. I.J.F. is a CPRIT Scholar in Cancer Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation.	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edelstein A. D., 2014, J BIOL METHODS, V1, P10, DOI DOI 10.14440/JBM.2014.36; Efron B., 1993, INTRO BOOTSTRAP; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maneewongvatana S., 1999, CTR GEOM COMP 4 ANN, P1; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Press W. H., 2007, NUMERICAL RECIPES; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tome JM, 2014, NAT METHODS, V11, P683, DOI [10.1038/nmeth.2970, 10.1038/NMETH.2970]; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu Xuebing, 2014, Quant Biol, V2, P59; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	51	0	0	12	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					35	+		10.1016/j.cell.2017.05.044				26	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	WOS:000404358500008	28666121				2018-01-05	
J	Xiao, YB; Luo, M; Hayes, RP; Kim, J; Ng, S; Ding, F; Liao, MF; Ke, AL				Xiao, Yibei; Luo, Min; Hayes, Robert P.; Kim, Jonathan; Ng, Sherwin; Ding, Fang; Liao, Maofu; Ke, Ailong			Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System	CELL			English	Article							GUIDED SURVEILLANCE COMPLEX; BACTERIAL IMMUNE-SYSTEM; ESCHERICHIA-COLI; VITRO RECONSTITUTION; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; SEED SEQUENCE; DNA TARGET; RNA; CASCADE	Type I CRISPR systems feature a sequential dsDNA target searching and degradation process, by crRNA-displaying Cascade and nuclease-helicase fusion enzyme Cas3, respectively. Here we present two cryo-EM snapshots of the Thermobifida fusca type I-E Cascade: (1) unwinding 11 bp of dsDNA at the seed-sequence region to scout for sequence complementarity, and (2) further unwinding of the entire protospacer to form a full R-loop. These structures provide the much-needed temporal and spatial resolution to resolve key mechanistic steps leading to Cas3 recruitment. In the early steps, PAM recognition causes severe DNA bending, leading to spontaneous DNA unwinding to form a seed-bubble. The full R-loop formation triggers conformational changes in Cascade, licensing Cas3 to bind. The same process also generates a bulge in the non-target DNA strand, enabling its handover to Cas3 for cleavage. The combination of both negative and positive checkpoints ensures stringent yet efficient target degradation in type I CRISPR-Cas systems.	[Xiao, Yibei; Hayes, Robert P.; Kim, Jonathan; Ng, Sherwin; Ding, Fang; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA; [Luo, Min; Liao, Maofu] Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave,SGM 509, Boston, MA 02115 USA; [Hayes, Robert P.] Merck & Co Inc, 770 Sumneytown Pike, West Point, PA 19486 USA	Ke, A (reprint author), Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA.; Liao, MF (reprint author), Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave,SGM 509, Boston, MA 02115 USA.	maofu_liao@hms.harvard.edu; ailong.ke@cornell.edu			National Institutes of Health (NIH) [GM118174, GM116632]	This work is supported by National Institutes of Health (NIH) grants GM118174 and GM116632 to A.K. We thank M. Chambers and Z. Li for EM technical support; B. Carragher, C. Potter, and R. Grassucci for initial EM analysis; and I. Finkelstein, I. Price, R. Battaglia, and A. Dolan for discussions. Reprints and permissions information are available at XXXX. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to A.K. (ailong.ke@cornell.edu) or M.L. (maofu_liao@hms.harvard.edu). A. K. dedicates this work to his colleague, Professor David B. Wilson (deceased), in memory of his scientific contribution in exploring the bacterium Thermobifida fusca.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Emsley P., 2004, D BIOL CRYSTALLOGR, V60, P2126, DOI DOI 10.1107/S0907444904019158; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0                                                                ; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Rutkauskas M., 2015, CELL REP; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	55	1	1	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					48	+		10.1016/j.cell.2017.06.012				24	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	WOS:000404358500009	28666122				2018-01-05	
J	Wang, JL; Elsheikha, HM; Zhu, WN; Chen, K; Li, TT; Yue, DM; Zhang, XX; Huang, SY; Zhu, XQ				Wang, Jin-Lei; Elsheikha, Hany M.; Zhu, Wei-Ning; Chen, Kai; Li, Ting-Ting; Yue, Dong-Mei; Zhang, Xiao-Xuan; Huang, Si-Yang; Zhu, Xing-Quan			Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice	FRONTIERS IN IMMUNOLOGY			English	Article						Toxoplasma gondii; immunization; live-attenuated vaccine; Delta GRA17; Th1/Th2 cytokines	TOXOPLASMA-GONDII INFECTION; CONGENITAL TOXOPLASMOSIS; IFN-GAMMA; T-CELLS; MIC1-3 KNOCKOUT; INNATE IMMUNITY; PREGNANT MICE; B-CELLS; VACCINE; TRANSMISSION	Toxoplasmosis remains a world-threatening disease largely because of the lack of a fully effective vaccine. Here, we created a Delta GRA17 mutant by disrupting the virulence factor GRA17 using CRISPR-Cas9 method. Then, we tested whether Delta GRA17 tachyzoites can be used as a live-attenuated vaccine against acute, chronic, and congenital Toxoplasma gondii infection in mice. Immune response evoked by Delta GRA17 immunization suggested a sequential Th1 and Th2 T cell response, indicated by high levels of Th1 and a mixed Th1/Th2 cytokines at 28 and 70 days after immunization, respectively. Delta GRA17-mediated immunity fully protected mice against lethal infection with wild-type (wt) RH strain, heterologous challenge with PYS, and TgC7 strains of the Chinese ToxoDB#9 genotype, and T. gondii Pru strain. Although parasite cysts were detected in 8 out of 10 immunized mice, cyst burden in the brain was significantly reduced (P < 0.05) in immunized mice (53 +/- 15 cysts/brain) compared to non-immunized mice (4,296 +/- 687 cysts/brain). In respect to congenital infection, the litter size, survival rate, and body weight (BW) of pups born to Delta GRA17-immunized dams were not different compared to pups born to naive control dams (P = 0.24). However, a marked reduction in the litter size (P < 0.001), survival rate, and BW (P < 0.01) of pups born to non-immunized and infected dams was detected. Also, immunized dams infected with type II Pru strain had significantly (P < 0.001) less cyst burden in the brain compared with non-immunized and infected dams. These findings show that immunization with Delta GRA17 strain evokes cell-mediated and neutralizing antibody responses and confers some degree of protection against challenge with homologous and heterologous virulent T. gondii strains.	[Wang, Jin-Lei; Zhu, Wei-Ning; Chen, Kai; Li, Ting-Ting; Yue, Dong-Mei; Zhang, Xiao-Xuan; Huang, Si-Yang; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China; [Elsheikha, Hany M.] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Loughborough, Leics, England; [Zhu, Wei-Ning] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Huang, SY; Zhu, XQ (reprint author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	siyang.huang@hotmail.com; xingquanzhu1@hotmail.com			Natural Science Foundation of Gansu Province [1506RJDA133]; National Natural Science Foundation of China [31472184, 31230073]; National Key Research and Development Program of China [2017YFD0501300]; Fundamental Research Funds of Chinese Academy of Agricultural Sciences [Y2016JC05]	This research was supported, in part, by the Natural Science Foundation of Gansu Province for Distinguished Young Scholars (Grant No. 1506RJDA133), the National Natural Science Foundation of China (Grant Nos. 31472184 and 31230073), the National Key Research and Development Program of China (2017YFD0501300), and the Fundamental Research Funds of Chinese Academy of Agricultural Sciences (Grant No. Y2016JC05).	Abou-Bacar A, 2004, PARASITE IMMUNOL, V26, P315, DOI 10.1111/j.0141-9838.2004.00713.x; Akbar H, 2015, INFECT IMMUN, V83, P3601, DOI 10.1128/IAI.00217-15; Bastos LM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00059; BUXTON D, 1991, VET REC, V129, P89, DOI 10.1136/vr.129.5.89                                                             ; Cao LL, 2016, PARASITOL RES, V115, P797, DOI 10.1007/s00436-015-4807-2; Craver MPJ, 2007, MOL BIOCHEM PARASIT, V153, P149, DOI 10.1016/j.molbiopara.2007.02.013; Doliwa C, 2013, PARASITE, V20, DOI 10.1051/parasite/2013020; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009; Fox BA, 2015, INFECT IMMUN, V83, P2148, DOI 10.1128/IAI.02756-14; Fux B, 2007, INFECT IMMUN, V75, P2580, DOI 10.1128/IAI..00085-07; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hiszczynska-Sawicka E, 2014, PARASITOLOGY, V141, P1365, DOI 10.1017/S0031182014000481; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Ismael AB, 2006, J INFECT DIS, V194, P1176, DOI 10.1086/507706; Ivanova DL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00347; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9                                                   ; Katlama C, 1996, CLIN INFECT DIS, V22, P268, DOI 10.1093/clinids/22.2.268                                                        ; Lao KX, 2015, MICROB PATHOGENESIS, V89, P210, DOI 10.1016/j.micpath.2015.10.002; Ma JS, 2014, J EXP MED, V211, P2013, DOI 10.1084/jem.20131272; Mercier C, 1998, INFECT IMMUN, V66, P4176; Mevelec MN, 2010, VET RES, V41, DOI 10.1051/vetres/2010021; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574                                                     ; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Petersen E, 2001, INT J PARASITOL, V31, P115, DOI 10.1016/S0020-7519(00)00140-5; Pfaff A. W., 2008, Parassitologia (Rome), V50, P55; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Robert-Gangneux F, 2014, J INFECTION, V68, pS125, DOI 10.1016/j.jinf.2013.09.023; ROBERTS CW, 1992, PARASITOLOGY, V104, P19, DOI 10.1017/S0031182000060753                                                       ; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sayles PC, 2000, INFECT IMMUN, V68, P1026, DOI 10.1128/IAI.68.3.1026-1033.2000; Schmidt DR, 2006, EUR J PEDIATR, V165, P19, DOI 10.1007/s00431-005-1665-4; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263                                                    ; Shiono Y, 2007, PARASITOL INT, V56, P141, DOI 10.1016/j.parint.2007.01.008; SHIRAHATA T, 1993, MICROBIOL IMMUNOL, V37, P583, DOI 10.1111/j.1348-0421.1993.tb01680.x                                              ; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; Thouvenin M., 1997, Parassitologia (Rome), V39, P279; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Wang Jin-Lei, 2017, Front Microbiol, V8, P84, DOI 10.3389/fmicb.2017.00084; Wang JL, 2016, TRENDS PARASITOL, V32, P542, DOI 10.1016/j.pt.2016.04.013; Wang JL, 2016, PARASITOL RES, V115, P697, DOI 10.1007/s00436-015-4791-6; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zhang NZ, 2015, EXPERT REV VACCINES, V14, P1609, DOI 10.1586/14760584.2015.1098539; Zhang NZ, 2015, EXPERT REV VACCINES, V14, P1289, DOI 10.1586/14760584.2015.1061938; Zhang NZ, 2013, EXPERT REV VACCINES, V12, P1287, DOI 10.1586/14760584.2013.844652; Zhou CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19557	50	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	JUN 29	2017	8								730	10.3389/fimmu.2017.00730				14	Immunology	Immunology	EZ3AT	WOS:000404582900001	28706518				2018-01-05	
J	Angelos, MG; Ruh, PN; Webber, BR; Blum, RH; Ryan, CD; Bendzick, L; Shim, S; Yingst, AM; Tufa, DM; Verneris, MR; Kaufman, DS				Angelos, Mathew G.; Ruh, Paige N.; Webber, Beau R.; Blum, Robert H.; Ryan, Caitlin D.; Bendzick, Laura; Shim, Seonhui; Yingst, Ashley M.; Tufa, Dejene M.; Verneris, Michael R.; Kaufman, Dan S.			Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells	BLOOD			English	Article							INNATE LYMPHOID-CELLS; HEMATOPOIETIC PROGENITOR CELLS; NATURAL-KILLER-CELLS; DIFFERENTIATION CULTURES; IN-VITRO; GENE-REGULATION; AHR; ENDOTHELIUM; EXPRESSION; EXPANSION	The aryl hydrocarbon receptor (AHR) plays an important physiological role in hematopoiesis. AHR is highly expressed in hematopoietic stem and progenitor cells (HSPCs) and inhibition of AHR results in a marked expansion of human umbilical cord blood-derived HSPCs following cytokine stimulation. It is unknown whether AHR also contributes earlier in human hematopoietic development. To model hematopoiesis, human embryonic stem cells (hESCs) were allowed to differentiate in defined conditions in the presence of the AHR antagonist StemReginin-1 (SR-1) or the AHR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). We demonstrate a significant increase in CD34(+)CD31(+) hematoendothelial cells in SR-1-treated hESCs, as well as a twofold expansion of CD34(+)CD45(+) hematopoietic progenitor cells. Hematopoietic progenitor cells were also significantly increased by SR-1 as quantified by standard hematopoietic colony-forming assays. Using a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-engineered hESC-RUNX1c-tdTomato reporter cell line with AHR deletion, we further demonstrate a marked enhancement of hematopoietic differentiation relative to wild-type hESCs. We also evaluated whether AHR antagonism could promote innate lymphoid cell differentiation from hESCs. SR-1 increased conventional natural killer (cNK) cell differentiation, whereas TCDD treatment blocked cNK development and supported group 3 innate lymphoid cell (ILC3) differentiation. Collectively, these results demonstrate that AHR regulates early human hematolymphoid cell development and may be targeted to enhance production of specific cell populations derived from human pluripotent stem cells.	[Angelos, Mathew G.; Ruh, Paige N.; Ryan, Caitlin D.; Bendzick, Laura; Kaufman, Dan S.] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA; [Angelos, Mathew G.; Ruh, Paige N.; Ryan, Caitlin D.; Bendzick, Laura; Verneris, Michael R.; Kaufman, Dan S.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA; [Angelos, Mathew G.] Univ Minnesota, Med Sci Training Program, Minneapolis, MN USA; [Webber, Beau R.; Shim, Seonhui; Yingst, Ashley M.; Tufa, Dejene M.; Verneris, Michael R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Blum, Robert H.; Kaufman, Dan S.] Univ Calif San Diego, Dept Med, Div Regenerat Med, 9500 Gilman Dr,MC 0695, La Jolla, CA 92093 USA; [Shim, Seonhui; Yingst, Ashley M.; Tufa, Dejene M.; Verneris, Michael R.] Univ Colorado, Dept Pediat, Div Pediat Hematol Oncol Bone Marrow Transplantat, Denver, CO 80202 USA	Kaufman, DS (reprint author), Univ Calif San Diego, Dept Med, Div Regenerat Med, 9500 Gilman Dr,MC 0695, La Jolla, CA 92093 USA.	dskaufman@ucsd.edu			National Institutes of Health grants: National Cancer Institute [R01CA203348]; National Institute of Diabetes and Digestive and Kidney Diseases [F30DK107071]; National Institute of Allergy and Immunology [R01AI100879]; National Institute of General Medicine Sciences [T32GM113846, T32GM008244]; Regenerative Medicine Minnesota program	This work was supported in part by the following National Institutes of Health grants: National Cancer Institute R01CA203348 (D.S.K.), National Institute of Diabetes and Digestive and Kidney Diseases F30DK107071 (M.G.A.), National Institute of Allergy and Immunology R01AI100879 (M.R.V.), and National Institute of General Medicine Sciences T32GM113846 (M.G.A. and D.S.K.) and T32GM008244 (M.G.A.). Other support was received from the Regenerative Medicine Minnesota program (D.S.K.).	Ahn YO, 2013, BLOOD, V121, P2234, DOI 10.1182/blood-2012-07-440099; Bai H, 2016, J CELL PHYSIOL, V231, P1065, DOI 10.1002/jcp.25199; Bai H, 2010, J CELL BIOCHEM, V109, P363, DOI 10.1002/jcb.22410; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Choi KD, 2012, CELL REPORTS, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Choi KD, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.184; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ferrell PI, 2015, STEM CELLS, V33, P1130, DOI 10.1002/stem.1940; Flaveny C, 2008, ARCH BIOCHEM BIOPHYS, V471, P215, DOI 10.1016/j.abb.2008.01.014; Flaveny CA, 2010, TOXICOL SCI, V114, P217, DOI 10.1093/toxsci/kfp308; Forgacs AL, 2013, TOXICOL SCI, V133, P54, DOI 10.1093/toxsci/kft028; Gori JL, 2015, J CLIN INVEST, V125, P1243, DOI 10.1172/JCI79328; Gori JL, 2012, BLOOD, V120, pE35, DOI 10.1182/blood-2012-05-433797; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Hermanson DL, 2016, STEM CELLS, V34, P93, DOI 10.1002/stem.2230; Hirose S, 2013, STEM CELL REP, V1, P499, DOI 10.1016/j.stemcr.2013.10.010; Julliard W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00458; Karrich JJ, 2016, CURR OPIN HEMATOL, V23, P410, DOI 10.1097/MOH.0000000000000262; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598                                                          ; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kerzee JK, 2001, CIRC RES, V89, P573, DOI 10.1161/hh1901.097083; Knorr DA, 2013, STEM CELLS DEV, V22, P1861, DOI 10.1089/scd.2012.0608; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lindsey S, 2012, STEM CELL REV REP, V8, P1223, DOI 10.1007/s12015-012-9384-5; Lohmann F, 2008, DEVELOPMENT, V135, P2071, DOI 10.1242/dev.018200; Martin CH, 2008, BLOOD, V112, P2730, DOI 10.1182/blood-2008-01-133801; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Nakajima-Takagi Y, 2013, BLOOD, V121, P447, DOI 10.1182/blood-2012-05-431403; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Ni Zhenya, 2013, Methods Mol Biol, V1029, P33, DOI 10.1007/978-1-62703-478-4_3; Pollenz RS, 2002, CHEM-BIOL INTERACT, V141, P41, DOI 10.1016/S0009-2797(02)00065-0; Roeven MWH, 2015, STEM CELLS DEV, V24, P2886, DOI 10.1089/scd.2014.0597; Schneider AJ, 2014, INT J MOL SCI, V15, P17852, DOI 10.3390/ijms151017852; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x                                              ; Singh KP, 2014, STEM CELLS DEV, V23, P95, DOI 10.1089/scd.2013.0346; Singh KP, 2011, STEM CELLS DEV, V20, P769, DOI 10.1089/scd.2010.0333; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Slukvin II, 2013, CELL CYCLE, V12, P720, DOI 10.4161/cc.23823; Smith BW, 2013, BLOOD, V122, P376, DOI 10.1182/blood-2012-11-466722; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI [10.1038/nbt.2915, 10.1038/nbt.2195]; Tian XH, 2009, STEM CELLS, V27, P2675, DOI 10.1002/stem.204; Toscano MG, 2015, MOL THER, V23, P158, DOI 10.1038/mt.2014.196; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wagage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128335; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; WHITELAW ML, 1993, EMBO J, V12, P4169; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Zape JP, 2011, SEMIN CELL DEV BIOL, V22, P1036, DOI 10.1016/j.semcdb.2011.10.003; Zhou L, 2016, TRENDS IMMUNOL, V37, P17, DOI 10.1016/j.it.2015.11.007	64	0	0	4	4	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	JUN 29	2017	129	26					3428	3439		10.1182/blood-2016-07-730440				12	Hematology	Hematology	EY9WU	WOS:000404350500007	28533309				2018-01-05	
J	Machado, H; Gram, L				Machado, Henrique; Gram, Lone			Comparative Genomics Reveals High Genomic Diversity in the Genus Photobacterium	FRONTIERS IN MICROBIOLOGY			English	Article						Photobacterium; Vibrionaceae; comparative genomics; pan-genome; core-genome	MULTILOCUS SEQUENCE-ANALYSIS; DAMSELAE SUBSP DAMSELAE; DNA-DNA HYBRIDIZATION; SP-NOV.; HIGH-PRESSURE; SUBSYSTEMS TECHNOLOGY; PHYLOGENETIC ANALYSIS; HORIZONTAL TRANSFER; VIRULENCE PLASMID; UNITED-STATES	Vibrionaceae is a large marine bacterial family, which can constitute up to 50% of the prokaryotic population in marine waters. Photobacterium is the second largest genus in the family and we used comparative genomics on 35 strains representing 16 of the 28 species described so far, to understand the genomic diversity present in the Photobacterium genus. Such understanding is important for ecophysiology studies of the genus. We used whole genome sequences to evaluate phylogenetic relationships using several analyses (16S rRNA, MLSA, fur, amino-acid usage, ANI), which allowed us to identify two misidentified strains. Genome analyses also revealed occurrence of higher and lower GC content clades, correlating with phylogenetic clusters. Pan-and core-genome analysis revealed the conservation of 25% of the genome throughout the genus, with a large and open pan-genome. The major source of genomic diversity could be traced to the smaller chromosome and plasmids. Several of the physiological traits studied in the genus did not correlate with phylogenetic data. Since horizontal gene transfer (HGT) is often suggested as a source of genetic diversity and a potential driver of genomic evolution in bacterial species, we looked into evidence of such in Photobacterium genomes. Genomic islands were the source of genomic differences between strains of the same species. Also, we found transposase genes and CRISPR arrays that suggest multiple encounters with foreign DNA. Presence of genomic exchange traits was widespread and abundant in the genus, suggesting a role in genomic evolution. The high genetic variability and indications of genetic exchange make it difficult to elucidate genome evolutionary paths and raise the awareness of the roles of foreign DNA in the genomic evolution of environmental organisms.	[Machado, Henrique; Gram, Lone] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Machado, Henrique] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Gram, L (reprint author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	gram@bio.dtu.dk			People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7-People-ITN [317058]	HM was supported by a Ph.D. grant from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7-People-2012-ITN, under grant agreement No. 317058, "BACTORY."	Andreoni F, 2014, J IMMUNOL RES, DOI 10.1155/2014/793817; Ast JC, 2004, ARCH MICROBIOL, V181, P352, DOI 10.1007/s00203-004-0663-7; Ast JC, 2007, INT J SYST EVOL MICR, V57, P2073, DOI 10.1099/ijs.0.65153-0; Attar N, 2015, NAT REV MICROBIOL, V13, P738, DOI 10.1038/nrmicro3585; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Bjornsdottir-Butler K, 2016, APPL ENVIRON MICROB, V82, P2167, DOI 10.1128/AEM.02833-15; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Choi EJ, 2015, CHEM BIOL, V22, P1270, DOI 10.1016/j.chembiol.2015.07.014; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Dunlap P.V., 2009, ENCY MICROBIOLOGY, P45; Eloe EA, 2008, APPL ENVIRON MICROB, V74, P6298, DOI 10.1128/AEM.01316-08; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Figge MJ, 2014, SYST APPL MICROBIOL, V37, P329, DOI 10.1016/j.syapm.2014.05.003; Gabriel MW, 2014, APPL ENVIRON MICROB, V80, P5359, DOI 10.1128/AEM.01206-14; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Gomez-Gil B, 2011, INT J SYST EVOL MICR, V61, P315, DOI 10.1099/ijs.0.019687-0; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gram L, 2010, MAR BIOTECHNOL, V12, P439, DOI 10.1007/s10126-009-9233-y; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gu JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S11; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Holmes B., 2008, INT J SYST EVOL MICR, V59, P2638, DOI [10.1099/ijs.0.017145-0, DOI 10.1099/IJS.0.017145-0]; Hundenborn J, 2013, CASE REP MED, V2013, DOI DOI 10.1155/2013/610632; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Kanki M, 2004, INT J FOOD MICROBIOL, V92, P79, DOI 10.1016/j.ijfoodmicro.2003.08.019; Kanki M, 2007, APPL ENVIRON MICROB, V73, P1467, DOI 10.1128/AEM.01907-06; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Kim BC, 2011, CURR MICROBIOL, V63, P433, DOI 10.1007/s00284-011-9994-1; Kim EJ, 2015, TRENDS MICROBIOL, V23, P479, DOI 10.1016/j.tim.2015.03.010; Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P606, DOI 10.1128/AAC.01216-07; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Lauro FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096953; LeRoux F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00830; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; Lilburn TG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-369; Liu Y, 2014, INT J SYST EVOL MICR, V64, P475, DOI 10.1099/ijs.0.055020-0; Lo N, 2014, INT J SYST EVOL MICR, V64, P625, DOI 10.1099/ijs.0.056861-0; Loman NJ, 2015, NAT REV MICROBIOL, V13, P787, DOI 10.1038/nrmicro3565; Lucena T, 2011, INT J SYST EVOL MICR, V61, P1579, DOI 10.1099/ijs.0.025171-0; Lukjancenko O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00073; Luo HW, 2015, MATH PROBL ENG, DOI 10.1155/2015/917259; Machado H., 2014, GENOME ANNOUNC, V2, P9, DOI 10.1128/genomeA.00535-14; Machado H, 2015, INT J SYST EVOL MICR, V65, P4503, DOI 10.1099/ijsem.0.000603; Machado H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1365-z; Machado H, 2015, APPL ENVIRON MICROB, V81, P2745, DOI 10.1128/AEM.00058-15; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; Mathew D. C., 2015, GENOME ANNOUNC, V3, P12204, DOI 10.1128/genomeA.00530-15; Mathew DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121178; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moreira APB, 2014, PEERJ, V2, DOI 10.7717/peerj.427; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Nielsen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084992; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Nonaka L, 2012, MICROBES ENVIRON, V27, P263, DOI 10.1264/jsme2.ME11338; Osorio CR, 2008, J BACTERIOL, V190, P3353, DOI 10.1128/JB.00109-08; Osorio CR, 2015, APPL ENVIRON MICROB, V81, P5867, DOI 10.1128/AEM.01580-15; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE766, DOI 10.1073/pnas.1500203112; Park YD, 2006, INT J SYST EVOL MICR, V56, P745, DOI 10.1099/ijs.0.63811-0; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Pennotti R, 2013, FOODBORNE PATHOG DIS, V10, P1059, DOI 10.1089/fpd.2013.1514; Qin QL, 2014, ENVIRON MICROBIOL, V16, P1642, DOI 10.1111/1462-2920.12318; Rajpara N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00057; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; Rivas AJ, 2013, INFECT IMMUN, V81, P3287, DOI 10.1128/IAI.00155-13; Rivas AJ, 2011, INFECT IMMUN, V79, P4617, DOI 10.1128/IAI.05436-11; Rivas R, 2006, INT J SYST EVOL MICR, V56, P1067, DOI 10.1099/ijs.0.64099-0                                                           ; Romano S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00387; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; Seo HJ, 2005, INT J SYST EVOL MICR, V55, P2293, DOI 10.1099/ijs.0.63765-0; Srinivas TNR, 2013, SYST APPL MICROBIOL, V36, P160, DOI 10.1016/j.syapm.2012.12.002; Stauder M, 2012, ENV MICROBIOL REP, V4, P439, DOI 10.1111/j.1758-2229.2012.00356.x; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Urbanczyk H, 2008, J BACTERIOL, V190, P3494, DOI 10.1128/JB.00101-08; Urbanczyk H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082917; Urbanczyk H, 2012, ENV MICROBIOL REP, V4, P412, DOI 10.1111/j.1758-2229.2012.00355.x; Urbanczyk H, 2011, FEMS MICROBIOL REV, V35, P324, DOI 10.1111/j.1574-6976.2010.00250.x; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; Vesth T, 2010, MICROB ECOL, V59, P1, DOI 10.1007/s00248-009-9596-7; Vitulo N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S23; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wietz M, 2010, MAR DRUGS, V8, P2946, DOI 10.3390/md8122946; Wietz M, 2010, AQUAT MICROB ECOL, V61, P179, DOI 10.3354/ame01443; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	104	0	0	14	14	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUN 29	2017	8								1204	10.3389/fmicb.2017.01204				14	Microbiology	Microbiology	EY9PL	WOS:000404330400002	28706512				2018-01-05	
J	Romanel, A; Garritano, S; Stringa, B; Blattner, M; Dalfovo, D; Chakravarty, D; Soong, D; Cotter, KA; Petris, G; Dhingra, P; Gasperini, P; Cereseto, A; Elemento, O; Sboner, A; Khurana, E; Inga, A; Rubin, MA; Demichelis, F				Romanel, Alessandro; Garritano, Sonia; Stringa, Blerta; Blattner, Mirjam; Dalfovo, Davide; Chakravarty, Dimple; Soong, David; Cotter, Kellie A.; Petris, Gianluca; Dhingra, Priyanka; Gasperini, Paola; Cereseto, Anna; Elemento, Olivier; Sboner, Andrea; Khurana, Ekta; Inga, Alberto; Rubin, Mark A.; Demichelis, Francesca			Inherited determinants of early recurrent somatic mutations in prostate cancer	NATURE COMMUNICATIONS			English	Article							GENOME-WIDE ASSOCIATION; BINDING; RISK; GENE; SPOP; IDENTIFICATION; FREQUENCY; VARIANTS; TMPRSS2; FUSION	Prostate cancer is a highly heritable molecularly and clinically heterogeneous disease. To discover germline events involved in prostate cancer predisposition, we develop a computational approach to nominate heritable facilitators of somatic genomic events in the context of the androgen receptor signaling. Here, we use a ranking score and benign prostate transcriptomes to identify a non-coding polymorphic regulatory element at 7p14.3 that associates with DNA repair and hormone-regulated transcript levels and with an early recurrent prostate cancer-specific somatic mutation in the Speckle-Type POZ protein (SPOP) gene. The locus shows allele-specific activity that is concomitantly modulated by androgen receptor and by CCAAT/enhancer-binding protein (C/EBP) beta (CEBPB). Deletion of this locus via CRISPR-Cas9 leads to deregulation of the genes predicted to interact with the 7p14.3 locus by Hi-C chromosome conformation capture data. This study suggests that a polymorphism at 7p14.3 may predispose to SPOP mutant prostate cancer subclass through a hormone-dependent DNA damage response.	[Romanel, Alessandro; Garritano, Sonia; Stringa, Blerta; Blattner, Mirjam; Dalfovo, Davide; Petris, Gianluca; Gasperini, Paola; Cereseto, Anna; Inga, Alberto; Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, Via Sommarive 9, I-38123 Trento, Italy; [Chakravarty, Dimple; Cotter, Kellie A.; Elemento, Olivier; Sboner, Andrea; Khurana, Ekta; Rubin, Mark A.; Demichelis, Francesca] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York Presbyterian Hosp, 413 East 69th St, New York, NY 10021 USA; [Soong, David; Dhingra, Priyanka; Elemento, Olivier] Weill Cornell Med, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA; [Rubin, Mark A.] Weill Cornell Med, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10065 USA; [Rubin, Mark A.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, 1300 York Ave, New York, NY 10065 USA	Demichelis, F (reprint author), Univ Trento, Ctr Integrat Biol, Via Sommarive 9, I-38123 Trento, Italy.; Demichelis, F (reprint author), Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York Presbyterian Hosp, 413 East 69th St, New York, NY 10021 USA.	f.demichelis@unitn.it		Cotter, Kellie/0000-0002-2574-815X; Romanel, Alessandro/0000-0003-4855-8620; Petris, Gianluca/0000-0002-2420-6359; Romanel, Alessandro/0000-0002-2376-8552	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 13562, IG 19221]; U.S. Department of Defense [PC094516]	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 13562 and IG 19221 to F.D.) and the U.S. Department of Defense (PC094516 to F.D.). We would like to thank Nima Sharifi and Francesca Lorenzin for constructive discussions on the manuscript, Myriam Kossai for technical work, and the LaBSSAH-CIBIO Next Generation Sequencing Facility of the University of Trento for sequencing samples.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blattner M, 2014, NEOPLASIA, V16, P14, DOI 10.1593/neo.131704; Boysen G, 2015, ELIFE, V4, DOI 10.7554/eLife.09207; Bu HJ, 2016, HUM MUTAT, V37, P52, DOI 10.1002/humu.22909; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Clinckemalie L, 2013, MOL ENDOCRINOL, V27, P2028, DOI 10.1210/me.2013-1098; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695; Demichelis F, 2012, P NATL ACAD SCI USA, V109, P6686, DOI 10.1073/pnas.1117405109; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FitzGerald LM, 2011, CANCER EPIDEM BIOMAR, V20, P1196, DOI 10.1158/1055-9965.EPI-10-1299; Garritano S, 2015, ONCOTARGET, V6, P4816, DOI 10.18632/oncotarget.3019                                                        ; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Habegger L, 2011, BIOINFORMATICS, V27, P281, DOI 10.1093/bioinformatics/btq643; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hofer MD, 2009, CANCER RES, V69, P640, DOI 10.1158/0008-5472.CAN-08-2008; Jakobsen JS, 2013, GENOME RES, V23, P592, DOI 10.1101/gr.146399.112; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089; Luedeke M, 2016, HUM MOL GENET, V25, P5490, DOI 10.1093/hmg/ddw349; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rickman DS, 2012, P NATL ACAD SCI USA, V109, P9083, DOI 10.1073/pnas.1112570109; Schaefer G, 2013, PROSTATE CANCER P D, V16, P132, DOI 10.1038/pcan.2013.4; Schug J, 2008, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953. bi0206s21, DOI 10.1002/0471250953.BI0206S21]; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Walker EJ, 2012, CANCER RES, V72, P636, DOI 10.1158/0008-5472.CAN-11-2266; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Zhang J, 2010, ONCOGENE, V29, P723, DOI 10.1038/onc.2009.373	43	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUN 29	2017	8								48	10.1038/s41467-017-00046-0				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EY9QL	WOS:000404333000007	28663546	gold			2018-01-05	
J	Kunzelmann, S; Forstemann, K				Kunzelmann, Stefan; Foerstemann, Klaus			Reversible perturbations of gene regulation after genome editing in Drosophila cells	PLOS ONE			English	Article							SOMATIC-CELLS; ENDO-SIRNAS; RNA PATHWAY; C-ELEGANS; HETEROCHROMATIN	The prokaryotic phage defense CRISPR/cas-system has developed into a versatile toolbox for genome engineering and genetic studies in many organisms. While many efforts were spent on analyzing the consequences of off-target effects, only few studies addressed side-effects that occur due to the targeted manipulation of the genome. Here, we show that the CRISPR/cas9-mediated integration of an epitope tag in combination with a selection cassette can trigger an siRNA-mediated, epigenetic genome surveillance pathway in Drosophila melanogaster cells. After homology-directed insertion of the sequence coding for the epitope tag and the selection marker, a moderate level of siRNAs covering the inserted sequence and extending into the targeted locus was detected. This response affected protein levels less than two-fold and it persisted even after single cell cloning. However, removal of the selection cassette abolished the siRNA generation, demonstrating that this response is reversible. Consistently, marker-free genome engineering did not trigger the same surveillance mechanism. These two observations indicate that the selection cassette we employed induces an aberrant transcriptional arrangement and ultimately sets off the siRNA production. There have been prior concerns about undesirable effects induced by selection markers, but fortunately we were able to show that at least one of the epigenetic changes reverts as the marker gene is excised. Although the effects observed were rather weak (less than twofold de-repression upon ago2 or dcr-2 knock-down), we recommend that when selection markers are used during genome editing, a strategy for their subsequent removal should always be included.	[Kunzelmann, Stefan; Foerstemann, Klaus] Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Munich, Germany	Forstemann, K (reprint author), Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Munich, Germany.	foerstemann@lmb.uni-muenchen.de			Sondeforschungsbereich (SFB) of the Deutsche Forschungsgemeinschaft (DFG) [646]	The work was supported by the Sondeforschungsbereich (SFB) 646 of the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bottcher R, 2014, NUCL ACIDS RES; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Elmer K, 2014, METHODS MOL BIOL, V1173, P33, DOI 10.1007/978-1-4939-0931-5_4; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kunzelmann S, 2016, G3-GENES GENOM GENET, V6, P1777, DOI 10.1534/g3.116.028241; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Lin CC, 2016, G3 BETHESDA; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180135	10.1371/journal.pone.0180135				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ3JT	WOS:000404607900064	28658280	gold			2018-01-05	
J	Ye, RS; Pi, M; Cox, JV; Nishimoto, SK; Quarles, LD				Ye, Ruisong; Pi, Min; Cox, John V.; Nishimoto, Satoru K.; Quarles, L. Darryl			CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH			English	Article						Osteocalcin; GPRC6A; CRISPR/Cas9; Prostate cancer	PROTEIN-COUPLED RECEPTOR; IN-VITRO; RADICAL PROSTATECTOMY; PEPTIDE-1 SECRETION; METABOLIC SYNDROME; SIGNALING PATHWAY; ENERGY-METABOLISM; HUMAN OSTEOCALCIN; CELLS; EXPRESSION	Background: GPRC6A is implicated in the pathogenesis of prostate cancer, but its role remains uncertain because of a purported tolerant gene variant created by substitution of a K..Y polymorphism in the 3rd intracellular loop (IL) that evolved in the majority of humans and replaces the ancestral RKLP present in 40% of humans of African descent and all other species. Methods: We determined whether the K..Y polymorphism is present in human-derived prostate cancer cell lines by sequencing the region of the 3rd IL and assessed the cellular localization of a "humanized" mouse GPRC6A containing the K..Y sequence by immunofluorescence. We assessed functions of GPRC6A in PC-3 cells expressing endogenous GPRC6A and in GPRC6A-deficient PC-3 cells created using CRISPR/Cas9 technology. The effect of GPRC6A on basal and ligand stimulated cell proliferation and migration was evaluated in vitro in wild-type and PC-3-deficient cell lines. The effect of editing GPRC6A on prostate cancer growth and progression in vivo was assessed in a Xenograft mouse model implanted with wild-type and PC-3 deficient cells and treated with the GPRC6A ligand osteocalcin. Results: We found that all of the human prostate cancer cell lines tested endogenously express the "K.Y" polymorphism in the 3rd IL. Comparison of mouse wild-type GPRC6A with a "humanized" mouse GPRC6A construct created by replacing the "RKLP" with the "K..Y" sequence, found that both receptors were predominantly expressed on the cell surface. The transfected "humanized" GPRC6A receptor, however, preferentially activated mTOR compared to ERK signaling in HEK-293 cells. In contrast, in PC-3 cells expressing the endogenous GPRC6A with the "K..Y" polymorphism, the ligand osteocalcin stimulated ERK, AKT and mTOR phosphorylation, promoted cell proliferation and migration, and upregulated genes regulating testosterone biosynthesis. Targeting GPRC6A in PC-3 cells by CRISPR/Cas9 significantly blocked these responses in vitro. In addition, GPRC6A deficient PC-3 xenografts exhibited significantly less growth and were resistant to osteocalcin-induced prostate cancer progression compared to control PC-3 cells expressing GPRC6A. Conclusions: Human GPRC6A is a functional osteocalcin and testosterone sensing receptor that promotes prostate cancer progression. GPRC6A may contribute to racial disparities in prostate cancer, and is a potential therapeutic target to develop antagonists to treat prostate cancer.	[Ye, Ruisong; Pi, Min; Quarles, L. Darryl] Univ Tennessee, Hlth Sci Ctr, Dept Med, 19 S Manassas St, Memphis, TN 38163 USA; [Cox, John V.; Nishimoto, Satoru K.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, 19 S Manassas St, Memphis, TN 38163 USA	Pi, M; Quarles, LD (reprint author), Univ Tennessee, Hlth Sci Ctr, Dept Med, 19 S Manassas St, Memphis, TN 38163 USA.	mpi@uthsc.edu; dquarles@uthsc.edu			National Institutes of Health [R01-DK095812, R01-AR37308, R01-DK092176]; American Diabetes Association [ADA-1-13-149-BR]	This work was supported by grants from the National Institutes of Health (R01-DK095812, R01-AR37308 and R01-DK092176), grant from American Diabetes Association (ADA-1-13-149-BR).	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bhindi B, 2016, UROLOGY, V93, P77, DOI 10.1016/j.urology.2016.01.041; Chun JY, 2009, CLIN CANCER RES, V15, P4815, DOI 10.1158/1078-0432.CCR-09-0640; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dagogo-Jack S, 2003, J NATL MED ASSOC, V95, P774; De Toni L, 2016, ENDOCRINOLOGY, V157, P4473, DOI 10.1210/en.2016-1312; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092168; Ge C, 2016, ONCOGENE, V35, P366, DOI 10.1038/onc.2015.91; Gupta Aditi, 2013, Cancers (Basel), V5, P617, DOI 10.3390/cancers5020617; Haiman CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003419; Hayashi Y, 2016, J CANCER, V7, P1605, DOI 10.7150/jca.15523; Hill HS, 2014, HORM METAB RES, V46, P341, DOI 10.1055/s-0034-1368709; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Jorgensen S, 2017, J BIOL CHEM, V292, P1524, DOI 10.1074/jbc.M116.756577; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kinsey-Jones JS, 2015, OBESITY, V23, P1194, DOI 10.1002/oby.21083; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liu M, 2016, EUR REV MED PHARMACO, V20, P2235; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Long QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037866; Lv XC, 2016, PROTEIN CELL, V7, P325, DOI 10.1007/s13238-016-0263-8; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mera P, 2016, MOL METAB, V5, P1042, DOI 10.1016/j.molmet.2016.07.002; Mera P, 2016, CELL METAB, V23, P1078, DOI 10.1016/j.cmet.2016.05.004; Mizokami A, 2014, BONE, V69, P68, DOI 10.1016/j.bone.2014.09.006; Mostaghel EA, 2013, TRANSL ANDROL UROL, V2, P212, DOI 10.3978/j.issn.2223-4683.2013.09.16; Nimptsch K, 2009, CANCER EPIDEM BIOMAR, V18, P49, DOI 10.1158/1055-9965.EPI-08-0554; Otani T, 2015, CELL SIGNAL, V27, P532, DOI 10.1016/j.cellsig.2014.12.018; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JC165952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.006; Pi M, 2016, ENDOCRINOLOGY, V157, P1866, DOI 10.1210/en.2015-2010; Pi M, 2015, MOL ENDOCRINOL, V29, P1759, DOI 10.1210/me.2015-1161; Pi M, 2013, CURR OSTEOPOROS REP, V11, P391, DOI 10.1007/s11914-013-0178-8; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Powell IJ, 2007, J UROLOGY, V177, P444, DOI 10.1016/j.juro.2006.09.024; Rueda P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146846; Shahabi A, 2016, PROSTATE, V76, P1239, DOI 10.1002/pros.23211; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Thulin MH, 2016, MOL CELL ENDOCRINOL, V422, P182, DOI 10.1016/j.mce.2015.11.013; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Zarif JC, 2016, CELL SIGNAL, V28, P348, DOI 10.1016/j.cellsig.2016.01.013	57	0	0	7	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-9966			J EXP CLIN CANC RES	J. Exp. Clin. Cancer Res.	JUN 28	2017	36								90	10.1186/s13046-017-0561-x				13	Oncology	Oncology	EZ0OL	WOS:000404405300003	28659174				2018-01-05	
J	Tang, WX; Hu, JH; Liu, DR				Tang, Weixin; Hu, Johnny H.; Liu, David R.			Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation	NATURE COMMUNICATIONS			English	Article							IN-VITRO SELECTION; GENE-EXPRESSION; SMALL MOLECULES; TARGET DNA; RIBOSWITCHES; CRISPR; MODULATION; PROTEIN; CAS9; RECOGNITION	Programmable sequence-specific genome editing agents such as CRISPR-Cas9 have greatly advanced our ability to manipulate the human genome. Although canonical forms of genome-editing agents and programmable transcriptional regulators are constitutively active, precise temporal and spatial control over genome editing and transcriptional regulation activities would enable the more selective and potentially safer use of these powerful technologies. Here, by incorporating ligand-responsive self-cleaving catalytic RNAs (aptazymes) into guide RNAs, we developed a set of aptazyme-embedded guide RNAs that enable small molecule-controlled nuclease-mediated genome editing and small molecule-controlled base editing, as well as small molecule-dependent transcriptional activation in mammalian cells.	[Tang, Weixin; Hu, Johnny H.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA; [Tang, Weixin; Hu, Johnny H.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, 12 Oxford St, Cambridge, MA 02138 USA; [Tang, Weixin; Hu, Johnny H.; Liu, David R.] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA	Liu, DR (reprint author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.; Liu, DR (reprint author), Harvard Univ, Howard Hughes Med Inst, 12 Oxford St, Cambridge, MA 02138 USA.; Liu, DR (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02141 USA.	drliu@fas.harvard.edu			U.S. National Institutes of Health (NIH) [R01 EB022376]; NIH [R35 GM118062]; DARPA [HR0011-17-2-0049]; Howard Hughes Medical Institute; Harvard Biological and Biomedical Sciences Program; National Defense Science and Engineering Graduate Fellowship (NDSEG)	We thank Holly A. Rees for providing Cas9 protein for the in vitro cleavage assay. We thank Dr Adam Roth at Yale University and Dr James W. Nelson at Harvard University for helpful discussions. Mammalian cell sorting was performed by Dr Jeffery Nelson at the Bauer Core Facility of Harvard University. Mass spectrometry analysis was performed by Dr Sunia A. Trauger at the Small Molecule Mass Spectrometry Core Facility of Harvard University. This work was supported by U.S. National Institutes of Health (NIH) R01 EB022376, NIH R35 GM118062, DARPA HR0011-17-2-0049 and the Howard Hughes Medical Institute. W.T. is an HHMI Fellow of the Jane Coffin Childs Memorial Fund for Medical Research. J.H.H. was supported by the Harvard Biological and Biomedical Sciences Program and the National Defense Science and Engineering Graduate Fellowship (NDSEG).	Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cheng Z, 2013, NAT BIOTECHNOL, V31, P934, DOI 10.1038/nbt.2674; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Dent CL, 2007, GENE THER, V14, P1362, DOI 10.1038/sj.gt.3302985; Desai SK, 2004, J AM CHEM SOC, V126, P13247, DOI 10.1021/ja048634j; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hu JH, 2016, CELL CHEM BIOL, V23, P57, DOI 10.1016/j.chembiol.2015.12.009; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Link KH, 2009, GENE THER, V16, P1189, DOI 10.1038/gt.2009.81; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishida K, 2016, SCIENCE, V353, P8729; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nomura Y, 2012, CHEM COMMUN, V48, P7215, DOI 10.1039/c2cc33140c; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62; Soukup GA, 2000, J MOL BIOL, V298, P623, DOI 10.1006/jmbi.2000.3704                                                          ; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	36	4	4	16	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUN 28	2017	8								15939	10.1038/ncomms15939				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EY8DZ	WOS:000404226100001	28656978				2018-01-05	
J	Zhang, H; Xu, XF				Zhang, Hui; Xu, Xuanfu			Mutation-promoting molecular networks of uncontrolled inflammation	TUMOR BIOLOGY			English	Review						Chronic inflammatory microenvironment; cancer; uncontrolled inflammation	OXIDATIVE DNA-DAMAGE; NF-KAPPA-B; HUMAN LUNG CANCERS; SIGNALING PATHWAY; COLON-CANCER; SUBSTRATE-SPECIFICITY; GENETIC ALTERATIONS; CELL LYMPHOMAS; BREAST-CANCER; OGG1 PROTEIN	More and more studies show that chronic inflammation can lead to tumor formation. The complex interactions of inflammatory cells, stroma and tumor parenchymal cell are closely related to tumor formation. Under the state of chronic inflammatory microenvironment, long-term interaction of inflammatory cells and stromal cells as well as the parenchymal cells makes signaling pathway in parenchyma cells disordered. A series of gene level editor modification, epigenetic changes, and the regulation of transcription and translation changes will happen based on signaling pathway disorder. The changes ultimately lead to cell mutations and phenotypic transformation occurred. Recent findings provide an objective basis for cancer treatment and prevention. However, further discusses at the core of the possible molecular in tumor formation provide a theoretical foundation for future study of the pathogenesis and molecular targeted therapy of cancer. This review summarizes the research in the field of chronic inflammation and cancer in recent years, and analyze the molecules network in the process of the carcinogenic inflammation comprehensively. Beyond that, this review intends to describe possible carcinogenic inflammation core molecular and provides a theoretical basis for future study of the pathogenesis, chemoprevention and molecular targeted therapy of cancer.	[Zhang, Hui; Xu, Xuanfu] Shidong Hosp Shanghai, Dept Gastroenterol, Shanghai 200072, Peoples R China; [Zhang, Hui] Tongji Univ, Peoples Hosp Shanghai 10, Dept Gastroenterol, Shanghai, Peoples R China	Xu, XF (reprint author), Shidong Hosp Shanghai, Dept Gastroenterol, Shanghai 200072, Peoples R China.	shuanfusky@aliyun.com			National Natural Science Foundation of China [81172312]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by the National Natural Science Foundation of China (grant no. 81172312).	Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Arashidani K, 1998, MUTAT RES-FUND MOL M, V403, P223, DOI 10.1016/S0027-5107(98)00086-4; Audebert M, 2000, NUCLEIC ACIDS RES, V28, P2672, DOI 10.1093/nar/28.14.2672; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Baylin SB, 2000, J NATL CANCER I, V92, P1460, DOI 10.1093/jnci/92.18.1460; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CY, 2005, CLIN CHEM, V51, P759, DOI 10.1373/clinchem.2004.042093; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Crul M, 2002, J CLIN ONCOL, V20, P2726, DOI 10.1200/JCO.2002.09.116; Dantzer F, 2003, DNA REPAIR, V2, P707, DOI 10.1016/S1568-7864(03)00041-7; Bittencourt A., 2012, J ENDOCRINOL, V214, P301, DOI DOI 10.1530/J0E-12-0223; Davis CD, 2004, EXP BIOL MED, V229, P988; Eden Sharon, 1994, Current Opinion in Genetics and Development, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352                                                   ; He B, 2005, CLIN LUNG CANCER, V7, P54, DOI 10.3816/CLC.2005.n.022; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102                                                         ; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Hori M, 2010, FREE RADICAL BIO MED, V48, P1197, DOI 10.1016/j.freeradbiomed.2010.02.002; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jeon CH, 2008, INT J COLORECTAL DIS, V23, P29, DOI 10.1007/s00384-007-0373-0; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2                                                   ; Jin Z, 2014, ONCOL REP, V32, P1867, DOI 10.3892/or.2014.3437; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275                                                      ; Karahalil B, 1998, NUCLEIC ACIDS RES, V26, P1228, DOI 10.1093/nar/26.5.1228; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Kunisada M, 2005, CANCER RES, V65, P6006, DOI 10.1158/0008-5472.CAN-05-0724; Lamb A, 2013, J CELL BIOCHEM, V114, P491, DOI 10.1002/jcb.24389; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Liotti F, 2012, AM J CANCER RES, V2, P286; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Ma HX, 2008, TOXICOL APPL PHARM, V233, P247, DOI 10.1016/j.taap.2008.08.010; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Musgrove EA, 2004, BREAST CANCER RES, V6, P65, DOI 10.1186/bcr737; Noguchi C, 2007, J GEN VIROL, V88, P432, DOI 10.1099/vir.0.82319-0; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Oliva MR, 1997, MOL CARCINOGEN, V18, P232, DOI 10.1002/(SICI)1098-2744(199704)18:4<232::AID-MC7>3.0.CO;2-F; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Overmeyer JH, 2011, FRONT BIOSCI-LANDMRK, V16, P1693, DOI 10.2741/3814; Oving IM, 2002, EUR J CLIN INVEST, V32, P448, DOI 10.1046/j.1365-2362.2002.01004.x; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Parsa JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002518; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142                                                            ; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Rusin P, 2008, POSTEP HIG MED DOSW, V62, P490; Sasaki H, 2014, BIOMED REP, V2, P392, DOI 10.3892/br.2014.256; Schumacher MA, 2015, HELICOBACTER, V20, P19, DOI 10.1111/hel.12152; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Smolle E, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7879; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Su JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063502; Sundaram M.V., 2006, WORMBOOK, V11, P1; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637                                                   ; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590                                                               ; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Vogelauer M, 2000, NATURE, V408, P495; Xie JW, 2008, CURR ONCOL REP, V10, P107, DOI 10.1007/s11912-008-0018-7                                                       ; Xu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030309; Yamano Y, 1995, ENVIRON RES, V69, P102, DOI 10.1006/enrs.1995.1031; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-224	88	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1010-4283	1423-0380		TUMOR BIOL	Tumor Biol.	JUN 27	2017	39	6								10.1177/1010428317701310				8	Oncology	Oncology	EZ2AX	WOS:000404513300001					2018-01-05	
J	Broos, K; Keyaerts, M; Lecocq, Q; Renmans, D; Nguyen, T; Escors, D; Liston, A; Raes, G; Breckpot, K; Devoogdt, N				Broos, Katrijn; Keyaerts, Marleen; Lecocq, Quentin; Renmans, Dries; Tham Nguyen; Escors, David; Liston, Adrian; Raes, Geert; Breckpot, Karine; Devoogdt, Nick			Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers	ONCOTARGET			English	Article						immune checkpoints; programmed death-1/programmed death-ligand 1; biomarker; nanobodies; SPECT/CT imaging	CELL LUNG-CANCER; ADVANCED MELANOMA; BREAST-CANCER; T-CELLS; ANTI-PD-L1 ANTIBODY; CLINICAL ACTIVITY; PROSTATE-CANCER; DENDRITIC CELLS; CO-STIMULATION; MOUSE MODEL	Blockade of the inhibitory PD-1/PD-L1 immune checkpoint axis is a promising cancer treatment. Nonetheless, a significant number of patients and malignancies do not respond to this therapy. To develop a screen for response to PD-1/PD-L1 inhibition, it is critical to develop a non-invasive tool to accurately assess dynamic immune checkpoint expression. Here we evaluated non-invasive SPECT/CT imaging of PD-L1 expression, in murine tumor models with varying PD-L1 expression, using high affinity PD-L1-specific nanobodies (Nbs). We generated and characterized 37 Nbs recognizing mouse PD-L1. Among those, four Nbs C3, C7, E2 and E4 were selected and evaluated for preclinical imaging of PD-L1 in syngeneic mice. We performed SPECT/CT imaging in wild type versus PD-L1 knock-out mice, using Technetium-99m (Tc-99m) labeled Nbs. Nb C3 and E2 showed specific antigen binding and beneficial biodistribution. Through the use of CRISPR/Cas9 PD-L1 knock-out TC-1 lung epithelial cell lines, we demonstrate that SPECT/CT imaging using Nb C3 and E2 identifies PD-L1 expressing tumors, but not PD-L1 non-expressing tumors, thereby confirming the diagnostic potential of the selected Nbs. In conclusion, these data show that Nbs C3 and E2 can be used to non-invasively image PD-L1 levels in the tumor, with the strength of the signal correlating with PD-L1 levels. These findings warrant further research into the use of Nbs as a tool to image inhibitory signals in the tumor environment.	[Broos, Katrijn; Lecocq, Quentin; Renmans, Dries; Breckpot, Karine] Vrije Univ Brussel, LMCT, B-1090 Brussels, Belgium; [Keyaerts, Marleen; Tham Nguyen; Devoogdt, Nick] Vrije Univ Brussel, In Vivo Cellular & Mol Imaging Lab ICMI, B-1090 Brussels, Belgium; [Keyaerts, Marleen] UZ Brussel, Nucl Med Dept, B-1090 Brussels, Belgium; [Tham Nguyen; Raes, Geert] Vrije Univ Brussel, Unit Cellular & Mol Immunol CMIM, B-1050 Brussels, Belgium; [Raes, Geert] VIB, Inflammat Res Ctr, Myeloid Cell Immunol Lab, B-9052 Ghent, Belgium; [Escors, David] Navarrabiomed Biomed Res Ctr, Immunomodulat Grp, Navarra 31008, Spain; [Liston, Adrian] Univ Leuven KU Leuven, Dept Microbiol & Immunol, B-3000 Louvain, Belgium; [Liston, Adrian] VIB, Ctr Brain & Dis Res, B-3000 Louvain, Belgium	Devoogdt, N (reprint author), Vrije Univ Brussel, In Vivo Cellular & Mol Imaging Lab ICMI, B-1090 Brussels, Belgium.	ndevoogd@vub.ac.be	Devoogdt, Nick/H-5156-2013; Raes, Geert/H-5185-2013	Devoogdt, Nick/0000-0001-9220-4833; Raes, Geert/0000-0002-9065-1549	Agency of Innovation by Science and Technology (IWT-SBO); Kom op tegen Kanker; IWT-SB fellowship; 'Emmanuel van der Schueren' fellowship; Instituto de Salud Carlos III (ISCIII), Spain [CP12/03114]; ISCIII [FIS. PI14/00579]; Government of Navarre [BMED 033-2014]	This research was performed with the financial support of the Agency of Innovation by Science and Technology (IWT-SBO) and "Kom op tegen Kanker". Broos K. and Renmans D. are funded via an IWT-SB fellowship. Lecocq Q. is funded via an 'Emmanuel van der Schueren' fellowship. Keyaerts M. is a senior clinical investigator of the Research Foundation-Flanders. Escors D. is funded by a "Miguel Servet" Fellowship (CP12/03114) from the Instituto de Salud Carlos III (ISCIII), Spain. Part of the work was funded by the ISCIII (FIS. PI14/00579 project grant) and the Government of Navarre (BMED 033-2014).	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Armand P, 2013, J CLIN ONCOL, V31, P4199, DOI 10.1200/JCO.2012.48.3685; Bradley ME, 2015, MOL PHARMACOL, V87, P251, DOI 10.1124/mol.114.094821; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Broisat A, 2012, CIRC RES, V110, P927, DOI 10.1161/CIRCRESAHA.112.265140; Chakravarty R, 2014, THERANOSTICS, V4, P386, DOI 10.7150/thno.8006; Chatterjee S, 2016, ONCOTARGET, V7, P10215, DOI 10.18632/oncotarget.7143; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; De Vos J, 2013, EXPERT OPIN BIOL TH, V13, P1149, DOI 10.1517/14712598.2013.800478; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Evazalipour M, 2014, CONTRAST MEDIA MOL I, V9, P211, DOI 10.1002/cmmi.1558; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Goyvaerts C, 2013, J VIROL, V87, P11304, DOI 10.1128/JVI.01498-13; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Heskamp S, 2015, CANCER RES, V75, P2928, DOI 10.1158/0008-5472.CAN-14-3477; Hettich M, 2016, THERANOSTICS, V6, P1629, DOI 10.7150/thno.15253; Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6; Josefsson A, 2016, CANCER RES, V76, P472, DOI 10.1158/0008-5472.CAN-15-2141; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Keyaerts M, 2016, J NUCL MED, V57, P27, DOI 10.2967/jnumed.115.162024; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI 10.1056/NEJMoa1504030; Lemaire M, 2014, LEUKEMIA, V28, P444, DOI 10.1038/leu.2013.292; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Liechtenstein T, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.945378; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Mayer AT, 2017, J NUCL MED, V58, P538, DOI 10.2967/jnumed.116.177659; Mease RC, 2013, CURR TOP MED CHEM, V13, P951, DOI 10.2174/1568026611313080008                                                     ; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Natarajan A, 2015, BIOCONJUGATE CHEM, V26, P2062, DOI 10.1021/acs.bioconjchem.5b00318; Pen JJ, 2014, GENE THER, V21, P262, DOI 10.1038/gt.2013.80; Pen JJ, 2014, IMMUNE RESPONSE ACTI, DOI [10.5772/57539, DOI 10.5772/57539]; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Pruszynski M, 2013, NUCL MED BIOL, V40, P52, DOI 10.1016/j.nucmedbio.2012.08.008; Put S, 2013, J NUCL MED, V54, P807, DOI 10.2967/jnumed.112.111781; Rexer H, 2016, UROLOGE, V55, P1491, DOI 10.1007/s00120-016-0248-5; Ritprajak P, 2015, ORAL ONCOL, V51, P221, DOI 10.1016/j.oraloncology.2014.11.014; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsushima F, 2007, BLOOD, V110, P180, DOI 10.1182/blood-2006-11-060087; Van der Jeught K, 2014, ONCOTARGET, V5, P10100; Vaneycken I, 2011, FASEB J, V25, P2433, DOI 10.1096/fj.10-180331; Vanhove C, 2009, EUR J NUCL MED MOL I, V36, P1049, DOI 10.1007/s00259-009-1062-8; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Westin JR, 2014, LANCET ONCOL, V15, P69, DOI 10.1016/S1470-2045(13)70551-5; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Xavier Catarina, 2012, Methods Mol Biol, V911, P485, DOI 10.1007/978-1-61779-968-6_30	61	1	1	4	4	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUN 27	2017	8	26					41932	41946		10.18632/oncotarget.16708				15	Oncology; Cell Biology	Oncology; Cell Biology	FA5OQ	WOS:000405493400018	28410210	green_published			2018-01-05	
J	Termini, JM; Silver, ZA; Connor, B; Antonopoulos, A; Haslam, SM; Dell, A; Desrosiers, RC				Termini, James M.; Silver, Zachary A.; Connor, Bryony; Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne; Desrosiers, Ronald C.			HEK293T cell lines defective for O-linked glycosylation	PLOS ONE			English	Article							EPIMERASE-DEFICIENCY GALACTOSEMIA; MAMMALIAN-CELLS; LELOIR PATHWAY; MUTANTS; GLYCANS; ENZYMES; SYSTEMS; MOUSE	Here we describe derivatives of the HEK293T cell line that are defective in their ability to generate mucin-type O-linked glycosylation. Using CRISPR/Cas9 and a single-cell GFP-sorting procedure, the UDP-galactose-4-epimerase (GALE), galactokinase 1 (GALK1), and galactokinase 2 (GALK2) genes were knocked out individually and in combinations with greater than 90% of recovered clones having the desired mutations. Although HEK293T cells are tetraploid, we found this approach to be an efficient method to target and disrupt all 4 copies of the target gene. Deficient glycosylation in the GALE knockout cell line could be rescued by the addition of galactose and N-acetylgalactosamine (GalNAc) to the cell culture media. However, when key enzymes of the galactose/GalNAc salvage pathways were disrupted in tandem (GALE+GALK1 or GALE+GALK2), O-glycosylation was eliminated and could not be rescued by the addition of either galactose plus GalNAc or UDP-galactose plus UDP-GalNAc. GALK1 and GALK2 are key enzymes of the galactose/GalNAc salvage pathways. Mass spectrometry was performed on whole cell lysate of the knockout cell lines to verify the glycosylation phenotype. As expected, the GALE knockout was almost completely devoid of all O-glycosylation, with minimal glycosylation as a result of functional salvage pathways. However, the GALE+GALK1 and GALE+GALK2 knockout lines were devoid of all O-glycans. Mass spectrometry analysis revealed that the disruption of GALE, GALK1, and GALE+GALK2 had little effect on the N-glycome. But when GALE was knocked out in tandem with GALK1, N-glycans were exclusively of the high mannose type. Due to the well-characterized nature of these five knockout cell lines, they will likely prove useful for a wide variety of applications.	[Termini, James M.; Silver, Zachary A.; Desrosiers, Ronald C.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Connor, Bryony; Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London, England	Desrosiers, RC (reprint author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	r.desrosiers@med.miami.edu			National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI104523]; State of Florida contract CODMR; Biotechnology and Biological Sciences Research Council [BB/K016164/1]	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov/) R01 AI104523. This study was also partially supported by State of Florida contract CODMR (http://hivaidsinstitute.med.miami.edu/) and grant BB/K016164/1 from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) (to A.D., and S.M.H.). A.D. is a Wellcome Trust Senior Research Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch N, 2017, J BIOL CHEM, V292, P1068, DOI 10.1074/jbc.M116.743740; Butler M, 2014, CURR OPIN BIOTECH, V30, P107, DOI 10.1016/j.copbio.2014.06.010; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Frey PA, 1996, FASEB J, V10, P461; Fridovich-Keil J, 1993, GENEREVIEWS R; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; Lai K, 2009, IUBMB LIFE, V61, P1063, DOI 10.1002/iub.262; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Openo KK, 2006, AM J HUM GENET, V78, P89, DOI 10.1086/498985; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Rehwinkel J, 2014, CELL MOL LIFE SCI, V71, P3749, DOI 10.1007/s00018-014-1646-8; Schulz JM, 2005, J BIOL CHEM, V280, P13493, DOI 10.1074/jbc.M414045200; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521                                             ; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; Stansell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124784; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027; Timson DJ, 2006, IUBMB LIFE, V58, P83, DOI 10.1080/15216540600644846; Varki A., 2015, ESSENTIALS GLYCOBIOL; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263	31	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179949	10.1371/journal.pone.0179949				19	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ2LT	WOS:000404541500040	28654657	gold			2018-01-05	
J	Kaczmarek, JC; Kowalski, PS; Anderson, DG				Kaczmarek, James C.; Kowalski, Piotr S.; Anderson, Daniel G.			Advances in the delivery of RNA therapeutics: from concept to clinical reality	GENOME MEDICINE			English	Review						Antisense oligonucleotide; Clinical trial; CRISPR; Gene editing; Gene therapy; Messenger RNA delivery; mRNA vaccine; RNA nanoparticle; Short interfering RNA delivery	MODIFIED MESSENGER-RNA; SMALL INTERFERING RNA; ANTISENSE OLIGONUCLEOTIDE THERAPY; LIPID-LIKE MATERIALS; EDITING IN-VITRO; SYSTEMIC DELIVERY; DENDRITIC CELLS; SIRNA DELIVERY; CHEMICAL-MODIFICATION; PROTEIN EXPRESSION	The rapid expansion of the available genomic data continues to greatly impact biomedical science and medicine. Fulfilling the clinical potential of genetic discoveries requires the development of therapeutics that can specifically modulate the expression of disease-relevant genes. RNA-based drugs, including short interfering RNAs and antisense oligonucleotides, are particularly promising examples of this newer class of biologics. For over two decades, researchers have been trying to overcome major challenges for utilizing such RNAs in a therapeutic context, including intracellular delivery, stability, and immune response activation. This research is finally beginning to bear fruit as the first RNA drugs gain FDA approval and more advance to the final phases of clinical trials. Furthermore, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, have triggered a major expansion of the RNA-therapeutics field. In this review, we discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene/protein expression and genome editing that are currently being investigated both in the laboratory as well as in the clinic.	[Kaczmarek, James C.; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kaczmarek, James C.; Kowalski, Piotr S.; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Inst Med Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Harvard & MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Anderson, DG (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, Inst Med Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, Harvard & MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu			Juvenile Diabetes Research Foundation (JDRF) postdoctoral fellowship [3-PDF-2017-383-A-N]; NCI [P30-CA14051]	PSK acknowledges funding from the Juvenile Diabetes Research Foundation (JDRF) postdoctoral fellowship Grant 3-PDF-2017-383-A-N. The authors acknowledge funding from the Cancer Center Support (core) Grant P30-CA14051 from the NCI.	Agrawal S, 1999, BBA-GENE STRUCT EXPR, V1489, P53, DOI 10.1016/S0167-4781(99)00141-4; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2009, MOL THER, V17, P872, DOI 10.1038/mt.2009.36; Allard SD, 2012, CLIN IMMUNOL, V142, P252, DOI 10.1016/j.clim.2011.10.010; Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244; Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051; Askari FK, 1996, NEW ENGL J MED, V334, P316, DOI 10.1056/NEJM199602013340508                                                     ; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Beg MS, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-CT327; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Behr JP, 1997, CHIMIA, V51, P34; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Blenke EO, 2016, J CONTROL RELEASE, V244, P139, DOI 10.1016/j.jconrel.2016.08.002; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; BusinessWire. com, 2016, MIRN THER HALTS PHAS; Chadwick AC, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0830-5; Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Chery Jessica, 2016, Postdoc J, V4, P35; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chi X, 2017, DRUG DISCOV TODAY, V22, P823, DOI 10.1016/j.drudis.2017.01.013; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; ClinicalTrials. gov, NCT01676259 CLINICAL; ClinicalTrials. gov, NCT01960348 CLINICAL; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crooke ST, 2017, NAT BIOTECHNOL, V35, P230, DOI 10.1038/nbt.3779; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/nnano.2014.84, 10.1038/NNANO.2014.84]; Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308; DeFrancesco L, 2017, NAT BIOTECHNOL, V35, P193, DOI 10.1038/nbt.3812; DeRosa F, 2016, GENE THER, V23, P699, DOI 10.1038/gt.2016.46; Desigaux L, 2007, P NATL ACAD SCI USA, V104, P16534, DOI 10.1073/pnas.0707431104; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dolgin E, 2017, NAT BIOTECHNOL, V35, P99, DOI 10.1038/nbt0217-99; Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111; Dosta P, 2015, ACTA BIOMATER, V20, P82, DOI 10.1016/j.actbio.2015.03.029; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dowdy SF, 2017, NAT BIOTECHNOL, V35, P222, DOI 10.1038/nbt.3802; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Fenton OS, 2016, ADV MATER, V28, P2939, DOI 10.1002/adma.201505822; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Garber K, 2016, NAT BIOTECHNOL, V34, P1213, DOI 10.1038/nbt1216-1213; Geary RS, 2002, CLIN PHARMACOKINET, V41, P255, DOI 10.2165/00003088-200241040-00002; Golan T, 2015, ONCOTARGET, V6, P24560, DOI 10.18632/oncotarget.4183; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Guo JF, 2012, EUR J PHARM SCI, V45, P521, DOI 10.1016/j.ejps.2011.11.024; Harcourt EM, 2017, NATURE, V541, P339, DOI 10.1038/nature21351; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Jarvis JN, 2010, GENOME MED, V2, DOI 10.1186/gm165; Jemielity J, 2003, RNA, V9, P1108, DOI 10.1261/rna.5430403; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Judge A, 2008, HUM GENE THER, V19, P111, DOI 10.1089/hum.2007.179; Kaczmarek JC, 2016, ANGEW CHEM INT EDIT, V55, P13808, DOI 10.1002/anie.201608450; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kauffman KJ, 2016, BIOMATERIALS, V109, P78, DOI 10.1016/j.biomaterials.2016.09.006; Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, CELL, V168, P1, DOI DOI 10.1016/J.CE11.2016.10.044; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kozielski KL, 2013, CHEM COMMUN, V49, P5319, DOI 10.1039/c3cc40718g; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Leus NGJ, 2014, INT J PHARMACEUT, V469, P121, DOI 10.1016/j.ijpharm.2014.04.041; Li B, 2016, BIOCONJUGATE CHEM, V27, P849, DOI 10.1021/acs.bioconjchem.6b00090; Li RQ, 2016, ADV MATER, V28, P7204, DOI 10.1002/adma.201602319; Liang X, 2016, NAT BIOTECHNOL, V34, P1; Lin MK, 2014, GENOME MED, V6, DOI 10.1186/gm566; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lorenz C, 2004, BIOORG MED CHEM LETT, V14, P4975, DOI 10.1016/j.bmcl.2004.07.018; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Manoharan M., 2014, GALNAC SIRNA ENHANCE; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Merhautova J, 2016, PHYSIOL RES, V65, pS481; Merki E, 2008, CIRCULATION, V118, P743, DOI 10.1161/CIRCULATIONAHA.108.786822; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Mockey M, 2006, BIOCHEM BIOPH RES CO, V340, P1062, DOI 10.1016/j.bbrc.2005.12.105; Moreno AM, 2017, WILEY INTERDISCIP RE, pe1380; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Moschos SA, 2007, BIOCONJUGATE CHEM, V18, P1450, DOI 10.1021/bc070077d; Mout R, 2017, ACS NANO, V11, P2452, DOI 10.1021/acsnano.6b07600; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishina K, 2008, MOL THER, V16, P734, DOI 10.1038/mt.2008.14; Oberli MA, 2017, NANO LETT, V17, P1326, DOI 10.1021/acs.nanolett.6b03329; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Prakash TP, 2005, J MED CHEM, V48, P4247, DOI 10.1021/jm050044o; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Ramaswamy S, 2017, P NATL ACAD SCI USA, V114, pE1941, DOI 10.1073/pnas.1619653114; Rehman ZU, 2013, ACS NANO, V7, P3767, DOI 10.1021/nn3049494; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schroeder A, 2010, J INTERN MED, V267, P9, DOI 10.1111/j.1365-2796.2009.02189.x; Scoles DR, 2017, NATURE, V544, P362, DOI 10.1038/nature22044; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Strenkowska M, 2016, NUCLEIC ACIDS RES, V44, P9578, DOI 10.1093/nar/gkw896; Suhr OB, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0326-6; Sullenger BA, 2016, SCIENCE, V352, P1417, DOI 10.1126/science.aad8709; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Svitkin YV, 2017, NUCLEIC ACIDS RES, V45, P6023, DOI 10.1093/nar/gkx135; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103; Tsutsumi T, 2007, J CONTROL RELEASE, V119, P349, DOI 10.1016/j.jconrel.2007.03.013; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Tzeng SY, 2012, BIOMATERIALS, V33, P8142, DOI 10.1016/j.biomaterials.2012.07.036; Ulmer JB, 2016, CURR OPIN IMMUNOL, V41, P18, DOI 10.1016/j.coi.2016.05.008; Vartak SV, 2015, FEBS J, V282, P4289, DOI 10.1111/febs.13416; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wolinetz CD, 2016, EMERGING BIOTECHNOLO; Won YY, 2009, J CONTROL RELEASE, V139, P88, DOI 10.1016/j.jconrel.2009.06.031; Wroblewska L, 2015, NAT BIOTECHNOL, V33, P839, DOI 10.1038/nbt.3301; Xia CF, 2009, MOL PHARMACEUT, V6, P747, DOI 10.1021/mp800194y; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Young CS, 2016, CELL, V167, P1144, DOI 10.1016/j.cell.2016.10.050; Yu RZ, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.26; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	160	2	2	84	84	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-994X			GENOME MED	Genome Med.	JUN 27	2017	9								60	10.1186/s13073-017-0450-0				16	Genetics & Heredity	Genetics & Heredity	EY7EN	WOS:000404151600001	28655327	gold			2018-01-05	
J	Fagerlund, RD; Wilkinson, ME; Klykov, O; Barendregt, A; Pearce, FG; Kieper, SN; Maxwell, HWR; Capolupo, A; Heck, AJR; Krause, KL; Bostina, M; Scheltema, RA; Staals, RHJ; Fineran, PC				Fagerlund, Robert D.; Wilkinson, Max E.; Klykov, Oleg; Barendregt, Arjan; Pearce, F. Grant; Kieper, Sebastian N.; Maxwell, Howard W. R.; Capolupo, Angela; Heck, Albert J. R.; Krause, Kurt L.; Bostina, Mihnea; Scheltema, Richard A.; Staals, Raymond H. J.; Fineran, Peter C.			Spacer capture and integration by a type I-F Cas1-Cas2-3 CRISPR adaptation complex	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR-Cas; phage resistance; horizontal gene transfer; spacer acquisition; mass spectrometry	CAS ADAPTIVE IMMUNITY; GUIDED SURVEILLANCE COMPLEX; SHORT PALINDROMIC REPEATS; ESCHERICHIA-COLI; FOREIGN DNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SYSTEM; ACQUISITION; PROTEIN	CRISPR-Cas adaptive immune systems capture DNA fragments from invading bacteriophages and plasmids and integrate them as spacers into bacterial CRISPR arrays. In type I-E and II-A CRISPR-Cas systems, this adaptation process is driven by Cas1-Cas2 complexes. Type I-F systems, however, contain a unique fusion of Cas2, with the type I effector helicase and nuclease for invader destruction, Cas3. By using biochemical, structural, and biophysical methods, we present a structural model of the 400-kDa Cas14-Cas2-32 complex from Pectobacterium atrosepticum with bound protospacer substrate DNA. Two Cas1 dimers assemble on a Cas2 domain dimeric core, which is flanked by two Cas3 domains forming a groove where the protospacer binds to Cas1-Cas2. We developed a sensitive in vitro assay and demonstrated that Cas1-Cas2-3 catalyzed spacer integration into CRISPR arrays. The integrase domain of Cas1 was necessary, whereas integration was independent of the helicase or nuclease activities of Cas3. Integration required at least partially duplex protospacers with free 3'-OH groups, and leader-proximal integration was stimulated by integration host factor. In a coupled capture and integration assay, Cas1-Cas2-3 processed and integrated protospacers independent of Cas3 activity. These results provide insight into the structure of protospacer-bound type I Cas1-Cas2-3 adaptation complexes and their integration mechanism.	[Fagerlund, Robert D.; Wilkinson, Max E.; Kieper, Sebastian N.; Maxwell, Howard W. R.; Bostina, Mihnea; Staals, Raymond H. J.; Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Wilkinson, Max E.; Krause, Kurt L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Klykov, Oleg; Barendregt, Arjan; Capolupo, Angela; Heck, Albert J. R.; Scheltema, Richard A.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Klykov, Oleg; Barendregt, Arjan; Capolupo, Angela; Heck, Albert J. R.; Scheltema, Richard A.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Klykov, Oleg; Barendregt, Arjan; Capolupo, Angela; Heck, Albert J. R.; Scheltema, Richard A.] Univ Utrecht, Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Pearce, F. Grant] Univ Canterbury, Biomol Interact Ctr, Christchurch 8020, New Zealand; [Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Christchurch 8020, New Zealand; [Bostina, Mihnea] Univ Otago, Otago Ctr Electron Microscopy, Dunedin 9054, New Zealand; [Wilkinson, Max E.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Kieper, Sebastian N.] Delft Univ Technol, Kavli Inst Nanosci, NL-2629 HZ Delft, Netherlands; [Kieper, Sebastian N.] Delft Univ Technol, Dept BioNanosci, NL-2629 HZ Delft, Netherlands; [Staals, Raymond H. J.] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6708 WE Wageningen, Netherlands	Fineran, PC (reprint author), Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand.	peter.fineran@otago.ac.nz			Marsden Fund; Royal Society of New Zealand; Rutherford Discovery Fellowship; Otago Research Grant; Otago Health Sciences Career Development Award; Netherlands Organisation for Scientific Research (NWO) - NWO Roadmap Initiative Proteins@Work [184.032.201]	We thank L. Burga for EM data collection, S. Jackson for reading the manuscript, and C. Richter and S. Luckner for purification trials. This research was funded by the Marsden Fund, Royal Society of New Zealand, a Rutherford Discovery Fellowship (to P.C.F.), and an Otago Research Grant (to M.B., P.C.F., and K.L.K.). R.H.J.S. was supported by an Otago Health Sciences Career Development Award. A.J.R.H. was financed by The Netherlands Organisation for Scientific Research (NWO) funded by the NWO Roadmap Initiative Proteins@Work (Project 184.032.201).	Almendros C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.81, 10.1038/nmicrobiol.2016.81]; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Di Tommaso, 2011, NUC ACIDS RES, V39, pW13; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Ivancic-Bace Ivana, 2015, Nucleic Acids Res, V43, P10821, DOI 10.1093/nar/gkv1213; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Musharova O, 2017, NUCLEIC ACIDS RES, V45, P3297, DOI 10.1093/nar/gkx097; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; Rames M, 2014, JOVE-J VIS EXP, DOI 10.3791/51087; Rao CT, 2016, CELL MICROBIOL, V18, P1319, DOI 10.1111/cmi.12586; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/nmeth.2208, 10.1038/NMETH.2208]; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger L., 2010, PYMOL MOL GRAPHICS S; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0                                                   ; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Wang JY, 2016, CELL RES, V26, P1165, DOI 10.1038/cr.2016.103; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wilkinson ME, 2016, BIOCHEM J, V473, P1063, DOI 10.1042/BCJ20160078; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	62	4	4	9	9	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 27	2017	114	26					E5122	E5128		10.1073/pnas.1618421114				7	Multidisciplinary Sciences	Science & Technology - Other Topics	EY6QN	WOS:000404108400015	28611213				2018-01-05	
J	Fei, T; Chen, YW; Xiao, TF; Li, W; Cato, L; Zhang, P; Cotter, MB; Bowden, M; Lis, RT; Zhao, SG; Wu, Q; Feng, FY; Loda, M; He, HSH; Liu, XS; Brown, M				Fei, Teng; Chen, Yiwen; Xiao, Tengfei; Li, Wei; Cato, Laura; Zhang, Peng; Cotter, Maura B.; Bowden, Michaela; Lis, Rosina T.; Zhao, Shuang G.; Wu, Qiu; Feng, Felix Y.; Loda, Massimo; He, Housheng Hansen; Liu, X. Shirley; Brown, Myles			Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR screen; HNRNPL; prostate cancer; RNA binding protein; alternative splicing	DIFFERENTIAL EXPRESSION ANALYSIS; MESSENGER-RNA; HUMAN-CELLS; BINDING PROTEINS; ESSENTIAL GENES; CIRCULAR RNAS; SEQ; MICROARRAY; SPLICEOSOME; BIOGENESIS	Alternative RNA splicing plays an important role in cancer. To determine which factors involved in RNA processing are essential in prostate cancer, we performed a genome-wide CRISPR/Cas9 knockout screen to identify the genes that are required for prostate cancer growth. Functional annotation defined a set of essential spliceosome and RNA binding protein (RBP) genes, including most notably heterogeneous nuclear ribonucleoprotein L (HNRNPL). We defined the HNRNPL-bound RNA landscape by RNA immunoprecipitation coupled with next-generation sequencing and linked these RBP-RNA interactions to changes in RNA processing. HNRNPL directly regulates the alternative splicing of a set of RNAs, including those encoding the androgen receptor, the key lineage-specific prostate cancer oncogene. HNRNPL also regulates circular RNA formation via back splicing. Importantly, both HNRNPL and its RNA targets are aberrantly expressed in human prostate tumors, supporting their clinical relevance. Collectively, our data reveal HNRNPL and its RNA clients as players in prostate cancer growth and potential therapeutic targets.	[Fei, Teng] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110819, Peoples R China; [Fei, Teng; Xiao, Tengfei; Cato, Laura; Brown, Myles] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02215 USA; [Fei, Teng; Xiao, Tengfei; Cato, Laura; Brown, Myles] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Fei, Teng; Xiao, Tengfei; Cato, Laura; Brown, Myles] Harvard Med Sch, Boston, MA 02215 USA; [Fei, Teng; Xiao, Tengfei; Li, Wei; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Chen, Yiwen; Zhang, Peng] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Cotter, Maura B.; Bowden, Michaela; Lis, Rosina T.; Loda, Massimo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Cotter, Maura B.; Bowden, Michaela; Lis, Rosina T.; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Zhao, Shuang G.; Feng, Felix Y.] Univ Michigan, Ctr Comprehens Canc, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Zhao, Shuang G.; Feng, Felix Y.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Wu, Qiu] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Loda, Massimo] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA; [Loda, Massimo] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [He, Housheng Hansen] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [He, Housheng Hansen] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	Fei, T (reprint author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02215 USA.; Fei, T; Brown, M (reprint author), Harvard Med Sch, Boston, MA 02215 USA.; Fei, T; Liu, XS (reprint author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Biostat & Computat Biol, Boston, MA 02215 USA.	feiteng@mail.neu.edu.cn; xsliu@jimmy.harvard.edu; myles_brown@dfci.harvard.edu			Department of Defense Prostate Cancer Research Program Postdoctoral Training Award [W81XWH-14-1-0513]; National Cancer Institute [P50 CA090381-13, 5P01 CA163227]; NIH [R01 HG008927]; DOD [PC140817P1]	We thank Dr. Albrecht Bindereif and Dr. Shaoyong Chen for sharing of reagents; and Dr. Ting Ni, Miao Han, and all members of the M. Brown and X.S.L. laboratories for helpful discussions. This project was supported by Department of Defense Prostate Cancer Research Program Postdoctoral Training Award W81XWH-14-1-0513 (to T.F.) and National Cancer Institute Grants P50 CA090381-13 (to L.C.), 5P01 CA163227 (to M. Brown), NIH R01 HG008927 (to X.S.L.), and DOD PC140817P1 (to M. Brown and X.S.L.).	Agell L, 2012, AM J PATHOL, V181, P1585, DOI 10.1016/j.ajpath.2012.08.005; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2015, ONCOGENE, V34, P1, DOI 10.1038/onc.2013.570; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chiou NT, 2013, MOL CELL, V49, P972, DOI [10.1016/j.molcel.2012.12.025, 10.1016/j.molce1.2012.12.025]; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178                                                             ; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; DeMiguel F, 2002, PROSTATE, V52, P123, DOI 10.1002/pros.10110; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoefer J, 2012, AM J PATHOL, V180, P2097, DOI 10.1016/j.ajpath.2012.01.026; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Lee DH, 2009, BIOCHEM BIOPH RES CO, V382, P583, DOI 10.1016/j.bbrc.2009.03.069; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569                                                          ; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossbach O, 2014, RNA BIOL, V11, P146, DOI 10.4161/rna.27991; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shankarling G, 2014, MOL CELL BIOL, V34, P71, DOI 10.1128/MCB.00740-13; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	62	2	2	16	16	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 27	2017	114	26					E5207	E5215		10.1073/pnas.1617467114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EY6QN	WOS:000404108400024	28611215				2018-01-05	
J	Rollins, MF; Chowdhury, S; Carter, J; Golden, SM; Wilkinson, RA; Bondy-Denomy, J; Lander, GC; Wiedenheft, B				Rollins, MaryClare F.; Chowdhury, Saikat; Carter, Joshua; Golden, Sarah M.; Wilkinson, Royce A.; Bondy-Denomy, Joseph; Lander, Gabriel C.; Wiedenheft, Blake			Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR; Cas; Cas1; Cas2/3; type I-F	GUIDED SURVEILLANCE COMPLEX; PRIMED CRISPR ADAPTATION; BACTERIAL IMMUNE-SYSTEM; IN-VITRO RECONSTITUTION; SPACER ACQUISITION; FOREIGN DNA; PSEUDOMONAS-AERUGINOSA; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; STRUCTURAL BASIS	The type I-F CRISPR adaptive immune system in Pseudomonas aeruginosa (PA14) consists of two CRISPR loci and six CRISPR-associated (cas) genes. Type I-F systems rely on a CRISPR RNA (crRNA)-guided surveillance complex (Csy complex) to bind foreign DNA and recruit a trans-acting nuclease (i.e., Cas2/3) for target degradation. In most type I systems, Cas2 and Cas3 are separate proteins involved in adaptation and interference, respectively. However, in I-F systems, these proteins are fused into a single polypeptide. Here we use biochemical and structural methods to show that two molecules of Cas2/3 assemble with four molecules of Cas1 (Cas2/3(2):Cas1(4)) into a four-lobed propeller-shaped structure, where the two Cas2 domains form a central hub (twofold axis of symmetry) flanked by two Cas1 lobes and two Cas3 lobes. We show that the Cas1 subunits repress Cas2/3 nuclease activity and that foreign DNA recognition by the Csy complex activates Cas2/3, resulting in bidirectional degradation of DNA targets. Collectively, this work provides a structure of the Cas1-2/3 complex and explains how Cas1 and the target-bound Csy complex play opposing roles in the regulation of Cas2/3 nuclease activity.	[Rollins, MaryClare F.; Carter, Joshua; Golden, Sarah M.; Wilkinson, Royce A.; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Chowdhury, Saikat; Lander, Gabriel C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Wiedenheft, B (reprint author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	bwiedenheft@gmail.com			National Institutes of Health [DP2EB020402, P20GM103500, P30GM110732-03, R01GM110270, R01GM108888]; University of California San Francisco Program for Breakthrough in Biomedical Research; Sandler Foundation; NIH Office of the Director Early Independence Award [DP5-OD021344]; National Science Foundation EPSCoR Grant [EPS-110134]; M.J. Murdock Charitable Trust; Amgen; Montana State University Agricultural Experimental Station	We thank members of the B.W. laboratory for critical feedback and thoughtful discussion regarding this manuscript. We thank the anonymous referees for pointing out the nicking product in our EDTA control lanes. G.C.L. is supported as a Searle Scholar, a Pew Scholar, and by National Institutes of Health Grant DP2EB020402. J.B.-D. is supported by the University of California San Francisco Program for Breakthrough in Biomedical Research, funded in part by the Sandler Foundation, and NIH Office of the Director Early Independence Award DP5-OD021344. Research in the B.W. laboratory is supported by National Institutes of Health Grants P20GM103500, P30GM110732-03, R01GM110270, and R01GM108888; National Science Foundation EPSCoR Grant EPS-110134, the M.J. Murdock Charitable Trust, a young investigator award from Amgen, and the Montana State University Agricultural Experimental Station.	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Briner AE, 2016, CURR OPIN MICROBIOL, V31, P101, DOI 10.1016/j.mib.2016.03.006; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Carter J, 2015, CELL, V163, P260, DOI 10.1016/j.cell.2015.09.011; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heussler GE, 2016, J BACTERIOL, V198, P3080, DOI 10.1128/JB.00458-16; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Ivancic-Bace Ivana, 2015, Nucleic Acids Res, V43, P10821, DOI 10.1093/nar/gkv1213; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Mallon J, 2016, NAT STRUCT MOL BIOL, V23, P765, DOI 10.1038/nsmb.3287; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Rutkauskas M, 2015, CELL REPORTS S, VS2211-1247; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang JY, 2016, CELL RES, V26, P1165, DOI 10.1038/cr.2016.103; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Westra ER, 2012, RNA BIOL, V9, P1134, DOI 10.4161/rna.21410; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2013, RNA BIOL, V10, P886, DOI 10.4161/rna.23591; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	67	4	4	7	7	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 27	2017	114	26					E5113	E5121		10.1073/pnas.1616395114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EY6QN	WOS:000404108400014	28438998	green_published			2018-01-05	
J	Abriouel, H; Montoro, BP; Munoz, MDC; Knapp, CW; Galvez, A; Benomar, N				Abriouel, Hikmate; Perez Montoro, Beatriz; Casado Munoz, Maria del Carmen; Knapp, Charles W.; Galvez, Antonio; Benomar, Nabil			In silico genomic insights into aspects of food safety and defense mechanisms of a potentially probiotic Lactobacillus pentosus MP-10 isolated from brines of naturally fermented Alorena green table olives	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTIC-RESISTANCE; ANTIVIRAL DEFENSE; IDENTIFICATION; SEQUENCE; GENES; PROKARYOTES; ANNOTATION; DIVERSITY; EMPHASIS	Lactobacillus pentosus MP-10, isolated from brines of naturally fermented Alorena green table olives, exhibited high probiotic potential. The genome sequence of L. pentosus MP10 is currently considered the largest genome among lactobacilli, highlighting the microorganism's ecological flexibility and adaptability. Here, we analyzed the complete genome sequence for the presence of acquired antibiotic resistance and virulence determinants to understand their defense mechanisms and explore its putative safety in food. The annotated genome sequence revealed evidence of diverse mobile genetic elements, such as prophages, transposases and transposons involved in their adaptation to brine-associated niches. In-silico analysis of L. pentosus MP-10 genome sequence identified a CRISPR (clustered regularly interspaced short palindromic repeats)/cas (CRISPR-associated protein genes) as an immune system against foreign genetic elements, which consisted of six arrays (4-12 repeats) and eleven predicted cas genes [CRISPR1 and CRISPR2 consisted of 3 (Type II-C) and 8 (Type I) genes] with high similarity to L. pentosus KCA1. Bioinformatic analyses revealed L. pentosus MP-10 to be absent of acquired antibiotic resistance genes, and most resistance genes were related to efflux mechanisms; no virulence determinants were found in the genome. This suggests that L. pentosus MP-10 could be considered safe and with high-adaptation potential, which could facilitate its application as a starter culture and probiotic in food preparations.	[Abriouel, Hikmate; Perez Montoro, Beatriz; Casado Munoz, Maria del Carmen; Galvez, Antonio; Benomar, Nabil] Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen, Spain; [Knapp, Charles W.] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland	Abriouel, H (reprint author), Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen, Spain.	hikmate@ujaen.es			Ministerio de Economia y Competitividad, MINECO, FEDER [AGL2013-43571-P]; Plan Propio UJA [UJA2014/07/02];  [EI_BI01_2017]	Research grant AGL2013-43571-P (Ministerio de Economia y Competitividad, MINECO, FEDER), HA. Research grant UJA2014/07/02 (Plan Propio UJA), HA. Research Team EI_BI01_2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge research grants AGL2013-43571-P (Ministerio de Economia y Competitividad, MINECO, FEDER), UJA2014/07/02 (Plan Propio UJA) and Research Team EI_BIO01_2017.	Abriouel H, 2016, GENOME ANNOUNC, V4; Abriouel H, 2011, J BACTERIOL, V193, P4559, DOI 10.1128/JB.05171-11; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Anukam KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059239; Bartkiene E, 2013, FOOD TECHNOL BIOTECH, V51, P471; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cammarota M, 2009, INT J FOOD MICROBIOL, V135, P90, DOI 10.1016/j.ijfoodmicro.2009.08.022; Munoz MDC, 2016, INT J FOOD MICROBIOL, V222, P8, DOI 10.1016/j.ijfoodmicro.2016.01.012; Chang JH, 2010, J APPL MICROBIOL, V109, P220, DOI 10.1111/j.1365-2672.2009.04648.x; Di Cagno R, 2010, FOOD MICROBIOL, V27, P381, DOI 10.1016/j.fm.2009.11.012; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; EFSA (European Food Safety Authority), 2008, EFSA J, V923, P1; Florez AB, 2006, FEMS MICROBIOL LETT, V263, P21, DOI 10.1111/j.1574-6968.2006.00371.x; Food and Agricultural Organization of the United Nations and World Health Organization, 2002, REP JOINT FAO WHO WO; Fournier B, 2000, J BACTERIOL, V182, P664, DOI 10.1128/JB.182.3.664-671.2000; Granato D, 2010, COMPR REV FOOD SCI F, V9, P292, DOI 10.1111/j.1541-4337.2010.00110.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jaomanjaka F, 2013, INT J FOOD MICROBIOL, V166, P331, DOI 10.1016/j.ijfoodmicro.2013.06.032; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Maldonado-Barragan A, 2011, J BACTERIOL, V193, P5605, DOI 10.1128/JB.05736-11; Mercanti DJ, 2016, APPL ENVIRON MICROB, V82, P95, DOI 10.1128/AEM.02723-15; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Ranadheera RDCS, 2010, FOOD RES INT, V43, P1, DOI 10.1016/j.foodres.2009.09.009; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shanahan F, 2012, GASTROENTEROL CLIN N, V41, P869, DOI 10.1016/j.gtc.2012.08.006; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Spurr Harvey W. Jr., 1994, P11; Swain MR, 2012, BIOTECHNOL RES INT, V2014; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Venema K, 2015, PROBIOTICS AND PREBIOTICS: CURRENT RESEARCH AND FUTURE TRENDS, P29; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Wacher C, 2010, FERMENTED FOODS BEVE, P149; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Yoon BH, 2011, ARCH VIROL, V156, P1681, DOI 10.1007/s00705-011-1048-2; Yoshida K, 2004, J BACTERIOL, V186, P5640, DOI 10.1128/JB.186.17.5640-5648.2004; Young JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038077; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang WY, 2010, INT J DAIRY TECHNOL, V63, P413, DOI 10.1111/j.1471-0307.2010.00576.x; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	47	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0176801	10.1371/journal.pone.0176801				21	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ2KD	WOS:000404537300044	28651019	gold			2018-01-05	
J	Lobs, AK; Engel, R; Schwartz, C; Flores, A; Wheeldon, I				Lobs, Ann-Kathrin; Engel, Ronja; Schwartz, Cory; Flores, Andrew; Wheeldon, Ian			CRISPR-Cas9-enabled genetic disruptions for understanding ethanol and ethyl acetate biosynthesis in Kluyveromyces marxianus	BIOTECHNOLOGY FOR BIOFUELS			English	Article						Acetate esters; Bioethanol; CRISPR-Cas9; Hemiacetal; Metabolic engineering; Thermotolerant yeast	YEAST ALCOHOL ACETYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; DEHYDROGENASE ISOZYMES; ALCALIGENES-EUTROPHUS; YARROWIA-LIPOLYTICA; ESCHERICHIA-COLI; GENOME SEQUENCE; THERMOTOLERANT; INTEGRATION	Background: The thermotolerant yeast Kluyveromyces marxianus shows promise as an industrial host for the biochemical production of fuels and chemicals. Wild-type strains are known to ferment high titers of ethanol and can effectively convert a wide range of C-5, C-6, and C-12 sugars into the volatile short-chain ester ethyl acetate. Strain engineering, however, has been limited due to a lack of advanced genome-editing tools and an incomplete understanding of ester and ethanol biosynthesis. Results: Enabled by the design of hybrid RNA polymerase III promoters, this work adapts the CRISPR-Cas9 system from Streptococcus pyogenes for use in K. marxianus. The system was used to rapidly create functional disruptions to alcohol dehydrogenase (ADH) and alcohol-O-acetyltransferase (ATF) genes with putative function in ethyl acetate and ethanol biosynthesis. Screening of the KmATF disrupted strain revealed that Atf activity contributes to ethyl acetate biosynthesis, but the knockout reduced ethyl acetate titers by only similar to 15%. Overexpression experiments revealed that KmAdh7 can catalyze the oxidation of hemiacetal to ethyl acetate. Finally, analysis of the KmADH2 disrupted strain showed that the knockout almost completely eliminated ethanol production and resulted in the accumulation of acetaldehyde. Conclusions: Newly designed RNA polymerase III promoters for sgRNA expression in K. marxianus enable a CRISPRCas9 genome-editing system for the thermotolerant yeast. This system was used to disrupt genes involved in ethyl acetate biosynthesis, specifically KmADH1-7 and KmATF. KmAdh2 was found to be critical for aerobic and anaerobic ethanol production. Aerobically produced ethanol supplies the biosynthesis of ethyl acetate catalyzed by KmAtf. KmAdh7 was found to exhibit activity toward the oxidation of hemiacetal, a possible alternative route for the synthesis of ethyl acetate.	[Lobs, Ann-Kathrin; Engel, Ronja; Schwartz, Cory; Flores, Andrew; Wheeldon, Ian] Univ Calif Riverside, Dept Chem & Environm Engn, 900 Univ Ave, Riverside, CA 92521 USA; [Engel, Ronja] Mannheim Univ Appl Sci, Mannheim, Germany	Wheeldon, I (reprint author), Univ Calif Riverside, Dept Chem & Environm Engn, 900 Univ Ave, Riverside, CA 92521 USA.	iwheeldon@engr.ucr.edu		Wheeldon, Ian/0000-0002-3492-7539	NSF [CBET-1510697]	This work was supported by NSF CBET-1510697.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Antunes DF, 2000, WORLD J MICROB BIOT, V16, P653, DOI 10.1023/A:1008984403732                                                         ; BANAT IM, 1992, WORLD J MICROB BIOT, V8, P259, DOI 10.1007/BF01201874; Bozzi A, 1997, BBA-PROTEIN STRUCT M, V1339, P133, DOI 10.1016/S0167-4838(96)00225-7; de Smidt O, 2008, FEMS YEAST RES, V8, P967, DOI 10.1111/j.1567-1364.2008.00387.x; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fonseca GG, 2013, APPL MICROBIOL BIOT, V97, P5055, DOI 10.1007/s00253-013-4748-6; FUJII T, 1994, APPL ENVIRON MICROB, V60, P2786; Gao JQ, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0295-y; Gethins L, 2015, YEAST, V32, P67, DOI 10.1002/yea.3047; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gombert AK, 2016, APPL MICROBIOL BIOT, V100, P6193, DOI 10.1007/s00253-016-7645-y; Heo P, 2013, J BIOTECHNOL, V167, P323, DOI 10.1016/j.jbiotec.2013.06.020; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; JENDROSSEK D, 1988, J BACTERIOL, V170, P5248, DOI 10.1128/jb.170.11.5248-5256.1988                                                ; Jeong H, 2012, EUKARYOT CELL, V11, P1584, DOI 10.1128/EC.00260-12; KALLELMHIRI H, 1993, FEMS MICROBIOL LETT, V111, P207; Kruis AJ, 2017, METAB ENG, V41, P92, DOI 10.1016/j.ymben.2017.03.004; Kusano M, 1999, J BIOSCI BIOENG, V87, P690, DOI 10.1016/S1389-1723(99)80135-2; Kusano M, 1998, BIOSCI BIOTECH BIOCH, V62, P1956, DOI 10.1271/bbb.62.1956; Lee KS, 2013, APPL MICROBIOL BIOT, V97, P2029, DOI 10.1007/s00253-012-4306-7; Lertwattanasakul N, 2007, BIOSCI BIOTECH BIOCH, V71, P1170, DOI 10.1271/bbb.60622; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lertwattanasakul N, 2009, BIOSCI BIOTECH BIOCH, V73, P2720, DOI 10.1271/bbb.90609; Liang JJ, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-45; Lilly M, 2006, YEAST, V23, P641, DOI 10.1002/yea.1382; Lin JL, 2016, BIOTECHNOL J, V11, P700, DOI 10.1002/biot.201500406; Lin JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104141; Lobs AK, 2016, BIOTECHNOL J, V11, P1274, DOI 10.1002/biot.201600060; Loser C, 2015, APPL MICROBIOL BIOT, V99, P1131, DOI 10.1007/s00253-014-6098-4; Loser C, 2014, APPL MICROBIOL BIOT, V98, P5397, DOI 10.1007/s00253-014-5765-9; Loser C, 2013, J BIOTECHNOL, V163, P17, DOI 10.1016/j.jbiotec.2012.10.009; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; Nagasawa N, 1998, BIOSCI BIOTECH BIOCH, V62, P1852, DOI 10.1271/bbb.62.1852; Nelson MD, 2011, METHODS MOL BIOL, V772, P459, DOI 10.1007/978-1-61779-228-1_27; Nonklang S, 2008, APPL ENVIRON MICROB, V74, P7514, DOI 10.1128/AEM.01854-08; Park YC, 2009, APPL MICROBIOL BIOT, V85, P13, DOI 10.1007/s00253-009-2170-x; Park YC, 2007, APPL MICROBIOL BIOT, V76, P349, DOI 10.1007/s00253-007-0998-5; Pecota DC, 2007, J BIOTECHNOL, V127, P408, DOI 10.1016/j.jbiotec.2006.07.031; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plata C, 2005, WORLD J MICROB BIOT, V21, P115, DOI 10.1007/s11274-004-2780-5; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Ribeiro O, 2007, J BIOTECHNOL, V131, P20, DOI 10.1016/j.jbiotec.2007.05.027; Rocha SN, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-4; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Schwartz C, 2017, ACS SYNTH BIOL, V6, P402, DOI 10.1021/acssynbio.6b00285; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; STEINBUCHEL A, 1984, EUR J BIOCHEM, V141, P555, DOI 10.1111/j.1432-1033.1984.tb08229.x; Urit T, 2011, BIOPROC BIOSYST ENG, V34, P547, DOI 10.1007/s00449-010-0504-9; Van Laere SDM, 2008, APPL MICROBIOL BIOT, V78, P783, DOI 10.1007/s00253-008-1366-9; Verstrepen KJ, 2003, APPL ENVIRON MICROB, V69, P5228, DOI 10.1128/AEM.69.9.5228-5237.2003; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wagner JM, 2016, FUNGAL GENET BIOL, V89, P126, DOI [10.1010/j.fgb.2015.12.001, 10.1016/j.fgb.2015.12.001]; Weninger A, 2016, J BIOTECHNOL, V235, P139, DOI 10.1016/j.jbiotec.2016.03.027; Wheeldon I, 2017, CURR OPIN BIOTECH, V45, P127, DOI 10.1016/j.copbio.2017.02.019; Zhu J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0221-9	59	1	1	20	20	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-6834			BIOTECHNOL BIOFUELS	Biotechnol. Biofuels	JUN 24	2017	10								164	10.1186/s13068-017-0854-5				14	Biotechnology & Applied Microbiology; Energy & Fuels	Biotechnology & Applied Microbiology; Energy & Fuels	EY5YH	WOS:000404058000003	28652865	gold			2018-01-05	
J	Hullahalli, K; Rodrigues, M; Palmer, KL				Hullahalli, Karthik; Rodrigues, Marinelle; Palmer, Kelli L.			Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations	ELIFE			English	Article							SEQUENCE-SPECIFIC ANTIMICROBIALS; VANCOMYCIN RESISTANCE; STREPTOCOCCUS-THERMOPHILUS; PHEROMONE RESPONSE; ESCHERICHIA-COLI; GENOME ANALYSIS; PLASMID PAD1; TARGET DNA; RNA; BACTERIA	CRISPR-Cas provides a barrier to horizontal gene transfer in prokaryotes. It was previously observed that functional CRISPR-Cas systems are absent from multidrug-resistant (MDR) Enterococcus faecalis, which only possess an orphan CRISPR locus, termed CRISPR2, lacking cas genes. Here, we investigate how the interplay between CRISPR-Cas genome defense and antibiotic selection for mobile genetic elements shapes in vitro E. faecalis populations. We demonstrate that CRISPR2 can be reactivated for genome defense in MDR strains. Interestingly, we observe that E. faecalis transiently maintains CRISPR targets despite active CRISPR-Cas systems. Subsequently, if selection for the CRISPR target is present, toxic CRISPR spacers are lost over time, while in the absence of selection, CRISPR targets are lost over time. We find that forced maintenance of CRISPR targets induces a fitness cost that can be exploited to alter heterogeneous E. faecalis populations.	[Hullahalli, Karthik; Rodrigues, Marinelle; Palmer, Kelli L.] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA	Palmer, KL (reprint author), Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA.	kelli.palmer@utdallas.edu		Palmer, Kelli/0000-0002-7343-9271	National Institutes of Health [R01 AI116610]; American Society for Microbiology	National Institutes of Health R01 AI116610 Kelli L Palmer; American Society for Microbiology Undergraduate Research Fellowship Karthik Hullahalli	Al-Nassir WN, 2008, ANTIMICROB AGENTS CH, V52, P2403, DOI 10.1128/AAC.00090-08; Almendros C, 2014, MBIO, V5, DOI 10.1128/mBio.00767-13; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bachmann NL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-389; Baharoglu Z, 2014, FEMS MICROBIOL REV, V38, P1126, DOI 10.1111/1574-6976.12077; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beisel CL, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0516-x; Bhardwaj P, 2016, ANTIMICROB AGENTS CH, V60, P2209, DOI 10.1128/AAC.02595-15; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Birkhaug KE, 1927, J INFECT DIS, V40, P549; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Dunny GM, 1978, PNAS, V75, P3479, DOI [10.1073/pnas.75.7.3479, DOI 10.1073/PNAS.75.7.3479]; Centers for Disease Control and Prevention, 2014, ANTIBIOTIC RESISTANC; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; CLEWELL DB, 1974, J BACTERIOL, V117, P283; Clewell DB, 2007, PLASMID, V58, P205, DOI 10.1016/j.plasmid.2007.05.001; Clutter DS, 2013, ANTIMICROB AGENTS CH, V57, P4501, DOI 10.1128/AAC.01120-13; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; DebRoy S, 2012, J MICROBIOL METH, V90, P1, DOI 10.1016/j.mimet.2012.04.011; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; d'Herouel A Fouquier, 2011, NUCLEIC ACIDS RES, V39, pe46, DOI [10.1093/nar/gkr012, DOI 10.1093/NAR/GKR012]; Domann E, 2007, INT J MED MICROBIOL, V297, P533, DOI 10.1016/j.ijmm.2007.02.008; Duerkop BA, 2016, MBIO, V7, DOI 10.1128/mBio.01304-16; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fritzenwanker M, 2016, GENOME ANNOUNCEMENTS, V4, DOI [10.1128/genomeA.01061-16, DOI 10.1128/GENOMEA.01061-16]; GOLD OG, 1975, ARCH ORAL BIOL, V20, P473, DOI 10.1016/0003-9969(75)90236-8; Gomaa AA, 2014, MBIO, V5, DOI [10.1128/mBio.00928-13, DOI 10.1128/MBIO.00928-13]; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Harrington SM, 2004, J CLIN MICROBIOL, V42, P5895, DOI 10.1128/JCM.42.12.5895-5898.2004; Hirt H, 2005, J BACTERIOL, V187, P1044, DOI 10.1128/JB.187.3.1044-1054.2005; Hoyland-Kroghsbo NM, 2017, PNAS, V114, P131, DOI [10.1073/pnas.1617415113, DOI 10.1073/PNAS.1617415113]; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hullahalli K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138890; Huo WW, 2015, J BACTERIOL, V197, P1939, DOI 10.1128/JB.00130-15; IKE Y, 1984, J BACTERIOL, V158, P777; Innocenti N, 2015, RNA, V21, P1018, DOI 10.1261/rna.048470.114; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Kristich CJ, 2005, APPL ENVIRON MICROB, V71, P5837, DOI 10.1128/AEM.71.10.5837-5849.2005; Kristich CJ, 2014, ENTEROCOCCI COMMENSA; Lebreton F, 2014, ENTEROCOCCI COMMENSA; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Lloyd AL, 2005, J MICROBIOL METH, V60, P291, DOI 10.1016/j.mimet.2004.10.009; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI [10.1093/nar/gks216, DOI 10.1093/NAR/GKS216]; Neuhaus K, 2017, ARCH MICROBIOL, V199, P203, DOI 10.1007/s00203-016-1291-8; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer K. L., 2014, ENTEROCOCCI COMMENSA; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991                                                 ; Price VJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00064-16; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Raven KE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.33, 10.1038/nmicrobiol.2015.33]; Rice Louis B, 2013, Trans Am Clin Climatol Assoc, V124, P123; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588                                                           ; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Selle K, 2015, TRENDS MICROBIOL, V23, P225, DOI 10.1016/j.tim.2015.01.008; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sinel C, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02763-16, 10.1128/aac.02763-16]; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wardal E, 2010, POL J MICROBIOL, V59, P79; Weaver KE, 2012, RNA BIOL, V9, P1498, DOI 10.4161/rna.22311; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112	80	0	0	4	4	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUN 23	2017	6								e26664	10.7554/eLife.26664				23	Biology	Life Sciences & Biomedicine - Other Topics	EY9SV	WOS:000404339300001		gold			2018-01-05	
J	Ohmori, T; Nagao, Y; Mizukami, H; Sakata, A; Muramatsu, S; Ozawa, K; Tominaga, S; Hanazono, Y; Nishimura, S; Nureki, O; Sakata, Y				Ohmori, Tsukasa; Nagao, Yasumitsu; Mizukami, Hiroaki; Sakata, Asuka; Muramatsu, Shin-ichi; Ozawa, Keiya; Tominaga, Shin-ichi; Hanazono, Yutaka; Nishimura, Satoshi; Nureki, Osamu; Sakata, Yoichi			CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice	SCIENTIFIC REPORTS			English	Article							HOMOLOGY-DIRECTED REPAIR; IN-VIVO; MUSCULAR-DYSTROPHY; MOUSE MODEL; CRISPR-CAS; GENE; CELLS; DNA; SPECIFICITY; HEMOSTASIS	Haemophilia B, a congenital haemorrhagic disease caused by mutations in coagulation factor IX gene (F9), is considered an appropriate target for genome editing technology. Here, we describe treatment strategies for haemophilia B mice using the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system. Administration of adeno-associated virus (AAV) 8 vector harbouring Staphylococcus aureus Cas9 (SaCas9) and single guide RNA (sgRNA) to wild-type adult mice induced a double-strand break (DSB) at the target site of F9 in hepatocytes, sufficiently developing haemophilia B. Mutation-specific gene editing by simultaneous induction of homology-directed repair (HDR) sufficiently increased FIX levels to correct the disease phenotype. Insertion of F9 cDNA into the intron more efficiently restored haemostasis via both processes of non-homologous end-joining (NHEJ) and HDR following DSB. Notably, these therapies also cured neonate mice with haemophilia, which cannot be achieved with conventional gene therapy with AAV vector. Ongoing haemophilia therapy targeting the antithrombin gene with antisense oligonucleotide could be replaced by SaCas9/sgRNA-expressing AAV8 vector. Our results suggest that CRISPR/Cas9-mediated genome editing using an AAV8 vector provides a flexible approach to induce DSB at target genes in hepatocytes and could be a good strategy for haemophilia gene therapy.	[Ohmori, Tsukasa; Tominaga, Shin-ichi] Jichi Med Univ, Sch Med, Dept Biochem, Shimotsuke, Tochigi 3290498, Japan; [Nagao, Yasumitsu] Jichi Med Univ, Ctr Expt Med, Dept Biochem, Shimotsuke, Tochigi 3290498, Japan; [Mizukami, Hiroaki] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi 3290498, Japan; [Sakata, Asuka; Nishimura, Satoshi; Sakata, Yoichi] Jichi Med Univ, Ctr Mol Med, Div Cell & Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Sch Med, Dept Neurol, Shimotsuke, Tochigi 3290498, Japan; [Tominaga, Shin-ichi; Hanazono, Yutaka] Univ Tokyo, Inst Med Sci, Tokyo 1080071, Japan; [Hanazono, Yutaka] Jichi Med Univ, Ctr Mol Med, Div Regenerat Med, Shimotsuke, Tochigi 3290498, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Nishimura, Satoshi] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo 1138655, Japan; [Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan	Ohmori, T (reprint author), Jichi Med Univ, Sch Med, Dept Biochem, Shimotsuke, Tochigi 3290498, Japan.	tohmori@jichi.ac.jp		Muramatsu, Shinichi/0000-0002-3185-7790	Research Program on HIV/AIDS from the Japan Agency for Medical Research and Development (AMED); Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED	We thank Tamaki Aoki, Mika Kishimoto, and Yaeko Sutoh (Jichi Medical University) for their technical assistance. This study was supported by the Research Program on HIV/AIDS from the Japan Agency for Medical Research and Development (AMED); the Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED.	Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Dai Wei-Jing, 2016, Mol Ther Nucleic Acids, V5, pe349, DOI 10.1038/mtna.2016.58; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li T, 2013, MOL GENET GENOM MED, V1, P238, DOI 10.1002/mgg3.30; Lisowski L, 2015, CURR OPIN PHARMACOL, V24, P59, DOI 10.1016/j.coph.2015.07.006; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659                                                            ; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Matsumoto T, 2009, INT J HEMATOL, V90, P576, DOI 10.1007/s12185-009-0450-y; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Mimuro J, 2014, J MED VIROL, V86, P1990, DOI 10.1002/jmv.23818; Mimuro J, 2013, MOL THER, V21, P318, DOI 10.1038/mt.2012.258; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001                                                ; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ohmori T, 2015, J THROMB HAEMOST, V13, pS133, DOI 10.1111/jth.12926; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Srivastava A, 2017, HUM GENE THER, V28, P323, DOI 10.1089/hum.2016.147; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vartak SV, 2015, FEBS J, V282, P4289, DOI 10.1111/febs.13416; Wang LL, 2012, HUM GENE THER, V23, P533, DOI 10.1089/hum.2011.183; Young G, 2012, HEMATOL-AM SOC HEMAT, P362, DOI 10.1182/asheducation-2012.1.362; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	39	1	1	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 23	2017	7								4159	10.1038/s41598-017-04625-5				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EY6UL	WOS:000404118700050	28646206	gold			2018-01-05	
J	Kim, HS; Lee, K; Bae, S; Park, J; Lee, CK; Kim, M; Kim, E; Kim, M; Kim, S; Kim, C; Kim, JS				Kim, Heon Seok; Lee, Kyungjin; Bae, Sangsu; Park, Jeongbin; Lee, Chong-Kyo; Kim, Meehyein; Kim, Eunji; Kim, Minju; Kim, Seokjoong; Kim, Chonsaeng; Kim, Jin-Soo			CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; host-pathogen interaction; poliovirus; RNA virus; sialic acid; CRISPR screen; Enterovirus D68; whole-genome sequencing	RNA-GUIDED ENDONUCLEASES; HUMAN-CELLS; ENTEROVIRUS D68; LIBRARY; GLYCOSYLATION; RESISTANCE; COMPLEX	Several groups have used genome-wide libraries of lentiviruses encoding small guide RNAs (sgRNAs) for genetic screens. In most cases, sgRNA expression cassettes are integrated into cells by using lentiviruses, and target genes are statistically estimated by the readout of sgRNA sequences after targeted sequencing. We present a new virus-free method for human gene knockout screens using a genome-wide library of CRISPR/Cas9 sgRNAs based on plasmids and target gene identification via whole-genome sequencing (WGS) confirmation of authentic mutations rather than statistical estimation through targeted amplicon sequencing. We used 30,840 pairs of individually synthesized oligonucleotides to construct the genome-scale sgRNA library, collectively targeting 10,280 human genes (i.e. three sgRNAs per gene). These plasmid libraries were co-transfected with a Cas9-expression plasmid into human cells, which were then treated with cytotoxic drugs or viruses. Only cells lacking key factors essential for cytotoxic drug metabolism or viral infection were able to survive. Genomic DNA isolated from cells that survived these challenges was subjected to WGS to directly identify CRISPR/Cas9-mediated causal mutations essential for cell survival. With this approach, we were able to identify known and novel genes essential for viral infection in human cells. We propose that genome-wide sgRNA screens based on plasmids coupled with WGS are powerful tools for forward genetics studies and drug target discovery.	[Kim, Heon Seok; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151747, South Korea; [Kim, Heon Seok; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Lee, Kyungjin; Lee, Chong-Kyo; Kim, Chonsaeng] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea; [Kim, Meehyein] Korea Res Inst Chem Technol, Virus Res & Testing Ctr, Daejeon 34114, South Korea; [Bae, Sangsu; Park, Jeongbin] Hanyang Univ, Dept Chem, Seoul 04763, South Korea; [Kim, Eunji; Kim, Minju; Kim, Seokjoong] ToolGen Inc, Byucksan Kyoungin Digital Valley 2 Cha, Seoul 153023, South Korea	Kim, JS (reprint author), Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151747, South Korea.; Kim, JS (reprint author), Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea.; Kim, C (reprint author), Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea.	chonskim@krict.re.kr; jskim01@snu.ac.kr		Park, Jeongbin/0000-0002-9064-4912	IBS Grant [IBS-R021-D1]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant [2016R1C1B2009585]; National Research Council of Science and Technology by the Korean government Grant [CRC-16-01-KRICT]	This work was supported by IBS Grant IBS-R021-D1 (to J. S. K.), Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning Grant 2016R1C1B2009585, and National Research Council of Science and Technology by the Korean government Grant CRC-16-01-KRICT (to C. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim JH, 2002, ANTIVIR RES, V54, P163, DOI 10.1016/S0166-3542(01)00221-2; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kim YK, 2013, NAT STRUCT MOL BIOL, V20, P1458, DOI 10.1038/nsmb.2701; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Pallansch M., 2007, ENTEROVIRUSES POLIOV; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Principi N, 2015, EXPERT REV RESP MED, V9, P711, DOI 10.1586/17476348.2015.1109451; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	22	0	0	3	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10664	10671		10.1074/jbc.M117.782425				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EY6TE	WOS:000404115400025	28446605	green_published			2018-01-05	
J	Ye, Q; Ji, QQ; Yan, W; Yang, F; Wang, ED				Ye, Qing; Ji, Quan-Quan; Yan, Wei; Yang, Fang; Wang, En-Duo			Acetylation of lysine E-amino groups regulates aminoacyl-tRNA synthetase activity in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; amino acid; aminoacyl tRNA synthetase; catalysis; transfer RNA (tRNA); translation	C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; PROTEIN ACETYLATION; SIGNATURE SEQUENCE; EDITING PROPERTIES; GENE CLONING; CRUCIAL ROLE; CP1 DOMAIN; PURIFICATION; OVERPRODUCTION	Previous proteomic analyses have shown that aminoacyl-tRNA synthetases in many organisms can be modified by acetylation of Lys. In this present study, leucyl-tRNA synthetase and arginyl-tRNA synthetase from Escherichia coli (EcLeuRS and EcArgRS) were overexpressed and purified and found to be acetylated on Lys residues by MS. Gln scanning mutagenesis revealed that Lys(619), Lys(624), and Lys(809) in EcLeuRS and Lys(126) and Lys(408) in EcArgRS might play important roles in enzyme activity. Furthermore, we utilized a novel protein expression system to obtain enzymes harboring acetylated Lys at specific sites and investigated their catalytic activity. Acetylation of these Lys residues could affect their aminoacylation activity by influencing amino acid activation and/or the affinity for tRNA. In vitro assays showed that acetyl-phosphate nonenzymatically acetylates EcLeuRS and EcArgRS and suggested that the sirtuin class deacetylase CobB might regulate acetylation of these two enzymes. These findings imply a potential regulatory role for Lys acetylation in controlling the activity of aminoacyl-tRNA synthetases and thus protein synthesis.	[Ye, Qing; Ji, Quan-Quan; Yan, Wei; Yang, Fang; Wang, En-Duo] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, En-Duo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Wang, ED (reprint author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Wang, ED (reprint author), Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	edwang@sibcb.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences Grant [XDB19000000]; National Natural Science Foundation of China [31570792, 31130064, 91440204]	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000 and National Natural Science Foundation of China Grants 31570792, 31130064, and 91440204. The authors declare that they have no conflicts of interest with the contents of this article.	AbouElfetouh A, 2015, MICROBIOLOGYOPEN, V4, P66, DOI 10.1002/mbo3.223; Cao XY, 2017, P NATL ACAD SCI USA, V114, P687, DOI 10.1073/pnas.1608488114; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; Chen JF, 1999, PROTEIN EXPRES PURIF, V15, P115, DOI 10.1006/prep.1998.0999; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599                                                        ; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Geslain R, 2003, BIOCHEMISTRY-US, V42, P15092, DOI 10.1021/bi035581u; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617                                                ; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kosono S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131169; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Li J, 2003, BIOCHEM J, V376, P773, DOI 10.1042/BJ20030957; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; LIN SX, 1988, BIOCHEMISTRY-US, V27, P6343, DOI 10.1021/bi00417a022; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu MF, 1999, BIOCHEMISTRY-US, V38, P11006, DOI 10.1021/bi990392q                                                               ; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MECHULAM Y, 1991, J MOL BIOL, V217, P465, DOI 10.1016/0022-2836(91)90750-Z; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; Mizuno Y, 2016, MICROBIOLOGYOPEN, V5, P152, DOI 10.1002/mbo3.320; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; SCHULMAN LH, 1989, SCIENCE, V246, P1595, DOI 10.1126/science.2688091; Sekine S, 2001, J BIOL CHEM, V276, P3723, DOI 10.1074/jbc.C000756200; Shimada A, 2001, ACTA CRYSTALLOGR D, V57, P272, DOI 10.1107/S0907444900016255; Sissler M, 1996, EMBO J, V15, P5069; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; Soppa J, 2010, ARCHAEA, DOI 10.1155/2010/820681; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Tan M, 2013, BIOCHEM J, V449, P123, DOI 10.1042/BJ20121258; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tu S., 2015, ELIFE; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wu JF, 1999, ACTA BIOCH BIOPH SIN, V31, P226; Yan W, 2015, J BIOL CHEM, V290, P12256, DOI 10.1074/jbc.M115.639492; Ye Q, 2015, J BIOL CHEM, V290, P24391, DOI 10.1074/jbc.M115.672824; [叶青 Ye Qingi], 2016, [生命科学, Chinese Bulletin of Life Sciences], V28, P427; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng YG, 2004, NUCLEIC ACIDS RES, V32, P3294, DOI 10.1093/nar/gkh665; Zhu B, 2007, RNA, V13, P15, DOI 10.1261/rna.228707	64	1	1	4	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10709	10722		10.1074/jbc.M116.770826				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EY6TE	WOS:000404115400029	28455447				2018-01-05	
J	So, Y; Park, SY; Park, EH; Park, SH; Kim, EJ; Pan, JG; Choi, SK				So, Younju; Park, Soo-Young; Park, Eun-Hye; Park, Seung-Hwan; Kim, Eui-Joong; Pan, Jae-Gu; Choi, Soo-Keun			A Highly Efficient CRISPR-Cas9-Mediated Large Genomic Deletion in Bacillus subtilis	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR-Cas9; Bacillus subtilis; genome engineering; large genomic deletion; genomic point mutation; gene insertion	MARKER-FREE DELETIONS; CRISPR-CAS SYSTEMS; HETEROLOGOUS HOST; ESCHERICHIA-COLI; PLASMID; RNA; DNA; PROMOTER; VECTOR	In Bacillus subtilis, large genomic deletions have been carried out for genome reduction, antibiotic overproduction, and heterologous protein overexpression. In view of the eco-friendliness of B. subtilis, it is critical that engineering preserves its food-grade status and avoids leaving foreign DNA in the genome. Existing methods of generating large genomic deletions leave antibiotic resistance markers or display low mutation efficiency. In this study, we introduced a clustered regularly interspaced short palindromic repeat-derived genome engineering technique to develop a highly efficient method of generating large genomic deletions in B. subtilis without any trace of foreign DNA. Using our system, we produced 38 kb plipastatin-synthesizing pps operon deletion with 80% efficiency. The significant increase in mutation efficiency was due to plasmids-delivered Streptococcus pyogenes-originated SpCas9, target-specific sgRNA and a donor DNA template, which produces SpCas9/sgRNA endonuclease complex continuously for attacking target chromosome until the mutagenic repair occurs. Our system produced single-gene deletion in spo0A (similar to 100%), point mutation (similar to 68%) and GFP gene insertion (similar to 97%) in sigE and demonstrated its broad applicability for various types of site-directed mutagenesis in B. subtilis.	[So, Younju; Park, Seung-Hwan; Pan, Jae-Gu; Choi, Soo-Keun] Korea Res Inst Biosci & Biotechnol, Infect Dis Res Ctr, Daejeon, South Korea; [So, Younju; Park, Seung-Hwan; Choi, Soo-Keun] Korea Univ Sci & Technol UST, KRIBB Sch Biotechnol, Dept Biosyst & Bioengn, Daejeon, South Korea; [Park, Soo-Young; Park, Eun-Hye; Kim, Eui-Joong] Genofocus Inc, Daejeon, South Korea	Pan, JG; Choi, SK (reprint author), Korea Res Inst Biosci & Biotechnol, Infect Dis Res Ctr, Daejeon, South Korea.; Choi, SK (reprint author), Korea Univ Sci & Technol UST, KRIBB Sch Biotechnol, Dept Biosyst & Bioengn, Daejeon, South Korea.	jgpan@kribb.re.kr; sookeun@kribb.re.kr			Military Biodefense Laboratory Program [FDC0931722]; Industrial Source Technology Development Program of the Ministry of Trade, Industry, and Energy [10044909]; KRIBB Research Initiative Program of Ministry of Science, ICT, and Future Planning, South Korea	This study was supported by the Military Biodefense Laboratory Program (FDC0931722); the Industrial Source Technology Development Program of the Ministry of Trade, Industry, and Energy (10044909); and the KRIBB Research Initiative Program of Ministry of Science, ICT, and Future Planning, South Korea.	Ara K, 2007, BIOTECHNOL APPL BIOC, V46, P169, DOI 10.1042/BA20060111; Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cutting S. M., 1990, MOL BIOL METHODS BAC; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong HN, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-63; Dunn AK, 1999, GENE, V226, P297, DOI 10.1016/S0378-1119(98)00544-7; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x                                                ; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Jeong DE, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1380; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; KEGGINS KM, 1978, P NATL ACAD SCI USA, V75, P1423, DOI 10.1073/pnas.75.3.1423; KHASANOV FK, 1992, MOL GEN GENET, V234, P494, DOI 10.1007/BF00538711; Kim SY, 2015, J MICROBIOL BIOTECHN, V25, P1015, DOI 10.4014/jmb.1505.05036; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kumpfmuller J, 2016, APPL MICROBIOL BIOT, V100, P1209, DOI 10.1007/s00253-015-6990-6; Liu SH, 2008, MICROBIOL-SGM, V154, P2562, DOI 10.1099/mic.0.2008/016881-0; Morimoto T, 2008, DNA RES, V15, P73, DOI 10.1093/dnares/dsn002; Morimoto T, 2009, GENES GENET SYST, V84, P315, DOI 10.1266/ggs.84.315                                                              ; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Thwaite JE, 2002, APPL ENVIRON MICROB, V68, P227, DOI 10.1128/AEM.68.1.227-234.2002                                                   ; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westbrook AW, 2016, APPL ENVIRON MICROB, V82, P4876, DOI 10.1128/AEM.01159-16; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI [10.1093/molbev/msg219, 10.1093/molbev/msg.219]; Yamashiro D, 2011, APPL ENVIRON MICROB, V77, P2796, DOI 10.1128/AEM.02649-10; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27943; Zhang XZ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl358; Zobel S, 2015, APPL MICROBIOL BIOT, V99, P681, DOI 10.1007/s00253-014-6199-0	34	0	0	12	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUN 23	2017	8								1167	10.3389/fmicb.2017.01167				12	Microbiology	Microbiology	EY5GH	WOS:000404004700003	28690606	gold			2018-01-05	
J	Ferreira, THS; Tsunada, MS; Bassi, D; Araujo, P; Mattiello, L; Guidelli, GV; Righetto, GL; Goncalves, VR; Lakshmanan, P; Menossi, M				Ferreira, Thais H. S.; Tsunada, Max S.; Bassi, Denis; Araujo, Pedro; Mattiello, Lucia; Guidelli, Giovanna V.; Righetto, Germanna L.; Goncalves, Vanessa R.; Lakshmanan, Prakash; Menossi, Marcelo			Sugarcane Water Stress Tolerance Mechanisms and Its Implications on Developing Biotechnology Solutions	FRONTIERS IN PLANT SCIENCE			English	Review						drought; sugarcane; transgenic; bioethanol; abscisic acid; lipid peroxidation	SACCHARUM-OFFICINARUM L.; IMPROVES DROUGHT TOLERANCE; TRANSGENIC RICE PLANTS; HIGH-SALINITY STRESSES; CRISPR-CAS SYSTEM; ABSCISIC-ACID; GENE-EXPRESSION; ABIOTIC STRESS; SIGNAL-TRANSDUCTION; PROLINE ACCUMULATION	Sugarcane is a unique crop with the ability to accumulate high levels of sugar and is a commercially viable source of biomass for bioelectricity and second-generation bioethanol. Water deficit is the single largest abiotic stress affecting sugarcane productivity and the development of water use efficient and drought tolerant cultivars is an imperative for all major sugarcane producing countries. This review summarizes the physiological and molecular studies on water deficit stress in sugarcane, with the aim to help formulate more effective research strategies for advancing our knowledge on genes and mechanisms underpinning plant response to water stress. We also overview transgenic studies in sugarcane, with an emphasis on the potential strategies to develop superior sugarcane varieties that improve crop productivity in drought-prone environments.	[Ferreira, Thais H. S.; Tsunada, Max S.; Bassi, Denis; Araujo, Pedro; Mattiello, Lucia; Guidelli, Giovanna V.; Righetto, Germanna L.; Goncalves, Vanessa R.; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Funct Genome Lab, Campinas, SP, Brazil; [Lakshmanan, Prakash] Sugar Res Australia, Brisbane, Qld, Australia	Menossi, M (reprint author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Funct Genome Lab, Campinas, SP, Brazil.	menossi@unicamp.br			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2011/23264-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [404125/2013-1]; Brazilian Federal Agency; Evaluation of Graduate Education-CAPES	Authors thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (grant 2011/23264-8 to MM), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (grant 404125/2013-1 to MM) and Brazilian Federal Agency for Support and Evaluation of Graduate Education-CAPES (Ph.D. fellowships).	Abbas SR, 2014, J SOIL SCI PLANT NUT, V14, P233, DOI 10.4067/S0718-95162014005000019; Abdeeva I., 2012, TRANSGENIC PLANTS TO; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Altpeter F., 2010, Plant cell culture: essential methods, P217, DOI 10.1002/9780470686522.ch12; An YY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00482; Arencibia AD, 1998, TRANSGENIC RES, V7, P213, DOI 10.1023/A:1008845114531                                                         ; Augustine SM, 2015, MOL BIOTECHNOL, V57, P475, DOI 10.1007/s12033-015-9841-x; Augustine SM, 2015, PLANT SCI, V232, P23, DOI 10.1016/j.plantsci.2014.12.012; Augustine SM, 2015, PLANT CELL REP, V34, P247, DOI 10.1007/s00299-014-1704-6; BARCLAY KD, 1994, LIPIDS, V29, P877, DOI 10.1007/BF02536256; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Basnayake J, 2015, J EXP BOT, V66, P3945, DOI 10.1093/jxb/erv194; Basnayake J, 2012, J EXP BOT, V63, P6023, DOI 10.1093/jxb/ers251; BATTRAW MJ, 1990, PLANT MOL BIOL, V15, P527, DOI 10.1007/BF00017828; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; BENFEY PN, 1990, EMBO J, V9, P1677; Bhaskara GB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00484; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Boaretto LF, 2014, PLANT PHYSIOL BIOCH, V74, P165, DOI 10.1016/j.plaphy.2013.11.016; BOWER R, 1992, PLANT J, V2, P409, DOI 10.1111/j.1365-313X.1992.00409.x; Bueno L. C. S., 2006, MELHORAMENTO GENETIC, P319; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Camargo S. R., 2007, THESIS; Cha-Um S, 2008, PAK J BOT, V40, P2541; Chakravarthi M, 2016, MOL BIOL REP, V43, P17, DOI 10.1007/s11033-015-3934-2; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen YY, 2017, SCI CHINA LIFE SCI, V60, P520, DOI 10.1007/s11427-017-9021-5; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Cominelli E, 2013, NEW BIOTECHNOL, V30, P355, DOI 10.1016/j.nbt.2012.11.001; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; Cruz DC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI DOI 10.4161/PSB.3.3.5536; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Graça José Perez da, 2010, Braz. J. Plant Physiol., V22, P189, DOI 10.1590/S1677-04202010000300006; da Silva MD, 2013, J NUCLEIC ACIDS, DOI 10.1155/2013/763945; da Silva PP, 2012, IND CROP PROD, V37, P11, DOI 10.1016/j.indcrop.2011.11.015; Das K., 2014, FRONT ENV SCI, V2, P53, DOI [10.3389/fenvs.2014.00053, DOI 10.3389/FENVS.2014.00053]; Silva RLD, 2014, SCI WORLD J, DOI 10.1155/2014/357052; Delorge I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00147; Dhadi SR, 2009, GENE, V429, P65, DOI 10.1016/j.gene.2008.09.034; Dodd IC, 2003, J PLANT GROWTH REGUL, V22, P32, DOI 10.1007/s00344-003-0023-x; dos Santos CM, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1935-3; dos Santos CM, 2015, SUGAR TECH, V17, P291, DOI 10.1007/s12355-014-0325-2; Du YC, 1996, AUST J PLANT PHYSIOL, V23, P719, DOI 10.1071/PP9960719                                                               ; Dutt M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.47; Endres L., 2010, The Open Agriculture Journal, V4, P31, DOI 10.2174/1874331501004010031; Ferreira TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046703; Sales CRG, 2012, BRAGANTIA, V71, P319, DOI 10.1590/S0006-87052012000300001; Gentile A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00058; Gentile A, 2013, PLANTA, V237, P783, DOI 10.1007/s00425-012-1795-7; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GOLDSCHMIDT EE, 1992, PLANT PHYSIOL, V99, P1443, DOI 10.1104/pp.99.4.1443; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Guimaraes ER, 2008, SCI AGR, V65, P628, DOI 10.1590/S0103-90162008000600009; Guo JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07042; Guo Y, 2015, PHOTOCHEM PHOTOBIOL, V91, P1, DOI 10.1111/php.12362; Gupta P., 2001, PLANT BIOTECHNOL, V18, P275, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.18.275; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han C, 2015, PROTEOMICS, V15, P1671, DOI 10.1002/pmic.201400375; Hemaprabha G., 2006, Sugar Tech, V8, P59; Hemaprabha G., 2004, Sugar Tech, V6, P165, DOI 10.1007/BF02942718; Hemaprabha G, 2013, SUGAR TECH, V15, P9, DOI 10.1007/s12355-012-0182-9; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Inman-Bamber NG, 2008, AUST J AGR RES, V59, P13, DOI 10.1071/AR07167; Inman-Bamber NG, 2012, FIELD CROP RES, V134, P95, DOI 10.1016/j.fcr.2012.05.004; Inman-Bamber NG, 2005, FIELD CROP RES, V92, P185, DOI 10.1016/j.fcr.2005.01.023; Inman-Bamber NG, 2004, FIELD CROP RES, V89, P107, DOI 10.1016/j.fcr.2004.01.018; Iskandar HM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-12; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Ito T, 2000, PLANT CELL, V12, P1541, DOI 10.1105/tpc.12.9.1541; Jain R, 2015, SUGAR TECH, V17, P276, DOI 10.1007/s12355-014-0317-2; Jangpromma N., 2012, Australian Journal of Crop Science, V6, P1298; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Jung JH, 2016, PLANT MOL BIOL, V92, P131, DOI 10.1007/s11103-016-0499-y; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kingston G., 1994, Proceedings of the 1994 Conference of the Australian Society of Sugar Cane Technologists held at Townsville, Queensland, 26th April to 29th April 1994., P201; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Kondou Y, 2010, ANNU REV PLANT BIOL, V61, P373, DOI 10.1146/annurev-arplant-042809-112143; Kooyers NJ, 2015, PLANT SCI, V234, P155, DOI 10.1016/j.plantsci.2015.02.012; Kumar T, 2014, MOL BIOTECHNOL, V56, P199, DOI 10.1007/s12033-013-9695-z; Kumar V, 2015, J EXP BOT, V66, P47, DOI 10.1093/jxb/eru429; Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643; Lakshmanan P., 2014, SUGARCANE PHYSL BIOC, P411; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; LAST DI, 1991, THEOR APPL GENET, V81, P581, DOI 10.1007/BF00226722; Lembke CG, 2012, PLANT MOL BIOL, V79, P461, DOI 10.1007/s11103-012-9922-1; Levitt J., 1980, RESPONSES PLANTS ENV, VII; Li CN, 2013, GENES GENOM, V35, P101, DOI 10.1007/s13258-013-0065-9; Li CN, 2016, SCI REP-UK, V6, DOI 10.1038/srep25698; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Li XF, 2017, J GENET GENOMICS, V44, P175, DOI 10.1016/j.jgg.2017.02.001; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; LUIS A, 2015, J EXP BOT, V66, P2827, DOI DOI 10.1093/JXB/ERV099; Luna CM, 2005, J EXP BOT, V56, P417, DOI 10.1093/jxb/eri039; Machado RS, 2009, PESQUI AGROPECU BRAS, V44, P1575, DOI 10.1590/S0100-204X2009001200003; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; McCormick AJ, 2008, J PLANT PHYSIOL, V165, P1817, DOI 10.1016/j.jplph.2008.01.008; MCELROY D, 1991, MOL GEN GENET, V231, P150, DOI 10.1007/BF00293832; Medeiros DB, 2013, THEOR EXP PLANT PHYS, V25, P213, DOI 10.1590/S2197-00252013000300006; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Molinari HBC, 2004, PLANT SCI, V167, P1375, DOI 10.1016/j.plantsci.2004.07.007; MORAN JF, 1994, PLANTA, V194, P346; Moreira JR, 2007, PROCEEDINGS OF ISES SOLAR WORLD CONGRESS 2007: SOLAR ENERGY AND HUMAN SETTLEMENT, VOLS I-V, P38; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; NELSON N, 1994, J EXP BIOL, V196, P7; Nogueira FTS, 2003, PLANT PHYSIOL, V132, P1811, DOI 10.1104/pp.102.017483; Pagariya MC, 2012, PLANT SCI, V184, P1, DOI 10.1016/j.plantsci.2011.12.002; Papini-Terzi FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-120; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Park SH, 2010, J EXP BOT, V61, P2459, DOI 10.1093/jxb/erq076; Patade VY, 2008, PLANT GROWTH REGUL, V55, P169, DOI 10.1007/s10725-008-9270-y; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067                                                                ; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Pimentel C., 2004, RELACAO PLANTA COM A; Porto MS, 2014, MOL BIOTECHNOL, V56, P38, DOI 10.1007/s12033-013-9713-1; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ramesh P, 2000, J AGRON CROP SCI, V185, P83, DOI 10.1046/j.1439-037x.2000.00404.x; Ramiro DA, 2016, PLANT BIOTECHNOL J, V14, P1826, DOI 10.1111/pbi.12540; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Raza G, 2016, TURK J BIOL, V40, P109, DOI 10.3906/biy-1501-100; Reis RR, 2014, PLANT SCI, V221, P59, DOI 10.1016/j.plantsci.2014.02.003; Ren B, 2017, SCI CHINA LIFE SCI, V60, P516, DOI 10.1007/s11427-016-0406-x; Ribeiro RV, 2013, EXP AGR, V49, P212, DOI 10.1017/S0014479712001263; Robertson MJ, 1999, FIELD CROP RES, V64, P211, DOI 10.1016/S0378-4290(99)00042-8; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Rodrigues FA, 2011, BIOL PLANTARUM, V55, P43, DOI 10.1007/s10535-011-0006-x; Rodrigues FA, 2009, PLANT SCI, V176, P286, DOI 10.1016/j.plantsci.2008.11.007; Sales CRG, 2015, PHOTOSYNTHETICA, V53, P547, DOI 10.1007/s11099-015-0146-x; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7                                                              ; Schlorgl PS, 2008, PLANT CELL REP, V27, P335, DOI 10.1007/s00299-007-0468-7; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sharma P., 2012, J BOT, V2012, P1, DOI [DOI 10.1155/2012/217037, 10.1155/2012/217037]; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Shrawat AK, 2006, PLANT BIOTECHNOL J, V4, P575, DOI 10.1111/j.1467-7652.2006.00209.x; Shulaev V, 2006, PLANT PHYSIOL, V141, P367, DOI 10.1104/pp.106.077925; Silva ALC, 2004, TROPICAL AGR RES PER, V16, P1; Silva MD, 2014, J AGR SCI, V152, P104, DOI 10.1017/S0021859612000834; Silva Marcelo de A., 2007, Braz. J. Plant Physiol., V19, P193, DOI 10.1590/S1677-04202007000300003; Silva MD, 2013, BRAZ ARCH BIOL TECHN, V56, P735, DOI 10.1590/S1516-89132013000500004; Silva MD, 2008, SCI AGR, V65, P620, DOI 10.1590/S0103-90162008000600008; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh RK, 2013, ADV GENET ENG, V2, P112, DOI [10.4172/2169-0111.1000112, DOI 10.4172/2169-0111.1000112]; Skirycz A, 2011, NAT BIOTECHNOL, V29, P212, DOI 10.1038/nbt.1800; Skorzynska-Polit E, 2007, ACTA SOC BOT POL, V76, P49, DOI 10.5586/asbp.2007.006                                                           ; Smit MA, 2006, FIELD CROP RES, V98, P91, DOI 10.1016/j.fcr.2005.12.009; Smith DM, 2005, FIELD CROP RES, V92, P169, DOI 10.1016/j.fcr.2005.01.017; Soares R. A. B., 2004, STAB - Acucar, Alcool e Subprodutos, V22, P38; Somers DA, 2004, CURR OPIN BIOTECH, V15, P126, DOI 10.1016/j.copbio.2004.02.007; Songsri P, 2008, J AGRON CROP SCI, V194, P92, DOI 10.1111/j.1439-037X.2008.00296.x; Spiteller G, 2003, PHYSIOL PLANTARUM, V119, P5, DOI 10.1034/j.1399-3054.2003.00097.x; Su YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084426; Sugiharto B, 1997, PLANT CELL PHYSIOL, V38, P961, DOI 10.1093/oxfordjournals.pcp.a029258                                              ; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Tanaka Y, 2005, PLANT PHYSIOL, V138, P2337, DOI 10.1104/pp.105.063503; TARDIEU F, 1992, PLANT SOIL, V140, P291, DOI 10.1007/BF00010606; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; Thiebaut F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093822; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vantini JS, 2015, GENET MOL RES, V14, P7196, DOI 10.4238/2015.June.29.13; Vargas L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114744; VENEKAMP JH, 1987, J AGRON CROP SCI, V158, P304, DOI 10.1111/j.1439-037X.1987.tb00278.x; VENKATARAMANA S, 1986, FIELD CROP RES, V13, P345, DOI 10.1016/0378-4290(86)90035-3; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Wagih M. E., 2003, Sugar Tech, V5, P257, DOI 10.1007/BF02942482; Wahid A, 2007, BIOL PLANTARUM, V51, P104, DOI 10.1007/s10535-007-0021-0; Walter A., 2013, WILEY INTERDISCIPLIN, V3, P70, DOI DOI 10.1002/WENE.87; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wang H, 2009, ENVIRON EXP BOT, V65, P338, DOI 10.1016/j.envexpbot.2008.10.002; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; WEEKS JT, 1993, PLANT PHYSIOL, V102, P1077, DOI 10.1104/pp.102.4.1077                                                           ; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wu Y., 2008, Sugar Tech, V10, P36, DOI 10.1007/s12355-008-0006-0; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yang YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep07090; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang SZ, 2006, J INTEGR PLANT BIOL, V48, P453, DOI 10.1111/j.1744-7909.2006.00246.x; Zhangsun D, 2007, BIOLOGIA, V62, P386, DOI 10.2478/s11756-007-0096-2; Zhao DL, 2013, CROP SCI, V53, P1066, DOI 10.2135/cropsci2012.09.0554; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8                                                   ; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	216	0	0	16	16	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	JUN 23	2017	8								1077	10.3389/fpls.2017.01077				18	Plant Sciences	Plant Sciences	EY4XK	WOS:000403980800001	28690620	gold			2018-01-05	
J	Hindriksen, S; Bramer, AJ; Truong, MA; Vromans, MJM; Post, JB; Verlaan-Klink, I; Snippert, HJ; Lens, SMA; Hadders, MA				Hindriksen, Sanne; Bramer, Arne J.; My Anh Truong; Vromans, Martijn J. M.; Post, Jasmin B.; Verlaan-Klink, Ingrid; Snippert, Hugo J.; Lens, Susanne M. A.; Hadders, Michael A.			Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; MAMMALIAN-CELLS; GENE-EXPRESSION; HISTONE H3; HOMOLOGOUS RECOMBINATION; MULTIPROTEIN COMPLEXES; SPINDLE CHECKPOINT; VERTEBRATE CELLS; STEM-CELLS	The CRISPR/Cas9 system is a highly effective tool for genome editing. Key to robust genome editing is the efficient delivery of the CRISPR/Cas9 machinery. Viral delivery systems are efficient vehicles for the transduction of foreign genes but commonly used viral vectors suffer from a limited capacity in the genetic information they can carry. Baculovirus however is capable of carrying large exogenous DNA fragments. Here we investigate the use of baculoviral vectors as a delivery vehicle for CRISPR/Cas9 based genome-editing tools. We demonstrate transduction of a panel of cell lines with Cas9 and an sgRNA sequence, which results in efficient knockout of all four targeted subunits of the chromosomal passenger complex (CPC). We further show that introduction of a homology directed repair template into the same CRISPR/Cas9 baculovirus facilitates introduction of specific point mutations and endogenous gene tags. Tagging of the CPC recruitment factor Haspin with the fluorescent reporter YFP allowed us to study its native localization as well as recruitment to the cohesin subunit Pds5B.	[Hindriksen, Sanne; Bramer, Arne J.; My Anh Truong; Vromans, Martijn J. M.; Post, Jasmin B.; Verlaan-Klink, Ingrid; Snippert, Hugo J.; Lens, Susanne M. A.; Hadders, Michael A.] Univ Med Ctr Utrecht, Sect Mol Canc Res, Ctr Mol Med, Univ Weg 100, Utrecht, Netherlands	Lens, SMA; Hadders, MA (reprint author), Univ Med Ctr Utrecht, Sect Mol Canc Res, Ctr Mol Med, Univ Weg 100, Utrecht, Netherlands.	S.M.A.Lens@umcutrecht.nl; M.A.Hadders@umcutrecht.nl			Dutch Cancer Society, KWF Kankerbestrijding [UU2011-5134]; Netherlands Organization for Scientific Research [NWO-Vici 918.12.610, NWO-Veni 722.013.003]	This work was financially supported by The Dutch Cancer Society, KWF Kankerbestrijding (UU2011-5134 to S.M.A.L.) and The Netherlands Organization for Scientific Research (NWO-Vici 918.12.610 to S.M.A.L. and NWO-Veni 722.013.003 to M.A.H.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4                                                   ; Airenne KJ, 2013, MOL THER, V21, P739, DOI 10.1038/mt.2012.286; Airenne KJ, 2011, METHODS MOL BIOL, V737, P279, DOI 10.1007/978-1-61779-095-9_12; Barsoum J, 1997, HUM GENE THER, V8, P2011, DOI 10.1089/hum.1997.8.17-2011                                                      ; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cheshenko N, 2001, GENE THER, V8, P846, DOI 10.1038/sj.gt.3301459                                                           ; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Couturier AM, 2016, NUCLEIC ACIDS RES, V44, P10879, DOI 10.1093/nar/gkw921; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Edgerton H, 2016, J CELL BIOL, V213, P651, DOI 10.1083/jcb.201511080; Elkins JM, 2012, J MED CHEM, V55, P7841, DOI 10.1021/jm3008954; Fine EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10777; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Gutierrez LF, 2016, MOL CELL PROTEOMICS, V15, P2802; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4                                                   ; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kost TA, 1999, CURR OPIN BIOTECH, V10, P428, DOI 10.1016/S0958-1669(99)00005-1; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; Lei YN, 2011, MOL THER, V19, P942, DOI 10.1038/mt.2011.12; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mahonen AJ, 2007, J BIOTECHNOL, V131, P1, DOI 10.1016/j.jbiotec.2007.05.022; Mahonen AJ, 2010, J BIOTECHNOL, V145, P111, DOI 10.1016/j.jbiotec.2009.11.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansouri M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11529; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679                                                            ; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; O'Flynn Neil M J, 2012, Biosci Rep, V33, P23, DOI 10.1042/BSR20120093; Pan YF, 2009, J GENE MED, V11, P1030, DOI 10.1002/jgm.1390; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shoji I, 1997, J GEN VIROL, V78, P2657, DOI 10.1099/0022-1317-78-10-2657                                                    ; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Song SU, 2003, J GEN VIROL, V84, P697, DOI 10.1099/vir.0.18772-0; SOULE HD, 1990, CANCER RES, V50, P6075; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; TJIA ST, 1983, VIROLOGY, V125, P107; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Weiss MB, 2010, ONCOGENE, V29, P4715, DOI 10.1038/onc.2010.220; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoshida MM, 2016, J CELL BIOL, V213, P665, DOI 10.1083/jcb.201511079; Zhu HB, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt721	76	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179514	10.1371/journal.pone.0179514				25	Multidisciplinary Sciences	Science & Technology - Other Topics	EY6ZV	WOS:000404135800036	28640891	gold			2018-01-05	
J	Yan, X; Li, QY; Ni, DS; Xie, YJ; He, QL; Wan, QY; Liu, YM; Lyu, ZS; Mao, ZM; Zhou, Q				Yan, Xin; Li, Qianyin; Ni, Dongsheng; Xie, Yajun; He, Qingling; Wan, Qianya; Liu, Yamin; Lyu, Zhongshi; Mao, Zhaomin; Zhou, Qin			Apobec-1 complementation factor regulates cell migration and apoptosis through Dickkopf1 by acting on its 3 untranslated region in MCF7 cells	TUMOR BIOLOGY			English	Article						Apobec-1 complementation factor; Dickkopf1; migration; apoptosis; MCF7 cells	EPITHELIAL-MESENCHYMAL TRANSITION; COLON-CANCER; BETA-CATENIN/TCF; RNA-BINDING; GENE; IDENTIFICATION; INVASION; PATHWAY; TARGET; DKK1	A1CF (apobec-1 complementation factor) acts as a component of the apolipoprotein-B messenger RNA editing complex. Previous researches mainly focused on its post-transcriptional cytidine to uridine RNA editing. However, few study reported its role in progression of breast carcinoma cells. Wound healing assay and flow cytometry were applied to detect the migration and apoptosis; western blot, real-time polymerase chain reaction, and dual-luciferase assays were applied to investigate the potential regulation mechanism of A1CF-mediated cell migration and apoptosis. Knockdown of A1CF decreased cell migration and enhanced cell apoptosis in MCF7 cells in vitro. Western blot analysis showed that knockdown of A1CF decreased Dickkopf1 but increased c-Myc and -catenin expression, and overexpression of A1CF can get opposite results. Knockdown of Dickkopf1 in A1CF-overexpressed cells decreased cell migration and enhanced cell apoptosis compared with A1CF-overexpressed cells. Luciferase-fused 3 untranslated region of human Dickkopf1 activity was highly upregulated in A1CF-overexpressed MCF7 cells, but this upregulation can be inhibited by mutating conserved binding motifs of Dickkopf1 3 untranslated region. A1CF played a crucial role in cell migration and survival through affecting 3 untranslated region of Dickkopf1 to upregulate its expression in MCF7 cells.	[Yan, Xin; Ni, Dongsheng] Chongqing Med Univ, Coll Lab Med, Chongqing, Peoples R China; [Yan, Xin; Li, Qianyin; Ni, Dongsheng; Xie, Yajun; He, Qingling; Wan, Qianya; Liu, Yamin; Lyu, Zhongshi; Mao, Zhaomin; Zhou, Qin] Chongqing Med Univ, Div Mol Nephrol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China; [Yan, Xin; Li, Qianyin; Ni, Dongsheng; Xie, Yajun; He, Qingling; Wan, Qianya; Liu, Yamin; Lyu, Zhongshi; Mao, Zhaomin; Zhou, Qin] Chongqing Med Univ, Coll Lab Med, Creat Training Ctr Undergrad, Minist Educ,Key Lab Lab Med Diagnost, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China	Zhou, Q (reprint author), Chongqing Med Univ, Div Mol Nephrol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.; Zhou, Q (reprint author), Chongqing Med Univ, Coll Lab Med, Creat Training Ctr Undergrad, Minist Educ,Key Lab Lab Med Diagnost, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	zhouqin@cqmu.edu.cn			Natural Science Foundation of China [31271563, 81572076]; National Basic Research Program of China [2011CB944002]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Natural Science Foundation of China (Grant No. 31271563 and Grant No. 81572076) to Prof. Qin Zhou, MD, PhD, and grant from the National Basic Research Program of China (No. 2011CB944002) to Prof. Qin Zhou, MD, PhD.	Blanc V, 2005, MOL CELL BIOL, V25, P7260, DOI 10.1128/MCB.25.16.7260-7269.2005; Blanc V, 2010, J BIOL CHEM, V285, P19184, DOI 10.1074/jbc.M110.115147; Chen L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-157; Fossat N, 2014, RNA BIOL, V11, P1233, DOI 10.1080/15476286.2014.996054; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Galloway CA, 2010, BIOCHEM BIOPH RES CO, V398, P38, DOI 10.1016/j.bbrc.2010.06.021; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Han TY, 2013, CELL ADHES MIGR, V7, P395, DOI 10.4161/cam.26345; Hu WJ, 2015, P NATL ACAD SCI USA, V112, P5791, DOI 10.1073/pnas.1506167112; Huang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020197; Lehmann DM, 2006, NUCLEIC ACIDS RES, V34, P3299, DOI 10.1093/nar/gkl417; Mehta A, 2002, RNA, V8, P69, DOI 10.1017/S1355838202015649; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Polacheck WJ, 2013, CELL MOL LIFE SCI, V70, P1335, DOI 10.1007/s00018-012-1115-1; Qi LS, 2012, CANCER SCI, V103, P828, DOI 10.1111/j.1349-7006.2012.02222.x; Repouskou A, 2016, BBA-GENE REGUL MECH, V1859, P541, DOI 10.1016/j.bbagrm.2016.02.001; Shi RY, 2013, CANCER-AM CANCER SOC, V119, P993, DOI 10.1002/cncr.27788; Sikandar S, 2010, ONCOTARGET, V1, P596; Vanharanta S, 2014, ELIFE, V3, DOI 10.7554/eLife.02734; Wang B, 2013, J GASTROENTEROL, V48, P798, DOI 10.1007/s00535-012-0711-z; Zhao GX, 2015, ANN MED, V47, P305, DOI 10.3109/07853890.2015.1040831; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	23	0	0	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1010-4283	1423-0380		TUMOR BIOL	Tumor Biol.	JUN 22	2017	39	6								10.1177/1010428317706218				8	Oncology	Oncology	EY7RI	WOS:000404188500001					2018-01-05	
J	Bowman, CE; Rodriguez, S; Alpergin, ESS; Acoba, MG; Zhao, L; Hartung, T; Claypool, SM; Watkins, PA; Wolfgang, MJ				Bowman, Caitlyn E.; Rodriguez, Susana; Alpergin, Ebru S. Selen; Acoba, Michelle G.; Zhao, Liang; Hartung, Thomas; Claypool, Steven M.; Watkins, Paul A.; Wolfgang, Michael J.			The Mammalian Malonyl-CoA Synthetase ACSF3 Is Required for Mitochondrial Protein Malonylation and Metabolic Efficiency	CELL CHEMICAL BIOLOGY			English	Article							FATTY-ACID SYNTHESIS; SKELETAL-MUSCLE; LYSINE MALONYLATION; METHYLMALONIC ACIDURIA; ACYL-COENZYME; HUMAN GENOME; IN-VIVO; DECARBOXYLASE; HEART; SIRT5	Malonyl-coenzyme A (malonyl-CoA) is a central metabolite in mammalian fatty acid biochemistry generated and utilized in the cytoplasm; however, little is known about noncanonical organelle-specific malonyl-CoA metabolism. Intramitochondrial malonyl-CoA is generated by a malonyl-CoA synthetase, ACSF3, which produces malonyl-CoA from malonate, an endogenous competitive inhibitor of succinate dehydrogenase. To determine the metabolic requirement for mitochondrial malonyl-CoA, ACSF3 knockout (KO) cells were generated by CRISPR/Cas-mediated genome editing. ACSF3 KO cells exhibited elevated malonate and impaired mitochondrial metabolism. Unbiased and targeted metabolomics analysis of KO and control cells in the presence or absence of exogenous malonate revealed metabolic changes dependent on either malonate or malonyl-CoA. While ACSF3 was required for the metabolism and therefore detoxification of malonate, ACSF3-derived malonyl-CoA was specifically required for lysine malonylation of mitochondrial proteins. Together, these data describe an essential role for ACSF3 in dictating the metabolic fate of mitochondrial malonate and malonyl-CoA in mammalian metabolism.	[Bowman, Caitlyn E.; Alpergin, Ebru S. Selen; Watkins, Paul A.; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Rodriguez, Susana; Acoba, Michelle G.; Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Watkins, Paul A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Bowman, Caitlyn E.; Rodriguez, Susana; Alpergin, Ebru S. Selen; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Zhao, Liang; Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA; [Hartung, Thomas] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Watkins, Paul A.] Kennedy Krieger Inst, Baltimore, MD 21205 USA	Wolfgang, MJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.; Wolfgang, MJ (reprint author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	mwolfga1@jhmi.edu			NIH [R01NS072241, R01HL108882]; National Organization of Rare Disease; American Heart Association [15PRE25090309, 16PRE31140006]	We would like to thank Natasha Zachara for essential reagents. This work was supported in part by an NIH grant R01NS072241 to M. J. W. and R01HL108882 to S.M.C., and a pilot grant from the National Organization of Rare Disease to M. J.W.C.E.B. was supported in part by a fellowship from the American Heart Association 15PRE25090309. M. G. A. was supported in part by a fellowship from the American Heart Association 16PRE31140006.	Alfares A, 2011, J MED GENET, V48, P602, DOI 10.1136/jmedgenet-2011-100230; Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Asadollahi R, 2014, J MED GENET, V51, P677, DOI 10.1136/jmedgenet-2014-102588; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; Bowman CE, 2016, MOL CELL BIOL, V36, P2089, DOI 10.1128/MCB.00166-16; Chen H, 2011, PLANT CELL, V23, P2247, DOI 10.1105/tpc.111.086140; Colak G, 2015, MOL CELL PROTEOMICS, V14, P3056, DOI 10.1074/mcp.M115.048850; DE VELLIS J., 1963, PLANT PHYSIOL, V38, P686, DOI 10.1104/pp.38.6.686; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Du YP, 2015, MOL CELL PROTEOMICS, V14, P227, DOI 10.1074/mcp.M114.041947; Ellis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116587; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Ellis JM, 2012, CHEM BIOL, V19, P1333, DOI 10.1016/j.chembiol.2012.08.018; FitzPatrick DR, 1999, AM J HUM GENET, V65, P318, DOI 10.1086/302492; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Funai K, 2013, J CLIN INVEST, V123, P1229, DOI 10.1172/JCI65726; Gao JM, 1999, J LIPID RES, V40, P178; Guan X, 2016, PLANT J, V85, P581, DOI 10.1111/tpj.13130; HAYAISHI O, 1952, J BIOL CHEM, V197, P717; HEGRE CS, 1959, J AM CHEM SOC, V81, P6526, DOI 10.1021/ja01533a055                                                             ; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Kerner J, 2002, ANAL BIOCHEM, V306, P283, DOI 10.1006/abio.2002.5696; Kerner J, 2014, J BIOL CHEM, V289, P10223, DOI 10.1074/jbc.M113.524314; KIM JW, 1989, MECH AGEING DEV, V50, P277, DOI 10.1016/0047-6374(89)90105-X; KIM YS, 1978, ARCH BIOCHEM BIOPHYS, V190, P234, DOI 10.1016/0003-9861(78)90273-4; Kulkarni RA, 2017, CELL CHEM BIOL, V24, P231, DOI 10.1016/j.chembiol.2017.01.002; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Lee HY, 2000, EUR J BIOCHEM, V267, P7224, DOI 10.1046/j.1432-1327.2000.01834.x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moy LY, 2000, J NEUROCHEM, V74, P1656, DOI 10.1046/j.1471-4159.2000.0741656.x; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Pender C, 2006, J CELL BIOCHEM, V99, P860, DOI 10.1002/jcb.20944; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Pougovkina O, 2014, J INHERIT METAB DIS, V37, P709, DOI 10.1007/s10545-014-9684-9; Quastel JH, 1928, BIOCHEM J, V22, P689, DOI 10.1042/bj0220689                                                               ; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rodriguez S, 2014, BMC BIOCHEM, V15, DOI 10.1186/1471-2091-15-20; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Saha AK, 2000, J BIOL CHEM, V275, P24279, DOI 10.1074/jbc.C000291200; Sambandam N, 2004, EUR J BIOCHEM, V271, P2831, DOI 10.1111/j.1432-1033.2004.04218.x; Sloan JL, 2011, NAT GENET, V43, P883, DOI 10.1038/ng.908; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Vennesland B, 1944, J BIOL CHEM, V156, P783; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wightman PJ, 2003, HUM MUTAT, V22, P288, DOI 10.1002/humu.10264; Witkowski A, 2011, J BIOL CHEM, V286, P33729, DOI 10.1074/jbc.M111.291591; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Xia JG, 2011, BIOINFORMATICS, V27, P2455, DOI 10.1093/bioinformatics/btr392; Zeevalk GD, 1997, EUR J PHARMACOL, V320, P111, DOI 10.1016/S0014-2999(96)00892-8; Zeevalk GD, 1995, J PHARMACOL EXP THER, V275, P1124	58	3	3	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2451-9448			CELL CHEM BIOL	Cell Chem. Biol.	JUN 22	2017	24	6					673	+		10.1016/j.chembiol.2017.04.009				16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EY4AT	WOS:000403919100007	28479296				2018-01-05	
J	Stella, S; Alcon, P; Montoya, G				Stella, Stefano; Alcon, Pablo; Montoya, Guillermo			Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage	NATURE			English	Article							RNA-GUIDED ENDONUCLEASE; CRISPR RNA; MACROMOLECULAR STRUCTURES; HUMAN GENOME; HUMAN-CELLS; RECOGNITION; CAS9; SYSTEMS; SPECIFICITIES; REFINEMENT	Cpf1 is an RNA-guided endonuclease that is emerging as a powerful genome-editing tool(1,)2. Here we provide insight into its DNA-targeting mechanism by determining the structure of Francisella novicida Cpf1 with the triple-stranded R-loop generated after DNA cleavage. The structure reveals the machinery involved in DNA unwinding to form a CRISPR RNA (crRNA)-DNA hybrid and a displaced DNA strand. The protospacer adjacent motif (PAM) is recognized by the PAM-interacting domain. The loop-lysine helix-loop motif in this domain contains three conserved lysine residues that are inserted in a dentate manner into the double-stranded DNA. Unzipping of the double-stranded DNA occurs in a cleft arranged by acidic and hydrophobic residues facilitating the crRNA-DNA hybrid formation. The PAM single-stranded DNA is funnelled towards the nuclease site through a mixed hydrophobic and basic cavity. In this catalytic conformation, the PAM-interacting domain and the helix-loop-helix motif in the REC1 domain adopt a 'rail' shape and 'flap-on' conformations, respectively, channelling the PAM strand into the cavity. A steric barrier between the RuvC-II and REC1 domains forms the 'septum', separating the displaced PAM strand and the crRNA-DNA hybrid, avoiding DNA re-annealing. Mutations in key residues reveal a mechanism linking the PAM and DNA nuclease sites. Analysis of the Cpf1 structures(3,4) proposes a singular working model of RNA-guided DNA cleavage, suggesting new avenues for redesign of Cpf1.	[Stella, Stefano; Alcon, Pablo; Montoya, Guillermo] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Programme,Macromol Crystallog, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	Stella, S; Montoya, G (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Programme,Macromol Crystallog, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	stefano.stella@cpr.ku.dk; guillermo.montoya@cpr.ku.dk		Alcon, Pablo/0000-0002-7435-3859	Novo Nordisk Foundation [NNF14CC0001]; Danish Cancer Society	The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (Grant NNF14CC0001). This work was also supported by a grant from the Danish Cancer Society to G.M. We thank the beamline staff of X06SA at the Swiss Light Source (PSI, Switzerland) and the EMBL beamline P14 at DESY (Germany) for support during data collection. Data processing has been performed in the Computerome, the Danish National Computer for Life Sciences. We also thank H. Koc and M. Melynis from the Protein Production Facility Platform at CPR for excellent technical assistance.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bricogne G., 2016, BUSTER VERSION 2 10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255                                                       ; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	44	5	5	24	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					559	+		10.1038/nature22398				17	Multidisciplinary Sciences	Science & Technology - Other Topics	EY2QK	WOS:000403814100044	28562584				2018-01-05	
J	Zhang, X; Chen, XL; Liu, QY; Zhang, SJ; Hu, WQ				Zhang, Xu; Chen, Xiaoli; Liu, Qiuying; Zhang, Shaojie; Hu, Wenqian			Translation repression via modulation of the cytoplasmic poly(A)-binding protein in the inflammatory response	ELIFE			English	Article						Gene expression is precisely regulated during the inflammatory response to control; infection and limit the detrimental effects of inflammation. Here, we profiled global mRNA translation dynamics in the mouse primary macrophage-mediated inflammatory response and identified hundreds of differentially translated mRNAs. These mRNAs' 3'UTRs have enriched binding motifs for several RNA-binding proteins which implies extensive translational regulatory networks. We characterized one such protein Zfp36 as a translation repressor. Using primary macrophages from a Zfp36-V5 epitope tagged knock-in mouse generated by CRISPR/Cas9 mediated genome editing,we found that the endogenous Zfp36 directly interacts with the; cytoplasmicpoly(A)-binding protein. Importantly this interaction is required for the translational repression of Zfp36's target mRNAs in resolving inflammation. Altogether,these results uncovered critical roles of translational regulations in controlling appropriate gene expression during the inflammatory response and revealed a new biologically relevant molecular mechanism of translational repression via modulating the cytoplasmicpoly(A)-binding protein.	MESSENGER-RNA DECAY; AU-RICH ELEMENTS; NUCLEOTIDE-RESOLUTION; INITIATION-FACTOR; HITS-CLIP; TRISTETRAPROLIN; MECHANISMS; TTP; DEGRADATION; STRATEGY		[Zhang, Xu; Liu, Qiuying; Hu, Wenqian] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Chen, Xiaoli; Zhang, Shaojie] Univ Cent Florida, Dept Comp Sci, Orlando, FL 32816 USA	Hu, WQ (reprint author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	wenqian@mayo.edu		Hu, Wenqian/0000-0003-3577-3604; Zhang, Shaojie/0000-0002-4051-5549			Alvarez-Dominguez JR, 2017, BLOOD, V129, P619, DOI 10.1182/blood-2016-09-741835; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2007, METHOD ENZYMOL, V429, P299, DOI 10.1016/S0076-6879(07)29014-7; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Fu R, 2016, RNA, V22, P373, DOI 10.1261/rna.054833.115; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hu WQ, 2014, DEV CELL, V30, P660, DOI 10.1016/j.devcel.2014.07.008; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jvc.M110395200; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S13558382024627; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223                                                         ; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x                                               ; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Olshen AB, 2013, BIOINFORMATICS, V29, P2995, DOI 10.1093/bioinformatics/btt533; Qi MY, 2012, MOL CELL BIOL, V32, P913, DOI 10.1128/MCB.05340-11; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; chott J, 2014, PLOS GENET, V10, DOI [10.1371/journal.pgen.1004368, DOI 10.1371/J0URNAL.PGEN.1004368]; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67; Tao XZ, 2015, MOL CELL BIOL, V35, P3921, DOI 10.1128/MCB.00845-15; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2                                                   ; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Tiedje C, 2016, NUCLEIC ACIDS RES, V44, P7418, DOI 10.1093/nar/gkw474; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weischenfeldt J, 2008, COLD SPRING HARB PRO, V2008, DOI [10.1101/pdb.prot5080, DOI 10.1101/PDB.PR0T5080]; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112	43	0	0	3	3	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUN 21	2017	6								e27786	10.7554/eLife.27786				23	Biology	Life Sciences & Biomedicine - Other Topics	FA2NI	WOS:000405277700001		gold			2018-01-05	
J	Zhuo, CJ; Hou, WH; Lin, CG; Hu, LR; Li, J				Zhuo, Chuanjun; Hou, Weihong; Lin, Chongguang; Hu, Lirong; Li, Jie			Potential Value of Genomic Copy Number Variations in Schizophrenia	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Review						schizophrenia; copy number variations; single nucleotide polymorphisms; CRISPR/Cas9; neuropsychiatric disorder	RARE STRUCTURAL VARIANTS; MUSCULAR-DYSTROPHY; MOUSE MODEL; GENE; MICRODELETIONS; ASSOCIATION; DISEASE; DISORDERS; DELETION; SAP97	Schizophrenia is a devastating neuropsychiatric disorder affecting approximately 1% of the global population, and the disease has imposed a considerable burden on families and society. Although, the exact cause of schizophrenia remains unknown, several lines of scientific evidence have revealed that genetic variants are strongly correlated with the development and early onset of the disease. In fact, the heritability among patients suffering from schizophrenia is as high as 80%. Genomic copy number variations (CNVs) are one of the main forms of genomic variations, ubiquitously occurring in the human genome. An increasing number of studies have shown that CNVs account for population diversity and genetically related diseases, including schizophrenia. The last decade has witnessed rapid advances in the development of novel genomic technologies, which have led to the identification of schizophrenia-associated CNVs, insight into the roles of the affected genes in their intervals in schizophrenia, and successful manipulation of the target CNVs. In this review, we focus on the recent discoveries of important CNVs that are associated with schizophrenia and outline the potential values that the study of CNVs will bring to the areas of schizophrenia research, diagnosis, and therapy. Furthermore, with the help of the novel genetic tool known as the Clustered Regularly Interspaced Short Palindromic Repeats-associated nuclease 9 (CRISPR/Cas9) system, the pathogenic CNVs as genomic defects could be corrected. In conclusion, the recent novel findings of schizophrenia-associated CNVs offer an exciting opportunity for schizophrenia research to decipher the pathological mechanisms underlying the onset and development of schizophrenia as well as to provide potential clinical applications in genetic counseling, diagnosis, and therapy for this complex mental disease.	[Zhuo, Chuanjun; Lin, Chongguang; Hu, Lirong] Wenzhou Seventh Peoples Hosp, Dept Psychol Med, Wenzhou, Peoples R China; [Zhuo, Chuanjun; Li, Jie] Tianjin Anding Hosp, Dept Psychol Med, Tianjin, Peoples R China; [Hou, Weihong] Univ North Carolina Charlotte, Dept Biol, Charlotte, NC USA; [Hou, Weihong] Zhengzhou Univ, Dept Biochem & Mol Biol, Zhengzhou, Peoples R China	Zhuo, CJ (reprint author), Wenzhou Seventh Peoples Hosp, Dept Psychol Med, Wenzhou, Peoples R China.; Zhuo, CJ (reprint author), Tianjin Anding Hosp, Dept Psychol Med, Tianjin, Peoples R China.	chuanjunzhuotjmh@163.com			Tianjin Health Bureau Foundation [2014KR02]; Jiangsu Haosen Pharmaceutical Limited by Share Ltd. (Young Scholar Support Project); project from Haina Liou Pharmaceutical Limited by Share Ltd. (Young Scholar Support Project)	This work was supported by a grant from the Tianjin Health Bureau Foundation (2014KR02 to CZ), and projects from Jiangsu Haosen Pharmaceutical Limited by Share Ltd. (2016-Young Scholar Support Project to CZ) and Haina Liou Pharmaceutical Limited by Share Ltd. (2016-Young Scholar Support Project to CZ)	Ahn K, 2014, MOL PSYCHIATR, V19, P568, DOI 10.1038/mp.2013.59; Bassett AS, 2001, SCHIZOPHRENIA BULL, V27, P417, DOI 10.1093/oxfordjournals.schbul.a006884                                           ; Callaway E, 2016, NATURE, V532, P289, DOI 10.1038/532289a; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162                                                       ; Chen JC, 2015, NEUROSCI BULL, V31, P87, DOI 10.1007/s12264-014-1494-4; Crow TJ, 1999, MOL PSYCHIATR, V4, pS18; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Foster A, 2012, PSYCHIAT CLIN N AM, V35, P717, DOI 10.1016/j.psc.2012.06.010; Fullston T, 2011, AM J MED GENET B, V156B, P204, DOI 10.1002/ajmg.b.31157; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gordon-Smith K, 2010, BRIT J DERMATOL, V163, P515, DOI 10.1111/j.1365-2133.2010.09834.x; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Guha S, 2013, JAMA PSYCHIAT, V70, P253, DOI 10.1001/2013.jamapsychiatry.71; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; INTERNATIONAL S, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; International Schizophrenia Consortium, 2008, NATURE, V455, P237, DOI DOI 10.1038/NATURE07239; Jungerius BJ, 2008, MOL PSYCHIATR, V13, P1060, DOI 10.1038/sj.mp.4002080; Kavanagh DH, 2015, MOL PSYCHIATR, V20, P72, DOI 10.1038/mp.2014.148; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Krishan K, 2016, SCI ENG ETHICS, V22, P597, DOI 10.1007/s11948-015-9675-8; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; Mulle JG, 2014, BIOL PSYCHIAT, V75, P371, DOI 10.1016/j.biopsych.2013.05.040; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088                                                        ; Nash JE, 2010, J NEUROCHEM, V112, P677, DOI 10.1111/j.1471-4159.2009.06480.x; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ni XQ, 2007, J MED GENET, V44, P532, DOI 10.1136/jmg.2006.047944; Nielsen J, 2010, J PSYCHOPHARMACOL, V24, P965, DOI 10.1177/0269881108100320; Owen MJ, 2016, LANCET, V388, P86, DOI 10.1016/S0140-6736(15)01121-6; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pompili M, 2013, EXPERT REV NEUROTHER, V13, P809, DOI 10.1586/14737175.2013.811976; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rosenfeld JA, 2012, EUR J HUM GENET, V20, P754, DOI 10.1038/ejhg.2012.6; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shi YY, 2008, MOL PSYCHIATR, V13, P911, DOI 10.1038/mp.2008.69; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; St Clair D, 2009, SCHIZOPHRENIA BULL, V35, P9, DOI 10.1093/schbul/sbn147; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tai DJC, 2016, NAT NEUROSCI, V19, P517, DOI 10.1038/nn.4235; Vorstman JAS, 2009, AM J MED GENET B, V150B, P430, DOI 10.1002/ajmg.b.30827; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yuan JM, 2014, SCHIZOPHR RES, V156, P66, DOI 10.1016/j.schres.2014.04.004; Zhao Q, 2013, SCHIZOPHRENIA BULL, V39, P712, DOI 10.1093/schbul/sbr197; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	65	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JUN 21	2017	10								204	10.3389/fnmol.2017.00204				9	Neurosciences	Neurosciences & Neurology	EZ1BU	WOS:000404443400001	28680393	gold			2018-01-05	
J	Lv, TF; Zou, JW; Liu, HB; Shen, Q; Lu, ZF; Zhou, XJ; Wang, XN; Song, Y				Lv, Tangfeng; Zou, Jiawei; Liu, Hongbing; Shen, Qin; Lu, Zhenfeng; Zhou, XiaoJun; Wang, Xiaonan; Song, Yong			Detection of oncogenic mutations in resected bronchial margins by next-generation sequencing indicates early relapse in stage IA lung adenocarcinoma patients	ONCOTARGET			English	Article						next-generation sequencing; early relapse; cancer-related genes; oncogene; surgical margins	MICROSCOPIC RESIDUAL DISEASE; K-RAS MUTATIONS; TNM CLASSIFICATION; SURGICAL MARGINS; 7TH EDITION; CANCER; RECURRENCE; EXPRESSION; SIGNATURE; ASSOCIATION	Stage I non-small cell lung cancer (NSCLC) patients experience a relatively high rate of recurrence, ranging from about 30-35%. We hypothesized that this elevated risk of recurrence is due to the presence of tumor cells at bronchial margins which was undetected by conventional light microscopy. Patients with clinical stage IA (T1N0M0) NSCLC were enrolled in this study, which included 8 early-relapse(ER) and 6 no-relapse(NR) patients. Primary tumor, bronchial margin, and normal lung tissues were collected and sent to a central site for targeted next-generation sequencing analysis. All of the patients were lung adenocarcinoma. Gene mutations were identified in all tumor tissue samples (100%). Oncogenic mutations were identified in 87.5%(7/8) bronchial margins of early relapse patients, whereas only 16.7%(1/6) no-relapse (NR) patient of marginal tissue had identified gene mutation. Additionally, concordance between primary tumor and bronchial margins was relatively high, with 4 of 8 (50%) ER patients having at least one identical mutation. Moreover, according to the gene mutation status in marginal tissue, 87.5% (7/8) of patients with at least one gene mutation in the bronchial margins had local recurrence or metastasis, whereas only 16.7% (1/6) of patients without any mutation detected had signs of relapse, the recurrence rate was significantly higher than that of the negative mutation margin group ((p (log-rank) = 0.023). The existence of oncogenic mutations in bronchial margins may represent occult residual tumor and elevated risk of recurrence in early stage NSCLC patients. Thus, assessing molecular status in bronchial margins may help identify patients who might benefit from extensive surgery or adjuvant treatment.	[Lv, Tangfeng; Zou, Jiawei; Song, Yong] Southern Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Lv, Tangfeng; Liu, Hongbing] Nanjing Univ, Inst Resp Med, Nanjing, Jiangsu, Peoples R China; [Lv, Tangfeng; Liu, Hongbing] Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Jiangsu, Peoples R China; [Shen, Qin; Lu, Zhenfeng; Zhou, XiaoJun] Jinling Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaonan] Geneseeq Technol Inc, Div Precis Med, Dept Res & Dev, Toronto, ON, Canada	Song, Y (reprint author), Southern Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	yong_song6310@yahoo.com			National Natural Science Foundation of China [81602015, 81602636, 81401903, 81572937, 81572273]; Clinical Science and Technology Project of Jiangsu Province [BL2013026]; Natural Science Foundation of Jiangsu province [BK20161386, BK20140736]	This work was supported by grants from the National Natural Science Foundation of China (NO. 81602015, NO. 81602636, NO. 81401903, NO. 81572937, NO. 81572273), Clinical Science and Technology Project of Jiangsu Province (NO. BL2013026) and the Natural Science Foundation of Jiangsu province (NO. BK20161386, NO. BK20140736).	Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Cao B, 2016, ONCOTARGET; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763                                                   ; Hancock JG, 2015, ANN THORAC SURG, V99, P406, DOI 10.1016/j.athoracsur.2014.09.033; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Jassem J, 2004, CANCER, V100, P1951, DOI 10.1002/cncr.20191; Kawachi R, 2009, THORAC CARDIOV SURG, V57, P472, DOI 10.1055/s-0029-1185734; Koike T, 2003, J THORAC CARDIOV SUR, V125, P924, DOI 10.1067/mtc.2003.156; Lou F, 2013, J THORAC CARDIOV SUR, V145, P75, DOI 10.1016/j.jtcvs.2012.09.030; Ludovini V, 2016, ONCOTARGET, V7, P30561, DOI 10.18632/oncotarget.8723; Maeda R, 2011, CHEST, V140, P1494, DOI 10.1378/chest.10-3279; Masasyesva BG, 2005, INT J CANCER, V113, P1022, DOI 10.1002/ijc.20683; Pio R, 2015, J THORAC CARDIOV SUR, V150, P986, DOI 10.1016/j.jtcvs.2015.06.001; Riquet M, 2010, ANN THORAC SURG, V89, P870, DOI 10.1016/j.athoracsur.2009.11.052; Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Sawabata N, 2012, SURG TODAY, V42, P238, DOI 10.1007/s00595-011-0031-6; Schuchert MJ, 2012, ANN THORAC SURG, V93, P1780, DOI 10.1016/j.athoracsur.2011.11.074; Shiono S, 2011, J THORAC ONCOL, V6, P43, DOI 10.1097/JTO.0b013e3181f9abca; Tang XN, 2005, CANCER RES, V65, P7568, DOI 10.1158/0008-5472.CAN-05-1705; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Urban T, 2000, BRIT J CANCER, V82, P412; Vatan O, 2007, TUMORI, V93, P473; Wind J, 2007, EUR J CARDIO-THORAC, V32, P29, DOI 10.1016/j.ejcts.2007.04.003; Xu W, 2016, J THORAC ONCOL, V11, P2150, DOI 10.1016/j.jtho.2016.07.023	28	0	0	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUN 20	2017	8	25					40643	40653		10.18632/oncotarget.16539				11	Oncology; Cell Biology	Oncology; Cell Biology	EY8YG	WOS:000404283700057	28380452	green_published			2018-01-05	
J	Knuepfer, E; Napiorkowska, M; van Ooij, C; Holder, AA				Knuepfer, Ellen; Napiorkowska, Marta; van Ooij, Christiaan; Holder, Anthony A.			Generating conditional gene knockouts in Plasmodium - a toolkit to produce stable DiCre recombinase-expressing parasite lines using CRISPR/Cas9	SCIENTIFIC REPORTS			English	Article							MALARIA PARASITES; CRISPR-CAS9 SYSTEM; CONTINUOUS-CULTURE; HUMAN ERYTHROCYTES; CRE RECOMBINASE; FALCIPARUM; RESISTANCE; DNA; COMPLEMENTATION; MECHANISMS	Successful establishment of CRISPR/Cas9 genome editing technology in Plasmodium spp. has provided a powerful tool to transform Plasmodium falciparum into a genetically more tractable organism. Conditional gene regulation approaches are required to study the function of gene products critical for growth and erythrocyte invasion of blood stage parasites. Here we employ CRISPR/Cas9 to facilitate use of the dimerisable Cre-recombinase (DiCre) that is frequently used to mediate the excision and loss of loxP-flanked DNA sequences in a rapamycin controlled manner. We describe novel CRISPR/Cas9 transfection plasmids and approaches for the speedy, stable and marker-free introduction of transgenes encoding the DiCre recombinase into genomic loci dispensable for blood stage development. Together these plasmids form a toolkit that will allow the rapid generation of transgenic DiCre-expressing P. falciparum lines in any genetic background. Furthermore, the newly developed 3D7-derived parasite lines, constitutively and stably expressing DiCre, generated using this toolkit will prove useful for the analysis of gene products. Lastly, we introduce an improved treatment protocol that uses a lower rapamycin concentration and shorter treatment times, leading to loxP-guided recombination with close to 100% efficiency within the same replication cycle.	[Knuepfer, Ellen; Holder, Anthony A.] Francis Crick Inst, Malaria Parasitol Lab, 1 Midland Rd, London NW1 1AT, England; [Napiorkowska, Marta; van Ooij, Christiaan] Francis Crick Inst, Malaria Biochem Lab, 1 Midland Rd, London NW1 1AT, England; [Napiorkowska, Marta] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland	Knuepfer, E; Holder, AA (reprint author), Francis Crick Inst, Malaria Parasitol Lab, 1 Midland Rd, London NW1 1AT, England.; van Ooij, C (reprint author), Francis Crick Inst, Malaria Biochem Lab, 1 Midland Rd, London NW1 1AT, England.	Ellen.Knuepfer@crick.ac.uk; Christiaan.vanOoij@crick.ac.uk; Tony.Holder@crick.ac.uk	Holder, Anthony/A-7554-2013	Holder, Anthony/0000-0002-8490-6058	Francis Crick Institute; Cancer Research UK [FC001097]; UK Medical Research Council [FC001097]; Wellcome Trust [FC001097, 095836/A/1/Z]	We would like to thank Marcus Lee and David Fidock for the CRISPR/Cas9 vector pDC2-Cas9-U6-hdhfr and cloning instructions, Jose-Juan Lopes-Rubio for pL6 vector and tips on CRISPR/Cas9 technology, Christine Collins and Mike Blackman for the 1G5DC P. falciparum strain and plasmid pBS_DC_hsp86/BiP5', Shahid Khan for plasmid pL0034, Alex Maier for mPAC-TK vector and Munira Grainger as well as Fiona Hackett for parasite maintenance. We would further like to thank Philip Hobson from the Flow Cytometry and Aengus Stewart from the Bioinformatics and Biostatistics Science and Technology Platform at the Francis Crick Institute for their help and advice as well as the NHS Blood and Transplant service for the supply of research red cells. This work was funded by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001097), the UK Medical Research Council (FC001097) and the Wellcome Trust (FC001097), and a Wellcome Trust Career Re-Entry Fellowship to C.v.O. (095836/A/1/Z).	Andenmatten N., 2012, NAT METHODS, DOI [10.1038/nmeth.2301, DOI 10.1038/NMETH.2301]; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.moibiopara.2007.07.008; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BELL A, 1994, BIOCHEM PHARMACOL, V48, P495, DOI 10.1016/0006-2952(94)90279-8; Birnbaum J, 2017, NAT METHODS, V14, P450, DOI 10.1038/nmeth.4223; Carvalho TG, 2004, P NATL ACAD SCI USA, V101, P14931, DOI 10.1073/pnas.0404416101; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Goldfless SJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6329; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Hill RJ, 2016, J BIOL CHEM, V291, P24280, DOI 10.1074/jbc.M116.740506; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008354; Jones ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep21800; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kawano F, 2016, NAT CHEM BIOL, V12, P1059, DOI [10.1038/NCHEMBIO.2205, 10.1038/nchembio.2205]; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Knuepfer E, 2014, CELL MICROBIOL, V16, P657, DOI 10.1111/cmi.12181; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Lim MYX, 2016, NAT MICROBIOL, V1, DOI 10.1038/NMICROBIOL.2016.166; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; Sherling ES, 2017, ELIFE, V6, DOI 10.7554/eLife.23239; Singer M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0811-1; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; The RTS S Clinical Trials Partnership, 2012, NEW ENGL J MED, V367, P2284, DOI DOI 10.1056/NEJM0A1208394; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Schaijk BCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015121; Volz JC, 2016, CELL HOST MICROBE, V20, P60, DOI 10.1016/j.chom.2016.06.004; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; WHO, 2016, WORLD MAL REP 2016; Yap A, 2011, PLOS PATHOG, V16, P642; Zhang C, 2014, MBIO, V5, DOI 10.1128/mBio.01414-14	47	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 20	2017	7								3881	10.1038/s41598-017-03984-3				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EY0JJ	WOS:000403643900034	28634346	gold			2018-01-05	
J	Lee, J; Krivega, I; Dale, RK; Dean, A				Lee, Jongjoo; Krivega, Ivan; Dale, Ryan K.; Dean, Ann			The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions	CELL REPORTS			English	Article							GENOME-WIDE ANALYSIS; BETA-GLOBIN LOCUS; CHROMATIN INTERACTIONS; FETAL-HEMOGLOBIN; GENE-EXPRESSION; MOUSE GENOME; HUMAN-CELLS; IN-VIVO; HI-C; DIFFERENTIATION	Lineage-specific transcription factors are critical for long-range enhancer interactions, but direct or indirect contributions of architectural proteins such as CCCTC-binding factor (CTCF) to enhancer function remain less clear. The LDB1 complex mediates enhancer-gene interactions at the beta-globin locus through LDB1 self-interaction. We find that an LDB1-bound enhancer upstream of carbonic anhydrase 2 (Car2) activates its expression by interacting directly with CTCF at the gene promoter. Both LDB1 and CTCF are required for enhancer-Car2 looping, and the domain of LDB1 contacted by CTCF is necessary to rescue Car2 transcription in LDB1-deficient cells. Genome-wide studies and CRISPR/Cas9 genome editing indicate that LDB1-CTCF enhancer looping underlies activation of a substantial fraction of erythroid genes. Our results provide a mechanism by which long-range interactions of architectural protein CTCF can be tailored to achieve a tissue-restricted pattern of chromatin loops and gene expression.	[Lee, Jongjoo; Krivega, Ivan; Dale, Ryan K.; Dean, Ann] Natl Inst Diabet & Digest & Kidney Dis, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Lee, Jongjoo] Natl Inst Diabet & Digest & Kidney Dis, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Dean, A (reprint author), Natl Inst Diabet & Digest & Kidney Dis, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA.	anndean@helix.nih.gov			Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH [DK015508]	We thank Dr. Gary Felsenfeld for the GST-CTCF expression vectors. We acknowledge the NIDDK Sequencing Core for sequencing. This work was funded by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH (DK015508 to A.D.).	Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bouwman BAM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0730-1; Caputo L, 2015, CELL STEM CELL, V17, P287, DOI 10.1016/j.stem.2015.08.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costello I, 2015, GENE DEV, V29, P2108, DOI 10.1101/gad.268979.115; Cross AJ, 2010, J MOL BIOL, V399, P133, DOI 10.1016/j.jmb.2010.04.006; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Edwards Y, 2000, EXS, V90, P121; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Krivega I, 2014, GENE DEV, V28, P1278, DOI 10.1101/gad.239749.114; Li LQ, 2013, BLOOD, V121, P4575, DOI 10.1182/blood-2013-01-479451; Li LQ, 2010, J EXP MED, V207, P2543, DOI 10.1084/jem.20100504; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mylona A, 2013, BLOOD, V121, P2902, DOI 10.1182/blood-2012-11-467654; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Ing-Simmons E., 2015, GENOME RES, V25, P504; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Song SH, 2012, BBA-GENE REGUL MECH, V1819, P885, DOI 10.1016/j.bbagrm.2012.05.001; Song SH, 2010, BLOOD, V116, P2356, DOI 10.1182/blood-2010-03-272252; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Torigoi E, 2000, P NATL ACAD SCI USA, V97, P2686, DOI 10.1073/pnas.050586397                                                          ; van Meyel DJ, 2003, DEVELOPMENT, V130, P1915, DOI 10.1242/dev.00389; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang F, 2015, P NATL ACAD SCI USA, V112, P1380, DOI 10.1073/pnas.1424228112; Zhou Y, 2013, BLOOD, V122, P4199, DOI 10.1182/blood-2013-02-483875; Zhu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10812	63	1	1	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	JUN 20	2017	19	12					2490	2502		10.1016/j.celrep.2017.05.072				13	Cell Biology	Cell Biology	EY0TO	WOS:000403671700009	28636938	gold			2018-01-05	
J	Radis-Baptista, G; Campelo, IS; Morlighem, JERL; Melo, LM; Freitas, VJF				Radis-Baptista, Gandhi; Campelo, Iana S.; Morlighem, Jean-Etienne R. L.; Melo, Luciana M.; Freitas, Vicente J. F.			Cell-penetrating peptides (CPPs): From delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis	JOURNAL OF BIOTECHNOLOGY			English	Review						Cationic peptides; Cell-penetrating peptides (CPPs); CPP-mediated transduction; Engineered site-directed nucleases (ESDNs); CPP-nuclease fusion proteins; Transgenesis	PLURIPOTENT STEM-CELLS; GERM-LINE TRANSMISSION; TAT-FUSION PROTEINS; GENE DELIVERY; MAMMALIAN-CELLS; ANTISENSE OLIGONUCLEOTIDES; ANTENNAPEDIA HOMEODOMAIN; INTRACELLULAR DELIVERY; SURFACE PROTEOGLYCANS; MEDIATED DELIVERY	Cell-penetrating peptides (CPPs) have been studied for their capacity to translocate across the lipid membrane of several cell types. In membrane translocation, these peptides can remarkably transport biologically active hydrophilic molecules, such as pharmaceuticals, nucleic acids (DNA and RNA) and even high-molecular-weight proteins, Fig. 3 into the cell cytoplasm and organelles. The development of CPPs as transduction agents includes the modification of gene and protein expression, the reprogramming and differentiation of induced pluripotent stem cells and the preparation of cellular vaccines. A relatively recent field of CPP application is the transduction of plasmid DNA vectors and CPP-fusion proteins to modify genomes and introduce new traits in cells and organisms. CPP-mediated transduction of components for genome editing is an advantageous alternative to viral DNA vectors. Engineered site-specific nucleases, such as Cre recombinase, ZFN, TALENs and CRISPR associated protein (Cas), have been coupled to CPPs, and the fused proteins have been used to permeate targeted cells and tissues. The functionally active fusion CPP-nucleases subsequently home to the nucleus, incise genomic DNA at specific sites and induce repair and recombination. This review has the objective of discussing CPPs and elucidating the prospective use of CPP-mediated transduction technology, particularly in genome modification and transgenesis.	[Radis-Baptista, Gandhi; Morlighem, Jean-Etienne R. L.] Univ Fed Ceara, Lab Biochem & Biotechnol, Inst Marine Sci, Av Abolicao 3207, BR-60165081 Fortaleza, Ceara, Brazil; [Campelo, Iana S.; Melo, Luciana M.; Freitas, Vicente J. F.] Univ Estadual Ceara, Lab Physiol & Control Reprod, Fac Vet, BR-60714903 Fortaleza, Ceara, Brazil; [Morlighem, Jean-Etienne R. L.] Univ Fed Ceara, Northeast Biotechnol Network RENORBIO, Postgraduat Program Biotechnol, BR-60455900 Fortaleza, Ceara, Brazil	Radis-Baptista, G (reprint author), Univ Fed Ceara, Lab Biochem & Biotechnol, Inst Marine Sci, Av Abolicao 3207, BR-60165081 Fortaleza, Ceara, Brazil.; Freitas, VJF (reprint author), Univ Estadual Ceara, Lab Physiol & Control Reprod, Fac Vet, BR-60714903 Fortaleza, Ceara, Brazil.	gandhi.radis@ufc.br; vicente.freitas@uece.br	RADIS-BAPTISTA, GANDHI/H-9574-2016	RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Morlighem, Jean-Etienne/0000-0003-2754-8677	Coordination for the Improvement of Higher Education Personnel (CAPES); Ministry of Education (ME); Brazilian National Council for Scientific and Technological Development; Ministry of Science, Technology and Innovation (MCTI); State Agency, FUNCAP/PRONEX [PR2-010100059-01-00/15]	The authors are grateful to the following federal Brazilian funding agencies: the Coordination for the Improvement of Higher Education Personnel (CAPES), the Ministry of Education (ME) and the Brazilian National Council for Scientific and Technological Development, the Ministry of Science, Technology and Innovation (MCTI); and the State Agency, FUNCAP/PRONEX (grant # PR2-010100059-01-00/15).	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Agrawal P, 2016, NUCLEIC ACIDS RES, V44, pD1098, DOI 10.1093/nar/gkv1266; Akcan M, 2011, J MED CHEM, V54, P782, DOI 10.1021/jm101018r; Alves I. D., 2008, BIOCHIM BIOPHYS ACTA, V94, P8; Arenal A, 2008, BIOTECHNOL LETT, V30, P845, DOI 10.1007/s10529-008-9636-2; Aroui S, 2009, PHARM RES-DORD, V26, P836, DOI 10.1007/s11095-008-9782-1; Bae HD, 2016, MOL PHARMACEUT, V13, P3196, DOI 10.1021/acs.molpharmaceut.6b00408; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Belnoue E, 2016, MOL THER, V24, P1675, DOI 10.1038/mt.2016.134; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Boisguerin P, 2015, ADV DRUG DELIVER REV, V87, P52, DOI 10.1016/j.addr.2015.02.008; Brasseur R., 2010, BIOCHIM BIOPHYS ACTA, V217, P2177; Cai YJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01911; Campelo IS, 2016, ZYGOTE, V24, P48, DOI 10.1017/S0967199414000707; Caron NJ, 2004, BIOCHEM BIOPH RES CO, V319, P12, DOI 10.1016/j.bbrc.2004.04.180; Chen PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048913; Chen YJ, 2012, GENE, V493, P201, DOI 10.1016/j.gene.2011.11.060; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Chien WM, 2014, GENESIS, V52, P695, DOI 10.1002/dvg.22782; Child HW, 2011, ACS NANO, V5, P7910, DOI 10.1021/nn202163v; Chiu YL, 2004, CHEM BIOL, V11, P1165, DOI 10.1016/j.chembiol.2004.06.006; Cho HJ, 2012, PHARM RES-DORDR, V29, P1007, DOI 10.1007/s11095-011-0642-z; Chuah Marinee K. L., 2003, Current Gene Therapy, V3, P527, DOI 10.2174/1566523034578140; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; De Coupade C, 2005, BIOCHEM J, V390, P407, DOI 10.1042/BJ20050401; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188                                                        ; Derouazi M, 2015, CANCER RES, V75, P3020, DOI 10.1158/0008-5472.CAN-14-3017; Dixon JE, 2016, P NATL ACAD SCI USA, V113, pE291, DOI 10.1073/pnas.1518634113; Ebert KM, 1991, NAT BIOTECHNOL, V9, P835; Eguchi A, 2009, TRENDS PHARMACOL SCI, V30, P341, DOI 10.1016/j.tips.2009.04.009; Eiriksdottir E., 2010, BIOCHIM BIOPHYS ACTA, V1798, P9; El-Andaloussi S, 2007, BIOCHEM J, V407, P285, DOI 10.1042/BJ20070507; Elliott G, 1999, GENE THER, V6, P149, DOI 10.1038/sj.gt.3300850; Fan JL, 2015, PHARMACOL THERAPEUT, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Freitas VJF, 2012, SMALL RUMINANT RES, V105, P105, DOI 10.1016/j.smallrumres.2012.03.009; Freitas VJF, 2014, CLON TRANSGEN, V3, P1; GAGNE MB, 1991, MOL REPROD DEV, V29, P6, DOI 10.1002/mrd.1080290103; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gautam A, 2015, METHODS MOL BIOL, V1324, P59, DOI 10.1007/978-1-4939-2806-4_4; Gitton Y, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-40; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; GONCALVES JM, 1947, ARCH BIOCHEM, V13, P253; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4; Hashimoto M, 2008, J BIOCHEM, V143, P87, DOI 10.1093/jb/mvm198; Hayashi MAF, 2008, TOXICON, V52, P508, DOI 10.1016/j.toxicon.2008.06.029; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Huang YW, 2015, BIOMED RES INT, DOI 10.1155/2015/834079; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5                                                    ; Irvine AS, 2000, NAT BIOTECHNOL, V18, P1273, DOI 10.1038/82383                                                                   ; Izabela R, 2016, N-S ARCH PHARMACOL, V389, P485, DOI 10.1007/s00210-016-1219-5; Jiang YH, 2014, CURR PHARM BIOTECHNO, V15, P256, DOI 10.2174/1389201015666140813130114                                               ; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929                                                             ; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Kaitsuka T, 2015, INT J MOL SCI, V16, P26667, DOI 10.3390/ijms161125986; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Karagiannis ED, 2013, ACS NANO, V7, P8616, DOI 10.1021/nn4027382; KATO T, 1984, MOL CELL BIOCHEM, V60, P83; Keefer CL, 2004, ANIM REPROD SCI, V82-3, P5, DOI 10.1016/j.anireprosci.2004.04.010; Kerkis A, 2004, FASEB J, V18, P1407, DOI 10.1096/fj.03-1459fje; Kerkis I, 2017, CELL MOL LIFE SCI, V74, P647, DOI 10.1007/s00018-016-2343-6; Kerkis I, 2010, EXPERT OPIN INV DRUG, V19, P1515, DOI 10.1517/13543784.2010.534457; Kim JS, 2016, NAT PROTOC, V11, P1573, DOI 10.1038/nprot.2016.104; Kim MJ, 2015, BIOMATERIALS, V64, P45, DOI 10.1016/j.biomaterials.2015.06.015; Kind A, 2008, TRANSGENIC RES, V17, P1025, DOI 10.1007/s11248-008-9206-3; Kizil C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124073; Kleemann E, 2005, J CONTROL RELEASE, V109, P299, DOI 10.1016/j.jconrel.2005.09.036; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Laible Goetz, 2009, Biotechnology Journal, V4, P1278, DOI 10.1002/biot.200900006; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lehto T, 2012, EXPERT OPIN DRUG DEL, V9, P823, DOI 10.1517/17425247.2012.689285; Li ZY, 1998, INVEST OPHTH VIS SCI, V39, P808; Lim Sangho, 2016, Immune Netw, V16, P33, DOI 10.4110/in.2016.16.1.33; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Liu YB, 2013, CELL REPROGRAM, V15, P107, DOI 10.1089/cell.2012.0062; Madani F., 2011, J BIOPHYS, V2011, DOI DOI 10.1155/2011/414729; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mai JC, 2002, J BIOL CHEM, V277, P30208, DOI 10.1074/jbc.M204202200; Maiolo J. R., 2005, BIOCHIM BIOPHYS ACTA, V16, P161; MANN DA, 1991, EMBO J, V10, P1733; Matsubara Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05043; Matsumoto R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12884; Maurisse R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-9; McClorey G, 2015, CURR OPIN PHARMACOL, V24, P52, DOI 10.1016/j.coph.2015.07.005; Mehier-Humbert S, 2005, ADV DRUG DELIVER REV, V57, P733, DOI 10.1016/j.addr.2004.12.007; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nakase I, 2010, BIOPOLYMERS, V94, P763, DOI 10.1002/bip.21487; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Nielsen EJB, 2014, J CONTROL RELEASE, V189, P19, DOI 10.1016/j.jconrel.2014.06.022; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; Park H, 2013, BIOMATERIALS, V34, P4872, DOI 10.1016/j.biomaterials.2013.03.049; Persson D, 2001, FEBS LETT, V505, P307, DOI 10.1016/S0014-5793(01)02843-5                                                   ; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pooga M, 1998, FASEB J, V12, P67; Pooga M, 2015, METHODS MOL BIOL, V1324, P3, DOI 10.1007/978-1-4939-2806-4_1; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788                                                              ; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Qian ZQ, 2015, CHEM COMMUN, V51, P2162, DOI 10.1039/c4cc09441g; Raagel H, 2009, J CONTROL RELEASE, V139, P108, DOI 10.1016/j.jconrel.2009.06.028; Radis-Baptista G, 2008, J MED CHEM, V51, P7041, DOI 10.1021/jm8009475; Radis-Baptista G, 2011, CURR PHARM DESIGN, V17, P4351, DOI 10.2174/138161211798999429                                                      ; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Regberg Jakob, 2012, Pharmaceuticals (Basel), V5, P991, DOI 10.3390/ph5090991; Regberg Jakob, 2013, Front Biosci (Elite Ed), V5, P509; Rennert R., 2006, BIOCHIM BIOPHYS ACTA, V34, P347; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rizzuti M, 2015, DRUG DISCOV TODAY, V20, P76, DOI 10.1016/j.drudis.2014.09.017; Rodrigues M, 2011, BIOCONJUGATE CHEM, V22, P2339, DOI 10.1021/bc200421z; Roeder GE, 2004, BIOTECHNOL APPL BIOC, V40, P157, DOI 10.1042/BA20030172; Ru Renli, 2013, Cell Regen (Lond), V2, P5, DOI 10.1186/2045-9769-2-5; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Shukla RS, 2014, MOL PHARMACEUT, V11, P3395, DOI 10.1021/mp500426r; Soler M, 2014, ORG BIOMOL CHEM, V12, P1652, DOI 10.1039/c3ob42422g; Sonsteng KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091219; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Sovova T, 2017, CURR ISSUES MOL BIOL, V21, P41, DOI 10.21775/cimb.021.041; Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c; Stone J., 1998, THESIS; Sun Y, 2015, VET IMMUNOL IMMUNOP, V167, P96, DOI 10.1016/j.vetimm.2015.07.008; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7                                                    ; Tiriveedhi V, 2007, BIOCHEMISTRY-US, V46, P3888, DOI 10.1021/bi602527t; Tisseyre Celine, 2013, Pharmaceuticals (Basel), V6, P320, DOI 10.3390/ph6030320; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010                                                        ; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Walrant A., 2011, BIOCHIM BIOPHYS ACTA, V38, P382; Walther C, 2009, BIOPOLYMERS, V92, P445, DOI 10.1002/bip.21218; Wang HY, 2012, ADV IMMUNOL, V114, P151, DOI 10.1016/B978-0-12-396548-6.00006-8; Wanjale M. V., 2016, EXPERT OPIN DRUG DEL; WHARTON SA, 1988, J GEN VIROL, V69, P1847, DOI 10.1099/0022-1317-69-8-1847; WRIGHT G, 1991, BIO-TECHNOL, V9, P830, DOI 10.1038/nbt0991-830; Xu YY, 2008, GENE, V419, P70, DOI 10.1016/j.gene.2008.04.020; Yu X, 2016, VACCINE, V34, P4399, DOI 10.1016/j.vaccine.2016.07.017; Zhou Y, 2012, J OCEAN U CHINA, V11, P197, DOI 10.1007/s11802-012-1862-5; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	144	3	3	31	36	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1656	1873-4863		J BIOTECHNOL	J. Biotechnol.	JUN 20	2017	252						15	26		10.1016/j.jbiotec.2017.05.002				12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EY1MV	WOS:000403730900003	28479163				2018-01-05	
J	Rolland, DCM; Basrur, V; Jeon, YK; McNeil-Schwalm, C; Fermin, D; Conlon, KP; Zhou, YQ; Ng, SY; Tsou, CC; Brown, NA; Thomas, DG; Bailey, NG; Omenn, GS; Nesvizhskii, AI; Root, DE; Weinstock, DM; Faryabi, RB; Lim, MS; Elenitoba-Johnson, KSJ				Rolland, Delphine C. M.; Basrur, Venkatesha; Jeon, Yoon-Kyung; McNeil-Schwalm, Carla; Fermin, Damian; Conlon, Kevin P.; Zhou, Yeqiao; Ng, Samuel Y.; Tsou, Chih-Chiang; Brown, Noah A.; Thomas, Dafydd G.; Bailey, Nathanael G.; Omenn, Gilbert S.; Nesvizhskii, Alexey I.; Root, David E.; Weinstock, David M.; Faryabi, Robert B.; Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.			Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						proteomics; RNA-seq; CRISPR screen; biomarkers; lymphoma	INTERACTION NETWORKS; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; STATISTICAL-MODEL; DATA SETS; DATABASE; IDENTIFICATION; ANTIBODY; QUANTIFICATION; CHEMOTHERAPY	Identification of biomarkers and therapeutic targets is a critical goal of precision medicine. N-glycoproteins are a particularly attractive class of proteins that constitute potential cancer biomarkers and therapeutic targets for smallmolecules, antibodies, and cellular therapies. Using mass spectrometry (MS), we generated a compendium of 1,091 N-glycoproteins (from 40 human primary lymphomas and cell lines). Hierarchical clustering revealed distinct subtype signatures that included several subtype-specific biomarkers. Orthogonal immunological studies in 671 primary lymphoma tissue biopsies and 32 lymphoma-derived cell lines corroborated MS data. In anaplastic lymphoma kinase-positive (ALK(+)) anaplastic large cell lymphoma (ALCL), integration of N-glycoproteomics and transcriptome sequencing revealed an ALK-regulated cytokine/receptor signaling network, including vulnerabilities corroborated by a genome-wide clustered regularly interspaced short palindromic screen. Functional targeting of IL-31 receptor beta, an ALCL-enriched and ALK-regulated N-glycoprotein in this network, abrogated ALK(+) ALCL growth in vitro and in vivo. Our results highlight the utility of functional proteogenomic approaches for discovery of cancer biomarkers and therapeutic targets.	[Rolland, Delphine C. M.; Zhou, Yeqiao; Faryabi, Robert B.; Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Basrur, Venkatesha; Fermin, Damian; Conlon, Kevin P.; Tsou, Chih-Chiang; Brown, Noah A.; Thomas, Dafydd G.; Bailey, Nathanael G.; Nesvizhskii, Alexey I.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Jeon, Yoon-Kyung] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [McNeil-Schwalm, Carla] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Ng, Samuel Y.; Weinstock, David M.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.; Nesvizhskii, Alexey I.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Root, David E.; Weinstock, David M.] Broad Inst Massachusetts Inst Technol & Harvard M, Boston, MA 02142 USA; [Faryabi, Robert B.; Elenitoba-Johnson, Kojo S. J.] Univ Penn, Perelman Sch Med, Ctr Personalized Diagnost, Philadelphia, PA 19104 USA	Lim, MS; Elenitoba-Johnson, KSJ (reprint author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Elenitoba-Johnson, KSJ (reprint author), Univ Penn, Perelman Sch Med, Ctr Personalized Diagnost, Philadelphia, PA 19104 USA.	megan.lim@uphs.upenn.edu; kojo.elenitoba-johnson@uphs.upenn.edu			NIGMS NIH HHS [R01 GM094231]		Auguste P, 1997, J BIOL CHEM, V272, P15760, DOI 10.1074/jbc.272.25.15760                                                        ; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Fermin D, 2011, PROTEOMICS, V11, P1340, DOI 10.1002/pmic.201000650; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oflazoglu E, 2008, BRIT J HAEMATOL, V142, P69, DOI 10.1111/j.1365-2141.2008.07146.x; Pan S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003251; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; PICKER LJ, 1987, AM J PATHOL, V128, P181; Porter DL, 2011, J CANCER, V2, P331, DOI 10.7150/jca.2.331; R Core Team, 2014, R LANG ENV STAT COMP; Ramos-Medina R, 2011, IMMUNOL LETT, V134, P150, DOI 10.1016/j.imlet.2010.10.007; REFF ME, 1994, BLOOD, V83, P435; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow SH, 2008, WHO CLASSIFICATION T, V2; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tanaka M, 2003, Rev Physiol Biochem Pharmacol, V149, P39; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhou Y, 2007, ANAL CHEM, V79, P5826, DOI 10.1021/ac0623181	35	2	2	6	6	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 20	2017	114	25					6581	6586		10.1073/pnas.1701263114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EY0YL	WOS:000403687300045	28607076				2018-01-05	
J	Marson, FAL; Bertuzzo, CS; Ribeiro, JD				Marson, Fernando A. L.; Bertuzzo, Carmen S.; Ribeiro, Jose D.			Personalized or Precision Medicine? The Example of Cystic Fibrosis	FRONTIERS IN PHARMACOLOGY			English	Review						CFTR; genotype; gene-therapy; lung disease; phenotype; variability	PLURIPOTENT STEM-CELLS; CFTR MUTATION; GENE-THERAPY; MODULATORS; DIAGNOSIS; MODEL; ERA; CHALLENGES; DISEASES; REALITY	The advent of the knowledge on human genetics, by the identification of disease-associated variants, culminated in the understanding of human variability. With the genetic knowledge, the specificity of the clinical phenotype and the drug response of each individual were understood. Using the cystic fibrosis (CF) as an example, the new terms that emerged such as personalized medicine and precision medicine can be characterized. The genetic knowledge in CF is broad and the presence of a monogenic disease caused by mutations in the CFTR gene enables the phenotype-genotype association studies (including the response to drugs), considering the wide clinical and laboratory spectrum dependent on the mutual action of genotype, environment, and lifestyle. Regarding the CF disease, personalized medicine is the treatment directed at the symptoms, and this treatment is adjusted depending on the patient's phenotype. However, more recently, the term precision medicine began to be widely used, although its correct application and understanding are still vague and poorly characterized. In precision medicine, we understand the individual as a response to the interrelation between environment, lifestyle, and genetic factors, which enabled the advent of new therapeutic models, such as conventional drugs adjustment by individual patient dosage and drug type and response, development of new drugs (read through, broker, enhancer, stabilizer, and amplifier compounds), genome editing by homologous recombination, zinc finger nucleases, TALEN (transcription activator-like effector nuclease), CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPR-associated endonuclease 9), and gene therapy. Thus, we introduced the terms personalized medicine and precision medicine based on the CF.	[Marson, Fernando A. L.; Bertuzzo, Carmen S.] Univ Estadual Campinas, Dept Med Genet, Fac Med Sci, Campinas, SP, Brazil; [Marson, Fernando A. L.; Ribeiro, Jose D.] Univ Estadual Campinas, Dept Pediat, Fac Med Sci, Campinas, SP, Brazil	Marson, FAL (reprint author), Univ Estadual Campinas, Dept Med Genet, Fac Med Sci, Campinas, SP, Brazil.; Marson, FAL (reprint author), Univ Estadual Campinas, Dept Pediat, Fac Med Sci, Campinas, SP, Brazil.	fernandolimamarson@hotmail.com		Ribeiro, Jose Dirceu/0000-0002-3387-5642; Marson, Fernando/0000-0003-4955-4234	Sao Paulo Research Foundation (FAPESP) [2011/12939-4, 2015/12183-8, 2015/12858-5, 2011/18845-1]; Fund for the Support to Education, Research, and Extension of the University of Campinas [0648/2015]	FM: Sao Paulo Research Foundation (FAPESP) in the research support and fellowship grants numbers #2011/12939-4; #2015/12183-8, and #2015/12858-5; Fund for the Support to Education, Research, and Extension of the University of Campinas, grant number #0648/2015; JR: FAPESP, grant number #2011/18845-1 and #2015/12183-8.	Alapati D., 2016, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2016-0301PS, DOI 10.1165/rcmb.2016-0301PS]; Alton EWFW, 2016, PEDIATR PULM, V51, pS5, DOI 10.1002/ppul.23543; Baker MW, 2016, GENET MED, V18, P231, DOI 10.1038/gim.2014.209; Balfour-Lynn IM, 2014, PAEDIATR RESPIR REV, V15, P2, DOI 10.1016/j.prrv.2014.04.003; Bellec J, 2015, CURR GENE THER, V15, P447; Bianco AM, 2013, GENOMICS, V101, P75, DOI 10.1016/j.ygeno.2012.11.001; Biane C, 2016, BIOSYSTEMS, V150, P52, DOI 10.1016/j.biosystems.2016.08.006; Biller JA, 2015, CURR OPIN PULM MED, V21, P596, DOI 10.1097/MCP.0000000000000216; Bilton D, 2014, PAEDIATR RESPIR REV, V15, P6, DOI 10.1016/j.prrv.2014.04.004; Botkin JR, 2016, CURR OPIN PEDIATR, V28, P700, DOI 10.1097/MOP.0000000000000418; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Boyle MP, 2013, LANCET RESP MED, V1, P158, DOI 10.1016/S2213-2600(12)70057-7; Breckenridge A, 2016, NAT REV DRUG DISCOV, V15, P805, DOI 10.1038/nrd.2016.206; Brown SD, 2017, JAAPA-J AM ACAD PHYS, V30, P23, DOI 10.1097/01.JAA.0000515540.36581.92; Callebaut I, 2017, CELL MOL LIFE SCI, V74, P3, DOI 10.1007/s00018-016-2385-9; Castellani C, 2017, CELL MOL LIFE SCI, V74, P129, DOI 10.1007/s00018-016-2393-9; Chang EH, 2015, CTS-CLIN TRANSL SCI, V8, P606, DOI 10.1111/cts.12292; Cooney L., 2016, JCI INSIGHT, V1, DOI [10.1172/jci.insight.88730, DOI 10.1172/JCI.INSIGHT.88730]; Corvol H, 2016, TRANSL RES, V168, P40, DOI 10.1016/j.trsl.2015.04.008; Davies JC, 2015, CURR OPIN PULM MED, V21, P579, DOI 10.1097/MCP.0000000000000211; De Boeck K, 2016, LANCET RESP MED, V4, P662, DOI 10.1016/S2213-2600(16)00023-0; Marson FAD, 2015, CURR DRUG TARGETS, V16, P1007, DOI 10.2174/1389450115666141128121118; Duncan GA, 2016, MOL THER, V24, P2043, DOI 10.1038/mt.2016.182; Dzau VJ, 2016, JAMA-J AM MED ASSOC, V316, P1659, DOI 10.1001/jama.2016.14117; Farrell PM, 2017, J PEDIATR-US, V181, pS4, DOI 10.1016/j.jpeds.2016.09.064; Ferkol T, 2015, AM J RESP CRIT CARE, V192, P658, DOI 10.1164/rccm.201507-1428ED; Green Deanna M, 2013, N C Med J, V74, P486; Griesenbach U, 2016, CURR OPIN PULM MED, V22, P602, DOI 10.1097/MCP.0000000000000327; Guo WT, 2017, BIOMETRICS, V73, P367, DOI 10.1111/biom.12613; Ikpa PT, 2014, INT J BIOCHEM CELL B, V52, P192, DOI 10.1016/j.biocel.2014.02.008; Jordan CL, 2016, PEDIATR PULM, V51, pS61, DOI 10.1002/ppul.23505; Kersten ETG, 2017, CURR OPIN PULM MED, V23, P12, DOI 10.1097/MCP.0000000000000335; Liang F, 2017, SLAS TECHNOL, V22, P315, DOI 10.1177/2472630317692561; Lim RM, 2016, GENET MED, V18, P174, DOI 10.1038/gim.2015.52; Marson FAL, 2016, LANCET RESP MED, V4, pE37, DOI 10.1016/S2213-2600(16)30188-6; Lopes-Pacheco M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00275; Lundman E, 2016, J CYST FIBROS, V15, P318, DOI 10.1016/j.jcf.2015.12.017; Martin Ulrich, 2015, Mol Cell Pediatr, V2, P15, DOI 10.1186/s40348-015-0023-5; Martiniano SL, 2016, CURR OPIN PEDIATR, V28, P312, DOI 10.1097/MOP.0000000000000351; Mou H, 2015, PEDIATR PULM, V50, pS14, DOI 10.1002/ppul.23233; Oates GR, 2016, EXPERT REV RESP MED, V10, P967, DOI 10.1080/17476348.2016.1196140; Ozen Alahdab Y, 2016, MINERVA MED, V107, P427; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Perlman RL, 2016, GENET MED, V18, P1088, DOI 10.1038/gim.2016.5; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Priyadharshini VS, 2016, ADV PROTEIN CHEM STR, V102, P115, DOI 10.1016/bs.apcsb.2015.11.008; Quon BS, 2015, CAN RESPIR J, V22, P257, DOI 10.1155/2015/921712                                                             ; Rafeeq MM, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1193-9; Ramalingam S, 2014, CURR GENE THER, V14, P461, DOI 10.2174/1566523214666140918101725                                               ; Ratkiewicz M, 2017, WORLD J PEDIATR, V13, P129, DOI 10.1007/s12519-017-0015-8; Rutter WC, 2017, MICROB DRUG RESIST, V23, P51, DOI 10.1089/mdr.2016.0048; Samson C, 2016, RESP MED, V117, P1, DOI 10.1016/j.rmed.2016.05.025; Sathe MN, 2016, PEDIATR CLIN N AM, V63, P679, DOI 10.1016/j.pcl.2016.04.008; Schmidt BZ, 2016, CLIN PHARMACOL-ADV A, V8, P127, DOI 10.2147/CPAA.S100759; Schneider EK, 2017, CLIN PHARMACOL THER, V101, P130, DOI 10.1002/cpt.548; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Scott AR, 2016, NATURE, V537, pS54, DOI 10.1038/537S54a; Spielberg DR, 2016, ANNU REV GENOM HUM G, V17, P155, DOI 10.1146/annurev-genom-090314-050024; Steines B, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88728; Straniero L, 2016, J HUM GENET, V61, P977, DOI 10.1038/jhg.2016.101; Suzuki S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.43; Camarasa MV, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0275-6; Wang Zheng-Guo, 2016, Chin J Traumatol, V19, P249; Xu C, 2017, GENET EPIDEMIOL, V41, P187, DOI 10.1002/gepi.22015; Xue Y, 2016, GENOM PROTEOM BIOINF, V14, P253, DOI 10.1016/j.gpb.2016.10.001; Yuan B, 2016, CHIN J INTEGR MED, V22, P883, DOI 10.1007/s11655-016-2605-z; Zietkiewicz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089094	67	1	1	21	21	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JUN 20	2017	8								390	10.3389/fphar.2017.00390				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EY1YF	WOS:000403763700001	28676762				2018-01-05	
J	Gaj, T; Staahl, BT; Rodrigues, GAMC; Limsirichai, P; Ekman, FK; Doudna, JA; Schaffer, DV				Gaj, Thomas; Staahl, Brett T.; Rodrigues, Goncalo M. C.; Limsirichai, Prajit; Ekman, Freja K.; Doudna, Jennifer A.; Schaffer, David V.			Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery	NUCLEIC ACIDS RESEARCH			English	Article							ZINC-FINGER NUCLEASES; PLURIPOTENT STEM-CELLS; ADENOASSOCIATED VIRUS; MESSENGER-RNA; HEMATOPOIETIC STEM; EFFICIENT DELIVERY; HUMAN FIBROBLASTS; MAMMALIAN-CELLS; VIRAL VECTORS; DNA-REPAIR	Realizing the full potential of genome editing requires the development of efficient and broadly applicable methods for delivering programmable nucleases and donor templates for homology-directed repair (HDR). The RNA-guided Cas9 endonuclease can be introduced into cells as a purified protein in complex with a single guide RNA (sgRNA). Such ribonucleoproteins (RNPs) can facilitate the high-fidelity introduction of single-base substitutions via HDR following co-delivery with a single-stranded DNA oligonucleotide. However, combining RNPs with transgene-containing donor templates for targeted gene addition has proven challenging, which in turn has limited the capabilities of the RNP-mediated genome editing toolbox. Here, we demonstrate that combining RNP delivery with naturally recombinogenic adeno-associated virus (AAV) donor vectors enables site-specific gene insertion by homology-directed genome editing. Compared to conventional plasmid-based expression vectors and donor templates, we show that combining RNP and AAV donor delivery increases the efficiency of gene addition by up to 12-fold, enabling the creation of lineage reporters that can be used to track the conversion of striatal neurons from human fibroblasts in real time. These results thus illustrate the potential for unifying nuclease protein delivery with AAV donor vectors for homology-directed genome editing.	[Gaj, Thomas; Rodrigues, Goncalo M. C.; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Staahl, Brett T.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rodrigues, Goncalo M. C.] Univ Lisbon, Dept Bioengn, P-1049001 Lisbon, Portugal; [Rodrigues, Goncalo M. C.] Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, P-1049001 Lisbon, Portugal; [Limsirichai, Prajit] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ekman, Freja K.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	doudna@berkeley.edu; schaffer@berkeley.edu			Ruth L. Kirschstein National Research Service Award (NRSA) [F32GM113446]; F. Hoffmann-La Roche Postdoctoral Fellowship [RPF311]; Fundacao para a Ciencia e a Tecnologia (FCT) de Portugal [SFRH/BD/89374/2012]; National Institutes of Health (NIH) [R01EY022975]; Roche Pharmaceutical's Roche Alliance with Distinguished Scientists (ROADS) Fund Award; HHMI; NIH	Ruth L. Kirschstein National Research Service Award (NRSA) (F32GM113446) (to T.G.); F. Hoffmann-La Roche Postdoctoral Fellowship [RPF311 to B.T.S.]; Fundacao para a Ciencia e a Tecnologia (FCT) de Portugal [SFRH/BD/89374/2012 to G.M.C.R.]; National Institutes of Health (NIH) [R01EY022975 to D.V.S.]; Roche Pharmaceutical's Roche Alliance with Distinguished Scientists (ROADS) Fund Award (to J.A.D.); HHMI Investigator and a Paul Allen Frontiers in Science investigator (to J.A.D.). Funding for open access charge: NIH.	Arbab M, 2015, STEM CELL REP, V5, P908, DOI 10.1016/j.stemcr.2015.09.022; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Asuri P, 2012, MOL THER, V20, P329, DOI 10.1038/mt.2011.255; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bibikova M, 2002, GENETICS, V161, P1169; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chang KW, 2013, BIOCHEM BIOPH RES CO, V434, P854, DOI 10.1016/j.bbrc.2013.04.031; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Choi VW, 2006, J VIROL, V80, P10346, DOI 10.1128/JVI.00841-06; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ellis BL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-74; Gaj T., 2016, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot086868, DOI 10.1101/PDB.PROT086868]; Gaj T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023754; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; Gaj T, 2014, ACS CHEM BIOL, V9, P1662, DOI 10.1021/cb500282g; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Hirata RK, 2000, J VIROL, V74, P4612, DOI 10.1128/JVI.74.10.4612-4620.2000; Hirsch ML, 2015, GENE THER, V22, P190, DOI 10.1038/gt.2014.109; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jackman J., 2001, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0803S00; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu J, 2015, NAT PROTOC, V10, P1842, DOI 10.1038/nprot.2015.117; Liu J, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.6; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Mock U, 2016, NAT PROTOC, V11, P598, DOI 10.1038/nprot.2016.027; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Richner M, 2015, NAT PROTOC, V10, P1543, DOI 10.1038/nprot.2015.102; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325                                                              ; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415                                       ; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Victor MB, 2014, NEURON, V84, P311, DOI 10.1016/j.neuron.2014.10.016; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	76	2	2	15	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUN 20	2017	45	11							e98	10.1093/nar/gkx154				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EY1AG	WOS:000403693000006	28334779	gold			2018-01-05	
J	Read, A; Gao, SJ; Batchelor, E; Luo, J				Read, Abigail; Gao, Shaojian; Batchelor, Eric; Luo, Ji			Flexible CRISPR library construction using parallel oligonucleotide retrieval	NUCLEIC ACIDS RESEARCH			English	Article							ESSENTIAL GENES; HUMAN-CELLS; IN-VIVO; CANCER; SCREENS; GENOME; IDENTIFICATION; DESIGN; VULNERABILITIES; REVEAL	CRISPR/Cas9-based gene knockout libraries have emerged as a powerful tool for functional screens. We present here a set of pre-designed human and mouse sgRNA sequences that are optimized for both high on-target potency and low off-target effect. To maximize the chance of target gene inactivation, sgRNAs were curated to target both 5' constitutive exons and exons that encode conserved protein domains. We describe here a robust and cost-effective method to constructmultiple small sized CRISPR library from a single oligo pool generated by array synthesis using parallel oligonucleotide retrieval. Together, these resources provide a convenient means for individual labs to generate customized CRISPR libraries of variable size and coverage depth for functional genomics application.	[Read, Abigail; Luo, Ji] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Gao, Shaojian] NCI, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Batchelor, Eric] NCI, Pathol Lab, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA	Luo, J (reprint author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	ji.luo@nih.gov			US National Cancer Institute [ZIA BC 011304]; NIH	US National Cancer Institute Intramural Grant [ZIA BC 011304 to J.L.]. Funding for open access charge: NIH Intramural Funding.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	24	0	0	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUN 20	2017	45	11							e101	10.1093/nar/gkx181				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EY1AG	WOS:000403693000009	28334828	gold			2018-01-05	
J	O'Hayre, M; Eichel, K; Avino, S; Zhao, XF; Steffen, DJ; Feng, XD; Kawakami, K; Aoki, J; Messer, K; Sunahara, R; Inoue, A; von Zastrow, M; Gutkind, JS				O'Hayre, Morgan; Eichel, Kelsie; Avino, Silvia; Zhao, Xuefeng; Steffen, Dana J.; Feng, Xiaodong; Kawakami, Kouki; Aoki, Junken; Messer, Karen; Sunahara, Roger; Inoue, Asuka; von Zastrow, Mark; Gutkind, J. Silvio			Genetic evidence that beta-arrestins are dispensable for the initiation of beta(2)-adrenergic receptor signaling to ERK	SCIENCE SIGNALING			English	Article							PROTEIN-COUPLED RECEPTORS; ADRENERGIC-RECEPTOR; DYNAMIC PROCESS; G-ALPHA; KINASE; RAS; ACTIVATION; CELLS; TRANSDUCTION; TRAFFICKING	The beta(2)-adrenergic receptor (beta(2)AR) has provided a paradigm to elucidate how G protein-coupled receptors (GPCRs) control intracellular signaling, including the discovery that beta-arrestins, which bind to ligand-activated GPCRs, are central for GPCR function. We used genome editing, conditional gene deletion, and small interfering RNAs (siRNAs) to determine the roles of beta-arrestin 1 (beta-arr1) and beta-arr2 in beta(2)AR internalization, trafficking, and signaling to ERK. We found that only beta-arr2 was essential for beta(2)AR internalization. Unexpectedly, beta-arr1 and beta-arr2 and receptor internalization were dispensable for ERK activation. Instead, beta(2)AR signaled through G alpha(s) and G beta gamma subunits through a pathway that involved the tyrosine kinase SRC, the adaptor protein SHC, the guanine nucleotide exchange factor SOS, the small GTPase RAS, and the kinases RAF and MEK, which led to ERK activation. These findings provide a molecular framework for beta(2)AR signaling through beta-arrestin-independent pathways in key physiological functions and under pathological conditions.	[O'Hayre, Morgan; Avino, Silvia; Zhao, Xuefeng; Feng, Xiaodong; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Rockville, MD 20852 USA; [Eichel, Kelsie; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Avino, Silvia] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Via Pietro Bucci, I-87036 Arcavacata Di Rende, CS, Italy; [Zhao, Xuefeng; Steffen, Dana J.; Feng, Xiaodong; Messer, Karen; Sunahara, Roger; Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhao, Xuefeng; Steffen, Dana J.; Feng, Xiaodong; Messer, Karen; Sunahara, Roger; Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Zhao, Xuefeng] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China; [Kawakami, Kouki; Aoki, Junken; Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1000004, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Gutkind, JS (reprint author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Rockville, MD 20852 USA.; Gutkind, JS (reprint author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Gutkind, JS (reprint author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	sgutkind@ucsd.edu	Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482	National Institute of Dental and Craniofacial Research intramural program at the NIH; Japan Science and Technology Agency; Precursory Research for Embryonic Science and Technology [JPMJPR1331]; PRIME, Japan Agency for Medical Research and Development; Core Research for Evolutional Science and Technology; University of California, San Diego (UCSD) Moores Cancer Center and Department of Pharmacology; National Institute on Drug Abuse [DA012864, DA06511]; NSF; UCSD through National Institute of General Medical Sciences [T32 GM007752]; Japan Agency for Medical Research and Development	This study was partially supported by the National Institute of Dental and Craniofacial Research intramural program at the NIH (J.S.G. and M.O.). A.I. received funding from Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (JPMJPR1331) and the PRIME, Japan Agency for Medical Research and Development, and J.A. received funding from Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology. J.S.G. received funding from University of California, San Diego (UCSD) Moores Cancer Center and Department of Pharmacology. M.v.Z. received funding from the National Institute on Drug Abuse (DA012864 and DA06511). K.E. is a recipient of an NSF Graduate Research Fellowship. D.J.S. was supported in part by the UCSD Graduate Training Program in Cellular and Molecular Pharmacology through an institutional training grant from the National Institute of General Medical Sciences (T32 GM007752).	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5                                                   ; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen JJ, 2013, ONCOTARGET, V4, P206, DOI 10.18632/oncotarget.813                                                         ; Conner DA, 1997, CIRC RES, V81, P1021; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Fernandez-Medarde A, 2011, BBA-REV CANCER, V1815, P170, DOI 10.1016/j.bbcan.2010.11.001; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x                                                ; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x                                                ; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6                                                   ; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Schmitt JM, 2002, J BIOL CHEM, V277, P43024, DOI 10.1074/jbc.M204006200; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Stallaert W, 2017, MOL PHARMACOL, V91, P533, DOI 10.1124/mol.116.106419; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/nchembio.1611, 10.1038/NCHEMBIO.1611]; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104	44	2	2	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1945-0877	1937-9145		SCI SIGNAL	Sci. Signal.	JUN 20	2017	10	484							eaal3395	10.1126/scisignal.aal3395				13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EY0PJ	WOS:000403660200002					2018-01-05	
J	Kim, J; Hyun, J; Wang, S; Lee, C; Lee, JW; Moon, EY; Cha, H; Diehl, AM; Jung, Y				Kim, Jieun; Hyun, Jeongeun; Wang, Sihyung; Lee, Chanbin; Lee, Jae-Wook; Moon, Eun-Yi; Cha, Heejae; Diehl, Anna Mae; Jung, Youngmi			Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling	SCIENTIFIC REPORTS			English	Article							INTEGRIN-LINKED KINASE; NF-KAPPA-B; ACTIN-SEQUESTERING PROTEIN; LIVER FIBROSIS; SONIC-HEDGEHOG; MESENCHYMAL TRANSITION; CANCER; EXPRESSION; RAT; PROMOTES	The molecular mechanisms of thymosin beta-4 (TB4) involved in regulating hepatic stellate cell (HSC) functions remain unclear. Therefore, we hypothesize that TB4 influences HSC activation through hedgehog (Hh) pathway. HSC functions declined in a TB4 siRNA-treated LX-2. TB4 suppression down-regulated both integrin linked kinase ( ILK), an activator of smoothened, and phosphorylated glycogen synthase kinase 3 beta (pGSK-3B), an inactive form of GSK-3B degrading glioblastoma 2 (GLI2), followed by the decreased expression of both smoothened and GLI2. A TB4 CRISPR also blocked the activation of primary HSCs, with decreased expression of smoothened, GLI2 and ILK compared with cells transfected with nontargeting control CRISPR. Double immunostaining and an immunoprecipitation assay revealed that TB4 interacted with either smoothened at the cytoplasm or GLI2 at the nucleus in LX-2. Smoothened suppression in primary HSCs using a Hh antagonist or adenovirus transduction decreased TB4 expression with the reduced activation of HSCs. Tb4-overexpressing transgenic mice treated with CCl4 were susceptible to the development hepatic fibrosis with higher levels of ILK, pGSK3b, and Hh activity, as compared with wild-type mice. These findings demonstrate that TB4 regulates HSC activation by influencing the activity of Smoothened and GLI2, suggesting TB4 as a novel therapeutic target in liver disease.	[Kim, Jieun; Hyun, Jeongeun; Wang, Sihyung; Lee, Chanbin; Jung, Youngmi] Pusan Natl Univ, Coll Nat Sci, Dept Integrated Biol Sci, 63-2 Pusandaehak Ro, Pusan 46241, South Korea; [Jung, Youngmi] Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, 63-2 Pusandaehak Ro, Pusan 46241, South Korea; [Lee, Jae-Wook; Moon, Eun-Yi] Sejong Univ, Dept Biosci & Biotechnol, 209 Neungdong Ro, Seoul 05006, South Korea; [Cha, Heejae] Kosin Univ, Coll Med, Dept Parasitol & Genet, 262 Gamcheon Ro, Pusan 49267, South Korea; [Diehl, Anna Mae] Duke Univ, Dept Med, Div Gastroenterol, 595 LaSalle St, Durham, NC 27710 USA	Jung, Y (reprint author), Pusan Natl Univ, Coll Nat Sci, Dept Integrated Biol Sci, 63-2 Pusandaehak Ro, Pusan 46241, South Korea.; Jung, Y (reprint author), Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, 63-2 Pusandaehak Ro, Pusan 46241, South Korea.	y.jung@pusan.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MEST) [2014M2B2A9030333]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2014M2B2A9030333).	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Bang D, 2013, CANCER DISCOV, V3, P690, DOI 10.1158/2159-8290.CD-12-0541; Barakat B, 2013, EMBO REP, V14, P837, DOI 10.1038/embor.2013.110; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Choi SS, 2010, HEPATOLOGY, V52, P278, DOI 10.1002/hep.23649; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Cohen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7709; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051                                                         ; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211                                                        ; Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126                                                            ; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247                                                          ; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Hyun J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10993; Jeong D, 2015, LEUKEMIA, V29, P1868, DOI 10.1038/leu.2015.101; Jo JO, 2010, BBA-MOL CELL RES, V1803, P1244, DOI 10.1016/j.bbamcr.2010.07.005; Kim J, 2015, INT J MOL SCI, V16, P10624, DOI 10.3390/ijms160510624; Kim J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122758; Kim Y, 2014, CANCER-AM CANCER SOC, V120, P3058, DOI 10.1002/cncr.28843; Kinkel AD, 2004, CYTOTECHNOLOGY, V46, P49, DOI 10.1007/s10616-004-3903-4; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Marra F, 1997, GASTROENTEROLOGY, V112, P1297, DOI 10.1016/S0016-5085(97)70144-6; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; McCormack SA, 1999, AM J PHYSIOL-CELL PH, V276, pC459; Merchant JL, 2014, CANCER TREAT REV, V40, P12, DOI [10.1016/j.ctry.2013.08.003, 10.1016/j.ctrv.2013.08.003]; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Moon EY, 2010, CLIN EXP METASTAS, V27, P601, DOI 10.1007/s10585-010-9350-z; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Philips GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023943; Pichiri G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067999; Piludu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119642; Pratap A, 2012, J DRUG TARGET, V20, P770, DOI 10.3109/1061186X.2012.719900; Qiu P, 2011, FASEB J, V25, P1815, DOI 10.1096/fj.10-167940; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves                                                                  ; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Ruiz IAA, 1999, DEVELOPMENT, V126, P3205; Ryu YK, 2012, INT J CANCER, V131, P2067, DOI 10.1002/ijc.27490; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shafiei MS, 2006, J BIOL CHEM, V281, P24863, DOI 10.1074/jbc.M513544200; Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155; Shevde LA, 2014, INT J CANCER, V135, P1, DOI 10.1002/ijc.28424; Sicklick JK, 2005, LAB INVEST, V85, P1368, DOI 10.1038/labinvest.3700349; Someya H, 2015, INT J MOL MED, V35, P1169, DOI 10.3892/ijmm.2015.2118; Sosne G, 2004, EXP CELL RES, V293, P175, DOI 10.1016/j.yexcr.2003.09.022; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; Sun HQ, 2007, ANN NY ACAD SCI, V1112, P45, DOI 10.1196/annals.1415.021; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Treadwell T, 2012, ANN NY ACAD SCI, V1270, P37, DOI 10.1111/j.1749-6632.2012.06717.x; Xiao YT, 2014, CELL PHYSIOL BIOCHEM, V34, P356, DOI 10.1159/000363005; Yang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y; Yang HJ, 2013, J BIOL CHEM, V288, P2965, DOI 10.1074/jbc.M112.385989; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yu FJ, 2015, MOL MED REP, V12, P8121, DOI 10.3892/mmr.2015.4452; Zhang YN, 2006, HEPATOLOGY, V44, P612, DOI 10.1002/hep.21315; Zhao YB, 2011, J CELL PHYSIOL, V226, P2798, DOI 10.1002/jcp.22624; Zuo YQ, 2013, KIDNEY INT, V84, P1166, DOI 10.1038/ki.2013.209	66	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 19	2017	7								3815	10.1038/s41598-017-03782-x				16	Multidisciplinary Sciences	Science & Technology - Other Topics	EY0LT	WOS:000403650300058	28630423	gold			2018-01-05	
J	Marshall, JM; Buchman, A; Sanchez, HM; Akbari, OS				Marshall, John M.; Buchman, Anna; Sanchez, Hector M.; Akbari, Omar S.			Overcoming evolved resistance to population-suppressing homing-based gene drives	SCIENTIFIC REPORTS			English	Article							ANOPHELES-GAMBIAE; CRISPR/CAS9 SYSTEM; ENDONUCLEASE GENES; PEST-MANAGEMENT; MALARIA VECTOR; DNA-SEQUENCES; GUIDE RNAS; DROSOPHILA; TOOLS; CELLS	The recent development of a CRISPR-Cas9-based homing system for the suppression of Anopheles gambiae is encouraging; however, with current designs, the slow emergence of homing-resistant alleles is expected to result in suppressed populations rapidly rebounding, as homing-resistant alleles have a significant fitness advantage over functional, population-suppressing homing alleles. To explore this concern, we develop a mathematical model to estimate tolerable rates of homing-resistant allele generation to suppress a wild population of a given size. Our results suggest that, to achieve meaningful population suppression, tolerable rates of resistance allele generation are orders of magnitude smaller than those observed for current designs for CRISPR-Cas9-based homing systems. To remedy this, we theoretically explore a homing system architecture in which guide RNAs (gRNAs) are multiplexed, increasing the effective homing rate and decreasing the effective resistant allele generation rate. Modeling results suggest that the size of the population that can be suppressed increases exponentially with the number of multiplexed gRNAs and that, with four multiplexed gRNAs, a mosquito species could potentially be suppressed on a continental scale. We also demonstrate successful proof-of-principle use of multiplexed ribozyme flanked gRNAs to induce mutations in vivo in Drosophila melanogaster - a strategy that could readily be adapted to engineer stable, homing-based drives in relevant organisms.	[Marshall, John M.] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [Marshall, John M.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Buchman, Anna; Akbari, Omar S.] Univ Calif Riverside, Ctr Dis Vector Res, Dept Entomol, Riverside, CA 92521 USA; [Buchman, Anna; Akbari, Omar S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Sanchez, Hector M.] Tecnol Monterrey, Sch Med, Bioinformat Res Grp, Ciudad Lopez Mateos 52926, Estado De Mexic, Mexico	Marshall, JM (reprint author), Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA.; Marshall, JM (reprint author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.; Akbari, OS (reprint author), Univ Calif Riverside, Ctr Dis Vector Res, Dept Entomol, Riverside, CA 92521 USA.; Akbari, OS (reprint author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	john.marshall@berkeley.edu; omar.akbari@ucr.edu		Akbari, Omar/0000-0002-6853-9884	University of California, Riverside (UCR) laboratory start-up funds; US National Institutes of Health (NIH) K22 grant [5K22AI113060-02]; NIH-R21 grant [R21AI123937-01]; UC MEXUS grant [CN-15-47]	This work was supported by generous University of California, Riverside (UCR) laboratory start-up funds awarded to O.S.A., a private donation by www.MaxMind.com awarded to O.S.A., a US National Institutes of Health (NIH) K22 grant (5K22AI113060-02) and an NIH-R21 grant (R21AI123937-01) awarded to O.S.A., a UC MEXUS grant (CN-15-47) awarded to J.M.M., and a gift from The Parker Foundation to the University of California, San Francisco, Global Health Group Malaria Elimination Initiative.	Akbari OS, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-8; Alphey L, 2016, N BIOTECHNOL; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; BRUCECHWATT LJ, 1981, T ROY SOC TROP MED H, V75, P131, DOI 10.1016/0035-9203(81)90041-9                                                    ; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Eckhoff PA, 2017, P NATL ACAD SCI USA, V114, pE255, DOI 10.1073/pnas.1611064114; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Galizi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31139; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gould F, 2008, EVOLUTION, V62, P500, DOI 10.1111/j.1558-5646.2007.00298.x; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Jack BR, 2015, ACS SYNTH BIOL, V4, P939, DOI 10.1021/acssynbio.5b00068; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Keightley PD, 2015, MOL BIOL EVOL, V32, P239, DOI 10.1093/molbev/msu302; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; North A, 2013, J APPL ECOL, V50, P1216, DOI 10.1111/1365-2664.12133; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ranganathan V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5516; Roth A, 2014, NAT CHEM BIOL, V10, P56, DOI [10.1038/NCHEMBIO.1386, 10.1038/nchembio.1386]; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Takken W., 2003, ECOLOGICAL ASPECTS A; Taylor C, 2001, GENETICS, V157, P743; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; Unckless R. L., 2016, BIORXIV058438, DOI [10.1101/058438, DOI 10.1101/058438]; Wilson TJ, 2011, RNA, V17, P213, DOI 10.1261/rna.2473711; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341	43	5	5	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 19	2017	7								3776	10.1038/s41598-017-02744-7				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EY0LT	WOS:000403650300019	28630470	gold			2018-01-05	
J	Park, JJ; Dempewolf, E; Zhang, WZ; Wang, ZY				Park, Jong-Jin; Dempewolf, Emma; Zhang, Wenzheng; Wang, Zeng-Yu			RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis	PLOS ONE			English	Article							GENOME; SYSTEM; COMPLEX; ENDONUCLEASE; IMMUNITY; LEAF	Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR associated protein 9 (Cas9) system allows effective gene modification through RNA-guided DNA targeting. The Cas9 has undergone a series of functional alterations from the original active endonuclease to partially or completely deactivated Cas9. The catalytically deactivated Cas9 (dCas9) offers a platform to regulate transcriptional expression with the addition of activator or repressor domains. We redesigned a CRISPR/Cas9 activation system by adding the p65 transactivating subunit of NF-kappa B and a heat-shock factor 1 (HSF) activation domain to dCas9 bound with the VP64 (tetramer of VP16) activation domain for application in plants. The redesigned CRISPR/Cas9 activation system was tested in Arabidopsis to increase endogenous transcriptional levels of production of anthocyanin pigment 1 (PAP1) and Arabidopsis thaliana vacuolar H+-pyrophosphatase (AVP1). The expression of PAP1 was increased two- to three-fold and the activated plants exhibited purple leaves similar to that of PAP1 overexpressors. The AVP1 gene expression was increased two- to five-fold in transgenic plants. In comparison to the wild type, AVP1 activated plants had increased leaf numbers, larger single-leaf areas and improved tolerance to drought stress. The AVP1 activated plants showed similar phenotypes to AVP1 overexpressors. Therefore, the redesigned CRISPR/Cas9 activation system containing modified p65-HSF provides a simple approach for producing activated plants by upregulating endogenous transcriptional levels.	[Park, Jong-Jin; Dempewolf, Emma; Zhang, Wenzheng; Wang, Zeng-Yu] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA; [Park, Jong-Jin; Wang, Zeng-Yu] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37830 USA	Wang, ZY (reprint author), Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA.	zywang@noble.org			BioEnergy Science Center; Samuel Roberts Noble Foundation	This work was supported by BioEnergy Science Center and The Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Demirci Y, 2017, J CELL PHYSL; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	23	0	0	17	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179410	10.1371/journal.pone.0179410				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EX8NF	WOS:000403506300029	28622347	gold			2018-01-05	
J	Deng, ZL; Szafranski, SP; Jarek, M; Bhuju, S; Wagner-Dobler, I				Deng, Zhi-Luo; Szafranski, Szymon P.; Jarek, Michael; Bhuju, Sabin; Wagner-Doebler, Irene			Dysbiosis in chronic periodontitis: Key microbial players and interactions with the human host	SCIENTIFIC REPORTS			English	Article							HUMAN ORAL-CAVITY; ANKYRIN REPEAT; PEPTIDYLARGININE DEIMINASE; PORPHYROMONAS-GINGIVALIS; RHEUMATOID-ARTHRITIS; PROTEIN; DISEASE; GENE; BACTERIOPHAGE; ASSOCIATION	Periodontitis is an extremely prevalent disease worldwide and is driven by complex dysbiotic microbiota. Here we analyzed the transcriptional activity of the periodontal pocket microbiota from all domains of life as well as the human host in health and chronic periodontitis. Bacteria showed strong enrichment of 18 KEGG functional modules in chronic periodontitis, including bacterial chemotaxis, flagellar assembly, type III secretion system, type III CRISPR-Cas system, and two component system proteins. Upregulation of these functions was driven by the red-complex pathogens and candidate pathogens, e.g. Filifactor alocis, Prevotella intermedia, Fretibacterium fastidiosum and Selenomonas sputigena. Nine virulence factors were strongly up-regulated, among them the arginine deiminase arcA from Porphyromonas gingivalis and Mycoplasma arginini. Viruses and archaea accounted for about 0.1% and 0.22% of total putative mRNA reads, respectively, and a protozoan, Entamoeba gingivalis, was highly enriched in periodontitis. Fourteen human transcripts were enriched in periodontitis, including a gene for a ferric iron binding protein, indicating competition with the microbiota for iron, and genes associated with cancer, namely nucleolar phosphoprotein B23, ankyrin-repeat domain 30B-like protein and beta-enolase. The data provide evidence on the level of gene expression in vivo for the potentially severe impact of the dysbiotic microbiota on human health.	[Deng, Zhi-Luo; Wagner-Doebler, Irene] Helmholtz Ctr Infect Res HZI, Dept Mol Infect Biol, Res Grp Microbial Commun, Braunschweig, Germany; [Szafranski, Szymon P.] Hannover Med Sch MHH, Hannover, Germany; [Jarek, Michael; Bhuju, Sabin] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany	Wagner-Dobler, I (reprint author), Helmholtz Ctr Infect Res HZI, Dept Mol Infect Biol, Res Grp Microbial Commun, Braunschweig, Germany.	Irene.Wagner-Doebler@helmholtz-hzi.de			COMBACTE grant; Deutsche Forschungsgemeinschaft (DFG) [Transregio-SFB TR51]	This work was funded by COMBACTE grant and Deutsche Forschungsgemeinschaft (DFG) in Transregio-SFB TR51.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abdullah SN, 2013, ANAEROBE, V23, P102, DOI 10.1016/j.anaerobe.2013.07.001; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Aronesty E., 2011, EA UTILS COMMAND LIN; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bonner M, 2014, PARASITE, V21, DOI 10.1051/parasite/2014029; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Desvarieux M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000254; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Downes J, 2009, INT J SYST EVOL MICR, V59, P972, DOI 10.1099/ijs.0.000364-0; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Edlund A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27423; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Falagas ME, 2015, INT J ANTIMICROB AG, V46, P231, DOI 10.1016/j.ijantimicag.2015.04.002; Fitzpatrick SG, 2010, J DENT, V38, P83, DOI 10.1016/j.jdent.2009.10.007; Gabarrini G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13936; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Horz HP, 2015, ANAEROBE, V35, P10, DOI 10.1016/j.anaerobe.2015.02.008; Horz HP, 2006, J CLIN MICROBIOL, V44, P2914, DOI 10.1128/JCM.00568-06; Huynh HTT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121565; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Kalisky T, 2011, NAT METHODS, V8, P311, DOI [10.1038/nmeth0411-311, 10.1038/nmeth0411-308]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim A. Y., 2015, MOL CARCINOG; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krauss JL, 2000, PERIODONTOL, V52, P141, DOI DOI 10.1111/J.1600-0757.2009.00324.X; Kumada H, 1997, ORAL MICROBIOL IMMUN, V12, P162, DOI 10.1111/j.1399-302X.1997.tb00373.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEE JY, 1991, INFECT IMMUN, V59, P383; Li H., 2013, ARXIV13033997; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Ly M, 2014, MBIO, V5, DOI 10.1128/mBio.01133-14; Lyons T, 1983, Quintessence Int Dent Dig, V14, P1245; McGraw WT, 1999, INFECT IMMUN, V67, P3248; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miyamoto M, 2006, INFECT IMMUN, V74, P2462, DOI 10.1128/IAI.74.4.2462-2467.2006; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nguyen-Hieu Tung, 2013, APMIS, V121, P467, DOI 10.1111/apm.12015; Oliveira RRDS, 2016, J DENT RES, V95, P711, DOI 10.1177/0022034516634619; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUUTH E, 1989, IMMUNOL REV, V112, P133, DOI 10.1111/j.1600-065X.1989.tb00556.x; Santiago-Rodriguez TM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1781-0; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; Sillo P, 2012, J CLIN MICROBIOL, V50, P1113, DOI 10.1128/JCM.05568-11; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Smith DJ, 2013, EUR RESPIR J, V42, P1723, DOI 10.1183/09031936.00124012; Smuts H, 2014, J VIROL, V88, P1398, DOI 10.1128/JVI.03206-13; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x                                              ; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szafranski S. P., 2015, NPJ BIOFILMS MICROBI, V57, P10; Szafranski SP, 2015, APPL ENVIRON MICROB, V81, P1047, DOI 10.1128/AEM.03534-14; Teng F, 2015, CELL HOST MICROBE, V18, P296, DOI 10.1016/j.chom.2015.08.005; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van M. L., 2009, PLOS GENET, V5; Vartoukian SR, 2013, INT J SYST EVOL MICR, V63, P458, DOI 10.1099/ijs.0.041038-0; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311                                                         ; Yost S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0153-3; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; Zhou HY, 2015, PROTEIN CELL, V6, P541, DOI 10.1007/s13238-015-0182-0	75	1	1	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 16	2017	7								3703	10.1038/s41598-017-03804-8				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EX7FN	WOS:000403413700065	28623321	gold			2018-01-05	
J	Golyshina, OV; Tran, H; Reva, ON; Lemak, S; Yakunin, AF; Goesmann, A; Nechitaylo, TY; LaCono, V; Smedile, F; Slesarev, A; Rojo, D; Barbas, C; Ferrer, M; Yakimov, MM; Golyshin, PN				Golyshina, Olga V.; Tran, Hai; Reva, Oleg N.; Lemak, Sofia; Yakunin, Alexander F.; Goesmann, Alexander; Nechitaylo, Taras Y.; LaCono, Violetta; Smedile, Francesco; Slesarev, Alexei; Rojo, David; Barbas, Coral; Ferrer, Manuel; Yakimov, Michail M.; Golyshin, Peter N.			Metabolic and evolutionary patterns in the extremely acidophilic archaeon Ferroplasma acidiphilum Y-T	SCIENTIFIC REPORTS			English	Article							GENOME SEQUENCE; HYDROGENOBACTER-THERMOPHILUS; FERREDOXIN OXIDOREDUCTASE; LACTOBACILLUS-PLANTARUM; CRISPR-CAS; ORIGIN; ENVIRONMENTS; PROTEINS; MUTATION; IRON	Ferroplasmaceae represent ubiquitous iron-oxidising extreme acidophiles with a number of unique physiological traits. In a genome-based study of Ferroplasma acidiphilum Y-T, the only species of the genus Ferroplasma with a validly published name, we assessed its central metabolism and genome stability during a long-term cultivation experiment. Consistently with physiology, the genome analysis points to F. acidiphilum Y-T having an obligate peptidolytic oligotrophic lifestyle alongside with anaplerotic carbon assimilation. This narrow trophic specialisation abridges the sugar uptake, although all genes for glycolysis and gluconeogenesis, including bifunctional unidirectional fructose 1,6-bisphosphate aldolase/phosphatase, have been identified. Pyruvate and 2-oxoglutarate dehydrogenases are substituted by 'ancient' CoA-dependent pyruvate and alpha-ketoglutarate ferredoxin oxidoreductases. In the lab culture, after -550 generations, the strain exhibited the mutation rate of >= 1.3 x 10(-8) single nucleotide substitutions per site per generation, which is among the highest values recorded for unicellular organisms. All but one base substitutions were G: C to A: T, their distribution between coding and non-coding regions and synonymous-to-non-synonymous mutation ratios suggest the neutral drift being a prevalent mode in genome evolution in the lab culture. Mutations in nature seem to occur with lower frequencies, as suggested by a remarkable genomic conservation in F. acidiphilum Y-T variants from geographically distant populations.	[Golyshina, Olga V.; Tran, Hai; Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Reva, Oleg N.] Univ Pretoria, Dept Biochem, Ctr Bioinformat & Computat Biol, ZA-0002 Pretoria, South Africa; [Lemak, Sofia; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Goesmann, Alexander] CeBiTec Bielefeld Univ, Univ Str 25, Bielefeld, Germany; [Nechitaylo, Taras Y.] Max Planck Inst Chem Ecol, Insect Symbiosis Grp, Hans Knoll Str 8, D-33615 Jena, Germany; [LaCono, Violetta; Smedile, Francesco; Yakimov, Michail M.] CNR, Inst Coastal Marine Environm, Spianata S Raineri 86, I-98122 Messina, Italy; [Slesarev, Alexei] Zylacta Corp, Fidel Syst, 7965 Cessna Ave, Gaithersburg, MD 20879 USA; [Rojo, David; Barbas, Coral] Univ CEU San Pablo, Ctr Metabol & Bioanal CEMBIO, Fac Farm, Campus Monteprincipe, Madrid, Spain; [Ferrer, Manuel] CSIC, Inst Catalysis, Campus Cantoblanco, Madrid 28049, Spain; [Yakimov, Michail M.] Immanuel Kant Baltic Fed Univ, Univ Skaya 1, Kaliningrad 36040, Russia; [Goesmann, Alexander] Justus Liebig Univ Giessen, Dept Bioinformat & Syst Biol, Heinrich Buff Ring 58, D-35392 Giessen, Germany	Golyshina, OV (reprint author), Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.	o.golyshina@bangor.ac.uk	Barbas, Coral/K-3871-2014	Barbas, Coral/0000-0003-4722-491X; Goesmann, Alexander/0000-0002-7086-2568; Yakunin, Alexander/0000-0003-0813-6490; Golyshin, Peter/0000-0002-5433-0350	ERA Net IB2 Project MetaCat through UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M029085/1]; NSERC Strategic Network grant IBN; Spanish Ministry of Economy and Competitiveness (ERA Net IB2 Program) [PCIN-2014-107]; Spanish Ministry of Economy and Competitiveness [CTQ2014-55279-R]	We are very much thankful to Dr. Ivan Berg (University of Freiburg, Germany) for careful reading of the manuscript and important suggestions. The work of T.H. and P.N.G. was supported by ERA Net IB2 Project MetaCat through UK Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/M029085/1, S.L. and A.F.Y. were supported by the NSERC Strategic Network grant IBN. This work was also supported by the Spanish Ministry of Economy and Competitiveness (PCIN-2014-107 within the ERA Net IB2 Program, and CTQ2014-55279-R) to which M.F., C.B., and D.R. would like to acknowledge their funding.	Adams MWW, 1996, ADV PROTEIN CHEM, V48, P101; Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker-Austin C, 2010, EXTREMOPHILES, V14, P485, DOI 10.1007/s00792-010-0328-1; Banfield JF, 2005, OMICS, V9, P301, DOI 10.1089/omi.2005.9.301                                                          ; Bezuidt O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025702; BLAUT M, 1994, ANTON LEEUW INT J G, V66, P187, DOI 10.1007/BF00871639; Bron PA, 2004, J BACTERIOL, V186, P7829, DOI 10.1128/JB.186.23.7829-7835.2004; Castelle CJ, 2015, BBA-BIOENERGETICS, V1847, P717, DOI 10.1016/j.bbabio.2015.04.006; Danson MJ, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P260; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Dias PJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-901; Dopson M, 2004, APPL ENVIRON MICROB, V70, P2079, DOI 10.1128/AEM.70.4.2079-2088.2004; Dopson M, 2007, EXTREMOPHILES, V11, P159, DOI 10.1007/s00792-006-0029-y; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186                                                              ; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175                                                              ; Ferrer M, 2008, P NATL ACAD SCI USA, V105, P8878, DOI 10.1073/pnas.0800071105; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Filee J, 2007, MICROBIOL MOL BIOL R, V71, P121, DOI 10.1128/MMBR.00031-06; Futterer O, 2004, P NATL ACAD SCI USA, V101, P9091, DOI 10.1073/pnas.0401356101; Ganesan H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-333; Golyshina OV, 2016, SCI REP-UK, V6, DOI 10.1038/srep39034; Golyshina OV, 2011, APPL ENVIRON MICROB, V77, P5071, DOI 10.1128/AEM.00726-11; Golyshina OV, 2000, INT J SYST EVOL MICR, V50, P997, DOI 10.1099/00207713-50-3-997                                                       ; Golyshina OV, 2005, ENVIRON MICROBIOL, V7, P1277, DOI 10.1111/j.1462-2920.2005.00861.x; Golyshina OV, 2006, ENVIRON MICROBIOL, V8, P416, DOI 10.1111/j.1462-2920.2005.00907.x; Gophna U, 2015, ISME J, V9, P2021, DOI 10.1038/ismej.2015.20; Gordon D, 2003, CURR PROTOC BIOINFOR, V2, P43, DOI DOI 10.1002/0471250953; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Han C. S., 2006, P 2006 INT C BIOINF, P142; Ikeda T, 2010, FEBS J, V277, P501, DOI 10.1111/j.1742-4658.2009.07506.x; KAWASUMI T, 1984, INT J SYST BACTERIOL, V34, P5, DOI 10.1099/00207713-34-1-5                                                         ; KERSCHER L, 1981, EUR J BIOCHEM, V116, P595, DOI 10.1111/j.1432-1033.1981.tb05377.x; Lane N, 2012, CELL, V151, P1406, DOI 10.1016/j.cell.2012.11.050; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Malykh Andrei, 2004, Methods Mol Biol, V255, P295; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Menigaud S, 2012, BIOINFORMATICS, V28, P1270, DOI 10.1093/bioinformatics/bts118; Mwirichia R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19181; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pierneef R, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav058; Pivovarova T. A., 2002, Mikrobiologiya, V71, P809; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schonheit P, 2016, TRENDS MICROBIOL, V24, P12, DOI 10.1016/j.tim.2015.10.003; Soppa J., 1998, MICROBIOLOGY BIOGEOC, V5, P249; Sousa FL, 2016, BBA-BIOENERGETICS, V1857, P1027, DOI 10.1016/j.bbabio.2016.04.284; Sousa FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019117; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7                                                   ; Tompkins JD, 2003, J BACTERIOL, V185, P3469, DOI 10.1128/JB.185.11.3469-3472.2003; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xiong LF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-42; Yamamoto M, 2010, EXTREMOPHILES, V14, P79, DOI 10.1007/s00792-009-0289-4; Yoon KS, 1996, J BACTERIOL, V178, P3365, DOI 10.1128/jb.178.11.3365-3368.1996                                                ; Zuniga M, 2002, MOL PHYLOGENET EVOL, V25, P429, DOI 10.1016/S1055-7903(02)00277-4	68	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 16	2017	7								3682	10.1038/s41598-017-03904-5				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EX7FN	WOS:000403413700044	28623373	gold			2018-01-05	
J	Kerros, C; Tripathi, SC; Zha, DX; Mehrens, JM; Sergeeva, A; Philips, AV; Qiao, N; Peters, HL; Katayama, H; Sukhumalchandra, P; Ruisaard, KE; Perakis, AA; John, LSS; Lu, SJ; Mittendorf, EA; Clise-Dwyer, K; Herrmann, AC; Alatrash, G; Toniatti, C; Hanash, SM; Ma, Q; Molldrem, JJ				Kerros, Celine; Tripathi, Satyendra C.; Zha, Dongxing; Mehrens, Jennifer M.; Sergeeva, Anna; Philips, Anne V.; Qiao, Na; Peters, Haley L.; Katayama, Hiroyuki; Sukhumalchandra, Pariya; Ruisaard, Kathryn E.; Perakis, Alexander A.; John, Lisa S. St.; Lu, Sijie; Mittendorf, Elizabeth A.; Clise-Dwyer, Karen; Herrmann, Amanda C.; Alatrash, Gheath; Toniatti, Carlo; Hanash, Samir M.; Ma, Qing; Molldrem, Jeffrey J.			Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; END-RULE PEPTIDES; CATHEPSIN-G; MYELOID MALIGNANCIES; IMMUNE-RESPONSE; T-CELLS; RECEPTOR; PR1; PROGRESSION; LEUKEMIA	Neutrophil elastase (NE) can be rapidly taken up by tumor cells that lack endogenous NE expression, including breast cancer, which results in cross-presentation of PR1, an NE-derived HLA-A2-restricted peptide that is an immunotherapy target in hematological and solid tumor malignancies. The mechanism of NE uptake, however, remains unknown. Using the mass spectrometry-based approach, we identify neuropilin-1 (NRP1) as a NE receptor that mediates uptake and PR1 cross-presentation in breast cancer cells. We demonstrated that soluble NE is a specific, high-affinity ligand for NRP1 with a calculated Kd of 38.7nM. Furthermore, we showed that NRP1 binds to the RRXR motif in NE. Notably, NRP1 knockdown with interfering RNA or CRISPR-cas9 system and blocking using anti-NRP1 antibody decreased NE uptake and, subsequently, susceptibility to lysis by PR1-specific cytotoxic T cells. Expression of NRP1 in NRP1 deficient cells was sufficient to induce NE uptake. Altogether, because NRP1 is broadly expressed in tumors, our findings suggest a role for this receptor in immunotherapy strategies that target cross-presented antigens.	[Kerros, Celine; Tripathi, Satyendra C.; Zha, Dongxing; Mehrens, Jennifer M.; Sergeeva, Anna; Philips, Anne V.; Qiao, Na; Peters, Haley L.; Katayama, Hiroyuki; Sukhumalchandra, Pariya; Ruisaard, Kathryn E.; Perakis, Alexander A.; John, Lisa S. St.; Lu, Sijie; Mittendorf, Elizabeth A.; Clise-Dwyer, Karen; Herrmann, Amanda C.; Alatrash, Gheath; Toniatti, Carlo; Hanash, Samir M.; Ma, Qing; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Molldrem, JJ (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Sect Transplantat Immunol, Unit 900, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jmolldre@mdanderson.org		kerros, celine/0000-0002-7826-4167; Tripathi, Satyendra/0000-0003-3917-9645	Leukemia and Lymphoma Society Translational Research Program Grant [6030-12]; National Institutes of Health (NIH) SPORE [P50 CA100632]; NIH Training Program in Cancer Immunobiology [T32 CA009598]; National Cancer Institute Grant [P30CA16672];  [P01 CA049639];  [P01 CA148600]	This work was supported by the Leukemia and Lymphoma Society Translational Research Program Grant (6030-12), National Institutes of Health (NIH) SPORE (P50 CA100632), Research Program Project (P01 CA049639 and P01 CA148600) grants (to J. J. M), NIH Training Program in Cancer Immunobiology T32 CA009598 (to H. L. P and C. K.), and National Cancer Institute Grant P30CA16672 (to the South Campus Flow Cytometry & Cell Sorting Core Facility and the Characterized Cell Line Core Facility at MDACC). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akizuki M, 2007, NEOPLASIA, V9, P260, DOI 10.1593/neo.06808; Alatrash G, 2012, J IMMUNOL, V189, P5476, DOI 10.4049/jimmunol.1201221; Alatrash G, 2012, J IMMUNOTHER, V35, P309, DOI 10.1097/CJI.0b013e31824b3b14; Bagheri-Yarmand R, 2010, CANCER RES, V70, P5074, DOI 10.1158/0008-5472.CAN-09-4094; CAMPBELL EJ, 1982, P NATL ACAD SCI-BIOL, V79, P6941, DOI 10.1073/pnas.79.22.6941; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Cheng W, 2014, TUMOR BIOL, V35, P6089, DOI 10.1007/s13277-014-1806-3; Djordjevic S, 2013, DRUG DISCOV TODAY, V18, P447, DOI 10.1016/j.drudis.2012.11.013; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Grandclement Camille, 2011, Cancers (Basel), V3, P1899, DOI 10.3390/cancers3021899; Gregory AD, 2012, J BIOL CHEM, V287, P35341, DOI 10.1074/jbc.M112.385617; Hattar K, 2014, CANCER IMMUNOL IMMUN, V63, P1297, DOI 10.1007/s00262-014-1606-z; Henriksen PA, 2014, CURR OPIN HEMATOL, V21, P23, DOI 10.1097/MOH.0000000000000001; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Li LH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0291-5; Ma Q, 2016, CYTOTHERAPY, V18, P985, DOI 10.1016/j.jcyt.2016.05.001; MCGOWAN SE, 1983, AM REV RESPIR DIS, V128, P688; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; Mittendorf EA, 2012, CANCER RES, V72, P3153, DOI 10.1158/0008-5472.CAN-11-4135; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mukherjee S, 1997, PHYSIOL REV, V77, P759; Nawa M, 2012, ANTICANCER RES, V32, P13; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Qazilbash MH, 2017, LEUKEMIA, V31, P697, DOI 10.1038/leu.2016.254; Rezvani K, 2011, HAEMATOL-HEMATOL J, V96, P432, DOI 10.3324/haematol.2010.031674; Sato Nagato, 2007, Nihon Kokyuki Gakkai Zasshi, V45, P237; Sergeeva A, 2016, LEUKEMIA, V30, P1475, DOI 10.1038/leu.2016.57; Sergeeva A, 2011, BLOOD, V117, P4262, DOI 10.1182/blood-2010-07-299248; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6                                                   ; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7                                                   ; Taguchi K, 2014, BIOANALYSIS, V6, P1679, DOI 10.4155/bio.14.120; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Yamashita JI, 2006, BREAST J, V12, P288, DOI 10.1111/j.1075-122X.2006.00265.x; Zanuy D, 2013, J STRUCT BIOL, V182, P78, DOI 10.1016/j.jsb.2013.02.006; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736	44	0	0	5	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10295	10305		10.1074/jbc.M116.773051				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EX9LW	WOS:000403580600037	28468826				2018-01-05	
J	Xu, QQ; Hou, YX; Chang, XB				Xu, Qinqin; Hou, Yue-xian; Chang, Xiu-bao			CRISPR/Cas9-Mediated Three Nucleotide Insertion Corrects a Deletion Mutation in MRP1/ABCC1 and Restores Its Proper Folding and Function	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							PLURIPOTENT STEM-CELLS; FACTOR-VIII GENE; CYSTIC-FIBROSIS; HOMOLOGOUS RECOMBINATION; POINT MUTATION; HEMOPHILIA-B; HEREDITARY HEMOCHROMATOSIS; MOLECULAR-GENETICS; MISSENSE MUTATION; MAMMALIAN-CELLS	A three-nucleotide deletion in cystic fibrosis transmembrane conductance regulator/ATP-binding cassette transporter C7 (CFTR/ABCC7) resulting in the absence of phenylalanine at 508 leads to mis-fold of the mutated protein and causes cystic fibrosis. We have used a comparable three-nucleotide deletion mutant in another ABCC family member, multidrug resistance-associated protein (MRP1)/ABCC1, to determine whether CRISPR-Cas9-mediated recombination can safely and efficiently knock in three-nucleotide to correct the mutation. We have found that the rate of homology-directed recombination mediated by guideRNA (gRNA) complementary to the deletion mutant is significantly higher than the one mediated by gRNA complementary to the wild-type (WT) donor. In addition, the rate of homology-directed recombination mediated by gRNA complementary to the WT donor is significantly higher than that of gRNAs complementary to the 50 or 30 side of the deletion mutant. Interestingly, the frequency of mutations introduced by gRNA complementary to the deletion mutant is significantly higher than with gRNA complementary to WT donor. However, combination of gRNAs complementary to both WT donor and deletion mutant decreased the rate of homology-directed recombination, but did not significantly decrease the mutation rate introduced by this system. Thus, the data presented here provide guidance for designing of gRNA and donor DNA to do genome editing, especially to correct the mutations with three mismatched nucleotides, such as three-nucleotide deletion or insertion.	[Xu, Qinqin; Hou, Yue-xian; Chang, Xiu-bao] Mayo Clin Arizona, Coll Med, Dept Biochem & Mol Biol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA	Chang, XB (reprint author), Mayo Clin Arizona, Coll Med, Dept Biochem & Mol Biol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	xbchang@mayo.edu					Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; Bisceglia M, 2006, ADV ANAT PATHOL, V13, P26, DOI 10.1097/01.pap.0000201831.77472.d3                                              ; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; CHANG XB, 1987, P NATL ACAD SCI USA, V84, P4959, DOI 10.1073/pnas.84.14.4959; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; DAVIS LM, 1987, BLOOD, V69, P140; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0                                                                ; DIUGUID DL, 1986, P NATL ACAD SCI USA, V83, P5803, DOI 10.1073/pnas.83.16.5803; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775                                                         ; Hollywood JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32230; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LYONNET S, 1989, AM J HUM GENET, V44, P511; MACKEY DA, 1994, EYE, V8, P431, DOI 10.1038/eye.1994.102                                                            ; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Pietrangelo A, 1999, NEW ENGL J MED, V341, P725, DOI 10.1056/NEJM199909023411003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; REES DJG, 1985, NATURE, V316, P643, DOI 10.1038/316643a0; ROTH DB, 1989, MOL CELL BIOL, V9, P3049, DOI 10.1128/MCB.9.7.3049                                                            ; Sargent RG, 2014, METHODS MOL BIOL, V1114, P279, DOI 10.1007/978-1-62703-761-7_18; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; WEITZ CJ, 1992, AM J HUM GENET, V50, P498; WINDERICKX J, 1992, NAT GENET, V1, P251, DOI 10.1038/ng0792-251                                                              ; YOUSSOUFIAN H, 1986, NATURE, V324, P380, DOI 10.1038/324380a0	45	0	0	12	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	JUN 16	2017	7						429	438		10.1016/j.omtn.2017.05.005				10	Medicine, Research & Experimental	Research & Experimental Medicine	EW0PL	WOS:000402193600001	28624219	gold			2018-01-05	
J	Lattanzi, A; Duguez, S; Moiani, A; Izmiryan, A; Barbon, E; Martin, S; Mamchaoui, K; Mouly, V; Bernardi, F; Mavilio, F; Bovolenta, M				Lattanzi, Annalisa; Duguez, Stephanie; Moiani, Arianna; Izmiryan, Araksya; Barbon, Elena; Martin, Samia; Mamchaoui, Kamel; Mouly, Vincent; Bernardi, Francesco; Mavilio, Fulvio; Bovolenta, Matteo			Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; COMPARATIVE GENOMIC HYBRIDIZATION; GENE-THERAPY; MOUSE MODEL; STEM-CELLS; MUSCLE; CRISPR-CAS9; EXPRESSION; NUCLEASES; ARRAY	Exonic duplications account for 10%-15% of all mutations in Duchenne muscular dystrophy (DMD), a severe hereditary neuromuscular disorder. We report a CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9-based strategy to correct the most frequent (exon 2) duplication in the DMD gene by targeted deletion, and tested the efficacy of such an approach in patient-derived myogenic cells. We demonstrate restoration of wild-type dystrophin expression at transcriptional and protein level in myotubes derived from genome-edited myoblasts in the absence of selection. Removal of the duplicated exon was achieved by the use of only one guide RNA (gRNA) directed against an intronic duplicated region, thereby increasing editing efficiency and reducing the risk of off-target effects. This study opens a novel therapeutic perspective for patients carrying disease-causing duplications.	[Lattanzi, Annalisa; Moiani, Arianna; Izmiryan, Araksya; Martin, Samia; Mavilio, Fulvio; Bovolenta, Matteo] Genethon, INSERM UMR951, 1 Bis,Rue Int BP60, F-91002 Evry, France; [Duguez, Stephanie; Mamchaoui, Kamel; Mouly, Vincent] UPMC, Sorbonne Univ, INSERM, Inst Myol,FRE CNRS 3617,UMRS 974, GH Pitie Salpetriere 47 Bd Hop, F-75651 Paris 13, France; [Barbon, Elena; Bernardi, Francesco; Bovolenta, Matteo] Univ Ferrara, Dept Life Sci & Biotechnol, Fossato Mortara 74, I-44121 Ferrara, Italy; [Duguez, Stephanie] Univ Ulster, Altnagelvin Area Hosp, Northern Ireland Ctr Stratified Med, Biomed Sci Res Inst, C-TRIC Bldg,Glenshane Rd, Derry Londonderry BT47 6SB, Ireland; [Moiani, Arianna] Inst Curie 26, Rue Ulm, F-75248 Paris, France; [Moiani, Arianna] CNRS, INSERM, UMR 3215, U934, F-75248 Paris, France; [Izmiryan, Araksya] Imagine Inst, INSERM, UMR 1163, F-75015 Paris, France; [Izmiryan, Araksya] Univ Paris Descartes Sorbonne Cite, F-75015 Paris, France	Bovolenta, M (reprint author), Univ Ferrara, Dept Life Sci & Biotechnol, Via Fossato Mortara 74, I-44121 Ferrara, Italy.	bvlmtt@unife.it		Bovolenta, Matteo/0000-0002-9937-009X; Mamchoui, kamel/0000-0002-0323-9290; Mouly, Vincent/0000-0003-3809-4033	European Research Council (GT-SKIN) [ERC-2010-AdG]; Horinzon 2020 Marie Sklodowska-Curie Individual Fellowship Action [703093]; "Amici di Edy," AFM-Teleton [17247]	France Leturcq (Laboratoire de biochimie et genetique, moleculaire, Hopital Cochin et Institut de Myologie, Groupe hospitalier La Pitie Salpetriere, APHP, France) and AFM-Telethon Biobank are gratefully acknowledged for providing patients samples and cells. Plasmids MLM3636 (Addgene plasmid # 43860), JDS246 (# 43861), and LentiCRISPRv2 (# 52961) were a gift from Keith Joung and Feng Zhang. This work was supported by grants from the European Research Council (ERC-2010-AdG, GT-SKIN), the association "Amici di Edy," AFM-Teleton (Trampoline grant no. 17247), and Horinzon 2020 Marie Sklodowska-Curie Individual Fellowship Action (Project DMD2CURE # 703093) to M.B. Federica Brugnoli (Section of Anatomy and Histology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy) is also acknowledged for the technical support.	Aartsma-Rus A, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-43; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Bovolenta M, 2012, HUM MUTAT, V33, P572, DOI 10.1002/humu.22017; Bovolenta M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-572; Cantore A, 2015, SCI TRANSL MED, V7, DOI DOI 10.1126/SCITRANSLMED.AAA1405; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; del Gaudio D, 2008, HUM MUTAT, V29, P1100, DOI 10.1002/humu.20841; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Fu YF, 2014, METHOD ENZYMOL, V546, P21, DOI 10.1016/B978-0-12-801185-0.00002-7; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Goyenvalle A, 2015, NAT MED, V21, P270, DOI 10.1038/nm.3765; Greer KL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.8; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Le Hir M, 2013, MOL THER, V21, P1551, DOI 10.1038/mt.2013.121; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lu QL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.6; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ousterout DG, 2015, MOL THER, V23, P523, DOI [10.1038/mt.2074.234, 10.1038/mt.2014.234]; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ryan NJ, 2014, DRUGS, V74, P1709, DOI 10.1007/s40265-014-0287-4; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Taylor PJ, 2007, J MED GENET, V44, P368, DOI 10.1136/jmg.2006.047464; Traynor K, 2016, AM J HEALTH-SYST PH, V73, P1719, DOI 10.2146/news160063; van Vliet L, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-105; Vila MC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0070-6; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wein N, 2014, NAT MED, V20, P992, DOI 10.1038/nm.3628; White SJ, 2006, HUM MUTAT, V27, P938, DOI 10.1002/humu.20367; Wilton SD, 2015, TRENDS MOL MED, V21, P417, DOI 10.1016/j.molmed.2015.04.006; Wojtal D, 2016, AM J HUM GENET, V98, P90, DOI 10.1016/j.ajhg.2015.11.012; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Zanta-Boussif MA, 2009, GENE THER, V16, P605, DOI 10.1038/gt.2009.3; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	50	1	1	5	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	JUN 16	2017	7						11	19		10.1016/j.omtn.2017.02.004				9	Medicine, Research & Experimental	Research & Experimental Medicine	EU7RZ	WOS:000401233700002	28624187	gold			2018-01-05	
J	Zhu, P; Wu, FR; Mosenson, J; Zhang, HM; He, TC; Wu, WS				Zhu, Pei; Wu, Furen; Mosenson, Jeffrey; Zhang, Hongmei; He, Tong-Chuan; Wu, Wen-Shu			CRISPR/Cas9-Mediated Genome Editing Corrects Dystrophin Mutation in Skeletal Muscle Stem Cells in a Mouse Model of Muscle Dystrophy	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; EX-VIVO EXPANSION; IN-VIVO; REPLICATIVE SENESCENCE; SATELLITE CELLS; SELF-RENEWAL; RECOMBINANT ADENOVIRUSES; PROGENITOR CELLS; FIBRIN GELS; MDX MICE	Muscle stem cells (MuSCs) hold great therapeutic potential for muscle genetic disorders, such as Duchenne muscular dystrophy (DMD). The CRISP/Cas9-based genome editing is a promising technology for correcting genetic alterations in mutant genes. In this study, we used fibrin-gel culture system to selectively expand MuSCs from crude skeletal muscle cells of mdx mice, a mouse model of DMD. By CRISP/Cas9-based genome editing, we corrected the dystrophin mutation in expanded MuSCs and restored the skeletal muscle dystrophin expression upon transplantation in mdx mice. Our studies established a reliable and feasible platform for gene correction in MuSCs by genome editing, thus greatly advancing tissue stem cell-based therapies for DMD and other muscle disorders.	[Zhu, Pei; Wu, Furen; Mosenson, Jeffrey; Wu, Wen-Shu] Univ Illinois, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Zhu, Pei; Wu, Furen; Mosenson, Jeffrey; Wu, Wen-Shu] Univ Illinois, Ctr Canc, Chicago, IL 60612 USA; [Zhang, Hongmei; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Chicago, IL 60637 USA	Wu, WS (reprint author), Univ Illinois, Coll Med, Dept Med, 909 South Wolcott Ave,COMRB 5111, Chicago, IL 60612 USA.	wuwenshu@uic.edu			NIA/NIH grant [R01AG040182]	We would like to thank members of the W.-S.W. Laboratory for their suggestions. We also thank the Research Resources Center Flow Cytometry Service at UIC for cell analysis and sorting. This work was supported by NIA/NIH grant R01AG040182.	Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonner M, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.9; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550; Fu X, 2015, CELL RES, V25, P1082, DOI 10.1038/cr.2015.102; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509                                                          ; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149                                                            ; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008; Kapsa R, 2001, HUM GENE THER, V12, P629, DOI 10.1089/104303401300057324; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kimura E, 2010, MOL THER, V18, P206, DOI 10.1038/mt.2009.253; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Messina G, 2009, GENE DEV, V23, P902, DOI 10.1101/gad.1797009; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nik-Ahd F, 2014, STEM CELLS, V32, P1817, DOI 10.1002/stem.1668; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Piacibello W, 2005, FOLIA HISTOCHEM CYTO, V43, P197; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; RYDERCOOK AS, 1988, EMBO J, V7, P3017; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schallmoser K, 2010, HAEMATOL-HEMATOL J, V95, P867, DOI 10.3324/haematol.2009.011692; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Strouse B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03791; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Uibo R, 2009, BBA-MOL CELL RES, V1793, P924, DOI 10.1016/j.bbamcr.2009.01.007; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wu N, 2014, GENE THER, V21, P629, DOI 10.1038/gt.2014.40; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhu P., 2017, STEM CELLS TRANSL ME	61	0	0	26	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	JUN 16	2017	7						31	41		10.1016/j.omtn.2017.02.007				11	Medicine, Research & Experimental	Research & Experimental Medicine	EU7RZ	WOS:000401233700004	28624206	gold			2018-01-05	
J	Song, F; Stieger, K				Song, Fei; Stieger, Knut			Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							ONE-STEP GENERATION; GENOME; CRISPR-CAS9; EFFICIENCY; PATHWAYS; ELEGANS; EMBRYOS	The CRISPR-Cas (clustered regularly interspaced short palindromic repeats-associated proteins) technology enables rapid and precise genome editing at any desired genomic position in almost all cells and organisms. In this study, we analyzed the impact of different repair templates on the frequency of homology-directed repair (HDR) and non-homologous end joining (NHEJ). We used a stable HEK293 cell line expressing the traffic light reporter (TLR-3) system to quantify HDR and NHEJ events following transfection with Cas9, eight different guide RNAs, and a 1,000 bp donor template generated either as circular plasmid, as linearized plasmid with long 3' or 5' backbone overhang, or as PCR product. The sequence to be corrected was either centrally located (RS55), with a shorter 50 homologous region (RS37), or with a shorter 3' homologous region (RS73). Guide RNAs targeting the transcriptionally active strand (T5, T7) showed significantly higher NHEJ frequencies compared with guide RNAs targeting the transcriptionally inactive strand. HDR activity was highest when using the linearized plasmid with the short 5' backbone overhang and the RS37 design. The results demonstrate the importance of the design of the guide RNA and template DNA on the frequency of DNA repair events and, ultimately, on the outcome of treatment approaches using HDR.	[Song, Fei; Stieger, Knut] Justus Liebig Univ Giessen, Dept Ophthalmol, D-35392 Giessen, Germany	Stieger, K (reprint author), Justus Liebig Univ Giessen, Dept Ophthalmol, D-35392 Giessen, Germany.	knut.stieger@uniklinikum-giessen.de			Institute for Clinical Immunology and Transfusion Medicine Giessen	We thank the Institute for Clinical Immunology and Transfusion Medicine Giessen for support with the FACS analysis. We thank Claudia Lopez, Tobias Wimmer, Jessica Grebe, Annabella Janise, and Bettina Gill for technical assistance and support. We also thank Mert Yanik and Brigitte Muller for critical reading of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Carroll D, 2014, METHODS, V69, P137, DOI 10.1016/j.ymeth.2014.03.026; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Maeder M. L., 2016, MOL THER S1, V23, pS273; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Srivastava M, 2015, CHEM BIOL, V22, P17, DOI 10.1016/j.chembiol.2014.11.013; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	21	1	1	12	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	JUN 16	2017	7						53	60		10.1016/j.omtn.2017.02.006				8	Medicine, Research & Experimental	Research & Experimental Medicine	EU7RZ	WOS:000401233700006	28624224	gold			2018-01-05	
J	Chira, S; Gulei, D; Hajitou, A; Zimta, AA; Cordelier, P; Berindan-Neagoe, I				Chira, Sergiu; Gulei, Diana; Hajitou, Amin; Zimta, Alina-Andreea; Cordelier, Pierre; Berindan-Neagoe, Ioana			CRISPR/Cas9: Transcending the Reality of Genome Editing	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Review							INDUCIBLE CRISPR-CAS9 SYSTEM; HUMAN-CELLS; IN-VIVO; CANCER-CELLS; FUNCTIONAL GENOMICS; TUMOR-SUPPRESSOR; GENE-THERAPY; CHROMOSOMAL REARRANGEMENTS; PANCREATIC-CANCER; HYBRID VECTOR	With the expansion of the microbiology field of research, a new genome editing tool arises from the biology of bacteria that holds the promise of achieving precise modifications in the genome with a simplicity and versatility that surpasses previous genome editing methods. This new technique, commonly named CRISPR/Cas9, led to a rapid expansion of the biomedical field; more specifically, cancer characterization and modeling have benefitted greatly from the genome editing capabilities of CRISPR/Cas9. In this paper, we briefly summarize recent improvements in CRISPR/Cas9 design meant to overcome the limitations that have arisen from the nuclease activity of Cas9 and the influence of this technology in cancer research. In addition, we present challenges that might impede the clinical applicability of CRISPR/Cas9 for cancer therapy and highlight future directions for designing CRISPR/Cas9 delivery systems that might prove useful for cancer therapeutics.	[Chira, Sergiu; Zimta, Alina-Andreea; Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Gen Biomed & Translat Med, 23 Gheorge Marinescu St,8 Victor Babes St, Cluj Napoca 400377, Cluj, Romania; [Gulei, Diana] Iuliu Hatieganu Univ Med & Pharm, MedFuture Res Ctr Adv Med, Cluj Napoca 400377, Cluj, Romania; [Hajitou, Amin] Imperial Coll London, Div Brain Sci, Cancer Phage Therapy Grp, London SW7 2AZ, England; [Cordelier, Pierre] Univ Toulouse 3 Paul Sabatier, Univ Fed Toulouse Midi Pyrenees, Cancer Res Ctr Toulouse, INSERM, F-31100 Toulouse, France; [Berindan-Neagoe, Ioana] Oncol Inst Prof Dr Ion Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca 400015, Cluj, Romania	Chira, S (reprint author), Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Gen Biomed & Translat Med, 23 Gheorge Marinescu St,8 Victor Babes St, Cluj Napoca 400377, Cluj, Romania.; Cordelier, P (reprint author), Univ Toulouse 3 Paul Sabatier, Univ Fed Toulouse Midi Pyrenees, Cancer Res Ctr Toulouse, INSERM, F-31100 Toulouse, France.	sergiu.chira@umfcluj.ro; pierre.cordelier@inserm.fr	Cordelier, Pierre/D-1150-2014		 [128,014-PN-II-PT-PCCA-2013-4-2166];  [35/01.09.2016];  [37_796]	We would like to thank Mihail Buse for English proofreading of the manuscript. This work was supported by national grants Nr.128,014-PN-II-PT-PCCA-2013-4-2166 (GenCanD) and POC Nr. 35/01.09.2016, ID 37_796 (CANTEMIR).	Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bassett AR, 2015, J GENET GENOMICS, V42, P301, DOI 10.1016/j.jgg.2015.03.011; Berindan-Neagoe I, 2014, CLIN CANCER RES, V20, P6247, DOI 10.1158/1078-0432.CCR-13-2500; Berindan-Neagoe I, 2014, CA-CANCER J CLIN, V64, P311, DOI 10.3322/caac.21244; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Braicu C, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.17; Braicu C, 2014, CURR PHARM DESIGN, V20, P6565, DOI 10.2174/1381612820666140826153529                                               ; Cao Jian, 2016, Nucleic Acids Res, V44, pe149; Castro NP, 2015, ONCOTARGET, V6, P11910, DOI 10.18632/oncotarget.4182                                                        ; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen YH, 2016, MOL THER, V24, P1508, DOI 10.1038/mt.2016.172; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Chira S, 2015, ONCOTARGET, V6, P30675, DOI 10.18632/oncotarget.5169; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; de Bruin EC, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.985549; de Solis CA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00070; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Feng W, 2016, GENE, V587, P91, DOI 10.1016/j.gene.2016.04.046; Feng Y, 2015, J ORTHOP RES, V33, P199, DOI 10.1002/jor.22745; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Ghosh A, 2008, MOL THER, V16, P124, DOI 10.1038/sj.mt.6300322; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heigwer F, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0915-2; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang G, 2016, ONCOTARGET, V7, P77124, DOI 10.18632/oncotarget.12808; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293; Khan FA, 2016, ONCOTARGET, V7, P52541, DOI 10.18632/oncotarget.9646; Kia A, 2012, MOL CANCER THER, V11, P2566, DOI 10.1158/1535-7163.MCT-12-0587; Kimura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10710; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Krachulec J.M., 2016, CELL BIOL, V94, P289; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lagutina IV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004951; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Raza U, 2016, ONCOTARGET, V7, P49859, DOI 10.18632/oncotarget.10489; Ren J, 2016, CLIN CANC RES; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sicard F, 2013, MOL THER, V21, P986, DOI 10.1038/mt.2013.35; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Togashi Y, 2015, LUNG CANCER, V90, P590, DOI 10.1016/j.lungcan.2015.10.020; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Wang H, 2017, CANCER LETT, V385, P137, DOI 10.1016/j.canlet.2016.10.033; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	93	3	3	35	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	JUN 16	2017	7						211	222		10.1016/j.omtn.2017.04.001				12	Medicine, Research & Experimental	Research & Experimental Medicine	EU7RZ	WOS:000401233700020	28624197	gold			2018-01-05	
J	Bloh, KM; Bialk, PA; Gopalakrishnapillai, A; Kolb, EA; Kmiec, EB				Bloh, Kevin M.; Bialk, Pawel A.; Gopalakrishnapillai, Anilkumar; Kolb, E. Anders; Kmiec, Eric B.			CRISPR/Cas9-Directed Reassignment of the GATA1 Initiation Codon in K562 Cells to Recapitulate AML in Down Syndrome	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							ACUTE MEGAKARYOBLASTIC LEUKEMIA; MYELOPROLIFERATIVE DISORDER; CRISPR-CAS9 SYSTEM; MUTATIONS; TRANSLATION; EFFICIENCY; SEQUENCE; BIOLOGY; GENES; IPSCS	Using a CRISPR/Cas9 system, we have reengineered a translational start site in the GATA1 gene in K562 cells. This mutation accounts largely for the onset of myeloid leukemia in Down syndrome (ML-DS). For this reengineering, we utilized CRISPR/Cas9 to generate mammalian cell lines that express truncated versions of the Gata1s protein similar to that seen in ML-DS, as determined by analyzing specific genetic alterations resulting from CRISPR/Cas9 cleavage. During this work, 73 cell lines were clonally expanded, with allelic variance analyzed. Using Tracking of Indels by DEcomposition (TIDE) and Sanger sequencing, we defined the DNA sequence and variations within each allele. We found significant heterogeneity between alleles in the same clonally expanded cell, as well as among alleles from other clonal expansions. Our data demonstrate and highlight the importance of the randomness of resection promoted by non-homologous end joining after CRISPR/Cas9 cleavage in cells undergoing genetic reengineering. Such heterogeneity must be fully characterized to predict altered functionality inside target tissues and to accurately interpret the associated phenotype. Our data suggest that in cases where the objective is to rearrange specific nucleotides to redirect gene expression in human cells, it is imperative to analyze genetic composition at the individual allelic level.	[Bloh, Kevin M.; Bialk, Pawel A.; Kmiec, Eric B.] Christiana Care Hlth Serv Inc, Helen Graham Canc Ctr & Res Inst, Gene Editing Inst, Newark, DE 19713 USA; [Bloh, Kevin M.; Gopalakrishnapillai, Anilkumar; Kolb, E. Anders] Alfred I DuPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA	Kmiec, EB (reprint author), Christiana Care Hlth Serv Inc, Helen Graham Canc Ctr & Res Inst, Gene Editing Inst, Newark, DE 19713 USA.	eric.b.kmiec@christianacare.org			NIH [1P20GM109021, P20 GM103446]; Leukemia Research Foundation of Delaware	We thank Dr. Lynn Opdenaker for outstanding technical assistance with the FACS analysis, and Drs. Nicholas Petrelli (CCHS) and Sonali Barwe (Nemours) for important discussions at various stages during this project. We also acknowledge the valuable advice and input from all the members of the Kmiec laboratory. This project was supported by grants 1P20GM109021 (to E.A.K. and E.B.K.) and P20 GM103446 (to A.G.) from the NIH and by the Leukemia Research Foundation of Delaware (to E.A.K.).	Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Angioletti M, 2004, BRIT J HAEMATOL, V124, P224, DOI 10.1046/j.1365-2141.2003.04754.x; DeWitt M., 2016, EFFICIENT CORRECTION; Greene ME, 2003, BLOOD CELL MOL DIS, V31, P351, DOI 10.1016/j.bemd.2003.08.001; Gruber TA, 2015, BLOOD, V126, P943, DOI 10.1182/blood-2015-05-567859; Halsey C, 2010, BLOOD, V115, P3415, DOI 10.1182/blood-2010-02-267930; Hasle H, 2003, LEUKEMIA, V17, P277, DOI 10.1038/sj.leu.240765; Hitzler JK, 2007, PEDIATR BLOOD CANCER, V49, P1066, DOI 10.1002/pbc.21353; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kaneko H, 2012, J BIOL CHEM, V287, P21439, DOI 10.1074/jbc.M112.370437; Kanezaki R, 2010, BLOOD, V116, P4631, DOI 10.1182/blood-2010-05-282426; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Li HJ, 2016, HAEMATOLOGICA, V101, pE216, DOI 10.3324/haematol.2015.135723; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; MITELMAN F, 1990, AM J MED GENET, P262; Naumann S, 2001, LEUKEMIA RES, V25, P313, DOI 10.1016/S0145-2126(00)00125-9; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reeder CB, 2010, BLOOD, V115, P3416, DOI 10.1182/blood-2010-02-271676; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; ZIPURSKY A, 1992, PEDIATR HEMAT ONCOL, V9, P139, DOI 10.3109/08880019209018329	37	0	0	11	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	JUN 16	2017	7						288	298		10.1016/j.omtn.2017.04.009				11	Medicine, Research & Experimental	Research & Experimental Medicine	EU7RZ	WOS:000401233700027	28624204	gold			2018-01-05	
J	Yang, FY; Liu, CB; Chen, D; Tu, MJ; Xie, HB; Sun, HH; Ge, XL; Tang, LC; Li, J; Zheng, JY; Song, ZM; Qu, J; Gu, F				Yang, Fayu; Liu, Changbao; Chen, Ding; Tu, Mengjun; Xie, Haihua; Sun, Huihui; Ge, Xianglian; Tang, Lianchao; Li, Jin; Zheng, Jiayong; Song, Zongming; Qu, Jia; Gu, Feng			CRISPR/Cas9-loxP- Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							EMBRYONIC STEM-CELLS; CRISPR-CAS9 NUCLEASES; MAMMALIAN-CELLS; CAS9 NUCLEASES; GENOME-WIDE; IN-VIVO; CRE; GENERATION; KNOCKOUT; MOUSE	Cre-loxP, as one of the site-specific genetic manipulation tools, offers a method to study the spatial and temporal regulation of gene expression/inactivation in order to decipher gene function. CRISPR/Cas9-mediated targeted genome engineering technologies are sparking a new revolution in biological research. Whether the traditional site-specific genetic manipulation tool and CRISPR/Cas9 could be combined to create a novel genetic tool for highly specific gene editing is not clear. Here, we successfully generated a CRISPR/Cas9-loxP system to perform gene editing in human cells, providing the proof of principle that these two technologies can be used together for the first time. Wealso showed that distinct non-homologous end-joining (NHEJ) patterns from CRISPR/Cas9-mediated gene editing of the targeting sequence locates at the level of plasmids (episomal) and chromosomes. Specially, the CRISPR/ Cas9-mediated NHEJ pattern in the nuclear genome favors deletions (64%-68% at the human AAVS1 locus versus 4%-28% plasmid DNA). CRISPR/Cas9-loxP, a novel site-specific genetic manipulation tool, offers a platform for the dissection of gene function and molecular insights into DNA-repair pathways.	[Yang, Fayu; Chen, Ding; Tu, Mengjun; Xie, Haihua; Sun, Huihui; Ge, Xianglian; Tang, Lianchao; Li, Jin; Song, Zongming; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou 325027, Zhejiang, Peoples R China; [Yang, Fayu; Chen, Ding; Tu, Mengjun; Xie, Haihua; Sun, Huihui; Ge, Xianglian; Tang, Lianchao; Li, Jin; Song, Zongming; Qu, Jia; Gu, Feng] Minist Hlth, Key Lab Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China; [Yang, Fayu; Chen, Ding; Tu, Mengjun; Xie, Haihua; Sun, Huihui; Ge, Xianglian; Tang, Lianchao; Li, Jin; Song, Zongming; Qu, Jia; Gu, Feng] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China; [Liu, Changbao] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China; [Liu, Changbao] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China; [Zheng, Jiayong] Peoples Hosp Wenzhou, Dept Gynecol & Obstet, Wenzhou 325000, Zhejiang, Peoples R China	Gu, F (reprint author), Wenzhou Med Univ, Ctr Vis Res, Eye Hosp, 270 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China.	gufenguw@gmail.com			Chinese National Program on Key Basic Research Project (973 Program) [2013CB967502]; Natural Science Foundation of China [81201181, 81670840, 81473295, 81670882]; Zhejiang Provincial and Ministry of Health research fund for medical sciences [WKJ2013-2-023, 2016KYA145, 2016KYA146]; Science Technology project of Zhejiang Province [2017C37176]; Wenzhou City [Y20140633, Y20150071, Y20160055]; Wenzhou Medical University [QTJ12011]; Eye Hospital at Wenzhou Medical University [YNZD201602]	This work was supported by grants from the Chinese National Program on Key Basic Research Project (973 Program, 2013CB967502 to F.G.), the Natural Science Foundation of China (81201181 to F.G., 81670840 to J.L., and 81473295 and 81670882 to Z.S.), the Zhejiang Provincial and Ministry of Health research fund for medical sciences (WKJ2013-2-023 to F.G., 2016KYA145 to X.G., and 2016KYA146 to D.C.), the Science Technology project of Zhejiang Province (2017C37176 to F.G.), Wenzhou City (Y20140633 to F.G., Y20150071 to D.C., and Y20160055 to J.L.), the Wenzhou Medical University (QTJ12011 to F.G.), and the Eye Hospital at Wenzhou Medical University (YNZD201602 to F.G.).	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bu L, 2010, CELL RES, V20, P379, DOI 10.1038/cr.2010.23; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eroshenko N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3509; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Gantz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046971; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Oberdoerffer P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng140; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	33	1	1	15	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	JUN 16	2017	7						378	386		10.1016/j.omtn.2017.04.018				9	Medicine, Research & Experimental	Research & Experimental Medicine	EU7RZ	WOS:000401233700035	28624213	gold			2018-01-05	
J	Bottanelli, F; Kilian, N; Ernst, AM; Rivera-Molina, F; Schroeder, LK; Kromann, EB; Lessard, MD; Erdmann, RS; Schepartz, A; Baddeley, D; Bewersdorf, J; Toomre, D; Rothman, JE				Bottanelli, Francesca; Kilian, Nicole; Ernst, Andreas M.; Rivera-Molina, Felix; Schroeder, Lena K.; Kromann, Emil B.; Lessard, Mark D.; Erdmann, Roman S.; Schepartz, Alanna; Baddeley, David; Bewersdorf, Joerg; Toomre, Derek; Rothman, James E.			A novel physiological role for ARF1 in the formation of bidirectional tubules from the Golgi	MOLECULAR BIOLOGY OF THE CELL			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; LIVING CELLS; ENDOPLASMIC-RETICULUM; MEMBRANE-TRANSPORT; SECRETORY VESICLE; COATED VESICLES; LIVE CELLS; BULK FLOW; NETWORK	Capitalizing on CRISPR/Cas9 gene-editing techniques and super-resolution nanoscopy, we explore the role of the small GTPase ARF1 in mediating transport steps at the Golgi. Besides its well-established role in generating COPI vesicles, we find that ARF1 is also involved in the formation of long (similar to 3 mu m), thin (similar to 110 nm diameter) tubular carriers. The anterograde and retrograde tubular carriers are both largely free of the classical Golgi coat proteins coatomer (COPI) and clathrin. Instead, they contain ARF1 along their entire length at a density estimated to be in the range of close packing. Experiments using a mutant form of ARF1 affecting GTP hydrolysis suggest that ARF1[GTP] is functionally required for the tubules to form. Dynamic confocal and stimulated emission depletion imaging shows that ARF1-rich tubular compartments fall into two distinct classes containing 1) anterograde cargoes and clathrin clusters or 2) retrograde cargoes and coatomer clusters.	[Bottanelli, Francesca; Kilian, Nicole; Ernst, Andreas M.; Rivera-Molina, Felix; Schroeder, Lena K.; Kromann, Emil B.; Lessard, Mark D.; Erdmann, Roman S.; Baddeley, David; Bewersdorf, Joerg; Toomre, Derek; Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA; [Kromann, Emil B.; Bewersdorf, Joerg] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Erdmann, Roman S.; Schepartz, Alanna] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Schepartz, Alanna] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Baddeley, David; Bewersdorf, Joerg; Toomre, Derek; Rothman, James E.] Yale Univ, Nanobiol Inst, West Haven, CT 06516 USA	Rothman, JE (reprint author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.; Rothman, JE (reprint author), Yale Univ, Nanobiol Inst, West Haven, CT 06516 USA.	james.rothman@yale.edu	Kromann, Emil/N-6552-2016	Kromann, Emil/0000-0002-0782-1624; Bewersdorf, Joerg/0000-0002-4085-7020	Deutsche Forschungsgemeinschaft; Denmark-America Foundation (Coloplast); Civilingenior Frants Allings Legat; Knud Hojgaards Fond; Reinholdt W. Jorcks Fond; Berg Nielsens Legat; Ingenior Alexandre Haynman og Hustru Nina Haynmans Fond; Swiss National Science Foundation; Wellcome Trust [095927/A/11/Z, 092096]; National Institutes of Health [DK045735, RO1GM83257, S10 OD020142]	We thank Morven Graham, Christina Horensavitz, Xinran N. Liu, and Kimberly A. Zichichi at the EM facility, James Knight at the Yale Center for Genome Analysis, and Geoffrey Lyon at the FACS facility. We thank Stephanie Wood Baguley for the Halo-CLC plasmid, the Thijn Brummelkamp lab at the Netherlands Cancer Institute for kindly providing HAP1 cells, Promega for the kind gift of the SiR Halo ligand, and Alexander D. Thompson for providing BG-NH2 and CA-NH2. We thank Edward Allgeyer for help with data analysis and Arunima Chaudhuri and Saad Syed for critically reading the manuscript. A.M.E. is supported by a fellowship from the Deutsche Forschungsgemeinschaft. E.B.K. is supported by the Denmark-America Foundation (Coloplast), Civilingenior Frants Allings Legat, Knud Hojgaards Fond, Reinholdt W. Jorcks Fond, Berg Nielsens Legat, and Ingenior Alexandre Haynman og Hustru Nina Haynmans Fond. R.S.E. is supported by an Advanced Postdoc. Mobility fellowship from the Swiss National Science Foundation. This project was supported by the Wellcome Trust (095927/A/11/Z, 092096) and the National Institutes of Health (DK045735 to J.B., RO1GM83257 to A.S., and S10 OD020142 for imaging support).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Beznoussenko GV, 2014, ELIFE, V3, DOI 10.7554/eLife.02009; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bottanelli F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10778; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Deng YQ, 2016, P NATL ACAD SCI USA, V113, P6677, DOI 10.1073/pnas.1602875113; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751; GRIFFITHS G, 1984, J CELL BIOL, V98, P2133, DOI 10.1083/jcb.98.6.2133                                                           ; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; KAHN RA, 1984, J BIOL CHEM, V259, P6228; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Lavieu G, 2014, MOL BIOL CELL, V25, P3028, DOI 10.1091/mbc.E14-04-0931; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605                                                                  ; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/nmeth.2972, 10.1038/NMETH.2972]; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/NCHEM.1546, 10.1038/nchem.1546]; Martinez-Alonso E, 2013, HISTOCHEM CELL BIOL, V140, P327, DOI 10.1007/s00418-013-1114-9; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Muller MJI, 2010, BIOPHYS J, V98, P2610, DOI 10.1016/j.bpj.2010.02.037; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Paczkowski JE, 2014, DEV CELL, V30, P610, DOI 10.1016/j.devcel.2014.07.014; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Presley JF, 1997, NATURE, V389, P81; Presley JF, 1998, MOL BIOL CELL, V9, P1617, DOI 10.1091/mbc.9.7.1617                                                            ; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a                                                                 ; Puertollano R, 2003, MOL BIOL CELL, V14, P1545, DOI 10.1091/mbc.02-07-0109; Puertollano R, 2001, MOL BIOL CELL, V12, P1869, DOI 10.1091/mbc.12.6.1869                                                           ; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055                                                          ; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sengupta P, 2015, P NATL ACAD SCI USA, V112, pE6752, DOI 10.1073/pnas.1520957112; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y                                                    ; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/NMETH.1171; Toomre D, 1999, J CELL SCI, V112, P21; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273	62	1	1	3	3	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	JUN 15	2017	28	12					1676	1687		10.1091/mbc.E16-12-0863				12	Cell Biology	Cell Biology	FA4SF	WOS:000405432800008	28428254	green_published			2018-01-05	
J	Biagioni, A; Chilla, A; Andreucci, E; Laurenzana, A; Margheri, F; Peppicelli, S; Del Rosso, M; Fibbi, G				Biagioni, A.; Chilla, A.; Andreucci, E.; Laurenzana, A.; Margheri, F.; Peppicelli, S.; Del Rosso, M.; Fibbi, G.			Type II CRISPR/Cas9 approach in the oncological therapy	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH			English	Review						CRISPR; Gene therapy; Gene delivery; Genetic engineering; Immune therapy; Oncology	DOUBLE-STRAND BREAKS; HUMAN-CELLS; PEDIATRIC GLIOBLASTOMA; CRISPR-CAS9 SYSTEM; DRIVER MUTATIONS; GENE-EXPRESSION; IMMUNE-SYSTEM; RNA; CAS; ARCHAEA	CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a prokaryotic adaptable immune mechanism used by many bacteria and archaea to protect themselves from foreign nucleic acids. This complex system can recognize and cut non-self DNA in order to provide the prokaryotic organisms a strong defense against foreign viral or plasmid attacks and make the cell immune from further assaults. Today, it has been adapted to be used in vitro and in vivo in eukaryotic cells to perform a complete and highly selective gene knockout or a specific gene editing. The ease of use and the low cost are only two features that have made it very popular among the scientific community and the possibility to be used as a clinical treatment in several genetic derived pathologies has rapidly spread its fame worldwide. However, CRISPR is still not fully understood and many efforts need to be done in order to make it a real power tool for the human clinical treatment especially for oncological patients. Indeed, since cancer originates from non-lethal genetic disorders, CRISPR discovery fuels the hope to strike tumors on their roots. More than 4000 papers regarding CRISPR were published in the last ten years and only few of them take in count the possible applications in oncology. The purpose of this review is to clarify many problematics on the CRISPR usage and highlight its potential in oncological therapy.	[Biagioni, A.; Chilla, A.; Andreucci, E.; Laurenzana, A.; Margheri, F.; Peppicelli, S.; Del Rosso, M.; Fibbi, G.] Univ Florence, Sect Expt Pathol & Oncol, Dept Expt & Clin Biomed Sci, Viale GB Morgagni 50, I-50134 Florence, Italy	Biagioni, A; Chilla, A (reprint author), Univ Florence, Sect Expt Pathol & Oncol, Dept Expt & Clin Biomed Sci, Viale GB Morgagni 50, I-50134 Florence, Italy.	alessio.biagioni@unifi.it; anastasiachilla@hotmail.it		ANDREUCCI, Elena/0000-0003-3980-3073; Biagioni, Alessio/0000-0002-6193-7417	Associazione Italiana Ricerca sul Cancro (AIRC) [IG 2013 N.14266]	The ongoing authors' work using CRISPR technology is being performed in the framework of a grant of Associazione Italiana Ricerca sul Cancro (AIRC) (grant IG 2013 N.14266).	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJ, 2008, SCIENCE, V321, P5891; Chandrakasan S, 2014, HEMATOL ONCOL CLIN N, V28, P199, DOI 10.1016/j.hoc.2013.12.003; Chang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22312; Chaoran Y, 2017, MOL THER, V25, P5; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen S, 2015, CELL, V160, P6; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Cyranoski D., 2016, NATURE NEWS, V535, P7613; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Guernet A, 2017, METHODS, DOI [10.1016/j.ymeth.2017.03.007, DOI 10.1016/J.YMETH.2017.03.007]; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu Z, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/612823; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kennedy EM, 2014, J VIROL, V88, P20; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Long C, 2016, SCIENCE, V351, P6271; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Mohanad A, 2016, J EXP CLIN CANC RES, V35, P157; Mojica FJ, 2005, J MOL EVOL, V60, P2; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Paladini L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0375-2; Pourcel C, 2005, MICROBIOLOGY, V151, P3; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran AF, 2013, CELL, V154, P6; Ran AF, 2013, NATURE PROTOCOLS, V8, P2281; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Rezza A, 2016, CELL REP, V14, P3001, DOI 10.1016/j.celrep.2016.02.078; Ruan GX, 2017, MOL THER, V25, P331, DOI 10.1016/j.ymthe.2016.12.006; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P6; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Nguyen TH, 2016, EMBO MOL MED, V8, P439, DOI 10.15252/emmm.201606325; van Soolingen D, 1987, J CLIN MICROBIOL, V31, P8; Vasconcelos L, 2013, THER DELIV, V4, P573, DOI [10.4155/tde.13.22, 10.4155/TDE.13.22]; Wang J, 2014, P NATL ACAD SCI USA, V111, pE2703, DOI 10.1073/pnas.1402342111; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yuen KS, 2015, J GEN VIROL, V96, P3; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2	72	1	1	10	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-9966			J EXP CLIN CANC RES	J. Exp. Clin. Cancer Res.	JUN 15	2017	36								80	10.1186/s13046-017-0550-0				8	Oncology	Oncology	EZ0NZ	WOS:000404404100002	28619109	gold			2018-01-05	
J	Dong, D; Guo, MH; Wang, SH; Zhu, YW; Wang, S; Xiong, Z; Yang, JZ; Xu, ZL; Huang, ZW				Dong, De; Guo, Minghui; Wang, Sihan; Zhu, Yuwei; Wang, Shuo; Xiong, Zhi; Yang, Jianzheng; Xu, Zengliang; Huang, Zhiwei			Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein	NATURE			English	Article							TARGET DNA RECOGNITION; ADAPTIVE IMMUNITY; NUCLEASE SPECIFICITY; BACTERIAL IMMUNITY; CAS SYSTEMS; RNA; COMPLEX; PROKARYOTES; ARCHAEA; ENDONUCLEASE	CRISPR-Cas9 systems are bacterial adaptive immune systems that defend against infection by phages. Through the RNA-guided endonuclease activity of Cas9 they degrade double-stranded DNA with a protospacer adjacent motif (PAM) and sequences complementary to the guide RNA(1-5). Recently, two anti-CRISPR proteins (AcrIIA2 and AcrIIA4 from Listeria monocytogenes prophages) were identified, both of which inhibit Streptococcus pyogenes Cas9 (SpyCas9) and L. monocytogenes Cas9 activity in bacteria and human cells(6). However, the mechanism of AcrIIA2- or AcrIIA4-mediated Cas9 inhibition remains unknown. Here we report a crystal structure of SpyCas9 in complex with a single-guide RNA (sgRNA) and AcrIIA4. Our data show that AcrIIA2 and AcrIIA4 interact with SpyCas9 in a sgRNA-dependent manner. The structure reveals that AcrIIA4 inhibits SpyCas9 activity by structurally mimicking the PAM to occupy the PAM-interacting site in the PAM-interacting domain, thereby blocking recognition of double-stranded DNA substrates by SpyCas9. AcrIIA4 further inhibits the endonuclease activity of SpyCas9 by shielding its RuvC active site. Structural comparison reveals that formation of the AcrIIA4-binding site of SpyCas9 is induced by sgRNA binding. Our study reveals the mechanism of SpyCas9 inhibition by AcrIIA4, providing a structural basis for developing 'off-switch' tools for SpyCas9 to avoid unwanted genome edits within cells and tissues.	[Dong, De; Guo, Minghui; Wang, Sihan; Zhu, Yuwei; Wang, Shuo; Xiong, Zhi; Yang, Jianzheng; Xu, Zengliang; Huang, Zhiwei] Harbin Inst Technol, Sch Life Sci & Technol, HIT Ctr Life Sci, Harbin 150080, Peoples R China	Huang, ZW (reprint author), Harbin Inst Technol, Sch Life Sci & Technol, HIT Ctr Life Sci, Harbin 150080, Peoples R China.	huangzhiwei@hit.edu.cn			National Natural Science Foundation of China [31422014, 31450001, 31300605]	We thank J. He at Shanghai Synchrotron Radiation Facility (SSRF) for help with data collection. We thank J. Chai for critical reading of the manuscript. This research was funded by the National Natural Science Foundation of China grant no. 31422014, 31450001 and 31300605 to Z.H.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; DeLano W. L., 2002, PYMOL MOL VIEWER; Emsley P., 2004, D BIOL CRYSTALLOGR, V60, P2126, DOI DOI 10.1107/S0907444904019158; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	35	6	6	26	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					436	+		10.1038/nature22377				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EX5BK	WOS:000403250900041	28448066				2018-01-05	
J	Ratzan, W; Falco, R; Salanga, C; Salanga, M; Horb, ME				Ratzan, Wil; Falco, Rosalia; Salanga, Cristy; Salanga, Matthew; Horb, Marko E.			Generation of a Xenopus laevis F1 albino J strain by genome editing and oocyte host-transfer	DEVELOPMENTAL BIOLOGY			English	Article						Xenopus laevis; TALENs; J strain; Tyrosinase; Oocyte host-transfer; Genome editing	TARGETED GENE DISRUPTION; GERM PLASM; TROPICALIS; EMBRYOS; TALENS; BLASTOMERES; NUCLEASES; FERTILIZATION; EVOLUTION; SYSTEM	Completion of the Xenopus laevis genome sequence from inbred J strain animals has facilitated the generation of germline mutant X. laevis using targeted genome editing. In the last few years, numerous reports have demonstrated that TALENs are able to induce mutations in F0 Xenopus embryos, but none has demonstrated germline transmission of such mutations in X. laevis. In this report we used the oocyte host-transfer method to generate mutations in both tyrosinase homeologs and found highly-penetrant germline mutations; in contrast, embryonic injections yielded few germline mutations. We also compared the distribution of mutations in several F0 somatic tissues and germ cells and found that the majority of mutations in each tissue were different. These results establish that X. laevis J strain animals are very useful for generating germline mutations and that the oocyte host-transfer method is an efficient technique for generating mutations in both homeologs. (C) 2016 The Authors. Published by Elsevier Inc.	[Ratzan, Wil; Falco, Rosalia; Salanga, Cristy; Salanga, Matthew; Horb, Marko E.] Marine Biol Lab, Natl Xenopus Resource & Eugene Bell Ctr Regenerat, Woods Hole, MA 02543 USA	Horb, ME (reprint author), Marine Biol Lab, Natl Xenopus Resource & Eugene Bell Ctr Regenerat, Woods Hole, MA 02543 USA.	mhorb@mbl.edu		Horb, Marko/0000-0002-5067-0518	NIH [OD010997, HD084409]	We wish to thank Sean McNamara, Brian Suh, Lynn Ware and Alyssa Arseneau for their care of the frogs and help in the breeding and to Esther Pearl for her help throughout this project. This work was supported by grants from the NIH (OD010997 and HD084409). We also thank Dr. Doug Houston for showing us the oocyte host-transfer technique.	Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; DALE L, 1987, DEVELOPMENT, V99, P527; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Houston DW, 1998, DEVELOPMENT, V125, P171; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Ishibashi S, 2012, BIOL OPEN, V1, P1273, DOI 10.1242/bio.20123228; James-Zorn C, 2015, GENESIS, V53, P486, DOI 10.1002/dvg.22873; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Krylov V, 2015, CYTOGENET GENOME RES, V145, P192, DOI 10.1159/000406550; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Matsuda Y, 2015, CYTOGENET GENOME RES, V145, P187, DOI 10.1159/000381292; Miyamoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142946; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; Nakade S, 2015, IN VITRO CELL DEV-AN, V51, P879, DOI 10.1007/s11626-015-9912-0; Nakajima K, 2015, BIOL OPEN, V4, P259, DOI 10.1242/bio.201410926; Nakajima K, 2015, BIOL OPEN, V4, P180, DOI 10.1242/bio.201410009; Nakajima K, 2012, DEV GROWTH DIFFER, V54, P777, DOI 10.1111/dgd.12006; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Olson D.J., 2012, MATERNAL MRNA KNOCK, P167; Pearl EJ, 2012, GENESIS, V50, P155, DOI 10.1002/dvg.22013; Peng Y, 2014, DEVELOPMENT, V141, P4042, DOI 10.1242/dev.102186; RESSOM RE, 1988, DEVELOPMENT, V103, P507; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; TOCHINAI S, 1975, DEV GROWTH DIFFER, V17, P383	33	1	1	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JUN 15	2017	426	2			SI		188	193		10.1016/j.ydbio.2016.03.006				6	Developmental Biology	Developmental Biology	EY6AM	WOS:000404064800006	26993591	gold			2018-01-05	
J	Banach, M; Edholm, ES; Robert, J				Banach, Maureen; Edholm, Eva-Stina; Robert, Jacques			Exploring the functions of nonclassical MHC class Ib genes in Xenopus laevis by the CRISPR/Cas9 system	DEVELOPMENTAL BIOLOGY			English	Article						Gene knockout; Reverse genetic; Genomics; Amphibians; Comparative immunology; XNC	INVARIANT T-CELLS; CLAWED FROGS XENOPUS; OFF-TARGET ACTIVITY; AMPHIBIAN XENOPUS; IMMUNE-SYSTEM; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; GENOME EVOLUTION; LARGE FAMILY; CD1 GENES	A large family of highly related and clustered Xenopus nonclassical MHC class lb (XNC) genes influences Xenopus laevis immunity and potentially other physiological functions. Using RNA interference (RNAi) technology, we previously demonstrated that one of XNC genes, XNC10.1, is critical for the development and function of a specialized innate T (iT) cell population. However, RNAi limitation such as a variable and unstable degree of gene silencing in F0 and F1 generations is hampering a thorough functional analysis of XNC10.1 and other XNC genes. To overcome this obstacle, we adapted the CRISPR/Cas9-mediated gene editing technique for XNC genes. We efficiently and specifically generated single gene knockouts of XNC10.1, XNC11, and XNC1 as well as double gene knockouts of XNC10.1 and XNC11 in X. laevis. In single XNC10.1 knockout X laevis tadpoles, the absence of XNC10.1 and V alpha 6-J alpha 1.43 invariant T cell receptor rearrangement transcripts indicated XNC10.1 loss-of-function and deficiency in Va6-Ja1.43 iT cells. Notably, targeting XNC10.1 did not affect neighboring XNC genes exhibiting high sequence similarity. Furthermore, XNC1 gene disruption induced mortality during developmental stage 47, suggesting some non-immune but essential function of this gene. These data demonstrate that the CRISPR/Cas9 system can be successfully adapted for genetic analysis in FO generation of X laevis. (C) 2016 Elsevier Inc. All rights reserved.	[Banach, Maureen; Edholm, Eva-Stina; Robert, Jacques] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	Robert, J (reprint author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Jacques_Robert@urmc.rochester.edu			National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R24-AI-059830]; Ruth L. Kirschstein Predoctoral F31 from the National Cancer Institute (NIH/NCI) [F31CA192664]; NIH-T32 training grant [AI007285]; Nation Science Foundation [IOS-1456213]	We would like to thank Francisco De Jesus Andino and Tina Martin for the animal husbandry. We also thank the Cold Spring Harbor Laboratory Xenopus 2015 course and especially Drs. Karen Liu, Mustafa Khokha, and Emily Miss for excellent training and reagents. This research was supported by R24-AI-059830 grant from the National Institute of Allergy and Infectious Diseases (NIH/NIAID). M.B. was supported by a predoctoral fellowship Ruth L. Kirschstein Predoctoral F31 (F31CA192664) from the National Cancer Institute (NIH/NCI) and NIH-T32 training grant AI007285. E-S.E. was supported by the Nation Science Foundation IOS-1456213.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Bartl S, 1997, J IMMUNOL, V159, P6097; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bhattacharya D, 2015, DEV BIOL, V408, P196, DOI 10.1016/j.ydbio.2015.11.003; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521                                                          ; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dascher CC, 2007, CURR TOP MICROBIOL, V314, P3; Dijkstra JM, 2007, IMMUNOGENETICS, V59, P305, DOI 10.1007/s00251-007-0198-6; Du Pasquier L, 1977, IMMUNOGENETICS, V5, P129; Edholm ES, 2015, J IMMUNOL, V195, P576, DOI 10.4049/jimmunol.1500458; Edholm ES, 2014, IMMUNOGENETICS, V66, P411, DOI 10.1007/s00251-014-0774-5; Edholm ES, 2013, P NATL ACAD SCI USA, V110, P14342, DOI 10.1073/pnas.1309840110; Evans BJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4687, DOI 10.2741/3033; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Fernandez CS, 2014, IMMUNOL CELL BIOL, V92, P578, DOI 10.1038/icb.2014.25; FLAJNIK MF, 1986, J IMMUNOL, V137, P3891; FLAJNIK MF, 1993, EMBO J, V12, P4385; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Goyos A, 2011, J IMMUNOL, V186, P372, DOI 10.4049/jimmunol.1001467; Goyos A, 2009, FRONT BIOSCI, V14, P167, DOI 10.2741/3238; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Grayfer L, 2015, J VIROL, V89, P5072, DOI 10.1128/JVI.00051-15; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Haynes-Gilmore N, 2014, CARCINOGENESIS, V35, P1807, DOI 10.1093/carcin/bgu100; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Juno JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002838; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Macho-Fernandez E, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00362; Matsuda Y, 2015, CYTOGENET GENOME RES, V145, P187, DOI 10.1159/000381292; McEwen-Smith RM, 2015, CANCER IMMUNOL RES, V3, P425, DOI 10.1158/2326-6066.CIR-15-0062; Miller MM, 2005, P NATL ACAD SCI USA, V102, P8674, DOI 10.1073/pnas.0500105102                                                         ; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nieuwkoop P. D., 1967, NORMAL TABLE XENOPUS; Riegert P, 1998, J IMMUNOL, V161, P4066; Robert J, 2014, IMMUNOGENETICS, V66, P513, DOI 10.1007/s00251-014-0781-6; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Robertson FC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00543; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Salomonsen J, 2005, P NATL ACAD SCI USA, V102, P8668, DOI 10.1073/pnas.0409213102                                                         ; Sammut B, 1999, EUR J IMMUNOL, V29, P2897, DOI 10.1002/(SICI)1521-4141(199909)29:09<2897::AID-IMMU2897>3.0.CO;2-2              ; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Subleski JJ, 2011, IMMUNOTHERAPY-UK, V3, P1167, DOI [10.2217/IMT.11.117, 10.2217/imt.11.117]; Tsukamoto K, 2013, IMMUNOGENETICS, V65, P115, DOI 10.1007/s00251-012-0666-5; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Yang Z, 2015, IMMUNOGENETICS, V67, P337, DOI 10.1007/s00251-015-0837-2; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	56	1	1	4	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JUN 15	2017	426	2			SI		261	269		10.1016/j.ydbio.2016.05.023				9	Developmental Biology	Developmental Biology	EY6AM	WOS:000404064800014	27318386				2018-01-05	
J	Tandon, P; Conlon, F; Furlow, JD; Horb, ME				Tandon, Panna; Conlon, Frank; Furlow, J. David; Horb, Marko E.			Expanding the genetic toolkit in Xenopus: Approaches and opportunities for human disease modeling	DEVELOPMENTAL BIOLOGY			English	Review						CRISPR-Cas; TALENs; J strain; Xenopus laevis; Xenopus tropicalis; Knock-in; Human disease model	CONGENITAL HEART-DISEASE; CRISPR-CAS SYSTEMS; CENTRIOLE BIOGENESIS; FUNCTIONAL GENOMICS; LAEVIS EMBRYOS; HUMAN-CELLS; TROPICALIS; TALENS; DNA; TRANSGENESIS	The amphibian model Xenopus, has been used extensively over the past century to study multiple aspects of cell and developmental biology. Xenopus offers advantages of a non-mammalian system, including high fecundity, external development, and simple housing requirements, with additional advantages of large embryos, highly conserved developmental processes, and close evolutionary relationship to higher vertebrates. There are two main species of Xenopus used in biomedical research, Xenopus laevis and Xenopus tropicalis; the common perception is that both species are excellent models for embryological and cell biological studies, but only Xenopus tropicalis is useful as a genetic model. The recent completion of the Xenopus laevis genome sequence combined with implementation of genome editing tools, such as TALENs (transcription activator-like effector nucleases) and CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR associated nucleases), greatly facilitates the use of both Xenopus laevis and Xenopus tropicalis for understanding gene function in development and disease. In this paper, we review recent advances made in Xenopus laevis and Xenopus tropicalis with TALENs and CRISPR-Cas and discuss the various approaches that have been used to generate knockout and knock-in animals in both species. These advances show that both Xenopus species are useful for genetic approaches and in particular counters the notion that Xenopus laevis is not amenable to genetic manipulations. (C) 2016 The Authors. Published by Elsevier Inc.	[Tandon, Panna; Conlon, Frank] Univ North Carolina Chapel Hill, Univ North Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Furlow, J. David] Univ Calif Davis, Deparment Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Horb, Marko E.] Marine Biol Lab, Natl Xenopus Resource & Eugene Bell Ctr Regenerat, Woods Hole, MA 02543 USA	Tandon, P (reprint author), Univ North Carolina Chapel Hill, Univ North Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA.; Horb, ME (reprint author), Marine Biol Lab, Natl Xenopus Resource & Eugene Bell Ctr Regenerat, Woods Hole, MA 02543 USA.	ptandon@email.unc.edu; mhorb@mbl.edu		Horb, Marko/0000-0002-5067-0518	National Institutes of Health [P40 OD010997, R01 HD084409, R01 HL112618, R01 HL127640]; U.S. Environmental Protection Agency [G11E10367]	This work was supported by the National Institutes of Health (P40 OD010997 to M.E.H., R01 HD084409 to M.E.H., R01 HL112618 to P.T. and F.C., and R01 HL127640 to P.T. and F.C.; and the U.S. Environmental Protection Agency (G11E10367 to D.F.).	Afelik S, 2006, GENE DEV, V20, P1441, DOI 10.1101/gad.378706; Allen BG, 2006, NAT PROTOC, V1, P1248, DOI 10.1038/nprot.2006.183; Amodeo AA, 2015, P NATL ACAD SCI USA, V112, pE1086, DOI 10.1073/pnas.1413990112; Bhattacharya D, 2015, DEV BIOL, V408, P196, DOI 10.1016/j.ydbio.2015.11.003; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bier E, 2015, SCIENCE, V348, DOI 10.1126/science.aaa5838; Blitz IL, 2006, SEMIN CELL DEV BIOL, V17, P133, DOI 10.1016/j.semcdb.2005.11.002; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Blitz Ira L, 2012, Methods Mol Biol, V917, P43, DOI 10.1007/978-1-61779-992-1_4; Bodart Jean-Francois L., 2006, V322, P43; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Buchholz DR, 2015, DEV BIOL, V408, P188, DOI 10.1016/j.ydbio.2015.02.018; Buchholz D.R., 2012, XENOPUS PROTOCOL POS, P265; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chalmers AD, 2000, DEVELOPMENT, V127, P381; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chernet BT, 2013, DIS MODEL MECH, V6, P595, DOI 10.1242/dmm.010835; Chesneau A, 2008, BIOL CELL, V100, P503, DOI 10.1042/BC20070148; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi JY, 2015, ENDOCRINOLOGY, V156, P735, DOI 10.1210/en.2014-1554; Chung MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01439; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cross MK, 2009, DIS MODEL MECH, V2, P541, DOI 10.1242/dmm.002022; Davidson E H, 1973, Symp Soc Dev Biol, V31, P251; Dehring DAK, 2013, DEV CELL, V27, P103, DOI 10.1016/j.devcel.2013.08.021; Dickinson A.J.G., 2016, SEMIN CELL DEV BIOL, P1; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dubaissi E, 2011, DIS MODEL MECH, V4, P179, DOI 10.1242/dmm.006494; Duncan AR, 2016, SEMIN CELL DEV BIOL, V51, P73, DOI 10.1016/j.semcdb.2016.02.022; Erdogan B, 2016, SEMIN CELL DEV BIOL, V51, P64, DOI 10.1016/j.semcdb.2016.02.003; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Geach Timothy J, 2012, Methods Mol Biol, V917, P69, DOI 10.1007/978-1-61779-992-1_5; Grant IM, 2015, DEV BIOL, V408, P345, DOI 10.1016/j.ydbio.2015.09.004; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Gurdon JB, 2013, DEVELOPMENT, V140, P2449, DOI 10.1242/dev.097170; Hardwick LJA, 2015, DEV BIOL, V408, P180, DOI 10.1016/j.ydbio.2015.02.003; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Haynes-Gilmore N, 2014, CARCINOGENESIS, V35, P1807, DOI 10.1093/carcin/bgu100; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hunt T, 2002, BIOSCIENCE REP, V22, P465, DOI 10.1023/A:1022077317801; Ishibashi S., 2012, METHOD MOL BIOL, P185; Ishibashi S, 2012, BIOL OPEN, V1, P1273, DOI 10.1242/bio.20123228; Iwasaki Y, 2014, DEVELOPMENT, V141, P3740, DOI 10.1242/dev.106658; Jaffe KM, 2016, CELL REP, V14, P1841, DOI 10.1016/j.celrep.2016.01.069; James-Zorn C, 2015, GENESIS, V53, P486, DOI 10.1002/dvg.22873; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jarikji ZH, 2007, DEV BIOL, V304, P786, DOI 10.1016/j.ydbio.2007.01.027; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kaltenbrun E, 2011, BIRTH DEFECTS RES A, V91, P495, DOI 10.1002/bdra.20793; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kataoka K, 2006, MECH DEVELOP, V123, P746, DOI 10.1016/j.mod.2006.07.006; Kay B.K., 1991, XENOPUS LAEVIS PRACT; Kelley C.M., 2012, METHOD MOL BIOL, P231; Khokha MK, 2012, GENESIS, V50, P133, DOI 10.1002/dvg.22015; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kofent J, 2016, SEMIN CELL DEV BIOL, V51, P106, DOI 10.1016/j.semcdb.2016.01.005; Krylov V, 2015, CYTOGENET GENOME RES, V145, P192, DOI 10.1159/000406550; LaBonne C, 2015, DEV BIOL, V408, P179, DOI 10.1016/j.ydbio.2015.11.019; Lane AB, 2015, DEV CELL, V34, P373, DOI 10.1016/j.devcel.2015.06.003; Lane MC, 2006, DEV BIOL, V296, P12, DOI 10.1016/j.ydbio.2006.04.447; Langdon Y, 2012, DEVELOPMENT, V139, P948, DOI 10.1242/dev.067579; Langdon YG, 2007, DEVELOPMENT, V134, P4119, DOI 10.1242/dev.009290; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Lienkamp SS, 2016, SEMIN CELL DEV BIOL, V51, P117, DOI 10.1016/j.semcdb.2016.02.002; Love NR, 2011, DEVELOPMENT, V138, P5451, DOI 10.1242/dev.066498; Ma LN, 2014, GENE DEV, V28, P1461, DOI 10.1101/gad.243832.114; Macha J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-315; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maksaev G, 2015, METHODS MOL BIOL, V1309, P151, DOI 10.1007/978-1-4939-2697-8_13; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuda Y, 2015, CYTOGENET GENOME RES, V145, P187, DOI 10.1159/000381292; Mitchison T.J., 2015, COLD SPRING HARB PER, V7; Miyamoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142946; Miyamoto K, 2015, JOVE-J VIS EXP, DOI 10.3791/52496; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Munoz R, 2015, DEV BIOL, V408, P229, DOI 10.1016/j.ydbio.2015.03.009; Nakade S, 2015, IN VITRO CELL DEV-AN, V51, P879, DOI 10.1007/s11626-015-9912-0; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakajima K, 2015, BIOL OPEN, V4, P259, DOI 10.1242/bio.201410926; Nakajima K, 2015, BIOL OPEN, V4, P180, DOI 10.1242/bio.201410009; Nakayama T, 2015, DEV BIOL, V408, P328, DOI 10.1016/j.ydbio.2015.02.012; Nakayama T, 2014, METHOD ENZYMOL, V546, P355, DOI 10.1016/B978-0-12-801185-0.00017-9; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Olson D.J., 2012, XENOPUS LAEVIS XENOP, P167; Onjiko RM, 2015, P NATL ACAD SCI USA, V112, P6545, DOI 10.1073/pnas.1423682112; Paranjpe SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-762; Pearl EJ, 2012, GENESIS, V50, P155, DOI 10.1002/dvg.22013; Pearl EJ, 2011, DEV BIOL, V351, P135, DOI 10.1016/j.ydbio.2010.12.043; Pearl EJ, 2009, DEV DYNAM, V238, P1271, DOI 10.1002/dvdy.21935; Peng Y, 2014, DEVELOPMENT, V141, P4042, DOI 10.1242/dev.102186; Peshkin L, 2015, DEV CELL, V35, P383, DOI 10.1016/j.devcel.2015.10.010; Pollet N, 2006, GENOME DYN, V2, P138, DOI 10.1159/000095101; Pratt KG, 2013, DIS MODEL MECH, V6, P1057, DOI 10.1242/dmm.012138; Rankin SA, 2015, DEV DYNAM, V244, P69, DOI 10.1002/dvdy.24180; Rankin SA, 2011, DEV BIOL, V351, P297, DOI 10.1016/j.ydbio.2010.11.037; Ratzan W., 2016, DEV BIOL, P1; ROE BA, 1985, J BIOL CHEM, V260, P9759; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Salanga Matthew C, 2015, Curr Pathobiol Rep, V3, P137; Schmitt SM, 2014, ADV DRUG DELIVER REV, V69, P225, DOI 10.1016/j.addr.2014.02.004; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Showell C, 2007, GENESIS, V45, P418, DOI 10.1002/dvg.20286; Showell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022392; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; Sojka S, 2014, DEVELOPMENT, V141, P3040, DOI 10.1242/dev.106518; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; Takagi C, 2013, DEV GROWTH DIFFER, V55, P422, DOI 10.1111/dgd.12042; TOCHINAI S, 1975, DEV GROWTH DIFFER, V17, P383; Tymowska J., 1991, P259; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; Van Nieuwenhuysen Tom, 2015, Oncoscience, V2, P555; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Wen L, 2015, FASEB J, V29, P385, DOI 10.1096/fj.14-252171; Wen L, 2015, ENDOCRINOLOGY, V156, P721, DOI 10.1210/en.2014-1439; Womble M, 2016, SEMIN CELL DEV BIOL, V51, P92, DOI 10.1016/j.semcdb.2016.02.001; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Wylie LA, 2015, DIS MODEL MECH, V8, P429, DOI 10.1242/dmm.018630; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yang J, 2015, CURR TOP DEV BIOL, V113, P271, DOI 10.1016/bs.ctdb.2015.07.021; Yergeau DA, 2009, DEV DYNAM, V238, P1727, DOI 10.1002/dvdy.21994; Zhang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065058	136	5	5	10	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JUN 15	2017	426	2			SI		325	335		10.1016/j.ydbio.2016.04.009				11	Developmental Biology	Developmental Biology	EY6AM	WOS:000404064800018	27109192	gold			2018-01-05	
J	Ledford, KL; Martinez-De Luna, RI; Theisen, MA; Rawlins, KD; Viczian, AS; Zuber, ME				Ledford, Kelley L.; Martinez-De Luna, Reyna I.; Theisen, Matthew A.; Rawlins, Karisa D.; Viczian, Andrea S.; Zuber, Michael E.			Distinct cis-acting regions control six6 expression during eye field and optic cup stages of eye formation	DEVELOPMENTAL BIOLOGY			English	Article							OPTX2 HOMEOBOX GENE; I-SCEI MEGANUCLEASE; TRANSCRIPTION FACTORS; XENOPUS-TROPICALIS; PITUITARY HYPOPLASIA; CELL-PROLIFERATION; RETINA FORMATION; BMP4 EXPRESSION; WEB TOOL; ANOPHTHALMIA	The eye field transcription factor, Six6, is essential for both the early (specification and proliferative growth) phase of eye formation, as well as for normal retinal progenitor cell differentiation. While genomic regions driving six6 optic cup expression have been described, the sequences controlling eye field and optic vesicle expression are unknown. Two evolutionary conserved regions 5' and a third 3' to the six6 coding region were identified, and together they faithfully replicate the endogenous X. laevis six6 expression pattern. Transgenic lines were generated and used to determine the onset and expression patterns controlled by the regulatory regions. The conserved 3' region was necessary and sufficient for eye field and optic vesicle expression. In contrast, the two conserved enhancer regions located 5' of the coding sequence were required together for normal optic cup and mature retinal expression. Gain-of-function experiments indicate endogenous six6 and GFP expression in F1 transgenic embryos are similarly regulated in response to candidate trans-acting factors. Importantly, CRISPR/CAS9-mediated deletion of the 3' eye field/optic vesicle enhancer in X. laevis, resulted in a reduction in optic vesicle size. These results identify the cis-acting regions, demonstrate the modular nature of the elements controlling early versus late retinal expression, and identify potential regulators of six6 expression during the early stages of eye formation.	[Ledford, Kelley L.; Martinez-De Luna, Reyna I.; Theisen, Matthew A.; Rawlins, Karisa D.; Viczian, Andrea S.; Zuber, Michael E.] SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA; [Ledford, Kelley L.; Martinez-De Luna, Reyna I.; Theisen, Matthew A.; Rawlins, Karisa D.; Viczian, Andrea S.; Zuber, Michael E.] SUNY Upstate Med Univ, Ctr Vis Res, Syracuse, NY 13210 USA; [Ledford, Kelley L.; Viczian, Andrea S.; Zuber, Michael E.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Viczian, Andrea S.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [Viczian, Andrea S.; Zuber, Michael E.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	Viczian, AS (reprint author), SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA.; Viczian, AS (reprint author), SUNY Upstate Med Univ, Ctr Vis Res, Syracuse, NY 13210 USA.	vicziana@upstate.edu			National Eye Institute of the National Institutes of Health [R01EY017964, R01EY015748, R01EY19517]; Research to Prevent Blindness Unrestricted Grant; Lions Club of Central New York	We would like to thank Drs. Richard Harland, Hajime Ogino and Haruki Ochi for generously sharing their unpublished data on X. laevis six6 promoter analysis. Drs. Takenobu Katagiri, Yonglong Chen and Rene Choi provided or generated the Smad-DVD, pCS2+3XFLAG-NLS-SpCas9-NLS, and Xtr six6 R2R1 -> GFP constructs, respectively (Guo et al., 2014; Nojima et al., 2010). Our thanks also to Drs. Ronald Gregg, Marko Horb and the National Xenopus Resource Center for advice on the use of CRISPR and mutant screening as well as and Matt Mellini for excellent technical assistance. Research reported in this work was supported in part by the National Eye Institute of the National Institutes of Health under award numbers R01EY017964 and R01EY015748 (MEZ) and R01EY19517 (AV), a Research to Prevent Blindness Unrestricted Grant to the Upstate Medical University Department of Ophthalmology, and the Lions Club of Central New York.	Abu-Amero K, 2015, INT J MOL SCI, V16, P28886, DOI 10.3390/ijms161226135; Aijaz S, 2005, GENOMICS, V86, P86, DOI 10.1016/j.ygeno.2005.03.002; Aijaz S, 2004, INVEST OPHTH VIS SCI, V45, P3871, DOI 10.1167/iovs.04-0641; Aldahmesh MA, 2013, CLIN GENET, V84, P198, DOI 10.1111/cge.12046; Bar-Yosef U, 2004, HUM GENET, V115, P302, DOI 10.1007/s00439-004-1154-2; BENNETT CP, 1991, J MED GENET, V28, P280, DOI 10.1136/jmg.28.4.280; Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9; Carnes MU, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004372; Cheng CY, 2015, INVEST OPHTH VIS SCI, V56, P478, DOI 10.1167/iovs.14-15863; Conte I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r137; Conte I, 2010, DEVELOPMENT, V137, P2307, DOI 10.1242/dev.045294; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dixit R, 2014, GENE EXPR PATTERNS, V14, P42, DOI 10.1016/j.gep.2013.10.003; ELLIOTT J, 1993, J MED GENET, V30, P251, DOI 10.1136/jmg.30.3.251; Ermakova GV, 2007, DEV BIOL, V307, P483, DOI 10.1016/j.ydbio.2007.03.524; Gallardo ME, 2004, AM J MED GENET A, V129A, P92, DOI 10.1002/ajmg.a.30126; Gallardo ME, 1999, GENOMICS, V61, P82, DOI 10.1006/geno.1999.5916; Gestri G, 2005, DEVELOPMENT, V132, P2401, DOI 10.1242/dev.01814; Gomez-Skarmeta JL, 1999, MECH DEVELOP, V80, P15, DOI 10.1016/S0925-4773(98)00190-7; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Haeri Mohammad, 2012, Methods Mol Biol, V884, P17, DOI 10.1007/978-1-61779-848-1_2; Hartley KO, 2001, DEV BIOL, V238, P168, DOI 10.1006/dbio.2001.0398; Haworth KE, 2009, INT J DEV BIOL, V53, P159, DOI 10.1387/ijdb.072472ke; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4                                                   ; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee B, 2012, DEV BIOL, V366, P393, DOI 10.1016/j.ydbio.2012.04.023; Lemyre E, 1998, AM J MED GENET, V77, P162, DOI 10.1002/(SICI)1096-8628(19980501)77:2<162::AID-AJMG10>3.3.CO;2-L; Li X, 2002, SCIENCE, V297, P1180; Lopez-Rios J, 1999, MECH DEVELOP, V83, P155, DOI 10.1016/S0925-4773(99)00017-9                                                   ; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Mariani FV, 1998, DEVELOPMENT, V125, P5019; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Motahari Z, 2016, DEVELOPMENT, V143, P3560, DOI 10.1242/dev.130955; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakayama T, 2014, METHOD ENZYMOL, V546, P355, DOI 10.1016/B978-0-12-801185-0.00017-9; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nolen LD, 2006, AM J MED GENET A, V140A, P1711, DOI 10.1002/ajmg.a.31335; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Ogino Hajime, 2012, Methods Mol Biol, V917, P245, DOI 10.1007/978-1-61779-992-1_15; Pan FC, 2006, DEV DYNAM, V235, P247, DOI 10.1002/dvdy.20608; Pohl BS, 2005, GENE, V344, P21, DOI 10.1016/j.gene.2004.09.037; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Sinn R, 2013, MECH DEVELOP, V130, P347, DOI 10.1016/j.mod.2013.05.001; Tetreault N, 2009, DEV BIOL, V327, P541, DOI 10.1016/j.ydbio.2008.12.022; Toy J, 1999, MECH DEVELOP, V83, P183, DOI 10.1016/S0925-4773(99)00049-0                                                   ; Toy J, 1998, P NATL ACAD SCI USA, V95, P10643, DOI 10.1073/pnas.95.18.10643                                                        ; Viczian AS, 2004, FEBS LETT, V577, P259, DOI 10.1016/j.febslet.2004.10.008; Viczian AS, 2003, DEVELOPMENT, V130, P1281, DOI 10.1242/dev.00343; Viczian A.S., 2010, J VIS EXP; Wang JCC, 2005, DEV BIOL, V285, P101, DOI 10.1016/j.ydbio.2005.05.041; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Wong KA, 2015, BIOL OPEN, V4, P573, DOI 10.1242/bio.20149977; Yariz KO, 2015, CLIN GENET, V87, P192, DOI 10.1111/cge.12374; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7                                                   ; Zuber ME, 2012, GENESIS, V50, P325, DOI 10.1002/dvg.22006; Zuber ME, 2010, CURR TOP DEV BIOL, V93, P29, DOI [10.1016/B978-0-12-385044-7.00002-3, 10.1016/S0070-2153(10)93002-0]	61	0	0	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JUN 15	2017	426	2			SI		418	428		10.1016/j.ydbio.2017.04.003				11	Developmental Biology	Developmental Biology	EY6AM	WOS:000404064800026	28438336				2018-01-05	
J	Huang, YY; Cho, ST; Haryono, M; Kuo, CH				Huang, Ya-Yi; Cho, Shu-Ting; Haryono, Mindia; Kuo, Chih-Horng			Complete chloroplast genome sequence of common bermudagrass (Cynodon dactylon (L.) Pers.) and comparative analysis within the family Poaceae	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; ACETYL-COA CARBOXYLASE; TRANSFER-RNA GENES; HIGHER-PLANTS; DNA; PROTEIN; EVOLUTION; MULTIPLE; INTRON; REARRANGEMENTS	Common bermudagrass (Cynodon dactylon (L.) Pers.) belongs to the subfamily Chloridoideae of the Poaceae family, one of the most important plant families ecologically and economically. This grass has a long connection with human culture but its systematics is relatively understudied. In this study, we sequenced and investigated the chloroplast genome of common bermudagrass, which is 134,297 bp in length with two single copy regions (LSC: 79,732 bp; SSC: 12,521 bp) and a pair of inverted repeat (IR) regions ( 21,022 bp). The annotation contains a total of 128 predicted genes, including 82 protein-coding, 38 tRNA, and 8 rRNA genes. Additionally, our in silico analyses identified 10 sets of repeats longer than 20 bp and predicted the presence of 36 RNA editing sites. Overall, the chloroplast genome of common bermudagrass resembles those from other Poaceae lineages. Compared to most angiosperms, the accD gene and the introns of both clpP and rpoC1 genes are missing. Additionally, the ycf1, ycf2, ycf15, and ycf68 genes are pseudogenized and two genome rearrangements exist. Our phylogenetic analysis based on 47 chloroplast protein-coding genes supported the placement of common bermudagrass within Chloridoideae. Our phylogenetic character mapping based on the parsimony principle further indicated that the loss of the accD gene and clpP introns, the pseudogenization of four ycf genes, and the two rearrangements occurred only once after the most recent common ancestor of the Poaceae diverged from other monocots, which could explain the unusual long branch leading to the Poaceae when phylogeny is inferred based on chloroplast sequences.	[Huang, Ya-Yi; Cho, Shu-Ting; Haryono, Mindia; Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei, Taiwan	Kuo, CH (reprint author), Acad Sinica, Inst Plant & Microbial Biol, Taipei, Taiwan.	chk@gate.sinica.edu.tw			Institute of Plant and Microbial Biology at Academia Sinica	This study is supported by the Institute of Plant and Microbial Biology at Academia Sinica. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; BALDAUF SL, 1990, P NATL ACAD SCI USA, V87, P5317, DOI 10.1073/pnas.87.14.5317                                                         ; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573                                                            ; BUBUNENKO MG, 1994, J MOL BIOL, V240, P28, DOI 10.1006/jmbi.1994.1415; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen HY, 2011, J INTEGR PLANT BIOL, V53, P961, DOI 10.1111/j.1744-7909.2011.01082.x; Cheon KS, 2016, MITOCHONDRIAL DNA A, V27, P2169, DOI 10.3109/19401736.2014.982610; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; CLARK LG, 1995, SYST BOT, V20, P436, DOI 10.2307/2419803                                                                 ; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; COZENS AL, 1986, BIOCHEM J, V236, P453, DOI 10.1042/bj2360453                                                               ; Downie SR, 1996, SYST BOT, V21, P135, DOI 10.2307/2419744; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; Fang MF, 2016, MITOCHONDRIAL DNA A, V27, P2732, DOI 10.3109/19401736.2015.1046169; Sanchez-Ken JG, 2010, AM J BOT, V97, P1732, DOI 10.3732/ajb.1000024; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; HARLAN JR, 1969, CROP SCI, V9, P774, DOI 10.2135/cropsci1969.0011183X000900060031x                                       ; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880                                                              ; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; HUDSON GS, 1988, J MOL BIOL, V200, P639, DOI 10.1016/0022-2836(88)90477-9; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; KATAYAMA H, 1993, CURR GENET, V23, P160, DOI 10.1007/BF00352016                                                              ; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920                                              ; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068518; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P716, DOI 10.1093/nar/gkg155; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McNeal JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005982; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Raman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141329; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rousseau-Gueutin M, 2015, MOL PHYLOGENET EVOL, V93, P5, DOI 10.1016/j.ympev.2015.06.013; SASAKI Y, 1993, J BIOL CHEM, V268, P25118; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0567-4; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Su HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113049; Uthaipaisanwong P, 2012, GENE, V500, P172, DOI 10.1016/j.gene.2012.03.061; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wallace RS, 1996, CURR GENET, V29, P275; Way AG, 2014, AGR HIST, V88, P354, DOI 10.3098/ah.2014.88.3.354; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020596	54	1	1	13	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179055	10.1371/journal.pone.0179055				16	Multidisciplinary Sciences	Science & Technology - Other Topics	EX6PQ	WOS:000403364600020	28617867	gold			2018-01-05	
J	Rahman, S; Magnussen, M; Leon, TE; Farah, N; Li, ZD; Abraham, BJ; Alapi, KZ; Mitchell, RJ; Naughton, T; Fielding, AK; Pizzey, A; Bustraan, S; Allen, C; Popa, T; Pike-Overzet, K; Garcia-Perez, L; Gale, RE; Linch, DC; Staal, FJT; Young, RA; Look, AT; Mansour, MR				Rahman, Sunniyat; Magnussen, Michael; Leon, Theresa E.; Farah, Nadine; Li, Zhaodong; Abraham, Brian J.; Alapi, Krisztina Z.; Mitchell, Rachel J.; Naughton, Tom; Fielding, Adele K.; Pizzey, Arnold; Bustraan, Sophia; Allen, Christopher; Popa, Teodora; Pike-Overzet, Karin; Garcia-Perez, Laura; Gale, Rosemary E.; Linch, David C.; Staal, Frank J. T.; Young, Richard A.; Look, A. Thomas; Mansour, Marc R.			Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia	BLOOD			English	Article							TRANSGENIC MICE; GENE-THERAPY; EXPRESSION; TRANSLOCATIONS; REARRANGEMENT; MUTATIONS; SCID-X1; RBTN2	Somatic mutations within noncoding genomic regions that aberrantly activate oncogenes have remained poorly characterized. Here we describe recurrent activating intronic mutations of LMO2, a prominent oncogenein T-cell acute lymphoblastic leukemia (T-ALL). Heterozygous mutations were identified in PF-382 and DU.528 T-ALL cell lines in addition to 3.7% of pediatric (6 of 160) and 5.5% of adult (9 of 163) T-ALL patient samples. The majority of indels harbor putative de novo MYB, ETS1, or RUNX1 consensus binding sites. Analysis of 5'-capped RNA transcripts in mutant cell lines identified the usage of an intermediate promoter site, with consequential monoallelic LMO2 overexpression. CRISPR/Cas9-mediated disruption of the mutant allele in PF-382 cells markedly downregulated LMO2 expression, establishing clear causality between the mutation and oncogene dysregulation. Furthermore, the spectrum of CRISPR/Cas9-derived mutations provides important insights into the interconnected contributions of functional transcription factor binding. Finally, these mutations occur in the same intronas retroviral integrationsites in gene therapy-inducedT-ALL, suggesting that such events occur at preferential sites in the noncoding genome.	[Rahman, Sunniyat; Magnussen, Michael; Leon, Theresa E.; Farah, Nadine; Alapi, Krisztina Z.; Mitchell, Rachel J.; Naughton, Tom; Fielding, Adele K.; Pizzey, Arnold; Bustraan, Sophia; Allen, Christopher; Popa, Teodora; Gale, Rosemary E.; Linch, David C.; Mansour, Marc R.] UCL, Inst Canc, Dept Haematol, 72 Huntley St, London WC1E 6BT, England; [Li, Zhaodong; Look, A. Thomas] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA; [Abraham, Brian J.; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Pike-Overzet, Karin; Garcia-Perez, Laura; Staal, Frank J. T.] Leiden Univ, Med Ctr, Dept Immunohematol, Leiden, Netherlands; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA USA; [Look, A. Thomas] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Mansour, MR (reprint author), UCL, Inst Canc, Dept Haematol, 72 Huntley St, London WC1E 6BT, England.	m.mansour@ucl.ac.uk			National Institutes of Health, National Cancer Institute [1R01CA176746-01, 5P01CA109901-08, 5P01CA68484]; Bloodwise and Gabrielle's Angels Foundation; Freemason's Grand Charity; Alex's Lemonade Stand Foundation for Childhood Cancer; Bloodwise; Medical Research Council (UK) [ISRCTN07355119]; Cancer Research UK [ISRCTN66541317]; Department of Health's National Institute of Health Research Biomedical Research Centre	This work was supported by National Institutes of Health, National Cancer Institute grants 1R01CA176746-01, 5P01CA109901-08, and 5P01CA68484 (A.T.L.), by Bloodwise and Gabrielle's Angels Foundation (M.R.M. and S.R.), by the Freemason's Grand Charity (M.M.), by Alex's Lemonade Stand Foundation for Childhood Cancer (Z.L.), by grants from Bloodwise (formerly known as Leukaemia and Lymphoma Research, UK) and the Medical Research Council (UK) for the UKALL2003 trial (ISRCTN07355119), and by Cancer Research UK for the UKALL14 trial (ISRCTN66541317). This work was undertaken at University College London, which receives funding from the Department of Health's National Institute of Health Research Biomedical Research Centre. B.J.A. is a Hope Funds for Cancer Research Grillo-Marxuach Family Fellow.	BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Chambers J, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150062; Chen S, 2011, LEUKEMIA, V25, P1632, DOI 10.1038/leu.2011.119; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; DONG WF, 1995, LEUKEMIA, V9, P1812; Farley EK, 2016, P NATL ACAD SCI USA, V113, P6508, DOI 10.1073/pnas.1605085113; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Ferrando AA, 2003, SEMIN HEMATOL, V40, P274, DOI 10.1053/S0037-1963(03)00195-1; FISCH P, 1992, ONCOGENE, V7, P2389; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819                                                                   ; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Larson RC, 1996, EMBO J, V15, P1021; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Molvaersmyr AK, 2010, NUCLEIC ACIDS RES, V38, P4970, DOI 10.1093/nar/gkq245; Navarro JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7094; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Van Vlierberghe P, 2008, LEUKEMIA, V22, P1434, DOI 10.1038/sj.leu.2405063; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wiekmeijer AS, 2016, EXP HEMATOL, V44, P838, DOI 10.1016/j.exphem.2016.06.002	27	4	5	5	5	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	JUN 15	2017	129	24					3221	3226		10.1182/blood-2016-09-742148				6	Hematology	Hematology	EX5VZ	WOS:000403312100013	28270453				2018-01-05	
J	Hori, I; Otomo, T; Nakashima, M; Miya, F; Negishi, Y; Shiraishi, H; Nonoda, Y; Magara, S; Tohyama, J; Okamoto, N; Kumagai, T; Shimoda, K; Yukitake, Y; Kajikawa, D; Morio, T; Hattori, A; Nakagawa, M; Ando, N; Nishino, I; Kato, M; Tsunoda, T; Saitsu, H; Kanemura, Y; Yamasaki, M; Kosaki, K; Matsumoto, N; Yoshimori, T; Saitoh, S				Hori, Ikumi; Otomo, Takanobu; Nakashima, Mitsuko; Miya, Fuyuki; Negishi, Yutaka; Shiraishi, Hideaki; Nonoda, Yutaka; Magara, Shinichi; Tohyama, Jun; Okamoto, Nobuhiko; Kumagai, Takeshi; Shimoda, Konomi; Yukitake, Yoshiya; Kajikawa, Daigo; Morio, Tomohiro; Hattori, Ayako; Nakagawa, Motoo; Ando, Naoki; Nishino, Ichizo; Kato, Mitsuhiro; Tsunoda, Tatsuhiko; Saitsu, Hirotomo; Kanemura, Yonehiro; Yamasaki, Mami; Kosaki, Kenjiro; Matsumoto, Naomichi; Yoshimori, Tamotsu; Saitoh, Shinji			Defects in autophagosome-lysosome fusion underlie Vici syndrome, a neurodevelopmental disorder with multisystem involvement	SCIENTIFIC REPORTS			English	Article							SENSORINEURAL HEARING-LOSS; OF-THE-LITERATURE; CORPUS-CALLOSUM; DEVELOPMENTAL DELAY; MUSCLE BIOPSY; MUTATION; EPG5; AGENESIS; NEURODEGENERATION; IMMUNODEFICIENCY	Vici syndrome (VICIS) is a rare, autosomal recessive neurodevelopmental disorder with multisystem involvement characterized by agenesis of the corpus callosum, cataracts, cardiomyopathy, combined immunodeficiency, developmental delay, and hypopigmentation. Mutations in EPG5, a gene that encodes a key autophagy regulator, have been shown to cause VICIS, however, the precise pathomechanism underlying VICIS is yet to be clarified. Here, we describe detailed clinical (including brain MRI and muscle biopsy) and genetic features of nine Japanese patients with VICIS. Genetic dissection of these nine patients from seven families identified 14 causative mutations in EPG5. These included five nonsense, two frameshift, three splicing, one missense, and one multi-exon deletion mutations, and two initiation codon variants. Furthermore, cultured skin fibroblasts (SFs) from two affected patients demonstrated partial autophagic dysfunction. To investigate the function of EPG5, siRNA based EPG5 knock-down, and CRISPR/Cas9 mediated EPG5 knock-out HeLa cells were generated. EPG5-depleted cells exhibited a complete block of autophagic flux caused by defective autophagosome-lysosome fusion. Unexpectedly, endocytic degradation was normal in both VICIS SFs and EPG5 depleted cells, suggesting that EPG5 function is limited to the regulation of autophagosome-lysosome fusion.	[Hori, Ikumi; Negishi, Yutaka; Hattori, Ayako; Ando, Naoki; Saitoh, Shinji] Nagoya City Univ, Dept Pediat & Neonatol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Otomo, Takanobu; Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Grad Sch Med, Osaka 5650871, Japan; [Otomo, Takanobu; Yoshimori, Tamotsu] Osaka Univ, Res Ctr Autophagy, Grad Sch Med, Osaka 5650871, Japan; [Nakashima, Mitsuko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo 1138510, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Lab Med Sci Math, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Shiraishi, Hideaki] Hokkaido Univ, Dept Pediat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Nonoda, Yutaka] Kitasato Univ, Dept Pediat, Sch Med, Sagamihara, Kanagawa 2520373, Japan; [Magara, Shinichi; Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Pediat, Epilepsy Ctr, Niigata 9502085, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Med Genet, Osaka 5941101, Japan; [Kumagai, Takeshi] Wakayama Med Univ, Dept Pediat, Wakayama 6418509, Japan; [Shimoda, Konomi] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1138655, Japan; [Yukitake, Yoshiya] Ibaraki Childrens Hosp, Dept Neonatol, Mito, Ibaraki 3114145, Japan; [Kajikawa, Daigo] Univ Tsukuba, Dept Child Hlth, Fac Med, Tsukuba, Ibaraki 3058576, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat, Fac Med, Tokyo 1138519, Japan; [Nakagawa, Motoo] Nagoya City Univ, Dept Radiol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878551, Japan; [Kato, Mitsuhiro] Showa Univ, Dept Pediat, Sch Med, Tokyo 1428666, Japan; [Saitsu, Hirotomo] Hamamatsu Univ Sch Med, Dept Biochem, Hamamatsu, Shizuoka 4313192, Japan; [Kanemura, Yonehiro] Osaka Natl Hosp, Inst Clin Res, Natl Hosp Org, Div Regenerat Med, Osaka 5400006, Japan; [Kanemura, Yonehiro] Osaka Natl Hosp, Natl Hosp Org, Dept Neurosurg, Osaka 5400006, Japan; [Yamasaki, Mami] Takatsuki Gen Hosp, Dept Neurosurg, Osaka 5691192, Japan; [Kosaki, Kenjiro] Keio Univ, Ctr Med Genet, Sch Med, Tokyo 1608582, Japan	Saitoh, S (reprint author), Nagoya City Univ, Dept Pediat & Neonatol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan.	ss11@med.nagoya-cu.ac.jp		Saitsu, Hirotomo/0000-0003-0723-0960; Nakagawa, Motoo/0000-0002-1075-731X; Saitoh, Shinji/0000-0001-6911-3351	Ministry of Health, Labour and Welfare of Japan; Research on Measures for Intractable Diseases; Comprehensive Research on Disability Health and Welfare; Strategic Research Program for Brain Science; Japanese Agency for Medical Research and Development; Initiative on Rare and Undiagnosed Diseases in Adults from the Japanese Agency for Medical Research and Development; Japanese Science and Technology Agency; Takeda Science Foundation; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP; Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science and Technology of Japan	We are extremely grateful to all the patients and their parents who took part in this study. This study was supported in part by grants for Research on Applying Health Technology from the Ministry of Health, Labour and Welfare of Japan (F.M., N.O., M.K., M.Y., K.Y., K.K., and S.S.); Research on Measures for Intractable Diseases (N.M.); Comprehensive Research on Disability Health and Welfare (N.M.); the Strategic Research Program for Brain Science (N.M.); the Initiative on Rare and Undiagnosed Diseases in Pediatrics from the Japanese Agency for Medical Research and Development (N.M.); the Initiative on Rare and Undiagnosed Diseases in Adults from the Japanese Agency for Medical Research and Development (N.M); a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (N.M); Grants-in-Aid for Scientific Research (T.O.); Grants-in-Aid for Scientific Research (B) (H. Saitsu.); Grants-in-Aid for Scientific Research (C) (M. Nakashima.); the fund for the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japanese Science and Technology Agency (N.M); and the Takeda Science Foundation (H. Saitsu., N.M.); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP (I.N.); Health and Labour Sciences Research Grants for Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (I.N.).	Al-Owain M, 2010, AM J MED GENET A, V152A, P1849, DOI 10.1002/ajmg.a.33421; Byrne S, 2016, BRAIN, V139, P765, DOI 10.1093/brain/awv393; Chiyonobu T, 2002, AM J MED GENET, V109, P61, DOI 10.1002/ajmg.10298; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; del Campo M, 1999, AM J MED GENET, V85, P479, DOI 10.1002/(SICI)1096-8628(19990827)85:5<479::AID-AJMG9>3.3.CO;2-4; Dionisi Vici C, 1988, Am J Med Genet, V29, P1; Ebrahimi-Fakhari D, 2016, BRAIN, V139, P317, DOI 10.1093/brain/awv371; Ehmke N, 2014, AM J MED GENET A, V164, P3170, DOI 10.1002/ajmg.a.36772; El-Kersh K, 2015, PEDIATRICS, V136, pE1390, DOI 10.1542/peds.2015-0297; Filloux FM, 2014, J PEDIAT OPHTH STRAB, V51, P214, DOI 10.3928/01913913-20140423-02; Finocchi A, 2012, AM J MED GENET A, V158A, P434, DOI 10.1002/ajmg.a.34244; Fujita A, 2016, J HUM GENET, V61, P835, DOI 10.1038/jhg.2016.54; HINDMAN J, 1972, CLIN CHEM, V18, P971; Huenerberg K, 2016, AM J MED GENET A, V170, P1343, DOI 10.1002/ajmg.a.37589; Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kane MS, 2016, BRAIN, V139, DOI 10.1093/brain/aww135; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451                                                               ; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Li XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067744; Maillard C, 2017, AM J MED GENET A, V173, P706, DOI 10.1002/ajmg.a.38061; Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x; McClelland V, 2010, AM J MED GENET A, V152A, P741, DOI 10.1002/ajmg.a.33296; Merlini L, 2014, NEUROMUSCULAR DISORD, V24, P546, DOI 10.1016/j.nmd.2014.03.009; Miyata R, 2007, AM J MED GENET A, V143A, P189, DOI 10.1002/ajmg.a.31584; Miyata R, 2014, AM J MED GENET A, V164, P3203, DOI 10.1002/ajmg.a.36753; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Okamoto N, 2014, J HUM GENET, V59, P639, DOI 10.1038/jhg.2014.80; Ozkale M, 2012, PEDIATR NEUROL, V47, P375, DOI 10.1016/j.pediatrneurol.2012.07.007; Rittie L, 2005, METH MOLEC MED, V117, P83; Rogers R. C., 2011, CASE REP GENET, V2011; Said E, 2012, AM J MED GENET A, V158A, P440, DOI 10.1002/ajmg.a.34273; Schell-Apacik CC, 2008, AM J MED GENET A, V146A, P2501, DOI 10.1002/ajmg.a.32476; Tasdemir S, 2016, AM J MED GENET A, V170, P220, DOI 10.1002/ajmg.a.37398; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Wang Z, 2016, MOL CELL, V63, P781, DOI 10.1016/j.molcel.2016.08.021; Zhao HY, 2013, J CELL BIOL, V200, P731, DOI 10.1083/jcb.201211014; Zhao YG, 2013, AUTOPHAGY, V9, P1258, DOI 10.4161/auto.24856	39	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 14	2017	7								3552	10.1038/s41598-017-02840-8				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EX5YG	WOS:000403318400106	28615637	gold			2018-01-05	
J	Mou, HW; Smith, JL; Peng, LT; Yin, H; Moore, J; Zhang, XO; Song, CQ; Sheel, A; Wu, QQ; Ozata, DM; Li, YX; Anderson, DG; Emerson, CP; Sontheimer, EJ; Moore, MJ; Weng, ZP; Xue, W				Mou, Haiwei; Smith, Jordan L.; Peng, Lingtao; Yin, Hao; Moore, Jill; Zhang, Xiao-Ou; Song, Chun-Qing; Sheel, Ankur; Wu, Qiongqiong; Ozata, Deniz M.; Li, Yingxiang; Anderson, Daniel G.; Emerson, Charles P.; Sontheimer, Erik J.; Moore, Melissa J.; Weng, Zhiping; Xue, Wen			CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion	GENOME BIOLOGY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; BETA-CATENIN GENE; MOUSE MODEL; IN-VIVO; CELLS; MUSCLE; MUTATIONS; NONSENSE; SYSTEM; CAS9	CRISPR is widely used to disrupt gene function by inducing small insertions and deletions. Here, we show that some single-guide RNAs (sgRNAs) can induce exon skipping or large genomic deletions that delete exons. For example, CRISPR-mediated editing of beta-catenin exon 3, which encodes an autoinhibitory domain, induces partial skipping of the in-frame exon and nuclear accumulation of beta-catenin. A single sgRNA can induce small insertions or deletions that partially alter splicing or unexpected larger deletions that remove exons. Exon skipping adds to the unexpected outcomes that must be accounted for, and perhaps taken advantage of, in CRISPR experiments.	[Mou, Haiwei; Smith, Jordan L.; Peng, Lingtao; Song, Chun-Qing; Sheel, Ankur; Ozata, Deniz M.; Sontheimer, Erik J.; Moore, Melissa J.; Xue, Wen] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Yin, Hao; Wu, Qiongqiong; Anderson, Daniel G.; Weng, Zhiping] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Moore, Jill; Zhang, Xiao-Ou; Li, Yingxiang; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Li, Yingxiang] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai, Peoples R China; [Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02142 USA; [Anderson, Daniel G.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Emerson, Charles P.] Univ Massachusetts, Sch Med, Dept Neurol, Wellstone Muscular Dystrophy Program, Worcester, MA 01605 USA; [Sontheimer, Erik J.; Xue, Wen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, 368 Plantat St, Worcester, MA 01605 USA	Moore, MJ; Xue, W (reprint author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.; Weng, ZP (reprint author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.; Weng, ZP (reprint author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.; Xue, W (reprint author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.; Moore, MJ (reprint author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.; Xue, W (reprint author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, 368 Plantat St, Worcester, MA 01605 USA.	Melissa.Moore@umassmed.edu; Zhiping.Weng@umassmed.edu; Wen.Xue@umassmed.edu			Skoltech Center; NCI in the MIT-Harvard Center of Cancer Nanotechnology Excellence [5-U54-CA151884-04]; China Scholarship Council [201506260151]; Chinese government; NIH [DP2HL137167, P01HL131471, R00CA169512, GM115911]; American Cancer Society [129056-RSG-16-093]; Lung Cancer Research Foundation	HY was supported by the Skoltech Center and the NCI in the MIT-Harvard Center of Cancer Nanotechnology Excellence (5-U54-CA151884-04). YL was supported by the China Scholarship Council (201506260151) and the Thousand Talent Plan funding to ZW from the Chinese government. This work was supported by grants from the NIH (DP2HL137167, P01HL131471, and R00CA169512 to WX; GM115911 to EJS), the American Cancer Society (129056-RSG-16-093), and the Lung Cancer Research Foundation to WX.	Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Burghes AHM, 2010, GENE DEV, V24, P1574, DOI 10.1101/gad.1961710; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iwao K, 1998, CANCER RES, V58, P1021; Kalantari R, 2016, NUCLEIC ACIDS RES, V44, P524, DOI 10.1093/nar/gkv1305; Kapahnke M, 2016, CELLS, V5, P45; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Li YX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0680-7; Liu HX, 2001, NAT GENET, V27, P55; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mou HW, 2017, P NATL ACAD SCI USA, V114, P3648, DOI 10.1073/pnas.1620861114; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Robinson-Hamm JN, 2016, HUM GENET, V135, P1029, DOI 10.1007/s00439-016-1725-z; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Singh G, 2015, ANNU REV BIOCHEM, V84, P325, DOI 10.1146/annurev-biochem-080111-092106; Song CQ, 2016, GASTROENTEROLOGY, V152; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	39	5	5	16	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	JUN 14	2017	18								108	10.1186/s13059-017-1237-8				8	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EX4XN	WOS:000403239100003	28615073	gold			2018-01-05	
J	Song, YN; Liu, TJ; Wang, Y; Deng, JC; Chen, M; Yuan, L; Lu, Y; Xu, YX; Yao, HB; Li, ZJ; Lai, LX				Song, Yuning; Liu, Tingjun; Wang, Yong; Deng, Jichao; Chen, Mao; Yuan, Lin; Lu, Yi; Xu, Yuxin; Yao, Haobin; Li, Zhanjun; Lai, Liangxue			Mutation of the Sp1 binding site in the 5 ' flanking region of SRY causes sex reversal in rabbits	ONCOTARGET			English	Article						Sp1; SRY; CRISPR/Cas9; sex reversed; Pathology Section	Y-CHROMOSOME; PROMOTER; MOUSE; GENE; EXPRESSION; EVOLUTION; DELETION; TALEN	Sex-determining region Y is a crucial gene that initiates male sex determination in mammals. Mutations of the Sp1-binding site in the 5' flanking region of SRY are associated with clinical male-to-female sex reversal syndrome, although such occurrences are rare and, until now, have not been reported in animal models. In this study, we mutated Sp1-binding sites in the 5' flanking region of the rabbit SRY gene using the CRISPR/Cas9 system. As expected, the SRY-Sp1 knockout rabbits had female external and internal genitalia and exhibited normal female copulatory behaviors, but they were infertile, and the adults displayed reduced follicles. Interestingly, we successfully obtained offspring from sex-reversed SRY-Sp1 knockout rabbits using embryo transfer. In summary, our study demonstrates that Sp1 is a major regulator in SRY gene transcription, and mutations of the Sp1 binding sites (Sp1-B and Sp1-C) in the 5' flanking region of SRY induce sex reversal in rabbits, which can be used as targets for clinical research of male-to-female sex reversal syndrome. Additionally, we provide the first evidence that sex reversal syndrome patients have the potential to become pregnant with the use of embryo transfer.	[Song, Yuning; Liu, Tingjun; Wang, Yong; Deng, Jichao; Chen, Mao; Yuan, Lin; Lu, Yi; Xu, Yuxin; Yao, Haobin; Li, Zhanjun; Lai, Liangxue] Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Changchun, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cells & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	Li, ZJ; Lai, LX (reprint author), Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Changchun, Peoples R China.; Lai, LX (reprint author), Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.; Lai, LX (reprint author), Chinese Acad Sci, Guangdong Prov Key Lab Stem Cells & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	lizj_1998@jlu.edu.cn; lai_liangxue@gibh.ac.cn			National Natural Science Foundation of China [31201080, 31272394]	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31201080 and 31272394).	Assumpcao JG, 2005, J ENDOCRINOL INVEST, V28, P651, DOI 10.1007/BF03347266                                                              ; Daniel-Carlier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060451; Desclozeaux M, 1998, BBA-GENE STRUCT EXPR, V1397, P247, DOI 10.1016/S0167-4781(98)00041-4                                                   ; Geraldes A, 2010, MOL BIOL EVOL, V27, P2437, DOI 10.1093/molbev/msq139; Grujicic NK, 2005, GENE, V344, P287, DOI 10.1016/j.gene.2004.11.006; Kato T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03136; Kaur G, 2010, BIOCHEM J, V430, P39, DOI 10.1042/BJ20091758; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lei N, 2004, MOL CELL BIOL, V24, P377, DOI 10.1128/MCB.24.1.377-388.2004; Poulat F, 1998, HUM MUTAT, pS192; Queney G, 2001, MOL BIOL EVOL, V18, P2169, DOI 10.1093/oxfordjournals.molbev.a003763                                           ; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189                                                           ; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Veitia R, 1997, HUM GENET, V99, P648, DOI 10.1007/s004390050422; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang Yu, 2014, Cell Regen (Lond), V3, P3, DOI 10.1186/2045-9769-3-3; Waters PD, 2007, SEMIN CELL DEV BIOL, V18, P389, DOI 10.1016/j.semcdb.2007.02.007	18	0	0	5	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUN 13	2017	8	24					38176	38183		10.18632/oncotarget.16979				8	Oncology; Cell Biology	Oncology; Cell Biology	EX5VX	WOS:000403311900013	28445127	green_published			2018-01-05	
J	Yu, JH; Alharbi, A; Shan, HC; Hao, YW; Snetsinger, B; Rauh, MJ; Yang, XL				Yu, Jihang; Alharbi, Adel; Shan, Hongchao; Hao, Yawei; Snetsinger, Brooke; Rauh, Michael J.; Yang, Xiaolong			TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1	ONCOTARGET			English	Article						Hippo; TAZ; ALDH1A1; lung cancer; cancer stem cells	ALDEHYDE DEHYDROGENASE 1A1; TUMOR-SUPPRESSOR; HIPPO PATHWAY; EXPRESSION; PROGRESSION; METASTASIS; THERAPIES; PROGNOSIS; ONCOGENE; SURVIVAL	Recent studies suggest that lung cancer stem cells (CSCs) may play major roles in lung cancer. Therefore, identification of lung CSC drivers may provide promising targets for lung cancer. TAZ is a transcriptional co-activator and key downstream effector of the Hippo pathway, which plays critical roles in various biological processes. TAZ has been shown to be overexpressed in lung cancer and involved in tumorigenicity of lung epithelial cells. However, whether TAZ is a driver for lung CSCs and tumor formation in vivo is unknown. In addition, the molecular mechanism underlying TAZ-induced lung tumorigenesis remains to be determined. In this study, we provided evidence that constitutively active TAZ (TAZ-S89A) is a driver for lung tumorigenesis in vivo in mice and formation of lung CSC. Further RNA-seq and qRT-PCR analysis identified Aldh1a1, a well-established CSC marker, as critical TAZ downstream target and showed that TAZ induces Aldh1a1 transcription by activating its promoter activity through interaction with the transcription factor TEAD. Most significantly, inhibition of ALDH1A1 with its inhibitor A37 or CRISPR gene knockout in lung cancer cells suppressed lung tumorigenic and CSC phenotypes in vitro, and tumor formation in mice in vivo. In conclusion, this study identified TAZ as a novel inducer of lung CSCs and the first transcriptional activator of the stem cell marker ALDH1A1. Most significantly, we identified ALDH1A1 as a critical meditator of TAZ-induced tumorigenic and CSC phenotypes in lung cancer. Our studies provided preclinical data for targeting of TAZ-TEAD-ALDH1A1 signaling to inhibit CSC-induced lung tumorigenesis in the future.	[Yu, Jihang; Alharbi, Adel; Shan, Hongchao; Hao, Yawei; Snetsinger, Brooke; Rauh, Michael J.; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Alharbi, Adel] Umm Al Qura Univ, Dept Lab Med, Mecca, Saudi Arabia	Yang, XL (reprint author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	yangx@queensu.ca			Canadian Institute of Health Research (CIHR) [119325]; Canadian Breast Cancer Foundation (CBCF), Canada; Canada Foundation for Innovation; Ontario Institute for Cancer Research; CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research; Queen's Graduate Studentship; Umm Al-Qura University in Saudi Arabia	This work was supported by grants from Canadian Institute of Health Research (CIHR#119325) and Canadian Breast Cancer Foundation (CBCF), Canada, to X.Y, and from the Canada Foundation for Innovation and Ontario Institute for Cancer Research to M.R. JY is supported by the CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research and Queen's Graduate Studentship. AA is supported by a Scholarship from Umm Al-Qura University in Saudi Arabia. We would like to thank Dr. Leda Raptis for providing the E10 cell line, Dr. John Rosssiter for pathological analysis, Dr. David lebrun and Ms Marina Lochhead for help in CHIP analysis, and Dr. David Berman for using the Applied Biosystems ViiA 7 Real-Time PCR System.	Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Brambilla E, 2009, EUR RESPIR J, V33, P1485, DOI 10.1183/09031936.00014009; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Codony-Servat J, 2016, TRANSL LUNG CANCER R, V5, P16, DOI 10.3978/j.issn.2218-6751.2016.01.01; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dawood S, 2014, ONCOLOGY-NY, V28, P1101; Dimou A, 2012, AM J PATHOL, V181, P1436, DOI 10.1016/j.ajpath.2012.06.037; Gao F, 2015, BIOCHEM BIOPH RES CO, V462, P91, DOI 10.1016/j.bbrc.2015.04.029; Hao J, 2013, J CELL PHYSL; Hao J, 2014, J CELL PHYSIOL, V229, P266, DOI 10.1002/jcp.24455; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200                                                          ; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Li Q, 2014, CELL PHYSIOL BIOCHEM, V33, P1, DOI 10.1159/000356645; Li X, 2012, J THORAC ONCOL, V7, P1235, DOI 10.1097/JTO.0b013e318257cc6d; Li XC, 2014, INT J ONCOL, V45, P1507, DOI 10.3892/ijo.2014.2544; Li YW, 2015, CELL CYCLE, V14, P146, DOI 10.4161/15384101.2014.967106; Liu Chenying, 2011, Int J Biochem Mol Biol, V2, P247; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Liu XW, 2016, ONCOTARGET, V7, P58516, DOI 10.18632/oncotarget.11305; Mohamed AD, 2015, BBA-REV CANCER, V1856, P121, DOI 10.1016/j.bbcan.2015.05.006; O'Flaherty JD, 2012, J THORAC ONCOL, V7, P1880, DOI 10.1097/JTO.0b013e31826bfbc6; Salah Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.53; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Visser-Grieve S, 2012, ONCOGENE, V31, P1189, DOI 10.1038/onc.2011.318; Wang J, 2014, CELL BIOCHEM BIOPHYS, V69, P389, DOI 10.1007/s12013-014-9844-4; Wang W, 2017, J CELL PHYSIOL, V232, P2829, DOI 10.1002/jcp.25706; Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b; Yeung B, 2016, INT J CANCER, V138, P533, DOI 10.1002/ijc.29457; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhao YL, 2015, INT J CANCER, V137, P2767, DOI 10.1002/ijc.29293; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	37	0	0	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUN 13	2017	8	24					38426	38443		10.18632/oncotarget.16430				18	Oncology; Cell Biology	Oncology; Cell Biology	EX5VX	WOS:000403311900032	28415606	green_published			2018-01-05	
J	Chen, W; He, WR; Cai, HB; Hu, BC; Zheng, CS; Ke, XL; Xie, L; Zheng, ZH; Wu, XX; Wang, HZ				Chen, Wen; He, Wenrong; Cai, Hongbing; Hu, Bicheng; Zheng, Caishang; Ke, Xianliang; Xie, Li; Zheng, Zhenhua; Wu, Xinxing; Wang, Hanzhong			A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer	ONCOTARGET			English	Article						A-to-I RNA editing; BLCAP gene; cervical carcinogenesis; STAT3; YXXQ motif	HUMAN BLADDER-CANCER; SIGNAL TRANSDUCER; INOSINE RNA; PROTEIN; CARCINOMA; APOPTOSIS; EXPRESSION; ADENOSINE; TARGETS; CELLS	Bladder cancer-associated protein (BLCAP) gene is a highly conserved gene with tumor-suppressor function in different carcinomas. It is also a novel ADAR-mediated editing substrate undergoes multiple A-to-I RNA editing events. Although the anti-tumorigenic role of BLCAP has been examined in preliminarily studies, the relationship between BLCAP function and A-to-I RNA editing in cervical carcinogenesis still require further exploration. Herein, we analyzed the coding sequence of BLCAP transcripts in 35 paired cervical cancer samples using high-throughput sequencing. Of note, editing levels of three novel editing sites were statistically different between cancerous and adjacent cervical tissues, and editing of these three sites was closely correlated. Moreover, two editing sites of BLCAP coding region were mapped-in the key YXXQ motif which can bind to SH2 domain of STAT3. Further studies revealed that BLCAP interacted with signal transducer and activator of transcription 3 (STAT3) and inhibited its phosphorylation, while A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer cell lines. Our findings reveal that A-to-I RNA editing events alter the genetically coded amino acid in BLCAP YXXQ motif, which drive the progression of cervical carcinogenesis through regulating STAT3 signaling pathway.	[Chen, Wen; Hu, Bicheng; Wu, Xinxing] Wuhan Univ, State Key Lab Virol, Inst Med Virol, Sch Basic Med Sci, Wuhan 430071, Peoples R China; [Zheng, Caishang; Ke, Xianliang; Xie, Li; Zheng, Zhenhua; Wang, Hanzhong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [He, Wenrong] Yangtze Univ, Dept Gynaecol & Obstet, Peoples Hosp Jingzhou 1, Jingzhou 434000, Peoples R China; [Cai, Hongbing] Wuhan Univ, Zhongnan Hosp, Dept Gynecol Oncol, Wuhan 430071, Peoples R China	Wu, XX (reprint author), Wuhan Univ, State Key Lab Virol, Inst Med Virol, Sch Basic Med Sci, Wuhan 430071, Peoples R China.; Zheng, ZH (reprint author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	zhengzh@wh.iov.cn; wuxinxing9755@163.com		zheng, zhen hua/0000-0002-4117-9364	National Natural Science Foundation of China [81072123, 30571955]; Youth Innovation Promotion Association of CAS [2016302]	We thank Doctor Min Zhao who kindly provided C33A cell lines. This work was supported by grants provided by the National Natural Science Foundation of China (No. 81072123 and No. 30571955) and Youth Innovation Promotion Association of CAS (2016302)	Chen CL, 2007, BRIT J CANCER, V96, P591, DOI 10.1038/sj.bjc.6603597; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Fan DG, 2011, EXP BIOL MED, V236, P1030, DOI 10.1258/ebm.2011.010315; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gromova I, 2002, INT J CANCER, V98, P539, DOI 10.1002/ijc.10244; Gromova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045967; Hu XD, 2015, CANCER LETT, V357, P510, DOI 10.1016/j.canlet.2014.12.006; Kamimura D, 2003, Rev Physiol Biochem Pharmacol, V149, P1; Kim BH, 2016, ARCH PHARM RES, V39, P1085, DOI 10.1007/s12272-016-0795-8; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Lin JP, 2009, J MOL GRAPH MODEL, V28, P347, DOI 10.1016/j.jmgm.2009.08.013; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Moreira JMA, 2010, MOL CELL PROTEOMICS, V9, P161, DOI 10.1074/mcp.M900294-MCP200; Nishimoto Y, 2008, NEUROSCI RES, V61, P201, DOI 10.1016/j.neures.2008.02.009; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Sekine Y, 2014, BIOL PHARM BULL, V37, P185, DOI 10.1248/bpb.b13-00421                                                           ; Shukla S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-282; Takemoto S, 2009, BRIT J CANCER, V101, P967, DOI 10.1038/sj.bjc.6605212; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Yao J, 2007, MOL CELL BIOCHEM, V297, P81, DOI 10.1007/s11010-006-9332-2; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang HF, 2014, CANCERS, V6, P1408, DOI 10.3390/cancers6031408; Zhao M, 2016, ONCOL REP, V35, P3050, DOI 10.3892/or.2016.4686; Zilberman DE, 2011, UROL ONCOL-SEMIN ORI, V29, P21, DOI 10.1016/j.urolonc.2008.11.006; Zuo ZH, 2006, TUMOR BIOL, V27, P221, DOI 10.1159/000093057	31	1	1	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUN 13	2017	8	24					39417	39429		10.18632/oncotarget.17034				13	Oncology; Cell Biology	Oncology; Cell Biology	EX5VX	WOS:000403311900111	28455960	green_published			2018-01-05	
J	Lou, DJ; Wang, HP; Liang, G; Yu, DQ				Lou, Dengji; Wang, Houping; Liang, Gang; Yu, Diqiu			OsSAPK2 Confers Abscisic Acid Sensitivity and Tolerance to Drought Stress in Rice	FRONTIERS IN PLANT SCIENCE			English	Article						SAPK2; abscisic acid (ABA); rice; CRISPR/Cas9 system; germination; drought tolerance; reactive oxygen species (ROS)	RESPONSIVE GENE-EXPRESSION; 2C PROTEIN PHOSPHATASES; ARABIDOPSIS-THALIANA; SNF1-RELATED PROTEIN-KINASE-2; SEED-GERMINATION; WATER-STRESS; SALT STRESS; KINASES; IDENTIFICATION; PLANTS	SNF 1-RELATED PROTEIN KINASE 2 (SnRK2) is a family of plant-specific protein kinases which is the key regulator of hyper-osmotic stress signaling and abscisic acid (ABA)-dependent development in various plants. Among the rice subclass-I and -II SnRK2s, osmotic stress/ABA-activated protein kinase 2 (SAPK2) may be the primary mediator of ABA signaling. However, SAPK2 has not been comprehensively characterized. In this study, we elucidated the functional properties of SAPK2 using loss-of- function mutants produced with the CRISPR/Cas9 system. The SAPK2 expression level was strongly upregulated by drought, high-salinity, and polyethylene glycol (PEG) treatments. The sapk2 mutants exhibited an ABA-insensitive phenotype during the germination and post-germination stages, suggesting that SAPK2 had a pivotal role related to ABA-mediated seed dormancy. The sapk2 mutants were more sensitive to drought stress and reactive oxygen species (ROS) than the wild-type plants, indicating that SAPK2 was important for responses to drought conditions in rice. An additional investigation revealed that SAPK2 increased drought tolerance in the following two ways: (i) by reducing water loss via the accumulation of compatible solutes, promoting stomatal closure, and upregulating the expression levels of stress-response genes such as OsRab16b, OsRab21, OsbZIP23, OsLEA3, OsOREB1 and slow anion channel (SLAC)-associated genes such as OsSLAC1 and OsSLAC7; (ii) by inducing the expression of antioxidant enzyme genes to promote ROS-scavenging abilities that will ultimately decrease ROS damages. Moreover, we also observed that SAPK2 significantly increased the tolerance of rice plants to salt and PEG stresses. These findings imply that SAPK2 is a potential candidate gene for future crop improvement studies.	[Lou, Dengji; Wang, Houping; Liang, Gang; Yu, Diqiu] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming, Peoples R China; [Lou, Dengji; Wang, Houping] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China	Yu, DQ (reprint author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming, Peoples R China.	ydq@xtbg.ac.cn	yu, diqiu/D-2011-2009		National Natural Science Foundation of China [U1202264]; Strategic Priority Research Program of the Chinese Academy of Sciences (Class A) [XDA08020203]; program for Innovative Research Team of Yunnan Province [2014HC017]	This work was supported by the National Natural Science Foundation of China (U1202264), the Strategic Priority Research Program of the Chinese Academy of Sciences (Class A) (XDA08020203), and the program for Innovative Research Team of Yunnan Province (2014HC017).	BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Chae MJ, 2007, PLANT MOL BIOL, V63, P151, DOI 10.1007/s11103-006-9079-x; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Das K., 2014, FRONT ENV SCI, V2, P53, DOI [10.3389/fenvs.2014.00053, DOI 10.3389/FENVS.2014.00053]; Dey A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0845-x; Diedhiou CJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-49; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fan XL, 2015, J INTEGR PLANT BIOL, V57, P1063, DOI 10.1111/jipb.12350; Farooq M, 2009, CRIT REV PLANT SCI, V28, P199, DOI 10.1080/07352680902952173; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; He H, 2014, PLANT PHYSIOL, V164, P853, DOI 10.1104/pp.113.228635; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jiang YJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00145; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Lee B, 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot4970, DOI 10.1101/PDB.PROT4970]; Liang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21451; Lin QB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8981; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; McLoughlin F, 2012, PLANT J, V72, P436, DOI 10.1111/j.1365-313X.2012.05089.x; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mizoguchi M, 2010, PLANT CELL PHYSIOL, V51, P842, DOI 10.1093/pcp/pcq041; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sopory SK, 1998, CRIT REV PLANT SCI, V17, P245, DOI 10.1080/07352689891304230                                                       ; Sun SJ, 2016, PLANTA, V243, P489, DOI 10.1007/s00425-015-2418-x; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Tian SJ, 2013, J EXP BOT, V64, P2063, DOI 10.1093/jxb/ert072; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Weiner JJ, 2010, CURR OPIN PLANT BIOL, V13, P495, DOI 10.1016/j.pbi.2010.09.007; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; YAMAGUCHISHINOZAKI K, 1990, PLANT MOL BIOL, V14, P29, DOI 10.1007/BF00015652; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhang L, 2011, J EXP BOT, V62, P4229, DOI 10.1093/jxb/err131; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang Z., 2013, BIO PROTOCOL, V3, pe817; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zong W, 2016, PLANT PHYSIOL, V171, P2810, DOI 10.1104/pp.16.00469	61	0	0	17	17	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	JUN 13	2017	8								993	10.3389/fpls.2017.00993				15	Plant Sciences	Plant Sciences	EX5TZ	WOS:000403306700002	28659944	gold			2018-01-05	
J	Khin, NC; Lowe, JL; Jensen, LM; Burgio, G				Khin, Nay Chi; Lowe, Jenna L.; Jensen, Lora M.; Burgio, Gaetan			No evidence for genome editing in mouse zygotes and HEK293T human cell line using the DNA-guided Natronobacterium gregoryi Argonaute (NgAgo)	PLOS ONE			English	Article								A recently published research article reported that the extreme halophile archaebacterium Natronobacterium gregoryi Argonaute enzyme (NgAgo) could cleave the cellular DNA under physiological temperature conditions in cell line and be implemented as an alternative to CRISPR/Cas9 genome editing technology. We assessed this claim in mouse zygotes for four loci (Sptb, Tet-1, Tet-2 and Tet-3) and in the human HEK293T cell line for the EMX1 locus. Over 100 zygotes were microinjected with nls-NgAgo-GK plasmid provided from Addgene and various concentrations of 5'-phosphorylated guide DNA (gDNA) from 2.5 ng/mu l to 50 ng/mu l and cultured to blastocyst stage of development. The presence of indels was verified using T7 endonuclease 1 assay (T7E1) and Sanger sequencing. We reported no evidence of successful editing of the mouse genome. We then assessed the lack of editing efficiency in HEK293T cell line for the EMX1 endogenous locus by monitoring the NgAgo protein expression level and the editing efficiency by T7E1 assay and Sanger sequencing. We reported that the NgAgo protein was expressed from 8 hours to a maximum expression at 48 hours post-transfection, confirming the efficient delivery of the plasmid and the gDNA but no evidence of successful editing of EMX1 target in all transfected samples. Together our findings indicate that we failed to edit using NgAgo.	[Khin, Nay Chi; Lowe, Jenna L.; Jensen, Lora M.; Burgio, Gaetan] Australian Natl Univ, Dept Immunol & Infect Dis, John Curtin Sch Med Res, Canberra, ACT, Australia	Burgio, G (reprint author), Australian Natl Univ, Dept Immunol & Infect Dis, John Curtin Sch Med Res, Canberra, ACT, Australia.	Gaetan.burgio@anu.edu.au		Burgio, Gaetan/0000-0002-7434-926X	National Collaborative Research Infrastructure (NCRIS) through Australian Phenomics Network in Australia	This work was supported from the National Collaborative Research Infrastructure (NCRIS) through the Australian Phenomics Network in Australia. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; Martinez-Galvez G, 2016, HUM GENE THER, V27, P419, DOI 10.1089/hum.2016.071; Qi Jialing, 2016, Cell Res, V26, P1349, DOI 10.1038/cr.2016.134; Richardson Lorna, 2014, Methods Mol Biol, V1092, P61, DOI 10.1007/978-1-60327-292-6_5; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	9	0	0	12	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178768	10.1371/journal.pone.0178768				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EX5IQ	WOS:000403274700012	28609472	gold			2018-01-05	
J	Kohlera, S; Wojcik, M; Xu, K; Dernburg, AF				Koehlera, Simone; Wojcik, Michal; Xu, Ke; Dernburg, Abby F.			Superresolution microscopy reveals the three-dimensional organization of meiotic chromosome axes in intact Caenorhabditis elegans tissue	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						meiosis; chromosome axis; superresolution microscopy; C. elegans; cohesin	SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAK; OPTICAL RECONSTRUCTION MICROSCOPY; SYNAPTONEMAL COMPLEX; C. ELEGANS; CHIASMA FORMATION; HOMOLOGOUS RECOMBINATION; MOUSE SPERMATOCYTES; LATERAL ELEMENT; PARTNER CHOICE	When cells enter meiosis, their chromosomes reorganize as linear arrays of chromatin loops anchored to a central axis. Meiotic chromosome axes form a platform for the assembly of the synaptonemal complex (SC) and play central roles in other meiotic processes, including homologous pairing, recombination, and chromosome segregation. However, little is known about the 3D organization of components within the axes, which include cohesin complexes and additional meiosis-specific proteins. Here, we investigate the molecular organization of meiotic chromosome axes in Caenorhabditis elegans through STORM (stochastic optical reconstruction microscopy) and PALM (photo-activated localization microscopy) superresolution imaging of intact germ-line tissue. By tagging one axis protein (HIM-3) with a photoconvertible fluorescent protein, we established a spatial reference for other components, which were localized using antibodies against epitope tags inserted by CRISPR/Cas9 genome editing. Using 3D averaging, we determined the position of all known components within synapsed chromosome axes to high spatial precision in three dimensions. We find that meiosis-specific HORMA domain proteins span a gap between cohesin complexes and the central region of the SC, consistent with their essential roles in SC assembly. Our data further suggest that the two different meiotic cohesin complexes are distinctly arranged within the axes: Although cohesin complexes containing the kleisin REC-8 protrude above and below the plane defined by the SC, complexes containing COH-3 or -4 kleisins form a central core, which may physically separate sister chromatids. This organization may help to explain the role of the chromosome axes in promoting interhomolog repair of meiotic double-strand breaks by inhibiting intersister repair.	[Koehlera, Simone; Dernburg, Abby F.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Koehlera, Simone; Dernburg, Abby F.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wojcik, Michal; Xu, Ke] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wojcik, Michal; Xu, Ke; Dernburg, Abby F.] Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Xu, Ke] Lawrence Berkeley Natl Lab, Div Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA; [Dernburg, Abby F.] Lawrence Berkeley Natl Lab, Div Biol Syst & Engn, Berkeley, CA 94720 USA	Dernburg, AF (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Dernburg, AF (reprint author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Xu, K (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Xu, K; Dernburg, AF (reprint author), Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Xu, K (reprint author), Lawrence Berkeley Natl Lab, Div Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA.; Dernburg, AF (reprint author), Lawrence Berkeley Natl Lab, Div Biol Syst & Engn, Berkeley, CA 94720 USA.	xuk@berkeley.edu; afdernburg@berkeley.edu		Kohler, Simone/0000-0002-1119-8855; Xu, Ke/0000-0002-2788-194X	NIH Office of Research Infrastructure Programs [P40 OD010440]; Human Frontier Science Program [LT000903/2013-C]; NSF Graduate Research Fellowship [DGE 1106400]; Pew Biomedical Scholars Award; Packard Fellowship for Science and Engineering; National Institutes of Health [R01 GM065591]; Howard Hughes Medical Institute	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by a postdoctoral fellowship of the Human Frontier Science Program (LT000903/2013-C) (to S.K.), an NSF Graduate Research Fellowship (DGE 1106400) (to M.W.), the Pew Biomedical Scholars Award and the Packard Fellowship for Science and Engineering (to K.X.), and National Institutes of Health Grant R01 GM065591 (to A.F.D.) and the Howard Hughes Medical Institute.	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4                                                   ; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Brar GA, 2009, MOL BIOL CELL, V20, P1030, DOI 10.1091/mbc.E08-06-0637; BRENNER S, 1974, GENETICS, V77, P71; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Couteau F, 2011, DEV CELL, V20, P353, DOI 10.1016/j.devcel.2011.01.015; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; DIETRICH AJJ, 1992, J STRUCT BIOL, V109, P196, DOI 10.1016/1047-8477(92)90031-5; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Ferdous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002507; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devce1.2007.11.016; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4                                                   ; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030                                                    ; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Hopkins J, 2014, PLOS GENET, V10; Horn HF, 2013, J CELL BIOL, V202, P1023, DOI 10.1083/jcb.201304004; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Ishiguro K, 2014, GENE DEV, V28, P594, DOI 10.1101/gad.237313.113; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kim Y, 2015, DEV CELL, V35, P247, DOI 10.1016/j.devcel.2015.09.021; Kim Y, 2014, DEV CELL, V31, P487, DOI 10.1016/j.devcel.2014.09.013; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Li XCL, 2011, GENETICS, V189, P71, DOI 10.1534/genetics.111.130674; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; NEBEL BR, 1962, CHROMOSOMA, V13, P272, DOI 10.1007/BF00577043; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Ortiz R, 2016, EXP CELL RES, V344, P22, DOI 10.1016/j.yexcr.2016.03.025; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Phillips CM, 2009, METHODS MOL BIOL, V558, P171, DOI 10.1007/978-1-60761-103-5_11; Phillips D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039539; Prakash K, 2015, P NATL ACAD SCI USA, V112, P14635, DOI 10.1073/pnas.1516928112; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Rog O, 2017, ELIFE, V6, DOI 10.7554/eLife.21455; Rong M, 2016, J REPROD DEVELOP, V62, P623, DOI 10.1262/jrd.2016-127; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Schucker K, 2015, P NATL ACAD SCI USA, V112, P2029, DOI 10.1073/pnas.1414814112; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Severson AF, 2014, ELIFE, V3, DOI 10.7554/eLife.03467; Severson AF, 2009, GENE DEV, V23, P1763, DOI 10.1101/gad.1808809; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Smolikov S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000088; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Suleiman H, 2013, ELIFE, V2, DOI 10.7554/eLife.01149; Syrjanen JL, 2014, ELIFE, V3, DOI 10.7554/eLife.02963; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/NMETH.1171; Tzur YB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001378; Uhlmann F, 1999, NATURE, V400, P37; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; Wang CJR, 2009, GENETICS, V183, P905, DOI 10.1534/genetics.109.108688; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; WESTERGA.M, 1970, CR TRAV LAB CARLSB, V37, P239; Winters T, 2014, EMBO J, V33, P1256, DOI 10.1002/embj.201387330; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Xu K, 2015, SPRINGER SERIES FLUO, P27; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; Zhang NG, 2009, CELL CYCLE, V8, P399, DOI 10.4161/cc.8.3.7586; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	82	1	1	10	12	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 13	2017	114	24					E4734	E4743		10.1073/pnas.1702312114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EX4BV	WOS:000403179300005	28559338	green_published			2018-01-05	
J	Wen, JG; Tao, WJ; Hao, SY; Zu, YL				Wen, Jianguo; Tao, Wenjing; Hao, Suyang; Zu, Youli			Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing	JOURNAL OF HEMATOLOGY & ONCOLOGY			English	Article						CRISPR/Cas9 genome editing; Hematopoietic stem/progenitor cell colonies; Sickle cell disease	GUIDED CAS9 NUCLEASES; MULTIPLE-MYELOMA; BETA-GLOBIN; BONE-MARROW; GENE; TARGET; TRANSPLANTATION; SPECIFICITY; MUTAGENESIS; GENERATION	Background: Sickle cell disease (SCD) is a disorder of red blood cells (RBCs) expressing abnormal hemoglobin-S (HbS) due to genetic inheritance of homologous HbS gene. However, people with the sickle cell trait (SCT) carry a single allele of HbS and do not usually suffer from SCD symptoms, thus providing a rationale to treat SCD. Methods: To validate gene therapy potential, hematopoietic stem cells were isolated from the SCD patient blood and treated with CRISPR/Cas9 approach. To precisely dissect genome-editing effects, erythroid progenitor cells were cloned from single colonies of CRISPR-treated cells and then expanded for simultaneous gene, protein, and cellular function studies. Results: Genotyping and sequencing analysis revealed that the genome-edited erythroid progenitor colonies were converted to SCT genotype from SCD genotype. HPLC protein assays confirmed reinstallation of normal hemoglobin at a similar level with HbS in the cloned genome-edited erythroid progenitor cells. For cell function evaluation, in vitro RBC differentiation of the cloned erythroid progenitor cells was induced. As expected, cell sickling assays indicated function reinstitution of the genome-edited offspring SCD RBCs, which became more resistant to sickling under hypoxia condition. Conclusions: This study is an exploration of genome editing of SCD HSPCs.	[Wen, Jianguo; Hao, Suyang; Zu, Youli] Houston Methodist Hosp, Houston Methodist Res Inst, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Tao, Wenjing] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	Zu, YL (reprint author), Houston Methodist Hosp, Houston Methodist Res Inst, Dept Pathol & Genom Med, Houston, TX 77030 USA.	yzu@houstonmethodist.org			Physician Academic Performance Award; Pathology Department Endowed Chair fund of Houston Methodist Hospital	This study was partially supported by the Physician Academic Performance Award and Pathology Department Endowed Chair fund of Houston Methodist Hospital.	Al-Mawali A, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0292-z; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhat VS, 2010, INDIAN J CLIN BIOCHE, V25, P435, DOI 10.1007/s12291-010-0053-7; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; England SJ, 2011, BLOOD, V117, P2708, DOI 10.1182/blood-2010-07-299743; Fabre L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002671; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hoban MD, 2016, MOL THER; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Ji P, 2011, TRENDS CELL BIOL, V21, P409, DOI 10.1016/j.tcb.2011.04.003; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; John Nitin, 2010, Oman Med J, V25, P3, DOI 10.5001/omj.2010.2; Lukusa AK, 2009, PEDIATR HEMAT ONCOL, V26, P186, DOI 10.1080/07357900902892780; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Payen E, 2012, HEMATOL-AM SOC HEMAT, P276, DOI 10.1182/asheducation-2012.1.276; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Romero Z, 2013, J CLIN INVEST; Sakashita K, 2015, LEUKEMIA, V29, P606, DOI 10.1038/leu.2014.239; Serjeant GR, 2010, BRIT J HAEMATOL, V151, P425, DOI 10.1111/j.1365-2141.2010.08419.x; Thompson LM, 2012, AM J HEALTH-SYST PH, V69, P1295, DOI 10.2146/ajhp110308; Wen J, 2016, LEUKEMIA, V30, P987, DOI 10.1038/leu.2015.216; Wen JG, 2015, INT J CANCER, V136, P991, DOI 10.1002/ijc.29078; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047	37	0	0	6	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-8722			J HEMATOL ONCOL	J. Hematol. Oncol.	JUN 13	2017	10								119	10.1186/s13045-017-0489-9				11	Oncology; Hematology	Oncology; Hematology	EX3RA	WOS:000403148600001	28610635	gold			2018-01-05	
J	Pina, A; Dal Corso, A; Caruso, M; Belvisi, L; Arosio, D; Zanella, S; Gasparri, F; Albanese, C; Cucchi, U; Fraietta, I; Marsiglio, A; Pignataro, L; Donati, D; Gennari, C				Pina, Arianna; Dal Corso, A.; Caruso, Michele; Belvisi, Laura; Arosio, Daniela; Zanella, Simone; Gasparri, Fabio; Albanese, Clara; Cucchi, Ulisse; Fraietta, Ivan; Marsiglio, Aurelio; Pignataro, Luca; Donati, Daniele; Gennari, Cesare			Targeting Integrin alpha(V)beta(3) with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario	CHEMISTRYSELECT			English	Article						CRISPR-Cas9 technology; alpha(V)beta(3)-integrin; internalization; RGD-drug conjugates; theranostic conjugates	BREAST-CANCER CELLS; IN-VIVO; DELIVERY-SYSTEMS; DRUG CONJUGATE; ANTIBODY; THERAPY; DESIGN; TUMORS; VITRO; PEPTIDOMIMETICS	Theranostic RGD-camptothecin conjugates, possessing a disulfide linker and a fluorescent naphthalimide moiety, were synthesized and biologically evaluated. The conjugates showed nanomolar affinity for the purified (V3)-integrin receptor. For antiproliferative assays, the U87 human glioblastoma were chosen as alpha(V)beta(3)-expressing cells, whereas a non alpha(V)beta(3)-expressing clone (U87 beta(3)-KO) was generated as negative control. Although the U87 beta(3)-KO cells treated with the conjugates showed a statistically significant reduced fluorescence intensity (in the range 7-12%) compared to the parental U87, internalization of the conjugates was clearly observed in both cell lines. Stability studies showed premature cleavage of the disulfide linker in the cell media, with consequent release of free camptothecin. Consistent with the results of the internalization and stability studies, the conjugates did not show significant selectivity against the U87 cells compared to the U87 beta(3)-KO clone.	[Pina, Arianna; Dal Corso, A.; Belvisi, Laura; Zanella, Simone; Pignataro, Luca; Gennari, Cesare] Univ Milan, Dipartimento Chim, Via C Golgi 19, I-20133 Milan, Italy; [Dal Corso, A.; Gasparri, Fabio; Albanese, Clara; Cucchi, Ulisse; Fraietta, Ivan; Marsiglio, Aurelio; Donati, Daniele] NMS, Via Pasteur 10, I-20014 Nerviano, Italy; [Arosio, Daniela] CNR, ISTM, Via C Golgi 19, I-20133 Milan, Italy	Gennari, C (reprint author), Univ Milan, Dipartimento Chim, Via C Golgi 19, I-20133 Milan, Italy.	cesare.gennari@unimi.it	Dal Corso, Alberto/R-7111-2016; Pignataro, Luca/K-1332-2015	Dal Corso, Alberto/0000-0003-4437-8307; Pignataro, Luca/0000-0002-7200-9720; PINA, ARIANNA/0000-0002-1644-8665	Milan University for PhD fellowships; Ministero dell'Universita e della Ricerca [20157WW5EH]	We thank Milan University for PhD fellowships (to A.P., A.D. C.,S.Z.). We also gratefully acknowledge Ministero dell'Universita e della Ricerca for financial support (PRIN project 20157WW5EH: Tumor- targeting peptidomimetics: synthesis and bio- medical applications).	Auzzas L, 2010, CURR MED CHEM, V17, P1255, DOI 10.2174/092986710790936301                                                      ; Bhuniya S., 2014, ANGEW CHEM, V126, P4558; Bhuniya S, 2014, ANGEW CHEM INT EDIT, V53, P4469, DOI 10.1002/anie.201311133; Brulisauer L, 2014, J CONTROL RELEASE, V195, P147, DOI 10.1016/j.jconrel.2014.06.012; Cazzamalli S, 2016, MOL CANCER THER, V15, P2926, DOI 10.1158/1535-7163.MCT-16-0283; Chari RVJ, 2014, ANGEW CHEM INT EDIT, V53, P3796, DOI 10.1002/anie.201307628; Chari R. V., 2014, ANGEW CHEM, V126, P3872; Cheetham AG, 2014, CHEM COMMUN, V50, P6039, DOI 10.1039/c3cc49453e; Colombo R, 2012, J MED CHEM, V55, P10460, DOI 10.1021/jm301058f; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Dal Corso A, 2016, CURR TOP MED CHEM, V16, P314, DOI 10.2174/1568026615666150701114343; Dal Corso A, 2015, CHEM-EUR J, V21, P6921, DOI 10.1002/chem.201500158; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Dao KL, 2012, BIOCONJUGATE CHEM, V23, P785, DOI 10.1021/bc200645n; DiJoseph JF, 2008, HEMATOLOGY M REPORTS, V5, P74; Eriste E, 2013, BIOCONJUGATE CHEM, V24, P305, DOI 10.1021/bc300370w; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Grogan TM, 2000, HUM PATHOL, V31, P475, DOI 10.1053/hp.2000.6546; Guzzetti I, 2013, ORG BIOMOL CHEM, V11, P3886, DOI 10.1039/c3ob40540k; Kellogg BA, 2011, BIOCONJUGATE CHEM, V22, P717, DOI 10.1021/bc100480a; Kirchner M., 2015, ANGEW CHEM, V127, P13710; Kirchner M, 2015, ANGEW CHEM INT EDIT, V54, P13508, DOI 10.1002/anie.201504741; Krall N., 2013, ANGEW CHEM, V125, P1424; Krall N., 2014, ANGEW CHEM, V126, P4315; Krall N, 2014, ANGEW CHEM INT EDIT, V53, P4231, DOI 10.1002/anie.201310709; Krall N, 2013, ANGEW CHEM INT EDIT, V52, P1384, DOI 10.1002/anie.201204631; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Lee MH, 2015, ACCOUNTS CHEM RES, V48, P2935, DOI 10.1021/acs.accounts.5b00406; Lee MH, 2012, J AM CHEM SOC, V134, P12668, DOI 10.1021/ja303998y; Legigan T., 2012, ANGEW CHEM, V124, P11774; Legigan T, 2012, ANGEW CHEM INT EDIT, V51, P11606, DOI 10.1002/anie.201204935; Mahato R, 2011, ADV DRUG DELIVER REV, V63, P659, DOI 10.1016/j.addr.2011.02.002; Marchini M, 2012, CHEM-EUR J, V18, P6195, DOI 10.1002/chem.201200457; Mingozzi M, 2014, ORG BIOMOL CHEM, V12, P3288, DOI 10.1039/c4ob00207e; Moncelet D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082777; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Quici S, 2015, J MED CHEM, V58, P2003, DOI 10.1021/jm501945w; Roy J, 2015, J MED CHEM, V58, P3094, DOI 10.1021/jm5018384; Roy S, 2017, CHEM COMMUN, V53, P4234, DOI 10.1039/c7cc00745k; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Soudy R, 2013, J MED CHEM, V56, P7564, DOI 10.1021/jm400647r; Thayer A. M., 2014, CHEM ENG NEWS, V92, P13; Vineberg JG, 2015, J MED CHEM, V58, P2406, DOI 10.1021/jm5019115; Vineberg JG, 2014, J MED CHEM, V57, P5777, DOI 10.1021/jm500631u; Vlahov IR, 2012, BIOCONJUGATE CHEM, V23, P1357, DOI 10.1021/bc2005522; Wang XN, 2011, MOL CANCER THER, V10, P1728, DOI 10.1158/1535-7163.MCT-11-0191; Wong PT, 2015, CHEM REV, V115, P3388, DOI 10.1021/cr5004634; Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103; Zanella S, 2017, CHEM-EUR J, V23, P7910, DOI 10.1002/chem.201701844; Zanella S, 2015, CHEMISTRYOPEN, V4, P633, DOI 10.1002/open.201500062; Zhao RY, 2011, J MED CHEM, V54, P3606, DOI 10.1021/jm2002958; Zheng ZB, 2005, BIOCONJUGATE CHEM, V16, P598, DOI 10.1021/bc0499634	52	1	1	6	6	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2365-6549			CHEMISTRYSELECT	ChemistrySelect	JUN 12	2017	2	17					4759	4766		10.1002/slct.201701052				8	Chemistry, Multidisciplinary	Chemistry	EY3PX	WOS:000403886100027					2018-01-05	
J	Natale, F; Rapp, A; Yu, W; Maiser, A; Harz, H; Scholl, A; Grulich, S; Anton, T; Horl, D; Chen, W; Durante, M; Taucher-Scholz, G; Leonhardt, H; Cardoso, MC				Natale, Francesco; Rapp, Alexander; Yu, Wei; Maiser, Andreas; Harz, Hartmann; Scholl, Annina; Grulich, Stephan; Anton, Tobias; Hoerl, David; Chen, Wei; Durante, Marco; Taucher-Scholz, Gisela; Leonhardt, Heinrich; Cardoso, M. Cristina			Identification of the elementary structural units of the DNA damage response	NATURE COMMUNICATIONS			English	Article							DOUBLE-STRAND-BREAK; HISTONE H2AX PHOSPHORYLATION; FLUORESCENCE MICROSCOPY; GAMMA-H2AX FOCI; HUMAN GENOME; X-RAY; REPAIR; CTCF; HETEROCHROMATIN; DYNAMICS	Histone H2AX phosphorylation is an early signalling event triggered by DNA double-strand breaks (DSBs). To elucidate the elementary units of phospho-H2AX-labelled chromatin, we integrate super-resolution microscopy of phospho-H2AX during DNA repair in human cells with genome-wide sequencing analyses. Here we identify phospho-H2AX chromatin domains in the nanometre range with median length of similar to 75 kb. Correlation analysis with over 60 genomic features shows a time-dependent euchromatin-to-heterochromatin repair trend. After X-ray or CRISPR-Cas9-mediated DSBs, phospho-H2AX-labelled heterochromatin exhibits DNA decondensation while retaining heterochromatic histone marks, indicating that chromatin structural and molecular determinants are uncoupled during repair. The phospho-H2AX nano-domains arrange into higher-order clustered structures of discontinuously phosphorylated chromatin, flanked by CTCF. CTCF knockdown impairs spreading of the phosphorylation throughout the 3D-looped nano-domains. Co-staining of phospho-H2AX with phospho-Ku70 and TUNEL reveals that clusters rather than nano-foci represent single DSBs. Hence, each chromatin loop is a nano-focus, whose clusters correspond to previously known phospho-H2AX foci.	[Natale, Francesco; Rapp, Alexander; Yu, Wei; Scholl, Annina; Grulich, Stephan; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany; [Maiser, Andreas; Harz, Hartmann; Anton, Tobias; Hoerl, David; Leonhardt, Heinrich] Ludwig Maximilians Univ Munchen, CIPSM, Dept Biol 2, D-82152 Martinsried, Germany; [Chen, Wei] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Durante, Marco; Taucher-Scholz, Gisela] GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, D-64291 Darmstadt, Germany; [Yu, Wei] Inst Pasteur, Immunol Dept, Lymphocyte Dev & Oncogenesis G5, F-75724 Paris 15, France; [Durante, Marco] Trento Inst Fundamental Phys & Applicat TIFPA INF, Via Sommarive 14, I-38123 Trento, Italy	Cardoso, MC (reprint author), Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany.	cardoso@bio.tu-darmstadt.de	Rapp, Alexander/F-5327-2012; Durante, Marco/L-4795-2017; Leonhardt, Heinrich/B-2791-2014	Rapp, Alexander/0000-0001-9108-3929; Durante, Marco/0000-0002-4615-553X; 	Deutsche Forschungsgemeinschaft [GRK1657/TP1B, GRK1657/TP1C, DFG CA198/8-1, DFG CA198/8-2]; Bundesministerium fur Bildung und Forschung [02NUK017D, 02S8355, 02NUK036D]; Beilsetein-Institute, NanoBiC collaboration	We are indebted to Dr Diana Pignalosa and Dr Sylvia Ritter for SKY analysis. This work was supported by grants of the Deutsche Forschungsgemeinschaft (GRK1657/TP1B to M.C.C.; GRK1657/TP1C to A.R.; DFG CA198/8-1 and 2 to M.C.C.), the Bundesministerium fur Bildung und Forschung Grants 02NUK017D and 02S8355 to M.C.C. and 02NUK036D to A.R. and the Beilsetein-Institute, NanoBiC collaboration.	Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Caron P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002460; Chaumeil J, 2012, CURR OPIN IMMUNOL, V24, P153, DOI 10.1016/j.coi.2012.01.003; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gonzalez-Sandoval A, 2015, CELL, V163, P1333, DOI 10.1016/j.cell.2015.10.066; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greinert R, 2012, NUCLEIC ACIDS RES, V40, P10263, DOI 10.1093/nar/gks824; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780                                                            ; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Lee CS, 2014, NAT STRUCT MOL BIOL, V21, P103, DOI 10.1038/nsmb.2737; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050                                                        ; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newman HC, 1997, INT J RADIAT BIOL, V71, P347; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Perez RL, 2016, FASEB J, V30, P2767, DOI 10.1096/fj.201500106R; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Plasschaert RN, 2014, NUCLEIC ACIDS RES, V42, P774, DOI 10.1093/nar/gkt910; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; R Core Team, 2014, R LANG ENV STAT COMP; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858                                                         ; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706.5715.2003; Savic V, 2009, CELL CYCLE, V8, P3285, DOI 10.4161/cc.8.20.9719                                                            ; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Solovei I, 2016, CURR OPIN CELL BIOL, V40, P47, DOI 10.1016/j.ceb.2016.02.014; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Tark-Dame M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003877; Tsantoulis PK, 2008, ONCOGENE, V27, P3256, DOI 10.1038/sj.onc.1210989; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061	52	2	2	15	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUN 12	2017	8								15760	10.1038/ncomms15760				18	Multidisciplinary Sciences	Science & Technology - Other Topics	EX2PC	WOS:000403067600001	28604675	gold			2018-01-05	
J	Jang, YJ; Seo, SO; Kim, SA; Li, L; Kim, TJ; Kim, SC; Jin, YS; Han, NS				Jang, Ye-Ji; Seo, Seung-Oh; Kim, Seul-Ah; Li, Ling; Kim, Tae-Jip; Kim, Sun Chang; Jin, Yong-Su; Han, Nam Soo			Elimination of the cryptic plasmid in Leuconostoc citreum by CRISPR/Cas9 system	JOURNAL OF BIOTECHNOLOGY			English	Article						CRISPR/Cas9; Lactic acid bacteria; Leuconostoc; Cryptic plasmid; Genetic engineering	LACTIC-ACID BACTERIA; COMPLETE GENOME SEQUENCE; FOOD-GRADE VECTOR; LACTOBACILLUS-REUTERI; SHUTTLE VECTOR; GENE; IMMUNITY; EXPRESSION; LACTATE; KIMCHI	Leuconostoc spp. are important lactic acid bacteria for the fermentation of foods. In particular, L. citreum strains isolated from various foods have been used as host strains for genetic and metabolic engineering studies. In order to develop a food-grade genetic engineering system, L. citreum CB2567 was isolated from Kimchi. However, the isolated bacterium contained a cryptic plasmid which was difficult to eliminate. As the existence of the plasmid might hinder strain engineering, we eliminated the plasmid using an RNA-guided DNA endonuclease CRISPR/Cas9 system. We demonstrated that a plasmid-free L. citreum CB2567 host strain could be efficiently constructed through a two-step procedure: 1) transformation of the "killer" plasmid expressing Cas9 endonuclease and a guide RNA (gRNA) targeting for a specific sequence in the cryptic plasmid, and 2) serial subculture without antibiotics for curing the killer plasmid. When the crude extract of L. citreum expressing Cas9 and the guide RNA was incubated with a PCR fragment containing the specific sequence recognized by the guide RNA, the PCR fragment was cleaved. Also, the cryptic plasmid pCB42 was successfully eliminated from the host strain after transforming the plasmid harboring Cas9 and the guide RNA. The Cas9 and gRNA expression plasmid used in this study can be applied for genome engineering purposes by additionally introducing an editing DNA template to repair the double strand DNA breakage caused by Cas9 in the genome of L. citreum. This study demonstrates the feasibility of developing CRISPR/Cas9-based genetic engineering tools to develop a safe host strain and construct food-grade lactic acid bacteria without residual antibiotic markers.	[Jang, Ye-Ji; Kim, Seul-Ah; Kim, Tae-Jip; Han, Nam Soo] Chungbuk Natl Univ, Div Anim Hort & Food Sci, Brain Korea Ctr Bioresource Dev 21, Chungbuk 28644, South Korea; [Seo, Seung-Oh; Jin, Yong-Su] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Seo, Seung-Oh; Jin, Yong-Su] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Li, Ling] Zhejiang Univ Sci & Technol, Sch Biol & Chem Engn, Zhejiang Prov Key Lab Chem & Bio Proc Technol Far, Hangzhou 310023, Zhejiang, Peoples R China; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea	Han, NS (reprint author), Chungbuk Natl Univ, Div Anim Hort & Food Sci, Brain Korea Ctr Bioresource Dev 21, Chungbuk 28644, South Korea.; Jin, YS (reprint author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.; Jin, YS (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	ysjin@illinois.edu; namsoo@cbnu.ac.kr	Kim, Sun Chang/C-2026-2011		Intelligent Synthetic Biology Center of the Global Frontier Project [NRF-2014M3A6A8066443]; National Research Foundation of Korea - Ministry of Science, ICT and Future Planning (MSIP) [NRF-2015R1A2A2A01007674]	This work was supported by the Intelligent Synthetic Biology Center of the Global Frontier Project (Grant no. NRF-2014M3A6A8066443) and by the National Research Foundation of Korea (Grant no. NRF-2015R1A2A2A01007674) funded by the Ministry of Science, ICT and Future Planning (MSIP).	Biet F, 1999, FEMS MICROBIOL LETT, V179, P375, DOI 10.1016/S0378-1097(99)00437-1; Biet F, 2002, APPL ENVIRON MICROB, V68, P6451, DOI 10.1128/AEM.68.12.6451-6456.2002; Cho SK, 2015, J MICROBIOL BIOTECHN, V25, P2100, DOI 10.4014/jmb.1505.05072; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eom HJ, 2008, J IND MICROBIOL BIOT, V35, P953, DOI 10.1007/s10295-008-0369-y; Eom HJ, 2007, INT J FOOD MICROBIOL, V117, P61, DOI 10.1016/j.ijfoodmicro.2007.02.027; Eom HJ, 2012, PLASMID, V67, P35, DOI 10.1016/j.plasmid.2011.11.003; Eom HJ, 2010, BIOTECHNOL BIOPROC E, V15, P946, DOI 10.1007/s12257-010-0089-9; Eom HJ, 2009, BIOTECHNOL LETT, V31, P1783, DOI 10.1007/s10529-009-0079-1; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hemme D, 2004, INT DAIRY J, V14, P467, DOI 10.1016/j.idairyj.2003.10.005; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jin Q, 2012, LETT APPL MICROBIOL, V55, P314, DOI 10.1111/j.1472-765X.2012.03300.x; Jin Q, 2009, J BIOTECHNOL, V144, P160, DOI 10.1016/j.jbiotec.2009.08.012; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim JF, 2008, J BACTERIOL, V190, P3093, DOI 10.1128/JB.01862-07; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Oh HM, 2010, J BACTERIOL, V192, P3844, DOI 10.1128/JB.00508-10; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Otgonbayar GE, 2011, J MICROBIOL BIOTECHN, V21, P968, DOI 10.4014/jmb.1105.05034; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Son YJ, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-015-0400-8; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; STILES ME, 1994, J DAIRY SCI, V77, P2718, DOI 10.3168/jds.S0022-0302(94)77214-3                                               ; Sun ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9322; Sung IK, 2012, BIOPROC BIOSYST ENG, V35, P715, DOI 10.1007/s00449-011-0651-7; van der Meulen SB, 2016, RNA BIOL, V13, P353, DOI 10.1080/15476286.2016.1146855; van Pijkeren JP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S10; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005	33	0	0	9	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1656	1873-4863		J BIOTECHNOL	J. Biotechnol.	JUN 10	2017	251						151	155		10.1016/j.jbiotec.2017.04.018				5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EW4KL	WOS:000402470300020	28433723				2018-01-05	
J	Strezoska, Z; Perkett, MR; Chou, ET; Maksimova, E; Anderson, EM; McClelland, S; Kelley, ML; Vermeulen, A; Smith, AV				Strezoska, Zaklina; Perkett, Matthew R.; Chou, Eldon T.; Maksimova, Elena; Anderson, Emily M.; McClelland, Shawn; Kelley, Melissa L.; Vermeulen, Annaleen; Smith, Anja van Brabant			High-content analysis screening for cell cycle regulators using arrayed synthetic crRNA libraries	JOURNAL OF BIOTECHNOLOGY			English	Article						CRISPR-Cas9; Gene editing; High-content analysis screen; Synthetic crRNA; Arrayed crRNA libraries; Cell cycle regulators	MALE GERM-CELLS; FUNCTIONAL GENOMICS; ESSENTIAL GENES; RNAI SCREENS; CRISPR/CAS9; SYSTEMS; KINASES; CANCER; TRANSCRIPTS; ALIGNMENT	The CRISPR-Cas9 system has been utilized for large-scale, loss-of-function screens mainly using lentiviral pooled formats and cell-survival phenotypic assays. Screening in an arrayed format expands the types of phenotypic readouts that can be used to now include high-content, morphology-based assays, and with the recent availability of synthetic crRNA libraries, new studies are emerging. Here, we use a cell cycle reporter cell line to perform an arrayed, synthetic crRNA: tracrRNA screen targeting 169 genes (> 600 crRNAs) and used high content analysis (HCA) to identify genes that regulate the cell cycle. Seven parameters were used to classify cells into cell cycle categories and multiple parameters were combined using a new analysis technique to identify hits. Comprehensive hit follow-up experiments included target gene expression analysis, confirmation of DNA insertions/deletions, and validation with orthogonal reagents. Our results show that most hits had three or more independent crRNAs per gene that demonstrated a phenotype with consistent individual parameters, indicating that our screen produced high-confidence hits with low off-target effects and allowed us to identify hits with more subtle phenotypes. The results of our screen demonstrate the power of using arrayed, synthetic crRNAs for functional phenotypic screening using multiparameter HCA assays.	[Strezoska, Zaklina; Perkett, Matthew R.; Chou, Eldon T.; Maksimova, Elena; Anderson, Emily M.; McClelland, Shawn; Kelley, Melissa L.; Vermeulen, Annaleen; Smith, Anja van Brabant] Dharmacon, Lafayette, CO 80026 USA	Smith, AV (reprint author), Dharmacon, Lafayette, CO 80026 USA.	anja.smith@ge.com					Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Andrews S, 2017, FASTQC QUALITY CONTR; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Loukil Abdelhalim, 2015, World J Biol Chem, V6, P346, DOI 10.4331/wjbc.v6.i4.346; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mazumder S, 2007, CELL CYCLE, V6, P1437; McCleland ML, 2016, J CLIN INVEST, V126, P639, DOI 10.1172/JCI83265; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Okayama H, 2012, J BIOCHEM, V152, P297, DOI 10.1093/jb/mvs083; Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987; Schonenberger F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0618-9; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tigan AS, 2016, ONCOGENE, V35, P3083, DOI 10.1038/onc.2015.407; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaid R, 2016, PROTEIN PEPTIDE LETT, V23, P185, DOI 10.2174/092986652302160105143348; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wang T., 2016, COLD SPRING HARB PRO; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Wolgemuth DJ, 2004, INT J ANDROL, V27, P192, DOI 10.1111/j.1365-2605.2004.00480.x                                                ; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	46	1	1	3	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1656	1873-4863		J BIOTECHNOL	J. Biotechnol.	JUN 10	2017	251						189	200		10.1016/j.jbiotec.2017.04.017				12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EW4KL	WOS:000402470300026	28445693	gold			2018-01-05	
J	Mirra, V; Werner, C; Santamaria, F				Mirra, Virginia; Werner, Claudius; Santamaria, Francesca			Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment Strategies	FRONTIERS IN PEDIATRICS			English	Review						primary ciliary dyskinesia; Kartagener's syndrome; bronchiectasis; ciliopathy; mucociliary clearance	CYSTIC-FIBROSIS BRONCHIECTASIS; NASAL NITRIC-OXIDE; RANDOMIZED CONTROLLED-TRIAL; RADIAL-SPOKE DEFECTS; MUCOCILIARY CLEARANCE DISORDER; DYNEIN REGULATORY COMPLEX; CONGENITAL HEART-DISEASE; SITUS-INVERSUS TOTALIS; MULTIPLE MOTILE CILIA; GROWTH-FACTOR-I	Primary ciliary dyskinesia (PCD) is an orphan disease (MIM 244400), autosomal recessive inherited, characterized by motile ciliary dysfunction. The estimated prevalence of PCD is 1: 10,000 to 1: 20,000 live-born children, but true prevalence could be even higher. PCD is characterized by chronic upper and lower respiratory tract disease, infertility/ectopic pregnancy, and situs anomalies, that occur in approximate to 50% of PCD patients (Kartagener syndrome), and these may be associated with congenital heart abnormalities. Most patients report a daily year-round wet cough or nose congestion starting in the first year of life. Daily wet cough, associated with recurrent infections exacerbations, results in the development of chronic suppurative lung disease, with localized-to-diffuse bronchiectasis. No diagnostic test is perfect for confirming PCD. Diagnosis can be challenging and relies on a combination of clinical data, nasal nitric oxide levels plus cilia ultrastructure and function analysis. Adjunctive tests include genetic analysis and repeated tests in ciliary culture specimens. There are currently 33 known genes associated with PCD and correlations between genotype and ultrastructural defects have been increasingly demonstrated. Comprehensive genetic testing may hopefully screen young infants before symptoms occur, thus improving survival. Recent surprising advances in PCD genetic designed a novel approach called "gene editing" to restore gene function and normalize ciliary motility, opening up new avenues for treating PCD. Currently, there are no data from randomized clinical trials to support any specific treatment, thus, management strategies are usually extrapolated from cystic fibrosis. The goal of treatment is to prevent exacerbations, slowing the progression of lung disease. The therapeutic mainstay includes airway clearance maneuvers mainly with nebulized hypertonic saline and chest physiotherapy, and prompt and aggressive administration of antibiotics. Standardized care at specialized centers using a multidisciplinary approach that imposes surveillance of lung function and of airway biofilm composition likely improves patients' outcome. Pediatricians, neonatologists, pulmonologists, and ENT surgeons should maintain high awareness of PCD and refer patients to the specialized center before sustained irreversible lung damage develops. The recent creation of a network of PCD clinical centers, focusing on improving diagnosis and treatment, will hopefully help to improve care and knowledge of PCD patients.	[Mirra, Virginia; Santamaria, Francesca] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Mirra, Virginia; Santamaria, Francesca] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Werner, Claudius] Univ Childrens Hosp Muenster, Dept Gen Pediat, Munster, Germany	Santamaria, F (reprint author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.; Santamaria, F (reprint author), Univ Naples Federico II, Dept Pediat, Naples, Italy.	santamar@unina.it					Abete P, 2013, EUR J CLIN INVEST, V43, P1097, DOI 10.1111/eci.12131; Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; AFZELIUS BA, 1981, AM J HUM GENET, V33, P852; AFZELIUS BA, 1976, SCIENCE, V193, P317, DOI 10.1126/science.1084576; Alanin MC, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.020; Altenburg J, 2013, JAMA-J AM MED ASSOC, V309, P1251, DOI 10.1001/jama.2013.1937; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P912, DOI DOI 10.1164/RCCM.200406-710ST; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Behan L, 2016, EUR RESPIR J, V48, P1096, DOI 10.1183/13993003.02018-2015; Bhatt JM, 2013, EUR RESPIR REV, V22, P205, DOI 10.1183/09059180.00006512; Bilton D, 2014, THORAX, V69, P1073, DOI 10.1136/thoraxjnl-2014-205587; Boaretto F, 2016, J MOL DIAGN, V18, P912, DOI 10.1016/j.jmoldx.2016.07.002; Boe J, 2001, EUR RESPIR J, V18, P228; Boon M, 2015, THORAX, V70, P339, DOI 10.1136/thoraxjnl-2014-206578; Boon M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5418; Boon M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-11; Bradley J, 2002, COCHRANE DB SYST REV, V3; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown DE, 2008, PEDIATR PULM, V43, P514, DOI 10.1002/ppul.20792; Bush A, 1998, EUR RESPIR J, V12, P982, DOI 10.1183/09031936.98.12040982; Bush A, 2012, EXPERT REV RESP MED, V6, P663, DOI [10.1586/ERS.12.60, 10.1586/ers.12.60]; Campbell R, 2012, CURR OPIN ALLERGY CL, V12, P32, DOI 10.1097/ACI.0b013e32834eccc6; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-1; Chang CC, 2007, COCHRANE DB SYST REV, V2, DOI 10.1002/14651858.CD006218.pub2; Chang CC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006316.pub3; CHERNICK WS, 1959, PEDIATRICS, V24, P739; Cohen-Cymberknoh M, 2014, CHEST, V145, P738, DOI 10.1378/chest.13-1162; COLE PJ, 1986, EUR J RESPIR DIS, V69, P6; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; Davis SD, 2015, AM J RESP CRIT CARE, V191, P316, DOI 10.1164/rccm.201409-1672OC; Daviskas E, 2013, EXPERT REV RESP MED, V7, P65, DOI [10.1586/ERS.12.72, 10.1586/ers.12.72]; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; Desai M, 1995, PEDIATR PULM, V20, P307, DOI 10.1002/ppul.1950200509                                                         ; Deuse T, 2009, ANN THORAC SURG, V88, P1002, DOI 10.1016/j.athoracsur.2009.01.060; Eastham KM, 2004, THORAX, V59, P324, DOI 10.1136/thx.2003.011577; El-Abiad NM, 2007, RESP MED, V101, P2224, DOI 10.1016/j.rmed.2007.05.014; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; Elkins MR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003147.pub3; Ellerman A, 1997, EUR RESPIR J, V10, P2376, DOI 10.1183/09031936.97.10102376; Fedakar A, 2011, TURKISH J PEDIATR, V53, P173; Ferkol T, 2006, SEMIN PERINATOL, V30, P335, DOI 10.1053/j.semperi.2005.11.001; Ferkol TW, 2013, J PEDIATR-US, V163, P383, DOI 10.1016/j.jpeds.2013.01.061; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Fretzayas Andrew, 2016, World J Clin Pediatr, V5, P57, DOI 10.5409/wjcp.v5.i1.57; Frommer A, 2015, AM J RESP CELL MOL, V53, P563, DOI 10.1165/rcmb.2014-0483OC; Fuchs SI, 2012, PEDIATR PULM, V47, P649, DOI 10.1002/ppul.21610; Gokdemir Y, 2014, PEDIATR PULM, V49, P611, DOI 10.1002/ppul.22861; Goutaki M, 2016, EUR RESPIR J, V48, P1081, DOI 10.1183/13993003.00736-2016; Halbert SA, 1997, HUM REPROD, V12, P55, DOI 10.1093/humrep/12.1.55; Hart A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002996.pub3; Hellinckx J, 1998, EUR J PEDIATR, V157, P422, DOI 10.1007/s004310050843; Hill AT, 2011, PRIM CARE RESP J, V20, P135, DOI 10.4104/pcrj.2011.00007; Horani A, 2016, PAEDIATR RESPIR REV, V18, P18, DOI 10.1016/j.prrv.2015.09.001; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; Irving SJ, 2013, AM J RESP CRIT CARE, V188, P545, DOI 10.1164/rccm.201304-0800OC; Jeanson L, 2015, AM J HUM GENET, V97, P153, DOI 10.1016/j.ajhg.2015.05.004; Kartagener M, 1933, BEITR KLIN ERFORSCH, V83, P489, DOI DOI 10.1007/BF02141468; Kellett F, 2011, RESP MED, V105, P1831, DOI 10.1016/j.rmed.2011.07.019; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kennedy MP, 2007, AM J ROENTGENOL, V188, P1232, DOI 10.2214/AJR.06.0965; Kennedy MP, 2006, CURR ALLERGY ASTHM R, V6, P513, DOI 10.1007/s11882-006-0030-7                                                       ; Kim HY, 2011, ALLERGY ASTHMA IMMUN, V3, P39, DOI 10.4168/aair.2011.3.1.39; King PT, 2012, REV RECENT CLIN TRIA, V7, P24, DOI 10.2174/157488712799363280; Knowles MR, 2014, AM J RESP CRIT CARE, V189, P707, DOI [10.1164/rccm.201311-20470C, 10.1164/rccm.201311-2047OC]; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kobbernagel HE, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0261-x; Konstan MW, 2012, J CYST FIBROS, V11, P78, DOI 10.1016/j.jcf.2011.10.003; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Kumar A, 2015, INDIAN PEDIATR, V52, P35, DOI 10.1007/s13312-015-0563-8                                                       ; Lai M, 2016, J MED GENET, V53, P242, DOI 10.1136/jmedgenet-2015-103539; Lebl J, 2001, ACTA PAEDIATR, V90, P868, DOI 10.1080/08035250152509564; Leigh Margaret W, 2013, Ann Am Thorac Soc, V10, P574, DOI 10.1513/AnnalsATS.201305-110OC; Lucas JSA, 2011, EUR RESPIR MONOGR, P201, DOI 10.1183/1025448x.10008310; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Lucas JS, 2014, ARCH DIS CHILD, V99, P850, DOI 10.1136/archdischild-2013-304831; Lucas Jane S, 2013, Ann Am Thorac Soc, V10, P645, DOI 10.1513/AnnalsATS.201309-328ED; MACCHIARINI P, 1994, J THORAC CARDIOV SUR, V108, P86; Mackerness Kathryn J., 2009, Pediatric Asthma Allergy & Immunology, V22, P163, DOI 10.1089/pai.2009.0022; Madsen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071409; Maglione M, 2014, PEDIATR PULM, V49, P1243, DOI 10.1002/ppul.22984; Maglione M, 2012, PEDIATR PULM, V47, P498, DOI 10.1002/ppul.21569; Manna A, 2015, PEDIATR PULM, V50, P85, DOI 10.1002/ppul.23094; Marks JH, 2007, PAEDIATR RESPIR REV, V8, P17, DOI 10.1016/j.prrv.2007.02.003; Marthin JK, 2011, EUR RESPIR J, V37, P559, DOI 10.1183/09031936.00032610; Marthin JK, 2010, AM J RESP CRIT CARE, V181, P1262, DOI 10.1164/rccm.200811-1731OC; Marthin JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057262; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; McManus I Christopher, 2003, BMC Pulm Med, V3, P4, DOI 10.1186/1471-2466-3-4; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mirra V, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0119-5; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Montella S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020296; Montella S, 2012, RESPIROLOGY, V17, P87, DOI 10.1111/j.1440-1843.2011.02067.x; Montella S, 2011, EUR J CLIN INVEST, V41, P1063, DOI 10.1111/j.1365-2362.2011.02501.x; Montella S, 2009, INVEST RADIOL, V44, P532, DOI 10.1097/RLI.0b013e3181b4c1ba; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; MOSSBERG B, 1978, SCAND J RESPIR DIS, V59, P55; Mullowney T, 2014, PEDIATRICS, V134, P1160, DOI 10.1542/peds.2014-0808; MUNRO NC, 1994, THORAX, V49, P684, DOI 10.1136/thx.49.7.684; Nakhleh N, 2012, CIRCULATION, V125, P2232, DOI 10.1161/CIRCULATIONAHA.111.079780; Nicolson CHH, 2012, RESP MED, V106, P661, DOI 10.1016/j.rmed.2011.12.021; Noone PG, 1999, AM J RESP CRIT CARE, V160, P144, DOI 10.1164/ajrccm.160.1.9806146                                                    ; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; O'Callaghan C, 2011, EUR RESPIR J, V38, P603, DOI 10.1183/09031936.00108410; O'Callaghan C, 2010, ARCH DIS CHILD, V95, P51, DOI 10.1136/adc.2009.158493; Oktem S, 2013, PEDIATR PULM, V48, P897, DOI 10.1002/ppul.22710; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Paff T, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01770-2016; Paff T, 2017, AM J HUM GENET, V100, P160, DOI 10.1016/j.ajhg.2016.11.019; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Patella V, 2015, Minerva Med, V106, P1; Phillips GE, 1998, EUR RESPIR J, V11, P1389, DOI 10.1183/09031936.98.11061389; PICOT R, 1978, THORAX, V33, P235, DOI 10.1136/thx.33.2.235; Pifferi M, 2011, EUR RESPIR J, V37, P566, DOI 10.1183/09031936.00068810; POTTER JL, 1969, AM REV RESPIR DIS, V99, P909; Pruliere-Escabasse V, 2010, ARCH OTOLARYNGOL, V136, P1121, DOI 10.1001/archoto.2010.183; Raidt J, 2014, EUR RESPIR J, V44, P1579, DOI 10.1183/09031936.00052014; Rogers D, 2005, CURR PAEDIAT, V15, P233; RUTLAND J, 1982, J CLIN PATHOL, V35, P357, DOI 10.1136/jcp.35.3.357; Sagel Scott D, 2011, Proc Am Thorac Soc, V8, P438, DOI 10.1513/pats.201103-024SD; Santamaria F, 2008, CHEST, V134, P351, DOI 10.1378/chest.07-2812; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.12273; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; Shah A, 2016, EUR RESPIR J, V48, P441, DOI 10.1183/13993003.00209-2016; Shapiro AJ, 2016, PEDIATR PULM, V51, P115, DOI 10.1002/ppul.23304; Shoemark A, 2012, J CLIN PATHOL, V65, P267, DOI 10.1136/jclinpath-2011-200415; Sommer JU, 2011, EUR ARCH OTO-RHINO-L, V268, P383, DOI 10.1007/s00405-010-1341-9; Spagnolo P, 2013, EUR RESPIR J, V42, P239, DOI 10.1183/09031936.00136712; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Stillwell PC, 2011, PEDIAT ALLER IMM PUL, V24, P191, DOI 10.1089/ped.2011.0099; STURGESS JM, 1984, PERSPECT PEDIAT PATH, V8, P133; Svobodova T, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/731423; ten Berge M, 1999, PEDIATR PULM, V27, P59; Valerio G, 2012, EUR J CLIN INVEST, V42, P617, DOI 10.1111/j.1365-2362.2011.02626.x; Walker WT, 2012, EUR RESPIR J, V40, P1024, DOI 10.1183/09031936.00176111; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Werner C, 2016, EUR RESPIR J, V47, P849, DOI 10.1183/13993003.00776-2015; Werner Claudius, 2015, Cilia, V4, P2, DOI 10.1186/s13630-014-0011-8; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; Yan- Wei S, 2014, ASIAN J ANDROL, V16, P101, DOI [10.4103/1008-682X.122192, DOI 10.4103/1008-682X.122192]; Zimmerman K, 2015, CELL, V161, P692, DOI [10.1016/j.cell.2015/04.015, 10.1016/j.cell.2015.04.015]	152	0	0	8	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	JUN 9	2017	5								135	10.3389/fped.2017.00135				13	Pediatrics	Pediatrics	EY1TH	WOS:000403748500002	28649564	gold			2018-01-05	
J	Chirieleison, SM; Marsh, RA; Kumar, P; Rathkey, JK; Dubyak, GR; Abbott, DW				Chirieleison, Steven M.; Marsh, Rebecca A.; Kumar, Prathna; Rathkey, Joseph K.; Dubyak, George R.; Abbott, Derek W.			Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; ALPHA-DEPENDENT APOPTOSIS; XIAP DEFICIENCY; CROHNS-DISEASE; STRUCTURAL BASIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; CARD15 MUTATIONS; LIGASE ACTIVITY; GENE-MUTATIONS	The X-linked inhibitor of apoptosis (XIAP) protein has been identified as a key genetic driver of two distinct inflammatory disorders, X-linked lymphoproliferative syndrome 2 (XLP-2) and very-early-onset inflammatory bowel disease (VEO-IBD). Molecularly, the role of XIAP mutations in the pathogenesis of these disorders is unclear. Recent work has consistently shown XIAP to be critical for signaling downstream of the Crohn's disease susceptibility protein nucleotide-binding oligomerization domain-containing 2 (NOD2); however, the reported effects of XLP-2 and VEO-IBD XIAP mutations on cell death have been inconsistent. In this manuscript, we describe a CRISPR-mediated genetic system for cells of the myeloid lineage in which XIAP alleles can be replaced with disease-associated XIAP variants expressed at endogenous levels to simultaneously study inflammation-related cell death and NOD2 signaling. We show that, consistent with previous studies, NOD2 signaling is critically dependent on the BIR2 domain of XIAP. We further used this system to reconcile the aforementioned inconsistent XIAP cell death data to show that XLP-2 and VEO-IBD XIAP mutations that exhibit a loss-of-function NOD2 phenotype also lower the threshold for inflammatory cell death. Last, we identified and studied three novel patient XIAP mutations and used this system to characterize NOD2 and cell death phenotypes driven by XIAP. The results of this work support the role of XIAP in mediating NOD2 signaling while reconciling the role of XLP-2 and VEO-IBD XIAP mutations in inflammatory cell death and provide a set of tools and framework to rapidly test newly discovered XIAP variants.	[Chirieleison, Steven M.; Kumar, Prathna; Rathkey, Joseph K.; Abbott, Derek W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Marsh, Rebecca A.] Cincinnati Childrens Hosp, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA	Abbott, DW (reprint author), Rm 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu		Chirieleison, Steven/0000-0002-3997-5652; Dubyak, George/0000-0001-9720-4226; Abbott, Derek/0000-0003-4387-8094	National Institutes of Health [R01 GM086550, P01 DK091222]; Case Western Reserve University National Institutes of Health Medical Scientist Training Program [T32 GM007250]; Case Western Reserve University Immunology Training Program [T32 AI089474]	This work was supported by National Institutes of Health Grants R01 GM086550 and P01 DK091222 (to D. W. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Case Western Reserve University National Institutes of Health Medical Scientist Training Program Grant T32 GM007250 and Case Western Reserve University Immunology Training Program Grant T32 AI089474.	Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Aguilar C, 2014, J ALLERGY CLIN IMMUN, V134, P1131, DOI 10.1016/j.jaci.2014.04.031; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chirieleison SM, 2016, J IMMUNOL, V196, P4291, DOI 10.4049/jimmunol.1502631; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901                                                                   ; Duan W, 2010, J ALLERGY CLIN IMMUN, V126, P1284, DOI 10.1016/j.jaci.2010.09.021; Duckett CS, 1996, EMBO J, V15, P2685; Dziadzio M, 2015, J CLIN IMMUNOL, V35, P439, DOI 10.1007/s10875-015-0166-0; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Flygare JA, 2012, J MED CHEM, V55, P4101, DOI 10.1021/jm300060k; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hehlio T, 2003, GUT, V52, P558; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsieh WC, 2014, BLOOD, V124, P2847, DOI 10.1182/blood-2014-03-564609; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(02)02075-5; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107                                                                ; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Jiang MY, 2016, EXP THER MED, V12, P1341, DOI 10.3892/etm.2016.3498; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925                                                    ; Marsh RA, 2013, BLOOD, V121, P877, DOI 10.1182/blood-2012-06-432500; Marsh RA, 2010, BLOOD, V116, P1079, DOI 10.1182/blood-2010-01-256099; Marsh RA, 2009, CYTOM PART B-CLIN CY, V76B, P334, DOI 10.1002/cyto.b.20473; Mufti AR, 2006, MOL CELL, V21, P775, DOI 10.1016/j.molcel.2006.01.033; Negroni A, 2009, INFLAMM BOWEL DIS, V15, P1145, DOI 10.1002/ibd.20907; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Prakash H, 2010, J BIOL CHEM, V285, P20291, DOI 10.1074/jbc.M109.096297; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Schurmann M, 2003, EUR RESPIR J, V22, P748, DOI 10.1183/09031936.03.00040602; Schwerd T, 2017, GUT, V66, P1060, DOI 10.1136/gutjnl-2015-310382; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Speckmann C, 2013, CLIN IMMUNOL, V149, P133, DOI 10.1016/j.clim.2013.07.004; Sun CH, 1999, NATURE, V401, P818; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tigno-Aranjuez JT, 2014, J BIOL CHEM, V289, P29651, DOI 10.1074/jbc.M114.591388; Tigno-Aranjuez JT, 2012, BBA-MOL CELL RES, V1823, P2022, DOI 10.1016/j.bbamcr.2012.03.017; Tsuma Y, 2015, PEDIATR TRANSPLANT, V19, pE25, DOI 10.1111/petr.12405; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yao QP, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3462; Zeissig Y, 2015, GUT, V64, P66, DOI 10.1136/gutjnl-2013-306520	68	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9666	9679		10.1074/jbc.M117.781500				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EX3DU	WOS:000403113000017	28404814				2018-01-05	
J	Guo, YX; VanDusen, NJ; Zhang, LN; Gu, WL; Sethi, I; Guatimosim, S; Ma, Q; Jardin, BD; Ai, YL; Zhang, DH; Chen, BY; Guo, A; Yuan, GC; Song, LS; Pu, WT				Guo, Yuxuan; VanDusen, Nathan J.; Zhang, Lina; Gu, Weiliang; Sethi, Isha; Guatimosim, Silvia; Ma, Qing; Jardin, Blake D.; Ai, Yulan; Zhang, Donghui; Chen, Biyi; Guo, Ang; Yuan, Guo-Cheng; Song, Long-Sheng; Pu, William T.			Analysis of Cardiac Myocyte Maturation Using CASAAV, a Platform for Rapid Dissection of Cardiac Myocyte Gene Function In Vivo	CIRCULATION RESEARCH			English	Article						alleles; gene silencing; heart failure; maturation; mutagenesis; transverse tubule	T-TUBULE; HEART-FAILURE; JUNCTOPHILIN-2; PROTEINS; ROLES; CARDIOMYOCYTES; MEMBRANE; FAMILY; MODEL; MICE	Rationale: Loss-of-function studies in cardiac myocytes (CMs) are currently limited by the need for appropriate conditional knockout alleles. The factors that regulate CM maturation are poorly understood. Previous studies on CM maturation have been confounded by heart dysfunction caused by whole organ gene inactivation. Objective: To develop a new technical platform to rapidly characterize cell-autonomous gene function in postnatal murine CMs and apply it to identify genes that regulate transverse tubules (T-tubules), a hallmark of mature CMs. Methods and Results: We developed CRISPR/Cas9/AAV9-based somatic mutagenesis, a platform in which AAV9 delivers tandem guide RNAs targeting a gene of interest and cardiac troponin-T promoter-driven Cre to Rosa(Cas9GFP/Cas9GFP) neonatal mice. When directed against junctophilin-2 (Jph2), a gene previously implicated in T-tubule maturation, we achieved efficient, rapid, and CM-specific JPH2 depletion. High-dose AAV9 ablated JPH2 in 64% CMs and caused lethal heart failure, whereas low-dose AAV9 ablated JPH2 in 22% CMs and preserved normal heart function. In the context of preserved heart function, CMs lacking JPH2 developed T-tubules that were nearly morphologically normal, indicating that JPH2 does not have a major, cell-autonomous role in T-tubule maturation. However, in hearts with severe dysfunction, both adeno-associated virus-transduced and nontransduced CMs exhibited T-tubule disruption, which was more severe in the transduced subset. These data indicate that cardiac dysfunction disrupts T-tubule structure and that JPH2 protects T-tubules in this context. We then used CRISPR/Cas9/AAV9-based somatic mutagenesis to screen 8 additional genes for required, cell-autonomous roles in T-tubule formation. We identified RYR2 (Ryanodine Receptor-2) as a novel, cell-autonomously required T-tubule maturation factor. Conclusions: CRISPR/Cas9/AAV9-based somatic mutagenesis is a powerful tool to study cell-autonomous gene functions. Genetic mosaics are invaluable to accurately define cell-autonomous gene function. JPH2 has a minor role in normal T-tubule maturation but is required to stabilize T-tubules in the failing heart. RYR2 is a novel T-tubule maturation factor.	[Guo, Yuxuan; VanDusen, Nathan J.; Ma, Qing; Jardin, Blake D.; Ai, Yulan; Zhang, Donghui; Pu, William T.] Boston Childrens Hosp, Cardiol, Boston, MA 02115 USA; [Zhang, Lina] Shanghai Univ Tradit Chinese Med, Inst Basic Med, Shanghai, Peoples R China; [Gu, Weiliang] Shanghai Univ Tradit Chinese Med, Pharmacol, Sch Pharm, Shanghai, Peoples R China; [Sethi, Isha; Yuan, Guo-Cheng] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA; [Guatimosim, Silvia] Univ Fed Minas Gerais, Physiol & Biophys, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Chen, Biyi; Guo, Ang; Song, Long-Sheng] Univ Iowa, Carver Coll Med, Francois M Abboud Cardiovasc Res Ctr, Dept Internal Med,Cardiovasc Med, Iowa City, IA USA; [Song, Long-Sheng] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Pu, William T.] Harvard Stem Cell Inst, Cambridge, MA USA	Pu, WT (reprint author), Boston Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	wpu@pulab.org		Sethi, Isha/0000-0001-7965-0150	National Heart, Lung, and Blood Institute [UM1 HL098166, R01 HL116461, U01HL131003]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais;  [R01HL090905];  [R01HL130464];  [T32HL007572];  [F32HL13423501]	The project was supported by UM1 HL098166, R01 HL116461, and U01HL131003 from the National Heart, Lung, and Blood Institute. L.-S. Song was supported by R01HL090905 and R01HL130464. N.J. VanDusen was supported by T32HL007572 and F32HL13423501. S. Guatimosim was a recipient of a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior fellowship and funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.	Beavers DL, 2014, CARDIOVASC RES, V103, P198, DOI 10.1093/cvr/cvu151; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen BY, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00134; Chen BY, 2013, CARDIOVASC RES, V100, P54, DOI 10.1093/cvr/cvt180; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Guo A, 2014, P NATL ACAD SCI USA, V111, P12240, DOI 10.1073/pnas.1412729111; Guo A, 2014, BIOPHYS J, V106, P2729, DOI 10.1016/j.bpj.2014.05.013; Guo YX, 2015, MOL BIOL CELL, V26, P3379, DOI 10.1091/mbc.E15-07-0482; Guo YX, 2014, MOL BIOL CELL, V25, P1287, DOI 10.1091/mbc.E13-11-0644; He A, 2010, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB2120S92; Hong TT, 2014, NAT MED, V20, P624, DOI 10.1038/nm.3543; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Landstrom AP, 2014, TRENDS MOL MED, V20, P353, DOI 10.1016/j.molmed.2014.02.004; Lin ZQ, 2014, CIRC RES, V115, P354, DOI 10.1161/CIRCRESAHA.115.303632; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; O'Connell TD, CARDIOVASCULAR PROTE, P271; Orchard C, 2008, CARDIOVASC RES, V77, P237, DOI 10.1093/cvr/cvm002; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Polakova E, 2013, CARDIOVASC RES, V98, P233, DOI 10.1093/cvr/cvt026; Prendiville TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128105; Reynolds JO, 2013, CARDIOVASC RES, V100, P44, DOI 10.1093/cvr/cvt133; Salle L, 2007, ARCH MAL COEUR VAISS, V100, P225; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309                                                        ; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558	35	7	7	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7330	1524-4571		CIRC RES	Circ.Res.	JUN 9	2017	120	12					1874	+		10.1161/CIRCRESAHA.116.310283				34	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	EX0RE	WOS:000402927700013	28356340	gold			2018-01-05	
J	Rychener, L; InAlbon, S; Djordjevic, SP; Chowdhury, PR; Ziech, RE; de Vargas, AC; Frey, J; Falquet, L				Rychener, Lorenz; InAlbon, Saria; Djordjevic, Steven P.; Chowdhury, Piklu R.; Ziech, Rosangela E.; de Vargas, Agueda C.; Frey, Joachim; Falquet, Laurent			Clostridium chauvoei, an Evolutionary Dead-End Pathogen	FRONTIERS IN MICROBIOLOGY			English	Article						Clostridium chauvoei; CRISPR; virulence genes; flagellin genes; blackleg; dead-end evolution	PHYLOGENETIC ANALYSIS; GENOMES; CATTLE; FLAGELLA; BLACKLEG; TOOL; NEURAMINIDASE; METAGENOMES; VIRULENCE; SIALIDASE	Full genome sequences of 20 strains of Clostridium chauvoei, the etiological agent of blackleg of cattle and sheep, isolated from four different continents over a period of 64 years (1951-2015) were determined and analyzed. The study reveals that the genome of the species C. chauvoei is highly homogeneous compared to the closely related species C. perfringens, a widespread pathogen that affects human and many animal species. Analysis of the CRISPR locus is sufficient to differentiate most C. chauvoei strains and is the most heterogenous region in the genome, containing in total 187 different spacer elements that are distributed as 30 - 77 copies in the various strains. Some genetic differences are found in the 3 allelic variants of fliC1, fliC2 and fliC3 genes that encode structural flagellin proteins, and certain strains do only contain one or two alleles. However, the major virulence genes including the highly toxic C. chauvoei toxin A, the sialidase and the two hyaluronidases are fully conserved as are the metabolic and structural genes of C. chauvoei. These data indicate that C. chauvoei is a strict ruminant-associated pathogen that has reached a dead end in its evolution.	[Rychener, Lorenz; InAlbon, Saria; Frey, Joachim] Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland; [Djordjevic, Steven P.; Chowdhury, Piklu R.] Univ Technol Sydney, Inst i3, Ultimo, NSW, Australia; [Ziech, Rosangela E.; de Vargas, Agueda C.] Univ Fed Santa Maria, Dept Prevent Vet Med, Santa Maria, RS, Brazil; [Falquet, Laurent] Univ Fribourg, Swiss Inst Bioinformat, Dept Biol, Fribourg, Switzerland	Frey, J (reprint author), Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland.	joachim.frey@vetsuisse.unibe.ch		castagna de vargas, agueda/0000-0002-9637-4028			Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Antipov D, 2016, BIOINFORMATICS, V32, P3380, DOI 10.1093/bioinformatics/btw493; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bagge E, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-8; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; CHANDLER HM, 1974, J GEN MICROBIOL, V84, P128, DOI 10.1099/00221287-84-1-128                                                       ; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Darling AE, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-4; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Falquet L., 2013, GENOME ANNOUNC, V1, DOI 10.1128/genomeA.00593-13; Frey J, 2015, RES MICROBIOL, V166, P384, DOI 10.1016/j.resmic.2014.10.013; Frey J, 2012, VACCINE, V30, P5500, DOI 10.1016/j.vaccine.2012.06.050; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Groseth PK, 2011, VET REC, V169, DOI 10.1136/vr.d4628; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66; Jubb K. V. F., 1991, PATHOLOGY DOMESTIC A; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12                                                         ; Lange M, 2010, MOL CELL PROBE, V24, P204, DOI 10.1016/j.mcp.2010.03.003; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mattar MA, 2002, FEMS IMMUNOL MED MIC, V33, P9, DOI 10.1016/S0928-8244(01)00302-9; Nagano N, 2008, J CLIN MICROBIOL, V46, P1545, DOI 10.1128/JCM.01895-07; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAMURA Y, 1987, VET MICROBIOL, V14, P81; TAMURA Y, 1995, MICROBIOL-UK, V141, P605, DOI 10.1099/13500872-141-3-605                                                      ; TANAKA M, 1987, INFECT IMMUN, V55, P1779; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Useh NA, 2006, CELL BIOCHEM FUNCT, V24, P347, DOI 10.1027/cbf.1240; Useh NM, 2006, VET REC, V158, P100, DOI 10.1136/vr.158.3.100                                                            ; Useh NM, 2003, VET QUART, V25, P155, DOI 10.1080/01652176.2003.9695158                                                   ; Usharani J, 2015, ANAEROBE, V33, P48, DOI 10.1016/j.anaerobe.2015.02.001; Uzal FA, 2012, VET CLIN N AM-FOOD A, V28, P71, DOI 10.1016/j.cvfa.2011.12.006; Vilei EM, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-2; Weatherhead JE, 2012, J INFECTION, V64, P225, DOI 10.1016/j.jinf.2011.09.004; Wolf R, 2017, PREV VET MED, V138, P134, DOI 10.1016/j.prevetmed.2017.01.019	39	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUN 9	2017	8								1054	10.3389/fmicb.2017.01054				13	Microbiology	Microbiology	EX1CI	WOS:000402956800002	28649238	gold			2018-01-05	
J	Frischkorn, K				Frischkorn, Kyle			A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution	SCIENCE			English	Book Review									[Frischkorn, Kyle] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Frischkorn, K (reprint author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	kylef@ldeo.columbia.edu					DOUDNA JA, 2017, CRACK CREATION GENE	1	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1005	1006						2	Multidisciplinary Sciences	Science & Technology - Other Topics	EW9XC	WOS:000402871700021					2018-01-05	
J	Guo, DS; Liu, HK; Ruzi, A; Gao, G; Nasir, A; Liu, YL; Yang, F; Wu, FM; Xu, GS; Li, YX				Guo, Dongsheng; Liu, Haikun; Ruzi, Aynisahan; Gao, Ge; Nasir, Abbas; Liu, Yanli; Yang, Fan; Wu, Feima; Xu, Guosheng; Li, Yin-xiong			Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9	SCIENTIFIC REPORTS			English	Article							INSULIN-PRODUCING CELLS; K-ATP CHANNELS; MOLECULAR-MECHANISMS; EFFICIENT DIFFERENTIATION; DIABETES-MELLITUS; KNOCKOUT MICE; BETA-CELLS; IN-VITRO; SECRETION; RELEASE	Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by excess insulin secretion, which results in hypoglycemia. Mutation of sulfonylurea receptor 1 (SUR1), encoded by the ABCC8 gene, is the main cause of CHI. Here, we captured the phenotype of excess insulin secretion through pancreatic differentiation of ABCC8-deficient stem cells generated by the CRISPR/Cas9 system. ABCC8-deficient insulin-producing cells secreted higher insulin than their wild-type counterparts, and the excess insulin secretion was rescued by nifedipine, octreotide and nicorandil. Further, we tested the role of SUR1 in response to different potassium levels and found that dysfunction of SUR1 decreased the insulin secretion rate in low and high potassium environments. Hence, pancreatic differentiation of ABCC8-deficient cells recapitulated the CHI disease phenotype in vitro, which represents an attractive model to further elucidate the function of SUR1 and to develop and screen for novel therapeutic drugs.	[Guo, Dongsheng; Liu, Haikun; Ruzi, Aynisahan; Gao, Ge; Nasir, Abbas; Liu, Yanli; Yang, Fan; Wu, Feima; Xu, Guosheng; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Guo, Dongsheng; Ruzi, Aynisahan; Nasir, Abbas; Liu, Yanli; Wu, Feima; Xu, Guosheng; Li, Yin-xiong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Guo, Dongsheng; Liu, Haikun; Ruzi, Aynisahan; Gao, Ge; Nasir, Abbas; Liu, Yanli; Yang, Fan; Wu, Feima; Xu, Guosheng; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Guo, Dongsheng; Liu, Haikun; Ruzi, Aynisahan; Gao, Ge; Nasir, Abbas; Liu, Yanli; Yang, Fan; Wu, Feima; Xu, Guosheng; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou, Guangdong, Peoples R China	Li, YX (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.; Li, YX (reprint author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Li, YX (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China.; Li, YX (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou, Guangdong, Peoples R China.	li_yinxiong@gibh.ac.cn			Thousand Talents Program [ODCCC2268]; Ministry of Science and Technology 973 Program [2015CB964700]; Guangdong Province Science and Technology Plan [2014B020225004, 2015B020230007, 2016B030301007]	We thank all members of the lab of Prof. Yin-xiong Li. This work was financially supported by Thousand Talents Program (ODCCC2268, Yin-xiong Li), the Ministry of Science and Technology 973 Program (2015CB964700) and the Guangdong Province Science and Technology Plan (2014B020225004, 2015B020230007, 2016B030301007).	ARKHAMMAR P, 1990, BIOCHEM J, V265, P203, DOI 10.1042/bj2650203                                                               ; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Chatterjee R, 2011, EXPERT REV ENDOCRINO, V6, P665, DOI 10.1586/EEM.11.60; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davis SN, 2004, J DIABETES COMPLICAT, V18, P367, DOI 10.1016/j.jdiacomp.2004.07.001; Demirbilek H, 2014, J CLIN ENDOCR METAB, V99, P3660, DOI 10.1210/jc.2014-1866; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Fournet JC, 2003, HORM RES, V59, P30, DOI 10.1159/000067842; FRAMPTON J, 1992, DRUGS, V44, P625, DOI 10.2165/00003495-199244040-00008; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/1573399811309010025; Geisler JC, 2013, ENDOCRINOLOGY, V154, P675, DOI 10.1210/en.2012-1818; Gonzalez F, 2016, DEV DYNAM, V245, P788, DOI [10.1002/DVDY.24414, 10.1002/dvdy.24414]; Guo DS, 2016, STEM CELL RES, V17, P640, DOI 10.1016/j.scr.2016.11.011; Guo DS, 2016, STEM CELL RES, V17, P670, DOI 10.1016/j.scr.2016.11.014; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; James C, 2009, J MED GENET, V46, P289, DOI 10.1136/jmg.2008.064337; Kapoor RR, 2013, EUR J ENDOCRINOL, V168, P557, DOI 10.1530/EJE-12-0673; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; LARSSON O, 1993, J PHYSIOL-LONDON, V463, P349, DOI 10.1113/jphysiol.1993.sp019598                                                  ; LEFEBVRE PJ, 1972, BIOCHEM PHARMACOL, V21, P339, DOI 10.1016/0006-2952(72)90345-0; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin G. M., 2017, ELIFE, V6, DOI [10.7554/eLife.24149, DOI 10.7554/ELIFE.24149]; MARTINEZ R, 1991, EXPERIENTIA, V47, P270, DOI 10.1007/BF01958157; Massi-Benedetti M, 2003, CLIN THER, V25, P799, DOI 10.1016/S0149-2918(03)80109-1                                                   ; MOORE RD, 1983, BIOCHIM BIOPHYS ACTA, V737, P1, DOI 10.1016/0304-4157(83)90013-8; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; NATALI A, 1993, CLIN SCI, V85, P327, DOI 10.1042/cs0850327                                                               ; Nessa A, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00029; Nessa A, 2015, HUM MOL GENET, V24, P5142, DOI 10.1093/hmg/ddv233; Passier R, 2016, CELL STEM CELL, V18, P309, DOI 10.1016/j.stem.2016.02.011; Rahman SA, 2015, J MOL ENDOCRINOL, V54, pR119, DOI 10.1530/JME-15-0016; Ringer S., 1882, J PHYSL, V3; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8                                                    ; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270                                                         ; Senniappan Senthil, 2013, Indian J Endocrinol Metab, V17, P19, DOI 10.4103/2230-8210.107822; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Song DK, 2001, BRIT J PHARMACOL, V133, P193, DOI 10.1038/sj.bjp.0704062; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/endo.141.1.7263; Szollosi A, 2010, BRIT J PHARMACOL, V159, P669, DOI 10.1111/j.1476-5381.2009.00588.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; TRINER L, 1969, CIRC RES, V25, P119; TUCH BE, 1990, CELL CALCIUM, V11, P1, DOI 10.1016/0143-4160(90)90043-T                                                    ; Welters A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0367-x; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Yorifuji Tohru, 2014, Ann Pediatr Endocrinol Metab, V19, P57, DOI 10.6065/apem.2014.19.2.57; Yu HJ, 2016, MOL ENDOCRINOL, V30, P575, DOI 10.1210/me.2015-1290; Zeng H, 2016, CELL STEM CELL, V19, P326, DOI 10.1016/j.stem.2016.07.002; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	53	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 9	2017	7								3156	10.1038/s41598-017-03349-w				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EX1CM	WOS:000402957400037	28600547	gold			2018-01-05	
J	White, CW; Vanyai, HK; See, HB; Johnstone, EKM; Pfleger, KDG				White, Carl W.; Vanyai, Hannah K.; See, Heng B.; Johnstone, Elizabeth K. M.; Pfleger, Kevin D. G.			Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time	SCIENTIFIC REPORTS			English	Article							RESONANCE ENERGY-TRANSFER; TRANSFER BRET; COUPLED RECEPTORS; PLASMA-MEMBRANE; BETA-ARRESTINS; LIVING CELLS; FLUORESCENT PROTEIN; BIOSENSORS REVEAL; RAB GTPASES; HIV-1 ENTRY	Bioluminescence resonance energy transfer (BRET) has been a vital tool for understanding G protein-coupled receptor (GPCR) function. It has been used to investigate GPCR-protein and/or -ligand interactions as well as GPCR oligomerisation. However the utility of BRET is limited by the requirement that the fusion proteins, and in particular the donor, need to be exogenously expressed. To address this, we have used CRISPR/Cas9-mediated homology-directed repair to generate protein-Nanoluciferase (Nluc) fusions under endogenous promotion, thus allowing investigation of proximity between the genome-edited protein and an exogenously expressed protein by BRET. Here we report BRET monitoring of GPCR-mediated beta-arrestin2 recruitment and internalisation where the donor luciferase was under endogenous promotion, in live cells and in real time. We have investigated the utility of CRISPR/Cas9 genome editing to create genome-edited fusion proteins that can be used as BRET donors and propose that this strategy can be used to overcome the need for exogenous donor expression.	[White, Carl W.; See, Heng B.; Johnstone, Elizabeth K. M.; Pfleger, Kevin D. G.] Harry Perkins Inst Med Res, QEII Med Ctr, Mol Endocrinol & Pharmacol, Nedlands, WA 6009, Australia; [White, Carl W.; Vanyai, Hannah K.; See, Heng B.; Johnstone, Elizabeth K. M.; Pfleger, Kevin D. G.] Univ Western Australia, Ctr Med Res, Crawley, WA 6009, Australia; [Vanyai, Hannah K.] Harry Perkins Inst Med Res, QEII Med Ctr, Brain Growth & Dis Lab, Nedlands, WA 6009, Australia; [Pfleger, Kevin D. G.] Dimerix Ltd, Nedlands, WA 6009, Australia	White, CW; Pfleger, KDG (reprint author), Harry Perkins Inst Med Res, QEII Med Ctr, Mol Endocrinol & Pharmacol, Nedlands, WA 6009, Australia.; White, CW; Pfleger, KDG (reprint author), Univ Western Australia, Ctr Med Res, Crawley, WA 6009, Australia.; Pfleger, KDG (reprint author), Dimerix Ltd, Nedlands, WA 6009, Australia.	carl.white@perkins.uwa.edu.au; pfleger@perkins.uwa.edu.au		Johstone, Elizabeth/0000-0001-7990-371X	ARC [LP130100037, LP160100857]; National Health and Medical Research Council (NHMRC) of Australia; CJ Martin Research Fellowship [1088334]; RD Wright Biomedical Research Fellowship [1085842]; UWA Fellowship	The authors would like to thank Ruohan Li for helpful discussion regarding the initial design of the CRISPR targeting constructs and Rekhati Abhayawardana for technical assistance with DNA preparation and sequencing. This work was funded in part by ARC Linkage Grants LP130100037 and LP160100857, with fellowship support from the National Health and Medical Research Council (NHMRC) of Australia to C.W.W. (CJ Martin Research Fellowship, 1088334) and K.D.G.P. (RD Wright Biomedical Research Fellowship, 1085842) as well as a UWA Fellowship Support Grant to C.W.W.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Audet M, 2010, FASEB J, V24, P2829, DOI 10.1096/fj.09-144816; Bassoni Daniel L, 2012, Methods Mol Biol, V897, P181, DOI 10.1007/978-1-61779-909-9_9; Beletkaia E, 2016, BBA-MOL CELL RES, V1863, P607, DOI 10.1016/j.bbamcr.2015.12.020; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chan F, 2011, NUCLEIC ACIDS RES, V39, P5955, DOI 10.1093/nar/gkr196; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dacres H, 2012, BIOCHEM BIOPH RES CO, V425, P625, DOI 10.1016/j.bbrc.2012.07.133; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Esseltine Jessica L, 2013, Small GTPases, V4, P132, DOI 10.4161/sgtp.24304; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Goyet E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28231; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kain S. R., 2001, CURR PROTOC MOL BIOL, DOI 10.1002/0471142727.mb0906s36; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lackner DH, 2015, NAT COMMUN, V6; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Mahen R, 2014, MOL BIOL CELL, V25, P3610, DOI 10.1091/mbc.E14-06-1091; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Moriuchi M, 1999, J IMMUNOL, V162, P5986; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Robers MB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10091; Rojas-Fernandez A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09811; Savage EE, 2013, BIOTECHNIQUES, V54, P217, DOI 10.2144/000114013; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/nmeth.3398, 10.1038/NMETH.3398]; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tiulpakov A, 2016, MOL ENDOCRINOL, V30, P889, DOI 10.1210/me.2016-1002; Wysoczynski M, 2005, BLOOD, V105, P40, DOI 10.1128/blood-2004-04-1430; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao HL, 2015, ONCOTARGET, V6, P5022, DOI 10.18632/oncotarget.3217                                                        ; Zhao J, 2016, ACS CHEM BIOL, V11, P132, DOI 10.1021/acschembio.5b00758; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	69	0	0	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 9	2017	7								3187	10.1038/s41598-017-03486-2				14	Multidisciplinary Sciences	Science & Technology - Other Topics	EX1CM	WOS:000402957400068	28600500	gold			2018-01-05	
J	Wallace, JA; Kagele, DA; Eiring, AM; Kim, CN; Hu, R; Runtsch, MC; Alexander, M; Huffaker, TB; Lee, SH; Patel, AB; Mosbruger, TL; Voth, WP; Rao, DS; Miles, RR; Round, JL; Deininger, MW; O'Connell, RM				Wallace, Jared A.; Kagele, Dominique A.; Eiring, Anna M.; Kim, Carissa N.; Hu, Ruozhen; Runtsch, Marah C.; Alexander, Margaret; Huffaker, Thomas B.; Lee, Soh-Hyun; Patel, Ami B.; Mosbruger, Timothy L.; Voth, Warren P.; Rao, Dinesh S.; Miles, Rodney R.; Round, June L.; Deininger, Michael W.; O'Connell, Ryan M.			miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response	BLOOD			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; STEM-CELLS; FLT3; MICRORNA; MODEL; GENE; PROLIFERATION; EXPRESSION; NETWORK	FLT3-ITD+ acute myeloid leukemia (AML) accounts for similar to 25% of all AML cases and is a subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically overexpressed in FLT3-ITD+ AML compared with FLT3 wild-type (FLT3-WT) AML and is critical for the growth of FLT3-ITD+ AML cells in vitro. However, miR-155' s role in regulating FLT3-ITD-mediated disease in vivo remains unclear. In this study, we used a genetic mouse model to determine whether miR-155 influences the development of FLT3-ITD-induced myeloproliferative disease. Results indicate that miR-155 promotes FLT3-ITD-induced myeloid expansion in the bone marrow, spleen, and peripheral blood. Mechanistically, miR-155 increases proliferation of the hematopoietic stem and progenitor cell compartments by reducing the growth-inhibitory effects of the interferon (IFN) response, and this involves targeting of Cebpb. Consistent with our observations in mice, primary FLT3-ITD+ AML clinical samples have significantly higher miR-155 levels and a lower IFN response compared with FLT3-WTAML samples. Further, inhibition of miR-155 in FLT3-ITD+ AML cell lines using CRISPR/Cas9, or primary FLT3-ITD+ AML samples using locked nucleic acid antisense inhibitors, results in an elevated IFN response and reduces colony formation. Altogether, our data reveal that miR-155 collaborates with FLT3-ITD to promote myeloid cell expansion in vivo and that this involves a multitarget mechanism that includes repression of IFN signaling.	[Wallace, Jared A.; Kagele, Dominique A.; Kim, Carissa N.; Hu, Ruozhen; Runtsch, Marah C.; Alexander, Margaret; Huffaker, Thomas B.; Lee, Soh-Hyun; Voth, Warren P.; Miles, Rodney R.; Round, June L.; O'Connell, Ryan M.] Univ Utah, Dept Pathol, 15 North Med Dr East, Salt Lake City, UT 84112 USA; [Eiring, Anna M.; Patel, Ami B.; Mosbruger, Timothy L.; Miles, Rodney R.; Deininger, Michael W.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Rao, Dinesh S.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA; [Deininger, Michael W.] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA	O'Connell, RM (reprint author), Univ Utah, Dept Pathol, 15 North Med Dr East, Salt Lake City, UT 84112 USA.	ryan.oconnell@path.utah.edu		Alexander, Margaret/0000-0003-2972-7521	University of Utah Flow Cytometry Facility; National Cancer Institute, National Institutes of Health (NIH) [5P30CA042014-4]; NIH under Ruth L. Kirschstein National Research Service Award from the National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK007115]; NIH National Cancer Institute [F30CA217027]; NIH [R01CA166450]; NIH National Institute of General Medical Sciences New Innovator Award [DP2GM111099-01]; Gabrielle Angel's Foundation Medical Research Award	This work was supported by the University of Utah Flow Cytometry Facility in addition to the National Cancer Institute, National Institutes of Health (NIH) through award 5P30CA042014-4. This work was also supported by the NIH under Ruth L. Kirschstein National Research Service Award 5T32DK007115 from the National Institute of Diabetes and Digestive and Kidney Diseases (J.A.W.), the NIH National Cancer Institute under award F30CA217027 (J.A.W.), the NIH under grant R01CA166450 (D.S.R.), NIH National Institute of General Medical Sciences New Innovator Award DP2GM111099-01 (R.M.O.), and a Gabrielle Angel's Foundation Medical Research Award (R.M.O).	Anguille S, 2011, LEUKEMIA, V25, P739, DOI 10.1038/leu.2010.324; Benjamin R, 2007, BLOOD, V109, P1244, DOI 10.1182/blood-2006-02-002915; Cammarata G, 2010, AM J HEMATOL, V85, P331, DOI 10.1002/ajh.21667; Ersvaer E, 2007, CANCER IMMUNOL IMMUN, V56, P13, DOI 10.1007/s00262-006-0159-1; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gerloff D, 2015, LEUKEMIA, V29, P535, DOI 10.1038/leu.2014.231; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Greenblatt S, 2012, BLOOD, V119, P2883, DOI 10.1182/blood-2011-10-382283; Jiang LJ, 2011, P NATL ACAD SCI USA, V108, P1897, DOI 10.1073/pnas.1019059108; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Khalife J, 2015, LEUKEMIA, V29, P1981, DOI 10.1038/leu.2015.106; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Li L, 2008, BLOOD, V111; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Marcucci G, 2013, J CLIN ONCOL, V31, P2086, DOI 10.1200/JCO.2012.45.6228; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Connell RM, J EXP MED; Ramamurthy R, 2016, PEDIATR BLOOD CANCER, V63, P2096, DOI 10.1002/pbc.26157; Reddy PNG, 2012, BLOOD, V120, P1691, DOI 10.1182/blood-2010-08-301416; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626                                                        ; Salemi D, 2015, LEUKEMIA RES, V39, P883, DOI 10.1016/j.leukres.2015.04.017; Schessl C, 2005, J CLIN INVEST, V115, P2159, DOI 10.1172/JCI24225; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; SMALL D, 1994, P NATL ACAD SCI USA, V91, P459, DOI 10.1073/pnas.91.2.459                                                           ; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810                                                         ; Wallace J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153689; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648; Xiao WH, 2001, J BIOL CHEM, V276, P23275, DOI 10.1074/jbc.M010047200                                                          	36	3	3	1	1	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	JUN 8	2017	129	23					3074	3086		10.1182/blood-2016-09-740209				13	Hematology	Hematology	EW9YK	WOS:000402875100007	28432220	green_published			2018-01-05	
J	Yan, XY; Yan, ZY; Han, YZ				Yan, Xiaoyuan; Yan, Zongyun; Han, Yuzhen			RRP42, a Subunit of Exosome, Plays an Important Role in Female Gametophytes Development and Mesophyll Cell Morphogenesis in Arabidopsis	FRONTIERS IN PLANT SCIENCE			English	Article						Arabidopsis; cell morphogenesis; exosome; female gametophytes; mRNA decay	MESSENGER-RNA DECAY; LEAF DEVELOPMENT; YEAST EXOSOME; ENDOXYLOGLUCAN TRANSFERASE; POSTEMBRYONIC DEVELOPMENT; WALL CONSTRUCTION; RIBOSOMAL-RNA; CORE SUBUNIT; GROWTH; EXPRESSION	The exosome complex plays a central and essential role in RNA metabolism. However, current research on functions of exosome subunit in plants is limited. Here, we used an egg cell-specific promoter-controlled CRISPR/Cas9 system to knock out RRP42 which encodes a core subunit of the Arabidopsis exosome and presented evidence that RRP42 is essential for the development of female gametophytes. Next, we designed three different amiRNAs targeting RRP42. The rrp42 knock-down mutants mainly displayed variegated and serrated leaves, especially in cauline leaves. The internal anatomy of cauline leaves displayed irregularly shaped palisade cells and a reduced density of mesophyll cells. Interestingly, we detected highly accumulated mRNAs that encode xyloglucan endotransglucosylase/ hydrolases (XTHs) and expansins (EXPAs) during later growth stages in rrp42 knock-down mutants. The mRNA decay kinetics analysis for XTH19, EXPA10, and EXPA11 revealed that RRP42 had a role in the decay of these mRNAs in the cytoplasm. RRP42 is localized to both the nucleus and cytoplasm, and RRP42 is preferentially expressed in cauline leaves during later growth stages. Altogether, our results demonstrate that RRP42 is essential for the development of female gametophytes and plays an important role in mesophyll cell morphogenesis.	[Yan, Xiaoyuan; Yan, Zongyun; Han, Yuzhen] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing, Peoples R China	Han, YZ (reprint author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing, Peoples R China.	hanyuzhen@cau.edu.cn		yan, zongyun/0000-0002-8556-5929	National Natural Science Foundation of China [21025057]	This work was supported by the National Natural Science Foundation of China (grant no. 21025057).	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Chekanova JA, 2002, NUCLEIC ACIDS RES, V30, P695, DOI 10.1093/nar/30.3.695; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Christie M, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00099; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Han Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00624; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826                                                           ; Johnson MA, 2000, P NATL ACAD SCI USA, V97, P13991, DOI 10.1073/pnas.240354097; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; KOCH E, 1990, PLANT CELL, V2, P437; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001                                                               ; Kumakura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079219; Lange H, 2010, ADV EXP MED BIOL, V702, P50; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Maris A, 2009, J EXP BOT, V60, P3959, DOI 10.1093/jxb/erp229; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8                                                   ; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; OKAZAWA K, 1993, J BIOL CHEM, V268, P25364; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Pitaksaringkarn W, 2014, PLANT J, V80, P604, DOI 10.1111/tpj.12654; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; SMYTH DR, 1990, PLANT CELL, V2, P755; Vissenberg K, 2005, PLANT CELL PHYSIOL, V46, P192, DOI 10.1093/pcp/pci013; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Xu J, 2009, PLANT CELL, V21, P3270, DOI 10.1105/tpc.109.070078; Yang M, 2013, PLANT PHYSIOL, V161, P165, DOI 10.1104/pp.112.206706; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P1025, DOI 10.1093/pcp/pce154; Zhang WP, 2010, P NATL ACAD SCI USA, V107, P15981, DOI 10.1073/pnas.1007060107	53	0	0	7	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	JUN 8	2017	8								981	10.3389/fpls.2017.00981				13	Plant Sciences	Plant Sciences	EW9SQ	WOS:000402860000002	28642780	gold			2018-01-05	
J	Hoy, JJ; Kallifatidis, G; Smith, DK; Lokeshwar, BL				Hoy, James J.; Kallifatidis, Georgios; Smith, Diandra K.; Lokeshwar, Bal L.			Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival	SCIENTIFIC REPORTS			English	Article							IN-VIVO; RADICAL PROSTATECTOMY; SIGNALING AXIS; PROGRESSION; GROWTH; EGFR; EXPRESSION; PROLIFERATION; INDEPENDENCE; DEPRIVATION	The atypical C-X-C chemokine receptor 7 (CXCR7) has been implicated in supporting aggressive cancer phenotypes in several cancers including prostate cancer. However, the mechanisms driving overexpression of this receptor in cancer are poorly understood. This study investigates the role of androgen receptor (AR) in regulating CXCR7. Androgen deprivation or AR inhibition significantly increased CXCR7 expression in androgen-responsive prostate cancer cell lines, which was accompanied by enhanced epidermal growth factor receptor (EGFR)-mediated mitogenic signaling, promoting tumor cell survival through an androgen-independent signaling program. Using multiple approaches we demonstrate that AR directly binds to the CXCR7 promoter, suppressing transcription. Clustered regularly interspaced short palindromic repeats (CRISPR) directed Cas9 nuclease-mediated gene editing of CXCR7 revealed that prostate cancer cells depend on CXCR7 for proliferation, survival and clonogenic potential. Loss of CXCR7 expression by CRISPR-Cas9 gene editing resulted in a halt of cell proliferation, severely impaired EGFR signaling and the onset of cellular senescence. Characterization of a mutated CXCR7-expressing LNCaP cell clone showed altered intracellular signaling and reduced spheroid formation potential. Our results demonstrate that CXCR7 is a potential target for adjuvant therapy in combination with androgen deprivation therapy (ADT) to prevent androgen-independent tumor cell survival.	[Hoy, James J.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Hoy, James J.; Kallifatidis, Georgios; Smith, Diandra K.; Lokeshwar, Bal L.] Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA; [Kallifatidis, Georgios; Lokeshwar, Bal L.] Charlie Norwood VA Med Ctr, Res Serv, Augusta, GA 30904 USA	Lokeshwar, BL (reprint author), Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA.; Lokeshwar, BL (reprint author), Charlie Norwood VA Med Ctr, Res Serv, Augusta, GA 30904 USA.	blokeshwar@augusta.edu			Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center (Miami, FL); Veterans Health Administration Merit Award [BX 001517-01]; United States' Public Health Services awards [NIH-1R01CA156776-01]	We would like to thank Dr. Vinata Lokeshwar (Augusta University, GA) for advice and for supplying equipment and analysis software for RT-q-PCR as well as Andre Jordan (Augusta University, GA) for sassistance with SA-gal staining protocols and reagents. We are also grateful to Dr. Nicole Salazar (Stanford University, CA), Dr. Karoline Briegel, Dr. Guy Howard, Dr. Xiang-Xi Xu, Dr. Mark Gonzalgo, Daniel Munoz, and Santas Rosario (University of Miami, FL) for helpful discussions, assistance with the experiments, advice and encouragement throughout the completion of this work. James J. Hoy acknowledges partial support and assistance from the Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center (Miami, FL). This work was supported in parts by the Veterans Health Administration Merit Award: BX 001517-01 (BLL); and the United States' Public Health Services awards: NIH-1R01CA156776-01 (BLL).	Aach J., 2014, BIORXIV, DOI [DOI 10.1101/005074, 10.1101/005074]; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Denes V, 2015, INT J CANCER, V136, P1528, DOI 10.1002/ijc.29155; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gjertson CK, 2007, UROLOGY, V70, P723, DOI 10.1016/j.urology.2007.05.014; GLEAVE M, 1991, CANCER RES, V51, P3753; Gregory CW, 2001, CANCER RES, V61, P2892; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hsiao JJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1201-5; Ischia J, 2013, INT J UROL, V20, P290, DOI 10.1111/iju.12069; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Iwakiri S, 2009, CANCER, V115, P2580, DOI 10.1002/cncr.24281; Kallifatidis G, 2016, MOL CANCER RES, V14, P493, DOI 10.1158/1541-7786.MCR-15-0498; Katzenwadel A, 2015, CANCER LETT, V367, P12, DOI 10.1016/j.canlet.2015.06.021; KAWATA H, 2010, THE PROSTATE, V70, P745, DOI DOI 10.1002/PR0S.21107; Kiyoshima T, 2012, INT J MOL MED, V30, P1007, DOI 10.3892/ijmm.2012.1102; Lin L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.392; Liu CF, 2014, PROSTATE, V74, P201, DOI 10.1002/pros.22741; Lorenzo Giuseppe Di, 2003, Clin Prostate Cancer, V2, P50; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; Rafehi H, 2011, JOVE-J VIS EXP, V49, P2573, DOI DOI 10.3791/2573; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sailer Scott L, 2006, N C Med J, V67, P149; Salazar N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-198; Salazar N, 2013, CRIT REV EUKAR GENE, V23, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2013006905                                      ; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsao CK, 2012, BJU INT, V110, P1580, DOI 10.1111/j.1464-410X.2012.11445.x; Wang HX, 2015, EXP THER MED, V10, P1720, DOI 10.3892/etm.2015.2748; WANG J, 2008, THE JOURNAL OF BIOLO, V283, P4283, DOI DOI 10.1074/JBC.M707465200; Yang D, 2015, INT J CLIN EXP PATHO, V8, P13051; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1	45	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 8	2017	7								3058	10.1038/s41598-017-02918-3				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EW9UJ	WOS:000402864600009	28596572	gold			2018-01-05	
J	Lu, S; Shen, XR; Chen, BS				Lu, Shan; Shen, Xiaorui; Chen, Baoshan			Development of an efficient vector system for gene knock-out and near in-cis gene complementation in the sugarcane smut fungus	SCIENTIFIC REPORTS			English	Article							T-DNA INTEGRATION; TUMEFACIENS-MEDIATED TRANSFORMATION; GENOME-WIDE ANALYSIS; HOMOLOGOUS RECOMBINATION; CRISPR/CAS9 SYSTEM; TARGETED INTEGRATION; USTILAGO-SCITAMINEA; AGROBACTERIUM; REPLACEMENT; PLANTS	Sporisorium scitamineum is the causative agent responsible for smut disease of sugarcane worldwide. However, lack of efficient gene manipulation system makes this fungus much behind the type model of the smut fungi in molecular biology. Here, we report the development of a CRISPR/Cas9 and T-DNA based dual vector system that allowed efficient knock-out or knock-in of a gene of interest in the S. scitamineum in a site-specific manner. By using Mfa2, a key player in the mating event in S. scitamineum as a tester gene, site-specific insertions of the introduced fragments were achieved both for Mfa2 knockout and complementation. Of particular advantage of this system is the simplicity of selection and identification for the desired transformants by using drug resistance coupled with PCR. This system greatly facilitates the gene function study in S. scitamineum, and could potentially be used for other basidiomycete fungi.	[Lu, Shan; Chen, Baoshan] State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Lu, Shan; Shen, Xiaorui; Chen, Baoshan] Guangxi Univ, Coll Life Sci & Technol, Nanning 530004, Peoples R China	Chen, BS (reprint author), State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.; Chen, BS (reprint author), Guangxi Univ, Coll Life Sci & Technol, Nanning 530004, Peoples R China.	chenyaoj@gxu.edu.cn			Major State Basic Research Development Program of China (973 Program) [2015CB1506000]; Guangxi Cooperation and Innovation Center for Sugarcane Industry; Innovation Project of Guangxi Graduate Education	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program, No. 2015CB1506000) and Guangxi Cooperation and Innovation Center for Sugarcane Industry to B.C., and Innovation Project of Guangxi Graduate Education to S.L. We thank L.H. Ji and L.H. Sun for kindly providing pEX2 and pNGR1.2 plasmids, and Y.G. Liu for kindly providing pAtU3b vector.	Albert HH, 1996, PLANT DIS, V80, P1189, DOI 10.1094/PD-80-1189                                                              ; BOULTON MI, 1989, PLANT MOL BIOL, V12, P31, DOI 10.1007/BF00017445; BYTEBIER B, 1987, P NATL ACAD SCI USA, V84, P5345, DOI 10.1073/pnas.84.15.5345; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111172; Chilton MDM, 2003, PLANT PHYSIOL, V133, P956, DOI 10.1104/pp.103.026104; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Kress MR, 2006, EUKARYOT CELL, V5, P207, DOI DOI 10.1128/EC.5.1.207-211.2006; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dutheil JY, 2016, GENOME BIOL EVOL, V8, P681, DOI 10.1093/gbe/evw026; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; GONDO Y, 1994, BIOCHEM BIOPH RES CO, V202, P830, DOI 10.1006/bbrc.1994.2005; Guo RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29855; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Ishibashi K, 2006, P NATL ACAD SCI USA, V103, P14871, DOI 10.1073/pnas.0604477103; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Kim SI, 2007, PLANT J, V51, P779, DOI 10.1111/j.1365-313X.2007.03183.x; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lan XW, 2008, CURR GENET, V53, P59, DOI 10.1007/s00294-007-0162-x; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Liu YB, 2013, APPL MICROBIOL BIOT, V97, P719, DOI 10.1007/s00253-012-4223-9; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Main G D, 1995, Methods Mol Biol, V44, P405; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; MARKLUND BI, 1995, J BACTERIOL, V177, P6100, DOI 10.1128/jb.177.21.6100-6105.1995                                                ; MAYERHOFER R, 1991, EMBO J, V10, P697; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Pombert J.-F., 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0129318, DOI 10.1371/JOURNAL.PONE.0129318]; Puchta H, 2002, PLANT MOL BIOL, V48, P173, DOI 10.1023/A:1013761821763; Que YX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-996; Rolloos M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08345; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Singh N, 2004, PLANT SCI, V167, P987, DOI 10.1016/j.plantsci.2004.05.006; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; SPELLIG T, 1994, SEMBO JOURNAL, V13, P1620; Sun LH, 2014, BIOTECHNOL LETT, V36, P1309, DOI 10.1007/s10529-014-1486-5; Tzfira T, 2003, PLANT PHYSIOL, V133, P1011, DOI 10.1104/pp.103.032128; WILLNOW TE, 1994, METHOD CELL BIOL, V43, P305; Yan MX, 2016, FUNGAL GENET BIOL, V86, P1, DOI 10.1016/j.fgb.2015.11.005	45	0	0	21	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 8	2017	7								3113	10.1038/s41598-017-03233-7				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EW9UP	WOS:000402865200025	28596577	gold			2018-01-05	
J	Xie, ZC; Pang, DX; Wang, KK; Li, MJ; Guo, NN; Yuan, HM; Li, JN; Zou, XD; Jiao, HP; Ouyang, HS; Li, ZJ; Tang, XC				Xie, Zicong; Pang, Daxin; Wang, Kankan; Li, Mengjing; Guo, Nannan; Yuan, Hongming; Li, Jianing; Zou, Xiaodong; Jiao, Huping; Ouyang, Hongsheng; Li, Zhanjun; Tang, Xiaochun			Optimization of a CRISPR/Cas9-mediated Knock-in Strategy at the Porcine Rosa26 Locus in Porcine Foetal Fibroblasts	SCIENTIFIC REPORTS			English	Article							STRAND BREAK REPAIR; ONE-STEP GENERATION; CONDITIONAL ALLELES; GENE-EXPRESSION; CRISPR RNA; PIGS; IDENTIFICATION; SPECIFICITY; CELLS; INHIBITION	Genetically modified pigs have important roles in agriculture and biomedicine. However, genome-specific knock-in techniques in pigs are still in their infancy and optimal strategies have not been extensively investigated. In this study, we performed electroporation to introduce a targeting donor vector (a non-linearized vector that did not contain a promoter or selectable marker) into Porcine Foetal Fibroblasts (PFFs) along with a CRISPR/Cas9 vector. After optimization, the efficiency of the EGFP site-specific knock-in could reach up to 29.6% at the pRosa26 locus in PFFs. Next, we used the EGFP reporter PFFs to address two key conditions in the process of achieving transgenic pigs, the limiting dilution method and the strategy to evaluate the safety and feasibility of the knock-in locus. This study demonstrates that we establish an efficient procedures for the exogenous gene knock-in technique and creates a platform to efficiently generate promoter-less and selectable marker-free transgenic PFFs through the CRISPR/Cas9 system. This study should contribute to the generation of promoter-less and selectable marker-free transgenic pigs and it may provide insights into sophisticated site-specific genome engineering techniques for additional species.	[Xie, Zicong; Pang, Daxin; Wang, Kankan; Li, Mengjing; Guo, Nannan; Yuan, Hongming; Li, Jianing; Zou, Xiaodong; Jiao, Huping; Ouyang, Hongsheng; Li, Zhanjun; Tang, Xiaochun] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun, Jilin Province, Peoples R China	Tang, XC (reprint author), Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun, Jilin Province, Peoples R China.	xiaochuntang@jlu.edu.cn			Special Funds for Cultivation and Breeding of New Transgenic Organisms [2016ZX08006003, 2014ZX0800604B]; China National Natural Science Foundation [31472053, 31572345]	We thank the members of the Animal Biotechnology laboratory, College of Animal Science, Jilin University. This work was supported by Special Funds for Cultivation and Breeding of New Transgenic Organisms (Nos 2016ZX08006003 & 2014ZX0800604B) and the China National Natural Science Foundation (31472053 and 31572345).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fratelli F, 2011, TOXICON, V57, P1093, DOI 10.1016/j.toxicon.2011.04.015; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Kong QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107945; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Liang FS, 2016, CELL REP, V15, P2118, DOI 10.1016/j.celrep.2016.05.007; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Matsunami K, 2008, TRANSPL P, V40, P2776, DOI 10.1016/j.transproceed.2008.08.023; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rahman SH, 2013, HUM GENE THER, V24, P67, DOI 10.1089/hum.2012.168; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; Ruan J. X., 2015, SCI REPORTS, V5; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang K. K., 2015, SCI REPORTS, V5; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	36	1	1	20	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 8	2017	7								3036	10.1038/s41598-017-02785-y				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EW9UA	WOS:000402863700018	28596588	gold			2018-01-05	
J	He, JZ; Kim, D; Zhou, XD; Ahn, SJ; Burne, RA; Richards, VP; Koo, H				He, Jinzhi; Kim, Dongyeop; Zhou, Xuedong; Ahn, Sang-Joon; Burne, Robert A.; Richards, Vincent P.; Koo, Hyun			RNA-Seq Reveals Enhanced Sugar Metabolism in Streptococcus mutans Co-cultured with Candida albicans within Mixed-Species Biofilms	FRONTIERS IN MICROBIOLOGY			English	Article						early childhood caries; biofilms; Streptococcus mutans; Candida albicans; transcriptome; RNA-Seq	EARLY-CHILDHOOD CARIES; SUCROSE PHOSPHOTRANSFERASE SYSTEM; DIFFERENTIAL EXPRESSION ANALYSIS; STRESS TOLERANCE; GENE-EXPRESSION; COMPETENCE DEVELOPMENT; BACTERIOCIN PRODUCTION; GLUCOSYLTRANSFERASE B; MUTACIN PRODUCTION; DENTAL-CARIES	Early childhood caries (ECC), which can lead to rampant tooth-decay that is painful and costly to treat, is one of the most prevalent infectious diseases affecting children worldwide. Previous studies support that interactions between Streptococcus mutans and Candida albicans are associated with the pathogenesis of ECC. The presence of Candida enhances S. mutans growth, fitness and accumulation within biofilms in vitro, although the molecular basis for these behaviors is undefined. Using an established co-cultivation biofilm model and RNA-Seq, we investigated how C. albicans influences the transcriptome of S. mutans. The presence of C. albicans dramatically altered gene expression in S. mutans in the dual-species biofilm, resulting in 393 genes differentially expressed, compared to mono-species biofilms of S. mutans. By Gene Ontology analysis, the majority of up-regulated genes were related to carbohydrate transport and metabolic/catabolic processes. KEGG pathway impact analysis showed elevated pyruvate and galactose metabolism, suggesting that co-cultivation with C. albicans influences carbohydrate utilization by S. mutans. Analysis of metabolites confirmed the increases in carbohydrate metabolism, with elevated amounts of formate in the culture medium of co-cultured biofilms. Moreover, co-cultivation with C. albicans altered transcription of S. mutans signal transduction (comC and ciaRH) genes associated with fitness and virulence. Interestingly, the expression of genes for mutacins (bacteriocins) and CRISPR were down-regulated. Collectively, the data provide a comprehensive insight into S. mutans transcriptomic changes induced by C. albicans, and offer novel insights into how bacterial-fungal interactions may enhance the severity of dental caries.	[He, Jinzhi; Zhou, Xuedong] Sichuan Univ, West China Hosp Stomatol, Dept Endodont, State Key Lab Oral Dis, Chengdu, Peoples R China; [He, Jinzhi; Kim, Dongyeop; Koo, Hyun] Univ Penn, Dept Orthodont, Levy Ctr Oral Hlth, Biofilm Res Labs,Sch Dent Med, Philadelphia, PA 19104 USA; [Ahn, Sang-Joon; Burne, Robert A.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Richards, Vincent P.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Koo, H (reprint author), Univ Penn, Dept Orthodont, Levy Ctr Oral Hlth, Biofilm Res Labs,Sch Dent Med, Philadelphia, PA 19104 USA.	koohy@upenn.edu	yang, xueqin/K-1830-2017		National Institute for Dental and Craniofacial Research (NIDCR) [DE025220, DE018023]	This work was supported in part by the National Institute for Dental and Craniofacial Research (NIDCR) grants DE025220 and DE018023 (HK).	ABBE K, 1982, J BACTERIOL, V152, P175; Abranches J, 2004, APPL ENVIRON MICROB, V70, P6047, DOI 10.1128/AEM.70.10.6047-6052.2004; Ahn SJ, 2006, INFECT IMMUN, V74, P1631, DOI 10.1128/IAI.74.3.1631-1642.2006; Ajdic D, 1996, GENE, V180, P137, DOI 10.1016/S0378-1119(96)00434-9; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; BERKOWITZ RJ, 1984, ARCH ORAL BIOL, V29, P949, DOI 10.1016/0003-9969(84)90097-9; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Bluthgen Nils, 2005, Genome Inform, V16, P106; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; BRANTING C, 1989, ARCH ORAL BIOL, V34, P347, DOI 10.1016/0003-9969(89)90108-8; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burne RA, 2001, METHOD ENZYMOL, V337, P403, DOI 10.1016/S0076-6879(01)37029-5                                                   ; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Busuioc M, 2010, J BACTERIOL, V192, P4395, DOI 10.1128/JB.00574-10; Calin V., 2016, RONTOTOOLS R ONTO TO; CHASSY BM, 1979, BIOCHEM BIOPH RES CO, V89, P307, DOI 10.1016/0006-291X(79)90979-3                                                    ; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; de Carvalho FG, 2006, ARCH ORAL BIOL, V51, P1024, DOI 10.1016/j.archoralbio.2006.06.001; DEVOS WM, 1994, FEMS MICROBIOL REV, V15, P217, DOI 10.1016/0168-6445(94)90114-7                                                    ; Diaz PI, 2012, INFECT IMMUN, V80, P620, DOI 10.1128/IAI.05896-11; DISTLER W, 1986, CARIES RES, V20, P1, DOI 10.1159/000260913                                                               ; Dutton LC, 2016, MOL ORAL MICROBIOL, V31, P136, DOI [10.111, 10.1111/omi.12111]; Falsetta ML, 2014, INFECT IMMUN, V82, P1968, DOI 10.1128/IAI.00087-14; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gregoire S, 2011, APPL ENVIRON MICROB, V77, P6357, DOI 10.1128/AEM.05203-11; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Hajishengallis E, 2017, MOL ORAL MICROBIOL, V32, P24, DOI 10.1111/omi.12152; Hale JDF, 2005, APPL ENVIRON MICROB, V71, P7613, DOI 10.1128/AEM.71.11.7613-7617.2005; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hossain MS, 2011, APPL ENVIRON MICROB, V77, P2428, DOI 10.1128/AEM.02320-10; Hwang G, 2015, J DENT RES, V94, P1310, DOI 10.1177/0022034515592859; Jarosz LM, 2009, EUKARYOT CELL, V8, P1658, DOI 10.1128/EC.00070-09; Jenkinson HF, 2002, POLYMICROBIAL DISEASES, P357; JENKINSON HF, 1990, INFECT IMMUN, V58, P1429; Kamthan M, 2013, FUNGAL GENET BIOL, V54, P15, DOI 10.1016/j.fgb.2013.02.006; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kilic AO, 2007, FEMS MICROBIOL LETT, V266, P218, DOI 10.1111/j.1574-6968.2006.00522.x; Kim D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41332; Kim JN, 2015, APPL ENVIRON MICROB, V81, P5015, DOI 10.1128/AEM.01160-15; Klinke T, 2014, CARIES RES, V48, P24, DOI 10.1159/000351673; Klinke T, 2009, CARIES RES, V43, P83, DOI 10.1159/000204911; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Korithoski B, 2008, FEMS MICROBIOL LETT, V289, P13, DOI 10.1111/j.1574-6968.2008.01351.x; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Marsh PD, 2000, PERIODONTOL, V55, P16, DOI DOI 10.1111/J.1600-0757.2009.00339.X; Merritt J, 2012, MOL ORAL MICROBIOL, V27, P57, DOI 10.1111/j.2041-1014.2011.00634.x; Metwalli KH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003616; Moulos P, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1273; Moye ZD, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.24878; Palmer CA, 2010, J DENT RES, V89, P1224, DOI 10.1177/0022034510376543; Parisotto TM, 2010, ORAL HLTH PREV DENT, V8, P59; POY F, 1990, INFECT IMMUN, V58, P1479; Qi FX, 2004, INFECT IMMUN, V72, P4895, DOI 10.1128/IAI.72.8.4895-4899.204; Qiu RM, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0134-3; Raja M, 2010, CARIES RES, V44, P272, DOI 10.1159/000314675; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha DJP, 2015, ANTON LEEUW INT J G, V108, P685, DOI 10.1007/s10482-015-0524-1; SATO Y, 1989, J BACTERIOL, V171, P263, DOI 10.1128/jb.171.1.263-271.1989                                                   ; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Son M, 2015, APPL ENVIRON MICROB, V81, P5622, DOI 10.1128/AEM.01421-15; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183                                                ; Sztajer H, 2014, ISME J, V8, P2256, DOI 10.1038/ismej.2014.73; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; TAO L, 1993, J DENT RES, V72, P1386, DOI 10.1177/00220345930720100701; Thein ZM, 2009, MYCOSES, V52, P467, DOI 10.1111/j.1439-0507.2009.01719.x; van der Ploeg JR, 2005, J BACTERIOL, V187, P3980, DOI 10.1128/JB.187.12.3980-3989.2005; Wang BY, 2005, APPL ENVIRON MICROB, V71, P354, DOI 10.1128/AEM.71.1.354-362.2005; WILLIAMSON PR, 1993, BIOCHEM J, V291, P765, DOI 10.1042/bj2910765                                                               ; Xu H, 2014, CELL MICROBIOL, V16, P214, DOI 10.1111/cmi.12216; Yang XQ, 2012, ARCH ORAL BIOL, V57, P1048, DOI 10.1016/j.archoralbio.2012.05.012; Zeng L, 2016, APPL ENVIRON MICROB, V82, P146, DOI 10.1128/AEM.02681-15; Zeng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060465; Zeng L, 2013, J BACTERIOL, V195, P833, DOI 10.1128/JB.02042-12; Zeng L, 2010, J BACTERIOL, V192, P2434, DOI 10.1128/JB.01624-09	84	2	2	12	16	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	JUN 8	2017	8								1036	10.3389/fmicb.2017.01036				15	Microbiology	Microbiology	EW9RJ	WOS:000402856600001	28642749	gold			2018-01-05	
J	Ng, HP; Jennings, S; Wang, J; Molina, PE; Nelson, S; Wang, GS				Ng, Hang Pong; Jennings, Scott; Wang, Jack; Molina, Patricia E.; Nelson, Steve; Wang, Guoshun			Non-canonical Glucocorticoid Receptor Transactivation of gilz by Alcohol Suppresses Cell Inflammatory Response	FRONTIERS IN IMMUNOLOGY			English	Article						glucocorticoid receptor; glucocorticoid-induced leucine zipper; glucocorticoid; alcohol; LPS; inflammatory response	INDUCED LEUCINE-ZIPPER; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTECTS T-LYMPHOCYTES; KAPPA-B; NUCLEAR-LOCALIZATION; DOWN-REGULATION; LIVER-DISEASE; EXPRESSION; ETHANOL; INHIBITION	Acute alcohol exposure suppresses cell inflammatory response. The underlying mechanism has not been fully defined. Here we report that alcohol was able to activate glucocorticoid receptor (GR) signaling in the absence of glucocorticoids (GCs) and upregulated glucocorticoid-induced leucine zipper (gilz), a prominent GC-responsive gene. Such a non-canonical activation of GR was not blocked by mifepristone, a potent GC competitor. The proximal promoter of gilz, encompassing five GC-responsive elements (GREs), was incorporated and tested in a luciferase reporter system. Deletion and/or mutation of the GREs abrogated the promoter responsiveness to alcohol. Thus, the GR-GRE interaction transduced the alcohol action on gilz. Alcohol induced GR nuclear translocation, which was enhanced by the alcohol dehydrogenase inhibitor fomepizole, suggesting that it was alcohol, not its metabolites, that engendered the effect. Gel mobility shift assay showed that unliganded GR was able to bind GREs and such interaction withstood clinically relevant levels of alcohol. GR knockout via CRISPR/Cas9 gene targeting or GILZ depletion via small RNA interference diminished alcohol suppression of cell inflammatory response to LPS. Thus, a previously unrecognized, non-canonical GR activation of gilz is involved in alcohol modulation of cell immune response.	[Ng, Hang Pong; Jennings, Scott; Wang, Jack; Wang, Guoshun] Louisiana State Univ, Alcohol & Drug Abuse Ctr, Dept Microbiol Immunol & Parasitol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Molina, Patricia E.] Louisiana State Univ, Dept Physiol, Hlth Sci Ctr, New Orleans, LA USA; [Nelson, Steve] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA	Wang, GS (reprint author), Louisiana State Univ, Alcohol & Drug Abuse Ctr, Dept Microbiol Immunol & Parasitol, Hlth Sci Ctr, New Orleans, LA 70112 USA.	gwang@lsuhsc.edu			NIH [R21AA021824, R21AA024549]; LSUHSC Comprehensive Alcohol Research Center - NIH [P60AA09803]	This work was supported by NIH grants to GW (R21AA021824 and R21AA024549) and a pilot grant from LSUHSC Comprehensive Alcohol Research Center funded by NIH grant P60AA09803 (SN and PM).	Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003.12.4295; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743                                                         ; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; Bengtsson AA, 2002, RHEUMATOLOGY, V41, P563, DOI 10.1093/rheumatology/41.5.563; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Cheng Q, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00169; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2                                                   ; Delfino DV, 2006, INT IMMUNOPHARMACOL, V6, P1126, DOI 10.1016/j.intimp.2006.02.001; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; ELLIS FW, 1966, J PHARMACOL EXP THER, V153, P121; EVANS RM, 1989, RECENT PROG HORM RES, V45, P1; Feng Y, 2010, INT J ONCOL, V36, P1541, DOI 10.3892/ijo_00000641; Gomez M, 2010, J IMMUNOL, V184, P5715, DOI 10.4049/jimmunol.0903521; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Guess A, 2010, AM J PHYSIOL-RENAL, V299, pF845, DOI 10.1152/ajprenal.00161.2010; Hahn RT, 2014, ATHEROSCLEROSIS, V234, P391, DOI 10.1016/j.atherosclerosis.2014.03.028; Hapgood JP, 2016, PHARMACOL THERAPEUT, V165, P93, DOI 10.1016/j.pharmthera.2016.06.002; Hardy CJ, 1998, ANN RHEUM DIS, V57, P451, DOI 10.1136/ard.57.8.451; Haynes D. R., 2006, Inflammopharmacology, V14, P193, DOI 10.1007/s10787-006-0006-1; Hillier SG, 2007, J ENDOCRINOL, V195, P1, DOI 10.1677/JOE-07-0309; Hoppstadter J, 2015, J IMMUNOL, V194, P6057, DOI 10.4049/jimmunol.1403207; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Ji JY, 2003, CIRC RES, V92, P279, DOI 10.1161/01.RES.000057753.57106.0B; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kloner RA, 2007, CIRCULATION, V116, P1306, DOI 10.1161/CIRCULATIONAHA.106.678375; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lo Presti R, 2007, NUTRITION, V23, P598, DOI 10.1016/j.nut.2007.04.012; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1872, DOI 10.1097/01.ALC.0000042220.48841.9E; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Moss M, 2003, CRIT CARE MED, V31, pS207, DOI 10.1097/01.CCM.0000057845.77458.25; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Ni ZH, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-47; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Oakley RH, 1997, ENDOCRINOLOGY, V138, P5028, DOI 10.1210/endo.138.11.5501; PICARD D, 1987, EMBO J, V6, P3333; Pinheiro I, 2013, EMBO MOL MED, V5, P456, DOI 10.1002/emmm.201201683; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0                                                                ; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045                                                    ; SANCHEZ ER, 1992, J BIOL CHEM, V267, P17; Scheschowitsch K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00016; Srinivasan M, 2011, J BIOL CHEM, V286, P44799, DOI 10.1074/jbc.M111.279257; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243                                                     ; THIAGARAJAN AB, 1989, NEUROENDOCRINOLOGY, V50, P427, DOI 10.1159/000125259; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; WEINBERGER C, 1985, SCIENCE, V228, P740, DOI 10.1126/science.2581314; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316                                                            ; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010; Zhang P, 2002, FRONT BIOSCI, V7, pD1314; Zhang Ping, 2008, Curr Drug Abuse Rev, V1, P56; Zhang XH, 2009, CLIN EXP ALLERGY, V39, P647, DOI 10.1111/j.1365-2222.2008.03198.x; Zisman DA, 1998, ALCOHOL CLIN EXP RES, V22, P621, DOI 10.1111/j.1530-0277.1998.tb04303.x	61	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	JUN 7	2017	8								661	10.3389/fimmu.2017.00661				11	Immunology	Immunology	EW9MF	WOS:000402843200001	28638383	gold			2018-01-05	
J	Zhang, XC; Wang, JM; Cheng, QX; Zheng, X; Zhao, GP; Wang, J				Zhang, Xiaochun; Wang, Jingman; Cheng, Qiuxiang; Zheng, Xuan; Zhao, Guoping; Wang, Jin			Multiplex gene regulation by CRISPR-ddCpf1	CELL DISCOVERY			English	Article						CRISPR; Cpf1; DNase-dead Cpf1 (ddCpf1); CRISPRi; multiplex gene regulation	CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; RNA-SEQ; TARGETED MUTAGENESIS; 2-COMPONENT SYSTEMS; HUMAN-CELLS; CPF1; REPRESSION; TRANSCRIPTION; ACTIVATION	The clustered regularly interspaced short palindromic repeats (CRISPR)/dCas9 system has been widely applied in both transcriptional regulation and epigenetic studies. However, for multiple targets, independent expression of multiple single guide RNAs (sgRNAs) is needed, which is less convenient. To address the problem, we employed a DNase-dead Cpf1 mutant (ddCpf1) for multiplex gene regulation. We demonstrated that ddCpf1 alone could be employed for gene repression in Escherichia coli, and the repression was more effective with CRISPR RNAs (crRNAs) specifically targeting to the template strand of its target genes, which was different from that of dCas9. When targeting the promoter region, both strands showed effective repression by the ddCpf1/crRNA complex. The whole-transcriptome RNA-seq technique was further employed to demonstrate the high specificity of ddCpf1-mediated repression. Besides, we proved that the remaining RNase activity in ddCpf1 was capable of processing a precursor CRISPR array to simply generate multiple mature crRNAs in vivo, facilitating multiplex gene regulation. With the employment of this multiplex gene regulation strategy, we also showed how to quickly screen a library of candidate targets, that is, the two-component systems in E. coli. Therefore, based on our findings here, the CRISPR-ddCpf1 system may be further developed and widely applied in both biological research and clinical studies.	[Zhang, Xiaochun; Zheng, Xuan; Zhao, Guoping; Wang, Jin] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhang, Xiaochun] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Zhang, Xiaochun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Jingman] Shenzhen Univ, State Engn Lab Med Key Technol Applicat Synthet, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Shenzhen, Peoples R China; [Wang, Jingman] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Cheng, Qiuxiang] Shanghai Tolo Biotechnol Co Ltd, Shanghai, Peoples R China	Wang, J (reprint author), Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	wangj01@hotmail.com			Chinese Academy of Sciences [XDB19040200]; Youth Innovation Promotion Association CAS; National Natural Science Foundation of China [31430004, 31421061]	This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB19040200), the Youth Innovation Promotion Association CAS and the National Natural Science Foundation of China (31430004 and 31421061).	Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Didovyk A, 2016, ACS SYNTH BIOL, V5, P81, DOI [10.1021/acssynbio5b00147, 10.1021/acssynbio.5b00147]; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Dudoit S, 2008, BIOMETRICAL J, V50, P716, DOI 10.1002/bimj.200710473; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Horlbeck M. A., 2016, ELIFE, V5; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li SY, 2016, ACS SYNTH BIOL, V5, P1383, DOI 10.1021/acssynbio.6b00114; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Ortet P, 2015, NUCLEIC ACIDS RES, V43, pD536, DOI 10.1093/nar/gku968; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shao ZH, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0264-y; Stachler AE, 2016, J BIOL CHEM, V291, P15226, DOI [10.1074/jbc.M116/724062, 10.1074/jbc.M116.724062]; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183                                                ; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ungerer J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39681; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Vora S, 2016, FEBS J, V283, P3181, DOI 10.1111/febs.13768; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wang Y, 2016, BIOTECHNOL BIOENG, V113, P2739, DOI 10.1002/bit.26020; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2017, NAT BIOTECHNOL, V35, P178, DOI 10.1038/nbt0217-178b; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zheng X, 2017, BIOCHEM BIOPH RES CO, V485, P768, DOI 10.1016/j.bbrc.2017.02.129; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	52	4	4	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2056-5968			CELL DISCOV	Cell Discov.	JUN 6	2017	3								UNSP 17018	10.1038/celldisc.2017.18				9	Cell Biology	Cell Biology	FM3OF	WOS:000414915700001	28607761	gold			2018-01-05	
J	Benedetti, L; Cereda, M; Monteverde, L; Desai, N; Ciccarelli, FD				Benedetti, Lorena; Cereda, Matteo; Monteverde, LeeAnn; Desai, Nikita; Ciccarelli, Francesca D.			Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1	ONCOTARGET			English	Article						synthetic lethality; cohesin complex; paralog dependency; cancer vulnerability; precision medicine	ACUTE MYELOID-LEUKEMIA; SISTER-CHROMATID COHESION; GENOMIC LANDSCAPE; BLADDER-CANCER; DRUG-SENSITIVITY; EWING SARCOMA; WHOLE-GENOME; MUTATIONS; ANEUPLOIDY; TARGET	Cohesin is a multi-protein complex that tethers sister chromatids during mitosis and mediates DNA repair, genome compartmentalisation and regulation of gene expression. Cohesin subunits frequently acquire cancer loss-of-function alterations and act as tumour suppressors in several tumour types. This has led to increased interest in cohesin as potential target in anti-cancer therapy. Here we show that the loss-of-function of STAG2, a core component of cohesin and an emerging tumour suppressor, leads to synthetic dependency of mutated cancer cells on its paralog STAG1. STAG1 and STAG2 share high sequence identity, encode mutually exclusive cohesin subunits and retain partially overlapping functions. We inhibited STAG1 and STAG2 in several cancer cell lines where the two genes have variable mutation and copy number status. In all cases, we observed that the simultaneous blocking of STAG1 and STAG2 significantly reduces cell proliferation. We further confirmed the synthetic lethal interaction developing a vector-free CRISPR system to induce STAG1/STAG2 double gene knockout. We provide strong evidence that STAG1 is a promising therapeutic target in cancers with inactivating alterations of STAG2.	[Benedetti, Lorena; Cereda, Matteo; Monteverde, LeeAnn; Desai, Nikita; Ciccarelli, Francesca D.] Kings Coll London, Div Canc Studies, London SE1 1UL, England; [Benedetti, Lorena; Cereda, Matteo; Monteverde, LeeAnn; Desai, Nikita; Ciccarelli, Francesca D.] Francis Crick Inst, Canc Syst Biol Lab, London NW1 1AT, England	Ciccarelli, FD (reprint author), Kings Coll London, Div Canc Studies, London SE1 1UL, England.; Ciccarelli, FD (reprint author), Francis Crick Inst, Canc Syst Biol Lab, London NW1 1AT, England.	francesca.ciccarelli@kcl.ac.uk		Cereda, Matteo/0000-0003-1799-5537	Guy's and St Thomas' Charity; King's College London	We acknowledge the support of the Guy's and St Thomas' Charity and King's College London. Open access for this article was funded by King's College London.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; An O, 2016, NUCLEIC ACIDS RES, V44, pD992, DOI 10.1093/nar/gkv1123; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Bailey ML, 2014, MOL CANCER THER, V13, P724, DOI 10.1158/1535-7163.MCT-13-0749; Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Cancer Genome Atlas Research Network, 2014, NATURE, V507, P315, DOI DOI 10.1038/NATURE12965; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Cereda Matteo, 2016, Trends Cancer, V2, P160, DOI 10.1016/j.trecan.2016.03.003; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI [10.1158/2159-8290.00-13-1037, 10.1158/2159-8290.CD-13-1037]; D'Antonio M, 2013, CELL REP, V5, P1519, DOI 10.1016/j.celrep.2013.11.033; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Lange J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9399; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Feoktistova M., 2016, COLD SPRING HARBOR P, V2016, DOI DOI 10.1101/PDB.PR0T087379; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Kim JS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005865; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Kong XD, 2014, MOL CELL BIOL, V34, P685, DOI 10.1128/MCB.01503-13; Kotani H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128319; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; McLellan JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002574; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Mehta GD, 2013, FEBS LETT, V587, P2299, DOI 10.1016/j.febslet.2013.06.035; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; O'Neil NJ, 2013, TRENDS GENET, V29, P290, DOI 10.1016/j.tig.2012.12.004; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shen CH, 2016, NAT MED, V22, P1056, DOI 10.1038/nm.4155; Shihab HA, 2013, BIOINFORMATICS, V29, P1504, DOI 10.1093/bioinformatics/btt182; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stewart E, 2014, CELL REP, V9, P829, DOI 10.1016/j.celrep.2014.09.028; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI [10.1158/2159-8290.CD-14-0622, 10.1158/2159-8290.00-14-0622]; Vangamudi B, 2015, CANCER RES, V75, P3865, DOI 10.1158/0008-5472.CAN-14-3798; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yu X, 2016, BIOTECHNOL LETT, V38, P919, DOI 10.1007/s10529-016-2064-9	63	1	1	4	4	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUN 6	2017	8	23					37619	37632		10.18632/oncotarget.16838				14	Oncology; Cell Biology	Oncology; Cell Biology	EX4WQ	WOS:000403236400059	28430577	green_published			2018-01-05	
J	Huang, L; Hua, ZD; Xiao, HW; Cheng, Y; Xu, K; Gao, Q; Xia, Y; Liu, Y; Zhang, X; Zheng, XM; Mu, YL; Li, K				Huang, Lei; Hua, Zaidong; Xiao, Hongwei; Cheng, Ying; Xu, Kui; Gao, Qian; Xia, Ying; Liu, Yang; Zhang, Xue; Zheng, Xinming; Mu, Yulian; Li, Kui			CRISPR/Cas9-mediated ApoE(-/-) and LDLR-/- double gene knockout in pigs elevates serum LDL-C and TC levels	ONCOTARGET			English	Article						cardiovascular disease; dyslipidemia; animal model; multiple-gene knockout; gene editing	EFFICIENT GENERATION; ZYGOTE INJECTION; SYSTEM; LOCUS; MICE	The traditional method to establish a cardiovascular disease model induced by high fat and high cholesterol diets is time consuming and laborious and may not be appropriate in all circumstances. A suitable pig model to study metabolic disorders and subsequent atherosclerosis is not currently available. For this purpose, we applied the CRISPR/Cas9 system to Bama minipigs, targeting apolipoprotein E (ApoE) and low density lipoprotein receptor (LDLR) gene simultaneously. Six biallelic knockout pigs of these two genes were obtained successfully in a single step. No off-target incidents or mosaic mutations were detected by an unbiased analysis. Serum biochemical analyses of gene-modified piglets showed that the levels of low density lipoprotein choleserol (LDL-C), total cholesterol (TC) and apolipoprotein B (APOB) were elevated significantly. This model should prove valuable for the study of human cardiovascular disease and related translational research.	[Huang, Lei; Cheng, Ying; Xu, Kui; Gao, Qian; Xia, Ying; Liu, Yang; Zhang, Xue; Mu, Yulian; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Hua, Zaidong; Xiao, Hongwei; Zheng, Xinming] Hubei Acad Agr Sci, Inst Anim Sci & Vet Med, Hubei Key Lab Anim Embryo Engn & Mol Breeding, Wuhan 430064, Peoples R China; [Huang, Lei] Chinese Acad Agr Sci, Agr Genomes Inst Shenzhen, Anim Funct Genom Grp, Shenzhen 518120, Peoples R China	Mu, YL (reprint author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	mouyulian@caas.cn			Major National Scientific Research Projects [2015CB943101]; National Science and Technology Major Project [2016ZX08010004]; International Advanced Agricultural Science and Technology Import Program [2016-X36]; Agricultural Science and Technology Innovation Program of CAAS [ASTIP-IAS05]	This work was supported by grant from the Major National Scientific Research Projects (2015CB943101), National Science and Technology Major Project (2016ZX08010004), International Advanced Agricultural Science and Technology Import Program (2016-X36) and the Agricultural Science and Technology Innovation Program (ASTIP-IAS05) of CAAS.	Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Bordignon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064613; Carrington B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv802; Chen FJ, 2015, J GENET GENOMICS, V42, P437, DOI 10.1016/j.jgg.2015.05.002; Davis BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093457; Georgiadou D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027037; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; Lai LX, 2003, CLONING STEM CELLS, V5, P233, DOI 10.1089/153623003772032754; Langheinrich AC, 2007, ATHEROSCLEROSIS, V191, P73, DOI 10.1016/j.atherosclerosis.2006.05.021; Li YX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002779; Ogita M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163055; Gutierrez LLP, 2008, BIOCHEM PHARMACOL, V75, P2245, DOI 10.1016/j.bcp.2008.03.002; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Reyes LM, 2014, J IMMUNOL, V193, P5751, DOI 10.4049/jimmunol.1402059; Ruan JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14253; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Vilahur G, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/907575; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zhou XY, 2016, HUM MUTAT, V37, P110, DOI 10.1002/humu.22913	26	1	1	3	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	JUN 6	2017	8	23					37751	37760		10.18632/oncotarget.17154				10	Oncology; Cell Biology	Oncology; Cell Biology	EX4WQ	WOS:000403236400070	28465483	green_published			2018-01-05	
J	Harayama, T; Riezman, H				Harayama, Takeshi; Riezman, Howard			Detection of genome-edited mutant clones by a simple competition-based PCR method	PLOS ONE			English	Article							QUANTITATIVE PCR; CRISPR-CAS9; CRISPR/CAS9; DESIGN; SYSTEM; CAS9	Genome editing by the CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats / CRISPR-associated protein 9) system is a revolutionary strategy to study gene functions. Since the efficiency of gene disruption in cell culture does not reach 100% typically, cloning of mutant cells is often performed to obtain fully mutated cells. Therefore, a method to discriminate accurately mutated clones easily and quickly is crucial to accelerate the research using CRISPR/Cas9. Here, we show that knockout cells can be discriminated by a competition-based PCR, using a mixture of three primers, among which one primer overlaps with the Cas9 cleavage site. Together, we show how to optimize primer design in order to improve the effectiveness of the discrimination. Finally, we applied this method to show that mutations conferring drug resistance can be detected with high accuracy. The provided method is easy to perform and requires only basic laboratory equipment, making it suitable for almost all laboratories.	[Harayama, Takeshi; Riezman, Howard] Univ Geneva, Dept Biochem, Geneva, Switzerland; Univ Geneva, NCCR Chem Biol, Sci 2, Geneva, Switzerland	Harayama, T; Riezman, H (reprint author), Univ Geneva, Dept Biochem, Geneva, Switzerland.	harayama-t@umin.net; Howard.Riezman@unige.ch		Riezman, Howard/0000-0003-4680-9422	Swiss National Science Foundation (SNSF) [31003A-146142]; National Centre of Competence in Research (NCCR) Chemical Biology [51NF40-160589]; Japan Society for the Promotion of Science (JSPS); Canton of Geneva; SystemsX [LipidX]	This work was supported by the Swiss National Science Foundation (SNSF) [31003A-146142 to HR]; the National Centre of Competence in Research (NCCR) Chemical Biology [51NF40-160589]; SystemsX (evaluated by the SNSF) [LipidX]; and the Canton of Geneva. TH was supported by the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hashidate-Yoshida T, 2015, ELIFE, V4; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; LIAO SR, 2015, NUCLEIC ACIDS RES, V43, P32733, DOI DOI 10.1093/NAR/GKV675; MORRISON C, 1994, BBA-GENE STRUCT EXPR, V1219, P493, DOI 10.1016/0167-4781(94)90076-0; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368	21	0	0	9	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179165	10.1371/journal.pone.0179165				16	Multidisciplinary Sciences	Science & Technology - Other Topics	EW9YQ	WOS:000402875700051	28586390	gold			2018-01-05	
J	Kuan, PF; Powers, S; He, SY; Li, KQ; Zhao, XY; Huang, B				Kuan, Pei Fen; Powers, Scott; He, Shuyao; Li, Kaiqiao; Zhao, Xiaoyu; Huang, Bo			A systematic evaluation of nucleotide properties for CRISPR sgRNA design	BMC BIOINFORMATICS			English	Article						CRISPR; Machine learning; Predictive modeling; Thermodynamics	DEPENDENT DNA-STRUCTURE; CONFORMATIONAL MAPS; OFF-TARGET; SEQUENCE; SELECTION; ENDONUCLEASE; POTENCY; CELLS; MODEL	Background: CRISPR is a versatile gene editing tool which has revolutionized genetic research in the past few years. Optimizing sgRNA design to improve the efficiency of target/DNA cleavage is critical to ensure the success of CRISPR screens. Results: By borrowing knowledge from oligonucleotide design and nucleosome occupancy models, we systematically evaluated candidate features computed from a number of nucleic acid, thermodynamic and secondary structure models on real CRISPR datasets. Our results showed that taking into account position-dependent dinucleotide features improved the design of effective sgRNAs with area under the receiver operating characteristic curve (AUC) > 0.8, and the inclusion of additional features offered marginal improvement (similar to 2% increase in AUC). Conclusion: Using a machine-learning approach, we proposed an accurate prediction model for sgRNA design efficiency. An R package predictSGRNA implementing the predictive model is available at http://www.ams.sunysb.edu/similar to pfkuan/softwares.html#predictsgrna.	[Kuan, Pei Fen; He, Shuyao; Li, Kaiqiao] SUNY Stony Brook, Dept Appl Math & Stat, 100 Nicolls Rd, Stony Brook, NY 11794 USA; [Powers, Scott; Zhao, Xiaoyu] SUNY Stony Brook, Dept Pathol, 100 Nicolls Rd, Stony Brook, NY 11794 USA; [Huang, Bo] Pfizer Inc, Oncol Business Unit, 558 Eastern Point Rd, Groton, CT 06340 USA	Kuan, PF (reprint author), SUNY Stony Brook, Dept Appl Math & Stat, 100 Nicolls Rd, Stony Brook, NY 11794 USA.	peifen.kuan@stonybrook.edu			NIH [U01CA168409]	This work was supported in part by NIH grant U01CA168409 to S.P. The funding body had no role in the design, collection, analysis or interpretation of this study.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324                                                         ; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fellmann C, 2005, MOL CEL, V41, P733; Fisher RA, 1921, METRON, V1, P3; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451                                                          ; Fusi N, 2015, BIORXIV, V1; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kao HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052678; Knott SRV, 2014, MOL CELL, V56, P796, DOI 10.1016/j.molcel.2014.10.025; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Liu L, 2013, GENOMICS, V102, P215, DOI 10.1016/j.ygeno.2013.07.009; Myers L., 2006, SPEARMAN CORRELATION; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nicodemus K, 2010, BMC BIOINFORMATICS, V11; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Sambrook J, 1989, MOL CLONING LAB MANU; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Watanabe C, 2016, RNA BIOL, V13, P25, DOI 10.1080/15476286.2015.1128062; Wei HR, 2008, NUCLEIC ACIDS RES, V36, P2926, DOI 10.1093/nar/gkn133; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x                                                	36	0	0	6	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	JUN 6	2017	18								297	10.1186/s12859-017-1697-6				9	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	EW9LG	WOS:000402840700003	28587596	gold			2018-01-05	
J	Rodrigues, GMC; Gaj, T; Adil, MM; Wahba, J; Rao, AT; Lorbeer, FK; Kulkarni, RU; Diogo, MM; Cabral, JMS; Miller, EW; Hockemeyer, D; Schaffer, DV				Rodrigues, Goncalo M. C.; Gaj, Thomas; Adil, Maroof M.; Wahba, Joyce; Rao, Antara T.; Lorbeer, Franziska K.; Kulkarni, Rishi U.; Diogo, Maria Margarida; Cabral, Joaquim M. S.; Miller, Evan W.; Hockemeyer, Dirk; Schaffer, David V.			Defined and Scalable Differentiation of Human Oligodendrocyte Precursors from Pluripotent Stem Cells in a 3D Culture System	STEM CELL REPORTS			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; EFFICIENT GENERATION; TRANSCRIPTION FACTOR; REMYELINATE; MODULATION; MYELINATE; NKX2.2; RESCUE	Oligodendrocyte precursor cells (OPCs) offer considerable potential for the treatment of demyelinating diseases and injuries of the CNS. However, generating large quantities of high-quality OPCs remains a substantial challenge that impedes their therapeutic application. Here, we show that OPCs can be generated from human pluripotent stem cells (hPSCs) ina three-dimensional (3D), scalable, and fully defined thermoresponsive biomaterial system. We used CRISPR/Cas9 tocreate aNKX2.2-EGFP human embryonic stem cell reporter line that enabled fine-tuning of early OPC specification and identification of conditions that markedly increased the number of OLIG2(+) and NKX2.2(+) cells generated from hPSCs. Transplantation of 50-day-old OPCs into the brains of NOD/SCID mice revealed that progenitors generated in 3D without cell selection or purification subsequently engrafted, migrated, and matured into myelinating oligodendrocytes in vivo. These results demonstrate the potential of harnessing lineage reporter lines to develop 3D platforms for rapid and large-scale production of OPCs.	[Rodrigues, Goncalo M. C.; Gaj, Thomas; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Rodrigues, Goncalo M. C.; Diogo, Maria Margarida; Cabral, Joaquim M. S.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1049001 Lisbon, Portugal; [Rodrigues, Goncalo M. C.; Diogo, Maria Margarida; Cabral, Joaquim M. S.] Univ Lisbon, Inst Super Tecn, Inst Bioengn & Biosci, P-1049001 Lisbon, Portugal; [Adil, Maroof M.; Wahba, Joyce; Rao, Antara T.; Kulkarni, Rishi U.; Miller, Evan W.; Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Lorbeer, Franziska K.; Miller, Evan W.; Hockemeyer, Dirk; Schaffer, David V.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Miller, Evan W.; Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Schaffer, DV (reprint author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	schaffer@berkeley.edu	Cabral, Joaquim/G-2052-2010	Cabral, Joaquim/0000-0002-2405-5845; Hockemeyer, Dirk/0000-0002-5598-5092; Lorbeer, Franziska/0000-0002-3152-6852	California Institute for Regenerative Medicine [RT3-07800, DISC2-08982]; Fundacao para a Ciencia e a Tecnologia (FCT) Portugal [SFRH/BD/89374/2012]; Ruth L. Kirschstein National Research Service Award [F32GM113446]; CIRM Training Grant [TG2-01164]; NIH Training Grant [GMT32GM066698]; UC Berkeley Hellman Fellows Fund; NIH [R00NS078561]	We thank Claudia Cattoglio for insightful discussions, Tina Wagner for helping with electroporations, and Gokul Nathan Ramadoss for helping with IHC analysis. This work was supported by the California Institute for Regenerative Medicine grants RT3-07800 and DISC2-08982 and a kind gift from Mr. Dennis Chan. G.M.C.R. was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) Portugal (SFRH/BD/89374/2012). T.G. was supported by a Ruth L. Kirschstein National Research Service Award (F32GM113446). M.M.A. was supported in part by CIRM Training Grant TG2-01164, R.U.K. was supported in part by an NIH Training Grant (GMT32GM066698), and E.W.M. was supported by UC Berkeley Hellman Fellows Fund and the NIH (R00NS078561). D.V.S., G.M.C.R., and M.M.A. are inventors on patent applications related to biomaterials for stem cell culture.	Adil MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40573; Alper J., 2009, J BIOTECHNOL, V27, P213; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Barratt HE, 2016, NEUROSCIENCE, V319, P146, DOI 10.1016/j.neuroscience.2016.01.026; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Czepiel M, 2015, GLIA, V63, P513, DOI 10.1002/glia.22769; Diogo MM, 2012, BIOTECHNOL BIOENG, V109, P2699, DOI 10.1002/bit.24706; Douvaras P, 2015, NAT PROTOC, V10, P1143, DOI 10.1038/nprot.2015.075; Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012; Franklin RJM, 2014, GLIA, V62, P1905, DOI 10.1002/glia.22622; Fu H, 2002, DEVELOPMENT, V129, P681; Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Helman G, 2015, PEDIATR CLIN N AM, V62, P649, DOI 10.1016/j.pcl.2015.03.006; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Kulkarni RU, 2017, ACS CHEM BIOL, V12, P407, DOI 10.1021/acschembio.6b00981; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lebkowski Jane, 2011, Regen Med, V6, P11, DOI 10.2217/rme.11.77; Lebkowski J.S., 2017, ASGCT 20 ANN M WASH, P330; Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Livesey MR, 2016, STEM CELLS, V34, P1040, DOI 10.1002/stem.2273; Lourenco T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21563; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Priest CA, 2015, REGEN MED, V10, P939, DOI 10.2217/rme.15.57; Qi YC, 2001, DEVELOPMENT, V128, P2723; Serra M, 2012, TRENDS BIOTECHNOL, V30, P350, DOI 10.1016/j.tibtech.2012.03.003; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; SONTHEIMER H, 1989, NEURON, V2, P1135, DOI 10.1016/0896-6273(89)90180-3                                                    ; Stacpoole SRL, 2013, STEM CELL REP, V1, P437, DOI 10.1016/j.stemcr.2013.09.006; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Wu SQ, 2014, BIOMATERIALS, V35, P8496, DOI 10.1016/j.biomaterials.2014.06.039; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318	57	3	3	4	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	JUN 6	2017	8	6					1770	1783		10.1016/j.stemcr.2017.04.027				14	Cell & Tissue Engineering; Cell Biology	Cell Biology	EX1EX	WOS:000402964700028	28552605	gold			2018-01-05	
J	Fu, L; Qin, YR; Ming, XY; Zuo, XB; Diao, YW; Zhang, LY; Ai, JY; Liu, BL; Huang, TX; Cao, TT; Tan, BB; Xiang, D; Zeng, CM; Gong, J; Zhang, QF; Dong, SS; Chen, J; Liu, HB; Wu, JL; Qi, RZ; Xie, D; Wang, LD; Guan, XY				Fu, Li; Qin, Yan-Ru; Ming, Xiao-Yan; Zuo, Xian-Bo; Diao, Yu-Wen; Zhang, Li-Yi; Ai, Jiaoyu; Liu, Bei-Lei; Huang, Tu-Xiong; Cao, Ting-Ting; Tan, Bin-Bin; Xiang, Di; Zeng, Chui-Mian; Gong, Jing; Zhang, Qiangfeng; Dong, Sui-Sui; Chen, Juan; Liu, Haibo; Wu, Jian-Lin; Qi, Robert Z.; Xie, Dan; Wang, Li-Dong; Guan, Xin-Yuan			RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						RNA editing; metastasis suppressor; familial ESCC; SLC22A3; ADAR2	SQUAMOUS-CELL CARCINOMA; GENOME-WIDE ASSOCIATION; TO-INOSINE RNA; SUSCEPTIBILITY LOCI; COLORECTAL-CANCER; BREAST-CANCER; EXPRESSION; CHINA; ALPHA-ACTININ-4; ACTININ-4	Like many complex human diseases, esophageal squamous cell carcinoma (ESCC) is known to cluster in families. Familial ESCC cases often show early onset and worse prognosis than the sporadic cases. However, the molecular genetic basis underlying the development of familial ESCC is mostly unknown. We reported that SLC22A3 is significantly down-regulated in nontumor esophageal tissues from patients with familial ESCC compared with tissues from patients with sporadic ESCCs. A-to-I RNA editing of the SLC22A3 gene results in its reduced expression in the nontumor esophageal tissues of familial ESCCs and is significantly correlated with lymph node metastasis. The RNA-editing enzyme ADAR2, a familial ESCC susceptibility gene identified by our post hoc genome-wide association study, is positively correlated with the editing level of SLC22A3. Moreover, functional studies showed that SLC22A3 is a metastasis suppressor in ESCC, and deregulation of SLC22A3 facilitates cell invasion and filopodia formation by reducing its direct association with alpha-actinin-4 (ACTN4), leading to the increased actin-binding activity of ACTN4 in normal esophageal cells. Collectively, we now show that A-to-I RNA editing of SLC22A3 contributes to the early development and progression of familial esophageal cancer in high-risk individuals.	[Fu, Li; Diao, Yu-Wen; Liu, Bei-Lei; Huang, Tu-Xiong; Cao, Ting-Ting; Tan, Bin-Bin; Xiang, Di; Zeng, Chui-Mian] Shenzhen Univ, Sch Med, Dept Pharmacol, Shenzhen 518060, Peoples R China; [Fu, Li; Diao, Yu-Wen; Liu, Bei-Lei; Huang, Tu-Xiong; Cao, Ting-Ting; Tan, Bin-Bin; Xiang, Di; Zeng, Chui-Mian] Shenzhen Univ, Hlth Sci Ctr, Canc Res Ctr, Shenzhen 518060, Peoples R China; [Qin, Yan-Ru; Ai, Jiaoyu] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou 450000, Peoples R China; [Ming, Xiao-Yan; Zhang, Li-Yi; Dong, Sui-Sui; Chen, Juan; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Zuo, Xian-Bo] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei 230000, Peoples R China; [Zuo, Xian-Bo] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei 230000, Peoples R China; [Gong, Jing; Zhang, Qiangfeng] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhang, Qiangfeng] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China; [Gong, Jing; Zhang, Qiangfeng] Tsinghua Univ, Sch Life Sci, Ctr Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Haibo] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China; [Wu, Jian-Lin] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Qi, Robert Z.] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Xie, Dan; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Li-Dong] Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Esophageal Canc Res, Zhengzhou 450000, Henan, Peoples R China	Fu, L (reprint author), Shenzhen Univ, Sch Med, Dept Pharmacol, Shenzhen 518060, Peoples R China.; Fu, L (reprint author), Shenzhen Univ, Hlth Sci Ctr, Canc Res Ctr, Shenzhen 518060, Peoples R China.; Guan, XY (reprint author), Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.; Guan, XY (reprint author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	gracelfu@szu.edu.cn; xyguan@hku.hk			National Natural Science Foundation of China (NSFC) [81372583, 81472250, 81572359, U1601229, 81272416, 81272227]; Science and Technology Foundation of Shenzhen [CXZZ20150430092951135, KQTD20140630100658078, JCYJ20150422150029094]; Natural Science Foundation of SZU [201573]; Key Laboratory Project of Shenzhen [ZDSY20130329101130496]; Hong Kong Research Grant Council (RGC) [GRF 767313, 17143716, CUHK/766613, RGC CRF C7038-14G, C7027-14G]; Health and Medical Research Fund [02131876]; Theme-based Research Scheme Fund [T12-704/16-R]; China National Key Projects of Research and Development [2016YFC0904600, 2016YFC1302305]; China National Basic Research Program [012CB967001]; Macau Science and Technology Development Fund Grant [087/2013/A3]	This work was supported by National Natural Science Foundation of China (NSFC) Grants 81372583, 81472250, 81572359, U1601229, 81272416, and 81272227; Science and Technology Foundation of Shenzhen Grants CXZZ20150430092951135, KQTD20140630100658078, and JCYJ20150422150029094; Natural Science Foundation of SZU Grant 201573; Key Laboratory Project of Shenzhen Grant ZDSY20130329101130496; the Hong Kong Research Grant Council (RGC) Grants GRF 767313, 17143716, and CUHK/766613 and Grants RGC CRF C7038-14G and C7027-14G; Health and Medical Research Fund 02131876; Theme-based Research Scheme Fund Grant T12-704/16-R; China National Key Projects of Research and Development Grants 2016YFC0904600 and 2016YFC1302305; China National Basic Research Program Grant 012CB967001; and Macau Science and Technology Development Fund Grant 087/2013/A3. X.-Y.G. is a Sophie YM Chan Professor of Cancer Research.	An HT, 2016, ONCOGENE, V35, P5893, DOI 10.1038/onc.2016.117; Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CARTER CL, 1992, J NATL CANCER I, V84, P771, DOI 10.1093/jnci/84.10.771; Castellsague X, 2000, INT J CANCER, V88, P658, DOI 10.1002/1097-0215(20001115)88:4<658::AID-IJC22>3.0.CO;2-T; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen L, 2013, PHARMACOGENOMICS J, V13, P110, DOI 10.1038/tpj.2011.60; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Deng M, 2013, NAT GENET, V45, P697, DOI 10.1038/ng.2627; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fu L, 2007, CANCER-AM CANCER SOC, V110, P2672, DOI 10.1002/cncr.23110; Grisanzio C, 2012, P NATL ACAD SCI USA, V109, P11252, DOI 10.1073/pnas.1200853109; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383                                                          ; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hu N, 2005, GENE CHROMOSOME CANC, V44, P271, DOI 10.1002/gcc.20242; Hu N, 2003, CANCER EPIDEM BIOMAR, V12, P1112; HU N, 1992, INT J EPIDEMIOL, V21, P877, DOI 10.1093/ije/21.5.877; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2000, CARCINOGENESIS, V21, P2019, DOI 10.1093/carcin/21.11.2019                                                       ; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Koepsell H, 2004, TRENDS PHARMACOL SCI, V25, P375, DOI 10.1016/j.tips.2004.05.005; Li K, 2002, INT J CANCER, V102, P271, DOI 10.1002/jhc.10706; Lu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088918; Nakano M, 2017, J BIOL CHEM, V292, P4873, DOI 10.1074/jbc.M117.775684; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Paz-Yaacov N., 2015, P NATL ACAD SCI USA, V13, P267; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pickens A, 2003, ANN THORAC SURG, V76, pS1367, DOI 10.1016/S0003-4975(03)01202-5                                                   ; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Su H, 2003, CANCER RES, V63, P3872; Thrift AP, 2012, INT J CANCER, V131, pE759, DOI 10.1002/ijc.27420; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wen DG, 2009, EUR J MED GENET, V52, P381, DOI 10.1016/j.ejmg.2009.07.003; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu X, 1998, J BIOL CHEM, V273, P32776, DOI 10.1074/jbc.273.49.32776; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	52	1	1	29	29	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 6	2017	114	23					E4631	E4640		10.1073/pnas.1703178114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EW7OJ	WOS:000402703800014	28533408				2018-01-05	
J	Sun, S; Li, ZQ; Glencer, P; Cai, BC; Zhang, XM; Yang, J; Li, XR				Sun, Shuo; Li, ZhiQing; Glencer, Patrick; Cai, BinCui; Zhang, XiaoMin; Yang, Jin; Li, XiaoRong			Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology	STEM CELL RESEARCH & THERAPY			English	Review						AMD; ARMS2; RPE cells; Stem cells; Genetic model	GROWTH-FACTOR TREATMENT; 5-YEAR INCIDENCE; ASSOCIATION; PREVALENCE; THERAPY; MODEL; CFH; TRANSPLANTATION; POLYMORPHISMS; ANTIOXIDANTS	Age-related macular degeneration (AMD) is a major cause of blindness in older adults in developed countries. It is a multifactorial disease triggered by both environmental and genetic factors. High-temperature requirement A serine peptidase 1 (HTRA1) and age-related maculopathy susceptibility 2 (ARMS2) are two genes that are strongly associated with AMD. Because ARMS2 is an evolutionarily recent primate-specific gene and because the ARMS2/HTRA1 genes are positioned at a locus on chromosome 10q26 in a region with strong linkage disequilibrium, it is difficult to distinguish the functions of the individual genes. Therefore, it is necessary to bring these genes into focus. Patient-specific induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) provides direct access to a patient's genetics and allows for the possibility of identifying the initiating events of RPE-associated degenerative diseases. In this paper, a review of recent epidemiological studies of AMD is offered. An argument for a definite correlation between the ARMS2 gene and AMD is presented. A summary of the use of ARMS2 genotyping for medical treatment is provided. Several ARMS2-related genetic models based on such stem cells as iPSCs are introduced. The possibility of applying gene-editing techniques and stem-cell techniques to better explore the mechanisms of the ARMS2 high-risk allele, which will lead to important guidance for treatment, is also discussed.	[Sun, Shuo; Li, ZhiQing; Cai, BinCui; Zhang, XiaoMin; Yang, Jin; Li, XiaoRong] Tianjin Med Univ, Eye Hosp, Tianjin 300384, Peoples R China; [Glencer, Patrick] Nova Southeastern Coll Optometry, Ft Lauderdale, FL 33314 USA	Yang, J; Li, XR (reprint author), Tianjin Med Univ, Eye Hosp, Tianjin 300384, Peoples R China.	yangjinchina324@gmail.com; lixiaorong@tmu.edu.cn			National Natural Science Funds, China [81400412, 81670875]; Tianjin Natural Science Foundation, Tianjin, China [15JCZDJC34500]; LangMu young scientist scholarship [BJ-LM2015008L]	National Natural Science Funds (81400412), China; National Natural Science Funds (81670875), China; The Key Program of Tianjin Natural Science Foundation (15JCZDJC34500), Tianjin, China; a Grant of Dr. Henry Norman Bethune: LangMu young scientist scholarship (BJ-LM2015008L).	Armstrong Richard A, 2015, J Stem Cells, V10, P171; Awh CC, 2013, OPHTHALMOLOGY, V120, P2317, DOI 10.1016/j.ophtha.2013.07.039; Awh CC, 2015, OPHTHALMOLOGY, V122, pe58; Bonyadi MHJ, 2016, CURR EYE RES, V41, P1519, DOI 10.3109/02713683.2016.1158274; Buchholz DE, 2013, STEM CELL TRANSL MED, V2, P384, DOI 10.5966/sctm.2012-0163; Cheng CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7063; Cheung CMG, 2014, OPHTHALMOLOGY, V121, P1598, DOI 10.1016/j.ophtha.2014.02.004; Chew EY, 2014, OPHTHALMOLOGY, V121, P2173, DOI 10.1016/j.ophtha.2014.05.008; Cramer-Morales K, 2015, FREE RADICAL BIO MED, V89, P379, DOI 10.1016/j.freeradbiomed.2015.07.017; Dedania VS, 2015, RETINA-J RET VIT DIS, V35, P381, DOI 10.1097/IAE.0000000000000466; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fields M., 2016, CELLS, V5, P44; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143272; Grassmann F, 2017, GENETICS, V205, P919, DOI 10.1534/genetics.116.195966; Guan Y, 2013, CURR MOL MED, V13, P1419; Hu ZZ, 2015, BRIT J OPHTHALMOL, V99, P593, DOI 10.1136/bjophthalmol-2014-305488; Johnston SS, 2013, ADV THER, V30, P1111, DOI 10.1007/s12325-013-0078-4; Kortvely E, 2016, ADV EXP MED BIOL, V854, P23, DOI 10.1007/978-3-319-17121-0_4; Krause L, 2013, CURR MED RES OPIN, V29, P1391, DOI 10.1185/03007995.2013.832184; Lee AY, 2008, PHARMACOGENOMICS, V9, P1547, DOI 10.2217/14622416.9.10.1547; Li Y, 2016, ADV EXP MED BIOL, V854, P549, DOI 10.1007/978-3-319-17121-0_73; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Megaw R, 2015, LANCET, V385, P69; Micklisch S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0776-3; Mukesh BN, 2004, OPHTHALMOLOGY, V111, P1176, DOI 10.1016/j.ophtha.2003.08.042; Nazari H, 2015, PROG RETIN EYE RES, V48, P1, DOI 10.1016/j.preteyeres.2015.06.004; Nguyen HV, 2015, J CLIN MED, V4, P567, DOI 10.3390/jcm4040567; Nori S, 2015, STEM CELL REP, V4, P360, DOI 10.1016/j.stemcr.2015.01.006; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Park SJ, 2015, OPHTHALMOLOGY, V122, P2063, DOI 10.1016/j.ophtha.2015.06.018; Park UC, 2014, MOL VIS, V20, P1680; Piermarocchi S, 2015, ACTA OPHTHALMOL, V93, pE451, DOI 10.1111/aos.12587; Qu ZP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0207-x; Saini JS, 2017, CELL STEM CELL, V20, P635, DOI 10.1016/j.stem.2016.12.015; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Silva M, 2015, CELL STEM CELL, V16, P13, DOI 10.1016/j.stem.2014.12.013; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; Smailhodzic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112682; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tzameret A, 2014, EXP EYE RES, V118, P135, DOI 10.1016/j.exer.2013.10.023; Wang G., 2013, SCI WORLD J, V2013, P1; Wang GF, 2014, EXP EYE RES, V119, P1, DOI 10.1016/j.exer.2013.11.009; Wang IK, 2016, RETINA-J RET VIT DIS, V36, P1866, DOI 10.1097/IAE.0000000000001011; Yang J, 2014, HUM MOL GENET, V23, P3445, DOI 10.1093/hmg/ddu053; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yonekawa Y., 2014, COLD SPRING HARB PER, V5; You QS, 2012, OPHTHALMOLOGY, V119, P2519, DOI 10.1016/j.ophtha.2012.06.043; Yvon C, 2015, COMPUT STRUCT BIOTEC, V13, P382, DOI 10.1016/j.csbj.2015.05.001	50	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	JUN 6	2017	8								135	10.1186/s13287-017-0584-4				7	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	EW6UM	WOS:000402645900001	28583181	gold			2018-01-05	
J	Oike, A; Kodama, M; Yasumasu, S; Yamamoto, T; Nakamura, Y; Ito, E; Nakamura, M				Oike, Akira; Kodama, Maho; Yasumasu, Shigeki; Yamamoto, Takashi; Nakamura, Yoriko; Ito, Etsuro; Nakamura, Masahisa			Participation of androgen and its receptor in sex determination of an amphibian species	PLOS ONE			English	Article							FROG RANA-RUGOSA; DM-DOMAIN GENE; EXPRESSION; MICE; CHROMOSOMES; KNOCKOUT; REVERSAL; P450C17; DMRT1; CYP17	Introduction In the Japanese frog Rana (R.) rugosa the androgen receptor (AR) gene on theWchromosome (W-AR) is barely expressed. Previously we showed that incomplete female-to-male sex-reversal occurred in Z-AR transgenic female frogs. To date, however, there is no report showing that AR with androgens can determine genetically programed male sex fate in any vertebrate species. Here, we examined whether AR together with androgens functions as a sex determinant in an amphibian species. Methods To examine whether complete female-to-male sex-reversal occurs in R. rugosa frogs, we produced AR-transgenic (Tg) and -knockdown (KD) female R. rugosa frogs by the I-SceI meganuclease-mediated gene trap and CRISPR/Cas9 system, respectively. AR-Tg and -KD tadpoles were reared in water containing testosterone (T) at 0 to 7.1 ng/ml. Frozen sections were prepared from the gonads of metamorphosed frogs and immunostained for laminin, Vasa, Pat1a, CYP17 and AR. We also employed PCR analysis to examine Dmrt1, Pat1a and CYP17 expression in the gonads of KD and placebo-KD female frogs. Results Complete female-to-male sex-reversal occurred in the AR-Tg ZW female frogs when a low dosage of T was supplied in the rearing water of tadpoles. However, no sex-reversal was observed in AR-KD ZW female frogs when the gonads were treated with dosages of T high enough to induce complete female-to-male sex-reversal even in wild type frogs. Discussion These results suggest that AR with its androgen ligand functions as a male sex-determinant in the ZW type R. rugosa frogs.	[Oike, Akira; Kodama, Maho; Ito, Etsuro; Nakamura, Masahisa] Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Yasumasu, Shigeki] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo, Japan; [Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Hiroshima, Japan; [Nakamura, Yoriko] Ehime Univ, Fac Educ, Dept Sci Educ, Matsuyama, Ehime, Japan	Nakamura, M (reprint author), Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Biol, Shinjuku Ku, Tokyo, Japan.	nakamra@waseda.jp	Yamamoto, Takashi/U-4790-2017	Yamamoto, Takashi/0000-0002-6516-2903	Ministry of Education, Science, and Culture of Japan [15K07137]; Waseda University Grant for Special Research projects Category A [A-16]	This work was supported by Grants-in-Aid to MN from the Ministry of Education, Science, and Culture of Japan (no. 15K07137) and FY2016 Waseda University Grant for Special Research projects Category A (no. A-16) to MN.	Fujii J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093655; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Iwade R, 2008, GEN COMP ENDOCR, V155, P79, DOI 10.1016/j.ygcen.2007.02.032; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Maruo K, 2008, GEN COMP ENDOCR, V158, P87, DOI 10.1016/j.ygcen.2008.04.019; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Nakamura Y, 2015, J EXP ZOOL PART A, V323, P516, DOI 10.1002/jez.1938; Nishioka Midori, 1994, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V13, P1; Ogata M, 2002, CYTOGENET GENOME RES, V99, P185, DOI 10.1159/000071592; Oike A, 2016, J EXP ZOOL PART A, V325, P532, DOI 10.1002/jez.2037; Sakurai N, 2008, J STEROID BIOCHEM, V112, P5, DOI 10.1016/j.jsbmb.2008.07.002; Saotome K, 2010, J EXP ZOOL PART A, V313A, P369, DOI 10.1002/jez.607; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Shen HC, 2012, MOL ENDOCRINOL, V26, P1836, DOI 10.1210/me.2012-1222; Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4                                                   ; Shumway W, 1940, ANAT REC, V78, P139, DOI 10.1002/ar.1090780202                                                           ; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0                                                                ; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Takehana Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5157; TAYLOR AC, 1946, ANAT REC, V94, P7, DOI 10.1002/ar.1090940103; Uno Y, 2008, CHROMOSOME RES, V16, P637, DOI 10.1007/s10577-008-1217-7; Wallace H, 1999, CELL MOL LIFE SCI, V55, P901, DOI 10.1007/s000180050343                                                           ; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yokoyama S, 2009, J EXP ZOOL PART A, V311A, P1; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105	27	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178067	10.1371/journal.pone.0178067				16	Multidisciplinary Sciences	Science & Technology - Other Topics	EW9KF	WOS:000402837600009	28582396	gold			2018-01-05	
J	Fertin, G; Jean, G; Tannier, E				Fertin, Guillaume; Jean, Geraldine; Tannier, Eric			Algorithms for computing the double cut and join distance on both gene order and intergenic sizes	ALGORITHMS FOR MOLECULAR BIOLOGY			English	Article						DCJ; Intergenic regions; Genome rearrangements; Algorithms	GENOME REARRANGEMENTS; REGIONS	Background: Combinatorial works on genome rearrangements have so far ignored the influence of intergene sizes, i.e. the number of nucleotides between consecutive genes, although it was recently shown decisive for the accuracy of inference methods (Biller et al. in Genome Biol Evol 8: 1427-39, 2016; Biller et al. in Beckmann A, Bienvenu L, Jonoska N, editors. Proceedings of Pursuit of the Universal-12th conference on computability in Europe, CiE 2016, Lecture notes in computer science, vol 9709, Paris, France, June 27-July 1, 2016. Berlin: Springer, p. 35-44, 2016). In this line, we define a new genome rearrangement model called wDCJ, a generalization of the well-known double cut and join (or DCJ) operation that modifies both the gene order and the intergene size distribution of a genome. Results: We first provide a generic formula for the wDCJ distance between two genomes, and show that computing this distance is strongly NP-complete. We then propose an approximation algorithm of ratio 4/3, and two exact ones: a fixed-parameter tractable (FPT) algorithm and an integer linear programming (ILP) formulation. Conclusions: We provide theoretical and empirical bounds on the expected growth of the parameter at the center of our FPT and ILP algorithms, assuming a probabilistic model of evolution under wDCJ, which shows that both these algorithms should run reasonably fast in practice.	[Fertin, Guillaume; Jean, Geraldine] Univ Nantes, CNRS, UMR 6004, LS2N, 2 Rue Houssiniere, F-44322 Nantes, France; [Tannier, Eric] Inst Natl Rech Informat & Automat Inria Grenoble, 655 Ave Europe, F-38330 Montbonnot St Martin, France; [Tannier, Eric] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, 43 Blvd 11 Novembre 1918, F-69622 Villeurbanne, France	Jean, G (reprint author), Univ Nantes, CNRS, UMR 6004, LS2N, 2 Rue Houssiniere, F-44322 Nantes, France.	geraldine.jean@univ-nantes.fr			GRIOTE project; Region Pays de la Loire; ANCESTROME project, Investissement d'avenir [ANR-10-BINF-01-01]	Supported by GRIOTE project, funded by Region Pays de la Loire, and the ANCESTROME project, Investissement d'avenir ANR-10-BINF-01-01.	Alexeev N, 2015, IEEE 5 INT C COMP AD; Baudet C, 2014, LECT N BIOINFORMAT, V8826, P99, DOI 10.1007/978-3-319-12418-6_13; Biller P, 2016, LECT NOTES COMPUT SC, V9709, P35, DOI 10.1007/978-3-319-40189-8_4; Biller P, 2016, GENOME BIOL EVOL, V8, P1427, DOI 10.1093/gbe/evw083; Bulteau L, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1264-6; Fertin G, 2009, COMBINATORICS GENOME, P312; Fertin G, 2016, LECT N BIOINFORMAT, V9838, P162, DOI 10.1007/978-3-319-43681-4_13; Garey MR, 1990, COMPUTERS INTRACTABI; HELD M, 1962, J SOC IND APPL MATH, V10, P196, DOI 10.1137/0110015                                                                 ; Lynch M, 2007, ORIGIN GENOME ARCHIT; Swenson KM, 2015, LECT N BIOINFORMAT, V9289, P243, DOI 10.1007/978-3-662-48221-6_18; van der Zanden T., 2016, COMMUNICATION; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535	13	0	0	4	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1748-7188			ALGORITHM MOL BIOL	Algorithms. Mol. Biol.	JUN 5	2017	12								16	10.1186/s13015-017-0107-y				11	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	EX2AC	WOS:000403026900001	28592988	gold			2018-01-05	
J	Osumi-Sutherland, D; Courtot, M; Balhoff, JP; Mungall, C				Osumi-Sutherland, David; Courtot, Melanie; Balhoff, James P.; Mungall, Christopher			Dead simple OWL design patterns	JOURNAL OF BIOMEDICAL SEMANTICS			English	Article						OWL; OBO; Design pattern	ONTOLOGY	Background: Bio-ontologies typically require multiple axes of classification to support the needs of their users. Development of such ontologies can only be made scalable and sustainable by the use of inference to automate classification via consistent patterns of axiomatization. Many bio-ontologies originating in OBO or OWL follow this approach. These patterns need to be documented in a form that requires minimal expertise to understand and edit and that can be validated and applied using any of the various programmatic approaches to working with OWL ontologies. Results: Here we describe a system, Dead Simple OWL Design Patterns (DOS-DPs), which fulfills these requirements, illustrating the system with examples from the Gene Ontology. Conclusions: The rapid adoption of DOS-DPs by multiple ontology development projects illustrates both the ease-of use and the pressing need for the simple design pattern system we have developed.	[Osumi-Sutherland, David; Courtot, Melanie] European Bioinformat Inst EMBL EBI, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Balhoff, James P.] RTI Int, Res Triangle Pk, NC 27709 USA; [Mungall, Christopher] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	Osumi-Sutherland, D (reprint author), European Bioinformat Inst EMBL EBI, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	davidos@ebi.ac.uk			National Human Genome Research Institute (NHGRI) [5U41HG002273- 14]; BD2K [U01 HG009453]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; EMBL-EBI	This work was funded by the Gene Ontology Consortium P41 grant from the National Human Genome Research Institute (NHGRI) [grant 5U41HG002273- 14] and by BD2K [grant U01 HG009453]. CJM acknowledges the support of the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy (DE-AC02-05CH11231). MC was funded by the Gene Ontology Consortium P41 grant from the National Human Genome Research Institute (NHGRI) [grant 5U41HG002273- 14] and EMBL-EBI core funds.	Antezana E, OBO 1 4; Balhoff JP, 2016, DOSDP SCALA; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brinkman RR, 2010, J BIOMED SEMANTIC S1, V1, P7, DOI DOI 10.1186/2041-1480-1-S1-S7; Buttigieg PL, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-43; Costa M, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-32; Dietze H, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-48; Egana M, 2009, CEUR WORKSHOP P, V496, DOI [:10.1038/npre.2009.4006.1, DOI 10.1038/NPRE.2009.4006.1]; Gangemi A., 2005, LECT NOTES COMPUTER, V3729; Haendel MA, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-21; Hammar K, 2016, P WORKSH ONT SEM WEB; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Hitzler P, 2009, OWL2 WEB ONTOLOGY LA; Lord P., 2013, P 10 INT WORKSH OWL, V1080; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Milyaev N, 2012, BIOINFORMATICS, V28, P411, DOI 10.1093/bioinformatics/btr677; Mungall C, 2014, CEUR WORKSHOP P, V1265, P25; Musen Mark A, 2015, AI Matters, V1, P4; Osumi-Sutherland DJ, 2016, DEAD SIMPLE OWL DESI; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102	20	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2041-1480			J BIOMED SEMANT	J. Biomed. Semant.	JUN 5	2017	8								18	10.1186/s13326-017-0126-0				7	Mathematical & Computational Biology	Mathematical & Computational Biology	EW8HN	WOS:000402759900001	28583177	gold			2018-01-05	
J	Li, Q; Wang, W; Zhao, N; Li, PC; Xin, Y; Hu, W				Li, Qing; Wang, Wan; Zhao, Nan; Li, Pengcheng; Xin, Yue; Hu, Wei			Identification and validation of a Schistosoma japonicum U6 promoter	PARASITES & VECTORS			English	Article						Schistosoma japonicum; U6 promoter; sgRNA; RNAi; Lentivirus; Cas9 nuclease	RNA INTERFERENCE; MANSONI; GENOME	Background: RNA polymerase III promoters have been widely used to express short hairpin-RNA (shRNA), microRNA (miRNA), and small guide RNA (sgRNA) in gene functional analysis in a variety of organisms including Schistosoma mansoni. However, no endogenous RNA polymerase III promoters have been identified in Schistosoma japonicum. The lack of appropriate promoters in S. japonicum has hindered its gene functional analysis. Identification of functional promoters in S. japonicum is therefore in urgent need. Results: Via sequence alignment, a 347 bp sequence upstream from the coding region of S. japonicum U6 small nuclear RNA (snRNA) was identified, cloned, and named as S. japonicum U6 (sjU6) promoter. A sgRNA sequence named as sgRNA970 was designed, and its Cas9 nuclease guiding activity was confirmed by in vitro cleavage assay. The sjU6 promoter was ligated with sgRNA970 coding sequence by overlap PCR to generate a sjU6-sgRNA970 expression cassette. The expression cassette was inserted into a lentiviral plasmid to construct the pHBLV-sgRNA970 plasmid. First, we tested the sjU6 promoter activity in HEK293 cells by transfecting HEK293 cells with the pHBLV-sgRNA970 plasmid. RT-PCR amplification of the total RNA from the transfected HEK293 cells confirmed the presence of sgRNA970 transcript and indicated sjU6 promoter was functional to initiate transcription in HEK293 cells. Then we transduced the lentivirus expressing Cas9-ZsGreen fusion protein into 14 dpi schistosomula to test whether lentivirus was capable to induce exogenous gene expression in S. japonicum. Fluorescence microscopy and western blot results confirmed the expression of Cas9-ZsGreen fusion protein in S. japonicum. Therefore, this lentiviral system was adapted to test promoter activity in S. japonicum. Finally, we transduced 14 dpi S. japonicum with lentivirus produced from the pHBLV-sgRNA970 plasmid. RT-PCR amplification of the total RNA from transduced schistosomula confirmed the presence of sgRNA970 transcript and therefore indicated sjU6 promoter was functional to initiate transcription in S. japonicum. Conclusion: To our knowledge, sjU6 promoter would be the first identified and validated endogenous RNA polymerase III promoter in S. japonicum, which could be used for future CRISPR/Cas9 studies in S. japonicum.	[Li, Qing; Wang, Wan; Zhao, Nan; Li, Pengcheng; Xin, Yue; Hu, Wei] Fudan Univ, State Key Lab Genet Engn, Minist Educ,Sch Life Sci, Key Lab Contemporary Anthropol,Dept Microbiol & M, Shanghai 200433, Peoples R China; [Hu, Wei] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, WHO Cooperat Ctr Trop Dis, Key Lab Parasite & Vector Biol MOH, Shanghai 200025, Peoples R China	Hu, W (reprint author), Fudan Univ, State Key Lab Genet Engn, Minist Educ,Sch Life Sci, Key Lab Contemporary Anthropol,Dept Microbiol & M, Shanghai 200433, Peoples R China.; Hu, W (reprint author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, WHO Cooperat Ctr Trop Dis, Key Lab Parasite & Vector Biol MOH, Shanghai 200025, Peoples R China.	huw@fudan.edu.cn			National Natural Science Foundation of China [91431104]	This work was funded by the National Natural Science Foundation of China (ref no.91431104).	Ayuk MA, 2011, INT J PARASITOL, V41, P783, DOI 10.1016/j.ijpara.2011.02.004; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Cummins David, 2008, J RNAi Gene Silencing, V4, P289; Da'dara AA, 2015, METHODS MOL BIOL, V1201, P143, DOI 10.1007/978-1-4939-1438-8_8; Duvoisin R, 2012, TRANSGENIC RES, V21, P511, DOI 10.1007/s11248-011-9548-0; Hagen J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6375; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Liang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098302; Liu S, 2012, MOL BIOCHEM PARASIT, V182, P75, DOI 10.1016/j.molbiopara.2011.12.007; Mann VH, 2014, TRANSGENIC RES, V23, P539, DOI 10.1007/s11248-013-9779-3; Oliveira G, 2008, ACTA TROP, V108, P179, DOI 10.1016/j.actatropica.2008.04.022; Rinaldi G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002820; Schistosoma japonicum Genome Sequencing Functional Analysis Consortium, 2009, NATURE, V460, P345; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; Tchoubrieva EB, 2010, CELL MOL LIFE SCI, V67, P3739, DOI 10.1007/s00018-010-0345-3; Yuan XS, 2005, EXP PARASITOL, V111, P244, DOI 10.1016/j.exppara.2005.08.010; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096908	17	0	0	8	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 5	2017	10								281	10.1186/s13071-017-2207-4				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EW7JI	WOS:000402685200002	28583151	gold			2018-01-05	
J	Liu, YZ; Qi, XW; Zeng, ZZ; Wang, L; Wang, J; Zhang, T; Xu, QA; Shen, CL; Zhou, GD; Yang, SM; Chen, XM; Lu, FM				Liu, Yongzhen; Qi, Xuewei; Zeng, Zhenzhen; Wang, Lu; Wang, Jie; Zhang, Ting; Xu, Qiang; Shen, Congle; Zhou, Guangde; Yang, Shaomin; Chen, Xiangmei; Lu, Fengmin			CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice	SCIENTIFIC REPORTS			English	Article							FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; IN-VIVO; TUMOR-SUPPRESSOR; MOUSE-LIVER; CANCER; GENES; INTEGRATION; SYSTEM; EXPRESSION	The p53 mutation and altered Pten expression are two most common genetic events in Hepatitis B virus (HBV) infection related hepatocellular carcinoma (HCC). To confirm the causative role of p53 and Pten somatic mutation in HCC development, we established CRISPR/Cas9-mediated somatic gene disruption via hydrodynamic tail vein injection, allowing for in vivo targeting p53 and Pten simultaneously in adult HBV transgenic mice. Here we demonstrated that the utility of this approach resulted in macroscopic liver tumors as early as 4 months' post injection and most tumors harbored both p53 and Pten loss-of-function alterations. Immunohistochemical (IHC) and histopathology analysis demonstrated that the tumors were positive for Glutamine synthetase (GS), a marker of HCC and accompanied with prominent lipid accumulation. The study here indicated that CRISPR/Cas9-mediated p53 and Pten somatic mutation accelerated hepatocarcinogenesis in adult HBV transgenic mice. This method also provides a fast and convenient system for generating mouse model of HCC with HBV infection characteristics.	[Liu, Yongzhen; Qi, Xuewei; Zeng, Zhenzhen; Wang, Lu; Wang, Jie; Zhang, Ting; Xu, Qiang; Shen, Congle; Chen, Xiangmei; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing 100191, Peoples R China; [Zhou, Guangde] Beijing 302 Hosp, Dept Pathol & Hepatol, Beijing 100039, Peoples R China; [Yang, Shaomin] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China	Chen, XM (reprint author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing 100191, Peoples R China.	xm_chen6176@bjmu.edu.cn			National Natural Science Foundation of China [81572366, 81471938, 81372603]; 111 Project [B07001]	This study was supported by grants from National Natural Science Foundation of China (Nos. 81572366, 81471938 and 81372603) and the 111 Project (B07001).	Amaddeo G, 2015, GUT, V64, P820, DOI 10.1136/gutjnl-2013-306228; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bai YC, 2016, G3-GENES GENOM GENET, V6, P917, DOI 10.1534/g3.116.027706; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Ding SL, 2015, WORLD J GASTROENTERO, V21, P6317, DOI 10.3748/wjg.v21.i20.6317; DUNSFORD HA, 1990, CANCER RES, V50, P3400; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Horie Y., 2004, AUTOPHAGY, V113, P1774; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Jiang SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040363; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009; Kawai-Kitahata F, 2016, J GASTROENTEROL, V51, P473, DOI 10.1007/s00535-015-1126-4; Li XJ, 2014, J HEPATOL, V60, P975, DOI 10.1016/j.jhep.2013.12.014; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lunn RM, 1997, CANCER RES, V57, P3471; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Murata S, 2015, INT J MOL SCI, V16, P12051, DOI 10.3390/ijms160612051; Page JM, 2009, CLIN LIVER DIS, V13, P631, DOI 10.1016/j.cld.2009.07.007; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Rapti Irene, 2015, World J Hepatol, V7, P1064, DOI 10.4254/wjh.v7.i8.1064; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song PP, 2016, WORLD J GASTROENTERO, V22, P262, DOI 10.3748/wjg.v22.i1.262; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Tarocchi M, 2014, WORLD J GASTROENTERO, V20, P11630, DOI 10.3748/wjg.v20.i33.11630; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wen X., 2016, MEDICINE, V94, pe577; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yao MJ, 2016, ONCOTARGET, V7, P3702, DOI 10.18632/oncotarget.6913; Yao YJ, 1999, ONCOGENE, V18, P3181, DOI 10.1038/sj.onc.1202659; Zhang C, 2015, INT J CANCER, V137, P1818, DOI 10.1002/ijc.29548; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	46	1	1	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 5	2017	7								2796	10.1038/s41598-017-03070-8				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EW7LB	WOS:000402690200012	28584302	gold			2018-01-05	
J	Chang, HT; Liu, Y; Ai, D; Jiang, XC; Dong, SL; Wang, GR				Chang, Hetan; Liu, Yang; Ai, Dong; Jiang, Xingchuan; Dong, Shuanglin; Wang, Guirong			A Pheromone Antagonist Regulates Optimal Mating Time in the Moth Helicoverpa armigera	CURRENT BIOLOGY			English	Article							SEX-PHEROMONE; HELIOTHIS-ARMIGERA; COTTON BOLLWORM; BEHAVIORAL-RESPONSES; MATE CHOICE; COMPONENTS; LEPIDOPTERA; DROSOPHILA; NOCTUIDAE; SYSTEM	Many insect species use multi-component sex pheromones to discriminate among potential mating partners [1-5]. In moths, pheromone blends tend to be dominated by one or two major components, but behavioral responses are frequently optimized by the inclusion of less abundant minor components [6]. An increasing number of studies have shown that female insects use these chemicals to convey their mating availability to males, who can assess the maturity of females and thus decide when to mate [7, 8]. However, little is known about the biological mechanisms that enable males to assess female reproductive status. In this study, we found that females of Helicoverpa armigera avoid nonoptimal mating by inhibiting males with pheromone antagonist cis-11-Hexadecenol (Z11-16: OH). We also show that this antagonist-mediated optimization of mating time ensures maximum fecundity. To further investigate molecular aspects of this phenomenon, we used the CRISPR/Cas9 system to knock out odorant receptor 16 (OR16), the only pheromone receptor tuned to Z11-16: OH. In mutant males, electrophysiological and behavioral responses to Z11-16: OH were abolished. Inability to detect Z11-16: OH prompted the males to mate with immature females, which resulted in significantly reduced viability of eggs. In conclusion, our study demonstrates that the sensitivity of OR16 to Z11-16: OH regulates optimalmating time and thus ensures maximum fecundity. These results may suggest novel strategies to disrupt pest insect mating.	[Chang, Hetan; Liu, Yang; Ai, Dong; Wang, Guirong] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Chang, Hetan; Dong, Shuanglin] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China; [Jiang, Xingchuan] Anhui Agr Univ, Sch Plant Protect, Hefei 230036, Peoples R China	Wang, GR (reprint author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	wangguirong@caas.cn			National Natural Science Foundation of China [31230062, 31621064]	We thank Drs. P. Pelosi, E. Jacquin-Joly, Z. Sayed, and F. Gould for comments and editorial assistance with the manuscript and Dr. A. Tan for advice on CRISPR/Cas9. This work was funded by the National Natural Science Foundation of China (31230062 and 31621064).	Baker TC, 1976, J CHEM ECOL, V2, P333, DOI 10.1007/BF00988281; BAKER TC, 1981, ENTOMOL EXP APPL, V30, P269, DOI 10.1111/j.1570-7458.1981.tb03110.x                                              ; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Beumer KJ, 2014, METHODS, V68, P29, DOI 10.1016/j.ymeth.2013.12.002; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Carazo P, 2004, ANIM BEHAV, V68, P123, DOI 10.1016/j.anbehav.2003.10.014; Chang HT, 2016, SCI REP-UK, V6, DOI 10.1038/srep18742; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Cosse AA, 1998, J COMP PHYSIOL A, V182, P585, DOI 10.1007/s003590050205; Dweck HKM, 2015, P NATL ACAD SCI USA, V112, pE2829, DOI 10.1073/pnas.1504527112; Ferrero DM, 2013, NATURE, V502, P368, DOI 10.1038/nature12579; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Hillier NK, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P301; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; KEHAT M, 1980, ENTOMOL EXP APPL, V27, P188, DOI 10.1111/j.1570-7458.1980.tb02963.x                                              ; KEHAT M, 1990, J INSECT BEHAV, V3, P75, DOI 10.1007/BF01049196; LINN CE, 1987, SCIENCE, V237, P650, DOI 10.1126/science.237.4815.650                                                    ; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23864; Ming QL, 2007, J INSECT PHYSIOL, V53, P170, DOI 10.1016/j.jinsphys.2006.11.007; NESBITT BF, 1979, J INSECT PHYSIOL, V25, P535, DOI 10.1016/S0022-1910(79)80012-8; ROELOFS WL, 1977, ANNU REV ENTOMOL, V22, P377, DOI 10.1146/annurev.en.22.010177.002113; Singh AK, 2002, J APPL ENTOMOL, V126, P14, DOI 10.1046/j.1439-0418.2002.00600.x; Thomas ML, 2011, BIOL REV, V86, P1, DOI 10.1111/j.1469-185X.2010.00130.x; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wu U, 1997, ENTOMOL SIN, V4, P227; Wyatt T. D., 2003, PHEROMONES ANIMAL BE; Zhang JP, 2012, J INSECT PHYSIOL, V58, P1209, DOI 10.1016/j.jinsphys.2012.05.018; [张万娜 Zhang Wanna], 2013, [昆虫学报, Acta Entomologica Sinica], V56, P358	32	3	3	67	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	JUN 5	2017	27	11					1610	+		10.1016/j.cub.2017.04.035				9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EW9CO	WOS:000402814600046	28528905				2018-01-05	
J	Yang, WQ; Zhang, SL; Zhang, Y; Huang, X				Yang, Wenqing; Zhang, Siliang; Zhang, Yi; Huang, Xin			A novel strategy to dissect endogenous gene transcriptional regulation in live cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						CRISPR-Cas9; ARID1A; Transcription regulation	SWI/SNF-RELATED COMPLEXES; DNA-DAMAGE; ARID1A MUTATIONS; TUMOR-SUPPRESSOR; CERVICAL-CANCER; CYCLE ARREST; TARGET; MICRORNAS; HETEROGENEITY	Gene transcription is a central tenet of biology, traditionally measured by RT-PCR, microarray, or more recently, RNA sequencing. However, these measurements only provide a snapshot of the state of gene transcription and only represent an overall readout of complex transcriptional networks that regulate gene expression. In this report, we describe a novel strategy to dissect endogenous gene transcription regulation in live cells by knocking in a reporter gene, EGFP, under the control of the endogenous gene promoter, using the ARID1A gene as an example. The ARID1A gene, encoding a subunit of the ATP dependent chromatin remodeling complex SNF/SWI, has recently been identified as a tumor suppressor in multiple cancers. Despite studies that elucidate the mechanism of ARID1A's tumor suppressor function, little is known of the genes/events that regulate ARIDIA expression. Using the HEK293 cells as a model, we discovered novel aspects of ARIDIA transcription regulation in response to cell cycle progression, DNA damage, and microRNAs, exemplifying the potential of our strategy in providing new insight to the mechanism of gene transcription regulation. This strategy can be generalized to essentially any gene of interest, making it a powerful tool for the study of gene expression heterogeneity, especially in cancer cells, and a robust readout for high-throughput screening of agents that modulate gene transcription. (C) 2017 Elsevier Inc. All rights reserved.	[Yang, Wenqing; Zhang, Yi] Cent S Univ, Dept Obstet & Gynecol, Xiangya Hosp, Changsha 410005, Hunan, Peoples R China; [Yang, Wenqing; Zhang, Siliang; Huang, Xin] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Yang, Wenqing; Zhang, Siliang; Huang, Xin] Univ Pittsburgh, Canc Inst, Womens Canc Res Ctr, Pittsburgh, PA 15213 USA; [Zhang, Siliang] Harbin Med Univ, Dept Radiat Oncol, Affiliated Hosp 3, Harbin 150081, Heilongjiang Pr, Peoples R China	Zhang, Y (reprint author), Cent S Univ, Dept Obstet & Gynecol, Xiangya Hosp, Changsha 410005, Hunan, Peoples R China.; Huang, X (reprint author), Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	zhangyi20080903@163.com; huangx2@upmc.edu			NCI-RPCI-UPCI Ovarian Cancer [SPORE - P50 CA159981]; American Cancer Society (ACS) [RSG-12-188-01-RMC]; Liz Tilberis Scholars Award [OCRF 258940]	This work was supported by the NCI-funded RPCI-UPCI Ovarian Cancer(grant number SPORE - P50 CA159981), the American Cancer Society (ACS) (grant number RSG-12-188-01-RMC), and the Liz Tilberis Scholars Award (grant number OCRF 258940).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chandler RL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7118; DELBINO G, 1991, EXP CELL RES, V193, P27, DOI 10.1016/0014-4827(91)90534-2; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615                                                           ; Joshua T. Mendell, 2012, CELL, V148, P1172; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu WC, 2016, ONCOTARGET, V7, P57254, DOI 10.18632/oncotarget.11138; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schmitt MW, 2016, NAT REV CLIN ONCOL, V13, P335, DOI 10.1038/nrclinonc.2015.175; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Tong I. Lee, 2013, CELL, V152, P1237; Wang N, 2014, GYNECOL ONCOL, V134, P129, DOI 10.1016/j.ygyno.2014.04.047; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Yang Y, 2016, EUR REV MED PHARMACO, V20, P1509; Zeng Y, 2013, HEAD NECK ONCOL, V5, P6	30	0	0	6	18	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUN 3	2017	487	3					573	579		10.1016/j.bbrc.2017.04.092				7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EV5DT	WOS:000401783400014	28433629				2018-01-05	
J	Boehm, E; Zaganelli, S; Maundrell, K; Jourdain, AA; Thore, S; Martinou, JC				Boehm, Erik; Zaganelli, Sofia; Maundrell, Kinsey; Jourdain, Alexis A.; Thore, Stephane; Martinou, Jean-Claude			FASTKD1 and FASTKD4 have opposite effects on expression of specific mitochondrial RNAs, depending upon their endonuclease-like RAP domain	NUCLEIC ACIDS RESEARCH			English	Article							GENE-EXPRESSION; PROTEIN; GRANULES; TRANSLATION; ORGANIZATION; NUCLEOIDS; RESIDES; DNA	FASTK family proteins have been identified as regulators of mitochondrial RNA homeostasis linked to mitochondrial diseases, but much remains unknown about these proteins. We show that CRISPR-mediated disruption of FASTKD1 increases ND3 mRNA level, while disruption of FASTKD4 reduces the level of ND3 and of other mature mRNAs including ND5 and CYB, and causes accumulation of ND5-CYB precursor RNA. Disrupting both FASTKD1 and FASTKD4 in the same cell results in decreased ND3 mRNA similar to the effect of depleting FASTKD4 alone, indicating that FASTKD4 loss is epistatic. Interestingly, very low levels of FASTKD4 are sufficient to prevent ND3 loss and ND5-CYB precursor accumulation, suggesting that FASTKD4 may act catalytically. Furthermore, structural modeling predicts that each RAP domain of FASTK proteins contains a nuclease fold with a conserved aspartate residue at the putative active site. Accordingly, mutation of this residue in FASTKD4 abolishes its function. Experiments with FASTK chimeras indicate that the RAP domain is essential for the function of the FASTK proteins, while the region upstream determines RNA targeting and protein localization. In conclusion, this paper identifies new aspects of FASTK protein biology and suggests that the RAP domain function depends on an intrinsic nucleolytic activity.	[Boehm, Erik; Zaganelli, Sofia; Maundrell, Kinsey; Jourdain, Alexis A.; Martinou, Jean-Claude] Univ Geneva, Cell Biol Dept, CH-1211 Geneva 4, Switzerland; [Thore, Stephane] Univ Bordeaux, CNRS UMR 5320, INSERM U 1212, ARNA Lab, F-33000 Bordeaux, France; [Jourdain, Alexis A.] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA	Martinou, JC (reprint author), Univ Geneva, Cell Biol Dept, CH-1211 Geneva 4, Switzerland.	Jean-Claude.Martinou@unige.ch			Swiss National Science Foundation [310030B_160257/1, 31003A_140924, 31003A_124909]; IGE3; State of Geneva	Swiss National Science Foundation [310030B_160257/1 to J.-C.M.; 31003A_140924 and 31003A_124909 to S.T.]; IGE3; State of Geneva. Funding for open access charge: Swiss National Science Foundation [310030B_160257/1 to J.-C.M.; 31003A_140924 and 31003A_124909 to S.T.]	Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Boulouis A, 2015, PLANT CELL, V27, P984, DOI 10.1105/tpc.15.00010; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Eberhard S, 2011, PLANT J, V67, P1055, DOI 10.1111/j.1365-313X.2011.04657.x; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kleinknecht L, 2014, PLANT CELL, V26, P777, DOI 10.1105/tpc.114.122853; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Perron K, 2004, RNA, V10, P704, DOI 10.1261/rna.5237804; Popow J, 2015, RNA, V21, P1873, DOI 10.1261/rna.052365.115; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Silva D. D., 2015, CELL CYCLE, V14, P2226; Simarro M, 2010, BIOCHEM BIOPH RES CO, V401, P440, DOI 10.1016/j.bbrc.2010.09.075; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; Tsutakawa SE, 1999, MOL CELL, V3, P621, DOI 10.1016/S1097-2765(00)80355-X; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; Wang F, 2015, PLANT J, V82, P861, DOI 10.1111/tpj.12858; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847	32	1	1	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	JUN 2	2017	45	10					6135	6146		10.1093/nar/gkx164				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW4YH	WOS:000402510700057	28335001	gold			2018-01-05	
J	Patterson, AG; Yevstigneyeva, MS; Fineran, PC				Patterson, Adrian G.; Yevstigneyeva, Mariya S.; Fineran, Peter C.			Regulation of CRISPR-Cas adaptive immune systems	CURRENT OPINION IN MICROBIOLOGY			English	Review							QUORUM SENSING CONTROLS; H-NS; ESCHERICHIA-COLI; MEDIATED ACTIVATION; MYXOCOCCUS-XANTHUS; SPACER ACQUISITION; RECEPTOR PROTEIN; GENE-EXPRESSION; FOREIGN DNA; TRANSCRIPTION	CRISPR-Cas systems are prokaryotic immune systems that allow defense against invasion by foreign genetic elements. Through the acquisition of genetic memory representing prior exposure, the CRISPR-Cas machinery identifies complementary nucleic acids and mediates their destruction. Since their discovery, CRISPR-Cas research has exploded, with major progress into their mechanism and biotechnological application. In contrast, we are only beginning to understand how CRISPR-Cas activity is regulated. Recent studies have uncovered both conserved regulatory pathways, in addition to more specific mechanisms. Identifying the stimuli linking invasion with CRISPR-Cas activation will be essential in unraveling their ecological roles, evolutionary success and might offer strategies to control immunity for particular applications. We highlight factors impinging on CRISPR-Cas regulation across diverse bacterial and archaeal species.	[Patterson, Adrian G.; Yevstigneyeva, Mariya S.; Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand; [Fineran, Peter C.] Univ Otago, Bioprotect Res Ctr, POB 56, Dunedin 9054, New Zealand	Fineran, PC (reprint author), Univ Otago, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand.; Fineran, PC (reprint author), Univ Otago, Bioprotect Res Ctr, POB 56, Dunedin 9054, New Zealand.	peter.fineran@otago.ac.nz			Rutherford Discovery Fellowship (PCF) from the Royal Society of New Zealand (RSNZ); Marsden Fund (RSNZ), a University of Otago Research; Bio-Protection Research Centre (Tertiary Education Commission); University of Otago	We thank members of the Fineran laboratory and our collaborators for helpful discussions and for comments on the manuscript. This work was supported by a Rutherford Discovery Fellowship (PCF) from the Royal Society of New Zealand (RSNZ), the Marsden Fund (RSNZ), a University of Otago Research Grant and the Bio-Protection Research Centre (Tertiary Education Commission). AGP and MSY were supported by University of Otago Doctoral Scholarships.	Abedon ST, 2012, VIRUSES-BASEL, V4, P663, DOI 10.3390/v4050663; Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; Arslan Z, 2013, RNA BIOL, V10, P708, DOI 10.4161/rna.23765; Babic A, 2011, MBIO, V2, DOI 10.1128/mBio.00027-11; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bowden SD, 2013, MOL MICROBIOL, V90, P457, DOI 10.1111/mmi.12369; Chevallereau A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006134; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; De Smet J, 2016, ISME J, V10, P1823, DOI 10.1038/ismej.2016.3; Deng DM, 2007, J DENT RES, V86, P606, DOI 10.1177/154405910708600705                                                      ; Deng L, 2012, NUCLEIC ACIDS RES, V40, P2470, DOI 10.1093/nar/gkr1111; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; Fusco S, 2015, BIOCHIMIE, V118, P322, DOI 10.1016/j.biochi.2015.04.006; Gao R, 2015, APPL ENVIRON MICROB, V81, P7993, DOI 10.1128/AEM.01043-15; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; He F, 2017, NUCLEIC ACIDS RES, V45, P1902, DOI 10.1093/nar/gkw1265; Hernandez-Lucas I, 2008, J BACTERIOL, V190, P1658, DOI 10.1128/JB.01649-07; Hogema BM, 1997, MOL MICROBIOL, V24, P857, DOI 10.1046/j.1365-2958.1997.3991761.x                                              ; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098                                                         ; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Lin TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31644; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Liu T, 2015, NUCLEIC ACIDS RES, V43, P1044, DOI 10.1093/nar/gku1383; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Majsec K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0643-5; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Medina-Aparicio L, 2011, J BACTERIOL, V193, P2396, DOI 10.1128/JB.01480-10; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Patterson AG, 2015, NUCLEIC ACIDS RES, V43, P6038, DOI 10.1093/nar/gkv517; Peng X, 2003, J BACTERIOL, V185, P2410, DOI 10.1128/JB.185.8.2410-2417.2003; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Poranen MM, 2006, J VIROL, V80, P8081, DOI 10.1128/JVI.00065-06; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Quax TEF, 2013, CELL REP, V4, P938, DOI 10.1016/j.celrep.2013.07.049; Quax TEF, 2013, J VIROL, V87, P8419, DOI 10.1128/JVI.01020-13; Ratner HK, 2015, CURR OPIN INFECT DIS, V28, P267, DOI 10.1097/QCO.0000000000000154; Samuels DJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-602; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Serbanescu MA, 2015, J BACTERIOL, V197, P749, DOI 10.1128/JB.02333-14; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Skennerton CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020095; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Stratmann T, 2012, MOL MICROBIOL, V83, P1109, DOI 10.1111/j.1365-2958.2012.07993.x; Swarts DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124880; Vale PF, 2015, P ROY SOC B-BIOL SCI, V282, P41, DOI 10.1098/rspb.2015.1270; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yang CD, 2014, MOL MICROBIOL, V92, P1072, DOI 10.1111/mmi.12614; Yosef I, 2011, P NATL ACAD SCI USA, V108, P20136, DOI 10.1073/pnas.1113519108; Young JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038077	64	3	3	0	2	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						1	7		10.1016/j.mib.2017.02.004				7	Microbiology	Microbiology	FO1EM	WOS:000416499500003	28359988				2018-01-05	
J	Koonin, EV; Makarova, KS; Zhang, F				Koonin, Eugene V.; Makarova, Kira S.; Zhang, Feng			Diversity, classification and evolution of CRISPR-Cas systems	CURRENT OPINION IN MICROBIOLOGY			English	Review							GUIDED SURVEILLANCE COMPLEX; TARGET DNA RECOGNITION; CRYSTAL-STRUCTURE; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; RNASE ACTIVITIES; STRUCTURAL BASIS; CLEAVAGE; ENDONUCLEASE	The bacterial and archaeal CRISPR-Cas systems of adaptive immunity show remarkable diversity of protein composition, effector complex structure, genome locus architecture and. mechanisms of adaptation, pre-CRISPR (cr)RNA processing and interference. The CRISPR-Cas systems belong to two classes, with multi-subunit effector complexes in Class 1 and single-protein effector modules in Class 2. Concerted genomic and experimental efforts on comprehensive characterization of Class 2 CRISPR-Cas systems led to the identification of two new types and several subtypes. The newly characterized type VI systems are the first among the CRISPR-Cas variants to exclusively target RNA. Unexpectedly, in some of the class 2 systems, the effector protein is additionally responsible for the pre-crRNA processing. Comparative analysis of the effector complexes indicates that Class 2 systems evolved from mobile genetic elements on multiple, independent occasions.	[Koonin, Eugene V.; Makarova, Kira S.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Zhang, Feng] Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Zhang, Feng] Dept Biol Engn, Cambridge, MA 02139 USA	Koonin, EV (reprint author), Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kapitonov VV, 2016, J BACTERIOL, V198, P797, DOI 10.1128/JB.00783-15; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Koonin Eugene V, 2017, Bioessays, V39, P1, DOI 10.1002/bies.201600186; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Krupovic M, 2017, CURR OPIN MICROBIOL, V38, P36, DOI 10.1016/j.mib.2017.04.004; Krupovic M, 2016, CURR OPIN MICROBIOL, V31, P25, DOI 10.1016/j.mib.2016.01.006; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Kuznedelov K, 2016, NUCLEIC ACIDS RES, V44, P10849, DOI 10.1093/nar/gkw914; Lewis KM, 2017, MOL CELL, V65, P377, DOI 10.1016/j.molcel.2017.01.024; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pasternak C, 2013, MOL MICROBIOL, V88, P443, DOI 10.1111/mmi.12194; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Shmakov S, 2017, NAT REV MICROBIOL; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	71	14	14	7	7	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						67	78		10.1016/j.mib.2017.05.008				12	Microbiology	Microbiology	FO1EM	WOS:000416499500013	28605718				2018-01-05	
J	Hidalgo-Cantabrana, C; O'Flaherty, S; Barrangou, R				Hidalgo-Cantabrana, Claudio; O'Flaherty, Sarah; Barrangou, Rodolphe			CRISPR-based engineering of next-generation lactic acid bacteria	CURRENT OPINION IN MICROBIOLOGY			English	Review							ANTHRACIS PROTECTIVE ANTIGEN; TOXIN FRAGMENT-C; LACTOBACILLUS-ACIDOPHILUS; LACTOCOCCUS-LACTIS; CORYNEBACTERIUM-GLUTAMICUM; LETHAL CHALLENGE; TETANUS TOXIN; CAS SYSTEMS; GENE; EXPRESSION	The advent of CRISPR-based technologies has opened new avenues for the development of next-generation food microorganisms and probiotics with enhanced functionalities. Building off two decades of functional genomics studies unraveling the genetic basis for food fermentations and host-probiotic interactions, CRISPR technologies offer a wide range of opportunities to engineer commercially-relevant Lactobacillus and Bifidobacteria. Endogenous CRISPR-Cas systems can be repurposed to enhance gene expression or provide new features to improve host colonization and promote human health. Alternatively, engineered CRISPR-Cas systems can be harnessed to genetically modify probiotics and enhance their therapeutic potential to deliver vaccines or modulate the host immune response.	[Hidalgo-Cantabrana, Claudio; O'Flaherty, Sarah; Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	Barrangou, R (reprint author), North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu		Hidalgo-Cantabrana, Claudio/0000-0002-7248-4564; O'Flaherty, Sarah/0000-0001-8629-0675; Barrangou, Rodolphe/0000-0002-0648-3504	NC State University; North Carolina Ag Foundation; FEMS	The authors would like to thank their colleagues and support from NC State University, the North Carolina Ag Foundation and FEMS.	Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Barrangou R, 2016, ANNU REV FOOD SCI T, V7, P395, DOI 10.1146/annurev-food-022814-015729; Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Bermudez-Humaran LG, 2009, HUM VACCINES, V5, P264, DOI 10.4161/hv.5.4.7553                                                             ; Briner AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133661; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Dong XY, 2017, J MICROBIOL METH, V139, P79, DOI 10.1016/j.mimet.2017.05.008; FAO/WHO:, 2002, GUID EV PROB FOOD; Gogleva AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-202; Goh YJ, 2015, ANNU REV FOOD SCI T, V6, P137, DOI 10.1146/annurev-food-022814-015706; Goh YJ, 2013, MOL MICROBIOL, V89, P1187, DOI 10.1111/mmi.12338; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Grimm V, 2014, BIOMED RES INT, DOI 10.1155/2014/960826; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hidalgo-Cantabrana C, 2015, APPL ENVIRON MICROB, V81, P7960, DOI 10.1128/AEM.02095-15; Hidalgo-Cantabrana C, 2014, APPL ENVIRON MICROB, V80, P9, DOI 10.1128/AEM.02977-13; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; IWAKI M, 1990, INFECT IMMUN, V58, P2929; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson B, 2013, MICROBIOL-SGM, V159, P2269, DOI 10.1099/mic.0.070755-0; Johnson BR, 2016, APPL ENVIRON MICROB, V82, P134, DOI 10.1128/AEM.01968-15; Karav S, 2016, APPL ENVIRON MICROB, V82, P3622, DOI 10.1128/AEM.00547-16; Kim JY, 2010, J MICROBIOL BIOTECHN, V20, P1022, DOI 10.4014/jmb.1003.03014; Kim J, 2016, NAT BIOTECHNOL, V34, P1014, DOI 10.1038/nbt.3680; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P163, DOI 10.1586/14760584.7.2.163; Norton PM, 1997, VACCINE, V15, P616, DOI 10.1016/S0264-410X(96)00241-1; O'Flaherty S, 2016, APPL ENVIRON MICROB, V82, P6091, DOI 10.1128/AEM.01533-16; O'Flaherty S, 2011, ANNU REV FOOD SCI T, V2, P353, DOI 10.1146/annurev-food-030810-110338; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Price VJ, 2016, MSPHERE, P1; Ruas-Madiedo P., 2012, HDB ANIMAL BASED FER, P125; Ruiz L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01193; Ruiz L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00396; Ruiz L, 2011, GENES NUTR, V6, P307, DOI 10.1007/s12263-010-0207-5; Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Sun ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9322; Tojo R, 2014, WORLD J GASTROENTERO, V20, P15163, DOI 10.3748/wjg.v20.i41.15163; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Vlasova AN, 2016, VET IMMUNOL IMMUNOP, V172, P72, DOI 10.1016/j.vetimm.2016.01.003; Wang JF, 2016, ENVIRON MICROBIOL, V18, P2143, DOI 10.1111/1462-2920.12923; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; WELLS JM, 1993, MOL MICROBIOL, V8, P1155, DOI 10.1111/j.1365-2958.1993.tb01660.x; Westbrook AW, 2016, APPL ENVIRON MICROB, V82, P4876, DOI 10.1128/AEM.01159-16; Westermann C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01220; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Zhao C, 2017, APPL ENV MICROBIOL; Arigoni DM, 2008, [WO, US Patent], Patent No. [2008019886 Al, 2008019886]; [Anonymous], 2016, EFSA J, V14, P23	65	1	1	3	3	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						79	87		10.1016/j.mib.2017.05.015				9	Microbiology	Microbiology	FO1EM	WOS:000416499500014	28622636				2018-01-05	
J	Karvelis, T; Gasiunas, G; Siksnys, V				Karvelis, Tautvydas; Gasiunas, Giedrius; Siksnys, Virginijus			Harnessing the natural diversity and in vitro evolution of Cas9 to expand the genome editing toolbox	CURRENT OPINION IN MICROBIOLOGY			English	Review							RNA-GUIDED ENDONUCLEASE; STAPHYLOCOCCUS-AUREUS CAS9; ALTERED PAM SPECIFICITIES; TARGET DNA RECOGNITION; CRISPR RNA; STREPTOCOCCUS-THERMOPHILUS; CRYSTAL-STRUCTURE; HUMAN-CELLS; ENGINEERED CRISPR-CAS9; NUCLEASE SPECIFICITY	In the past few years, the Cas9 endonuclease from the type II CRISPR-Cas bacterial antiviral defense system has revolutionized the genome editing field. Guided by an RNA molecule, Cas9 can be reprogrammed to target almost any DNA sequence: the only limitation being the short nucleotide sequence in the vicinity of the target, termed the PAM, which is characteristic for each Cas9 protein. Streptococcus pyogenes Cas9 which recognizes the NGG PAM is currently most widely used for genome manipulation. However, Cas9 orthologues and engineered Cas9 variants offer expanded genome targeting capabilities, improved specificity and biochemical properties.	[Karvelis, Tautvydas; Gasiunas, Giedrius; Siksnys, Virginijus] Vilnius Univ, Inst Biotechnol, Sauletekio Av 7, LT-10257 Vilnius, Lithuania	Siksnys, V (reprint author), Vilnius Univ, Inst Biotechnol, Sauletekio Av 7, LT-10257 Vilnius, Lithuania.	siksnys@ibt.lt			Agency for Science, Innovation and Technology (MITA) [31v-107]	This work was supported by the Agency for Science, Innovation and Technology (MITA) grant #31v-107.	Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Glemzaite M, 2015, RNA BIOL, V12, P1, DOI 10.1080/15476286.2015.1017209; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim E, 2017, NAT COMMUN, V8, P1; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144970; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Siksnys V, 2016, MOL CELL, V61, P793, DOI 10.1016/j.molcel.2016.03.002; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	61	1	1	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						88	94		10.1016/j.mib.2017.05.009				7	Microbiology	Microbiology	FO1EM	WOS:000416499500015	28645099				2018-01-05	
J	Lemay, ML; Horvath, P; Moineau, S				Lemay, Marie-Laurence; Horvath, Philippe; Moineau, Sylvain			The CRISPR-Cas app goes viral	CURRENT OPINION IN MICROBIOLOGY			English	Review							BACTERIAL IMMUNE-SYSTEM; STREPTOCOCCUS-THERMOPHILUS; PSEUDOMONAS-AERUGINOSA; LYTIC BACTERIOPHAGES; ESCHERICHIA-COLI; HOST-RANGE; RESISTANCE; TEMPERATE; TECHNOLOGIES; SENSITIVITY	If biology laboratories were smartphones, CRISPR-Cas would be the leading app. Nowadays, technology users rely on apps to communicate, get directions, entertain, and more. Likewise, many life scientists now rely on CRISPR-Cas systems to study the interactions between microbes and their viruses, to track strains as well as to modify and modulate genomes. Considering their high level of polymorphism, CRISPR arrays can increase the resolution of a microbial typing scheme. As dynamic systems, they allow the identification and the tracking of specific sequences, which is highly valuable for epidemiological studies. As a defense mechanism, they offer an opportunity to generate virus-resistant strains or even to construct strains refractory to the acquisition of specific genes. And last but not least, as customizable and transferable tools, CRISPR-Cas systems are particularly promising to fight multi-drug resistant bacteria through the engineering of phages.	[Lemay, Marie-Laurence; Moineau, Sylvain] Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Quebec City, PQ G1V 0A6, Canada; [Horvath, Philippe] DuPont Nutr & Hlth, BP10, F-86220 Dange St Romain, France; [Moineau, Sylvain] Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada; [Moineau, Sylvain] Univ Laval, Grp Rech Ecol Buccale, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada	Moineau, S (reprint author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Quebec City, PQ G1V 0A6, Canada.; Moineau, S (reprint author), Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada.; Moineau, S (reprint author), Univ Laval, Grp Rech Ecol Buccale, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada.	Sylvain.Moineau@bcm.ulaval.ca		Moineau, Sylvain/0000-0002-2832-5101	le Fonds de recherche du Quebec Nature et technologies (FRQNT); Novalait; Op+laic; NSERC	We thank A.P. Hynes for critical reading of the manuscript. M.-L.L. is supported by scholarships from le Fonds de recherche du Quebec Nature et technologies (FRQNT), Novalait and Op+laic. S.M. acknowledges funding from the NSERC Discovery program. S.M. holds a Tier I Canada Research Chair in Bacteriophages.	Achigar R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43438; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, ANNU REV FOOD SCI T, V7, P395, DOI 10.1146/annurev-food-022814-015729; Barrangou R, 2013, BIOCHEM SOC T, V41, P1383, DOI 10.1042/BST20130160; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Boudry P, 2015, MBIO, V6, DOI 10.1128/mBio.01112-15; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buerger P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02077; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hodyra-Stefaniak K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14802; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Hynes AP, 2016, CURR OPIN CHEM BIOL, V34, P30, DOI 10.1016/j.cbpa.2016.05.021; Hynes AP, 2016, MBIO, V7, DOI 10.1128/mBio.00202-16; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Jakutyte-Giraitiene L, 2016, J IND MICROBIOL BIOT, V43, P1183, DOI 10.1007/s10295-016-1784-0; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiro R, 2014, RNA BIOL, V11, P42, DOI 10.4161/rna.27766; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lemay M-L, 2017, ACS SYNTH BIOL; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Martel B, 2014, NUCLEIC ACIDS RES, V42, P9504, DOI 10.1093/nar/gku628; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; Nayak DD, 2017, P NATL ACAD SCI USA, V114, P2976, DOI 10.1073/pnas.1618596114; Ojala V, 2013, EVOL APPL, V6, P925, DOI 10.1111/eva.12076; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; PARK JY, 2017, SCI REP, V7; Patterson AG, 2015, NUCLEIC ACIDS RES, V43, P6038, DOI 10.1093/nar/gkv517; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pires DP, 2016, MICROBIOL MOL BIOL R, V80, P523, DOI 10.1128/MMBR.00069-15; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Shin H, 2014, APPL ENVIRON MICROB, V80, P374, DOI 10.1128/AEM.02279-13; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Stout E, 2017, ANNU REV FOOD SCI T, V8, P413, DOI 10.1146/annurev-food-072816-024723; Strotskaya A, 2017, NUCLEIC ACIDS RES, V45, P1946, DOI 10.1093/nar/gkx042; Vale PF, 2015, P ROY SOC B-BIOL SCI, V282, P41, DOI 10.1098/rspb.2015.1270; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; WHO, 2017, GLOB PRIOR LIST ANT; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112; Zhang H, 2013, MICROBIOL-SGM, V159, P1023, DOI 10.1099/mic.0.067116-0	55	0	0	4	4	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						103	109		10.1016/j.mib.2017.06.001				7	Microbiology	Microbiology	FO1EM	WOS:000416499500017	28623719				2018-01-05	
J	Jackson, RN; van Erp, PBG; Sternberg, SH; Wiedenheft, B				Jackson, Ryan N.; van Erp, Paul B. G.; Sternberg, Samuel H.; Wiedenheft, Blake			Conformational regulation of CRISPR-associated nucleases	CURRENT OPINION IN MICROBIOLOGY			English	Review							TARGET DNA RECOGNITION; GUIDED SURVEILLANCE COMPLEX; STAPHYLOCOCCUS-AUREUS CAS9; IN-VITRO RECONSTITUTION; R-LOOP FORMATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; SPACER ACQUISITION; BACTERIAL IMMUNITY	Adaptive immune systems in bacteria and archaea rely on small CRISPR-derived RNAs (crRNAs) to guide specialized nucleases to foreign nucleic acids. The activation of these nucleases is controlled by a series of molecular checkpoints that ensure precise cleavage of nucleic acid targets, While minimizing toxic off-target cleavage events. In this review, we highlight recent advances in understanding regulatory mechanisms responsible for controlling the activation of these nucleases and identify emerging regulatory themes conserved across diverse CRISPR systems.	[Jackson, Ryan N.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [van Erp, Paul B. G.; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Sternberg, Samuel H.] Caribou Biosci Inc, Berkeley, CA 94710 USA	Jackson, RN (reprint author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.; van Erp, PBG; Wiedenheft, B (reprint author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	ryanjackson@usu.edu; pbgvanerp@gmail.com; bwiedenheft@gmail.com			National Institutes of Health [P20GM103500, P30GM110732-03, R01G1M110270, R01GM108888]; National Science Foundation EPSCoR [EPS-110134]; M.J. Murdock Charitable Trust; Amgen; Gordon and Betty Moore Foundation; Montana State University Agricultural Experimental Station and Montana University System Research Initiative [51040-MUSRI2015-03]; Utah State University from the Department of Chemistry and Biochemistry; Research and Graduate Studies Office; College of Science	Research in the Wiedenheft lab is supported by the National Institutes of Health (P20GM103500, P30GM110732-03, R01G1M110270, and R01GM108888), the National Science Foundation EPSCoR (EPS-110134), the M.J. Murdock Charitable Trust, a young investigator award from Amgen, Gordon and Betty Moore Foundation, and the Montana State University Agricultural Experimental Station and Montana University System Research Initiative (51040-MUSRI2015-03). Research in the Jackson Lab is supported by Utah State University New Faculty Start-up funding from the Department of Chemistry and Biochemistry, the Research and Graduate Studies Office, and the College of Science.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Han WY, 2017, NUCLEIC ACIDS RES, V45, P1983, DOI 10.1093/nar/gkw1274; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Liu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170552; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; van Erp PBG, 2015, CURR OPIN VIROL, V12, P85, DOI 10.1016/j.coviro.2015.03.011; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang J, 2016, NUCLEIC ACIDS RES, V44, P1789, DOI 10.1093/nar/gkw020; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	77	2	2	2	2	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						110	119		10.1016/j.mib.2017.05.010				10	Microbiology	Microbiology	FO1EM	WOS:000416499500018	28646675				2018-01-05	
J	Sontheimer, EJ; Davidson, AR				Sontheimer, Erik J.; Davidson, Alan R.			Inhibition of CRISPR-Cas systems by mobile genetic elements	CURRENT OPINION IN MICROBIOLOGY			English	Review							BACTERIAL IMMUNE-SYSTEM; NEISSERIA-MENINGITIDIS; STREPTOCOCCUS-THERMOPHILUS; RNA; BACTERIOPHAGE; DNA; RESISTANCE; PROKARYOTES; MECHANISMS; PROTEINS	Clustered, regularly interspaced, short, palindromic repeats (CRISPR) loci, together with their CRISPR-associated (Cas) proteins, provide bacteria and archaea with adaptive immunity against invasion by bacteriophages, plasmids, and other mobile genetic elements. These host defenses impart selective pressure on phages and mobile elements to evolve countermeasures against CRISPR immunity. As a consequence of this pressure, phages and mobile elements have evolved 'anti-CRISPR' proteins that function as direct inhibitors of diverse CRISPR-Cas effector complexes. Some of these CRISPR-Cas complexes can be deployed as genome engineering platforms, and anti-CRISPRs could therefore be useful in exerting spatial, temporal, or conditional control over genome editing and related applications. Here we describe the discovery of anti-CRISPRs, the range of CRISPR-Cas systems that they inhibit, their mechanisms of action, and their potential utility in biotechnology.	[Sontheimer, Erik J.] Univ Massachusetts, Med Sch, RNA Therapeut Inst, Worcester, MA 01605 USA; [Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	Sontheimer, EJ (reprint author), Univ Massachusetts, Med Sch, RNA Therapeut Inst, Worcester, MA 01605 USA.; Davidson, AR (reprint author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Davidson, AR (reprint author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	erik.sontheimer@umassmed.edu; alan.davidson@utoronto.ca		Sontheimer, Erik/0000-0002-0881-0310	National Institutes of Health [GM115911]; Canadian Institutes of Health Research [MOP-130482]	We thank Karen Maxwell, Scot Wolfe, and past and present members of the Davidson and Sontheimer labs for many helpful discussions. This work was supported by the National Institutes of Health (grant number GM115911 to EJS) and the Canadian Institutes of Health Research (grant number MOP-130482 to ARD). EJS is a co-founder and scientific advisor of Intellia Therapeutics.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gophna U, 2015, ISME J, V9, P2021, DOI 10.1038/ismej.2015.20; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shin CS, 2017, SCI ADV IN PRESS; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang JY, 2016, CELL RES, V26, P1165, DOI 10.1038/cr.2016.103; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yang H, 2017, MOL CELL IN PRESS, P1024; Young RF, 2008, SCIENCE, V321, P922, DOI 10.1126/science.1162910; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	50	2	2	3	3	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						120	127		10.1016/j.mib.2017.06.003				8	Microbiology	Microbiology	FO1EM	WOS:000416499500019	28668720				2018-01-05	
J	Pyenson, NC; Marraffini, LA				Pyenson, Nora C.; Marraffini, Luciano A.			Type III CRISPR-Cas systems: when DNA cleavage just isn't enough	CURRENT OPINION IN MICROBIOLOGY			English	Review							CMR COMPLEX; ANTIVIRAL DEFENSE; ESCHERICHIA-COLI; RNA CLEAVAGE; IMMUNITY; DEGRADATION; PROKARYOTES; ADAPTATION; MECHANISM; RECOGNITION	Type III CRISPR-Cas systems have a unique targeting mechanism that requires the transcription of the DNA target and results in the degradation of not only the genome of the invader but also its transcripts. Here we discuss the most recent studies describing dual DNA and RNA targeting by these systems, as well as the implications of this complex molecular mechanism for immunity in vivo.	[Pyenson, Nora C.; Marraffini, Luciano A.] Rockefeller Univ, Lab Bacteriol, 1230 York Ave, New York, NY 10065 USA	Marraffini, LA (reprint author), Rockefeller Univ, Lab Bacteriol, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu			Rita Allen Scholars Program; Burroughs Wellcome Fund PATH Award; NIH Director's New Innovator Award [1DP2AI104556-01]; HHMI-Simons Faculty Scholar Award	LAM is supported by the Rita Allen Scholars Program, a Burroughs Wellcome Fund PATH Award, an NIH Director's New Innovator Award (1DP2AI104556-01) and a HHMI-Simons Faculty Scholar Award.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Sokolowski RD, 2014, NUCLEIC ACIDS RES, V42, P6532, DOI 10.1093/nar/gku308; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zebec Z, 2014, NUCLEIC ACIDS RES, V42, P5280, DOI 10.1093/nar/gku161; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	37	0	0	4	4	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						150	154		10.1016/j.mib.2017.08.003				5	Microbiology	Microbiology	FO1EM	WOS:000416499500023	28865392				2018-01-05	
J	Bikard, D; Barrangou, R				Bikard, David; Barrangou, Rodolphe			Using CRISPR-Cas systems as antimicrobials	CURRENT OPINION IN MICROBIOLOGY			English	Review							SEQUENCE-SPECIFIC ANTIMICROBIALS; GENETICALLY-ENGINEERED PHAGE; ESCHERICHIA-COLI; IMMUNE-SYSTEM; STREPTOCOCCUS-THERMOPHILUS; GENE-EXPRESSION; SEED SEQUENCE; DNA; RNA; BACTERIOPHAGE	Although CRISPR-Cas systems naturally evolved to provide adaptive immunity in bacteria and archaea, Cas nucleases can be co-opted to target chromosomal sequences rather than invasive genetic elements. Although genome editing is the primary outcome of self-targeting using CRISPR-based technologies in eukaryotes, self-targeting by CRISPR is typically lethal in bacteria. Here, we discuss how DNA damage introduced by Cas nucleases in bacteria can efficiently and specifically lead to plasmid curing or drive cell death. Specifically, we discuss how various CRISPR-Cas systems can be engineered and delivered using phages or phagemids as vectors. These principles establish CRISPR-Cas systems as potent and programmable antimicrobials, and open new avenues for the development of CRISPR-based tools for selective removal of bacterial pathogens and precise microbiome composition alteration.	[Bikard, David] Inst Pasteur, Microbiol Dept, Synthet Biol Grp, F-75015 Paris, France; [Barrangou, Rodolphe] North Carolina State Univ, Dept Food Proc & Nutr Sci, Raleigh, NC 27695 USA	Bikard, D (reprint author), Inst Pasteur, Microbiol Dept, Synthet Biol Grp, F-75015 Paris, France.; Barrangou, R (reprint author), North Carolina State Univ, Dept Food Proc & Nutr Sci, Raleigh, NC 27695 USA.	david.bikard@pasteur.fr; rbarran@ncsu.edu			European Research Council (ERC) under the Europe Union's Horizon research and innovation program [677823]; French Government's Investissement d'Avenir program; Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; Pasteur-Weizmann consortium; NC State University; North Carolina Ag Foundation	This work was supported by the European Research Council (ERC) under the Europe Union's Horizon 2020 research and innovation program (grant agreement No [677823]); the French Government's Investissement d'Avenir program; Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; the Pasteur-Weizmann consortium and funds from NC State University and the North Carolina Ag Foundation.	Ando H, 2015, CELL SYST, V1, P187, DOI 10.1016/j.cels.2015.08.013; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gomaa AA, 2013, MBIO, V5; Goren M, 2017, DRUG RESIST UPDATE, V30, P1, DOI 10.1016/j.drup.2016.11.001; Hagens S, 2004, ANTIMICROB AGENTS CH, V48, P3817, DOI 10.1128/ACC.48.10.3817-3822.2004; Hagens S, 2003, LETT APPL MICROBIOL, V37, P318, DOI 10.1046/j.1472-765X.2003.01400.x; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mapes Abigail C, 2016, Bacteriophage, V6, pe1096995, DOI 10.1080/21597081.2015.1096995; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Moradpour Z, 2009, FEMS MICROBIOL LETT, V296, P67, DOI 10.1111/j.1574-6968.2009.01620.x; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Westwater C, 2003, ANTIMICROB AGENTS CH, V47, P1301, DOI 10.1128/AAC.47.4.1301-1307.2003; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Yosef I, 2017, MOL CELL, V66, P721, DOI 10.1016/j.molcel.2017.04.025; Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112	51	0	0	3	3	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	JUN	2017	37						155	160		10.1016/j.mib.2017.08.005				6	Microbiology	Microbiology	FO1EM	WOS:000416499500024	28888103				2018-01-05	
J	Li, SY; Zhao, GP; Wang, J				Li, Shi-Yuan; Zhao, Guo-Ping; Wang, Jin			Protocols for C-Brick DNA Standard Assembly Using Cpf1	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Genetics; Issue 124; synthetic biology; CRISPR; Cpf1; C-Brick; sticky ends; DNA assembly; in vitro; assembly standard	SYNTHETIC BIOLOGY; ENDONUCLEASE; PARTS	CRISPR-associated protein Cpf1 cleaves double-stranded DNA under the guidance of CRISPR RNA (crRNA), generating sticky ends. Because of this characteristic, Cpf1 has been used for the establishment of a DNA assembly standard called C-Brick, which has the advantage of long recognition sites and short scars. On a standard C-Brick vector, there are four Cpf1 recognition sites - the prefix (T1 and T2 sites) and the suffix (T3 and T4 sites) - flanking biological DNA parts. The cleavage of T2 and T3 sites produces complementary sticky ends, which allow for the assembly of DNA parts with T2 and T3 sites. Meanwhile, a short "GGATCC" scar is generated between parts after assembly. As the newly formed plasmid once again contains the four Cpf1 cleavage sites, the method allows for the iterative assembly of DNA parts, which is similar to those of BioBrick and BglBrick standards. A procedure outlining the use of the C-Brick standard to assemble DNA parts is described here. The C-Brick standard can be widely used by scientists, graduate and undergraduate students, and even amateurs.	[Li, Shi-Yuan; Zhao, Guo-Ping; Wang, Jin] Chinese Acad Sci, Shanghai Insititutes Biol Sci, Inst Plant Physiol & Ecol, Beijing, Peoples R China	Wang, J (reprint author), Chinese Acad Sci, Shanghai Insititutes Biol Sci, Inst Plant Physiol & Ecol, Beijing, Peoples R China.	wangj01@hotmail.com			Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]	We thank Shanghai Tolo Biotech for their technical assistance during the development of the C-Brick standard. This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB19040200).	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Knight T., 2003, IDEMPOTENT VECTOR DE, P1; Li SY, 2016, ACS SYNTH BIOL, V5, P1383, DOI 10.1021/acssynbio.6b00114; Liu JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110852; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	16	0	0	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2017		124							e55775	10.3791/55775				7	Multidisciplinary Sciences	Science & Technology - Other Topics	FN1LU	WOS:000415751100014					2018-01-05	
J	Sternburg, EL; Dias, KC; Karginov, FV				Sternburg, Erin L.; Dias, Kristen C.; Karginov, Fedor V.			Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Genetics; Issue 124; CRISPR/Cas9; homology-driven repair; non-homologous end joining; dot blot; clonal selection; screening	DOUBLE-STRAND BREAKS; HOMOLOGY-DIRECTED REPAIR; ZINC-FINGER NUCLEASES; BACTERIAL IMMUNITY; TAL EFFECTORS; TARGETING DNA; SMALL RNA; CLEAVAGE; SYSTEMS; BACTERIOPHAGE	The CRISPR/Cas9 genome engineering system has revolutionized biology by allowing for precise genome editing with little effort. Guided by a single guide RNA (sgRNA) that confers specificity, the Cas9 protein cleaves both DNA strands at the targeted locus. The DNA break can trigger either non-homologous end joining (NHEJ) or homology directed repair (HDR). NHEJ can introduce small deletions or insertions which lead to frame-shift mutations, while HDR allows for larger and more precise perturbations. Here, we present protocols for generating knockout cell lines by coupling established CRISPR/Cas9 methods with two options for downstream selection/screening. The NHEJ approach uses a single sgRNA cut site and selection-independent screening, where protein production is assessed by dot immunoblot in a high-throughput manner. The HDR approach uses two sgRNA cut sites that span the gene of interest. Together with a provided HDR template, this method can achieve deletion of tens of kb, aided by the inserted selectable resistance marker. The appropriate applications and advantages of each method are discussed.	[Sternburg, Erin L.; Dias, Kristen C.; Karginov, Fedor V.] Univ Calif Riverside, Cell Biol & Neurosci, Riverside, CA 92521 USA	Karginov, FV (reprint author), Univ Calif Riverside, Cell Biol & Neurosci, Riverside, CA 92521 USA.	fedor.karginov@ucr.edu					Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bibikova M, 2002, GENETICS, V161, P1169; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Green M.R., 2012, MOL CLONING LAB MANU; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Luo YL, 2014, BIOTECHNIQUES, V56, P263, DOI 10.2144/000114169; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moore JK, 1996, MOL CELL BIOL, V16, P2164; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Porteus MH, 2003, MOL CELL BIOL, V23, P3558, DOI 10.1128/MCB.23.10.3558-3565.2003; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	33	0	0	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2017		124							e55903	10.3791/55903				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FN1LU	WOS:000415751100019					2018-01-05	
J	Mulvihill, JJ; Capps, B; Joly, Y; Lysaght, T; Zwart, HAE; Chadwick, R				Mulvihill, John J.; Capps, Benjamin; Joly, Yann; Lysaght, Tamra; Zwart, Hub A. E.; Chadwick, Ruth		Int Human Genome Org HUGO Comm Eth	Ethical issues of CRISPR technology and gene editing through the lens of solidarity	BRITISH MEDICAL BULLETIN			English	Review						CRISPR; ethics; gene editing; genetic engineering; germ cell mutation; solidarity	EUGENICS; ENDONUCLEASE; CHEMICALS; GENOMICS; CHILDREN; HISTORY; DISEASE; SYSTEM; RIGHTS; CELLS	Background: The avalanche of commentaries on CRISPR-Cas9 technology, a bacterial immune system modified to recognize any short DNA sequence, cut it out, and insert a new one, has rekindled hopes for gene therapy and other applications and raised criticisms of engineering genes in future generations. Sources of data: This discussion draws on articles that emphasize ethics, identified partly through PubMed and Google, 2014-2016. Areas of agreement: CRISPR-Cas9 has taken the pace and prospects for genetic discovery and applications to a high level, stoking anticipation for somatic gene engineering to help patients. We support a moratorium on germ line manipulation. Areas of controversy: We place increased emphasis on the principle of solidarity and the public good. The genetic bases of some diseases are not thoroughly addressable with CRISPR-Cas9. We see no new ethical issues, compared with gene therapy and genetic engineering in general, apart from the explosive rate of findings. Other controversies include eugenics, patentability and unrealistic expectations of professionals and the public. Growing points: Biggest issues are the void of research on human germ cell biology, the appropriate routes for oversight and transparency, and the scientific and ethical areas of reproductive medicine. Areas timely for developing research: The principle of genomic solidarity and priority on public good should be a lens for bringing clarity to CRISPR debates. The valid claim of genetic exceptionalism supports restraint on experimentation in human germ cells, given the trans-generational dangers and the knowledge gap in germ cell biology.	[Mulvihill, John J.] Univ Oklahoma, Sect Genet, Dept Pediat, Hlth Sci Ctr, Suite 12100,1200 Childrens Ave, Oklahoma City, OK 73104 USA; [Capps, Benjamin] Dalhousie Univ, Dept Bioeth, 5849 Univ Ave,Room C-312,CRC Bldg,POB 15000, Halifax, NS B3H 4R2, Canada; [Joly, Yann] McGill Univ, Dept Human Genet, Ctr Genom & Policy, 740 Ave Dr Penfield,Suite 5200, Montreal, PQ H3A 0G1, Canada; [Lysaght, Tamra] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Biomed Eth, Clin Res Ctr, Level 2 Block MD11,10 Med Dr, Singapore 117576, Singapore; [Zwart, Hub A. E.] Radboud Univ Nijmegen, Fac Sci, Dept Philosophy & Sci Studies, POB 9010, NL-6500 GL Nijmegen, Netherlands; [Chadwick, Ruth] Univ Manchester, Sch Law, Williamson Bldg 2-13, Manchester M13 9PL, Lancs, England	Mulvihill, JJ (reprint author), Univ Oklahoma, Sect Genet, Dept Pediat, Hlth Sci Ctr, Suite 12100,1200 Childrens Ave, Oklahoma City, OK 73104 USA.	John-Mulvihill@ouhsc.edu					Bagley Margo A, 2003, William Mary Law Rev, V45, P469; Beale K., 2016, BOSTON COLL INTELLEC, P2; Bearn AG, 1993, ARCHIBALD GARROD IND; Berg K., 2007, GENOMICS SOC POLICY, V3, P44; Berg P, 2008, NATURE, V455, P290, DOI 10.1038/455290a; Boneva RS, 2001, CLIN MICROBIOL REV, V14, P1, DOI 10.1128/CMR.14.1.1-14.2001; Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Callaway E, 2016, NATURE, V530, P18, DOI 10.1038/nature.2016.19270; Caplan AL, 2015, EMBO REP, V16, P1421, DOI 10.15252/embr.201541337; Capps B, IMAGINED FUTURES CAP; Capps B, 2016, BRIT MED BULL, V118, P5, DOI 10.1093/bmb/ldw014; Chadwick R, 2001, NAT REV GENET, V2, P318, DOI 10.1038/35066094; Chadwick R, 2013, LIFE SCI SOC POLICY, V9, P3, DOI [10.1186/2195-7819-9-3, DOI 10.1186/2195-7819-9-3]; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cong LI, 2016, GENOMICS SOC ETHICAL, V135, P139; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Evitt NH, 2015, AM J BIOETHICS, V15, P25, DOI 10.1080/15265161.2015.1104160; Friedmann T, 2015, MOL THER, V23, P1282, DOI 10.1038/mt.2015.118; Hayden EC, 2016, NATURE, V530, P402; Hayden EC, 2010, NATURE, V464, P664, DOI 10.1038/464664a; Hayry M, 2005, CAMB Q HEALTHC ETHIC, V14, P199; The Hinxton Group, 2015, STAT GEN ED TECHN HU; HUGO Ethics Committee, 2000, STAT BEN SHAR; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joly Y, 2014, NEW GENET SOC, V33, P167, DOI 10.1080/14636778.2014.914849; Kahn J, 2015, NY TIMES MAGAZINE; Kaiser J., 2016, SCIENCEINSIDER, DOI [10.1126/science.aaf5796, DOI 10.1126/SCIENCE.AAF5796]; Kevles DJ, 2011, ANN HUM GENET, V75, P326, DOI 10.1111/j.1469-1809.2011.00648.x; Kohn DB, 2016, BLOOD, V127, P2553, DOI 10.1182/blood-2016-01-678136; Krishan K, 2016, SCI ENG ETHICS, V22, P597, DOI 10.1007/s11948-015-9675-8; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Ledford H, 2016, NATURE, V531, P149, DOI 10.1038/531149a; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; MILLER J R, 1983, Mutation Research, V123, P1; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; MULVIHILL JJ, 1976, J NATL CANCER I, V57, P3, DOI 10.1093/jnci/57.1.3                                                             ; Mulvihill JJ, 2012, J COMMUN GENET, V3, P205, DOI 10.1007/s12687-012-0104-2; The National Academies of Sciences, 2016, 1 DAT GATH M FEB 11; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research,, 1978, THE BELM REP; Nuffield Council on Bioethics, 2016, GEN ED ETH REV EXPL; O'Reilly M, 2015, ADV EXP MED BIOL, V871, P31, DOI 10.1007/978-3-319-18618-4_2; Olson MV, 2002, J MOL BIOL, V319, P931, DOI 10.1016/S0022-2836(02)00333-9; Organizing Committee for the International Summit on Human Gene Editing, HUM GEN ED INT SUMM; Plomer A, 2010, EMBRYONIC STEM CELL; Pollack R, 2015, SCIENCE, V348, P871, DOI 10.1126/science.348.6237.871-a; Porteus MH, 2015, MOL THER, V23, P979, DOI 10.1038/mt.2015.83; Prainsack B., 2011, SOLIDARITY REFLECTIO; Rasko John EJ, 2006, ETHICS INHERITABLE G, P1; REARDON S, 2015, NATURE, V527, P152; Rojahn S., 2014, MIT TECH REV; Savulescu J, 2001, BIOETHICS, V15, P413, DOI 10.1111/1467-8519.00251                                                         ; Savulescu J, 2001, J MED ETHICS, V27, P148, DOI 10.1136/jme.27.3.148                                                            ; Secretariat of the Convention on Biological Diversity, 2011, NAG PROT ACC GEN RES; Shakespeare T, 1998, DISABIL SOC, V13, P665, DOI 10.1080/09687599826452                                                          ; Shelby MD, 1996, MUTAT RES-FUND MOL M, V352, P159, DOI 10.1016/0027-5107(95)00222-7; Sherkow JS, 2015, ANNU REV GENET, V49, P161, DOI 10.1146/annurev-genet-112414-054731; SOBELS FH, 1993, ENVIRON HEALTH PERSP, V101, P327, DOI 10.2307/3431746; Tauxe W, 2015, NATURE, V528, pS14, DOI 10.1038/528S14a; Travis J, 2015, SCIENCE, V350, P1299, DOI 10.1126/science.350.6266.1299; University of Washington, ETH MED WEBS; Vasiliou SK, 2016, CLIN CHEM; Watts G, 2012, NOVEL TECHNIQUES PRE; Wilson JM, 2016, HUM GENE THER CL DEV, V27, P5, DOI 10.1089/humc.2016.29007.ive; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935; Yauk CL, 2013, MUTAT RES-REV MUTAT, V752, P6, DOI 10.1016/j.mrrev.2012.08.002; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zimmer C., 2015, QUANTA MAGAZINE	70	3	3	13	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-1420	1471-8391		BRIT MED BULL	Br. Med. Bull.	JUN	2017	122	1					17	29		10.1093/bmb/ldx002				13	Medicine, General & Internal	General & Internal Medicine	FK8HT	WOS:000413749300003	28334154	gold			2018-01-05	
J	Sun, WJ; Gu, Z				Sun, Wujin; Gu, Zhen			Tailoring non-viral delivery vehicles for transporting genome-editing tools	SCIENCE CHINA-MATERIALS			English	Review						CRISPR-Cas9; drug delivery; gene therapy; nanomedicine; genome editing	GENE-THERAPY; IN-VIVO; EFFICIENT DELIVERY; MEDIATED DELIVERY; DRUG-DELIVERY; HUMAN-CELLS; STEM-CELLS; SYSTEM; CRISPR-CAS9; CAS9	The CRISPR-Cas system, especially the type II CRISPR-Cas9 system from Streptococcuspyogenes, has rapidly emerged as a popular genome editing tool. The development of Cas9 derivatives further expanded the toolbox of CRISPR-Cas9 based genome editing kit. However, therapeutic translation of the CRISPR-Cas9 systemin vivo is severely impeded by the absence of an appropriate delivery carrier. The complexity and high molecular weight of the CRISPR-Cas9 system, together with the physiological barriers for nucleus targeted cargo transportation have made it a huge challenge for in vivo therapeutic CRISPR-Cas9 delivery. Currently, the main stream carriers for systemic delivery of CRISPR-Cas9 are viral based, such as adeno-associated virus. However, the safety concerns surrounding viral vectors call for the development of non-viral nanocarriers. In this review, we survey the recent advances in the development of non-viral delivery systems for CRISPR-Cas9. Challenges and future directions in this field are also discussed.	[Sun, Wujin; Gu, Zhen] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Sun, Wujin; Gu, Zhen] North Carolina State Univ, Raleigh, NC 27695 USA; [Sun, Wujin; Gu, Zhen] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Sun, Wujin; Gu, Zhen] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA; [Gu, Zhen] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA	Gu, Z (reprint author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.; Gu, Z (reprint author), North Carolina State Univ, Raleigh, NC 27695 USA.; Gu, Z (reprint author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27599 USA.; Gu, Z (reprint author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA.; Gu, Z (reprint author), Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA.	zgu@email.unc.edu					Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Dickel DE, 2014, NAT METHODS, V11, P566, DOI [10.1038/NMETH.2886, 10.1038/nmeth.2886]; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Evans CH, 2015, NAT REV RHEUMATOL, V11, P234, DOI 10.1038/nrrheum.2015.28; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Hotta A, 2015, ANNU REV GENET, V49, P47, DOI 10.1146/annurev-genet-112414-054926; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keener AB, 2015, NAT MED, V21, P1239, DOI 10.1038/nm1115-1239; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Li L, 2017, ACS NANO, V11, P95, DOI 10.1021/acsnano.6b04261; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lu Y, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.75; Lundberg AS, 2015, AM J BIOETHICS, V15, P38, DOI 10.1080/15265161.2015.1103817; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Philippidis A, 2014, HUM GENE THER, V25, P92, DOI 10.1089/hum.2014.2502; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ren J, 2016, CLIN CANC RES; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; Simonato M, 2013, NAT REV NEUROL, V9, P277, DOI 10.1038/nrneurol.2013.56; SOMMER D, 2014, NATCOMMUN, V5, DOI DOI 10.1038/NCOMMS4045; Sun WJ, 2017, PHYSIOL REV, V97, P189, DOI 10.1152/physrev.00015.2016; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Sun WJ, 2015, THER DELIV, V6, P765, DOI [10.4155/tde.15.27, 10.4155/TDE.15.27]; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tauxe W, 2015, NATURE, V528, pS14, DOI 10.1038/528S14a; Walsh CE, 2013, TRANSL RES, V161, P307, DOI 10.1016/j.trsl.2012.12.016; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	42	0	0	11	11	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	2095-8226	2199-4501		SCI CHINA MATER	Sci. China-Mater.	JUN	2017	60	6			SI		511	515		10.1007/s40843-016-5154-4				5	Materials Science, Multidisciplinary	Materials Science	FI8CE	WOS:000412227300005					2018-01-05	
J	Badia, R; Ballana, E; Este, JA; Riveira-Munoz, E				Badia, Roger; Ballana, Ester; Este, Jose A.; Riveira-Munoz, Eva			Antiviral treatment strategies based on gene silencing and genome editing	CURRENT OPINION IN VIROLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESPIRATORY SYNCYTIAL VIRUS; PLURIPOTENT STEM-CELLS; HEPATITIS-B-VIRUS; SMALL INTERFERING RNA; CD4(+) T-CELLS; HIV-1 INFECTION; LATENT HIV-1; CRISPR/CAS9 SYSTEM; VIRAL REPLICATION	The ability of some viruses to establish latently infected chronic reservoirs that escape to immune control becomes a major roadblock that impedes the cure of these infections. Therefore, new alternatives are needed to pursuit the eradication of viral persistent infections. Gene silencing technologies are in constant evolution and provide an outstanding sequence specificity that allows targeting any coding sequence of interest. Here we provide an overview of the development of gene silencing technologies ranging from initially RNA interference to the recently developed CRISPR/Cas9 and their potential as new antiviral strategies focusing on the eradication of HIV.	[Este, Jose A.; Riveira-Munoz, Eva] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain; Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Hlth Res Inst Germans Trias & Pujol IGTP, Badalona, Spain	Este, JA; Riveira-Munoz, E (reprint author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain.	jaeste@irsicaixa.es; eriveira@irsicaixa.es			Spanish MINECO project [BFU2015-63800-R, FIS PI13/01083, PI16/00103, CP14/00016]	Work in our laboratory is supported in part by the Spanish MINECO projects BFU2015-63800-R, FIS PI13/01083, PI16/00103 and CP14/00016. EB and RB are research fellows from FIS and PERIS.	Anderson J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-53; Badia R, 2014, ANTIMICROB AGENTS CH, V58, P4318, DOI 10.1128/AAC.02690-14; Badia R, 2014, J ANTIMICROB CHEMOTH, V69, P1755, DOI 10.1093/jac/dku072; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boutimah F, 2013, ANTIVIR RES, V98, P121, DOI 10.1016/j.antiviral.2013.02.011; Buchholz F, 2016, CURR OPIN VIROL, V20, P85, DOI 10.1016/j.coviro.2016.09.012; Chiu YL, 2004, J VIROL, V78, P2517, DOI 10.1128/JVI.78.5.2517-2529.2004; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Das AT, 2011, J VIROL, V85, P9506, DOI 10.1128/JVI.00650-11; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Durantel D, 2016, J HEPATOL, V64, pS117, DOI 10.1016/j.jhep.2016.02.016; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Gabrielson NP, 2012, MOL THER, V20, P1599, DOI 10.1038/mt.2012.78; Gish RG, 2015, ANTIVIR RES, V121, P97, DOI 10.1016/j.antiviral.2015.06.019; Hirsch AJ, 2010, FUTURE MICROBIOL, V5, P303, DOI 10.2217/FMB.09.121; Ho W, 2016, ADV HEALTHC MATER, V5, P2715, DOI 10.1002/adhm.201600418; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Huffer G., 2009, NEW ENGL J MED, V360, P692; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Karpinski J, 2016, NAT BIOTECHNOL, V34, P401, DOI 10.1038/nbt.3467; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Knoepfel Stefanie A, 2012, World J Virol, V1, P79, DOI 10.5501/wjv.v1.i3.79; Kruse EM, 2016, PLOS PATHOG, V12; Li GL, 2015, EXP THER MED, V10, P395, DOI 10.3892/etm.2015.2573; Liang C, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0270-0; Liang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19176; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213; Lin A, 2016, MOL THER, V24, P416, DOI 10.1038/mt.2016.30; Martinez MA, 2002, AIDS, V16, P2385, DOI 10.1097/00002030-200212060-00002; Martinez MA, 2002, TRENDS IMMUNOL, V23, P559, DOI 10.1016/S1471-4906(02)02328-1; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Motavaf M, 2012, J VIRAL HEPATITIS, V19, P757, DOI 10.1111/jvh.12006; Nishitsuji H, 2006, J VIROL, V80, P7658, DOI 10.1128/JVI.00078-06; Paul AM, 2014, J GEN VIROL, V95, P1712, DOI 10.1099/vir.0.066084-0; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ping YH, 2004, RETROVIROLOGY, V1, P46, DOI 10.1186/1742-4690-1-46; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Shearer RF, 2015, GENES CELLS, V20, P1, DOI 10.1111/gtc.12183; Stein DA, 2011, J VIROL, V85, P10154, DOI 10.1128/JVI.05298-11; Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08; Suzuki K, 2011, RNA BIOL, V8, P1035, DOI 10.4161/rna.8.6.16264; TAKEUCHI Y, 1988, J VIROL, V62, P3900; Tobin SC, 2016, AIDS, V30, pN17, DOI 10.1097/QAD.0000000000001138; Ueda S, 2016, MICROBIOL IMMUNOL, V60, P483, DOI 10.1111/1348-0421.12395; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Wollebo HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136046; Wolstein O, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2013.11; Yao YC, 2012, HUM GENE THER, V23, P238, DOI 10.1089/hum.2011.126; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207	75	0	0	2	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1879-6257			CURR OPIN VIROL	Curr. Opin. Virol.	JUN	2017	24						46	54		10.1016/j.coviro.2017.04.001				9	Virology	Virology	FD3DC	WOS:000407412700008	28437703				2018-01-05	
J	Delerue, F; Ittner, LM				Delerue, Fabien; Ittner, Lars M.			Generation of Genetically Modified Mice through the Microinjection of Oocytes	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Developmental Biology; Issue 124; Mice; microinjection; pronuclear; cytoplasmic; CRISPR; transgenic; genome editing; oocytes	TRANSGENIC MICE; MOUSE; DNA; GENOME; EXPRESSION; EFFICIENCY; MUTATIONS; KNOCKOUT; EMBRYOS; STRAIN	The use of genetically modified mice has significantly contributed to studies on both physiological and pathological in vivo processes. The pronuclear injection of DNA expression constructs into fertilized oocytes remains the most commonly used technique to generate transgenic mice for overexpression. With the introduction of CRISPR technology for gene targeting, pronuclear injection into fertilized oocytes has been extended to the generation of both knockout and knockin mice. This work describes the preparation of DNA for injection and the generation of CRISPR guides for gene targeting, with a particular emphasis on quality control. The genotyping procedures required for the identification of potential founders are critical. Innovative genotyping strategies that take advantage of the "multiplexing" capabilities of CRISPR are presented herein. Surgical procedures are also outlined. Together, the steps of the protocol will allow for the generation of genetically modified mice and for the subsequent establishment of mouse colonies for a plethora of research fields, including immunology, neuroscience, cancer, physiology, development, and others.	[Delerue, Fabien; Ittner, Lars M.] Univ New South Wales, Transgen Anim Unit, Mark Wainwright Analyt Ctr, Sydney, NSW, Australia	Delerue, F (reprint author), Univ New South Wales, Transgen Anim Unit, Mark Wainwright Analyt Ctr, Sydney, NSW, Australia.	fabien.delerue@unsw.edu.au			National Health and Medical Research Council; Australian Research Council	The authors thank the staff of the animal facility (BRC) for their ongoing support. This work was funded by the National Health and Medical Research Council and the Australian Research Council.	Auerbach AB, 2004, ACTA BIOCHIM POL, V51, P9; Auerbach AB, 2003, TRANSGENIC RES, V12, P59, DOI 10.1023/A:1022166921766; Biggers JD, 2008, FERTIL STERIL, V90, P473, DOI 10.1016/j.fertnstert.2008.08.010; BRINSTER RL, 1980, NATURE, V283, P499, DOI 10.1038/283499a0                                                                ; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Delerue F, 2015, CLON TRANSGEN, V4, P135; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380                                                         ; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; Marantz Henig R, 2000, MONK GARDEN; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; JAENISCH R, 1974, P NATL ACAD SCI USA, V71, P1250, DOI 10.1073/pnas.71.4.1250; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Ke YD, 2015, ACTA NEUROPATHOL, V130, P661, DOI 10.1007/s00401-015-1486-0; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227                                                           ; Merriman JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095711; NAKAGATA N, 1992, EXP ANIM TOKYO, V41, P387, DOI 10.1538/expanim1978.41.3_387                                                    ; Nakagawa Y, 2016, BIOL OPEN, V5, P1142, DOI 10.1242/bio.019349; Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007                                                                    ; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki K, 2016, NATURE; Truett GE, 2000, BIOTECHNIQUES, V29, P52; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399                                                           ; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Ye S, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.17.e88                                                           ; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	37	0	0	3	3	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2017		124							e55765	10.3791/55765				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FD3QS	WOS:000407448100047					2018-01-05	
J	Shen, B; Powell, RH; Behnke, MS				Shen, Bang; Powell, Robin H.; Behnke, Michael S.			QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Genetics; Issue 124; Quantitative Trait Locus (QTL) mapping; Clustered regularly interspaced short palindromic repeats (CRISPR); guide RNA (gRNA); sinefungin; single nucleotide polymorphism (SNP); genetic cross; whole genome sequencing (WGS)	VIRULENCE; LOCUS; RECOMBINATION; PARASITE; DNA; IDENTIFICATION; PSEUDOKINASES; DISCOVERY; REVEALS; HISTORY	Scientific knowledge is intrinsically linked to available technologies and methods. This article will present two methods that allowed for the identification and verification of a drug resistance gene in the Apicomplexan parasite Toxoplasma gondii, the method of Quantitative Trait Locus (QTL) mapping using a Whole Genome Sequence (WGS) -based genetic map and the method of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 - based gene editing. The approach of QTL mapping allows one to test if there is a correlation between a genomic region(s) and a phenotype. Two datasets are required to run a QTL scan, a genetic map based on the progeny of a recombinant cross and a quantifiable phenotype assessed in each of the progeny of that cross. These datasets are then formatted to be compatible with R/qtl software that generates a QTL scan to identify significant loci correlated with the phenotype. Although this can greatly narrow the search window of possible candidates, QTLs span regions containing a number of genes from which the causal gene needs to be identified. Having WGS of the progeny was critical to identify the causal drug resistance mutation at the gene level. Once identified, the candidate mutation can be verified by genetic manipulation of drug sensitive parasites. The most facile and efficient method to genetically modify T. gondii is the CRISPR/Cas9 system. This system comprised of just 2 components both encoded on a single plasmid, a single guide RNA (gRNA) containing a 20 bp sequence complementary to the genomic target and the Cas9 endonuclease that generates a double-strand DNA break (DSB) at the target, repair of which allows for insertion or deletion of sequences around the break site. This article provides detailed protocols to use CRISPR/Cas9 based genome editing tools to verify the gene responsible for sinefungin resistance and to construct transgenic parasites.	[Shen, Bang] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Powell, Robin H.; Behnke, Michael S.] Louisiana State Univ, Sch Vet Med, Pathobiol Sci, Baton Rouge, LA 70803 USA	Shen, B (reprint author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.; Behnke, MS (reprint author), Louisiana State Univ, Sch Vet Med, Pathobiol Sci, Baton Rouge, LA 70803 USA.	shenbang@mail.hzau.edu.cn; mbehnke@lsu.edu			National Institutes of Health [AI108721]	We would like to thank L. David Sibley and Asis Khan for their contribution to the original publication on which these protocols are based. This work was funded by National Institutes of Health grant AI108721.	Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Behnke MS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005434; Behnke MS, 2015, EUKARYOT CELL, V14, P140, DOI 10.1128/EC.00229-14; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Coleman B. I., 2012, J VIS EXP; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Khan A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1168; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12                                                         ; LANDER ES, 1989, GENETICS, V121, P185; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Long SJ, 2016, INFECT IMMUN, V84, P1262, DOI [10.1128/IAI.01173-15, 10.1128/IAI.00175-16]; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; PFEFFERKORN LC, 1980, EXP PARASITOL, V50, P305, DOI 10.1016/0014-4894(80)90034-X; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Roos DS, 1996, CURR TOP MICROBIOL, V219, P247; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Rugarabamu G, 2015, MOL MICROBIOL, V97, P244, DOI 10.1111/mmi.13021; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij J. P., NATURE, V445, P324; Shaik JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1309-7; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Smith R, 2009, METHODS MOL BIOL, V573, P175, DOI 10.1007/978-1-60761-247-6_10; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Sugi T., 2016, PARASITOL INT; Sullivan WJ, 1999, MOL BIOCHEM PARASIT, V103, P1, DOI 10.1016/S0166-6851(99)00114-0                                                   ; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Varberg JM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00088-15; Walwyn O., 2015, J VIS EXP; Wang J. L., 2016, TRENDS PARASITOL; Wang K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150561; Yang MJ, 2016, ACSR ADV COMPUT, V71, P1; Zhang WH, 2016, PROCEEDINGS OF 2016 IEEE INTERNATIONAL CONFERENCES ON BIG DATA AND CLOUD COMPUTING (BDCLOUD 2016) SOCIAL COMPUTING AND NETWORKING (SOCIALCOM 2016) SUSTAINABLE COMPUTING AND COMMUNICATIONS (SUSTAINCOM 2016) (BDCLOUD-SOCIALCOM-SUSTAINCOM 2016), P1, DOI 10.1109/BDCloud-SocialCom-SustainCom.2016.12; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003	52	0	0	1	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2017		124							e55185	10.3791/55185				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FD3QS	WOS:000407448100006					2018-01-05	
J	Furrow, BR; Richards, BJ				Furrow, Barry R.; Richards, Bernadette J.			Regulating the New: A Consideration of CRISPR and Approaches to Professional Standards of Practitioners of Chinese Medicine in Australia and Accessing the NDIS	JOURNAL OF BIOETHICAL INQUIRY			English	Article						CRISPR; Gene editing; Patient safety: Professional standards; Financial sustainability; NDIS			[Furrow, Barry R.] Drexel Univ, Thomas R Kline Sch Law, 3320 Market St, Philadelphia, PA 19104 USA; [Richards, Bernadette J.] Univ Adelaide, Sch Law, North Terrace, Adelaide, SA 5005, Australia	Richards, BJ (reprint author), Univ Adelaide, Sch Law, North Terrace, Adelaide, SA 5005, Australia.	barry_furrow@hotmail.com; bernadette.richards@adelaide.edu.au					Church G., 2015, NAT AC SCI ENG MED I; Furrow B. R., ANN HLTH LAW; Gerstein D. M., 2016, HOW GENETIC EDITING; Greely H., 2015, SCI CRISPR CAS9 ASIL; Heidari R., 2016, SCI ENG ETHICS, P1; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; National Academies of Sciences Engineering and Medicine, 2017, HUM GEN ED SCI ETH G; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Productivity Commission, 2011, DIS CAR SUPP PROD CO; Skerrett P., 2015, EXPERTS DEBATE ARE W; Specter M., 2015, NEW YORKER      1116	11	1	1	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1176-7529	1872-4353		J BIOETHIC INQ	J. Bioethical Inq.	JUN	2017	14	2					167	172		10.1007/s11673-017-9785-x				6	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	FB7ZP	WOS:000406358800002	28429203				2018-01-05	
J	Fajac, I; Wainwright, CE				Fajac, Isabelle; Wainwright, Claire E.			New treatments targeting the basic defects in cystic fibrosis	PRESSE MEDICALE			English	Review							F508DEL-CFTR MUTATION; DOUBLE-BLIND; CFTR POTENTIATOR; G551D MUTATION; STOP MUTATIONS; CLINICAL-TRIAL; GENE-THERAPY; LUNG-DISEASE; IN-VITRO; IVACAFTOR	Cystic fibrosis (CF) is a monogenic autosomal recessive disorder affecting around 75,000 individuals worldwide. It is a multi-system disease but the main morbidity and mortality is caused by chronic lung disease. Due to newborn screening, a multidisciplinary approach to care and intensive symptomatic treatment, the prognosis has dramatically improved over the last decades and there are currently more adults than children in many countries. However, CF is still a very severe disease with a current median age of life expectancy in the fourth decade of life. The disease is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene which encodes the CFTR protein, a protein kinase A-activated ATP-gated anion channel that regulates the transport of electrolytes such as chloride and bicarbonate. More than 2000 mutations have been reported, although not all of these have functional consequences. An enormous research effort and progress has been made in understanding the consequences of these mutations on the CFTR protein structure and function, and this has led to the approval of two new drug therapies that are able to bind to defective CFTR proteins and partially restore their function. They are mutation-specific therapies and available at present for specific mutations only. They are the first personalized medicine for CF with a possible disease-modifying effect. A pipeline of other compounds is under development with different mechanisms of action. It is foreseeable that new combinations of compounds will further improve the correction of CFTR function. Other strategies including premature stop codon read-through drugs, antisense oligonucleotides that correct the basic defect at the mRNA level or gene editing to restore the defective gene as well as gene therapy approaches are all in the pipeline. All these strategies are needed to develop disease-modifying therapies for all patients with CF.	[Fajac, Isabelle] Univ Paris 05, Sorbonne Paris Cite, Site Cochin,24 Rue Faubourg St Jacques, F-75014 Paris, France; [Fajac, Isabelle] Hop Cochin, AP HP, Serv Physiol & Explorat fonctionnelles, 27 Rue Faubourg St Jacques, F-75014 Paris, France; [Wainwright, Claire E.] Univ Queensland, Brisbane, Qld 4072, Australia; [Wainwright, Claire E.] Lady Cilento Childrens Hosp, 501 Stanley St, Brisbane, Qld 4101, Australia	Fajac, I (reprint author), Univ Paris 05, Sorbonne Paris Cite, Site Cochin,24 Rue Faubourg St Jacques, F-75014 Paris, France.	isabelle.fajac@parisdescartes.fr		Fajac, Isabelle/0000-0002-1532-1486	Bayer; Novartis; Vertex Pharmaceuticals; Children's Hospital Foundation Brisbane, Australia	IF: Principal or co-investigator for clinical trials sponsored by Bayer, Novartis and Vertex Pharmaceuticals. Consultancy for EPG Health Media, Galapagos and Vertex Pharmaceuticals. Conferences: invitation as speaker for Vertex Pharmaceuticals, as auditor by PTC Therapeutics.	Accurso FJ, 2014, J CYST FIBROS, V13, P139, DOI 10.1016/j.jcf.2013.09.007; Althaus Mike, 2013, Curr Mol Pharmacol, V6, P3; Alton EWFW, 2017, THORAX, V72, P137, DOI 10.1136/thoraxjnl-2016-208406; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013                                            ; Bellin MD, 2013, PEDIATR DIABETES, V14, P417, DOI 10.1111/pedi.12026; Brodlie M, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0223-6; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; Davies JC, 2016, LANCET RESP MED, V4, P107, DOI 10.1016/S2213-2600(15)00545-7; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; De Boeck K, 2014, J CYST FIBROS, V13, P674, DOI 10.1016/j.jcf.2014.09.005; Dekkers JF, 2016, EUR RESPIR J, V48, P451, DOI 10.1183/13993003.01192-2015; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Ferec C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009480; Ferkol T, 2015, AM J RESP CRIT CARE, V192, P658, DOI 10.1164/rccm.201507-1428ED; Flume PA, 2012, CHEST, V142, P718, DOI 10.1378/chest.11-2672; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; GRAHAM A, 1993, EUR RESPIR J, V6, P1243; Griesenbach U, 2015, HUM GENE THER, V26, P266, DOI 10.1089/hum.2015.027; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; KNOWLES MR, 1990, NEW ENGL J MED, V322, P1189, DOI 10.1056/NEJM199004263221704; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; Mall MA, 2014, EUR RESPIR MONOGR, P1, DOI 10.1183/1025448x.10008513; McKone EF, 2014, LANCET RESP MED, V2, P902, DOI [10.1016/s2213-2600(14)70218-8, 10.1016/S2213-2600(14)70218-8]; Merlin T, 2013, MED DECIS MAKING, V33, P333, DOI 10.1177/0272989X12452341; Milla C, 2016, PEDIATR PULM, V51, P259; Moss RB, 2015, LANCET RESP MED, V3, P524, DOI 10.1016/S2213-2600(15)00201-5; Moss RB, 2013, J PEDIATR-US, V162, P676, DOI 10.1016/j.jpeds.2012.11.034; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Reinhardt U, 2015, JAMA-J AM MED ASSOC, V314, P981, DOI 10.1001/jama.2015.9593; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Sawicki GS, 2015, AM J RESP CRIT CARE, V192, P836, DOI 10.1164/rccm.201503-0578OC; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001.0137OC; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Siracusa CM, 2015, J CYST FIBROS, V14, P621, DOI 10.1016/j.jcf.2015.05.009; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Taylor-Cousar J, 2016, J CYST FIBROS, V15, P116, DOI 10.1016/j.jcf.2015.01.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wilschanski M, 2000, AM J RESP CRIT CARE, V161, P860, DOI 10.1164/ajrccm.161.3.9904116                                                    ; Zaman K, 2016, AM J PHYSIOL-LUNG C, V310, pL263, DOI 10.1152/ajplung.00269.2014; Zamecnik PC, 2004, P NATL ACAD SCI USA, V101, P8150, DOI 10.1073/pnas.0401933101; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021                                             	62	0	0	9	9	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0755-4982	2213-0276		PRESSE MED	Presse Med.	JUN	2017	46	6	2				E165	E175		10.1016/j.lpm.2017.01.024				11	Medicine, General & Internal	General & Internal Medicine	FB8PW	WOS:000406402100007	28554723				2018-01-05	
J	Liang, PP; Zhang, XY; Chen, YX; Huang, JJ				Liang, Puping; Zhang, Xiya; Chen, Yuxi; Huang, Junjiu			Developmental history and application of CRISPR in human disease	JOURNAL OF GENE MEDICINE			English	Review						cell therapy; gene therapy; gene-editing	HEPATITIS-B-VIRUS; ZINC-FINGER NUCLEASES; PLURIPOTENT STEM-CELLS; STAPHYLOCOCCUS-AUREUS CAS9; DUCHENNE MUSCULAR-DYSTROPHY; CD4(+) T-CELLS; INHIBIT HIV-1 REPLICATION; HOMOLOGY-DIRECTED REPAIR; HUMAN HEMATOPOIETIC STEM; RNA-GUIDED ENDONUCLEASE	Genome-editing tools are programmable artificial nucleases, mainly including zinc-finger nucleases, transcription activator-like effector nucleases and clustered regularly interspaced short palindromic repeat (CRISPR). By recognizing and cleaving specific DNA sequences, genome-editing tools make it possible to generate site-specific DNA double-strand breaks (DSBs) in the genome. DSBs will then be repaired by either error-prone nonhomologous end joining or high-fidelity homologous recombination mechanisms. Through these two different mechanisms, endogenous genes can be knocked out or precisely repaired/modified. Rapid developments in genome-editing tools, especially CRISPR, have revolutionized human disease models generation, for example, various zebrafish, mouse, rat, pig, monkey and human cell lines have been constructed. Here, we review the developmental history of CRISPR and its application in studies of human diseases. In addition, we also briefly discussed the therapeutic application of CRISPR in the near future.	[Liang, Puping; Zhang, Xiya; Chen, Yuxi; Huang, Junjiu] Sun Yat Sen Univ, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Zhang, Xiya; Chen, Yuxi; Huang, Junjiu] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Puping; Huang, Junjiu] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Liang, Puping; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Junjiu] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Huang, JJ (reprint author), Sun Yat Sen Univ, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.; Huang, JJ (reprint author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	hjunjiu@mail.sysu.edu.cn			Natural Science Foundation of Guangdong Province [2016A030310206]; Guangzhou Science and Technology Project [201707010085]; Fundamental Research Funds for the Central Universities [161gzd13, 161gpy31]; Science and Technology Planning Project of Guangdong Province [2015B020228002, 2015A020212005]; National Natural Science Foundation of China [31371508, 31671540, 31601196]	Natural Science Foundation of Guangdong Province, Grant/Award Number: 2016A030310206; Guangzhou Science and Technology Project, Grant/Award Number: 201707010085; Fundamental Research Funds for the Central Universities, Grant/Award Number: 161gzd13 and 161gpy31; Science and Technology Planning Project of Guangdong Province, Grant/Award Number: 2015B020228002 and 2015A020212005; National Natural Science Foundation of China, Grant/Award Number: 31371508, 31671540 and 31601196	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Byrne M, 2014, ANN NY ACAD SCI, V1310, P89, DOI 10.1111/nyas.12370; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carroll D, 2012, MOL THER, V20, P1658, DOI 10.1038/mt.2012.171; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen ZL, 2009, PROTEIN ENG DES SEL, V22, P249, DOI 10.1093/protein/gzp001; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168                                                        ; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Flynn R, 2015, EXP HEMATOL, V43, P838, DOI 10.1016/j.exphem.2015.06.002; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, METHOD ENZYMOL, V546, P21, DOI 10.1016/B978-0-12-801185-0.00002-7; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gore M. E., 2003, GENE THER, V10, P4; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013                                                            ; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; Kaiser J., 2016, SCIENCE; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Katsuyama T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt638; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li H, 2016, INT J BIOL SCI, V12, P1104, DOI 10.7150/ijbs.16064; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lo T. W., 2013, GENETICS, V195, P331, DOI [10.1534/genetics.113.155382, DOI 10.1534/GENETICS.113.155382]; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; McMahon BJ, 2017, CLIN GASTROENTEROL H, V15, P431, DOI 10.1016/j.cgh.2016.10.012; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2016, TRENDS MICROBIOL, V24, P811, DOI 10.1016/j.tim.2016.06.005; Mojica FJM, 2016, FEBS J, V283, P3162, DOI 10.1111/febs.13766; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishida K, 2016, SCIENCE, V353, P8729; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Osborn MJ, 2015, HUM GENE THER, V26, P114, DOI 10.1089/hum.2014.111; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reardon S., 2017, NATURE; Reardon S, 2015, NATURE, V528, P173, DOI 10.1038/528173a; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Sera T, 2002, BIOCHEMISTRY-US, V41, P7074, DOI 10.1021/bi020095c; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; THIESEN HJ, 1993, ANN NY ACAD SCI, V684, P246, DOI 10.1111/j.1749-6632.1993.tb32299.x                                              ; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9                                                   ; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wan HF, 2015, CELL RES, V25, P258, DOI 10.1038/cr.2014.158; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183                                                ; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Yu GH, 2006, J GEN VIROL, V87, P1019, DOI 10.1099/vir.0.81384-0; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32565; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	227	0	0	28	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1099-498X	1521-2254		J GENE MED	J. Gene. Med.	JUN-JUL	2017	19	6-7							e2963	10.1002/jgm.2963				14	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FB8VY	WOS:000406418800001					2018-01-05	
J	Germini, D; Saada, YB; Tsfasman, T; Osina, K; Robin, C; Lomov, N; Rubtsov, M; Sjakste, N; Lipinski, M; Vassetzky, Y				Germini, Diego; Saada, Yara Bou; Tsfasman, Tatiana; Osina, Kristina; Robin, Chloe; Lomov, Nikolay; Rubtsov, Mikhail; Sjakste, Nikolajs; Lipinski, Mars; Vassetzky, Yegor			A One-Step PCR-Based Assay to Evaluate the Efficiency and Precision of Genomic DNA-Editing Tools	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOMAL TRANSLOCATIONS; CELLS; NUCLEASES; SYSTEM	Despite rapid progress, many problems and limitations persist and limit the applicability of gene-editing techniques. Making use of meganucleases, TALENs, or CRISPR/Cas9-based tools requires an initial step of pre-screening to determine the efficiency and specificity of the designed tools. This step remains time consuming and material consuming. Here we propose a simple, cheap, reliable, time-saving, and highly sensitive method to evaluate a given gene-editing tool based on its capacity to induce chromosomal translocations when combined with a reference engineered nuclease. In the proposed technique, designated engineered nuclease-induced translocations (ENIT), a plasmid coding for the DNA-editing tool to be tested is co-transfected into carefully chosen target cells along with that for an engineered nuclease of known specificity and efficiency. If the new enzyme efficiently cuts within the desired region, then specific chromosomal translocations will be generated between the two targeted genomic regions and be readily detectable by a one-step PCR or qPCR assay. The PCR product thus obtained can be directly sequenced, thereby determining the exact position of the double-strand breaks induced by the gene-editing tools. As a proof of concept, ENIT was successfully tested in different cell types and with different meganucleases, TALENs, and CRISPR/Cas9-based editing tools.	[Germini, Diego; Saada, Yara Bou; Tsfasman, Tatiana; Osina, Kristina; Robin, Chloe; Lomov, Nikolay; Lipinski, Mars; Vassetzky, Yegor] Univ Paris Sud Paris Saclay, CNRS, Inst Gustave Roussy, UMR8126, F-94805 Villejuif, France; [Germini, Diego; Saada, Yara Bou; Tsfasman, Tatiana; Lomov, Nikolay; Rubtsov, Mikhail; Lipinski, Mars; Vassetzky, Yegor] French Russian Joint Canc Res Lab, LIA 1066, F-94805 Villejuif, France; [Germini, Diego] Peter Great St Petersburg Polytech Univ, Inst Phys Nanotechnol & Telecommun, Dept Biophys, St Petersburg 195251, Russia; [Osina, Kristina; Sjakste, Nikolajs] Univ Latvia, LV-1586 Riga, Latvia; [Lomov, Nikolay; Rubtsov, Mikhail; Vassetzky, Yegor] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Rubtsov, Mikhail] IM Sechenov First Moscow State Med Univ, Dept Biochem, Moscow 119048, Russia; [Rubtsov, Mikhail] IM Sechenov First Moscow State Med Univ, Strateg Management Dept, Moscow 119048, Russia	Vassetzky, Y (reprint author), Univ Paris Sud Paris Saclay, CNRS, Inst Gustave Roussy, UMR8126, F-94805 Villejuif, France.	vassetzky@igr.fr	Rubtsov, Mikhail/A-8435-2014; Vassetzky, Yegor/C-6447-2008	Vassetzky, Yegor/0000-0003-3101-7043	AFM (MEGAFSHD); INSERM (ENVIBURKITT); ANRS; INSERM	This work was supported by the AFM (MEGAFSHD), INSERM (ENVIBURKITT), and ANRS (to Y.V.). T.T. acknowledges fellowship from the ANRS. Funding for the open access charge was provided by INSERM.	Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Iarovaia OV, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-249; Inazuka M, 1997, GENOME RES, V7, P1094, DOI 10.1101/gr.7.11.1094                                                            ; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Richardson C, 2000, NATURE, V405, P697; Roschke AV, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00302; Saada YB, 2016, BIOCHEMISTRY-MOSCOW+, V81, P678, DOI 10.1134/S000629791607004X; Sedlak RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20064; Serth J, 2000, AM J PATHOL, V156, P1189, DOI 10.1016/S0002-9440(10)64989-9                                                   ; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996                                                             ; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yu B., 2006, CURR PROTOC HUM GENE, P7	26	0	0	4	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2329-0501			MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.	JUN	2017	5						43	50		10.1016/j.omtm.2017.03.001				8	Medicine, Research & Experimental	Research & Experimental Medicine	FB7CV	WOS:000406299600005	28480303	gold			2018-01-05	
J	Ortinski, PI; O'Donovan, B; Dong, XY; Kantor, B				Ortinski, Pavel I.; O'Donovan, Bernadette; Dong, Xiaoyu; Kantor, Boris			Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GUIDED DNA ENDONUCLEASE; ALPHA-SUBUNIT ISOFORM; HUMAN-CELLS; T-CELL; NUCLEASE SPECIFICITY; SP1-BINDING SITES; SEQUENCING DATA; CAS9 NUCLEASES; STEM-CELLS	The CRISPR/Cas9 systems have revolutionized the field of genome editing by providing unprecedented control over gene sequences and gene expression in many species, including humans. Lentiviral vectors (LVs) are one of the primary delivery platforms for the CRISPR/Cas9 system due to their ability to accommodate large DNA payloads and sustain robust expression in a wide range of dividing and non-dividing cells. However, long-term expression of LV-delivered Cas9/guide RNA may lead to undesirable off-target effects characterized by non-specific RNA-DNA interactions and off-target DNA cleavages. Integrase-deficient lentiviral vectors (IDLVs) present an attractive means for delivery of CRISPR/Cas9 components because: (1) they are capable of transducing a broad range of cells and tissues, (2) have superior packaging capacity compared to other vectors (e.g., adeno-associated viral vectors), and (3) they are expressed transiently and demonstrate very weak integration capability. In this manuscript, we aimed to establish IDLVs as a means for safe and efficient delivery of CRISPR/Cas9. To this end, we developed an all-in-one vector cassette with increased production efficacy and demonstrated that CRISPR/Cas9 delivered by the improved IDLV vectors can mediate rapid and robust gene editing in human embryonic kidney (HEK293T) cells and post-mitotic brain neurons in vivo, via transient expression and with higher gene-targeting specificity than the corresponding integrase-competent vectors.	[Ortinski, Pavel I.; O'Donovan, Bernadette; Dong, Xiaoyu; Kantor, Boris] Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC 29208 USA; [Dong, Xiaoyu; Kantor, Boris] Univ South Carolina, Sch Med, Viral Vector Core, Dept Pharmacol Physiol & Neurosci, Columbia, SC 29208 USA; [Kantor, Boris] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Kantor, B (reprint author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.; Kantor, B (reprint author), Duke Dept Neurobiol, Sch Med, Bryan Res Bldg,Rm 213-311 Res Dr, Durham, NC 27710 USA.	boris.kantor@duke.edu	Ortinski, Pavel/N-7195-2017	Ortinski, Pavel/0000-0003-0814-4490	University of South Carolina-School of Medicine grant [RDF18080-E202]; National Institute on Drug Abuse (NIDA) grant [K01 DA031747]	We thank Duke Center for genomic and computational biology and Sequencing and Genomic Technologies and Genomic Analysis and Bioinformatics Cores for performing and analyzing WES. We thank Udai Singh and the Flow Cytometry Core at the University of South Carolina for assistance. The all-in-one expression plasmid lenti-CRISPRv2 (Addgene plasmid #52961) was a kind gift from Feng Zhang (Broad Institute). We thank Sriram Vijayraghavan (Duke University) for his comments and help with manuscript preparation and submission. Support was provided by University of South Carolina-School of Medicine grant RDF18080-E202 (to B.K.) and National Institute on Drug Abuse (NIDA) grant K01 DA031747 (to P.I.O)	Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Bayer M, 2008, MOL THER, V16, P1968, DOI 10.1038/mt.2008.199; Bellec J, 2015, CURR GENE THER, V15, P447; Berkhout B, 1999, J VIROL, V73, P1138; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Chen Q, 2007, BIOCHEM BIOPH RES CO, V356, P733, DOI 10.1016/j.bbrc.2007.03.041; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Coluccio A, 2013, MOL THER, V21, P1695, DOI 10.1038/mt.2013.143; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gingrich KJ, 1995, J PHYSIOL-LONDON, V489, P529, DOI 10.1113/jphysiol.1995.sp021070                                                  ; Goffin W, 2005, NUCLEIC ACIDS RES, V33, P4285, DOI 10.1093/nar/gki720; Gomez-Gonzalo M, 2001, J BIOL CHEM, V276, P35435, DOI 10.1074/jbc.M103020200; Hoban MD, 2016, CURR PROTOC STEM CEL, V36; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joglekar AV, 2013, MOL THER, V21, P1705, DOI 10.1038/mt.2013.106; Kantor B, 2014, ADV GENET, V87, P71, DOI 10.1016/B978-0-12-800149-3.00002-0; Kantor B, 2014, ADV GENET, V87, P125, DOI 10.1016/B978-0-12-800149-3.00003-2; Kantor B, 2011, MOL THER, V19, P547, DOI 10.1038/mt.2010.277; Kantor B, 2009, P NATL ACAD SCI USA, V106, P18786, DOI 10.1073/pnas.0905859106; Karwacz K, 2009, J VIROL, V83, P3094, DOI 10.1128/JVI.02519-08; Kennedy EM, 2015, METHODS, V91, P82, DOI 10.1016/j.ymeth.2015.08.012; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YS, 2005, J BIOL CHEM, V280, P21545, DOI 10.1074/jbc.m414136200; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8                                                   ; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michelini Z, 2009, VACCINE, V27, P4622, DOI 10.1016/j.vaccine.2009.05.070; Negri DRM, 2007, MOL THER, V15, P1716, DOI 10.1038/sj.mt.600241; Negri DRM, 2011, EXPERT OPIN BIOL TH, V11, P739, DOI 10.1517/14712598.2011.571670; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146; Rossi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107377; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Suwanmanee T, 2014, MOL THER, V22, P567, DOI 10.1038/mt.2013.188; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V43, P11, DOI DOI 10.1002/0471250953.BI1110S43; VanLint C, 1997, J VIROL, V71, P6113; VANLINT C, 1994, J VIROL, V68, P2632; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Yang YM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5564; Yi GH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.52	69	0	0	8	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2329-0501			MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.	JUN	2017	5						153	164		10.1016/j.omtm.2017.04.002				12	Medicine, Research & Experimental	Research & Experimental Medicine	FB7CV	WOS:000406299600017	28497073	gold			2018-01-05	
J	Seo, JH; Baek, SW; Lee, J; Park, JB				Seo, Joo-Hyun; Baek, So-Won; Lee, Jinwon; Park, Jin-Byung			Engineering Escherichia coli BL21 genome to improve the heptanoic acid tolerance by using CRISPR-Cas9 system	BIOTECHNOLOGY AND BIOPROCESS ENGINEERING			English	Article						acid tolerance; dsrA; rcsB; CRISPR-Cas; Escherichia coli BL21; genome engineering	CARBOXYLIC-ACIDS; STRESS; RNA; BIOTRANSFORMATION; BIOCATALYST; INHIBITION; RESISTANCE; RCSB; GADE; DSRA	Acid tolerance is one of the critical factors to determine the quality of the industrial production strains. Therefore, we have investigated the introduction of the acid tolerance genes into the genome of Escherichia coli BL21 by using CRISPR-Cas9 system. The dsrA and rcsB genes of E. coli K-12, which are involved in the heptanoic acid tolerance, were inserted into the genome of E. coli BL21 without scar. The native transcription unit (TU) of dsrA and the synthetic TU of rcsB were integrated in E. coli BL21 genome. We found that the position of genomic coordinate of 1,300,270 was more efficient to integrate dsrA and rcsB than genomic coordinate of 3,876,428. Furthermore, the rcsB was successfully expressed in the resulting engineered strains (i.e., rcsB (+) or dsrA (+) rcsB (+) strains). The engineered strains expressing dsrA and/or rcsB showed the higher survival rate and specific growth rate under n-heptanoic acid stress than wild-type E. coli BL21. These results indicate that the newly introduced acid-tolerance systems were active in the E. coli BL21 strain.	[Seo, Joo-Hyun] Sunmoon Univ, Dept BT Convergent Pharmaceut Engn, Asan 31460, South Korea; [Baek, So-Won; Park, Jin-Byung] Ewha Womans Univ, Dept Food Sci & Engn, Seoul 03760, South Korea; [Lee, Jinwon] Sogang Univ, Dept Chem & Biomol Engn, Seoul 04107, South Korea; [Park, Jin-Byung] Ewha Womans Univ, Inst Mol Microbiol & Biosyst Engn, Seoul 03760, South Korea	Park, JB (reprint author), Ewha Womans Univ, Dept Food Sci & Engn, Seoul 03760, South Korea.	jbpark06@ewha.ac.kr			MOTIE/KEIT, Republic of Korea [10044604]	This study was supported by the R&D Program of MOTIE/KEIT [10044604], Republic of Korea.	Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Benard L, 2004, RNA, V10, P458, DOI 10.1261/rna.5183804; Bryant JA, 2014, NUCLEIC ACIDS RES, V42, P11383, DOI 10.1093/nar/gku828; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Gaida SM, 2013, NUCLEIC ACIDS RES, V41, P8726, DOI 10.1093/nar/gkt651; Jang HY, 2016, GREEN CHEM, V18, P1089, DOI 10.1039/c5gc01017a; Jarboe LR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00272; Jeon EY, 2016, ACS CATAL, V6, P7547, DOI 10.1021/acscatal.6b01884; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Johnson MD, 2011, J BACTERIOL, V193, P3653, DOI 10.1128/JB.05040-11; Koppireddi S, 2016, ADV SYNTH CATAL, V358, P3084, DOI 10.1002/adsc.201600216; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lee NR, 2015, BIOTECHNOL BIOPROC E, V20, P1088, DOI 10.1007/s12257-015-0607-x; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; Li RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34651; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; RIESENBERG D, 1991, CURR OPIN BIOTECH, V2, P380, DOI 10.1016/S0958-1669(05)80142-9                                                   ; Seo JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28223; Trussart M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14665; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Woo JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163265	23	0	0	10	10	KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING	SEOUL	KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1226-8372	1976-3816		BIOTECHNOL BIOPROC E	Biotechnol. Bioprocess Eng.	JUN	2017	22	3					231	238		10.1007/s12257-017-0158-4				8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FB1OI	WOS:000405912700002					2018-01-05	
J	Hu, XJ; Shen, B; Liao, SY; Ning, Y; Ma, LF; Chen, J; Lin, XW; Zhang, DQ; Li, Z; Zheng, CW; Feng, YM; Huang, XX; Han, CS				Hu, Xiangjing; Shen, Bin; Liao, Shangying; Ning, Yan; Ma, Longfei; Chen, Jian; Lin, Xiwen; Zhang, Daoqin; Li, Zhen; Zheng, Chunwei; Feng, Yanmin; Huang, Xingxu; Han, Chunsheng			Gene knockout of Zmym3 in mice arrests spermatogenesis at meiotic metaphase with defects in spindle assembly checkpoint	CELL DEATH & DISEASE			English	Article							LINKED MENTAL-RETARDATION; SPERMATOGONIAL STEM-CELLS; MALE GERM-CELLS; MEIOSIS; PROGRESSION; LSD1; EXPRESSION; GENERATION; CHROMATIN; DXS6673E	ZMYM3, a member of the MYM-type zinc finger protein family and a component of a LSD1-containing transcription repressor complex, is predominantly expressed in the mouse brain and testis. Here, we show that ZMYM3 in the mouse testis is expressed in somatic cells and germ cells until pachytene spermatocytes. Knockout (KO) of Zmym3 in mice using the CRISPR-Cas9 system resulted in adult male infertility. Spermatogenesis of the KO mice was arrested at the metaphase of the first meiotic division (MI). ZMYM3 co-immunoprecipitated with LSD1 in spermatogonial stem cells, but its KO did not change the levels of LSD1 or H3K4me1/2 or H3K9me2. However, Zmym3 KO resulted in elevated numbers of apoptotic germ cells and of MI spermatocytes that are positive for BUB3, which is a key player in spindle assembly checkpoint. Zmym3 KO also resulted in up-regulated expression of meiotic genes in spermatogonia. These results show that ZMYM3 has an essential role in metaphase to anaphase transition during mouse spermatogenesis by regulating the expression of diverse families of genes.	[Hu, Xiangjing; Liao, Shangying; Ning, Yan; Ma, Longfei; Chen, Jian; Lin, Xiwen; Zhang, Daoqin; Li, Zhen; Zheng, Chunwei; Feng, Yanmin; Han, Chunsheng] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, 1-5 Bei Chen West Rd, Beijing 100101, Peoples R China; [Hu, Xiangjing; Ning, Yan; Ma, Longfei; Zhang, Daoqin; Li, Zhen; Zheng, Chunwei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shen, Bin; Chen, Jian; Feng, Yanmin] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Huang, Xingxu] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Huang, XX; Han, CS (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, 1-5 Bei Chen West Rd, Beijing 100101, Peoples R China.	huangxx@shanghaitech.edu.cn; hancs@ioz.ac.cn			Ministry of Science and Technology of China [2016YFC1000600, 2015CB943002, 2013CB945001]; National Natural Science Foundation of China [31271379, 31471349]	We thank Dr. Qingyuan Sun from the State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences for his valuable suggestions on phenotypic analysis of the KO mice. This work was supported by grants from the Ministry of Science and Technology of China (2016YFC1000600, 2015CB943002, 2013CB945001); and National Natural Science Foundation of China (31271379, 31471349).	Bandiera R, 2015, MOL CELL ENDOCRINOL, V408, P145, DOI 10.1016/j.mce.2015.01.009; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Chen J, 2017, NUCLEIC ACIDS RES, V45, P4142, DOI 10.1093/nar/gkw1287; Cheng CL, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/1851829; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Hou M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3329-3; Jia L, 2013, TRENDS BIOCHEM SCI, V38, P311; Kim J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10116; Lambrot R, 2015, FASEB J, V29, P4402, DOI 10.1096/fj.14-267328; Leung JWC, 2017, GENE DEV, V31, P260, DOI 10.1101/gad.292516.116; Maiques-Diaz A, 2016, EPIGENOMICS-UK, V8, P1103, DOI 10.2217/epi-2016-0009; Marangos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9706; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Scheer MP, 2000, GENOMICS, V63, P123, DOI 10.1006/geno.1999.6027                                                          ; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Vanhoutteghem A, 2014, DEVELOPMENT, V141, P4298, DOI 10.1242/dev.112888; Vernet N, 2011, CURR BIOL, V21, P787, DOI 10.1016/j.cub.2011.03.057; Wang S, 2015, STEM CELLS DEV, V24, P471, DOI 10.1089/scd.2014.0376; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	31	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUN	2017	8								e2910	10.1038/cddis.2017.228				11	Cell Biology	Cell Biology	FB1HT	WOS:000405895200014	28661483				2018-01-05	
J	Kasai, S; Furuichi, Y; Ando, N; Kagami, K; Abe, M; Nakane, T; Goi, K; Inukai, T; Saitoh, S; Ohno, S; Okazaki, S; Nagano, O; Saya, H; Sugita, K				Kasai, Shin; Furuichi, Yoshiyuki; Ando, Norie; Kagami, Keiko; Abe, Masako; Nakane, Takaya; Goi, Kumiko; Inukai, Takeshi; Saitoh, Sei; Ohno, Shinichi; Okazaki, Shogo; Nagano, Osamu; Saya, Hideyuki; Sugita, Kanji			Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression	CELL DEATH & DISEASE			English	Article							CANCER STEM-CELLS; T-CELLS; RELEASE; DEATH; FEVER; HMGB1; REGRESSION; RECEPTORS; AUTOPHAGY; SURVIVAL	Acute lymphoblastic leukemia (ALL) with mixed lineage leukemia (MLL) gene rearrangements (MLL+ALL) has a dismal prognosis and is characterized by high surface CD44 expression. Known that CD44 has the specific binding sites for a natural ligand hyaluronan ( HA), we investigated biological effects of HA with different molecular sizes on MLL+ALL cell lines, and found that the addition of ultra-low-molecular-weight (ULMW)-HA strongly suppressed their thymidine uptakes. The MLL+ALL cell line lacking surface CD44 expression established by genome editing showed no suppression of thymidine uptake. Surface CD44-high B-precursor ALL cell lines other than MLL+, but not T-ALL cell lines, were also suppressed in their thymidine uptakes. The inhibition of thymidine uptakes was because of induction of cell death, but dead cells lacked features of apoptosis on cytospin smears and flow cytometric analysis. The cell death was neither blocked by pan-caspase inhibitor nor autophagy inhibitor, but was completely blocked by necrosis inhibitor necrostatin-1. Necrotic cell death was further supported by a marked release of a high-mobility protein group B1 and morphological changes on transmission electron microscopy. Elevation of intracellular reactive oxygen species production suggested a role for inducing this necrotic cell death. ULMW-HA-triggered cell death was similarly demonstrated in surface CD44-high primary B-precursor leukemia cells. Assuming that ULMW-HA is abundantly secreted at the site of infection and inflammation, this study sheds light on understanding the mechanism of a transient inflammation-associated remission of leukemia. Further, the CD44-targeting may become an effective approach in future for the treatment of refractory B-precursor ALL by its capability of predominantly eradicating CD44-high leukemia-initiating cells.	[Kasai, Shin; Furuichi, Yoshiyuki; Ando, Norie; Kagami, Keiko; Abe, Masako; Nakane, Takaya; Goi, Kumiko; Inukai, Takeshi; Sugita, Kanji] Univ Yamanashi, Grad Sch Med, Dept Pediat, Kofu, Yamanashi, Japan; [Saitoh, Sei; Ohno, Shinichi] Univ Yamanashi, Grad Sch Med, Dept Anat, Kofu, Yamanashi, Japan; [Saitoh, Sei; Ohno, Shinichi] Univ Yamanashi, Grad Sch Med, Dept Mol Histol, Kofu, Yamanashi, Japan; [Okazaki, Shogo; Nagano, Osamu; Saya, Hideyuki] Keio Univ, Inst Adv Med Res, Sch Med, Div Gene Regulat, Tokyo, Japan; [Saitoh, Sei] Natl Inst Physiol Sci, Support Ctr Brain Res, Sect Electron Microscopy, Okazaki, Aichi, Japan	Sugita, K (reprint author), Univ Yamanashi, Grad Sch Med, Dept Pediat, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	ksugita@yamanashi.ac.jp			Ministry of Culture and Science of Japan [25461585]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Culture and Science of Japan (No. 25461585).	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beyer C, 2012, INNATE IMMUN-LONDON, V18, P727, DOI 10.1177/1753425912437981; CHALLIS GB, 1990, ACTA ONCOL, V29, P545, DOI 10.3109/02841869009090048                                                       ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Furuichi Y, 2007, CANCER RES, V67, P9852, DOI 10.1158/0008-5472.CAN-07-0105; Grigoreas GHA, 2003, ANAL BIOCHEM, V320, P179, DOI 10.1016/S0003-2697(03)00386-5; Hobohm U, 2005, BRIT J CANCER, V92, P421, DOI 10.1038/sj.bjc.6602386; Hobohm U, 2001, CANCER IMMUNOL IMMUN, V50, P391; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Kostner AH, 2013, ACTA ONCOL, V52, P455, DOI 10.3109/0284186X.2012.711954; Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875; Larkin J, 2006, J IMMUNOL, V177, P268, DOI 10.4049/jimmunol.177.1.268                                                      ; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Nikitovic D, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00169; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Okamoto I, 1998, J NATL CANCER I, V90, P307, DOI 10.1093/jnci/90.4.307                                                           ; PUI CH, 1994, J CLIN ONCOL, V12, P909, DOI 10.1200/JCO.1994.12.5.909                                                       ; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schwertfeger KL, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00236; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Taki T, 1996, LEUKEMIA, V10, P1303; Trapasso S, 2012, BIOL-TARGETS THER, V6, P379, DOI 10.2147/BTT.S37906; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vistejnova L, 2014, CYTOKINE, V70, P97, DOI 10.1016/j.cyto.2014.07.006; Yoshida GJ, 2016, CANCER SCI, V107, P5, DOI 10.1111/cas.12817; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	37	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUN	2017	8								e2857	10.1038/cddis.2017.249				11	Cell Biology	Cell Biology	FB1HT	WOS:000405895200034	28569787	gold			2018-01-05	
J	Yao, X; Wang, X; Liu, JL; Hu, XD; Shi, LY; Shen, XW; Ying, WQ; Sun, XY; Wang, X; Huang, PY; Yang, H				Yao, Xuan; Wang, Xing; Liu, Junlai; Hu, Xinde; Shi, Linyu; Shen, Xiaowen; Ying, Wenqin; Sun, Xinyao; Wang, Xin; Huang, Pengyu; Yang, Hui			CRISPR/Cas9 - Mediated Precise Targeted Integration In Vivo Using a Double Cut Donor with Short Homology Arms	EBIOMEDICINE			English	Article						MMEJ; CRISPR/Cas9; In vivo targeted integration; Fah(-/-) mice; Gene therapy	KNOCK-IN; ZEBRAFISH; SYSTEM; REPAIR; CELLS; DNA; EFFICIENCY; GENES; MICE	Precisely targeted genome editing is highly desired for clinical applications. However, the widely used homology-directed repair (HDR)-based genome editing strategies remain inefficient for certain in vivo applications. We here demonstrate a microhomology-mediated end-joining (MMEJ)-based strategy for precisely targeted gene integration in transfected neurons and hepatocytes in vivo with efficiencies up to 20%, much higher (up to 10 fold) than HDR-based strategy in adult mouse tissues. As a proof of concept of its therapeutic potential, we demonstrate the efficacy of MMEJ-based strategy in correction of Fah mutation and rescue of Fah(-/-) liver failure mice, offering an efficient approach for precisely targeted gene therapies. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.	[Yao, Xuan; Wang, Xing; Hu, Xinde; Shi, Linyu; Shen, Xiaowen; Ying, Wenqin; Sun, Xinyao; Yang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,State Key Lab Neurosci,Key Lab Prim, Shanghai 200031, Peoples R China; [Liu, Junlai; Huang, Pengyu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Yao, Xuan; Wang, Xing; Liu, Junlai] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Liu, Junlai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Wang, Xin] Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot 010070, Peoples R China; [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Yang, H (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,State Key Lab Neurosci,Key Lab Prim, Shanghai 200031, Peoples R China.; Huang, PY (reprint author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	huangpy@shanghaitech.edu.cn; huiyang@ion.ac.cn		yang, hui/0000-0003-3590-722X	CAS Strategic Priority Research Program [XDB02050007, XDA01010409]; MoST863 Program [2015AA020307]; NSFC [31522037, 31500825]; China Youth Thousand Talents Program; Break through project of Chinese Academy of Sciences; Ministry of Science and Technology of China (MOST) [2016YFA0100500]; National Natural Science Foundation of China (NSFC) [31571509, 31522038]; Shanghai Sailing Plan for the Young Scientific Talents [14YF1406900]	This work was supported by CAS Strategic Priority Research Program (XDB02050007, XDA01010409), the MoST863 Program (2015AA020307), NSFC grants (31522037, 31500825), China Youth Thousand Talents Program (to H.Y.), Break through project of Chinese Academy of Sciences (to H.Y.). The Ministry of Science and Technology of China (MOST; 2016YFA0100500), the National Natural Science Foundation of China (NSFC; 31571509, 31522038), Shanghai Sailing Plan for the Young Scientific Talents (14YF1406900) (P.Y.H.)	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Liu YG, 2015, J NEUROSCI, V35, P9336, DOI 10.1523/JNEUROSCI.3975-14.2015; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Takahashi M, 2008, DEV GROWTH DIFFER, V50, P485, DOI [10.1111/j.1440-169X.2008.01046.x, 10.1111/j.1440-169x.2008.01046.x]; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yin H., 2014, NAT BIOTECHNOL; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003	20	2	2	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-3964			EBIOMEDICINE	EBioMedicine	JUN	2017	20						19	26		10.1016/j.ebiom.2017.05.015				8	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	FA8TT	WOS:000405719700010	28527830	gold			2018-01-05	
J	Rattanasinchai, C; Llewellyn, BJ; Conrad, SE; Gallo, KA				Rattanasinchai, C.; Llewellyn, B. J.; Conrad, S. E.; Gallo, K. A.			MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells	ONCOGENESIS			English	Article							CIRCULATING TUMOR-CELLS; MATRIX-METALLOPROTEINASE EXPRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; LINEAGE KINASE 3; C-JUN; COLORECTAL-CANCER; IN-VIVO; B-RAF; METASTASIS; TRANSCRIPTION	Mixed-lineage kinase 3 (MLK3), a mitogen-activated protein kinase kinase kinase (MAP3K), has critical roles in metastasis of triple-negative breast cancer (TNBC), in part by regulating paxillin phosphorylation and focal adhesion turnover. However the mechanisms and the distinct step(s) of the metastatic processes through which MLK3 exerts its influence are not fully understood. Here we report that in non-metastatic, estrogen receptor-positive breast cancer (ER+ BC) cells, induced MLK3 expression robustly upregulates the oncogenic transcription factor, FOS-related antigen-1 (FRA-1), which is accompanied by elevation of matrix metalloproteinases (MMPs), MMP-1 and MMP-9. MLK3-induced ER+ BC cell invasion is abrogated by FRA-1 silencing, demonstrating that MLK3 drives invasion through FRA-1. Conversely, in metastatic TNBC models, high FRA-1 levels are significantly reduced upon depletion of MLK3 by either gene silencing or by the CRISPR/Cas9n editing approach. Furthermore, ablation of MLK3 or MLK inhibitor treatment decreases expression of both MMP-1 and MMP-9. Consistent with the role of tumor cell-derived MMP-1 in endothelial permeability and transendothelial migration, both of these are reduced in MLK3-depleted TNBC cells. In addition, MLK inhibitor treatment or MLK3 depletion, which downregulates MMP-9 expression, renders TNBC cells defective in Matrigel invasion. Furthermore, circulating tumor cells derived from TNBC-bearing mice display increased levels of FRA-1 and MMP-1 compared with parental cells, supporting a role for the MLK3-FRA-1-MMP-1 signaling axis in vascular intravasation. Our results demonstrating the requirement for MLK3 in controlling the FRA-1/MMPs axis suggest that MLK3 is a promising therapeutic target for treatment of TNBC.	[Rattanasinchai, C.; Llewellyn, B. J.; Gallo, K. A.] Michigan State Univ, Dept Physiol, 567 Wilson Rd,4164 Biomed & Phys Sci, E Lansing, MI 48824 USA; [Rattanasinchai, C.; Conrad, S. E.; Gallo, K. A.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Conrad, S. E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Gallo, KA (reprint author), Michigan State Univ, Dept Physiol, 567 Wilson Rd,4164 Biomed & Phys Sci, E Lansing, MI 48824 USA.	gallok@msu.edu			Thai Royal Government fellowship; Aitch Foundation Cancer Fellowship	CR is the recipient of Thai Royal Government fellowship and Aitch Foundation Cancer Fellowship. BJL is an MSU Professorial Assistantship Undergraduate Research Program fellow.	Adiseshaiah P, 2005, ONCOGENE, V24, P4193, DOI 10.1038/sj.onc.1208583; Adiseshaiah P, 2008, J CELL PHYSIOL, V216, P405, DOI 10.1002/jcp.21410; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Bakiri L, 2015, CELL DEATH DIFFER, V22, P336, DOI 10.1038/cdd.2014.157; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Belguise K, 2012, ONCOGENE, V31, P4889, DOI 10.1038/onc.2011.659; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bidard FC, 2008, ANN ONCOL, V19, P496, DOI 10.1093/annonc/mdm507; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chen J, 2010, ONCOGENE, V29, P4399, DOI 10.1038/onc.2010.198; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Cheng FF, 2016, CANCER LETT, V375, P274, DOI 10.1016/j.canlet.2016.03.010; Cierna Z, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-472; Colleoni M, 2016, J CLIN ONCOL, V34, P927, DOI 10.1200/JCO.2015.62.3504; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766                                                            ; Cristofanilli M, 2007, CLIN BREAST CANCER, V7, P471, DOI 10.3816/CBC.2007.n.004                                                          ; Cronan MR, 2012, ONCOGENE, V31, P3889, DOI 10.1038/onc.2011.544; Debinski W, 2005, MOL CANCER RES, V3, P237; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Diesch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088950; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Foley CJ, 2014, J CELL PHYSIOL, V229, P1875, DOI 10.1002/jcp.24650; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Henckels Eric, 2013, F1000Res, V2, P229, DOI 10.12688/f1000research.2-229.v1; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Iskit S, 2015, ONCOTARGET, V6, P43146, DOI 10.18632/oncotarget.6454; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Juncker-Jensen A, 2013, CANCER RES, V73, P4196, DOI 10.1158/0008-5472.CAN-12-4495; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim J, 2011, ONCOGENE, V30, P323, DOI 10.1038/onc.2010.415; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lee HS, 2012, NUTR RES PRACT, V6, P294, DOI 10.4162/nrp.2012.6.4.294; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Liu H, 2015, CARCINOGENESIS, V36, P459, DOI 10.1093/carcin/bgv017; Liu MC, 2009, J CLIN ONCOL, V27, P5153, DOI 10.1200/JCO.2008.20.6664; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Marker DF, 2013, J NEUROSCI, V33, P9998, DOI 10.1523/JNEUROSCI.0598-13.2013; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; Marusiak AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4901; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932                                                        ; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mohammed RAA, 2011, MODERN PATHOL, V24, P774, DOI 10.1038/modpathol.2011.4; Moquet-Torcy G, 2014, NUCLEIC ACIDS RES, V42, P11011, DOI 10.1093/nar/gku814; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; *PARK STUD GROUP P, 2007, NEUROLOGY, V69, P1480; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rattanasinchai C, 2016, CANCERS, V8, DOI 10.3390/cancers8050051; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Rizwan Asif, 2015, NPJ Breast Cancer, V1, P15017, DOI 10.1038/npjbcancer.2015.17; Schachter KA, 2006, J BIOL CHEM, V281, P19134, DOI 10.1074/jbc.M603324200; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh NK, 2010, J BIOL CHEM, V285, P16830, DOI 10.1074/jbc.M110.106187; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tewes M, 2009, BREAST CANCER RES TR, V115, P581, DOI 10.1007/s10549-008-0143-x; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wang S, 2009, P NATL ACAD SCI USA, V106, P151, DOI 10.1073/pnas.0808703105; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/25.22.9949-9959.2005; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zeng ZS, 1999, CARCINOGENESIS, V20, P749, DOI 10.1093/carcin/20.5.749; Zhan Y, 2012, EXP CELL RES, V318, P1641, DOI 10.1016/j.yexcr.2012.05.002; Zhang H, 2004, J BIOL CHEM, V279, P19457, DOI 10.1074/jbc.M311377200; Zhao CY, 2014, CANCER RES, V74, P3983, DOI 10.1158/0008-5472.CAN-13-3396	85	0	0	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2157-9024			ONCOGENESIS	Oncogenesis	JUN	2017	6								e345	10.1038/oncsis.2017.44				11	Oncology	Oncology	FB3MR	WOS:000406047300002	28604765	gold			2018-01-05	
J	Gao, B; Bian, XM; Chi, L; Tu, PC; Ru, HY; Lu, K				Gao, Bei; Bian, Xiaoming; Chi, Liang; Tu, Pengcheng; Ru, Hongyu; Lu, Kun			Organophosphate Diazinon Altered Quorum Sensing, Cell Motility, Stress Response, and Carbohydrate Metabolism of Gut Microbiome	TOXICOLOGICAL SCIENCES			English	Article						organophosphate; gut microbiome; metatranscriptomics; quorum sensing	RNA-SEQ DATA; CRISPR-CAS SYSTEMS; OXIDATIVE STRESS; PSEUDOMONAS-AERUGINOSA; ARSENIC EXPOSURE; REFERENCE GENOME; GENE-EXPRESSION; QUANTIFICATION; IDENTIFICATION; IMMUNITY	The gut microbiome plays a key role in energy production, immune system development, and host resistance against invading pathogens, etc. Disruption of gut bacterial homeostasis is associated with a number of human diseases. Several environmental chemicals have been reported to induce alterations of the gut microbiome. Diazinon, one of important organophosphate insecticides, has been widely used in agriculture. Diazinon and its metabolites are readily detected in different environmental settings and human urine. The toxicity of organophosphates has been a long-standing public health concern. We recently demonstrated that organophosphate insecticide diazinon perturbed the gut microbiome composition of mice. However, the functional impact of exposure on the gut microbiome has not been adequately assessed yet. In particular, the molecular mechanism responsible for exposure-induced microbial profile and community structure changes has not been identified. Therefore, in this study, we used metatranscriptomics to examine the effects of diazinon exposure on the gut metatranscriptome in C57BL/6 mice. Herein, we demonstrated for the first time that organophosphate diazinon modulated quorum sensing, which may serve as a key mechanism to regulate bacterial population, composition, and more importantly, their functional genes. In addition, we also found that diazinon exposure activated diverse stress response pathways and profoundly impaired energy metabolism of gut bacteria. These findings provide new understandings of the functional interplay between the gut microbiome and environmental chemicals, such as organophosphates.	[Gao, Bei; Bian, Xiaoming] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Gao, Bei; Bian, Xiaoming; Chi, Liang; Tu, Pengcheng; Lu, Kun] Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Ru, Hongyu] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27607 USA	Lu, K (reprint author), Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.	kunlu@unc.edu		Gao, Bei/0000-0002-3321-2339	University of Georgia; University of North Carolina at Chapel Hill; National Institute of Health/National Institute of Environmental Health Sciences [R01ES024950]	This study was partially supported by the University of Georgia, University of North Carolina at Chapel Hill and the National Institute of Health/National Institute of Environmental Health Sciences (grant number R01ES024950).	Aggarwal V, 2013, REV ENVIRON CONTAM T, V223, P107, DOI 10.1007/978-1-4614-5577-6_5; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Banks CN, 2012, NEUROTOXICOLOGY, V33, P575, DOI 10.1016/j.neuro.2012.02.002; Boussabbeh M, 2016, ENVIRON SCI POLLUT R, V23, P2882, DOI 10.1007/s11356-015-5519-y; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Chi L, 2016, CHEM RES TOXICOL, V29, P949, DOI 10.1021/acs.chemrestox.6b00066; Chitra MA, 2015, VET WORLD, V8, P902, DOI 10.14202/vetworld.2015.902-907; Darkoh C, 2015, MBIO, V6, DOI 10.1128/mBio.02569-14; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; FUQUA WC, 1994, J BACTERIOL, V176, P269; Gaidenko TA, 1998, J BACTERIOL, V180, P3730; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gao B., 2016, ENV HLTH PERSPECT, V125, P198; Gaur M, 2016, GENOM DATA, V9, P87, DOI 10.1016/j.gdata.2016.06.007; Giordano G, 2007, TOXICOL APPL PHARM, V219, P181, DOI 10.1016/j.taap.2006.09.016; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gweon TG, 2016, GASTROENT RES PRACT, DOI 10.1155/2016/2687605; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Jafari M, 2012, TOXICOL MECH METHOD, V22, P638, DOI 10.3109/15376516.2012.716090; Jones RR, 2015, OCCUP ENVIRON MED, V72, P496, DOI 10.1136/oemed-2014-102728; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Kashanian S, 2008, DNA CELL BIOL, V27, P325, DOI 10.1089/dna.2007.0718; Knecht LD, 2016, EBIOMEDICINE, V9, P161, DOI 10.1016/j.ebiom.2016.05.037; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livernois A, 2016, IMMUNOGENETICS, V68, P719, DOI 10.1007/s00251-016-0922-1; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001                                                   ; Manukhov IV, 2010, J BACTERIOL, V192, P5549, DOI 10.1128/JB.00754-10; Martinez-Hernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123313; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moos WH, 2016, BIORESEARCH OPEN ACC, V5, P137, DOI 10.1089/biores.2016.0010; Mora-Ortiz M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3083-6; Nakamura S, 2008, JPN J INFECT DIS, V61, P375; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Park EY, 2002, MOL CELL BIOCHEM, V240, P47, DOI 10.1023/A:1020600509965                                                         ; Portune K. J., 2016, MOL NUTR FOOD RES, DOI [10.1002/mnfr.201600252, DOI 10.1002/MNFR.201600252.]; Qin T. T., 2015, ANN TRANSL MED, V8, P3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santocchi E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0887-5; SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997                                                ; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x                                                ; Schulze Thomas T, 2016, J Genomics, V4, P29, DOI 10.7150/jgen.16885; Serbanescu MA, 2015, J BACTERIOL, V197, P749, DOI 10.1128/JB.02333-14; Subramoni S, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00016; Thiel V, 2009, CHEMBIOCHEM, V10, P479, DOI 10.1002/cbic.200800606; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Yang Q, 2015, ENVIRON MICROBIOL, V17, P960, DOI 10.1111/1462-2920.12420; Yen J, 2011, NEUROTOXICOL TERATOL, V33, P735, DOI 10.1016/j.ntt.2011.10.004; Zhang SB, 2015, CHEM RES TOXICOL, V28, P2000, DOI 10.1021/acs.chemrestox.5b00237	56	1	1	9	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	JUN	2017	157	2					354	364		10.1093/toxsci/kfx053				11	Toxicology	Toxicology	FA8LV	WOS:000405698400009	28369659				2018-01-05	
J	Hunt, CPJ; Pouton, CW; Haynes, JM				Hunt, C. P. J.; Pouton, C. W.; Haynes, J. M.			Characterising the developmental profile of human embryonic stem cell-derived medium spiny neuron progenitors and assessing mature neuron function using a CRISPR-generated human DARPP-32(WT/eGFP-AMP) reporter line	NEUROCHEMISTRY INTERNATIONAL			English	Article						Human embryonic stem cells; Gene editing; Medium spiny neurons; Development; Neural differentiation; Pharmacology	CAUDAL GANGLIONIC EMINENCE; D1-D2 RECEPTOR HETEROMER; HUNTINGTONS-DISEASE; ACTIVIN-A; DOPAMINE-RECEPTORS; HUMAN ES; PARKINSONS-DISEASE; OLFACTORY-BULB; BASAL GANGLIA; DIFFERENTIATION	In the developing ventral telencephalon, cells of the lateral ganglionic eminence (LGE) give rise to all medium spiny neurons (MSNs). This development occurs in response to a highly orchestrated series of morphogenetic stimuli that pattern the resultant neurons as they develop. Striatal MSNs are characterised by expression of dopamine receptors, dopamine-and cyclic AMP-regulated phosphoprotein (DARPP32) and the neurotransmitter GABA. In this study, we demonstrate that fine tuning Wnt and hedgehog (SHH) signaling early in human embryonic stem cell differentiation can induce a subpallial progenitor molecular profile. Stimulation of TGF beta signaling pathway by activin-A further supports patterning of progenitors to striatal precursors which adopt an LGE-specific gene signature. Moreover, we report that these MSNs also express markers associated with mature neuron function (cannabinoid, adenosine and dopamine receptors). To facilitate live-cell identification we generated a human embryonic stem cell line using CRISPR-mediated gene editing at the DARPP32 locus (DARPP32(WT/eGFP-AMP-LacZ)). The addition of dopamine to MSNs either increased, decreased or had no effect on intracellular calcium, indicating the presence of multiple dopamine receptor subtypes. In summary, we demonstrate greater control over early fate decisions using activin-A, Wnt and SHH to direct differentiation into MSNs. We also generate a DARPP32 reporter line that enables deeper pharmacological profiling and interrogation of complex receptor interactions in human MSNs. (C) 2017 Elsevier Ltd. All rights reserved.	[Hunt, C. P. J.; Pouton, C. W.; Haynes, J. M.] Monash Univ, Fac Pharm & Pharmaceut Sci, Drug Discovery Biol, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia	Haynes, JM (reprint author), Monash Univ, Fac Pharm & Pharmaceut Sci, Drug Discovery Biol, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	john.haynes@monash.edu		, john/0000-0003-3075-1553	Australian Research Council's (ARC) Discovery Projects funding scheme [DP140103743]; National Health and Medical Research Council (NHMRC) [APP1099372]	This research was supported by Australian Research Council's (ARC) Discovery Projects funding scheme (DP140103743) and the National Health and Medical Research Council (NHMRC, APP1099372).	Arber C, 2015, DEVELOPMENT, V142, P1375, DOI 10.1242/dev.117093; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beccari L, 2013, MECH DEVELOP, V130, P95, DOI 10.1016/j.mod.2012.10.004; BERGER B, 1993, HIPPOCAMPUS, V3, P279, DOI 10.1002/hipo.450030305                                                          ; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Delli, 2013, STEM CELL REV, V9, P461; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Galvan L, 2012, J HUNTINGTONS DIS, V1, P17, DOI 10.3233/JHD-2012-120009; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hughes PE, 1999, NEUROSCIENCE, V92, P197, DOI 10.1016/S0306-4522(98)00724-6                                                   ; Hunt CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078759; Jaber M, 1996, NEUROPHARMACOLOGY, V35, P1503, DOI 10.1016/S0028-3908(96)00100-1                                                   ; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jose P A, 1995, Hypertens Res, V18 Suppl 1, pS39, DOI 10.1291/hypres.18.SupplementI_S39; Kelly CM, 2009, BIOCHEM SOC T, V37, P323, DOI 10.1042/BST0370323; Kirkeby Agnete, 2012, Front Cell Neurosci, V6, P64, DOI 10.3389/fncel.2012.00064; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Lee Y, 2013, NEUROTOXICOL TERATOL, V39, P91, DOI 10.1016/j.ntt.2013.07.004; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2009, INT REV NEUROBIOL, V89, P1, DOI 10.1016/S0074-7742(09)89001-6; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Maira M, 2010, J NEURODEV DISORD, V2, P48, DOI 10.1007/s11689-009-9035-6; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Miyoshi G, 2015, J NEUROSCI, V35, P12869, DOI 10.1523/JNEUROSCI.1164-15.2015; Mizuno K, 2012, J NEUROCHEM, V122, P702, DOI 10.1111/j.1471-4159.2012.07827.x; MURRAY AM, 1994, P NATL ACAD SCI USA, V91, P11271, DOI 10.1073/pnas.91.23.11271; Nasonkin I, 2009, STEM CELLS, V27, P2414, DOI 10.1002/stem.177; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Niclis JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00037; Nicoleau C, 2013, STEM CELLS, V31, P1763, DOI 10.1002/stem.1462; Onorati M, 2014, NAT NEUROSCI, V17, P1804, DOI 10.1038/nn.3860; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0                                                   ; Pauly MC, 2014, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00054; Perreault ML, 2012, NEUROSCIENCE, V225, P130, DOI 10.1016/j.neuroscience.2012.08.042; Perreault ML, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00031; Rodriguez-Martinez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043797; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schmierer B, 2003, J BIOL CHEM, V278, P21197, DOI 10.1074/jbc.M212425200; Sousa VH, 2010, CURR OPIN GENET DEV, V20, P391, DOI 10.1016/j.gde.2010.04.008; Straccia M, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.30; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Tang TS, 2004, J BIOL CHEM, V279, P42082, DOI 10.1074/jbc.M407389200; Thibault D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067219; Timmer J, 2005, DEV BIOL, V285, P1, DOI 10.1016/j.ydbio.2005.05.039; Toresson H, 2001, DEVELOPMENT, V128, P4769; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Tucker ES, 2008, J NEUROSCI, V28, P9504, DOI 10.1523/JNEUROSCI.2341-08.2008; Watmuff B, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00104, 10.3389/fncel.2015.00104]; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	66	1	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2017	106				SI		3	13		10.1016/j.neuint.2017.01.003				11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	FB1DL	WOS:000405883800002	28065797				2018-01-05	
J	Liu, YQ; Xu, Y; Ling, S; Liu, SS; Yao, JL				Liu, Yaqin; Xu, Ya; Ling, Sheng; Liu, Shasha; Yao, Jialing			Anther-preferential expressing gene PMR is essential for the mitosis of pollen development in rice	PLANT CELL REPORTS			English	Article						Pollen; Mitosis; Fertility; Rice; Cell cycle	CELL-CYCLE PROGRESSION; LIPID TRANSFER PROTEIN; PHD-FINGER; HISTONE H3; REPRODUCTIVE DEVELOPMENT; TRANSCRIPTION FACTOR; SEED DEVELOPMENT; E3 LIGASES; ARABIDOPSIS; CHROMATIN	Key message Phenotype identification, expression examination, and function prediction declared that the anther-preferential expressing gene PMR may participate in regulation of male gametophyte development in rice. Male germline development in flowering plants produces the pair of sperm cells for double fertilization and the pollen mitosis is a key process of it. Although the structural features of male gametophyte have been defined, the molecular mechanisms regulating the mitotic cell cycle are not well elucidated in rice. Here, we reported an anther-preferential expressing gene in rice, PMR (Pollen Mitosis Relative), playing an essential role in male gametogenesis. When PMR gene was suppressed via RNAi, the mitosis of microspore was severely damaged, and the plants formed unmatured pollens containing only one or two nucleuses at the anthesis, ultimately leading to serious reduction of pollen fertility and seed-setting. The CRISPR mutants, pmr-1 and pmr-2, both showed the similar defects as the PMRRNAi lines. Further analysis revealed that PMR together with its co-expressing genes were liable to participate in the regulation of DNA metabolism in the nucleus, and affected the activities of some enzymes related to the cell cycle. We finally discussed that unknown protein PMR contained the PHD, SWIB and Plus-3 domains and they might have coordinating functions in regulation pathway of the pollen mitosis in rice.	[Liu, Yaqin; Xu, Ya; Ling, Sheng; Liu, Shasha; Yao, Jialing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Yao, JL (reprint author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	liuyq_aya@163.com; xu_ya_1991@163.com; lingshengkaka@163.com; 15927559101@163.com; yaojlmy@mail.hzau.edu.cn			National Natural Science Foundation of China [31570321]	We thank Prof. Honghong Hu and Yidan Ouyang for their helpful suggestions and revision. This research received the support of a grant from the National Natural Science Foundation of China (Grant No.: 31570321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FM, 2012, PLANT CELL PHYSIOL, V53, P1737, DOI 10.1093/pcp/pcs118; Bennett-Lovsey R, 2002, BIOINFORMATICS, V18, P626, DOI 10.1093/bioinformatics/18.4.626; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038                                                          ; Brownfield L, 2009, PLANT CELL, V21, P1940, DOI 10.1105/tpc.109.066373; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Cuttino LW, 2006, INT J RADIAT ONCOL, V66, pS30, DOI 10.1016/j.ijrobp.2006.07.1359; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Durbarry A, 2005, PLANT PHYSIOL, V137, P297, DOI 10.1104/pp.104.053165; Endo M, 2012, PLANT J, V69, P967, DOI 10.1111/j.1365-313X.2011.04847.x; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Guo JX, 2012, J INTEGR PLANT BIOL, V54, P967, DOI 10.1111/j.1744-7909.2012.01172.x; Gusti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004780; Halbach T, 2000, NUCL ACIDS RES; Han MJ, 2006, PLANT CELL PHYSIOL, V47, P1457, DOI 10.1093/pcp/pcl013; Hu YF, 2012, P NATL ACAD SCI USA, V109, P5773, DOI 10.1073/pnas.1203148109; Li H, 2011, PLANT PHYSIOL, V156, P615, DOI 10.1104/pp.111.175760; Ling S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1305-y; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Luo G, 2012, J INTEGR PLANT BIOL, V54, P814, DOI 10.1111/j.1744-7909.2012.01152.x; Ma H, 2005, ANN REV PLANT BIOL; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Pena PV, 2009, MAGN RESON CHEM, V47, P352, DOI 10.1002/mrc.2390; Qi YB, 2014, THEOR APPL GENET, V127, P1173, DOI 10.1007/s00122-014-2289-8; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Song YP, 2013, PLANT CELL REP, V32, P1407, DOI 10.1007/s00299-013-1454-x; Tao JY, 2007, PLANT J, V51, P919, DOI 10.1111/j.1365-313X.2007.03190.x; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang P, 2011, CAN J MICROBIOL, V57, P590, DOI [10.1139/W11-048, 10.1139/w11-048]; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang X, 2015, PLANT SCI, V239, P200, DOI 10.1016/j.plantsci.2015.07.016; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Zhang DB, 2009, CHINESE SCI BULL, V54, P2342, DOI 10.1007/s11434-009-0348-3; Zhang DS, 2010, PLANT PHYSIOL, V154, P149, DOI 10.1104/pp.110.158865; Zhu YY, 2013, MOL CELL, V49, P298, DOI 10.1016/j.molcel.2012.11.011; Zou W, 2015, BIOCHEM BIOPH RES CO, V458, P208, DOI 10.1016/j.bbrc.2015.01.113	39	1	1	24	24	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	JUN	2017	36	6					919	931		10.1007/s00299-017-2123-2				13	Plant Sciences	Plant Sciences	FA3YV	WOS:000405381900011	28299429				2018-01-05	
J	Ryder, P; McHale, M; Fort, A; Spillane, C				Ryder, Peter; McHale, Marcus; Fort, Antoine; Spillane, Charles			Generation of stable nulliplex autopolyploid lines of Arabidopsis thaliana using CRISPR/Cas9 genome editing	PLANT CELL REPORTS			English	Article						Genome editing; CRISPR/Cas9; Arabidopsis thaliana; Polyploidy; Genome dosage		RNA-guided endonuclease-mediated targeted mutagenesis using the clustered regularly interspersed short palindromic repeats (CRISPR)/Cas9 system has been successful at targeting specific loci for modification in plants. While polyploidy is an evolutionary mechanism enabling plant adaptation, the analysis of gene function in polyploid plants has been limited due to challenges associated with generating polyploid knockout mutants for all gene copies in polyploid plant lines. This study investigated whether CRISPR/Cas9 mediated targeted mutagenesis can generate nulliplex tetraploid mutant lines in Arabidopsis thaliana, while also comparing the relative efficiency of targeted mutagenesis in tetraploid (4x) versus diploid (2x) backgrounds. Using CRISPR/Cas9 genome editing to generate knockout alleles of the TTG1 gene, we demonstrate that homozygous nulliplex mutants can be directly generated in tetraploid Arabidopsis thaliana plants. CRISPR/Cas9 genome editing now provides a route to more efficient generation of polyploid mutants for improving understanding of genome dosage effects in plants.	[Ryder, Peter; McHale, Marcus; Fort, Antoine; Spillane, Charles] Natl Univ Ireland Galway, Genet & Biotechnol Lab, Sch Nat Sci, Plant & AgriBiosci Res Ctr PABC, Univ Rd, Galway, Ireland	Spillane, C (reprint author), Natl Univ Ireland Galway, Genet & Biotechnol Lab, Sch Nat Sci, Plant & AgriBiosci Res Ctr PABC, Univ Rd, Galway, Ireland.	charles.spillane@nuigalway.ie		Spillane, Charles/0000-0003-3318-323X	Science Foundation Ireland (SFI) [13/IA/1820]; Irish Research Council (IRC)	We are grateful to Prof. Chen, Qi- Jun for kindly providing the vector pHEE401 for subsequent vector construction in this study. This work was supported by grant funding from Science Foundation Ireland (SFI) to CS (Principal Investigator Grant 13/IA/1820), and a postdoctoral fellowship from the Irish Research Council (IRC) to MMH.	De Storme N, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0700-5; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fort A, 2016, NEW PHYTOL, V209, P590, DOI 10.1111/nph.13650; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0	5	3	3	26	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	JUN	2017	36	6					1005	1008		10.1007/s00299-017-2125-0				4	Plant Sciences	Plant Sciences	FA3YV	WOS:000405381900018	28289885				2018-01-05	
J	Batzir, NA; Tovin, A; Hendel, A				Batzir, Nurit Assia; Tovin, Adi; Hendel, Ayal			Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications	PEDIATRIC ENDOCRINOLOGY REVIEWS PER			English	Article						Gene therapy; Genome editing; Nonhomologous end-joining; Homologous recombination; ZFNs; TALENs; CRISPR-Cas9; Chemically modified RNAs	ZINC-FINGER NUCLEASES; HEPATITIS-B-VIRUS; HUMAN HEMATOPOIETIC STEM; CHRONIC GRANULOMATOUS-DISEASE; INHIBIT HIV-1 REPLICATION; IN-VIVO; GENE-THERAPY; HUMAN-CELLS; T-CELLS; PROGRAMMABLE NUCLEASES	Genome editing with engineered nucleases is a rapidly growing field thanks to transformative technologies that allow researchers to precisely alter genomes for numerous applications including basic research, biotechnology, and human gene therapy. The genome editing process relies on creating a site-specific DNA double-strand break (DSB) by engineered nucleases and then allowing the cell's repair machinery to repair the break such that precise changes are made to the DNA sequence. The recent development of CRISPR-Cas systems as easily accessible and programmable tools for genome editing accelerates the progress towards using genome editing as a new approach to human therapeutics. Here we review how genome editing using engineered nucleases works and how using different genome editing outcomes can be used as a tool set for treating human diseases. We then review the major challenges of therapeutic genome editing and we discuss how its potential enhancement through CRISPR guide RNA and Cas9 protein modifications could resolve some of these challenges.	[Batzir, Nurit Assia; Tovin, Adi; Hendel, Ayal] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Batzir, Nurit Assia; Tovin, Adi; Hendel, Ayal] Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-52900 Ramat Gan, Israel	Hendel, A (reprint author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.; Hendel, A (reprint author), Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-52900 Ramat Gan, Israel.	ayal.hendel@biu.ac.il					Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bauer DE, 2012, BLOOD, V120, P2945, DOI [10.1182/blood2012-06-292078, 10.1182/blood-2012-06-292078]; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bisaria N, 2017, CELL SYST, V4, P21, DOI 10.1016/j.cels.2016.12.010; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Booth C, 2016, TRENDS MOL MED, V22, P317, DOI 10.1016/j.molmed.2016.02.002; Bortug K, 2010, NEW ENGL J MED, V363, P1918; Bousso P, 2000, P NATL ACAD SCI USA, V97, P274, DOI 10.1073/pnas.97.1.274; Bramsen Jesper B., 2012, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00154; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cekaite L, 2007, J MOL BIOL, V365, P90, DOI 10.1016/j.jmb.2006.09.034; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Eckstein F, 2014, NUCLEIC ACID THER, V24, P374, DOI 10.1089/nat.2014.0506; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Abina Hacein-Bey, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI DOI 10.1001/JAMA.2015.3253; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hoos A, 2016, NAT REV DRUG DISCOV, V15, P235, DOI 10.1038/nrd.2015.35; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JH, 2016, CELL CHEM BIOL, V23, P57, DOI 10.1016/j.chembiol.2015.12.009; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lander ES, 2011, SCIENCE, V331, P1024, DOI 10.1126/science.1204037; Leenay RT, 2017, J MOL BIOL, V429, P177, DOI 10.1016/j.jmb.2016.11.024; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lloyd A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00221; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Malkki Hemi, 2016, Nat Rev Neurol, V12, P614, DOI 10.1038/nrneurol.2016.151; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35794; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; PUTNEY SD, 1981, P NATL ACAD SCI-BIOL, V78, P7350, DOI 10.1073/pnas.78.12.7350; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Randar M., 2015, P NATL ACAD SCI USA, V112, pE7110, DOI DOI 10.1073/PNAS.1520883112; Sanghvi YS, 2011, CURR PROTOC NUCL ACI, P41; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Shariati L, 2016, J GENE MED, V18, P294, DOI 10.1002/jgm.2928; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; Voit RA, 2013, MOL THER, V21, P786, DOI 10.1038/mt.2012.284; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yokota T, 2007, Acta Myol, V26, P179; Yu KR, 2016, HUM GENE THER, V27, P729, DOI 10.1089/hum.2016.107; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z	108	0	0	5	5	MEDICAL MEDIA	NETANYA	PO BOX 8214, NETANYA, 4250543, ISRAEL	1565-4753			PEDIATR ENDOCR REV P	Pediatr. Endocrinol. Rev. PER	JUN	2017	14	4					353	363		10.17458/per.vol14.2017.BTH.Therapeu				11	Endocrinology & Metabolism	Endocrinology & Metabolism	FA7RT	WOS:000405645300004	28613045				2018-01-05	
J	Brown, N; Song, LJ; Kollu, NR; Hirsch, ML				Brown, Nolan; Song, Liujiang; Kollu, Nageswara R.; Hirsch, Matthew L.			Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?	HUMAN GENE THERAPY			English	Article						AAV vectors; ITR; stem cell; stem cell therapy; gene therapy	HEMATOPOIETIC PROGENITOR CELLS; DNA-DAMAGE RESPONSE; HUMAN PARVOVIRUS B19; TOLL-LIKE RECEPTORS; MEDIATED GENE-EXPRESSION; CENTRAL-NERVOUS-SYSTEM; MESENCHYMAL STEM; IN-VIVO; TRANSGENE EXPRESSION; INTRACELLULAR TRAFFICKING	The infusion of healthy stem cells into a patient-termed "stem-cell therapy"-has shown great promise for the treatment of genetic and non-genetic diseases, including mucopolysaccharidosis type 1, Parkinson's disease, multiple sclerosis, numerous immunodeficiency disorders, and aplastic anemia. Stem cells for cell therapy can be collected from the patient (autologous) or collected from another "healthy" individual (allogeneic). The use of allogenic stem cells is accompanied with the potentially fatal risk that the transplanted donor T cells will reject the patient's cells-a process termed "graft-versus-host disease." Therefore, the use of autologous stem cells is preferred, at least from the immunological perspective. However, an obvious drawback is that inherently as "self," they contain the disease mutation. As such, autologous cells for use in cell therapies often require genetic "correction" (i.e., gene addition or editing) prior to cell infusion and therefore the requirement for some form of nucleic acid delivery, which sets the stage for the AAV controversy discussed herein. Despite being the most clinically applied gene delivery context to date, unlike other more concerning integrating and non-integrating vectors such as retroviruses and adenovirus, those based on adeno-associated virus (AAV) have not been employed in the clinic. Furthermore, published data regarding AAV vector transduction of stem cells are inconsistent in regards to vector transduction efficiency, while the pendulum swings far in the other direction with demonstrations of AAV vector-induced toxicity in undifferentiated cells. The variation present in the literature examining the transduction efficiency of AAV vectors in stem cells may be due to numerous factors, including inconsistencies in stem-cell collection, cell culture, vector preparation, and/or transduction conditions. This review summarizes the controversy surrounding AAV vector transduction of stem cells, hopefully setting the stage for future elucidation and eventual therapeutic applications.	[Brown, Nolan; Song, Liujiang; Kollu, Nageswara R.; Hirsch, Matthew L.] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC USA; [Brown, Nolan; Song, Liujiang; Kollu, Nageswara R.; Hirsch, Matthew L.] Univ North Carolina Chapel Hill, Dept Ophthalmol, Chapel Hill, NC USA	Hirsch, ML (reprint author), Univ N Carolina, Gene Therapy Ctr, Dept Ophthalmol, Thurston Bldg CB7352,104 Manning Dr, Chapel Hill, NC 27517 USA.	mhirsch@email.unc.edu			National Institutes of Health [RO1AI072176-06A1, RO1AR064369-01A1]	Funding was providing by the National Institutes of Health (RO1AI072176-06A1, RO1AR064369-01A1).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Alexander IE, 1997, HUM GENE THER, V8, P1911, DOI 10.1089/hum.1997.8.16-1911                                                      ; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Asuri P, 2012, MOL THER, V20, P329, DOI 10.1038/mt.2011.255; Bao CY, 2008, SCAND CARDIOVASC J, V42, P56, DOI 10.1080/14017430701543556; Bartlett JS, 1999, NAT BIOTECHNOL, V17, P181, DOI 10.1038/6185; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Belay E, 2011, CURR GENE THER, V11, P406; Bevington JM, 2007, VIROLOGY, V357, P102, DOI 10.1016/j.virol.2006.07.050; BOTQUIN V, 1994, J GEN VIROL, V75, P2655, DOI 10.1099/0022-1317-75-10-2655; Braam SR, 2008, NAT METHODS, V5, P389, DOI [10.1038/nmeth.1200, 10.1038/NMETH.1200]; Broxmeyer HE, 1995, ANN NY ACAD SCI, V770, P105, DOI 10.1111/j.1749-6632.1995.tb31048.x; Cao F, 2010, MOL IMAGING BIOL, V12, P15, DOI 10.1007/s11307-009-0236-x; Chamberlain JR, 2008, MOL THER, V16, P187, DOI 10.1038/sj.mt.6300339; Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757; Chatterjee S, 1999, BLOOD, V93, P1882; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Chen D, 2003, GENE THER, V10, P991, DOI 10.1038/sj.gt.3302031; CHENG S, 1995, GENE DEV, V9, P2335, DOI 10.1101/gad.9.19.2335; Chng K, 2007, J GENE MED, V9, P22, DOI 10.1002/jgm.990; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Collaco RF, 2009, VIROLOGY, V392, P24, DOI 10.1016/j.virol.2009.06.005; Collins M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3003; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034                                                     ; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Ellis BL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-74; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Ferrari FK, 1996, J VIROL, V70, P3227; FisherAdams G, 1996, BLOOD, V88, P492; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Fragkos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022946; FriedmanEinat M, 1997, J CLIN MICROBIOL, V35, P71; Fu XP, 2002, J VIROL, V76, P5866, DOI 10.1128/JVI.76.12.5866-5874.2002; Furthauer M, 2009, MOL ONCOL, V3, P339, DOI 10.1016/j.molonc.2009.05.006; Gabriel N, 2017, J TISSUE ENG REGEN M, V11, P1354, DOI 10.1002/term.2034; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057                                                        ; Garner E, 2007, CANCER RES, V67, P7631, DOI 10.1158/0008-5472.CAN-07-0334; Gerolami R, 2000, CANCER GENE THER, V7, P1286, DOI 10.1038/sj.cgt.7700225; Gillespie KA, 2012, J VIROL, V86, P9520, DOI 10.1128/JVI.00247-12; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973                                                      ; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; GOODMAN S, 1994, BLOOD, V84, P1492; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Grieger JC, 2006, J VIROL, V80, P5199, DOI 10.1128/JVI.02723-05; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Grieger JC, 2007, J VIROL, V81, P7833, DOI 10.1128/JVI.00580-07; Handa A, 2000, J GEN VIROL, V81, P2077, DOI 10.1099/0022-1317-81-8-2077                                                     ; HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8; Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002; Hewitt FC, 2009, J VIROL, V83, P3919, DOI 10.1128/JVI.02466-08; Hirata RK, 2000, J VIROL, V74, P4612, DOI 10.1128/JVI.74.10.4612-4620.2000; Hirsch ML, 2014, METHODS MOL BIOL, V1114, P291, DOI 10.1007/978-1-62703-761-7_19; Hirsch ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027520; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Ito H, 2004, GENE THER, V11, P34, DOI 10.1038/sj.gt.3302102; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson JS, 2010, J VIROL, V84, P8888, DOI 10.1128/JVI.00687-10; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Ju XD, 2004, ACTA PHARMACOL SIN, V25, P196; Kaminsky PM, 2012, MOL THER, V20, P972, DOI 10.1038/mt.2011.295; Kang Y, 2007, ACTA PHARMACOL SIN, V28, P839, DOI 10.1111/j.1745-7254.2007.00583.x; Kauss MA, 2010, HUM GENE THER, V21, P1129, DOI 10.1089/hum.2010.016; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kelich JM, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.47; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Kiehl K, 2002, PLACENTA, V23, P410, DOI 10.1053/plac.2002.0827; Kim JH, 2007, YONSEI MED J, V48, P109, DOI 10.3349/ymj.2007.48.1.109; Kimbrel EA, 2016, REGEN MED, V11, P831, DOI 10.2217/rme-2016-0117; Klein RL, 1998, EXP NEUROL, V150, P183, DOI 10.1006/exnr.1997.6736; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kumar S, 2004, HUM GENE THER, V15, P1197, DOI 10.1089/hum.2004.15.1197                                                        ; Kurpad C, 1999, J HEMATOTH STEM CELL, V8, P585, DOI 10.1089/152581699319740                                                         ; Laredj LN, 2011, J VIROL, V85, P13133, DOI 10.1128/JVI.05407-11; Li MX, 2010, HUM GENE THER, V21, P1527, DOI 10.1089/hum.2010.005; Li M, 2012, NAT REV MOL CELL BIO, V13, P524, DOI 10.1038/nrm3393; Ling C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35495; Lisowski L, 2012, MOL THER, V20, P1912, DOI 10.1038/mt.2012.164; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Lou S, 2012, J VIROL, V86, P10748, DOI 10.1128/JVI.01007-12; Luo Y, 2015, FUTURE VIROL, V10, P155, DOI 10.2217/FVL.14.103; Malik P, 1997, J VIROL, V71, P1776; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McKinney CC, 2015, VIRUSES-BASEL, V7, P2450, DOI 10.3390/v7052450; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Megias J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MILLER JL, 1994, P NATL ACAD SCI USA, V91, P10183, DOI 10.1073/pnas.91.21.10183; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mitsui K, 2009, BIOCHEM BIOPH RES CO, V388, P711, DOI 10.1016/j.bbrc.2009.08.075; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Monahan PE, 2010, MOL THER, V18, P1907, DOI 10.1038/mt.2010.170; Moore JC, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt23; Murlidharan G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00076; Nakai H, 2000, J VIROL, V74, P9451, DOI 10.1128/JVI.74.20.9451-9463.2000                                                ; Nathwani AC, 2000, GENE THER, V7, P183, DOI 10.1038/sj.gt.3301068                                                           ; Nicolson SC, 2014, J VIROL, V88, P4132, DOI 10.1128/JVI.02660-13; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nonnenmacher M, 2011, CELL HOST MICROBE, V10, P563, DOI 10.1016/j.chom.2011.10.014; O'Donnell J, 2009, VIROLOGY, V385, P434, DOI 10.1016/j.virol.2008.11.037; Okada T, 2006, MOL THER, V13, P738, DOI 10.1016/j.ymthe.2005.11.010; Pagnotto MR, 2007, GENE THER, V14, P804, DOI 10.1038/sj.gt.3302938; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Pelekanos RA, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-15; Ponnazhagan S, 1998, J VIROL, V72, P5224; Ponnazhagan S, 1997, J VIROL, V71, P8262; Popa-Wagner R, 2012, J VIROL, V86, P9163, DOI 10.1128/JVI.00282-12; Prosch S, 1996, BIOL CHEM H-S, V377, P195, DOI 10.1515/bchm3.1996.377.3.195; Qing K, 1999, NAT MED, V5, P71; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; Rapti K, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.67; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325                                                              ; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; SAMULSKI RJ, 1989, J VIROL, V63, P3822; SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/pnas.79.6.2077; Sanlioglu S, 2000, J VIROL, V74, P9184, DOI 10.1128/JVI.74.19.9184-9196.2000                                                ; Santat L, 2005, P NATL ACAD SCI USA, V102, P11053, DOI 10.1073/pnas.0502902102; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schuhmann NK, 2010, EXP HEMATOL, V38, P707, DOI 10.1016/j.exphem.2010.04.016; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103                                                         ; Sellner L, 2008, EXP HEMATOL, V36, P957, DOI 10.1016/j.exphem.2008.03.007; Sheng W, 2016, AM J TRANSL RES, V8, P2079; Shevchenko EK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-138; Sipo I, 2007, GENE THER, V14, P1319, DOI 10.1038/sj.gt.3302987; Smith LJ, 2014, MOL THER, V22, P1625, DOI 10.1038/mt.2014.107; Smith S, 2015, FUTURE VIROL, V10, P383, DOI 10.2217/FVL.15.18; Song LJ, 2013, CYTOTHERAPY, V15, P986, DOI 10.1016/j.jcyt.2013.04.003; Song LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058757; Stahnke S, 2011, VIROLOGY, V409, P77, DOI 10.1016/j.virol.2010.09.025; Stambrook PJ, 2010, ADV EXP MED BIOL, V695, P59, DOI 10.1007/978-1-4419-7037-4_5; Summerford C, 1998, J VIROL, V72, P1438; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tenenbaum L., 2003, Current Gene Therapy, V3, P545, DOI 10.2174/1566523034578131; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; TOBIASCH E, 1994, J MED VIROL, V44, P215, DOI 10.1002/jmv.1890440218; Tolmachov OE, TENE THERAPY TOOLS P; Tsubouchi T, 2013, CURR TOP DEV BIOL, V104, P223, DOI 10.1016/B978-0-12-416027-9.00007-3; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Veldwijk MR, 2010, CYTOTHERAPY, V12, P107, DOI 10.3109/14653240903348293; Vihinen-Ranta M, 2004, J VIROL, V78, P6709, DOI 10.1128/JVI.78.13.6709-6714.2004; Vogel R, 2012, J VIROL, V86, P143, DOI 10.1128/JVI.05694-11; Vollweiler JL, 2003, BONE MARROW TRANSPL, V32, P1, DOI 10.1038/sj.bmt.1704081; WALSH CE, 1994, J CLIN INVEST, V94, P1440, DOI 10.1172/JCI117481                                                               ; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang QS, 2013, BIOSCIENCE REP, V33, P199, DOI 10.1042/BSR20110124; Wang XS, 1995, P NATL ACAD SCI USA, V92, P12416, DOI 10.1073/pnas.92.26.12416; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Wang ZY, 2012, MOL THER, V20, P1902, DOI 10.1038/mt.2012.157; Wei GJ, 2017, CELL PHYSIOL BIOCHEM, V41, P1435, DOI 10.1159/000468057; Xiao PJ, 2012, J VIROL, V86, P10462, DOI 10.1128/JVI.00935-12; Xiao XA, 1996, J VIROL, V70, P8098; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Yang QC, 1998, HUM GENE THER, V9, P1929, DOI 10.1089/hum.1998.9.13-1929                                                      ; Zhang FL, 2011, GENE THER, V18, P128, DOI 10.1038/gt.2010.120; Zhang Minjie, 2013, [Genomics, Proteomics & Bioinformatics, 基因组蛋白质组与生物信息学报], V11, P320, DOI 10.1016/j.gpb.2013.09.006; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zhong L, 2004, HUM GENE THER, V15, P1207, DOI 10.1089/hum.2004.15.1207                                                        ; ZHOU SZ, 1994, J EXP MED, V179, P1867, DOI 10.1084/jem.179.6.1867                                                          ; Zhou XH, 2008, MOL THER, V16, P494, DOI 10.1038/sj.mt.6300397; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	173	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	JUN	2017	28	6					450	463		10.1089/hum.2017.038				14	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	EX2RY	WOS:000403075400002	28490211				2018-01-05	
J	Mojarad, BA; Gupta, GD; Hasegan, M; Goudiam, O; Basto, R; Gingras, AC; Pelletier, L				Mojarad, Bahareh A.; Gupta, Gagan D.; Hasegan, Monica; Goudiam, Oumou; Basto, Renata; Gingras, Anne-Claude; Pelletier, Laurence			CEP19 cooperates with FOP and CEP350 to drive early steps in the ciliogenesis programme	OPEN BIOLOGY			English	Article						centrosomes; cilia; centrioles; ciliopathies; super-resolution microscopy	CENTRIOLAR SATELLITE; PRIMARY CILIUM; HUMAN INTERACTOME; TRANSITION ZONE; PROTEIN; CENTROSOME; CILIOPATHIES; TRAFFICKING; MECHANISMS; PROTEOMICS	Primary cilia are microtubule-based sensory organelles necessary for efficient transduction of extracellular cues. To initiate cilia formation, ciliary vesicles (CVs) are transported to the vicinity of the centrosome where they dock to the distal end of the mother centriole and fuse to initiate cilium assembly. However, to this date, the early steps in cilia formation remain incompletely understood. Here, we demonstrate functional interplay between CEP19, FOP and CEP350 in ciliogenesis. Using three-dimensional structured-illumination microscopy (3D-SIM) imaging, we mapped the relative spatial distribution of these proteins at the distal end of the mother centriole and show that CEP350/FOP act upstream of CEP19 in their recruitment hierarchy. We demonstrate that CEP19 CRISPR KO cells are severely impaired in their ability to form cilia, analogous to the loss of function of CEP19 binding partners FOP and CEP350. Notably, in the absence of CEP19 microtubule anchoring at centromes is similar in manner to its interaction partners FOP and CEP350. Using GFP-tagged deletion constructs of CEP19, we show that the C-terminus of CEP19 is required for both its localization to centrioles and for its function in ciliogenesis. Critically, this region also mediates the interaction between CEP19 and FOP/CEP350. Interestingly, a morbid-obesity-associated R82* truncated mutant of CEP19 cannot ciliate nor interact with FOP and CEP350, indicative of a putative role for CEP19 in ciliopathies. Finally, analysis of CEP19 KO cells using thin-section electron microscopy revealed marked defects in the docking of CVs to the distal end of the mother centrioles. Together, these data demonstrate a role for the CEP19, FOP and CEP350 module in ciliogenesis and the possible effect of disrupting their functions in ciliopathies.	[Mojarad, Bahareh A.; Gupta, Gagan D.; Hasegan, Monica; Gingras, Anne-Claude; Pelletier, Laurence] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Mojarad, Bahareh A.; Gingras, Anne-Claude; Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Goudiam, Oumou; Basto, Renata] PSL Res Univ, CNRS, UMR144, Inst Curie, 12 Rue Lhomond, F-75005 Paris, France	Pelletier, L (reprint author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.; Pelletier, L (reprint author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.	pelletier@lunenfeld.ca		GOUNDIAM, Oumou/0000-0002-0714-7860	Ontario Trillium studentship Fund; Ontario Student Opportunity Trust Fund; INCa [2015/118]; NSERC [RGPIN355644-2008]; CIHR [MOP-123468, MOP-130507]; Krembil Foundation	B.A.M. was funded by Ontario Trillium studentship and Ontario Student Opportunity Trust Funds. This work was funded by grants from INCa (2015/118) to R.B. and NSERC (RGPIN355644-2008), CIHR (MOP-123468, MOP-130507) and the Krembil Foundation to L.P.	Adly N, 2014, HUM MUTAT, V35, P36, DOI 10.1002/humu.22477; ANDERSON RG, 1972, J CELL BIOL, V54, P246, DOI 10.1083/jcb.54.2.246; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Failler M, 2014, AM J HUM GENET, V94, P905, DOI 10.1016/j.ajhg.2014.05.002; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181                                                           ; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kanie T, DEV CELL IN PRESS; Klinger M, 2014, MOL BIOL CELL, V25, P495, DOI 10.1091/mbc.E13-09-0526; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Kurtulmus B, 2016, J CELL SCI, V129, P621, DOI 10.1242/jcs.179713; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052382; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shalata A, 2013, AM J HUM GENET, V93, P1061, DOI 10.1016/j.ajhg.2013.10.025; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wang G., 2013, BOOMED RES INT, V2013, P1, DOI DOI 10.1097/FJC.0B013E31829875EF; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yuya N, 2017, MOL BIOL CELL, V28, P1652, DOI [10.1091/mbc.E17-01-0017, DOI 10.1091/MBC.E17-01-0017]	42	0	0	1	1	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2046-2441			OPEN BIOL	Open Biol	JUN	2017	7	6							170114	10.1098/rsob.170114				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6QD	WOS:000404841600010					2018-01-05	
J	Trabulo, S; Aires, A; Aicher, A; Heeschen, C; Cortajarena, AL				Trabulo, Sara; Aires, Antonio; Aicher, Alexandra; Heeschen, Christopher; Cortajarena, Aitziber L.			Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Pancreatic cancer; Magnetic nanoparticles; Multifunctionalization; Nanocarriers; CD47; Gemcitabine; Controlled drug release; Active targeting; Nanomedicine	ALBUMIN-BOUND PACLITAXEL; MAGNETIC NANOPARTICLES; STEM-CELLS; NAB-PACLITAXEL; DRUG-DELIVERY; GENE DELIVERY; THERAPY; HYPERTHERMIA; GEMCITABINE; IDENTIFICATION	Nanomedicine nowadays offers novel solutions in cancer therapy by introducing multimodal treatments in one single formulation. In addition, nanoparticles act as nanocarriers changing the solubility, biodistribution and efficiency of the therapeutic molecules, thus generating more efficient treatments and reducing their side effects. To apply these novel therapeutic approaches, efforts are focused on the multi-functionalization of the nanoparticles and will open up new avenues to advanced combinational therapies. Pancreatic ductal adenocarcinoma (PDAC) is a cancer with unmet medical needs. Abundant expression of the anti-phagocytosis signal CD47 has also been observed on pancreatic cancer cells, in particular a subset of cancer stem cells (CSCs) responsible for resistance to standard therapy and metastatic potential. CD47 receptor is found on pancreatic cancer and highly expressed on CSCs, but not on normal pancreas. Inhibiting CD47 using monoclonal antibodies has been shown as an effective strategy to treat PDAC in vivo. However, CD47 inhibition effectively slowed tumor growth only in combination with Gemcitabine or Abraxane. In this work, we present the generation of multifunctionalized iron oxide magnetic nanoparticles (MNPs) that include the anti-CD47 antibody and the chemotherapeutic drug Gemcitabine in a single formulation. We demonstrate the in vitro efficacy of the formulation against CD47-positive pancreatic cancer cells. This article is part of a Special Issue entitled "Recent Advances in Bionanomaterials" Guest Editor: Dr. Marie-Louise Saboungi and Dr. Samuel D. Bader. (C) 2017 Elsevier B.V. All rights reserved.	[Trabulo, Sara; Aicher, Alexandra; Heeschen, Christopher] Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Mol Pathol Programme, Madrid 28029, Spain; [Trabulo, Sara; Heeschen, Christopher] Queen Mary Univ London, Ctr Stem Cells Canc & Ageing, Barts Canc Inst, London EC1M 6BQ, England; [Aires, Antonio; Cortajarena, Aitziber L.] CIC BiomaGUNE, Parque Tecnol San Sebastian,Paseo Miramon 182, Donostia San Sebastian 20009, Spain; [Aires, Antonio; Cortajarena, Aitziber L.] CSIC, IMDEA Nanociencia & Nanobiotechnol Unit, Ctr Nacl Biotecnol, Campus Univ Cantoblanco, Madrid 28049, Spain; [Cortajarena, Aitziber L.] Ikerbasque, Basque Fdn Sci, Ma Diaz de Haro 3, Bilbao 48013, Spain	Heeschen, C (reprint author), Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Mol Pathol Programme, Madrid 28029, Spain.; Cortajarena, AL (reprint author), CIC BiomaGUNE, Parque Tecnol San Sebastian,Paseo Miramon 182, Donostia San Sebastian 20009, Spain.	c.heeschen@qmul.ac.uk; alcortajarena@cicbiomagune.es	biomaGUNE, CIC/J-9136-2014; Cortajarena, Aitziber/J-6202-2012	biomaGUNE, CIC/0000-0001-7690-0660; Cortajarena, Aitziber/0000-0002-5331-114X	EU-FP7 MULTIFUN project [262943]; Comunidad de Madrid NANOFRONTMAG-CM project [S2013/MIT-2850]	This work was supported by EU-FP7 MULTIFUN project (no. 262943), and by the Comunidad de Madrid NANOFRONTMAG-CM project (S2013/MIT-2850).	Ahmed MA, 2013, MATER SCI ENG B-ADV, V178, P744, DOI 10.1016/j.mseb.2013.03.011; Aires A, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/6/065103; Aires A, 2015, J MATER CHEM B, V3, P6239, DOI 10.1039/c5tb00833f; Au M, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030020; Beveridge JS, 2011, ANNU REV ANAL CHEM, V4, P251, DOI 10.1146/annurev-anchem-061010-114041; Borlido L, 2013, BIOTECHNOL ADV, V31, P1374, DOI 10.1016/j.biotechadv.2013.05.009; Boyd BJ, 2008, EXPERT OPIN DRUG DEL, V5, P69, DOI 10.1517/17425247.5.1.69; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403                                                      ; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Cheng CM, 2011, NEW J CHEM, V35, P1072, DOI 10.1039/c0nj00986e; Cioffi M, 2015, CLIN CANCER RES, V21, P2325, DOI 10.1158/1078-0432.CCR-14-1399; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Desai N, 2009, TRANSL ONCOL, V2, P59, DOI 10.1593/tlo.09109; Desai NP, 2008, ANTI-CANCER DRUG, V19, P899, DOI 10.1097/CAD.0b013e32830f9046; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Fernandes E, 2015, J CONTROL RELEASE, V209, P288, DOI 10.1016/j.jconrel.2015.05.003; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; Gandhi S, 2016, NANO LETT, V16, P3668, DOI 10.1021/acs.nanolett.6b00867; Gardner ER, 2008, CLIN CANCER RES, V14, P4200, DOI 10.1158/1078-0432.CCR-07-4592; Gruttner C, 2007, J MAGN MAGN MATER, V311, P181, DOI 10.1016/j.jmmm.2006.10.1151; Hadjidemetriou M, 2015, ACS NANO, V9, P8142, DOI 10.1021/acsnano.5b03300; He JC, 2014, J PHARMACEUT BIOMED, V101, P84, DOI 10.1016/j.jpba.2014.04.017; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200                                                         ; Hsieh V, 2012, ACS CHEM NEUROSCI, V3, P593, DOI 10.1021/cn300059r; Hudson R, 2014, GREEN CHEM, V16, P4493, DOI 10.1039/c4gc00418c; Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1; Jeong U, 2007, ADV MATER, V19, P33, DOI 10.1002/adma.200600674; Khandhar AP, 2013, BIOMATERIALS, V34, P3837, DOI 10.1016/j.biomaterials.2013.01.087; Kossatz S, 2014, PHARM RES-DORDR, V31, P3274, DOI 10.1007/s11095-014-1417-0; Latorre A, 2014, EUR J MED CHEM, V82, P355, DOI 10.1016/j.ejmech.2014.05.078; Laurent S, 2011, ADV COLLOID INTERFAC, V166, P8, DOI 10.1016/j.cis.2011.04.003; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li W, 2005, J MAGN RESON IMAGING, V21, P46, DOI 10.1002/jmri.20235; Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006; Markides H, 2012, J NANOMATER, DOI 10.1155/2012/614094; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; Miranda-Lorenzo I, 2014, NAT METHODS, V11, P1161, DOI [10.1038/NMETH.3112, 10.1038/nmeth.3112]; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Perez JM, 2003, J AM CHEM SOC, V125, P10192, DOI 10.1021/ja036409g; Peters C, 2015, BIOSCI REP, V35; Puertas S., 2010, J PHYS D, V43; Sparreboom A, 2005, CLIN CANCER RES, V11, P4136, DOI 10.1158/1078-0432.CCR-04-2291                                                   ; Sun Yu, 2009, Yao Xue Xue Bao, V44, P943; Talelli M, 2016, CURR ORG CHEM, V20, P1252, DOI 10.2174/1385272819666150810221009; Tang SCN, 2013, WATER RES, V47, P2613, DOI 10.1016/j.watres.2013.02.039; Thiesen B, 2008, INT J HYPERTHER, V24, P467, DOI 10.1080/02656730802104757; Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009; Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Xie J, 2012, THERANOSTICS, V2, P122, DOI 10.7150/thno.4051; You CC, 2007, NAT NANOTECHNOL, V2, P318, DOI 10.1038/nnano.2007.99; [Anonymous], 1989, DISULFIDE BONDS CYST, P155	54	3	3	16	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	JUN	2017	1861	6			SI		1597	1605		10.1016/j.bbagen.2017.01.035				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EZ9NE	WOS:000405056300014	28161480				2018-01-05	
J	Zhang, Y				Zhang, Yan			The CRISPR-Cas9 system in Neisseria spp	PATHOGENS AND DISEASE			English	Review						CRISPR-Cas9; genome engineering; RNA-guided adaptive interference; Neisseria spp	CAS ADAPTIVE IMMUNITY; RNA-GUIDED ENDONUCLEASE; TARGET DNA RECOGNITION; ESCHERICHIA-COLI; NATURAL TRANSFORMATION; SPACER ACQUISITION; BACTERIAL IMMUNITY; CRISPR/CAS SYSTEM; GENE-REGULATION; FOREIGN DNA	Bacteria and archaea possess numerous defense systems to combat viral infections and other mobile genetic elements. Uniquely among these, CRISPR-Cas (clustered, regularly interspaced short palindromic repeats-CRISPR associated) provides adaptive genetic interference against foreign nucleic acids. Here we review recent advances on the CRISPR-Cas9 system in Neisseria spp, with a focus on its biological functions in genetic transfer, its mechanistic features that establish new paradigms and its technological applications in eukaryotic genome engineering.	[Zhang, Yan] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Zhang, Yan] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Zhang, Y (reprint author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.; Zhang, Y (reprint author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	yzhangbc@med.umich.edu			National Institute of Health (NIH) [K99 GM117268]; University of Michigan	YZ is supported by National Institute of Health (NIH) grant K99 GM117268 and funds from University of Michigan.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bratcher HB, 2012, FUTURE MICROBIOL, V7, P873, DOI [10.2217/FMB.12.62, 10.2217/fmb.12.62]; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Heussler GE, 2016, J BACTERIOL, V198, P1481, DOI 10.1128/JB.00086-16; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hooton Steven P T, 2014, Front Microbiol, V5, P744, DOI 10.3389/fmicb.2014.00744; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Johnston C, 2013, TRENDS MICROBIOL, V21, P516, DOI 10.1016/j.tim.2013.08.002; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Louwen R, 2013, EUR J CLIN MICROBIOL, V32, P207, DOI 10.1007/s10096-012-1733-4; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Rotman E, 2014, ANNU REV GENET, V48, P405, DOI 10.1146/annurev-genet-120213-092007; Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037; Sampson TR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003621; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; World Health Organization (WHO), 2016, WHO GUID TREATM NEIS; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	82	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2049-632X			PATHOG DIS	Pathog. Dis.	JUN	2017	75	4							ftx036	10.1093/femspd/ftx036				10	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	FA0RJ	WOS:000405142700001					2018-01-05	
J	Cermak, T; Curtin, SJ; Gil-Humanes, J; Cegan, R; Kono, TJY; Konecna, E; Belanto, JJ; Starker, CG; Mathre, JW; Greenstein, RL; Voytasa, DF				Cermak, Tomas; Curtin, Shaun J.; Gil-Humanes, Javier; Cegan, Radim; Kono, Thomas J. Y.; Konecna, Eva; Belanto, Joseph J.; Starker, Colby G.; Mathre, Jade W.; Greenstein, Rebecca L.; Voytas, Daniel F.			A Multipurpose Toolkit to Enable Advanced Genome Engineering in Plants	PLANT CELL			English	Article							CRISPR/CAS9-MEDIATED TARGETED MUTAGENESIS; ZINC-FINGER NUCLEASES; PANICUM-VIRGATUM L.; CRISPR-CAS SYSTEM; OF-THE-ART; ARABIDOPSIS-THALIANA; PAIRED NICKASES; TRANSCRIPTIONAL REGULATION; HOMOLOGOUS RECOMBINATION; FUNCTIONAL-ANALYSIS	We report a comprehensive toolkit that enables targeted, specific modification of monocot and dicot genomes using a variety of genome engineering approaches. Our reagents, based on transcription activator-like effector nucleases (TALENs) and the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, are systematized for fast, modular cloning and accommodate diverse regulatory sequences to drive reagent expression. Vectors are optimized to create either single or multiple gene knockouts and large chromosomal deletions. Moreover, integration of geminivirus-based vectors enables precise gene editing through homologous recombination. Regulation of transcription is also possible. A Web-based tool streamlines vector selection and construction. One advantage of our platform is the use of the Csy-type (CRISPR system yersinia) ribonuclease 4 (Csy4) and tRNA processing enzymes to simultaneously express multiple guide RNAs (gRNAs). For example, we demonstrate targeted deletions in up to six genes by expressing 12 gRNAs from a single transcript. Csy4 and tRNA expression systems are almost twice as effective in inducing mutations as gRNAs expressed from individual RNA polymerase III promoters. Mutagenesis can be further enhanced 2.5-fold by incorporating the Trex2 exonuclease. Finally, we demonstrate that Cas9 nickases induce gene targeting at frequencies comparable to native Cas9 when they are delivered on geminivirus replicons. The reagents have been successfully validated in tomato (Solanum lycopersicum), tobacco (Nicotiana tabacum), Medicago truncatula, wheat (Triticum aestivum), and barley (Hordeum vulgare).	[Cermak, Tomas; Gil-Humanes, Javier; Konecna, Eva; Belanto, Joseph J.; Starker, Colby G.; Mathre, Jade W.; Greenstein, Rebecca L.; Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Cermak, Tomas; Gil-Humanes, Javier; Konecna, Eva; Belanto, Joseph J.; Starker, Colby G.; Mathre, Jade W.; Greenstein, Rebecca L.; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Curtin, Shaun J.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Curtin, Shaun J.; Kono, Thomas J. Y.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Cegan, Radim] CAS, Inst Biophys, Dept Plant Dev Genet, CZ-61265 Brno, Czech Republic; [Curtin, Shaun J.] ARS, USDA, Cereal Dis Lab, St Paul, MN 55108 USA; [Gil-Humanes, Javier] Calyxt Inc, New Brighton, MN 55112 USA	Voytasa, DF (reprint author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	voytas@umn.edu		Kono, Thomas/0000-0002-1388-3194	National Science Foundation [IOS-1339209, IOS-1444511]; Department of Energy [DE-SC0008769]; laboratory of Nevin D. Young under National Science Foundation [IOS-1237993]	We thank members of the Voytas lab for helpful discussions and insights. We particularly thank Lynn Hu for technical assistance, Lazaro Peres (Universidade de Sao Paulo, Brazil) and Agustin Zsogon (Universidade Federal de Vicosa, Brazil) for input on target genes in tomato, Joseph Guhlin (College of Biological Sciences, University of Minnesota) for inputon M. truncatula NCR target genes, Aaron Hummel for providing the plasmids with structurally optimized gRNA scaffolds, Evan Ellison for the GmUbi promoter reagents, and Kit Leffler for help with the figures. This work was funded by grants from the National Science Foundation (IOS-1339209 and IOS-1444511) and the Department of Energy (DE-SC0008769). S.J.C. was supported by the laboratory of Nevin D. Young under National Science Foundation Award IOS-1237993.	Aeby E, 2010, NUCLEIC ACIDS RES, V38, P5833, DOI 10.1093/nar/gkq345; Arimbasseri AG, 2013, BBA-GENE REGUL MECH, V1829, P318, DOI 10.1016/j.bbagrm.2012.10.006; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cermak T., 2015, BIOL, V16, P232; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Certo MT, 2012, NAT METHODS, V9, P973, DOI [10.1038/NMETH.2177, 10.1038/nmeth.2177]; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cosson V, 2006, METH MOL B, V343, P115; Curtin SJ, 2017, PLANT PHYSIOL, V173, P921, DOI 10.1104/pp.16.01923; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Geisinger JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1542; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Gil-Humanes J, 2011, GENETIC TRANSFORMATION, P135; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2016, J INTEGR PLANT BIOL, V58, P705, DOI 10.1111/jipb.12474; Kungulovski G, 2016, TRENDS GENET, V32, P101, DOI 10.1016/j.tig.2015.12.001; Kwon YI, 2012, PLANT CELL PHYSIOL, V53, P2142, DOI 10.1093/pcp/pcs155; La Russa MF, 2015, MOL CELL BIOL, V35, P3800, DOI 10.1128/MCB.00512-15; Li J, 2016, PLANT BIOTECHNOL J, V14, P533, DOI 10.1111/pbi.12403; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li YX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0680-7; Liang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21451; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Liu WS, 2014, PLANT BIOTECHNOL J, V12, P436, DOI 10.1111/pbi.12150; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Luo S, 2015, MOL PLANT, V8, P1425, DOI 10.1016/j.molp.2015.05.012; Ma X., 2015, MOL PLANT, V8, P1474; Maiti IB, 1997, TRANSGENIC RES, V6, P143, DOI 10.1023/A:1018477705019; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mann DGJ, 2012, PLANT BIOTECHNOL J, V10, P226, DOI 10.1111/j.1467-7652.2011.00658.x; Mann DGJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-74; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagaya S, 2010, PLANT CELL PHYSIOL, V51, P328, DOI 10.1093/pcp/pcp188; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; NORRIS SR, 1993, PLANT MOL BIOL, V21, P895, DOI 10.1007/BF00027120; Ordon J, 2017, PLANT J, V89, P155, DOI 10.1111/tpj.13319; Park BS, 2014, PLANT CELL, V26, P454, DOI 10.1105/tpc.113.120311; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sahoo DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098988; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Stavolone L, 2003, PLANT MOL BIOL, V53, P703, DOI 10.1023/B:PLAN.0000019110.95420.bb; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Sugio T, 2008, J BIOSCI BIOENG, V105, P300, DOI 10.1263/jbb.105.300; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Thole V, 2007, PLANT PHYSIOL, V145, P1211, DOI 10.1104/pp.107.108563; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	91	11	11	43	43	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	1040-4651	1532-298X		PLANT CELL	Plant Cell	JUN	2017	29	6					1196	1217		10.1105/tpc.16.00922				22	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	EZ8PR	WOS:000404989600006	28522548	gold			2018-01-05	
J	Li, GT; Jain, R; Chern, M; Pham, NT; Martin, JA; Wei, T; Schackwitz, WS; Lipzen, AM; Duong, PQ; Jones, KC; Jiang, LR; Ruan, DL; Bauer, D; Peng, Y; Barry, KW; Schmutz, J; Ronald, PC				Li, Guotian; Jain, Rashmi; Chern, Mawsheng; Pham, Nikki T.; Martin, Joel A.; Wei, Tong; Schackwitz, Wendy S.; Lipzen, Anna M.; Duong, Phat Q.; Jones, Kyle C.; Jiang, Liangrong; Ruan, Deling; Bauer, Diane; Peng, Yi; Barry, Kerrie W.; Schmutz, Jeremy; Ronald, Pamela C.			The Sequences of 1504 Mutants in the Model Rice Variety Kitaake Facilitate Rapid Functional Genomic Studies	PLANT CELL			English	Article							FAST-NEUTRON IRRADIATION; REVERSE GENETICS; INSERTIONAL MUTAGENESIS; STRUCTURAL VARIATIONS; ARABIDOPSIS-THALIANA; WIDE ASSOCIATION; ALPHA-SUBUNIT; PLANT GENOMES; INDICA RICE; PAIRED-END	The availability of a whole-genome sequenced mutant population and the cataloging of mutations of each line at a single-nucleotide resolution facilitate functional genomic analysis. To this end, we generated and sequenced a fast-neutron-induced mutant population in the model rice cultivar Kitaake (Oryza sativa ssp japonica), which completes its life cycle in 9 weeks. We sequenced 1504 mutant lines at 45-fold coverage and identified 91,513 mutations affecting 32,307 genes, i.e., 58% of all rice genes. We detected an average of 61 mutations per line. Mutation types include single-base substitutions, deletions, insertions, inversions, translocations, and tandem duplications. We observed a high proportion of loss-of-function mutations. We identified an inversion affecting a single gene as the causative mutation for the short-grain phenotype in one mutant line. This result reveals the usefulness of the resource for efficient, cost-effective identification of genes conferring specific phenotypes. To facilitate public access to this genetic resource, we established an open access database called KitBase that provides access to sequence data and seed stocks. This population complements other available mutant collections and gene-editing technologies. This work demonstrates how inexpensive next-generation sequencing can be applied to generate a high-density catalog of mutations.	[Li, Guotian; Jain, Rashmi; Chern, Mawsheng; Pham, Nikki T.; Wei, Tong; Duong, Phat Q.; Jones, Kyle C.; Jiang, Liangrong; Ruan, Deling; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Li, Guotian; Jain, Rashmi; Chern, Mawsheng; Pham, Nikki T.; Wei, Tong; Duong, Phat Q.; Jones, Kyle C.; Jiang, Liangrong; Ruan, Deling; Ronald, Pamela C.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Li, Guotian; Jain, Rashmi; Chern, Mawsheng; Pham, Nikki T.; Wei, Tong; Jones, Kyle C.; Ruan, Deling; Ronald, Pamela C.] Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Grass Genet, Berkeley, CA 94720 USA; [Li, Guotian; Jain, Rashmi; Chern, Mawsheng; Wei, Tong; Ruan, Deling; Ronald, Pamela C.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol, Berkeley, CA 94720 USA; [Martin, Joel A.; Schackwitz, Wendy S.; Lipzen, Anna M.; Bauer, Diane; Peng, Yi; Barry, Kerrie W.; Schmutz, Jeremy] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Jiang, Liangrong] Xiamen Univ, Sch Life Sci, Xiamen 361102, Peoples R China; [Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA	Chern, M; Ronald, PC (reprint author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.; Chern, M; Ronald, PC (reprint author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Chern, M; Ronald, PC (reprint author), Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Grass Genet, Berkeley, CA 94720 USA.	mschern@ucdavis.edu; pcronald@ucdavis.edu	Wei, Tong/F-5007-2010	Wei, Tong/0000-0002-2692-7192; Barry, Kerrie/0000-0002-8999-6785	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NIH [GM59962]; NSF [IOS-1237975]	We thank Patrick E. Canlas, Shuwen Xu, Li Pan, Kira H. Lin, Rick A. Rios, Anton D. Rotter-Sieren, Saghi Nojoomi, Hans A. Vasquez-Gross, Maria E. Hernandez, Furong Liu, Anna Joe, and Natasha Brown for assistance in genomic DNA isolation and submission, seed organization, and data processing. We thank Catherine R. Nelson for her extensive, high-quality editing and Jenny C. Mortimer, Brittany Anderton, and Oliver X. Dong for critical reading of the manuscript. We also thank Chongyun Fu, Jiandi Xu, and other Ronald lab members for insightful discussions. This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The work conducted by the U.S. Department of Energy JGI was supported by the Office of Science of the U.S. Department of Energy under Contract DE-AC02-05CH11231. This work was also supported by NIH (GM59962) and NSF (IOS-1237975) to P.C.R.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; Belfield EJ, 2012, GENOME RES, V22, P1306, DOI 10.1101/gr.131474.111; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; Bolon YT, 2014, GENETICS, V198, P967, DOI 10.1534/genetics.114.170340; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen SY, 2003, PLANT J, V36, P105, DOI 10.1046/j.1365-313X.2003.01860.x; Cheng XF, 2014, NEW PHYTOL, V201, P1065, DOI 10.1111/nph.12575; Chern M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006049; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Dobbels AA, 2017, G3-GENES GENOM GENET, V7, P1215, DOI 10.1534/g3.116.038596; Droc G, 2006, NUCLEIC ACIDS RES, V34, pD736, DOI 10.1093/nar/gkj012; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Hsing YI, 2007, PLANT MOL BIOL, V63, P351, DOI 10.1007/s11103-006-9093-z; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Itoh T, 2007, GENOME RES, V17, P175, DOI DOI 10.1101/GR.5509507.PUBMED:17210932; Izawa T, 1996, TRENDS PLANT SCI, V1, P95, DOI 10.1016/S1360-1385(96)80041-0                                                   ; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiao YP, 2016, PLANT CELL, V28, P1551, DOI 10.1105/tpc.16.00373; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kolesnik T, 2004, PLANT J, V37, P301, DOI 10.1046/j.1365-313X.2003.01948.x; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Krishnan A, 2009, PLANT PHYSIOL, V149, P165, DOI 10.1104/pp.108.128918; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Li CLF, 2016, GENOME RES, V26, P1268, DOI 10.1101/gr.205682.116; Li GT, 2016, MOL PLANT, V9, P1078, DOI 10.1016/j.molp.2016.03.009; Heng Li., 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li XB, 2016, PLANT CELL, V28, P367, DOI 10.1105/tpc.15.00465; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Michael T.P., 2013, PLANT GENOME, V6; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nio-Liu D. O., 2006, MOL PLANT PATHOL, V7, P303, DOI DOI 10.1111/J.1364-3703.2006.00344.X; Park CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009262; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Pruitt RN, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500245; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Saxena RK, 2014, BRIEF FUNCT GENOMICS, V13, P296, DOI 10.1093/bfgp/elu016; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Schwessinger B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004809; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; van Enckevort LJG, 2005, PLANT MOL BIOL, V59, P99, DOI 10.1007/s11103-005-8532-6; Wang L, 2013, PLANT BIOTECHNOL J, V11, P997, DOI 10.1111/pbi.12093; Wang NL, 2013, MOL PLANT, V6, P596, DOI 10.1093/mp/sss142; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wei FJ, 2013, RICE, V6, DOI 10.1186/1939-8433-6-39; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamamoto E, 2012, RICE, V5, DOI 10.1186/1939-8433-5-26; Yang SH, 2015, NATURE, V523, P463, DOI 10.1038/nature14649; Yang WN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6087; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zhang JW, 2016, P NATL ACAD SCI USA, V113, pE5163, DOI 10.1073/pnas.1611012113; Zhang JW, 2006, NUCLEIC ACIDS RES, V34, pD745, DOI 10.1093/nar/gkj016; Zhang ZH, 2015, PLANT CELL, V27, P1595, DOI 10.1105/tpc.114.135848; Zmienko A, 2014, THEOR APPL GENET, V127, P1, DOI 10.1007/s00122-013-2177-7	88	3	3	7	7	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	1040-4651	1532-298X		PLANT CELL	Plant Cell	JUN	2017	29	6					1218	1231		10.1105/tpc.17.00154				14	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	EZ8PR	WOS:000404989600007	28576844				2018-01-05	
J	Downey, SS; Sun, GW; Norquest, P				Downey, Sean S.; Sun, Guowei; Norquest, Peter			alineR: an R Package for Optimizing Feature-Weighted Alignments and Linguistic Distances	R JOURNAL			English	Article							LANGUAGES; COEVOLUTION; BOUNDARIES; DIVERSITY; EUROPE; GENES	Linguistic distance measurements are commonly used in anthropology and biology when quantitative and statistical comparisons between words are needed. This is common, for example, when analyzing linguistic and genetic data. Such comparisons can provide insight into historical population patterns and evolutionary processes. However, the most commonly used linguistic distances are derived from edit distances, which do not weight phonetic features that may, for example, represent smaller-scale patterns in linguistic evolution. Thus, computational methods for calculating feature-weighted linguistic distances are needed for linguistic, biological, and evolutionary applications; additionally, the linguistic distances presented here are generic and may have broader applications in fields such as text mining and search, as well as applications in psycholinguistics and morphology. To facilitate this research, we are making available an open-source R software package that performs feature-weighted linguistic distance calculations. The package also includes a supervised learning methodology that uses a genetic algorithm and manually determined alignments to estimate 13 linguistic parameters including feature weights and a skip penalty. Here we present the package and use it to demonstrate the supervised learning methodology by estimating the optimal linguistic parameters for both simulated data and for a sample of Austronesian languages. Our results show that the methodology can estimate these parameters for both simulated and real language data, that optimizing feature weights improves alignment accuracy by approximately 29%, and that optimization significantly affects the resulting distance measurements. Availability: alineR is available on CRAN.	[Downey, Sean S.] Univ Maryland, Dept Anthropol, 4302 Chapel Lane, College Pk, MD 20742 USA; [Sun, Guowei] Univ Maryland, Dept Math, 176 Campus Dr, College Pk, MD 20742 USA; [Norquest, Peter] Univ Arizona, Dept Anthropol, 1009 E South Campus Dr, Tucson, AZ 85721 USA	Downey, SS (reprint author), Univ Maryland, Dept Anthropol, 4302 Chapel Lane, College Pk, MD 20742 USA.	sdowney2@umd.edu; gwsun@umd.edu; norquesp@email.arizona.edu			National Science Foundation [SBS-1030031]; University of Maryland	This work was supported by the National Science Foundation [Grant number SBS-1030031 to P.N. and S.D.], and the University of Maryland.	Back T., 1997, HDB EVOLUTIONARY COM, P143; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; Borg A., 2016, RECORDLINKAGE RECORD, P139; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CAVALLISFORZA LL, 1991, SCI AM, V265, P72; Chen J., 1995, HUM BIOL, p[595, 138]; Covington M. A., 1998, P 36 ANN M ASS COMP, V1, p[275, 138]; Cox MP, 2006, AM J HUM BIOL, V18, P35, DOI 10.1002/ajhb.20459; Cox M. P., 2003, THESIS, P138; Croft W, 2008, ANNU REV ANTHROPOL, V37, P219, DOI 10.1146/annurev.anthro.37.081407.085156; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208                                                         ; Downey SS, 2008, J QUANT LINGUIST, V15, P340, DOI 10.1080/09296170802326681; Fine AB, 2013, COGNITIVE SCI, V37, P578, DOI 10.1111/cogs.12022; Gooskens Charlotte, 2004, LANG VAR CHANGE, V16, P189; Horn F, 2004, BIOINFORMATICS, V20, P557, DOI 10.1093/bioinformatics/btg449; Huff P. A., 2010, THESIS, P139; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; I. P. Association, 1999, HDB INT PHON ASS GUI, P140; Kondrak G, 2003, COMPUT HUMANITIES, V37, P273, DOI 10.1023/A:1025071200644                                                         ; Kondrak G, 2000, P 1 N AM CHAPT ASS C, P288; Lansing JS, 2007, P NATL ACAD SCI USA, V104, P16022, DOI 10.1073/pnas.0704451104; Levenshtein V.I, 1966, SOV PHYS DOKL, V10, P707; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Nettle D., 2003, HUM BIOL, p[331, 138]; Pagel M., 2012, WIRED CULTURE ORIGIN, P138; Pages H., 2017, BIOSTRINGS STRING OB, P139; Petroni F, 2010, PHYSICA A, V389, P2280, DOI 10.1016/j.physa.2010.02.004; Qiujun L., 2010, J COMPUTATIONAL INFO, V6, p[3761, 138]; Revolution Analytics and Steve Weston, 2015, DOMC FOR PAR AD PAR, P145; SMOUSE PE, 1992, YEARB PHYS ANTHROPOL, V35, P187; SOKAL RR, 1988, P NATL ACAD SCI USA, V85, P1722, DOI 10.1073/pnas.85.5.1722; Somers H. L., 1998, P 17 INT C COMP LING, V2, p[1227, 138]; Tumonggor MK, 2014, J HUM GENET, V59, P494, DOI 10.1038/jhg.2014.62; van der Loo MPJ, 2014, R J, V6, P111; Wichmann S, 2010, PHYSICA A, V389, P3632, DOI 10.1016/j.physa.2010.05.011	35	0	0	1	1	R FOUNDATION STATISTICAL COMPUTING	WIEN	WIRTSCHAFTSUNIVERSITAT, INST STATISTICS & MATHEMATICS, AUGASSE 2-6, WIEN, 1090, AUSTRIA	2073-4859			R J	R Journal	JUN	2017	9	1					138	152						15	Computer Science, Interdisciplinary Applications; Statistics & Probability	Computer Science; Mathematics	EZ5LB	WOS:000404756200010					2018-01-05	
J	Kramarzova, KS; Osborn, MJ; Webber, BR; Defeo, AP; McElroy, AN; Kim, CJ; Tolar, J				Kramarzova, Karolina Skvarova; Osborn, Mark J.; Webber, Beau R.; Defeo, Anthony P.; McElroy, Amber N.; Kim, Chong Jai; Tolar, Jakub			CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						gene editing; CRISPR/Cas9; Fanconi anemia; fibroblasts; Fanconi anemia D1; poly adenosine diphosphate-ribose polymerase inhibitors	FANCONI-ANEMIA PATIENTS; ZINC-FINGER NUCLEASES; STRAND BREAK REPAIR; DNA-REPAIR; CRISPR-CAS9 NUCLEASES; HEMATOPOIETIC STEM; SOMATIC MOSAICISM; PARP INHIBITORS; THERAPY; INTEGRATION	Fanconi anemia (FA) is an inherited condition characterized by impaired DNA repair, physical anomalies, bone marrow failure, and increased incidence of malignancy. Gene editing holds great potential to precisely correct the underlying genetic cause such that gene expression remains under the endogenous control mechanisms. This has been accomplished to date only in transformed cells or their reprogrammed induced pluripotent stem cell counterparts; however, it has not yet been reported in primary patient cells. Here we show the ability to correct a mutation in Fanconi anemia D1 (FANCD1) primary patient fibroblasts. The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system was employed to target and correct a FANCD1 gene deletion. Homologous recombination using an oligonucleotide donor was achieved and a pure population of modified cells was obtained by using inhibitors of poly adenosine diphosphate-ribose polymerase (poly ADP-ribose polymerase). FANCD1 function was restored and we did not observe any promiscuous cutting of the CRISPR/Cas9 at off target sites. This consideration is crucial in the context of the pre-malignant FA phenotype. Altogether we show the ability to correct a patient mutation in primary FANCD1 cells in a precise manner. These proof of principle studies support expanded application of gene editing for FA.	[Kramarzova, Karolina Skvarova; Osborn, Mark J.; Webber, Beau R.; Defeo, Anthony P.; McElroy, Amber N.; Tolar, Jakub] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Kramarzova, Karolina Skvarova] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, CLIP, Prague 15006, Czech Republic; [Osborn, Mark J.; Tolar, Jakub] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Osborn, Mark J.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Osborn, Mark J.; Tolar, Jakub] Univ Minnesota, Asan Minnesota Inst Innovating Transplantat, Minneapolis, MN 55455 USA; [Kim, Chong Jai] Asan Minnesota Inst Innovating Transplantat, Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea	Osborn, MJ (reprint author), Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA.; Osborn, MJ (reprint author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.; Osborn, MJ (reprint author), Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA.; Osborn, MJ (reprint author), Univ Minnesota, Asan Minnesota Inst Innovating Transplantat, Minneapolis, MN 55455 USA.	karolina.skvarova@gmail.com; osbor026@umn.edu; webb0178@umn.edu; apdefeo@umn.edu; leira001@umn.edu; ckim@amc.seoul.kr; tolar003@umn.edu		Tolar, Jakub/0000-0002-0957-4380	Czech Science Foundation [17-04941Y]; NIH [T32-HL007062]; Regenerative Medicine of Minnesota; National Research Foundation of Korea [NRF-2015K1A4A3046807]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114];  [8UL1TR000114-02];  [R01 AR063070];  [P01 CA065493]	We are grateful to Nancy Griggs Morgan for help with manuscript preparation. Karolina Skvarova Kramarzova was supported by 17-04941Y from the Czech Science Foundation. Beau R. Webber is supported by NIH T32-HL007062. We appreciate the generosity of the Kidz 1st Fund, the Fanconi Anemia Research Fund, the Children's Cancer Research Fund, the Lindahl Family & the Corrigan Family. Mark J. Osborn is also supported by 8UL1TR000114-02 and Regenerative Medicine of Minnesota. Jakub Tolar is supported in part by R01 AR063070 and P01 CA065493. Chong Jai Kim is supported by research funds from the National Research Foundation of Korea (NRF-2015K1A4A3046807). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114 (Mark J. Osborn). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair JE, 2016, CURR GENE THER, V16, P338, DOI 10.2174/1566523217666170119113029; Adair JE, 2016, BLOOD, V128; Anur P, 2016, BONE MARROW TRANSPL, V51, P938, DOI 10.1038/bmt.2016.32; Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011                                                ; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200                                                          ; Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cerrato A, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0456-2; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cumming RC, 1996, BLOOD, V88, P4558; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Digweed M, 2002, CARCINOGENESIS, V23, P1121, DOI 10.1093/carcin/23.7.1121                                                        ; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Esposito MT, 2015, NAT MED, V21, P1481, DOI 10.1038/nm.3993; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Godthelp BC, 2002, ONCOGENE, V21, P5002, DOI 10.1038/sj.onc.1205656; Gregory JJ, 2001, P NATL ACAD SCI USA, V98, P2532, DOI 10.1073/pnas.051609898; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hirsch B, 2004, BLOOD, V103, P2554, DOI 10.1182/blood-2003-06-1970                                                      ; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590                                                                ; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Longerich S, 2014, BLOOD, V124, P2812, DOI 10.1182/blood-2014-04-526293; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Lo Ten Foe J. R., 1997, EUR J HUM GENET, V5, P137; MacMillan ML, 2015, BLOOD, V125, P3798, DOI 10.1182/blood-2015-02-626002; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mehta PA, 2017, BLOOD, V129, P2308, DOI 10.1182/blood-2016-09-743112; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Moreno A, 2016, P NATL ACAD SCI USA, V113, pE5757, DOI 10.1073/pnas.1603252113; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Myers K, 2012, PEDIATR BLOOD CANCER, V58, P462, DOI 10.1002/pbc.23168; Osborn MJ, 2016, STEM CELLS DEV, V25, P1591, DOI 10.1089/scd.2016.0149; Osborn MJ, 2015, HUM GENE THER, V26, P114, DOI 10.1089/hum.2014.111; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Rio P, 2014, EMBO MOL MED, V6, P835, DOI 10.15252/emmm.201303374; Shen Y., 2015, CANC CELL MICROENVIR, V2, pe986; Soulier J, 2005, BLOOD, V105, P1329, DOI 10.1182/blood-2004-05-1852; Stephen SL, 2010, J VIROL, V84, P9987, DOI 10.1128/JVI.00751-10; Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005	57	0	0	1	1	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JUN	2017	18	6							1269	10.3390/ijms18061269				15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	EZ3AF	WOS:000404581500167		gold			2018-01-05	
J	Parfett, CL; Desaulniers, D				Parfett, Craig L.; Desaulniers, Daniel			A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review						carcinogenesis; carcinogenicity tests; carcinogens; chemical safety; chromatin; DNA methylation; environmental exposure; epigenesis; epigenomics; gene silencing; tumour suppressor; histones; neoplasms; nucleosomes; risk assessment	TUMOR-SUPPRESSOR GENE; LONG NONCODING RNA; EMBRYONIC STEM-CELLS; CHROMATIN REMODELING COMPLEX; MEDIATED TRANSCRIPTIONAL ACTIVATION; INDUCED MALIGNANT-TRANSFORMATION; HISTONE LYSINE METHYLATION; BRONCHIAL EPITHELIAL-CELLS; ABERRANT DNA METHYLATION; BINDING-PROTEIN MECP2	An emerging vision for toxicity testing in the 21st century foresees in vitro assays assuming the leading role in testing for chemical hazards, including testing for carcinogenicity. Toxicity will be determined by monitoring key steps in functionally validated molecular pathways, using tests designed to reveal chemically-induced perturbations that lead to adverse phenotypic endpoints in cultured human cells. Risk assessments would subsequently be derived from the causal in vitro endpoints and concentration vs. effect data extrapolated to human in vivo concentrations. Much direct experimental evidence now shows that disruption of epigenetic processes by chemicals is a carcinogenic mode of action that leads to altered gene functions playing causal roles in cancer initiation and progression. In assessing chemical safety, it would therefore be advantageous to consider an emerging class of carcinogens, the epigenotoxicants, with the ability to change chromatin and/or DNA marks by direct or indirect effects on the activities of enzymes (writers, erasers/editors, remodelers and readers) that convey the epigenetic information. Evidence is reviewed supporting a strategy for in vitro hazard identification of carcinogens that induce toxicity through disturbance of functional epigenetic pathways in human somatic cells, leading to inactivated tumour suppressor genes and carcinogenesis. In the context of human cell transformation models, these in vitro pathway measurements ensure high biological relevance to the apical endpoint of cancer. Four causal mechanisms participating in pathways to persistent epigenetic gene silencing were considered: covalent histone modification, nucleosome remodeling, non-coding RNA interaction and DNA methylation. Within these four interacting mechanisms, 25 epigenetic toxicity pathway components (SET1, MLL1, KDM5, G9A, SUV39H1, SETDB1, EZH2, JMJD3, CBX7, CBX8, BMI, SUZ12, HP1, MPP8, DNMT1, DNMT3A, DNMT3B, TET1, MeCP2, SETDB2, BAZ2A, UHRF1, CTCF, HOTAIR and ANRIL) were found to have experimental evidence showing that functional perturbations played driver roles in human cellular transformation. Measurement of epigenotoxicants presents challenges for short-term carcinogenicity testing, especially in the high-throughput modes emphasized in the Tox21 chemicals testing approach. There is need to develop and validate in vitro tests to detect both, locus-specific, and genome-wide, epigenetic alterations with causal links to oncogenic cellular phenotypes. Some recent examples of cell-based high throughput chemical screening assays are presented that have been applied or have shown potential for application to epigenetic endpoints.	[Parfett, Craig L.] Hlth Canada, Environm Hlth Sci & Res Bur, Mechanist Studies Div, HealthyEnvironm & Consumer Safety Branch, 50 Columbine Driveway, Ottawa, ON K1A 0K9, Canada; [Desaulniers, Daniel] Hlth Canada, Environm Hlth Sci & Res Bur, Hazard Identificat Div, HealthyEnvironm & Consumer Safety Branch, 50 Columbine Driveway, Ottawa, ON K1A 0K9, Canada	Parfett, CL (reprint author), Hlth Canada, Environm Hlth Sci & Res Bur, Mechanist Studies Div, HealthyEnvironm & Consumer Safety Branch, 50 Columbine Driveway, Ottawa, ON K1A 0K9, Canada.	craig.parfett@canada.ca; daniel.desaulniers@canada.ca					Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007; Akagi T, 2004, TRENDS MOL MED, V10, P542, DOI 10.1016/j.molmed.2004.09.001; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Alhosin M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-41; Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255; Andreu-Vieyra CV, 2013, ADV EXP MED BIOL, V754, P109, DOI 10.1007/978-1-4419-9967-2_5; Anosova I, 2015, NUCLEIC ACIDS RES, V43, P5208, DOI 10.1093/nar/gkv365; Ansari KI, 2013, ONCOGENE, V32, P3359, DOI 10.1038/onc.2012.352; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Babbio F, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-19; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9                                                   ; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Baylin S. B., 2007, EPIGENETICS, P457; Bedi U, 2014, ONCOTARGET, V5, P2016, DOI 10.18632/oncotarget.1875                                                        ; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4                                                   ; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Bergo A, 2015, J BIOL CHEM, V290, P3223, DOI 10.1074/jbc.M114.608125; Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Bhan A, 2013, J MOL BIOL, V425, P3707, DOI 10.1016/j.jmb.2013.01.022; Bistulfi G, 2006, CANCER RES, V66, P10308, DOI 10.1158/0008-5472.CAN-06-1052; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Bortoluzzi A, 2017, BIOCHEM J, V474, P1633, DOI 10.1042/BCJ20161053; Bouhifd M, 2014, BASIC CLIN PHARMACOL, V115, P24, DOI 10.1111/bcpt.12198; Boukhari A, 2015, ANTICANCER RES, V35, P149; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542                                                            ; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Brocato J, 2015, J TRACE ELEM MED BIO, V31, P209, DOI 10.1016/j.jtemb.2014.04.001; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Brodie SA, 2014, CANCER PREV RES, V7, P351, DOI 10.1158/1940-6207.CAPR-13-0254; Bronner C, 2013, BIOCHEM PHARMACOL, V86, P1643, DOI 10.1016/j.bcp.2013.10.002; Buck-Koehntop BA, 2013, EPIGENETICS-US, V8, P131, DOI 10.4161/epi.23632; Camarena V, 2016, CELL MOL LIFE SCI, V73, P1645, DOI 10.1007/s00018-016-2145-x; Campbell MJ, 2013, ADV EXP MED BIOL, V754, P81, DOI 10.1007/978-1-4419-9967-2_4; Carcagno AL, 2009, IUBMB LIFE, V61, P537, DOI 10.1002/iub.197; Cartularo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155002; Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540; Chen DQ, 2013, J BIOL CHEM, V288, P21678, DOI 10.1074/jbc.M113.476630; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chiacchiera F, 2013, CELL MOL LIFE SCI, V70, P1495, DOI 10.1007/s00018-013-1293-5; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Ciccarone F, 2017, SEMIN CELL DEV BIOL, V63, P123, DOI 10.1016/j.semcdb.2016.11.010; Ciccarone F, 2014, ONCOTARGET, V5, P10356, DOI 10.18632/oncotarget.1905                                                        ; Combes R, 1999, ATLA-ALTERN LAB ANIM, V27, P745; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930                                                                   ; Conway E, 2015, CURR OPIN CELL BIOL, V37, P42, DOI 10.1016/j.ceb.2015.10.003; Corlazzoli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004305; Cui CH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0819-6; Cui HM, 2007, DIS MARKERS, V23, P105, DOI 10.1155/2007/363464                                                             ; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Davalos-Salas M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-232; Davies AH, 2014, STEM CELLS, V32, P1437, DOI 10.1002/stem.1707; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Desaulniers D., 2016, CURR TOP TOXICOL, V12, P47; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Ding N, 2016, J MOL CELL BIOL, V8, P244, DOI 10.1093/jmcb/mjv050; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Du Q, 2015, EPIGENOMICS-UK, V7, P1051, DOI 10.2217/epi.15.39; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Dykhuizen EC, 2012, J BIOMOL SCREEN, V17, P1221, DOI 10.1177/1087057112455060; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557                                                         ; Ehrlich M, 2013, ADV EXP MED BIOL, V754, P31, DOI 10.1007/978-1-4419-9967-2_2; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Engle SJ, 2014, J BIOL CHEM, V289, P4562, DOI 10.1074/jbc.R113.529156; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Extended Advisory Group on Molecular Screening and Toxicogenomics, 2016, HDB SUPPL GUID DOC D; Farias N, 2015, J NUTR BIOCHEM, V26, P818, DOI 10.1016/j.jnutbio.2015.02.002; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Ferraro A, 2013, INT J BIOCHEM CELL B, V45, P243, DOI 10.1016/j.biocel.2012.10.009; Fiorentino FP, 2012, J CELL PHYSIOL, V227, P479, DOI 10.1002/jcp.22780; Fischle W, 2014, BBA-GENE REGUL MECH, V1839, P621, DOI 10.1016/j.bbagrm.2014.06.003; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gao A, 2010, TOXICOL LETT, V195, P114, DOI 10.1016/j.toxlet.2010.03.005; Gao A, 2010, TOXICOL LETT, V193, P236, DOI 10.1016/j.toxlet.2010.01.017; Gao F, 2014, GENOMICS, V103, P204, DOI 10.1016/j.ygeno.2013.12.006; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gertych A, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-11; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Greally JM, 2013, ALTEX-ALTERN ANIM EX, V30, P445, DOI 10.14573/altex.2013.4.445                                                       ; Grimm FA, 2016, GREEN CHEM, V18, P4407, DOI 10.1039/c6gc01147k; Gu L, 2015, NAT GENET, V47, P22, DOI 10.1038/ng.3165; Guastafierro T, 2013, BIOCHEM J, V449, P623, DOI 10.1042/BJ20121429; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gustafson CB, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0087-z; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartung T, 2017, EXPERT OPIN DRUG MET, V13, P1, DOI 10.1080/17425255.2017.1246535; Herceg Z, 2013, CARCINOGENESIS, V34, P1955, DOI 10.1093/carcin/bgt212; Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262; Hickok JR, 2013, J BIOL CHEM, V288, P16004, DOI 10.1074/jbc.M112.432294; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hoffman AR, 2006, CELL MOL NEUROBIOL, V26, P425, DOI 10.1007/s10571-006-9057-5; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Holoch D., 2017, TRENDS BIOCHEM SCI, DOI [10.1016/j.tibs.2017.04.00328483375, DOI 10.1016/J.TIBS.2017.04.00328483375]; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Hsiao SH, 2010, BIOCHEM BIOPH RES CO, V400, P305, DOI 10.1016/j.bbrc.2010.08.048; Hsu CW, 2016, J BIOMOL SCREEN, V21, P643, DOI 10.1177/1087057116629381; Hsu CH, 2012, CELL REPORTS, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Hua KT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-189; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Huen K, 2016, ENVIRON RES, V148, P55, DOI 10.1016/j.envres.2016.03.025; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Isfort RJ, 1997, MOL CARCINOGEN, V20, P189, DOI 10.1002/(SICI)1098-2744(199710)20:2<189::AID-MC5>3.0.CO;2-I; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681                                                          ; Jacobs MN, 2016, ALTEX-ALTERN ANIM EX, V33, P359, DOI 10.14573/altex.1601201; Jasencakova Z, 2010, BIOESSAYS, V32, P847, DOI 10.1002/bies.201000055; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jene-Sanz A, 2013, MOL CELL BIOL, V33, P3951, DOI 10.1128/MCB.00426-13; Jensen TJ, 2009, TOXICOL APPL PHARM, V235, P39, DOI 10.1016/j.taap.2008.10.013; Ji WD, 2008, CARCINOGENESIS, V29, P1267, DOI 10.1093/carcin/bgn012; Jiang RR, 2014, TOXICOL LETT, V227, P91, DOI 10.1016/j.toxlet.2014.03.020; Jin CL, 2014, NUCLEIC ACIDS RES, V42, P6956, DOI 10.1093/nar/gku372; Judson R, 2013, ALTEX-ALTERN ANIM EX, V30, P51, DOI 10.14573/altex.2013.1.051                                                       ; Kanai Y, 2010, CANCER SCI, V101, P36, DOI 10.1111/j.1349-7006.2009.01383.x; Karanikolas BDW, 2009, MOL CANCER RES, V7, P1456, DOI 10.1158/1541-7786.MCR-09-0121; Karpf AR, 2013, ADV EXP MED BIOL, V754, pV; Karpinets TV, 2005, CARCINOGENESIS, V26, P1323, DOI 10.1093/carcin/bgi079; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kemp CJ, 2014, CELL REP, V7, P1020, DOI 10.1016/j.celrep.2014.04.004; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kinde B, 2015, P NATL ACAD SCI USA, V112, P6800, DOI 10.1073/pnas.1411269112; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Kleensang A, 2014, ALTEX-ALTERN ANIM EX, V31, P53, DOI 10.14573/altex.1309261; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914; Ko M, 2015, IMMUNOL REV, V263, P6, DOI 10.1111/imr.12239; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kolybaba A, 2014, CELL TISSUE RES, V356, P477, DOI 10.1007/s00441-014-1824-x; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Koturbash I, 2011, TOXICOL MECH METHOD, V21, P289, DOI 10.3109/15376516.2011.557881; Krewski D, 2014, ENVIRON HEALTH PERSP, V122, P796, DOI 10.1289/ehp.1307260; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Kroeze LI, 2015, BBA-REV CANCER, V1855, P144, DOI 10.1016/j.bbcan.2015.01.001; Kugel JF, 2012, TRENDS BIOCHEM SCI, V37, P144, DOI 10.1016/j.tibs.2011.12.003; Kuppusamy SP, 2015, INT J TOXICOL, V34, P384, DOI 10.1177/1091581815599350; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; Larman HB, 2014, NUCLEIC ACIDS RES, V42, P9146, DOI 10.1093/nar/gku636; Leick MB, 2012, AM J STEM CELLS, V1, P59; Li L, 2015, INT J MOL SCI, V16, P5125, DOI 10.3390/ijms16035125; Li Q, 2015, NEUROBIOL DIS, V77, P155, DOI 10.1016/j.nbd.2015.03.009; Li X, 2013, BRIT J CANCER, V109, P2266, DOI 10.1038/bjc.2013.548; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Lin RK, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-46; Lin YS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-3; Liu H, 2007, ONCOGENE, V26, P5900, DOI 10.1038/sj.onc.1210400; Liu XC, 2017, ONCOTARGET, V8, P10510, DOI 10.18632/oncotarget.14446; Liu Y, 2014, MOL BIOSYST, V10, P251, DOI 10.1039/c3mb70413k; Livide G, 2012, PATHOL ONCOL RES, V18, P703, DOI 10.1007/s12253-012-9498-8; Locke WJ, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0086-0; Luense S, 2015, J BIOMOL SCREEN, V20, P190, DOI 10.1177/1087057114559668; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Luo T, 2013, BIOCHEM BIOPH RES CO, V441, P65, DOI 10.1016/j.bbrc.2013.10.018; Magdalou I, 2014, SEMIN CELL DEV BIOL, V30, P154, DOI 10.1016/j.semcdb.2014.04.035; Marczylo EL, 2016, CRIT REV TOXICOL, V46, P676, DOI 10.1080/10408444.2016.1175417; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Marshall AD, 2014, CURR OPIN GENET DEV, V24, P8, DOI 10.1016/j.gde.2013.10.011; Maslov AY, 2012, ONCOGENE, V31, P5172, DOI 10.1038/onc.2012.9; Matouk I, 2013, INT J MOL SCI, V14, P4298, DOI 10.3390/ijms14024298; Mazzio EA, 2012, EPIGENETICS-US, V7, P119, DOI 10.4161/epi.7.2.18764; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal/pbio.0040051; Meng H, 2015, INT J BIOL SCI, V11, P604, DOI 10.7150/ijbs.11218; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Monnier P, 2013, P NATL ACAD SCI USA, V110, P20693, DOI 10.1073/pnas.1310201110; Montes M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7967; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Mulji A, 2012, J BIOMOL SCREEN, V17, P108, DOI 10.1177/1087057111418229; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Muthusamy V, 2013, J INVEST DERMATOL, V133, P1827, DOI 10.1038/jid.2013.48; Nakamura M, 2001, LAB INVEST, V81, P77, DOI 10.1038/labinvest.3780213                                                       ; National Center for Advancing Translational Sciences (NCATS), 2017, ASS DEV SCREEN ASS G; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Nestor CE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0576-y; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Nishida N, 2013, DIGEST DIS, V31, P459, DOI 10.1159/000355245; Nishikawaji T, 2016, ONCOTARGET, V7, P67251, DOI 10.18632/oncotarget.11625; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; *NRC, 2007, TOX TEST 21 CENT VIS; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pacaud R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04230; Pandey M, 2014, TOXICOL APPL PHARM, V280, P296, DOI 10.1016/j.taap.2014.08.015; Papadopoulou C, 2015, CELL REP, V13, P2491, DOI 10.1016/j.celrep.2015.11.039; Pickles JC, 2016, MUTAT RES-GEN TOX EN, V802, P50, DOI 10.1016/j.mrgentox.2016.04.002; Pierre CC, 2015, BBA-MOL BASIS DIS, V1852, P1846, DOI 10.1016/j.bbadis.2015.06.011; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Pogribny IP, 2013, ADV EXP MED BIOL, V754, P215, DOI 10.1007/978-1-4419-9967-2_11; Pohodich AE, 2015, HUM MOL GENET, V24, pR10, DOI 10.1093/hmg/ddv217; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501                                                              ; Putiri EL, 2014, ONCOTARGET, V5, P6338, DOI 10.18632/oncotarget.2215                                                        ; Qin SS, 2015, CHINESE J CANCER RES, V27, P148, DOI 10.3978/j.issn.1000-9604.2015.04.03; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rasko JEJ, 2001, CANCER RES, V61, P6002; Rasmussen KD, 2015, NAT IMMUNOL, V16, P592, DOI 10.1038/ni.3176; Ray PD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00201; Ray SS, 2004, J BIOL CHEM, V279, P27187, DOI 10.1074/jbc.M402771200; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Reddington JP, 2014, BIOESSAYS, V36, P134, DOI 10.1002/bies.201300130; Reddington JP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r25; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Riggs JW, 2013, STEM CELLS DEV, V22, P37, DOI 10.1089/scd.2012.0375; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Sajadian SO, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0213-6; Saldana-Meyer R, 2011, EPIGENETICS-US, V6, P1068, DOI 10.4161/epi.6.9.16683; Salz T, 2014, CANCER RES, V74, P775, DOI 10.1158/0008-5472.CAN-13-1400; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043                                                    ; Khare Satyajeet P., 2011, NUCL ACIDS RES; Schackmann RCJ, 2013, J CELL SCI, V126, P3515, DOI 10.1242/jcs.134411; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Severson PL, 2013, EPIGENETICS-US, V8, P1080, DOI 10.4161/epi.25926; Severson PL, 2012, EPIGENETICS-US, V7, P1238, DOI 10.4161/epi.22163; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Sherr CJ, 2012, WIRES DEV BIOL, V1, P731, DOI 10.1002/wdev.40; Shorter KR, 2015, PROG BIOPHYS MOL BIO, V118, P14, DOI 10.1016/j.pbiomolbio.2015.03.007; Sidler C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00411; Sierra M, 2016, INT J NANOMED, V11, P6297, DOI 10.2147/IJN.S120104; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simpson DJ, 2000, CANCER RES, V60, P1211; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Smith MT, 2016, ENVIRON HEALTH PERSP, V124, P713, DOI 10.1289/ehp.1509912; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Steensma DP, 2015, MAYO CLIN PROC, V90, P969, DOI 10.1016/j.mayocp.2015.04.001; Stirzaker C, 2017, ONCOGENE, V36, P1328, DOI 10.1038/onc.2016.297; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Sun WP, 2010, J CANCER, V1, P136; Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236; Swygert SG, 2014, BBA-GENE REGUL MECH, V1839, P728, DOI 10.1016/j.bbagrm.2014.02.013; Takai H, 2014, CELL REP, V9, P48, DOI 10.1016/j.celrep.2014.08.071; Takeshima H, 2015, CARCINOGENESIS, V36, P192, DOI 10.1093/carcin/bgu238; Tallant C, 2015, STRUCTURE, V23, P80, DOI 10.1016/j.str.2014.10.017; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Teneng I, 2015, ONCOGENE, V34, P621, DOI 10.1038/onc.2013.580; Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tomasetti M, 2011, MUTAGENESIS, V26, P585, DOI 10.1093/mutage/ger020; Tran TA, 2014, ACS CHEM BIOL, V9, P2603, DOI 10.1021/cb500532x; Treas J, 2013, PROSTATE, V73, P1660, DOI 10.1002/pros.22701; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsai YP, 2014, INT J CANCER, V134, P249, DOI 10.1002/ijc.28190; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Vanparys P, 2012, MUTAT RES-GEN TOX EN, V744, P111, DOI 10.1016/j.mrgentox.2012.02.001; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vertino PM, 1996, MOL CELL BIOL, V16, P4555; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Waldmann T, 2013, CURR OPIN CELL BIOL, V25, P184, DOI 10.1016/j.ceb.2013.01.001; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang HH, 2014, ARCH TOXICOL, V88, P1549, DOI 10.1007/s00204-014-1214-x; Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Wei YD, 2004, J BIOL CHEM, V279, P4110, DOI 10.1074/jbc.M310800200; Whetstine JR, 2014, BBA-GENE REGUL MECH, V1839, P1351, DOI 10.1016/j.bbagrm.2014.09.005; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wnek SM, 2011, TOXICOL APPL PHARM, V257, P1, DOI 10.1016/j.taap.2011.08.029; Wong CM, 2016, HEPATOLOGY, V63, P474, DOI 10.1002/hep.28304; Wu BK, 2014, CELL REP, V9, P1827, DOI 10.1016/j.celrep.2014.10.063; Wu BK, 2014, CELL CYCLE, V13, P3222, DOI 10.4161/15384101.2014.950886; Wu XQ, 2015, TOXICOL APPL PHARM, V288, P74, DOI 10.1016/j.taap.2015.07.010; Xi SC, 2013, J CLIN INVEST, V123, P1241, DOI 10.1172/JCI61271; Xiao CL, 2015, TOXICOL SCI, V145, P80, DOI 10.1093/toxsci/kfv019; Xu J, 2014, P NATL ACAD SCI USA, V111, P2620, DOI 10.1073/pnas.1400150111; Yan H, 2016, ONCOGENE, V35, P3995, DOI 10.1038/onc.2015.423; Yang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088052; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yasaei H, 2013, ONCOGENE, V32, P171, DOI 10.1038/onc.2012.45; Ye F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-93; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu DH, 2014, J CLIN INVEST, V124, P3708, DOI 10.1172/JCI76507; Yuan DX, 2013, MUTAT RES-GEN TOX EN, V757, P125, DOI 10.1016/j.mrgentox.2013.07.007; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhang YA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090955, 10.1371/journal.pone.0085089, 10.1371/journal.pone.0093458]; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001; Zhou L, 2015, CANCER BIOL THER, V16, P1241, DOI 10.1080/15384047.2015.1056411; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	339	0	0	7	7	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JUN	2017	18	6							1179	10.3390/ijms18061179				76	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	EZ3AF	WOS:000404581500078		gold			2018-01-05	
J	Rouanet, M; Lebrin, M; Gross, F; Bournet, B; Cordelier, P; Buscail, L				Rouanet, Marie; Lebrin, Marine; Gross, Fabian; Bournet, Barbara; Cordelier, Pierre; Buscail, Louis			Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review						gene therapy; pancreatic cancer; expression vectors; clinical trial; oncovirus; vaccination; endoscopic ultrasound	COLONY-STIMULATING FACTOR; PHASE-I TRIAL; CYTOSINE-DEAMINASE/URACIL-PHOSPHORIBOSYLTRANSFERASE; EXPRESSING MESOTHELIN CRS-207; I/II CLINICAL-TRIAL; CELL-CYCLE ARREST; DUCTAL ADENOCARCINOMA; FUSION GENE; DENDRITIC CELLS; K-RAS	A recent death projection has placed pancreatic ductal adenocarcinoma as the second cause of death by cancer in 2030. The prognosis for pancreatic cancer is very poor and there is a great need for new treatments that can change this poor outcome. Developments of therapeutic innovations in combination with conventional chemotherapy are needed urgently. Among innovative treatments the gene therapy offers a promising avenue. The present review gives an overview of the general strategy of gene therapy as well as the limitations and stakes of the different experimental in vivo models, expression vectors (synthetic and viral), molecular tools (interference RNA, genome editing) and therapeutic genes (tumor suppressor genes, antiangiogenic and pro-apoptotic genes, suicide genes). The latest developments in pancreatic carcinoma gene therapy are described including gene-based tumor cell sensitization to chemotherapy, vaccination and adoptive immunotherapy (chimeric antigen receptor T-cells strategy). Nowadays, there is a specific development of oncolytic virus therapies including oncolytic adenoviruses, herpes virus, parvovirus or reovirus. A summary of all published and on-going phase-1 trials is given. Most of them associate gene therapy and chemotherapy or radiochemotherapy. The first results are encouraging for most of the trials but remain to be confirmed in phase 2 trials.	[Rouanet, Marie; Bournet, Barbara; Buscail, Louis] CHU Rangueil, Dept Gastroenterol, 1 Ave Jean Poulhes, F-31059 Toulouse, France; [Rouanet, Marie; Bournet, Barbara; Cordelier, Pierre; Buscail, Louis] INSERM, UMR 1037, Canc Res Ctr Toulouse, F-31037 Toulouse, France; [Lebrin, Marine; Gross, Fabian; Buscail, Louis] CHU Rangueil, Module Biotherapy, Ctr Clin Invest 1436, 1 Ave Jean Poulhes, Toulouse 9, France; [Bournet, Barbara; Buscail, Louis] Univ Toulouse III, Med Sch Med Rangueil, F-31062 Toulouse, France	Buscail, L (reprint author), CHU Rangueil, Dept Gastroenterol, 1 Ave Jean Poulhes, F-31059 Toulouse, France.; Buscail, L (reprint author), INSERM, UMR 1037, Canc Res Ctr Toulouse, F-31037 Toulouse, France.; Buscail, L (reprint author), CHU Rangueil, Module Biotherapy, Ctr Clin Invest 1436, 1 Ave Jean Poulhes, Toulouse 9, France.; Buscail, L (reprint author), Univ Toulouse III, Med Sch Med Rangueil, F-31062 Toulouse, France.	marie.rouanetvidal@gmail.com; lebrin.m@chu-toulouse.fr; gross.f@chu-toulouse.fr; bournet.b@chu-toulouse.fr; pierre.cordelier@inserm.fr; buscail.l@chu-toulouse.fr					Aguilar LK, 2015, CANCER IMMUNOL IMMUN, V64, P727, DOI 10.1007/s00262-015-1679-3; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alberts SR, 2004, J CLIN ONCOL, V22, P4944, DOI 10.1200/JCO.2004.05.034; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Angelova AL, 2009, CLIN CANCER RES, V15, P511, DOI 10.1158/1078-0432.CCR-08-1088; Armstrong L, 2012, SURGERY, V152, P114, DOI 10.1016/j.surg.2012.02.017; Azmi AS, 2010, CURR CANCER DRUG TAR, V10, P319, DOI 10.2174/156800910791190229                                                      ; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Bernhardt SL, 2006, BRIT J CANCER, V95, P1474, DOI 10.1038/sj.bjc.6603437; Bertrand E, 2011, CHEM COMMUN, V47, P12547, DOI 10.1039/c1cc15716g; Bhattacharyya M, 2011, CANCER GENE THER, V18, P734, DOI 10.1038/cgt.2011.45; Bournet B., 2015, EUR J CANC OXF ENGL, V54, P75, DOI [10.1016/j.ejca.2015.11.01226735353, DOI 10.1016/J.EJCA.2015.11.01226735353]; Breitbach CJ, 2016, EBIOMEDICINE, V9, P31, DOI 10.1016/j.ebiom.2016.06.046; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8                                                   ; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403                                                      ; Buscail L, 2006, PANCREATOLOGY, V6, P7, DOI 10.1159/000090022; Buscail L, 2015, MOL THER, V23, P779, DOI 10.1038/mt.2015.1; Carrio M, 2002, J GENE MED, V4, P141, DOI 10.1002/jgm.247; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chawla SP, 2010, MOL THER, V18, P435, DOI 10.1038/mt.2009.228; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Craig C, 1998, ONCOGENE, V16, P265, DOI 10.1038/sj.onc.1201493; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; DeSelm C. J., 2017, J SURG ONCOL, DOI [10.1002/jso.2462728346697, DOI 10.1002/jso.2462728346697]; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Doody AM, 2006, J CONTROL RELEASE, V116, P227, DOI 10.1016/j.jcornel.2006.07.019; Drew Y, 2011, J NATL CANCER I, V103, P334, DOI 10.1093/jnci/djq509; Ducreux M, 2007, SEMIN ONCOL, V34, pS25, DOI 10.1053/j.seminoncol.2007.01.006; Erbs P, 2000, CANCER RES, V60, P3813; Fogar P, 2003, EUR J SURG ONCOL, V29, P721, DOI 10.1016/j.ejso.2003.08.001; Fogar P, 2007, PANCREAS, V35, P224, DOI 10.1097/mpa.0b013e3180622519                                                    ; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forrest ML, 2004, PHARM RES, V21, P365, DOI 10.1023/B:PHAM.0000016251.42392.1e; Galanis E, 2008, MOL THER, V16, P979, DOI 10.1038/mt.2008.29; Gayral M, 2015, HUM GENE THER, V26, P104, DOI 10.1089/hum.2014.072; Geletneky K, 2015, COMPARATIVE MED, V65, P36; Geletneky K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-99; Gilly FN, 1999, HEPATO-GASTROENTEROL, V46, P1268; Gjertsen MK, 2001, INT J CANCER, V92, P441, DOI 10.1002/ijc.1205; Golan T, 2015, ONCOTARGET, V6, P24560, DOI 10.18632/oncotarget.4183; Gordon EM, 2004, INT J ONCOL, V24, P177; Greco Eliana, 2002, Pancreas, V25, pe21, DOI 10.1097/00006676-200208000-00020; Green NK, 1997, CANCER GENE THER, V4, P229; Grove JI, 1999, ANTI-CANCER DRUG DES, V14, P461; Gupta S, 2010, PANCREATOLOGY, V10, P565, DOI 10.1159/000317254; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Hahn SA, 1998, DIGESTION, V59, P493, DOI 10.1159/000007526                                                               ; Hanna N, 2012, CANCER GENE THER, V19, P374, DOI 10.1038/cgt.2012.10; Hanoun N, 2016, HUM GENE THER, V27, P184, DOI 10.1089/hum.2015.151; Hardacre JM, 2013, J GASTROINTEST SURG, V17, P94, DOI 10.1007/s11605-012-2064-6; Hecht JR, 2012, GASTROINTEST ENDOSC, V75, P332, DOI 10.1016/j.gie.2011.10.007; Hecht JR, 2003, CLIN CANCER RES, V9, P555; Herman JM, 2013, J CLIN ONCOL, V31, P886, DOI 10.1200/JCO.2012.44.7516; Hill R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.307; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X                                                   ; Huang F, 2016, WORLD J GASTROENTERO, V22, P7999, DOI 10.3748/wjg.v22.i35.7999; Huang Z., 2017, GENE THER, DOI [10.1038/gt.2017.3528471431, DOI 10.1038/GT.2017.3528471431]; Husseini F, 2017, ANN ONCOL, V28, P169, DOI 10.1093/annonc/mdw440; Ilkow CS, 2015, NAT MED, V21, P530, DOI 10.1038/nm.3848; Johansson H, 2016, WORLD J GASTROENTERO, V22, P9457, DOI 10.3748/wjg.v22.i43.9457; Johnson BA, 2017, CLIN CANCER RES, V23, P1656, DOI 10.1158/1078-0432.CCR-16-2318; Joshi US, 1998, PANCREAS, V16, P107, DOI 10.1097/00006676-199803000-00001                                                ; Katz MH, 2003, ANN SURG ONCOL, V10, P762, DOI 10.1245/ASO.2003.01.021; Kaufman HL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-60; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kimura M, 1998, CANCER LETT, V128, P47, DOI 10.1016/S0304-3835(98)00050-0                                                   ; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Kobayashi S, 1999, CLIN CANCER RES, V5, P4182; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Kubuschok B, 2012, HUM GENE THER, V23, P1224, DOI 10.1089/hum.2011.153; Kudrin A, 2012, HUM VACC IMMUNOTHER, V8, P1335, DOI 10.4161/hv.20518; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Laheru D, 2008, CLIN CANCER RES, V14, P1455, DOI 10.1158/1078-0432.CCR-07-0371; Le DT, 2015, J CLIN ONCOL, V33, P1325, DOI 10.1200/JCO.2014.57.4244; Le DT, 2013, J IMMUNOTHER, V36, P382, DOI 10.1097/CJI.0b013e31829fb7a2; Le DT, 2012, CLIN CANCER RES, V18, P858, DOI 10.1158/1078-0432.CCR-11-2121; Liu LH, 2012, ONCOL REP, V27, P1497, DOI 10.3892/or.2012.1663; Liu SX, 2014, WORLD J GASTROENTERO, V20, P13343, DOI 10.3748/wjg.v20.i37.13343; Lohr J Matthias, 2014, Pharmaceutics, V6, P447, DOI 10.3390/pharmaceutics6030447; Lohr M, 1998, GENE THER, V5, P1070, DOI 10.1038/sj.gt.3300671; Lohr M, 2001, LANCET, V357, P1591, DOI 10.1016/S0140-6736(00)04749-8; Lortal B, 2009, CANCER GENE THER, V16, P329, DOI 10.1038/cgt.2008.88; Lucas T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117254; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Maki RG, 2007, DIGEST DIS SCI, V52, P1964, DOI 10.1007/s10620-006-9205-2; Mazzolini G, 2005, J CLIN ONCOL, V23, P999, DOI 10.1200/JCO.2005.00.463; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Mohammed S, 2017, MOL THER, V25, P249, DOI 10.1016/j.ymthe.2016.10.016; Morioka CY, 2005, IN VIVO, V19, P535; Mout R, 2017, BIOCONJUGATE CHEM, V28, P880, DOI 10.1021/acs.bioconjchem.7b00057; Mulvihlll S, 2001, GENE THER, V8, P308, DOI 10.1038/sj.gt.3301398; Murugesan SR, 2009, CANCER GENE THER, V16, P841, DOI 10.1038/cgt.2009.32; Nakao A, 2011, CANCER GENE THER, V18, P167, DOI 10.1038/cgt.2010.65; Nayerossadat Nouri, 2012, Adv Biomed Res, V1, P27, DOI 10.4103/2277-9175.98152; Noonan AM, 2016, MOL THER, V24, P1150, DOI 10.1038/mt.2016.66; O'Hara M, 2016, IMMUNOTHERAPY-UK, V8, P449, DOI 10.2217/imt.16.4; Ogawa T, 2002, CANCER GENE THER, V9, P633, DOI 10.1038/sj.cgt.7700478; Oskuee RK, 2009, J GENE MED, V11, P921, DOI 10.1002/jgm.1374; Pecher G, 2002, CANCER IMMUNOL IMMUN, V51, P669, DOI 10.1007/s00262-002-0317-z; Plate JMD, 2012, DISCOV MED, V14, P89; Pol J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28694; Pol J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28185; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ravet E, 2010, CANCER GENE THER, V17, P315, DOI 10.1038/cgt.2009.79; Rejiba S, 2007, CANCER SCI, V98, P1128, DOI 10.1111/j.1349-7006.2007.00506.x; Rejiba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070594; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rigg AS, 2001, CANCER GENE THER, V8, P869, DOI 10.1038/sj.cgt.7700387; Riley MK, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7050094; Rochaix P, 1999, HUM GENE THER, V10, P995, DOI 10.1089/10430349950018391; Rong YF, 2012, CLIN EXP MED, V12, P173, DOI 10.1007/s10238-011-0159-0; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Salmons B, 2003, J GASTROENTEROL, V38, P78; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Senzer N, 2004, J CLIN ONCOL, V22, P592, DOI 10.1200/JCO.2004.01.227; Seo YD, 2017, CANCER GENE THER, V24, P106, DOI 10.1038/cgt.2016.66; Shan YF, 2013, PANCREATOLOGY, V13, P393, DOI 10.1016/j.pan.2013.05.012; Shen W, 2008, WORLD J GASTROENTERO, V14, P6254, DOI 10.3748/wjg.14.6254; Shen YM, 2008, WORLD J GASTROENTERO, V14, P5176, DOI 10.3748/wjg.14.5176; Sicard F, 2013, MOL THER, V21, P986, DOI 10.1038/mt.2013.35; Sideras K, 2014, CANCER TREAT REV, V40, P513, DOI 10.1016/j.ctrv.2013.11.005; Song M., 2017, BIOTECHNOL PROGR, DOI [10.1002/btpr.248428440027, DOI 10.1002/BTPR.248428440027]; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Thorne B., 2017, ADV BIOCHEM ENG BIOT, DOI [10.1007/10_2016_53, DOI 10.1007/10_2016_53]; Touchefeu Y, 2010, ALIMENT PHARM THER, V32, P953, DOI 10.1111/j.1365-2036.2010.04424.x; Tysome JR, 2009, GENE THER, V16, P1223, DOI 10.1038/gt.2009.74; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Vassaux G, 2016, HUM GENE THER, V27, P127, DOI 10.1089/hum.2015.141; Vernejoul F, 2002, CANCER RES, V62, P6124; von Ahrens D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0448-5; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang J, 2004, WORLD J GASTROENTERO, V10, P400; Wang WQ, 2016, BRIT J SURG, V103, P1189, DOI 10.1002/bjs.10187; Wennier S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001876; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xu C, 2013, CANCER LETT, V333, P1, DOI 10.1016/j.canlet.2013.01.035; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Zhang XF, 2007, CLIN CANCER RES, V13, P3968, DOI 10.1158/1078-0432.CCR-07-0245	146	1	1	7	7	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JUN	2017	18	6							1231	10.3390/ijms18061231				25	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	EZ3AF	WOS:000404581500130		gold			2018-01-05	
J	Merk, K; Breinig, M; Bottcher, R; Krebs, S; Blum, H; Boutros, M; Forstemann, K				Merk, Karin; Breinig, Marco; Boettcher, Romy; Krebs, Stefan; Blum, Helmut; Boutros, Michael; Foerstemann, Klaus			Splicing stimulates siRNA formation at Drosophila DNA double-strand breaks	PLOS GENETICS			English	Article							DEPENDENT RNA-POLYMERASE; HEPATITIS-DELTA-VIRUS; HOMOLOGOUS RECOMBINATION; GENOME INSTABILITY; REPETITIVE DNA; FISSION YEAST; ENDO-SIRNAS; GENE LISTS; REPAIR; DAMAGE	DNA double-strand breaks trigger the production of locus-derived siRNAs in fruit flies, human cells and plants. At least in flies, their biogenesis depends on active transcription running towards the break. Since siRNAs derive from a double-stranded RNA precursor, a major question is how broken DNA ends can generate matching sense and antisense transcripts. We performed a genome-wide RNAi-screen in cultured Drosophila cells, which revealed that in addition to DNA repair factors, many spliceosome components are required for efficient siRNA generation. We validated this observation through site-specific DNA cleavage with CRISPR-cas9 followed by deep sequencing of small RNAs. DNA breaks in intron-less genes or upstream of a gene's first intron did not efficiently trigger siRNA production. When DNA double-strand breaks were induced downstream of an intron, however, this led to robust siRNA generation. Furthermore, a downstream break slowed down splicing of the upstream intron and a detailed analysis of siRNA coverage at the targeted locus revealed that unspliced pre-mRNA contributes the sense strand to the siRNA precursor. Since splicing factors are stimulating the response but unspliced transcripts are entering the siRNA biogenesis, the spliceosome is apparently stalled in a pre-catalytic state and serves as a signaling hub. We conclude that convergent transcription at DNA breaks is stimulated by a splicing dependent control process. The resulting double-stranded RNA is converted into siRNAs that instruct the degradation of cognate mRNAs. In addition to a potential role in DNA repair, the break-induced transcription may thus be a means to cull improper RNAs from the transcriptome of Drosophila melanogaster. Since the splicing factors identified in our screen also stimulated siRNA production from high copy transgenes, it is possible that this surveillance mechanism serves in genome defense beyond DNA double-strand breaks.	[Merk, Karin; Boettcher, Romy; Foerstemann, Klaus] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Merk, Karin; Boettcher, Romy; Foerstemann, Klaus] Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany; [Breinig, Marco; Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, Neuenheimer Feld 580, Heidelberg, Germany; [Breinig, Marco; Boutros, Michael] Heidelberg Univ, Neuenheimer Feld 580, Heidelberg, Germany; [Krebs, Stefan; Blum, Helmut] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany	Forstemann, K (reprint author), Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany.; Forstemann, K (reprint author), Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany.	Foerstemann@lmb.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [SFB646/TPA13]; DFG DRiC grant	This work was supported by grant SFB646/TPA13 from the Deutsche Forschungsgemeinschaft (DFG) to KF. The work in the lab of MB was in part supported by a DFG DRiC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bayne EH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0481-4; Bottcher R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku289; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elmer K, 2014, METHODS MOL BIOL, V1173, P33, DOI 10.1007/978-1-4939-0931-5_4; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Gaillard H, 2013, BBA-GENE REGUL MECH, V1829, P141, DOI 10.1016/j.bbagrm.2012.09.008; Gao M, 2014, CELL RES, V24, P532, DOI 10.1038/cr.2014.36; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hur JK, 2016, GENE DEV, V30, P840, DOI 10.1101/gad.276030.115; Kallgren SP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004334; KONARSKA MM, 1990, CELL, V63, P609, DOI 10.1016/0092-8674(90)90456-O; Kraus A, 2016, PURINERG SIGNAL, V12, P687, DOI 10.1007/s11302-016-9532-5; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/VI.79.13.7951-7958.2005; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone CD, 2014, GENE DEV, V28, P1786, DOI 10.1101/gad.245829.114; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Michalik KM, 2012, NUCLEIC ACIDS RES, V40, P9596, DOI 10.1093/nar/gks711; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Ohsawa Ryosuke, 2013, Frontiers in Genetics, V4, P136, DOI 10.3389/fgene.2013.00136; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Pankotai Tibor, 2013, Transcription, V4, P34, DOI 10.4161/trns.22879; RACKWITZ HR, 1981, NATURE, V291, P297, DOI 10.1038/291297a0; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rong M, 1998, J BIOL CHEM, V273, P10253, DOI 10.1074/jbc.273.17.10253                                                        ; Schmidts I, 2016, NUCLEIC ACIDS RES, V44, P8261, DOI 10.1093/nar/gkw570; Shah C, 2008, BBA-GENE REGUL MECH, V1779, P766, DOI 10.1016/j.bbagrm.2008.06.008; Shkreta L, 2015, BIOMOLECULES, V5, P2935, DOI 10.3390/biom5042935; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Tseng CH, 2009, VIRUSES-BASEL, V1, P818, DOI 10.3390/v1030818; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Volanakis A, 2013, GENE DEV, V27, P2025, DOI 10.1101/gad.221960.113; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wickramasinghe VO, 2016, MOL CELL, V61, P496, DOI 10.1016/j.molcel.2016.02.001; Xiong XP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005475; Xiong XP, 2013, P NATL ACAD SCI USA, V110, P16520, DOI 10.1073/pnas.1315803110; Yang QY, 2015, GENE DEV, V29, P526, DOI 10.1101/gad.255828.114; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030; Zhang ZY, 2014, J BIOL CHEM, V289, P9365, DOI 10.1074/jbc.M113.528521; Zhang ZY, 2013, GENE DEV, V27, P145, DOI 10.1101/gad.209494.112	54	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	JUN	2017	13	6							e1006861	10.1371/journal.pgen.1006861				22	Genetics & Heredity	Genetics & Heredity	EZ2AQ	WOS:000404512600038	28628606	gold			2018-01-05	
J	Li, JH; Shen, WZ; Gu, XQ; Hong, WK; Wang, ZQ				Li, Jun-Hua; Shen, Wei-Zhong; Gu, Xiao-Qing; Hong, Wei-Kang; Wang, Zhi-Qiang			Prognostic value of EUS combined with MSCT in predicting the recurrence and metastasis of patients with gastric cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						endoscopic ultrasonography; fragile histidine triad; gastric cancer; metastasis; multi-slice computed tomography; prognosis; recurrence	FHIT PROTEIN; ENDOSCOPIC ULTRASONOGRAPHY; DISEASE PROGRESSION; CARCINOMA; EXPRESSION; HETEROZYGOSITY; ACCURACY; EDITION; GENE; CT	Objective: This study aims to explore the prognostic value of endoscopic ultrasonography combined with multi-slice spiral computed tomography in predicting the recurrence and metastasis of gastric cancer, as well as investigate the correlation of fragile histidine triad protein expression with the tumor node metastasis stage of gastric cancer patients. Methods: A total of 81 gastric cancer patients were selected in our study. All patients were examined by endoscopic ultrasonography and multi-slice spiral computed tomography before operation, and gastric cancer tissues and adjacent normal tissues were obtained after operation. Immunohistochemistry was performed to detect fragile histidine triad expression. All patients were followed up for 3 years after operation. Univariate and multivariate analysis of risk factors were conducted for the prognosis of gastric cancer patients. Results: Endoscopic ultrasonography combined with multi-slice spiral computed tomography could increase the accuracy of preoperative tumor node metastasis stage of gastric cancer patients. In gastric cancer tissues, fragile histidine triad expression was mostly weakly positive with a positive rate of 60.5%. In gastric cancer adjacent normal tissues, the positive fragile histidine triad expression was mostly moderate with a positive rate of 79.0%. The fragile histidine triad expression was negatively correlated with tumor node metastasis stage of gastric cancer patients. The fragile histidine triad expression decreased along with the increase of T-stage, N-stage and M-stage of gastric cancer patients. Univariate and multivariate analysis showed that T-stage and N-stage were risk factors for the recurrence/metastasis and 3-year mortality of gastric cancer patients, while fragile histidine triad expression was a protective factor. Conclusion: Our study demonstrated that endoscopic ultrasonography combined with multi-slice spiral computed tomography may be more accurate in assessing the preoperative tumor node metastasis stage of gastric cancer patients.	[Li, Jun-Hua; Shen, Wei-Zhong; Gu, Xiao-Qing] Jiangsu Shengze Hosp, Dept Radiol, Suzhou, Peoples R China; [Hong, Wei-Kang] Jiangsu Shengze Hosp, Dept Gastroenterol, Suzhou, Peoples R China; [Wang, Zhi-Qiang] Xiangnan Univ, Dept Med Imaging, 25 Renmin West Rd, Chenzhou 423000, Hunan Province, Peoples R China	Wang, ZQ (reprint author), Xiangnan Univ, Dept Med Imaging, 25 Renmin West Rd, Chenzhou 423000, Hunan Province, Peoples R China.	zhiqiangwang0815@163.com					Boylston JA, 2014, CELL CYCLE, V13, P2913, DOI 10.4161/15384101.2014.946858; Cardoso R, 2012, GASTRIC CANCER, V15, pS19, DOI 10.1007/s10120-011-0115-4; Chowers I, 1998, BRIT J OPHTHALMOL, V82, P1316, DOI 10.1136/bjo.82.11.1316                                                          ; Gatalica Z, 2000, CANCER, V88, P1378, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1378::AID-CNCR15>3.3.CO;2-9; Golosio B, 2009, MED PHYS, V36, P3607, DOI 10.1118/1.3160107; Hara K, 2011, DIGEST ENDOSC, V23, P26, DOI 10.1111/j.1443-1661.2011.01137.x; Hu BC, 2014, CANCER RES, V74, P2283, DOI 10.1158/0008-5472.CAN-13-3279; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Lee YT, 2005, GUT, V54, P1541, DOI 10.1136/gut.2004.055772; Marrelli D, 2007, ANN SURG ONCOL, V14, P25, DOI 10.1245/s10434-006-9063-3; Meyer Lutz, 2012, Pol Przegl Chir, V84, P152, DOI 10.2478/v10035-012-0024-1; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Park JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003955; Rocco A, 2003, J CANCER RES CLIN, V129, P84, DOI 10.1007/s00432-002-0409-3; Shirahata A, 2010, ANTICANCER RES, V30, P3441; Rabelo RAS, 2013, CLIN EXP OBSTET GYN, V40, P89; Takao M, 1998, J COMPUT ASSIST TOMO, V22, P288, DOI 10.1097/00004728-199803000-00024                                                ; Yang QF, 2002, CLIN CANCER RES, V8, P2890; Yin DT, 2010, INT J CLIN EXP PATHO, V3, P482; Yoo CH, 1999, WORLD J SURG, V23, P492, DOI 10.1007/PL00012337                                                              	21	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2017	47	6					487	493		10.1093/jjco/hyx024				7	Oncology	Oncology	EY5VP	WOS:000404049000003	28334806				2018-01-05	
J	Tangprasertchai, NS; Di Felice, R; Zhang, XJ; Slaymaker, IM; Reyes, CV; Jiang, W; Rohs, R; Qin, PZ				Tangprasertchai, Narin S.; Di Felice, Rosa; Zhang, Xiaojun; Slaymaker, Ian M.; Reyes, Carolina Vazquez; Jiang, Wei; Rohs, Remo; Qin, Peter Z.			CRISPR-Cas9 Mediated DNA Unwinding Detected Using Site-Directed Spin Labeling	ACS CHEMICAL BIOLOGY			English	Article							GUIDED ENDONUCLEASE CAS9; TARGET DNA; CRYSTAL-STRUCTURE; RNA; CLEAVAGE; COMPLEX; RECOGNITION; SPECIFICITY; IMMUNITY; INTERROGATION	The RNA-guided CRISPR-Cas9 nuclease has revolutionized genome engineering, yet its mechanism for DNA target selection is not fully understood. A crucial step in Cas9 target recognition involves unwinding of the DNA duplex to form a three-stranded R-loop structure. Work reported here demonstrates direct detection of Cas9-mediated DNA unwinding by a combination of site-directed spin labeling and molecular dynamics simulations. The results support a model in which the unwound nontarget strand is stabilized by a positively charged patch located between the two nuclease domains of Cas9 and reveal uneven increases in flexibility along the unwound nontarget strand upon scissions of the DNA backbone. This work establishes the synergistic combination of spin-labeling and molecular dynamics to directly monitor Cas9-mediated DNA conformational changes and yields information on the target DNA in different stages of Cas9 function, thus advancing mechanistic understanding of CRISPRCas9 and aiding future technological development.	[Tangprasertchai, Narin S.; Zhang, Xiaojun; Reyes, Carolina Vazquez; Jiang, Wei; Rohs, Remo; Qin, Peter Z.] Univ Southern Calif, Dept Chem, Los Angeles, CA 90089 USA; [Di Felice, Rosa; Rohs, Remo] Univ Southern Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA; [Di Felice, Rosa; Rohs, Remo; Qin, Peter Z.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Di Felice, Rosa] CNR, Inst Nanosci, Ctr S3, Via Campi 213-A, I-41125 Modena, Italy; [Slaymaker, Ian M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Qin, PZ (reprint author), Univ Southern Calif, Dept Chem, Los Angeles, CA 90089 USA.; Qin, PZ (reprint author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	pzq@usc.edu			National Science Foundation [CHE-1213673]; National Institutes of Health [RR028992, R01GM106056, U01GM103804]; NVIDIA Corp.; Simons Center for the Social Brain	We thank L. Chen for help and advice on Cas9 expression and purification. Research reported was supported in part by the National Science Foundation (P.Z.Q, CHE-1213673), the National Institutes of Health (P.Z.Q, RR028992; R.R., R01GM106056 and U01GM103804), and the NVIDIA Corp. I.M.S. is supported by the Simons Center for the Social Brain.	Anders C, 2014, METHOD ENZYMOL, V546, P1, DOI 10.1016/B978-0-12-801185-0.00001-5; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding Y., 2015, ELECT PARAMAGNETIC R, P122; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Josephs EA, 2015, NUCLEIC ACIDS RES, V43, P8924, DOI 10.1093/nar/gkv892; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Popova AM, 2009, BIOCHEMISTRY-US, V48, P8540, DOI 10.1021/bi900860w; Qin PZ, 2007, NAT PROTOC, V2, P2354, DOI 10.1038/nprot.2007.308; Vazquez Reyes C, 2016, CELL BIOCH BIOPHYS, P1; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tangprasertchai NS, 2015, METHOD ENZYMOL, V564, P427, DOI 10.1016/bs.mie.2015.07.007; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	31	1	1	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	JUN	2017	12	6					1489	1493		10.1021/acschembio.6b01137				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EY3EI	WOS:000403854000008	28437608				2018-01-05	
J	Brachova, P; Alvarez, NS; Van Voorhis, BJ; Christenson, LK				Brachova, Pavia; Alvarez, Nehemiah S.; Van Voorhis, Bradley J.; Christenson, Lane K.			Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid	GYNECOLOGIC ONCOLOGY			English	Article						Follicular fluid; Fallopian tube; Apobec; Ovulation; DNA damage; Ovarian cancer	SEROUS OVARIAN-CANCER; HUMAN PROTEIN ATLAS; INTRAEPITHELIAL CARCINOMA; TP53 MUTATIONS; OVULATION; TUBE; CELLS; CARCINOGENESIS; INFLAMMATION; PRECURSOR	Objective. Ovarian carcinomas that originate from fallopian epithelial cells are suggested to arise due to repeated exposure to ovulatory follicular fluid (FF). Mechanistic explanation(s) for how this occurs are unknown. Here, we sought to understand if FF exposure to fallopian epithelial cells could induce DNA damage and expression of a known family of DNA mutators, apolipoprotein B mRNA editing enzyme, catalytic polypeptide (APOBEC) cytidine deaminases. Methods. Follicular fluid and matched patient plasma samples were obtained from donors. Fallopian epithelial cells (FT33-TAg, FT189, FT190, and FT194) were cultured with FF or plasma for 24 h, and cell proliferation and DNA damage were assessed. Effects of FF on Apobec gene expression were determined by qRT-PCR and western blot analyses. Fallopian epithelial cells were transfected with an APOBEC3A expression vector and DNA damage was assessed. Results. Follicular fluid exposure increased epithelial cell proliferation as measured by three independent methods, and DNA damage accumulation as assessed using three independent measures. This effect was specific to FF, as matched patient plasma did not have the same effects. Increased expression of Apobec3a was observed in fallopian epithelial cells following exposure to 5 of 8 patient FF samples, and transient overexpression of APOBEC3A was sufficient to induce double strand DNA breaks. Conclusions. Follicular fluid can induce cell proliferation and DNA damage accumulation in cultured fallopian epithelial cells. Increased expression of APOBEC3A, a known DNA mutator, may explain the high incidence of DNA damage after FF exposure. The role of Apobec3a in ovulation-induced inflammation warrants further investigation. (C) 2017 Elsevier Inc. All rights reserved.	[Brachova, Pavia; Christenson, Lane K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Alvarez, Nehemiah S.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Van Voorhis, Bradley J.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	Christenson, LK (reprint author), 3075 HLSIC,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	pbrachova@kumc.edu; nalvarez@kumc.edu; brad-van-voorhis@uiowa.edu; lchristenson@kumc.edu			NIH [HD082484]; NCI University of Kansas Cancer Center [P30 CA168524]; Lalor Foundation Postdoctoral Fellowship;  [F32CA200357]	This work was supported by NIH HD082484 (LKC) and a pilot project (LKC) from the NCI P30 CA168524 University of Kansas Cancer Center, a Lalor Foundation Postdoctoral Fellowship and F32CA200357 training grant (PB). The funding agencies had no involvement in study design, collection, analysis and interpretation of data, writing of the report, or the decision to submit the paper for publication.	Arumugam A, 2012, STEROIDS, V77, P791, DOI 10.1016/j.steroids.2012.03.009; Auersperg N, 2008, GYNECOL ONCOL, V110, P452, DOI 10.1016/j.ygyno.2008.05.031; Bahar-Shany K, 2014, GYNECOL ONCOL, V132, P322, DOI 10.1016/j.ygyno.2013.12.015; Buscher U, 1999, HUM REPROD, V14, P162, DOI 10.1093/humrep/14.1.162                                                         ; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; Chien J, 2015, NUCLEIC ACIDS RES, V43, P6945, DOI 10.1093/nar/gkv111; Cookingham LM, 2015, J ASSIST REPROD GEN, V32, P737, DOI 10.1007/s10815-015-0447-9; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f                                                    ; de los Santos MJ, 2013, HUM REPROD, V28, P224, DOI 10.1093/humrep/des349; Emori MM, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-60; Fathalla MF, 2013, FACTS VIEWS VIS OBGY, V5, P292; FATHALLA MF, 1971, LANCET, V2, P163; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Huang H. S., 2015, CARCINOGENESIS; Huang WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27471; Kampf C, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-103; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; King SM, 2011, ENDOCR-RELAT CANCER, V18, P627, DOI 10.1530/ERC-11-0107; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lau A, 2014, EXP BIOL MED, V239, P24, DOI 10.1177/1535370213508216; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Lepej SZ, 2003, REPROD FERT DEVELOP, V15, P423, DOI 10.1071/RD03020; Narvaiza I, 2012, CELL CYCLE, V11, P33, DOI 10.4161/cc.11.1.18706; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Sapoznik S, 2016, NEOPLASIA, V18, P90, DOI 10.1016/j.neo.2015.12.003; Schmitt K, 2013, VIROLOGY, V442, P82, DOI 10.1016/j.virol.2013.04.002; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tu WZ, 2013, FEBS LETT, V587, P3437, DOI 10.1016/j.febslet.2013.08.028; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Zamah AM, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9077-6	39	1	1	4	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	JUN	2017	145	3					577	583		10.1016/j.ygyno.2017.02.017				7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	EY4WE	WOS:000403977500026	28215840				2018-01-05	
J	Schmidt, ST; Zimmerman, SM; Wang, JB; Kini, SK; Quake, SR				Schmidt, Stephanie Tzouanas; Zimmerman, Stephanie M.; Wang, Jianbin; Kini, Stuart K.; Quake, Stephen R.			Quantitative Analysis of Synthetic Cell Lineage Tracing Using Nuclease Barcoding	ACS SYNTHETIC BIOLOGY			English	Article						DNA barcoding; lineage tracing; CRISPR/Cas9	NEMATODE CAENORHABDITIS-ELEGANS; CLONAL DYNAMICS; STEM-CELLS; TRACKING; HEMATOPOIESIS; INJECTION	Lineage tracing by the determination and mapping of progeny arising from single cells is an important approach enabling the elucidation of mechanisms underlying diverse biological processes ranging from development to disease. We developed a dynamic sequence-based barcode system for synthetic lineage tracing and have demonstrated its performance in C. elegans, a model organism whose lineage tree is well established. The strategy we use creates lineage trees based upon the introduction of synthetically controlled mutations into cells and the propagation of these. mutations to daughter cells at each cell division. We analyzed this experimental proof of concept along with a corresponding simulation and analytical model to gain a deeper understanding of the coding capacity of the system. Our results provide specific bounds on the fidelity of lineage tracing using such approaches.	[Schmidt, Stephanie Tzouanas; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zimmerman, Stephanie M.; Kini, Stuart K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kini, Stuart K.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Chan Zuckerberg Biohub, San Francisco, CA 94518 USA	Quake, SR (reprint author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Quake, SR (reprint author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Quake, SR (reprint author), Chan Zuckerberg Biohub, San Francisco, CA 94518 USA.	quake@stanford.edu			NIH [P40 OD010440]; Fannie and John Hertz Foundation; National Science Foundation; Gabilan Stanford Graduate Fellowship; National Heart, Lung, and Blood Institute (NHLBI) [U0IHL099995]	We thank Robert Phillips, John Beausang, and Winston Koh for helpful discussions; Norma Neff and Gary Mantalas for assistance with sequencing; and Ben Passarelli, Derek Croote, and Mark Kowarsky for computing support. C. elegans strains were provided by the University of Minnesota's Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). STS is supported by the Fannie and John Hertz Foundation Fellowship, National Science Foundation Graduate Research Fellowship, and Gabilan Stanford Graduate Fellowship. This work was supported by a National Heart, Lung, and Blood Institute (NHLBI) U0IHL099995 Progenitor Cell Biology Consortium Grant (STS, JW, SRQ).	Ahringer J., 2006, REVERSE GENETICS, DOI [10.1895/wormbook.1.47.1, DOI 10.1895/WORMBOOK.1.47.1]; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6                                                   ; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Bolker B., 2010, PHYLOBASE BASE PACKA; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen CH, 2016, DEV CELL, V36, P668, DOI 10.1016/j.devcel.2016.02.017; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cover T., 2006, ELEMENTS INFORM THEO; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376                                                           ; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Durbin R., 2005, BIOL SEQUENCE ANAL; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Frumkin D, 2008, CANCER RES, V68, P5924, DOI 10.1158/0008-5472.CAN-07-6216; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reizel Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002477; Reizel Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002192; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shakhnarovich D., 2006, NEAREST NEIGHBOR MET; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shlush LI, 2012, BLOOD, V120, P603, DOI 10.1182/blood-2011-10-388629; Sneath P. H., 1973, NUMERICAL TAXONOMY P; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Van Rijsbergen C. J., 1979, INFORM RETRIEVAL; Vogt W., 1929, DES GENES EVOL, V120, P384; Walther V, 2016, WIRES DEV BIOL, V5, P103, DOI 10.1002/wdev.203; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; WEISBLAT DA, 1978, SCIENCE, V202, P1295, DOI 10.1126/science.725606; Wilson H. V., 1891, EMBRYOLOGY SEA BASS; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020	44	3	3	10	10	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUN	2017	6	6					936	942		10.1021/acssynbio.6b00309				7	Biochemical Research Methods	Biochemistry & Molecular Biology	EY3IN	WOS:000403864900003	28264564				2018-01-05	
J	Van Hove, B; Guidi, C; De Wannemaeker, L; Maertens, J; De Mey, M				Van Hove, Bob; Guidi, Chiara; De Wannemaeker, Lien; Maertens, Jo; De Mey, Marjan			Recursive DNA Assembly Using Protected Oligonucleotide Duplex Assisted Cloning (PODAC)	ACS SYNTHETIC BIOLOGY			English	Article						molecular cloning; DNA assembly; recursive cloning; pathway assembly; CRISPR; Golden Gate cloning	SYNTHETIC BIOLOGY; VIOLACEIN; BIOSYNTHESIS; PATHWAYS; CIRCUITS; STANDARD; PROVIDES; PARTS	A problem rarely tackled by current DNA assembly methods is the issue of cloning additional parts into an already assembled construct. Costly PCR workflows are often hindered by repeated sequences, and restriction based strategies impose design constraints for each enzyme used. Here we present Protected Oligonucleotide Duplex Assisted Cloning (PODAC), a novel technique that makes use of an oligonucleotide duplex for iterative Golden Gate cloning using only one restriction enzyme. Methylated bases confer protection from digestion during the assembly reaction and are removed during replication in vivo, unveiling a new cloning site in the process. We used this method to efficiently and accurately assemble a biosynthetic pathway and demonstrated its robustness toward sequence repeats by constructing artificial CRISPR arrays. As PODAC is readily amenable to standardization, it would make a useful addition to the synthetic biology toolkit.	[Van Hove, Bob; Guidi, Chiara; De Wannemaeker, Lien; Maertens, Jo; De Mey, Marjan] Univ Ghent, Dept Biochem & Microbial Technol, Ctr Synthet Biol, B-9000 Ghent, Belgium	De Mey, M (reprint author), Univ Ghent, Dept Biochem & Microbial Technol, Ctr Synthet Biol, B-9000 Ghent, Belgium.	marjan.demey@ugent.be			Fund for Scientific Research Flanders (FWO) [G.0321.13N]; Ghent University Special Research Fund (BOF) [BOF16/IOP/040]	The authors thank the Fund for Scientific Research Flanders (FWO) for support in the form of the projects G.0321.13N and a Ph.D. grant for the first author, as well as the Ghent University Special Research Fund (BOF) for the IOP project BOF16/IOP/040.	Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Colloms SD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1101; Coussement P, 2014, METAB ENG, V23, P70, DOI 10.1016/j.ymben.2014.02.012; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Duran N, 2007, BIOTECHNOL APPL BIOC, V48, P127, DOI 10.1042/BA20070115; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Galdzicki M, 2014, NAT BIOTECHNOL, V32, P545, DOI 10.1038/nbt.2891; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hommelsheim CM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05052; Jones JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11301; Knight T. F., 2003, REGISTRY STANDARD BI; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; MacConkey A, 1905, J HYG-CAMBRIDGE, V5, P333, DOI 10.1017/S002217240000259X                                                       ; Moore SJ, 2016, ACS SYNTH BIOL, V5, P1059, DOI 10.1021/acssynbio.6b00031; Mutalik V. K., 2013, NAT METHODS, V10, P1; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5245, DOI 10.1021/bi015687u; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Storch M, 2015, ACS SYNTH BIOL, V4, P781, DOI 10.1021/sb500356d; Torella JP, 2014, NUCLEIC ACIDS RES, V42, P681, DOI 10.1093/nar/gkt860; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Wang XY, 2016, ACS CHEM BIOL, V11, P444, DOI 10.1021/acschembio.5b00867; Warren DJ, 2011, ANAL BIOCHEM, V413, P206, DOI 10.1016/j.ab.2011.02.036; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	34	0	0	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUN	2017	6	6					943	949		10.1021/acssynbio.7b00017				7	Biochemical Research Methods	Biochemistry & Molecular Biology	EY3IN	WOS:000403864900004	28320206				2018-01-05	
J	Xiong, X; Zhang, YX; Yan, J; Jain, S; Chee, S; Ren, B; Zhao, HM				Xiong, Xiong; Zhang, Yanxiao; Yan, Jian; Jain, Surbhi; Chee, Sora; Ren, Bing; Zhao, Huimin			A Scalable Epitope Tagging Approach for High Throughput ChIP-Seq Analysis	ACS SYNTHETIC BIOLOGY			English	Article						ChIP-Seq; microhomology mediated end joining; CRISPR/Cas9; genome engineering; FLAG tagging	DOUBLE-STRAND BREAKS; TRANSCRIPTION FACTOR; ENDOGENOUS PROTEINS; CRISPR-CAS9 SYSTEM; COLON-CANCER; C-MYC; DNA; GENOME; BINDING; CELLS	Eukaryotic transcriptional factors (TFs) typically recognize short genomic sequences alone or together with other proteins to modulate gene expression. Mapping of TF-DNA interactions in the genome is crucial for understanding the gene regulatory programs in cells. While chromatin immunoprecipitation followed by sequencing (ChIP-Seq) is commonly used for this purpose, its application is severely limited by the availability of suitable antibodies for TFs. To overcome this limitation, we developed an efficient and scalable strategy named cmChIP-Seq that combines the clustered regularly interspaced short palindromic repeats (CRISPR) technology with microhomology mediated end joining (MMEJ) to genetically engineer a TF with an epitope tag. We demonstrated the utility of this tool by applying it to four TFs in a human colorectal cancer cell line. The highly scalable procedure makes this strategy ideal for ChIP-Seq analysis of TFs in diverse species and cell types.	[Xiong, Xiong; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Zhang, Yanxiao; Yan, Jian; Ren, Bing] Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Jain, Surbhi] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Chee, Sora; Ren, Bing] Univ Calif San Diego, Inst Genome Med, Moores Canc Ctr, Dept Cellular & Mol Med,Sch Med, San Diego, CA 92093 USA; [Zhao, Huimin] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA; [Yan, Jian] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Zhao, HM (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.; Ren, B (reprint author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Ren, B (reprint author), Univ Calif San Diego, Inst Genome Med, Moores Canc Ctr, Dept Cellular & Mol Med,Sch Med, San Diego, CA 92093 USA.; Zhao, HM (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA.	biren@ucsd.edu; zhao5@illinois.edu		Zhao, Huimin/0000-0002-9069-6739	Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana Champaign; National Institutes of Health [1U54DK107965, P50 GM085764-04, 1U54DK107977-01]; Ludwig Institute for Cancer Research; Swedish Vetenskapsradet [537-2014-6796]	This work was supported by the Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana Champaign (H.Z.), National Institutes of Health (1U54DK107965) (H.Z.), the Ludwig Institute for Cancer Research (B.R.), National Institutes of Health (P50 GM085764-04, 1U54DK107977-01) (B.R), and an International Postdoctoral fellowship from the Swedish Vetenskapsradet (537-2014-6796) (J.Y.). The authors thank Dr. Barbara Pilas (Flow Cytometry Facility, Biotechnology Center, University of Illinois at Urbana Champaign, Urbana, IL 61801, USA) for helpful suggestions.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Chen C, 2013, BIOCHEM BIOPH RES CO, V430, P505, DOI 10.1016/j.bbrc.2012.12.006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crespan E, 2012, NUCLEIC ACIDS RES, V40, P5577, DOI 10.1093/nar/gks186; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Hawkins RD, 2006, HUM MOL GENET, V15, pR1, DOI 10.1093/hmg/ddl043; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Kuan CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147886; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu M., 2011, BACTERIAL ARTIFICIAL, DOI [10.5772/32167, DOI 10.5772/32167]; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mudduluru G, 2008, BIOSCIENCE REP, V28, P161, DOI 10.1042/BSR20080046; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Rodriguez R, 2014, NAT REV GENET, V15, P783, DOI 10.1038/nrg3796; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115; Seitz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026837; Tam W. L., 2008, STEMBOOK; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Vizcaino C, 2015, PHARMACOL THERAPEUT, V152, P111, DOI 10.1016/j.pharmthera.2015.05.008; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang ZH, 2009, METHODS MOL BIOL, V567, P87, DOI 10.1007/978-1-60327-414-2_6; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yin YW, 2015, GENE EXPRESSION, V16, P187, DOI 10.3727/105221615X14399878166230; Zhang XD, 2008, NAT METHODS, V5, P163, DOI 10.1038/NMETH1170; Zhang Y, 2008, GENOME BIOL, V9, pR137, DOI DOI 10.1186/GB-2008-9-9-R137; Zhao J, 2010, DIABETOLOGIA, V53, P2340, DOI 10.1007/s00125-010-1852-3	41	2	2	7	7	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUN	2017	6	6					1034	1042		10.1021/acssynbio.6b00358				9	Biochemical Research Methods	Biochemistry & Molecular Biology	EY3IN	WOS:000403864900013	28215080	green_accepted			2018-01-05	
J	Furuya, A; Kawano, F; Nakajima, T; Ueda, Y; Sato, M				Furuya, Akihiro; Kawano, Fuun; Nakajima, Takahiro; Ueda, Yoshibumi; Sato, Moritoshi			Assembly Domain-Based Optogenetic System for the Efficient Control of Cellular Signaling	ACS SYNTHETIC BIOLOGY			English	Article						Magnet system; optogenetics; assembly domain; Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) association domain (CAD); dorsal ruffle; Tiaml	CIRCULAR DORSAL RUFFLES; SPATIOTEMPORAL CONTROL; PROTEIN INTERACTIONS; GENE-EXPRESSION; LIVING CELLS; LIGHT; MEMBRANE; MACROPINOCYTOSIS; LOCALIZATION; ACTIVATION	We previously developed the Magnet system, which consists of two distinct Vivid protein variants, one positively and one negatively charged, designated the positive Magnet (pMag) and negative Magnet (nMag), respectively. These two proteins bind to each other through electrostatic interactions, preventing unwanted homodimerization and providing selective light-induced heterodimerization. The Magnet system enables the manipulation of cellular functions such as protein protein interactions and genome editing, although the system could be improved further. To enhance the ability of pMagFast2 (a pMag variant with fast kinetics) to bind nMag, we introduced several pMagFast2 modules in tandem into a single construct, pMagFast2(3x). However, the expression level of this construct decreased drastically with increasing number of pMagFast2 molecules integrated into a single construct. In the present study, we applied a new approach to improve the Magnet system based on an assembly domain (AD). Among several ADs, the Ca2+/calmodulin-dependent protein kinase Ha association domain (CAD) most enhanced the Magnet system. The present CAD-Magnet system overcame a trade-off issue between the expression level and binding affinity. The CAD-converged 12 pMag photoswitches exhibited a stronger interaction with nMag after blue light irradiation compared with monomeric pMag. Additionally, the CAD played a key role in converging effector proteins as well in a single complex. Owing to these substantial improvements, the CAD-Magnet system combined with Tiam 1 allowed us to robustly induce localized formation of vertical ruffles on the apical plasma membrane. The CAD-Magnet system combined with 4D imaging was instrumental in revealing the dynamics of ruffle formation.	[Furuya, Akihiro; Kawano, Fuun; Nakajima, Takahiro; Ueda, Yoshibumi; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan; [Ueda, Yoshibumi] Japan Agcy Med Res & Dev, AMED PRIME, Tokyo, Japan	Sato, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp			Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science (JSPS); CREST; JST	This work was supported by Platform for Dynamic Approaches to Living System from Japan Agency for Medical Research and Development (AMED) and by grants from the Japan Society for the Promotion of Science (JSPS). This work was also supported by CREST, JST.	Abella JV, 2010, J BIOL CHEM, V285, P24956, DOI 10.1074/jbc.M110.127985; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Bugaj LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7898; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cortesio CL, 2010, MOL BIOL CELL, V21, P186, DOI 10.1091/mbc.E09-02-0106; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Kawano F, 2016, NAT CHEM BIOL, V12, P1059, DOI [10.1038/NCHEMBIO.2205, 10.1038/nchembio.2205]; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/NMETH.2940, 10.1038/nmeth.2940]; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Nguyen MK, 2016, NAT CHEM BIOL, V12, P431, DOI [10.1038/NCHEMBIO.2064, 10.1038/nchembio.2064]; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Wang H, 2016, NAT METHODS, V13, P755, DOI [10.1038/NMETH.3926, 10.1038/nmeth.3926]; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yang XJ, 2013, MOL BIOL CELL, V24, P2419, DOI 10.1091/mbc.E13-03-0126; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Yu GG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35777; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	42	0	0	7	7	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUN	2017	6	6					1086	1095		10.1021/acssynbio.7b00022				10	Biochemical Research Methods	Biochemistry & Molecular Biology	EY3IN	WOS:000403864900018	28195693				2018-01-05	
J	Tsui, TKM; Hand, TH; Duboy, EC; Li, H				Tsui, Tsz Kin Martin; Hand, Travis H.; Duboy, Emily C.; Li, Hong			The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9	ACS SYNTHETIC BIOLOGY			English	Article						Cas9; PAM; RNA-guided DNA cleavage; CRISPR	STAPHYLOCOCCUS-AUREUS CAS9; NEISSERIA-MENINGITIDIS; STREPTOCOCCUS-THERMOPHILUS; CRISPR-CAS9 NUCLEASES; CRYSTAL-STRUCTURE; DUAL-RNA; SYSTEMS; IMMUNITY; CLEAVAGE; COMPLEX	Cas9 is an RNA-guided DNA cleavage enzyme being actively developed for genome editing and gene regulation. To be cleaved by Cas9, a double stranded DNA, or the protospacer, must be complementary to the guide region, typically 20-nucleotides in length, of the Cas9-bound guide RNA, and adjacent to a short Cas9-specific element called Protospacer Adjacent Motif (PAM). Understanding the correct juxtaposition of the protospacer- and PAM-interaction with Cas9 will enable development of versatile and safe Cas9-based technology. We report identification and biochemical characterization of Cas9 from Acidothermus cellulolyticus (AceCas9). AceCas9 depends on a 5'-NNNCC-3' PAM and is more efficient in cleaving negative supercoils than relaxed DNA. Kinetic as well as in vivo activity assays reveal that AceCas9 achieves optimal activity when combined with a guide RNA containing a 24-nucleotide complementarity region. The cytosine-specific, DNA topology-sensitive, and extended guide-dependent properties of AceCas9 may be explored for specific genome editing applications.	[Tsui, Tsz Kin Martin; Hand, Travis H.; Li, Hong] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Duboy, Emily C.; Li, Hong] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	Li, H (reprint author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.; Li, H (reprint author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	hong.li@fsu.edu			American Heart Association predoctoral fellowship [15PRE25330004]; NIH [R0I GM099604]	We thank A. Cocozaki, J. Pennington, G. Yu for discussion; B.P. Kleinstiver and B. Miller for advice on in vivo studies; D. Edgell for providing cells and plasmid for in vivo studies; J. Terrell for assistance in preparing DNA plasmids; B. Washburn and C. Pye of the Molecular Cloning Facility at FSU for the cloning experiments. This work was supported by American Heart Association predoctoral fellowship 15PRE25330004 to T.K.M.T., and by NIH grant R0I GM099604 to H.L.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Beisel CL, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0516-x; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Campbell FE, 2002, J MOL BIOL, V317, P21, DOI 10.1006/jmbi.2001.5413; Charpentier E, 2014, CURR OPIN MICROBIOL, V19, P114, DOI 10.1016/j.mib.2014.07.001; Chen ZL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni148; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; MOHAGHEGHI A, 1986, INT J SYST BACTERIOL, V36, P435, DOI 10.1099/00207713-36-3-435                                                       ; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsui TKM, 2015, ANNU REV BIOPHYS, V44, P229, DOI 10.1146/annurev-biophys-060414-033939; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Westra ER, 2012, RNA BIOL, V9, P1134, DOI 10.4161/rna.21410; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	0	0	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	JUN	2017	6	6					1103	1113		10.1021/acssynbio.7b00050				11	Biochemical Research Methods	Biochemistry & Molecular Biology	EY3IN	WOS:000403864900020	28277645				2018-01-05	
J	Luttgeharm, KD; Wong, KS; Siembieda, S				Luttgeharm, Kyle D.; Wong, Kit-Sum; Siembieda, Steve			Heteroduplex cleavage assay for screening of probable zygosities resulting from CRISPR mutations in diploid single cell lines	BIOTECHNIQUES			English	Article						T7 endonuclease I; heteroduplex cleavage assay; CRISPR; gene editing; mutation detection	ZINC-FINGER NUCLEASES; T7 ENDONUCLEASE; GENOME; RESOLVASES; SYSTEM	The most common gene editing methods, such as CRISPR, involve random repair of an induced double-stranded DNA break through the non-homologous end joining (NHEJ) repair pathway, resulting in small insertions/deletions. In diploid cells, these mutations can take on one of three zygosities: monoallelic, diallelic heterozygous, or diallelic homozygous. While many advances have been made in CRISPR delivery systems and gene editing efficiency, little work has been done to streamline detection of gene editing events. The only current method to determine the zygosity of an edited gene in a diploid organism is DNA sequencing, which is costly and time-consuming. Here, we describe the development of a T7 endonuclease I (T7EI)-based heteroduplex cleavage assay, along with statistical models relating the percentage of cleaved DNA to the zygosity of a mutation, that provides a rapid screening step prior to DNA sequencing. By isolating candidates likely to contain the desired zygosity for the edited gene, our screening method can decrease the number of clones requiring DNA sequencing.	[Luttgeharm, Kyle D.; Wong, Kit-Sum; Siembieda, Steve] Adv Analyt Technol Inc, 2450 SE Oak Tree Ct,Suite 101, Ankeny, IA 50021 USA	Luttgeharm, KD (reprint author), Adv Analyt Technol Inc, 2450 SE Oak Tree Ct,Suite 101, Ankeny, IA 50021 USA.	kluttgeharm@aati-us.com					Babon JJ, 2003, MOL BIOTECHNOL, V23, P73, DOI 10.1385/MB:23:1:73; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Guan C, 2004, BIOCHEMISTRY-US, V43, P4313, DOI 10.1021/bi036033j; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Pan C., 2016, NAT SCI REP, V6, P24765, DOI DOI 10.1038/SREP24765; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Samarut E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2881-1; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang Liu, 2014, Journal of Environmental & Occupational Medicine, V31, P1; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	20	0	0	2	2	BIOTECHNIQUES OFFICE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0736-6205	1940-9818		BIOTECHNIQUES	Biotechniques	JUN	2017	62	6					268	274		10.2144/000114556				6	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EX9FU	WOS:000403563300005	28625156				2018-01-05	
J	Williams, TJ; Liao, Y; Ye, J; Kuchel, RP; Poljak, A; Raftery, MJ; Cavicchioli, R				Williams, Timothy J.; Liao, Yan; Ye, Jun; Kuchel, Rhiannon P.; Poljak, Anne; Raftery, Mark J.; Cavicchioli, Ricardo			Cold adaptation of the Antarctic haloarchaea Halohasta litchfieldiae and Halorubrum lacusprofundi	ENVIRONMENTAL MICROBIOLOGY			English	Article							S-LAYER GLYCOPROTEIN; ARCHAEON METHANOCOCCOIDES-BURTONII; BACILLUS-SPHAERICUS NCTC-9602; TRANSFER-RNA MODIFICATION; UNIVERSAL STRESS-PROTEIN; HORIZONTAL GENE-TRANSFER; HALOFERAX-VOLCANII; ESCHERICHIA-COLI; PROTEOMIC ANALYSIS; DEEP LAKE	Halohasta litchfieldiae represents similar to 44% and Halorubrum lacusprofundi similar to 10% of the hypersaline, perennially cold (>= -20 degrees C) Deep Lake community in Antarctica. We used proteomics and microscopy to define physiological responses of these haloarchaea to growth at high (30 degrees C) and low (10 and 4 degrees C) temperatures. The proteomic data indicate that both species responded to low temperature by modifying their cell envelope including protein N-glycosylation, maintaining osmotic balance and translation initiation, and modifying RNA turnover and tRNA modification. Distinctions between the two species included DNA protection and repair strategies (e. g. roles of UspA and Rad50), and metabolism of glycerol and pyruvate. For Hrr. lacusprofundi, low temperature led to the formation of polyhydroxyalkanoate-like granules, with granule formation occurring by an unknown mechanism. Hrr. lacusprofundi also formed biofilms and synthesized high levels of Hsp20 chaperones. Hht. litchfieldiae was characterized by an active CRISPR system, and elevated levels of the core gene expression machinery, which contrasted markedly to the decreased levels of Hrr. lacusprofundi. These findings greatly expand the understanding of cellular mechanisms of cold adaptation in psychrophilic archaea, and provide insight into how Hht. litchfieldiae gains dominance in Deep Lake.	[Williams, Timothy J.; Liao, Yan; Ye, Jun; Cavicchioli, Ricardo] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Ye, Jun] Univ New South Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia; [Kuchel, Rhiannon P.] Univ New South Wales, Electron Microscopy Unit, Sydney, NSW 2052, Australia; [Poljak, Anne; Raftery, Mark J.] Univ New South Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia	Cavicchioli, R (reprint author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	r.cavicchioli@unsw.edu.au		Cavicchioli, Ricardo/0000-0001-8989-6402; YE, JUN/0000-0002-6476-6406	Australian Research Council [DP150100244]; China Scholarship Council [201206910027, 201206230085]	This work was supported by the Australian Research Council [DP150100244]. YL and JY were funded by the China Scholarship Council (File No. 201206910027 and 201206230085, respectively). Mass spectrometry results were obtained at the Bioanalytical Mass Spectrometry Facility and electron microscopy at the Electron Microscope Unit, both within the Analytical Centre of the University of New South Wales. Subsidized access to these facilities is gratefully acknowledged. We thank the PRIDE team and ProteomeXchange for efficiently processing and hosting the mass spectrometry data. We acknowledge the insightful and constructive comments provided by the reviewers during the review process.	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Arnold AR, 2013, J AM CHEM SOC, V135, P15726, DOI 10.1021/ja408760w; Barker R. J., 1981, ANARE SCI REP, V130, P73; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bergholz PW, 2009, J BACTERIOL, V191, P2340, DOI 10.1128/JB.01377-08; Bhuwal A. K., 2013, INT J BIOMATER, V2013; Blaby IK, 2011, RNA, V17, P1367, DOI 10.1261/rna.2712811; Blaby IK, 2010, ARCHAEA, DOI 10.1155/2010/426239; Blackwood JK, 2012, NUCLEIC ACIDS RES, V40, P3183, DOI 10.1093/nar/gkr1157; Boot HJ, 1996, MOL MICROBIOL, V21, P1117, DOI 10.1046/j.1365-2958.1996.711442.x                                               ; Boubriak Ivan, 2008, Saline Systems, V4, P13, DOI 10.1186/1746-1448-4-13; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Burns D, 2006, METHOD MICROBIOL, V35, P535, DOI 10.1016/S0580-9517(08)70025-4; Campanaro S, 2011, ENVIRON MICROBIOL, V13, P2018, DOI 10.1111/j.1462-2920.2010.02367.x; CAMPBELL PJ, 1978, AUST J MAR FRESH RES, V29, P717; Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390; Cavicchioli R, 2016, ISME J, V10, P793, DOI 10.1038/ismej.2015.160; Cavicchioli R, 2015, NAT REV MICROBIOL, V13, P691, DOI 10.1038/nrmicro3549; Cavicchioli R, 2011, ENVIRON MICROBIOL, V13, P1903, DOI 10.1111/j.1462-2920.2011.02512.x; Chen ZJ, 2015, EXTREMOPHILES, V19, P249, DOI 10.1007/s00792-014-0709-y; Chen ZJ, 2012, ENV MICROBIOL REP, V4, P633, DOI 10.1111/j.1758-2229.2012.00389.x; Chimileski S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0065-5; Chimileski S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00057; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9                                                   ; Cox MM, 2000, NATURE, V404, P37; Dannenmuller O, 2000, CHEM-EUR J, V6, P645, DOI 10.1002/(SICI)1521-3765(20000218)6:4<645::AID-CHEM645>3.3.CO;2-1; Dawson KS, 2012, ORG GEOCHEM, V48, P1, DOI 10.1016/j.orggeochem.2012.04.003; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; DeMaere MZ, 2013, P NATL ACAD SCI USA, V110, P16939, DOI 10.1073/pnas.1307090110; Dibrova DV, 2014, ENVIRON MICROBIOL, V16, P907, DOI 10.1111/1462-2920.12359; Duggin IG, 2015, NATURE, V519, P362, DOI 10.1038/nature13983; Eichler J, 2001, EUR J BIOCHEM, V268, P4366, DOI 10.1046/j.1432-1327.2001.02361.x                                                ; Eichler J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00403; El Yacoubi Basma, 2009, Archaea, V2, P211; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; FERRIS JM, 1988, HYDROBIOLOGIA, V165, P115, DOI 10.1007/BF00025579; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997                                                ; FRANZMANN PD, 1988, SYST APPL MICROBIOL, V11, P20, DOI 10.1016/S0723-2020(88)80044-4                                                   ; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; GARNIER M, 1985, EUR J BIOCHEM, V148, P539, DOI 10.1111/j.1432-1033.1985.tb08873.x; Gibson JAE, 2005, SYST APPL MICROBIOL, V28, P19, DOI 10.1016/j.syapm.2004.09.004; Grage K, 2009, BIOMACROMOLECULES, V10, P660, DOI 10.1021/bm801394s; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Haft DH, 2012, J BACTERIOL, V194, P36, DOI 10.1128/JB.06026-11; Han J, 2013, APPL ENVIRON MICROB, V79, P2922, DOI 10.1128/AEM.03915-12; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020                                                               ; Hou LL, 2014, NUCLEIC ACIDS RES, V42, P12691, DOI 10.1093/nar/gku969; HOURDOU ML, 1993, BIOCHEM J, V292, P563, DOI 10.1042/bj2920563                                                               ; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; Kandiba L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00661; Kandiba L, 2013, BBA-BIOMEMBRANES, V1828, P938, DOI 10.1016/j.bbamem.2012.11.023; Kates M., 1993, BIOCH ARCHAEA ARCHAE, P261; Konig H, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P315; KUZMINOV A, 1995, BIOESSAYS, V17, P733, DOI 10.1002/bies.950170810; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Legat A, 2010, APPL MICROBIOL BIOT, V87, P1119, DOI 10.1007/s00253-010-2611-6; Leuko S, 2009, J PROTEOME RES, V8, P2218, DOI 10.1021/pr800663c; Levy S, 2011, RNA BIOL, V8, P1073, DOI 10.4161/rna.8.6.16604; Li DC, 2012, CELL STRESS CHAPERON, V17, P103, DOI 10.1007/s12192-011-0289-z; Liao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37454; Liao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34639; Liu GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24015; Londei P, 2005, FEMS MICROBIOL REV, V29, P185, DOI 10.1016/j.femsre.2004.10.002; Lopez-Garcia P, 2015, NAT REV MICROBIOL, V13, P447, DOI 10.1038/nrmicro3485; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; McCready Shirley, 2005, Saline Systems, V1, P3, DOI 10.1186/1746-1448-1-3; MENGELE R, 1992, J BIOL CHEM, V267, P8182; Mesquita DP, 2015, ANAL CHIM ACTA, V865, P8, DOI 10.1016/j.aca.2015.01.018; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Morozova D, 2007, FEMS MICROBIOL ECOL, V61, P16, DOI 10.1111/j.1574-6941.2007.00316.x; Mou YZ, 2012, EXTREMOPHILES, V16, P895, DOI 10.1007/s00792-012-0485-5; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Najnin T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24278; Nichols DS, 2004, J BACTERIOL, V186, P8508, DOI 10.1128/JB.186.24.8508-8515.2004; Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003; Nunn BL, 2015, ENVIRON MICROBIOL, V17, P2319, DOI 10.1111/1462-2920.12691; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; OLSSON M, 1980, J BIOL CHEM, V255, P569; Oren A, 2002, J IND MICROBIOL BIOT, V28, P56, DOI 10.1038/sj.jim.7000176; Oren A, 1999, HYDROBIOLOGIA, V405, P1, DOI 10.1023/A:1003879932328                                                         ; Oren Aharon, 2015, Microorganisms, V3, P407, DOI 10.3390/microorganisms3030407; Oren Aharon, 2008, Saline Systems, V4, P2, DOI 10.1186/1746-1448-4-2; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238; Phillips G, 2008, J BACTERIOL, V190, P7876, DOI 10.1128/JB.00874-08; Reid IN, 2006, INT J ASTROBIOL, V5, P89, DOI 10.1017/S1473550406002916; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Russell N. J., 2009, EXTREMOPHILES, VII, P67; Shih CJ, 2010, CAN J MICROBIOL, V56, P295, DOI [10.1139/w10-008, 10.1139/W10-008]; Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514; Sinha AK, 2013, MOL MICROBIOL, V89, P792, DOI 10.1111/mmi.12315; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; STEINBUCHEL A, 1992, APPL MICROBIOL BIOT, V37, P1; Szabo Z, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00207; Taha, 2016, ENVIRON MICROBIOL, V18, P2810, DOI 10.1111/1462-2920.13229; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Todor H, 2014, MOL MICROBIOL, V93, P1172, DOI 10.1111/mmi.12726; Tschitschko B., 2015, ISME J, V1, P1; Tschitschko B, 2016, APPL ENVIRON MICROB, V82, P3165, DOI 10.1128/AEM.00473-16; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; Wagner S, 2007, J BIOL CHEM, V282, P13966, DOI 10.1074/jbc.M701166200; Watanabe M, 1997, J BIOL CHEM, V272, P20146, DOI 10.1074/jbc.272.32.20146; Williams TJ, 2017, ENVIRON MICROBIOL, V19, P864, DOI 10.1111/1462-2920.13580; Williams TJ, 2014, ISME J, V8, P1645, DOI 10.1038/ismej.2014.18; Williams TJ, 2011, ENVIRON MICROBIOL, V13, P2186, DOI 10.1111/j.1462-2920.2011.02467.x; Williams TJ, 2010, J PROTEOME RES, V9, P640, DOI 10.1021/pr900509n; Wilson ME, 2013, BIOCHEMISTRY-US, V52, P5708, DOI 10.1021/bi400804z; Woods WG, 1997, MOL MICROBIOL, V23, P791, DOI 10.1046/j.1365-2958.1997.2651626.x; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138; Zhou L, 2007, PROTEOMICS, V7, P3194, DOI 10.1002/pmic.200700137	118	0	0	13	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-2912	1462-2920		ENVIRON MICROBIOL	Environ. Microbiol.	JUN	2017	19	6			SI		2210	2227		10.1111/1462-2920.13705				18	Microbiology	Microbiology	EY5HL	WOS:000404007700012	28217912				2018-01-05	
J	Schnodt, M; Buning, H				Schnoedt, Maria; Buening, Hildegard			Improving the Quality of Adeno-Associated Viral Vector Preparations: The Challenge of Product-Related Impurities	HUMAN GENE THERAPY METHODS			English	Review						AAV vectors; vector purification; vector characterization; empty capsids; DNA impurities	ION-EXCHANGE CHROMATOGRAPHY; REFERENCE-STANDARD MATERIAL; HUMAN GENE-THERAPY; VIRUS TYPE-2; WILD-TYPE; HIGH-TITER; IN-VIVO; TRANSGENE EXPRESSION; AAV VECTORS; NONHOMOLOGOUS RECOMBINATION	Adeno-associated viral (AAV) vectors have emerged as one of the most popular gene transfer systems in both research and clinical gene therapy. As AAV vectors are derived from a stealth, nonpathogenic virus and lack active integrase activity, these vectors are frequently applied for in vivo gene therapy of liver, muscle, and other postmitotic tissues. Although long-term transgene expression from AAV vector episomes is reported from these tissues, the episomal nature of AAV-once regarded as disadvantage-has become an attractive feature for gene-editing approaches targeting proliferating cells. In response to the high demand, AAV vector production is receiving special attention. Besides particle yields and biological activity, the most important concern is improving vector purity. The most difficult task in this regard is removal of defective particles, that is, capsids that are either empty or contain DNA other than the full-length vector genomes. Herein, we characterize and discuss these so-called product-related impurities, methods for their detection, as well as strategies to avoid or reduce their formation.	[Schnoedt, Maria; Buening, Hildegard] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Schnoedt, Maria; Buening, Hildegard] German Ctr Infect Res, Bonn Cologne & Hannover Braunschweig Partner Site, Braunschweig, Germany; [Schnoedt, Maria; Buening, Hildegard] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Buening, Hildegard] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany	Buning, H (reprint author), Hannover Med Sch, Inst Expt Hematol, Lab Infect Biol & Gene Transfer, Carl Neuberg Str 1, D-30625 Hannover, Germany.	buening.hildegard@mh-hannover.de			German Federal Ministry of Economics and Technology [KF2429612AJ3]; Center for Molecular Medicine Cologne (CMMC) of the University of Cologne [CMMC-C1]; Hannover Medical School (MHH)	This work was supported by the German Federal Ministry of Economics and Technology (KF2429612AJ3), the Center for Molecular Medicine Cologne (CMMC) of the University of Cologne (CMMC-C1) and Hannover Medical School (MHH).	Allay JA, 2011, HUM GENE THER, V22, P595, DOI 10.1089/hum.2010.202; Allen JM, 1997, J VIROL, V71, P6816; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Ayuso E, 2014, HUM GENE THER, V25, P977, DOI 10.1089/hum.2014.057; Ayuso E, 2010, CURR GENE THER, V10, P423, DOI 10.2174/156652310793797685                                                      ; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Benskey MJ, 2016, HUM GENE THER METHOD, V27, P32, DOI 10.1089/hgtb.2015.117; Bleker S, 2005, J VIROL, V79, P2528, DOI 10.1128/JVI.79.4.2528-2540.2005; Burnham B, 2015, HUM GENE THER METHOD, V26, P228, DOI 10.1089/hgtb.2015.048; Cao L, 2000, J VIROL, V74, P11456, DOI 10.1128/JVI.74.24.11456-11463.2000; Carter BJ, 2004, MOL THER, V10, P981, DOI 10.1016/j.ymthe.2004.09.011; Chadeuf G, 2005, MOL THER, V12, P744, DOI 10.1016/j.ymthe.2005.06.003; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; Clement N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.2; Davidoff AM, 2004, J VIROL METHODS, V121, P209, DOI 10.1016/j.jviromet.2004.07.001; Dong B, 2013, NUCLEIC ACIDS RES, V41, P6609, DOI 10.1093/nar/gkt404; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Drouin LM, 2016, J VIROL, V90, P8542, DOI 10.1128/JVI.00575-16; Emmerling VV, 2016, BIOTECHNOL J, V11, P290, DOI 10.1002/biot.201500176; Galibert L, 2011, J INVERTEBR PATHOL, V107, pS80, DOI 10.1016/j.jip.2011.05.008; Gao GP, 1998, HUM GENE THER, V9, P2353, DOI 10.1089/hum.1998.9.16-2353; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao Kai, 2014, Mol Ther Methods Clin Dev, V1, P20139; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Grieger JC, 2016, MOL THER, V24, P287, DOI 10.1038/mt.2015.187; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745                                                      ; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; Grimm D, 1999, GENE THER, V6, P1322, DOI 10.1038/sj.gt.3300946                                                           ; Halbert CL, 2011, GENE THER, V18, P411, DOI 10.1038/gt.2010.167; Hastie E, 2015, HUM GENE THER, V26, P257, DOI 10.1089/hum.2015.025; Hauck B, 2009, MOL THER, V17, P144, DOI 10.1038/mt.2008.227; Hirsch ML, 2016, METHODS MOL BIOL, V1382, P21, DOI 10.1007/978-1-4939-3271-9_2; Hosel M, 2012, HEPATOLOGY, V55, P287, DOI 10.1002/hep.24625; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; IM DS, 1992, J VIROL, V66, P1119; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K                                                    ; Kaludov N, 2002, HUM GENE THER, V13, P1235, DOI 10.1089/104303402320139014                                                      ; Kapranov P, 2012, HUM GENE THER, V23, P46, DOI 10.1089/hum.2011.160; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Kuck D, 2007, J VIROL METHODS, V140, P17, DOI 10.1016/j.jviromet.2006.10.005; Lecomte E, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.32; Li CW, 2005, VIROLOGY, V335, P10, DOI 10.1016/j.virol.2005.02.008; Ling C, 2015, J MOL GENET MED, V9; Ling C, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.29; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Lock M, 2010, HUM GENE THER, V21, P1273, DOI 10.1089/hum.2009.223; Lu H, 2011, HUM GENE THER, V22, P625, DOI 10.1089/hum.2011.005; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Mietzsch M, 2014, HUM GENE THER, V25, P212, DOI 10.1089/hum.2013.184; Miller DG, 2002, NAT GENET, V30, P147, DOI 10.1038/ng824; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Okada T, 2009, HUM GENE THER, V20, P1013, DOI 10.1089/hum.2009.006; Pierson EE, 2016, ANAL CHEM, V88, P6718, DOI 10.1021/acs.analchem.6b00883; Piras BA, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.15; Qu G, 2007, J VIROL METHODS, V140, P183, DOI 10.1016/j.jviromet.2006.11.019; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; ROLLING F, 1995, MOL BIOTECHNOL, V3, P9, DOI 10.1007/BF02821330                                                              ; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; SAMULSKI RJ, 1989, J VIROL, V63, P3822; Schnodt M, 2016, MOL THER-NUCL ACIDS, V5, DOI [10.1038/mtna.016.60, 10.1038/mtna.2016.60]; Sommer JM, 2003, MOL THER, V7, P122, DOI 10.1016/S1525-0016(02)00019-9; Srivastava A, 2016, CURR OPIN VIROL, V21, P75, DOI 10.1016/j.coviro.2016.08.003; Strobel B, 2015, HUM GENE THER METHOD, V26, P147, DOI 10.1089/hgtb.2015.051; Tan YD, 1999, HUM GENE THER, V10, P2153, DOI 10.1089/10430349950017149; Tomono T, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.58; Urabe M, 2006, MOL THER, V13, P823, DOI 10.1016/j.ymthe.2005.11.024; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347                                                       ; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Venkatakrishnan B, 2013, J VIROL, V87, P4974, DOI 10.1128/JVI.02524-12; Wang XS, 1998, J VIROL, V72, P5472; Wright JF, 2014, BIOMEDICINES, V2, P80, DOI 10.3390/biomedicines2010080; Wright JF, 2010, CURR GENE THER, V10, P341; Xiao X, 1998, J VIROL, V72, P2224; Zeltner N, 2010, GENE THER, V17, P872, DOI 10.1038/gt.2010.27; Zhou X, 2005, MOL THER, V11, pS156; Zinn E, 2014, CURR OPIN VIROL, V8, P90, DOI 10.1016/j.coviro.2014.07.008; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	85	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1946-6536	1946-6544		HUM GENE THER METHOD	Hum. Gene Ther. Methods	JUN	2017	28	3					101	108		10.1089/hgtb.2016.188				8	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	EY1DF	WOS:000403702700001	28322595				2018-01-05	
J	Cai, WP; Chen, ZX; Rane, G; Singh, SS; Choo, Z; Wang, C; Yuan, Y; Tan, TZ; Arfuso, F; Yap, CT; Pongor, LS; Yang, H; Lee, MB; Goh, BC; Sethi, G; Benoukraf, T; Tergaonkar, V; Kumar, AP				Cai, Wanpei; Chen, Zhi Xiong; Rane, Grishma; Singh, Shikha Satendra; Choo, Zhang'e; Wang, Chao; Yuan, Yi; Tan, Tuan Zea; Arfuso, Frank; Yap, Celestial T.; Pongor, Lorinc S.; Yang, Henry; Lee, Martin B.; Goh, Boon Cher; Sethi, Gautam; Benoukraf, Touati; Tergaonkar, Vinay; Kumar, Alan Prem			Wanted DEAD/H or Alive: Helicases Winding Up in Cancers	JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE			English	Review							P68 RNA HELICASE; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; NF-KAPPA-B; EUKARYOTIC TRANSLATION INITIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; BOX POLYPEPTIDE 3; CELL LUNG-CANCER; SMALL-MOLECULE INHIBITOR; POSITIVE BREAST-CANCER	Cancer is one of the most studied areas of human biology over the past century. Despite having attracted much attention, hype, and investments, the search to find a cure for cancer remains an uphill battle. Recent discoveries that challenged the central dogma of molecular biology not only further increase the complexity but also demonstrate how various types of noncoding RNAs such as microRNA and long noncoding RNA, as well as their related processes such as RNA editing, are important in regulating gene expression. Parallel to this aspect, an increasing number of reports have focused on a family of proteins known as DEAD/H-box helicases involved in RNA metabolism, regulation of long and short noncoding RNAs, and novel roles as "editing helicases" and their association with cancers. This review summarizes recent findings on the roles of RNA helicases in various cancers, which are broadly classified into adult solid tumors, childhood solid tumors, leukemia, and cancer stem cells. The potential small molecule inhibitors of helicases and their therapeutic value are also discussed. In addition, analyzing next-generation sequencing data obtained from public portals and reviewing existing literature, we provide new insights on the potential of DEAD/H-box helicases to act as pharmacological drug targets in cancers.	[Cai, Wanpei; Rane, Grishma; Singh, Shikha Satendra; Wang, Chao; Yuan, Yi; Tan, Tuan Zea; Yang, Henry; Goh, Boon Cher; Benoukraf, Touati; Kumar, Alan Prem] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Cai, Wanpei; Rane, Grishma; Singh, Shikha Satendra; Wang, Chao; Goh, Boon Cher; Sethi, Gautam; Kumar, Alan Prem] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, 14 Med Dr, Singapore 117599, Singapore; [Chen, Zhi Xiong; Choo, Zhang'e; Yap, Celestial T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Tergaonkar, Vinay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Chen, Zhi Xiong] KK Womens & Childrens Hosp, Singapore, Singapore; [Arfuso, Frank] Curtin Univ, Stem Cell & Canc Biol Lab, Perth, WA, Australia; [Rane, Grishma; Kumar, Alan Prem] Curtin Univ, Sch Biomed Sci, Perth, WA, Australia; [Kumar, Alan Prem] Curtin Univ, Curtin Med Sch, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Yap, Celestial T.; Goh, Boon Cher; Kumar, Alan Prem] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Pongor, Lorinc S.] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Pongor, Lorinc S.] Res Ctr Nat Sci, MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Lee, Martin B.] Natl Univ Hlth Syst, Dept Renal Med, Singapore, Singapore; [Goh, Boon Cher] Natl Univ Hlth Syst, Dept Hematol Oncol, Singapore, Singapore; [Tergaonkar, Vinay] ASTAR, Inst Mol & Cell Biol MCB, Singapore, Singapore; [Tergaonkar, Vinay] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Tergaonkar, Vinay] SA Pathol, Adelaide, SA, Australia; [Kumar, Alan Prem] Univ North Texas, Dept Biol Sci, Denton, TX USA	Kumar, AP (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, 14 Med Dr, Singapore 117599, Singapore.	csiapk@nus.edu.sg			Singapore Ministry of Education; National Medical Research Council of Singapore; NCIS Yong Siew Yoon Research Grant; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative; National University Hospital System; Merlion Project (Embassy of France, Singapore); KKH-VIVA Foundation for Children with Cancer; NUHS Basic seed grant; John Nott Cancer Fellowship from Cancer Council, Western Australia; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore	This work was supported by grants from Singapore Ministry of Education Tier 2, the National Medical Research Council of Singapore, and the NCIS Yong Siew Yoon Research Grant through donations from the Yong Loo Lin Trust to APK. APK and TB were supported by the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiative to Cancer Science Institute of Singapore, National University of Singapore. TB was also supported by grants from the National Medical Research Council of Singapore, National University Hospital System, and Merlion Project (Embassy of France, Singapore). ZXC was supported by grants from the National Medical Research Council of Singapore and KKH-VIVA Foundation for Children with Cancer. GS was supported by a grant from the NUHS Basic seed grant and by the John Nott Cancer Fellowship from Cancer Council, Western Australia. VT was supported by core funding from The Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.	Abdel-Fatah TMA, 2014, BRIT J CANCER, V110, P2450, DOI 10.1038/bjc.2014.168; Abou Faycal C, 2016, CURR OPIN ONCOL, V28, P58, DOI 10.1097/CCO.0000000000000254; AKAO Y, 1995, CANCER RES, V55, P3444; Alqahtani H, 2016, CELL SIGNAL, V28, P42, DOI 10.1016/j.cellsig.2015.11.004; Alshareeda AT, 2014, BREAST CANCER RES TR, V144, P519, DOI 10.1007/s10549-014-2897-7; Anderson SE, 1998, NAT GENET, V19, P254; Antony-Debre I, 2015, CANCER CELL, V27, P609, DOI 10.1016/j.ccell.2015.04.013; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Arai Y, 1997, BLOOD, V89, P3936; Bao B, 2013, CURR PROTOC PHARM, P25, DOI DOI 10.1002/0471141755.PH1425S61; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Bol GM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0461-7; Bol GM, 2015, CANCER CHEMOTH PHARM, V76, P821, DOI 10.1007/s00280-015-2851-3; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Borden KLB, 2010, LEUKEMIA LYMPHOMA, V51, P1805, DOI 10.3109/10428194.2010.496506; Borowski P, 2001, ACTA BIOCHIM POL, V48, P739; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113; Brandimarte L, 2013, BLOOD, V121, P5064, DOI 10.1182/blood-2013-02-487256; Carter CL, 2010, ONCOGENE, V29, P5427, DOI 10.1038/onc.2010.276; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Cencic R, 2013, BBA-GENE REGUL MECH, V1829, P894, DOI 10.1016/j.bbagrm.2013.01.008; Cencic R, 2012, METHOD ENZYMOL, V511, P437, DOI 10.1016/B978-0-12-396546-2.00020-6; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Chansky HA, 2001, CANCER RES, V61, P3586; Chen CY, 2013, VIRUS RES, V171, P357, DOI 10.1016/j.virusres.2012.06.022; Chen HH, 2015, ONCOGENE, V34, P2790, DOI 10.1038/onc.2014.190; Chen Q, 2013, GENET TEST MOL BIOMA, V17, P508, DOI 10.1089/gtmb.2012.0530; Chen ZX, 2014, CANCER DISCOV, V4, P434, DOI 10.1158/2159-8290.CD-13-0362; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720                                                            ; Chu J, 2015, BBA-GENE REGUL MECH, V1849, P781, DOI 10.1016/j.bbagrm.2014.09.006; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Culjkovic-Kraljacic B, 2013, TRENDS CELL BIOL, V23, P328, DOI 10.1016/j.tcb.2013.03.004; Dai TY, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0064-y; Dever TE, 1999, TRENDS BIOCHEM SCI, V24, P398, DOI 10.1016/S0968-0004(99)01457-7; Eckhardt SG, 2015, ASCO ANN M P; Epling LB, 2015, J MOL BIOL, V427, P1779, DOI 10.1016/j.jmb.2015.02.015; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8                                                   ; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4                                                   ; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2013, RNA BIOL, V10, P121, DOI 10.4161/rna.23312; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garbelli A, 2011, CURR MED CHEM, V18, P3015, DOI 10.2174/092986711796391688                                                      ; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Goh JN, 2016, BIOL REV, V91, P409, DOI 10.1111/brv.12176; Gorello P, 2013, CANCER GENET-NY, V206, P92, DOI 10.1016/j.cancergen.2013.02.001; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Calderon-Gonzalez KG, 2015, J PROTEOMICS, V124, P50, DOI 10.1016/j.jprot.2015.04.018; Guglielmi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.42; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Guturi KKN, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0496-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9                                                   ; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hashimoto K, 2001, CARCINOGENESIS, V22, P1965, DOI 10.1093/carcin/22.12.1965; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; He L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.127; He TY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21483; HIGA T, 1981, CHEM LETT, P1647, DOI 10.1246/cl.1981.1647; HOTTA Y, 1978, BIOCHEMISTRY-US, V17, P1872, DOI 10.1021/bi00603a011; Huang CL, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-11; Iliou MS, 2014, ONCOGENE, V33, P4003, DOI 10.1038/onc.2013.398; Jabbour E, 2014, AM J HEMATOL, V89, P547, DOI 10.1002/ajh.23691; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Jalal C, 2007, NUCLEIC ACIDS RES, V35, P3590, DOI 10.1093/nar/gkm058; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Jiao X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-165; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Kawai S, 2012, J CELL BIOL, V197, P201, DOI 10.1083/jcb.201110008; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KH, 2014, BIOCHEM BIOPH RES CO, V447, P315, DOI 10.1016/j.bbrc.2014.03.144; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim S, 2007, ANTICANCER RES, V27, P2175; Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200; Koshio J, 2013, CANCER IMMUNOL IMMUN, V62, P1619, DOI 10.1007/s00262-013-1467-x; Kost GC, 2015, J CELL BIOCHEM, V116, P1595, DOI 10.1002/jcb.25113; Kruse E, 2013, BBA-GENE REGUL MECH, V1829, P835, DOI 10.1016/j.bbagrm.2013.04.003; Lai YH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-50; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leary SES, 2012, CURR OPIN PEDIATR, V24, P33, DOI 10.1097/MOP.0b013e32834ec106; Lee CG, 1999, SOMAT CELL MOLEC GEN, V25, P33, DOI 10.1023/B:SCAM.0000007138.44216.3a                                              ; Lee Y, 2016, ASCO ANN M P, P524; Lee Y, 2016, ASCO ANN M P, P238; Li HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28637; Li QY, 1999, MOL CELL BIOL, V19, P7336; Li W, 2010, BIOORG MED CHEM LETT, V20, P3112, DOI 10.1016/j.bmcl.2010.03.093; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Li YH, 2015, NAT CELL BIOL, V17, P1327, DOI 10.1038/ncb3240; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Liang SH, 2014, INT J GYNECOL CANCER, V24, P908, DOI 10.1097/IGC.0000000000000152; Liggins Amanda P, 2010, Cancer Immun, V10, P8; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Lin HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09247; Lin J, 2014, LEUKEMIA RES, V38, P601, DOI 10.1016/j.leukres.2014.02.012; Lin MB, 2012, CLIN CANCER RES, V18, P3982, DOI 10.1158/1078-0432.CCR-11-2951; Lin S, 2013, ONCOGENE, V32, P4845, DOI 10.1038/onc.2012.482; Lomnytska MI, 2012, BRIT J CANCER, V106, P1297, DOI 10.1038/bjc.2012.67; Lorgeoux RP, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-79; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; Maga G, 2011, CHEMMEDCHEM, V6, P1371, DOI 10.1002/cmdc.201100166; Markiv A, 2012, CURR OPIN PHARMACOL, V12, P408, DOI 10.1016/j.coph.2012.04.003; Mathieu MG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.29; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Modelska A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.542; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Morerio C, 2006, CANCER GENET CYTOGEN, V171, P122, DOI 10.1016/j.cancergencyto.2006.07.002; Mrozek K, 2008, SEMIN ONCOL, V35, P365, DOI 10.1053/j.seminoncol.2008.04.007; Myohanen S, 2001, J BIOL CHEM, V276, P1634, DOI 10.1074/jbc.M004481200; Nakano K, 1998, AM J PATHOL, V153, P857, DOI 10.1016/S0002-9440(10)65627-1; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Network TCGA, 2012, NATURE, V490, P61, DOI DOI 10.1038/NATURE11412; Nishiyama M, 1999, GENE CHROMOSOME CANC, V26, P215, DOI 10.1002/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.0.CO;2-1; Nozaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111019; Oh S, 2016, ONCOTARGET, V7, P28169, DOI 10.18632/oncotarget.8612; Ojha J, 2015, BRIT J HAEMATOL, V169, P445, DOI 10.1111/bjh.13211; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Pahlich S, 2009, J PROTEOME RES, V8, P4455, DOI 10.1021/pr900235t; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Polprasert C, 2015, CANCER CELL, V27, P658, DOI 10.1016/j.ccell.2015.03.017; Poppe B, 2007, Verh K Acad Geneeskd Belg, V69, P47; Poppe B, 2004, BLOOD, V103, P229, DOI 10.1182/blood-2003-06-2163; Price C, 2014, GENES DIS, V1, P53, DOI 10.1016/j.gendis.2014.06.004; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Putnam AA, 2013, BBA-GENE REGUL MECH, V1829, P884, DOI 10.1016/j.bbagrm.2013.02.002; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Radi M, 2012, BIOORG MED CHEM LETT, V22, P2094, DOI 10.1016/j.bmcl.2011.12.135; Ravindar K, 2010, ORG LETT, V12, P4420, DOI 10.1021/ol1019663; Raza F, 2015, BIOCHEM SOC T, V43, P1227, DOI 10.1042/BST20150163; Redmond AM, 2015, ONCOGENE, V34, P3871, DOI 10.1038/onc.2014.323; Rim SH, 2009, CANCER, V115, P1967, DOI 10.1002/cncr.24216; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Robert F, 2013, WIRES RNA, V4, P333, DOI 10.1002/wrna.1163; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodriguez-Galindo C, 2003, MED PEDIATR ONCOL, V40, P276, DOI 10.1002/mpo.10240; Roman-Gomez J, 2007, HAEMATOL-HEMATOL J, V92, P153, DOI 10.3324/haematol.10782; Rosinski KV, 2008, BLOOD, V111, P4817, DOI 10.1182/blood-2007-06-096313; Rubio CA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0476-1; Russell R, 2015, J MOL BIOL, V427, P1797, DOI 10.1016/j.jmb.2015.03.009; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Samal SK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09982; Sarkar M, 2015, ONCOGENE, V34, P5843, DOI 10.1038/onc.2015.42; Savas S, 2015, BIOMED RES INT, V2015; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Sebestyen E, 2016, GENOME RES, V26, P732, DOI 10.1101/gr.199935.115; Sellmann L, 2010, CANCER GENET CYTOGEN, V203, P149, DOI 10.1016/j.cancergencyto.2010.09.002; Seto M, 1995, GENE, V166, P293, DOI 10.1016/0378-1119(95)00559-5; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Shadrick WR, 2013, J BIOMOL SCREEN, V18, P761, DOI 10.1177/1087057113482586; Shi D, 2016, ONCOGENE, V35, P528, DOI 10.1038/onc.2015.77; Shin EM, 2014, J CLIN INVEST, V124, P3807, DOI 10.1172/JCI73451; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Steimer L, 2012, RNA BIOL, V9, P751, DOI 10.4161/rna.20090; Su CY, 2015, ONCOTARGET, V6, P18602, DOI 10.18632/oncotarget.4329                                                        ; Sumegi J, 2011, MODERN PATHOL, V24, P333, DOI 10.1038/modpathol.2010.201; Sun MN, 2013, BBA-MOL CELL RES, V1833, P1489, DOI 10.1016/j.bbamcr.2013.02.026; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Sun ZF, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-32; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Takata A, 2013, HEPATOLOGY, V57, P162, DOI 10.1002/hep.26011; Takata A, 2012, BIOCHEM BIOPH RES CO, V420, P564, DOI 10.1016/j.bbrc.2012.03.034; Tanaka K, 2009, ONCOGENE, V28, P2142, DOI 10.1038/onc.2009.89; Tanaka T, 2011, FREE RADICAL BIO MED, V50, P1324, DOI 10.1016/j.freeradbiomed.2011.01.024; Taniguchi K, 2015, BBA-MOL BASIS DIS, V1852, P1971, DOI 10.1016/j.bbadis.2015.06.022; Thacker MM, 2005, EXPERT REV ANTICANC, V5, P319, DOI 10.1586/14737140.5.2.319; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Tsumuraya T, 2011, BIOCHEM PHARMACOL, V81, P713, DOI 10.1016/j.bcp.2010.12.025; Valentin-Vega YA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25996; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; van Voss MRH, 2015, ONCOTARGET, V6, P28312, DOI 10.18632/oncotarget.4873; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang D, 2015, HEPATOL INT, V9, P438, DOI 10.1007/s12072-015-9642-0; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang ZD, 2015, CANCER SCI, V106, P1303, DOI 10.1111/cas.12755; Wei X, 2004, ONCOL REP, V11, P253; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wilky BA, 2016, ONCOGENE, V35, P2574, DOI 10.1038/onc.2015.336; Winter C, 2011, NAT REV ENDOCRINOL, V7, P43, DOI 10.1038/nrendo.2010.196; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107; Wu DW, 2016, ONCOTARGET, V7, P22687, DOI 10.18632/oncotarget.8143; Wu DW, 2011, CLIN CANCER RES, V17, P1895, DOI 10.1158/1078-0432.CCR-10-2316; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Xing F, 2014, CURR PHARM DESIGN, V20, P5319, DOI 10.2174/1381612820666140128210912                                               ; Yamamoto M, 2005, CANCER GENET CYTOGEN, V157, P104, DOI 10.1016/j.cancergencyto.2004.06.014; Yang F, 2014, FEBS J, V281, P802, DOI 10.1111/febs.12625; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yassin ER, 2010, LEUKEMIA, V24, P1001, DOI 10.1038/leu.2010.42; Ye XH, 2015, EUR J GYNAECOL ONCOL, V36, P514, DOI 10.12892/ejgo2659.2015; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Yoo HH, 2011, AGING CELL, V10, P557, DOI 10.1111/j.1474-9726.2011.00696.x; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086                                                        ; Zhang YD, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0449-z; Zhao LQ, 2016, AM J CANCER RES, V6, P387; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhou J, 2015, CARCINOGENESIS, V36, P441, DOI 10.1093/carcin/bgv014	230	0	0	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0027-8874	1460-2105		JNCI-J NATL CANCER I	JNCI-J. Natl. Cancer Inst.	JUN	2017	109	6							djw278	10.1093/jnci/djw278				15	Oncology	Oncology	EY5WA	WOS:000404050300008					2018-01-05	
J	Collins, DE; Reuter, JD; Rush, HG; Villano, JS				Collins, Dalis E.; Reuter, Jon D.; Rush, Howard G.; Villano, Jason S.			Viral Vector Biosafety in Laboratory Animal Research	COMPARATIVE MEDICINE			English	Article							SIMPLEX-VIRUS TYPE-1; GENE-THERAPY; LENTIVIRAL VECTORS; CLINICAL-TRIALS; TRANSDUCTION; CELLS; MODEL; CYTOTOXICITY; INACTIVATION; INTEGRATION	Viral vector research presents unique occupational health and safety challenges to institutions due to the rapid development of both in vivo and in vitro gene-editing technologies. Risks to human and animal health make it incumbent on institutions to appropriately evaluate viral vector usage in research on the basis of available information and governmental regulations and guidelines. Here we review the factors related to risk assessment regarding viral vector usage in animals and the relevant regulatory documents associated with this research, and we highlight the most commonly used viral vectors in research today. This review is particularly focused on the background, use in research and associated health and environmental risks related to adenoviral, adeno-associated viral, lentiviral, and herpesviral vectors.	[Collins, Dalis E.] Baylor Coll Med, Houston, TX 77030 USA; [Reuter, Jon D.] Univ Colorado, Boulder, CO 80309 USA; [Rush, Howard G.; Villano, Jason S.] Univ Michigan, Ann Arbor, MI 48109 USA	Villano, JS (reprint author), Univ Michigan, Ann Arbor, MI 48109 USA.	jvillano@med.umich.edu					Bagutti C, 2012, APPL BIOSAF, V17, P188; Baldo A, 2013, CURR GENE THER, V13, P385; Bauer G, 2008, MOL THER, V16, P1308, DOI 10.1038/mt.2008.93; Berto E, 2005, GENE THER, V12, pS98, DOI 10.1038/sj.gt.3302623; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Braun A., 2006, CURRENT PROTOCOLS CD; Campagna MV, 2016, J AM ASSOC LAB ANIM, V55, P175; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Centers for Disease Control and Prevention and National Institutes of Health, 2009, BIOS MICR BIOM LAB; Chuah Marinee K. L., 2003, Current Gene Therapy, V3, P527, DOI 10.2174/1566523034578140; CROUGHAN WS, 1988, J CLIN MICROBIOL, V26, P213; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Debyser Zeger, 2003, Current Gene Therapy, V3, P517, DOI 10.2174/1566523034578177; Deichmann A, 2013, CURR GENE THER, V13, P469; Dismuke DJ, 2013, CURR GENE THER, V13, P434; Dull T, 1998, J VIROL, V72, P8463; Dupont Francis, 2003, Current Gene Therapy, V3, P567, DOI 10.2174/1566523034578104; Fallaux FJ, 1998, HUM GENE THER, V9, P1909, DOI 10.1089/hum.1998.9.13-1909                                                      ; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Glorioso JC, 2014, HUM GENE THER, V25, P83, DOI 10.1089/hum.2014.2501; Gordon JW, 2001, MOL THER, V3, P557, DOI 10.1006/mthe.2001.0290; Hanawa H, 2005, J VIROL, V79, P8410, DOI 10.1128/JVI.79.13.8410-8421.2005; Janovitz T, 2013, J VIROL, V87, P8559, DOI 10.1128/JVI.01135-13; JOHNSON PA, 1992, J VIROL, V66, P2952; Khare R, 2011, CURR GENE THER, V11, P241, DOI 10.2174/156652311796150363                                                      ; King LM, 2002, CONTEMP TOP LAB ANIM, V41, P43; Lachmann RH, 2004, INT J EXP PATHOL, V85, P177, DOI 10.1111/j.0959-9673.2004.00383.x                                                ; LEWIS ME, 1984, J VIROL, V52, P300; Lim F, 2013, CURR GENE THER, V13, P478; Maheshwari G, 2004, J VIROL METHODS, V118, P141, DOI 10.1016/j.jviromet.2004.02.003; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244                                                   ; Meyers C, 2000, VIROLOGY, V272, P338, DOI 10.1006/viro.2000.0385; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354                                                      ; Miyagawa Y, 2015, P NATL ACAD SCI USA, V112, pE1632, DOI 10.1073/pnas.1423556112; Miyoshi H, 1998, J VIROL, V72, P8150; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; NIH Office of Science Policy, 2016, NIH GUID RES INV REC; Nowrouzi A, 2012, MOL THER, V20, P1177, DOI 10.1038/mt.2012.47; Pan YW, 2007, J VIROL, V81, P639, DOI 10.1128/JVI.01089-06; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Reuter JD, 2012, COMPARATIVE MED, V62, P361; Rosas LE, 2012, MOL THER, V20, P2098, DOI 10.1038/mt.2012.197; Schambach A, 2013, HUM GENE THER, V24, P132, DOI 10.1089/hum.2012.229; Schenk-Braat EAM, 2007, J GENE MED, V9, P910, DOI 10.1002/jgm.1096; SPAETE RR, 1985, P NATL ACAD SCI USA, V82, P694, DOI 10.1073/pnas.82.3.694; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; TEODORO JG, 1995, ONCOGENE, V11, P467; US Department of Health and Human Services, 2006, BIOS CONS RES LENT V; Valtierra HN., 2008, APPL BIOSAF, V13, P21; Wang Q, 1997, GENE THER, V4, P1300, DOI 10.1038/sj.gt.3300535; YALKINOGLU AO, 1988, CANCER RES, V48, P3123; Zou AH, 2004, VIROLOGY, V326, P240, DOI 10.1016/j.virol.2004.06.007	55	1	1	0	0	AMER ASSOC LABORATORY ANIMAL SCIENCE	MEMPHIS	9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA	1532-0820			COMPARATIVE MED	Comparative Med.	JUN	2017	67	3					215	221						7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	EX8UG	WOS:000403525100004	28662750				2018-01-05	
J	Ma, Y; Han, X; Bustamante, OQ; de Castro, RB; Zhang, K; Zhang, PC; Li, Y; Liu, ZB; Liu, XW; Ferrari, M; Hu, ZB; Segovia, JC; Qin, LD				Ma, Yuan; Han, Xin; Quintana Bustamante, Oscar; Bessa de Castro, Ricardo; Zhang, Kai; Zhang, Pengchao; Li, Ying; Liu, Zongbin; Liu, Xuewu; Ferrari, Mauro; Hu, Zhongbo; Segovia, Jose Carlos; Qin, Lidong			Highly efficient genome editing of human hematopoietic stem cells via a nano-silicon-blade delivery approach	INTEGRATIVE BIOLOGY			English	Article							MECHANOSENSITIVE CHANNEL; GENE-THERAPY; ELECTROPORATION; TRANSFECTION; CRISPR/CAS9; CEBPA; CAS9	Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 bacterial immunity system has opened a promising avenue to treat genetic diseases that affect the human hematopoietic stem cells (HSCs). Therefore, finding a highly efficient delivery method capable of modifying the genome in the hard-to-transfect HSCs, combined with the advanced CRISPR-Cas9 system, may meet the challenges for dissecting the hematologic disease mechanisms and facilitate future clinical applications. Here, we developed an effective HSC-specified delivery microfluidic chip to disrupt the cell membrane transiently by inducing rapid mechanical deformation that allowed the delivery of biomaterials into the cytoplasm from the surrounding matrix. Compared with the previous designs, the new nano-silicon-blade structure was specifically optimized for HSCs. Using the silicon substrate, the sharpness and rigidity of the nano-blade constriction was largely enhanced to improve the biomaterials delivery efficiency. We achieved highly efficient delivery results by transporting various macro-molecules into the HSCs. Moreover, the treated HSCs possess high viability and maintain inherent pluripotency after the delivery via the Nano-Blade Chip (NB-Chip). Subsequently, we disrupted the p42 isoform in C/EBPa on the NB-Chip and induced HSCs into a myeloid proliferation behavior. In conclusion, the NB-Chip provides a harmless, rapid and high-throughput gene editing approach for the HSC study and therapeutics.	[Ma, Yuan; Hu, Zhongbo] Univ Chinese Acad Sci, Coll Mat Sci & Optoelect, Beijing 100049, Peoples R China; [Ma, Yuan; Han, Xin; Zhang, Kai; Zhang, Pengchao; Li, Ying; Liu, Zongbin; Liu, Xuewu; Ferrari, Mauro; Qin, Lidong] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Ma, Yuan; Han, Xin; Bessa de Castro, Ricardo; Zhang, Kai; Zhang, Pengchao; Li, Ying; Liu, Zongbin; Liu, Xuewu; Ferrari, Mauro; Qin, Lidong] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Quintana Bustamante, Oscar] Inst Invest Sanitaria Fdn Jimenez Diaz, CIEMAT CIBERER, Hematopoiet Innovat Therapies Div, Madrid, Spain; [Bessa de Castro, Ricardo] Swansea Univ, Coll Engn, Singleton Pk, Swansea S82 8PP, W Glam, Wales	Qin, LD (reprint author), Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA.; Qin, LD (reprint author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA.	lqin@houstonmethodist.org	Segovia, Jose/L-2922-2014; Han, Xin/K-4480-2017	Segovia, Jose/0000-0003-4101-6124; Han, Xin/0000-0002-9620-7502; Li, Ying/0000-0001-8689-5578	 [R01 CA180083];  [R56 AG049714];  [R21 CA191179]	We are grateful for funding support from R01 CA180083, R56 AG049714, and R21 CA191179.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638                                                            ; Geng T, 2010, J CONTROL RELEASE, V144, P91, DOI 10.1016/j.jconrel.2010.01.030; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Han X., 2017, ADV BIOSYST, DOI [10.1002/adbi.201600007, DOI 10.1002/ADBI.201600007]; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Hoiles W, 2014, BIOPHYS J, V107, P1339, DOI 10.1016/j.bpj.2014.07.056; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Pak OS, 2015, P NATL ACAD SCI USA, V112, P9822, DOI 10.1073/pnas.1512152112; Quintana-Bustamante O, 2012, LEUKEMIA, V26, P1537, DOI 10.1038/leu.2012.38; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Talele S., 2013, EMERGING TRENDS COMP, P567; Wang J, 2010, LAB CHIP, V10, P2673, DOI [10.1039/c0lc00131g, 10.1039/c01c00131g]; Wang J, 2008, ANAL CHEM, V80, P9840, DOI 10.1021/ac801940w; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wiggins P, 2004, P NATL ACAD SCI USA, V101, P4071, DOI 10.1073/pnas.0307804101; Zhan YH, 2012, J CONTROL RELEASE, V160, P570, DOI 10.1016/j.jconrel.2012.04.006	27	0	0	10	10	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1757-9694	1757-9708		INTEGR BIOL-UK	Integr. Biol.	JUN 1	2017	9	6					548	554		10.1039/c7ib00060j				7	Cell Biology	Cell Biology	EY2EZ	WOS:000403782600006	28513735	green_accepted			2018-01-05	
J	Gingras, S; Kuliyev, E; Pelletier, S				Gingras, Sebastien; Kuliyev, Emin; Pelletier, Stephane			SCYL1 does not regulate REST expression and turnover	PLOS ONE			English	Article							CELL LUNG-CANCER; IN-VIVO; GENE; DEGRADATION; DIFFERENTIATION; CRISPR-CAS9; MUTATION	A recent study identified SCYL1 as one of the components of the oncogenic STP axis, which promotes triple-negative breast cancer by regulating degradation of the REST tumor suppressor. Contrary to the findings of that study, herein we show by using 3 distinct genetic approaches that SCYL1 does not regulate REST turnover. Specifically, REST protein levels and turnover were identical in Scyl1+/+ and Scyl1-/- mouse embryonic fibroblasts. Similarly, targeted inactivation of SCYL1 in Hek293T cells by using CRIPSR-Cas9 technology did not affect REST steady-state level and turnover. Furthermore, RNA interference-mediated depletion of SCYL1 in Hek293T or MDA-MB-231 cells did not alter REST steady-state level and turnover. Together, our findings indicate that SCYL1 does not contribute to REST turnover and thus do not support a previous study suggesting a role for SCYL1 in mediating REST degradation.	[Gingras, Sebastien] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Kuliyev, Emin; Pelletier, Stephane] St Jude Childrens Res Hosp, Dept Immunol, Embryon Stem Cell Lab, Memphis, TN 38105 USA	Pelletier, S (reprint author), St Jude Childrens Res Hosp, Dept Immunol, Embryon Stem Cell Lab, Memphis, TN 38105 USA.	stephane.pelletier@stjude.org			American Lebanese Syrian Associated Charities	Support was provided by American Lebanese Syrian Associated Charities.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BLOT S, 1995, J NEUROPATH EXP NEUR, V54, P812; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Coulson JM, 2000, CANCER RES, V60, P1840; Dai CL, 2013, J BIOL CHEM, V288, P23875, DOI 10.1074/jbc.M112.445148; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Karlin KL, 2014, CELL REP, V9, P1318, DOI 10.1016/j.celrep.2014.10.011; Kreisler A, 2010, ONCOGENE, V29, P5828, DOI 10.1038/onc.2010.321; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Nesti E, 2014, P NATL ACAD SCI USA, V111, pE3929, DOI 10.1073/pnas.1414770111; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Pelletier S, 2012, J NEUROSCI, V32, P16560, DOI 10.1523/JNEUROSCI.1787-12.2012; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178680	10.1371/journal.pone.0178680				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EW6HZ	WOS:000402611800102	28570664	gold			2018-01-05	
J	Lalonde, S; Stone, OA; Lessard, S; Lavertu, A; Desjardins, J; Beaudoin, M; Rivas, M; Stainier, DYR; Lettre, G				Lalonde, Simon; Stone, Oliver A.; Lessard, Samuel; Lavertu, Adam; Desjardins, Jessica; Beaudoin, Melissa; Rivas, Manuel; Stainier, Didier Y. R.; Lettre, Guillaume			Frameshift indels introduced by genome editing can lead to in-frame exon skipping	PLOS ONE			English	Article							CRISPR-CAS9 SYSTEM; HUMAN FETAL; HUMAN-CELLS; EXPRESSION; KNOCKOUTS; BINDING	The introduction of frameshift indels by genome editing has emerged as a powerful technique to study the functions of uncharacterized genes in cell lines and model organisms. Such mutations should lead to mRNA degradation owing to nonsense-mediated mRNA decay or the production of severely truncated proteins. Here, we show that frameshift indels engineered by genome editing can also lead to skipping of "multiple of three nucleotides" exons. Such splicing events result in in-frame mRNA that may encode fully or partially functional proteins. We also characterize a segregating nonsense variant (rs2273865) located in a "multiple of three nucleotides" exon of LGALS8 that increases exon skipping in human erythroblast samples. Our results highlight the potentially frequent contribution of exonic splicing regulatory elements and are important for the interpretation of negative results in genome editing experiments. Moreover, they may contribute to a better annotation of loss-of-function mutations in the human genome.	[Lalonde, Simon; Lessard, Samuel; Desjardins, Jessica; Beaudoin, Melissa; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ, Canada; [Stone, Oliver A.; Stainier, Didier Y. R.] UCSF, Dept Biochem & Biophys, San Francisco, CA USA; [Stone, Oliver A.; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Lessard, Samuel; Lettre, Guillaume] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Lavertu, Adam; Rivas, Manuel] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Lettre, G (reprint author), Montreal Heart Inst, Montreal, PQ, Canada.; Lettre, G (reprint author), Univ Montreal, Fac Med, Montreal, PQ, Canada.	guillaume.lettre@umontreal.ca		Stainier, Didier/0000-0002-0382-0026; Lavertu, Adam/0000-0003-2396-1915	NIH [HL54737]; Packard Foundation; Max Planck Society; Canadian Institutes of Health Research [136979, 123382]; Montreal Heart Institute Foundation; Canada Research Chair Program	D.Y.R.S. is funded by NIH (HL54737), Packard Foundation and Max Planck Society. G.L. is supported by grants from the Canadian Institutes of Health Research (operating grants #136979 and #123382), the Montreal Heart Institute Foundation, and the Canada Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoin M, 2015, ARTERIOSCL THROM VAS, V35, P1472, DOI 10.1161/ATVBAHA.115.305534; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charton K, 2016, HUM MOL GENET, V25, P4518, DOI 10.1093/hmg/ddw280; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Julien P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11558; Kapahnke M, 2016, CELLS, V5; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lessard S, 2016, HUM MOL GENET, V25, P2082, DOI 10.1093/hmg/ddw055; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MAQUAT LE, 1995, RNA, V1, P453; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; McCarthy S., 2016, BIORXIV; Voight BF, 2009, NAT GENET, V41, P334, DOI DOI 10.1038/NG.327; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Panousis NI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0467-2; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	27	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178700	10.1371/journal.pone.0178700				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EW6HZ	WOS:000402611800107	28570605	gold			2018-01-05	
J	Prykhozhij, SV; Steele, SL; Razaghi, B; Berman, JN				Prykhozhij, Sergey V.; Steele, Shelby L.; Razaghi, Babak; Berman, Jason N.			A rapid and effective method for screening, sequencing and reporter verification of engineered frameshift mutations in zebrafish	DISEASE MODELS & MECHANISMS			English	Article						CRISPR; Cas9; SgRNA; Zebrafish; Mutation; Reporter	EXONIC SPLICING ENHANCERS; TRANSLATION START SITES; IN-VIVO; GENOME MODIFICATIONS; CHARGE-SYNDROME; IDENTIFICATION; GENES; CELLS; ENDONUCLEASE; CRISPR/CAS9	Clustered regularly interspaced palindromic repeats (CRISPR)/Casbased adaptive immunity against pathogens in bacteria has been adapted for genome editing and applied in zebrafish (Danio rerio) to generate frameshift mutations in protein-coding genes. Although there are methods to detect, quantify and sequence CRISPR/Cas9-induced mutations, identifying mutations in F1 heterozygous fish remains challenging. Additionally, sequencing a mutation and assuming that it causes a frameshift does not prove causality because of possible alternative translation start sites and potential effects of mutations on splicing. This problem is compounded by the relatively few antibodies available for zebrafish proteins, limiting validation at the protein level. To address these issues, we developed a detailed protocol to screen F1 mutation carriers, and clone and sequence identified mutations. In order to verify that mutations actually cause frameshifts, we created a fluorescent reporter system that can detect frameshift efficiency based on the cloning of wild- type and mutant cDNA fragments and their expression levels. As proof of principle, we applied this strategy to three CRISPR/Cas9-induced mutations in pycr1a, chd7 and hace1 genes. An insertion of seven nucleotides in pycr1a resulted in the first reported observation of exon skipping by CRISPR/Cas9-induced mutations in zebrafish. However, of these three mutant genes, the fluorescent reporter revealed effective frameshifting exclusively in the case of a two-nucleotide deletion in chd7, suggesting activity of alternative translation sites in the other two mutants even though pycr1a exon-skipping deletion is likely to be deleterious. This article provides a protocol for characterizing frameshift mutations in zebrafish, and highlights the importance of checking mutations at the mRNA level and verifying their effects on translation by fluorescent reporters when antibody detection of protein loss is not possible.	[Prykhozhij, Sergey V.; Steele, Shelby L.; Razaghi, Babak; Berman, Jason N.] Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Berman, Jason N.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada; [Berman, Jason N.] Dalhousie Univ, Dept Pathol, Halifax, NS B3H4R2, Canada	Berman, JN (reprint author), Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada.; Berman, JN (reprint author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada.; Berman, JN (reprint author), Dalhousie Univ, Dept Pathol, Halifax, NS B3H4R2, Canada.	jason.berman@iwk.nshealth.ca			Terry Fox Research Institute (TFRI Grant) [1046]; Genome Canada; Canadian Institutes of Health Research Rare Disease Models and Mechanisms Network [CIHR RCN-137793]	This work was funded by the Terry Fox Research Institute (TFRI Grant #1046), Genome Canada, and the Canadian Institutes of Health Research Rare Disease Models and Mechanisms Network (CIHR RCN-137793).	Adriao A, 2016, ARCH BIOCHEM BIOPHYS, V591, P43, DOI 10.1016/j.abb.2015.12.004; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Caceres EF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r143; Carrington B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv802; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Carter B. S., 2016, ZEBRAFISH, P10; Chen JB, 2012, DNA RES, V19, P423, DOI 10.1093/dnares/dss023; Chen YC, 2010, NUCLEIC ACIDS RES, V38, P4635, DOI 10.1093/nar/gkq230; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cotter KA, 2013, GEN COMP ENDOCR, V194, P217, DOI 10.1016/j.ygcen.2013.09.014; D'Agostino Y, 2016, MOL BIOTECHNOL, V58, P73, DOI 10.1007/s12033-015-9905-y; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Daugaard M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3180; Desmet FO, 2012, METHODS MOL BIOL, V867, P17, DOI 10.1007/978-1-61779-767-5_2; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goncalves V, 2009, MUTAT RES-FUND MOL M, V662, P33, DOI 10.1016/j.mrfmmm.2008.12.001; Gonzales APW, 2014, METHOD ENZYMOL, V546, P377, DOI 10.1016/B978-0-12-801185-0.00018-0; Hahn MA, 2009, J ENDOCRINOL, V201, P387, DOI 10.1677/JOE-09-0038; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KIM JW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018556; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McGookin R, 1988, Methods Mol Biol, V4, P75, DOI 10.1385/0-89603-127-6:75; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Talbot JC, 2014, ZEBRAFISH, V11, P583, DOI 10.1089/zeb.2014.1047; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Uddin B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2284-8; Varshney GK, 2015, ADV GENET, V92, P1, DOI 10.1016/bs.adgen.2015.09.002; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103	55	4	4	2	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	JUN 1	2017	10	6					811	822		10.1242/dmm.026765				12	Cell Biology; Pathology	Cell Biology; Pathology	EX4FT	WOS:000403189500012	28280001	gold			2018-01-05	
J	Fujita, T; Yuno, M; Suzuki, Y; Sugano, S; Fujii, H				Fujita, Toshitsugu; Yuno, Miyuki; Suzuki, Yutaka; Sugano, Sumio; Fujii, Hodaka			Identification of physical interactions between genomic regions by enChIP-Seq	GENES TO CELLS			English	Article							CHROMATIN IMMUNOPRECIPITATION ENCHIP; CHROMOSOME CONFORMATION CAPTURE; LOCUS-CONTROL REGION; GLOBIN GENE-EXPRESSION; EFFICIENT ISOLATION; TRANSGENIC MICE; TAL PROTEINS; BINDING; CRISPR; CAS9	Physical interactions between genomic regions play critical roles in the regulation of genome functions, including gene expression. Here, we show the feasibility of using engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) in combination with next-generation sequencing (NGS) (enChIP-Seq) to detect such interactions. In enChIP-Seq, the target genomic region is captured by an engineered DNA-binding complex, such as a clustered regularly interspaced short palindromic repeats (CRISPR) system consisting of a catalytically inactive form of Cas9 and a single guide RNA. Subsequently, the genomic regions that physically interact with the target genomic region in the captured complex are sequenced by NGS. Using enChIP-Seq, we found that the 5HS5 locus, which is involved in the regulation of globin genes expression at the -globin locus, interacts with multiple genomic regions upon erythroid differentiation in the human erythroleukemia cell line K562. Genes near the genomic regions inducibly associated with the 5HS5 locus were transcriptionally up-regulated in the differentiated state, suggesting the existence of a coordinated transcription mechanism mediated by physical interactions between these loci. Thus, enChIP-Seq might be a potentially useful tool for detecting physical interactions between genomic regions in a nonbiased manner, which would facilitate elucidation of the molecular mechanisms underlying regulation of genome functions.	[Fujita, Toshitsugu; Yuno, Miyuki; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	Fujii, H (reprint author), Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/A-2420-2008	Fujii, Hodaka/0000-0003-1296-4256	Asahi Glass Foundation; Uehara Memorial Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [25830131, 15K06895, 15H04329, 23118516, 25118512, 15H01354, 221S0002, 26650059]	This work was supported by the Asahi Glass Foundation (H.F.), the Uehara Memorial Foundation (H.F.), the Kurata Memorial Hitachi Science and Technology Foundation (T.F. and H.F.), Grant-in-Aid for Young Scientists (B) (#25830131) (T.F.), Grant-in-Aid for Scientific Research (C) (#15K06895) (T.F.), Grant-in-Aid for Scientific Research (B) (#15H04329) (T.F., H.F.), Grant-in-Aid for Scientific Research on Innovative Areas 'Cell Fate' (#23118516) (T.F.), 'Transcription Cycle' (#25118512 and #15H01354) (H.F.), 'Genome Science' (#221S0002) (H.F.) and a Grant-in-Aid for Exploratory Research (#26650059) (H.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; CATERINA JJ, 1991, P NATL ACAD SCI USA, V88, P1626, DOI 10.1073/pnas.88.5.1626; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chien R, 2011, J BIOL CHEM, V286, P17870, DOI 10.1074/jbc.M110.207365; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng BW, 2013, SEMIN CANCER BIOL, V23, P65, DOI 10.1016/j.semcancer.2012.01.003; desWit E, 2012, GENE DEV, V26, P11, DOI DOI 10.1101/GAD.179804.111; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fujii H, 2015, INT J MOL SCI, V16, P21802, DOI 10.3390/ijms160921802; Fujita T, 2012, ADV BIOSCI BIOTECHNO, V3, P626, DOI DOI 10.4236/ABB.2012.35081; Fujita T, 2007, NUCLEIC ACIDS RES, V35, P1007, DOI 10.1093/nar/gkl1138; Fujita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30485; Fujita T, 2016, GENES CELLS, V21, P370, DOI 10.1111/gtc.12341; Fujita T, 2016, GENE REGUL SYST BIO, V10, P1, DOI 10.4137/GRSB.S32520; Fujita T, 2015, INT J MOL SCI, V16, P23143, DOI 10.3390/ijms161023143; Fujita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123387; Fujita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116579; Fujita T, 2014, BMC MOL BIOL, V15, DOI 10.1186/s12867-014-0026-0; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fujita T, 2012, MOL BIOL REP, V39, P9613, DOI 10.1007/s11033-012-1825-3; Fujita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026109; Gavrilov AA, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1322; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Ghirlando R, 2012, BBA-GENE REGUL MECH, V1819, P644, DOI 10.1016/j.bbagrm.2012.01.016; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895                                                            ; Nagano T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0753-7; Navas PA, 2001, J MOL BIOL, V312, P17, DOI 10.1006/jmbi.2001.4939; O'Green H., 2015, NUCLEIC ACIDS RES, V43, P3389; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313                                                ; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Seki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095374; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110	46	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	JUN	2017	22	6					506	520		10.1111/gtc.12492				15	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	EX5QF	WOS:000403296400001	28474362	gold			2018-01-05	
J	Shopan, J; Mou, HP; Zhang, LL; Zhang, CT; Ma, WW; Walsh, JA; Hu, ZY; Yang, JH; Zhang, MF				Shopan, Jannat; Mou, Haipeng; Zhang, Lili; Zhang, Changtong; Ma, Weiwei; Walsh, John A.; Hu, Zhongyuan; Yang, Jinghua; Zhang, Mingfang			Eukaryotic translation initiation factor 2B-beta (eIF2B beta), a new class of plant virus resistance gene	PLANT JOURNAL			English	Article						Brassica juncea; Turnip mosaic virus; eIF2B beta; virus resistance; mustard; new resistance gene	TURNIP-MOSAIC-VIRUS; BRASSICA-RAPA; CHINESE-CABBAGE; INFECTION; SEQUENCE; NAPUS; SUSCEPTIBILITY; IDENTIFICATION; POTYVIRUS; YEAST	Recessive resistances to plant viruses in the Potyvirus genus have been found to be based on mutations in the plant eukaryotic translation initiation factors, eIF4E and eIF4G or their isoforms. Here we report that natural, monogenic recessive resistance to the Potyvirus Turnip mosaic virus (TuMV) has been found in a number of mustard (Brassica juncea) accessions. Bulked segregant analysis and sequencing of resistant and susceptible plant lines indicated the resistance is controlled by a single recessive gene, recessive TuMV resistance 03 (retr03), an allele of the eukaryotic translation initiation factor 2B-beta (eIF2B beta). Silencing of eIF2B beta in a TuMV-susceptible mustard plant line and expression of eIF2B beta from a TuMV-susceptible line in a TuMV-resistant mustard plant line confirmed the new resistance mechanism. A functional copy of a specific allele of eIF2B beta is required for efficient TuMV infection. eIF2B beta represents a new class of virus resistance gene conferring resistance to any pathogen. eIF2B acts as a guanine nucleotide exchange factor (GEF) for its GTP-binding protein partner eIF2 via interaction with eIF2 center dot GTP at an early step in translation initiation. Further genotyping indicated that a single non-synonymous substitution (A120G) in the N-terminal region of eIF2B beta was responsible for the TuMV resistance. A reproducible marker has been developed, facilitating marker-assisted selection for TuMV resistance in B. juncea. Our findings provide a new target for seeking natural resistance to potyviruses and new opportunities for the control of potyviruses using genome editing techniques targeted on eIF2B beta.	[Shopan, Jannat; Mou, Haipeng; Zhang, Lili; Zhang, Changtong; Ma, Weiwei; Hu, Zhongyuan; Yang, Jinghua; Zhang, Mingfang] Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou 310058, Zhejiang, Peoples R China; [Walsh, John A.] Univ Warwick, Sch Life Sci, Warwick CV35 9EF, England; [Hu, Zhongyuan; Yang, Jinghua; Zhang, Mingfang] Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou 310058, Zhejiang, Peoples R China; [Hu, Zhongyuan; Yang, Jinghua; Zhang, Mingfang] Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou 310058, Zhejiang, Peoples R China	Yang, JH (reprint author), Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou 310058, Zhejiang, Peoples R China.; Yang, JH (reprint author), Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou 310058, Zhejiang, Peoples R China.; Yang, JH (reprint author), Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou 310058, Zhejiang, Peoples R China.	yangjinghua@zju.edu.cn	Yang, Jinghua/G-9164-2016		Science and Technology Program of ZHEJIANG Province [2015C32046]; Special Fund from Ministry of Agriculture of China [09162130135252]	We would like to thank Dr C.W. Zhang and Prof. I. Jupin for the pTY-S vector. This work was supported by grants from the Science and Technology Program of ZHEJIANG Province (2015C32046) and a specific grant from a Special Fund from the Ministry of Agriculture of China (09162130135252).	Bogorad AM, 2014, BIOCHEMISTRY-US, V53, P3432, DOI 10.1021/bi500346u; Chalhoub B, 2014, SCIENCE, V345, P1255; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Chung H, 2014, MOL GENET GENOMICS, V289, P149, DOI 10.1007/s00438-013-0798-9; Diaz-Pendon JA, 2004, MOL PLANT PATHOL, V5, P223, DOI 10.1111/J.1364-3703.2004.00223.X; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Edwardson J., 1991, FLA AGR EXP STN MONO, V16, P1; Elsby R, 2011, J VIROL, V85, P9716, DOI 10.1128/JVI.05146-11; Fekih R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068529; Gao Z, 2004, THEOR APPL GENET, V109, P488, DOI 10.1007/s00122-004-1652-6; Hill JT, 2013, GENOME RES, V23, P687, DOI 10.1101/gr.146936.112; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4, DOI DOI 10.1101/CSHPERSPECT.A011544; Hughes SL, 2003, THEOR APPL GENET, V107, P1169, DOI 10.1007/s00122-003-1363-4; Hughes SL, 2002, PLANT PATHOL, V51, P567, DOI 10.1046/j.1365-3059.2002.00755.x; Hwang J, 2013, VIROLOGY, V439, P105, DOI 10.1016/j.virol.2013.02.004; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jenner CE, 1996, PLANT PATHOL, V45, P848, DOI 10.1111/j.1365-3059.1996.tb02895.x                                              ; Jennings MD, 2014, CELL CYCLE, V13, P2660, DOI 10.4161/15384101.2014.948797; Jin M, 2014, THEOR APPL GENET, V127, P509, DOI 10.1007/s00122-013-2237-z; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZH, 2014, VIROLOGY, V448, P43, DOI 10.1016/j.virol.2013.09.012; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nellist CF, 2014, PLANT J, V77, P261, DOI 10.1111/tpj.12389; Nicaise V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00660; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511                                                     ; Ohshima K, 1996, ARCH VIROL, V141, P1991, DOI 10.1007/BF01718209; Pflieger S, 2008, PLANT J, V56, P678, DOI 10.1111/j.1365-313X.2008.03620.x; Qian W, 2013, THEOR APPL GENET, V126, P179, DOI 10.1007/s00122-012-1972-x; Reverchon F, 2015, ENVIRON SCI POLLUT R, V22, P2138, DOI 10.1007/s11356-014-3451-1; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; ROBBINS MA, 1994, THEOR APPL GENET, V89, P583, DOI 10.1007/BF00222452; Rusholme RL, 2007, J GEN VIROL, V88, P3177, DOI 10.1099/vir.0.83194-0; Sasvari Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002438; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; TOMLINSON JA, 1987, ANN APPL BIOL, V110, P661, DOI 10.1111/j.1744-7348.1987.tb04187.x; U N, 1935, JPN J BOT, V7, P389; Walsh JA, 2002, MOL PLANT PATHOL, V3, P289, DOI 10.1046/j.1364-3703.2002.00132.x; Walsh JA, 2002, EUR J PLANT PATHOL, V108, P15, DOI 10.1023/A:1013962911906; Walsh JA, 1999, THEOR APPL GENET, V99, P1149, DOI 10.1007/s001220051319; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657	47	2	2	25	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	JUN	2017	90	5					929	940		10.1111/tpj.13519				12	Plant Sciences	Plant Sciences	EX6IR	WOS:000403346500008	28244149				2018-01-05	
J	Yao, X; Wang, X; Hu, XD; Liu, Z; Liu, JL; Zhou, HB; Shen, XW; Wei, Y; Huang, ZJ; Ying, WQ; Wang, Y; Nie, YH; Zhang, CC; Li, SL; Cheng, LP; Wang, QF; Wu, Y; Huang, PY; Sun, Q; Shi, LY; Yang, H				Yao, Xuan; Wang, Xing; Hu, Xinde; Liu, Zhen; Liu, Junlai; Zhou, Haibo; Shen, Xiaowen; Wei, Yu; Huang, Zijian; Ying, Wenqin; Wang, Yan; Nie, Yan-Hong; Zhang, Chen-Chen; Li, Sanlan; Cheng, Leping; Wang, Qifang; Wu, Yan; Huang, Pengyu; Sun, Qiang; Shi, Linyu; Yang, Hui			Homology-mediated end joining-based targeted integration using CRISPR/Cas9	CELL RESEARCH			English	Article						homology-mediated end joining; CRISPR/Cas9; monkey embryos; neurons; knock-in	ZINC-FINGER NUCLEASES; IN-VIVO; CYNOMOLGUS MONKEY; KNOCK-IN; GENE; DNA; ZEBRAFISH; CELLS; GENERATION; CLEAVAGE	Targeted integration of transgenes can be achieved by strategies based on homologous recombination (HR), microhomology-mediated end joining (MMEJ) or non-homologous end joining (NHEJ). The more generally used HR is inefficient for achieving gene integration in animal embryos and tissues, because it occurs only during cell division, although MMEJ and NHEJ can elevate the efficiency in some systems. Here we devise a homology-mediated end joining (HMEJ)-based strategy, using CRISPR/Cas9-mediated cleavage of both transgene donor vector that contains guide RNA target sites and similar to 800 bp of homology arms, and the targeted genome. We found no significant improvement of the targeting efficiency by the HMEJ-based method in either mouse embryonic stem cells or the neuroblastoma cell line, N2a, compared to the HR-based method. However, the HMEJ-based method yielded a higher knockin efficiency in HEK293T cells, primary astrocytes and neurons. More importantly, this approach achieved transgene integration in mouse and monkey embryos, as well as in hepatocytes and neurons in vivo, with an efficiency much greater than HR-, NHEJ- and MMEJ-based strategies. Thus, the HMEJ-based strategy may be useful for a variety of applications, including gene editing to generate animal models and for targeted gene therapies.	[Yao, Xuan; Wang, Xing; Hu, Xinde; Liu, Zhen; Zhou, Haibo; Shen, Xiaowen; Wei, Yu; Huang, Zijian; Ying, Wenqin; Wang, Yan; Nie, Yan-Hong; Zhang, Chen-Chen; Li, Sanlan; Cheng, Leping; Wang, Qifang; Sun, Qiang; Shi, Linyu; Yang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Key Lab Primate Neurobiol,Inst Neurosci,State Key, Shanghai 200031, Peoples R China; [Yao, Xuan; Wang, Xing; Liu, Junlai; Huang, Zijian] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Liu, Junlai; Huang, Pengyu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Liu, Junlai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Wei, Yu] Shanghai Univ, Shanghai 200444, Peoples R China; [Wu, Yan] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Sun, Q; Shi, LY; Yang, H (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Key Lab Primate Neurobiol,Inst Neurosci,State Key, Shanghai 200031, Peoples R China.	qsun@ion.ac.cn; shilinyu@ion.ac.cn; huiyang@ion.ac.cn		yang, hui/0000-0003-3590-722X	CAS Strategic Priority Research Program [XDB02050007, XDA01010409]; National Hightech R&D Program (863 Program) [2015AA020307]; National Natural Science Foundation of China (NSFC) [31522037, 31500825]; China Youth Thousand Talents Program; Chinese Academy of Sciences; National Key Technology R& D Program of China [2014BAI03B00]; Shanghai City Committee of science and technology project [16JC1420202, 14140900100]; CAS Hundreds of Talents Program of China	We thank Mu-ming Poo for comments on the manuscript. This work was supported by CAS Strategic Priority Research Program (XDB02050007, XDA01010409), the National Hightech R&D Program (863 Program; 2015AA020307), the National Natural Science Foundation of China (NSFC grants 31522037 and 31500825), China Youth Thousand Talents Program (to HY), Break through project of Chinese Academy of Sciences, the National Key Technology R& D Program of China (2014BAI03B00 to QS), Shanghai City Committee of science and technology project (16JC1420202 to HY; 14140900100 to QS), CAS Hundreds of Talents Program of China (QS).	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Izpisua BJC, 2015, NEURON, V86, P617; Jennings C, 2016, NAT NEUROSCI, V19, P1123, DOI 10.1038/nn.4362; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Liu YG, 2015, J NEUROSCI, V35, P9336, DOI 10.1523/JNEUROSCI.3975-14.2015; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sun Q, 2008, P NATL ACAD SCI USA, V105, P12956, DOI 10.1073/pnas.0805639105; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Takahashi M, 2008, DEV GROWTH DIFFER, V50, P485, DOI [10.1111/j.1440-169X.2008.01046.x, 10.1111/j.1440-169x.2008.01046.x]; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8	30	3	4	17	17	INST BIOCHEMISTRY & CELL BIOLOGY	SHANGHAI	SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA	1001-0602	1748-7838		CELL RES	Cell Res.	JUN	2017	27	6					801	814		10.1038/cr.2017.76				14	Cell Biology	Cell Biology	EW5KR	WOS:000402545200010	28524166	gold			2018-01-05	
J	Wang, LB; Li, MY; Qu, C; Miao, WY; Yin, Q; Liao, JY; Cao, HT; Huang, M; Wang, K; Zuo, EW; Peng, GD; Zhang, SX; Chen, GD; Li, Q; Tang, K; Yu, Q; Li, ZJ; Wong, CCL; Xu, GL; Jing, NH; Yu, X; Li, JS				Wang, Lingbo; Li, Min-Yin; Qu, Chao; Miao, Wan-Ying; Yin, Qi; Liao, Jiaoyang; Cao, Hua-Teng; Huang, Min; Wang, Kai; Zuo, Erwei; Peng, Guangdun; Zhang, Shu-Xin; Chen, Guodong; Li, Qing; Tang, Ke; Yu, Qian; Li, Zhoujie; Wong, Catherine C. L.; Xu, Guoliang; Jing, Naihe; Yu, Xiang; Li, Jinsong			CRISPR-Cas9-mediated genome editing in one blastomere of two-cell embryos reveals a novel Tet3 function in regulating neocortical development	CELL RESEARCH			English	Article						CRISPR-Cas9; two-cell embryo; gene function; Tet3; cerebral cortex; neocortical development	HEART TUBE FORMATION; VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; MOUSE; DNA; GENERATION; CRISPR; GENES; RECOMBINATION	Studying the early function of essential genes is an important and challenging problem in developmental biology. Here, we established a method for rapidly inducing CRISPR-Cas9-mediated mutations in one blastomere of two-cell stage embryos, termed 2-cell embryo-CRISPR-Cas9 injection (2CC), to study the in vivo function of essential (or unknown) genes in founder chimeric mice. By injecting both Cre mRNA and CRISPR-Cas9 targeting the gene of interest into fluorescent reporter mice, the 2CC method can trace both wild-type and mutant cells at different developmental stages, offering internal control for phenotypic analyses of mutant cells. Using this method, we identified novel functions of the essential gene Tet3 in regulating excitatory and inhibitory synaptic transmission in the developing mouse cerebral cortex. By generating chimeric mutant mice, the 2CC method allows for the rapid screening of gene function in multiple tissues and cell types in founder chimeric mice, significantly expanding the current armamentarium of genetic tools.	[Wang, Lingbo; Qu, Chao; Yin, Qi; Liao, Jiaoyang; Wang, Kai; Zuo, Erwei; Li, Qing; Li, Jinsong] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Inst Biochem & C, State Key Lab Cell Biol,Shanghai Key Lab Mol Andr, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Li, Min-Yin; Miao, Wan-Ying; Cao, Hua-Teng; Zhang, Shu-Xin; Yu, Xiang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Neurosci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Li, Min-Yin; Miao, Wan-Ying; Cao, Hua-Teng; Zhang, Shu-Xin; Yu, Xiang] Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Neurosci, CAS Ctr Excellence Brain Sci & Intelligence Techn, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Huang, Min; Wong, Catherine C. L.] Chinese Acad Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, 333 Haike Rd, Shanghai 201203, Peoples R China; [Huang, Min; Wong, Catherine C. L.] Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai 201204, Peoples R China; [Peng, Guangdun; Jing, Naihe] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Chen, Guodong; Xu, Guoliang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China; [Yu, Qian; Li, Zhoujie] Chinese Acad Sci, Inst Biochem & Cell Biol, Anim Core Facil, Shanghai 200031, Peoples R China	Li, JS (reprint author), Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Inst Biochem & C, State Key Lab Cell Biol,Shanghai Key Lab Mol Andr, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Yu, X (reprint author), Univ Chinese Acad Sci, Chinese Acad Sci, Inst Neurosci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Yu, X (reprint author), Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Neurosci, CAS Ctr Excellence Brain Sci & Intelligence Techn, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	yuxiang@ion.ac.cn; jsli@sibcb.ac.cn			Ministry of Science and Technology of China [2014CB964803, 2015AA020307]; National Natural Science Foundation of China [31530048, 81672117, 31530030, 31601163]; Chinese Academy of Sciences [XDB19010204, XDB02010000]; Shanghai Municipal Commission for Science and Technology [16JC1420500]; China Postdoctoral Science Foundation [2016M601661]	We thank Yi Zeng (Shanghai Institute of Biochemistry and Cell Biology) for kindly providing mT/mG mice. This study was supported by the Ministry of Science and Technology of China (2014CB964803 and 2015AA020307 to JL), the National Natural Science Foundation of China (31530048 and 81672117 to JL, 31530030 to XY and 31601163 to KW), the Chinese Academy of Sciences (XDB19010204 to JL and XDB02010000 to XY), Shanghai Municipal Commission for Science and Technology (16JC1420500 to JL) and China Postdoctoral Science Foundation (2016M601661 to KW).	CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Edwards RG, 1997, MOL HUM REPROD, V3, P863, DOI 10.1093/molehr/3.10.863                                                         ; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Griffiths A.J.F., 2000, INTRO GENETIC ANAL; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Incontro S, 2014, NEURON, V83, P1051, DOI 10.1016/j.neuron.2014.07.043; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li T, 2015, MOL NEUROBIOL, V51, P142, DOI 10.1007/s12035-014-8734-5; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy A. G. M., 2003, MANIPULATING MOUSE E; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Picciotto MR, 1998, PHYSIOL REV, V78, P1131; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; Santiago M, 2014, GENOMICS, V104, P334, DOI 10.1016/j.ygeno.2014.08.018; Shen TJ, 2015, SCI BULL, V60, P1734, DOI 10.1007/s11434-015-0871-3; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Zheng JJ, 2014, NAT NEUROSCI, V17, P391, DOI 10.1038/nn.3634; Zhu XD, 2016, NEURON, V89, P100, DOI 10.1016/j.neuron.2015.11.030	43	0	0	8	8	INST BIOCHEMISTRY & CELL BIOLOGY	SHANGHAI	SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA	1001-0602	1748-7838		CELL RES	Cell Res.	JUN	2017	27	6					815	829		10.1038/cr.2017.58				15	Cell Biology	Cell Biology	EW5KR	WOS:000402545200011	28429771				2018-01-05	
J	Xiong, K; Zhou, Y; Blichfeld, KA; Hyttel, P; Bolund, L; Freude, KK; Luo, YL				Xiong, Kai; Zhou, Yan; Blichfeld, Kristian Aabo; Hyttel, Poul; Bolund, Lars; Freude, Kristine Karla; Luo, Yonglun			RNA-Guided Activation of Pluripotency Genes in Human Fibroblasts	CELLULAR REPROGRAMMING			English	Article						CRISPR; pluripotency genes; induced pluripotent stem cells; activation; reprogramming	TRANSCRIPTION FACTORS; STEM-CELLS; TARGETING ENHANCERS; EXPRESSION; CRISPR; SYSTEM; TALE; DIFFERENTIATION	Specific activation of endogenous genes can be achieved by programmable artificial transcription factors (ATFs). In this study, we compared two artificial, programmable, clustered regularly interspaced short palindromic repeats (CRISPR)-based, ubiquitous transcription factors: deficient CRISPR-associated protein 9 (dCas9)-VP64 (CRISPRa) alone, or a combination of dCas9-VP64 andMS2-P65-HSF1 [synergistic activation mediator (SAM) system] mediated activation of five pluripotency genes: KLF4 (K), LIN28 (L), MYC (M), OCT4 (O), and SOX2 (S) in human cells (HEK293T, HeLa, HepG2, and primary fibroblasts). Activation potential was monitored using a luciferase reporter system and we found that both CRISPRa and SAM can efficiently activate the proximal promoter of all five genes. We also observed that the guide RNA (gRNA) target sites and number of gRNAs have a major effect on gRNA-guided activation efficiency. Furthermore, increased activation efficiency (>3-folds) could be achieved by the SAM system compared to CRISPRa. In addition, we discovered that only the SAM system could efficiently activate LIN28, OCT4, and SOX2 expression (up to 100-folds compared to coexpression with a scrambled gRNA) in primary human fibroblasts. This SAM-mediated activation of LOS can be stably maintained for over 20 days in fibroblasts cultured in either fibroblasts or stem cell medium. However, when attempting to use the SAM-LOS activation as an approach for induced pluripotent stem cells-reprogramming, no embryonic stem-like colonies could be obtained from these SAM fibroblasts. In conclusion, our study showed that CRISPR/Cas9-based ATFs are potent to activate and maintain transcription of endogenous human pluripotent genes. However, future improvements of the system are still required to improve activation efficiency and cellular reprogramming using ATFs.	[Xiong, Kai; Hyttel, Poul; Freude, Kristine Karla] Univ Copenhagen, Dept Vet Clin & Anim Sci, Gronnegardsvej 7, DK-1870 Frederiksberg, Denmark; [Zhou, Yan; Blichfeld, Kristian Aabo; Bolund, Lars; Luo, Yonglun] Aarhus Univ, Danish Regenerat Engn Alliance Med, Dept Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus, Denmark	Freude, KK (reprint author), Univ Copenhagen, Dept Vet Clin & Anim Sci, Gronnegardsvej 7, DK-1870 Frederiksberg, Denmark.; Luo, YL (reprint author), Aarhus Univ, Danish Regenerat Engn Alliance Med, Dept Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus, Denmark.	kkf@sund.ku.dk; alun@biomed.au.dk	Luo, Yonglun/C-4708-2013	Luo, Yonglun/0000-0002-0007-7759	Det Frie Forskningsrad (Danish Council for Independent Research) [DFF-1337-00128, DFF-1335-00763A]; Lundbeckfonden (Lundbeck Foundation) [R173-2014-1105, R151-2013-14439]; European Union [PIAP-GA-2012-324451-STEMMAD]; Innovation Fund Denmark "Brainstem" [4108-00008B]; China Scholarship Council; HEALTH faculty of Aarhus University; University of Copenhagen [CDO2016: 2016CDO04210]	We are grateful to Lin Lin, Yong Liu, Trine Skov Petersen, and Bettina Hansen (Department of Biomedicine, Aarhus University) for their technical advice and support. This project is supported by grants from Det Frie Forskningsrad (Danish Council for Independent Research)-DFF-1337-00128, DFF-1335-00763A (Y.L.), Lundbeckfonden (Lundbeck Foundation)-R173-2014-1105 (Y.L.), R151-2013-14439 (L.B.), European Union 7th Framework Program (PIAP-GA-2012-324451-STEMMAD), and Innovation Fund Denmark "Brainstem" (4108-00008B). K.X. and Y.Z. are financially supported by the China Scholarship Council, as well as a PhD scholarship to Y.Z. from the HEALTH faculty of Aarhus University. K.X. is further supported by the programme of excellence 2016 (Copenhagen as the next leader in precise genetic engineering CDO2016: 2016CDO04210) from the University of Copenhagen.	Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen M, 2003, CLIN EXP DERMATOL, V28, P193, DOI 10.1046/j.1365-2230.2003.01191.x                                                ; Cheng AW, 2016, CELL RES, V26, P254, DOI 10.1038/cr.2016.3; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Ji QZ, 2014, NUCLEIC ACIDS RES, V42, P6158, DOI 10.1093/nar/gku243; Kang R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0137-7; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Selvaraj V, 2010, TRENDS BIOTECHNOL, V28, P214, DOI 10.1016/j.tibtech.2010.01.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Vad-Nielsen J, 2016, CELL MOL LIFE SCI, V73, P4315, DOI 10.1007/s00018-016-2271-5; Wei S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19648; Xiong K, 2016, STEM CELL RES, V17, P665, DOI 10.1016/j.scr.2016.10.011; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Zhou Y, 2017, STEM CELLS DEV, V26, P166, DOI 10.1089/scd.2016.0162	27	0	0	8	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-4971	2152-4998		CELL REPROGRAM	Cell. Reprogramm.	JUN	2017	19	3					189	198		10.1089/cell.2017.0006				10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Genetics & Heredity	Cell Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	EW3EL	WOS:000402377900006	28557624				2018-01-05	
J	Jaiswal, A; Peddinti, G; Akimov, Y; Wennerberg, K; Kuznetsov, S; Tang, J; Aittokallio, T				Jaiswal, Alok; Peddinti, Gopal; Akimov, Yevhen; Wennerberg, Krister; Kuznetsov, Sergey; Tang, Jing; Aittokallio, Tero			Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells	GENOME MEDICINE			English	Article						RNAi screening; Gene essentiality; Seed essentiality; Off-target effects; Reproducibility; Seed effects; Synthetic lethality; Cancer cells; Precision oncology	RNA INTERFERENCE SCREENS; BREAST-CANCER; OVARIAN-CANCER; PI3K PATHWAY; GENE; REVEALS; CRISPR-CAS9; SUPPRESSION; DEPENDENCIES; CRISPR/CAS9	Background: Genome-wide loss-of-function profiling is widely used for systematic identification of genetic dependencies in cancer cells; however, the poor reproducibility of RNA interference (RNAi) screens has been a major concern due to frequent off-target effects. Currently, a detailed understanding of the key factors contributing to the sub-optimal consistency is still a lacking, especially on how to improve the reliability of future RNAi screens by controlling for factors that determine their off-target propensity. Methods: We performed a systematic, quantitative analysis of the consistency between two genome-wide shRNA screens conducted on a compendium of cancer cell lines, and also compared several gene summarization methods for inferring gene essentiality from shRNA level data. We then devised novel concepts of seed essentiality and shRNA family, based on seed region sequences of shRNAs, to study in-depth the contribution of seed-mediated off-target effects to the consistency of the two screens. We further investigated two seed-sequence properties, seed pairing stability, and target abundance in terms of their capability to minimize the off-target effects in post-screening data analysis. Finally, we applied this novel methodology to identify genetic interactions and synthetic lethal partners of cancer drivers, and confirmed differential essentiality phenotypes by detailed CRISPR/Cas9 experiments. Results: Using the novel concepts of seed essentiality and shRNA family, we demonstrate how genome-wide loss-of-function profiling of a common set of cancer cell lines can be actually made fairly reproducible when considering seed-mediated off-target effects. Importantly, by excluding shRNAs having higher propensity for off-target effects, based on their seed-sequence properties, one can remove noise from the genome-wide shRNA datasets. As a translational application case, we demonstrate enhanced reproducibility of genetic interaction partners of common cancer drivers, as well as identify novel synthetic lethal partners of a major oncogenic driver, PIK3CA, supported by a complementary CRISPR/Cas9 experiment. Conclusions: We provide practical guidelines for improved design and analysis of genome-wide loss-of-function profiling and demonstrate how this novel strategy can be applied towards improved mapping of genetic dependencies of cancer cells to aid development of targeted anticancer treatments.	[Jaiswal, Alok; Peddinti, Gopal; Akimov, Yevhen; Wennerberg, Krister; Kuznetsov, Sergey; Tang, Jing; Aittokallio, Tero] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Tang, Jing; Aittokallio, Tero] Univ Turku, Dept Math & Stat, Turku, Finland	Aittokallio, T (reprint author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.; Aittokallio, T (reprint author), Univ Turku, Dept Math & Stat, Turku, Finland.	tero.aittokallio@helsinki.fi	Tang, Jing/H-4084-2012; Aittokallio, Tero/B-6583-2009	Tang, Jing/0000-0001-7480-7710; Aittokallio, Tero/0000-0002-0886-9769	Integrative Life Science (ILS) doctoral program; FIMM-EMBL PhD program; Academy of Finland [269862, 272437, 292611, 295504, 265966]; Cancer Society of Finland [269862, 272437, 292611, 295504, 265966]	AJ was supported by the Integrative Life Science (ILS) doctoral program, FIMM-EMBL PhD program. TA (grant number 269862, 272437, 292611 and 295504), GP (265966) and SK were supported by grants from the Academy of Finland and Cancer Society of Finland.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bhinder B, 2013, DRUG DISC WORLD, V14, P31; Bhinder B, 2014, COMB CHEM HIGH T SCR, V17, P98, DOI 10.2174/1386207317666140117101852; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Cancer Cell Line Encyclopedia Consortium & Genomics of Drug Sensitivity in Cancer Consortium, 2015, NATURE, V528, P84; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Guda S, 2015, MOL THER, V23, P1465, DOI 10.1038/mt.2015.113; Guo J, 2015, NUCLEIC ACIDS RES, V44, pD1011; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Horlbeck MA, 2016, ELIFE, V5; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamanu TKK, 2013, SCI REP-UK, V3, DOI 10.1038/srep02940; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Leenders F, 2004, EMBO J, V23, P3303, DOI 10.1038/sj.emboj.7600345; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li W., 2014, GENOME BIOL, V15, P1; Luo TP, 2012, P NATL ACAD SCI USA, V109, P2860, DOI 10.1073/pnas.1120589109; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Mpindi JP, 2016, NATURE, V540, pE5, DOI 10.1038/nature20171; Mukai H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18979; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Nijman SMB, 2013, SCIENCE, V342, P809, DOI 10.1126/science.1244669; Osmanbeyoglu HU, 2014, GENOME RES, V24, P1869, DOI 10.1101/gr.173039.114; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmich F, 2015, GENOME BIOL, V16, P1; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yilmazel B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-192; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhong R, 2014, NUCLEIC ACIDS RES, V42, P8214, DOI 10.1093/nar/gku306	65	2	2	2	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-994X			GENOME MED	Genome Med.	JUN 1	2017	9								51	10.1186/s13073-017-0440-2				15	Genetics & Heredity	Genetics & Heredity	EW5TP	WOS:000402569700001	28569207	gold			2018-01-05	
J	Braatz, J; Harloff, HJ; Mascher, M; Stein, N; Himmelbach, A; Jung, C				Braatz, Janina; Harloff, Hans-Joachim; Mascher, Martin; Stein, Nils; Himmelbach, Axel; Jung, Christian			CRISPR-Cas9 Targeted Mutagenesis Leads to Simultaneous Modification of Different Homoeologous Gene Copies in Polyploid Oilseed Rape (Brassica napus)	PLANT PHYSIOLOGY			English	Article							RNA-GUIDED CAS9; GENOME; ARABIDOPSIS; MUTATIONS; PLANTS; SPECIFICITY; NUCLEASES; SYSTEM; BARLEY; RICE	In polyploid species, altering a trait by random mutagenesis is highly inefficient due to gene redundancy. We have stably transformed tetraploid oilseed rape (Brassica napus) with a CRISPR-Cas9 construct targeting two ALCATRAZ (ALC) homoeologs. ALC is involved in valve margin development and, thus, contributes to seed shattering from mature fruits. Knocking out ALC would increase shatter resistance to avoid seed loss during mechanical harvest. We obtained a transgenic T1 plant with four alc mutant alleles by the use of a single target sequence. All mutations were stably inherited to the T2 progeny. The T2 generation was devoid of any wild-type alleles, proving that the underlying T1 was a nonchimeric double heterozygote. T-DNA and ALC loci were not linked, as indicated by random segregation in the T2 generation. Hence, we could select double mutants lacking the T-DNA already in the first offspring generation. However, whole-genome sequencing data revealed at least five independent insertions of vector backbone sequences. We did not detect any off-target effects in two genome regions homologous to the target sequence. The simultaneous alteration of multiple homoeologs by CRISPR-Cas9 mutagenesis without any background mutations will offer new opportunities for using mutant genotypes in rapeseed breeding.	[Braatz, Janina; Harloff, Hans-Joachim; Jung, Christian] Christian Albrechts Univ Kiel, Plant Breeding Inst, D-24098 Kiel, Germany; [Mascher, Martin; Stein, Nils; Himmelbach, Axel] Leibniz Inst Plant Genet & Crop Plant Res Gatersl, D-06466 Stadt Seeland, Germany; [Mascher, Martin] German Ctr Integrat Biodivers Res Halle Jena Leip, D-04103 Leipzig, Germany	Jung, C (reprint author), Christian Albrechts Univ Kiel, Plant Breeding Inst, D-24098 Kiel, Germany.	c.jung@plantbreeding.uni-kiel.de		Braatz, Janina/0000-0002-4446-8743; Himmelbach, Axel/0000-0001-7338-0946; Stein, Nils/0000-0003-3011-8731; Mascher, Martin/0000-0001-6373-6013	Stiftung Schleswig-Holsteinische Landschaft [2013/69]	This work was supported by the Stiftung Schleswig-Holsteinische Landschaft (project no. 2013/69).	Andersson M, 2017, PLANT CELL REP, V36, P117, DOI 10.1007/s00299-016-2062-3; Ballester P, 2017, CURR OPIN PLANT BIOL, V35, P68, DOI 10.1016/j.pbi.2016.11.008; Boszoradova E, 2011, PLANT CELL TISS ORG, V107, P317, DOI 10.1007/s11240-011-9982-y; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Bruce DM, 2002, BIOSYST ENG, V81, P179, DOI 10.1006/bioe.2001.0002; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Emrani N, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0236-2; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Harloff HJ, 2012, THEOR APPL GENET, V124, P957, DOI 10.1007/s00122-011-1760-z; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hua SJ, 2009, PLANTA, V230, P493, DOI 10.1007/s00425-009-0961-z; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li H., 2013, ARXIV13033997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li WX, 2016, J ZHEJIANG UNIV-SC B, V17, P992, DOI 10.1631/jzus.B1600301; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; Price JS, 1996, J AGR ENG RES, V65, P183, DOI 10.1006/jaer.1996.0091; R Core Team, 2015, R LANG ENV STAT COMP; Rajani S, 2001, CURR BIOL, V11, P1914, DOI 10.1016/S0960-9822(01)00593-0; Schmutzer T, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.72; Schouten HJ, 2017, PLANT CELL REP, V36, P493, DOI 10.1007/s00299-017-2098-z; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Tang Li, 2016, Yi Chuan, V38, P746, DOI 10.16288/j.yczz.16-052; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Wang GP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01324; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wells R, 2014, MOL BREEDING, V33, P349, DOI 10.1007/s11032-013-9954-5; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Yan WH, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0125-7; Zarhloul MK, 2006, MOL BREEDING, V18, P241, DOI 10.1007/s11032-006-9032-3	36	1	1	35	42	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	JUN	2017	174	2					935	942		10.1104/pp.17.00426				8	Plant Sciences	Plant Sciences	EX3SH	WOS:000403152200039	28584067				2018-01-05	
J	Wang, XL; Zhang, WM; Ding, Y; Guo, XR; Yuan, YH; Li, DS				Wang, Xiaoli; Zhang, Wenmei; Ding, Yan; Guo, Xingrong; Yuan, Yahong; Li, Dongsheng			CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo	ONCOLOGY REPORTS			English	Article						CXC chemokine receptor 4; hepatocellular carcinoma; CRISPR/Cas9; malignancy; migration; invasion	EPITHELIAL-MESENCHYMAL TRANSITION; CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; EXPRESSION; THERAPY; CHEMORESISTANCE; DISSEMINATION; CISPLATIN; CXCL12; MDR1	CXC chemokine receptor 4 (CXCR4) is associated with poor clinical outcomes and decreased survival in hepatocellular carcinoma (HCC). In the present study, we targeted CXCR4 by CRISPR/Cas9 in HepG2 cells and observed the effects both in vitro and in vivo. The results indicated that after targeting CXCR4 the expression of CXCR4 was significantly decreased and the cell proliferation was inhibited. Clonogenicity and scratch cell migration assays indicated that specific downregulation of CXCR4 inhibited cell migration. This disruption of CXCR4 led to less invasiveness, the genes related to epithelial-mesenchymal transition (EMT) and cell self-renewal were also affected. Moreover, sensitivity to the anticancer drug cisplatin was significantly increased in vitro by the downregulation of CXCR4. The results of the in vivo study showed that the growth volumes were significantly smaller in neoplasms derived from CXCR4-downregulated HepG2 cells compared to those derived from wild-type cells. These results showed that targeting CXCR4 by CRISPR/Cas9 could inhibit proliferation, migration and invasion, reversed EMT, increased chemosensitivity and decrease the malignancy of HCC in vitro and in vivo.	[Wang, Xiaoli; Zhang, Wenmei; Ding, Yan; Guo, Xingrong; Yuan, Yahong; Li, Dongsheng] Hubei Univ Med, Taihe Hosp, Hubei Key Lab Embryon Stem Cell Res, Shiyan 442000, Hubei, Peoples R China	Li, DS (reprint author), Hubei Univ Med, Taihe Hosp, Hubei Key Lab Embryon Stem Cell Res, Shiyan 442000, Hubei, Peoples R China.	dsli698@126.com			National Natural Science Foundation of Hubei province [2012FFA037]; Natural Science Foundation of Hubei Provincial Department of Education [Q20162110]; Key Science and Technology Project of Hubei Province [2016ACA157]; National Natural Science Foundation of China [81641028]	This study was supported by the National Natural Science Foundation of Hubei province (2012FFA037), the Natural Science Foundation of Hubei Provincial Department of Education (Q20162110), the Key Science and Technology Project of Hubei Province (2016ACA157) and the National Natural Science Foundation of China (81641028).	Andre F, 2009, ONCOLOGIST, V14, P1182, DOI 10.1634/theoncologist.2009-0161; Blot E, 2008, BREAST J, V14, P268, DOI 10.1111/j.1524-4741.2008.00573.x; Chen RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088543; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Flores A, 2014, CLIN MED INSIGHTS-ON, V8, P71, DOI 10.4137/CMO.S9926; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hattermann K, 2014, CELL TISSUE RES, V357, P253, DOI 10.1007/s00441-014-1823-y; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Katoh M, 2005, INT J ONCOL, V27, P1677; Nakayama K, 2002, INT J CANCER, V101, P488, DOI 10.1002/ijc.10608; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Schimanski CC, 2006, BRIT J CANCER, V95, P210, DOI 10.1038/sj.bjc.6603251; Shinoda M, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0559-9; Su FX, 2005, BIOCHEM BIOPH RES CO, V329, P888, DOI 10.1016/j.bbrc.2005.02.056; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Xiang ZL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-176; Zhou SL, 2012, HEPATOLOGY, V56, P2242, DOI 10.1002/hep.25907	21	0	0	4	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUN	2017	37	6					3565	3571		10.3892/or.2017.5601				7	Oncology	Oncology	EW7LT	WOS:000402692300047	28498420				2018-01-05	
J	Evans, TA				Evans, Timothy A.			CRISPR-based gene replacement reveals evolutionarily conserved axon guidance functions of Drosophila Robo3 and Tribolium Robo2/3	EVODEVO			English	Article						Axon guidance; Longitudinal pathways; Drosophila; Tribolium; Slit; Roundabout; CRISPR	LONG-RANGE GUIDANCE; LATERAL POSITION; RECEPTORS; SLIT; DOMAINS; MIDLINE; ROLES; CODE; CNS	Background: Axon guidance receptors of the Roundabout (Robo) family regulate a number of axon guidance outcomes in bilaterian animals in addition to their canonical role in Slit-dependent midline repulsion. In the fruit fly Drosophila melanogaster, three Robo paralogs (Robo1, Robo2, and Robo3) each have specialized roles in regulating midline crossing and the formation of longitudinal axon pathways in the embryonic ventral nerve cord. The number of robo genes differs in other insects, and it is unknown whether the roles and/or signaling mechanisms of Drosophila Robos are shared in other insect species. To directly compare the axon guidance activities of Robo receptors in Drosophila and the flour beetle Tribolium castaneum, I have used a CRISPR/Cas9-based approach to replace Drosophila robo3 with Tribolium robo2/3. Results: I show that when expressed from the robo3 locus in Drosophila embryos, Tribolium Robo2/3 (TcRobo2/3) protein is properly translated and localized to axons, where it reproduces the normal expression pattern of Drosophila Robo3. In embryos expressing TcRobo2/3 in place of robo3, two distinct subsets of longitudinal axons are guided properly to their normal positions in the intermediate neuropile, indicating that TcRobo2/3 can promote Robo3dependent axon guidance decisions in developing Drosophila neurons. Conclusions: These observations suggest that the mechanism by which Drosophila Robo3 promotes longitudinal pathway formation is evolutionarily conserved in Tribolium, where it is performed by TcRobo2/3. The CRISPR/Cas9based gene replacement approach described here can be applied to comparative evolutionary developmental studies of other Drosophila genes and their orthologs in other species.	[Evans, Timothy A.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	Evans, TA (reprint author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	evanst@uark.edu		Evans, Timothy/0000-0002-2756-8064	National Institutes of Health [R15 NS098406]; University of Arkansas	This work was supported by National Institutes of Health Grant R15 NS098406 (T.A.E.) and by funds from the University of Arkansas. The funders had no role in the design of the study, collection, analysis, and interpretation of data, decision to publish, or preparation of the manuscript.	Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Evans TA, 2016, CURR OPIN INSECT SCI, V18, P11, DOI 10.1016/j.cois.2016.08.007; Evans TA, 2012, DEV BIOL, V363, P266, DOI 10.1016/j.ydbio.2011.12.046; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Li XT, 2016, GENE, V577, P174, DOI 10.1016/j.gene.2015.11.035; Mauss A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000200; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5                                                   ; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rickert C, 2011, J NEUROSCI, V31, P15870, DOI 10.1523/JNEUROSCI.4009-11.2011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050; Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	21	0	0	8	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2041-9139			EVODEVO	EvoDevo	JUN 1	2017	8								10	10.1186/s13227-017-0073-y				10	Evolutionary Biology; Developmental Biology	Evolutionary Biology; Developmental Biology	EX1UT	WOS:000403013000001	28588759	gold			2018-01-05	
J	Jiang, X; Kanda, T; Haga, Y; Sasaki, R; Nakamura, M; Wu, S; Nakamoto, S; Shirasawa, H; Okamoto, H; Yokosuka, O				Jiang, Xia; Kanda, Tatsuo; Haga, Yuki; Sasaki, Reina; Nakamura, Masato; Wu, Shuang; Nakamoto, Shingo; Shirasawa, Hiroshi; Okamoto, Hiroaki; Yokosuka, Osamu			Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						CRISPR/Cas9; endoplasmic reticulum stress; glucose-regulated protein 78; hepatitis A virus	ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; RNA; CELLS; RECEPTOR; GRP78; MICE; CAS9	Infection with hepatitis A virus (HAV) is a major cause of acute hepatitis globally and it is important to identify the mechanisms of HAV replication. Glucose-regulated protein 78 (GRP78) is an endoplasmic reticulum (ER) chaperone and serves a role in unfolded protein response pathways. Previous studies have demonstrated that GRP78 functions as an endogenous antiviral factor. In the present study, two loss-of-function studies using GRP78 were completed to elucidate the role of GRP78 in HAV infection. HAV replication was observed to be enhanced by deficient GRP78 although GRP78-deficiency also led to lower expression of ER stress molecules downstream of GRP78. Therefore, GRP78 appears to be a potential novel defensive molecule against HAV in hepatocytes.	[Jiang, Xia; Kanda, Tatsuo; Haga, Yuki; Sasaki, Reina; Nakamura, Masato; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, 1-8-1 Inohana, Chiba 2608670, Japan; [Nakamoto, Shingo; Shirasawa, Hiroshi] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba 2608670, Japan; [Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Tochigi 3290498, Japan	Kanda, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, 1-8-1 Inohana, Chiba 2608670, Japan.	kandat-cib@umin.ac.jp	Okamoto, Hiroaki/H-4371-2011	Okamoto, Hiroaki/0000-0003-0827-0964	Ministry of Health, Labour and Welfare of Japan; Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED)	The authors thank Professor Ralf Bartenschlager for providing the Huh7 cells. The present study was supported by grants from the Ministry of Health, Labour and Welfare of Japan. This research was partially supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED).	Alhoot MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034060; Collier MG, 2014, LANCET INFECT DIS, V14, P976, DOI 10.1016/S1473-3099(14)70883-7; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x; Jiang X, 2014, EXP CELL RES, V323, P326, DOI 10.1016/j.yexcr.2014.02.017; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kanda T, 2004, J VIRAL HEPATITIS, V11, P479, DOI 10.1111/j.1365-2893.2004.00531.x; Kanda T, ONCOL LETT IN PRESS; Kanda Tatsuo, 2015, J Clin Transl Hepatol, V3, P205, DOI 10.14218/JCTH.2015.00016; Kanda T, 2015, BIOCHEM BIOPH RES CO, V466, P567, DOI 10.1016/j.bbrc.2015.09.083; Klinger MHF, 2001, ARCH VIROL, V146, P2291, DOI 10.1007/s007050170003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2009, MOL CELL PROTEOMICS, V8, P2582, DOI 10.1074/mcp.M900180-MCP200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyamura T, 2012, HEPATOL RES, V42, P248, DOI 10.1111/j.1872-034X.2011.00919.x; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Seggewiss N, 2016, ARCH VIROL, V161, P851, DOI 10.1007/s00705-015-2723-5; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Win NN, 2017, BIOCHEM BIOPH RES CO, V483, P694, DOI 10.1016/j.bbrc.2016.12.080; Wu S, 2012, J INFECT DIS, V206, P415, DOI 10.1093/infdis/jis363; Zhu GY, 2013, FASEB J, V27, P955, DOI 10.1096/fj.12-213330; Zhu GG, 2013, BIOCHEM BIOPH RES CO, V441, P856, DOI 10.1016/j.bbrc.2013.10.142	27	1	1	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2017	13	6					3305	3308		10.3892/etm.2017.4407				4	Medicine, Research & Experimental	Research & Experimental Medicine	EU5NW	WOS:000401080000101	28587404				2018-01-05	
J	Hsiao, KY; Sun, HS; Tsai, SJ				Hsiao, Kuei-Yang; Sun, H. Sunny; Tsai, Shaw-Jenq			Circular RNA - New member of noncoding RNA with novel functions	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						Circular RNA; miRNA sponge; molecular adaptor; cardiovascular disease; neuronal disease; cancer	MESSENGER-RNA; EXON CIRCULARIZATION; GENE; IDENTIFICATION; REVEALS; PATHWAY; TRANSCRIPTS; COMPLEXES; EFFICIENT; ABUNDANT	A growing body of evidence indicates that circular RNAs are not simply a side product of splicing but a new class of noncoding RNAs in higher eukaryotes. The progression for the studies of circular RNAs is accelerated by combination of several advanced technologies such as next generation sequencing, gene silencing (small interfering RNAs) and editing (CRISPR/Cas9). More and more studies showed that dysregulated expression of circular RNAs plays critical roles during the development of several human diseases. Herein, we review the current advance of circular RNAs for their biosynthesis, molecular functions, and implications in human diseases.	[Hsiao, Kuei-Yang; Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Sun, H. Sunny] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan	Tsai, SJ (reprint author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan.	seantsai@mail.ncku.edu.tw	Hsiao, Kuei-Yang/B-7484-2009	Hsiao, Kuei-Yang/0000-0002-1648-974X	Ministry of Science and Technology of Taiwan [MOST 104-2320-B-006-036-MY3]; National Health Research Institute [NHRI-EX102-10244BI]; Top University Grant of National Cheng Kung University [D10335A17]	The authors would like to acknowledge the financial support by the Ministry of Science and Technology of Taiwan (MOST 104-2320-B-006-036-MY3), the National Health Research Institute (NHRI-EX102-10244BI) and the Top University Grant of National Cheng Kung University (grant #D10335A17).	Ahmed I, 2016, ONCOTARGET, V7, P36366, DOI 10.18632/oncotarget.8917; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bachmayr-Heyda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08057; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Bohmdorfer G, 2015, TRENDS CELL BIOL, V25, P623, DOI 10.1016/j.tcb.2015.07.002; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Braun S, 1996, NUCLEIC ACIDS RES, V24, P4152, DOI 10.1093/nar/24.21.4152; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; COCQUERELLE C, 1992, EMBO J, V11, P1095; COCQUERELLE C, 1993, FASEB J, V7, P155; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Du WW, 2017, CELL DEATH DIFFER, V24, P357, DOI 10.1038/cdd.2016.133; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; HALBREICH A, 1980, CELL, V19, P321, DOI 10.1016/0092-8674(80)90506-1; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Hsiao KY, 2017, CANCER RES, V77, P2339, DOI 10.1158/0008-5472.CAN-16-1883; HSU MT, 1979, NATURE, V280, P339, DOI 10.1038/280339a0                                                                ; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Khan MAF, 2016, CIRC RES, V119, P996, DOI 10.1161/CIRCRESAHA.116.309568; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469                                                        ; Li SJ, 2013, NUCLEIC ACIDS RES, V41, P2659, DOI 10.1093/nar/gks1362; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S                                                    ; Pasman Z, 1996, RNA, V2, P603; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Yang W, 2016, ONCOGENE, V35, P3919, DOI 10.1038/onc.2015.460; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zhong ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30919	40	1	1	4	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1535-3702	1535-3699		EXP BIOL MED	Exp. Biol. Med.	JUN	2017	242	11					1136	1141		10.1177/1535370217708978				6	Medicine, Research & Experimental	Research & Experimental Medicine	EX0PS	WOS:000402923900003	28485684				2018-01-05	
J	Zhu, M; Yan, CW; Ren, CL; Huang, XD; Zhu, X; Gu, HY; Wang, ML; Wang, SY; Gao, Y; Ji, Y; Miao, XP; Yang, M; Chen, JF; Du, JB; Huang, TT; Jiang, Y; Dai, JC; Ma, HX; Zhou, JW; Wang, ZM; Hu, ZB; Ji, GZ; Zhang, ZD; Shen, HB; Shi, YY; Jin, GF				Zhu, Meng; Yan, Caiwang; Ren, Chuanli; Huang, Xiaodan; Zhu, Xun; Gu, Haiyong; Wang, Meilin; Wang, Shouyu; Gao, Yong; Ji, Yong; Miao, Xiaoping; Yang, Ming; Chen, Jinfei; Du, Jiangbo; Huang, Tongtong; Jiang, Yue; Dai, Juncheng; Ma, Hongxia; Zhou, Jianwei; Wang, Zhaoming; Hu, Zhibin; Ji, Guozhong; Zhang, Zhengdong; Shen, Hongbing; Shi, Yongyong; Jin, Guangfu			Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer	GASTROENTEROLOGY			English	Article						Stomach Cancer; Genetics; Mutation; Gene Regulation	GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RARE VARIANTS; GERMLINE MUTATIONS; SEQUENCE VARIANTS; STABILITY CHANGES; PROSTATE-CANCER; OVARIAN-CANCER; BREAST-CANCER; HUMAN-DISEASE	BACKGROUND & AIMS: Several genetic variants have been associated with gastric cancer risk, although these account for only a fraction of cases of gastric cancer. We aimed to identify low-frequency and other genetic variants that determine gastric cancer susceptibility. METHODS: We performed exome array analysis of DNA in blood samples from 1113 patients with gastric cancer, collected at hospitals from 2006 to 2010 in China, and 1848 individuals without cancer (controls) undergoing physical examinations. Among 71,290 variants analyzed (including 25,784 common variants), 24 variants were selected and replicated in an analysis of DNA in blood samples from 4687 additional cases of gastric cancer and 5780 controls. We compared expression of candidate genes in tumor vs normal gastric tissues using data from TCGA and performed functional annotation analyses. An immortalized human gastric epithelial cell line (GES1) and 7 human gastric cancer lines were used to express transgenes, knock down gene expression (with small interfering RNAs), disrupt genes (using the CRISPR/Cas9 system), or assess expression of reporter constructs. We measured cell proliferation, colony formation, invasion, and migration, and assessed growth of xenograft tumors in nude mice. RESULTS: A low-frequency missense variant rs112754928 in the SPOC domain containing 1 gene (SPOCD1; encoding p.Arg71Trp), at 1p35.2, was reproducibly associated with reduced risk of gastric cancer (odds ratio, 0.56; P = 3.48 x 10(-8)). SPOCD1 was overexpressed in gastric tumors, and knockout of SPOCD1 reduced gastric cancer cell proliferation, invasive activity, and migration, as well as growth of xenograft tumors in nude mice. We also associated the variant rs1679709 at 6p22.1 with reduced risk for gastric cancer (odds ratio, 0.80; P = 1.17 x 10(-13)). The protective allele rs1679709-A correlated with the surrounding haplotype rs2799077-T-rs2799079-C, which reduced the enhancer activity of this site to decrease expression of the butyrophilin subfamily 3 member A2 gene (BTN3A2). BTN3A2 is overexpressed in gastric tumors, and deletion of BTN3A2 inhibited proliferation, migration, and invasion of gastric cancer cells. CONCLUSIONS: We have associated variants at 1p35.2 and 6p22.1 with gastric cancer risk, indicating a role for SPOCD1 and BTN3A2 in gastric carcinogenesis.	[Zhu, Meng; Yan, Caiwang; Ren, Chuanli; Zhu, Xun; Du, Jiangbo; Huang, Tongtong; Jiang, Yue; Dai, Juncheng; Ma, Hongxia; Wang, Zhaoming; Hu, Zhibin; Shen, Hongbing; Jin, Guangfu] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Collaborat Innovat Ctr Canc Med, Dept Epidemiol & Biostat,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Zhu, Meng; Jin, Guangfu] Nanjing Med Univ, State Key Lab Reprod Med, Int Joint Res Ctr Environm & Human Hlth, Nanjing, Jiangsu, Peoples R China; [Ren, Chuanli] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Clin Med Testing Lab, Yangzhou, Jiangsu, Peoples R China; [Ren, Chuanli] Yangzhou Univ, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Huang, Xiaodan; Ji, Guozhong] Nanjing Med Univ, Affiliated Hosp 2, Inst Digest Endoscopy, Nanjing, Jiangsu, Peoples R China; [Huang, Xiaodan; Ji, Guozhong] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China; [Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Collaborat Innovat Ctr Canc Med, Nanjing, Jiangsu, Peoples R China; [Wang, Shouyu; Zhou, Jianwei] Nanjing Med Univ, Dept Mol Cell Biol & Toxicol, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Collaborat Innovat Ctr Canc Med,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Gao, Yong] Nanjing Med Univ, Dept Med Oncol, Affiliated Huaian Peoples Hosp 1, Huaian, Peoples R China; [Ji, Yong] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Cardiothorac Surg, Wuxi, Peoples R China; [Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, MOE Key Lab Environm & Hlth, Sch Publ Hlth, Wuhan, Peoples R China; [Yang, Ming] Shandong Univ, Shandong Acad Med Sci, Shandong Prov Key Lab Radiat Oncol, Canc Res Ctr,Shandong Canc Hosp, Jinan, Peoples R China; [Chen, Jinfei] Nanjing Med Univ, Dept Oncol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Shi, Yongyong] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Bio X Inst, Shanghai 200030, Peoples R China	Shi, YY (reprint author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Bio X Inst, Shanghai 200030, Peoples R China.; Shen, HB; Jin, GF (reprint author), Nanjing Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China.	hbshen@njmu.edu.cn; shiyongyong@gmail.com; guangfujin@njmu.edu.cn	Yang, Ming/G-4705-2012; miao, xiaoping/C-4336-2011	Yang, Ming/0000-0002-7722-7487; miao, xiaoping/0000-0002-6818-9722; Shi, Yongyong/0000-0003-1710-1505	National Basic Research Program (973) [2013CB910304]; National Key Research and Development Program of China [2016YFC1302703]; National Natural Science Foundation of China [81422042, 81373090, 8152100014, 81230067, 81301823, 31550003]; Science Foundation for Distinguished Young Scholars in Jiangsu [BK20130042]; Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions [15KJA330002]; Top-notch Academic Programs Project of Jiangsu Higher Education Institution [PPZY2015A067]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This work was supported by grants from the National Basic Research Program (973) (grant no. 2013CB910304); the National Key Research and Development Program of China (grant no. 2016YFC1302703); the National Natural Science Foundation of China (grant nos. 81422042, 81373090, 8152100014, 81230067, 81301823, 31550003); the Science Foundation for Distinguished Young Scholars in Jiangsu (grant no. BK20130042); the Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions (grant no. 15KJA330002); the Top-notch Academic Programs Project of Jiangsu Higher Education Institution (grant no. PPZY2015A067); and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chen CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S5; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Guo Y, 2014, NAT PROTOC, V9, P2643, DOI 10.1038/nprot.2014.174; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Helgason H, 2015, NAT GENET, V47, P906, DOI 10.1038/ng.3342; Hu N, 2016, GUT, V65, P1611, DOI 10.1136/gutjnl-2015-309340; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Igartua C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6965; Jin GF, 2015, AM J HUM GENET, V96, P832, DOI 10.1016/j.ajhg.2015.03.009; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Messal N, 2011, EUR J IMMUNOL, V41, P3443, DOI 10.1002/eji.201141404; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Nioi P, 2016, NEW ENGL J MED, V374, P2131, DOI 10.1056/NEJMoa1508419; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sampson JN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv279; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tachmazidou I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3872; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Tang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10206; Tukiainen T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004127; Wang C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10499; Wang Xuefeng, 2014, Front Genet, V5, P187, DOI 10.3389/fgene.2014.00187; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Wang ZM, 2017, GUT, V66, P581, DOI 10.1136/gutjnl-2015-310612; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	46	1	1	13	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JUN	2017	152	8					2011	2021		10.1053/j.gastro.2017.02.017				11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	EW9AG	WOS:000402808600038	28246015				2018-01-05	
J	Wakim, J; Goudenege, D; Perrot, R; Gueguen, N; Desquiret-Dumas, V; de la Barca, JMC; Rosa, ID; Manero, F; Le Mao, M; Chupin, S; Chevrollier, A; Procaccio, V; Bonneau, D; Logan, DC; Reynier, P; Lenaers, G; Khiati, S				Wakim, Jamal; Goudenege, David; Perrot, Rodolphe; Gueguen, Naig; Desquiret-Dumas, Valerie; de la Barca, Juan Manuel Chao; Rosa, Ilaria Dalla; Manero, Florence; Le Mao, Morgane; Chupin, Stephanie; Chevrollier, Arnaud; Procaccio, Vincent; Bonneau, Dominique; Logan, David C.; Reynier, Pascal; Lenaers, Guy; Khiati, Salim			CLUH couples mitochondrial distribution to the energetic and metabolic status	JOURNAL OF CELL SCIENCE			English	Article						CLUH; Metabolism; Mitochondria; Mitochondrial dynamics; Cell size	MESSENGER-RNAS; OUTER-MEMBRANE; CLUELESS; PARKIN; DROSOPHILA; GENE; ULTRASTRUCTURE; DICTYOSTELIUM; DECARBOXYLASE; AGGREGATION	Mitochondrial dynamics and distribution are critical for supplying ATP in response to energy demand. CLUH is a protein involved in mitochondrial distribution whose dysfunction leads to mitochondrial clustering, the metabolic consequences of which remain unknown. To gain insight into the role of CLUH on mitochondrial energy production and cellular metabolism, we have generated CLUH-knockout cells using CRISPR/Cas9. Mitochondrial clustering was associated with a smaller cell size and with decreased abundance of respiratory complexes, resulting in oxidative phosphorylation (OXPHOS) defects. This energetic impairment was found to be due to the alteration of mitochondrial translation and to a metabolic shift towards glucose dependency. Metabolomic profiling by mass spectroscopy revealed an increase in the concentration of some amino acids, indicating a dysfunctional Krebs cycle, and increased palmitoylcarnitine concentration, indicating an alteration of fatty acid oxidation, and a dramatic decrease in the concentrations of phosphatidylcholine and sphingomyeline, consistent with the decreased cell size. Taken together, our study establishes a clear function for CLUH in coupling mitochondrial distribution to the control of cell energetic and metabolic status.	[Wakim, Jamal; Goudenege, David; Gueguen, Naig; Desquiret-Dumas, Valerie; de la Barca, Juan Manuel Chao; Le Mao, Morgane; Chupin, Stephanie; Chevrollier, Arnaud; Procaccio, Vincent; Bonneau, Dominique; Reynier, Pascal; Lenaers, Guy; Khiati, Salim] Univ Angers, Inst MitoVasc, Equipe MitoLab, UMR CNRS 6015,INSERM U1083, F-49933 Angers, France; [Perrot, Rodolphe; Manero, Florence] Univ Angers, Inst Biol Sante, SCIAM, F-49933 Angers, France; [Rosa, Ilaria Dalla] MRC Mill Hill Lab, London NW3 2PF, England; [Logan, David C.] Univ Angers, Agrocampus Ouest, MitoStress Team, IRHS,INRA,SFR QuaSaV, F-49071 Beaucouze, France	Lenaers, G; Khiati, S (reprint author), Univ Angers, Inst MitoVasc, Equipe MitoLab, UMR CNRS 6015,INSERM U1083, F-49933 Angers, France.	guy.lenaers@inserm.fr; salim.khiati@univ-angers.fr		Desquiret-Dumas, Valerie/0000-0001-9551-9400; Bonneau, Dominique/0000-0002-6886-0969; lenaers, guy/0000-0003-2736-3349	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universite Angers; University Hospital of Angers; Region Pays de Loire and Angers Loire Metropole; Fondation VISIO; Ouvrir les Yeux; Union Nationale des Aveugles et Deficients Visuels; Association contre les Maladies Mitochondriales; Retina France; Kjer France	We acknowledge support from the Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), the Universite Angers, the University Hospital of Angers, the Region Pays de Loire and Angers Loire Metropole. This work was also supported by grants from the following patients' foundations: 'Fondation VISIO', 'Ouvrir les Yeux', 'Union Nationale des Aveugles et Deficients Visuels', 'Association contre les Maladies Mitochondriales', 'Retina France' and 'Kjer France'.	Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Cox RT, 2009, DIS MODEL MECH, V2, P490, DOI 10.1242/dmm.002378; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490; El Zawily AM, 2014, PLANT PHYSIOL, V166, P808, DOI 10.1104/pp.114.243824; Fields SD, 2002, J MUSCLE RES CELL M, V23, P829, DOI 10.1023/A:1024492031696; Fields SD, 1998, J CELL SCI, V111, P1717; Gao J, 2014, J CELL BIOL, V207, P213, DOI 10.1083/jcb.201403129; Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007; Haga N, 2003, ONCOGENE, V22, P5579, DOI 10.1038/sj.onc.1206576; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Logan DC, 2003, PLANT J, V36, P500, DOI 10.1046/j.1365-313X.2003.01894.x; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nguyen TT, 2014, P NATL ACAD SCI USA, V111, pE3631, DOI 10.1073/pnas.1402449111; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x                                                ; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schatton D, 2017, J CELL BIOL, V216, P675, DOI 10.1083/jcb.201607019; Sen A, 2016, BIOL OPEN, V5, P195, DOI 10.1242/bio.015313; Sen A, 2015, DIS MODEL MECH, V8, P577, DOI 10.1242/dmm.019208; Wang ZH, 2016, HUM MOL GENET, V25, P1946, DOI 10.1093/hmg/ddw067; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	32	0	0	2	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	JUN 1	2017	130	11					1940	1951		10.1242/jcs.201616				12	Cell Biology	Cell Biology	EW5NC	WOS:000402552100009	28424233				2018-01-05	
J	Angelov, B; Garamus, VM; Drechsler, M; Angelova, A				Angelov, Borislav; Garamus, Vasil M.; Drechsler, Markus; Angelova, Angelina			Structural analysis of nanoparticulate carriers for encapsulation of macromolecular drugs	JOURNAL OF MOLECULAR LIQUIDS			English	Article; Proceedings Paper	7th Conference of the Physics of Liquid Matter - Modern Problems (PLMMP)	MAY 27-30, 2016	Kyiv, UKRAINE	Taras Shevchenko Natl Univ Kyiv, Minist Educ & Sci Ukraine, Natl Acad Sci Ukraine		Self-assembled nanocarriers; Liquid crystalline phase transitions; Cationic lipids; Macromolecular drugs; CRISPR/Cas9 therapeutics; Synchrotron SAXS	SMALL-ANGLE NEUTRON; LIQUID-CRYSTALLINE NANOPARTICLES; SURFACE PRESSURE MEASUREMENTS; SYNCHROTRON-RADIATION SAXS; LIPID CUBIC NANOPARTICLES; BETA CYCLODEXTRIN SYSTEM; WATER-SOLUBLE DRUGS; X-RAY-SCATTERING; CRYO-TEM; CLINICAL-APPLICATIONS	Recently developed macromolecular drugs display strong potential to cure diseases involving genetic components, e.g. Rheumatoid arthritis, diabetes, Alzheimer's disease, Huntington's disease, Duchenne muscular dystrophy, Retinitis pigmentosa, and several types of cancers. Bioavailability and enhanced drug specificity necessitate the preparation of efficient carrier systems for the macromolecular therapeutics. We employ synchrotron small angle X-ray scattering (SAXS) and cryogenic transmission electron microscopy (Cryo-TEM) to study the nano structure formation, macromolecular drug upload, and the topological transformations occurring upon complexation of supercoiled plasmid DNA (encoding for the therapeutic protein brain-derived neurotrophic factor, BDNF) with cationic lipid nanocarrier assemblies. Understanding of the liquid crystalline nanostructure formation (hexosomes, cubosomes, inverted hexagonal and intermediate mesophases, or onion-type complexes) enabling efficient delivery of new generation sequencing systems is expected to contribute to the progress in precision nanomedicine and the treatment of various severe diseases. (C) 2016 Elsevier B.V. All rights reserved.	[Angelov, Borislav] Acad Sci Czech Republ, Inst Phys, ELI Beamlines, Slovance 2, CZ-18221 Prague, Czech Republic; [Garamus, Vasil M.] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, D-21502 Geesthacht, Germany; [Drechsler, Markus] Univ Bayreuth, Bayreuth Inst Macromol Res, Lab Soft Matter Electron Microscopy, D-95440 Bayreuth, Germany; [Angelova, Angelina] Univ Paris Saclay, Univ Paris Sud, CNRS UMR 8612, Inst Gallen Paris Sud,LabEx,LERMIT, F-92290 Chatenay Malabry, France	Garamus, VM (reprint author), Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, D-21502 Geesthacht, Germany.	Vasyl.Haramus@hzg.de	Angelov, Borislav/E-9074-2012; Angelova, Angelina/T-6403-2017	Drechsler, Markus/0000-0001-7192-7821; Angelova, Angelina/0000-0002-0285-0637	European Regional Development Fund [CZ.02.1.01/0.0/0.0/15_008/0000162]; BIMF (Bayreuth Institute of Macromolecular Research); BZKG (Bayreuth Center for Colloids and Interfaces)	We gratefully acknowledge the allocation of beam time at the Synchrotron Radiation Facility DESY (Deutsche Elektronen Synchrotron, Hamburg, Germany) - storage ring PETRA III, BioSAXS beamline P12 of the European Molecular Biology Laboratory (EMBL). B.A. was supported by the project ELI - Extreme Light Infrastructure - phase 2 (CZ.02.1.01/0.0/0.0/15_008/0000162) from European Regional Development Fund. M.D. thanks BIMF (Bayreuth Institute of Macromolecular Research) and BZKG (Bayreuth Center for Colloids and Interfaces) for financial support.	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Almsherqi Z, 2008, J R SOC INTERFACE, V5, P1023, DOI 10.1098/rsif.2007.1351; Angelov B, 2006, J AM CHEM SOC, V128, P5813, DOI 10.1021/ja060082c; Angelov B, 2007, J AM CHEM SOC, V129, P13474, DOI 10.1021/ja072725; Angelov B, 2015, SOFT MATTER, V11, P3686, DOI 10.1039/c5sm00169b; Angelov B, 2014, ACS NANO, V8, P5216, DOI 10.1021/nn5012946; Angelov B, 2013, J PHYS CHEM LETT, V4, P1959, DOI 10.1021/jz400857z; Angelov B, 2012, LANGMUIR, V28, P16647, DOI 10.1021/la302721n; Angelov B, 2012, J PHYS CONF SER, V351, DOI 10.1088/1742-6596/351/1/012004; Angelov B, 2011, SOFT MATTER, V7, P9714, DOI 10.1039/c1sm06447a; ANGELOVA A, 1994, THIN SOLID FILMS, V242, P289, DOI 10.1016/0040-6090(94)90547-9; Angelova A, 2005, J DRUG DELIV SCI TEC, V15, P108, DOI 10.1016/S1773-2247(05)50013-3                                                   ; Angelova A, 1999, J COLLOID INTERF SCI, V212, P280, DOI 10.1006/jcis.1999.6089                                                          ; Angelova A, 1999, J COLLOID INTERF SCI, V212, P275, DOI 10.1006/jcis.1999.6088                                                          ; Angelova A, 2008, J COLLOID INTERF SCI, V322, P304, DOI 10.1016/j.jcis.2008.03.023; Angelova A, 2015, J INORG ORGANOMET P, V25, P214, DOI 10.1007/s10904-014-0143-8; Angelova A, 2013, DRUG DISCOV TODAY, V18, P1263, DOI 10.1016/j.drudis.2013.07.010; Angelova A, 2013, INT J PHARMACEUT, V454, P625, DOI 10.1016/j.ijpharm.2013.06.006; Barauskas J, 2010, INT J PHARMACEUT, V391, P284, DOI 10.1016/j.ijpharm.2010.03.016; Barreleiro PCA, 2003, FARADAY DISCUSS, V122, P191, DOI 10.1039/b200796g; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Cano-Sarabia M, 2010, J COLLOID INTERF SCI, V350, P10, DOI 10.1016/j.jcis.2010.04.069; Chandrawati R, 2011, J PHYS CHEM LETT, V2, P2639, DOI 10.1021/jz200994n; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Chen S, 2014, J CONTROL RELEASE, V196, P106, DOI 10.1016/j.jconrel.2014.09.025; Chen YY, 2015, J MATER CHEM B, V3, P7734, DOI 10.1039/c5tb01193k; Chong JYT, 2012, LANGMUIR, V28, P9223, DOI 10.1021/la301874v; Croissant J, 2015, ADV MATER, V27, P145, DOI 10.1002/adma.201404226; Falsini S, 2014, J MED CHEM, V57, P1138, DOI 10.1021/jm400791q; GUSTAFSSON J, 1995, BBA-BIOMEMBRANES, V1235, P305, DOI 10.1016/0005-2736(95)80018-B; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hope MJ, 2014, THER DELIV, V5, P663, DOI [10.4155/tde.14.37, 10.4155/TDE.14.37]; Huebner S, 1999, BIOPHYS J, V76, P3158, DOI 10.1016/S0006-3495(99)77467-9; Martin VI, 2014, COLLOID SURFACE B, V114, P247, DOI 10.1016/j.colsurfb.2013.10.017; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78                                                     ; Kuang GC, 2012, CHEM MATER, V24, P71, DOI 10.1021/cm201913p; Leung AKK, 2014, ADV GENET, V88, P71, DOI 10.1016/B978-0-12-800148-6.00004-3; Lin PJC, 2014, CLIN LIPIDOL, V9, P317, DOI 10.2217/CLP.14.27; Ma BC, 2007, J CONTROL RELEASE, V123, P184, DOI 10.1016/j.jconrel.2007.08.022; Maeda H, 2010, BIOCONJUGATE CHEM, V21, P797, DOI 10.1021/bc100070g; Matsui H, 2015, INT J PHARMACEUT, V495, P171, DOI 10.1016/j.ijpharm.2015.08.044; McLoughlin D, 2004, CHEMPHYSCHEM, V5, P1619, DOI 10.1002/cphc.200400163; Miguel MG, 2003, COLLOID SURFACE A, V228, P43, DOI 10.1016/S0927-7757(03)00334-0; Mochizuki S, 2013, BBA-BIOMEMBRANES, V1828, P412, DOI 10.1016/j.bbamem.2012.10.017; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nazaruk E, 2014, LANGMUIR, V30, P1383, DOI 10.1021/la403694e; Negrini R, 2012, LANGMUIR, V28, P16455, DOI 10.1021/la303833s; Negrini R, 2011, LANGMUIR, V27, P5296, DOI 10.1021/la200591u; Silva JPN, 2011, BBA-BIOMEMBRANES, V1808, P2440, DOI 10.1016/j.bbamem.2011.07.002; Petrenko VI, 2010, COLLOID SURFACE A, V369, P160, DOI 10.1016/j.colsurfa.2010.08.023; Petrenko VI, 2010, PHYS SOLID STATE+, V52, P974, DOI 10.1134/S1063783410050185; PETROV JG, 1992, LANGMUIR, V8, P3109; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Sun W, 2015, ANGEW CHEM, V127, P12197, DOI DOI 10.1002/ANIE.201506030; Suzuki Y, 2015, J CONTROL RELEASE, V220, P44, DOI 10.1016/j.jconrel.2015.10.024; Tam P, 2000, GENE THER, V7, P1867, DOI 10.1038/sj.gt.3301308; Tarahovsky Y, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1293, DOI 10.1134/S0006297909120013; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; Tyler AII, 2015, SOFT MATTER, V11, P3279, DOI 10.1039/c5sm00311c; Wan C, 2014, DRUG DELIV TRANSL RE, V4, P74, DOI 10.1007/s13346-013-0161-z; Warren DB, 2011, LANGMUIR, V27, P9528, DOI 10.1021/la2011937; Yadav SS, 2015, UROLONCOL, V33, DOI [10.1016/j.urolonc.2015.02.009, DOI 10.1016/J.UROLONC.2015.02.009]; Yaghmur A, 2012, LANGMUIR, V28, P2881, DOI 10.1021/la203577v; Yaghmur A, 2011, PHYS CHEM CHEM PHYS, V13, P3115, DOI 10.1039/c0cp01036g; Yao SH, 2015, HUM GENE THER, V26, P463, DOI 10.1089/hum.2015.067; Ying B, 2014, BIOCHEM BIOPH RES CO, V446, P441, DOI 10.1016/j.bbrc.2014.02.120; Yu SJ, 2013, SOFT MATTER, V9, P2637, DOI 10.1039/c2sm27616j; Zabara A, 2014, J CONTROL RELEASE, V188, P31, DOI 10.1016/j.jconrel.2014.05.052; Zeng N, 2012, INT J NANOMED, V7, P3703, DOI 10.2147/IJN.S32599; Zerkoune L, 2016, SOFT MATTER, V12, P7539, DOI 10.1039/c6sm00661b; Zerkoune L, 2014, NANOMATERIALS-BASEL, V4, P741, DOI 10.3390/nano4030741; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	73	6	6	14	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	JUN	2017	235				SI		83	89		10.1016/j.molliq.2016.11.064				7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	EW2XC	WOS:000402358300013					2018-01-05	
J	Solvsten, CAE; Daugaard, TF; Luo, Y; de Paoli, F; Christensen, JH; Nielsen, AL				Solvsten, Christina A. E.; Daugaard, Tina F.; Luo, Yonglun; de Paoli, Frank; Christensen, Jane H.; Nielsen, Anders L.			The Effects of Voluntary Physical Exercise-Activated Neurotrophic Signaling in Rat Hippocampus on mRNA Levels of Downstream Signaling Molecules	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Bdnf; Igf1; VegfA; CRISPR-Cas9; dCas9-VP64	GROWTH-FACTOR-I; LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; SYNAPTIC-PLASTICITY; GENE-EXPRESSION; NEURONAL DEVELOPMENT; TRUNCATED TRKB; UP-REGULATION; COLON-CANCER; FACTOR VEGF	Physical exercise results in the increased expression of neurotrophic factors and the subsequent induction of signal transduction cascades with a positive impact on neuronal functions. In this study, we used a voluntary physical exercise rat model to determine correlations in hippocampus mRNA expression of the neurotropic factors Bdnf, VegfA, and Igf1; their receptors TrkB, Igf1R, VegfR1, and VegfrR2; and downstream signal transducers Creb, Syn1, and Vgf. In hippocampi of physically exercised rats, the mRNA expression levels of Bdnf transcript 4 (Bdnf-t4), VegfA, and Igf1, as well as VegfR1, TrkB, Creb, Vgf, and Syn1, were increased. Bdnf-t4 mRNA expression positively correlated with mRNA expression of Creb, Vgf, and Syn1 in hippocampi of exercised rats. A correlation between Bdnf-t4 and Syn1 mRNA expression was also observed in hippocampi of sedentary rats. Igf1 and VegfA mRNA expression was positively correlated in hippocampi of both exercised and sedentary rats. But, neither Igf1 nor VegfA mRNA expression was correlated with the expression of Bdnf-t4 or the expression of the signal transducers Creb, Syn1, and Vgf. In hippocampi of exercised rats, Creb mRNA expression was positively correlated with TrkB, Syn1, and Vgf mRNA expression and with the correlation between Creb and Vgf mRNA expression also observed in hippocampi of sedentary rats. To examine for causality of the in vivo observed correlated mRNA expression levels between Bdnf-t4 and the other examined transcripts, we used nuclease-deactivated CRISPR-Cas9 fused with VP64 to induce mRNA expression of endogenous Bdnf-t4 in rat PC12 cells. Following Bdnf-t4 mRNA induction, we observed increased Creb mRNA expression. This in vitro result is in accordance with the in vivo results and supports that under specified conditions, an increase in Creb mRNA expression can be a downstream signal transduction event due to induction of endogenous Bdnf mRNA expression.	[Solvsten, Christina A. E.; Daugaard, Tina F.; Luo, Yonglun; de Paoli, Frank; Christensen, Jane H.; Nielsen, Anders L.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Christensen, Jane H.; Nielsen, Anders L.] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Christensen, Jane H.] Aarhus Univ, Ctr Integrat Sequencing, iSEQ, Aarhus, Denmark	Nielsen, AL (reprint author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark.; Nielsen, AL (reprint author), iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark.	aln@biomed.au.dk	Luo, Yonglun/C-4708-2013	Luo, Yonglun/0000-0002-0007-7759; de Paoli, Frank Vincenzo/0000-0002-2174-2295; Nielsen, Anders Lade/0000-0003-4372-9961; Daugaard, Tina Fuglsang/0000-0003-0320-3076	Lundbeck Foundation [R100-A9606]	This work was supported by the Lundbeck Foundation (R100-A9606).	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Akagi Y, 1998, CANCER RES, V58, P4008; Alder J, 2003, J NEUROSCI, V23, P10800; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; AndroutsellisTheotokis A, 1996, BRAIN RES, V743, P40, DOI 10.1016/S0006-8993(96)00981-X; Anlar B, 1999, HORM METAB RES, V31, P120, DOI 10.1055/s-2007-978708; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Foltran RB, 2016, J NEUROCHEM, V138, P204, DOI 10.1111/jnc.13658; Bechara RG, 2014, BEHAV BRAIN RES, V275, P297, DOI 10.1016/j.bbr.2013.11.015; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carro E, 2001, J NEUROSCI, V21, P5678; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Chen MJ, 2007, GROWTH FACTORS, V25, P118, DOI 10.1080/08977190701602329; Chen MJ, 2009, HIPPOCAMPUS, V19, P962, DOI 10.1002/hipo.20579; Chen WG, 2003, J NEUROSCI, V23, P2572; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; De Meyts P, 2002, GROWTH HORM IGF RES, V12, P81, DOI 10.1054/ghir.2002.0264; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Eilam R, 1999, HIPPOCAMPUS, V9, P534, DOI 10.1002/(SICI)1098-1063(1999)9:5<534::AID-HIPO7>3.0.CO;2-R; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1046/j.1460-9568.2003.03041.x; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5                                                   ; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Goggi J, 2003, BRAIN RES, V967, P201, DOI 10.1016/S0006-8993(03)02225-X; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677                                                  ; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kojima M, 2001, J NEUROSCI RES, V64, P1, DOI 10.1002/jnr.1080; Kondo Y, 2010, ACTA HISTOCHEM CYTOC, V43, P139, DOI 10.1267/ahc.10027; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kristensen B, 1997, BRAIN RES, V775, P99, DOI 10.1016/S0006-8993(97)00966-9; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Murray P. S., 2011, INT J PEPT, V2011, DOI [DOI 10.1155/2011/654085, 10.1155/2011/654085]; Nakajima K, 2001, J NEUROSCI RES, V65, P322, DOI 10.1002/jnr.1157                                                                ; Nakajima K, 2002, J NEUROCHEM, V80, P697, DOI 10.1046/j.0022-3042.2001.00752.x; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Neufeld G, 1999, FASEB J, V13, P9; Patel NJ, 2010, EUR J PHARMACOL, V633, P1, DOI 10.1016/j.ejphar.2010.01.012; Pencea V, 2001, J NEUROSCI, V21, P6706; Poulaki V, 2003, J CLIN ENDOCR METAB, V88, P5392, DOI 10.1210/jc.2003-030389; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rajan P, 1996, J NEUROSCI RES, V43, P403, DOI 10.1002/(SICI)1097-4547(19960215)43:4<403::AID-JNR2>3.0.CO;2-J                  ; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3                                                   ; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629                                                          ; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; Solvsten CA, 2016, MOL NEUROBIOL, DOI [10.1007/s12035-016-0344-y, DOI 10.1007/S12035-016-0344-Y]; Udo H, 2014, BEHAV BRAIN RES, V275, P107, DOI 10.1016/j.bbr.2014.09.005; Uysal N, 2015, BIOTECH HISTOCHEM, V90, P55, DOI 10.3109/10520295.2014.946968; Valtorta F, 2011, SEMIN CELL DEV BIOL, V22, P378, DOI 10.1016/j.semcdb.2011.07.008; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Yang D, 2012, EUR J NEUROSCI, V36, P2573, DOI 10.1111/j.1460-9568.2012.08187.x; Yau SY, 2014, BIOMED RES INT, DOI 10.1155/2014/403120; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; ZAFRA F, 1992, J NEUROSCI, V12, P4793; Zhang N, 2015, NEUROSCIENCE, V311, P284, DOI 10.1016/j.neuroscience.2015.10.038; Zheng Fei, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P188	68	0	0	4	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JUN	2017	62	2					142	153		10.1007/s12031-017-0918-9				12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	EX1KQ	WOS:000402981900002	28439815				2018-01-05	
J	Chen, ZH; Yu, YP; Zuo, ZH; Nelson, JB; Michalopoulos, GK; Monga, S; Liu, S; Tseng, G; Luo, JH				Chen, Zhang-Hui; Yu, Yan P.; Zuo, Ze-Hua; Nelson, Joel B.; Michalopoulos, George K.; Monga, Satdatshan; Liu, Silvia; Tseng, George; Luo, Jian-Hua			Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene	NATURE BIOTECHNOLOGY			English	Article							PROSTATE-CANCER GROWTH; ADENOVIRUS VECTORS; FUSION TRANSCRIPTS; METASTASIS; DEATH; SPECIFICITY; INHIBITION; GENERATION; HALLMARKS; MYOPODIN	Specifically targeting genomic rearrangements and mutations in tumor cells remains an elusive goal in cancer therapy. Here, we used Cas9-based genome editing to introduce the gene encoding the prodrug-converting enzyme herpes simplex virus type 1 thymidine kinase (HSV1-tk) into the genomes of cancer cells carrying unique sequences resulting from genome rearrangements. Specifically, we targeted the breakpoints of TMEM135-CCDC67 and MAN2A1-FER fusions in human prostate cancer or hepatocellular carcinoma cells in vitro and in mouse xenografts. We designed one adenovirus to deliver the nickase Cas9(D10A) and guide RNAs targeting the breakpoint sequences, and another to deliver an EGFP-HSV1-tk construct flanked by sequences homologous to those surrounding the breakpoint. Infection with both viruses resulted in breakpoint-dependent expression of EGFP-tk and ganciclovir-mediated apoptosis. When mouse xenografts were treated with adenoviruses and ganciclovir, all animals showed decreased tumor burden and no mortality during the study. Thus, Cas9-mediated suicide-gene insertion may be a viable genotype-specific cancer therapy.	[Chen, Zhang-Hui; Yu, Yan P.; Zuo, Ze-Hua; Michalopoulos, George K.; Monga, Satdatshan; Luo, Jian-Hua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Nelson, Joel B.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA; [Liu, Silvia; Tseng, George] Univ Pittsburgh, Sch Med, Dept Biostat, Pittsburgh, PA USA	Luo, JH (reprint author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	luoj@msx.upmc.edu			National Cancer Institute [RO1 CA098249]; Department of Defense [W81XWH-16-1-0364]; University of Pittsburgh Cancer Institute	We thank S. Zheng for technical support. This work was supported by grants from the National Cancer Institute to JHL (RO1 CA098249 to J.-H.L.), the Department of Defense (W81XWH-16-1-0364) to J.-H.L. and the University of Pittsburgh Cancer Institute to J.-H.L., G.K.M. and J.B.N.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Bernardino J, 1997, CANCER GENET CYTOGEN, V96, P123, DOI 10.1016/S0165-4608(96)00258-0; Chen Z- H, 2017, GASTROENTEROLOGY; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Demetris AJ, 1996, AM J PATHOL, V149, P439; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Han YC, 2013, J PATHOL, V230, P184, DOI 10.1002/path.4169; Han YC, 2010, CANCER RES, V70, P4375, DOI 10.1158/0008-5472.CAN-09-4403; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9                                                   ; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jing L, 2004, AM J PATHOL, V164, P1799, DOI 10.1016/S0002-9440(10)63738-8                                                   ; Kozarsky K F, 1993, Curr Opin Genet Dev, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Lin F, 2001, AM J PATHOL, V159, P1603, DOI 10.1016/S0002-9440(10)63006-4                                                   ; Luo JH, 2015, AM J PATHOL, V185, P1834, DOI 10.1016/j.ajpath.2015.03.008; Luo KL, 2010, CANCER SCI, V101, P707, DOI 10.1111/j.1349-7006.2009.01425.x; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; OHNUKI Y, 1980, CANCER RES, V40, P524; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; Shi YK, 2010, CANCER GENE THER, V17, P694, DOI 10.1038/cgt.2010.25; SMITH KO, 1982, ANTIMICROB AGENTS CH, V22, P55, DOI 10.1128/AAC.22.1.55                                                             ; Van Rompay AR, 2000, PHARMACOL THERAPEUT, V87, P189, DOI 10.1016/S0163-7258(00)00048-6                                                   ; Wang H, 2012, J BIOL CHEM, V287, P16890, DOI 10.1074/jbc.M111.322636; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Yu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135982; Yu YP, 2014, AM J PATHOL, V184, P2840, DOI 10.1016/j.ajpath.2014.06.025; Yu YP, 2013, AM J PATHOL, V183, P1960, DOI 10.1016/j.ajpath.2013.08.018; Zhu ZH, 2009, ONCOGENE, V28, P41, DOI 10.1038/onc.2008.359; Zhu ZH, 2010, AM J PATHOL, V177, P1176, DOI 10.2353/ajpath.2010.091026	35	3	3	10	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2017	35	6					543	+		10.1038/nbt.3843				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EW9IK	WOS:000402831800022	28459452				2018-01-05	
J	Klann, TS; Black, JB; Chellappan, M; Safi, A; Song, LY; Hilton, IB; Crawford, GE; Reddy, TE; Gersbach, CA				Klann, Tyler S.; Black, Joshua B.; Chellappan, Malathi; Safi, Alexias; Song, Lingyun; Hilton, Isaac B.; Crawford, Gregory E.; Reddy, Timothy E.; Gersbach, Charles A.			CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome	NATURE BIOTECHNOLOGY			English	Article							BREAST-CANCER; HUMAN-CELLS; TRANSCRIPTION FACTORS; TARGETING ENHANCERS; DNA METHYLATION; GENE-EXPRESSION; OPEN CHROMATIN; CAS9; ENDONUCLEASE; ACTIVATION	Large genome-mapping consortia and thousands of genome-wide association studies have identified non-protein-coding elements in the genome as having a central role in various biological processes. However, decoding the functions of the millions of putative regulatory elements discovered in these studies remains challenging. CRISPR-Cas9-based epigenome editing technologies have enabled precise perturbation of the activity of specific regulatory elements. Here we describe CRISPR-Cas9-based epigenomic regulatory element screening (CERES) for improved high-throughput screening of regulatory element activity in the native genomic context. Using dCas9(KRAB) repressor and dCas9(p300) activator constructs and lentiviral single guide RNA libraries to target DNase I hypersensitive sites surrounding a gene of interest, we carried out both loss-and gain-of-function screens to identify regulatory elements for the beta-globin and HER2 loci in human cells. CERES readily identified known and previously unidentified regulatory elements, some of which were dependent on cell type or direction of perturbation. This technology allows the high-throughput functional annotation of putative regulatory elements in their native chromosomal context.	[Klann, Tyler S.; Black, Joshua B.; Chellappan, Malathi; Hilton, Isaac B.; Reddy, Timothy E.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Klann, Tyler S.; Black, Joshua B.; Chellappan, Malathi; Safi, Alexias; Song, Lingyun; Hilton, Isaac B.; Crawford, Gregory E.; Reddy, Timothy E.; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Crawford, Gregory E.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Reddy, Timothy E.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27708 USA; [Gersbach, Charles A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27708 USA	Reddy, TE; Gersbach, CA (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Crawford, GE; Reddy, TE; Gersbach, CA (reprint author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.; Crawford, GE (reprint author), Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA.; Reddy, TE (reprint author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27708 USA.; Gersbach, CA (reprint author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27708 USA.				Thorek Memorial Foundation; US National Institutes of Health (NIH) [R01DA036865, R41GM119914, U01HG007900, P30AR066527, T32GM008555, DP2OD008586]; National Science Foundation (NSF) (Faculty Early Career Development (CAREER) Award [CBET-1151035]	This work was supported by the Thorek Memorial Foundation, the US National Institutes of Health (NIH) (grants R01DA036865, R41GM119914, and U01HG007900 to G.E.C., T.E.R., and C.A.G.; core facility grant P30AR066527; Biotechnology Training Grant T32GM008555 to T.S.K. and J.B.B.; Director's New Innovator Award DP2OD008586 to C.A.G.), and the National Science Foundation (NSF) (Faculty Early Career Development (CAREER) Award CBET-1151035 to C.A.G.).	Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Baron MH, 1996, GENE EXPRESSION, V6, P129; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Chu PY, 2010, J BIOL CHEM, V285, P29279, DOI 10.1074/jbc.C110.114124; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DEAN A, 1983, P NATL ACAD SCI-BIOL, V80, P5515, DOI 10.1073/pnas.80.18.5515; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI [10.1586/era.10.226, 10.1586/ERA.10.226]; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5                                                   ; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; HINDORFF L, 2009, CATALOG PUBLISHED GE; Housden BE, 2017, NAT REV GENET, V18, P24, DOI 10.1038/nrg.2016.118; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Salmon P., 2006, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0421S37; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Song L, 2010, COLD SPRING HARB PRO, V2010, P5384, DOI DOI 10.1101/PDB.PR0T5384; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Vu Thuy, 2012, Front Oncol, V2, P62, DOI 10.3389/fonc.2012.00062; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9	56	12	12	39	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2017	35	6					561	+		10.1038/nbt.3853				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EW9IK	WOS:000402831800024	28369033	green_accepted			2018-01-05	
J	Roper, J; Tammela, T; Cetinbas, NM; Akkad, A; Roghanian, A; Rickelt, S; Almeqdadi, M; Wu, K; Oberli, MA; Sanchez-Rivera, F; Park, YK; Liang, X; Eng, G; Taylor, MS; Azimi, R; Kedrin, D; Neupane, R; Beyaz, S; Sicinska, ET; Suarez, Y; Yoo, J; Chen, LL; Zukerberg, L; Katajisto, P; Deshpande, V; Bass, AJ; Tsichlis, PN; Lees, J; Langer, R; Hynes, RO; Chen, JZ; Bhutkar, A; Jacks, T; Yilmaz, OH				Roper, Jatin; Tammela, Tuomas; Cetinbas, Naniye Malli; Akkad, Adam; Roghanian, Ali; Rickelt, Steffen; Almeqdadi, Mohammad; Wu, Katherine; Oberli, Matthias A.; Sanchez-Rivera, Francisco; Park, Yoona K.; Liang, Xu; Eng, George; Taylor, Martin S.; Azimi, Roxana; Kedrin, Dmitriy; Neupane, Rachit; Beyaz, Semir; Sicinska, Ewa T.; Suarez, Yvelisse; Yoo, James; Chen, Lillian; Zukerberg, Lawrence; Katajisto, Pekka; Deshpande, Vikram; Bass, Adam J.; Tsichlis, Philip N.; Lees, Jacqueline; Langer, Robert; Hynes, Richard O.; Chen, Jianzhu; Bhutkar, Arjun; Jacks, Tyler; Yilmaz, Oemer H.			In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis	NATURE BIOTECHNOLOGY			English	Article							MULTIPLE INTESTINAL NEOPLASIA; ENGINEERED MOUSE MODELS; LGR5(+) STEM-CELL; COLON-CANCER; DRUG DEVELOPMENT; VITRO EXPANSION; APC GENE; K-RAS; MICE; GENERATION	In vivo interrogation of the function of genes implicated in tumorigenesis is limited by the need to generate and cross germline mutant mice. Here we describe approaches to model colorectal cancer (CRC) and metastasis, which rely on in situ gene editing and orthotopic organoid transplantation in mice without cancer-predisposing mutations. Autochthonous tumor formation is induced by CRISPR-Cas9-based editing of the Apc and Trp53 tumor suppressor genes in colon epithelial cells and by orthotopic transplantation of Apc-edited colon organoids. Apc Delta Delta.; Kras(G12D/+); Trp53 Delta/Delta (AKP) mouse colon organoids and human CRC organoids engraft in the distal colon and metastasize to the liver. Finally, we apply the orthotopic transplantation model to characterize the clonal dynamics of Lgr5(+) stem cells and demonstrate sequential activation of an oncogene in established colon adenomas. These experimental systems enable rapid in vivo characterization of cancer-associated genes and reproduce the entire spectrum of tumor progression and metastasis.	[Roper, Jatin; Tammela, Tuomas; Cetinbas, Naniye Malli; Akkad, Adam; Roghanian, Ali; Rickelt, Steffen; Almeqdadi, Mohammad; Wu, Katherine; Oberli, Matthias A.; Sanchez-Rivera, Francisco; Park, Yoona K.; Liang, Xu; Eng, George; Azimi, Roxana; Kedrin, Dmitriy; Neupane, Rachit; Beyaz, Semir; Lees, Jacqueline; Langer, Robert; Hynes, Richard O.; Chen, Jianzhu; Bhutkar, Arjun; Jacks, Tyler; Yilmaz, Oemer H.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; Tufts Med Ctr, Div Gastroenterol, Boston, MA USA; [Roper, Jatin; Yoo, James; Tsichlis, Philip N.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Roghanian, Ali] Univ Southampton, Southampton Gen Hosp, Fac Med, Cancer Sci Unit, Southampton, Hants, England; [Eng, George; Taylor, Martin S.; Zukerberg, Lawrence; Deshpande, Vikram; Yilmaz, Oemer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sicinska, Ewa T.; Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Suarez, Yvelisse] Tufts Med Ctr, Dept Pathol, Boston, MA USA; [Yoo, James; Chen, Lillian] Tufts Med Ctr, Dept Surg, Boston, MA USA; [Katajisto, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Katajisto, Pekka] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Hynes, Richard O.; Jacks, Tyler] MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Yilmaz, OH (reprint author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ohyilmaz@mit.edu		Sanchez-Rivera, Francisco J./0000-0002-8466-8563	Howard Hughes Medical Institute; NIH [K08 CA198002, K99 CA187317, R01CA211184, U54-CA163109]; Sigrid Juselius Foundation; Maud Kuistila Foundation; Hope Funds for Cancer Research; Department of Defense (PRCRP Career Development Award) [CA120198]; V Foundation V Scholar Award; Sidney Kimmel Scholar Award; Pew-Stewart Trust Scholar Award; Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund; American Federation of Aging Research (AFAR); Metastasis/Cancer Research Postdoc fellowship from the MIT Ludwig Center for Molecular Oncology Research; Bloodwise (UK) [14043]; Koch Institute Support (core) Grant from the National Cancer Institute [P30-CA14051]	This work was supported by the Howard Hughes Medical Institute (T.J., R.O.H.), NIH (K08 CA198002, J.R.; K99 CA187317, T.T.; O.H.Y.; R01CA211184, O.H.Y.; U54-CA163109, R.O.H.), the Sigrid Juselius Foundation (O.H.Y), the Maud Kuistila Foundation and the Hope Funds for Cancer Research (O.H.Y.), Department of Defense (PRCRP Career Development Award CA120198; J.R.), and the V Foundation V Scholar Award (J.R. and O.H.Y.), the Sidney Kimmel Scholar Award (O.H.Y.), the Pew-Stewart Trust Scholar Award (O.H.Y.), the Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund (O.H.Y.), American Federation of Aging Research (AFAR, O.H.Y.), the Hope Funds for Cancer Research (T.T.), the Metastasis/Cancer Research Postdoc fellowship from the MIT Ludwig Center for Molecular Oncology Research (S.R.), the Bloodwise (UK) Visiting Fellowship Grant 14043 (A.R.), and by the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute. We thank T. Papagiannakopoulos for helpful discussions; Y. Soto-Feliciano for help and expertise with massively parallel sequencing; K. Bedrossian for assistance with human colorectal cancer sample collection at Tufts Medical Center; the Swanson Biotechnology Center at the Koch Institute for technical support, specifically K. Cormier and C. Condon at the Hope Babette Tang (1983) Histology Facility; S. Holder for histology support; and Y.D. Soo and the Peterson (1957) Nanotechnology Materials Core Facility for assistance with electron microscopy. L-WRN cells were a kind gift from T. Stappenbeck, Washington University.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Akama-Garren EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep16836; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Bhullar JS, 2011, J AM COLL SURGEONS, V213, P54, DOI 10.1016/j.jamcollsurg.2011.02.022; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345                                                         ; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Fukuda M, 2014, GENE DEV, V28, P1752, DOI 10.1101/gad.245233.114; Golovko D, 2015, EXPERT OPIN DRUG DIS, V10, P1217, DOI 10.1517/17460441.2015.1079618; Hadac JN, 2015, CANCER PREV RES, V8, P952, DOI 10.1158/1940-6207.CAPR-15-0003; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Koo B.K., 2013, CURR PROTOC STEM CEL, V27, P6; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li Y, 2013, J IMMUNOL, V191, P3192, DOI 10.4049/jimmunol.1300742; Maddalo D, 2016, CANCER RES, V76, P4918, DOI 10.1158/0008-5472.CAN-16-0726; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Martin ES, 2013, CLIN CANCER RES, V19, P2929, DOI 10.1158/1078-0432.CCR-12-2307; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Rourke K.P., 2017, NAT BIOTECHNOL, DOI [10.1038/nbt.3837, DOI 10.1038/NBT.3837]; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Roper J, 2014, CANCER LETT, V347, P204, DOI 10.1016/j.canlet.2014.02.018; Roper J, 2012, TRENDS PHARMACOL SCI, V33, P449, DOI 10.1016/j.tips.2012.05.001; Roper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025132; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477                                                    ; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5                                                    ; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takahashi T, 2004, CANCER SCI, V95, P514, DOI 10.1111/j.1349-7006.2004.tb03242.x; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ603; Xue YB, 2010, MOL CANCER RES, V8, P1095, DOI 10.1158/1541-7786.MCR-10-0195; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhao MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082138; Zigmond E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028858	62	5	5	28	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2017	35	6					569	+		10.1038/nbt.3836				11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EW9IK	WOS:000402831800025	28459449				2018-01-05	
J	O'Rourke, KP; Loizou, E; Livshits, G; Schatoff, EM; Baslan, T; Manchado, E; Simon, J; Romesser, PB; Leach, B; Han, T; Pauli, C; Beltran, H; Rubin, MA; Dow, LE; Lowe, SW				O'Rourke, Kevin P.; Loizou, Evangelia; Livshits, Geulah; Schatoff, Emma M.; Baslan, Timour; Manchado, Eusebio; Simon, Janelle; Romesser, Paul B.; Leach, Benjamin; Han, Teng; Pauli, Chantal; Beltran, Himisha; Rubin, Mark A.; Dow, Lukas E.; Lowe, Scott W.			Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer	NATURE BIOTECHNOLOGY			English	Article							COLON-CANCER; STEM-CELLS; IN-VITRO; TUMORIGENESIS; APC; INACTIVATION; CRISPR-CAS9; EXPRESSION; MICE	Colorectal cancer (CRC) is a leading cause of death in the developed world, yet facile preclinical models that mimic the natural stages of CRC progression are lacking. Through the orthotopic engraftment of colon organoids we describe a broadly usable immunocompetent CRC model that recapitulates the entire adenoma-adenocarcinoma-metastasis axis in vivo. The engraftment procedure takes less than 5 minutes, shows efficient tumor engraftment in two-thirds of mice, and can be achieved using organoids derived from genetically engineered mouse models (GEMMs), wild-type organoids engineered ex vivo, or from patient-derived human CRC organoids. In this model, we describe the genotype and time-dependent progression of CRCs from adenocarcinoma (6 weeks), to local disseminated disease (11-12 weeks), and spontaneous metastasis (>20 weeks). Further, we use the system to show that loss of dysregulated Wnt signaling is critical for the progression of disseminated CRCs. Thus, our approach provides a fast and flexible means to produce tailored CRC mouse models for genetic studies and pre-clinical investigation.	[O'Rourke, Kevin P.; Schatoff, Emma M.] Rockefeller Univ, Sloan Kettering Tri Inst MD PhD Program, Weill Cornell Med, 1230 York Ave, New York, NY 10021 USA; [O'Rourke, Kevin P.; Loizou, Evangelia; Livshits, Geulah; Baslan, Timour; Manchado, Eusebio; Simon, Janelle; Romesser, Paul B.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Loizou, Evangelia; Han, Teng] Weill Cornell Grad Sch Med Sci, New York, NY USA; [Schatoff, Emma M.; Leach, Benjamin; Han, Teng; Pauli, Chantal; Beltran, Himisha; Rubin, Mark A.; Dow, Lukas E.] Weill Cornell Med, Meyer Canc Ctr, Dept Med, Hematol & Med Oncol Div, New York, NY USA; [Romesser, Paul B.] Mem Sloan Kettering Canc Ctr, Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Pauli, Chantal; Beltran, Himisha; Rubin, Mark A.] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Lowe, SW (reprint author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.; Dow, LE (reprint author), Weill Cornell Med, Meyer Canc Ctr, Dept Med, Hematol & Med Oncol Div, New York, NY USA.; Lowe, SW (reprint author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	lud2005@med.cornell.edu; lowes@mskcc.org			Starr Cancer Consortium [I7-A771, I8-A8-030]; Department of Defense [PC121341]; Damon Runyon Cancer Research Foundation-Gordon Family Clinical Investigator Award [CI-67-13]; NIH [U54 OD020355-01, R01 CA195787-01, P30 CA008748]; NIH/NCI [1CA200110-01A1]; MSKCC Single-Cell Sequencing Initiative, The William and Joyce O'Neil Research Fund; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health [T32GM07739]; K12 Paul Calebresi Career Development Award for Clinical Oncology [CA 187069]; NCI/NIH [CA 181280-01]; NIH Small-Animal Imaging Research Program (SAIRP) [R24 CA83084]; NIH Center Grant [P30 CA08748]; NIH Prostate SPORE [P50-CA92629]	We thank D. Grace, S. Tian, and M. Taylor for technical assistance with animal colonies, other members of the Lowe laboratory for advice and discussions, J. Shia for assistance with histopathology, M. Gollub for assistance with interpreting MRI studies, and C. LeKaye, M. Lupu, and D. Winkleman for their technical support. We also thank members of the Englander Institute for Precision Medicine Organoid Platform, T. McNary, Y. Churakova, and C. Cheung. This work was supported by grants from the Starr Cancer Consortium (I7-A771, to M.A.R. and H.B.; and I8-A8-030 to. S.W.L. and L.E.D.), the Department of Defense (PC121341; to H.B.), and a Damon Runyon Cancer Research Foundation-Gordon Family Clinical Investigator Award (CI-67-13; to H.B.). This work was supported by grants from the NIH (U54 OD020355-01, R01 CA195787-01 and P30 CA008748). K.P.O'R. is supported by an F30 Award from the NIH/NCI (1CA200110-01A1). T.B. was supported by the MSKCC Single-Cell Sequencing Initiative, The William and Joyce O'Neil Research Fund. K.P.O'R. and E.M. S. were supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health under award number T32GM07739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program. P.B.R. is supported by a K12 Paul Calebresi Career Development Award for Clinical Oncology (CA 187069). L.E.D. was supported by a K22 Career Development Award from the NCI/NIH (CA 181280-01). Animal imaging studies were supported by the NIH Small-Animal Imaging Research Program (SAIRP), R24 CA83084; NIH Center Grant, P30 CA08748; NIH Prostate SPORE, P50-CA92629. S.W.L. is the Geoffrey Beene Chair of Cancer Biology and an Investigator of the Howard Hughes Medical Institute.	Baslan T, 2015, GENOME RES, V25, P714, DOI 10.1101/gr.188060.114; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Byun AJ, 2014, CANCER LETT, V347, P191, DOI 10.1016/j.canlet.2014.03.004; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Heijstek MW, 2005, DIGEST SURG, V22, P16, DOI 10.1159/000085342; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martin ES, 2013, CLIN CANCER RES, V19, P2929, DOI 10.1158/1078-0432.CCR-12-2307; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Oh B.Y., 2017, CANC LETT, V387, P114; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; O'Rourke K. P., 2016, BIO PROTOC, V6, pe1733; O'Rourke K. P., 2016, BIO PROTOC, V6, pe1732; Roper J., 2017, NAT BIOTECHNOL; Sato T, 2011, YGAST, V141, P1762, DOI DOI 10.1053/J.GASTR0.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tetteh PW, 2016, P NATL ACAD SCI USA, V113, P11859, DOI 10.1073/pnas.1614057113; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Xue YB, 2010, MOL CANCER RES, V8, P1095, DOI 10.1158/1541-7786.MCR-10-0195; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	30	3	3	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2017	35	6					577	+		10.1038/nbt.3837				8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EW9IK	WOS:000402831800026	28459450				2018-01-05	
J	Koehler, KR; Nie, J; Longworth-Mills, E; Liu, XP; Lee, J; Holt, JR; Hashino, E				Koehler, Karl R.; Nie, Jing; Longworth-Mills, Emma; Liu, Xiao-Ping; Lee, Jiyoon; Holt, Jeffrey R.; Hashino, Eri			Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							GENETIC CORRECTION; MOUSE; CULTURE; DIFFERENTIATION; LINEAGE; CRISPR-CAS9; PROGENITORS; INHIBITION; EPITHELIA; CHANNELS	The derivation of human inner ear tissue from pluripotent stem cells would enable in vitro screening of drug candidates for the treatment of hearing and balance dysfunction and may provide a source of cells for cell-based therapies of the inner ear. Here we report a method for differentiating human pluripotent stem cells to inner ear organoids that harbor functional hair cells. Using a three-dimensional culture system, we modulate TGF, BMP, FGF, and WNT signaling to generate multiple otic-vesicle-like structures from a single stem-cell aggregate. Over 2 months, the vesicles develop into inner ear organoids with sensory epithelia that are innervated by sensory neurons. Additionally, using CRISPR-Cas9, we generate an ATOH1-2A-eGFP cell line to detect hair cell induction and demonstrate that derived hair cells exhibit electrophysiological properties similar to those of native sensory hair cells. Our culture system should facilitate the study of human inner ear development and research on therapies for diseases of the inner ear.	[Koehler, Karl R.; Nie, Jing; Longworth-Mills, Emma; Lee, Jiyoon; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Longworth-Mills, Emma] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Liu, Xiao-Ping; Holt, Jeffrey R.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Otolaryngol, Boston, MA USA; [Liu, Xiao-Ping; Holt, Jeffrey R.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Neurol, Boston, MA USA; [Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Liu, Xiao-Ping] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Koehler, KR; Hashino, E (reprint author), Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA.; Hashino, E (reprint author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	krkoehle@iu.edu; ehashino@iupui.edu			National Institute of Health (NIH) [R01 DC013294, R03 DC015624]; Action on Hearing Loss International Project Grant; Indiana Clinical and Translational Sciences Institute Core Grant (NIH) [UL1 TR001108]; Research Facilities Improvement Program Grant from the National Center for Research Resources, NIH [C06 RR020128-01]	This work was supported by National Institute of Health (NIH) grants R01 DC013294 (E.H. and J.R.H.) and R03 DC015624 (K.R.K.), Action on Hearing Loss International Project Grant (E.H.), and an Indiana Clinical and Translational Sciences Institute Core Grant (NIH UL1 TR001108; K.R.K.). This work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR020128-01 from the National Center for Research Resources, NIH. The authors would like to thank A. Mikosz, P.-C. Tang, R. Nelson, S. Winfree, and M. Kamocka for their comments and technical assistance, and J. Bartles (Northwestern University) for the espin antibody.	Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chen JR, 2016, CELL DEATH DIFFER, V23, P1347, DOI 10.1038/cdd.2016.16; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; DeJonge RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162508; Ealy M, 2016, P NATL ACAD SCI USA, V113, P8508, DOI 10.1073/pnas.1605537113; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Geleoc GSG, 2014, SCIENCE, V344, P596, DOI 10.1126/science.1241062; Grigaliunas A, 2002, J NEUROPHYSIOL, V88, P2058, DOI 10.1152/jn.00889.2001; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hartman BH, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.7015.00079, 10.3389/fncel.2015.00079]; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Horwitz GC, 2011, J NEUROSCI, V31, P16814, DOI 10.1523/JNEUROSCI.3064-11.2011; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kwon HJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001133; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Leung AW, 2013, DEV BIOL, V379, P208, DOI 10.1016/j.ydbio.2013.04.023; Levin ME, 2012, J NEUROPHYSIOL, V108, P175, DOI 10.1152/jn.00098.2012; Lim R, 2016, HEARING RES, V338, P9, DOI 10.1016/j.heares.2016.02.004; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Muller U, 2015, NAT REV DRUG DISCOV, V14, P346, DOI 10.1038/nrd4533; Nasu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053024; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Oghalai JS, 1998, J NEUROPHYSIOL, V79, P2235; Ohnishi H, 2015, NEUROSCI LETT, V599, P49, DOI 10.1016/j.neulet.2015.05.032; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roberts RM, 2014, REPRODUCTION, V147, pD1, DOI 10.1530/REP-14-0080; Ronaghi M, 2014, STEM CELLS DEV, V23, P1275, DOI 10.1089/scd.2014.0033; ROSENHALL U, 1973, ACTA OTO-LARYNGOL, V76, P208, DOI 10.3109/00016487309121501; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Tang ZH, 2016, STEM CELL TRANSL MED, V5, P561, DOI 10.5966/sctm.2015-0252	41	3	3	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2017	35	6					583	+		10.1038/nbt.3840				9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EW9IK	WOS:000402831800027	28459451				2018-01-05	
J	Tang, SY; Wang, X; Li, WY; Yang, XY; Li, Z; Liu, WJ; Li, CH; Zhu, ZJ; Wang, LX; Wang, JX; Zhang, L; Sun, XL; Zhi, EL; Wang, HY; Li, H; Jin, L; Luo, Y; Wang, J; Yang, SM; Zhang, F				Tang, Shuyan; Wang, Xiong; Li, Weiyu; Yang, Xiaoyu; Li, Zheng; Liu, Wangjie; Li, Caihua; Zhu, Zijue; Wang, Lingxiang; Wang, Jiaxiong; Zhang, Ling; Sun, Xiaoling; Zhi, Erlei; Wang, Hongyan; Li, Hong; Jin, Li; Luo, Yang; Wang, Jian; Yang, Shenmin; Zhang, Feng			Biallelic Mutations in CFAP43 and CFAP44 Cause Male Infertility with Multiple Morphological Abnormalities of the Sperm Flagella	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOMIC ANALYSIS; HUMAN-SPERMATOZOA; SEQUENCING DATA; FIBROUS SHEATH; GENERATION; VARIANTS; DISEASE; DYNEIN; DNAH1; TRANSCRIPTOME	Sperm motility is vital to human reproduction. Malformations of sperm flagella can cause male infertility. Men with multiple morphological abnormalities of the flagella (MMAF) have abnormal spermatozoa with absent, short, coiled, bent, and/or irregular-caliber flagella, which impair sperm motility. The known human MMAF-associated genes, such as DNAH1, only account for fewer than 45% of affected individuals. Pathogenic mechanisms in the genetically unexplained MMAF remain to be elucidated. Here, we conducted genetic analyses by using whole-exome sequencing and genome-wide comparative genomic hybridization microarrays in a multi-center cohort of 30 Han Chinese men affected by MMAF. Among them, 12 subjects could not be genetically explained by any known MMAF-associated genes. Intriguingly, we identified compound-heterozygous mutations in CFAP43 in three subjects and a homozygous frame-shift mutation in CFAP44 in one subject. All of these recessive mutations were parentally inherited from heterozygous carriers but were absent in 984 individuals from three Han Chinese control populations. CFAP43 and CFAP44, encoding two cilia-and flagella-associated proteins (CFAPs), are specifically or preferentially expressed in the testis. Using CRISPR/ Cas9 technology, we generated two knockout models each deficient in mouse ortholog Cfap43 or Cfap44. Notably, both Cfap43- and Cfap44-deficient male mice presented with MMAF phenotypes, whereas the corresponding female mice were fertile. Our experimental observations on human subjects and animal models strongly suggest that biallelic mutations in either CFAP43 or CFAP44 can cause sperm flagellar abnormalities and impair sperm motility. Further investigations on other CFAP-encoding genes in more genetically unexplained MMAF-affected individuals could uncover novel mechanisms underlying sperm flagellar formation.	[Tang, Shuyan; Li, Weiyu; Liu, Wangjie; Wang, Lingxiang; Zhang, Ling; Wang, Hongyan; Jin, Li; Zhang, Feng] Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn, Sch Life Sci,Inst Reprod & Dev, Shanghai 200011, Peoples R China; [Tang, Shuyan; Li, Weiyu; Zhang, Ling; Wang, Hongyan; Jin, Li; Luo, Yang; Zhang, Feng] Fudan Univ, Key Lab Reprod Regulat NPFPC, Collaborat Innovat Ctr Genet & Dev, Shanghai 200032, Peoples R China; [Tang, Shuyan; Li, Weiyu; Zhang, Ling; Wang, Hongyan; Zhang, Feng] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Wang, Xiong] Shandong Univ, Med Coll, Dept Surg, Jinan 250012, Peoples R China; [Wang, Xiong] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Reprod Med Ctr, Yantai 264000, Peoples R China; [Yang, Xiaoyu] Nanjing Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Li, Zheng; Zhu, Zijue; Zhi, Erlei] Shanghai Jiao Tong Univ, Dept Androl, Ctr Mens Hlth, Urol Med Ctr,Shanghai Gen Hosp, Shanghai 200080, Peoples R China; [Li, Zheng; Zhu, Zijue; Zhi, Erlei] Shanghai Jiao Tong Univ, Dept ART, Inst Urol, Urol Med Ctr,Shanghai Gen Hosp, Shanghai 200080, Peoples R China; [Li, Caihua] Genesky Biotechnol Inc, Shanghai 200120, Peoples R China; [Wang, Jiaxiong; Li, Hong; Yang, Shenmin] Nanjing Med Univ, Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Peoples R China; [Sun, Xiaoling] Jinghua Hosp, Shenyang Eastern Med Grp, Shenyang 110005, Peoples R China; [Luo, Yang] China Med Univ, Res Ctr Med Genom, Minist Educ, Key Lab Med Cell Biol,Coll Basic Med Sci, Shenyang 110122, Peoples R China; [Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200127, Peoples R China; [Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Mol Diagnost Lab, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China	Zhang, F (reprint author), Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn, Sch Life Sci,Inst Reprod & Dev, Shanghai 200011, Peoples R China.; Zhang, F (reprint author), Fudan Univ, Key Lab Reprod Regulat NPFPC, Collaborat Innovat Ctr Genet & Dev, Shanghai 200032, Peoples R China.; Zhang, F (reprint author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.; Yang, SM (reprint author), Nanjing Med Univ, Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Peoples R China.	drim2004@126.com; zhangfeng@fudan.edu.cn	Jin, Li/C-1468-2009; Zhang, Feng/C-7735-2009	Jin, Li/0000-0002-4546-2415; Zhang, Feng/0000-0003-4556-8276	National Key Research and Development Program of China [2016YFC0905100, 2016YFC1000600]; Maternal and Child Health Research Project of Jiangsu Province [F201521]; National Natural Science Foundation of China [31625015, 31521003, 31571297]	We would like to thank Drs. Yufang Zheng and Hexige Saiyin for their critical comments and technical support. This work was supported by the National Key Research and Development Program of China (2016YFC0905100 and 2016YFC1000600), Maternal and Child Health Research Project of Jiangsu Province (F201521), and National Natural Science Foundation of China (31625015, 31521003, and 31571297).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; San Agustin J. T., 2015, MOL BIOL CELL, V26, P4358; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amiri-Yekta A, 2016, HUM REPROD, V31, P2872, DOI 10.1093/humrep/dew262; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arno G, 2016, AM J HUM GENET, V99, P1305, DOI 10.1016/j.ajhg.2016.10.008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Baccetti B, 2005, HUM REPROD, V20, P2790, DOI 10.1093/humrep/dei126; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Chemes HE, 2000, J ANDROL, V21, P799; CHEMES HE, 1987, FERTIL STERIL, V48, P664; Chemes HE, 2012, ASIAN J ANDROL, V14, P14, DOI 10.1038/aja.2011.168; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Firat-Karalar EN, 2014, J CELL SCI, V127, P4128, DOI 10.1242/jcs.157008; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; Jumeau F, 2015, J PROTEOME RES, V14, P3606, DOI 10.1021/acs.jproteome.5b00170; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16506; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Teves ME, 2016, CYTOSKELETON, V73, P3, DOI 10.1002/cm.21271; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ603; Wang X, 2017, CLIN GENET, V91, P313, DOI 10.1111/cge.12857; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Yang SM, 2015, ASIAN J ANDROL, V17, P513, DOI 10.4103/1008-682X.146100; Yang Y, 2011, MOL BIOL CELL, V22, P976, DOI 10.1091/mbc.E10-04-0331; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254	48	1	1	6	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					854	864		10.1016/j.ajhg.2017.04.012				11	Genetics & Heredity	Genetics & Heredity	EW7NL	WOS:000402700600003	28552195				2018-01-05	
J	Gonzalez-Prieto, C; Gabriel, R; Dehio, C; Schmidt, M; Llosa, M				Gonzalez-Prieto, Coral; Gabriel, Richard; Dehio, Christoph; Schmidt, Manfred; Llosa, Matxalen			The Conjugative Relaxase TrwC Promotes Integration of Foreign DNA in the Human Genome	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article						bacterial conjugation; genome editing; transkingdom DNA transfer; type IV secretion	IV SECRETION SYSTEM; SITE-SPECIFIC RECOMBINATION; BARTONELLA-HENSELAE; HUMAN-CELLS; BACTERIAL CONJUGATION; VECTOR INTEGRATION; TARGET SEQUENCES; RECIPIENT CELLS; PLASMID R388; AGROBACTERIUM	Bacterial conjugation is a mechanism of horizontal DNA transfer. The relaxase TrwC of the conjugative plasmid R388 cleaves one strand of the transferred DNA at the oriT gene, covalently attaches to it, and leads the single-stranded DNA (ssDNA) into the recipient cell. In addition, TrwC catalyzes site-specific integration of the transferred DNA into its target sequence present in the genome of the recipient bacterium. Here, we report the analysis of the efficiency and specificity of the integrase activity of TrwC in human cells, using the type IV secretion system of the human pathogen Bartonella henselae to introduce relaxase-DNA complexes. Compared to Mob relaxase from plasmid pBGR1, we found that TrwC mediated a 10-fold increase in the rate of plasmid DNA transfer to human cells and a 100-fold increase in the rate of chromosomal integration of the transferred DNA. We used linear amplification-mediated PCR and plasmid rescue to characterize the integration pattern in the human genome. DNA sequence analysis revealed mostly reconstituted oriT sequences, indicating that TrwC is active and recircularizes transferred DNA in human cells. One TrwC-mediated site-specific integration event was detected, proving that TrwC is capable of mediating site-specific integration in the human genome, albeit with very low efficiency compared to the rate of random integration. Our results suggest that TrwC may stabilize the plasmid DNA molecules in the nucleus of the human cell, probably by recircularization of the transferred DNA strand. This stabilization would increase the opportunities for integration of the DNA by the host machinery. IMPORTANCE Different biotechnological applications, including gene therapy strategies, require permanent modification of target cells. Long-term expression is achieved either by extrachromosomal persistence or by integration of the introduced DNA. Here, we studied the utility of conjugative relaxase TrwC, a bacterial protein with site-specific integrase activity in bacteria, as an integrase in human cells. Although it is not efficient as a site-specific integrase, we found that TrwC is active in human cells and promotes random integration of the transferred DNA in the human genome, probably acting as a DNA chaperone until it is integrated by host mechanisms. TrwC-DNA complexes can be delivered to human cells through a type IV secretion system involved in pathogenesis. Thus, TrwC could be used in vivo to transfer the DNA of interest into the appropriate cell and promote its integration. If used in combination with a site-specific nuclease, it could lead to site-specific integration of the incoming DNA by homologous recombination.	[Gonzalez-Prieto, Coral; Llosa, Matxalen] Univ Cantabria, CSIC, SODERCAN, Dept Biol Mol, Santander, Spain; [Gonzalez-Prieto, Coral; Llosa, Matxalen] Univ Cantabria, CSIC, SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain; [Gabriel, Richard; Schmidt, Manfred] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Gabriel, Richard; Schmidt, Manfred] German Canc Res Ctr, Heidelberg, Germany; [Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland	Llosa, M (reprint author), Univ Cantabria, CSIC, SODERCAN, Dept Biol Mol, Santander, Spain.; Llosa, M (reprint author), Univ Cantabria, CSIC, SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain.	llosam@unican.es			Spanish Ministry of Economy and Competitiveness [BIO2013-46414-P]; Swiss National Science Foundation [31003A_173119]; University of Cantabria, Spain	This work was supported by grant BIO2013-46414-P from the Spanish Ministry of Economy and Competitiveness to M.L. and in part by grant 31003A_173119 from the Swiss National Science Foundation to C.D. C.G.-P. was a recipient of a predoctoral fellowship from the University of Cantabria, Spain. The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.	Agundez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031047; Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10; Alperi A, 2013, J BACTERIOL, V195, P4999, DOI 10.1128/JB.00367-13; Arens A, 2012, HUM GENE THER METHOD, V23, P111, DOI 10.1089/hgtb.2011.219; Cesar CE, 2007, J BACTERIOL, V189, P9037, DOI 10.1128/JB.01152-07; Cesar CE, 2006, MOL MICROBIOL, V62, P984, DOI 10.1111/j.1365-2958.2006.05437.x; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102                                                         ; Fernandez-Gonzalez E, 2011, J BACTERIOL, V193, P6257, DOI 10.1128/JB.05905-11; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Gabriel R, 2014, JOVE-J VIS EXP, DOI 10.3791/51543; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Garcillan-Barcia MP, 2007, MOL MICROBIOL, V63, P404, DOI 10.1111/j.1365-2958.2006.05523.x; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gonzalez-Perez B, 2007, EMBO J, V26, P3847, DOI 10.1038/sj.emboj.7601806; Gonzalez-Prieto C, 2013, TRENDS BIOTECHNOL, V31, P41, DOI 10.1016/j.tibtech.2013.02.002; Han KD, 2008, P NATL ACAD SCI USA, V105, P19366, DOI 10.1073/pnas.0807866105; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hunt Michelle A, 2010, J Biomol Tech, V21, P66; Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; LLOSA M, 1995, J MOL BIOL, V246, P54, DOI 10.1006/jmbi.1994.0065; Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008; LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661                                                              ; Llosa M, 2012, TRENDS MICROBIOL, V20, P355, DOI 10.1016/j.tim.2012.05.008; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Moncalian G, 1999, MOL MICROBIOL, V31, P1643, DOI 10.1046/j.1365-2958.1999.01288.x; Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x; Rolloos M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08345; SADLER JR, 1980, GENE, V8, P279, DOI 10.1016/0378-1119(80)90005-0; Sambrook J, 2001, MOL CLONING LAB MANU; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmidt Manfred, 2007, Nat Methods, V4, P1051, DOI 10.1038/nmeth1103; Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Sullivan TD, 2002, EUKARYOT CELL, V1, P895, DOI 10.1128/EC.1.6.895-905.2002; Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Zechner EL, 2000, HORIZONTAL GENE POOL	41	2	2	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2017	83	12							UNSP e00207-17	10.1128/AEM.00207-17				16	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	EW3HP	WOS:000402386500006					2018-01-05	
J	Zhao, CL; Shu, XQ; Sun, BL				Zhao, Changlong; Shu, Xueqin; Sun, Baolin			Construction of a Gene Knockdown System Based on Catalytically Inactive ("Dead") Cas9 (dCas9) in Staphylococcus aureus	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article						CRISPRi; gene knockdown; Staphylococcus aureus; dCas9	ANTISENSE RNA; CRISPR INTERFERENCE; IDENTIFICATION; EXPRESSION; BACTERIA; DNA; RESISTANCE; REPRESSOR; IMMUNITY	There has been an absence of an efficient method of gene knockdown in the important human pathogen Staphylococcus aureus like RNA interference in eukaryotes. The previously developed antisense RNA technology is mainly applied for forward genetic screening but is rather limited in specific gene knockdown because of the lack of rational antisense RNA design strategies. Here we report an efficient and specific system for gene knockdown in S. aureus based on the type II clustered regularly interspaced short palindromic repeat (CRISPR) system from Streptococcus pyogenes. We can achieve gene silencing with the coexpression of dCas9, an RNA-guided DNA binding protein, and a small guide RNA complementary to the target gene. With this system, we have successfully silenced diverse sets of genes varying in size and expression level in different S. aureus strains. This system exhibited high-efficiency knockdown of both essential and nonessential genes, and its effect is inducible and reversible. In addition, the system can repress the expression of multiple genes simultaneously and silence an entire operon or part of it. This RNA-guided DNA targeting system thus provides a simple, rapid, and affordable method for selective gene knockdown in S. aureus. IMPORTANCE Staphylococcus aureus is an important human and animal pathogen that can cause a diversity of infectious diseases. Molecular genetic study of S. aureus has provided an avenue for the understanding of its virulence, pathogenesis, and drug resistance, leading to the discovery of new therapies for the treatment of staphylococcal infections. However, methodologies developed for genetic manipulation of S. aureus usually involve either low efficiency or laborious procedures. Here we report an RNA-guided system for gene knockdown in S. aureus and show its high efficiency and simplicity for selective gene silencing in different strains of S. aureus. This simple, rapid, and affordable system may serve as a promising tool for functional gene study in S. aureus, especially for the study of essential genes, thus facilitating the understanding of this pathogen and its interaction with its hosts.	[Zhao, Changlong; Shu, Xueqin; Sun, Baolin] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Hefei, Anhui, Peoples R China; [Zhao, Changlong; Shu, Xueqin; Sun, Baolin] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhao, Changlong; Shu, Xueqin; Sun, Baolin] Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China; [Sun, Baolin] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Sun, BL (reprint author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Hefei, Anhui, Peoples R China.; Sun, BL (reprint author), Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China.; Sun, BL (reprint author), Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China.; Sun, BL (reprint author), Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.	sunb@ustc.edu.cn		Sun, Baolin/0000-0002-2896-3015	National Natural Science Foundation of China [31670133]	This work was supported by the National Natural Science Foundation of China (31670133).	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Cho SH, 2015, CURR OPIN CHEM ENG, V10, P25, DOI 10.1016/j.coche.2015.07.008; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Clinical and Laboratory Standards Institute, 2009, METHODS FOR DILUTION; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; De Backer MD, 2001, NAT BIOTECHNOL, V19, P235, DOI 10.1038/85677; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Forsyth Allyn, 2008, V416, P307, DOI 10.1007/978-1-59745-321-9_20; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; Helle L, 2011, MICROBIOL-SGM, V157, P3314, DOI 10.1099/mic.0.052548-0; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jana M, 2000, PLASMID, V44, P100, DOI 10.1006/plas.2000.1473; Ji YD, 1999, J BACTERIOL, V181, P6585; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000                                                 ; Kernodle DS, 1997, INFECT IMMUN, V65, P179; Lindsay JA, 2008, STAPHYLOCOCCUS MOL G; Lowy FD, 1998, NEW ENGL J MED, V339, P2026; Man SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr034; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martin PK, 1999, J BACTERIOL, V181, P3666; Meng J, 2012, FEMS MICROBIOL LETT, V329, P45, DOI 10.1111/j.1574-6968.2012.02503.x; Mizuta T, 1999, NAT BIOTECHNOL, V17, P583; Nakashima N, 2014, INT J MOL SCI, V15, P2773, DOI 10.3390/ijms15022773; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Prax M, 2013, MICROBIOL-SGM, V159, P421, DOI 10.1099/mic.0.061705-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Romilly C, 2012, RNA BIOL, V9, P402, DOI 10.4161/rna.20103; Rubio A, 2011, ANTIMICROB AGENTS CH, V55, P364, DOI 10.1128/AAC.00429-10; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun JS, 2005, J BACTERIOL, V187, P7876, DOI 10.1128/JB.187.22.7876-7880.2005; ten Broeke-Smits NJP, 2010, NUCLEIC ACIDS RES, V38, P3263, DOI 10.1093/nar/gkq058; Valentino MD, 2014, MBIO, V5, DOI 10.1128/mBio.01729-14; Valihrach L, 2012, J MICROBIOL METH, V90, P214, DOI 10.1016/j.mimet.2012.05.008; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	41	0	0	6	7	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2017	83	12							UNSP e00291-17	10.1128/AEM.00291-17				15	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	EW3HP	WOS:000402386500009					2018-01-05	
J	Biswas, K; Sarkar, S; Du, KP; Brautigan, DL; Abbas, T; Larner, JM				Biswas, Kuntal; Sarkar, Sukumar; Du, Kangping; Brautigan, David L.; Abbas, Tarek; Larner, James M.			The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance	MOLECULAR CANCER RESEARCH			English	Article							PROTEIN-QUALITY CONTROL; BASE EXCISION-REPAIR; HEAT-SHOCK PROTEINS; UBIQUITIN LIGASE; PROTEASOMAL DEGRADATION; CANCER CELLS; C-TERMINUS; S-PHASE; CHAPERONE; P53	Lung cancer resists radiotherapy, making it one of the deadliest forms of cancer. Here, we show that human lung cancer cell lines can be rendered sensitive to ionizing radiation (IR) by RNAi knockdown of C-terminus of Hsc70-interacting protein (CHIP/STUB1), a U-box-type E3 ubiquitin ligase that targets a number of stress-induced proteins. Mechanistically, ubiquitindependent degradation of the cyclin-dependent kinase (CDK) inhibitor, p21 protein, is reduced by CHIP knockdown, leading to enhanced senescence of cells in response to exposure to IR. Cellular senescence and sensitivity to IR is prevented by CRISPR/Cas9-mediated deletion of the p21 gene (CDKN1A) in CHIP knockdown cells. Conversely, overexpression of CHIP potentiates p21 degradation and promotes greater radioresistance of lung cancer cells. In vitro and cell-based assays demonstrate that p21 is a novel and direct ubiquitylation substrate of CHIP that also requires the CHIP-associated chaperone HSP70. These data reveal that the inhibition of the E3 ubiquitin ligase CHIP promotes radiosensitivity, thus suggesting a novel strategy for the treatment of lung cancer. (C)2017 AACR.	[Biswas, Kuntal; Sarkar, Sukumar; Du, Kangping; Abbas, Tarek; Larner, James M.] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA USA; [Brautigan, David L.] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Brautigan, David L.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Abbas, Tarek] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA	Larner, JM (reprint author), Univ Virginia, POB 800383, Charlottesville, VA 22908 USA.	jml2p@virginia.edu			Charles Burnett fund;  [NIH-CA192669]	This work was supported by grant NIH-CA192669 and the Charles Burnett fund.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4                                                   ; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Connell P, 2001, NAT CELL BIOL, V3, P93; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529                                                            ; Dziegielewski J, 2008, FREE RADICAL BIO MED, V45, P1674, DOI 10.1016/j.freeradbiomed.2008.09.004; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Li F, 2009, J BIOL CHEM, V284, P20090, DOI 10.1074/jbc.M109.017046; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Ronnebaum SM, 2013, MOL CELL BIOL, V33, P4461, DOI 10.1128/MCB.00480-13; Sarkar S, 2014, ONCOGENE, V33, P26, DOI 10.1038/onc.2012.561; Schisler JC, 2013, J CLIN INVEST, V123, P3588, DOI 10.1172/JCI69080; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun C, 2014, J CANCER RES CLIN, V140, P189, DOI 10.1007/s00432-013-1571-5; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Tumati V, 2013, ONCOL REP, V29, P1094, DOI 10.3892/or.2012.2198; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	38	0	0	3	3	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1541-7786	1557-3125		MOL CANCER RES	Mol. Cancer Res.	JUN	2017	15	6					651	659		10.1158/1541-7786.MCR-16-0466				9	Oncology; Cell Biology	Oncology; Cell Biology	EW8KL	WOS:000402767500002	28232384				2018-01-05	
J	Lal, S; Cheung, EC; Zarei, M; Preet, R; Chand, SN; Mambelli-Lisboa, NC; Romeo, C; Stout, MC; Londin, E; Goetz, A; Lowder, CY; Nevler, A; Yeo, CJ; Campbell, PM; Winter, JM; Dixon, DA; Brody, JR				Lal, Shruti; Cheung, Edwin C.; Zarei, Mahsa; Preet, Ranjan; Chand, Saswati N.; Mambelli-Lisboa, Nicole C.; Romeo, Carmella; Stout, Matthew C.; Londin, Eric; Goetz, Austin; Lowder, Cinthya Y.; Nevler, Avinoam; Yeo, Charles J.; Campbell, Paul M.; Winter, Jordan M.; Dixon, Dan A.; Brody, Jonathan R.			CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype	MOLECULAR CANCER RESEARCH			English	Article							BINDING PROTEIN HUR; PANCREATIC DUCTAL ADENOCARCINOMA; CANCER CELLS; EXPRESSION; IDENTIFICATION; THERAPEUTICS; PROGNOSIS; SUBTYPES; GROWTH	Pancreatic ductal adenocarcinoma (PDA) is the third leading cause of cancer-related deaths in the United States, whereas colorectal cancer is the third most common cancer. The RNAbinding protein HuR (ELAVL1) supports a pro-oncogenic network in gastrointestinal (GI) cancer cells through enhanced HuR expression. Using a publically available database, HuR expression levels were determined to be increased in primary PDA and colorectal cancer tumor cohorts as compared with normal pancreas and colon tissues, respectively. CRISPR/ Cas9 technology was successfully used to delete the HuR gene in both PDA (MIA PaCa-2 and Hs 766T) and colorectal cancer (HCT116) cell lines. HuR deficiency has a mild phenotype, in vitro, as HuR-deficient MIA PaCa-2 (MIA. HuR-KO(-/-)) cells had increased apoptosis when compared with isogenic wildtype (MIA. HuR-WT(-/-)) cells. Using this isogenic system, mRNAs were identified that specifically bound to HuR and were required for transforming a two-dimensional culture into three dimensional (i. e., organoids). Importantly, HuR-deficient MIA PaCa-2 and Hs 766T cells were unable to engraft tumors in vivo compared with control HuR-proficient cells, demonstrating a unique xenograft lethal phenotype. Although not as a dramatic phenotype, CRISPR knockout HuR HCT116 colon cancer cells (HCT. HuR-KO(-/-)) showed significantly reduced in vivo tumor growth compared with controls (HCT. HuR-WT(-/-)). Finally, HuR deletion affects KRAS activity and controls a subset of pro-oncogenic genes. (C)2017 AACR.	[Lal, Shruti; Cheung, Edwin C.; Zarei, Mahsa; Chand, Saswati N.; Mambelli-Lisboa, Nicole C.; Romeo, Carmella; Goetz, Austin; Lowder, Cinthya Y.; Nevler, Avinoam; Yeo, Charles J.; Winter, Jordan M.; Brody, Jonathan R.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Surg, Div Surg Res,Jefferson Pancreas Biliary & Related, Philadelphia, PA 19107 USA; [Preet, Ranjan; Dixon, Dan A.] Univ Kansas, Med Ctr, Dept Canc Biol, 3020 Wahl Hall East,3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Preet, Ranjan; Dixon, Dan A.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA; [Stout, Matthew C.; Campbell, Paul M.] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19104 USA; [Londin, Eric] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Computat Med Ctr, Philadelphia, PA 19107 USA	Dixon, DA (reprint author), Univ Kansas, Med Ctr, Dept Canc Biol, 3020 Wahl Hall East,3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Brody, JR (reprint author), Thomas Jefferson Univ, 1015 Walnut St Curtis Bldg 618, Philadelphia, PA 19107 USA.; Winter, JM (reprint author), Thomas Jefferson Univ, Dept Surg, Jefferson Pancreas Biliary & Related Canc Ctr, 1015 Walnut St Curtis Bldg 618, Philadelphia, PA 19107 USA.	jordan.winter@jefferson.edu; ddixon3@kumc.edu; jonathan.brody@jefferson.edu		Nevler, Avinoam/0000-0002-5928-0559	NIH [R21 CA182692, R01 CA134609]; American Cancer Society [MRSG-14-019-01-CDD]; NIH/NCI Cancer Center Support Grant [P30 CA168524]; Research Starter Grant Award in Translational Medicine and Therapeutics; W.W Smith Charitable Trust; Prevent Cancer Foundation; K-INBRE [P20 GM103418]; Pancreatic Cancer Action Network-AACR Research Acceleration Network Grant [15-90-25-BROD]; Cancer Center Support Grant [5P30CA056036-17]; Hirshberg Foundation;  [1R01CA212600-01]	This work was supported by the NIH [R21 CA182692 (J.R. Brody), R01 CA134609 (D.A. Dixon)], 1R01CA212600-01 (J.R. Brody), American Cancer Society MRSG-14-019-01-CDD (J.M. Winter, J.R. Brody), NIH/NCI Cancer Center Support GrantP30 CA168524 (D.A. Dixon), a Research Starter Grant Award in Translational Medicine and Therapeutics (P.M. Campbell), a grant from the W.W Smith Charitable Trust (P.M. Campbell and J.R. Brody), and fellowship awards from Prevent Cancer Foundation and K-INBRE P20 GM103418 (R. Preet). We also wish to acknowledge the Mary M. Halinski Pancreatic Cancer Research Fund; Fund A Cure; Gail V. Coleman-Kenneth M. Bruntel Charitable Grant Fund, and Research supported by the 2015 Pancreatic Cancer Action Network-AACR Research Acceleration Network Grant, grant number 15-90-25-BROD. We are also supported by the Cancer Center Support Grant 5P30CA056036-17 and used the shared resource (the Core Genomics Laboratory). This work was initiated by a seed grant from the Hirshberg Foundation (J. R. Brody).	Baker Lindsey A, 2016, Trends Cancer, V2, P176; Blanco FF, 2016, ONCOGENE, V35, P2529, DOI 10.1038/onc.2015.325; Blanco FF, 2016, ONCOTARGET, V7, P74043, DOI 10.18632/oncotarget.12189; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8                                                   ; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chand S, 2016, INT J BIOL SCI, V12, P273, DOI 10.7150/ijbs.14951; Cohen R, 2015, ONCOTARGET, V6, P16832, DOI 10.18632/oncotarget.4160                                                        ; [Anonymous], 2012, NATURE, V487, P330, DOI DOI 10.1038/NATURE11252; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Cozzitorto JA, 2015, METHODS MOL BIOL, V1262, P239, DOI 10.1007/978-1-4939-2253-6_14; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fay Michael P, 2010, Stat Surv, V4, P1; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Giammanco A, 2014, CANCER RES, V74, P5322, DOI 10.1158/0008-5472.CAN-14-0726; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Herjan T, 2013, J IMMUNOL, V191, P640, DOI 10.4049/jimmunol.1203315; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Huang YH, 2016, CANCER RES, V76, P1549, DOI 10.1158/0008-5472.CAN-15-2073; Jimbo M, 2015, ONCOTARGET, V6, P27312, DOI 10.18632/oncotarget.4743; Kolmogorov A. N., 1933, GIORN I ITAL DEGLI A, V4, P83; Kraushar ML, 2014, P NATL ACAD SCI USA, V111, pE3815, DOI [10.1073/pnas.1408305111, 10.1073/pnas.1408305111/-/DCSupplemental]; Krueger KE, 2006, MOL CELL PROTEOMICS, V5, P1799, DOI 10.1074/mcp.R600009-MCP200; Lal S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33323; Lal S, 2014, CANCER RES, V74, P1128, DOI 10.1158/0008-5472.CAN-13-1915; Linnekamp JF, 2015, CANCER RES, V75, P245, DOI 10.1158/0008-5472.CAN-14-2240; Liu LH, 2014, MOL BIOL CELL, V25, P1446, DOI 10.1091/mbc.E14-01-0037; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Pineda DM, 2012, CANCER BIOL THER, V13, P946, DOI 10.4161/cbt.20952; Richards NG, 2010, ANN SURG, V252, P499, DOI 10.1097/SLA.0b013e3181f1fd44; Romeo C, 2016, MOL CANCER RES, V14, P599, DOI 10.1158/1541-7786.MCR-15-0448; Sgantzis N, 2011, DEV BIOL, V354, P267, DOI 10.1016/j.ydbio.2011.04.003; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Stout MC, 2014, METHODS MOL BIOL, V1170, P393, DOI 10.1007/978-1-4939-0888-2_21; Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Wurth L, 2015, BBA-GENE REGUL MECH, V1849, P881, DOI 10.1016/j.bbagrm.2014.10.001; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010	47	1	1	3	3	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1541-7786	1557-3125		MOL CANCER RES	Mol. Cancer Res.	JUN	2017	15	6					696	707		10.1158/1541-7786.MCR-16-0361				12	Oncology; Cell Biology	Oncology; Cell Biology	EW8KL	WOS:000402767500006	28242812				2018-01-05	
J	Shim, G; Kim, D; Park, GT; Jin, H; Suh, SK; Oh, YK				Shim, Gayong; Kim, Dongyoon; Park, Gyu Thae; Jin, Hyerim; Suh, Soo-Kyung; Oh, Yu-Kyoung			Therapeutic gene editing: delivery and regulatory perspectives	ACTA PHARMACOLOGICA SINICA			English	Review						gene editing; zinc finger nuclease; transcription activator-like effector nuclease; CRISPR/Cas9; delivery system; regulation; safety	ZINC-FINGER NUCLEASES; PLURIPOTENT STEM-CELLS; HEMATOPOIETIC STEM/PROGENITOR CELLS; CHRONIC GRANULOMATOUS-DISEASE; T-LYMPHOID-CELLS; IN-VIVO; IMMUNE-RESPONSES; FUNCTIONAL CORRECTION; NONVIRAL VECTORS; EPITHELIAL-CELLS	Gene-editing technology is an emerging therapeutic modality for manipulating the eukaryotic genome by using target-sequence-specific engineered nucleases. Because of the exceptional advantages that gene-editing technology offers in facilitating the accurate correction of sequences in a genome, gene editing-based therapy is being aggressively developed as a next-generation therapeutic approach to treat a wide range of diseases. However, strategies for precise engineering and delivery of gene-editing nucleases, including zinc finger nucleases, transcription activator-like effector nuclease, and CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats-associated nuclease Cas9), present major obstacles to the development of gene-editing therapies, as with other gene-targeting therapeutics. Currently, viral and non-viral vectors are being studied for the delivery of these nucleases into cells in the form of DNA, mRNA, or proteins. Clinical trials are already ongoing, and in vivo studies are actively investigating the applicability of CRISPR/Cas9 techniques. However, the concept of correcting the genome poses major concerns from a regulatory perspective, especially in terms of safety. This review addresses current research trends and delivery strategies for gene editing-based therapeutics in non-clinical and clinical settings and considers the associated regulatory issues.	[Shim, Gayong; Kim, Dongyoon; Park, Gyu Thae; Jin, Hyerim; Oh, Yu-Kyoung] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea; [Shim, Gayong; Kim, Dongyoon; Park, Gyu Thae; Jin, Hyerim; Oh, Yu-Kyoung] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea; [Suh, Soo-Kyung] Minist Food & Drug Safety, Adv Therapy Prod Res Div, Cheongju, Chungcheongbuk, South Korea	Shim, G; Oh, YK (reprint author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.; Shim, G; Oh, YK (reprint author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.	shimg@snu.ac.kr; ohyk@snu.ac.kr	Shim, Gayong/S-5423-2017		Ministry of Food and Drug Safety [16172MFDS206]; National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1A6A3A11930441]	This research was supported by a grant (No 16172MFDS206) from the Ministry of Food and Drug Safety in 2016 and from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No NRF-2016R1A6A3A11930441).	Abebordbar M, 2016, SCIENCE, V351, P407; Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Araki M, 2016, TRENDS BIOTECHNOL, V34, P86, DOI 10.1016/j.tibtech.2015.12.002; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Badia R, 2014, J ANTIMICROB CHEMOTH, V69, P1755, DOI 10.1093/jac/dku072; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Bellec J, 2015, CURR GENE THER, V15, P447; Benabdallah BF, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.55; Butler JR, 2016, TRANSPL IMMUNOL, V35, P47, DOI 10.1016/j.trim.2016.02.001; Chira S, 2015, ONCOTARGET, V6, P30675, DOI 10.18632/oncotarget.5169; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cottle RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16031; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Dai WJ, 2016, MOL THER-NUCL ACIDS, V5, P349; Ding WC, 2014, CLIN CANCER RES, V20, P6495, DOI 10.1158/1078-0432.CCR-14-0250; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Dreyer AK, 2015, BIOMATERIALS, V69, P191, DOI 10.1016/j.biomaterials.2015.07.057; [Anonymous], 2001, NOT GUID QUAL PRECL; [Anonymous], 2008, GUID NONCL STUD 1 CL; [Anonymous], 2007, GUID CLIN INV PHARM; [Anonymous], 2006, GUID NONCL TEST IN G; European Medicine Agency, 2012, GUID QUAL NONCL CLIN; [Anonymous], 2008, GUID HUM CELL BAS ME; [Anonymous], 1995, GEN THER PROD QUAL A; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Garate Z, 2015, STEM CELL REP, V5, P1053, DOI 10.1016/j.stemcr.2015.10.002; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Green NK, 2002, CANCER GENE THER, V9, P1036, DOI 10.1038/sj.cgt.7700541; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hareendran S, 2013, REV MED VIROL, V23, P399, DOI 10.1002/rmv.1762; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hu Z, 2015, J CLIN INVEST, V125, P425, DOI 10.1172/JCI78206; Hu Z, 2014, BIOMED RES INT, DOI 10.1155/2014/612823; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734; Kim BY, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.43; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kishida T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01001; Kohn DB, 2016, BLOOD, V127, P2553, DOI 10.1182/blood-2016-01-678136; LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029; Landau DJ, 2016, MOL THER, V24, P697, DOI 10.1038/mt.2016.35; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30422; Li HL, 2008, GENE THER, V15, P247, DOI 10.1038/sj.gt.3303038; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Li M, 2017, STEM CELLS, V35, P158, DOI 10.1002/stem.2463; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liao HQ, 2015, ONCOL RES, V22, P235, DOI 10.3727/096504015X14267282610858; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maggio I, 2016, NUCLEIC ACIDS RES, V44, P1449, DOI 10.1093/nar/gkv1540; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manotham K, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0130-6; Merling RK, 2015, MOL THER, V23, P147, DOI 10.1038/mt.2014.195; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354                                                      ; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Murlidharan G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.49; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Nishikawa M, 2008, CANCER SCI, V99, P856, DOI 10.1111/j.1349-7006.2008.00774.x; Niu XH, 2016, J BIOL CHEM, V291, P16576, DOI 10.1074/jbc.M116.719237; Norelli M, 2016, BBA-REV CANCER, V1865, P90, DOI 10.1016/j.bbcan.2015.12.001; Nyquist MD, 2013, P NATL ACAD SCI USA, V110, P17492, DOI 10.1073/pnas.1308587110; Osborn MJ, 2015, HUM GENE THER, V26, P114, DOI 10.1089/hum.2014.111; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Ousterout DG, 2015, MOL THER, V23, P523, DOI [10.1038/mt.2074.234, 10.1038/mt.2014.234]; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shin MH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005884; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Sung LY, 2014, NAT PROTOC, V9, P1882, DOI 10.1038/nprot.2014.130; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; [Anonymous], 2008, CONT REV CHEM MAN CO; U.S. Food and Drug Administration Center for Biologics Evaluation and Research, 2013, PRECL ASS INV CELL G; [Anonymous], 1998, GUID HUM SOM CELL TH; [Anonymous], 2011, POT TESTS CELL GEN T; [Anonymous], 2006, SUPPL GUID TEST REPL; Valletta S, 2015, ONCOTARGET, V6, P44061, DOI 10.18632/oncotarget.6392; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; [Anonymous], 2013, GUID QUL SAF EFF BIO; Wu B, 2016, ANTICANCER RES, V36, P1211; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Xue HY, 2016, GENE THER, V23, P557, DOI 10.1038/gt.2016.25; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yao YC, 2012, HUM GENE THER, V23, P238, DOI 10.1089/hum.2011.126; Yin CR, 2016, AIDS, V30, P1163, DOI 10.1097/QAD.0000000000001079; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310; Zaiss AK, 2005, CURR GENE THER, V5, P323, DOI 10.2174/1566523054065039; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhu W, 2016, VIRUS RES, V217, P125, DOI 10.1016/j.virusres.2016.04.003; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	123	2	2	11	20	ACTA PHARMACOLOGICA SINICA	SHANGHAI	294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA	1671-4083	1745-7254		ACTA PHARMACOL SIN	Acta Pharmacol. Sin.	JUN	2017	38	6			SI		738	753		10.1038/aps.2017.2				16	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	EW5EB	WOS:000402526900002	28392568	gold			2018-01-05	
J	Sakurai, M; Shiromoto, Y; Ota, H; Song, CZ; Kossenkov, AV; Wickramasinghe, J; Showe, LC; Skordalakes, E; Tang, HY; Speicher, DW; Nishikura, K				Sakurai, Masayuki; Shiromoto, Yusuke; Ota, Hiromitsu; Song, Chunzi; Kossenkov, Andrew V.; Wickramasinghe, Jayamanna; Showe, Louise C.; Skordalakes, Emmanuel; Tang, Hsin-Yao; Speicher, David W.; Nishikura, Kazuko			ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay	NATURE STRUCTURAL & MOLECULAR BIOLOGY			English	Article							EDITING ENZYME ADAR1; ADENOSINE-DEAMINASE; BINDING-PROTEINS; GENE-EXPRESSION; NUCLEAR EXPORT; DNA-DAMAGE; P38 MAPK; INTERFERON; PATHWAY; IDENTIFICATION	Both p150 and p110 isoforms of ADAR1 convert adenosine to inosine in double-stranded RNA (dsRNA). ADAR1p150 suppresses the dsRNA-sensing mechanism that activates MDA5-MAVS-IFN signaling in the cytoplasm. In contrast, the biological function of the ADAR1p110 isoform, which is usually located in the nucleus, is largely unknown. Here, we show that stress-activated phosphorylation of ADAR1p110 by MKK6-p38-MSK MAP kinases promotes its binding to Exportin-5 and its export from the nucleus. After translocating to the cytoplasm, ADAR1p110 suppresses apoptosis in stressed cells by protecting many antiapoptotic gene transcripts that contain 3'-untranslated-region dsRNA structures primarily comprising inverted Alu repeats. ADAR1p110 competitively inhibits binding of Staufen1 to the 3. -untranslated-region dsRNAs and antagonizes Staufen1-mediated mRNA decay. Our study reveals a new stress-response mechanism in which human ADAR1p110 and Staufen1 regulate surveillance of a set of mRNAs required for survival of stressed cells.	[Sakurai, Masayuki; Shiromoto, Yusuke; Ota, Hiromitsu; Song, Chunzi; Kossenkov, Andrew V.; Wickramasinghe, Jayamanna; Showe, Louise C.; Skordalakes, Emmanuel; Tang, Hsin-Yao; Speicher, David W.; Nishikura, Kazuko] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Nishikura, K (reprint author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	kazuko@wistar.org		Skordalakes, Emmanuel/0000-0002-7600-2833	National Institutes of Health [R01GM040536, R01CA175058]; Macula Vision Research Foundation; Japan Society for the Promotion of Science [S13204]; Roy and Dianna Vagelos Scholars Program in Molecular Life Sciences at the University of Pennsylvania; Japan Society for the Promotion of Science (JSPS) [2010-22]; National Cancer Institute [P30CA010815]	We thank Z. Paroo (University of Illinois), M. Cobb (University of Texas), S. Janiki (Wistar Institute), G. Dreyfuss (University of Pennsylvania), and L. Maquat (University of Rochester) for various recombinant-protein-expression constructs. We also thank J. Hayden for assistance with fluorescence microscopy, Y. Sakurai for technical assistance, and M. Murphy and J. M. Murray for critical reading of the manuscript. Research reported in this publication was supported by grants to K.N. from the National Institutes of Health (R01GM040536 and R01CA175058), the Macula Vision Research Foundation, and the Japan Society for the Promotion of Science (S13204). C.S. is supported as a member of the Roy and Dianna Vagelos Scholars Program in Molecular Life Sciences at the University of Pennsylvania. M. S. is supported in part by a fellowship from the Japan Society for the Promotion of Science (JSPS 2010-22). We also acknowledge services provided by the Animal, Bioinformatics, Genomics, Imaging, Protein Expression, and Proteomics Shared Facilities of The Wistar Cancer Center, which are supported by the National Cancer Institute (P30CA010815). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Balagopal V, 2012, BBA-GENE REGUL MECH, V1819, P593, DOI 10.1016/j.bbagrm.2012.01.001; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082                                                           ; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; de Lucas S, 2014, NUCLEIC ACIDS RES, V42, P4516, DOI 10.1093/nar/gku073; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Gleghorn ML, 2013, NAT STRUCT MOL BIOL, V20, P515, DOI 10.1038/nsmb.2528; Gong CG, 2013, NAT STRUCT MOL BIOL, V20, P1214, DOI 10.1038/nsmb.2664; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; Hajdarpasic A, 2012, BOSNIAN J BASIC MED, V12, P169, DOI 10.17305/bjbms.2012.2471                                                        ; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098                                                        ; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419                                                          ; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Ng SK, 2013, NUCLEIC ACIDS RES, V41, P9786, DOI 10.1093/nar/gkt750; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X                                                   ; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2013, RNA BIOL, V10, P1240, DOI 10.4161/rna.25947; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Park E, 2013, WIRES RNA, V4, P423, DOI 10.1002/wrna.1168; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Raderschall E, 2002, J CELL SCI, V115, P153; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Ricci EP, 2014, NAT STRUCT MOL BIOL, V21, P26, DOI 10.1038/nsmb.2739; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; [Anonymous], PYMOL MOL GRAPH SYST; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Takao N, 2000, FEBS LETT, V472, P133, DOI 10.1016/S0014-5793(00)01422-8; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44                                                               ; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang XL, 2015, NUCLEIC ACIDS RES, V43, P7566, DOI 10.1093/nar/gkv726; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wood CD, 2009, INT J BIOL SCI, V5, P428; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	65	4	4	5	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1545-9993	1545-9985		NAT STRUCT MOL BIOL	Nat. Struct. Mol. Biol.	JUN	2017	24	6					534	+		10.1038/nsmb.3403				13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EW8SZ	WOS:000402789700011	28436945				2018-01-05	
J	Shen, J; Chen, J; Jensen, PR; Solem, C				Shen, Jing; Chen, Jun; Jensen, Peter Ruhdal; Solem, Christian			A novel genetic tool for metabolic optimization of Corynebacterium glutamicum: efficient and repetitive chromosomal integration of synthetic promoter-driven expression libraries	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Corynebacterium glutamicum; Site-specific integration; Synthetic promoter; Metabolic optimization	SITE-SPECIFIC INTEGRATION; MUTANT LOX SITES; LACTOCOCCUS-LACTIS; GENOME; BACTERIA; TP901-1; DEHYDROGENASE; CRISPR-CAS9; GENERATION; MARKER	Fine-tuning the expression level of multiple genes is usually pivotal for metabolic optimization. We have developed a tool for this purpose for the important industrial workhorse Corynebacterium glutamicum that allows for the introduction of synthetic promoter-driven expression libraries of arbitrary genes. We first devised a method for introducing genetic elements into the chromosome repeatedly, relying on site-specific recombinases and the vector pJS31 serving as the carrier. The pJS31 vector contains a synthetic cassette including a phage attachment site attP for integration, a bacterial attachment site attB for subsequent integration, a multiple cloning site, and two modified loxP sites to facilitate easy removal of undesirable vector elements. Meanwhile, we constructed a derivative of the wild-type strain ATCC 13032 carrying an attB site in its chromosome (JS34) and demonstrated that pJS31 readily could integrate into the attB site in this strain providing expression of the corresponding integrase. Subsequent expression of the Cre recombinase promoted recombination between the modified loxP sites, resulting in a strain only retaining the target insertions and an attB site. To simplify the procedure, non-replicating circular expression units for the phage integrase and the Cre recombinase were used. As a showcase, we used the tool to construct a battery of strains simultaneously expressing the two reporter genes, lacZ (encoding beta-galactosidase) and gusA (encoding beta-glucuronidase), to arbitrary levels. In principle, an unlimited number of genes, whether native, heterologous, or synthetic, can be introduced using the developed approach, and this should greatly facilitate metabolic optimization of this important platform organism.	[Shen, Jing; Chen, Jun; Jensen, Peter Ruhdal; Solem, Christian] Tech Univ Denmark, Natl Food Inst, Soltofts Plads Bldg 221, DK-2800 Lyngby, Denmark	Jensen, PR; Solem, C (reprint author), Tech Univ Denmark, Natl Food Inst, Soltofts Plads Bldg 221, DK-2800 Lyngby, Denmark.	perj@food.dtu.dk; chso@food.dtu.dk			Novo Nordisk Foundation [NNF12OC0000818]; Bio-Value Strategic Platform for Innovation and Research - Danish Council for Strategic Research; Danish Council for Technology and Innovation [0603-00522B]	This work was supported by grant NNF12OC0000818 from the Novo Nordisk Foundation and by the Bio-Value Strategic Platform for Innovation and Research which is co-funded by the Danish Council for Strategic Research and the Danish Council for Technology and Innovation, grant no.: 0603-00522B.	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x                                              ; Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Barrett E, 2004, APPL ENVIRON MICROB, V70, P2861, DOI 10.1128/AEM.70.5.2861-2866.2004; Becker J, 2012, CURR OPIN BIOTECH, V23, P631, DOI 10.1016/j.copbio.2011.11.012; Binder S, 2013, NUCLEIC ACIDS RES, V41, P6360, DOI 10.1093/nar/gkt312; Breuner A, 2001, MICROBIOL-SGM, V147, P2051, DOI 10.1099/00221287-147-8-2051                                                     ; Brondsted L, 1999, APPL ENVIRON MICROB, V65, P752; Buchholz J, 2013, APPL ENVIRON MICROB, V79, P5566, DOI 10.1128/AEM.01741-13; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cohen N, 1980, J MICROBIOL BIOTECHN, V138, P179; Eggeling L., 2005, HDB CORYNEBACTERIUM; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035                                                               ; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Fukui K, 2011, J BIOTECHNOL, V154, P25, DOI 10.1016/j.jbiotec.2011.03.010; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540; JAGER W, 1992, J BACTERIOL, V174, P5462; JENSEN PR, 1993, EUR J BIOCHEM, V211, P181, DOI 10.1111/j.1432-1033.1993.tb19885.x                                              ; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3128.2006; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Moreau S, 1995, MICROBIOLOGY, V145, P539; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736; Nesvera J, 2011, APPL MICROBIOL BIOT, V90, P1641, DOI 10.1007/s00253-011-3272-9; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; NOVICK RP, 1987, MICROBIOL REV, V51, P381; Patek M, 2013, MICROB BIOTECHNOL, V6, P103, DOI 10.1111/1751-7915.12019; Petersen KV, 2013, APPL ENVIRON MICROB, V79, P3563, DOI 10.1128/AEM.00346-13; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rytter JV, 2014, APPL MICROBIOL BIOT, V98, P2617, DOI 10.1007/s00253-013-5481-x; Sambrook J, 1989, MOL CLONING LAB MANU; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SELBITSCHKA W, 1993, APPL MICROBIOL BIOT, V38, P615; Shukuo K, 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Solem C, 2003, J BACTERIOL, V185, P1564, DOI 10.1128/JB.185.5.1564-1571.2003; Stoll SM, 2002, J BACTERIOL, V184, P3657, DOI 10.1128/JB.184.13.3657-3663.2002; Suzuki N, 2007, APPL MICROBIOL BIOT, V77, P871, DOI 10.1007/s00253-007-1215-2; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	42	0	0	10	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUN	2017	101	11					4737	4746		10.1007/s00253-017-8222-8				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EV8CP	WOS:000402008300033	28361238				2018-01-05	
J	Sefcikova, J; Roth, M; Yu, G; Li, H				Sefcikova, Jana; Roth, Mitchell; Yu, Ge; Li, Hong			Cas6 processes tight and relaxed repeat RNA via multiple mechanisms: A hypothesis	BIOESSAYS			English	Article						Cas6; CRISPR; endoribonuclease; protein-RNA interactions; RNA binding proteins; stem-loop	CRISPR RNA; ADAPTIVE IMMUNITY; RECOGNITION; EVOLUTION; BACTERIA; BINDING; PROTEIN; ARCHAEA; SYSTEM; SPECIFICITY	RNA molecules are flexible yet foldable. Proteins must cope with this structural duality when forming biologically active complexes with RNA. Recent studies of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs)-mediated RNA immunity illustrate some remarkable mechanisms with which proteins interact with RNA. Currently known sstructure of CRISPR-Cas6 endoribonucleases bound with RNA suggest a conserved protein recognition mechanism mediated by RNA stem-loops. However, a survey of CRISPR RNA reveals that many repeats either lack a productive stem-loop(Relaxed) or possess stable but inhibitory structures (Tight), which raises the question of how the enzyme processes structurally diverse RNA. In reviewing recent literature, we propose a bivalent trapping and an unwinding mechanism for CRISPR-Cas6 to interact with the Relaxed and the Tight repeat RNA, respectively. Both mechanisms aim to create an identical RNA conformation at the cleavage site for accurate processing.	[Sefcikova, Jana; Li, Hong] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Roth, Mitchell; Yu, Ge; Li, Hong] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	Li, H (reprint author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.; Li, H (reprint author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	hong.li@fsu.edu			NIH [R01 GM099604]	This work was supported by NIH grant R01 GM099604 to H.L.	Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Chen E, 2015, BIOCHIMIE, V114, P147, DOI 10.1016/j.biochi.2015.02.005; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Ivica NA, 2013, J MOL EVOL, V77, P55, DOI 10.1007/s00239-013-9584-x; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Li H, 2015, STRUCTURE, V23, P13, DOI 10.1016/j.str.2014.10.006; MakarovaKS AravindL, 2011, BIOL DIRECT, V6, P38; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Musco G, 1997, NAT STRUCT BIOL, V4, P712, DOI 10.1038/nsb0997-712; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Reeks J, 2013, BIOCHEM J, V452, P223, DOI 10.1042/BJ20130269; Shao YM, 2016, STRUCTURE, V24, P547, DOI 10.1016/j.str.2016.02.009; Shao YM, 2013, STRUCTURE, V21, P385, DOI 10.1016/j.str.2013.01.010; SHEN LX, 1995, FASEB J, V9, P1023; Sokolowski RD, 2014, NUCLEIC ACIDS RES, V42, P6532, DOI 10.1093/nar/gku308; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Thornton JM, 1999, J MOL BIOL, V293, P333, DOI 10.1006/jmbi.1999.3054; Wang RY, 2012, PROTEIN SCI, V21, P463, DOI 10.1002/pro.2044; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wang XY, 2015, NUCLEIC ACIDS RES, V43, P7535, DOI 10.1093/nar/gkv679; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	JUN	2017	39	6							1700019	10.1002/bies.201700019				6	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	EV8GQ	WOS:000402019100009					2018-01-05	
J	McCauley, KB; Hawkins, F; Serra, M; Thomas, DC; Jacob, A; Kotton, DN				McCauley, Katherine B.; Hawkins, Finn; Serra, Maria; Thomas, Dylan C.; Jacob, Anjali; Kotton, Darrell N.			Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling	CELL STEM CELL			English	Article							MOUSE LUNG DEVELOPMENT; BETA-CATENIN; BRANCHING MORPHOGENESIS; PROGENITOR CELLS; EMBRYONIC LUNG; BASAL-CELLS; DIFFERENTIATION; GENERATION; FGF10; FOREGUT	Effective derivation of functional airway organoids from induced pluripotent stem cells (iPSCs) would provide valuable models of lung disease and facilitate precision therapies for airway disorders such as cystic fibrosis. However, limited understanding of human airway patterning has made this goal challenging. Here, we show that cyclical modulation of the canonical Wnt signaling pathway enables rapid directed differentiation of human iPSCs via an NKX2-1(+) progenitor intermediate into functional proximal airway organoids. We find that human NKX2-1(+) progenitors have high levels of Wnt activation but respond intrinsically to decreases in Wnt signaling by rapidly patterning into proximal airway lineages at the expense of distal fates. Using this directed approach, we were able to generate cystic fibrosis patient-specific iPSC-derived airway organoids with a defect in forskolin-induced swelling that is rescued by gene editing to correct the disease mutation. Our approach has many potential applications in modeling and drug screening for airway diseases.	[McCauley, Katherine B.; Hawkins, Finn; Serra, Maria; Thomas, Dylan C.; Jacob, Anjali; Kotton, Darrell N.] Boston Univ, Ctr Regenerat Med, Boston, MA 02118 USA; [McCauley, Katherine B.; Hawkins, Finn; Serra, Maria; Thomas, Dylan C.; Jacob, Anjali; Kotton, Darrell N.] Boston Med Ctr, Boston, MA 02118 USA; [McCauley, Katherine B.; Hawkins, Finn; Serra, Maria; Jacob, Anjali; Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [McCauley, Katherine B.; Hawkins, Finn; Serra, Maria; Jacob, Anjali; Kotton, Darrell N.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Kotton, DN (reprint author), Boston Univ, Ctr Regenerat Med, Boston, MA 02118 USA.; Kotton, DN (reprint author), Boston Med Ctr, Boston, MA 02118 USA.; Kotton, DN (reprint author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.; Kotton, DN (reprint author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	dkotton@bu.edu		McCauley, Katherine/0000-0002-8817-7120	NIH [R24HL123828, U01TR001810, F31HL129777-01, F31HL134274-01, TL1TR001410, R01HL122442, R01HL095993, R01HL128172, U01HL099997, U01HL134745, U01HL134766]; Cystic Fibrosis Foundation [CFF HAWKIN15XX0, CFF DAVIS15XX1]; Massachusetts Life Sciences Center;  [1UL1TR001430]	We thank members of the Kotton-Wilson-Ikonomou laboratory for helpful discussions and manuscript review. We thank Aleksander Szymaniak, Julia Berthet, and Anne Hinds for assistance with histology methods and Nicholas Skvir for microarray analysis. We are grateful to Brian Tilton of the Boston University Flow Cytometry Core, supported by grant 1UL1TR001430, and Drs. Greg Miller and Marianne James of the CReM, supported by NIH grants R24HL123828 and U01TR001810. This work was supported by NIH grant awards F31HL129777-01 (to K.B.M.), F31HL134274-01 and TL1TR001410 (to A.J.), and R01HL122442, R01HL095993, R01HL128172, U01HL099997, U01HL134745, and U01HL134766 (to D.N.K.); awards from the Cystic Fibrosis Foundation (CFF HAWKIN15XX0 to F.H. and CFF DAVIS15XX1 to D.N.K.), and an award from the Massachusetts Life Sciences Center to the CReM.	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bilodeau M, 2014, STEM CELL REP, V3, P634, DOI 10.1016/j.stemcr.2014.07.010; Cardoso WV, 1997, DEV DYNAM, V208, P398, DOI 10.1002/(SICI)1097-0177(199703)208:3<398::AID-AJA10>3.0.CO;2-X                  ; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Firth AL, 2014, P NATL ACAD SCI USA, V111, pE1723, DOI 10.1073/pnas.1403470111; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gotoh S, 2014, STEM CELL REP, V3, P394, DOI 10.1016/j.stemcr.2014.07.005; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Hashimoto S, 2012, J CELL SCI, V125, P932, DOI 10.1242/jcs.092734; Hawkins F., 2017, J CLIN INVEST; Huang SXL, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.023; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Hyatt BA, 2004, AM J PHYSIOL-LUNG C, V287, pL1116, DOI 10.1152/ajplung.00033.2004; IKEDA K, 1995, J BIOL CHEM, V270, P8108, DOI 10.1074/jbc.270.14.8108                                                         ; Kim BR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002581; Konishi S, 2016, STEM CELL REP, V6, P18, DOI 10.1016/j.stemcr.2015.11.010; Kurmann AA, 2015, CELL STEM CELL, V17, P527, DOI 10.1016/j.stem.2015.09.004; Li CG, 2009, DEV BIOL, V334, P97, DOI 10.1016/j.ydbio.2009.07.021; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Liu Yuru, 2002, Gene Expression Patterns, V2, P229, DOI 10.1016/S1567-133X(02)00057-1; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mou HM, 2016, CELL STEM CELL, V19, P217, DOI 10.1016/j.stem.2016.05.012; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; PHELPS DS, 1988, AM REV RESPIR DIS, V137, P939, DOI 10.1164/ajrccm/137.4.939                                                        ; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096                                                                    ; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Volckaert T, 2013, DEVELOPMENT, V140, P3731, DOI 10.1242/dev.096560; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014793; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wilson AA, 2010, J CLIN INVEST, V120, P379, DOI 10.1172/JCI36666; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC	52	4	4	14	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 1	2017	20	6					844	+		10.1016/j.stem.2017.03.001				20	Cell & Tissue Engineering; Cell Biology	Cell Biology	EW7ST	WOS:000402716800022	28366587				2018-01-05	
J	Ui-Tei, K; Maruyama, S; Nakano, Y				Ui-Tei, Kumiko; Maruyama, Shohei; Nakano, Yuko			Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering	GENOME			English	Article						CRISPR; Cas9; sgRNA; RNA polymerase III; RNA interference	SYSTEM; SEQUENCES; CAS9	Genomic engineering using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) protein is a promising approach for targeting the genomic DNA of virtually any organism in a sequence-specific manner. Recent remarkable advances in CRISPR/Cas technology have made it a feasible system for use in therapeutic applications and biotechnology. In the CRISPR/Cas system, a guide RNA (gRNA), interacting with the Cas protein, recognizes a genomic region with sequence complementarity, and the double-stranded DNA at the target site is cleaved by the Cas protein. A widely used gRNA is an RNA polymerase III (pol III)-driven single gRNA (sgRNA), which is produced by artificial fusion of CRISPR RNA (crRNA) and trans-activation crRNA (tracrRNA). However, we identified a TTTT stretch, known as a termination signal of RNA pol III, in the scaffold region of the sgRNA. Here, we revealed that sgRNA carrying a TTTT stretch reduces the efficiency of sgRNA transcription due to premature transcriptional termination, and decreases the efficiency of genome editing. Unexpectedly, it was also shown that the premature terminated sgRNA may have an adverse effect of inducing RNA interference. Such disadvantageous effects were avoided by substituting one base in the TTTT stretch.	[Ui-Tei, Kumiko; Nakano, Yuko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Ui-Tei, Kumiko; Maruyama, Shohei] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778651, Japan	Ui-Tei, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Ui-Tei, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778651, Japan.	ktei@bs.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15H04319, 26102713]	We thank Kimihiro Hino for specialistic experimental supports and helpful discussions. He is responsible to this study comparable to the author. The expression construct of hCas9 was obtained via plasmid distribution service addgene (#41815) from George Church. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H04319, 26102713) to K.U.-T. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript. The English in this document has been checked by at least two professional editors, both native speakers of English.	BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kennedy EM, 2015, VIROLOGY, V479, P213, DOI 10.1016/j.virol.2015.02.024; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143	17	1	1	3	5	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0831-2796	1480-3321		GENOME	Genome	JUN	2017	60	6					537	545		10.1139/gen-2016-0127				9	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EW5JF	WOS:000402541100008	28177825				2018-01-05	
J	Ratiu, JJ; Racine, JJ; Hasham, MG; Wang, QM; Branca, JA; Chapman, HD; Zhu, J; Donghia, N; Philip, V; Schott, WH; Wasserfall, C; Atkinson, MA; Mills, KD; Leeth, CM; Serreze, DV				Ratiu, Jeremy J.; Racine, Jeremy J.; Hasham, Muneer G.; Wang, Qiming; Branca, Jane A.; Chapman, Harold D.; Zhu, Jing; Donghia, Nina; Philip, Vivek; Schott, William H.; Wasserfall, Clive; Atkinson, Mark A.; Mills, Kevin D.; Leeth, Caroline M.; Serreze, David V.			Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes	JOURNAL OF IMMUNOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; HYPER-IGM SYNDROME; HOMOLOGOUS RECOMBINATION; SOMATIC HYPERMUTATION; ANTIBODY PREVENTS; GERMINAL-CENTERS; CELL TOLERANCE; CUTTING EDGE; MOUSE MODEL; ACTIVATION	B lymphocytes play a key role in type 1 diabetes (T1D) development by serving as a subset of APCs preferentially supporting the expansion of autoreactive pathogenic T cells. As a result of their pathogenic importance, B lymphocyte-targeted therapies have received considerable interest as potential T1D interventions. Unfortunately, the B lymphocyte-directed T1D interventions tested to date failed to halt b cell demise. IgG autoantibodies marking humans at future risk for T1D indicate that B lymphocytes producing them have undergone the affinity-maturation processes of class switch recombination and, possibly, somatic hypermutation. This study found that CRISPR/Cas9-mediated ablation of the activation-induced cytidine deaminase gene required for class switch recombination/somatic hypermutation induction inhibits T1D development in the NOD mouse model. The activation-induced cytidine deaminase protein induces genome-wide DNA breaks that, if not repaired through RAD51-mediated homologous recombination, result in B lymphocyte death. Treatment with the RAD51 inhibitor 4,49-diisothiocyanatostilbene-2, 29-disulfonic acid also strongly inhibited T1D development in NOD mice. The genetic and small molecule-targeting approaches expanded CD73(+) B lymphocytes that exert regulatory activity suppressing diabetogenic T cell responses. Hence, an initial CRISPR/Cas9-mediated genetic modification approach has identified the AID/RAD51 axis as a target for a potentially clinically translatable pharmacological approach that can block T1D development by converting B lymphocytes to a disease-inhibitory CD73(+) regulatory state.	[Ratiu, Jeremy J.; Racine, Jeremy J.; Hasham, Muneer G.; Wang, Qiming; Branca, Jane A.; Chapman, Harold D.; Donghia, Nina; Philip, Vivek; Schott, William H.; Serreze, David V.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Wang, Qiming] Tufts Univ, Grad Program Genet, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Zhu, Jing; Leeth, Caroline M.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, 175 West Campus Dr,MC 0306,Litton Reaves Hall, Blacksburg, VA 24061 USA; [Wasserfall, Clive; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA; [Mills, Kevin D.] Cyteir Therapeut, Cambridge, MA 02138 USA	Serreze, DV (reprint author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.; Leeth, CM (reprint author), Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, 175 West Campus Dr,MC 0306,Litton Reaves Hall, Blacksburg, VA 24061 USA.	cmcphee@vt.edu; dave.serreze@jax.org			National Cancer Institute [P30CA034196]; National Institutes of Health [P01-AI42288, DK-46266, DK-95735, OD-020351, DK101735, CA138646, 1F32DK111078]; Jackson Laboratory Principal Investigator Grant [TJL DIF FY13 KDM]	This work was supported by National Cancer Institute Grant P30CA034196. M.A.A. is supported by National Institutes of Health Grant P01-AI42288. D.V.S. is supported by National Institutes of Health Grants DK-46266, DK-95735, and OD-020351. C.M.L. is supported by National Institutes of Health Grant DK101735. K.D.M. is supported by National Institutes of Health Grant CA138646 and The Jackson Laboratory Principal Investigator Grant TJL DIF FY13 KDM. J.J. Racine is supported by National Institutes of Health Fellowship 1F32DK111078.	Akashi T, 1997, INT IMMUNOL, V9, P1159, DOI 10.1093/intimm/9.8.1159; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bonifacio E, 2001, DIABETES, V50, P2451, DOI 10.2337/diabetes.50.11.2451; Bonifacio E, 2010, ENDOCRIN METAB CLIN, V39, P513, DOI 10.1016/j.ecl.2010.05.007; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Britanova OV, 2014, J IMMUNOL, V192, P2689, DOI 10.4049/jimmunol.1302064; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P1653, DOI 10.1093/nar/26.7.1653; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Christianson GJ, 1997, J IMMUNOL, V159, P4781; Colwell RK, 2012, J PLANT ECOL-UK, V5, P3, DOI 10.1093/jpe/rtr044; Dahlberg CIM, 2014, J IMMUNOL, V193, P4732, DOI 10.4049/jimmunol.1401242; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; Henry-Bonami RA, 2013, J IMMUNOL, V190, P5992, DOI 10.4049/jimmunol.1201359; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Hulbert C, 2001, J IMMUNOL, V167, P5535, DOI 10.4049/jimmunol.167.10.5535                                                    ; Johnson EA, 2001, J IMMUNOL, V167, P2404, DOI 10.4049/jimmunol.167.4.2404                                                     ; JULIUS MH, 1974, J EXP MED, V140, P904, DOI 10.1084/jem.140.4.904; Kaku H, 2014, J IMMUNOL, V193, P5904, DOI [10.4049/jimmuno1.1400336, 10.4049/jimmunol.1400336]; Kleffel S, 2015, DIABETES, V64, P158, DOI 10.2337/db13-1639; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kuraoka M, 2011, P NATL ACAD SCI USA, V108, P11560, DOI 10.1073/pnas.1102571108; Lamont KR, 2013, J EXP MED, V210, P1021, DOI 10.1084/jem.20121258; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Marino E, 2013, DIABETES, V62, P662, DOI 10.2337/db13-er02                                                               ; Marino E, 2012, DIABETES, V61, P2893, DOI 10.2337/db12-0006; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Meyers G, 2011, P NATL ACAD SCI USA, V108, P11554, DOI 10.1073/pnas.1102600108; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941                                                       ; Pearson JA, 2016, J AUTOIMMUN, V66, P76, DOI 10.1016/j.jaut.2015.08.019; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Petro JB, 2002, J BIOL CHEM, V277, P48009, DOI 10.1074/jbc.M200305200; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9                                                   ; Bono MR, 2015, FEBS LETT, V589, P3454, DOI 10.1016/j.febslet.2015.07.027; Serreze DV, 2011, DIABETES, V60, P2914, DOI 10.2337/db11-0705; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; SERREZE DV, 1995, DIABETES, V44, P1392, DOI 10.2337/diabetes.44.12.1392; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Silveira PA, 2006, J IMMUNOL, V177, P7033, DOI 10.4049/jimmunol.177.10.7033                                                    ; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101                                                     ; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Turchaninova MA, 2016, NAT PROTOC, V11, P1599, DOI 10.1038/nprot.2016.093; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wan XX, 2016, J EXP MED, V213, P967, DOI 10.1084/jem.20151869; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Wong FS, 1998, J EXP MED, V187, P1985; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863                                                     	59	1	1	5	5	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUN 1	2017	198	11					4255	4267		10.4049/jimmunol.1700024				13	Immunology	Immunology	EV6HL	WOS:000401870400014	28461573				2018-01-05	
J	Zhang, JF; Niimi, M; Yang, DS; Liang, JY; Xu, J; Kimura, T; Mathew, AV; Guo, YH; Fan, YB; Zhu, TQ; Song, J; Ackermann, R; Koike, Y; Schwendeman, A; Lai, LX; Pennathur, S; Garcia-Barrio, M; Fan, JL; Chen, YE				Zhang, Jifeng; Niimi, Manabu; Yang, Dongshan; Liang, Jingyan; Xu, Jie; Kimura, Tokuhide; Mathew, Anna V.; Guo, Yanhong; Fan, Yanbo; Zhu, Tianqing; Song, Jun; Ackermann, Rose; Koike, Yui; Schwendeman, Anna; Lai, Liangxue; Pennathur, Subramaniam; Garcia-Barrio, Minerva; Fan, Jianglin; Chen, Y. Eugene			Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						apolipoprotein; atherosclerosis; cholesterol reduction; cholesteryl ester transfer protein genetics; high-density lipoprotein	HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; HERITABLE HYPERLIPIDEMIC RABBITS; ZINC-FINGER NUCLEASES; NEW-ZEALAND WHITE; FAMILIAL HYPERCHOLESTEROLEMIA; TRANSGENIC RABBITS; CETP ACTIVITY; GENE; TORCETRAPIB	Objective-CETP (cholesteryl ester transfer protein) plays an important role in lipoprotein metabolism; however, whether inhibition of CETP activity can prevent cardiovascular disease remains controversial. Approach and Results-We generated CETP knockout (KO) rabbits by zinc finger nuclease gene editing and compared their susceptibility to cholesterol diet-induced atherosclerosis to that of wild-type (WT) rabbits. On a chow diet, KO rabbits showed higher plasma levels of high-density lipoprotein (HDL) cholesterol than WT controls, and HDL particles of KO rabbits were essentially rich in apolipoprotein AI and apolipoprotein E contents. When challenged with a cholesterol-rich diet for 18 weeks, KO rabbits not only had higher HDL cholesterol levels but also lower total cholesterol levels than WT rabbits. Analysis of plasma lipoproteins revealed that reduced plasma total cholesterol in KO rabbits was attributable to decreased apolipoprotein B-containing particles, while HDLs remained higher than that in WT rabbits. Both aortic and coronary atherosclerosis was significantly reduced in KO rabbits compared with WT rabbits. Apolipoprotein B-depleted plasma isolated from CETP KO rabbits showed significantly higher capacity for cholesterol efflux from macrophages than that from WT rabbits. Furthermore, HDLs isolated from CETP KO rabbits suppressed tumor necrosis factor-ainduced vascular cell adhesion molecule 1 and E-selectin expression in cultured endothelial cells. Conclusions-These results provide evidence that genetic ablation of CETP activity protects against cholesterol diet-induced atherosclerosis in rabbits.	[Zhang, Jifeng; Yang, Dongshan; Liang, Jingyan; Xu, Jie; Guo, Yanhong; Fan, Yanbo; Zhu, Tianqing; Song, Jun; Koike, Yui; Garcia-Barrio, Minerva; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI 48109 USA; [Mathew, Anna V.; Pennathur, Subramaniam] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Niimi, Manabu; Kimura, Tokuhide; Fan, Jianglin] Univ Yamanashi, Dept Mol Pathol, Fac Med, Grad Sch Med Sci, Chuo, Yamanashi, Japan; [Ackermann, Rose; Schwendeman, Anna] Univ Michigan, Dept Pharmaceut Sci, Biointerfaces Inst, Coll Pharm, Ann Arbor, MI 48109 USA; [Lai, Liangxue] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Beijing, Peoples R China	Chen, YE (reprint author), Univ Michigan, Med Ctr, 2800 Plymouth Rd,NCRC Bldg 26,Rm 361S, Ann Arbor, MI 48109 USA.; Fan, JL (reprint author), Univ Yamanashi, Dept Mol Pathol, 1110 Shimokato, Yamanashi 4093898, Japan.	jianglin@yamanashi.ac.jp; echenum@umich.edu	Pennathur, Subramaniam/O-7032-2017		Ministry of Education, Culture, Sports and Technology, Japan [22390068, 25670190, 15H04718]; National Institutes of Health (NIH) [R01HL117491, R01HL129778]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology, Japan (22390068, 25670190, and 15H04718 to J. Fan) and National Institutes of Health (NIH) grant (R01HL117491 and R01HL129778 to Y.E. Chen).	Aghebati T, 2016, BIOMED PHARMACOTHER, V81, P468, DOI 10.1016/j.biopha.2016.04.035; Barter P, 2000, ARTERIOSCL THROM VAS, V20, P2029, DOI 10.1161/01.ATV.20.9.2029                                                        ; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2015, CIRCULATION, V132, P423, DOI 10.1161/CIRCULATIONAHA.114.014025; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fan JL, 2015, PHARMACOL THERAPEUT, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009; Fan JL, 2001, J BIOL CHEM, V276, P40071, DOI 10.1074/jbc.M105456200; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; GUO Y, 2015, THE JOURNAL OF CLINI, V125, P3819; Haraki T, 1997, ATHEROSCLEROSIS, V132, P229, DOI 10.1016/S0021-9150(97)00093-2; Huang ZP, 2002, CLIN SCI, V103, P587, DOI 10.1042/cs1030587                                                               ; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kastelein JJP, 2015, LANCET, V385, P2153, DOI 10.1016/S0140-6736(14)62115-2; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396                                                          ; Li S, 2016, ARTERIOSCL THROM VAS, V36, P810, DOI 10.1161/ATVBAHA.115.306871; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; McLain J.H., 2016, J CARDIOVASC PHARM T; Miyosawa K, 2015, AM J PHYSIOL-ENDOC M, V309, pE177, DOI 10.1152/ajpendo.00528.2014; Morehouse LA, 2007, J LIPID RES, V48, P1263, DOI 10.1194/jlr.M600332-JLR200; Moriyama Y, 1998, PREV MED, V27, P659, DOI 10.1006/pmed.1998.0340                                                          ; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119                                                                ; Rittershaus CW, 2000, ARTERIOSCL THROM VAS, V20, P2106, DOI 10.1161/01.ATV.20.9.2106                                                        ; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; TALL AR, 1993, J LIPID RES, V34, P1255; XU GR, 1995, J CLIN INVEST, V95, P1497, DOI 10.1172/JCI117821; YAMASHITA S, 1990, J CLIN INVEST, V86, P688, DOI 10.1172/JCI114764                                                               ; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Zhang ZY, 2001, ATHEROSCLEROSIS, V159, P67, DOI 10.1016/S0021-9150(01)00490-7                                                   ; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	35	2	2	9	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	JUN	2017	37	6					1068	+		10.1161/ATVBAHA.117.309114				15	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	EV7HY	WOS:000401947700014	28428219				2018-01-05	
J	Tian, HY; Ketova, T; Hardy, D; Xu, XJ; Gao, X; Zijlstra, A; Blobe, GC				Tian, Hongyu; Ketova, Tatiana; Hardy, Duriel; Xu, Xiaojiang; Gao, Xia; Zijlstra, Andries; Blobe, Gerard C.			Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						endoglin; endothelial cells; integrins; muscle; smooth; vascular; signal transduction	GROWTH-FACTOR-BETA; HEREDITARY HEMORRHAGIC TELANGIECTASIA; FOCAL ADHESION KINASE; RECEPTOR-LIKE KINASE-1; ENDOTHELIAL-CELLS; ARTERIOVENOUS-MALFORMATIONS; ANGIOGENESIS; INTEGRIN; PROTEIN; MICE	Objective-Endoglin, a transforming growth factor-beta superfamily coreceptor, is predominantly expressed in endothelial cells and has essential roles in vascular development. However, whether endoglin is also expressed in vascular smooth muscle cells (VSMCs), especially in vivo, remains controversial. Furthermore, the roles of endoglin in VSMC biology remain largely unknown. Our objective was to examine the expression and determine the function of endoglin in VSMCs during angiogenesis. Approach and Results-Here, we determine that endoglin is robustly expressed in VSMCs. Using CRISPR/CAS9 knockout and short hairpin RNA knockdown in the VSMC/endothelial coculture model system, we determine that endoglin in VSMCs, but not in endothelial cells, promotes VSMCs recruitment by the endothelial cells both in vitro and in vivo. Using an unbiased bioinformatics analysis of RNA sequencing data and further study, we determine that, mechanistically, endoglin mediates VSMC recruitment by promoting VSMC migration and spreading on endothelial cells via increasing integrin/FAK pathway signaling, whereas endoglin has minimal effects on VSMC adhesion to endothelial cells. In addition, we further determine that loss of endoglin in VSMCs inhibits VSMC recruitment in vivo. Conclusions-These studies demonstrate that endoglin has an important role in VSMC recruitment and blood vessel maturation during angiogenesis and also provide novel insights into how discordant endoglin function in endothelial and VSMCs may regulate vascular maturation and angiogenesis.	[Tian, Hongyu; Hardy, Duriel; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA; [Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Ketova, Tatiana; Zijlstra, Andries] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zijlstra, Andries] Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Xu, Xiaojiang] NIEHS, Integrat Bioinformat, POB 12233, Res Triangle Pk, NC 27709 USA; [Gao, Xia] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC USA; [Zijlstra, Andries] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Tian, HY; Blobe, GC (reprint author), B354 LSRC Res Dr,Box 91004, Durham, NC 27708 USA.	hongyu.tian@duke.edu; gerard.blobe@duke.edu			Komen for the Cure [CCR15333124]; HHT Young Scholar Award; NIH/NCI (National Cancer Institute/National Institutes of Health) [CA135006, CA143081]	This work was supported in part by Komen for the Cure Grants CCR15333124 (Dr Tian), HHT Young Scholar Award (Dr Tian), and NIH/NCI (National Cancer Institute/National Institutes of Health) grants CA135006 (Dr Blobe), CA143081 (Dr Zijlstra).	Adam PJ, 1998, BIOCHEM BIOPH RES CO, V247, P33, DOI 10.1006/bbrc.1998.8734                                                          ; Ardelean DS, 2014, ANGIOGENESIS, V17, P129, DOI 10.1007/s10456-013-9383-4; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569                                                    ; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Choi EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088511; Conley BA, 2000, ATHEROSCLEROSIS, V153, P323, DOI 10.1016/S0021-9150(00)00422-6; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Hawinkels LJAC, 2016, CLIN CANCER RES, V22, P96, DOI 10.1158/1078-0432.CCR-15-0743; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kain KH, 2014, DEV DYNAM, V243, P216, DOI 10.1002/dvdy.24093; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109                                                          ; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534                                                   ; Ljubimova JY, 2006, FRONT BIOSCI, V11, P81, DOI 10.2741/1781; Ma XL, 2000, ARTERIOSCL THROM VAS, V20, P2546, DOI 10.1161/01.ATV.20.12.2546                                                       ; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mancini ML, 2007, DEV BIOL, V308, P520, DOI 10.1016/j.ydbio.2007.06.009; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Milton I, 2012, STROKE, V43, P1432, DOI 10.1161/STROKEAHA.111.647024; O'Leary K, 2015, BRIT J CANCER, V113, P970, DOI 10.1038/bjc.2015.302; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pardali E, 2011, ONCOGENE, V30, P334, DOI 10.1038/onc.2010.418; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perez-Gomez Eduardo, 2010, ScientificWorldJournal, V10, P2367, DOI 10.1100/tsw.2010.230; Rossi E, 2016, CELL MOL LIFE SCI, V73, P1715, DOI 10.1007/s00018-015-2099-4; Rossi E, 2013, BLOOD, V121, P403, DOI [10.1182/blood-2012-06-435347, 10.1182/blood-201206-435347]; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680                                                           ; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Teranishi S, 2009, INVEST OPHTH VIS SCI, V50, P5646, DOI 10.1167/iovs.08-2534; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; Twardowski T, 2007, CURR PHARM DESIGN, V13, P3608, DOI 10.2174/138161207782794176; Urness LD, 2000, NAT GENET, V26, P328; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200; Yee KL, 2008, SYSTEMS BIOL IET, V2, P8; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784; Yu CF, 2000, AM J PHYSIOL-GASTR L, V278, pG952	62	5	5	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	JUN	2017	37	6					1115	+		10.1161/ATVBAHA.116.308859				74	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	EV7HY	WOS:000401947700018	28450296				2018-01-05	
J	Eskova, A; Chauvigne, F; Maischein, HM; Ammelburg, M; Cerda, J; Nusslein-Volhard, C; Irion, U				Eskova, Anastasia; Chauvigne, Francois; Maischein, Hans-Martin; Ammelburg, Moritz; Cerda, Joan; Nuesslein-Volhard, Christiane; Irion, Uwe			Gain-of-function mutations in Aqp3a influence zebrafish pigment pattern formation through the tissue environment	DEVELOPMENT			English	Article						Aquaporin; Pattern formation; Pigmentation; Zebrafish	WATER CHANNEL; NEURAL-CREST; DANIO-RERIO; STRIPE FORMATION; COLLECTING DUCT; PROTEIN; PROLIFERATION; SELECTIVITY; TRANSPORT; ENCODES	The development of the pigmentation pattern in zebrafish is a tightly regulated process that depends on both the self-organizing properties of pigment cells and extrinsic cues from other tissues. Many of the known mutations that alter the pattern act cell-autonomously in pigment cells, and our knowledge about external regulators is limited. Here, we describe novel zebrafish mau mutants, which encompass several dominant missense mutations in Aquaporin 3a (Aqp3a) that lead to broken stripes and short fins. A loss-of-function aqp3a allele, generated by CRISPR-Cas9, has no phenotypic consequences, demonstrating that Aqp3a is dispensable for normal development. Strikingly, the pigment cells from dominant mau mutants are capable of forming a wild-type pattern when developing in a wild-type environment, but the surrounding tissues in the mutants influence pigment cell behaviour and interfere with the patterning process. The mutated amino acid residues in the dominant alleles line the pore surface of Aqp3a and influence pore permeability. These results demonstrate an important effect of the tissue environment on pigment cell behaviour and, thereby, on pattern formation.	[Eskova, Anastasia; Maischein, Hans-Martin; Ammelburg, Moritz; Nuesslein-Volhard, Christiane; Irion, Uwe] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Chauvigne, Francois; Cerda, Joan] CSIC, IRTA Inst Ciencies Mar, E-08003 Barcelona, Spain; [Maischein, Hans-Martin] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Ammelburg, Moritz] Fish & Richardson, D-89897 Munich, Germany	Irion, U (reprint author), Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	uwe.irion@tuebingen.mpg.de	Chauvigne, Francois/D-6854-2017; Cerda, Joan/M-1099-2016	Chauvigne, Francois/0000-0001-5571-7517; Cerda, Joan/0000-0003-2568-6398; Irion, Uwe/0000-0003-2823-5840; Ammelburg, Moritz/0000-0001-8282-6487	Max-Planck-Gesellschaft	This work was funded by the Max-Planck-Gesellschaft. Deposited in PMC for immediate release.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chauvigne F, 2015, SCI REP-UK, V5, DOI 10.1038/srep07789; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Eom DS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002899; Fadeev A, 2015, ELIFE, V4, DOI 10.7554/eLife.06545; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Frohnhofer HG, 2016, BIOL OPEN, V5, P736, DOI 10.1242/bio.018721; Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Gray C, 2011, THROMB HAEMOSTASIS, V105, P811, DOI 10.1160/TH10-08-0525; Hamdi M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-104; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Imboden M, 1997, CR ACAD SCI III-VIE, V320, P689, DOI 10.1016/S0764-4469(97)84816-0                                                   ; Irion U, 2014, ELIFE, V3, DOI 10.7554/eLife.05125; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; Krauss J, 2014, BIOL OPEN, V3, P503, DOI 10.1242/bio.20148441; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Lee RTH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084858; Levesque MP, 2013, ZEBRAFISH, V10, P21, DOI 10.1089/zeb.2012.0775; Lister JA, 1999, DEVELOPMENT, V126, P3757; MA TH, 1994, J BIOL CHEM, V269, P21845; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Mahalwar P, 2016, BIOL OPEN, V5, P1680, DOI 10.1242/bio.022251; Mahalwar P, 2014, SCIENCE, V345, P1362, DOI 10.1126/science.1254837; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Odenthal J, 1996, DEVELOPMENT, V123, P391; Parichy DM, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12332; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Perathoner S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004080; Roudier N, 2002, J BIOL CHEM, V277, P45854, DOI 10.1074/jbc.M208999200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Singh AP, 2016, DEV CELL, V38, P316, DOI 10.1016/j.devcel.2016.06.020; Singh AP, 2015, CURR BIOL, V25, pR81, DOI 10.1016/j.cub.2014.11.013; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a                                                                 ; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778                                                         ; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; VANRAAMSDONK W, 1982, ANAT EMBRYOL, V164, P51; VERKMAN AS, 1986, AM J PHYSIOL, V250, pF633; Walderich B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11462; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Watanabe M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00473; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65	57	0	0	14	14	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	JUN 1	2017	144	11					2059	2069		10.1242/dev.143495				11	Developmental Biology	Developmental Biology	EW1TN	WOS:000402276800016	28506994	gold			2018-01-05	
J	Comfort, N				Comfort, Nathaniel			A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution	NATURE			English	Book Review									[Comfort, Nathaniel] Johns Hopkins Univ, Hist Med, Baltimore, MD 21218 USA; [Comfort, Nathaniel] DNA, Biog, Bombay, Maharashtra, India	Comfort, N (reprint author), Johns Hopkins Univ, Hist Med, Baltimore, MD 21218 USA.; Comfort, N (reprint author), DNA, Biog, Bombay, Maharashtra, India.	nccomfort@gmail.com					DOUDNA JA, 2017, CRACK CREATION GENE	1	1	1	3	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2017	546	7656					30	31		10.1038/546030a                                                                 				2	Multidisciplinary Sciences	Science & Technology - Other Topics	EW3CR	WOS:000402372800014	28569806	gold			2018-01-05	
J	Yin, H; Kauffman, KJ; Anderson, DG				Yin, Hao; Kauffman, Kevin J.; Anderson, Daniel G.			Delivery technologies for genome editing	NATURE REVIEWS DRUG DISCOVERY			English	Review							ZINC-FINGER NUCLEASES; HEMATOPOIETIC STEM-CELLS; HEMOPHILIA GENE-THERAPY; DOUBLE-STRAND BREAKS; OFF-TARGET CLEAVAGE; HUMAN T-CELLS; IN-VIVO; MESSENGER-RNA; REPLACEMENT THERAPY; MUSCULAR-DYSTROPHY	With the recent development of CRISPR technology, it is becoming increasingly easy to engineer the genome. Genome-editing systems based on CRISPR, as well as transcription activator-like effector nucleases (TALENs) and zinc-finger nucleases (ZFNs), are becoming valuable tools for biomedical research, drug discovery and development, and even gene therapy. However, for each of these systems to effectively enter cells of interest and perform their function, efficient and safe delivery technologies are needed. This Review discusses the principles of biomacromolecule delivery and gene editing, examines recent advances and challenges in non-viral and viral delivery methods, and highlights the status of related clinical trials.	[Yin, Hao; Kauffman, Kevin J.; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kauffman, Kevin J.; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Anderson, Daniel G.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA	Anderson, DG (reprint author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Anderson, DG (reprint author), MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.	dgander@mit.edu			Koch Institute Marble Center for Cancer Nanomedicine; Cancer Center Support (core) Grant [P30-CA14051]; Skoltech Center	H.Y., K.J.K. and D.G.A. acknowledge funding from the Koch Institute Marble Center for Cancer Nanomedicine and the Cancer Center Support (core) Grant P30-CA14051. H.Y. is supported by Skoltech Center. The authors apologize to those authors whose work was not cited directly owing to space limitations.	Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Bouard D., 2000, BRIT J PHARMACOL, V157, P153; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen X, 2016, MOL THER, V24, P447, DOI 10.1038/mt.2015.164; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Cools N., 2016, METHOD MOL BIOL, V1428, P139, DOI 10.1007/978-1-4939-3625-0_9; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; DiTommaso T, 2016, MOL THER, V24, pS229, DOI 10.1016/S1525-0016(16)33381-0                                                   ; Doerfler PA, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.53; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Frederickson RM, 2015, MOL THER, V23, P1795, DOI 10.1038/mt.2015.205; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gorzelany JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005007; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Herzog RW, 2015, MOL THER, V23, P1411, DOI 10.1038/mt.2015.135; Herzog RW, 2011, MOL THER, V19, P1923, DOI 10.1038/mt.2011.218; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Holz FG, 2014, J CLIN INVEST, V124, P1430, DOI 10.1172/JCI71029; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koudelka KJ, 2015, ANNU REV VIROL, V2, P379, DOI 10.1146/annurev-virology-100114-055141; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin S., 2015, ELIFE, V3; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mansoor M, 2008, GENE REGUL SYST BIO, V2, P275; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miller DG, 2003, MOL CELL BIOL, V23, P3550, DOI 10.1128/MCB.23.10.3550-3557.2003; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Morris EC, 2016, BLOOD, V127, P3305, DOI 10.1182/blood-2015-11-629071; Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; O'Connor TP, 2006, NAT REV GENET, V7, P261, DOI 10.1038/nrg1829; Oakes BL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10194; Pharmaceutical Research and Manufacturers of America, 2013, MED DEV RAR DIS REP; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rols Marie-Pierre, 2008, V423, P19, DOI 10.1007/978-1-59745-194-9_2; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sander JD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt716; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Srivastava A, 2004, BRIT J HAEMATOL, V127, P12, DOI 10.1111/j.1365-2141.2004.05110.x; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang LL, 2011, MOL THER, V19, P2012, DOI 10.1038/mt.2011.151; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wilson KA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.13; Winkel LPF, 2004, ANN NEUROL, V55, P495, DOI 10.1002/ana.20019; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang Q., 2012, YALE J BIOL MED, V85, P161; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, J HEPATOL, V64, P899, DOI 10.1016/j.jhep.2015.11.028; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	136	8	8	51	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1776	1474-1784		NAT REV DRUG DISCOV	Nat. Rev. Drug Discov.	JUN	2017	16	6					387	399		10.1038/nrd.2016.280				13	Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	EW4FS	WOS:000402458000012	28337020				2018-01-05	
J	Budak, G; Srivastava, R; Janga, SC				Budak, Gungor; Srivastava, Rajneesh; Janga, Sarath Chandra			Seten: a tool for systematic identification and comparison of processes, phenotypes, and diseases associated with RNA-binding proteins from condition-specific CLIP-seq profiles	RNA			English	Article						RNA-binding proteins; CLIP (crosslinking and immunoprecipitation); gene set enrichment; functional enrichment; genotype-phenotype; post-transcriptional networks	POSTTRANSCRIPTIONAL REGULATORY NETWORKS; UBIQUITIN LIGASE; BETA-TRCP; SITES; GENE; TRANSCRIPTOME; TRANSLATION; DDX6; DISCOVERY; SEQUENCE	RNA-binding proteins (RBPs) control the regulation of gene expression in eukaryotic genomes at post-transcriptional level by binding to their cognate RNAs. Although several variants of CLIP (crosslinking and immunoprecipitation) protocols are currently available to study the global protein RNA interaction landscape at single-nucleotide resolution in a cell, currently there are very few tools that can facilitate understanding and dissecting the functional associations of RBPs from the resulting binding maps. Here, we present Seten, a web-based and command line tool, which can identify and compare processes, phenotypes, and diseases associated with RBPs from condition-specific CLIP-seq profiles. Seten uses BED files resulting from most peak calling algorithms, which include scores reflecting the extent of binding of an RBP on the target transcript, to provide both traditional functional enrichment as well as gene set enrichment results for a number of gene set collections including BioCarta, KEGG, Reactome, Gene Ontology (GO), Human Phenotype Ontology (HPO), and MalaCards Disease Ontology for several organisms including fruit fly, human, mouse, rat, worm, and yeast. It also provides an option to dynamically compare the associated gene sets across data sets as bubble charts, to facilitate comparative analysis. Benchmarking of Seten using eCLIP data for IGF2BP1, SRSF7, and PTBP1 against their corresponding CRISPR RNA-seq in K562 cells as well as randomized negative controls, demonstrated that its gene set enrichment method outperforms functional enrichment, with scores significantly contributing to the discovery of true annotations. Comparative performance analysis using these CRISPR control data sets revealed significantly higher precision and comparable recall to that observed using ChIP-Enrich. Seten's web interface currently provides precomputed results for about 200 CLIP-seq data sets and both command line as well as web interfaces can be used to analyze CLIP-seq data sets. We highlight several examples to show the utility of Seten for rapid profiling of various CLIP-seq data sets. Seten is available on http://wwvv.iupuledu/similar to sysbio/seten/.	[Budak, Gungor; Srivastava, Rajneesh; Janga, Sarath Chandra] Indiana Univ Purdue Univ, Sch Informat & Comp, Dept Biohlth Informat, Indianapolis, IN 46202 USA; [Janga, Sarath Chandra] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Janga, Sarath Chandra] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Janga, SC (reprint author), Indiana Univ Purdue Univ, Sch Informat & Comp, Dept Biohlth Informat, Indianapolis, IN 46202 USA.; Janga, SC (reprint author), Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA.; Janga, SC (reprint author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	scjanga@iupui.edu		Budak, Gungor/0000-0003-1641-3304; Janga, Sarath Chandra/0000-0001-7351-6268			BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen BB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r18; Comoglio F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0470-y; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; D'Agostino Y, 2017, BRIEF FUNCT GENOMICS, DOI [10.1093/bfgp/e1w038, DOI 10.1093/BFGP/E1W038]; Darnell R.B., 2010, RNA, V1, P266; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; The ENCODE Project, 2017, RNA SEQ PROF CRISPR; Erhard F, 2013, BIOINFORMATICS, V29, P77, DOI 10.1093/bioinformatics/bts631; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521                                                                 ; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Janga SC, 2012, BRIEF FUNCT GENOMICS, V11, P505, DOI 10.1093/bfgp/els046; Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125                                                    ; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Kolde R., 2015, PACKAGE PHEATMAP; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lambert NJ, 2015, METHOD ENZYMOL, V558, P465, DOI 10.1016/bs.mie.2015.02.007; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491                                                         ; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Neelamraju Y, 2015, J PROTEOMICS, V127, P61, DOI 10.1016/j.jprot.2015.04.031; Nicholson CO, 2017, RNA, V23, P32, DOI 10.1261/rna.058115.116; Nishimura D, 2001, BIOTECT SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Ougolkov A, 2004, J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Patra P, 2015, IEEE ACM T COMPUT BI, P1; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Popow J, 2015, RNA, V21, P1873, DOI 10.1261/rna.052365.115; Poppe B, 2004, BLOOD, V103, P229, DOI 10.1182/blood-2003-06-2163; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rappaport N, 2014, CURR PROTOC BIOINFOR, V47, P1241, DOI DOI 10.1002/0471250953.BI0124S47; Reyes-Herrera PH, 2014, BIOINFORM BIOL INSIG, V8, P199, DOI 10.4137/BBI.S16803; Samuel CE, 2003, J BIOL CHEM, V278, P1389, DOI 10.1074/jbc.R200032200; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583                                                                   ; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Spitzer J, 2014, METHOD ENZYMOL, V539, P113, DOI 10.1016/B978-0-12-420120-0.00008-6; Stary S, 2013, GENE CHROMOSOME CANC, V52, P33, DOI 10.1002/gcc.22004; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095                                                         ; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Wang T, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r11; Wang Y, 2015, MOL CELL, V60, P118, DOI 10.1016/j.molcel.2015.08.014; Welch RP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku463; Winteringham LN, 2006, J BIOL CHEM, V281, P38791, DOI 10.1074/jbc.M605401200; Yang YCT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1273-2; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	61	0	0	4	7	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	JUN	2017	23	6					836	846		10.1261/rna.059089.116				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW1BG	WOS:000402224300002	28336542	gold			2018-01-05	
J	Li, RH; Harvey, AR; Hodgetts, SI; Fox, AH				Li, Ruohan; Harvey, Alan R.; Hodgetts, Stuart I.; Fox, Archa H.			Functional dissection of NEAT1 using genome editing reveals substantial localization of the NEAT1_1 isoform outside paraspeckles	RNA			English	Article						long noncoding RNAs; NEAT1; paraspeckles; CRISPR genome editing; DBHS proteins	NONCODING RNA NEAT1; REGULATED LNCRNA NEAT1; NUCLEAR PARASPECKLES; GENE-EXPRESSION; MESSENGER-RNAS; SC-35 DOMAINS; POLY(A) RNA; ORGANIZATION; CANCER; VISUALIZATION	Large numbers of long noncoding RNAs have been discovered in recent years, but only a few have been characterized. NEAT1 (nuclear paraspeckle assembly transcript 1) is a mammalian long noncoding RNA that is important for the reproductive physiology of mice, cancer development, and the formation of subnuclear bodies termed paraspeckles. The two major isoforms of NEAT1 (3.7 kb NEAT1_1 and 23 kb NEAT1_2 in human) are generated from a common promoter and are produced through the use of alternative transcription termination sites. This gene structure has made the functional relationship between the two isoforms difficult to dissect. Here we used CRISPR-Cas9 genome editing to create several different cell lines: total NEAT1 knockout cells, cells that only express the short form NEAT1_1, and cells with twofold more NEAT1_2. Using these reagents, we obtained evidence that NEAT1_1 is not a major component of paraspeckles. In addition, our data suggest NEAT1_1 localizes in numerous nonparaspeckle foci we termed "microspeckles," which may carry paraspeckle-independent functions. This study highlights the complexity of IncRNA and showcases how genome editing tools are useful in dissecting the structural and functional roles of overlapping transcripts.	[Li, Ruohan; Fox, Archa H.] Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Nedlands, WA 6009, Australia; [Li, Ruohan; Fox, Archa H.] Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia; [Li, Ruohan; Harvey, Alan R.; Hodgetts, Stuart I.; Fox, Archa H.] Univ Western Australia, Sch Human Sci, Crawley, WA 6009, Australia; [Harvey, Alan R.; Hodgetts, Stuart I.] Western Australian Neurosci Res Inst, Nedlands, WA 6009, Australia	Fox, AH (reprint author), Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Nedlands, WA 6009, Australia.; Fox, AH (reprint author), Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia.; Fox, AH (reprint author), Univ Western Australia, Sch Human Sci, Crawley, WA 6009, Australia.	archa.fox@uwa.edu.au	Fox, Archa/H-9219-2014	Fox, Archa/0000-0003-1962-270X	National Health and Medical Council of Australia [APP1048959]; Cancer Council of Western Australia Research Fellowship	We are grateful to F. Zhang for providing the pX330 and pX335 plasmids, G. Morahan for providing healthy human genomic DNA samples, and J. Cooper for providing assistance with the data analysis. We also want to thank A. Forrest for providing advice on the manuscript editing. This work was supported by grant APP1048959 from the National Health and Medical Council of Australia and a Cancer Council of Western Australia Research Fellowship to A. Fox.	Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Barry G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40127; Blankenberg D, 2010, CURR PROTOC MOL BIOL, V19, P1, DOI DOI 10.1002/0471142727.MB1910S89; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191                                                          ; Chai YQ, 2016, CANCER MED-US, V5, P1588, DOI 10.1002/cam4.710; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen X., 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.18632/0NC0TARGET.10084; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FINI ME, 1989, J CELL BIOL, V108, P2045, DOI 10.1083/jcb.108.6.2045; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7                                                   ; Fu JW, 2016, J CANCER RES CLIN, V142, P1571, DOI 10.1007/s00432-016-2152-1; GARBE JC, 1986, P NATL ACAD SCI USA, V83, P1812, DOI 10.1073/pnas.83.6.1812                                                          ; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Imamura K, 2014, MOL CELL, V23; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2016, WORLD J SURG ONCOL, V14, P1; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nishimoto Y, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-31; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saha S, 2006, J GEN VIROL, V87, P1991, DOI 10.1099/vir.0.81768-0; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617                                                           ; Souquere S, 2010, MOL BIOL CELL, V21, P4020, DOI 10.1091/mbc.E10-08-0690; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Sun CC, 2016, ONCOTARGET, V7, P51784, DOI 10.18632/oncotarget.10108; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Sunwoo JS, 2017, MOL NEUROBIOL, V54, P1577, DOI 10.1007/s12035-016-9928-9; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; VISA N, 1993, EXP CELL RES, V208, P19, DOI 10.1006/excr.1993.1218; Wang PW, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0351-x; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; West JA, 2016, J CELL BIOL, V214, P817, DOI 10.1083/jcb.201601071; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635	51	2	2	5	5	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	JUN	2017	23	6					872	881		10.1261/rna.059477.116				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW1BG	WOS:000402224300006	28325845	gold			2018-01-05	
J	Yoshikawa, R; Takeuchi, JS; Yamada, E; Nakano, Y; Misawa, N; Kimura, Y; Ren, F; Miyazawa, T; Koyanagi, Y; Sato, K				Yoshikawa, Rokusuke; Takeuchi, Junko S.; Yamada, Eri; Nakano, Yusuke; Misawa, Naoko; Kimura, Yuichi; Ren, Fengrong; Miyazawa, Takayuki; Koyanagi, Yoshio; Sato, Kei			Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3	JOURNAL OF VIROLOGY			English	Article						APOBEC3; FIV; Vif; evolutionary arms race; lentivirus; protease	PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; DOMESTIC CATS; RESTRICTION FACTORS; MAXIMUM-LIKELIHOOD; NONPANDEMIC HIV-1; ENZYME APOBEC3G; LENTIVIRAL VIF; SUBTYPE-B; ENV GENE	The interplay between viral and host proteins has been well studied to elucidate virus-host interactions and their relevance to virulence. Mammalian genes encode apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins, which act as intrinsic restriction factors against lentiviruses. To overcome APOBEC3-mediated antiviral actions, lentiviruses have evolutionarily acquired an accessory protein, viral infectivity factor (Vif), and Vif degrades host APOBEC3 proteins via a ubiquitin/proteasome-dependent pathway. Although the Vif-APOBEC3 interaction and its evolutionary significance, particularly those of primate lentiviruses (including HIV) and primates (including humans), have been well investigated, those of nonprimate lentiviruses and nonprimates are poorly understood. Moreover, the factors that determine lentiviral pathogenicity remain unclear. Here, we focus on feline immunodeficiency virus (FIV), a pathogenic lentivirus in domestic cats, and the interaction between FIV Vif and feline APOBEC3 in terms of viral virulence and evolution. We reveal the significantly reduced diversity of FIV subtype B compared to that of other subtypes, which may associate with the low pathogenicity of this subtype. We also demonstrate that FIV subtype B Vif is less active with regard to feline APOBEC3 degradation. More intriguingly, we further reveal that FIV protease cleaves feline APOBEC3 in released virions. Taken together, our findings provide evidence that a lentivirus encodes two types of anti-APOBEC3 factors, Vif and viral protease. IMPORTANCE During the history of mammalian evolution, mammals coevolved with retroviruses, including lentiviruses. All pathogenic lentiviruses, excluding equine infectious anemia virus, have acquired the vif gene via evolution to combat APOBEC3 proteins, which are intrinsic restriction factors against exogenous lentiviruses. Here we demonstrate that FIV, a pathogenic lentivirus in domestic cats, antagonizes feline APOBEC3 proteins by both Vif and a viral protease. Furthermore, the Vif proteins of an FIV subtype (subtype B) have attenuated their anti-APOBEC3 activity through evolution. Our findings can be a clue to elucidate the complicated evolutionary processes by which lentiviruses adapt to mammals.	[Yoshikawa, Rokusuke; Takeuchi, Junko S.; Yamada, Eri; Nakano, Yusuke; Misawa, Naoko; Kimura, Yuichi; Koyanagi, Yoshio; Sato, Kei] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto, Japan; [Ren, Fengrong] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo, Japan; [Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto, Japan; [Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Virolut, Kyoto, Japan; [Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Yoshikawa, Rokusuke] Nagasaki Univ, Inst Trop Med, Nagasaki, Japan; [Takeuchi, Junko S.] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Sato, K (reprint author), Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto, Japan.; Sato, K (reprint author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.	ksato@virus.kyoto-u.ac.jp		Sato, Kei/0000-0003-4431-1380	CREST, JST; MHLW [26361601]; Takeda Science Foundation; Sumitomo Foundation; Imai Memorial Trust; Ichiro Kanehara Foundation; Kanae Foundation; Suzuken Memorial Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; JSPS [C 15K07166, 16KT0111]; MEXT [24115008]; AMED [16fk0410203h002]; JSPS Research Fellowship [PD 15J06242]	This study was supported in part by CREST, JST (to K. Sato); Health Labor Sciences research grant 26361601 from MHLW (to K. Sato); the Takeda Science Foundation; a Sumitomo Foundation research grant (to K. Sato); the Imai Memorial Trust (to K. Sato); the Ichiro Kanehara Foundation (to K. Sato); the Kanae Foundation (to K. Sato); the Suzuken Memorial Foundation (to K. Sato); the Uehara Memorial Foundation (to K. Sato); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to K. Sato); Grants-in-Aid for Scientific Research C 15K07166 from JSPS (to K. Sato), Scientific Research B (Generative Research Fields) 16KT0111 from JSPS (to K. Sato), and Scientific Research on Innovative Areas 24115008 from MEXT (to Y. Koyanagi); JSPS Research Fellowship PD 15J06242 (to R. Yoshikawa); the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from AMED (to E. Yamada and Y. Koyanagi); the JSPS Core-to-Core Program, A. Advanced Research Networks (to Y. Koyanagi); and Research on HIV/AIDS 16fk0410203h002 from AMED (to Y. Koyanagi).	Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055; Braciale TJ, 2007, FIELDS VIROLOGY, V1, P279; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334                                           ; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Compton AA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0496; Compton AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003135; Compton AA, 2012, CELL HOST MICROBE, V11, P91, DOI 10.1016/j.chom.2011.11.010; de Castro FL, 2014, INFECT GENET EVOL, V27, P389, DOI 10.1016/j.meegid.2014.08.024; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Duarte A, 2006, VET MICROBIOL, V114, P25, DOI 10.1016/j.vetmic.2005.11.056; FENNER F, 1983, PROC R SOC SER B-BIO, V218, P259, DOI 10.1098/rspb.1983.0039; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Kane JR, 2015, CELL REP, V11, P1236, DOI 10.1016/j.celrep.2015.04.038; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kemler I, 2012, J VIROL, V86, P8402, DOI 10.1128/JVI.00692-12; Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; KIYOMASU T, 1991, J VIROL, V65, P4539; Kohmoto M, 1998, J VET MED SCI, V60, P315, DOI 10.1292/jvms.60.315; KOHMOTO M, 1994, J GEN VIROL, V75, P1935, DOI 10.1099/0022-1317-75-8-1935                                                     ; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lockridge KM, 1999, VIROLOGY, V261, P25, DOI 10.1006/viro.1999.9831                                                          ; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Martins AN, 2008, J VIROL, V82, P7863, DOI 10.1128/JVI.00310-08; MIYAZAWA T, 1991, J VIROL, V65, P1572; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Nishimura Y, 1998, VIRUS RES, V57, P101, DOI 10.1016/S0168-1702(98)00085-9; Nowak MA., 2006, EVOLUTIONARY DYNAMIC; Pecoraro MR, 1996, J GEN VIROL, V77, P2031, DOI 10.1099/0022-1317-77-9-2031; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; Peng C, 2016, P NATL ACAD SCI USA, V113, P3855, DOI 10.1073/pnas.1515613113; PETTIT SC, 1991, J BIOL CHEM, V266, P14539; Pistello M, 1997, J GEN VIROL, V78, P2247, DOI 10.1099/0022-1317-78-9-2247                                                     ; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817                                                 ; Reggeti F, 2004, J GEN VIROL, V85, P1843, DOI 10.1099/vir.0.19743-0; RIGBY MA, 1993, J GEN VIROL, V74, P425, DOI 10.1099/0022-1317-74-3-425; Saenz Dyana T, 2012, Cold Spring Harb Protoc, V2012, P71, DOI 10.1101/pdb.ip067579; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sharp PM, 2010, PHILOS T R SOC B, V365, P2487, DOI 10.1098/rstb.2010.0031; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Shen XY, 2007, J GEN VIROL, V88, P2793, DOI 10.1099/vir.0.83268-0; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; SODORA DL, 1994, J VIROL, V68, P2230; SODORA DL, 1995, AIDS RES HUM RETROV, V11, P531; Steinrigl A, 2003, J GEN VIROL, V84, P1301, DOI 10.1099/vir.0.18736-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Teixeira BM, 2011, VIRUS RES, V160, P59, DOI 10.1016/j.virusres.2011.05.007; Teixeira BM, 2012, VIRUSES-BASEL, V4, P383, DOI 10.3390/v4030383; Teixeira BM, 2010, ARCH VIROL, V155, P379, DOI 10.1007/s00705-009-0587-2; Troyer RM, 2013, J VIROL, V87, P7940, DOI 10.1128/JVI.00752-13; Wang JW, 2011, J VIROL, V85, P12482, DOI 10.1128/JVI.05218-11; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yamamoto JK, 2007, AIDS, V21, P547, DOI 10.1097/QAD.0b013e328013d88a; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshikawa R, 2016, MICROBIOL IMMUNOL, V60, P272, DOI 10.1111/1348-0421.12371; Yoshikawa R, 2016, J VIROL, V90, P474, DOI 10.1128/JVI.02612-15; Yoshikawa R, 2015, J GEN VIROL, V96, P887, DOI 10.1099/jgv.0.000027; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zielonka J, 2010, J VIROL, V84, P7312, DOI 10.1128/JVI.00209-10	68	1	1	17	18	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JUN	2017	91	11							UNSP e00250-17	10.1128/JVI.00250-17				16	Virology	Virology	EW0GI	WOS:000402166500017		gold			2018-01-05	
J	Shen, JP; Zhao, DX; Sasik, R; Luebeck, J; Birmingham, A; Bojorquez-Gomez, A; Licon, K; Klepper, K; Pekin, D; Beckett, AN; Sanchez, KS; Thomas, A; Kuo, CC; Du, D; Roguev, A; Lewis, NE; Chang, AN; Kreisberg, JF; Krogan, N; Qi, L; Ideker, T; Mali, P				Shen, John Paul; Zhao, Dongxin; Sasik, Roman; Luebeck, Jens; Birmingham, Amanda; Bojorquez-Gomez, Ana; Licon, Katherine; Klepper, Kristin; Pekin, Daniel; Beckett, Alex N.; Sanchez, Kyle Salinas; Thomas, Alex; Kuo, Chih-Chung; Du, Dan; Roguev, Assen; Lewis, Nathan E.; Chang, Aaron N.; Kreisberg, Jason F.; Krogan, Nevan; Qi, Lei; Ideker, Trey; Mali, Prashant			Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions	NATURE METHODS			English	Article							FALSE DISCOVERY RATE; INTERACTION MAP; CANCER-THERAPY; GENOME-SCALE; SGRNA DESIGN; NETWORKS; CAS9; FITNESS; BIOLOGY; YEAST	We developed a systematic approach to map human genetic networks by combinatorial CRISPR Cas9 perturbations coupled to robust analysis of growth kinetics. We targeted all pairs of 73 cancer genes with dual guide RNAs in three cell lines, comprising 141,912 tests of interaction. Numerous therapeutically relevant interactions were identified, and these patterns replicated with combinatorial drugs at 75% precision. From these results, we anticipate that cellular context will be critical to synthetic-lethal therapies.	[Shen, John Paul; Bojorquez-Gomez, Ana; Licon, Katherine; Klepper, Kristin; Pekin, Daniel; Beckett, Alex N.; Sanchez, Kyle Salinas; Kreisberg, Jason F.; Ideker, Trey] Univ Calif San Diego, Div Genet, Dept Med, La Jolla, CA 92093 USA; [Shen, John Paul; Ideker, Trey; Mali, Prashant] Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Shen, John Paul; Zhao, Dongxin; Du, Dan; Roguev, Assen; Kreisberg, Jason F.; Krogan, Nevan; Qi, Lei; Ideker, Trey; Mali, Prashant] Canc Cell Map Initiat, La Jolla, CA 92037 USA; [Shen, John Paul; Zhao, Dongxin; Du, Dan; Roguev, Assen; Kreisberg, Jason F.; Krogan, Nevan; Qi, Lei; Ideker, Trey; Mali, Prashant] Canc Cell Map Initiat, San Francisco, CA 94143 USA; [Zhao, Dongxin; Kuo, Chih-Chung; Mali, Prashant] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Sasik, Roman; Birmingham, Amanda; Chang, Aaron N.; Ideker, Trey] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA; [Luebeck, Jens; Thomas, Alex] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Thomas, Alex; Lewis, Nathan E.] Univ Calif San Diego, Novo Nordisk Ctr Biosustainabil, La Jolla, CA 92093 USA; [Du, Dan] Univ Calif San Francisco, Dept Cell & Tissue Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Roguev, Assen; Krogan, Nevan] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Lewis, Nathan E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Qi, Lei] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Ideker, T (reprint author), Univ Calif San Diego, Div Genet, Dept Med, La Jolla, CA 92093 USA.; Ideker, T; Mali, P (reprint author), Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.; Ideker, T; Mali, P (reprint author), Canc Cell Map Initiat, La Jolla, CA 92037 USA.; Ideker, T; Mali, P (reprint author), Canc Cell Map Initiat, San Francisco, CA 94143 USA.; Mali, P (reprint author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Ideker, T (reprint author), Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA.	tideker@ucsd.edu; pmali@ucsd.edu			UC San Diego School of Engineering and School of Medicine institutional funds; Burroughs Wellcome Fund [1013926]; March of Dimes Foundation [5-FY15-450]; Sidney Kimmel Foundation [SKF-16-150]; California Institute for Regenerative Medicine; National Cancer Institute [R21 CA199292, L30 CA171000]; National Institute for Environmental Health Sciences [R01 ES014811]; National Institute for General Medical Sciences [T32 GM008806, RO1 GM084279, P50 GM085764]; UC San Diego Clinical and Translational Research Institute Grant [UL1TR001442]; Novo Nordisk Foundation Center for Biosustainability at DTU [NNF16CC0021858]	This work was generously supported by the following sources: UC San Diego School of Engineering and School of Medicine institutional funds (P.M., T.I., R.S. and A.B.), the Burroughs Wellcome Fund (1013926 to P.M.), the March of Dimes Foundation (5-FY15-450 to P.M.), the Sidney Kimmel Foundation (SKF-16-150 to P.M.), the California Institute for Regenerative Medicine (T.I. and J.P.S.), the National Cancer Institute (R21 CA199292 to N.E.L. and L30 CA171000 to J.P.S.), the National Institute for Environmental Health Sciences (R01 ES014811 to T.I.), the National Institute for General Medical Sciences (T32 GM008806 to J.L,, RO1 GM084279 to T.I. and N.K. and P50 GM085764 to T.I.), the UC San Diego Clinical and Translational Research Institute Grant (UL1TR001442 to R.S. and A.B.) and the Novo Nordisk Foundation Center for Biosustainability at DTU (NNF16CC0021858 to N.E.L.).	AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90140-Y; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Baryshnikova A, 2013, ANNU REV GENOM HUM G, V14, P111, DOI 10.1146/annurev-genom-082509-141730; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Chari R., NAT METHODS, V12; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; DELEAN A, 1978, AM J PHYSIOL, V235, pE97; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Krogan NJ, 2015, MOL CELL, V58, P690, DOI 10.1016/j.molcel.2015.05.008; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Lori F., J CLIN INFECT DIS S, V30, pS193; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798                                                          ; Pollard KS, 2004, J STAT PLAN INFER, V125, P85, DOI 10.1016/j.jspi.2003.07.019; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shen J. P., 2017, PROTOCOL EXCHANGE; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Srivas R, 2016, MOL CELL, V63, P514, DOI 10.1016/j.molcel.2016.06.022; Storey J, 2015, R PACKAGE VERSION 2; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335                                                          ; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115	38	6	6	7	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUN	2017	14	6					573	+		10.1036/NMETH.4225				9	Biochemical Research Methods	Biochemistry & Molecular Biology	EW1YK	WOS:000402291800016	28319113				2018-01-05	
J	Du, D; Roguev, A; Gordon, DE; Chen, M; Chen, SH; Shales, M; Shen, JP; Ideker, T; Mali, P; Qi, LS; Krogan, NJ				Du, Dan; Roguev, Assen; Gordon, David E.; Chen, Meng; Chen, Si-Han; Shales, Michael; Shen, John Paul; Ideker, Trey; Mali, Prashant; Qi, Lei S.; Krogan, Nevan J.			Genetic interaction mapping in mammalian cells using CRISPR interference	NATURE METHODS			English	Article							INTERACTION MAP; REVEALS LINKS; ACTIVATION; RNAI; REPRESSION; COMPLEXES; NETWORKS; YEAST	We describe a combinatorial CRISPR interference (CRISPRi) screening platform for mapping genetic interactions in mammalian cells. We targeted 107 chromatin -regulation factors in human cells with pools of either single or double single guide RNAs (sgRNAs) to downregulate individual genes or gene pairs, respectively. Relative enrichment analysis of individual sgRNAs or sgRNA pairs allowed for quantitative characterization of genetic interactions, and comparison with protein -protein -interaction data revealed a functional map of chromatin regulation.	[Du, Dan; Chen, Meng; Qi, Lei S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Du, Dan; Qi, Lei S.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Du, Dan; Qi, Lei S.] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA; [Roguev, Assen; Gordon, David E.; Chen, Si-Han; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Roguev, Assen; Gordon, David E.; Chen, Si-Han; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Chen, Meng; Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA USA; [Shen, John Paul; Ideker, Trey] Univ Calif San Diego, Dept Med, Div Genet, La Jolla, CA 92093 USA; [Shen, John Paul; Ideker, Trey; Mali, Prashant] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Qi, LS (reprint author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Qi, LS (reprint author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Qi, LS (reprint author), Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA.; Krogan, NJ (reprint author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Krogan, NJ (reprint author), Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA.; Krogan, NJ (reprint author), J David Gladstone Inst, San Francisco, CA USA.	stanley.qi@stanford.edu; nevan.krogan@ucsf.edu		Qi, Lei S/0000-0002-3965-3223; du, dan/0000-0002-3470-2890	NIH Office of the Director (OD); National Institute of Dental & Craniofacial Research (NIDCR); Department of Defense Breast Cancer Research Breakthrough Program; Pew Charitable Trusts; Alfred P. Sloan Foundation; Quantitative Bioscience Institute (QBI); J. David Gladstone Biofulcrum Program; NIH [RO1 DA036858, NIH U01EB021240, DOD W81XWH-17-1-0018, P50 GM082250, U19 AI106754, P01 HL089707, RO1 GM084279, U19 AI118610, RO1 AI120694]; Pew Scholar Fellowship; Alfred P. Sloan Fellowship;  [DP5 0D017887]	The authors thank the members of the laboratories of L.S.Q. and N.J.K. for advice and helpful discussions, and the Stanford Functional Genomics Facility and UCSD Sequencing Facility for technical support. We thank D. Zhao from the laboratory of L.S.Q. for advice and help in cloning the sgRNA library. L.S.Q. acknowledges support from the NIH Office of the Director (OD), the National Institute of Dental & Craniofacial Research (NIDCR), the Department of Defense Breast Cancer Research Breakthrough Program, the Pew Charitable Trusts and the Alfred P. Sloan Foundation. D.D. and A.R. acknowledge support from the Quantitative Bioscience Institute (QBI). M.C., N.J.K. and L.S.Q. acknowledge support from the J. David Gladstone Biofulcrum Program. This work was supported by DP5 0D017887, NIH RO1 DA036858, NIH U01EB021240, DOD W81XWH-17-1-0018, a Pew Scholar Fellowship and an Alfred P. Sloan Fellowship to L.S.Q., as well as by NIH grants P50 GM082250, U19 AI106754, P01 HL089707, RO1 GM084279, U19 AI118610 and RO1 AI120694 to N.J.K.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Du D., 2016, COLD SPRING HARB PRO, V2016; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fischer B, 2015, ELIFE, V4, DOI 10.7554/eLife.05464; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/NMETH.2398, 10.1038/nmeth.2398]; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012	26	2	2	9	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUN	2017	14	6					577	+		10.1038/NMETH.4286				7	Biochemical Research Methods	Biochemistry & Molecular Biology	EW1YK	WOS:000402291800017	28481362				2018-01-05	
J	Cameron, P; Fuller, CK; Donohoue, PD; Jones, BN; Thompson, MS; Carter, MM; Gradia, S; Vidal, B; Garner, E; Slorach, EM; Lau, E; Banh, LM; Lied, AM; Edwards, LS; Settle, AH; Capurso, D; Llaca, V; Deschamps, S; Cigan, M; Young, JK; May, AP				Cameron, Peter; Fuller, Chris K.; Donohoue, Paul D.; Jones, Brittnee N.; Thompson, Matthew S.; Carter, Matthew M.; Gradia, Scott; Vidal, Bastien; Garner, Elizabeth; Slorach, Euan M.; Lau, Elaine; Banh, Lynda M.; Lied, Alexandra M.; Edwards, Leslie S.; Settle, Alexander H.; Capurso, Daniel; Llaca, Victor; Deschamps, Stephane; Cigan, Mark; Young, Joshua K.; May, Andrew P.			Mapping the genomic landscape of CRISPR-Cas9 cleavage	NATURE METHODS			English	Article							OFF-TARGET CLEAVAGE; HUMAN-CELLS; CAS NUCLEASES; DIGENOME-SEQ; DNA CLEAVAGE; GUIDE RNA; ENDONUCLEASE; SPECIFICITY; IMMUNITY; COMPLEX	RNA-guided CRISPR-Cas9 endonucleases are widely used for genome engineering, but our understanding of Cas9 specificity remains incomplete. Here, we developed a biochemical method (SITE-Seq), using Cas9 programmed with single-guide RNAs (sgRNAs), to identify the sequence of cut sites within genomic DNA. Cells edited with the same Cas9-sgRNA complexes are then assayed for mutations at each cut site using amplicon sequencing. We used SITE-Seq to examine Cas9 specificity with sgRNAs targeting the human genome. The number of sites identified depended on sgRNA sequence and nuclease concentration. Sites identified at lower concentrations showed a higher propensity for off-target mutations in cells. The list of off-target sites showing activity in cells was influenced by sgRNP delivery, cell type and duration of exposure to the nuclease. Collectively, our results underscore the utility of combining comprehensive biochemical identification of off-target sites with independent cell-based measurements of activity at those sites when assessing nuclease activity and specificity.	[Cameron, Peter; Fuller, Chris K.; Donohoue, Paul D.; Jones, Brittnee N.; Thompson, Matthew S.; Carter, Matthew M.; Gradia, Scott; Vidal, Bastien; Garner, Elizabeth; Slorach, Euan M.; Lau, Elaine; Banh, Lynda M.; Lied, Alexandra M.; Edwards, Leslie S.; Settle, Alexander H.; Capurso, Daniel; May, Andrew P.] Caribou Biosci, Berkeley, CA 94710 USA; [Llaca, Victor; Deschamps, Stephane; Cigan, Mark; Young, Joshua K.] DuPont Pioneer, Johnston, IA 50131 USA; [Jones, Brittnee N.] Omicia Inc, Oakland, CA USA; [Cigan, Mark] Genus Res, De Forest, WI USA; [May, Andrew P.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	May, AP (reprint author), Caribou Biosci, Berkeley, CA 94710 USA.; Young, JK (reprint author), DuPont Pioneer, Johnston, IA 50131 USA.; May, AP (reprint author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	josh.young@pioneer.com; apmay1@gmail.com					Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bailey T. L., 1994, P 2 INT C INT SYST M, P28; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Cameron P., 2017, PROTOCOL EXCHANGE; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu BXH, 2016, NUCLEIC ACIDS RES, V44, P5365, DOI 10.1093/nar/gkw417; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Richardson CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12463; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	5	5	11	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUN	2017	14	6					600	+		10.1038/NMETH.4284				10	Biochemical Research Methods	Biochemistry & Molecular Biology	EW1YK	WOS:000402291800023	28459459				2018-01-05	
J	Tsai, SQ; Nguyen, NT; Malagon-Lopez, J; Topkar, VV; Aryee, MJ; Joung, JK				Tsai, Shengdar Q.; Nguyen, Nhu T.; Malagon-Lopez, Jose; Topkar, Ved V.; Aryee, Martin J.; Joung, J. Keith			CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR Cas9 nuclease off-targets	NATURE METHODS			English	Article							STRAND BREAK REPAIR; EDITING TECHNOLOGIES; DIGENOME-SEQ; SPECIFICITY; ENDONUCLEASE; CLEAVAGE; CELLS; GENE; RECOGNITION; ACTIVATION	Sensitive detection of off-target effects is important for translating CRISPR-Cas9 nucleases into human therapeutics. In vitro biochemical methods for finding off-targets offer the potential advantages of greater reproducibility and scalability while avoiding limitations associated with strategies that require the culture and manipulation of living cells. Here we describe circularization for in vitro reporting of cleavage effects by sequencing (CIRCLE-seq), a highly sensitive, sequencing-efficient in vitro screening strategy that outperforms existing cell-based or biochemical approaches for identifying CRISPR-Cas9 genome-wide off-target mutations. In contrast to previously described in vitro methods, we show that CIRCLE-seq can be practiced using widely accessible next-generation sequencing technology and does not require reference genome sequences. Importantly, CIRCLE-seq can be used to identify off-target mutations associated with cell-type-specific single-nucleotide polymorphisms, demonstrating the feasibility and importance of generating personalized specificity profiles. CIRCLE-seq provides an accessible, rapid, and comprehensive method for identifying genome-wide off-target mutations of CRISPR-Cas9.	[Tsai, Shengdar Q.; Nguyen, Nhu T.; Malagon-Lopez, Jose; Topkar, Ved V.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Nguyen, Nhu T.; Malagon-Lopez, Jose; Topkar, Ved V.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Nguyen, Nhu T.; Malagon-Lopez, Jose; Topkar, Ved V.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Malagon-Lopez, Jose; Aryee, Martin J.; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Malagon-Lopez, Jose; Aryee, Martin J.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Tsai, Shengdar Q.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA	Tsai, SQ; Joung, JK (reprint author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.; Tsai, SQ; Joung, JK (reprint author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Tsai, SQ; Joung, JK (reprint author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA.; Tsai, SQ; Joung, JK (reprint author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.; Tsai, SQ (reprint author), St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA.	shengdar.tsai@stjude.org; jjoung@mgh.harvard.edu		Aryee, Martin/0000-0002-6848-1344	National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]; NIH [R35 GM118158, R01 GM107427]; Jim and Ann Orr Research Scholar Award	This work was supported by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R35 GM118158, and NIH R01 GM107427 (to J.K.J.); and the Jim and Ann Orr Research Scholar Award (to J.K.J.).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin J, 2016, FEBS J, V283, P3222, DOI 10.1111/febs.13763; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai S. Q., 2017, PROTOCOL EXCHANGE; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507	43	10	10	12	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUN	2017	14	6					607	+		10.1038/NMETH.4278				10	Biochemical Research Methods	Biochemistry & Molecular Biology	EW1YK	WOS:000402291800024	28459458				2018-01-05	
J	Agudelo, D; Duringer, A; Bozoyan, L; Huard, CC; Carter, S; Loehr, J; Synodinou, D; Drouin, M; Salsman, J; Dellaire, G; Laganiere, J; Doyon, Y				Agudelo, Daniel; Duringer, Alexis; Bozoyan, Lusine; Huard, Caroline C.; Carter, Sophie; Loehr, Jeremy; Synodinou, Dafni; Drouin, Mathieu; Salsman, Jayme; Dellaire, Graham; Laganiere, Josee; Doyon, Yannick			Marker-free coselection for CRISPR-driven genome editing in human cells	NATURE METHODS			English	Article							HOMOLOGY-DIRECTED REPAIR; STRAND BREAK REPAIR; CAENORHABDITIS-ELEGANS; MAMMALIAN-CELLS; CAS9 NUCLEASES; ALPHA-SUBUNIT; STEM-CELLS; K+-ATPASE; GENE; SPECIFICITY	Targeted genome editing enables the creation of bona fide cellular models for biological research and may be applied to human cell-based therapies. Therefore, broadly applicable and versatile methods for increasing its efficacy in cell populations are highly desirable. We designed a simple and robust coselection strategy for enrichment of cells with either nuclease-driven nonhomologous end joining (N H EJ) or homology-directed repair (HDR) events by harnessing the multiplexing capabilities of CRISPR Cas9 and Cpfl systems. Selection for dominant alleles of the ubiquitous sodium/ potassium pump (Na+/K+ ATPase) that rendered cells resistant to ouabain was used to enrich for custom genetic modifications at another unlinked locus of interest, thereby effectively increasing the recovery of engineered cells. The process is readily adaptable to transformed and primary cells, including hematopoietic stem and progenitor cells. The use of universal CRISPR reagents and a commercially available small-molecule inhibitor streamlines the incorporation of marker-free genetic changes in human cells.	[Agudelo, Daniel; Duringer, Alexis; Bozoyan, Lusine; Huard, Caroline C.; Carter, Sophie; Loehr, Jeremy; Synodinou, Dafni; Doyon, Yannick] Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Bozoyan, Lusine; Drouin, Mathieu; Laganiere, Josee] Hema Quebec, Res & Dev, Quebec City, PQ, Canada; [Salsman, Jayme; Dellaire, Graham] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada	Doyon, Y (reprint author), Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ, Canada.	yannick.doyon@crchudequebec.ulaval.ca		Agudelo Pinto, Daniel Steven/0000-0002-8794-4279; Doyon, Yannick/0000-0002-3889-9563	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-059680]; Canadian Institutes of Health Research (CIHR) [MOP-84260]; Fonds de La Recherche du Quebec-Sante (FRQS); Beatrice Hunter Cancer Research Institute (BHCRI); Mitacs Accelerate program	This study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-059680) to Y.D. and the Canadian Institutes of Health Research (CIHR; MOP-84260) to G.D. Salary support was provided by the Fonds de La Recherche du Quebec-Sante (FRQS) to D.A. and Y.D. and by a Bridge Grant from the Beatrice Hunter Cancer Research Institute (BHCRI) to J.S. Partial salary support to L.B. was obtained through the Mitacs Accelerate program. We thank the staff at the Hopital St-Francois d'Assise for their assistance in collecting UCB units, M.-E. Rheaume for processing and HSPC purification, and our colleagues for critical reading of the manuscript. We thank A. Fradet-Turcotte (Centre de Recherche du CHU de Quebec-Universite Laval), G. Church (Department of Genetics, Harvard Medical School), and F. Zhang (Broad Institute of MIT and Harvard) for providing materials.	Agudelo D., 2017, PROTOCOL EXCHANGE; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Croyle ML, 1997, EUR J BIOCHEM, V248, P488, DOI 10.1111/j.1432-1033.1997.00488.x                                                ; Dalvai M, 2015, CELL REP, V13, P621, DOI 10.1016/j.celrep.2015.09.009; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doyon Y, 2016, METHOD ENZYMOL, V573, P303, DOI 10.1016/bs.mie.2016.01.017; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Ge DT, 2016, G3-GENES GENOM GENET, V6, P3197, DOI 10.1534/g3.116.032557; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kane NS, 2017, G3-GENES GENOM GENET, V7, P87, DOI 10.1534/g3.116.036723; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Liao SR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv675; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mitzelfelt KA, 2017, STEM CELL REP, V8, P491, DOI 10.1016/j.stemcr.2017.01.021; Moriarity BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096114; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Shy BR, 2016, NUCLEIC ACIDS RES, V44, P7997, DOI 10.1093/nar/gkw685; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Ujvari B, 2015, P NATL ACAD SCI USA, V112, P11911, DOI 10.1073/pnas.1511706112; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Ward JD, 2015, GENETICS, V199, P363, DOI 10.1534/genetics.114.172361; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	48	6	6	15	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUN	2017	14	6					615	+		10.1038/NMETH.4265				8	Biochemical Research Methods	Biochemistry & Molecular Biology	EW1YK	WOS:000402291800025	28417998				2018-01-05	
J	Bentley, BP; Haas, BJ; Tedeschi, JN; Berry, O				Bentley, Blair P.; Haas, Brian J.; Tedeschi, Jamie N.; Berry, Oliver			Loggerhead sea turtle embryos (Caretta caretta) regulate expression of stress response and developmental genes when exposed to a biologically realistic heat stress	MOLECULAR ECOLOGY			English	Article						Caretta caretta; climate change; reptile; sea turtle; thermal stress; transcriptome; trinity; Trinotate	SHOCK TRANSCRIPTION FACTOR; DNA-BINDING ACTIVITY; CLIMATE-CHANGE; MOLECULAR CHAPERONES; THERMAL-STRESS; TEMPERATURE STRESS; WESTERN-AUSTRALIA; NATATOR-DEPRESSUS; REFERENCE GENOME; NEXT-GENERATION	Oviparous reptile embryos are expected to breach their critical thermal maxima if temperatures reach those predicted under current climate change models due to the lack of the maternal buffering processes and parental care. Heat-shock proteins (HSPs) are integral in the molecular response to thermal stress, and their expression is heritable, but the roles of other candidate families such as the heat-shock factors (HSFs) have not been determined in reptiles. Here, we subject embryonic sea turtles (Caretta caretta) to a biologically realistic thermal stress and employ de novo transcriptomic profiling of brain tissue to investigate the underlying molecular response. From a reference transcriptome of 302293 transcripts, 179 were identified as differentially expressed between treatments. As anticipated, genes enriched in the heat-shock treatment were primarily associated with the Hsp families, or were genes whose products play similar protein editing and chaperone functions (e.g. bag3, MYOC and serpinh1). Unexpectedly, genes encoding the HSFs were not significantly upregulated under thermal stress, indicating their presence in unstressed cells in an inactive state. Genes that were downregulated under thermal stress were less well functionally defined but were associated with stress response, development and cellular organization, suggesting that developmental processes may be compromised at realistically high temperatures. These results confirm that genes from the Hsp families play vital roles in the thermal tolerance of developing reptile embryos and, in addition with a number of other genes, should be targets for evaluating the capacity of oviparous reptiles to respond adaptively to the effects of climate change.	[Bentley, Blair P.; Tedeschi, Jamie N.] Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Perth, WA 6009, Australia; [Bentley, Blair P.; Berry, Oliver] CSIRO, Oceans & Atmosphere, Floreat 6014, Australia; [Haas, Brian J.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA	Bentley, BP (reprint author), Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Perth, WA 6009, Australia.; Bentley, BP (reprint author), CSIRO, Oceans & Atmosphere, Floreat 6014, Australia.	blair.bentley@research.uwa.edu.au	Tedeschi, Jamie/K-5276-2012	Tedeschi, Jamie/0000-0002-0662-0484	Commonwealth Science and Industry Research Organization (CSIRO)	Funding for this project was generously provided by the Commonwealth Science and Industry Research Organization (CSIRO) as a CSIRO Vacation Studentship in summer 2014.	Ackerman Ralph A., 1997, P83; Aitola M, 2003, J HISTOCHEM CYTOCHEM, V51, P455, DOI 10.1177/002215540305100407                                                      ; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amin Shorash, 2014, BMC Research Notes, V7, P488, DOI 10.1186/1756-0500-7-488; Anckar J, 2007, MOL ASPECTS STRESS R, P78; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486                                                           ; Barcenas-Ibarra A, 2015, BIRTH DEFECTS RES A, V103, P203, DOI 10.1002/bdra.23342; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4                                                   ; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; Broderick AC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P161, DOI 10.1086/319661                                                                  ; CALOW P, 1991, COMP BIOCHEM PHYS C, V100, P3, DOI 10.1016/0742-8413(91)90110-F; Carr Archie, 1967, SO EXCELLENT FISHE N; Chang J, 2000, AM J PHYSIOL-REG I, V278, pR209; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1                                                   ; Deeming D.C., 2004, P229; Department of the Environment Water Heritage & the Arts, 2010, CAR CAR; desSousa AR, 2009, MOL BIOSYST, V5, P1512; Diamond SE, 2016, ANN NY ACAD SCI, V1389, P5, DOI DOI 10.1111/NYAS.13223); Doody JS, 2010, HERPETOL CONSERV BIO, V5, P283; Du WG, 2015, BIOL REV, V90, P19, DOI 10.1111/brv.12089; EDWARDS MJ, 1968, TERATOLOGY, V1, P173, DOI 10.1002/tera.1420010206; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FERNANDES M, 1994, BIOL HEAT SHOCK PROT, P375; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Georges A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P18, DOI 10.1086/425200; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Godley BJ, 2001, J EXP MAR BIOL ECOL, V263, P45, DOI 10.1016/S0022-0981(01)00269-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARRY JL, 1989, AUST WILDLIFE RES, V16, P317; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Heikkila JJ, 2017, COMP BIOCHEM PHYS A, V203, P179, DOI 10.1016/j.cbpa.2016.09.011; Hewavisenthi S, 2001, COPEIA, P668, DOI 10.1643/0045-8511(2001)001[0668:IOIEOT]2.0.CO;2; HOFFMANN A, 2015, CLIMATE CHANGE RESPO, V2, P1, DOI DOI 10.1186/S40665-014-0009-X; HOFFMANN AA, 1995, TRENDS ECOL EVOL, V10, P1; Howard R, 2014, ENDANGER SPECIES RES, V26, P75, DOI 10.3354/esr00636; HU ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huth TJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-805; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIMATE CHANGE 2013; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Joe MK, 2014, J BIOL CHEM, V289, P10155, DOI 10.1074/jbc.M113.547091; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679                                                          ; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; kerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545; Kesaraju S, 2009, J NEUROCHEM, V109, P1413, DOI 10.1111/j.1471-4159.2009.06068.x; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x                                              ; Krasnov A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krone PH, 1997, BIOCHEM CELL BIOL, V75, P487, DOI 10.1139/bcb-75-5-487; Kuparinen A, 2010, FOREST ECOL MANAG, V259, P1003, DOI 10.1016/j.foreco.2009.12.006; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leder EH, 2015, MOL BIOL EVOL, V32, P674, DOI 10.1093/molbev/msu328; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li XL, 2012, J ZHEJIANG UNIV-SC B, V13, P465, DOI 10.1631/jzus.B1100309; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Mardia K. V., 1979, MULTIVARIATE ANAL; Miller J.D., 1985, Biology of Reptilia, V14, P269; Miller Jeffrey D., 1997, P51; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637                                                         ; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317                                                           ; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427                                                           ; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; Newton JR, 2013, MAR GENOM, V11, P45, DOI 10.1016/j.margen.2013.07.002; Packard GC, 1988, BIOL REPTILIA, P523; Pechenik J.A., 1987, P551; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Pike DA, 2014, GLOBAL CHANGE BIOL, V20, P7, DOI 10.1111/gcb.12397; Porcelli D, 2015, HEREDITY, V114, P502, DOI 10.1038/hdy.2014.119; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Quiros L, 2007, CHEMOSPHERE, V67, P1144, DOI 10.1016/j.chemosphere.2006.11.032; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552                                                          ; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rice RH, 2013, J PROTEOME RES, V12, P771, DOI 10.1021/pr301036k; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Sakatani M, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-3; Schoville SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-170; Sekine Y, 2012, MOL CELL, V48, P692, DOI 10.1016/j.molcel.2012.09.018; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654                                                            ; Shine R, 2002, ECOLOGY, V83, P2808, DOI 10.1890/0012-9658(2002)083[2808:SLIHEO]2.0.CO;2; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stubbs J.L., 2014, CLIM CHANGE RESPONSE, V1, P1; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Tedeschi JN, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2320; Tedeschi JN, 2014, AUST J ZOOL, V62, P454, DOI 10.1071/ZO14076; Tedeschi JN, 2015, J THERM BIOL, V47, P42, DOI 10.1016/j.jtherbio.2014.11.006; Telemeco RS, 2013, AM NAT, V181, P637, DOI 10.1086/670051; Theissinger K, 2016, MAR GENOM, V28, P7, DOI 10.1016/j.margen.2016.02.006; Trocini S, 2013, THESIS; Tzika AC, 2015, GENOME BIOL EVOL, V7, P1827, DOI 10.1093/gbe/evv106; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; Ungerer MC, 2008, HEREDITY, V100, P178, DOI 10.1038/sj.hdy.6800992; Valenzuela N, 2004, REPTILIAN INCUBATION; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1365-2486.2004.00817.x; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; Whiting AU, 2008, AUST J ZOOL, V56, P297, DOI 10.1071/ZO08038; Woolgar L, 2013, J EXP MAR BIOL ECOL, V449, P77, DOI 10.1016/j.jembe.2013.09.001; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang J, 2005, I C WIREL COMM NETW, P15; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	139	1	1	25	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	JUN	2017	26	11					2978	2992		10.1111/mec.14087				15	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	EV8OB	WOS:000402040000012	28267875				2018-01-05	
J	Shine, R				Shine, Richard			NEW WEAPONS IN THE TOAD TOOLKIT	QUARTERLY REVIEW OF BIOLOGY			English	Review						Bufo marinus; conditioned taste aversion; containment; genome engineering; mitigation; suppression	INVASIVE CANE TOADS; FRESH-WATER CROCODILES; BUFO-MARINUS; RHINELLA-MARINA; TROPICAL AUSTRALIA; TOXIC INVADER; ENVIRONMENTAL DNA; ARID AUSTRALIA; TASTE-AVERSION; NATIVE FROGS	Our best hope of developing innovative methods to combat invasive species is likely to come from the study of high-profile invaders that have attracted intensive research not only into control, but also basic biology. Here we illustrate that point by reviewing current thinking about novel ways to control one of the world's most well-studied invasions: that of the cane toad in Australia. Recently developed methods for population suppression include more effective traps based on the toad's acoustic and pheromonal biology. New tools for containing spread include surveillance technologies (e.g., eDNA sampling and automated call detectors), as well as landscape-level barriers that exploit the toad's vulnerability to desiccation-a strategy that could be significantly enhanced through the introduction of sedentary, rangecore genotypes ahead of the invasion front. New methods to reduce the ecological impacts of toads include conditioned taste aversion in free-ranging predators, gene banking, and targeted gene flow. Lastly, recent advances in gene editing and gene drive technology hold the promise of modifying toad phenotypes in ways that may facilitate control or buffer impact. Synergies between these approaches hold great promise for novel and more effective means to combat the toad invasion and its consequent impacts on biodiversity.	[Shine, Richard] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	Shine, R (reprint author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au					Alford RA, 1999, TADPOLES, P240; Alford R. A., 1995, WETLAND RES WET DRY, P172; Alford RA, 2009, WILDLIFE RES, V36, P23, DOI 10.1071/WR08021; Barton DP, 1997, AUST J ECOL, V22, P316, DOI 10.1111/j.1442-9993.1997.tb00677.x; Beckmann C, 2011, BIOL INVASIONS, V13, P1447, DOI 10.1007/s10530-010-9903-8; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425                                                                 ; Brown GP, 2016, BIOL INVASIONS, V18, P103, DOI 10.1007/s10530-015-0993-1; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Brown GP, 2011, ECOLOGY, V92, P422, DOI 10.1890/10-0536.1; Cabrera-Guzman E, 2015, HERPETOL MONOGR, V29, P28, DOI 10.1655/HERPMONOGRAPHS-D-13-00007                                               ; Cabrera-Guzman E, 2015, J PEST SCI, V88, P143, DOI 10.1007/s10340-014-0586-2; Cabrera-Guzman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079496; Cabrera-Guzman E, 2013, FRESHWATER BIOL, V58, P2584, DOI 10.1111/fwb.12235; Cabrera-Guzman E, 2013, AUSTRAL ECOL, V38, P896, DOI 10.1111/aec.12029; Cabrera-Guzman E, 2012, BIOL CONSERV, V153, P1, DOI 10.1016/j.biocon.2012.04.012; Cabrera-Guzman E, 2011, J APPL ECOL, V48, P462, DOI 10.1111/j.1365-2664.2010.01933.x; Child T, 2008, AUSTRAL ECOL, V33, P630, DOI 10.1111/j.1442-9993.2007.01829.x; Child T, 2008, J EXP ZOOL PART A, V309A, P215, DOI 10.1002/jez.450; Clarke GS, 2016, ECOL APPL, V26, P463, DOI 10.1890/14-2365; Clarke GS, 2015, J APPL ECOL, V52, P1547, DOI 10.1111/1365-2664.12528; Clulow J, 2016, REPROD FERT DEVELOP, V28, P1116, DOI 10.1071/RD15466; Clulow J, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-60; Commonwealth of Australia, 2011, THREAT AB PLAN BIOL; Crossland MR, 2012, P ROY SOC B-BIOL SCI, V279, P3436, DOI 10.1098/rspb.2012.0821; Davis JL, 2015, INT J PEST MANAGE, V61, P305, DOI 10.1080/09670874.2015.1058991; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; DELVINQUIER BLJ, 1988, AUST J ZOOL, V36, P301, DOI 10.1071/ZO9880301; Di Giallonardo F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004865; Doody JS, 2009, ANIM CONSERV, V12, P46, DOI 10.1111/j.1469-1795.2008.00219.x; Doody JS, 2015, ECOLOGY, V96, P2544, DOI 10.1890/14-1332.1; Doody JS, 2014, BIOL INVASIONS, V16, P2303, DOI 10.1007/s10530-014-0665-6; Doody JS, 2013, BIOL INVASIONS, V15, P559, DOI 10.1007/s10530-012-0308-8; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Estoup A, 2004, EVOLUTION, V58, P2021; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Florance D, 2011, P ROY SOC B-BIOL SCI, V278, P2900, DOI 10.1098/rspb.2011.0032; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Freeland W. J., 1994, P171; FREELAND WJ, 1986, AUST WILDLIFE RES, V13, P321; FREELAND WJ, 1986, AUST WILDLIFE RES, V13, P489; Fukuda Y, 2016, ANIM CONSERV, V19, P75, DOI 10.1111/acv.12218; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824                                                    ; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gonzalez-Bernal E, 2016, POPUL ECOL, V58, P293, DOI 10.1007/s10144-016-0539-0; Gonzalez-Bernal E, 2015, AUSTRAL ECOL, V40, P953, DOI 10.1111/aec.12279; Grigg G., 2006, SCI CANE TOAD INVASI, P47; Hagman M, 2006, AUSTRAL ECOL, V31, P551, DOI 10.1111/j.1442-9993.2006.01627.x; Howard JG, 2016, ANIM CONSERV, V19, P102, DOI 10.1111/acv.12229; Hu W, 2009, ACM T SENSOR NETWORK, V5, DOI 10.1145/1464420.1464424; Hyatt A., 2008, DEV CANE TOAD BIOL C; Hyatt A. D., 1998, IDENTIFICATION CHARA; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Jessop TS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1444; Jolly CJ, 2015, ECOL EVOL, V5, P3879, DOI 10.1002/ece3.1657; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kelehear C, 2012, CONSERV LETT, V5, P360, DOI 10.1111/j.1755-263X.2012.00251.x; Kelehear C, 2011, OECOLOGIA, V165, P585, DOI 10.1007/s00442-010-1836-5; Kelly E, 2016, CONSERV BIOL, V30, P259, DOI 10.1111/cobi.12623; Koopman P., 2006, SCI CANE TOAD INVASI, P111; Kraus F, 2015, ANNU REV ECOL EVOL S, V46, P75, DOI 10.1146/annurev-ecolsys-112414-054450; Lawson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060760; Letnic M, 2008, BIOL CONSERV, V141, P1773, DOI 10.1016/j.biocon.2008.04.031; Letnic M, 2015, J APPL ECOL, V52, P341, DOI 10.1111/1365-2664.12390; Letnic M, 2014, J APPL ECOL, V51, P795, DOI 10.1111/1365-2664.12232; Lever C., 2001, CANE TOAD HIST ECOLO; Linzey DW, 2003, INT J ENVIRON HEAL R, V13, P125, DOI 10.1080/0960312031000098053; Llewelyn J, 2014, AUSTRAL ECOL, V39, P190, DOI 10.1111/aec.12058; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Molloy K., 2006, SCI CANE TOAD INVASI, P134; Massam M, 2011, CANE TOAD BUFO MARIN; McCallum H, 2006, SCI CANE TOAD INVASI, P123; Measey GJ, 2016, DIVERS DISTRIB, V22, P970, DOI 10.1111/ddi.12462; O'Donnell S, 2010, J APPL ECOL, V47, P558, DOI 10.1111/j.1365-2664.2010.01802.x; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Pallister J., 2008, 14 AUSTR VERT PEST C, P131; Pallister JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014576; Peacock D., 2006, SCI CANE TOAD INVASI, P98; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Phillips BL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3037; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Phillips BL, 2003, CONSERV BIOL, V17, P1738, DOI 10.1111/j.1523-1739.2003.00353.x; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Pizzatto L, 2012, ANIM CONSERV, V15, P545, DOI 10.1111/j.1469-1795.2012.00564.x; Pizzatto L, 2008, BEHAV ECOL, V19, P990, DOI 10.1093/beheco/arn060; Pizzatto L, 2011, INT J PARASITOL, V41, P943, DOI 10.1016/j.ijpara.2011.03.013; Pizzatto L, 2010, J WILDLIFE DIS, V46, P1152, DOI 10.7589/0090-3558-46.4.1152                                                     ; Price-Rees SJ, 2013, ANIM CONSERV, V16, P386, DOI 10.1111/acv.12004; Price-Rees SJ, 2011, ETHOLOGY, V117, P749, DOI 10.1111/j.1439-0310.2011.01935.x; Rees HC, 2014, ECOL EVOL, V4, P4023, DOI 10.1002/ece3.1272; Reidinger R.F., 2013, WILDLIFE DAMAGE MANA; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Robinson T., 2006, SCI CANE TOAD INVASI, P86; Rollins LA, 2015, MOL ECOL, V24, P2264, DOI 10.1111/mec.13184; Saunders G, 2010, BIOL CONTROL, V52, P288, DOI 10.1016/j.biocontrol.2009.06.014; Schwarzkopf L, 2007, WILDLIFE RES, V34, P366, DOI 10.1071/WR06173; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Schwarzkopf L, 2002, OIKOS, V96, P492, DOI 10.1034/j.1600-0706.2002.960311.x; Semeniuk M, 2007, WILDLIFE RES, V34, P59, DOI 10.1071/WR06112; Shanmuganathan T, 2010, ANIM CONSERV, V13, P16, DOI 10.1111/j.1469-1795.2009.00319.x; Shannon M. F., 2008, REV CSIRO BIOL CONTR; Shigeta M, 2016, GENES CELLS, V21, P755, DOI 10.1111/gtc.12379; SHINE R, 2011, PAC CONSERV BIOL, V17, P6; Shine R., 2015, BIOL OPEN, DOI [10.1242/bio.012179, DOI 10.1242/BI0.012179]; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D, 2012, BIOCONTROL, V57, P263, DOI 10.1007/s10526-011-9392-4; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Smith MA, 2005, ECOGRAPHY, V28, P110; Somaweera R, 2012, ANIM CONSERV, V15, P152, DOI 10.1111/j.1469-1795.2011.00500.x; Somaweera R, 2011, BEHAVIOUR, V148, P501, DOI 10.1163/000579511X565763; Somaweera R, 2010, BIOL CONSERV, V143, P1477, DOI 10.1016/j.biocon.2010.03.027; Southwell D, 2017, J APPL ECOL, V54, P216, DOI 10.1111/1365-2664.12744; Speare R, 1997, J WILDLIFE DIS, V33, P105, DOI 10.7589/0090-3558-33.1.105                                                      ; Speare R., 1990, WILDLIFE RES, V17, P387; Taylor A, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P1564; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thresher R. E., 2006, SCI CANE TOAD INVASI, P117; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Tingley R, 2013, J APPL ECOL, V50, P129, DOI 10.1111/1365-2664.12021; Tingley R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025979; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Towsey M, 2012, BIOACOUSTICS, V21, P107, DOI 10.1080/09524622.2011.648753; Trumbo DR, 2016, MOL ECOL, V25, P4161, DOI 10.1111/mec.13754; Turvey N, 2013, ANIM PUB, P1; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; Ward-Fear G, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0863; Ward-Fear G, 2010, BIOL J LINN SOC, V99, P738, DOI 10.1111/j.1095-8312.2010.01395.x; Ward-Fear G, 2010, J APPL ECOL, V47, P273, DOI 10.1111/j.1365-2664.2010.01773.x; Ward-Fear G, 2009, FUNCT ECOL, V23, P559, DOI 10.1111/j.1365-2435.2009.01556.x; Webb JK, 2008, AUSTRAL ECOL, V33, P821, DOI 10.1111/j.1442-9993.2008.01847.x; Webb JK, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1014; Webb JK, 2011, WILDLIFE RES, V38, P726, DOI 10.1071/WR10206; Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112; White AW, 2009, ANIM CONSERV, V12, P38, DOI 10.1111/j.1469-1795.2008.00218.x; White Arthur W., 2007, P16; Wingate DB, 2011, BIOL INVASIONS, V13, P1487, DOI 10.1007/s10530-010-9925-2; Yasumiba K, 2015, ANIM BEHAV, V109, P141, DOI 10.1016/j.anbehav.2015.08.015; Yeager A, 2014, J PEST SCI, V87, P323, DOI 10.1007/s10340-014-0555-9; Zug G. R., 1979, SMITHSON CONTRIB ZOO, V284, P1, DOI [10.1371/journal.pone.0100176, DOI 10.5479/SI.00810282.284]	148	0	0	69	69	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0033-5770	1539-7718		Q REV BIOL	Q. Rev. Biol.	JUN	2017	92	2					125	149						25	Biology	Life Sciences & Biomedicine - Other Topics	EU6QL	WOS:000401158400001					2018-01-05	
J	Hryhorowicz, M; Lipianki, D; Zeyland, J; Slomski, R				Hryhorowicz, Magdalena; Lipianki, Daniel; Zeyland, Joanna; Slomski, Ryszard			CRISPR/Cas9 Immune System as a Tool for Genome Engineering	ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS			English	Review						CRISPR/Cas9; Genome editing; Off-target effect; Guide RNA	PLURIPOTENT STEM-CELLS; PROVIDES ACQUIRED-RESISTANCE; MUSCULAR-DYSTROPHY; ESCHERICHIA-COLI; CAS9 NUCLEASES; GENE; RNA; DNA; CRISPR-CAS9; SPECIFICITY	CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated) adaptive immune systems constitute a bacterial defence against invading nucleic acids derived from bacteriophages or plasmids. This prokaryotic system was adapted in molecular biology and became one of the most powerful and versatile platforms for genome engineering. CRISPR/Cas9 is a simple and rapid tool which enables the efficient modification of endogenous genes in various species and cell types. Moreover, a modified version of the CRISPR/Cas9 system with transcriptional repressors or activators allows robust transcription repression or activation of target genes. The simplicity of CRISPR/Cas9 has resulted in the widespread use of this technology in many fields, including basic research, biotechnology and biomedicine.	[Hryhorowicz, Magdalena; Lipianki, Daniel; Zeyland, Joanna; Slomski, Ryszard] Poznan Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland; [Slomski, Ryszard] Polish Acad Sci, Inst Human Genet, Poznan, Poland	Hryhorowicz, M (reprint author), Poznan Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland.	magdalena.hryhorowicz@gmail.com			National Centre for Research and Development [INNOMED/I/17/NCBR/2014]	This work was supported by The National Centre for Research and Development (Grant No. INNOMED/I/17/NCBR/2014) in the framework of the "INNOMED'' programme titled "Development of an innovative technology using transgenic porcine tissues for biomedical purposes''. Acronym: "MEDPIG''.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; BERG P, 1974, SCIENCE, V185, P303, DOI 10.1126/science.185.4148.303; Charpentier E, 2014, CURR OPIN MICROBIOL, V19, P114, DOI 10.1016/j.mib.2014.07.001; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c                                                             ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Forde A, 1999, ANTON LEEUW INT J G, V76, P89, DOI 10.1023/A:1002027321171                                                         ; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Harms DW, 2014, CURR PROTOC HUM GENE, V83; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2	61	2	2	17	31	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0004-069X	1661-4917		ARCH IMMUNOL THER EX	Arch. Immunol. Ther. Exp.	JUN	2017	65	3					233	240		10.1007/s00005-016-0427-5				8	Immunology	Immunology	EV2ZS	WOS:000401627000004	27699445	gold			2018-01-05	
J	Missiroli, S; Danese, A; Iannitti, T; Patergnani, S; Perrone, M; Previati, M; Giorgi, C; Pinton, P				Missiroli, Sonia; Danese, Alberto; Iannitti, Tommaso; Patergnani, Simone; Perrone, Mariasole; Previati, Maurizio; Giorgi, Carlotta; Pinton, Paolo			Endoplasmic reticulum-mitochondria Ca2+ crosstalk in the control of the tumor cell fate	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article; Proceedings Paper	14th International Meeting of the European-Calcium-Society (ECS)	SEP 25-29, 2016	Valladolid, SPAIN	European Calcium Soc, NIH, BBA, Gobierno Espana, Ministerio Economia & Competitividad, Univ Valladolid, Diputac Valladolid, Ayuntamiento Valladolid, Co Biologists, Citospin, AECC, Nanion, Hamamatsu			INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; PHOSPHOLIPID-SYNTHESIS; MOLECULAR-MECHANISMS; REGULATES APOPTOSIS; CALCIUM-RELEASE; MEMBRANES MAM; CANCER-CELLS; MITOFUSIN 2; ER; PROTEIN	Mitochondria-associated membranes are juxtaposed between the endoplasmic reticulum and mitochondria and have been identified as a critical hub in the regulation of apoptosis and tumor growth. One Key function of mitochondria-associated membranes is to provide asylum to a number of proteins with tumor suppressor and oncogenic properties. In this review, we discuss how Ca2+ flux manipulation represents the primary mechanism underlying the action of several oncogenes and tumor-suppressor genes and how these networks might be manipulated to provide novel therapies for cancer. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. (C) 2017 Elsevier B.V. All rights reserved.	[Missiroli, Sonia; Danese, Alberto; Patergnani, Simone; Perrone, Mariasole; Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, Lab Technol Adv Therapies LTTA, Ferrara, Italy; [Iannitti, Tommaso] KWS BioTest, Marine View Off Pk, Portishead BS20 7AW, Somerset, England; [Previati, Maurizio] Univ Ferrara, Lab Technol Adv Therapies LTTA, Sect Human Anat & Histol, Dept Morphol Surg & Expt Med, Ferrara, Italy	Pinton, P (reprint author), Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, Lab Technol Adv Therapies LTTA, Ferrara, Italy.	paolo.pinton@unife.it		Previati, Maurizio/0000-0002-2912-4029	Telethon [GGP15219/B]; Italian Association for Cancer Research (AIRC) [IG-18624]; Italian Cystic Fibrosis Research Foundation [19/2014]; Italian Ministry of Education, University and Research (COFIN) [20129JLHSY_002]; Italian Ministry of Education, University and Research (FIRB) [RBAP11FXBC_002]; Italian Ministry of Education, University and Research (Futuro in Ricerca) [RBFR10EGVP_001]; University of Ferrara; Italian Ministry of Health [RF-2011-02349806, GR-2013-02356747]; AIRC [MFAG-13521]; Cariplo [2014-1075]; FISM-Fondazione Italiana Sclerosi Multipla [2014/B/3]	P.P. is grateful to Camilla degli Scrovegni for continuous support. P.P. is supported by: Telethon (GGP15219/B), the Italian Association for Cancer Research (AIRC) (IG-18624), the Italian Cystic Fibrosis Research Foundation (19/2014), the Italian Ministry of Education, University and Research (COFIN no. 20129JLHSY_002, FIRB no. RBAP11FXBC_002, and Futuro in Ricerca no. RBFR10EGVP_001), local funds from the University of Ferrara and the Italian Ministry of Health (RF-2011-02349806). C.G is supported by AIRC (MFAG-13521), the Italian Ministry of Health (GR-2013-02356747), Cariplo (2014-1075) and local funds from the University of Ferrara. S.P. is supported by a research fellowship FISM-Fondazione Italiana Sclerosi Multipla-cod. 2014/B/3.	Akl H, 2014, BBA-MOL CELL RES, V1843, P2240, DOI 10.1016/j.bbamcr.2014.04.017; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Aufschnaiter A., 2016, CELL TISSUE RES; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Bittremieux M, 2016, BBA-MOL CELL RES, V1863, P1364, DOI 10.1016/j.bbamcr.2016.01.002; Bononi A, 2013, CELL DEATH DIFFER, V20, P1631, DOI 10.1038/cdd.2013.77; Bonora M, 2014, CELL DEATH DIFFER, V21, P1198, DOI 10.1038/cdd.2014.35; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Booth DM, 2016, MOL CELL, V63, P240, DOI 10.1016/j.molcel.2016.05.040; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bultynck G, 2016, TRENDS BIOCHEM SCI, V41, P390, DOI 10.1016/j.tibs.2016.03.006; Cardenas C, 2016, CELL REP, V14, P2313, DOI 10.1016/j.celrep.2016.02.030; Crottes D, 2016, CANCER RES, V76, P607, DOI 10.1158/0008-5472.CAN-15-1465; Csordas G, 2012, MOL CELL ENDOCRINOL, V353, P109, DOI 10.1016/j.mce.2011.11.011; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016                                                           ; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; Doghman-Bouguerra M., 2016, EMBO REP; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Eno CO, 2012, MOL BIOL CELL, V23, P2605, DOI 10.1091/mbc.E12-02-0090; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Fujimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P635, DOI 10.1016/j.bbrc.2011.12.022; Giorgi C, 2015, ANTIOXID REDOX SIGN, V22, P995, DOI 10.1089/ars.2014.6223; Giorgi C, 2015, ONCOTARGET, V6, P1435, DOI 10.18632/oncotarget.2935                                                        ; Giorgi C, 2015, P NATL ACAD SCI USA, V112, P1779, DOI 10.1073/pnas.1410723112; Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Gutierrez T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00291; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hedgepeth SC, 2015, J BIOL CHEM, V290, P7304, DOI 10.1074/jbc.M114.611186; Huang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.419; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Krols M, 2016, J CELL BIOL, V214, P367, DOI 10.1083/jcb.201607124; Krols M, 2016, ACTA NEUROPATHOL, V131, P505, DOI 10.1007/s00401-015-1528-7; Lebiedzinska M, 2010, BBA-BIOENERGETICS, V1797, P952, DOI 10.1016/j.bbabio.2010.03.005; Lovy A, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1185563; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45; Marchi S., 2012, J SIGNAL TRANSDUCT, V2012, P2012, DOI DOI 10.1155/2012/329635; Marchi S, 2016, CURR OPIN PHARMACOL, V29, P1, DOI 10.1016/j.coph.2016.03.002; Marchi S, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.956469; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Marriott KSC, 2012, J PHARMACOL EXP THER, V343, P578, DOI 10.1124/jpet.112.198168; Meunier J, 2010, J PHARMACOL EXP THER, V332, P388, DOI 10.1124/jpet.109.160960; Missiroli S., 2016, CELL REP; Monaco G, 2015, J BIOL CHEM, V290, P9150, DOI 10.1074/jbc.M114.622514; Morciano G, 2016, MOL BIOL CELL, V27, P20, DOI 10.1091/mbc.E15-01-0028; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Naghdi S, 2016, BBA-MOL CELL RES, V1863, P2503, DOI 10.1016/j.bbamcr.2016.04.020; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Patergnani S, 2015, ONCOTARGET, V6, P23427, DOI 10.18632/oncotarget.4370; Patergnani S, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00173; Pierro C, 2014, J CELL SCI, V127, P1607, DOI 10.1242/jcs.141408; Poston CN, 2013, J PROTEOMICS, V79, P219, DOI 10.1016/j.jprot.2012.12.018; Raturi A, 2016, J CELL BIOL, V214, P433, DOI 10.1083/jcb.201512077; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Rimessi A, 2014, ONCOGENE, V33, P2329, DOI 10.1038/onc.2013.192; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sala-Vila A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27351; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; van Vliet AR, 2016, BIOL CHEM, V397, P649, DOI 10.1515/hsz-2016-0108; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200; Zhang A., 2011, MOL CELL PROTEOMICS, V10; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	78	4	4	2	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	JUN	2017	1864	6			SI		858	864		10.1016/j.bbamcr.2016.12.024				7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV3TQ	WOS:000401682400006	28064002				2018-01-05	
J	Krebs, J				Krebs, Joachim			Implications of the thyroid hormone on neuronal development with special emphasis on the calmodulin-kinase IV pathway	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article; Proceedings Paper	14th International Meeting of the European-Calcium-Society (ECS)	SEP 25-29, 2016	Valladolid, SPAIN	European Calcium Soc, NIH, BBA, Gobierno Espana, Ministerio Economia & Competitividad, Univ Valladolid, Diputac Valladolid, Ayuntamiento Valladolid, Co Biologists, Citospin, AECC, Nanion, Hamamatsu		Thyroid hormone; CaMKIV; PMCA1a; Alternative splicing; Neuronal development	DEPENDENT PROTEIN-KINASE; MEMBRANE CALCIUM-PUMP; RAT-BRAIN; GENE-EXPRESSION; CREB PHOSPHORYLATION; SYNAPTIC PLASTICITY; SIGNALING COMPLEX; RESPONSE ELEMENT; BINDING PROTEIN; PHOSPHATASE 2A	Thyroid hormones influence brain development through regulation of gene expression. This is especially true for Ca2+-dependent regulation since a major pathway is controlled by the Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) which in turn is induced by the thyroid hormone T-3. In addition, CaMKIV is involved in regulation of alternative splicing of a number of protein isoforms, among them PMCAla, the neuronal specific isoform of the plasma membrane calcium pump. On the other hand, hypothyroidism or CaMKIV deficiency can have a severe influence on brain development. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. (C) 2016 Elsevier B.V. All rights reserved.	[Krebs, Joachim] MPI Biophys Chem, NMR Based Struct Biol, Gottingen, Germany	Krebs, J (reprint author), MPI Biophys Chem, NMR Based Struct Biol, Gottingen, Germany.						Altman J., 1982, EXP BRAIN RES, V16, P8; Anderson GW, 2008, CEREBELLUM, V7, P60, DOI 10.1007/s12311-008-0021-4; Anderson GW, 2003, THYROID, V13, P1039, DOI 10.1089/105072503770867219                                                      ; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Auso E, 2004, ENDOCRINOLOGY, V145, P4037, DOI 10.1210/en.2004-0274; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; BALAZS R, 1971, BRAIN RES, V25, P555, DOI 10.1016/0006-8993(71)90460-4; Bernal J., 2015, THYROID HORMONES BRA, P2000; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BRANDT P, 1992, J NEUROCHEM, V59, P1566, DOI 10.1111/j.1471-4159.1992.tb08476.x                                              ; Brini M, 2013, FEBS J, V280, P5385, DOI 10.1111/febs.12193; Buetfering C, 2014, NAT NEUROSCI, V17, P710, DOI 10.1038/nn.3696; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; Chow FA, 2007, N COMP BIOC, V41, P345; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0                                                                ; Cohen SM, 2016, NEURON, V90, P292, DOI 10.1016/j.neuron.2016.03.001; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25; DEESCOBAR GM, 1990, ENDOCRINOLOGY, V126, P2765, DOI 10.1210/endo-126-5-2765                                                         ; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890                                                         ; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4                                                   ; Ensten H., 1994, J BIOL CHEM, V269, P15520; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Fukushima H, 2008, J NEUROSCI, V28, P9910, DOI 10.1523/JNEUROSCI.2625-08.2008; Gong JA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-50; Guerini D, 1999, J BIOL CHEM, V274, P1667, DOI 10.1074/jbc.274.3.1667; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; HILFIKER H, 1993, J BIOL CHEM, V268, P19717; Ho N, 2000, J NEUROSCI, V20, P6459; HONEGGER P, 1979, NATURE, V282, P305, DOI 10.1038/282305a0; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; JAMES P, 1988, J BIOL CHEM, V263, P2905; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kenyon KA, 2010, J COMP NEUROL, V518, P3169, DOI 10.1002/cne.22409; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kip SN, 2006, HIPPOCAMPUS, V16, P20, DOI 10.1002/hipo.20129                                                              ; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; Krebs J, 1996, J BIOL CHEM, V271, P11055, DOI 10.1074/jbc.271.19.11055                                                        ; Krebs J, 1998, BBA-MOL CELL RES, V1448, P183, DOI 10.1016/S0167-4889(98)00142-6                                                   ; Krebs J, 2015, BBA-MOL CELL RES, V1853, P2018, DOI 10.1016/j.bbamcr.2014.12.020; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Krebs J, 2009, BBA-MOL CELL RES, V1793, P979, DOI 10.1016/j.bbamcr.2008.12.006; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; LEGRAND J, 1979, TRENDS NEUROSCI, V2, P234, DOI 10.1016/0166-2236(79)90091-2                                                    ; Liu GD, 2012, J BIOL CHEM, V287, P22709, DOI 10.1074/jbc.M112.357343; Liu YY, 2002, MOL ENDOCRINOL, V16, P2439, DOI 10.1210/me.2001-0324; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107                                                           ; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960                                                           ; Min H, 2016, MOL NEUROBIOL, V53, P1613, DOI 10.1007/s12035-015-9101-x; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Morte B, 2010, ENDOCRINOLOGY, V151, P810, DOI 10.1210/en.2009-0958; Naz H, 2016, PROG BIOPHYS MOL BIO, V121, P54, DOI 10.1016/j.pbiomolbio.2015.12.016; Nimura T, 2010, J BIOCHEM, V147, P857, DOI 10.1093/jb/mvq021; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Razanau A, 2013, CELL MOL LIFE SCI, V70, P4527, DOI 10.1007/s00018-013-1390-5; Ribar TJ, 2000, J NEUROSCI, V20, part. no.; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Seibert M.A., 1995, J BIOL CHEM, V270, P17616; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483                                                         ; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.069408; SHULL GE, 1988, J BIOL CHEM, V263, P8646; SIKELA JM, 1989, GENOMICS, V4, P21, DOI 10.1016/0888-7543(89)90309-1                                                    ; STAUFFER TP, 1993, J BIOL CHEM, V268, P25993; Strehler EE, 2001, PHYSIOL REV, V81, P21; STREHLER EE, 1989, P NATL ACAD SCI USA, V86, P6908, DOI 10.1073/pnas.86.18.6908; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; VERMA AK, 1988, J BIOL CHEM, V263, P14152; Viguerie N, 2003, CURR OPIN CLIN NUTR, V6, P377, DOI 10.1097/01.mco.0000078998.96795.e7; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn855; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200; Zhang YY, 2015, MOL NEUROBIOL, V52, P432, DOI 10.1007/s12035-014-8855-x	78	0	0	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	JUN	2017	1864	6			SI		877	882		10.1016/j.bbamcr.2016.12.004				6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV3TQ	WOS:000401682400008	27939430				2018-01-05	
J	Roy, S; Dey, K; Hershfinkel, M; Ohana, E; Sekler, I				Roy, Soumitra; Dey, Kuntal; Hershfinkel, Michal; Ohana, Ehud; Sekler, Israel			Identification of residues that control Li+ versus Na+ dependent Ca2+ exchange at the transport site of the mitochondrial NCLX	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						NCLX; Na+/Ca2+ exchange; Li+/Ca2+ exchange; Permeabilized cells; 3D modelling	SODIUM-CALCIUM EXCHANGER; NA+/CA2+ EXCHANGER; GENE FAMILY; SODIUM/CALCIUM EXCHANGER; PHYLOGENETIC ANALYSIS; STRUCTURE PREDICTION; NA+-CA2+ EXCHANGER; STRUCTURAL BASIS; ION-EXCHANGE; MECHANISM	Background: The Na+/Ca2+/Li+ exchanger (NCLX) is a member of the Na+/Ca2+ exchanger family. NCLX is unique in its capacity to transport both Na+ and Li+, unlike other members, which are Na+ selective. The major aim of this study was twofold, i.e., to identify NCLX residues that confer Li+ or Na+ selective Ca2+ transport and map their putative location on NCLX cation transport site. Method: We combined molecular modeling to map transport site of NCLX with euryarchaeal H+/Ca2+ exchanger, CAX_Af, and fluorescence analysis to monitor Li+ versus Na+ dependent mitochondrial Ca2+ efflux of transport site mutants of NCLX in permeabilized cells. Result: Mutation of Asn149, Pro152, Asp153, Gly176, Asn467, Ser468, Gly494 and Asn498 partially or strongly abolished mitochondria(Ca2+ exchange activity in intact cells. In permeabilized cells, N149A, P152A, D153A, N467Q S468T and G494S demonstrated normal Li+/Ca2+ exchange activity but a reduced Na+/Ca2+ exchange activity. On the other hand, D471A showed dramatically reduced Li+/Ca2+ exchange, but Na+/Ca2+ exchange activity was unaffected. Finally, simultaneous mutation of four putative Ca2+ binding residues was required to completely abolish both Na+/Ca2+ and Li+/Ca2+ exchange activities. Conclusions: We identified distinct Na+ and Li+ selective residues in the NCLX transport site. We propose that functional segregation in Li+ and Na+ sites reflects the functional properties of NCLX required for Ca2+ exchange under the unique membrane potential and ion gradient across the inner mitochondria' membrane. General significance: The results of this study provide functional insights into the unique Li+ and Na+ selectivity of the mitochondrial exchanger. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. (C) 2017 Elsevier B.V. All rights reserved.	[Roy, Soumitra; Dey, Kuntal; Hershfinkel, Michal; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel; [Ohana, Ehud] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	Sekler, I (reprint author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel.; Ohana, E (reprint author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel.	ohanaeh@bgu.ac.il; israel.sekler@gmail.com		Hershfinkel, Michal/0000-0003-1652-1989	Planning and Budgeting Committee, Israel [BA1007/7-1 SE 2372/1-1]; ISF-China [1210/2014]; ISF [271/16, 2164/16]	This work was supported by post-doctoral fellowship by Planning and Budgeting Committee, Israel to SR, DIP (BA1007/7-1 SE 2372/1-1) & ISF-China (1210/2014) grant to IS, and ISF grants 271/16 and 2164/16 to EO.	Altimimi HF, 2010, J BIOL CHEM, V285, P15245, DOI 10.1074/jbc.M109.090738; Blaustein MP, 1999, PHYSIOL REV, V79, P763; Bozidis P., 2007, CURR PROTOC CELL BIO; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cai XJ, 2004, J BIOL CHEM, V279, P5867, DOI 10.1074/jbc.M310908200; Di Tommaso Paolo, 2011, Nucleic Acids Res, V39, pW13, DOI 10.1093/nar/gkr245; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778                                                           ; Emery L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00001; Giladi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20753; Giladi M, 2016, FRONT PHYSIOL, V7, DOI [10.3389/fphys.2016.00030, 10.3359/fphys.7016.00030]; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kostic M, 2015, CELL REP, V13, P376, DOI 10.1016/j.celrep.2015.08.079; Liao J, 2016, NAT STRUCT MOL BIOL, V23, P590, DOI 10.1038/nsmb.3230; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Marinelli F, 2014, P NATL ACAD SCI USA, V111, pE5354, DOI 10.1073/pnas.1415751111; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385                                                        ; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Palty R, 2006, BIOCHEMISTRY-US, V45, P11856, DOI 10.1021/bi060633b; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Patty R., 2004, J BIOL CHEM, V279, P25234; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Refaeli B, 2016, BIOCHEMISTRY-US, V55, P1673, DOI 10.1021/acs.biochem.6b00119; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9                                                   ; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Waight AB, 2013, NATURE, V499, P107, DOI 10.1038/nature12233; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu MS, 2013, P NATL ACAD SCI USA, V110, P11367, DOI 10.1073/pnas.1302515110; Young AH, 2007, BRIT J PSYCHIAT, V191, P474, DOI 10.1192/bip.bp.107.043133	35	0	0	3	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	JUN	2017	1864	6			SI		997	1008		10.1016/j.bbamcr.2017.01.011				12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV3TQ	WOS:000401682400020	28130126				2018-01-05	
J	Chan, JD; Zhang, D; Liu, X; Zarowiecki, M; Berriman, M; Marchant, JS				Chan, John D.; Zhang, Dan; Liu, Xiaolong; Zarowiecki, Magdalena; Berriman, Matthew; Marchant, Jonathan S.			Utilizing the planarian voltage-gated ion channel transcriptome to resolve a role for a Ca2+ channel in neuromuscular function and regeneration	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Voltage-operated Ca2+ channels; Neuromuscular signaling; Regeneration; Transcriptome	PARASITE SCHISTOSOMA-MANSONI; MEDITERRANEA GENOME DATABASE; ANTERIOR-POSTERIOR POLARITY; SCHMIDTEA-MEDITERRANEA; HEAD-REGENERATION; GENE-EXPRESSION; STEM-CELLS; CALCIUM; PROGRAM; DIFFERENTIATION	The robust regenerative capacity of planarian flatworms depends on the orchestration of signaling events from early wounding responses through the stem cell enacted differentiative outcomes that restore appropriate tissue types. Acute signaling events in excitable cells play an important role in determining regenerative polarity, rationalized by the discovery that sub-epidermal muscle cells express critical patterning genes known to control regenerative outcomes. These data imply a dual conductive (neuromuscular signaling) and instructive (anterior-posterior patterning) role for Ca2+ signaling in planarian regeneration. Here, to facilitate study of acute signaling events in the excitable cell niche, we provide a de novo transcriptome assembly from the planarian Dugesia japonica allowing characterization of the diverse ionotropic portfolio of this model organism. We demonstrate the utility of this resource by proceeding to characterize the individual role of each of the planarian voltage-operated Ca2+ channels during regeneration, and demonstrate that knockdown of a specific voltage operated Ca2+ channel (CavlB) that impairs muscle function uniquely creates an environment permissive for anteriorization. Provision of the full transcriptomic dataset should facilitate further investigations of molecules within the planarian voltage-gated channel portfolio to explore the role of excitable cell physiology on regenerative outcomes. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. (C) 2016 Elsevier B.V. All rights reserved.	[Chan, John D.; Zhang, Dan; Liu, Xiaolong; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Zarowiecki, Magdalena; Berriman, Matthew] Wellcome Trust Sanger Inst, Parasite Genom Grp, Hinxton, England; [Marchant, Jonathan S.] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA	Marchant, JS (reprint author), Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA.	march029@umn.edu	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Marchant, Jonathan/0000-0001-6592-0877	NSF [MCB1615538]; Stem Cell Biology Training Grant [T32 GM113846]	Supported by the NSF (MCB1615538, JSM) and a Stem Cell Biology Training Grant (T32 GM113846, JDC). We thank the Parasite Genomics Group at the Wellcome Trust Sanger Institute for their assistance with sequencing samples.	Abnave P, 2014, CELL HOST MICROBE, V16, P338, DOI 10.1016/j.chom.2014.08.002; Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boulware MJ, 2008, CURR BIOL, V18, pR769, DOI 10.1016/j.cub.2008.07.018; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Cebria F, 2007, DEV GENES EVOL, V217, P733, DOI 10.1007/s00427-007-0188-6; Chan J. D., 2011, J VIS EXP; Chan J. D., 2016, INT J PARASITOL DRUG; Chan J. D., PLOS NEGL TROP DIS, V9; Chan JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003942; Chan JD, 2013, PARASITOL INT, V62, P619, DOI 10.1016/j.parint.2012.12.001; Cobbett P, 2003, COMP BIOCHEM PHYS A, V134, P593, DOI 10.1016/S1095-6433(02)00350-1                                                   ; Collins JJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003396; Cowles MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004746; Cowles M. W., DEVELOPMENT, V140; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Deng HS, 2015, NATURE, V528, P212, DOI 10.1038/nature16170; Durant F, 2016, REGENERATION, V3, P78, DOI 10.1002/reg2.54; Elliot S. A., 2012, WIRES DEV BIOL; FLICKINGER REED A., 1959, GROWTH, V23, P251; Forsthoefel DJ, 2009, CURR OPIN GENET DEV, V19, P412, DOI 10.1016/j.gde.2009.05.003; Greenberg Robert M, 2014, Curr Clin Microbiol Rep, V1, P51; Hamdan FF, 1999, J BIOL CHEM, V274, P21746, DOI 10.1074/jbc.274.31.21746; Hao BX, 2016, CELL CALCIUM, V59, P67, DOI 10.1016/j.ceca.2016.01.004; Hobert O., 2013, C ELEGANS RES COMMUN; Iglesias M, 2011, DEV BIOL, V358, P68, DOI 10.1016/j.ydbio.2011.07.013; KANATANI HARUO, 1958, JOUR FAC SCI TOKYO UNIV SECT IV ZOOL, V8, P253; Kao D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-797; Klassen TL, 2006, J NEUROPHYSIOL, V95, P3035, DOI 10.1152/jn.00858.2005; LANGE CS, 1978, DIFFERENTIATION, V11, P1, DOI 10.1111/j.1432-0436.1978.tb00965.x                                              ; Lei K., 2016, DEV CELL; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MARSH G, 1952, J CELL COMPAR PHYSL, V39, P191, DOI 10.1002/jcp.1030390203; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nishimura O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143525; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Nogi T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000464; Novozhilova E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000790; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Pang QX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151597; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Reddien PW, 2011, TRENDS GENET, V27, P277, DOI 10.1016/j.tig.2011.04.004; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Robb SMC, 2015, GENESIS, V53, P535, DOI 10.1002/dvg.22872; RODRIGUEZ LV, 1971, BIOL BULL-US, V140, P117, DOI 10.2307/1540031; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Rustia CP, 1925, J EXP ZOOL, V42, P111, DOI 10.1002/jez.1400420106                                                          ; Salvetti A, 2009, DEV BIOL, V328, P305, DOI 10.1016/j.ydbio.2009.01.029; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Sarnat Harvey B, 2002, Semin Pediatr Neurol, V9, P240, DOI 10.1053/spen.2002.32502; Shibata N, 2016, DEV CELL, V37, P226, DOI 10.1016/j.devcel.2016.04.009; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Teshirogi W., 1955, Bulletin Marine Biological Station of Asamushi, V7, P141; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wheeler T. J., 2009, P 9 WORKSH ALG BIOIN; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1052/[hysrev.00023.2005; Witchley JN, 2013, CELL REP, V4, P633, DOI 10.1016/j.celrep.2013.07.022; Wolstenholme AJ, 2011, INT J PARASITOL-DRUG, V1, P2, DOI 10.1016/j.ijpddr.2011.09.003; Wurtzel O, 2015, DEV CELL, V35, P632, DOI 10.1016/j.devcel.2015.11.004; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhang D, 2011, J NEUROSCI, V31, P15983, DOI 10.1523/JNEUROSCI.3029-11.2011	71	0	0	12	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	JUN	2017	1864	6			SI		1036	1045		10.1016/j.bbamcr.2016.10.010				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV3TQ	WOS:000401682400024	27771293				2018-01-05	
J	Alajbegovic, A; Turczynska, KM; Hien, TT; Cidad, P; Sward, K; Hellstrand, P; Della Corte, A; Forte, A; Albinsson, S				Alajbegovic, Azra; Turczynska, Karolina M.; Hien, Tran Thi; Cidad, Pilar; Sward, Karl; Hellstrand, Per; Della Corte, Alessandro; Forte, Amalia; Albinsson, Sebastian			Regulation of microRNA expression in vascular smooth muscle by MRTF-A and actin polymerization	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Vascular disease; Smooth muscle; Phenotype; Actin polymerization; MRTF-A; MicroRNA	SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; IN-VIVO; CONTRACTILE DIFFERENTIATION; POSTNATAL-DEVELOPMENT; TARGETED DELETION; ENRICHED MICRORNA	The dynamic properties of the actin cytoskeleton in smooth muscle cells play an important role in a number of cardiovascular disease states. The state of actin does not only mediate mechanical stability and contractile function but can also regulate gene expression via myocardin related transcription factors (MRTFs). These transcriptional co-activators regulate genes encoding contractile and cytoskeletal proteins in smooth muscle. Regulation of small non-coding microRNAs (miRNAs) by actin polymerization may mediate some of these effects. MiRNAs are short non-coding RNAs that modulate gene expression by post-transcriptional regulation of target messenger RNA. In this study we aimed to determine a profile of miRNAs that were 1) regulated by actin/MRTF-A, 2) associated with the contractile smooth muscle phenotype and 3) enriched in muscle cells. This analysis was performed using cardiovascular disease-focused miRNA arrays in both mouse and human cells. The potential clinical importance of actin polymerization in aortic aneurysm was evaluated using biopsies from mildly dilated human thoracic aorta in patients with stenotic tricuspid or bicuspid aortic valve. By integrating information from multiple qPCR based miRNA arrays we identified a group of five miRNAs (miR-1, miR-22, miR-143, miR-145 and miR-378a) that were sensitive to actin polymerization and MRTF-A overexpression in both mouse and human vascular smooth muscle. With the exception of miR-22, these miRNAs were also relatively enriched in striated and/or smooth muscle containing tissues. Actin polymerization was found to be dramatically reduced in the aorta from patients with mild aortic dilations. This was associated with a decrease in actin/MRTF-regulated miRNAs. In conclusion, the transcriptional co-activator MRTF-A and actin polymeriiation regulated a subset of miRNAs in vascular smooth muscle. Identification of novel miRNAs regulated by actin/MRTF-A may provide further insight into the mechanisms underlying vascular disease states, such as aortic aneurysm, as well as novel ideas regarding therapeutic strategies. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. (C) 2016 Elsevier B.V. All rights reserved.	[Alajbegovic, Azra; Turczynska, Karolina M.; Hien, Tran Thi; Sward, Karl; Hellstrand, Per; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden; [Cidad, Pilar] Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain; [Cidad, Pilar] Univ Valladolid, IBGM, Valladolid, Spain; [Cidad, Pilar] CSIC, Valladolid, Spain; [Della Corte, Alessandro] Univ Naples 2, Dept Cardiothorac Sci, Naples, Italy; [Forte, Amalia] Univ Naples 2, Dept Expt Med, Naples, Italy	Albinsson, S (reprint author), Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden.	sebastian.albinsson@med.lu.se		Albinsson, Sebastian/0000-0001-6936-3967	Swedish Research Council [2012-2197]; Crafoord Foundation [20150629]; Swedish Heart and Lung Foundation [20150664]; Royal Physiographic Society; Per-Eric and Ulla Schyberg Foundation; Magnus Bergvall foundation; Spanish Instituto de Salud Carlos III [ISCIII-FEDER RD12/0042/0006]; MINECO [BFU2013-45867-R]; European Union FP7 Marie Curie Initial Training Network on Small Artery Remodeling (SmArt)	This work was supported by grants from the Swedish Research Council (2012-2197), the Crafoord Foundation (20150629), the Swedish Heart and Lung Foundation (20150664), the Royal Physiographic Society, the Per-Eric and Ulla Schyberg Foundation, the Magnus Bergvall foundation, the Spanish Instituto de Salud Carlos III (ISCIII-FEDER RD12/0042/0006, Heracles Program) and MINECO (BFU2013-45867-R). K.M.T. was supported by the European Union FP7 Marie Curie Initial Training Network on Small Artery Remodeling (SmArt).	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Bhattachariya A., 2015, ACTA PHYSL; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dahan D, 2014, AM J PHYSIOL-CELL PH, V307, pC1093, DOI 10.1152/ajpcell.00250.2014; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Elia L, 2009, CELL DEATH DIFFER; Femandez-Tenorio M., 2011, CIRC RES, V108, P1348; Forte A, 2013, CLIN SCI, V124, P97, DOI 10.1042/CS20120324; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Hien T. Thi, 2015, J BIOL CHEM; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Imamura M, 2013, J CELL PHYSIOL, V228, P1819, DOI 10.1002/jcp.24333; Jiang Y., 2010, J CELL PHYSL; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Liao XB, 2013, ENDOCRINOLOGY, V154, P3344, DOI 10.1210/en.2012-2236; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Lovren F, 2012, CIRCULATION, V126, pS81, DOI 10.1161/CIRCULATIONAHA.111.084186; Lu H., 2016, J BIOL CHEM; Lu H, 2015, P NATL ACAD SCI USA, V112, pE4168, DOI 10.1073/pnas.1507587112; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200                                                          ; Malloy LE, 2012, J BIOL CHEM, V287, P28398, DOI 10.1074/jbc.M112.371914; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Minami T, 2012, EMBO J, V31, P4428, DOI 10.1038/emboj.2012.296; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nagalingam RS, 2013, J BIOL CHEM, V288, P11216, DOI 10.1074/jbc.M112.442384; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Shen DX, 2011, CIRC RES, V109, P616, DOI 10.1161/CIRCRESAHA.110.239343; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Sward K., 2016, J PHYSL; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Turczynska KM, 2015, ARTERIOSCL THROM VAS, V35, P1489, DOI 10.1161/ATVBAHA.114.305065; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Urena J, 2012, TRENDS CARDIOVAS MED, V22, P155, DOI 10.1016/j.tcm.2012.07.013; van der Ree MH, 2014, ANTIVIR RES, V111, P53, DOI 10.1016/j.antiviral.2014.08.015; Vengrenyuk Y, 2015, ARTERIOSCL THROM VAS, V35, P535, DOI 10.1161/ATVBAHA.114.304029; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Weinl C, 2015, P NATL ACAD SCI USA, V112, P9914, DOI 10.1073/pnas.1509047112; Weinl C, 2013, J CLIN INVEST, V123, P2193, DOI 10.1172/JCI64201; Weise-Cross L, 2015, ARTERIOSCL THROM VAS, V35, P2374, DOI 10.1161/ATVBAHA.115.305879; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002; Zhao HQ, 2015, ARTERIOSCL THROM VAS, V35, P918, DOI 10.1161/ATVBAHA.114.305212; Zhao J., 2016, THROMB VASC BIOL; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	80	0	0	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	JUN	2017	1864	6			SI		1088	1098		10.1016/j.bbamcr.2016.12.005				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV3TQ	WOS:000401682400029	27939432				2018-01-05	
J	Urban, JA; Doherty, CA; Jordan, WT; Bliss, JE; Feng, J; Soruco, MM; Rieder, LE; Tsiarli, MA; Larschan, EN				Urban, Jennifer A.; Doherty, Caroline A.; Jordan, William T., III; Bliss, Jacob E.; Feng, Jessica; Soruco, Marcela M.; Rieder, Leila E.; Tsiarli, Maria A.; Larschan, Erica N.			The essential Drosophila CLAMP protein differentially regulates non-coding roX RNAs in male and females	CHROMOSOME RESEARCH			English	Article						Drosophila; dosage compensation; gene regulation; transcription factor	DOSAGE COMPENSATION; X-CHROMOSOME; MSL COMPLEX; EXPRESSION; CHROMATIN; GENES	Heterogametic species require chromosome-wide gene regulation to compensate for differences in sex chromosome gene dosage. In Drosophila melanogaster, transcriptional output from the single male X-chromosome is equalized to that of XX females by recruitment of the male-specific lethal (MSL) complex, which increases transcript levels of active genes 2-fold. The MSL complex contains several protein components and two non-coding RNA on the X ( roX) RNAs that are transcriptionally activated by the MSL complex. We previously discovered that targeting of the MSL complex to the X-chromosome is dependent on the chromatin-linked adapter for MSL proteins (CLAMP) zinc finger protein. To better understand CLAMP function, we used the CRISPR/Cas9 genome editing system to generate a frameshift mutation in the clamp gene that eliminates expression of the CLAMP protein. We found that clamp null females die at the third instar larval stage, while almost all clamp null males die at earlier developmental stages. Moreover, we found that in clamp null females roX gene expression is activated, whereas in clamp null males roX gene expression is reduced. Therefore, CLAMP regulates roX abundance in a sex-specific manner. Our results provide new insights into sex-specific gene regulation by an essential transcription factor.	[Urban, Jennifer A.; Doherty, Caroline A.; Jordan, William T., III; Bliss, Jacob E.; Feng, Jessica; Soruco, Marcela M.; Rieder, Leila E.; Tsiarli, Maria A.; Larschan, Erica N.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Doherty, Caroline A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Feng, Jessica] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Soruco, Marcela M.] LGC Biosearch Technol, Petaluma, CA 94954 USA	Larschan, EN (reprint author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Erica_Larschan@Brown.edu			National Institutes of Health [F31GM108423, R01GM098461-1]; American Cancer Society [123682-RSG-13-040-01-DMC]; Pew Biomedical Scholars program grant	We thank Dr. Koen Venken for providing us with the PacMan vector. We would also like to thank John Urban for the valuable input on experimental analysis and critical review of the manuscript. Additional thanks are given to Dr. Mitzi Kuroda and Dr. Peter Becker for providing antibodies. J.A.U. was supported by the National Institutes of Health award F31GM108423. All experiments were supported by the National Institutes of Health R01GM098461-1, American Cancer Society Research Scholar 123682-RSG-13-040-01-DMC, and a Pew Biomedical Scholars program grant.	Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; Cai W, 2010, J VIS EXP; Cugusi S, 2015, MOL CELL PROTEOMICS, V14, P1478, DOI 10.1074/mcp.M114.040667; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0                                                   ; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1                                                    ; Larschan E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002830; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Meller VH, 2003, MECH DEVELOP, V120, P759, DOI 10.1016/S0925-4773(03)00157-6; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Pimpinelli S, 2000, DROSOPHILA PROTOCOLS, P728; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soruco MML, 2013, GENE DEV, V27, P1551, DOI 10.1101/gad.214585.113; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Villa R, 2016, NATURE, V537, P244, DOI 10.1038/nature19338	19	3	3	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2017	25	2					101	113		10.1007/s10577-016-9541-9				13	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	EV6WG	WOS:000401914700002	27995349				2018-01-05	
J	Jiang, QF; Crews, LA; Holm, F; Jamieson, CHM				Jiang, Qingfei; Crews, Leslie A.; Holm, Frida; Jamieson, Catriona H. M.			RNA editing-dependent epitranscriptome diversity in cancer stem cells	NATURE REVIEWS CANCER			English	Review							ACUTE MYELOID-LEUKEMIA; SINGLE NUCLEOTIDE RESOLUTION; CHRONIC LYMPHOCYTIC-LEUKEMIA; MESSENGER-RNA; HEMATOPOIETIC STEM; GENE-EXPRESSION; OVARIAN-CANCER; PROSPECTIVE IDENTIFICATION; MYELODYSPLASTIC SYNDROMES; HEPATOCELLULAR-CARCINOMA	Cancer stem cells (CSCs) can regenerate all facets of a tumour as a result of their stem cell-like capacity to self-renew, survive and become dormant in protective microenvironments. CSCs evolve during tumour progression in a manner that conforms to Charles Darwin's principle of natural selection. Although somatic DNA mutations and epigenetic alterations promote evolution, post-transcriptional RNA modifications together with RNA binding protein activity (the 'epitranscriptome') might also contribute to clonal evolution through dynamic determination of RNA function and gene expression diversity in response to environmental stimuli. Deregulation of these epitranscriptomic events contributes to CSC generation and maintenance, which governs cancer progression and drug resistance. In this Review, we discuss the role of malignant RNA processing in CSC generation and maintenance, including mechanisms of RNA methylation, RNA editing and RNA splicing, and the functional consequences of their aberrant regulation in human malignancies. Finally, we highlight the potential of these events as novel CSC biomarkers as well as therapeutic targets.	[Jamieson, Catriona H. M.] Univ Calif San Diego, Div Regenerat Med, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA	Jamieson, CHM (reprint author), Univ Calif San Diego, Div Regenerat Med, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA.	cjamieson@ucsd.edu			Moores Foundation; California Institute for Regenerative Medicine (CIRM) [RN2-00910-1, DR1-01430, RS1-00228-1]; CIRM Training Grant [TG2-01154]; National Institutes of Health (NIH) National Institute of General Medical Sciences [5K12GM068524]; NIH National Cancer Institute (NCI) [2P30CA023100-28]; NIH NCI [R01CA205944, R21CA189705, R21CA194679]; Leukemia & Lymphoma Society [0754-14]; Sanford Stem Cell Clinical Center; San Diego Foundation; Ratner Family Foundation; Swedish Childhood Cancer Foundation (Barncancerfonden)	The authors acknowledge the inspiration and support of their patients and their professional colleagues. This work was supported by the Moores Foundation, California Institute for Regenerative Medicine (CIRM) grants (RN2-00910-1, DR1-01430 and RS1-00228-1); CIRM Training Grant (TG2-01154); National Institutes of Health (NIH) National Institute of General Medical Sciences grant 5K12GM068524; NIH National Cancer Institute (NCI) grant 2P30CA023100-28; NIH NCI grants R01CA205944, R21CA189705 and R21CA194679; the Leukemia & Lymphoma Society (0754-14); the Sanford Stem Cell Clinical Center; the San Diego Foundation; the Ratner Family Foundation; and the Swedish Childhood Cancer Foundation (Barncancerfonden).	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Adamia S, 2014, CLIN CANCER RES, V20, P1135, DOI 10.1158/1078-0432.CCR-13-0956; Adler AS, 2014, GENE DEV, V28, P1068, DOI 10.1101/gad.237206.113; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anadon C, 2016, ONCOGENE, V35, P4407, DOI 10.1038/onc.2015.469; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Barrett CL, 2015, P NATL ACAD SCI USA, V112, pE3050, DOI 10.1073/pnas.1508057112; Basanta-Sanchez M, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv971; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Beghini A, 2000, HUM MOL GENET, V9, P2297, DOI 10.1093/oxfordjournals.hmg.a018921                                              ; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/EPI.12.18, 10.2217/epi.12.18]; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen T, 2015, CELL RES, V25, P459, DOI 10.1038/cr.2015.24; Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Crews LA, 2016, CELL STEM CELL, V19, P599, DOI 10.1016/j.stem.2016.08.003; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Crews LA, 2013, CANCER LETT, V338, P15, DOI 10.1016/j.canlet.2012.08.006; Dai B, 2007, STEM CELLS, V25, P2567, DOI 10.1634/stemcells.2007-0131; Darwin C., 1859, ORIGIN SPECIES MEANS; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; DeBoever C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004105; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DESROSIERS RC, 1975, BIOCHEMISTRY-US, V14, P4367, DOI 10.1021/bi00691a004; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI 10.1038/leu.2014.331; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Fox RG, 2015, ANNU REV CELL DEV BI, V31, P249, DOI 10.1146/annurev-cellbio-100814-125446; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Garofalo M, 2015, ADV DRUG DELIVER REV, V81, P53, DOI 10.1016/j.addr.2014.11.014; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Goff DJ, 2013, CELL STEM CELL, V12, P316, DOI 10.1016/j.stem.2012.12.011; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; Gonda TJ, 2015, NAT REV CANCER, V15, P686, DOI 10.1038/nrc4018; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Guo JS, 2016, CELL CYCLE, V15, P1591, DOI 10.1080/15384101.2016.1176657; Hahn CN, 2012, NAT GENET, V44, P9, DOI 10.1038/ng.1045; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heale BSE, 2009, EMBO J, V28, P3145, DOI [10.1038/sj.emboj.2009.244, 10.1038/emboj.2009.244]; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holm F, 2015, P NATL ACAD SCI USA, V112, P15444, DOI 10.1073/pnas.1506943112; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hu TS, 2008, CANCER RES, V68, P6533, DOI 10.1158/0008-5472.CAN-07-6642; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Isobe T, 2014, ELIFE, V3, DOI 10.7554/eLife.01977; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Iv SR, 2014, INT J CANCER, V135, P2741, DOI [10.1002/ijc.28690, DOI 10.1002/IJC.28690]; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V124, P472, DOI 10.1016/0003-9861(68)90355-X; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jeffs AR, 1998, HUM MOL GENET, V7, P767, DOI 10.1093/hmg/7.5.767; Jiang LY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005895; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kashyap MK, 2015, HAEMATOLOGICA, V100, P945, DOI 10.3324/haematol.2014.122069; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Keller L, 2011, J ALZHEIMERS DIS, V23, P461, DOI 10.3233/JAD-2010-101068; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kwon HY, 2015, CELL STEM CELL, V17, P152, DOI 10.1016/j.stem.2015.06.006; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lasho TL, 2012, LEUKEMIA, V26, P1135, DOI 10.1038/leu.2011.320; Lechman ER, 2016, CANCER CELL, V29, P602, DOI 10.1016/j.ccell.2016.03.015; Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Licht K, 2016, NUCLEIC ACIDS RES, V44, P6398, DOI 10.1093/nar/gkw325; Licht K, 2016, J CELL BIOL, V213, P15, DOI 10.1083/jcb.201511041; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mizrahi RA, 2013, ACS CHEM BIOL, V8, P832, DOI 10.1021/cb300692k; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; MOSS B, 1977, J VIROL, V23, P234; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X                                                    ; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Niu Yamei, 2013, Genomics, Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okano H, 2002, J CELL SCI, V115, P1355; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Park SM, 2015, J CLIN INVEST, V125, P1286, DOI 10.1172/JCI78440; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6                                                    ; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Qi LH, 2014, CANCER RES, V74, P1301, DOI 10.1158/0008-5472.CAN-13-3485; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798                                                          ; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175; Salton M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8103; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Schirle NT, 2010, ORG BIOMOL CHEM, V8, P4898, DOI 10.1039/c0ob00309c; Sebestyen E, 2016, GENOME RES, V26, P732, DOI 10.1101/gr.199935.115; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shefer K, 2014, COMPUT STRUCT BIOTEC, V11, P113, DOI 10.1016/j.csbj.2014.09.008; Solomon O, 2013, RNA, V19, P591, DOI 10.1261/rna.038042.112; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Wulff BE, 2012, CURR TOP MICROBIOL, V353, P91, DOI 10.1007/82_2011_151; Xiao N, 2012, BLOOD, V119, P4898, DOI 10.1182/blood-2012-01-403089; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090                                                          ; Zhang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23226; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	147	4	4	28	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-175X	1474-1768		NAT REV CANCER	Nat. Rev. Cancer	JUN	2017	17	6					381	392		10.1038/nrc.2017.23				12	Oncology	Oncology	EV6QG	WOS:000401895300004	28416802				2018-01-05	
J	Xu, RF; Qin, RY; Li, H; Li, DD; Li, L; Wei, PC; Yang, JB				Xu, Rongfang; Qin, Ruiying; Li, Hao; Li, Dongdong; Li, Li; Wei, Pengcheng; Yang, Jianbo			Generation of targeted mutant rice using a CRISPR-Cpf1 system	PLANT BIOTECHNOLOGY JOURNAL			English	Article						genome editing; Cpf1; CRISPR; rice	CRISPR/CAS9 SYSTEM; CAS SYSTEM; PLANTS; GENE; CPF1; RNA; ARABIDOPSIS; VERSATILE; MICE	CRISPR-Cpf1 is a newly identified CRISPR-Cas system, and Cpf1 was recently engineered as a molecular tool for targeted genome editing in mammalian cells. To test whether the engineered CRISPR-Cpf1 system could induce the production of rice mutants, we selected two genome targets in the OsPDS and OsBEL genes. Our results show that both targets could be efficiently mutated in transgenic rice plants using CRISPR-Cpf1. We found that pre-crRNAs with a full-length direct repeat sequence exhibited considerably increased efficiencies compared with mature crRNAs. In addition, the specificity and transmission of the mutation were investigated, and the behaviours of crRNA-Cpf1-induced plant targeted genome mutagenesis were assessed. Taken together, our results indicate that CRISPR-Cpf1 expression via stable transformation can efficiently generate specific and heritable targeted mutations in rice and thereby constitutes a novel and important approach to specific and precise plant genome editing.	[Xu, Rongfang; Qin, Ruiying; Li, Hao; Li, Dongdong; Li, Li; Wei, Pengcheng; Yang, Jianbo] Anhui Acad Agr Sci, Rice Res Inst, Key Lab Rice Genet Breeding Anhui Prov, Hefei, Peoples R China	Wei, PC; Yang, JB (reprint author), Anhui Acad Agr Sci, Rice Res Inst, Key Lab Rice Genet Breeding Anhui Prov, Hefei, Peoples R China.	weipengcheng@gmail.com; yjianbo@263.net			Genetically Modified Breeding Major Projects [2016ZX08010-002-008]; National Natural Science Foundation of China [31501239]	This work was supported by the Genetically Modified Breeding Major Projects (No. 2016ZX08010-002-008) and the National Natural Science Foundation of China (No. 31501239). The authors declare no conflict of interest.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Duan YB, 2012, PLANT CELL REP, V31, P1611, DOI 10.1007/s00299-012-1275-3; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Ikeda T, 2015, GENES GENET SYST, V90, P231, DOI 10.1266/ggs.15-00030; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li QL, 2016, J GENET GENOMICS, V43, P415, DOI 10.1016/j.jgg.2016.04.011; Liu DG, 2016, CURR OPIN PLANT BIOL, V30, P70, DOI 10.1016/j.pbi.2016.01.007; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Osakabe Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26685; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sun YW, 2016, MOL PLANT, V9, P628, DOI 10.1016/j.molp.2016.01.001; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu R, 2014, RICE N Y, V7, P1; Xu RF, 2016, J GENET GENOMICS, V43, P529, DOI 10.1016/j.jgg.2016.07.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838	30	15	15	70	92	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	JUN	2017	15	6					713	717		10.1111/pbi.12669				5	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	EV7CO	WOS:000401932200005	27875019	gold			2018-01-05	
J	Morineau, C; Bellec, Y; Tellier, F; Gissot, L; Kelemen, Z; Nogue, F; Faure, JD				Morineau, Celine; Bellec, Yannick; Tellier, Frederique; Gissot, Lionel; Kelemen, Zsolt; Nogue, Fabien; Faure, Jean-Denis			Selective gene dosage by CRISPR-Cas9 genome editing in hexaploid Camelina sativa	PLANT BIOTECHNOLOGY JOURNAL			English	Article						CRISPR-Cas9; oleic acid; Camelina; FAD2	AGROBACTERIUM-MEDIATED TRANSFORMATION; FATTY-ACID COMPOSITION; ARABIDOPSIS FAD2 GENE; TARGETED MUTAGENESIS; GUIDE RNA; CRISPR/CAS9 SYSTEM; TRANSGENIC PLANTS; CRISPRCAS SYSTEM; BIOFUEL CROP; CAS SYSTEM	In many plant species, gene dosage is an important cause of phenotype variation. Engineering gene dosage, particularly in polyploid genomes, would provide an efficient tool for plant breeding. The hexaploid oilseed crop Camelina sativa, which has three closely related expressed subgenomes, is an ideal species for investigation of the possibility of creating a large collection of combinatorial mutants. Selective, targeted mutagenesis of the three delta-12-desaturase (FAD2) genes was achieved by CRISPR-Cas9 gene editing, leading to reduced levels of polyunsaturated fatty acids and increased accumulation of oleic acid in the oil. Analysis of mutations over four generations demonstrated the presence of a large variety of heritable mutations in the three isologous CsFAD2 genes. The different combinations of single, double and triple mutants in the T3 generation were isolated, and the complete loss-of-function mutants revealed the importance of delta-12-desaturation for Camelina development. Combinatorial association of different alleles for the three FAD2 loci provided a large diversity of Camelina lines with various lipid profiles, ranging from 10% to 62% oleic acid accumulation in the oil. The different allelic combinations allowed an unbiased analysis of gene dosage and function in this hexaploid species, but also provided a unique source of genetic variability for plant breeding.	[Morineau, Celine; Bellec, Yannick; Tellier, Frederique; Gissot, Lionel; Kelemen, Zsolt; Nogue, Fabien; Faure, Jean-Denis] Univ Paris Saclay, Saclay Plant Sci, CNRS, Inst Jean Pierre Bourgin,INRA,AgroParisTech, Versailles, France	Faure, JD (reprint author), Univ Paris Saclay, Saclay Plant Sci, CNRS, Inst Jean Pierre Bourgin,INRA,AgroParisTech, Versailles, France.	jean-denis.faure@infr.fr		Nogue, Fabien/0000-0003-0619-4638	Carnot 3BCar program CamelinOil2 [75000058]; Agence National de la Recherche [ANR-11-BTBR-0001-GENIUS]	C. M. was funded by Carnot 3BCar program CamelinOil2 (contract 75000058). F. N. was supported by the Agence National de la Recherche (program ANR-11-BTBR-0001-GENIUS). We thank Martine Miquel, Bertrand Dubreucq and Mark Tepfer for their advice and careful reading of the manuscript. The authors declare no conflict of interest.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Bui M, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-1; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collonnier C, 2017, PLANT BIOTECHNOL J, V15, P122, DOI 10.1111/pbi.12596; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Faure J, 2016, OILSEEDS FATS CROPS, V23, P5, DOI [10.1051/ocl/2016023, DOI 10.1051/OCL/2016023]; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Haslam RP, 2016, PLANT J, V87, P76, DOI 10.1111/tpj.13172; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; JAMES DW, 1991, THEOR APPL GENET, V82, P409, DOI 10.1007/BF00588591; JAMES DW, 1990, THEOR APPL GENET, V80, P241, DOI 10.1007/BF00224393; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang W., 2014, INT J MULTIMED UBIQU, V9, P21; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Julie-Galau S, 2014, TRANSGENIC RES, V23, P67, DOI 10.1007/s11248-013-9722-7; Kagale S, 2016, PLANT J, V88, P879, DOI 10.1111/tpj.13302; Kagale S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4706; Kang JL, 2011, PLANT PHYSIOL BIOCH, V49, P223, DOI 10.1016/j.plaphy.2010.12.004; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; Mudalkar S, 2014, PLANT MOL BIOL, V84, P159, DOI 10.1007/s11103-013-0125-1; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nguyen HT, 2013, PLANT BIOTECHNOL J, V11, P759, DOI 10.1111/pbi.12068; Nogue F, 2016, PLANT CELL REP, V35, P1475, DOI 10.1007/s00299-016-1993-z; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Rajeevkumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00693; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Song W, 2010, PLANT J, V62, P1004, DOI 10.1111/j.1365-313X.2010.04212.x; Stoutjesdijk PA, 2002, PLANT PHYSIOL, V129, P1723, DOI 10.1104/pp.006353; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Wang YF, 2014, LECT NOTES COMPUT SC, V8544, P1; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	60	7	7	18	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	JUN	2017	15	6					729	739		10.1111/pbi.12671				11	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	EV7CO	WOS:000401932200007	27885771	gold			2018-01-05	
J	Auslander, S; Auslander, D; Fussenegger, M				Auslander, Simon; Auslander, David; Fussenegger, Martin			Synthetic Biology-The Synthesis of Biology	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Review						bioengineering; chemical biology; genome engineering; metabolic engineering; synthetic biology	PLURIPOTENT STEM-CELLS; CONTROLLING TRANSGENE EXPRESSION; STRAND DISPLACEMENT CASCADES; INDUCIBLE CRISPR-CAS9 SYSTEM; FUNCTIONAL QUADRUPLET CODON; DYNAMIC PATHWAY REGULATION; EXPANDED GENETIC-CODE; MAMMALIAN-CELLS; IN-VITRO; DIRECTED EVOLUTION	Synthetic biology concerns the engineering of man-made living biomachines from standardized components that can perform predefined functions in a (self-) controlled manner. Different research strategies and interdisciplinary efforts are pursued to implement engineering principles to biology. The "top-down" strategy exploits nature's incredible diversity of existing, natural parts to construct synthetic compositions of genetic, metabolic, or signaling networks with predictable and controllable properties. This mainly applicationdriven approach results in living factories that produce drugs, biofuels, biomaterials, and fine chemicals, and results in living pills that are based on engineered cells with the capacity to autonomously detect and treat disease states in vivo. In contrast, the "bottom-up" strategy seeks to be independent of existing living systems by designing biological systems from scratch and synthesizing artificial biological entities not found in nature. This more knowledge-driven approach investigates the reconstruction of minimal biological systems that are capable of performing basic biological phenomena, such as self-organization, self-replication, and self-sustainability. Moreover, the syntheses of artificial biological units, such as synthetic nucleotides or amino acids, and their implementation into polymers inside living cells currently set the boundaries between natural and artificial biological systems. In particular, the in vitro design, synthesis, and transfer of complete genomes into host cells point to the future of synthetic biology: the creation of designer cells with tailored desirable properties for biomedicine and biotechnology.	[Auslander, Simon; Auslander, David; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland; [Fussenegger, Martin] Univ Basel, Fac Sci, Mattenstr 26, CH-4058 Basel, Switzerland	Fussenegger, M (reprint author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.; Fussenegger, M (reprint author), Univ Basel, Fac Sci, Mattenstr 26, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch			European Research Council (ERC) [321381]; National Centre of Competence in Research (NCCR) Molecular Systems Engineering	Synthetic Biology Research in the laboratory of M.F. is supported by the European Research Council (ERC) advanced grant (ProNet, no. 321381) and in part by the National Centre of Competence in Research (NCCR) Molecular Systems Engineering.	Acevedo-Rocha CG, 2016, MICROB BIOTECHNOL, V9, P666, DOI 10.1111/1751-7915.12398; Acevedo-Rocha CG, 2013, TRENDS GENET, V29, P273, DOI 10.1016/j.tig.2012.11.001; Acevedo-Rocha CG, 2011, ANGEW CHEM INT EDIT, V50, P6960, DOI 10.1002/anie.201103010; Acevedo-Rocha C. G., 2011, ANGEW CHEM, V123, P7094; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Akter F, 2015, ACS SYNTH BIOL, V4, P655, DOI 10.1021/sb500314r; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/NCHEM.1781, 10.1038/nchem.1781]; Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007; Auslander D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5408; Auslander D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr829; Auslander S, 2014, NAT METHODS, V11, P1154, DOI [10.1038/NMETH.3136, 10.1038/nmeth.3136]; Auslander S, 2013, TRENDS BIOTECHNOL, V31, P155, DOI 10.1016/j.tibtech.2012.11.006; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Auslander S, 2012, METAB ENG, V14, P252, DOI 10.1016/j.ymben.2011.06.003; Auslander S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw117; Aw SS, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw108; Bacchus W, 2012, NAT BIOTECHNOL, V30, P991, DOI 10.1038/nbt.2351; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Banala S, 2013, ACS CHEM BIOL, V8, P2127, DOI 10.1021/cb400406x; Beilstein K, 2015, ACS SYNTH BIOL, V4, P526, DOI 10.1021/sb500270h; Beisel CL, 2011, NUCLEIC ACIDS RES, V39, P2981, DOI 10.1093/nar/gkq954; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Berschneider B., 2009, ANGEW CHEM, V121, P7701; Berschneider B, 2009, ANGEW CHEM INT EDIT, V48, P7564, DOI 10.1002/anie.200900851; Bhadra S, 2014, RNA, V20, P1183, DOI 10.1261/rna.045047.114; Billerbeck S, 2013, CURR OPIN BIOTECH, V24, P1037, DOI [10.1016/j.cophio.2013.03.007, 10.1016/j.copbio.2013.03.007]; Biner O, 2016, FEBS LETT, V590, P2051, DOI 10.1002/1873-3468.12233; Blain JC, 2014, ANNU REV BIOCHEM, V83, P615, DOI 10.1146/annurev-biochem-080411-124036; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Borkowski O, 2016, CURR OPIN MICROBIOL, V33, P123, DOI 10.1016/j.mib.2016.07.009; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Bradley RW, 2016, J MOL BIOL, V428, P862, DOI 10.1016/j.jmb.2015.10.004; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Brun MA, 2011, J AM CHEM SOC, V133, P16235, DOI 10.1021/ja206915m; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; Buckley CE, 2016, DEV CELL, V36, P117, DOI 10.1016/j.devcel.2015.12.011; Budisa N, 2004, ANGEW CHEM INT EDIT, V43, P6426, DOI 10.1002/anie.200300646; Budisa N., 2004, ANGEW CHEM, V116, P6586, DOI DOI 10.1002/ANGE.200300646; Bujara M, 2011, NAT CHEM BIOL, V7, P271, DOI 10.1038/nchembio.541; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Cellitti SE, 2011, NAT CHEM BIOL, V7, P528, DOI [10.1038/NCHEMBIO.586, 10.1038/nchembio.586]; Chakravarti D, 2015, TRENDS BIOTECHNOL, V33, P449, DOI 10.1016/j.tibtech.2015.05.001; Charpentier E, 2014, CURR OPIN MICROBIOL, V19, P114, DOI 10.1016/j.mib.2014.07.001; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen TJ, 2016, NAT CHEM, V8, P557, DOI 10.1038/NCHEM.2493; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Chmielewski M, 2015, EXPERT OPIN BIOL TH, V15, P1145, DOI 10.1517/14712598.2015.1046430; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courbet A, 2016, EMBO MOL MED, V8, P987, DOI 10.15252/emmm.201606541; Courbet A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3601; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Currin A, 2015, CHEM SOC REV, V44, P1172, DOI 10.1039/c4cs00351a; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; Danchin A, 2016, MICROB BIOTECHNOL, V9, P530, DOI 10.1111/1751-7915.12384; Danino T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3519; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Diafa S, 2015, MOLECULES, V20, P16643, DOI 10.3390/molecules200916643; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Din MO, 2016, NATURE, V536, P81, DOI 10.1038/nature18930; Ding Yunfeng, 2014, Life-Basel, V4, P1092, DOI 10.3390/life4041092; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/nchembio.1659, 10.1038/NCHEMBIO.1659]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Dudley QM, 2015, BIOTECHNOL J, V10, P69, DOI 10.1002/biot.201400330; Edwards WF, 2009, ACS CHEM BIOL, V4, P441, DOI 10.1021/cb900041s; Ehrlich M, 2015, CHEM-EUR J, V21, P7701, DOI 10.1002/chem.201500971; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Famulok M, 2011, ACCOUNTS CHEM RES, V44, P1349, DOI 10.1021/ar2000293; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fernandes R, 2010, NAT NANOTECHNOL, V5, P213, DOI [10.1038/nnano.2009.457, 10.1038/NNANO.2009.457]; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Florea M, 2016, P NATL ACAD SCI USA, V113, pE3431, DOI 10.1073/pnas.1522985113; Folcher M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6392; Forlin M, 2012, CURR OPIN CHEM BIOL, V16, P586, DOI 10.1016/j.cbpa.2012.10.020; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131                                                                ; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gitzinger M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1251; Gitzinger M, 2009, P NATL ACAD SCI USA, V106, P10638, DOI 10.1073/pnas.0901501106; Goldfless SJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks028; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gordley RM, 2016, CURR OPIN STRUC BIOL, V39, P106, DOI 10.1016/j.sbi.2016.06.012; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grabow WW, 2014, ACCOUNTS CHEM RES, V47, P1871, DOI 10.1021/ar500076k; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Griss R, 2014, NAT CHEM BIOL, V10, P598, DOI [10.1038/NCHEMBIO.1554, 10.1038/nchembio.1554]; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2663, DOI 10.1093/nar/gkq139; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407                                                         ; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guinn M, 2014, ACS SYNTH BIOL, V3, P627, DOI 10.1021/sb4001596; Gupta S, 2013, ACS SYNTH BIOL, V2, P715, DOI 10.1021/sb4000417; Guye P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10243; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Heidebrecht A, 2013, ADV APPL MICROBIOL, V82, P115, DOI 10.1016/B978-0-12-407679-2.00004-1; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Heinisch T, 2016, ACCOUNTS CHEM RES, V49, P1711, DOI 10.1021/acs.accounts.6b00235; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hilvert D, 2013, ANNU REV BIOCHEM, V82, P447, DOI 10.1146/annurev-biochem-072611-101825; Hodgman CE, 2012, METAB ENG, V14, P261, DOI 10.1016/j.ymben.2011.09.002; Hoesl M. G., 2015, ANGEW CHEM, V127, P10168; Hoesl MG, 2015, ANGEW CHEM INT EDIT, V54, P10030, DOI 10.1002/anie.201502868; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hunsicker A, 2009, CHEM BIOL, V16, P173, DOI 10.1016/j.chembiol.2008.12.008; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Hwang IY, 2014, ACS SYNTH BIOL, V3, P228, DOI 10.1021/sb400077j; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jackel C, 2010, CURR OPIN BIOTECH, V21, P753, DOI 10.1016/j.copbio.2010.08.008; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Jeschek M, 2016, NATURE, V537, P661, DOI 10.1038/nature19114; Jeschek M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11163; Jimenez M, 2013, ENVIRON MICROBIOL, V15, P3158, DOI 10.1111/1462-2920.12214; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juhas M, 2012, TRENDS BIOTECHNOL, V30, P601, DOI 10.1016/j.tibtech.2012.08.002; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Juillot S, 2016, MOL BIOSYST, V12, P345, DOI 10.1039/c5mb00763a; Karig DK, 2012, NUCLEIC ACIDS RES, V40, P3763, DOI 10.1093/nar/gkr1191; Karpinski J, 2016, NAT BIOTECHNOL, V34, P401, DOI 10.1038/nbt.3467; Kashida S, 2012, NUCLEIC ACIDS RES, V40, P9369, DOI 10.1093/nar/gks668; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim DS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-23; Kim T., 2015, ANGEW CHEM, V127, P6031; Kim T, 2015, METAB ENG, V29, P169, DOI 10.1016/j.ymben.2015.03.016; Kim T, 2015, ANGEW CHEM INT EDIT, V54, P5933, DOI 10.1002/anie.201412204; KIM YG, 1994, P NATL ACAD SCI USA, V91, P883, DOI 10.1073/pnas.91.3.883                                                           ; Klauser B, 2015, ACS SYNTH BIOL, V4, P516, DOI 10.1021/sb500062p; Klauser B, 2012, MOL BIOSYST, V8, P2242, DOI 10.1039/c2mb25091h; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/nmeth.2918, 10.1038/NMETH.2918]; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Krishnan Y., 2011, ANGEW CHEM, V123, P3180; Krishnan Y, 2011, ANGEW CHEM INT EDIT, V50, P3124, DOI 10.1002/anie.200907223; Kumar D, 2009, J AM CHEM SOC, V131, P13906, DOI 10.1021/ja905596t; Lai A. C., 2016, ANGEW CHEM, V128, P818; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lambertz C, 2016, NANO LETT, V16, P3540, DOI 10.1021/acs.nanolett.6b00507; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Laos R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00565; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li YR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12137; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Linko V, 2013, CURR OPIN BIOTECH, V24, P555, DOI 10.1016/j.copbio.2013.02.001; Liu CC, 2012, NAT METHODS, V9, P1088, DOI [10.1038/NMETH.2184, 10.1038/nmeth.2184]; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Lluch-Senar M, 2015, MOL SYST BIOL, V11; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Ma KC, 2016, J MOL BIOL, V428, P893, DOI 10.1016/j.jmb.2016.02.018; Ma Y, 2014, MOLECULES, V19, P1004, DOI 10.3390/molecules19011004; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Mandell DJ, 2015, NATURE, V527, P264, DOI 10.1038/nature15536; Marliere Philippe, 2009, Syst Synth Biol, V3, P77, DOI 10.1007/s11693-009-9040-9; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Meyer S, 2016, BIOTECHNOL BIOENG, V113, P216, DOI 10.1002/bit.25693; Michener JK, 2012, METAB ENG, V14, P306, DOI 10.1016/j.ymben.2012.04.004; Millman JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11463; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264                                                                   ; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt002; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Nakayama S, 2012, CHEM COMMUN, V48, P9059, DOI 10.1039/c2cc34379g; Navarro R, 2016, ACS CHEM BIOL, V11, P2101, DOI 10.1021/acschembio.6b00234; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Niederholtmeyer H, 2015, ELIFE, V4, DOI 10.7554/eLife.09771; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Niopek D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10624; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Niu W, 2013, ACS CHEM BIOL, V8, P1640, DOI 10.1021/cb4001662; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Pellinen T, 2004, ANAL BIOCHEM, V330, P52, DOI 10.1016/j.ab.2004.03.064; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pinheiro VB, 2012, CURR OPIN CHEM BIOL, V16, P245, DOI [10.1016/j.cbpa.2012.05.108, 10.1016/j.cbpa.2012.05.198]; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Prochazka L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5729; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rakhit R, 2014, CHEM BIOL, V21, P1238, DOI 10.1016/j.chembiol.2014.08.011; Raman S, 2014, TRENDS GENET, V30, P521, DOI 10.1016/j.tig.2014.09.004; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Renata H., 2015, ANGEW CHEM, V127, P3408; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Renicke C, 2013, CHEM BIOL, V20, P619, DOI 10.1016/j.chembiol.2013.03.005; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rossger K, 2014, METAB ENG, V21, P81, DOI 10.1016/j.ymben.2013.11.003; Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825; Rossger K, 2013, P NATL ACAD SCI USA, V110, P18150, DOI 10.1073/pnas.1312414110; Rogers JK, 2016, CURR OPIN BIOTECH, V42, P84, DOI 10.1016/j.copbio.2016.03.005; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Saeidi N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.55; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Saragliadis A, 2013, RNA BIOL, V10, P1010, DOI 10.4161/rna.24482; Saxena P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11247; Saxena P, 2016, P NATL ACAD SCI USA, V113, P1244, DOI 10.1073/pnas.1514383113; Schaerli Y, 2014, NUCLEIC ACIDS RES, V42, P12322, DOI 10.1093/nar/gku884; Schmitt Christine, 2016, Frontiers in Bioengineering and Biotechnology, V4, DOI 10.3389/fbioe.2016.00019; Schukur L, 2016, WIRES SYST BIOL MED, V8, P402, DOI 10.1002/wsbm.1345; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; Schwille P, 2011, SCIENCE, V333, P1252, DOI 10.1126/science.1211701; Schwille P, 2009, CRIT REV BIOCHEM MOL, V44, P223, DOI 10.1080/10409230903074549; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shin J, 2012, ACS SYNTH BIOL, V1, P29, DOI 10.1021/sb200016s; Siegmund V, 2012, CHEM COMMUN, V48, P9870, DOI 10.1039/c2cc35028a; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Skjoedt ML, 2016, NAT CHEM BIOL, V12, P951, DOI [10.1038/NCHEMBIO.2177, 10.1038/nchembio.2177]; Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112; Slomovic S, 2015, NAT METHODS, V12, P1085, DOI [10.1038/NMETH.3585, 10.1038/nmeth.3585]; Smanski MJ, 2016, NAT REV MICROBIOL, V14, P135, DOI 10.1038/nrmicro.2015.24; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stano P, 2013, CURR OPIN BIOTECH, V24, P633, DOI 10.1016/j.copbio.2013.01.002; Stein V, 2015, TRENDS BIOTECHNOL, V33, P101, DOI 10.1016/j.tibtech.2014.11.010; Stein V, 2014, P NATL ACAD SCI USA, V111, P15934, DOI 10.1073/pnas.1405220111; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Takahashi MK, 2015, METHODS, V86, P60, DOI 10.1016/j.ymeth.2015.05.020; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Taylor AI, 2015, NATURE, V518, P427, DOI 10.1038/nature13982; Taylor ND, 2016, NAT METHODS, V13, P177, DOI [10.1038/NMETH.3696, 10.1038/nmeth.3696]; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tizei PAG, 2016, BIOCHEM SOC T, V44, P1165, DOI 10.1042/BST20160076; Toure M., 2016, ANGEW CHEM, V128, P2002; Toure M, 2016, ANGEW CHEM INT EDIT, V55, P1966, DOI 10.1002/anie.201507978; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; van Roekel HWH, 2015, CHEM SOC REV, V44, P7465, DOI 10.1039/c5cs00361j; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vater A, 2015, DRUG DISCOV TODAY, V20, P147, DOI 10.1016/j.drudis.2014.09.004; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Venayak N, 2015, CURR OPIN BIOTECH, V34, P142, DOI 10.1016/j.copbio.2014.12.022; Wals K, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00015; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wang YR, 2011, CHEM BIOL, V18, P372, DOI 10.1016/j.chembiol.2010.12.019; Weber W, 2002, NAT BIOTECHNOL, V20, P901, DOI 10.1038/nbt731; Weber W, 2009, METAB ENG, V11, P117, DOI 10.1016/j.ymben.2008.12.001; Weigand JE, 2007, NUCLEIC ACIDS RES, V35, P4179, DOI 10.1093/nar/gkm425; Weitz M, 2014, NAT CHEM, V6, P295, DOI [10.1038/NCHEM.1869, 10.1038/nchem.1869]; Wieland M., 2009, ANGEW CHEM, V121, P2753; Wieland M, 2010, CURR OPIN BIOTECH, V21, P760, DOI 10.1016/j.copbio.2010.06.010; Wieland M, 2010, CHEM BIOL, V17, P236, DOI 10.1016/j.chembiol.2010.02.012; Wieland M, 2009, ANGEW CHEM INT EDIT, V48, P2715, DOI 10.1002/anie.200805311; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winnacker M., 2013, ANGEW CHEM, V125, P12728; Winnacker M, 2013, ANGEW CHEM INT EDIT, V52, P12498, DOI 10.1002/anie.201305267; Wittmann A, 2012, FEBS LETT, V586, P2076, DOI 10.1016/j.febslet.2012.02.038; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Wong A, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0146-0; Wong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135965; Woolston BM, 2013, ANNU REV CHEM BIOMOL, V4, P259, DOI 10.1146/annurev-chembioeng-061312-103312; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Wu CY, 2015, CURR OPIN IMMUNOL, V35, P123, DOI 10.1016/j.coi.2015.06.015; Wu HC, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.71; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Xu P, 2014, P NATL ACAD SCI USA, V111, P11299, DOI 10.1073/pnas.1406401111; Ye HF, 2013, P NATL ACAD SCI USA, V110, P141, DOI 10.1073/pnas.1216801110; Ye YN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35082; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang F, 2015, HUM GENE THER, V26, P409, DOI 10.1089/hum.2015.29002.fzh; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhu FY, 2014, BIOTECHNOL BIOENG, V111, P1396, DOI 10.1002/bit.25198; Zieske K., 2013, ANGEW CHEM, V125, P477; Zieske K, 2014, ELIFE, V3, DOI 10.7554/eLife.03949; Zieske K, 2013, ANGEW CHEM INT EDIT, V52, P459, DOI 10.1002/anie.201207078	341	5	5	89	123	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	JUN 1	2017	56	23					6396	6419		10.1002/anie.201609229				24	Chemistry, Multidisciplinary	Chemistry	EV5GV	WOS:000401791900005	27943572				2018-01-05	
J	Badia, R; Pujantell, M; Torres-Torronteras, J; Menendez-Arias, L; Marti, R; Ruzo, A; Pauls, E; Clotet, B; Ballana, E; Este, JA; Riveira-Munoz, E				Badia, Roger; Pujantell, Maria; Torres-Torronteras, Javier; Menendez-Arias, Luis; Marti, Ramon; Ruzo, Albert; Pauls, Eduardo; Clotet, Bonaventura; Ballana, Ester; Este, Jose A.; Riveira-Munoz, Eva			SAMHD1 is active in cycling cells permissive to HIV-1 infection	ANTIVIRAL RESEARCH			English	Article						CRISPR; Genome editing; SAMHDI; dNTPase activity	REVERSE-TRANSCRIPTASE INHIBITORS; RESTRICTION FACTOR SAMHD1; CD4(+) T-CELLS; VIRUS TYPE-1; RETROVIRAL RESTRICTION; RIBONUCLEASE-ACTIVITY; DNTPASE ACTIVITY; PHOSPHORYLATION; REPLICATION; MACROPHAGES	SAMHDI is a triphosphohydrolase that restricts HIV-1 by limiting the intracellular dNTP pool required for reverse transcription. Although SAMHDI is expressed and active/unphosphorylated in most cell lines, its restriction activity is thought to be relevant only in non-cycling cells. However, an in depth evaluation of SAMHD1 function and relevance in cycling cells is required. Here, we show that SAMHDI-induced degradation by HIV-2 Vpx affects the dNTP pool and HIV-1 replication capacity in the presence of the 3'-azido-3'-deoxythymidine (AZT) in cycling cells. Similarly, in SAMHD1 knockout cells, HIV-1 showed increased replicative capacity in the presence of nucleoside inhibitors, especially AZT, that was reverted by re-expression of wild type SAMHDI. Sensitivity to non-nucleoside inhibitors (nevirapine and efavirenz) or the integrase inhibitor raltegravir was not affected by SAMHDI. Combination of three mutations (S18A, T21A, T25A) significantly prevented SAMHDI phosphorylation but did not significantly affect HIV-1 replication in the presence of AZT. Our results demonstrate that SAMHDI is active in HIV-1 permissive cells, does not modify susceptibility to HIV-1 infection but strongly affects sensitivity to nucleoside inhibitors. (C) 2017 Elsevier B.V. All rights reserved.	[Badia, Roger; Pujantell, Maria; Pauls, Eduardo; Clotet, Bonaventura; Ballana, Ester; Este, Jose A.; Riveira-Munoz, Eva] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa & Hlth Res, IGTP, Badalona, Spain; [Torres-Torronteras, Javier; Marti, Ramon] Univ Autonoma Barcelona, Biomed Network Res Ctr Rare Dis CIBERER, Vall dHebron Inst Recerca,Inst Salud Carlos III, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona, Spain; [Menendez-Arias, Luis] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain; [Ruzo, Albert] Rockefeller Univ, Lab Mol Embryol, 1230 York Ave, New York, NY 10021 USA; [Pauls, Eduardo] Barcelona Inst Sci & Technol, Inst Res Biomed, Joint IRB BSC CRG Program Computat Biol, Barcelona, Spain	Este, JA; Riveira-Munoz, E (reprint author), Hosp Badalona Germans Trias & Pujol, IrsiCaixa, C Canyet S-N, Badalona 08916, Spain.	jaeste@irsicaixa.es; eriveira@irsicaixa.es		Pauls, Eduardo/0000-0002-2511-0711	Spanish Ministerio de Economia y Competitividad (MINECO) [BFU2015-63800-R, BIO2013-48788-C2-1-R]; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) - FEDER [PI13/01083, PI15/00492, P116/00103]	We thank the National Institutes of Health (AIDS Research and Reference Reagent Program) and the EU Programme EVA Centralised Facility for AIDS Reagents, NIBSC, UK for reagents. This work was supported in part by the Spanish Ministerio de Economia y Competitividad (MINECO) project BFU2015-63800-R and BIO2013-48788-C2-1-R and Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) PI13/01083, PI15/00492 and P116/00103 cofinanced by FEDER. RB and EB are research fellows from FIS.	Amie SM, 2013, J BIOL CHEM, V288, P20683, DOI 10.1074/jbc.M113.472159; Antonucci JM, 2016, NAT MED, V22, P1072, DOI 10.1038/nm.4163; Arnold LH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005194; Badia R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005829; Badia R, 2016, J ANTIMICROB CHEMOTH, V71, P387, DOI 10.1093/jac/dkv363; Badia R, 2015, ANTIVIR RES, V123, P62, DOI 10.1016/j.antiviral.2015.09.004; Badia R, 2014, ANTIMICROB AGENTS CH, V58, P4318, DOI 10.1128/AAC.02690-14; Badia R, 2014, J ANTIMICROB CHEMOTH, V69, P1755, DOI 10.1093/jac/dku072; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Ballana E, 2015, TRENDS MICROBIOL, V23, P680, DOI 10.1016/j.tim.2015.08.002; Ballana E, 2014, ANTIMICROB AGENTS CH, V58, P4804, DOI 10.1128/AAC.03145-14; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Chen ZM, 2014, BIOCHEM BIOPH RES CO, V450, P1462, DOI 10.1016/j.bbrc.2014.07.023; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Ducu RI, 2011, VIROLOGY, V416, P1, DOI 10.1016/j.virol.2011.04.012; Ferraro R, 2010, NUCLEIC ACIDS RES, V38, pe85; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Guo HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066201; Herold N, 2017, NAT MED, V23, P256, DOI 10.1038/nm.4265; Herrmann A, 2016, CURR HIV RES, V14, P225, DOI 10.2174/1570162X14999160224102515; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huber AD, 2014, ANTIMICROB AGENTS CH, V58, P4915, DOI 10.1128/AAC.02745-14; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kyei GB, 2015, CELL HOST MICROBE, V17, P98, DOI 10.1016/j.chom.2014.11.009; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Mangeot PE, 2000, J VIROL, V74, P8307, DOI 10.1128/JVI.74.18.8307-8315.2000; Pauls E, 2014, AIDS, V28, P2213, DOI 10.1097/QAD.0000000000000399; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Pauls E, 2014, P NATL ACAD SCI USA, V111, pE1322, DOI 10.1073/pnas.1322059111; Pauls E, 2013, ANTIVIR RES, V97, P180, DOI 10.1016/j.antiviral.2012.12.009; Pujantell M, 2016, ANTIVIR RES, V133, P145, DOI 10.1016/j.antiviral.2016.08.004; Rice AP, 2015, CELL HOST MICROBE, V17, P736, DOI 10.1016/j.chom.2015.05.010; Riveira-Munoz E, 2014, J ANTIMICROB CHEMOTH, V69, P3057, DOI 10.1093/jac/dku276; Ruiz A, 2015, CELL CYCLE, V14, P1657, DOI 10.1080/15384101.2015.1030558; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Schaller T, 2012, SCIENCE, V335, P1313, DOI 10.1126/science.1221057; Schneider C, 2017, NAT MED, V23, P250, DOI 10.1038/nm.4255; Seamon K.J., 2015, NUCL ACIDS RES; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Sommer AFR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26616; St Gelais C, 2014, J VIROL, V88, P7689, DOI 10.1128/JVI.01089-14; Sze A, 2013, J MOL BIOL, V425, P4981, DOI 10.1016/j.jmb.2013.10.022; Sze A, 2013, CELL HOST MICROBE, V14, P422, DOI 10.1016/j.chom.2013.09.009; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588	57	2	2	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	JUN	2017	142						123	135		10.1016/j.antiviral.2017.03.019				13	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	EU7GK	WOS:000401203100012	28359840				2018-01-05	
J	Reyes, CV; Tangprasertchai, NS; Yogesha, SD; Nguyen, RH; Zhang, XJ; Rajan, R; Qin, PZ				Reyes, Carolina Vazquez; Tangprasertchai, Narin S.; Yogesha, S. D.; Nguyen, Richard H.; Zhang, Xiaojun; Rajan, Rakhi; Qin, Peter Z.			Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						CRISPR; Cas9; Spin labeling; EPR; Conformational change	GUIDED ENDONUCLEASE CAS9; TARGET DNA RECOGNITION; RESONANCE SPECTROSCOPY; CRYSTAL-STRUCTURE; RNA; CLEAVAGE; COMPLEX; SYSTEMS; DYNAMICS; IMMUNITY	In a type II clustered regularly interspaced short palindromic repeats (CRISPR) system, RNAs that are encoded at the CRISPR locus complex with the CRISPR-associated (Cas) protein Cas9 to form an RNA-guided nuclease that cleaves double-stranded DNAs at specific sites. In recent years, the CRISPR-Cas9 system has been successfully adapted for genome engineering in a wide range of organisms. Studies have indicated that a series of conformational changes in Cas9, coordinated by the RNA and the target DNA, direct the protein into its active conformation, yet details on these conformational changes, as well as their roles in the mechanism of function of Cas9, remain to be elucidated. Here, nucleic acid-dependent conformational changes in Streptococcus pyogenes Cas9 (SpyCas9) were investigated using the method of site-directed spin labeling (SDSL). Single nitroxide spin labels were attached, one at a time, at one of the two native cysteine residues (Cys80 and Cys574) of SpyCas9, and the spin-labeled proteins were shown to maintain their function. X-band continuous-wave electron paramagnetic resonance spectra of the nitroxide attached at Cys80 revealed conformational changes of SpyCas9 that are consistent with a large-scale domain re-arrangement upon binding to its RNA partner. The results demonstrate the use of SDSL to monitor conformational changes in CRISPR-Cas9, which will provide key information for understanding the mechanism of CRISPR function.	[Reyes, Carolina Vazquez; Tangprasertchai, Narin S.; Zhang, Xiaojun; Qin, Peter Z.] Univ Southern Calif, Dept Chem, Los Angeles, CA 90089 USA; [Yogesha, S. D.; Nguyen, Richard H.; Rajan, Rakhi] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Qin, PZ (reprint author), Univ Southern Calif, Dept Chem, Los Angeles, CA 90089 USA.	pzq@usc.edu			National Science Foundation [CHE-1213673]; National Institutes of Health [RR028992]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103640]; Research Council of the University of Oklahoma Norman Campus	This work has been supported, in part, by the National Science Foundation (P.Z.Q., CHE-1213673) and the National Institutes of Health (P.Z.Q., RR028992). Research in RR's lab was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under the Grant Number P20GM103640 and partly by a grant from the Research Council of the University of Oklahoma Norman Campus.	Altenbach C, 2015, METHOD ENZYMOL, V564, P59, DOI 10.1016/bs.mie.2015.08.006; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding Y., 2015, ROYAL SOC CHEM, V24, P122; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fang Y, 2005, BIOCHEMISTRY-US, V44, P9348, DOI 10.1021/bi0475020; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hubbell WL, 2013, CURR OPIN STRUC BIOL, V23, P725, DOI 10.1016/j.sbi.2013.06.008; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956                                                                   ; Ishii TM, 1998, METHOD ENZYMOL, V293, P53; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Josephs EA, 2015, NUCLEIC ACIDS RES, V43, P8924, DOI 10.1093/nar/gkv892; Krstic I, 2012, TOP CURR CHEM, V321, P159, DOI 10.1007/128_2011_300; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Qin PZ, 2007, NAT PROTOC, V2, P2354, DOI 10.1038/nprot.2007.308; Reginsson GW, 2011, BIOCHEM SOC T, V39, P128, DOI 10.1042/BST0390128; Shelke SA, 2012, EUR J ORG CHEM, P2291, DOI 10.1002/ejoc.201101434; Smirnova TI, 2015, METHOD ENZYMOL, V564, P219, DOI 10.1016/bs.mie.2015.08.018; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Sowa GZ, 2008, PROG NUCLEIC ACID RE, V82, P147, DOI 10.1016/S0079-6603(08)00005-6; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tangprasertchai NS, 2015, METHOD ENZYMOL, V564, P427, DOI 10.1016/bs.mie.2015.07.007; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Voinov MA, 2015, METHOD ENZYMOL, V564, P191, DOI 10.1016/bs.mie.2015.08.007; Yang ZY, 2012, P NATL ACAD SCI USA, V109, pE993, DOI 10.1073/pnas.1200733109; Zhang XJ, 2009, METHOD ENZYMOL, V469, P303, DOI 10.1016/S0076-6879(09)69015-7	40	3	3	12	16	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	JUN	2017	75	2			SI		203	210		10.1007/s12013-016-0738-5				8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EU2OB	WOS:000400867700007	27342128				2018-01-05	
J	Lahdeniemi, IA; Misiorek, JO; Antila, CJM; Landor, SKJ; Stenvall, CGA; Fortelius, LE; Bergstrom, LK; Sahlgren, C; Toivola, DM				Lahdeniemi, Iris A. K.; Misiorek, Julia O.; Antila, Christian J. M.; Landor, Sebastian K-J; Stenvall, Carl-Gustaf A.; Fortelius, Lina E.; Bergstrom, Linda K.; Sahlgren, Cecilia; Toivola, Diana M.			Keratins regulate colonic epithelial cell differentiation through the Notch1 signalling pathway	CELL DEATH AND DIFFERENTIATION			English	Article							INTERMEDIATE-FILAMENTS; STEM-CELLS; NESTIN EXPRESSION; INTESTINAL CRYPTS; CANCER; PROLIFERATION; ORGANIZATION; DISEASE; LOCALIZATION; INTEGRITY	Keratins (K) are intermediate filament proteins important in stress protection and mechanical support of epithelial tissues. K8, K18 and K19 are the main colonic keratins, and K8-knockout (K8(-/-)) mice display a keratin dose-dependent hyperproliferation of colonic crypts and a colitis-phenotype. However, the impact of the loss of K8 on intestinal cell differentiation has so far been unknown. Here we show that K8 regulates Notch1 signalling activity and differentiation in the epithelium of the large intestine. Proximity ligation and immunoprecipitation assays demonstrate that K8 and Notch1 co-localize and interact in cell cultures, and in vivo in the colonic epithelial cells. K8 with its heteropolymeric partner K18 enhance Notch1 protein levels and activity in a dose dependent manner. The levels of the full-length Notch1 receptor (FLN), the Notch1 intracellular domain (NICD) and expression of Notch1 downstream target genes are reduced in the absence of K8, and the K8-dependent loss of Notch1 activity can be rescued with re-expression of K8/K18 in K8-knockout CRISPR/Cas9 Caco-2 cells protein levels. In vivo, K8 deletion with subsequent Notch1 downregulation leads to a shift in differentiation towards a goblet cell and enteroendocrine phenotype from an enterocyte cell fate. Furthermore, the K8(-/-) colonic hyperproliferation results from an increased number of transit amplifying progenitor cells in these mice. K8/K18 thus interact with Notch1 and regulate Notch1 signalling activity during differentiation of the colonic epithelium.	[Lahdeniemi, Iris A. K.; Misiorek, Julia O.; Antila, Christian J. M.; Landor, Sebastian K-J; Stenvall, Carl-Gustaf A.; Fortelius, Lina E.; Bergstrom, Linda K.; Sahlgren, Cecilia; Toivola, Diana M.] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Biosci, Tykistokatu 6A, FIN-20520 Turku, Finland; [Antila, Christian J. M.; Landor, Sebastian K-J; Sahlgren, Cecilia] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Antila, Christian J. M.; Landor, Sebastian K-J; Sahlgren, Cecilia] Abo Akad Univ, Turku, Finland; [Landor, Sebastian K-J] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Sahlgren, Cecilia] Tech Univ Eindhoven, Eindhoven, Netherlands; [Toivola, Diana M.] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland	Toivola, DM (reprint author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, Biosci, Tykistokatu 6A, FIN-20520 Turku, Finland.	dtoivola@abo.fi			Academy of Finland [140759/126161, 218062]; Sigrid Juselius Foundation; Liv och Halsa foundation; EU FP7 IRG; Swedish Cultural Foundation; Turku Doctoral Programme in Molecular Biosciences at AAU; Turku Doctoral Programme of Biomedical Sciences; Abo Akademi foundation; Oskar Oflund Foundation; K Albin Johansson foundation; Magnus Ehrnrooth Foundation; Waldemar von Frenckell Foundation; Swedish Research Council; EU; AAU Center of Excellence of Cell Stress and Molecular Aging	We thank Helena Saarento, Jonas Silvander, Joel Nystrom, Terhi Helenius and other members of the Toivola laboratory (Biosciences, Faculty of Science and Engineering, Abo Akademi University; AAU), members of Sahlgren, Sistonen and Eriksson laboratories (Turku Center of Biotechnology, University of Turku and AAU/ Cell Biology AAU) as well as Turku Center of Biotechnology Cell Imaging Core and Pasi Kankaanpaa for technical support, samples and advice. Professor Bishr Omary is also acknowledged for the L2A1 antibody. This work was financed by the Academy of Finland 140759/126161 (Diana M Toivola) and 218062 (Cecilia Sahlgren), Sigrid Juselius Foundation, Liv och Halsa foundation (Diana M Toivola), EU FP7 IRG (Diana M Toivola), AAU Center of Excellence of Cell Stress and Molecular Aging (Diana M Toivola, Cecilia Sahlgren),Swedish Cultural Foundation (Iris AK Lahdeniemi, Christian JM Antila, Sebastian K-J Landor), Turku Doctoral Programme in Molecular Biosciences at AAU (Iris AK Lahdeniemi), Turku Doctoral Programme of Biomedical Sciences (Julia O Misiorek), Abo Akademi foundation (Julia O Misiorek) and Oskar Oflund Foundation (Julia O Misiorek), K Albin Johansson foundation (Julia O Misiorek, Sebastian K-J Landor), Magnus Ehrnrooth Foundation (Sebastian K-J Landor), Waldemar von Frenckell Foundation (Sebastian K-J Landor), the Swedish Research Council, EU (ITN NotchIT, Sebastian K-J Landor).	Alam CM, 2013, J CELL SCI, V126, P5635, DOI 10.1242/jcs.132795; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Asfaha S, 2015, CELL STEM CELL, V16, P627, DOI 10.1016/j.stem.2015.04.013; Asghar MN, 2016, AM J PHYSIOL-GASTR L, V310, pG1147, DOI 10.1152/ajpgi.00354.2015; Asghar MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127436; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Becker S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055620; Chen Y, 2015, J PATHOL, V237, P343, DOI 10.1002/path.4580; Colman H, 2006, AM J SURG PATHOL, V30, P657, DOI 10.1097/01.pas.0000202048.28203.25; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Desai D, 2016, INT J NANOMED, V11, P299, DOI 10.2147/IJN.S94013; Fu DJ, 2014, J INVEST DERMATOL, V134, P754, DOI 10.1038/jid.2013.356; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021; Garg P, 2007, GASTROENTEROLOGY, V132, P1877, DOI 10.1053/j.gastro.2007.02.048; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5                                                   ; Green KJ, 2005, ADV PROTEIN CHEM, V70, P143, DOI 10.1016/S0065-3233(04)70006-6; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Helenius TO, 2016, CELLS, V5; Hobbs RP, 2016, ONCOGENE, V35, P5653, DOI 10.1038/onc.2016.102; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Hyder CL, 2015, J CELL SCI, V128, P2057, DOI 10.1242/jcs.160341; Jensen J, 2000, NAT GENET, V24, P36; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/nmeth.2047, 10.1038/NMETH.2047]; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Mamaeva V, 2011, MOL THER, V19, P1538, DOI 10.1038/mt.2011.105; Mantani Y, 2014, J VET MED SCI, V76, P833, DOI 10.1292/jvms.14-0026; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Misiorek JO, 2016, CARCINOGENESIS, V37, P777, DOI 10.1093/carcin/bgw063; Miyamoto S, 2011, CANCER SCI, V102, P1938, DOI 10.1111/j.1349-7006.2011.02049.x; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977                                                     ; Pallari Hanna-Mari, 2006, Sci STKE, V2006, ppe53, DOI 10.1126/stke.3662006pe53; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Ramakrishnan G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08782; Robine S, 1997, AM J PHYSIOL-GASTR L, V273, pG759; Sakamoto K, 2012, LAB INVEST, V92, P688, DOI 10.1038/labinvest.2012.9; Santio NM, 2016, ONCOTARGET, V7, P43220, DOI 10.18632/oncotarget.9215; Schepers A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007989; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Sjoqvist M, 2014, CELL RES, V24, P433, DOI 10.1038/cr.2014.34; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Thanasupawat T, 2013, ONCOL REP, V29, P149, DOI 10.3892/or.2012.2119; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Toivola DM, 1997, J CELL SCI, V110, P23; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhong BH, 2007, MOL BIOL CELL, V18, P4969, DOI 10.1091/mbc.E07-02-0180; Zhou Q, 2003, MOL BIOL CELL, V14, P2959, DOI 10.1091/mbc.E03-02-0059	60	1	1	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	JUN	2017	24	6					984	996		10.1038/cdd.2017.28				13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV4AY	WOS:000401701800006	28475172	gold			2018-01-05	
J	Lehmann, J; Seebode, C; Smolorz, S; Schubert, S; Emmert, S				Lehmann, Janin; Seebode, Christina; Smolorz, Sabine; Schubert, Steffen; Emmert, Steffen			XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						CRISPR/Cas9; Xeroderma pigmentosum group F; Nucleotide excision repair; Interstrand crosslink repair; Homologous recombination repair	NUCLEOTIDE EXCISION-REPAIR; INTERSTRAND CROSS-LINK; PIGMENTOSUM GROUP-F; XERODERMA-PIGMENTOSUM; MAMMALIAN-CELLS; FANCONI-ANEMIA; GENE ERCC1; IN-VITRO; HOMOLOGOUS RECOMBINATION; COCKAYNE-SYNDROME	The XPF/ERCC1 heterodimeric complex is essentially involved in nucleotide excision repair (NER), interstrand crosslink (ICL), and double-strand break repair. Defects in XPF lead to severe diseases like xeroderma pigmentosum (XP). Up until now, XP-F patient cells have been utilized for functional analyses. Due to the multiple roles of the XPF/ERCC1 complex, these patient cells retain at least one full-length allele and residual repair capabilities. Despite the essential function of the XPF/ERCC1 complex for the human organism, we successfully generated a viable immortalised human XPF knockout cell line with complete loss of XPF using the CRISPR/Cas9 technique in fetal lung fibroblasts (MRC5Vi cells). These cells showed a markedly increased sensitivity to UVC, cisplatin, and psoralen activated by UVA as well as reduced repair capabilities for NER and ICL repair as assessed by reporter gene assays. Using the newly generated knockout cells, we could show that human XPF is markedly involved in homologous recombination repair (HRR) but dispensable for non-homologous end-joining (NHEJ). Notably, ERCC1 was not detectable in the nucleus of the XPF knockout cells indicating the necessity of a functional XPF/ERCC1 heterodimer to allow ERCC1 to enter the nucleus. Overexpression of wild-type XPF could reverse this effect as well as the repair deficiencies.	[Lehmann, Janin; Seebode, Christina; Emmert, Steffen] Univ Med Ctr Rostock, Clin & Policlin Dermatol & Venereol, Strempelstr 13, D-18057 Rostock, Germany; [Lehmann, Janin; Smolorz, Sabine; Schubert, Steffen; Emmert, Steffen] Univ Med Ctr Goettingen, Dept Dermatol Venereol & Allergol, Robert Koch Str 40, D-37075 Gottingen, Germany	Emmert, S (reprint author), Univ Med Ctr Rostock, Clin & Policlin Dermatol & Venereol, Strempelstr 13, D-18057 Rostock, Germany.; Emmert, S (reprint author), Univ Med Ctr Goettingen, Dept Dermatol Venereol & Allergol, Robert Koch Str 40, D-37075 Gottingen, Germany.	steffen.emmert@med.uni-rostock.de			German Cancer Aid (Deutsche Krebshilfe e.V.) [111377]; Heinz and Heide Duerr Foundation [2014-2.2.1/02]	This work was supported by the German Cancer Aid (Deutsche Krebshilfe e.V.) [111377] and the Heinz and Heide Duerr Foundation [2014-2.2.1/02 to S.E.].	Adair GR, 2000, EMBO J, V19, P5552, DOI 10.1093/emboj/19.20.5552; Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; BIGGERSTAFF M, 1993, EMBO J, V12, P3685; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Boulikas T, 1997, ANTICANCER RES, V17, P843; Brookman KW, 1996, MOL CELL BIOL, V16, P6553; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Silva IU, 2002, NUCLEIC ACIDS RES, V30, P3848, DOI 10.1093/nar/gkf479; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Enoiu M, 2012, NUCLEIC ACIDS RES, V40, P8953, DOI 10.1093/nar/gks670; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026; GUPTA AK, 1987, J AM ACAD DERMATOL, V17, P703, DOI 10.1016/S0190-9622(87)70255-2; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; HAYAKAWA H, 1981, MUTAT RES, V80, P381, DOI 10.1016/0027-5107(81)90110-X; HEARST JE, 1981, ANNU REV BIOPHYS BIO, V10, P69, DOI 10.1146/annurev.bb.10.060181.000441; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f                                                               ; Hodskinson MRG, 2014, MOL CELL, V54, P472, DOI 10.1016/j.molcel.2014.03.014; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; JONES JC, 1991, J BIOL CHEM, V266, P7101; Jordheim LP, 2013, MOL PHARMACOL, V84, P12, DOI 10.1124/mol.112.082347; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kraemer KH, 2015, PHOTOCHEM PHOTOBIOL, V91, P452, DOI 10.1111/php.12345; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Lehmann J, 2014, J DTSCH DERMATOL GES, V12, P867, DOI 10.1111/ddg.12419; [李君 Li Jun], 2013, [遗传, Hereditas(Beijing)], V35, P1265, DOI 10.3724/SP.J.1005.2013.01265; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; McHugh P J, 2001, Lancet Oncol, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mogi S, 2006, DNA REPAIR, V5, P731, DOI 10.1016/j.dnarep.2006.03.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285                                                         ; Murray D, 1996, INT J RADIAT BIOL, V69, P319, DOI 10.1080/095530096145878; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Nowotny M, 2016, CURR OPIN STRUC BIOL, V36, P97, DOI 10.1016/j.sbi.2016.01.003; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Perez-Oliva AB, 2015, EMBO J, V34, P326, DOI 10.15252/embj.201489184; Pizzolato J, 2015, J BIOL CHEM, V290, P22602, DOI 10.1074/jbc.M115.663666; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rahn JJ, 2010, ENVIRON MOL MUTAGEN, V51, P567, DOI 10.1002/em.20583; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sargent RG, 2000, NUCLEIC ACIDS RES, V28, P3771, DOI 10.1093/nar/28.19.3771; Sargent RG, 1997, P NATL ACAD SCI USA, V94, P13122, DOI 10.1073/pnas.94.24.13122; Schafer A, 2013, J INVEST DERMATOL, V133, P1841, DOI 10.1038/jid.2013.54; Schafer A, 2013, EXP DERMATOL, V22, P24, DOI 10.1111/exd.12052; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Schubert S, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.233; Seluanov A, 2010, JOVE-J VIS EXP, DOI [10.3791/2002, DOI 10.3791/2002]; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Takahashi D, 2015, J BIOCHEM, V158, P263, DOI 10.1093/jb/mvv043; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; VANVUUREN AJ, 1993, EMBO J, V12, P3693; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Wei CX, 2013, J GENET GENOMICS, V40, P281, DOI 10.1016/j.jgg.2013.03.013; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; WOOD RD, 1983, INT J RADIAT BIOL, V43, P207, DOI 10.1080/09553008314550241; Wood RD, 2010, ENVIRON MOL MUTAGEN, V51, P520, DOI 10.1002/em.20569; Yagi T, 1997, MUTAGENESIS, V12, P41, DOI 10.1093/mutage/12.1.41; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018	79	1	1	4	5	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUN	2017	74	11					2081	2094		10.1007/s00018-017-2455-7				14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EU2KD	WOS:000400856800010	28130555				2018-01-05	
J	Singh, NK				Singh, Nagendra Kumar			miRNAs target databases: developmental methods and target identification techniques with functional annotations	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Bioinformatics; Data mining; Genome; Biomarker; Pathology; High-throughput	GENE REGULATORY NETWORKS; SUPPORT VECTOR MACHINE; MICRORNA TARGETS; LINKING POLYMORPHISMS; POLYMIRTS DATABASE; COMPUTATIONAL PREDICTION; ARABIDOPSIS-THALIANA; INTEGRATED-SYSTEM; LEARNING APPROACH; ANIMAL MICRORNAS	Purpose microRNA (miRNA) regulates diverse biological mechanisms and metabolisms in plants and animals. Thus, the discoveries of miRNA has revolutionized the life sciences and medical research.The miRNA represses and cleaves the targeted mRNA by binding perfect or near perfect or imperfect complementary base pairs by RNA-induced silencing complex (RISC) formation during biogenesis process. One miRNA interacts with one or more mRNA genes and vice versa, hence takes part in causing various diseases. In this paper, the different microRNA target databases and their functional annotations developed by various researchers have been reviewed. The concurrent research review aims at comprehending the significance of miRNA and presenting the existing status of annotated miRNA target resources built by researchers henceforth discovering the knowledge for diagnosis and prognosis. Methods and results This review discusses the applications and developmental methodologies for constructing target database as well as the utility of user interface design. An integrated architecture is drawn and a graphically comparative study of present status of miRNA targets in diverse diseases and various biological processes is performed. These databases comprise of information such as miRNA target-associated disease, transcription factor binding sites (TFBSs) in miRNA genomic locations, polymorphism in miRNA target, A-to-I edited target, Gene Ontology (GO), genome annotations, KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways, target expression analysis, TF-miRNA and miRNA-mRNA interaction networks, drugs-targets interactions, etc. Conclusion miRNA target databases contain diverse experimentally and computationally predicted target through various algorithms. The comparison of various miRNA target database has been performed on various parameters. The computationally predicted target databases suffer from false positive information as there is no common theory for prediction of miRNA targets. The review conclusion emphasizes the need of more intelligent computational improvement for the miRNA target identification, their functional annotations and datasbase development.	[Singh, Nagendra Kumar] Maulana Azad Natl Inst Technol, Dept Biol Sci & Engn, Bhopal 462003, India	Singh, NK (reprint author), Maulana Azad Natl Inst Technol, Dept Biol Sci & Engn, Bhopal 462003, India.	nagendravns@gmail.com					Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Ahmadi H, 2013, GENOMICS, V101, P94, DOI 10.1016/j.ygeno.2012.11.005; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Bandyopadhyay S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-190; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9                                                   ; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chandra V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S2; Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168; Cho S, 2011, NUCLEIC ACIDS RES, V39, pD158, DOI 10.1093/nar/gkq1094; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dimitrov R, 2014, MOJ PROTEOMICS BIOIN, V1, DOI 10.15406/mojpb.2014.01.00024; Donal C, 2012, NEUROPSYCHOPHARMACOL, V38, P39, DOI [10.1038/npp.2012.87, DOI 10.1038/NPP.2012.87]; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eckardt NA, 2012, PLANT CELL, V24, P840, DOI 10.1105/tpc.112.240311; Ekimler S, 2014, GENES-BASEL, V5, P671, DOI 10.3390/genes5030671; Elefant N, 2011, NUCLEIC ACIDS RES, V39, pD188, DOI 10.1093/nar/gkq1233; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Friedman Y, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau043; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gennarino VA, 2011, GENE, V480, P51, DOI 10.1016/j.gene.2011.03.005; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; GUO ZW, 2015, DATABASE OXFORD 1021, DOI DOI 10.1093/DATABASE/BAV102; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Hulanicka M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0205-8; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Jha A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-636; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger Rehmsmeier M, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI [10.1093/nar/gkl243, DOI 10.1093/NAR/GKL243]; Kumar A, 2012, GENOMICS, V100, P352, DOI 10.1016/j.ygeno.2012.08.006; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Lagana A, 2012, BIOINFORMATICS, V28, P3166, DOI 10.1093/bioinformatics/bts589; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YJ, 2015, DRUG DEVELOP RES, V76, P389, DOI 10.1002/ddr.21278; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li SC, 2008, NUCLEIC ACIDS RES, V36, pD184, DOI 10.1093/nar/gkm610; Li SC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-164; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Mao YP, 2013, PHARMACOL RES, V75, P37, DOI 10.1016/j.phrs.2013.06.005; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martinez-Sanchez Aida, 2013, Biology (Basel), V2, P189, DOI 10.3390/biology2010189; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; Pio G, 2013, IT S ADV DAT SYST SE; Pio G, 2014, MACHINE LEARNING KNO, V8726, P508; Pio G, 2012, INT EUR C ART INT EC; Pio G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S9-S7; Pio G, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S4; Pio G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S8; Piriyapongsa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033888; Qu ZG, 2014, BIOMED RES INT, DOI 10.1155/2014/527895; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reyes-Herrera Paula H, 2012, Genomics, Proteomics & Bioinformatics, V10, P254, DOI 10.1016/j.gpb.2012.10.001; Reyes-Herrera PH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-454; Ru YB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku631; Rukov JL, 2014, BRIEF BIOINFORM, V15, P648, DOI 10.1093/bib/bbs082; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Saetrom O, 2005, RNA, V11, P995, DOI 10.1261/rna.7290705; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Singh Y, 2013, J BIOL CHEM, V288, P5056, DOI 10.1074/jbc.C112.439778; Sonali Bej, 2014, American Journal of Plant Sciences, V5, P748; Spadaro Paola A., 2012, Frontiers in Genetics, V3, P132, DOI 10.3389/fgene.2012.00132; Srivastava PK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-348; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Sun XL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-174; Sun YH, 2011, METHODS MOL BIOL, V744, P175, DOI 10.1007/978-1-61779-123-9_12; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xie FL, 2010, BIOINFORMATICS, V26, P3002, DOI 10.1093/bioinformatics/btq568; Yan XQ, 2007, FEBS LETT, V581, P1587, DOI 10.1016/j.febslet.2007.03.022; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang YL, 2009, DRUG DISCOV TODAY, V14, P147, DOI 10.1016/j.drudis.2008.12.005; Yang YC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S4; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	121	2	2	6	20	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUN	2017	74	12					2239	2261		10.1007/s00018-017-2469-1				23	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EU6CS	WOS:000401122200008	28204845				2018-01-05	
J	Lu, Q; Livi, GP; Modha, S; Yusa, K; Macarron, R; Dow, DJ				Lu, Quinn; Livi, George P.; Modha, Sundip; Yusa, Kosuke; Macarron, Ricardo; Dow, David J.			Applications of CRISPR genome editing technology in drug target identification and validation	EXPERT OPINION ON DRUG DISCOVERY			English	Review						CRISPR; drug discovery; genome editing; target validation	PLURIPOTENT STEM-CELLS; ORGANS-ON-CHIPS; HUMAN-DISEASE; ESSENTIAL GENES; REGULATORY DNA; CAS9 RIBONUCLEOPROTEINS; MUSCULAR-DYSTROPHY; CYNOMOLGUS MONKEY; VECTOR SYSTEM; RNAI SCREENS	Introduction: The analysis of pharmaceutical industry data indicates that the major reason for drug candidates failing in late stage clinical development is lack of efficacy, with a high proportion of these due to erroneous hypotheses about target to disease linkage. More than ever, there is a requirement to better understand potential new drug targets and their role in disease biology in order to reduce attrition in drug development. Genome editing technology enables precise modification of individual protein coding genes, as well as noncoding regulatory sequences, enabling the elucidation of functional effects in human disease relevant cellular systems. Areas covered: This article outlines applications of CRISPR genome editing technology in target identification and target validation studies. Expert opinion: Applications of CRISPR technology in target validation studies are in evidence and gaining momentum. Whilst technical challenges remain, we are on the cusp of CRISPR being applied in complex cell systems such as iPS derived differentiated cells and stem cell derived organoids. In the meantime, our experience to date suggests that precise genome editing of putative targets in primary cell systems is possible, offering more human disease relevant systems than conventional cell lines.	[Lu, Quinn; Livi, George P.; Macarron, Ricardo] GlaxoSmithKline R&D, Target Sci, Collegeville, PA USA; [Modha, Sundip; Dow, David J.] GlaxoSmithKline R&D, Target Sci, Stevenage, Herts, England; [Yusa, Kosuke] Wellcome Trust Sanger Inst, Cambridge, England; [Modha, Sundip; Dow, David J.] GlaxoSmithKline R&D, Discovery Res Cell & Gene Therapy, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England	Dow, DJ (reprint author), GSK Med Res Ctr, Stevenage SG1 2NY, Herts, England.	David.J.Dow@gsk.com			Wellcome Trust; GlaxoSmithKline	K Yusa is supported by the Wellcome Trust. All other authors are supported by GlaxoSmithKline.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Banno K, 2016, CELL REP, V15, P1228, DOI 10.1016/j.celrep.2016.04.031; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carlson-Stevermer J, 2016, STEM CELL REP, V6, P109, DOI 10.1016/j.stemcr.2015.11.014; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen Y, 2016, J INTERN MED, V280, P246, DOI 10.1111/joim.12469; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Clontech, 2016, EFF DEL ACT CAS9 PRO; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eder J, 2014, NAT REV DRUG DISCOV, V13, P577, DOI 10.1038/nrd4336; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Farnier M, 2014, ARCH CARDIOVASC DIS, V107, P58, DOI 10.1016/j.acvd.2013.10.007; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Grone BP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151148; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hofsteen P, 2016, P NATL ACAD SCI USA, V113, P1002, DOI 10.1073/pnas.1523930113; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu XL, 2013, CELL RES, V23, P1322, DOI 10.1038/cr.2013.141; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361                                                         ; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Kasap C, 2014, NAT CHEM BIOL, V10, P626, DOI 10.1038/nchembio.1551; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kiessling MK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3042-2; Kim D., 2015, NAT METHODS, V12, P1; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Lagutina IV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004951; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leung AWY, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0546-y; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liszczak GP, 2017, P NATL ACAD SCI USA, V114, P681, DOI 10.1073/pnas.1615723114; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Ma DY, 2015, GENOM PROTEOM BIOINF, V13, P336, DOI 10.1016/j.gpb.2015.12.001; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Marx V, 2014, NAT METHODS, V11, P1021, DOI 10.1038/nmeth.3108; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Munoz L, 2017, NAT REV DRUG DISCOV, DOI [10.1038/nrd.2016.266, DOI 10.1038/NRD.2016.266]; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Neggers JE, 2015, CHEM BIOL, V22, P107, DOI 10.1016/j.chembiol.2014.11.015; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nie J, 2017, EMBO REP, V18, P367, DOI 10.15252/embr.201643732; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Pannicke T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.317; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Patel DV, 1996, DRUG DISCOV TODAY, V1, P134, DOI 10.1016/1359-6446(96)89062-3                                                    ; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Plenge RM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2608; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reardon S, 2015, NATURE, V523, P266, DOI 10.1038/523266a; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Scannell JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147215; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Singh Atul K, 2016, Nucleic Acids Res, V44, pe143; Singh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131370; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Steyer B, 2016, ACTA BIOMATER, V34, P143, DOI 10.1016/j.actbio.2015.12.036; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wan HF, 2015, CELL RES, V25, P258, DOI 10.1038/cr.2014.158; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wanzel I, 2016, NAT CHEM BIOL, V12, P22, DOI [10.1038/NCHEMBIO.1965, 10.1038/nchembio.1965]; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu X, 2016, BIOTECHNOL LETT, V38, P919, DOI 10.1007/s10529-016-2064-9; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	142	0	0	16	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-0441	1746-045X		EXPERT OPIN DRUG DIS	Expert. Opin. Drug Discov.	JUN	2017	12	6					541	552		10.1080/17460441.2017.1317244				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EU8FB	WOS:000401272000002	28388235				2018-01-05	
J	Sun, C; Jin, WG; Shi, HC				Sun, Chao; Jin, Weiguo; Shi, Hongcan			Oligomeric proanthocyanidins protects A549 cells against H2O2-induced oxidative stress via the Nrf2-ARE pathway	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						oxidative stress; oligomeric proanthocyanidin; hydrogen peroxide; NF-E2-related factor 2; CPISPR/Cas9	EXPRESSION; ANTIOXIDANT; ACTIVATION; ROS; PROLIFERATION; MECHANISMS; RESISTANCE; TOXICITY; RADICALS; CANCER	Oxidative signaling and oxidative stress contribute to aging, cancer and diseases resulting from lung fibrosis. In this study, we explored the anti-oxidative potential of oligomeric proanthocyanidins (OPCs), natural flavonoid compounds. We examined the protective effects of OPCs against hydrogen peroxide (H2O2)-induced oxidative stress in non-small cell lung cancer cells (A549). We demonstrated that OPC markedly attenuated H2O2-induced A549 cell viability, as shown by by 3-[4,5-dimethylthiazol-2-yl)]-2,5-diphenyl-tetrazolium bromide (MTT) assay. At the same time, OPC inhibited H2O2-induced oxidative stress by significantly increasing the activities of superoxide dismutase, catalase and glutathione, and reducing the levels of reactive oxygen species (ROS) and malondialdehyde (MDA). Treatment of the A549 cells with OPC significantly promoted the nuclear translocation of NF-E2-related factor 2 (Nrf2) and significantly enhanced the expression of its target genes [heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1) and thioredoxin reductase 1 (TXNRD1)] with different fold change values at both the mRNA and protein level. The knockout of Nrf2 using CRISPR/Cas9 technology attenuated OPC-mediated ARE gene transcription, and almost abolished the OPC-mediated protective effects against H2O2-induced oxidative stress. On the whole, our study suggests that OPC plays an important role in controlling the antioxidant response of A549 cells via the Nrf2-ARE pathway.	[Sun, Chao; Jin, Weiguo; Shi, Hongcan] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Cardiothorac Surg, 98 West Nantong Rd, Yangzhou 225001, Jiangsu, Peoples R China	Shi, HC (reprint author), Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Cardiothorac Surg, 98 West Nantong Rd, Yangzhou 225001, Jiangsu, Peoples R China.	hongcanshi01@163.com					Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Forkink M, 2015, REDOX BIOL, V6, P607, DOI 10.1016/j.redox.2015.09.003; Garcia-Conesa MT, 2009, MOL NUTR FOOD RES, V53, P266, DOI 10.1002/mnfr.200800134; Hamilton JW, 1989, CARCINOGENESIS, V2, P274; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Hong H, 2004, PLANTA MED, V70, P427, DOI 10.1055/s-2004-818970; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kobayashi E., 2013, OXID MED CELL LONGEV, V2013; Min KJ, 2011, CELL SIGNAL, V23, P1505, DOI 10.1016/j.cellsig.2011.05.013; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Ray SD, 2005, MUTAT RES-FUND MOL M, V579, P81, DOI 10.1016/j.mrfmmm.2005.02.017; Reddy NM, 2008, ONCOGENE, V27, P5821, DOI 10.1038/onc.2008.188; SHASBY DM, 1982, AM REV RESPIR DIS, V125, P443; Tatsuno T., 2012, PHARM B, V35, P909; Villeneuve NF, 2013, MOL CELL, V51, P68, DOI 10.1016/j.molcel.2013.04.022; Wang ZG, 2015, BIOCHEM BIOPH RES CO, V458, P757, DOI 10.1016/j.bbrc.2015.01.153; Zubovych IO, 2010, MOL BIOL CELL, V21, P956, DOI 10.1091/mbc.E09-08-0673	29	0	0	15	27	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUN	2017	39	6					1548	1554		10.3892/ijmm.2017.2971				7	Medicine, Research & Experimental	Research & Experimental Medicine	EU5LV	WOS:000401073900023	28487966				2018-01-05	
J	Tang, LC; Zeng, YT; Du, HZ; Gong, MM; Peng, J; Zhang, BX; Lei, M; Zhao, F; Wang, WH; Li, XW; Liu, JQ				Tang, Lichun; Zeng, Yanting; Du, Hongzi; Gong, Mengmeng; Peng, Jin; Zhang, Buxi; Lei, Ming; Zhao, Fang; Wang, Weihua; Li, Xiaowei; Liu, Jianqiao			CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein	MOLECULAR GENETICS AND GENOMICS			English	Article						CRISPR/Cas9; Homology-directed repair (HDR); Cas9 protein; Gene modification; Human zygotes	ONE-STEP GENERATION; BREAK REPAIR; GENOME; MUTATIONS; SYSTEMS; MICE; DNA; RIBONUCLEOPROTEINS; ELECTROPORATION; PATHWAY	Previous works using human tripronuclear zygotes suggested that the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system could be a tool in correcting disease-causing mutations. However, whether this system was applicable in normal human (dual pronuclear, 2PN) zygotes was unclear. Here we demonstrate that CRISPR/Cas9 is also effective as a gene-editing tool in human 2PN zygotes. By injection of Cas9 protein complexed with the appropriate sgRNAs and homology donors into one-cell human embryos, we demonstrated efficient homologous recombination-mediated correction of point mutations in HBB and G6PD. However, our results also reveal limitations of this correction procedure and highlight the need for further research.	[Tang, Lichun; Gong, Mengmeng; Peng, Jin; Zhang, Buxi] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China; [Tang, Lichun] Natl Ctr Prot Sci Beijing, Life Sci Pk, Beijing 102206, Peoples R China; [Zeng, Yanting; Du, Hongzi; Lei, Ming; Liu, Jianqiao] Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510150, Guangdong, Peoples R China; [Zhao, Fang] Guangxi Med Univ, Collaborat Innovat Ctr Targeting Tumor Diag & The, Natl Ctr Int Res Biol Targeting Diag & Therapy, Guangxi, Guangxi 530021, Peoples R China; [Wang, Weihua] Houston Fertil Inst, Houston, TX 77063 USA; [Li, Xiaowei] Nanjing Univ Chineses Med, Dept Cardiol, Bayi Hosp, Nanjing 210002, Jiangsu, Peoples R China	Tang, LC (reprint author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.; Tang, LC (reprint author), Natl Ctr Prot Sci Beijing, Life Sci Pk, Beijing 102206, Peoples R China.; Liu, JQ (reprint author), Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510150, Guangdong, Peoples R China.; Li, XW (reprint author), Nanjing Univ Chineses Med, Dept Cardiol, Bayi Hosp, Nanjing 210002, Jiangsu, Peoples R China.	1212qq-@163.com; lxw7402@126.com; ljq88gz@163.com			Beijing Municipal Committee on Science and Technology [Z141100000214015]; National Basic Research Program (973 Program) [2013CB910300]; Science and Technology Program of Guangzhou, China [2014KZDXM047]; Innovation of Science and Technology Commission of Guangzhou, China [201604020075]; Department of Science and Technology of Guangdong, China [2016A020218012]; China Postdoctoral Science Foundation [2013M532214];  [2013DFB30210]	This study was funded by a Grant from the Beijing Municipal Committee on Science and Technology (#Z141100000214015), by an international collaboration Grant from the Chinese Minister of Science and Technology (#2013DFB30210), by The National Basic Research Program (973 Program, No. 2013CB910300), by a Grant from the Science and Technology Program of Guangzhou, China (#2014KZDXM047), by The Innovation of Science and Technology Commission of Guangzhou, China (No. 201604020075), by The Department of Science and Technology of Guangdong, China (No. 2016A020218012), and a Grant from the China Postdoctoral Science Foundation (#2013M532214).	Capmany G, 1996, Mol Hum Reprod, V2, P299, DOI 10.1093/molehr/2.5.299; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Du CS, 1999, HUM HERED, V49, P133, DOI 10.1159/000022860                                                               ; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586                                                          ; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; KIMURA A, 1983, J BIOL CHEM, V258, P2748; Lee JS, 2014, G3-GENES GENOM GENET, V4, P1291, DOI 10.1534/g3.114.012179; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	26	20	20	63	75	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	JUN	2017	292	3					525	533		10.1007/s00438-017-1299-z				9	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	EU9EZ	WOS:000401342100004	28251317				2018-01-05	
J	Zhang, MZM; Wong, FT; Wang, YJ; Luo, SW; Lim, YH; Heng, E; Yeo, WL; Cobb, RE; Enghiad, B; Ang, EL; Zhao, HM				Zhang, Mingzi M.; Wong, Fong Tian; Wang, Yajie; Luo, Shangwen; Lim, Yee Hwee; Heng, Elena; Yeo, Wan Lin; Cobb, Ryan E.; Enghiad, Behnam; Ang, Ee Lui; Zhao, Huimin			CRISPR-Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCTS; CLONING; IDENTIFICATION; ROSEOSPORUS; EXPRESSION; DISCOVERY; PATHWAY; SYSTEM; ALBUS	Here we report an efficient CRISPR-Cas9 knock-in strategy to activate silent biosynthetic gene clusters (BGCs) in streptomycetes. We applied this one-step strategy to activate multiple BGCs of different classes in five Streptomyces species and triggered the production of unique metabolites, including a novel pentangular type II polyketide in Streptomyces viridochromogenes. This potentially scalable strategy complements existing activation approaches and facilitates discovery efforts to uncover new compounds with interesting bioactivities.	[Zhang, Mingzi M.; Yeo, Wan Lin; Ang, Ee Lui; Zhao, Huimin] Agcy Sci Technol & Res, Metab Engn Res Lab, Sci & Engn Inst, Singapore, Singapore; [Wong, Fong Tian; Heng, Elena] ASTAR, Biomed Sci Inst, Mol Engn Lab, Singapore, Singapore; [Wang, Yajie; Luo, Shangwen; Cobb, Ryan E.; Enghiad, Behnam; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Lim, Yee Hwee] ASTAR, Inst Chem & Engn Sci, Organ Chem, Singapore, Singapore	Zhao, HM (reprint author), Agcy Sci Technol & Res, Metab Engn Res Lab, Sci & Engn Inst, Singapore, Singapore.; Zhao, HM (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA.	zhao5@illinois.edu		Wong, Fong T./0000-0001-6145-5904	National Institutes of Health [GM077596]; A*STAR Visiting Investigator Program; National Research Foundation, Singapore [NRF2013-THE001-094]; NIH [S10-RR028833]	We gratefully acknowledge financial support from the National Institutes of Health (GM077596) (H.Z.), the A*STAR Visiting Investigator Program (H.Z.), and the National Research Foundation, Singapore (NRF2013-THE001-094) (M.M.Z., F.T.W., Y.H.L., E.L.A. and H.Z.). NMR data collection at the UIUC IGB Core was funded by NIH (S10-RR028833). Conjugative donor strains of E. coli were gifted by Prof. William Metcalf at UIUC. We thank members of the Zhao laboratory in UIUC, co-workers in MEL and MERL in A*STAR for constructive comments, Dr. Xudong Guan and Dr. Lingyang Zhu from UIUC for assisting with NMR data acquisition, and Dr. Ying Swan Ho from BTI, A*STAR for HRMS data acquisition.	Bruheim P, 2002, J IND MICROBIOL BIOT, V28, P103, DOI 10.1038/sj/jim/7000219; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cobb RE, 2012, NAT BIOTECHNOL, V30, P405, DOI 10.1038/nbt.2207; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; Hillenmeyer ME, 2015, P NATL ACAD SCI USA, V112, P13952, DOI 10.1073/pnas.1511688112; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kang HS, 2016, ACS SYNTH BIOL, V5, P1002, DOI 10.1021/acssynbio.6b00080; Kieser T., 2000, PRACTICAL STREPTOMYC; Lackner G, 2007, J AM CHEM SOC, V129, P9306, DOI 10.1021/ja0718624; Liu WT, 2014, J ANTIBIOT, V67, P99, DOI 10.1038/ja.2013.99; Luo YZ, 2015, ACS SYNTH BIOL, V4, P1001, DOI 10.1021/acssynbio.5b00016; Luo YZ, 2014, CURR OPIN BIOTECH, V30, P230, DOI 10.1016/j.copbio.2014.09.002; Luo YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3894; MALPARTIDA F, 1990, GENE, V93, P91, DOI 10.1016/0378-1119(90)90141-D; Moree WJ, 2014, ACS CHEM BIOL, V9, P2300, DOI 10.1021/cb500432j; OKUHARA M, 1980, J ANTIBIOT, V33, P13, DOI 10.7164/antibiotics.33.13                                                       ; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Rhee KH, 2006, J MICROBIOL BIOTECHN, V16, P1841; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Wang WS, 2013, APPL ENVIRON MICROB, V79, P4484, DOI 10.1128/AEM.00985-13; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Zeng H, 2015, APPL MICROBIOL BIOT, V99, P10575, DOI 10.1007/s00253-015-6931-4; Zhang MM, 2016, NAT PROD REP, V33, P963, DOI 10.1039/c6np00017g	27	4	4	15	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2017	13	6					607	U173		10.1038/nchembio.2341				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV0HN	WOS:000401419300011					2018-01-05	
J	Uehara, T; Minoshima, Y; Sagane, K; Sugi, NH; Mitsuhashi, KO; Yamamoto, N; Kamiyama, H; Takahashi, K; Kotake, Y; Uesugi, M; Yokoi, A; Inoue, A; Yoshida, T; Mabuchi, M; Tanaka, A; Owa, T				Uehara, Taisuke; Minoshima, Yukinori; Sagane, Koji; Sugi, Naoko Hata; Mitsuhashi, Kaoru Ogawa; Yamamoto, Noboru; Kamiyama, Hiroshi; Takahashi, Kentaro; Kotake, Yoshihiko; Uesugi, Mai; Yokoi, Akira; Inoue, Atsushi; Yoshida, Taku; Mabuchi, Miyuki; Tanaka, Akito; Owa, Takashi			Selective degradation of splicing factor CAPER alpha by anticancer sulfonamides	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE PROTACS; E3 UBIQUITIN LIGASE; INTEGRIN ALPHA-2; IN-VIVO; PROTEIN-DEGRADATION; INHIBITOR; EXPRESSION; COMPLEX; THALIDOMIDE; CEREBLON	Target-protein degradation is an emerging field in drug discovery and development. In particular, the substrate-receptor proteins of the cullin-ubiquitin ligase system play a key role in selective protein degradation, which is an essential component of the anti-myeloma activity of immunomodulatory drugs (IMiDs), such as lenalidomide. Here, we demonstrate that a series of anticancer sulfonamides NSC 719239 (E7820), indisulam, and NSC 339004 (chloroquinoxaline sulfonamide, CQS) induce proteasomal degradation of the U2AF-related splicing factor coactivator of activating protein-1 and estrogen receptors (CAPER alpha) via CRL4(DCAF15) mediated ubiquitination in human cancer cell lines. Both CRISPR-Cas9-based knockout of DCAF15 and a single amino acid substitution of CAPER alpha conferred resistance against sulfonamide-induced CAPER alpha degradation and cell-growth inhibition. Thus, these sulfonamides represent selective chemical probes for disrupting CAPER alpha function and designate DCAFs as promising drug targets for promoting selective protein degradation in cancer therapy.	[Uehara, Taisuke; Minoshima, Yukinori; Sagane, Koji; Sugi, Naoko Hata; Mitsuhashi, Kaoru Ogawa; Yamamoto, Noboru; Kamiyama, Hiroshi; Takahashi, Kentaro; Kotake, Yoshihiko; Uesugi, Mai; Yokoi, Akira; Inoue, Atsushi; Yoshida, Taku] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan; [Mabuchi, Miyuki; Tanaka, Akito] Hyogo Univ Hlth Sci, Sch Pharm, Chuo Ku, Kobe, Hyogo, Japan; [Owa, Takashi] Eisai Inc, Woodcliff Lake, NJ USA	Uehara, T (reprint author), Eisai & Co Ltd, Tsukuba, Ibaraki, Japan.	t3-uehara@hhc.eisai.co.jp; takashi_owa@91.alumni.u-tokyo.ac.jp					Abbate F, 2004, BIOORG MED CHEM LETT, V14, P217, DOI 10.1016/j.bmcl.2003.09.062; Baur M, 2007, MELANOMA RES, V17, P329, DOI 10.1097/CMR.0b013e3282ef4189                                                    ; Bekaii-Saab TS, 2006, INVEST NEW DRUG, V24, P343, DOI 10.1007/s10637-005-4827-3; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/nchembio.1858, 10.1038/NCHEMBIO.1858]; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Egertson JD, 2015, NAT PROTOC, V10, P887, DOI 10.1038/nprot.2015.055; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Funahashi Y, 2002, CANCER RES, V62, P6116; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Huang GX, 2012, CANCER-AM CANCER SOC, V118, P2106, DOI 10.1002/cncr.26488; IMAI H, 1993, J CLIN INVEST, V92, P2419, DOI 10.1172/JCI116848; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jung DJ, 2002, J BIOL CHEM, V277, P1229, DOI 10.1074/jbc.M110417200; Kang YK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005116; Kim KB, 2013, NAT PROD REP, V30, P600, DOI 10.1039/c3np20126k; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loerch S, 2014, J BIOL CHEM, V289, P17325, DOI 10.1074/jbc.M114.558825; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mita M, 2011, CLIN CANCER RES, V17, P193, DOI 10.1158/1078-0432.CCR-10-0010; Ozawa Y, 2001, EUR J CANCER, V37, P2275, DOI 10.1016/S0959-8049(01)00275-1; Petzold G., 2016, NATURE, V532, P127, DOI DOI 10.1038/NATURE16979;PMID:26909574; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Semba T, 2004, CLIN CANCER RES, V10, P1430, DOI 10.1158/1078-0432.CCR-0109-03                                                   ; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Toure M, 2016, ANGEW CHEM INT EDIT, V55, P1966, DOI 10.1002/anie.201507978; Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yokoi A, 2002, MOL CANCER THER, V1, P275; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216	44	5	5	14	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2017	13	6					675	+		10.1038/nchembio.2363				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV0HN	WOS:000401419300022	28437394				2018-01-05	
J	Walters, BJ; Mercaldo, V; Gillon, CJ; Yip, M; Neve, RL; Boyce, FM; Frankland, PW; Josselyn, SA				Walters, Brandon J.; Mercaldo, Valentina; Gillon, Colleen J.; Yip, Matthew; Neve, Rachael L.; Boyce, Frederick M.; Frankland, Paul W.; Josselyn, Sheena A.			The Role of The RNA Demethylase FTO (Fat Mass and Obesity-Associated) and mRNA Methylation in Hippocampal Memory Formation	NEUROPSYCHOPHARMACOLOGY			English	Article							PROTEIN-SYNTHESIS; FEAR; CONSOLIDATION; M(6)A; N-6-METHYLADENOSINE; RETRIEVAL; MICE; REPRESENTATIONS; M6A; CA1	The formation of long-lasting memories requires coordinated changes in gene expression and protein synthesis. Although many studies implicate DNA modifications (DNA methylation, histone modifications) in memory formation, the contributions of RNA modifications remain largely unexplored. Here we investigated the role of mRNA methylation in hippocampal-dependent memory formation in mice. RNA modifications are highly dynamic and readily reversible. Methyltransferases add a methyl group to mRNA while demethylases remove methyl groups. Here we focused on examining the role of the best characterized RNA demethylase, FTO (fat mass and obesityassociated) in memory. We observed that FTO is expressed in the nuclei, dendrites and near dendritic spines of mouse dorsal hippocampal CA1 neurons. Next, we found that contextual fear conditioning transiently (0.5 h) decreased Fto levels in these neurons, with the largest decrease in FTO observed near synapses. The decrease in FTO observed shortly after contextual fear conditioning suggests that FTO normally constrains memory formation. To directly test this, we artificially decreased FTO levels in dorsal hippocampus of otherwise normal (wild-type) mice by microinjecting before training a single herpes simplex virus (HSV) vector expressing either CRISPR/Cas9 or shRNA targeted against Fto. Decreasing FTO using either method specifically enhanced contextual fear memory. Together, these results show the importance of FTO during memory formation and, furthermore, implicate mRNA modification and epi-transcriptomics as novel regulators of memory formation.	[Walters, Brandon J.; Mercaldo, Valentina; Gillon, Colleen J.; Yip, Matthew; Frankland, Paul W.; Josselyn, Sheena A.] Hosp Sick Children, Dept Neurosci & Mental Hlth, Toronto, ON, Canada; [Walters, Brandon J.; Mercaldo, Valentina; Gillon, Colleen J.; Yip, Matthew; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Walters, Brandon J.; Mercaldo, Valentina; Yip, Matthew; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Boyce, Frederick M.] Massachusetts Gen Hosp, Dept Neurol, Cambridge, MA USA	Josselyn, SA (reprint author), Univ Toronto, Hosp Sick Children, IMS, Dept Psychol,Physiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	Sheena.Josselyn@SickKids.ca			Canadian Institutes of Health Research (CIHR) [MOP-74650, FDN143227]; Natural Science and Engineering Council of Canada (NSERCs); Brain Canada; Brain & Behavior Foundation; SickKids Research Training Centre Restracomp Fellowship	This work was supported by grants from the Canadian Institutes of Health Research (CIHR, grant numbers MOP-74650 to SAJ, FDN143227 to PWF), Natural Science and Engineering Council of Canada (NSERCs to SAJ and PWF), Brain Canada (SAJ) and a Brain & Behavior Foundation grant (SAJ). BJW was partially supported by a SickKids Research Training Centre Restracomp Fellowship (to BJW). SAJ and PWF are both members of the Canadian Institute for Advanced Research (CIFAR). The authors declare no conflict of interest.	Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; BOLLES RC, 1982, ANNU REV PSYCHOL, V33, P87, DOI 10.1146/annurev.ps.33.020182.000511                                             ; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/NMETH.1328, 10.1038/nmeth.1328]; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Duvarci S, 2008, LEARN MEMORY, V15, P747, DOI 10.1101/lm.1027208; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037//0735-7044.112.4.863; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hernandez PJ, 2008, NEUROBIOL LEARN MEM, V89, P293, DOI 10.1016/j.nlm.2007.09.010; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hoernes TP, 2016, NUCLEIC ACIDS RES, V44, P852, DOI 10.1093/nar/gkv1182; Ji JZ, 2008, LEARN MEMORY, V15, P244, DOI 10.1101/lm.794808; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu N, 2016, NAT STRUCT MOL BIOL, V23, P98, DOI 10.1038/nsmb.3162; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nakazawa Y, 2016, HIPPOCAMPUS, V26, P1140, DOI 10.1002/hipo.22596; Neve RL, 2012, CURR PROTOC NEUROSCI; Niu Yamei, 2013, Genomics, Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pilo Boyl Pietro, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Sekeres MJ, 2010, LEARN MEMORY, V17, P280, DOI 10.1101/lm.1785510; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3                                                   ; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Widagdo J, 2016, J NEUROSCI, V36, P6771, DOI 10.1523/JNEUROSCI.4053-15.2016; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037//0735-7044.115.1.26; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Wood SC, 2011, NEUROSCI LETT, V505, P134, DOI 10.1016/j.neulet.2011.10.006; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zovkic IB, 2014, NATURE, V515, P582, DOI 10.1038/nature13707	45	1	1	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	JUN	2017	42	7					1502	1510		10.1038/npp.2017.31				9	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	EU7TW	WOS:000401238600014	28205605				2018-01-05	
J	Xie, XD; Qin, GY; Si, P; Luo, ZP; Gao, JP; Chen, X; Zhang, JF; Wei, P; Xia, QY; Lin, FC; Yang, J				Xie, Xiaodong; Qin, Guangyong; Si, Ping; Luo, Zhaopeng; Gao, Junping; Chen, Xia; Zhang, Jianfeng; Wei, Pan; Xia, Qingyou; Lin, Fucheng; Yang, Jun			Analysis of Nicotiana tabacum PIN genes identifies NtPIN4 as a key regulator of axillary bud growth	PHYSIOLOGIA PLANTARUM			English	Article							POLAR AUXIN TRANSPORT; PLANT DEVELOPMENT; ENDOPLASMIC-RETICULUM; ABIOTIC STRESS; ARABIDOPSIS; EXPRESSION; HOMEOSTASIS; PROTEINS; FAMILY; CYTOKININ	The plant-specific PIN-FORMED (PIN) auxin efflux proteins have been well characterized in many plant species, where they are crucial in the regulation of auxin transport in various aspects of plant development. However, little is known about the exact roles of the PIN genes during plant development in Nicotiana species. This study investigated the PIN genes in tobacco (Nicotiana tabacum) and in two ancestral species (Nicotiana sylvestris and Nicotiana tomentosiformis). Genome-wide analysis of the N. tabacum genome identified 20 genes of the PIN family. An in-depth phylogenetic analysis of the PIN genes of N. tabacum, N. sylvestris and N. tomentosiformis was conducted. NtPIN4 expression was strongly induced by the application of exogenous indole-3-acetic acid (IAA), but was downregulated by the application of ABA, a strigolactone analogue, and cytokinin, as well as by decapitation treatments, suggesting that the NtPIN4 expression level is likely positively regulated by auxin. Expression analysis indicated that NtPIN4 was highly expressed in tobacco stems and shoots, which was further validated through analysis of the activity of the NtPIN4 promoter. We used CRISPR-Cas9 technology to generate mutants for NtPIN4 and observed that both T-0 and T-1 plants had a significantly increased axillary bud growth phenotype, as compared with the wild-type plants. Therefore, NtPIN4 offers an opportunity for studying auxin-dependent branching processes.	[Xie, Xiaodong; Luo, Zhaopeng; Chen, Xia; Zhang, Jianfeng; Wei, Pan; Lin, Fucheng; Yang, Jun] Zhengzhou Tobacco Res Inst CNTC, China Tobacco Gene Res Ctr, Zhengzhou 450001, Peoples R China; [Xie, Xiaodong; Qin, Guangyong] Zhengzhou Univ, Coll Phys Engn, Zhengzhou 450001, Peoples R China; [Si, Ping] Univ Western Australia, Sch Plant Biol, Ctr Plant Genet & Breeding, Crawley 6009, Australia; [Gao, Junping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China	Yang, J (reprint author), Zhengzhou Tobacco Res Inst CNTC, China Tobacco Gene Res Ctr, Zhengzhou 450001, Peoples R China.	yangjun@ztri.com.cn		Si, Ping/0000-0001-9205-3908	Project of Tobacco Transcription Factors Array Design and Expression Regulation of Key Transcription Factors [902014AA0520]; postdoctoral scientific research project of Henan Province	This work was supported by the Project of Tobacco Transcription Factors Array Design and Expression Regulation of Key Transcription Factors (902014AA0520) and a grant for postdoctoral scientific research project of Henan Province. We also thank Dr John Hugh Snyder and Zhong Wang for his kind help in revising this manuscript.	Balzan Sara, 2014, Front Plant Sci, V5, P393, DOI 10.3389/fpls.2014.00393; Band LR, 2014, PLANT CELL, V26, P862, DOI 10.1105/tpc.113.119495; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Bennett T, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002446; Bennett T, 2015, TRENDS PLANT SCI, V20, P498, DOI 10.1016/j.tplants.2015.05.005; Bennett T, 2014, MOL BIOL EVOL, V31, P2042, DOI 10.1093/molbev/msu147; Boivin S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01240; Brewer PB, 2015, PLANT PHYSIOL, V168, P1820, DOI 10.1104/pp.15.00014; Brewer PB, 2009, PLANT PHYSIOL, V150, P482, DOI 10.1104/pp.108.134783; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Carraro N, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00017; Cervera M, 2005, METH MOL B, V286, P203; Clouse RM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00296; Dal Bosco C, 2012, PLANT SIGNAL BEHAV, V7, P1504, DOI 10.4161/psb.21953; Dal Bosco C, 2012, PLANT J, V71, P860, DOI 10.1111/j.1365-313X.2012.05037.x; Ding ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1941; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Dun EA, 2006, PLANT PHYSIOL, V142, P812, DOI 10.1104/pp.106.086868; Forestan C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00016; Friml J, 2002, NATURE, V415, P806; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2010, EUR J CELL BIOL, V89, P231, DOI 10.1016/j.ejcb.2009.11.003; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Ganguly A, 2014, PLANT CELL, V26, P1570, DOI 10.1105/tpc.113.118422; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Lazar G, 2006, P NATL ACAD SCI USA, V103, P472, DOI 10.1073/pnas.0509463102; Liu BB, 2014, J EXP BOT, V65, P2437, DOI 10.1093/jxb/eru129; Morris SE, 2005, PLANT PHYSIOL, V138, P1665, DOI 10.1104/pp.104.058743; Mounet F, 2012, J EXP BOT, V63, P4901, DOI 10.1093/jxb/ers167; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Naseem M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003026; O'Connor DL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003447; OKADA K, 1991, PLANT CELL, V3, P677; Pan X, 2015, CURR OPIN PLANT BIOL, V28, P144, DOI 10.1016/j.pbi.2015.10.009; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Pattison RJ, 2012, PLANT J, V70, P585, DOI 10.1111/j.1365-313X.2011.04895.x; Pernisova M, 2011, CURR PROTEIN PEPT SC, V12, P137, DOI 10.2174/138920311795684887                                                      ; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Sawchuk MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003294; Schaller GE, 2015, PLANT CELL, V27, P44, DOI 10.1105/tpc.114.133595; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Shen CJ, 2010, FEBS J, V277, P2954, DOI 10.1111/j.1742-4658.2010.07706.x; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Sierro N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r60; Simon S, 2016, NEW PHYTOL, V211, P65, DOI 10.1111/nph.14019; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Viaene T, 2014, CURR BIOL, V24, P2786, DOI 10.1016/j.cub.2014.09.056; Viaene T, 2013, TRENDS PLANT SCI, V18, P5, DOI 10.1016/j.tplants.2012.08.009; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; Wang YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2149-1; Yao C, 2015, PLANT PHYSIOL, V169, P611, DOI 10.1104/pp.15.00682; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	62	0	1	7	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-9317	1399-3054		PHYSIOL PLANTARUM	Physiol. Plant.	JUN	2017	160	2					222	239		10.1111/ppl.12547				18	Plant Sciences	Plant Sciences	EU7TS	WOS:000401238200008	28128458				2018-01-05	
J	Cooper, CA; Challagulla, A; Jenkins, KA; Wise, TG; O'Neil, TE; Morris, KR; Tizard, ML; Doran, TJ				Cooper, Caitlin A.; Challagulla, Arjun; Jenkins, Kristie A.; Wise, Terry G.; O'Neil, Terri E.; Morris, Kirsten R.; Tizard, Mark L.; Doran, Timothy J.			Generation of gene edited birds in one generation using sperm transfection assisted gene editing (STAGE)	TRANSGENIC RESEARCH			English	Article						Gene editing; CRISPR/Cas9; Avian models; Genome engineering	PRIMORDIAL GERM-CELLS; EXOGENOUS DNA; CRISPR/CAS9 SYSTEM; EGG-WHITE; GENOME; EFFICIENT; CHICKEN; MICE; REPAIR; TRANSMISSION	Generating transgenic and gene edited mammals involves in vitro manipulation of oocytes or single cell embryos. Due to the comparative inaccessibility of avian oocytes and single cell embryos, novel protocols have been developed to produce transgenic and gene edited birds. While these protocols are relatively efficient, they involve two generation intervals before reaching complete somatic and germline expressing transgenic or gene edited birds. Most of this work has been done with chickens, and many protocols require in vitro culturing of primordial germ cells (PGCs). However, for many other bird species no methodology for long term culture of PGCs exists. Developing methodologies to produce germline transgenic or gene edited birds in the first generation would save significant amounts of time and resource. Furthermore, developing protocols that can be readily adapted to a wide variety of avian species would open up new research opportunities. Here we report a method using sperm as a delivery mechanism for gene editing vectors which we call sperm transfection assisted gene editing (STAGE). We have successfully used this method to generate GFP knockout embryos and chickens, as well as generate embryos with mutations in the doublesex and mab-3 related transcription factor 1 (DMRT1) gene using the CRISPR/Cas9 system. The efficiency of the method varies from as low as 0% to as high as 26% with multiple factors such as CRISPR guide efficiency and mRNA stability likely impacting the outcome. This straightforward methodology could simplify gene editing in many bird species including those for which no methodology currently exists.	[Cooper, Caitlin A.; Challagulla, Arjun; Jenkins, Kristie A.; Wise, Terry G.; O'Neil, Terri E.; Morris, Kirsten R.; Tizard, Mark L.; Doran, Timothy J.] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia	Doran, TJ (reprint author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Timothy.Doran@csiro.au	Doran, Timothy/B-3824-2011; Morris, Kirsten/Q-4836-2017		Commonwealth Scientific and Industrial Research Organisation	The authors would like to thank Sandy Matheson, Noel Collins, Chris Darcy, and Susan Wilson for helping care for and handle the animals used in this study. We would also like to thank Matt Bruce for technical assistance with the flow cytometer. This study was funded by the Commonwealth Scientific and Industrial Research Organisation.	Ahammad MU, 2013, BRIT POULTRY SCI, V54, P270, DOI 10.1080/00071668.2013.778956; An LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25199; Balic A, 2014, DEVELOPMENT, V141, P3255, DOI 10.1242/dev.105593; Ball BA, 2008, EQUINE VET J, V40, P76, DOI 10.2746/042516407X235786; BISHOP JO, 1989, MOL BIOL MED, V6, P283; Brocal I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2563-z; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Celebi C, 2003, BIOL REPROD, V68, P1477, DOI 10.1095/biolreprod.102.009340; Collares T, 2011, J BIOSCIENCES, V36, P613, DOI 10.1007/s12038-011-9098-x; CONRAD K, 1971, J REPROD FERTIL, V27, P133; Dai J, 2010, INT J BIOL SCI, V6, P756; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Dhanapala P, 2015, MOL IMMUNOL, V65, P104, DOI 10.1016/j.molimm.2015.01.006; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Elis S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-110; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gandolfi F, 2000, THERIOGENOLOGY, V53, P127, DOI 10.1016/S0093-691X(99)00246-0; Garcia-Vazquez FA, 2009, THERIOGENOLOGY, V72, P506, DOI 10.1016/j.theriogenology.2009.04.006; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Huang AY, 2014, CELL RES, V24, P1311, DOI 10.1038/cr.2014.131; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lake P. E., 1957, Journal of Agricultural Science, V49, P120; LAKE PE, 1979, J REPROD FERTIL, V57, P149; Lambeth LS, 2016, ENDOCRINOLOGY, V157, P83, DOI 10.1210/en.2015-1697; Lambeth LS, 2014, DEV BIOL, V389, P160, DOI 10.1016/j.ydbio.2014.02.012; LAVITRANO M, 1989, CELL, V57, P717, DOI 10.1016/0092-8674(89)90787-3; LAVITRANO M, 1992, MOL REPROD DEV, V31, P161, DOI 10.1002/mrd.1080310302; Lee HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084272; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lin CY, 2016, DEV BIOL, V409, P420, DOI 10.1016/j.ydbio.2015.11.018; Liu TX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127922; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lord T, 2015, DEV BIOL, V406, P1, DOI 10.1016/j.ydbio.2015.07.024; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04489; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetti F, 2015, SCI REP-UK, V5, DOI 10.1038/srep07689; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MILLER DJ, 1993, J CELL BIOL, V123, P1431, DOI 10.1083/jcb.123.6.1431; Hoa NN, 2015, GENES CELLS, V20, P1059, DOI 10.1111/gtc.12310; Men NT, 2016, ANIM SCI J, V87, P1325, DOI 10.1111/asj.12554; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Oliver D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129457; Park TS, 2015, FASEB J, V29, P2386, DOI 10.1096/fj.14-264739; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Pereyra-Bonnet F, 2011, J REPROD DEVELOP, V57, P188, DOI 10.1262/jrd.10-063A; Shemesh M, 2000, MOL REPROD DEV, V56, P306, DOI 10.1002/(SICI)1098-2795(200006)56:2+<306::AID-MRD21>3.3.CO;2-V; Shen W, 2006, MOL REPROD DEV, V73, P589, DOI 10.1002/mrd.20401; Shimada K, 2014, GEN COMP ENDOCR, V196, P100, DOI 10.1016/j.ygcen.2013.11.001; Singh RP, 2016, GENOME, V59, P185, DOI 10.1139/gen-2015-0106; Siudzinska A, 2008, J APPL POULTRY RES, V17, P101, DOI 10.3382/japr.2007-00048; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith K, 2005, BIOESSAYS, V27, P551, DOI 10.1002/bies.20211; Song YH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113381; Suzuki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07621; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32271; Wei JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11735; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Wishart GJ, 1997, ANIM REPROD SCI, V48, P81, DOI 10.1016/S0378-4320(97)00042-0; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Zagris N, 1998, ZYGOTE, V6, P227, DOI 10.1017/S0967199498000161; ZANI M, 1995, EXP CELL RES, V217, P57, DOI 10.1006/excr.1995.1063; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	74	2	2	9	13	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	JUN	2017	26	3					331	347		10.1007/s11248-016-0003-0				17	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	EU3VK	WOS:000400958900002	27896535				2018-01-05	
J	Albers, E; Sbroggio, M; Martin-Gonzalez, J; Avram, A; Munk, S; Lopez-Contreras, A				Albers, Eliene; Sbroggio, Mauro; Martin-Gonzalez, Javier; Avram, Alexandra; Munk, Stephanie; Lopez-Contreras, Andres J.			A simple DNA recombination screening method by RT-PCR as an alternative to Southern blot	TRANSGENIC RESEARCH			English	Article						Transgenic mouse; mESC screening; Southern blot; RT-PCR	SYSTEM; GENOME	The generation of genetically engineered mouse models (GEMMs), including knock-out (KO) and knock-in (KI) models, often requires genomic screening of many mouse ES cell (mESC) clones by Southern blot. The use of large targeting constructs facilitates the recombination of exogenous DNA in a specific genomic locus, but limits the detection of its correct genomic integration by standard PCR methods. Genomic Long Range PCR (LR-PCR), using primers adjacent to the homology arms, has been used as an alternative to radioactive-based Southern blot screenings. However, LR-PCRs are often difficult and render many false positive and false negative results. Here, we propose an alternative screening method based on the detection of a genetic modification at the mRNA level, which we successfully optimized in two mouse models. This screening method consists of a reverse-transcription PCR (RT-PCR) using primers that match exons flanking the targeting construct. The detection of the expected modification in this PCR product confirms the integration at the correct genomic location and shows that the mutant mRNA is expressed. This is a simple and sensitive strategy to screen locus-specific recombination of targeting constructs which can also be useful to screen KO and KI mutant mice or cell lines including those generated by CRISPR/Cas9.	[Albers, Eliene; Sbroggio, Mauro; Avram, Alexandra; Munk, Stephanie; Lopez-Contreras, Andres J.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Chromosome Stabil, Copenhagen, Denmark; [Albers, Eliene; Sbroggio, Mauro; Avram, Alexandra; Munk, Stephanie; Lopez-Contreras, Andres J.] Univ Copenhagen, Panum Inst, Ctr Hlth Aging, Copenhagen, Denmark; [Martin-Gonzalez, Javier] Univ Copenhagen, Panum Inst, Dept Expt Med, Transgen Core Facil, Copenhagen, Denmark	Lopez-Contreras, A (reprint author), Univ Copenhagen, Dept Cellular & Mol Med, Ctr Chromosome Stabil, Copenhagen, Denmark.; Lopez-Contreras, A (reprint author), Univ Copenhagen, Panum Inst, Ctr Hlth Aging, Copenhagen, Denmark.	ajlopez@sund.ku.dk		Albers, Eliene/0000-0003-3207-0348; Sbroggio, Mauro/0000-0002-8266-661X; Lopez-Contreras, Andres Joaquin/0000-0002-5517-7327	Danish National Research Foundation [DNRF115]; Danish Council for Independent Research; Danish Cancer Society (KBVU); European Research Council [ERC-2015-STG-679068]; Lundbeck Foundation [R218-2016-415]	Research in Andres J Lopez-Contreras lab is funded by the Danish National Research Foundation (DNRF115), Danish Council for Independent Research (Sapere Aude, DFF-Starting Grant 2014), Danish Cancer Society (KBVU-2014), European Research Council (ERC-2015-STG-679068) and Lundbeck Foundation (R218-2016-415). We thank Dr Berta Sanchez-Laorden and David Pladevall for critical reading of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Hall B, 2009, CURR PROTOC CELL BIO, V19, P1, DOI [10.1002/0471143030.cb1912s44PMID: 19731224, DOI 10.1002/0471143030.CB1912S44]; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Lay JM, 1998, TRANSGENIC RES, V7, P135, DOI 10.1023/A:1008876526826; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Solanas M, 1997, J BIOCHEM BIOPH METH, V35, P153, DOI 10.1016/S0165-022X(97)00031-6                                                   	9	0	0	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	JUN	2017	26	3					429	434		10.1007/s11248-017-0008-3				6	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	EU3VK	WOS:000400958900010	28105543				2018-01-05	
J	Puschnik, AS; Majzoub, K; Ooi, YS; Carette, JE				Puschnik, Andreas S.; Majzoub, Karim; Ooi, Yaw Shin; Carette, Jan E.			A CRISPR toolbox to study virus-host interactions	NATURE REVIEWS MICROBIOLOGY			English	Review							HEPATITIS-C VIRUS; EMBRYONIC STEM-CELLS; NIEMANN-PICK C1; MOSQUITO AEDES-AEGYPTI; ESSENTIAL GENES; B-VIRUS; HUMAN GENOME; FUNCTIONAL GENOMICS; ENTRY REQUIRES; IN-VIVO	Viruses depend on their hosts to complete their replication cycles; they exploit cellular receptors for entry and hijack cellular functions to replicate their genome, assemble progeny virions and spread. Recently, genome-scale CRISPR-Cas screens have been used to identify host factors that are required for virus replication, including the replication of clinically relevant viruses such as Zika virus, West Nile virus, dengue virus and hepatitis C virus. In this Review, we discuss the technical aspects of genome-scale knockout screens using CRISPR-Cas technology, and we compare these screens with alternative genetic screening technologies. The relative ease of use and reproducibility of CRISPR-Cas make it a powerful tool for probing virus-host interactions and for identifying new antiviral targets.	[Puschnik, Andreas S.; Majzoub, Karim; Ooi, Yaw Shin; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Carette, JE (reprint author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	carette@stanford.edu					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551; Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778; Belser JA, 2016, MICROBIOL MOL BIOL R, V80, P733, DOI 10.1128/MMBR.00022-16; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Blondel CJ, 2016, CELL HOST MICROBE, V20, P226, DOI 10.1016/j.chom.2016.06.010; Bornholdt ZA, 2016, MBIO, V7, DOI 10.1128/mBio.02154-15; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854                                                              ; BRENNER S, 1974, GENETICS, V77, P71; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; DeJesus R, 2016, ELIFE, V5, DOI 10.7554/elife.17290; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352                                                           ; Harvey R, 2009, ANTIVIR RES, V82, P1, DOI 10.1016/j.antiviral.2008.12.015; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kou ZH, 2015, CELL RES, V25, P1372, DOI 10.1038/cr.2015.130; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Lei SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25222; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020; Liu S. J., 2016, SCIENCE, V355; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6                                                    ; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nag A, 2012, J VIROL, V86, P12616, DOI 10.1128/JVI.01351-12; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Olzmann JA, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A013185; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Pillay S, 2015, ANNU REV VIROL, V2, P219, DOI 10.1146/annurev-virology-100114-055119; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Popov LM, 2015, P NATL ACAD SCI USA, V112, P14337, DOI 10.1073/pnas.1510265112; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Saeed M, 2015, NATURE, V524, P471, DOI 10.1038/nature14899; Sagi I, 2016, NATURE, V532, P107, DOI 10.1038/nature17408; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987; Schoggins JW, 2015, NATURE, V525, P144, DOI [10.1038/nature14555, 10.1038/nature12862, 10.1038/nature14554]; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shwetha S, 2015, J VIROL, V89, P11356, DOI 10.1128/JVI.01714-15; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; SIMOES EAF, 1991, J VIROL, V65, P913; Staring J, 2017, NATURE, V541, P412, DOI 10.1038/nature21032; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786; TRONO D, 1988, SCIENCE, V241, P445, DOI 10.1126/science.2839901; Tschaharganeh DF, 2016, FEBS J, V283, P3194, DOI 10.1111/febs.13750; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011; Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.1; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Virreira Winter S., 2016, SCI REP, V6, P24242, DOI DOI 10.1038/SREP24242; Wool-Lewis RJ, 1998, J VIROL, V72, P3155; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Wutz A, 2014, ANNU REV CELL DEV BI, V30, P705, DOI 10.1146/annurev-cellbio-100913-012920; XIONG C, 1989, SCIENCE, V243, P1188, DOI 10.1126/science.2922607; Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	167	5	5	24	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1740-1526	1740-1534		NAT REV MICROBIOL	Nat. Rev. Microbiol.	JUN	2017	15	6					351	364		10.1038/nrmicro.2017.29				14	Microbiology	Microbiology	EU5HK	WOS:000401062000010	28420884				2018-01-05	
J	Piatek, A; Mahfouz, MM				Piatek, Agnieszka; Mahfouz, Magdy M.			Targeted genome regulation via synthetic programmable transcriptional regulators	CRITICAL REVIEWS IN BIOTECHNOLOGY			English	Review						CRISPR/Cas9 system; functional genomics; synthetic site-specific nucleases; synthetic transcriptional regulators; targeted genome regulation; transcriptional activator-like effectors; zinc fingers	ZINC-FINGER NUCLEASES; CRISPR-CAS SYSTEMS; SEQUENCE-SPECIFIC CONTROL; DNA-BINDING SPECIFICITY; GENE-EXPRESSION; MAMMALIAN-CELLS; TAL EFFECTORS; SACCHAROMYCES-CEREVISIAE; EFFICIENT CONSTRUCTION; ARABIDOPSIS-THALIANA	Regulation of gene transcription controls cellular functions and coordinates responses to developmental, physiological and environmental cues. Precise and efficient molecular tools are needed to characterize the functions of single and multiple genes in linear and interacting pathways in a native context. Modular DNA-binding domains from zinc fingers (ZFs) and transcriptional activator-like proteins (TALE) are amenable to bioengineering to bind DNA target sequences of interest. As a result, ZF and TALE proteins were used to develop synthetic programmable transcription factors. However, these systems are limited by the requirement to re-engineer proteins for each new target sequence. The clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR associated 9 (Cas9) genome editing tool was recently repurposed for targeted transcriptional regulation by inactivation of the nuclease activity of Cas9. Due to the facile engineering, simplicity, precision and amenability to library construction, the CRISPR/Cas9 system is poised to revolutionize the functional genomics field across diverse eukaryotic species. In this review, we discuss the development of synthetic customizable transcriptional regulators and provide insights into their current and potential applications, with special emphasis on plant systems, in characterization of gene functions, elucidation of molecular mechanisms and their biotechnological applications.	[Mahfouz, Magdy M.] King Abdullah Univ Sci & Technol, Lab Genome Engn, Ctr Desert Agr, Jeddah 239556900, Saudi Arabia; [Mahfouz, Magdy M.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Jeddah 239556900, Saudi Arabia	Mahfouz, MM (reprint author), King Abdullah Univ Sci & Technol, Lab Genome Engn, Ctr Desert Agr, Jeddah 239556900, Saudi Arabia.; Mahfouz, MM (reprint author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Jeddah 239556900, Saudi Arabia.	magdy.mahfouz@kaust.edu.sa	MAHFOUZ, MAGDY/O-1550-2016	Mahfouz, Magdy M/0000-0002-0616-6365			Ali Z, 2015, GENOME BIOL; Ali Z, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1044191; Aouida M, 2015, PLOS ONE, P10; Aouida M, 2015, J BIOSCI BIOENG, V120, P364, DOI 10.1016/j.jbiosc.2015.02.017; Aouida M, 2014, CURR GENET, V60, P61, DOI 10.1007/s00294-013-0412-z; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartsevich VV, 2003, STEM CELLS, V21, P632, DOI 10.1634/stemcells.21-6-632                                                      ; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bikard David, 2013, F1000Prime Rep, V5, P47, DOI 10.12703/P5-47; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chapdelaine P, 2013, MOL THER-NUCL ACIDS, P2; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, ADV MATER RES-SWITZ, V524-527, P3, DOI 10.4028/www.scientific.net/AMR.524-527.3; Cronin CA, 2001, GENE DEV, V15, P1506, DOI 10.1101/gad.892001; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fineran PC, 2014, CURR OPIN MICROBIOL, V18, P83, DOI 10.1016/j.mib.2014.02.007; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, NUCLEIC ACIDS RES, V41, P3937, DOI 10.1093/nar/gkt071; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Gao YB, 2014, P NATL ACAD SCI USA, V111, P4357, DOI 10.1073/pnas.1402295111; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Gasiunas G, 2014, CELL MOL LIFE SCI, V71, P449, DOI 10.1007/s00018-013-1438-6; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gommans WM, 2005, J MOL BIOL, V354, P507, DOI 10.1016/j.jmb.2005.06.082; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Heuer H, 2007, APPL ENVIRON MICROB, V73, P4379, DOI 10.1128/AEM.00367-07; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, P41; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kabadi AM, 2014, METHODS, V69, P188, DOI 10.1016/j.ymeth.2014.06.014; Kabir MH, 2008, AFR J BIOTECHNOL, V7, P4784; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/NMETH.2969, 10.1038/nmeth.2969]; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007                                                          ; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Laufer BI, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0023-7; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li LX, 2013, MOL PLANT, V6, P1318, DOI 10.1093/mp/sst006; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lindbo John A, 2012, Methods Mol Biol, V894, P1, DOI 10.1007/978-1-61779-882-5_1; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/NMETH.2366, 10.1038/nmeth.2366]; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; Meister GE, 2010, NUCLEIC ACIDS RES, V38, P1749, DOI 10.1093/nar/gkp1126; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Proudfoot C, 2011, PLOS ONE, P6; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Sanchez JP, 2006, PLANT BIOTECHNOL J, V4, P103, DOI 10.1111/j.1467-7652.2005.00161.x; Sanchez JP, 2002, PLANT CELL PHYSIOL, V43, P1465, DOI 10.1093/pcp/pcf186; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sera T, 2009, ADV DRUG DELIVER REV, V61, P513, DOI 10.1016/j.addr.2009.03.012; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Smyth DR, 1997, CURR BIOL, V7, pR793, DOI 10.1016/S0960-9822(06)00407-6                                                   ; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; THUKRAL SK, 1992, MOL CELL BIOL, V12, P2784, DOI 10.1128/MCB.12.6.2784                                                           ; Tremblay JP, 2012, HUM GENE THER, V23, P883, DOI 10.1089/hum.2012.034; Uhde-Stone C, 2014, BIOCHEM BIOPH RES CO, V443, P1189, DOI 10.1016/j.bbrc.2013.12.111; Urnov FD, 2002, BIOCHEM PHARMACOL, V64, P919, DOI 10.1016/S0006-2952(02)01150-4; Voytas DF, 2009, SCIENCE, V326, P1491, DOI 10.1126/science.1183604; Waldrip ZJ, 2014, EPIGENETICS-US, V9, P1207, DOI 10.4161/epi.29919; Wang XH, 2015, AIDS RES HUM RETROV, V31, P98, DOI [10.1089/aid.2014.0121, 10.1089/AID.2014.0121]; Yaghmai R, 2002, MOL THER, V5, P685, DOI 10.1006/mthe.2002.0610; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	120	1	1	22	77	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0738-8551	1549-7801		CRIT REV BIOTECHNOL	Crit. Rev. Biotechnol.	JUN	2017	37	4					429	440		10.3109/07388551.2016.1165180				12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ES5UD	WOS:000399609300002	27093352				2018-01-05	
J	Zakikhan, K; Pournasr, B; Vosough, M; Nassiri-Asl, M				Zakikhan, Kobra; Pournasr, Behshad; Vosough, Massoud; Nassiri-Asl, Marjan			In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery	CELL JOURNAL			English	Review						Hepatocyte; Cell Therapy; Gene Therapy; Drug Discovery	PLURIPOTENT STEM-CELLS; METABOLIC LIVER-DISEASE; FUNCTIONAL HEPATOCYTES; EFFICIENT DIFFERENTIATION; THERAPEUTIC APPLICATIONS; HEPATIC DIFFERENTIATION; HUMAN FIBROBLASTS; DIRECT CONVERSION; HUMAN BLASTOCYSTS; 3-STEP PROTOCOL	Hepatocyte-like cells (HLCs) are generated from either various human pluripotent stem cells (hPSCs) including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), or direct cell conversion, mesenchymal stem cells as well as other stem cells like gestational tissues. They provide potential cell sources for biomedical applications. Liver transplantation is the gold standard treatment for the patients with end stage liver disease, but there are many obstacles limiting this process, like insufficient number of donated healthy livers. Meanwhile, the number of patients receiving a liver organ transplant for a better life is increasing. In this regard, HLCs may provide an adequate cell source to overcome these shortages. New molecular engineering approaches such as CRISPR/Cas system applying in iPSCs technology provide the basic principles of gene correction for monogenic inherited metabolic liver diseases, as another application of HLCs. It has been shown that HLCs could replace primary human hepatocytes in drug discovery and hepatotoxicity tests. However, generation of fully functional HLCs is still a big challenge; several research groups have been trying to improve current differentiation protocols to achieve better HLCs according to morphology and function of cells. Large-scale generation of functional HLCs in bioreactors could make a new opportunity in producing enough hepatocytes for treating end-stage liver patients as well as other biomedical applications such as drug studies. In this review, regarding the biomedical value of HLCs, we focus on the current and efficient approaches for generating hepatocyte-like cells in vitro and discuss about their applications in regenerative medicine and drug discovery.	[Zakikhan, Kobra; Nassiri-Asl, Marjan] Qazvin Univ Med Sci, Sch Med, Dept Mol Med, Cellular & Mol Res Ctr, Qazvin, Iran; [Pournasr, Behshad] Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, ACECR, Tehran, Iran; [Vosough, Massoud] Royan Inst Stem Cell Biol & Technol, Dept Regenerat Biomed, Cell Sci Res Ctr, ACECR, POB 16635-148, Tehran, Iran; [Nassiri-Asl, Marjan] Qazvin Univ Med Sci, Sch Med, Dept Pharmacol, Cellular & Mol Res Ctr, POB 341197-5981, Qazvin, Iran	Vosough, M (reprint author), Royan Inst Stem Cell Biol & Technol, Dept Regenerat Biomed, Cell Sci Res Ctr, ACECR, POB 16635-148, Tehran, Iran.; Nassiri-Asl, M (reprint author), Qazvin Univ Med Sci, Sch Med, Dept Pharmacol, Cellular & Mol Res Ctr, POB 341197-5981, Qazvin, Iran.	masvos@RoyanInstitute.org; mnassiriasl@qums.ac.ir		Nassiri-Asl, Marjan/0000-0003-3701-0758; Pournasr, Behshad/0000-0002-5071-6563			Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Almutawaa Walaa, 2016, Methods Mol Biol, V1502, P53, DOI 10.1007/7651_2015_311; Asgari S, 2013, STEM CELL REV REP, V9, P493, DOI 10.1007/s12015-011-9330-y; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Ayatollahi Maryam, 2011, World J Stem Cells, V3, P113, DOI 10.4252/wjsc.v3.i12.113; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Baharvand H, 2008, DIFFERENTIATION, V76, P465, DOI 10.1111/j.1432-0436.2007.00252.x; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Bale SS, 2016, TISSUE ENG PART B-RE, V22, P383, DOI 10.1089/ten.teb.2016.0031; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Baxter M, 2015, J HEPATOL, V62, P581, DOI 10.1016/j.jhep.2014.10.016; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Bhatia SN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3005975; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Carpentier A, 2015, M S-MED SCI, V31, P256, DOI 10.1051/medsci/20153103010; Carpentier A, 2014, J CLIN INVEST, V124, P4953, DOI 10.1172/JCI75456; Chen Y, 2007, J CELL BIOCHEM, V102, P52, DOI 10.1002/jcb.21275; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521; Chivu M, 2009, TRANSL RES, V154, P122, DOI 10.1016/j.trsl.2009.05.007; Chun YS, 2010, INT J BIOL SCI, V6, P796; Davidson MD, 2015, DISCOV MED, V19, P349; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Donato M Teresa, 2013, Methods Mol Biol, V987, P135, DOI 10.1007/978-1-62703-321-3_12; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Du G., 2016, ANAL CHIM ACTA, V903, P36, DOI [10.1016/j.aca.2015.11.02326709297, DOI 10.1016/J.ACA.2015.11.023]; El-Ansary M, 2012, STEM CELL REV REP, V8, P972, DOI 10.1007/s12015-011-9322-y; Ellis ECS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078550; Farzaneh Z, 2014, HISTOCHEM CELL BIOL, V142, P217, DOI 10.1007/s00418-014-1183-4; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Fox IJ, 2004, AM J TRANSPLANT, V4, P7, DOI 10.1111/j.1600-6135.2004.0340.x                                                 ; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gerbal-Chaloin S, 2014, AM J PATHOL, V184, P332, DOI 10.1016/j.ajpath.2013.09.026; Ghodsizadeh A, 2010, STEM CELL REV REP, V6, P622, DOI 10.1007/s12015-010-9189-3; Gieseck RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086372; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Giobbe GG, 2015, NAT METHODS, V12, P637, DOI [10.1038/NMETH.3411, 10.1038/nmeth.3411]; Goldman O, 2016, CELL STEM CELL, V18, P703, DOI 10.1016/j.stem.2016.05.019; Gramignoli R, 2015, EUR SURG RES, V54, P162, DOI 10.1159/000369552; Gramignoli R, 2013, STEM CELL RES, V11, P563, DOI 10.1016/j.scr.2013.03.002; Grompe M, 2013, GASTROENTEROLOGY, V145, P1209, DOI 10.1053/j.gastro.2013.09.009; Hannoun Z, 2016, J HEPATOL, V65, P182, DOI 10.1016/j.jhep.2016.02.025; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hickey RD, 2014, STEM CELL RES, V13, P144, DOI 10.1016/j.scr.2014.05.003; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ito M, 2009, J HEPATO-BILIARY-PAN, V16, P97, DOI 10.1007/s00534-008-0023-0; Itskovitz-Eldor J, 2000, MOL MED, V6, P88; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kim JH, 2015, TOXICOL SCI, V147, P190, DOI 10.1093/toxsci/kfv121; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P237, DOI 10.2133/dmpk.DMPK-13-RG-104; Lavon N, 2005, J CELL BIOCHEM, V96, P1193, DOI 10.1002/jcb.20590; Lavon N, 2004, DIFFERENTIATION, V72, P230, DOI 10.1111/j.1432-0436.2004.07205002.x                                             ; Lavon N, 2010, METHODS MOL BIOL, V640, P237, DOI 10.1007/978-1-60761-688-7_11; Li Y, 2016, ADV EXP MED BIOL, V854, P549, DOI 10.1007/978-3-319-17121-0_73; Lin C, 2015, EXPERT OPIN DRUG DIS, V10, P519, DOI 10.1517/17460441.2015.1032241; Liu P, 2016, GENET RES, V98, DOI 10.1017/S001667231600001X; Liu WH, 2015, J CELL MOL MED, V19, P511, DOI 10.1111/jcmm.12482; Mazariegos G, 2014, MOL GENET METAB, V111, P418, DOI 10.1016/j.ymgme.2014.01.006; McCoy AT, 2013, J PHARMACOL EXP THER, V344, P141, DOI 10.1124/jpet.112.199497; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mohamadnejad M, 2007, ARCH IRAN MED, V10, P459; Mohamadnejad M, 2013, LIVER INT, V33, P1490, DOI 10.1111/liv.12228; Nagamoto Y, 2015, CELL TRANSPLANT, V24, P1127, DOI 10.3727/096368914X681702; Ng S, 2015, STEM CELL REP, V4, P348, DOI 10.1016/j.stemcr.2015.01.002; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k; Park HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132992; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Piscaglia AC, 2005, TRANSPLANT P, V37, P2711, DOI 10.1016/j.transproceed.2005.06.076; Piscaglia AC, 2010, STEM CELLS INT, V2010, DOI DOI 10.4061/2010/259461; Pournasr B, 2015, EUR J CELL BIOL, V94, P603, DOI 10.1016/j.ejcb.2015.10.003; Pournasr B, 2011, STEM CELLS, V29, P1933, DOI 10.1002/stem.760; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399; Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005; Sa-Ngiamsuntorn K, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0519-1; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sgodda M, 2013, CURR MOL MED, V13, P842, DOI 10.2174/1566524011313050015                                                     ; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Siller R, 2015, STEM CELL REP, V4, P939, DOI 10.1016/j.stemcr.2015.04.001; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; Sivertsson L, 2013, STEM CELLS DEV, V22, P581, DOI 10.1089/scd.2012.0202; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Song GQ, 2016, CELL STEM CELL, V18, P797, DOI 10.1016/j.stem.2016.01.010; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Stephenne X, 2010, WORLD J GASTROENTERO, V16, P1, DOI 10.3748/wjg.v16.i1.1; Strom SC, 2006, CELL TRANSPLANT, V15, pS105; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096                                                          ; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tang SB, 2016, J MED CHEM, V59, P2, DOI 10.1021/acs.jmedchem.5b00789; Tasnim F, 2015, BIOMATERIALS, V70, P115, DOI 10.1016/j.biomaterials.2015.08.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Tsolaki E, 2015, WORLD J GASTROENTERO, V21, P12334, DOI 10.3748/wjg.v21.i43.12334; Ulvestad M, 2013, BIOCHEM PHARMACOL, V86, P691, DOI 10.1016/j.bcp.2013.06.029; Vosough M, 2016, ARCH IRAN MED, V19, P131, DOI 0161902/AIM.0011; Vosough M, 2013, STEM CELLS DEV, V22, P2693, DOI 10.1089/scd.2013.0088; Vosough M, 2011, BRIT MED BULL, V100, P157, DOI 10.1093/bmb/ldr031; Wan ACA, 2016, TRENDS BIOTECHNOL, V34, P711, DOI 10.1016/j.tibtech.2016.02.015; L Warren, 2010, J IMMUNOTHER, V7, P618, DOI DOI 10.1016/J.STEM.2010.08.012; Weber A, 2009, LIVER TRANSPLANT, V15, P7, DOI 10.1002/lt.21670; Wu MH, 2010, LAB CHIP, V10, P939, DOI 10.1039/b921695b; Xu F, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0181-3; Xue G, 2016, BIOMED RES INT, V2016; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yi F, 2012, PROTEIN CELL, V3, P246, DOI 10.1007/s13238-012-2918-4; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Yu Y, 2014, SCI WORLD J, DOI 10.1155/2014/420841; Yu Y, 2014, J CLIN MED, V3, P997, DOI 10.3390/jcm3030997; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zakikhan K, 2016, BIOCHEM BIOPH RES CO, V474, P97, DOI 10.1016/j.bbrc.2016.04.076; Zhang SQ, 2011, HUM MOL GENET, V20, P3176, DOI 10.1093/hmg/ddr223; Zhang ZZ, 2013, J CELL PHYSIOL, V228, P298, DOI 10.1002/jcp.24150; Zhao W, 2012, WORLD J GASTROENTERO, V18, P1048, DOI 10.3748/wjg.v18.i10.1048	137	0	0	15	47	ROYAN INST	TEHRAN	PO BOX 19395-4644, TEHRAN, 00000, IRAN	2228-5806	2228-5814		CELL J	Cell J.	SUM	2017	19	2					204	217		10.22074/cellj.2016.4362				14	Cell Biology	Cell Biology	ES3DT	WOS:000399409000004	28670513				2018-01-05	
J	Pacheco-Lugo, L; Diaz-Olmos, Y; Saenz-Garcia, J; Probst, CM; DaRocha, WD				Pacheco-Lugo, Lisandro; Diaz-Olmos, Yirys; Saenz-Garcia, Jose; Probst, Christian Macagnan; DaRocha, Wanderson Duarte			Effective gene delivery to Trypanosoma cruzi epimastigotes through nucleofection	PARASITOLOGY INTERNATIONAL			English	Article						Transfection; Nucleofection; Electroporation; Trypanosoma cruzi	RNA INTERFERENCE; CHAGAS-DISEASE; EXPRESSION; CONSTRUCTION; BRUCEI	New opportunities have raised to study the gene function approaches of Trypanosoma cruzi after its genome sequencing in 2005. Functional genomic approaches in Trypanosome cruzi are challenging due to the reduced tools available for genetic manipulation, as well as to the reduced efficiency of the transient transfection conducted through conventional methods. The Amaxa nucleofector device was systematically tested in the present study in order to improve the electroporation conditions in the epimastigote forms of T. cruzi. The transfection efficiency was quantified using the green fluorescent protein (GFP) as reporter gene followed by cell survival assessment. The herein used nucleofection parameters have increased the survival rates (>90%) and the transfection efficiency by approximately 35%. The small amount of epimastigotes and DNA required for the nucleofection can turn the method adopted here into an attractive tool for high throughput screening (HTS) applications, and for gene editing in parasites where genetic manipulation tools remain relatively scarce. (C) 2017 Elsevier B.V. All rights reserved.	[Pacheco-Lugo, Lisandro; Saenz-Garcia, Jose; DaRocha, Wanderson Duarte] Univ Fed Parana, Lab Genom Func Parasitos, Curitiba, Parana, Brazil; [Pacheco-Lugo, Lisandro] Univ Simon Bolivar, Barranquilla, Colombia; [Diaz-Olmos, Yirys; Probst, Christian Macagnan] FIOCRUZ Parana, Inst Carlos Chagas, Lab Genom Func, Curitiba, Parana, Brazil	DaRocha, WD (reprint author), Univ Fed Parana, Lab Genom Func Parasitos, Curitiba, Parana, Brazil.	wandersondarocha@gmail.com	Probst, Christian/B-8678-2009	Probst, Christian/0000-0001-9993-6375	National Counsel of Technological and Scientific Development (CNPq) [CNPq - 309207/2014-2, 401355/2014-4]; CAPES agency	This work was supported by the National Counsel of Technological and Scientific Development (CNPq) (CNPq - 309207/2014-2 and 401355/2014-4) and the LPL and JSG received scholarship from CAPES agency. The authors thank the Program for Technological Development in Tools for Health (PDTIS) for use of the flow cytometry facility (RPTO8L) at Carlos Chagas Institute FlOCRUZ/PR, especially to Priscila Mazzocchi Hiraiwa for the technical assistance in the BD FACSAriaTm II flow cytometer (BD Biosciences, USA). We also are grateful with Axel Rulf Cofre for the technical assistance with the nucleofector.	Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Burle-Caldas GD, 2015, MOL BIOCHEM PARASIT, V203, P25, DOI 10.1016/j.molbiopara.2015.10.004; Chicaybam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060298; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Morris JC, 2002, EMBO J, V21, P4429, DOI 10.1093/emboj/cdf474; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687                                                        ; Padmanabhan PK, 2014, MOL BIOCHEM PARASIT, V198, P100, DOI 10.1016/j.molbiopara.2015.02.001; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Xu D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-90	19	1	1	8	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1383-5769			PARASITOL INT	Parasitol. Int.	JUN	2017	66	3					236	239		10.1016/j.parint.2017.01.019				4	Parasitology	Parasitology	ER5WN	WOS:000398874800006	28137669				2018-01-05	
J	Kehler, J; Greco, M; Martino, V; Pachiappan, M; Yokoe, H; Chen, A; Yang, M; Auerbach, J; Jessee, J; Gotte, M; Milanesi, L; Albertini, A; Bellipanni, G; Zucchi, I; Reinbold, RA; Giordano, A				Kehler, James; Greco, Marianna; Martino, Valentina; Pachiappan, Manickam; Yokoe, Hiroko; Chen, Alice; Yang, Miranda; Auerbach, Jonathan; Jessee, Joel; Gotte, Martin; Milanesi, Luciano; Albertini, Alberto; Bellipanni, Gianfranco; Zucchi, Ileana; Reinbold, Rolland A.; Giordano, Antonio			RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article							IPS CELLS; GENOME; DIFFERENTIATION; INDUCTION; CAS9; ENDONUCLEASE; CRISPR-CAS9; SPECIFICITY; INTEGRATION; DERIVATION	Cellular reprogramming by epigenomic remodeling of chromatin holds great promise in the field of human regenerative medicine. As an example, human-induced Pluripotent Stem Cells (iPSCs) obtained by reprograming of patient somatic cells are sufficiently similar to embryonic stem cells (ESCs) and can generate all cell types of the human body. Clinical use of iPSCs is dependent on methods that do not utilize genome altering transgenic technologies that are potentially unsafe and ethically unacceptable. Transient delivery of exogenous RNA into cells provides a safer reprogramming system to transgenic approaches that rely on exogenous DNA or viral vectors. RNA reprogrammed iPSCs lines may prove to be more suitable for clinical applications and provide stable starting cell lines for gene-editing, isolation, and characterization of patient iPSC lines. The introduction and rapid evolution of CRISPR/Cas9 gene-editing systems has provided a readily accessible research tool to perform functional human genetic experiments. Similar to RNA reprogramming, transient delivery of mRNA encoding Cas9 in combination with guide RNA sequences to target specific points in the genome eliminates the risk of potential integration of Cas9 plasmid constructs. We present optimized RNA-based laboratory procedure for making and editing iPSCs. In the near-term these two powerful technologies are being harnessed to dissect mechanisms of human development and disease in vitro, supporting both basic, and translational research. (C) 2016 Wiley Periodicals, Inc.	[Kehler, James; Greco, Marianna; Martino, Valentina; Milanesi, Luciano; Albertini, Alberto; Zucchi, Ileana; Reinbold, Rolland A.] CNR, ITB, Via Cervi 93, I-20090 Segrate, Milan, Italy; [Kehler, James] NIH, NIDDK, Lab Cell & Mol Biol, Rockville, MD USA; [Kehler, James; Pachiappan, Manickam; Yokoe, Hiroko; Auerbach, Jonathan; Jessee, Joel] MTI GlobalStem, Gaithersburg, MD USA; [Chen, Alice] Organovo, San Diego, CA USA; [Yang, Miranda] Ascendance Biotechnol, Medford, MD USA; [Gotte, Martin] Muenster Univ Hosp, Dept Gynecol & Obstet, Munster, Germany; [Bellipanni, Gianfranco; Giordano, Antonio] Temple Univ, Coll Sci & Technol, Dept Biol, Philadelphia, PA 19122 USA; [Bellipanni, Gianfranco; Giordano, Antonio] Temple Univ, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA	Zucchi, I; Reinbold, RA (reprint author), CNR, ITB, Via Cervi 93, I-20090 Segrate, Milan, Italy.	ileana.zucchi@itb.cnr.it; rreinbold@icloud.com	Giordano, Antonio/F-1927-2010	Giordano, Antonio/0000-0002-5959-016X; Gotte, Martin/0000-0003-2360-2496; Milanesi, Luciano/0000-0002-1201-3939	N.O.B.E.L. Grant; MIUR-FIRB Newton [RBAP11BYNP]	We thank Loredana Ansalone and John Hatton for administrative help. IZ grant support: the N.O.B.E.L. Grant and Cariplo Progetti-Internazionali n. 2008-2015 from Fondazione CARIPLO; MIUR-FIRB Newton grant N. RBAP11BYNP. MIUR-CNR Progetto Bandiera Interomics e MIUR-CNR Progetto Bandiera Epigen.	Awe JP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt246; Baghbaderani BA, 2016, STEM CELL REV REP, V12, P394, DOI 10.1007/s12015-016-9662-8; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Bhutani K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10536; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Carey BW, 2009, P NATL ACAD SCI USA, V106, P5449; Cerbini T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116032; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Durruthy-Durruthy J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094231; Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Grabel L, 2012, J CELL BIOCHEM, V113, P381, DOI 10.1002/jcb.23364; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kuo CH, 2013, J CELL BIOCHEM, V114, P275, DOI 10.1002/jcb.24385; Li WL, 2012, STEM CELLS, V30, P61, DOI 10.1002/stem.768; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Mitani K., 2002, Current Gene Therapy, V2, P135, DOI 10.2174/1566523024605591; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Paull D, 2015, NAT METHODS, V12, P885, DOI [10.1038/NMETH.3507, 10.1038/nmeth.3507]; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rao MS, 2012, J CELL BIOCHEM, V113, P3061, DOI 10.1002/jcb.24183; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Romano G, 2014, J CELL PHYSIOL, V229, P148, DOI 10.1002/jcp.24437; Romli F, 2013, J CELL BIOCHEM, V114, P1230, DOI 10.1002/jcb.24477; Scully SP, 2000, CLIN ORTHOP RELAT R, pS55; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Sommer CA, 2013, J CELL PHYSIOL, V228, P267, DOI 10.1002/jcp.24155; Soyombo AA, 2013, STEM CELL REP, V1, P336, DOI 10.1016/j.stemcr.2013.08.004; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wobus AM, 2011, ARCH TOXICOL, V85, P79, DOI 10.1007/s00204-010-0641-6; Woodard CM, 2014, CELL REP, V9, P1173, DOI 10.1016/j.celrep.2014.10.023; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yoshioka N, 2013, CELL STEM CELL, V13, P246, DOI 10.1016/j.stem.2013.06.001; Zhang SQ, 2011, HUM MOL GENET, V20, P3176, DOI 10.1093/hmg/ddr223; Zhao J, 2011, AGING-US, V3, P700, DOI 10.18632/aging.100364                                                           	51	1	1	11	70	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	JUN	2017	232	6					1262	1269		10.1002/jcp.25597				8	Cell Biology; Physiology	Cell Biology; Physiology	ER1KP	WOS:000398549800007	27631155				2018-01-05	
J	Mata-Greenwood, E; Goyal, D; Goyal, R				Mata-Greenwood, Eugenia; Goyal, Dipali; Goyal, Ravi			Comparative and Experimental Studies on the Genes Altered by Chronic Hypoxia in Human Brain Microendothelial Cells	FRONTIERS IN PHYSIOLOGY			English	Article						epigenetic; hypoxic acclimatization; DNA methylation; CpG islands; HBMEC	INDUCIBLE FACTOR-I; OXYGEN PARTIAL-PRESSURE; HUMAN SKELETAL-MUSCLE; COLLAGEN-SYNTHESIS; CAROTID ARTERIES; CROSS-LINKING; BINDING-SITE; DNA-BINDING; EXPRESSION; ADRENOMEDULLIN	Background : Hypoxia inducible factor 1 alpha (HIF1A) is a master regulator of acute hypoxia; however, with chronic hypoxia, HIF1A levels return to the normoxic levels. Importantly, the genes that are involved in the cell survival and viability under chronic hypoxia are not known. Therefore, we tested the hypothesis that chronic hypoxia leads to the upregulation of a core group of genes with associated changes in the promoter DNA methylation that mediates the cell survival under hypoxia. Results : We examined the effect of chronic hypoxia (3 days; 0.5% oxygen) on human brain micro endothelial cells (HBMEC) viability and apoptosis. Hypoxia caused a significant reduction in cell viability and an increase in apoptosis. Next, we examined chronic hypoxia associated changes in transcriptome and genome-wide promoter methylation. The data obtained was compared with 16 other microarray studies on chronic hypoxia. Nine genes were altered in response to chronic hypoxia in all 17 studies. Interestingly, HIF1 A was not altered with chronic hypoxia in any of the studies. Furthermore, we compared our data to three other studies that identified HIF-responsive genes by various approaches. Only two genes were found to be HIF dependent. We silenced each of these 9 genes using CRISPR/Cas9 system. Downregulation of EGLN3 significantly increased the cell death under chronic hypoxia, whereas downregulation of FRO1L, EN02, adrenomedullin, and spag4 reduced the cell death under hypoxia. Conclusions : We provide a core group of genes that regulates cellular acclimatization under chronic hypoxic stress, and most of them are HIF independent.	[Mata-Greenwood, Eugenia; Goyal, Dipali; Goyal, Ravi] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Goyal, Dipali; Goyal, Ravi] Epiaenuity LLC, Loma Linda, CA 92354 USA	Goyal, R (reprint author), Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.; Goyal, R (reprint author), Epiaenuity LLC, Loma Linda, CA 92354 USA.	rgoyal@llu.edu			NIH [1 R21 HD081283-01, R56 HL12677801A1, 1P01HD08313201A1, 1R01HL135786]	These studies were supported by NIH Grant 1 R21 HD081283-01, R56 HL12677801A1, 1P01HD08313201A1, and 1R01HL135786 to RG. The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and writing the manuscript.	BEERTHUIZEN GIJM, 1989, ARCH EMERG MED, V6, P172; Beltowski J, 2004, POL J PHARMACOL, V56, P5; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BOEKSTEGERS P, 1990, ADV EXP MED BIOL, V277, P507; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006                                                     ; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; BYLUNDFELLENIUS AC, 1981, BIOCHEM J, V200, P247, DOI 10.1042/bj2000247                                                               ; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045                                                ; EASTMAN NJ, 1954, AM J OBSTET GYNECOL, V67, P701, DOI 10.1016/0002-9378(54)90098-8                                                    ; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Evens AM, 2010, J CLIN ONCOL, V28, P1017, DOI 10.1200/JCO.2009.24.1893; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Goyal R, 2011, PLACENTA, V32, P134, DOI 10.1016/j.placenta.2010.11.004; Goyal R, 2014, PHYSIOL GENOMICS, V46, P725, DOI 10.1152/physiolgenomics.00073.2014; Goyal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082200; Goyal R, 2012, PEDIATR RES, V72, P137, DOI 10.1038/pr.2012.57; Goyal R, 2010, AM J PHYSIOL-REG I, V299, pR1377, DOI 10.1152/ajpregu.00344.2010; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Hartley I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077859; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Heinonen IHA, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00116; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076                                                         ; HOLTHOFER H, 1982, LAB INVEST, V47, P60; Horino Y, 2002, LIFE SCI, V71, P3031, DOI 10.1016/S0024-3205(02)02142-2; Ikossi DG, 2006, J TRAUMA, V61, P780, DOI 10.1097/01.ta.0000239500.71419.58; ISHIKAWA Y, 1988, EUR J HAEMATOL, V40, P126; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KIAER T, 1988, ARCH ORTHOP TRAUM SU, V107, P114, DOI 10.1007/BF00454498                                                              ; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Larrayoz IM, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0339-2; Lawrentschuk N, 2005, BJU INT, V96, P540, DOI 10.1111/j.1464-410X.2005.05681.x; Liu SS, 2013, INT J MOL SCI, V14, P24029, DOI 10.3390/ijms141224029; LONGO LD, 1987, ENVIRON HEALTH PERSP, V74, P93, DOI 10.2307/3430439; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Makris EA, 2014, P NATL ACAD SCI USA, V111, pE4832, DOI 10.1073/pnas.1414271111; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Matsui H, 2004, CIRCULATION, V109, P2246, DOI 10.1161/01.CIR.0000127950.13380.FD; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Perry SW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-411; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramirez TA, 2012, HYPERTENS RES, V35, P811, DOI 10.1038/hr.2012.32; Ratcliffe P. J., 1999, NAT GENET, V399, P271, DOI DOI 10.1038/20459; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Schmidt S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1084, DOI 10.1152/ajpendo.90491.2008; Semenza CL, 2001, PEDIATR RES, V49, P614; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Shoji K, 2013, AM J PATHOL, V182, P2191, DOI 10.1016/j.ajpath.2013.02.024; Smith K, 2007, CURR OPIN CLIN NUTR, V10, P582, DOI 10.1097/MCO.0b013e328285d858                                                    ; Su JJ, 2015, CELL SIGNAL, V27, P47, DOI 10.1016/j.cellsig.2014.10.003; Sun M, 2011, J CELL SCI, V124, P4096, DOI 10.1242/jcs.091363; Tabima DM, 2012, J BIOMECH, V45, P799, DOI 10.1016/j.jbiomech.2011.11.020; Tachezy M, 2010, HISTOL HISTOPATHOL, V25, P1239, DOI 10.14670/HH-25.1239; Tanaka A, 2011, DNA CELL BIOL, V30, P539, DOI 10.1089/dna.2009.1014; Tanaka T, 2014, J CANCER RES CLIN, V140, P503, DOI 10.1007/s00432-014-1593-7; Tarnasky H, 1998, CYTOGENET CELL GENET, V81, P65, DOI 10.1159/000014990                                                               ; van Vlimmeren MAA, 2010, J APPL PHYSIOL, V109, P1483, DOI 10.1152/japplphysiol.00571.2010; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang W, 2003, J PHYSIOL-LONDON, V549, P855, DOI 10.1113/jphysiol.2002.037994; Watson JA, 2009, HUM MOL GENET, V18, P3594, DOI 10.1093/hmg/ddp307; Zou WJ, 2015, J BONE MINER METAB, V33, P615, DOI 10.1007/s00774-014-0627-1	70	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	MAY 31	2017	8								365	10.3389/fphys.2017.00365				14	Physiology	Physiology	EX5JX	WOS:000403279000001	28620317	gold			2018-01-05	
J	Sin, YY; Price, PR; Ballantyne, LL; Funk, CD				Sin, Yuan Yan; Price, Phillipe R.; Ballantyne, Laurel L.; Funk, Colin D.			Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency	SCIENTIFIC REPORTS			English	Article							PLURIPOTENT STEM-CELLS; FLUORESCENT PROTEINS; SODIUM-BUTYRATE; IPS CELLS; MOUSE; GENOME; DIFFERENTIATION; EXPRESSION; CAS9; ENDONUCLEASE	Arginase-1 deficiency in humans is a rare genetic disorder of metabolism resulting from a loss of arginase-1, leading to impaired ureagenesis, hyperargininemia and neurological deficits. Previously, we generated a tamoxifen-inducible arginase-1 deficient mouse model harboring a deletion of Arg1 exons 7 and 8 that leads to similar biochemical defects, along with a wasting phenotype and death within two weeks. Here, we report a strategy utilizing the (C) under bar lustered, (R) under bar egularly (I) under bar nterspaced, (S) under bar hort (P) under bar alindromic (R) under bar epeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system in conjunction with piggyBac technology to target and reincorporate exons 7 and 8 at the specific Arg1 locus in attempts to restore the function of arginase-1 in induced pluripotent stem cell (iPSC)-derived hepatocyte-like cells (iHLCs) and macrophages in vitro. While successful gene targeted repair was achieved, minimal urea cycle function was observed in the targeted iHLCs compared to adult hepatocytes likely due to inadequate maturation of the cells. On the other hand, iPSC-derived macrophages expressed substantial amounts of "repaired" arginase. Our studies provide proof-of-concept for gene-editing at the Arg1 locus and highlight the challenges that lie ahead to restore sufficient liver-based urea cycle function in patients with urea cycle disorders.	[Sin, Yuan Yan; Price, Phillipe R.; Ballantyne, Laurel L.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Funk, CD (reprint author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca		Sin, Yuan Yan/0000-0001-6537-5266	Urea Cycle Disorders Consortium (UCDC), National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN) [U54HD061221]; Office of Rare Diseases Research (ORDR); National Center for Advancing Translational Science (NCATS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Rare Disease Foundation; BC Children's Hospital Foundation (BCCHF) [18-19]; Canada Research Chairs program; Canadian Institutes of Health Research (CIHR) [MOP-341036]	The authors thank Crystal McCracken for her technical assistance. YYS is supported by a fellowship from the Urea Cycle Disorders Consortium (UCDC; U54HD061221), which is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the Office of Rare Diseases Research (ORDR), the National Center for Advancing Translational Science (NCATS and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This work was supported by a microgrant from the Rare Disease Foundation and the BC Children's Hospital Foundation (BCCHF) (# 18-19 to YYS). CDF is supported by the Canada Research Chairs program and the Canadian Institutes of Health Research (CIHR) (MOP-341036).	Balasiddaiah A, 2013, J PHYSIOL BIOCHEM, V69, P835, DOI 10.1007/s13105-013-0260-9; Ballantyne LL, 2016, MOLEC GENET METAB RE, V9, P54, DOI 10.1016/j.ymgmr.2016.10.003; Ballantyne LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125967; Burrage LC, 2015, HUM MOL GENET, V24, P6417, DOI 10.1093/hmg/ddv352; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Carpentier A, 2014, J CLIN INVEST, V124, P4953, DOI 10.1172/JCI75456; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Gau CL, 2009, MOL THER, V17, P1155, DOI 10.1038/mt.2009.65; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; HIRSCH S, 1981, J EXP MED, V154, P713, DOI 10.1084/jem.154.3.713; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu CH, 2014, MOL THER, V22, P1792, DOI 10.1038/mt.2014.99; Iyer R, 1998, J INHERIT METAB DIS, V21, P86, DOI 10.1023/A:1005313809037; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kasten J, 2013, MOL GENET METAB, V110, P222, DOI 10.1016/j.ymgme.2013.06.020; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; Lee EK, 2013, GENE THER, V20, P785, DOI 10.1038/gt.2012.99; Lee EK, 2012, MOL THER, V20, P1844, DOI 10.1038/mt.2012.129; Lee PC, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.98; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Munder M, 1999, J IMMUNOL, V163, P3771; Piatkevich KD, 2011, METHOD CELL BIOL, V102, P431, DOI 10.1016/B978-0-12-374912-3.00017-1; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Silva ES, 2013, JIMD REP, V11, P25, DOI 10.1007/8904_2013_218; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sin YY, 2015, J MOL MED, V93, P1287, DOI 10.1007/s00109-015-1354-3; Sin YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zeitlin PL, 2000, KIDNEY INT, V57, P832, DOI 10.1046/j.1523-1755.2000.00922.x; Zeitlin PL, 2000, RESPIRATION, V67, P351, DOI 10.1159/000029528; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhuang LH, 2012, J IMMUNOL METHODS, V385, P1, DOI 10.1016/j.jim.2012.06.008	45	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 31	2017	7								2585	10.1038/s41598-017-02927-2				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EW5BE	WOS:000402519400049	28566761	gold			2018-01-05	
J	Cui, JZ; Chew, SJL; Shi, Y; Gong, ZY; Shen, HM				Cui, Jianzhou; Chew, Shirley Jia Li; Shi, Yin; Gong, Zhiyuan; Shen, Han-Ming			CRISPR system for genome engineering: the application for autophagy study	BMB REPORTS			English	Review						Autophagy; CRISPR/Cas9; gRNA; Off-target; PAM	RNA-GUIDED ENDONUCLEASE; ZINC-FINGER NUCLEASES; CAS SYSTEM; CAENORHABDITIS-ELEGANS; TARGETED MUTAGENESIS; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; ADAPTIVE IMMUNITY; GENE-EXPRESSION; DNA	CRISPR/Cas9 is the latest tool introduced in the field of genome engineering and is so far the best genome-editing tool as compared to its precedents such as, meganucleases, zinc finger nucleases (ZFNs) and transcription activator-like effectors (TALENs). The simple design and assembly of the CRISPR/Cas9 system makes genome editing easy to perform as it uses small guide RNAs that correspond to their DNA targets for high efficiency editing. This has helped open the doors for multiplexible genome targeting in many species that were intractable using old genetic perturbation techniques. Currently, The CRISPR system is revolutionizing the way biological researches are conducted and paves a bright future not only in research but also in medicine and biotechnology. In this review, we evaluated the history, types and structure, the mechanism of action of CRISPR/Cas System. In particular, we focused on the application of this powerful tool in autophagy research.	[Cui, Jianzhou; Chew, Shirley Jia Li; Shi, Yin; Shen, Han-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Shen, Han-Ming] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	Cui, JZ; Shen, HM (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.; Shen, HM (reprint author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.	csicuij@nus.edu.sg; han-ming_shen@nuhs.edu.sg			Singapore National Medical Research Council [NMRC/CIRG/1346/2012]	This work is supported by research grants from Singapore National Medical Research Council (NMRC/CIRG/1346/2012) to HMS and ZYG.	Allavena G, 2016, AUTOPHAGY, V12, P2085, DOI 10.1080/15548627.2016.1226733; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, SMART MAT RES, P1; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Cao Y, 2016, HEMATOLOGY, V21, P225, DOI 10.1179/1607845415Y.0000000027; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeJesus R, 2016, ELIFE, V5, DOI 10.7554/elife.17290; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Fodor E, 2017, METHOD ENZYMOL, V588, P467, DOI 10.1016/bs.mie.2016.10.028; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fulcher LJ, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160255; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Horne DJ, 2016, J INFECT DIS, V214, P1260, DOI 10.1093/infdis/jiw347; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Jiang F, 2017, ANNU REV BIOPHYS, V46, P1; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaizuka T, 2016, MOL CELL BIOL, V36, P585, DOI 10.1128/MCB.01005-15; Kim NY, 2016, CANCER LETT, V370, P19, DOI 10.1016/j.canlet.2015.10.008; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu Y., 2016, EVID-BASED COMPL ALT, V2016, P1, DOI DOI 10.1007/S10291-016-0529-X; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mout R, 2017, ACS NANO, V11, P2452, DOI 10.1021/acsnano.6b07600; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Niu JW, 2014, MOL BIOTECHNOL, V56, P681, DOI 10.1007/s12033-014-9771-z; O'Prey J, 2017, METHOD ENZYMOL, V588, P79, DOI 10.1016/bs.mie.2016.09.076; Ohshima J, 2014, J IMMUNOL, V192, P3328, DOI 10.4049/jimmunol.1302822; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Padman BS, 2017, AUTOPHAGY, V13, P772, DOI 10.1080/15548627.2017.1281492; Pan YZ, 2013, MOL BIOTECHNOL, V55, P54, DOI 10.1007/s12033-012-9613-9; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sasaki T, 2017, AUTOPHAGY, V13, P386, DOI 10.1080/15548627.2016.1256934; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Stavoe AKH, 2016, DEV CELL, V38, P171, DOI 10.1016/j.devcel.2016.06.012; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stranneheim H, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200153; Suzuki H, 2015, NAT STRUCT MOL BIOL, V22, P572, DOI 10.1038/nsmb.3036; Tan XJ, 2016, P NATL ACAD SCI USA, V113, P10896, DOI 10.1073/pnas.1523145113; Tang YL, 2015, FREE RADICAL BIO MED, V89, P944, DOI 10.1016/j.freeradbiomed.2015.09.012; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Uhde-Stone C, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-3; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24641; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu T, 2014, APPL ENVIRON MICROB, V80, P1544, DOI 10.1128/AEM.03786-13; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yuan N, 2015, HAEMATOLOGICA, V100, P345, DOI 10.3324/haematol.2014.113324; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	101	0	0	6	6	KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY	SEOUL	KOREA SCIENCE & TECHNOLOGY CENTER, # 801,  635-4 , YEOKSAM-DONG, KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-6696	1976-670X		BMB REP	BMB Rep.	MAY 31	2017	50	5					247	256		10.5483/BMBRep.2017.50.5.044				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW9HU	WOS:000402829600004	28288698				2018-01-05	
J	Shin, HY; Wang, CC; Lee, HK; Yoo, KH; Zeng, XK; Kuhns, T; Yang, CM; Mohr, T; Liu, CY; Hennighausen, L				Shin, Ha Youn; Wang, Chaochen; Lee, Hye Kyung; Yoo, Kyung Hyun; Zeng, Xianke; Kuhns, Tyler; Yang, Chul Min; Mohr, Teresa; Liu, Chengyu; Hennighausen, Lothar			CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome	NATURE COMMUNICATIONS			English	Article							DOUBLE-STRAND BREAKS; REGULATORY DNA ELEMENTS; ZINC-FINGER NUCLEASE; ONE-STEP GENERATION; GENE KNOCKOUT; FUNCTIONAL VALIDATION; EFFICIENT GENERATION; RAPID GENERATION; CAS9 NUCLEASE; MODIFIED MICE	Although CRISPR/Cas9 genome editing has provided numerous opportunities to interrogate the functional significance of any given genomic site, there is a paucity of data on the extent of molecular scars inflicted on the mouse genome. Here we interrogate the molecular consequences of CRISPR/Cas9-mediated deletions at 17 sites in four loci of the mouse genome. We sequence targeted sites in 632 founder mice and analyse 54 established lines. While the median deletion size using single sgRNAs is 9 bp, we also obtain large deletions of up to 600 bp. Furthermore, we show unreported asymmetric deletions and large insertions of middle repetitive sequences. Simultaneous targeting of distant loci results in the removal of the intervening sequences. Reliable deletion of juxtaposed sites is only achieved through two-step targeting. Our findings also demonstrate that an extended analysis of F1 genotypes is required to obtain conclusive information on the exact molecular consequences of targeting events.	[Shin, Ha Youn; Wang, Chaochen; Lee, Hye Kyung; Yoo, Kyung Hyun; Zeng, Xianke; Kuhns, Tyler; Yang, Chul Min; Mohr, Teresa; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, US NIH, Bethesda, MD 20892 USA; [Shin, Ha Youn] Konkuk Univ, Dept Biomed Sci & Engn, Seoul 05029, South Korea; [Lee, Hye Kyung] Seoul Natl Univ, Dept Cell & Dev Biol, Seoul 110749, South Korea; [Lee, Hye Kyung] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; Sookmyung Womens Univ, Dept Life Syst, Seoul 140742, South Korea; [Liu, Chengyu] NHLBI, Transgen Core, US NIH, Bldg 10, Bethesda, MD 20892 USA	Shin, HY (reprint author), NIDDK, Lab Genet & Physiol, US NIH, Bethesda, MD 20892 USA.; Shin, HY (reprint author), Konkuk Univ, Dept Biomed Sci & Engn, Seoul 05029, South Korea.	hayounshin@konkuk.ac.kr; lotharh@mail.nih.gov		Kuhns, Tyler/0000-0002-8479-3313	IPR of the NIDDK/NIH; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1184]	This research was funded by the IPR of the NIDDK/NIH and by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1184) to H.K.L.	An LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25199; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Boroviak K, 2016, GENESIS, V54, P78, DOI 10.1002/dvg.22915; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chuai Guohui, 2016, Mol Ther Nucleic Acids, V5, pe323, DOI 10.1038/mtna.2016.35; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Bruin LO, 2016, ONCOTARGET, V7, P12962, DOI 10.18632/oncotarget.7341; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Ge DT, 2016, G3-GENES GENOM GENET, V6, P3197, DOI 10.1534/g3.116.032557; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; Hara S, 2016, J REPROD DEVELOP, V62, P531, DOI 10.1262/jrd.2016-058; He MD, 2015, MUTAT RES-FUND MOL M, V780, P86, DOI 10.1016/j.mrfmmm.2015.08.004; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Hu JX, 2015, DEVELOPMENT, V142, P2775, DOI 10.1242/dev.126391; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Lu GQ, 2016, P NATL ACAD SCI USA, V113, P1256, DOI 10.1073/pnas.1521597113; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marusugi K, 2016, J VET MED SCI, V78, P1413, DOI 10.1292/jvms.16-0205; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Menoret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14410; Metser G, 2016, NUCLEIC ACIDS RES, V44, P1052, DOI 10.1093/nar/gkv999; Miyasaka Y, 2016, HUM MOL GENET, V25, P2045, DOI 10.1093/hmg/ddw078; Nakao H, 2016, GENESIS, V54, P65, DOI 10.1002/dvg.22914; Peng D, 2014, MBIO, V6, DOI DOI 10.1128/MBIO.02097-14; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Qu XY, 2014, MOL BIOL REP, V41, P5819, DOI 10.1007/s11033-014-3456-3; Robinson GW, 2014, MOL ENDOCRINOL, V28, P758, DOI 10.1210/me.2012-1387; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Shinmyo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20611; Singer M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0811-1; Spielmann M, 2016, GENOME RES, V26, P183, DOI 10.1101/gr.199430.115; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tsuchiya Y, 2015, GENES CELLS, V20, P992, DOI 10.1111/gtc.12305; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Willi M, 2016, NUCLEIC ACIDS RES, V44, P10277, DOI 10.1093/nar/gkw844; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Young SAM, 2015, INT J MOL SCI, V16, P24732, DOI 10.3390/ijms161024732; Zeng XK, 2016, CELL REP, V17, P3333, DOI 10.1016/j.celrep.2016.11.079; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhang WW, 2015, MBIO, V6, DOI 10.1128/mBio.00861-15; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	63	1	1	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 31	2017	8								15464	10.1038/ncomms15464				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EW3IU	WOS:000402389700001	28561021	gold			2018-01-05	
J	Park, MY; Jung, MH; Eo, EY; Kim, S; Lee, SH; Lee, YJ; Park, JS; Cho, YJ; Chung, JH; Kim, CH; Yoon, HI; Lee, JH; Lee, CT				Park, Mi-Young; Jung, Min Hee; Eo, Eun Young; Kim, Seokjoong; Lee, Sang Hoon; Lee, Yeon Joo; Park, Jong Sun; Cho, Young Jae; Chung, Jin Haeng; Kim, Cheol Hyeon; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon-Taek			Generation of lung cancer cell lines harboring EGFR T790M mutation by CRISPR/Cas9-mediated genome editing	ONCOTARGET			English	Article						lung cancer; resistance; EGFR T790M; CRISPR/Cas9	INHIBITORS; SENSITIVITY; RESISTANCE	Tyrosine kinase inhibitors (TKIs) such as gefitinib and erlotinib are effective against lung adenocarcinomas harboring epidermal growth factor receptor (EGFR) mutations. However, cancer cells can develop resistance to these agents with prolonged exposure; in over 50% of cases, this is attributable to the EGFR T790M mutation. Moreover, additional resistance mutations can arise with the use of new drugs. Cancer cell lines with specific mutations can enable the study of resistance mechanisms. In this study, we introduced the EGFR T790M mutation into the PC9 human lung cancer cell line-which has a deletion in exon 19 of the EGFR gene-by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9-mediated genome editing. EGFR pyrosequencing and peptide nucleic acid clamping revealed that PC9 cells with EGFR T790M generated by CRISPR/Cas 9 had a higher T790M mutation rate than those with the same mutation generated by long-term exposure to gefitinib (PC9-G); moreover, resistance to gefitinib in these clones was higher than that in PC9-G cells. The clones were also highly sensitive to the 3rd-generation EGFR TKI AZD9291, which is cytotoxic to lung cancer cells with EGFR T790M. The CRISPR/Cas9 programmable nuclease system can be used to generate various cancer cell lines with specific mutations that can facilitate studies on resistance mechanisms and drug efficacy.	[Park, Mi-Young; Eo, Eun Young; Lee, Sang Hoon; Lee, Yeon Joo; Park, Jong Sun; Cho, Young Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon-Taek] Seoul Natl Univ, Bundang Hosp, Div Pulmonol & Crit Care Med, Dept Internal Med, Seongnam, South Korea; [Park, Mi-Young; Eo, Eun Young; Lee, Sang Hoon; Lee, Yeon Joo; Park, Jong Sun; Cho, Young Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon-Taek] Seoul Natl Univ, Bundang Hosp, Resp Ctr, Seongnam, South Korea; [Jung, Min Hee; Kim, Seokjoong] Toolgen Inc, Seoul, South Korea; [Lee, Sang Hoon; Lee, Yeon Joo; Park, Jong Sun; Cho, Young Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon-Taek] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Chung, Jin Haeng] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea; [Kim, Cheol Hyeon] Korea Canc Ctr Hosp, Dept Internal Med, Seoul, South Korea	Lee, CT (reprint author), Seoul Natl Univ, Bundang Hosp, Div Pulmonol & Crit Care Med, Dept Internal Med, Seongnam, South Korea.; Lee, CT (reprint author), Seoul Natl Univ, Bundang Hosp, Resp Ctr, Seongnam, South Korea.; Lee, CT (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ctlee@snu.ac.kr			Seoul National University Bundang Hospital [02-2013-039]	This study was funded by Seoul National University Bundang Hospital (02-2013-039).	Amann J, 2005, CANCER RES, V65, P226; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dufort S, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-57; Kim ES, 2016, DRUGS, V76, P1153, DOI 10.1007/s40265-016-0606-z; Lee HJ, 2013, KOREAN J PATHOL, V47, P52, DOI 10.4132/KoreanJPathol.2013.47.1.52; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938                                                            ; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Niederst MJ, 2015, CLIN CANCER RES, V21, P3924, DOI 10.1158/1078-0432.CCR-15-0560; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Song Haa-Na, 2016, J Thorac Oncol, V11, pe45, DOI 10.1016/j.jtho.2015.12.093; Wanzel I, 2016, NAT CHEM BIOL, V12, P22, DOI [10.1038/NCHEMBIO.1965, 10.1038/nchembio.1965]; Yoon SH, 2015, CANCER RES TREAT, V47, P661, DOI 10.4143/crt.2014.282; Yu HA, 2015, JAMA ONCOL, V1, P981, DOI 10.1001/jamaoncol.2015.1066	17	1	1	8	8	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 30	2017	8	22					36331	36338		10.18632/oncotarget.16752				8	Oncology; Cell Biology	Oncology; Cell Biology	EX4UI	WOS:000403230000071	28422737	green_published			2018-01-05	
J	Zhao, KX; Ridgway, ND				Zhao, Kexin; Ridgway, Neale D.			Oxysterol-Binding Protein-Related Protein 1L Regulates Cholesterol Egress from the Endo-Lysosomal System	CELL REPORTS			English	Article							ENDOPLASMIC-RETICULUM; LIPID-BILAYERS; SENSOR ORP1L; TRANSPORT; RECEPTOR; CONTACTS; STEROL; GOLGI; ACTIVATION; NPC1	Lipoprotein cholesterol is delivered to the limiting membrane of late endosomes/lysosomes (LELs) by Niemann-Pick C1 (NPC1). However, the mechanism of cholesterol transport from LELs to the endoplasmic reticulum (ER) is poorly characterized. We report that oxysterol-binding protein-related protein 1L (ORP1L) is necessary for this stage of cholesterol export. CRISPR-mediated knockout of ORP1L in HeLa and HEK293 cells reduced esterification of cholesterol to the level in NPC1 knockout cells, and it increased the expression of sterol-regulated genes and de novo cholesterol synthesis, indicative of a block in cholesterol transport to the ER. In the absence of this transport pathway, cholesterol-enriched LELs accumulated in the Golgi/perinuclear region. Cholesterol delivery to the ER required the sterol-, phosphatidylinositol 4-phosphate-, and vesicle-associated membrane protein-associated protein (VAP)-binding activities of ORP1L, as well as NPC1 expression. These results suggest that ORP1L-dependent membrane contacts between LELs and the ER coordinate cholesterol transfer with the retrograde movement of endo-lysosomal vesicles.	[Zhao, Kexin; Ridgway, Neale D.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Box 15000, Halifax, NS B3H 4R2, Canada; [Zhao, Kexin; Ridgway, Neale D.] Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Box 15000, Halifax, NS B3H 4R2, Canada	Ridgway, ND (reprint author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Box 15000, Halifax, NS B3H 4R2, Canada.; Ridgway, ND (reprint author), Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Box 15000, Halifax, NS B3H 4R2, Canada.	nridgway@dal.ca			Canadian Institutes of Health Research [MOP-15284]; Bernard and Winnifred Mary Lockwood Endowment	We thank Mark Charman and Robert Douglas for technical assistance, Mary-Jane Travors for EM analysis, and Antonietta Pietrangelo for critical review of the manuscript. Dr. Thomas Lagace (Ottawa Heart Institute) provided the LDLR antibody. Funding was provided by the Canadian Institutes of Health Research MOP-15284 (to N.D.R.) and the Bernard and Winnifred Mary Lockwood Endowment.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Cianciola NL, 2017, J VIROL, V91, DOI 10.1128/JVI.01904-16; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Galmes R, 2016, EMBO REP, V17, P800, DOI 10.15252/embr.201541108; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2003, MOL BIOL CELL, V14, P903, DOI 10.1091/mbc.E02-08-0459; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li J, 2015, P NATL ACAD SCI USA, V112, P14876, DOI 10.1073/pnas.1520490112; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Ouimet M, 2016, ARTERIOSCL THROM VAS, V36, P942, DOI 10.1161/ATVBAHA.116.307282; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wijdeven RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11808; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u	39	2	2	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	MAY 30	2017	19	9					1807	1818		10.1016/j.celrep.2017.05.028				12	Cell Biology	Cell Biology	EW1RU	WOS:000402271100007	28564600	gold			2018-01-05	
J	Liu, WJ; Chen, HX; Wong, N; Haynes, W; Baker, CM; Wang, XW				Liu, Weijun; Chen, Hanxiang; Wong, Nathan; Haynes, Wesley; Baker, Callie M.; Wang, Xiaowei			Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma	CANCER LETTERS			English	Article						MicroRNA; miR-126; Renal cell carcinoma; Hypoxia; Pseudohypoxia	GENE-EXPRESSION ANALYSIS; INDUCIBLE FACTOR-I; REGULATES MTOR; KIDNEY CANCER; HYPOXIA; MICRORNA; METASTASIS; AUTOPHAGY; ACTIVATOR; UPDATE	Pseudohypoxia plays a central role in the progression and therapeutic resistance of clear cell renal cell carcinoma (ccRCC); however, the underlying mechanisms are poorly understood. MicroRNA miR-126 has decreased expression in metastatic or relapsed ccRCC as compared to primary tumors, but the mechanisms by which miR-126 is implicated in RCC remain unknown. Through RNA-seq profiling to evaluate the impact of overexpression or CRISPR knockout of miR-126, we have identified SERPINE1 as a miR-126-5p target regulating cell motility, and SLC7A5 as a miR-126-3p target regulating the mTOR/HIF pathway. Specifically, miR-126 inhibits HIFa protein expression independent of von Hippel-Lindau tumor suppressor (VHL). On the other hand, deactivation of miR-126 induces a pseudohypoxia state due to increased HIFa expression, which further enhances therapeutic resistance and cell motility mediated by SLC7A5 and SERPINE1, respectively. Finally, the clinical relevance of miR-126 modulated gene regulation in ccRCC has been confirmed with profiling data from The Cancer Genome Atlas. (C) 2017 Elsevier B.V. All rights reserved.	[Liu, Weijun; Chen, Hanxiang; Wong, Nathan; Haynes, Wesley; Baker, Callie M.; Wang, Xiaowei] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA; [Chen, Hanxiang] Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan, Shandong, Peoples R China	Wang, XW (reprint author), Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA.	xiaowei.wang@wustl.edu			National Institutes of Health [R01GM089784]	We are grateful to Drs. Maria Czyzyk-Krzeska at University of Cincinnati and Xin Huang at University of Pittsburgh for providing RCC cell lines. We thank Drs. Kareem Azab and Qing Yang at Washington University in St. Louis for sharing antibodies. This research was supported by the National Institutes of Health (grant R01GM089784).	Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Betsunoh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-509; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Chen R, 2014, J CELL BIOL, V206, P173, DOI 10.1083/jcb.201403009; Clark PE, 2008, CANCER-AM CANCER SOC, V113, P1768, DOI 10.1002/cncr.23645; de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5; Ebrahimi F, 2014, EXP MOL PATHOL, V96, P98, DOI 10.1016/j.yexmp.2013.12.004; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Frew IJ, 2015, ANNU REV PATHOL-MECH, V10, P263, DOI 10.1146/annurev-pathol-012414-040306; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; George CM, 2003, CANC TREAT, V116, P173; Gu LY, 2015, ONCOTARGET, V6, P32545, DOI 10.18632/oncotarget.5324; Heinzelmann J, 2014, ANN SURG ONCOL, V21, P1046, DOI 10.1245/s10434-013-3361-3; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817                                                         ; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Jiang Z, 2013, RNA, V19, P1745, DOI 10.1261/rna.039677.113; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Khella HWZ, 2015, AM J PATHOL, V185, P693, DOI 10.1016/j.ajpath.2014.11.017; Khella HWZ, 2012, TUMOR BIOL, V33, P131, DOI 10.1007/s13277-011-0255-5; Kietzmann T, 1999, BLOOD, V94, P4177; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Liu WJ, 2014, ONCOTARGET, V5, P11620, DOI 10.18632/oncotarget.2599                                                        ; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Massari F, 2015, CANC TREAT REV; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Rini BI, 2010, CLIN CANCER RES, V16, P1348, DOI 10.1158/1078-0432.CCR-09-2273; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Slaby O., 2012, CANCER, V51, P707; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang XW, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp864; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0	44	1	1	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3835	1872-7980		CANCER LETT	Cancer Lett.	MAY 28	2017	394						65	75		10.1016/j.canlet.2017.02.025				11	Oncology	Oncology	ES5ZZ	WOS:000399626900007	28257806				2018-01-05	
J	Zuberi, A; Misba, L; Khan, AU				Zuberi, Azna; Misba, Lama; Khan, Asad U.			CRISPR Interference (CRISPRi) Inhibition of IuxS Gene Expression in E-coli: An Approach to Inhibit Biofilm	FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY			English	Article						biofilms; CRISPR; Cas9; Autoinducer-2; quorum sensing; IuxS; knockdown	SEQUENCE-SPECIFIC CONTROL; BACTERIAL BIOFILMS; INFECTIONS; LUXS; AUTOINDUCER-2	Biofilm is a sessile bacterial accretion embedded in self-producing matrix. It is the root cause of about 80% microbial infections in human. Among them, E. col! biofilms are most prevalent in medical devices associated nosocomial infections. The objective of this study was to inhibit biofilm formation by targeting gene involved in quorum sensing, one of the main mechanisms of biofilm formation. Hence we have introduced the CRISPRi, first time to target luxS gene. luxS is a synthase, involved in the synthesis of Autoinducer-2(AI-2), which in turn guides the initial stage of biofilm formation. To implement CRISPRi system for luxS gene suppression, we have synthesized complementary sgRNA to target gene sequence and co-expressed with dCas9, a mutated form of an endonuclease. Suppression of luxS expression was confirmed through qRT-PCR. The effect of luxS gene on biofilm inhibition was studied through crystal violet assay, XTT reduction assay and scanning electron microscopy. We conclude that CRISPRi system could be a potential strategy to inhibit bacterial biofilm through mechanism base approach.	[Zuberi, Azna; Misba, Lama; Khan, Asad U.] Aligarh Muslim Univ, Med Microbiol & Mol Biol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Khan, AU (reprint author), Aligarh Muslim Univ, Med Microbiol & Mol Biol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com			internal funds of Interdisciplinary Biotechnology Unit	This work was supported by internal funds of Interdisciplinary Biotechnology Unit.	Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318                                                   ; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226                                                          ; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Keseler I.M., 2012, NUCLEIC ACIDS RES, V41, pD605, DOI DOI 10.1093/NAR/GKS1027; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lau E, 2014, NAT REV GENET, V15, P778, DOI [10.1038/nrg3850, 10.1016/j.cell.2014.09.029]; Misba L, 2016, BIOFOULING, V32, P313, DOI 10.1080/08927014.2016.1141899; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Radzisheuskaya A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw583; Reisner A, 2014, J BACTERIOL, V196, P931, DOI 10.1128/JB.00985-13; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x                                                ; Sharma G, 2016, J APPL MICROBIOL, V121, P309, DOI 10.1111/jam.13078; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vogeleer P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00317; Wang L, 2005, J BACTERIOL, V187, P8350, DOI 10.1128/JB.187.24.8350-8360.2005; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627                                                                	22	1	1	14	14	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2235-2988			FRONT CELL INFECT MI	Front. Cell. Infect. Microbiol.	MAY 26	2017	7								214	10.3389/fcimb.2017.00214				7	Immunology; Microbiology	Immunology; Microbiology	EV9KR	WOS:000402105400003	28603699	gold			2018-01-05	
J	Chen, L; Paquette, N; Mamoor, S; Rus, F; Nandy, A; Leszyk, J; Shaffer, SA; Silverman, N				Chen, Li; Paquette, Nicholas; Mamoor, Shahan; Rus, Florentina; Nandy, Anubhab; Leszyk, John; Shaffer, Scott A.; Silverman, Neal			Innate immune signaling in Drosophila is regulated by transforming growth factor beta (TGF beta)-activated kinase (Tak1)-triggered ubiquitin editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); Drosophila; mass spectrometry (MS); NF-B (NF-B); phosphorylation; ubiquitylation (ubiquitination); Imd; Tak1; ubiquitin editing	NF-KAPPA-B; POLYUBIQUITIN CHAINS; CONJUGATING ENZYMES; IMD-PATHWAY; PGRP-LC; ACTIVATION; PEPTIDOGLYCAN; E2; BINDING; TAK1	Coordinated regulation of innate immune responses is necessary in all metazoans. In Drosophila the Imd pathway detects Gram-negative bacterial infections through recognition of diaminopimelic acid (DAP)-type peptidoglycan and activation of the NF-kappa B precursor Relish, which drives robust antimicrobial peptide gene expression. Imd is a receptor-proximal adaptor protein homologous to mammalian RIP1 that is regulated by proteolytic cleavage and Lys-63-polyubiquitination. However, the precise events and molecular mechanisms that control the post-translational modification of Imd remain unclear. Here, we demonstrate that Imd is rapidly Lys-63-polyubiquitinated at lysine residues 137 and 153 by the sequential action of two E2 enzymes, Ubc5 and Ubc13-Uev1a, in conjunction with the E3 ligase Diap2. Lys-63-ubiquitination activates the TGF beta-activated kinase (Tak1), which feeds back to phosphorylate Imd, triggering the removal of Lys-63 chains and the addition of Lys-48 polyubiquitin. This ubiquitin-editing process results in the proteasomal degradation of Imd, which we propose functions to restore homeostasis to the Drosophila immune response.	[Chen, Li; Paquette, Nicholas; Mamoor, Shahan; Rus, Florentina; Nandy, Anubhab; Silverman, Neal] Univ Massachusetts, Med Sch, Div Infect Dis, Dept Med, 364 Plantat St, Worcester, MA 01605 USA; [Leszyk, John; Shaffer, Scott A.] Univ Massachusetts, Med Sch, Prote & Mass Spectrometry Facil, Worcester, MA 01605 USA	Silverman, N (reprint author), Univ Massachusetts, Med Sch, Div Infect Dis, Dept Med, 364 Plantat St, Worcester, MA 01605 USA.	neal.silverman@umassmed.edu			National Institutes of Health [AI060025]	This work was supported, in whole or in part, by National Institutes of Health Grant AI060025 (to N. S.).	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Bergmann A, 2010, CELL DEATH DIFFER, V17, P61, DOI 10.1038/cdd.2009.70; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guntermann S, 2009, DEV COMP IMMUNOL, V33, P127, DOI 10.1016/j.dci.2008.07.021; Jones D, 2002, GENOME BIOL, V3; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008                                                    ; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Khush RS, 2002, CURR BIOL, V12, P1728, DOI 10.1016/S0960-9822(02)01214-9; Kim CH, 2014, J BIOL CHEM, V289, P20092, DOI 10.1074/jbc.M113.544841; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413                                                     ; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S                                                    ; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; TREIER M, 1992, EMBO J, V11, P367; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Wooff J, 2004, FEBS LETT, V566, P229, DOI 10.1016/j.febslet.2004.04.038; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200; Zhuang ZH, 2006, CELL SIGNAL, V18, P964, DOI 10.1016/j.cellsig.2005.08.020	47	3	3	11	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8738	8749		10.1074/jbc.M117.788158				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW0BU	WOS:000402153900020	28377500				2018-01-05	
J	Montefiori, L; Hernandez, L; Zhang, ZJ; Gilad, Y; Ober, C; Crawford, G; Nobrega, M; Sakabe, NJ				Montefiori, Lindsey; Hernandez, Liana; Zhang, Zijie; Gilad, Yoav; Ober, Carole; Crawford, Gregory; Nobrega, Marcelo; Sakabe, Noboru Jo			Reducing mitochondrial reads in ATAC-seq using CRISPR/Cas9	SCIENTIFIC REPORTS			English	Article							CHROMATIN	ATAC-seq is a high-throughput sequencing technique that identifies open chromatin. Depending on the cell type, ATAC-seq samples may contain similar to 20-80% of mitochondrial sequencing reads. As the regions of open chromatin of interest are usually located in the nuclear genome, mitochondrial reads are typically discarded from the analysis. We tested two approaches to decrease wasted sequencing in ATAC-seq libraries generated from lymphoblastoid cell lines: targeted cleavage of mitochondrial DNA fragments using CRISPR technology and removal of detergent from the cell lysis buffer. We analyzed the effects of these treatments on the number of usable (unique, non-mitochondrial) reads and the number and quality of peaks called, including peaks identified in enhancers and transcription start sites. Both treatments resulted in considerable reduction of mitochondrial reads (1.7 and 3-fold, respectively). The removal of detergent, however, resulted in increased background and fewer peaks. The highest number of peaks and highest quality data was obtained by preparing samples with the original ATAC-seq protocol (using detergent) and treating them with CRISPR. This strategy reduced the amount of sequencing required to call a high number of peaks, which could lead to cost reduction when performing ATAC-seq on large numbers of samples and in cell types that contain a large amount of mitochondria.	[Montefiori, Lindsey; Hernandez, Liana; Zhang, Zijie; Gilad, Yoav; Ober, Carole; Nobrega, Marcelo; Sakabe, Noboru Jo] Univ Chicago, Dept Human Genet, 920 E 58th St Room 515, Chicago, IL 60637 USA; [Crawford, Gregory] Duke Univ, Dept Pediat, Ctr Genom & Computat Biol, Durham, NC 27708 USA	Nobrega, M; Sakabe, NJ (reprint author), Univ Chicago, Dept Human Genet, 920 E 58th St Room 515, Chicago, IL 60637 USA.	mnobrega@uchicago.edu; nsakabe@uchicago.edu			March of Dimes Prematurity Research Center at UChicago-Northwestern-Duke; National Institutes of Health [T32-GM007197]	This work was supported by the March of Dimes Prematurity Research Center at UChicago-Northwestern-Duke and the National Institutes of Health (training grant number T32-GM007197 from NIH-NIGMS to L.E.M).	Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Buenrostro J.D., 2015, CURR PROTOC MOL BIOL, V109; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2016, R LANG ENV STAT COMP; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	15	0	0	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 26	2017	7								2451	10.1038/s41598-017-02547-w				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EV8PW	WOS:000402045300019	28550296	gold			2018-01-05	
J	Hayut, SF; Bessudo, CM; Levy, AA				Hayut, Shdema Filler; Bessudo, Cathy Melamed; Levy, Avraham A.			Targeted recombination between homologous chromosomes for precise breeding in tomato	NATURE COMMUNICATIONS			English	Article							DOUBLE-STRAND BREAKS; SOMATIC PLANT-CELLS; GENE CONVERSION; MEIOTIC RECOMBINATION; ARABIDOPSIS-THALIANA; NICOTIANA-TABACUM; CRISPR/CAS SYSTEM; IN-PLANTA; GENOME; REPAIR	Homologous recombination (HR) between parental chromosomes occurs stochastically. Here, we report on targeted recombination between homologous chromosomes upon somatic induction of DNA double-strand breaks (DSBs) via CRISPR-Cas9. We demonstrate this via a visual and molecular assay whereby DSB induction between two alleles carrying different mutations in the PHYTOENE SYNTHASE (PSY1) gene results in yellow fruits with wild type red sectors forming via HR-mediated DSB repair. We also show that in heterozygote plants containing one psy1 allele immune and one sensitive to CRISPR, repair of the broken allele using the unbroken allele sequence template is a common outcome. In another assay, we show evidence of a somatically induced DSB in a cross between a psy1 edible tomato mutant and wild type Solanum pimpinellifolium, targeting only the S. pimpinellifolium allele. This enables characterization of germinally transmitted targeted somatic HR events, demonstrating that somatically induced DSBs can be exploited for precise breeding of crops.	[Hayut, Shdema Filler; Bessudo, Cathy Melamed; Levy, Avraham A.] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel	Levy, AA (reprint author), Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel.	avi.levy@weizmann.ac.il			Israel Science Foundation (ISF) [102714]; Israeli Ministry of Agriculture [15-01-0001]	We would like to thank Prof. Daniel Zamir, Prof. Yossi Hirschberg and Dr Itay Zemach (Hebrew University of Jerusalem) for providing the tomato mutant lines; Offir Lupo and Or Gross for the excellent technical help. This work was supported by the grants 102714 from the Israel Science Foundation (ISF); 15-01-0001 from the Israeli Ministry of Agriculture to A.A.L.	Amiard S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00405; ATHMA P, 1991, GENETICS, V128, P163; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bleuyard JY, 2006, DNA REPAIR, V5, P1, DOI 10.1016/j.dnarep.2005.08.017; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; CARLSON PS, 1974, GENET RES, V24, P109, DOI 10.1017/S0016672300015123                                                       ; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Charbonnel C, 2011, DNA REPAIR, V10, P611, DOI 10.1016/j.dnarep.2011.04.002; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Dooner HK, 1997, PLANT CELL, V9, P1633; Drouaud J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003922; DULIEU HL, 1974, MUTAT RES, V25, P289, DOI 10.1016/0027-5107(74)90057-8; Edlinger B, 2011, J EXP BOT, V62, P1545, DOI 10.1093/jxb/erq421; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Gisler B, 2002, PLANT J, V32, P277, DOI 10.1046/j.1365-313X.2002.01421.x; Gorbunova V, 2000, PLANT J, V24, P601, DOI 10.1046/j.1365-313x.2000.00905.x; Gorbunova V, 1997, NUCLEIC ACIDS RES, V25, P4650, DOI 10.1093/nar/25.22.4650; Gorbunova V, 1999, TRENDS PLANT SCI, V4, P263, DOI 10.1016/S1360-1385(99)01430-2                                                   ; Johnson RA, 2015, PLANT MOL BIOL, V87, P143, DOI 10.1007/s11103-014-0266-x; Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109; Li J, 2007, CURR OPIN PLANT BIOL, V10, P131, DOI 10.1016/j.pbi.2007.01.007; Li X, 2007, J INTEGR PLANT BIOL, V49, P222, DOI 10.1111/j.1672-9072.2007.00393.x; Lieberman-Lazarovich M, 2011, METHODS MOL BIOL, V701, P51, DOI 10.1007/978-1-61737-957-4_3; Lloyd AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032255; LOWE B, 1992, GENETICS, V132, P813; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; McCormick S., 1991, PLANT TISSUE CU B S7, P311; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Mercier R, 2005, CURR BIOL, V15, P692, DOI 10.1016/j.cub.2005.02.056; Mercier R, 2015, ANNU REV PLANT BIOL, V66, P297, DOI 10.1146/annurev-arplant-050213-035923; Molinier J, 2004, PLANT CELL, V16, P342, DOI 10.1105/tpc.019042; Orel N, 2003, PLANT J, V35, P604, DOI 10.1046/j.1365-313X.2003.01832.x; Preston CR, 1996, GENETICS, V144, P1611; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; PUCHTA H, 1995, PLANT J, V7, P203, DOI 10.1046/j.1365-313X.1995.7020203.x; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Puchta H, 1999, GENETICS, V152, P1173; Puchta H., 2015, ADV NEW TECHNOLOGY T, P1; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Rubin E, 1997, MOL CELL BIOL, V17, P6294, DOI 10.1128/MCB.17.11.6294                                                          ; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shalev G, 1997, GENETICS, V146, P1143; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; SWEETSER DB, 1994, MOL CELL BIOL, V14, P3863, DOI 10.1128/MCB.14.6.3863                                                           ; Tsaponina O, 2014, MOL CELL, V55, P615, DOI 10.1016/j.molcel.2014.06.025; Vu GTH, 2014, PLANT CELL, V26, P2156, DOI 10.1105/tpc.114.126607; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451	53	1	1	18	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 26	2017	8								15605	10.1038/ncomms15605				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EV8QQ	WOS:000402047700001		gold			2018-01-05	
J	Paul, D; Sinha, AN; Ray, A; Lal, M; Nayak, S; Sharma, A; Mehani, B; Mukherjee, D; Laddha, SV; Suri, A; Sarkar, C; Mukhopadhyay, A				Paul, Deepanjan; Sinha, Ashis Narayan; Ray, Arjun; Lal, Megha; Nayak, Subhashree; Sharma, Anchal; Mehani, Bharati; Mukherjee, Debasish; Laddha, Saurabh V.; Suri, Ashish; Sarkar, Chitra; Mukhopadhyay, Arijit			A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme	SCIENTIFIC REPORTS			English	Article							MESSENGER-RNA; HUMAN BRAIN; COMPREHENSIVE ANALYSIS; ADENOSINE DEAMINASES; ADAR DEAMINASES; MICRORNAS; EXPRESSION; TARGETS; IDENTIFICATION; TRANSCRIPTOME	Editing in microRNAs, particularly in seed can significantly alter the choice of their target genes. We show that out of 13 different human tissues, different regions of brain showed higher adenosine to inosine (A-to-I) editing in mature miRNAs. These events were enriched in seed sequence (73.33%), which was not observed for cytosine to uracil (17.86%) editing. More than half of the edited miRNAs showed increased stability, 72.7% of which had Delta Delta G values less than -6.0 Kcal/mole and for all of them the edited adenosines mis-paired with cytosines on the pre-miRNA structure. A seed-editing event in hsa-miR-411 (with A-C mismatch) lead to increased expression of the mature form compared to the unedited version in cell culture experiments. Further, small RNA sequencing of GBM patients identified significant miRNA hypoediting which correlated with downregulation of ADAR2 both in metadata and qRT-PCR based validation. Twenty-two significant (11 novel) A-to-I hypoediting events were identified in GBM samples. This study highlights the importance of specific sequence and structural requirements of pre-miRNA for editing along with a suggestive crucial role for ADAR2. Enrichment of A-to-I editing in seed sequence highlights this as an important layer for genomic regulation in health and disease, especially in human brain.	[Paul, Deepanjan; Sinha, Ashis Narayan; Ray, Arjun; Lal, Megha; Sharma, Anchal; Mehani, Bharati; Mukherjee, Debasish; Laddha, Saurabh V.; Mukhopadhyay, Arijit] CSIR, Inst Genom & Integrat Biol, Genom & Mol Med Unit, Delhi, India; [Paul, Deepanjan; Ray, Arjun; Lal, Megha; Sharma, Anchal; Mehani, Bharati; Mukhopadhyay, Arijit] Acad Sci & Innovat Res AcSIR, Delhi, India; [Nayak, Subhashree; Sarkar, Chitra] All India Inst Med Sci, Dept Pathol, Delhi, India; [Suri, Ashish] All India Inst Med Sci, Dept Neurosurg, Delhi, India; [Mukhopadhyay, Arijit] Univ Salford, Sch Environm & Life Sci, Salford, Lancs, England	Mukhopadhyay, A (reprint author), CSIR, Inst Genom & Integrat Biol, Genom & Mol Med Unit, Delhi, India.; Mukhopadhyay, A (reprint author), Acad Sci & Innovat Res AcSIR, Delhi, India.; Mukhopadhyay, A (reprint author), Univ Salford, Sch Environm & Life Sci, Salford, Lancs, England.	a.mukhopadhyay@salford.ac.uk	Mukherjee, Debasish/F-7339-2014	Mukherjee, Debasish/0000-0002-0158-0700	Council of Scientific and Industrial Research (CSIR), Government of India [BSC-0123]; CSIR	We acknowledge the Human Brain Bank at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India for providing the FC and CC samples. We thank Mr. Tony Jose and Dr. Mohammed Faruq for their technical help during the sample preparation and sequencing run of the small RNA libraries. We thank Mr. Asgar Hussain Ansari for helping us in depositing the raw sequencing data in sequence read archive (SRA). We also thank Dr. Dhurjhoti Saha for his technical help in cell culture overexpression experiment. The work is funded by the Council of Scientific and Industrial Research (CSIR), Government of India (Grant Number-BSC-0123). In addition, BSC-0121 (computing facility) is also acknowledged for central facility. Deepanjan Paul acknowledges CSIR for fellowship.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Chen W, 2017, ONCOTARGET, V8, P4208, DOI 10.18632/oncotarget.13758; Chen W, 2017, SCI REP-UK, V7, DOI 10.1038/srep40242; Chen W, 2016, SCI REP-UK, V6, DOI 10.1038/srep35123; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Feng Y, 2012, RNA, V18, P2083, DOI 10.1261/rna.033688.112; FIORE R, 2009, THE EMBO JOURNAL, V28, P697, DOI DOI 10.1038/EMB0J.2009.10; HEALE BS, 2009, THE EMBO JOURNAL, V28, P3145, DOI DOI 10.1038/EMB0J.2009.244; HORSCH M, 2011, THE JOURNAL OF BIOLO, V286, P18614, DOI DOI 10.1074/JBC.M110.200881; Kallman AM, 2003, NUCLEIC ACIDS RES, V31, P4874, DOI 10.1093/nar/gkg681; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Keegan L.P., 2001, GENETICS, V2, P869; Laddha SV, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-10; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Negi V, 2015, NUCLEIC ACIDS RES, V43, P8057, DOI 10.1093/nar/gkv752; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohman M, 2007, BIOCHIMIE, V89, P1171, DOI 10.1016/j.biochi.2007.06.002; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; POLSON AG, 1994, EMBO J, V13, P5701; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Tomaselli S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0575-z; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Warnefors M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r83; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X                                                       ; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zheng Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw471; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133                                                             	54	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 26	2017	7								2466	10.1038/s41598-017-02397-6				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EV8PX	WOS:000402045400008	28550310	gold			2018-01-05	
J	Elbarbary, RA; Miyoshi, K; Myers, JR; Du, PC; Ashton, JM; Tian, B; Maquat, LE				Elbarbary, Reyad A.; Miyoshi, Keita; Myers, Jason R.; Du, Peicheng; Ashton, John M.; Tian, Bin; Maquat, Lynne E.			Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G(1)/S phase transition	SCIENCE			English	Article							STAPHYLOCOCCAL NUCLEASE; FEEDBACK LOOP; RNA; EXPRESSION; CANCER; CYCLE; REGULATOR	MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression. The pathways that mediate mature miRNA decay are less well understood than those that mediate miRNA biogenesis. We found that functional miRNAs are degraded in human cells by the endonuclease Tudor-SN (TSN). In vitro, recombinant TSN initiated the decay of both protein-free and Argonaute 2-loaded miRNAs via endonucleolytic cleavage at CA and UA dinucleotides, preferentially at scissile bonds located more than five nucleotides away from miRNA ends. Cellular targets of TSN-mediated decay defined using microRNA sequencing followed this rule. Inhibiting TSN-mediated miRNA decay by CRISPR-Cas9 knockout of TSN inhibited cell cycle progression by up-regulating a cohort of miRNAs that down-regulates mRNAs that encode proteins critical for the G(1)-to-S phase transition. Our study indicates that targeting TSN nuclease activity could inhibit pathological cell proliferation.	[Elbarbary, Reyad A.; Miyoshi, Keita; Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Elbarbary, Reyad A.; Miyoshi, Keita; Maquat, Lynne E.] Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA; [Myers, Jason R.; Ashton, John M.] Univ Rochester, Genom Res Ctr, Rochester, NY 14642 USA; [Du, Peicheng] Rutgers State Univ, Off Adv Res Comp, Piscataway, NJ 08854 USA; [Tian, Bin] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Oncol, Rochester, NY 14642 USA	Maquat, LE (reprint author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.; Maquat, LE (reprint author), Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu		Ashton, John/0000-0001-9875-5994; Tian, Bin/0000-0001-8903-8256	NIH [R37 GM74593, R01 GM084089, P30 AR061307]; Uehara Memorial Foundation; Mochida Memorial Foundation	Raw data are deposited in the Gene Expression Omnibus (accession no. GSE77484). We thank F. Lopez for plasmid preparations; H. Siomi, K. Nishikura, and H. Yuan for plasmids; P. Svoboda for Dicer-kd 2b2 cells; M. Gleghorn for protein structure advice; A. Rosenberg for statistical analyses; and M. Popp for comments on the manuscript. Supported by NIH grants R37 GM74593 (L.E.M.), R01 GM084089 (B.T.), and P30 AR061307 (R.A.E.); the Uehara Memorial Foundation (K. M.); and the Mochida Memorial Foundation (K.M.). L.E.M. and R.A.E. are the inventors on U.S. provisional patent application 62/471627 filed 15 March 2017 by the University of Rochester (entitled "Compositions and Methods Targeting the TumiD Pathway for Treating and Preventing Cancer").	Augoff K, 2011, MOL CANCER RES, V9, P1500, DOI 10.1158/1541-7786.MCR-11-0311; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Jariwala N, 2015, INT J ONCOL, V46, P465, DOI 10.3892/ijo.2014.2766; Kim HS, 2015, ONCOTARGET, V6, P8089, DOI 10.18632/oncotarget.3512                                                        ; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; REDDI KK, 1960, NATURE, V187, P74, DOI 10.1038/187074a0; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Su C, 2015, J BIOL CHEM, V290, P7208, DOI 10.1074/jbc.M114.625046; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079	20	1	1	8	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2017	356	6340					859	862		10.1126/science.aai9372				4	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7LP	WOS:000401957900041	28546213	green_accepted			2018-01-05	
J	Gander, MW; Vrana, JD; Voje, WE; Carothers, JM; Klavins, E				Gander, Miles W.; Vrana, Justin D.; Voje, William E.; Carothers, James M.; Klavins, Eric			Digital logic circuits in yeast with CRISPR-dCas9 NOR gates	NATURE COMMUNICATIONS			English	Article							SEQUENCE-SPECIFIC CONTROL; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; REGULATORY NETWORKS; MAMMALIAN-CELLS; SYNTHETIC BIOLOGY; ZINC FINGERS; STEM-CELLS; TRANSCRIPTION; RNA	Natural genetic circuits enable cells to make sophisticated digital decisions. Building equally complex synthetic circuits in eukaryotes remains difficult, however, because commonly used components leak transcriptionally, do not arbitrarily interconnect or do not have digital responses. Here, we designed dCas9-Mxi1-based NOR gates in Saccharomyces cerevisiae that allow arbitrary connectivity and large genetic circuits. Because we used the chromatin remodeller Mxi1, our gates showed minimal leak and digital responses. We built a combinatorial library of NOR gates that directly convert guide RNA (gRNA) inputs into gRNA outputs, enabling the gates to be 'wired' together. We constructed logic circuits with up to seven gRNAs, including repression cascades with up to seven layers. Modelling predicted the NOR gates have effectively zero transcriptional leak explaining the limited signal degradation in the circuits. Our approach enabled the largest, eukaryotic gene circuits to date and will form the basis for large, synthetic, cellular decision-making systems.	[Gander, Miles W.; Klavins, Eric] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Vrana, Justin D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Voje, William E.; Carothers, James M.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [Carothers, James M.; Klavins, Eric] Univ Washington, Ctr Synthet Biol, Seattle, WA 98195 USA	Gander, MW (reprint author), Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA.	gandermiles@gmail.com		Carothers, James/0000-0001-6728-7833	Semiconductor Research Corporation; NSF [1317653, MCB 1517052]; University of Washington	Michelle Parks and the Klavins Lab technicians helped build strains and performed experimental assays. The computational work was facilitated through the use of the Hyak supercomputer system at the University of Washington. This research is funded in part by a grant from the Semiconductor Research Corporation and NSF Grant Number 1317653. J.M.C. was a fellow of the Alfred P. Sloan Foundation. W.E.V. and J.M.C. were supported in part by funds from the University of Washington and an NSF Award MCB 1517052.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bernot G, 2004, J THEOR BIOL, V229, P339, DOI 10.1016/j.jtbi.2004.04.003; Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bowyer J, 2016, IEEE T BIOMED CIRC S, V10, P1161, DOI 10.1109/TBCAS.2016.2526668; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Cambray G, 2013, NUCLEIC ACIDS RES, V41, P5139, DOI 10.1093/nar/gkt163; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Church GM, 2014, NAT REV MOL CELL BIO, V15, P289, DOI 10.1038/nrm3767; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Didovyk A, 2016, ACS SYNTH BIOL, V5, P81, DOI [10.1021/acssynbio5b00147, 10.1021/acssynbio.5b00147]; Dunn EF, 2005, GENE DEV, V19, P90, DOI 10.1101/gad.1267005; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gaber R, 2014, NAT CHEM BIOL, V10, P203, DOI [10.1038/NCHEMBIO.1433, 10.1038/nchembio.1433]; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guye P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10243; Hinkelmann F., 2009, ARXIV09122089; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Jayanthi S, 2013, ACS SYNTH BIOL, V2, P431, DOI 10.1021/sb300098w; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Keung AJ, 2015, NAT REV GENET, V16, P159, DOI 10.1038/nrg3900; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/NMETH.2969, 10.1038/nmeth.2969]; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Lapique N, 2014, NAT CHEM BIOL, V10, P1020, DOI 10.1038/nchembio.1680; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee E, 2014, JPN SOC INFL AMM REG, V34, P15; Lee TC, 1999, J BIOL CHEM, V274, P595, DOI 10.1074/jbc.274.2.595                                                           ; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; Mishra D, 2014, NAT BIOTECHNOL, V32, P1268, DOI 10.1038/nbt.3044; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Naumova N, 2012, METHODS, V58, P192, DOI 10.1016/j.ymeth.2012.07.022; Nelson VP, 1995, DIGITAL LOGIC CIRCUI; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rajkumar AS, 2013, NAT GENET, V45, P1207, DOI 10.1038/ng.2729; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Shankar S, 2011, MOL BIOSYST, V7, P1802, DOI 10.1039/c1mb05016h; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Shmulevich I, 2002, P IEEE, V90, P1778, DOI 10.1109/JPROC.2002.804686; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328                                                         ; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Trifonov EN, 2011, PHYS LIFE REV, V8, P39, DOI 10.1016/j.plrev.2011.01.004; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watterson S, 2008, DRUG DISCOV TODAY, V13, P447, DOI 10.1016/j.drudis.2008.03.019; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006; Yuh CH, 2001, DEVELOPMENT, V128, P617; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	72	2	2	8	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 25	2017	8								15459	10.1038/ncomms15459				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7NW	WOS:000401964700001	28541304	gold			2018-01-05	
J	Yang, B; Zhou, W; Jiao, J; Nielsen, JB; Mathis, MR; Heydarpour, M; Lettre, G; Folkersen, L; Prakash, S; Schurmann, C; Fritsche, L; Farnum, GA; Lin, MX; Othman, M; Hornsby, W; Driscoll, A; Levasseur, A; Thomas, M; Farhat, L; Dube, MP; Isselbacher, EM; Franco-Cereceda, A; Guo, DC; Bottinger, EP; Deeb, GM; Booher, A; Kheterpal, S; Chen, YE; Kang, HM; Kitzman, J; Cordell, HJ; Keavney, BD; Goodship, JA; Ganesh, SK; Abecasis, G; Eagle, KA; Boyle, AP; Loos, RJF; Eriksson, P; Tardif, JC; Brummett, CM; Milewicz, DM; Body, SC; Willer, CJ				Yang, Bo; Zhou, Wei; Jiao, Jiao; Nielsen, Jonas B.; Mathis, Michael R.; Heydarpour, Mahyar; Lettre, Guillaume; Folkersen, Lasse; Prakash, Siddharth; Schurmann, Claudia; Fritsche, Lars; Farnum, Gregory A.; Lin, Maoxuan; Othman, Mohammad; Hornsby, Whitney; Driscoll, Anisa; Levasseur, Alexandra; Thomas, Marc; Farhat, Linda; Dube, Marie-Pierre; Isselbacher, Eric M.; Franco-Cereceda, Anders; Guo, Dong-Chuan; Bottinger, Erwin P.; Deeb, G. Michael; Booher, Anna; Kheterpal, Sachin; Chen, Y. Eugene; Kang, Hyun Min; Kitzman, Jacob; Cordell, Heather J.; Keavney, Bernard D.; Goodship, Judith A.; Ganesh, Santhi K.; Abecasis, Goncalo; Eagle, Kim A.; Boyle, Alan P.; Loos, Ruth J. F.; Eriksson, Per; Tardif, Jean-Claude; Brummett, Chad M.; Milewicz, Dianna M.; Body, Simon C.; Willer, Cristen J.			Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve	NATURE COMMUNICATIONS			English	Article							CONGENITAL HEART-DISEASE; VENTRICULAR SEPTAL-DEFECTS; VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; GENOTYPE IMPUTATION; SEQUENCE VARIANTS; TUBE FORMATION; MUTATIONS; GENOME; NKX2.5	Bicuspid aortic valve (BAV) is a heritable congenital heart defect and an important risk factor for valvulopathy and aortopathy. Here we report a genome-wide association scan of 466 BAV cases and 4,660 age, sex and ethnicity-matched controls with replication in up to 1,326 cases and 8,103 controls. We identify association with a noncoding variant 151 kb from the gene encoding the cardiac-specific transcription factor, GATA4, and near-significance for p.Ser377Gly in GATA4. GATA4 was interrupted by CRISPR-Cas9 in induced pluripotent stem cells from healthy donors. The disruption of GATA4 significantly impaired the transition from endothelial cells into mesenchymal cells, a critical step in heart valve development.	[Yang, Bo; Jiao, Jiao; Deeb, G. Michael; Chen, Y. Eugene] Univ Michigan, Dept Cardiac Surg, Ann Arbor, MI 48109 USA; [Yang, Bo; Hornsby, Whitney; Driscoll, Anisa; Levasseur, Alexandra; Thomas, Marc; Farhat, Linda; Deeb, G. Michael; Booher, Anna; Chen, Y. Eugene; Ganesh, Santhi K.; Eagle, Kim A.; Willer, Cristen J.] Univ Michigan, Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA; [Zhou, Wei; Farnum, Gregory A.; Kitzman, Jacob; Boyle, Alan P.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Nielsen, Jonas B.; Lin, Maoxuan; Booher, Anna; Chen, Y. Eugene; Ganesh, Santhi K.; Eagle, Kim A.; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Mathis, Michael R.; Kheterpal, Sachin; Brummett, Chad M.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Heydarpour, Mahyar; Isselbacher, Eric M.; Body, Simon C.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Lettre, Guillaume; Dube, Marie-Pierre; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume; Dube, Marie-Pierre; Tardif, Jean-Claude] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Folkersen, Lasse; Eriksson, Per] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med, Cardiovasc Med Unit,Ctr Mol Med, SE-17176 Stockholm, Sweden; [Folkersen, Lasse] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Copenhagen, Denmark; [Prakash, Siddharth; Guo, Dong-Chuan; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr, Houston McGovern Med Sch, Div Med Genet, Dept Internal Med, Houston, TX 77030 USA; [Schurmann, Claudia; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Fritsche, Lars; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Fritsche, Lars] Norwegian Univ Sci & Technol, N-7491 Trondheim, Norway; [Othman, Mohammad] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Franco-Cereceda, Anders] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Cardiothorac Surg Unit, SE-17176 Stockholm, Sweden; [Kitzman, Jacob; Ganesh, Santhi K.; Boyle, Alan P.; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Cordell, Heather J.; Goodship, Judith A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Keavney, Bernard D.] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester M13 9PL, Lancs, England; [Keavney, Bernard D.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth Dev Inst, New York, NY 10029 USA	Yang, B (reprint author), Univ Michigan, Dept Cardiac Surg, Ann Arbor, MI 48109 USA.; Yang, B; Willer, CJ (reprint author), Univ Michigan, Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA.; Willer, CJ (reprint author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Willer, CJ (reprint author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.; Willer, CJ (reprint author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	boya@med.umich.edu; cristen@umich.edu		Eriksson, Per/0000-0002-5635-2692; Farnum, Gregory/0000-0002-0192-8252; Nielsen, Jonas Bille/0000-0002-6654-2852; Folkersen, Lasse/0000-0003-0708-9530; Fritsche, Lars/0000-0002-2110-1690	FCVC; Aikens Fund for Aortic Research; McKay research award; American Association of Thoracic Surgery (AATS) Graham Foundation; Thoracic Surgery Foundation of Research and Education (TSFRE); Doris Duke Charitable Foundation [2013104, HL122684]; Danish Heart Foundation; Lundbeck Foundation; A.P. Moller Foundation for the Advancement of Medical Science; MHI Foundation; Canada Research Chair Program; Leducq Foundation (MIBAVA); Andrea and Charles Bronfman Philanthropies; NIH [NHGRI U01HG007417]; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; Broad Institute [HHSN268201000029C]; van Andel Institute [10ST1035, HHSN261200800001E]; University of Miami [DA006227, DA033684, N01MH000028]; University of Geneva [MH090941, MH101814]; University of Chicago [MH090951, MH090937, MH101820, MH101825]; University of North Carolina-Chapel Hill [MH090936, MH101819]; Harvard University [MH090948]; Stanford University [MH101782]; Washington University St Louis [MH101810]; University of Pennsylvania [MH101822];  [HL109946];  [HL130705];  [HL127564];  [HL114823]	We thank all participants of the CHIP and BAV registry at the University of Michigan for their contribution to research. We appreciate the valuable efforts from the CHIP and BAV registry collection team (W.H., A.D., A.L., M.T., L.F., Jennifer McNamara, Joyvina Evans, Daniel Ferman, Neelima Goyal, Joanna Hider, Tom Jones, John Kruszewski, Brian Kulick, Jamie Love-Nichols, Joe Luciano, Alison Lunau, Phillip Nulty, Kevin Packard, Ian Patterson, Bailey Pearce, Mike Ranella, Alexander Shevchik, Carolyn Sommer, Christina White). The University of Michigan Health System - CHIP was supported by the FCVC. We appreciate the Aikens Fund for Aortic Research (C. J. W. and B.Y.) and McKay research award for supporting this project (B.Y.). B.Y. is supported by American Association of Thoracic Surgery (AATS) Graham Foundation and Thoracic Surgery Foundation of Research and Education (TSFRE). C. J. W. is supported by HL109946, HL130705 and HL127564. S.K.G. is supported by Doris Duke Charitable Foundation, grant #2013104 and HL122684. J.B.N. is supported by grants from The Danish Heart Foundation, the Lundbeck Foundation and the A.P. Moller Foundation for the Advancement of Medical Science. We thank all participants and staff of the Andre and France Desmarais MHI Biobank, and in particular John D. Rioux and Simon de Denus who participated in the design of the study. The MHI replication study was funded by the MHI Foundation and the Canada Research Chair Program. We thank all participants and physician investigators of the International Bicuspid Aortic Valve Consortium (BAVCon) for their scientific collaboration. Investigators of the International Bicuspid Aortic Valve Consortium (BAVCon): Eduardo Bossone, Azienda Ospedaliera Universitaria Salerno; Rodolfo Citro, Azienda Ospedaliera Universitaria Salerno; Stefano Nistri, CMSR Veneto Medica, Vicenza; Dan Gilon, Hadassah-Hebrew University Medical Center; Ronen Durst, Hadassah-Hebrew University Medical Center; Simon Body, Harvard University; Thoraf M. Sundt, Harvard University; J. Daniel Muehlschlegel, Harvard University; Carlo de Vincentis, IRCCS Policlinico San Donato; Francesca R. Pluchinotta, IRCCS Policlinico San Donato; Hector I. Michelena, Mayo Clinic; Maurice Sarano, Mayo Clinic; Bo Yang, University of Michigan; Kim Eagle, University of Michigan; Cristen J. Willer, University of Michigan; Giuseppe Limongelli, Monaldi Hospital; Malenka M. Bissell, Oxford University; Alessandro DellaCorte, Second University of Naples; Amalia Forte, Second University of Naples; Gordon Huggins, Tufts University; Victor Dayan, Universidad de la Republica, Uruguay; Yohan Bosse, Universite Laval; Evaldas Girdsaukas, University of Hamburg; Ashutosh Hardikar, University of Tasmania; Thomas Marwick, University of Tasmania; Joseph Bavaria, University of Pennsylvania; Rita C. Milewski, University of Pennsylvania; Dianna M. Milewicz, University of Texas Health Science Center at Houston; Siddarth K. Prakash, University of Texas Health Science Center at Houston; Arturo Evangelista, Vall d'Hebron University Hospital; Joshua C Denny, Vanderbilt University; and Edward Hulten, Walter Reed National Military Medical Center. The BAVCon efforts at Partners HealthCare (Boston, MA) are supported by HL114823 to S.C.B. The ASAP study was supported by the Leducq Foundation (MIBAVA). The Mount Sinai BioMe Biobank is supported by The Andrea and Charles Bronfman Philanthropies. BioMe is partially funded by a grant from NIH (NHGRI U01HG007417).; Analyses of BioMe data were supported in part through the computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS. Additional funding was provided to the Broad Institute (HHSN268201000029C), the van Andel Institute (10ST1035, HHSN261200800001E), University of Miami (DA006227, DA033684 and N01MH000028), the University of Geneva (MH090941 and MH101814), the University of Chicago (MH090951, MH090937, MH101820 and MH101825), the University of North Carolina-Chapel Hill (MH090936 and MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St Louis (MH101810) and the University of Pennsylvania (MH101822). The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 11 16 November 2015.	Adzhubei I, 2013, CURR PROTOC HUM GENE, V7, P20, DOI [DOI 10.1002/0471142905.HG0720S76, 10.1002/0471142905.hg0720s76]; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033; Bonachea EM, 2014, PEDIATR RES, V76, P211, DOI 10.1038/pr.2014.67; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cordell HJ, 2013, HUM MOL GENET, V22, P1473, DOI 10.1093/hmg/dds552; Cripe L, 2004, J AM COLL CARDIOL, V44, P138, DOI 10.1016/j.jacc.2004.03.050; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellison JW, 2007, J SURG RES, V142, P28, DOI 10.1016/j.jss.2006.04.040; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Foffa I, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-44; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Garg V, 2006, CURR OPIN CARDIOL, V21, P180, DOI 10.1097/01.hco.0000221578.18254.70; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7                                                   ; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HUANG WY, 1995, GENE, V155, P219, DOI 10.1016/0378-1119(94)00893-W; Jiao J, 2013, HUM MOL GENET, V22, P4241, DOI 10.1093/hmg/ddt275; Jiao J, 2013, STEM CELLS, V31, P729, DOI 10.1002/stem.1318; Kennedy SJ, 2001, AM J MED GENET, V104, P79, DOI 10.1002/1096-8628(20011115)104:1<79::AID-AJMG1598>3.0.CO;2-T; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Laforest B, 2011, J CLIN INVEST, V121, P2876, DOI 10.1172/JCI44555; LaHaye S, 2016, CIRC-CARDIOVASC GENE, V9, P320, DOI 10.1161/CIRCGENETICS.115.001324; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Losenno K. L., 2012, CARDIOL RES PRACT, V2012, DOI DOI 10.1155/2012/145202; Lourenco D, 2011, P NATL ACAD SCI USA, V108, P1597, DOI 10.1073/pnas.1010257108; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin LJ, 2007, HUM GENET, V121, P275, DOI 10.1007/s00439-006-0316-9; Mattapally S, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0152-7; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; Michelena HI, 2011, JAMA-J AM MED ASSOC, V306, P1104, DOI 10.1001/jama.2011.1286; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Padang R, 2012, J MOL CELL CARDIOL, V53, P277, DOI 10.1016/j.yjmcc.2012.05.009; Pasta S, 2013, J BIOMECH, V46, P1729, DOI 10.1016/j.jbiomech.2013.03.029; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; Sarkozy A, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.026740; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Su RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064496; Sveinbjornsson G, 2014, HUM MOL GENET, V23, P6935, DOI 10.1093/hmg/ddu399; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Tutar E, 2005, AM HEART J, V150, P513, DOI 10.1016/j.ahj.2004.10.036; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang J, 2011, INT J MOL MED, V28, P557, DOI 10.3892/ijmm.2011.715; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wirrig EE, 2014, ARTERIOSCL THROM VAS, V34, P737, DOI 10.1161/ATVBAHA.113.302071; Wooten EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008830; Yang YQ, 2013, ARCH MED SCI, V9, P976, DOI 10.5114/aoms.2013.39788; Yang YQ, 2013, HUM MUTAT, V34, P1662, DOI 10.1002/humu.22434; Yang YQ, 2012, MED SCI MONITOR, V18, pCR344, DOI 10.12659/MSM.882877                                                             ; Zhang WM, 2008, EUR J MED GENET, V51, P527, DOI 10.1016/j.ejmg.2008.06.005	70	6	6	8	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 25	2017	8								15481	10.1038/ncomms15481				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7NY	WOS:000401964900001	28541271	gold			2018-01-05	
J	Lovendahl, KN; Hayward, AN; Gordon, WR				Lovendahl, Klaus N.; Hayward, Amanda N.; Gordon, Wendy R.			Sequence-Directed Covalent Protein-DNA Linkages in a Single Step Using HUH-Tags	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							STRANDED-DNA; ENDONUCLEASE DOMAIN; BINDING; RELAXASES; ARM	We present a robust strategy to covalently link proteins and DNA using HUH-endonuclease domains as fusion partners (HUH-tags). We show that HUH-tags react robustly with specific sequences of unmodified single-stranded DNA, and we have identified five tags that react orthogonally with distinct DNA sequences. We demonstrate the versatility of HUH-tags as fusion partners in Cas9-mediated gene editing and the construction of doubly DNA-tethered proteins for single-molecule studies. Finally we demonstrate application to cellular imaging in live and fixed cells.	[Lovendahl, Klaus N.; Hayward, Amanda N.; Gordon, Wendy R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Gordon, WR (reprint author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	wrgordon@umn.edu		Gordon, Wendy/0000-0001-7696-5560; Lovendahl, Klaus/0000-0002-3871-3570	NIH NIGMS R35 [1R35GM119483]; Pew Biomedical Scholar Program [29634]; UMN	This study was supported by an NIH NIGMS R35 grant to W.R.G. (1R35GM119483), funds to W.R.G. from the Pew Biomedical Scholar Program (29634), and UMN startup funds. We would like to thank Peter Gordon for the kind gift of inducible GFP cell lines. We also would like to thank Eric Hendrickson and Brian Ruis for helpful discussions about the Cas9 experiments. Typhoon FLA9500 images were collected at the University of Minnesota Imaging Center.	Anders C, 2015, METHOD ENZYMOL, V558, P515, DOI 10.1016/bs.mie.2015.02.008; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; Datta S, 2003, STRUCTURE, V11, P1369, DOI 10.1016/j/str.2003.10.001; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Edwards JS, 2013, P NATL ACAD SCI USA, V110, P2804, DOI 10.1073/pnas.1219701110; Engelen W, 2016, CHEM COMMUN, V52, P3598, DOI 10.1039/c5cc09853j; Fu JL, 2014, NAT NANOTECHNOL, V9, P531, DOI [10.1038/nnano.2014.100, 10.1038/NNANO.2014.100]; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Halvorsen K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494005; Hariadi RF, 2014, P NATL ACAD SCI USA, V111, P4091, DOI 10.1073/pnas.1315923111; Harley MJ, 2003, P NATL ACAD SCI USA, V100, P11243, DOI 10.1073/pnas.2035001100; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/NMETH.2835, 10.1038/nmeth.2835]; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4333, DOI 10.1002/anie.200501089; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Mali P, 2013, NAT METHODS, V10, P403, DOI [10.1038/nmeth.2407, 10.1038/NMETH.2407]; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; Nakata E, 2012, ANGEW CHEM INT EDIT, V51, P2421, DOI 10.1002/anie.201108199; Nastasijevic B, 2008, BIOCHEM BIOPH RES CO, V366, P420, DOI 10.1016/j.bbrc.2007.11.169; Boer DR, 2009, EMBO J, V28, P1666, DOI 10.1038/emboj.2009.125; Sagredo S, 2016, ANGEW CHEM INT EDIT, V55, P4348, DOI 10.1002/anie.201510313; Shaw A, 2014, NAT METHODS, V11, P841, DOI [10.1038/NMETH.3025, 10.1038/nmeth.3025]; Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/NCHEMBIO.720, 10.1038/nchembio.720]; Vega-Rocha S, 2007, BIOCHEMISTRY-US, V46, P6201, DOI 10.1021/bi700159q; Vega-Rocha S, 2007, J MOL BIOL, V367, P473, DOI 10.1016/j.jmb.2007.01.002; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	30	0	0	6	7	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	MAY 24	2017	139	20					7030	7035		10.1021/jacs.7b02572				6	Chemistry, Multidisciplinary	Chemistry	EW4VH	WOS:000402498500037	28481515	green_accepted			2018-01-05	
J	Nawaz, G; Kang, H				Nawaz, Ghazala; Kang, Hunseung			Chloroplast- or Mitochondria-Targeted DEAD-Box RNA Helicases Play Essential Roles in Organellar RNA Metabolism and Abiotic Stress Responses	FRONTIERS IN PLANT SCIENCE			English	Review						chloroplast; DEAD-box RNA helicase; mitochondria; RNA metabolism; stress response	ARABIDOPSIS-THALIANA; ABSCISIC-ACID; RIBOSOMAL-RNA; GENE-REGULATION; NONCODING RNAS; PROTEIN; MECHANISM; FAMILY; BINDING; PLANTS	The yields and productivity of crops are greatly diminished by various abiotic stresses, including drought, cold, heat, and high salinity. Chloroplasts and mitochondria are cellular organelles that can sense diverse environmental stimuli and alter gene expression to cope with adverse environmental stresses. Organellar gene expression is mainly regulated at posttranscriptional levels, including RNA processing, intron splicing, RNA editing, RNA turnover, and translational control, during which a variety of nucleus-encoded RNA-binding proteins (RBPs) are targeted to chloroplasts or mitochondria where they play essential roles in organellar RNA metabolism. DEAD-box RNA helicases (RHs) are enzymes that can alter RNA structures and affect RNA metabolism in all living organisms. Although a number of DEAD-box RHs have been found to play important roles in RNA metabolism in the nucleus and cytoplasm, our understanding on the roles of DEAD-box RHs in the regulation of RNA metabolism in chloroplasts and mitochondria is only at the beginning. Considering that organellar RNA metabolism and gene expression are tightly regulated by anterograde signaling from the nucleus, it is imperative to determine the functions of nucleus-encoded organellar RBPs. In this review, we summarize the emerging roles of nucleus-encoded chloroplast-or mitochondria-targeted DEAD-box RHs in organellar RNA metabolism and plant response to diverse abiotic stresses.	[Nawaz, Ghazala; Kang, Hunseung] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Gwangju, South Korea	Kang, H (reprint author), Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Gwangju, South Korea.	hskang@jnu.ac.kr			Next-Generation BioGreen21 Program [PJ01105401]; Rural Development Administration, Republic of Korea; Mid-career Researcher Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2016R1A2B4009172]	This work was supported by a grant from the Next-Generation BioGreen21 Program (PJ01105401), Rural Development Administration, Republic of Korea, and by a grant from the Mid-career Researcher Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1A2B4009172), Republic of Korea.	Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; Asakura Y, 2012, PLANT PHYSIOL, V159, P961, DOI 10.1104/pp.112.197525; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; Biswal B, 2011, CURR SCI INDIA, V101, P47; Boudet N, 2001, GENOME RES, V11, P2101, DOI 10.1101/gr.200801; Carlotto N, 2016, PLANT CELL ENVIRON, V39, P165, DOI 10.1111/pce.12603; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1                                                   ; Chi W, 2012, PLANT PHYSIOL, V158, P693, DOI 10.1104/pp.111.186775; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; del Campo EM, 2009, GENE REGUL SYST BIO, V3, P31; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Floris M, 2009, INT J MOL SCI, V10, P3168, DOI 10.3390/ijms10073168; Gagliardi D, 1999, FEBS LETT, V458, P337, DOI 10.1016/S0014-5793(99)01168-0; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gu L, 2014, PLANT PHYSIOL BIOCH, V82, P309, DOI 10.1016/j.plaphy.2014.07.006; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; He JN, 2012, PLANT CELL, V24, P1815, DOI 10.1105/tpc.112.098707; Hotto AM, 2012, TRENDS PLANT SCI, V17, P737, DOI 10.1016/j.tplants.2012.08.002; Hsu YF, 2014, PLANT J, V77, P119, DOI 10.1111/tpj.12371; Huang CK, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0769-5; Huang CK, 2010, PLANT CELL PHYSIOL, V51, P694, DOI 10.1093/pcp/pcq045; Kanai M, 2013, PLANT CELL PHYSIOL, V54, P1431, DOI 10.1093/pcp/pct091; Kang H, 2013, TRENDS PLANT SCI, V18, P100, DOI 10.1016/j.tplants.2012.08.004; Kim JS, 2008, PLANT CELL PHYSIOL, V49, P1563, DOI 10.1093/pcp/pcn125; Kohler D, 2010, PLANT MOL BIOL, V72, P459, DOI 10.1007/s11103-009-9584-9; Komatsui S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00071; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Lee K, 2016, MOL CELLS, V39, P179, DOI 10.14348/molcells.2016.2359; Li XW, 2011, PLANT CELL, V23, P1416, DOI 10.1105/tpc.110.082636; Li YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30297; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154040; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Macovei Anca, 2012, Plant Signal Behav, V7, P1138, DOI 10.4161/psb.21343; Matthes A, 2007, PLANT PHYSIOL, V145, P1637, DOI 10.1104/pp.107.108076; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Millar AH, 2006, CURR OPIN PLANT BIOL, V9, P610, DOI 10.1016/j.pbi.2006.09.002; Mingam A, 2004, PLANT BIOTECHNOL J, V2, P401, DOI 10.1111/j.1467-7652.2004.00084.x; Nakamura T, 2004, PLANT SCI, V167, P63, DOI 10.1016/j.plantsci.2004.03.001; Nishimura K, 2010, PLANT J, V63, P766, DOI 10.1111/j.1365-313X.2010.04276.x; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Nouri MZ, 2015, INT J MOL SCI, V16, P20392, DOI 10.3390/ijms160920392; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; PAUSE A, 1992, EMBO J, V11, P2643; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Ranty B, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00327, 10.3389/fpls.2015.00327]; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Sahoo RK, 2014, RICE, V7, DOI 10.1186/s12284-014-0017-2; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Simpson GG, 1996, PLANT MOL BIOL, V32, P1, DOI 10.1007/BF00039375; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Sun AZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00398; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6                                                   ; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Tuteja N, 2013, PLANT J, V76, P115, DOI 10.1111/tpj.12277; Umate P, 2010, PLANT MOL BIOL, V73, P449, DOI 10.1007/s11103-010-9632-5; Valgardsdottir R, 2001, J BIOL CHEM, V276, P32056, DOI 10.1074/jbc.M011629200                                                          ; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3                                                   ; Wang D, 2016, MEDIAT INFLAMM, V2016, P1, DOI DOI 10.1371/J0URNAL.PGEN.1005844; Wang YC, 2000, PLANT CELL, V12, P2129, DOI 10.1105/tpc.12.11.2129; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Yang L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004791; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	73	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	MAY 24	2017	8								871	10.3389/fpls.2017.00871				9	Plant Sciences	Plant Sciences	EV8LU	WOS:000402032700001	28596782	gold			2018-01-05	
J	Bahreini, A; Li, ZQ; Wang, PL; Levine, KM; Tasdemir, N; Cao, L; Weir, HM; Puhalla, SL; Davidson, NE; Stern, AM; Chu, D; Park, BH; Lee, AV; Oesterreich, S				Bahreini, Amir; Li, Zheqi; Wang, Peilu; Levine, Kevin M.; Tasdemir, Nilgun; Cao, Lan; Weir, Hazel M.; Puhalla, Shannon L.; Davidson, Nancy E.; Stern, Andrew M.; Chu, David; Park, Ben Ho; Lee, Adrian V.; Oesterreich, Steffi			Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models	BREAST CANCER RESEARCH			English	Article						ESR1 mutations; Genome-edited cells; Metastatic breast cancer; Endocrine resistance; RNA-seq	ESTROGEN-RECEPTOR-ALPHA; ACQUIRED ENDOCRINE RESISTANCE; GENE-EXPRESSION; ER-ALPHA; INHIBITOR; MECHANISM; TAMOXIFEN; CRISPR; LINES	Background: Mutations in the estrogen receptor alpha (ER alpha) 1 gene (ESR1) are frequently detected in ER+ metastatic breast cancer, and there is increasing evidence that these mutations confer endocrine resistance in breast cancer patients with advanced disease. However, their functional role is not well-understood, at least in part due to a lack of ESR1 mutant models. Here, we describe the generation and characterization of genome-edited T47D and MCF7 breast cancer cell lines with the two most common ESR1 mutations, Y537S and D538G. Methods: Genome editing was performed using CRISPR and adeno-associated virus (AAV) technologies to knock-in ESR1 mutations into T47D and MCF7 cell lines, respectively. Various techniques were utilized to assess the activity of mutant ER, including transactivation, growth and chromatin-immunoprecipitation (ChIP) assays. The level of endocrine resistance was tested in mutant cells using a number of selective estrogen receptor modulators (SERMs) and degraders (SERDs). RNA sequencing (RNA-seq) was employed to study gene targets of mutant ER. Results: Cells with ESR1 mutations displayed ligand-independent ER activity, and were resistant to several SERMs and SERDs, with cell line and mutation-specific differences with respect to magnitude of effect. The SERD AZ9496 showed increased efficacy compared to other drugs tested. Wild-type and mutant cell co-cultures demonstrated a unique evolution of mutant cells under estrogen deprivation and tamoxifen treatment. Transcriptome analysis confirmed ligand-independent regulation of ERa target genes by mutant ERa, but also identified novel target genes, some of which are involved in metastasis-associated phenotypes. Despite significant overlap in the ligandindependent genes between Y537S and D538G, the number of mutant ERa-target genes shared between the two cell lines was limited, suggesting context-dependent activity of the mutant receptor. Some genes and phenotypes were unique to one mutation within a given cell line, suggesting a mutation-specific effect. Conclusions: Taken together, ESR1 mutations in genome-edited breast cancer cell lines confer ligand-independent growth and endocrine resistance. These biologically relevant models can be used for further mechanistic and translational studies, including context-specific and mutation site-specific analysis of the ESR1 mutations.	[Bahreini, Amir; Lee, Adrian V.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Bahreini, Amir; Li, Zheqi; Tasdemir, Nilgun; Lee, Adrian V.; Oesterreich, Steffi] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Bahreini, Amir; Li, Zheqi; Wang, Peilu; Levine, Kevin M.; Cao, Lan; Puhalla, Shannon L.; Davidson, Nancy E.; Lee, Adrian V.; Oesterreich, Steffi] Univ Pittsburgh, Inst Canc, Womens Canc Res Ctr, Pittsburgh, PA USA; [Bahreini, Amir; Li, Zheqi; Wang, Peilu; Levine, Kevin M.; Cao, Lan; Puhalla, Shannon L.; Davidson, Nancy E.; Lee, Adrian V.; Oesterreich, Steffi] Magee Women Res Inst, Pittsburgh, PA USA; [Wang, Peilu] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Levine, Kevin M.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Levine, Kevin M.] MSTP Program, Pittsburgh, PA USA; [Cao, Lan] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Weir, Hazel M.] AstraZeneca, Oncol iMed, Alderley Pk, Macclesfield, Cheshire, England; [Puhalla, Shannon L.; Davidson, Nancy E.] Univ Pittsburgh, Div Hematol Oncol, Dept Med, Pittsburgh, PA USA; [Stern, Andrew M.] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Chu, David; Park, Ben Ho] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Davidson, Nancy E.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Davidson, Nancy E.] Univ Washington, Seattle, WA 98195 USA	Oesterreich, S (reprint author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA.; Oesterreich, S (reprint author), Univ Pittsburgh, Inst Canc, Womens Canc Res Ctr, Pittsburgh, PA USA.	oesterreichs@upmc.edu			Nicole Meloche Foundation; Penguins Foundation; Penguins Alumni Foundation; Mario Lemieux Foundation; Fashion Footwear of New York (FFANY); Breast Cancer Research Foundation (BCRF); Avon Foundation (BH Park); Pilot Award from the Institute of Personalized Medicine (IPM) at Pitt (SP); PA Department of Health, SAP [4100068731]; NCI [P30CA047904]; China Scholarship Council award through Tsinghua Medical School, Beijing, China; Central South University Xiangya School of Medicine, China	The study was in part supported by funds from the Nicole Meloche Foundation, the Penguins Foundation, the Penguins Alumni Foundation, the Mario Lemieux Foundation, from the Fashion Footwear of New York (FFANY), Breast Cancer Research Foundation (BCRF; to AV Lee, S Oesterreich, BH Park and NE Davidson), the Avon Foundation (BH Park), through a Pilot Award from the Institute of Personalized Medicine (IPM) at Pitt (SP), through funds from the PA Department of Health, SAP #4100068731 (AM Stern), through a P30CA047904 from the NCI, and through support from Dr Adam Brufsky. S Oesterreich and AV Lee are recipients of Scientific Leadership awards from Susan G. Komen for the Cure. PW was supported by a China Scholarship Council award through Tsinghua Medical School, Beijing, China, and LC by funds from Central South University Xiangya School of Medicine, China.	Chandarlapaty S, 2016, JAMA ONCOL, V2, P1310, DOI 10.1001/jamaoncol.2016.1279; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fanning SW, 2016, ELIFE, V5, DOI 10.7554/eLife.12792; Fribbens C, 2016, J CLIN ONCOL, V34, P2961, DOI 10.1200/JCO.2016.67.3061; Fuqua SAW, 2014, BREAST CANCER RES TR, V144, P11, DOI 10.1007/s10549-014-2847-4; Gelsomino L, 2016, BREAST CANCER RES TR, V157, P253, DOI 10.1007/s10549-016-3829-5; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Harrod A, 2017, ONCOGENE, V36, P2286, DOI 10.1038/onc.2016.382; Jeselsohn R, 2015, NAT REV CLIN ONCOL, V12, P573, DOI 10.1038/nrclinonc.2015.117; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Jiang SM, 2006, MOL ENDOCRINOL, V20, P311, DOI 10.1210/me.2005-0100; Kumar V, 2015, J EXP BOT, V66, P47, DOI 10.1093/jxb/eru429; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mao CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34753; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Oesterreich S, 2013, NAT GENET, V45, P1415, DOI 10.1038/ng.2831; Patro R, 2015, BIORXIV, V14, P417; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rechoum Y, 2014, BREAST CANCER RES TR, V147, P473, DOI 10.1007/s10549-014-3082-8; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Ross RL, 2013, ONCOGENE, V32, P768, DOI 10.1038/onc.2012.87; Sikora MJ, 2016, ENDOCRINOLOGY, V157, P3760, DOI 10.1210/en.2016-1297; Sikora MJ, 2014, CANCER RES, V74, P1463, DOI 10.1158/0008-5472.CAN-13-2779; Spoerke JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11579; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang PL, 2016, CLIN CANCER RES, V22, P1130, DOI 10.1158/1078-0432.CCR-15-1534; Weir HM, 2016, CANCER RES, V76, P3307, DOI 10.1158/0008-5472.CAN-15-2357	29	0	0	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-542X	1465-5411		BREAST CANCER RES	Breast Cancer Res.	MAY 23	2017	19								60	10.1186/s13058-017-0851-4				10	Oncology	Oncology	EW7HP	WOS:000402680700003	28535794	green_published			2018-01-05	
J	Zahur, M; Tolo, J; Bahr, M; Kugler, S				Zahur, Muzna; Toloe, Johan; Baehr, Mathias; Kuegler, Sebastian			Long-Term Assessment of AAV-Mediated Zinc Finger Nuclease Expression in the Mouse Brain	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						genome editing; zinc finger nuclease; cathepsin D; adeno-associated virus; in vivo	CATHEPSIN-D; IN-VIVO; GENE-THERAPY; ENGINEERED NUCLEASES; NEUROTROPHIC FACTOR; LYSOSOMAL STORAGE; MICE; MODEL; DISEASE; CNS	Gene editing tools like TALENs, ZFNs and Crispr/Cas now offer unprecedented opportunities for targeted genetic manipulations in virtually all species. Most of the recent research in this area has concentrated on manipulation of the genome in isolated cells, which then give rise to transgenic animals or modified stem cell lines. Much less is known about applicability of genetic scissors in terminally differentiated, non-dividing cells like neurons of the adult brain. We addressed this question by expression of a pair of ZFNs targeting the murine cathepsin D gene in CNS neurons by means of an optimized AAV viral vector. We show that ZFN expression resulted in substantial depletion of cathepsin D from neuronal lysosomes, demonstrating a robust gene deletion. Importantly, long-term ZFN expression in CNS neurons did not impair essential neuronal functionality and did not cause inflammation or neurodegeneration, suggesting that potent genetic scissors can be expressed safely in the mouse brain. This finding opens up new venues to create novel research models for neurodegenerative disorders.	[Zahur, Muzna; Toloe, Johan; Baehr, Mathias; Kuegler, Sebastian] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Toloe, Johan; Baehr, Mathias; Kuegler, Sebastian] Univ Med Ctr Gottingen, Dept Neurol, Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany	Zahur, M; Kugler, S (reprint author), Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany.; Kugler, S (reprint author), Univ Med Ctr Gottingen, Dept Neurol, Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany.	mzahur@yahoo.com; sebastian.kuegler@med.uni-goettingen.de			Alexander von Humboldt Foundation; German Research council	MZ received funding from the Alexander von Humboldt Foundation. JT, MB, and SK received funding from the German Research council funded Center Nanoscale Microscopy and Physiology of the Brain (CNMPB).	Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cradick TJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-152; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; FAUST PL, 1987, J CELL BIOL, V105, P1937, DOI 10.1083/jcb.105.5.1937; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Hermann M, 2014, JOVE-J VIS EXP, DOI 10.3791/50930; Jo YI, 2015, CELL MOL LIFE SCI, V72, P3819, DOI 10.1007/s00018-015-1956-5; Klein RL, 2002, METHODS, V28, P286, DOI 10.1016/S1046-2023(02)00234-7                                                   ; Koike M, 2000, J NEUROSCI, V20, P6898; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kugler S, 2007, AM J HUM GENET, V80, P291, DOI 10.1086/511281; Kugler S, 2016, METHODS MOL BIOL, V1382, P81, DOI 10.1007/978-1-4939-3271-9_6; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Landau DJ, 2016, MOL THER, V24, P697, DOI 10.1038/mt.2016.35; Lee J, 2016, PLANT BIOTECHNOL J, V14, P448, DOI 10.1111/pbi.12465; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu GM, 2005, J NEUROSCI, V25, P9321, DOI 10.1523/JNEUROSCI.2936-05.2005; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; O'Geen H, 2015, CURR OPIN CHEM BIOL, V29, P72, DOI 10.1016/j.cbpa.2015.10.001; Piwnica D, 2006, MOL ENDOCRINOL, V20, P3263, DOI 10.1210/me.2006-0044; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rumi MAK, 2014, ENDOCRINOLOGY, V155, P1991, DOI 10.1210/en.2013-2150; SAFTIG P, 1995, EMBO J, V14, P3599; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shevtsova Z, 2010, AM J PATHOL, V177, P271, DOI 10.2353/ajpath.2010.091267; Sovova T, 2017, CURR ISSUES MOL BIOL, V21, P41, DOI 10.21775/cimb.021.041; Sung YH, 2014, METHODS, V69, P85, DOI 10.1016/j.ymeth.2014.02.009; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tereshchenko J, 2014, NEUROBIOL DIS, V65, P35, DOI 10.1016/j.nbd.2014.01.009; Tian L, 2014, J ALZHEIMERS DIS, V42, P511, DOI 10.3233/JAD-132192; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Ul Ain Q, 2015, J CONTROL RELEASE, V205, P120, DOI 10.1016/j.jconrel.2014.12.036; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vidoni C, 2016, MED RES REV, V36, P845, DOI 10.1002/med.21394; Weber ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097579; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589	41	0	0	5	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	MAY 23	2017	10								142	10.3389/fnmol.2017.00142				13	Neurosciences	Neurosciences & Neurology	EV9KZ	WOS:000402106200001	28588449	gold			2018-01-05	
J	Durant, F; Morokuma, J; Fields, C; Williams, K; Adams, DS; Levin, M				Durant, Fallon; Morokuma, Junji; Fields, Christopher; Williams, Katherine; Adams, Dany Spencer; Levin, Michael			Long-Term, Stochastic Editing of Regenerative Anatomy via Targeting Endogenous Bioelectric Gradients	BIOPHYSICAL JOURNAL			English	Article							MESENCHYMAL STEM-CELLS; FROG LIMB REGENERATION; RECTIFYING K+ CHANNEL; PLANARIAN REGENERATION; ION CHANNELS; IN-VIVO; POTASSIUM CHANNELS; MEMBRANE VOLTAGE; MOLECULAR BIOELECTRICITY; VERTEBRATE REGENERATION	We show that regenerating planarians' normal anterior-posterior pattern can be permanently rewritten by a brief perturbation of endogenous bioelectrical networks. Temporary modulation of regenerative bioelectric dynamics in amputated trunk fragments of planaria stochastically results in a constant ratio of regenerates with two heads to regenerates with normal morphology. Remarkably, this is shown to be due not to partial penetrance of treatment, but a profound yet hidden alteration to the animals' patterning circuitry. Subsequent amputations of the morphologically normal regenerates in water result in the same ratio of double-headed to normal morphology, revealing a cryptic phenotype that is not apparent unless the animals are cut. These animals do not differ from wild-type worms in histology, expression of key polarity genes, or neoblast distribution. Instead, the altered regenerative bodyplan is stored in seemingly normal planaria via global patterns of cellular resting potential. This gradient is functionally instructive, and represents a multistable, epigenetic anatomical switch: experimental reversals of bioelectric state reset subsequent regenerative morphology back to wild-type. Hence, bioelectric properties can stably override genome-default target morphology, and provide a tractable control point for investigating cryptic phenotypes and the stochasticity of large-scale epigenetic controls.	[Durant, Fallon; Morokuma, Junji; Williams, Katherine; Adams, Dany Spencer; Levin, Michael] Tufts Univ, Allen Discovery Ctr, Medford, MA 02155 USA; [Durant, Fallon; Morokuma, Junji; Williams, Katherine; Adams, Dany Spencer; Levin, Michael] Tufts Univ, Dept Biol, Medford, MA USA	Levin, M (reprint author), Tufts Univ, Allen Discovery Ctr, Medford, MA 02155 USA.; Levin, M (reprint author), Tufts Univ, Dept Biol, Medford, MA USA.	michael.levin@tufts.edu		Levin, Michael/0000-0001-7292-8084; Adams, Dany/0000-0003-2024-9746	Allen Discovery Center award from Paul G. Allen Frontiers [12171]; G. Harold and Leila Y. Mathers Charitable Foundation [TFU141]; Templeton World Charity Foundation [TWCF0089/AB55]; National Science Foundation (NSF) [EF-1124651, IGERT DGE-1144591]	We gratefully acknowledge support by an Allen Discovery Center award from the Paul G. Allen Frontiers Group (No. 12171), the G. Harold and Leila Y. Mathers Charitable Foundation (No. TFU141), the Templeton World Charity Foundation (No. TWCF0089/AB55), and the National Science Foundation (NSF) (Nos. EF-1124651 and IGERT DGE-1144591).	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Adams DS, 2013, CELL TISSUE RES, V352, P95, DOI 10.1007/s00441-012-1329-4; Adams Dany S, 2012, Cold Spring Harb Protoc, V2012, P385, DOI 10.1101/pdb.top067710; Adams Dany S, 2012, Cold Spring Harb Protoc, V2012, P459, DOI 10.1101/pdb.prot067702; Adams DS, 2008, TISSUE ENG PT A, V14, P1461, DOI 10.1089/ten.tea.2008.0080; Adams DS, 2016, J PHYSIOL-LONDON, V594, P3245, DOI 10.1113/JP271930; Adams DS, 2014, INT J DEV BIOL, V58, P851, DOI 10.1387/ijdb.140207m1; Adams DS, 2013, BIOL OPEN, V2, P306, DOI 10.1242/bio.20133665; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Bando Y, 2014, CEREB CORTEX, V24, P1017, DOI 10.1093/cercor/bhs387; Bates E, 2015, ANNU REV CELL DEV BI, V31, P231, DOI 10.1146/annurev-cellbio-100814-125338; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Beane WS, 2013, DEVELOPMENT, V140, P313, DOI 10.1242/dev.086900; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Becker R O, 1967, Med Times, V95, P657; BECKER RO, 1972, NATURE, V235, P109, DOI 10.1038/235109a0; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888                                                            ; BORGENS RB, 1977, J EXP ZOOL, V200, P403, DOI 10.1002/jez.1402000310; BORGENS RB, 1984, DIFFERENTIATION, V28, P87, DOI 10.1111/j.1432-0436.1984.tb00270.x; Burr HS, 1935, Q REV BIOL, V10, P322, DOI 10.1086/394488; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chernet BT, 2016, ONCOTARGET, V7, P19575, DOI 10.18632/oncotarget.8036; Dahal GR, 2012, DEVELOPMENT, V139, P3653, DOI 10.1242/dev.078592; De A., 2016, INT J PARALLEL EMERG, P1; Dexter JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep06388; Djamgoz MBA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0092; Durant F, 2016, REGENERATION, V3, P78, DOI 10.1002/reg2.54; Emmons-Bell M, 2015, INT J MOL SCI, V16, P27865, DOI 10.3390/ijms161126065; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Forrester JV, 2007, OPHTHALMIC RES, V39, P4, DOI 10.1159/000097901; Friston K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1383; Funk R., 2013, BIOL SYS OPEN ACCESS; Gallaher J, 2010, BIOSYSTEMS, V101, P149, DOI 10.1016/j.biosystems.2010.05.007; Garcia-Quismondo M, 2017, INFORM SCIENCES, V381, P229, DOI 10.1016/j.ins.2016.11.017; Gentile L, 2011, DIS MODEL MECH, V4, P12, DOI 10.1242/dmm.006692; Grossberg S, 2013, NEURAL NETWORKS, V37, P1, DOI 10.1016/j.neunet.2012.09.017; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hayashi T, 2011, DEVELOPMENT, V138, P3679, DOI 10.1242/dev.060194; JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305                                             ; JAFFE LF, 1981, PHILOS T ROY SOC B, V295, P553, DOI 10.1098/rstb.1981.0160; JAFFE LF, 1982, DEV ORDER ITS ORIGIN, P183; Jang SS, 2011, AM J PHYSIOL-CELL PH, V301, pC150, DOI 10.1152/ajpcell.00002.2010; Jenkins LS, 1996, DEV BIOL, V178, P251, DOI 10.1006/dbio.1996.0216; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Klyubin I V, 2000, Membr Cell Biol, V13, P557; Law R, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0019-9; Leppik LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18353; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 2012, BIOESSAYS, V34, P205, DOI 10.1002/bies.201100136; Levin M, 2014, MOL BIOL CELL, V25, P3835, DOI 10.1091/mbc.E13-12-0708; Levin M, 2014, J PHYSIOL-LONDON, V592, P2295, DOI 10.1113/jphysiol.2014.271940; Levin M, 2013, WIRES SYST BIOL MED, V5, P657, DOI 10.1002/wsbm.1236; Levin M, 2012, ANNU REV BIOMED ENG, V14, P295, DOI [10.1146/annurev-bioeng-071811-150114, 10.1146/annurev.bioeng-071811-150114]; Liebau S., 2013, STEM CELLS INT, V2013; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Lobikin M, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/065002; Lobo D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004295; Lobo D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0918; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lund E.J., 1947, BIOELECTRIC FIELDS G; MARSH G, 1949, ANAT REC, V105, P513; MARSH G, 1950, ANAT REC, V108, P512; MARSH G, 1952, J CELL COMPAR PHYSL, V39, P191, DOI 10.1002/jcp.1030390203; MARSH G, 1947, FED PROC, V6, P163; Martin-Granados C, 2014, ADV WOUND CARE, V3, P127, DOI 10.1089/wound.2013.0451; Masotti A, 2015, AM J HUM GENET, V96, P295, DOI 10.1016/j.ajhg.2014.12.011; Mathews J, 2017, DEV NEUROBIOL, V77, P643, DOI 10.1002/dneu.22405; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2002, TRENDS NEUROSCI, V25, P354, DOI 10.1016/S0166-2236(02)02174-4                                                   ; Meinhardt H, 2007, CURR OPIN GENET DEV, V17, P272, DOI 10.1016/j.gde.2007.05.004; Morgan TH, 1904, ARCH ENTWICKLUNG ORG, V17, P683, DOI 10.1007/BF02161815; Morgan T. H., 1898, DEV GENES EVOL, V7, P364; Mustard J, 2014, SOFT ROBOT, V1, P169, DOI 10.1089/soro.2014.0011; Nakazawa M, 2003, MOL BIOL EVOL, V20, P784, DOI 10.1039/molbev/msg086; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645                                                          ; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; Ozkucur N, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.295; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Oviedo N. J., 2008, CSH PROTOC, V2008; Oviedo N. J., 2008, CSH PROTOC, V2008; Owlarn S, 2016, REGENERATION, V3, P139, DOI 10.1002/reg2.56; Pai VP, 2016, REGENERATION, V3, P3, DOI 10.1002/reg2.48; Pai VP, 2012, DEVELOPMENT, V139, P313, DOI 10.1242/dev.073759; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Pezzulo G, 2015, INTEGR BIOL-UK, V7, P1487, DOI 10.1039/c5ib00221d; Pezzulo G, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0555; Pietak Alexis, 2016, Frontiers in Bioengineering and Biotechnology, V4, P55, DOI 10.3389/fbioe.2016.00055; Pullar CE, 2011, BIOL EFF ELECTROMAGN, P1; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reid B, 2014, ADV WOUND CARE, V3, P184, DOI 10.1089/wound.2013.0442; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023                                                          ; Salo E, 2009, INT J DEV BIOL, V53, P1317, DOI 10.1387/ijdb.072414es; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; SMITH SD, 1981, BIOELECTROCH BIOENER, V8, P661, DOI 10.1016/0302-4598(81)87008-0; SMITH SD, 1974, ANN NY ACAD SCI, V238, P500, DOI 10.1111/j.1749-6632.1974.tb26816.x                                              ; Somel M, 2006, CURR BIOL, V16, pR359, DOI 10.1016/j.cub.2006.04.024; Sullivan Kelly G, 2016, Commun Integr Biol, V9, pe1192733, DOI 10.1080/19420889.2016.1192733; Sundelacruz S, 2013, TISSUE ENG PT A, V19, P1889, DOI 10.1089/ten.tea.2012.0425.rev; Sundelacruz S, 2013, BIOMATERIALS, V34, P6695, DOI 10.1016/j.biomaterials.2013.05.040; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Tosenberger A, 2015, ACTA BIOTHEOR, V63, P283, DOI 10.1007/s10441-015-9249-9; Tseng AS, 2012, ANAT REC, V295, P1541, DOI 10.1002/ar.22495; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Tseng Aisun, 2013, Commun Integr Biol, V6, pe22595, DOI 10.4161/cib.22595; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vandenberg LN, 2011, DEV DYNAM, V240, P1889, DOI 10.1002/dvdy.22685; Weingart R, 1998, PFLUG ARCH EUR J PHY, V435, P310; Yasuda T, 2010, J NEUROCHEM, V114, P946, DOI 10.1111/j.1471-4159.2010.06822.x; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	119	2	2	3	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	MAY 23	2017	112	10					2231	2243		10.1016/j.bpj.2017.04.011				13	Biophysics	Biophysics	EV9QA	WOS:000402119300022	28538159	gold			2018-01-05	
J	Zhang, YQ; Hu, JF; Wang, H; Cui, JW; Gao, SJ; Hoffman, AR; Li, W				Zhang, Yiqun; Hu, Ji-Fan; Wang, Hong; Cui, Jiuwei; Gao, Sujun; Hoffman, Andrew R.; Li, Wei			CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors	ONCOTARGET			English	Article						IGF2 imprinting; tumor; epigenetics; histone K27 methylation; allelic expression	GROWTH-FACTOR-II; LONG NONCODING RNA; MYELOID-LEUKEMIA CELLS; PANCREATIC-CANCER; INTRACHROMOSOMAL INTERACTIONS; HEMATOPOIETIC MALIGNANCIES; ADAPTIVE IMMUNITY; CONTROL REGION; CTCF BINDING; WILMS-TUMOR	The normally imprinted insulin-like growth factor II(IGF2) gene is aberrantly upregulated in a variety of human malignancies, yet the mechanisms underlying this dysregulation are still poorly defined. In this report, we used a CRISPR Cas9-guided chromatin immunoprecipitation assay to characterize the molecular components that participate in the control of IGF2 gene expression in human tumor cells. We found that miR483, an oncogenic intronic miRNA, binds to the most upstream imprinted IGF2 promoter, P2. Ectopic expression of miR483 induced upregulation of IGF2 expression, in parallel with an increase in tumor cell proliferation, migration, invasion, and tumor colony formation. miR483 induced loss of IGF2 imprinting by altering the epigenotype at P2, with reduction in histone H3K27 methylation and a decrease in chromatin binding of two imprinting regulatory factors, CTCF and SUZ12. This study identifies a new role for miR483 in the regulation of IGF2 gene expression through the alteration of the promoter epigenotype.	[Zhang, Yiqun; Hu, Ji-Fan; Wang, Hong; Cui, Jiuwei; Gao, Sujun; Li, Wei] Jilin Univ, Affiliated Hosp 1, Stem Cell & Canc Ctr, Changchun 130061, Jilin, Peoples R China; [Zhang, Yiqun; Hu, Ji-Fan; Wang, Hong; Hoffman, Andrew R.] Stanford Univ, Sch Med, VA Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA	Hu, JF; Li, W (reprint author), Jilin Univ, Affiliated Hosp 1, Stem Cell & Canc Ctr, Changchun 130061, Jilin, Peoples R China.; Hu, JF; Hoffman, AR (reprint author), Stanford Univ, Sch Med, VA Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA.	jifan@stanford.edu; arhoffman@stanford.edu; jdyylw@163.com			California Institute for Regenerative Medicine (CIRM) grant [RT2-01942]; Jilin International Collaboration Grant [20120720]; National Natural Science Foundation of China grant [81272294, 31430021, 81372835, 81670143]; National Basic Research Program of China (973 Program) [2015CB943303]; NSFC grant [81172323, 81300207]; Jilin Science and Technique Department grant [20160101128JC]; Key Project of Chinese Ministry of Education [311015]	This work was supported by California Institute for Regenerative Medicine (CIRM) grant (RT2-01942), Jilin International Collaboration Grant (#20120720), the National Natural Science Foundation of China grant (#81272294, #31430021), the National Basic Research Program of China (973 Program) (#2015CB943303) to J.F.H; NSFC grant (#81172323) to S.G.; NSFC grant (#81300207) to H.W.; the National Natural Science Foundation of China grant (#81372835, #81670143) and Jilin Science and Technique Department grant (20160101128JC) to W.L.; and the grant of Key Project of Chinese Ministry of Education (#311015) to C.J.	Abue M, 2015, INT J ONCOL, V46, P539, DOI 10.3892/ijo.2014.2743; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8                                                   ; Archanioti P, 2011, J CROHNS COLITIS, V5, P520, DOI 10.1016/j.crohns.2011.05.007; Bergman D, 2013, GERONTOLOGY, V59, P240, DOI 10.1159/000343995; Bono JM, 2015, MOL ECOL, V24, P3810, DOI 10.1111/mec.13252; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chapuis N, 2010, HAEMATOL-HEMATOL J, V95, P415, DOI 10.3324/haematol.2009.010785; Chen HL, 2006, EMBO J, V25, P5329, DOI 10.1038/sj.emboj.7601399; Cui HM, 2001, CANCER RES, V61, P4947; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Danielsen SA, 2015, BBA-REV CANCER, V1855, P104, DOI 10.1016/j.bbcan.2014.09.008; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Feinberg AP, 2007, CANCER J, V13, P70, DOI 10.1097/PPO.0b013e31803c6e3b                                                    ; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Hofmann WK, 2002, EXP HEMATOL, V30, P318, DOI 10.1016/S0301-472X(01)00797-4; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JF, 1996, J BIOL CHEM, V271, P18253, DOI 10.1074/jbc.271.30.18253                                                        ; Huang GS, 2010, CLIN CANCER RES, V16, P2999, DOI 10.1158/1078-0432.CCR-09-3233; Kang LH, 2015, EUR J CANCER, V51, P260, DOI 10.1016/j.ejca.2014.10.031; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Li T, 2014, HUM MOL GENET, V23, P117, DOI 10.1093/hmg/ddt405; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu MZ, 2013, GENE DEV, V27, P2543, DOI [10.1101/gad.224170.113, 10.1101/gad.224170]; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Moresi V, 2015, BBA-GENE REGUL MECH, V1849, P309, DOI 10.1016/j.bbagrm.2015.01.002; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724; Pierre-Eugene C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041992; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Ribarska T, 2012, ASIAN J ANDROL, V14, P436, DOI 10.1038/aja.2011.160; Riccio A, 2009, ENDOCR DEV, V14, P1, DOI 10.1159/000207461; Rieder S, 2011, ANTI-CANCER AGENT ME, V11, P427, DOI 10.2174/187152011795677454                                                      ; Ruhrmann S, 2015, INT J BIOCHEM CELL B, V67, P49, DOI 10.1016/j.biocel.2015.05.010; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Srivastava M, 2000, GENE DEV, V14, P1186; Sun JN, 2014, NUCLEIC ACIDS RES, V42, P9588, DOI 10.1093/nar/gku549; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Vu TH, 2010, HUM MOL GENET, V19, P901, DOI 10.1093/hmg/ddp558; Wang HB, 2015, EXP CELL RES, V338, P214, DOI 10.1016/j.yexcr.2015.09.016; Wang H, 2014, INT J CANCER, V135, P2783, DOI 10.1002/ijc.28922; Warnecke-Eberz U, 2015, TUMOR BIOL, V36, P4643, DOI 10.1007/s13277-015-3112-0; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Yin HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16975; Yoon YS, 2007, MOL CELL BIOL, V27, P3499, DOI 10.1128/MCB.02170-06; Zhai YY, 2015, EXP CELL RES, V337, P61, DOI 10.1016/j.yexcr.2015.06.003; Zhang H, 2014, J CELL BIOL, V204, P61, DOI 10.1083/jcb.201304152; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zhang H, 2011, J CELL BIOL, V193, P475, DOI 10.1083/jcb.201101021; Zhang SH, 2014, INT J CANCER, V134, P1583, DOI 10.1002/ijc.28487; Zheng XH, 2014, CHIN J CANCER, V33, P330, DOI 10.5732/cjc.013.10246	66	2	2	2	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 23	2017	8	21					34177	34190		10.18632/oncotarget.10918				14	Oncology; Cell Biology	Oncology; Cell Biology	EV8RY	WOS:000402051700019	27486969	gold			2018-01-05	
J	Mekler, V; Minakhin, L; Severinov, K				Mekler, Vladimir; Minakhin, Leonid; Severinov, Konstantin			Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						Cas9; CRISPR; DNA interrogation; protein-DNA interactions; fluorescence spectroscopy	ENDONUCLEASE CAS9; STRUCTURAL BASIS; LIVING CELLS; DAMAGED BASE; RECOGNITION; CASCADE; TRANSCRIPTION; PROKARYOTES; COMPLEXES; DYNAMICS	The prokaryotic clustered regularly interspaced short palindromic repeats (CRISPR)-associated 9 (Cas9) endonuclease cleaves double-stranded DNA sequences specified by guide RNA molecules and flanked by a protospacer adjacent motif (PAM) and is widely used for genome editing in various organisms. The RNA-programmed Cas9 locates the target site by scanning genomic DNA. We sought to elucidate the mechanism of initial DNA interrogation steps that precede the pairing of target DNA with guide RNA. Using fluorometric and biochemical assays, we studied Cas9/guide RNA complexes with model DNA substrates that mimicked early intermediates on the pathway to the final Cas9/guide RNA-DNA complex. The results show that Cas9/guide RNA binding to PAM favors separation of a few PAM-proximal protospacer base pairs allowing initial target interrogation by guide RNA. The duplex destabilization is mediated, in part, by Cas9/guide RNA affinity for unpaired segments of nontarget strand DNA close to PAM. Furthermore, our data indicate that the entry of double-stranded DNA beyond a short threshold distance from PAM into the Cas9/single-guide RNA (sgRNA) interior is hindered. We suggest that the interactions unfavorable for duplex DNA binding promote DNA bending in the PAM-proximal region during early steps of Cas9/guide RNA-DNA complex formation, thus additionally destabilizing the protospacer duplex. The mechanism that emerges from our analysis explains how the Cas9/sgRNA complex is able to locate the correct target sequence efficiently while interrogating numerous nontarget sequences associated with correct PAMs.	[Mekler, Vladimir; Minakhin, Leonid; Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia; [Severinov, Konstantin] Peter Great State Polytech Inst, St Petersburg 195251, Russia	Mekler, V; Severinov, K (reprint author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.; Severinov, K (reprint author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.; Severinov, K (reprint author), Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia.; Severinov, K (reprint author), Peter Great State Polytech Inst, St Petersburg 195251, Russia.	mekler@waksman.rutgers.edu; severik@waksman.rutgers.edu			NIH [GM10407]; Russian Science Foundation [14-14-00988]; Ministry of Education and Science of Russian Federation Project [14.B25.31.0004]; Skoltech	We thank M. Jinek for the generous gift of a plasmid encoding Cas9KG. This study was supported by NIH Grant GM10407; Russian Science Foundation Grant 14-14-00988; Ministry of Education and Science of Russian Federation Project 14.B25.31.0004; and Skoltech institutional support (all to K.S.). Funding for an open access charge was provided by Skoltech.	Altan-Bonnet G, 2003, PHYS REV LETT, V90, DOI [10.1103/PhysRevLett.90.138101, 10.1103/PhysRevLEtt.90.138101]; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; Cao CY, 2004, NAT STRUCT MOL BIOL, V11, P1230, DOI 10.1038/nsmb864; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0                                                                ; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kuznedelov K, 2016, NUCLEIC ACIDS RES, V44, P10849, DOI 10.1093/nar/gkw914; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mekler V, 2016, NUCLEIC ACIDS RES, V44, P2837, DOI 10.1093/nar/gkw138; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111	29	2	2	14	20	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 23	2017	114	21					5443	5448		10.1073/pnas.1619926114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EV5IL	WOS:000401797800050	28484024	gold			2018-01-05	
J	Boyle, EA; Andreasson, JOL; Chircus, LM; Sternberg, SH; Wu, MJ; Guegler, CK; Doudna, JA; Greenleaf, WJ				Boyle, Evan A.; Andreasson, Johan O. L.; Chircus, Lauren M.; Sternberg, Samuel H.; Wu, Michelle J.; Guegler, Chantal K.; Doudna, Jennifer A.; Greenleaf, William J.			High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						DNA; molecular biophysics; kinetics; sequencing; CRISPR	GUIDED ENDONUCLEASE CAS9; GENOME-WIDE ANALYSIS; DNA CLEAVAGE; NUCLEASE SPECIFICITY; HUMAN-CELLS; CRISPR-CAS9; RECOGNITION; CRISPR/CAS9; LANDSCAPES	The bacterial adaptive immune system CRISPR-Cas9 has been appropriated as a versatile tool for editing genomes, controlling gene expression, and visualizing genetic loci. To analyze Cas9's ability to bind DNA rapidly and specifically, we generated multiple libraries of potential binding partners for measuring the kinetics of nuclease-dead Cas9 (dCas9) interactions. Using a massively parallel method to quantify protein-DNA interactions on a high-throughput sequencing flow cell, we comprehensively assess the effects of combinatorial mismatches between guide RNA (gRNA) and target nucleotides, both in the seed and in more distal nucleotides, plus disruption of the protospacer adjacent motif (PAM). We report two consequences of PAM-distal mismatches: reversal of dCas9 binding at long time scales, and synergistic changes in association kinetics when other gRNA-target mismatches are present. Together, these observations support a model for Cas9 specificity wherein gRNA-DNA mismatches at PAM-distal bases modulate different biophysical parameters that determine association and dissociation rates. The methods we present decouple aspects of kinetic and thermodynamic properties of the Cas9-DNA interaction and broaden the toolkit for investigating off-target binding behavior.	[Boyle, Evan A.; Andreasson, Johan O. L.; Greenleaf, William J.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Andreasson, Johan O. L.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Chircus, Lauren M.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Sternberg, Samuel H.; Guegler, Chantal K.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wu, Michelle J.] Stanford Univ, Biomed Informat Training Program, Stanford, CA 94305 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Sternberg, Samuel H.] Caribou Biosci Inc, Berkeley, CA 94710 USA; [Guegler, Chantal K.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Greenleaf, WJ (reprint author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Greenleaf, WJ (reprint author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	wjg@stanford.edu		Wu, Michelle/0000-0003-1734-7994; Boyle, Evan/0000-0003-4494-9771	Beckman Foundation; Human Frontiers Science Program; National Institutes of Health [5R01GM111990, 1P50HG00773501, UM1HG009436, 3P01GM066275]; NIH [5T32HG000044-19, T32GM067586]; National Science Foundation graduate research fellowship program (NSF-GRFP); NSF-GRFP; National Science Foundation [MCB-1244557]	We thank members of the W.J.G. laboratory for feedback on data visualization. This work was supported by grants from the Beckman Foundation, the Human Frontiers Science Program, and National Institutes of Health Grants 5R01GM111990, 1P50HG00773501, UM1HG009436, and 3P01GM066275 (to W.J.G.). W.J.G acknowledges support as a Chan-Zuckerberg Investigator. E.A.B. acknowledges support from NIH Training Grant 5T32HG000044-19. L.M.C. acknowledges support from NIH Training Grant T32GM067586 and the National Science Foundation graduate research fellowship program (NSF-GRFP). M.J.W. and E.A.B. also acknowledge support from the NSF-GRFP. J.A.D. acknowledges support from the National Science Foundation (Grant MCB-1244557 to J.A.D.). J.A.D. is an investigator of the Howard Hughes Medical Institute.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Josephs EA, 2016, NUCLEIC ACIDS RES, V44, P2474, DOI 10.1093/nar/gkv1293; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	29	1	1	31	33	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 23	2017	114	21					5461	5466		10.1073/pnas.1700557114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EV5IL	WOS:000401797800053	28495970				2018-01-05	
J	Rosenbluh, J; Xu, H; Harrington, W; Gill, S; Wang, XX; Vazquez, F; Root, DE; Tsherniak, A; Hahn, WC				Rosenbluh, Joseph; Xu, Han; Harrington, William; Gill, Stanley; Wang, Xiaoxing; Vazquez, Francisca; Root, David E.; Tsherniak, Aviad; Hahn, William C.			Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression	NATURE COMMUNICATIONS			English	Article							HUMAN-CELLS; HUMAN GENOME; SCREENS; IDENTIFICATION; DESIGN	CRISPR-Cas9 provides the means to perform genome editing and facilitates loss-of-function screens. However, we and others demonstrated that expression of the Cas9 endonuclease induces a gene-independent response that correlates with the number of target sequences in the genome. An alternative approach to suppressing gene expression is to block transcription using a catalytically inactive Cas9 (dCas9). Here we directly compare genome editing by CRISPR-Cas9 (cutting, CRISPRc) and gene suppression using KRAB-dCas9 (CRISPRi) in loss-of-function screens to identify cell essential genes. CRISPRc identified 98% of previously defined cell essential genes. After optimizing library construction by analysing transcriptional start sites (TSS), CRISRPi identified 92% of core cell essential genes and did not show a bias to regions involved in copy number alterations. However, bidirectional promoters scored as false positives in CRISRPi. We conclude that CRISPRc and CRISPRi have different off-target effects and combining these approaches provides complementary information in loss-of-function genetic screens.	[Rosenbluh, Joseph; Xu, Han; Harrington, William; Gill, Stanley; Wang, Xiaoxing; Vazquez, Francisca; Root, David E.; Tsherniak, Aviad; Hahn, William C.] Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA; [Rosenbluh, Joseph; Gill, Stanley; Wang, Xiaoxing; Vazquez, Francisca; Hahn, William C.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA; [Rosenbluh, Joseph] Monash Univ, Dept Biochem & Mol Biol, 23 Innovat Walk, Clayton, Vic 3800, Australia; [Rosenbluh, Joseph] Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia; [Xu, Han] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Sci Pk,1808 Pk Rd 1C, Smithville, TX 78957 USA	Hahn, WC (reprint author), Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA.; Hahn, WC (reprint author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	William_Hahn@dfci.harvard.edu		Tsherniak, Aviad/0000-0002-3797-1877	Svenson Family foundation; NIH [U01 CA176058, U01 CA199253]	We wish to thank Dr Andrew Aguirre and Dr John Doench as well as members of the Hahn laboratory for helpful discussions. We thank Tamara Mason for sequencing these samples. This work was supported by: The Svenson Family foundation (J.R.), NIH U01 CA176058 (W.C.H.) and NIH U01 CA199253 (W.C.H.).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Radzisheuskaya Aliaksandra, 2016, Nucleic Acids Res, V44, pe141; Rosenbluh J, 2016, CELL SYST, V3, P302, DOI 10.1016/j.cels.2016.09.001; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	22	2	2	5	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 23	2017	8								15403	10.1038/ncomms15403				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EV5UU	WOS:000401834000001	28534478	gold			2018-01-05	
J	Crawford, ED; Quan, JN; Horst, JA; Ebert, D; Wu, W; DeRisi, JL				Crawford, Emily D.; Quan, Jenai; Horst, Jeremy A.; Ebert, Daniel; Wu, Wesley; DeRisi, Joseph L.			Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733	PLOS ONE			English	Article							MALARIA PARASITE; RECOMBINATION; VARIANTS; SOFTWARE; SEQUENCE; SYSTEM; PFATP4; DRUGS	Genetic manipulation of the deadly malaria parasite Plasmodium falciparum remains challenging, but the rise of CRISPR/Cas9-based genome editing tools is increasing the feasibility of altering this parasite's genome in order to study its biology. Of particular interest is the investigation of drug targets and drug resistance mechanisms, which have major implications for fighting malaria. We present a new method for introducing drug resistance mutations in P. falciparum without the use of plasmids or the need for cloning homologous recombination templates. We demonstrate this method by introducing edits into the sodium efflux channel PfATP4 by transfection of a purified CRISPR/Cas9-guide RNA ribonucleoprotein complex and a 200-nucleotide single-stranded oligodeoxynucleotide (ssODN) repair template. Analysis of whole genome sequencing data with the variant-finding program MinorityReport confirmed that only the intended edits were made, and growth inhibition assays confirmed that these mutations confer resistance to the antimalarial SJ733. The method described here is ideally suited for the introduction of mutations that confer a fitness advantage under selection conditions, and the novel finding that an ssODN can function as a repair template in P. falciparum could greatly simplify future editing attempts regardless of the nuclease used or the delivery method.	[Crawford, Emily D.; Quan, Jenai; DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Crawford, Emily D.; Quan, Jenai; Horst, Jeremy A.; Ebert, Daniel; Wu, Wesley; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Crawford, Emily D.; Quan, Jenai; Ebert, Daniel; DeRisi, Joseph L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ebert, Daniel] Touro Coll Osteopath Med, Middletown, NY USA	DeRisi, JL (reprint author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; DeRisi, JL (reprint author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; DeRisi, JL (reprint author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	joe@czbiohub.org			Howard Hughes Medical Institute; Chan Zuckerberg Biohub; National Institutes of Health NIDCR [T32-DE007306]; Philippine California Advanced Research Institutes, project IHITM [63]	This work was supported by Howard Hughes Medical Institute and the Chan Zuckerberg Biohub. JAH was funded by National Institutes of Health NIDCR grant number T32-DE007306. WW was funded by the Philippine California Advanced Research Institutes, project IHITM 63. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bansal A, 2016, MBIO, V7, DOI [10.1128/mBio.02011-16, 10.1128/mbio.02011-16]; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Caro F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-22; Corey VC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11901; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Horst JA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1730-2; Huskey SEW, 2016, DRUG METAB DISPOS, V44, P672, DOI 10.1124/dmd.115.069187; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; LaMonte G, 2016, MBIO, V7, DOI 10.1128/mBio.00696-16; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Lim Michelle Yi-Xiu, 2016, Nat Microbiol, P16166, DOI 10.1038/nmicrobiol.2016.166; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; Peng D, 2015, MICROB GENOMICS, P1; Ruby JG, 2013, G3-GENES GENOM GENET, P3; Sonoiki E, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01949-16; Sonoiki E, 2016, ANTIMICROB AGENTS CH, V60, P4886, DOI 10.1128/AAC.00820-16; Spillman NJ, 2015, INT J PARASITOL-DRUG, V5, P149, DOI 10.1016/j.ijpddr.2015.07.001; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu W, 2015, ANTIMICROB AGENTS CH, V59, P356, DOI 10.1128/AAC.03342-14	34	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178163	10.1371/journal.pone.0178163				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EV8UA	WOS:000402058400065	28542423	gold			2018-01-05	
J	Metzakopian, E; Strong, A; Iyer, V; Hodgkins, A; Tzelepis, K; Antunes, L; Friedrich, MJ; Kang, QH; Davidson, T; Lamberth, J; Hoffmann, C; Davis, GD; Vassiliou, GS; Skarnes, WC; Bradley, A				Metzakopian, Emmanouil; Strong, Alex; Iyer, Vivek; Hodgkins, Alex; Tzelepis, Konstantinos; Antunes, Liliana; Friedrich, Mathias J.; Kang, Qiaohua; Davidson, Teresa; Lamberth, Jacob; Hoffmann, Christina; Davis, Gregory D.; Vassiliou, George S.; Skarnes, William C.; Bradley, Allan			Enhancing the genome editing toolbox: genome wide CRISPR arrayed libraries	SCIENTIFIC REPORTS			English	Article							EMBRYONIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; HOMOLOGOUS RECOMBINATION; PIGGYBAC; TRANSPOSITION; TRANSGENESIS; NUCLEASES; CLEAVAGE; TARGETS; REPAIR	CRISPR-Cas9 technology has accelerated biological research becoming routine for many laboratories. It is rapidly replacing conventional gene editing techniques and has high utility for both genome-wide and gene-focussed applications. Here we present the first individually cloned CRISPR-Cas9 genome wide arrayed sgRNA libraries covering 17,166 human and 20,430 mouse genes at a complexity of 34,332 sgRNAs for human and 40,860 sgRNAs for the mouse genome. For flexibility in generating stable cell lines the sgRNAs have been cloned in a lentivirus backbone containing PiggyBac transposase recognition elements together with fluorescent and drug selection markers. Over 95% of tested sgRNA induced specific DNA cleavage as measured by CEL-1 assays. Furthermore, sgRNA targeting GPI anchor protein pathway genes induced loss of function mutations in human and mouse cell lines measured by FLAER labelling. These arrayed libraries offer the prospect for performing screens on individual genes, combinations as well as larger gene sets. They also facilitate rapid deconvolution of signals from genome-wide screens. This set of vectors provide an organized comprehensive gene editing toolbox of considerable scientific value.	[Metzakopian, Emmanouil; Strong, Alex; Iyer, Vivek; Hodgkins, Alex; Tzelepis, Konstantinos; Antunes, Liliana; Friedrich, Mathias J.; Vassiliou, George S.; Skarnes, William C.; Bradley, Allan] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Kang, Qiaohua; Davidson, Teresa; Lamberth, Jacob; Hoffmann, Christina; Davis, Gregory D.] MilliporeSigma St Louis, 2909 Laclede Ave, St Louis, MO USA; [Kang, Qiaohua; Davidson, Teresa; Lamberth, Jacob; Hoffmann, Christina; Davis, Gregory D.] Business Merck KGaA, D-64293 Darmstadt, Germany	Bradley, A (reprint author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk		Vassiliou, George/0000-0003-4337-8022	Wellcome Trust [WT098051]; Portuguese Foundation for Science and Technology, FCT [SFRH/BD/84964/2012]; Parkinson's Disease UK [F-1501]	We gratefully acknowledge Dr. Gabriel Balmus for critical reading of the manuscript. We thank Dr. Sandeep Sundara Rajan for assistance with gene editing experiments. We also gratefully acknowledge Shawn Shafer and Gurpreet Balrey for their expertise and efforts with the collaboration between WTSI and MilliporeSIGMA for the distribution of the arrayed libraries. Research in the Allan Bradley laboratory is funded by the Wellcome Trust (WT098051). Liliana Antunes is a recipient of a Ph.D. fellowship from the Portuguese Foundation for Science and Technology, FCT (SFRH/BD/84964/2012). Emmanouil Metzakopian is funded by Parkinson's Disease UK (F-1501).	Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Barkley Noelle A, 2008, BMC Res Notes, V1, P28, DOI 10.1186/1756-0500-1-28; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bibikova M, 2002, GENETICS, V161, P1169; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679                                                            ; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Rong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138553; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Sutherland DR, 2007, CYTOM PART B-CLIN CY, V72B, P167, DOI 10.1002/cyto.b.20151; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Urschitz J, 2010, P NATL ACAD SCI USA, V107, P8117, DOI 10.1073/pnas.1003674107; Walters Brandon J, 2015, Front Genet, V6, P362, DOI 10.3389/fgene.2015.00362; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	34	1	1	3	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 22	2017	7								2244	10.1038/s41598-017-01766-5				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EV4TE	WOS:000401754200031	28533524	gold			2018-01-05	
J	Petris, G; Casini, A; Montagna, C; Lorenzin, F; Prandi, D; Romanel, A; Zasso, J; Conti, L; Demichelis, F; Cereseto, A				Petris, Gianluca; Casini, Antonio; Montagna, Claudia; Lorenzin, Francesca; Prandi, Davide; Romanel, Alessandro; Zasso, Jacopo; Conti, Luciano; Demichelis, Francesca; Cereseto, Anna			Hit and go CAS9 delivered through a lentiviral based self-limiting circuit	NATURE COMMUNICATIONS			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; RNA-GUIDED ENDONUCLEASE; HUMAN-CELLS; HUMAN GENOME; CRISPR-CAS9; NUCLEASES; SPECIFICITY; PROTEINS; SYSTEM; MODULATION	In vivo application of the CRISPR-Cas9 technology is still limited by unwanted Cas9 genomic cleavages. Long-term expression of Cas9 increases the number of genomic loci non-specifically cleaved by the nuclease. Here we develop a Self-Limiting Cas9 circuit for Enhanced Safety and specificity (SLiCES) which consists of an expression unit for Streptococcus pyogenes Cas9 (SpCas9), a self-targeting sgRNA and a second sgRNA targeting a chosen genomic locus. The self-limiting circuit results in increased genome editing specificity by controlling Cas9 levels. For its in vivo utilization, we next integrate SLiCES into a lentiviral delivery system (lentiSLiCES) via circuit inhibition to achieve viral particle production. Upon delivery into target cells, the lentiSLiCES circuit switches on to edit the intended genomic locus while simultaneously stepping up its own neutralization through SpCas9 inactivation. By preserving target cells from residual nuclease activity, our hit and go system increases safety margins for genome editing.	[Petris, Gianluca; Casini, Antonio; Montagna, Claudia; Cereseto, Anna] Univ Trento, Ctr Integrat Biol CIBIO, Lab Mol Virol, Via Sommarive 9, I-38123 Trento, Italy; [Lorenzin, Francesca; Prandi, Davide; Romanel, Alessandro; Demichelis, Francesca] Univ Trento, Ctr Integrat Biol CIBIO, Lab Computat Oncol, Via Sommarive 9, I-38123 Trento, Italy; [Zasso, Jacopo; Conti, Luciano] Ctr Integrat Biol CIBIO, Lab Stem Cell Biol, Via Sommarive 9, I-38123 Trento, Italy	Petris, G; Cereseto, A (reprint author), Univ Trento, Ctr Integrat Biol CIBIO, Lab Mol Virol, Via Sommarive 9, I-38123 Trento, Italy.	gianluca.petris@unitn.it; anna.cereseto@unitn.it		Conti, Luciano/0000-0002-2050-9846; Petris, Gianluca/0000-0002-2420-6359; Romanel, Alessandro/0000-0002-2376-8552; Zasso, Jacopo/0000-0002-3151-6443; Romanel, Alessandro/0000-0003-4855-8620	University of Trento; European Research Council [ERCCoG648670]	The authors wish to thank the LaBSSAH-CIBIO Next Generation Sequencing Facility of the University of Trento for sequencing samples. We are grateful to Sheref Mansy for the critical reading; to Mauro Giacca, Serena Zacchigna Lorena Zentilin and Daniele Arosio for helpful discussion throughout the development of this study. This work was supported by the intramural funding from the University of Trento and by European Research Council ERCCoG648670 (F.D.).	Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Casini A, 2015, J VIROL, V89, P2966, DOI 10.1128/JVI.02634-14; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chick HE, 2012, HUM GENE THER, V23, P1247, DOI 10.1089/hum.2012.042; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; Francis AC, 2014, AIDS RES HUM RETROV, V30, P717, DOI [10.1089/aid.2013.0277, 10.1089/AID.2013.0277]; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li EQ, 1997, PROTEIN ENG, V10, P731, DOI 10.1093/protein/10.6.731; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moore R, 2015, NUCLEIC ACIDS RES, V43, P1297, DOI 10.1093/nar/gku1326; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pattanayak V, 2014, METHOD ENZYMOL, V546, P47, DOI 10.1016/B978-0-12-801185-0.00003-9; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Petris G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096700; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ruozi G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8388; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vecchi L, 2012, J BIOL CHEM, V287, P20007, DOI 10.1074/jbc.M112.355107; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	54	0	0	7	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 22	2017	8								15334	10.1038/ncomms15334				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EV6TM	WOS:000401907100001	28530235	gold			2018-01-05	
J	Takayama, K; Igai, K; Hagihara, Y; Hashimoto, R; Hanawa, M; Sakuma, T; Tachibana, M; Sakurai, F; Yamamoto, T; Mizuguchi, H				Takayama, Kazuo; Igai, Keisuke; Hagihara, Yasuko; Hashimoto, Rina; Hanawa, Morifumi; Sakuma, Tetsushi; Tachibana, Masashi; Sakurai, Fuminori; Yamamoto, Takashi; Mizuguchi, Hiroyuki			Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system	NUCLEIC ACIDS RESEARCH			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; MOUSE FIBROBLASTS; MAMMALIAN-CELLS; RAD51 PROTEIN; NUCLEASES; DIFFERENTIATION; DEFINES; REPAIR; IPSCS	Genome editing research of human ES/iPS cells has been accelerated by clustered regularly interspaced short palindromic repeats/CRISPR-associated 9 (CRISPR/Cas9) and transcription activator-like effector nucleases (TALEN) technologies. However, the efficiency of biallelic genetic engineering in transcriptionally inactive genes is still low, unlike that in transcriptionally active genes. To enhance the biallelic homologous recombination efficiency in human ES/iPS cells, we performed screenings of accessorial genes and compounds. We found that RAD51 overexpression and valproic acid treatment enhanced biallelic-targeting efficiency in human ES/iPS cells regardless of the transcriptional activity of the targeted locus. Importantly, RAD51 overexpression and valproic acid treatment synergistically increased the biallelic homologous recombination efficiency. Our findings would facilitate genome editing study using human ES/iPS cells.	[Takayama, Kazuo; Igai, Keisuke; Hagihara, Yasuko; Hanawa, Morifumi; Tachibana, Masashi; Sakurai, Fuminori; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka 5650871, Japan; [Takayama, Kazuo] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Takayama, Kazuo] Kyoto Univ, K CONNEX, Kyoto 6068302, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat Hlth & Nutr, Lab Hepatocyte Regulat, Osaka 5670085, Japan; [Hashimoto, Rina; Sakurai, Fuminori; Mizuguchi, Hiroyuki] Osaka Univ, Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka 5650871, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima 7398526, Japan; [Sakurai, Fuminori] Osaka Univ, Grad Sch Pharmaceut Sci, Clin Drug Dev Project, Lab Regulatory Sci Oligonucleotide Therapeut, Osaka, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Global Ctr Med Engn & Informat, Osaka 5650871, Japan	Mizuguchi, H (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka 5650871, Japan.; Mizuguchi, H (reprint author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Hepatocyte Regulat, Osaka 5670085, Japan.; Mizuguchi, H (reprint author), Osaka Univ, Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka 5650871, Japan.; Mizuguchi, H (reprint author), Osaka Univ, Global Ctr Med Engn & Informat, Osaka 5650871, Japan.	mizuguch@phs.osaka-u.ac.jp	Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017	Yamamoto, Takashi/0000-0002-6516-2903; Tachibana, Masashi/0000-0002-0376-508X	Japan Society for the Promotion of Science (JSPS) KAKENHI [10759509]; Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX); Human Resource Development Program for Science and Technology, MEXT; Japan Agency for Medical Research and development, AMED [15fk0210002h0002, 15bk0104005h0003]	Japan Society for the Promotion of Science (JSPS) KAKENHI [10759509]; Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX), established by Human Resource Development Program for Science and Technology, MEXT; Japan Agency for Medical Research and development, AMED [15fk0210002h0002, 15bk0104005h0003].	Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Defoort EN, 2006, MOL PHARMACOL, V69, P1304, DOI 10.1124/mol.105.017855; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969                                                        ; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Sakuma T, 2014, DEV GROWTH DIFFER, V56, P2, DOI 10.1111/dgd.12111; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859                                                          ; Wang HX, 2014, CELL REP, V6, P951, DOI 10.1016/j.celrep.2014.01.038; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	23	0	0	5	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2017	45	9					5198	5207		10.1093/nar/gkx130				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV8WE	WOS:000402064200025	28334759	gold			2018-01-05	
J	Stachler, AE; Turgeman-Grott, I; Shtifman-Segal, E; Allers, T; Marchfelder, A; Gophna, U				Stachler, Aris-Edda; Turgeman-Grott, Israela; Shtifman-Segal, Ella; Allers, Thorsten; Marchfelder, Anita; Gophna, Uri			High tolerance to self-targeting of the genome by the endogenous CRISPR-Cas system in an archaeon	NUCLEIC ACIDS RESEARCH			English	Article							I-B SYSTEM; HALOFERAX-VOLCANII; ESCHERICHIA-COLI; DYNAMIC PROPERTIES; MODEL ARCHAEON; DNA; SULFOLOBUS; CLEAVAGE; DEFENSE; GENES	CRISPR-Cas systems allow bacteria and archaea to acquire sequence-specific immunity against selfish genetic elements such as viruses and plasmids, by specific degradation of invader DNA or RNA. However, this involves the risk of autoimmunity if immune memory against host DNA is mistakenly acquired. Such autoimmunity has been shown to be highly toxic in several bacteria and is believed to be one of the major costs of maintaining these defense systems. Here we generated an experimental system in which a non-essential gene, required for pigment production and the reddish colony color, is targeted by the CRISPR-Cas I-B system of the halophilic archaeon Haloferax volcanii. We show that under native conditions, where both the self-targeting and native crRNAs are expressed, self-targeting by CRISPR-Cas causes no reduction in transformation efficiency of the plasmid encoding the self-targeting crRNA. Furthermore, under such conditions, no effect on organismal growth rate or loss of the reddish colony phenotype due to mutations in the targeted region could be observed. In contrast, in cells deleted for the pre-crRNA processing gene cas6, where only the self-targeting crRNA exists as mature crRNA, self-targeting leads to moderate toxicity and the emergence of deletion mutants. Sequencing of the deletions caused by CRISPR-Cas self targeting indicated DNA repair viamicrohomology-mediated end joining.	[Stachler, Aris-Edda; Marchfelder, Anita] Ulm Univ, Dept Biol 2, D-89069 Ulm, Germany; [Turgeman-Grott, Israela; Shtifman-Segal, Ella; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-6997801 Tel Aviv, Israel; [Allers, Thorsten] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England	Marchfelder, A (reprint author), Ulm Univ, Dept Biol 2, D-89069 Ulm, Germany.; Gophna, U (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-6997801 Tel Aviv, Israel.	anita.marchfelder@uni-ulm.de; urigo@tauex.tau.ac.il		Allers, Thorsten/0000-0002-7308-3332; Gophna, Uri/0000-0001-5129-5652	Deutsche Forschungsgemeinschaft [MA1538/16-2]; Israel Science Foundation [535/15]; DFG; TAU	Deutsche Forschungsgemeinschaft [MA1538/16-2]; Israel Science Foundation [535/15]. Funding for open access charge: DFG internal funds; TAU internal funds.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Barilla D, 2016, TRENDS MICROBIOL, V24, P957, DOI 10.1016/j.tim.2016.07.001; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Cass SDB, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150043; CHARLEBOIS RL, 1987, P NATL ACAD SCI USA, V84, P8530, DOI 10.1073/pnas.84.23.8530; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Kiljunen S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0103-3; Li M, 2013, J BACTERIOL, V195, P867, DOI 10.1128/JB.01688-12; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Liu GN, 2016, NUCLEIC ACIDS RES, V44, P4233, DOI 10.1093/nar/gkw286; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Maier LK, 2013, RNA BIOL, V10, P865, DOI 10.4161/rna.24282; Maier L.K., 2012, MOB GENET ELEMENTS, V2, P228; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Naor A, 2012, CURR BIOL, V22, P1444, DOI 10.1016/j.cub.2012.05.056; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Quax TEF, 2013, J VIROL, V87, P8419, DOI 10.1128/JVI.01020-13; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Stachler AE, 2016, J BIOL CHEM, V291, P15226, DOI [10.1074/jbc.M116/724062, 10.1074/jbc.M116.724062]; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Stoll B, 2013, BIOCHEM SOC T, V41, P1444, DOI 10.1042/BST20130098; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Yosef I, 2011, P NATL ACAD SCI USA, V108, P20136, DOI 10.1073/pnas.1113519108; Zerulla K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094819	38	2	2	3	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2017	45	9					5208	5216		10.1093/nar/gkx150				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV8WE	WOS:000402064200026	28334774	gold			2018-01-05	
J	Martinez, A; Yamashita, S; Nagaike, T; Sakaguchi, Y; Suzuki, T; Tomita, K				Martinez, Anna; Yamashita, Seisuke; Nagaike, Takashi; Sakaguchi, Yuriko; Suzuki, Tsutomu; Tomita, Kozo			Human BCDIN3D monomethylates cytoplasmic histidine transfer RNA	NUCLEIC ACIDS RESEARCH			English	Article							7SK RNA; NONCODING RNA; CANCER CELLS; TRANSCRIPTION; PROTEIN; TRANSLATION; EXPRESSION; CODON; IDENTIFICATION; PROLIFERATION	Human RNA methyltransferase BCDIN3D is over-expressed in breast cancer cells, and is related to the tumorigenic phenotype and poor prognosis of breast cancer. Here, we show that cytoplasmic tRNA(His) is the primary target of BCDIN3D in human cells. Recombinant human BCDIN3D, expressed in Escherichia coli, monomethylates the 5'-monophosphate of cytoplasmic tRNA(His) efficiently in vitro. In BCDN3D-knockout cells, established by CRISPR/Cas9 editing, the methyl moiety at the 5'-monophosphate of cytoplasmic tRNA(His) is lost, and the exogenous expression of BCDIN3D in the knockout cells restores the modification in cytoplasmic tRNA(His). BCIDN3D recognizes the 5'-guanosine nucleoside at position - 1 (G(-1)) and the eight-nucleotide acceptor helix with the G(-1)-A(73) mis-pair at the top of the acceptor stem of cytoplasmic tRNA(His), which are exceptional structural features among cytoplasmic tRNA species. While the monomethylation of the 5'-monophosphate of cytoplasmic tRNA(His) affects neither the overall aminoacylation process in vitro nor the steady-state level of cytoplasmic tRNA(His) in vivo, it protects the cytoplasmic tRNA(His) transcript from degradation in vitro. Thus, BCDIN3D acts as a cytoplasmic tRNA(His)-specific 5'-methylphosphate capping enzyme. The present results also suggest the possible involvement of the monomethylation of the 5'-monophosphate of cytoplasmic tRNA(His) and/or cytoplasmic tRNA(His) itself in the tumorigenesis of breast cancer cells.	[Martinez, Anna; Yamashita, Seisuke; Nagaike, Takashi; Tomita, Kozo] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba 2778562, Japan; [Sakaguchi, Yuriko; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Tomita, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba 2778562, Japan.	kozo_tomita@cbms.k.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731	JSPS; Ministry of Education, Science, Sports and Culture of Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Hamaguchi Foundation for the Advancement of Biochemistry; Ministry of Education, Science, Sports, and Culture of Japan	Funding Program for Next Generation World-Leading Researchers of JSPS [to K.T.]; Grants-in-Aid for Scientific Research (A) [to K.T.] from JSPS and a Grant-in-Aid for Scientific Research on Innovative Areas from Ministry of Education, Science, Sports and Culture of Japan [to K.T., T.S.]; Takeda Science Foundation, Astellas Foundation for Research on Metabolic Disorders and Hamaguchi Foundation for the Advancement of Biochemistry [to K.T.]. Funding for open access charge: Grant-in-Aid for Scientific Research on Innovative Areas from Ministry of Education, Science, Sports, and Culture of Japan [to K.T.].	Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475                                                         ; Cosgrove MS, 2012, WIRES RNA, V3, P633, DOI 10.1002/wrna.1123; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Fromant M, 2000, BIOCHEMISTRY-US, V39, P4062, DOI 10.1021/bi9923297                                                               ; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; Gu WF, 2003, GENE DEV, V17, P2889, DOI 10.1101/gad.1148603; Hermann T, 1999, CHEM BIOL, V6, pR335, DOI 10.1016/S1074-5521(00)80003-4; Honda S, 2015, P NATL ACAD SCI USA, V112, pE3816, DOI 10.1073/pnas.1510077112; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kumar P, 2015, NUCLEIC ACIDS RES, V43, pD141, DOI 10.1093/nar/gku1138; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Ohira T, 2016, NAT CHEM BIOL, V12, P648, DOI [10.1038/NCHEMBIO.2117, 10.1038/nchembio.2117]; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Petrushenko ZM, 2002, EUR J BIOCHEM, V269, P4811, DOI 10.1046/j.1432-1033.2002.03178.x; Pyzocha NK, 2014, METHODS MOL BIOL, V1114, P269, DOI 10.1007/978-1-62703-761-7_17; ROSA MD, 1983, NUCLEIC ACIDS RES, V11, P853, DOI 10.1093/nar/11.3.853                                                            ; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shuman S, 2007, MOL CELL, V27, P517, DOI 10.1016/j.molcel.2007.08.001; Singh N, 2011, DEV BIOL, V352, P104, DOI 10.1016/j.ydbio.2011.01.017; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Tian QN, 2015, NUCLEIC ACIDS RES, V43, P2980, DOI 10.1093/nar/gkv129; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P4291, DOI 10.1093/nar/27.21.4291                                                          ; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P1683, DOI 10.1093/nar/27.7.1683; TSURUI H, 1994, ANAL BIOCHEM, V221, P166, DOI 10.1006/abio.1994.1393; Wu JY, 2014, GENE DEV, V28, P1556, DOI 10.1101/gad.244673.114; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Yao L, 2016, ONCOTARGET, V7, P53895, DOI 10.18632/oncotarget.9656; Zhu WC, 2000, GENE, V245, P329, DOI 10.1016/S0378-1119(00)00048-2	41	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2017	45	9					5423	5436		10.1093/nar/gkx051				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV8WE	WOS:000402064200043	28119416	gold			2018-01-05	
J	Lei, C; Li, SY; Liu, JK; Zheng, X; Zhao, GP; Wang, J				Lei, Chao; Li, Shi-Yuan; Liu, Jia-Kun; Zheng, Xuan; Zhao, Guo-Ping; Wang, Jin			The CCTL (Cpf1-assisted Cutting and Taq DNA ligase-assisted Ligation) method for efficient editing of large DNA constructs in vitro	NUCLEIC ACIDS RESEARCH			English	Article							STREPTOMYCES-COELICOLOR A3(2); GENE CLUSTERS; HUMAN-CELLS; CRISPR RNA; CPF1; GENOME; CLONING; SPECIFICITIES; ENDONUCLEASE; RECOGNITION	As Cpf1 cleaves double-stranded DNA in a staggered way, it can be used in DNA assembly. However, the Cpf1 cleavage was found to be inaccurate, which may cause errors in DNA assembly. Here, the Cpf1 cleavage sites were precisely characterized, where the cleavage site on the target strand was around the 22nd base relative to the protospacer adjacent motif site, but the cleavage on the non-target strand was affected by the spacer length. When the spacer length was 20 nt or longer, Cpf1 mainly cleaved around the 14th and the 18th bases on the non-target strand; otherwise, with a shorter spacer (i.e. 17-19 nt), Cpf1 mainly cleaved after the 14th base, generating 8-nt sticky ends. With this finding, Cpf1 with a 17-nt spacer crRNA were employed for in vitro substitution of the actII-orf4 promoter in the actinorhodin biosynthetic cluster with a constitutively expressing promoter. The engineered cluster yielded more actinorhodin and produced actinorhodin from an earlier phase. Moreover, Taq DNA ligase was further employed to increase both the ligation efficiency and the ligation accuracy of the method. We expect this CCTL (Cpf1-assisted Cutting and Taq DNA ligase-mediated Ligation) method can be widely used in in vitro editing of large DNA constructs.	[Lei, Chao; Li, Shi-Yuan; Liu, Jia-Kun; Zheng, Xuan; Zhao, Guo-Ping; Wang, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Li, Shi-Yuan; Liu, Jia-Kun; Zheng, Xuan; Zhao, Guo-Ping] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200032, Peoples R China; [Zhao, Guo-Ping] Fudan Univ, Ctr Synthet Biol, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200032, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li KaShing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Wang, J (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.	wangj01@hotmail.com			Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]; Youth Innovation Promotion Association CAS; China National Basic Research Program [973 Program] [2012CB721102]; National Natural Science Foundation of China [31421061, 31430004, 31300031]	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]; Youth Innovation Promotion Association CAS; the China National Basic Research Program [973 Program No. 2012CB721102]; National Natural Science Foundation of China [31421061, 31430004; 31300031]. Funding for open access charge: Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]; Youth Innovation Promotion Association CAS; the China National Basic Research Program [973 Program No. 2012CB721102]; National Natural Science Foundation of China [31421061, 31430004; 31300031].	BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Borodina I, 2008, J BIOL CHEM, V283, P25186, DOI 10.1074/jbc.M803105200; Carneiro FRG, 2006, BIOCHEM BIOPH RES CO, V343, P260, DOI 10.1016/j.bbrc.2006.02.140; Chen WH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt122; Chen WH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-243; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1016/S0378-1097(97)00392-3; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fujii T, 1996, J BACTERIOL, V178, P3402, DOI 10.1128/jb.178.11.3402-3405.1996                                                ; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9101; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kieser T., 2000, PRACTICAL STREPTOMYC; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Li L, 2015, METAB ENG, V29, P12, DOI 10.1016/j.ymben.2015.02.001; Li SY, 2016, ACS SYNTH BIOL, V5, P1383, DOI 10.1021/acssynbio.6b00114; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Shao ZH, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0264-y; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141	32	1	1	15	15	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2017	45	9							e74	10.1093/nar/gkx018				7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV8WE	WOS:000402064200009	28115632	gold			2018-01-05	
J	Peng, TJ; Ma, LY; Feng, X; Tao, JM; Nan, MH; Liu, YD; Li, JK; Shen, L; Wu, XL; Yu, RL; Liu, XD; Qiu, GZ; Zeng, WM				Peng, Tangjian; Ma, Liyuan; Feng, Xue; Tao, Jiemeng; Nan, Meihua; Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin			Genomic and transcriptomic analyses reveal adaptation mechanisms of an Acidithiobacillus ferrivorans strain YL15 to alpine acid mine drainage	PLOS ONE			English	Article							COLD-SHOCK RESPONSE; ESCHERICHIA-COLI; ACIDOPHILIC MICROORGANISMS; BIOFILM FORMATION; METAL RESISTANCE; LOW-TEMPERATURES; WEB SERVER; PROTEIN; BACTERIAL; DATABASE	Acidithiobacillus ferrivorans is an acidophile that often occurs in low temperature acid mine drainage, e.g., that located at high altitude. Being able to inhabit the extreme environment, the bacterium must possess strategies to copy with the survival stress. Nonetheless, information on the strategies is in demand. Here, genomic and transcriptomic assays were performed to illuminate the adaptation mechanisms of an A. ferrivorans strain YL15, to the alpine acid mine drainage environment in Yulong copper mine in southwest China. Genomic analysis revealed that strain has a gene repertoire for metal-resistance, e.g., genes coding for the mer operon and a variety of transporters/efflux proteins, and for low pH adaptation, such as genes for hopanoid-synthesis and the sodium: proton antiporter. Genes for various DNA repair enzymes and synthesis of UV-absorbing mycosporine-like amino acids precursor indicated hypothetical UV radiation-resistance mechanisms in strain YL15. In addition, it has two types of the acquired immune system-type III-B and type I-F CRISPR/Cas modules against invasion of foreign genetic elements. RNA-seq based analysis uncovered that strain YL15 uses a set of mechanisms to adapt to low temperature. Genes involved in protein synthesis, transmembrane transport, energy metabolism and chemotaxis showed increased levels of RNA transcripts. Furthermore, a bacterioferritin Dps gene had higher RNA transcript counts at 6 degrees C, possibly implicated in protecting DNA against oxidative stress at low temperature. The study represents the first to comprehensively unveil the adaptation mechanisms of an acidophilic bacterium to the acid mine drainage in alpine regions.	[Peng, Tangjian; Ma, Liyuan; Feng, Xue; Tao, Jiemeng; Nan, Meihua; Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin] Cent S Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China; [Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin] Cent S Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China; [Li, Jiaokun] Cent S Univ, Sch Met & Environm, Changsha, Hunan, Peoples R China; [Zeng, Weimin] CSIRO Proc Sci & Engn, Clayton, Vic, Australia	Zeng, WM (reprint author), Cent S Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China.; Zeng, WM (reprint author), Cent S Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China.; Zeng, WM (reprint author), CSIRO Proc Sci & Engn, Clayton, Vic, Australia.	zengweimin1024@sina.com			National Natural Science Foundation of China [31470230, 51320105006, 51604308]	This work was supported by the National Natural Science Foundation of China (No. 31470230, 51320105006, 51604308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alreshidi MM, 2015, J PROTEOMICS, V121, P44, DOI 10.1016/j.jprot.2015.03.010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784                                                         ; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Barahona S, 2014, RES MICROBIOL, V165, P782, DOI 10.1016/j.resmic.2014.07.015; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bayir H, 2005, CRIT CARE MED, V33, pS498, DOI 10.1097/01.CCM.0000186787.64500.12; Berger F, 1996, J BACTERIOL, V178, P2999, DOI 10.1128/jb.178.11.2999-3007.1996                                                ; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6                                                    ; Bresolin G, 2006, J BACTERIOL, V188, P2945, DOI 10.1128/JB.188.8.2945-2958.2006; Cavicchioli R, 2016, ISME J, V10, P793, DOI 10.1038/ismej.2015.160; Chen L, 2014, ISME J; Chen LX, 2013, ENVIRON MICROBIOL, V15, P2431, DOI 10.1111/1462-2920.12114; Chen ZJ, 2012, ENV MICROBIOL REP, V4, P633, DOI 10.1111/j.1758-2229.2012.00389.x; Christel S, 2016, EXTREMOPHILES, V20, P903, DOI 10.1007/s00792-016-0882-2; Christel S, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw057; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dopson M, 2007, BIOTECHNOL BIOENG, V97, P1205, DOI 10.1002/bit.21312; Dopson M, 2014, APPL MICROBIOL BIOT, V98, P8133, DOI 10.1007/s00253-014-5982-2; Elberling B, 2000, J CONTAM HYDROL, V41, P225, DOI 10.1016/S0169-7722(99)00085-6                                                   ; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gabani P, 2013, APPL MICROBIOL BIOT, V97, P993, DOI 10.1007/s00253-012-4642-7; GADD GM, 1978, MICROBIAL ECOL, V4, P303, DOI 10.1007/BF02013274; Gonzalez C, 2014, RES MICROBIOL, V165, P726, DOI 10.1016/j.resmic.2014.08.005; Goodchild A, 2004, MOL MICROBIOL, V53, P309, DOI 10.1111/j.1365-2958.2004.04130.x; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissal, 2007, NUCLEIC ACIDS RES, V35, pW52; Guazzaroni ME, 2013, ENVIRON MICROBIOL, V15, P1088, DOI 10.1111/1462-2920.12021; Hallberg KB, 2010, EXTREMOPHILES, V14, P9, DOI 10.1007/s00792-009-0282-y; Hua Z, 2014, ISME J; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; Johnson DB, 2001, ENVIRON MICROBIOL, V3, P630, DOI 10.1046/j.1462-2920.2001.00234.x                                                ; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Keto-Timonen R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01151; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12                                                         ; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Levin BR, 2013, PLOS GENET, V9; Liljeqvist M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv011; Liljeqvist M, 2013, APPL ENVIRON MICROB, V79, P951, DOI 10.1128/AEM.02989-12; Liljeqvist M, 2011, J BACTERIOL, V193, P4304, DOI 10.1128/JB.05373-11; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093289; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mon H, 2001, TRENDS MICROBIOL, V9, P494; Morgante V, 2014, ENV MICROBIOL; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9                                                   ; Rastogi RP, 2010, J IND MICROBIOL BIOT, V37, P537, DOI 10.1007/s10295-010-0718-5; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753                                                  ; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; SQUIRES CL, 1991, J BACTERIOL, V173, P4254; Talla E, 2014, RES MICROBIOL, V165, P753, DOI 10.1016/j.resmic.2014.08.002; Talla E, 2013, ADV MATER RES-SWITZ, V825, P145, DOI 10.4028/www.scientific.net/AMR.825.145; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YG, 2012, BIORESOURCE TECHNOL, V121, P348, DOI 10.1016/j.biortech.2012.06.114; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Williams TJ, 2010, J PROTEOME RES, V9, P640, DOI 10.1021/pr900509n; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xiao Y., 2016, APPL MICROBIOL BIOT, P1; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl1031; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	75	0	0	40	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178008	10.1371/journal.pone.0178008				17	Multidisciplinary Sciences	Science & Technology - Other Topics	EV3PW	WOS:000401672600040	28542527	gold			2018-01-05	
J	Wang, M; Huang, YP; Wu, H; Song, K; Wan, C; Chi, AN; Xiao, YM; Zhao, XY				Wang, Mei; Huang, Ya-Ping; Wu, Han; Song, Ke; Wan, Cong; Chi, A-Ni; Xiao, Ya-Mei; Zhao, Xiao-Yang			Mitochondrial complex I deficiency leads to the retardation of early embryonic development in Ndufs4 knockout mice	PEERJ			English	Article						Mitochondria complex I; Ndufs4; CRISPR/Cas9; Embryo development	ONE-STEP GENERATION; PREIMPLANTATION EMBRYO; OXIDATIVE STRESS; LEIGH-SYNDROME; VITRO; GENE; MUTATION; SUBUNIT; DISEASE; OOCYTES	Background. The NDUFS4 gene encodes an 18-kD subunit of mitochondria complex I, and mutations in this gene lead to the development of a severe neurodegenerative disease called Leigh syndrome (LS) in humans. To investigate the disease phenotypes and molecular mechanisms of Leigh syndrome, the Ndufs4 knockout (KO) mouse has been widely used as a novel animal model. Because the homozygotes cannot survive beyond child-bearing age, whether Ndufs4 and mitochondria) complex I influence early embryonic development remains unknown. In our study, we attempted to investigate embryonic development in Ndufs4 KO mice, which can be regarded as a Leigh disease model and were created through the CRISPR (clustered regularly interspaced short palindromic repeat) and Cas9 (CRISPR associated)-mediated genome editing system. Methods. We first designed a single guide RNA (sgRNA) targeting exon 2 of Ndufs4 to delete the NDUFS4 protein in mouse embryos to mimic Leigh syndrome. Then, we described the phenotypes of our mouse model by forced swimming land the open-field test as well as by assessing other behavioral characteristics. Intracytoplasrnic sperm injection (ICSI) was performed to obtain KO embryos to test the influence of NDUFS4 deletion on early embryonic development. Results. In this study, we first generated Ndufs4 KO mice with physical and behavioral phenotypes similar to Leigh syndrome using the CRISPR/Cas9 system. The low developmental rate of KO embryos that were derived from knockout gametes indicated that the absence of NDUFS4 impaired the development of preimplantation embryos. Discussion. In this paper, we first obtained Ndufs4 KO mice that could mimic Leigh syndrome using the CRISPR/Cas9 system. Then, we identified the role of NDUFS4 in early embryonic development, shedding light on its roles in the respiratory chain and fertility. Our model provides a useful tool with which to investigate the function of Ndufs4: Although the pathological mechanisms of the disease need to be discovered, it helps to understand the pathogenesis of NDUFS4 deficiency in mice and its effects on human diseases.	[Wang, Mei; Huang, Ya-Ping; Xiao, Ya-Mei] Hunan Normal Univ, State Key Lab Dev Biol Freshwater Fish, Changsha, Hunan, Peoples R China; [Wang, Mei; Huang, Ya-Ping; Wu, Han; Wan, Cong; Chi, A-Ni; Zhao, Xiao-Yang] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Guangzhou, Guangdong, Peoples R China; [Song, Ke] Southern Med Univ, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China	Xiao, YM (reprint author), Hunan Normal Univ, State Key Lab Dev Biol Freshwater Fish, Changsha, Hunan, Peoples R China.; Zhao, XY (reprint author), Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Guangzhou, Guangdong, Peoples R China.	yameix@hunnu.edu.cn; zhaoxiaoyang@smu.edu.cn			National Natural Science Foundation of China [31671544]; Hunan Provincial Innovation Foundation of Postgraduate [CX2014B228]; Ministry of Science and Technology of China [2016YFC1000606]	This work was supported by the National Natural Science Foundation of China (31671544), Hunan Provincial Innovation Foundation of Postgraduate (CX2014B228), and the Ministry of Science and Technology of China (2016YFC1000606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Anderson SL, 2008, J INHERIT METAB DIS, V31, pS461, DOI 10.1007/s10545-008-1049-9; Breuer ME, 2013, IUBMB LIFE, V65, P202, DOI 10.1002/iub.1127; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gerards M, 2014, BRAIN, V137, P2872, DOI 10.1093/brain/awu264; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175                                                          ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koopman WJH, 2010, ANTIOXID REDOX SIGN, V12, P1431, DOI 10.1089/ars.2009.2743; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lamont RE, 2017, AM J MED GENET A, V173, P596, DOI 10.1002/ajmg.a.37983; Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529                                                            ; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311                                                           ; Ren LK, 2015, HUM REPROD, V30, P2892, DOI 10.1093/humrep/dev228; Segal DJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00563; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Valsecchi F, 2013, MITOCHONDRION, V13, P436, DOI 10.1016/j.mito.2012.12.001; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954                                           ; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010; Zhou Q, 2016, CELL STEM CELL, V18, P330, DOI 10.1016/j.stem.2016.01.017; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	33	0	0	2	2	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	MAY 18	2017	5								e3339	10.7717/peerj.3339				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EV5YQ	WOS:000401846100009	28533980	gold			2018-01-05	
J	Nakajima, I; Ban, Y; Azuma, A; Onoue, N; Moriguchi, T; Yamamoto, T; Toki, S; Endo, M				Nakajima, Ikuko; Ban, Yusuke; Azuma, Akifumi; Onoue, Noriyuki; Moriguchi, Takaya; Yamamoto, Toshiya; Toki, Seiichi; Endo, Masaki			CRISPR/Cas9-mediated targeted mutagenesis in grape	PLOS ONE			English	Article							VITIS-VINIFERA L; GENETIC-TRANSFORMATION; BIOLISTIC TRANSFORMATION; SOMATIC EMBRYOGENESIS; KYOHO GRAPE; PLANTS; SYSTEM; ESTABLISHMENT; REGENERATION; LABRUSCANA	RNA-guided genome editing using the CRISPR/Cas9 CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system has been applied successfully in several plant species. However, to date, there are few reports on the use of any of the current genome editing approaches in grape-an important fruit crop with a large market not only for table grapes but also for wine. Here, we report successful targeted mutagenesis in grape (Vitis vinifera L., cv. Neo Muscat) using the CRISPR/Cas9 system. When a Cas9 expression construct was transformed to embryonic calli along with a synthetic sgRNA expression construct targeting the Vitis vinifera phytoene desaturase (VvPDS) gene, regenerated plants with albino leaves were obtained. DNA sequencing confirmed that the VvPDS gene was mutated at the target site in regenerated grape plants. Interestingly, the ratio of mutated cells was higher in lower, older, leaves compared to that in newly appearing upper leaves. This result might suggest either that the proportion of targeted mutagenized cells is higher in older leaves due to the repeated induction of DNA double strand breaks (DSBs), or that the efficiency of precise DSBs repair in cells of old grape leaves is decreased.	[Nakajima, Ikuko; Ban, Yusuke; Azuma, Akifumi; Onoue, Noriyuki; Moriguchi, Takaya; Yamamoto, Toshiya] Natl Agr & Food Res Org, Inst Fruit Tree & Tea Sci, Tsukuba, Ibaraki, Japan; [Toki, Seiichi; Endo, Masaki] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, Maioka Cho, Yokohama, Kanagawa, Japan; [Ban, Yusuke] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Nishifukatsu Cho, Fukuyama, Hiroshima, Japan	Endo, M (reprint author), Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	mendo@affrc.go.jp			Cabinet Office, Government of Japan; Cross-Ministerial Strategic Innovation Promotion Program (SIP); Bio-oriented Technology Research Advancement Institution, NARO	This work was supported by the Cabinet Office, Government of Japan, Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Bouquet A, 2008, COMPENDIUM TRANSGENI, P189, DOI DOI 10.1002/9781405181099.K0407; Bouquet A, 2011, GENETICS GENOMICS BR, V1, P1; Boyko A, 2006, PLANT PHYSIOL, V141, P488, DOI 10.1104/pp.105.074658; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Hoshino Y, 1998, PLANT BIOTECHNOL, V15, p29 ; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Iocco P, 2001, TRANSGENIC RES, V10, P105, DOI 10.1023/A:1008989610340; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; KAWALLECK P, 1993, PLANT MOL BIOL, V21, P673, DOI 10.1007/BF00014550; Kikkert JR, 1996, PLANT CELL REP, V15, P311, DOI 10.1007/BF00232362; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; MARTINELLI L, 1994, THEOR APPL GENET, V88, P621, DOI 10.1007/BF01253963; MATSUTA N, 1989, PLANT CELL REP, V7, P684, DOI 10.1007/BF00272061; MATSUTA N, 1992, JPN J BREED, V42, P879; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakajima I, 2006, J JPN SOC HORTIC SCI, V75, P188, DOI 10.2503/jjshs.75.188; Nakajima I, 2003, VITIS, V42, P53; Nakajima I, 2000, J JPN SOC HORTIC SCI, V69, P186; Nakano M, 1997, VITIS, V36, P141; NITSCH JP, 1969, SCIENCE, V163, P85, DOI 10.1126/science.163.3862.85                                                     ; Perl A, 1996, NAT BIOTECHNOL, V14, P624, DOI 10.1038/nbt0596-624; RAJASEKARAN K, 1983, AM J ENOL VITICULT, V34, P108; Ren C, 2016, SCI REP, V31; SRINIVASAN C, 1980, SCI HORTIC-AMSTERDAM, V13, P245, DOI 10.1016/0304-4238(80)90062-X; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Vidal JR, 2006, PLANT CELL REP, V25, P807, DOI 10.1007/s00299-006-0132-7; Wang Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0787-3; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Zhou Q, 2014, PLANT CELL TISS ORG, V118, P157, DOI 10.1007/s11240-014-0471-y	35	3	3	20	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177966	10.1371/journal.pone.0177966				16	Multidisciplinary Sciences	Science & Technology - Other Topics	EV3PV	WOS:000401672400122	28542349	gold			2018-01-05	
J	Osigus, HJ; Eitel, M; Schierwater, B				Osigus, Hans-Juergen; Eitel, Michael; Schierwater, Bernd			Deep RNA sequencing reveals the smallest known mitochondrial micro exon in animals: The placozoan cox1 single base pair exon	PLOS ONE			English	Article							TRICHOPLAX-ADHAERENS; EVOLUTION; GENOME; DNA; ORGANIZATION; CNIDARIANS; INTRONS; PHYLUM; MTDNA	The phylum Placozoa holds a key position for our understanding of the evolution of mitochondrial genomes in Metazoa. Placozoans possess large mitochondrial genomes which harbor several remarkable characteristics such as a fragmented cox1 gene and trans-splicing cox1 introns. A previous study also suggested the existence of cox1 mRNA editing in Trichoplax adhaerens, yet the only formally described species in the phylum Placozoa. We have analyzed RNA-seq data of the undescribed sister species, Placozoa sp. H2 ("Panama" clone), with special focus on the mitochondrial mRNA. While we did not find support for a previously postulated cox1 mRNA editing mechanism, we surprisingly found two independent transcripts representing intermediate cox1 mRNA splicing stages. Both transcripts consist of partial cox1 exon as well as overlapping intron fragments. The data suggest that the cox1 gene harbors a single base pair (cytosine) micro exon. Furthermore, conserved group I intron structures flank this unique micro exon also in other placozoans. We discuss the evolutionary origin of this micro exon in the context of a self-splicing intron gain in the cox1 gene of the last common ancestor of extant placozoans.	[Osigus, Hans-Juergen; Eitel, Michael; Schierwater, Bernd] Univ Vet Med Hannover, Ecol & Evolut, ITZ, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Schierwater, Bernd] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Schierwater, Bernd] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Eitel, Michael] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Paleontol & Geobiol, Munich, Germany	Osigus, HJ (reprint author), Univ Vet Med Hannover, Ecol & Evolut, ITZ, Hannover, Germany.	h.j.osigus@ecolevol.de			Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft [Schi 277/26-1, 29-1]	HJO acknowledges a doctoral fellowship of the Studienstiftung des deutschen Volkes. This project has been funded by the Deutsche Forschungsgemeinschaft (Schi 277/26-1 & 29-1), http/www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HJO acknowledges a doctoral fellowship of the Studienstiftung des deutschen Volkes. We would like to thank C. Heffelfinger, M. Moreno and S. L. Dellaporta for help and support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P328, DOI 10.1016/j.ympev.2012.10.020; Breton S, 2014, TRENDS GENET, V30, P555, DOI 10.1016/j.tig.2014.09.002; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; Collins AG, 2005, INTEGR COMP BIOL, V45, P585, DOI 10.1093/icb/45.4.585; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DeSalle R, 2017, FRONT BIOSCI-LANDMRK, V22, P873, DOI 10.2741/4522; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Eitel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057131; Feindt W, 2016, MITOCHONDRIAL DNA B, V1, P574, DOI 10.1080/23802359.2016.1192510; Feindt W, 2016, MITOCHONDRIAL DNA B, V1, P497, DOI 10.1080/23802359.2016.1192504; Guo L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18087; Herzog R, 2016, MITOCHONDRIAL DNA B, V1, P783, DOI 10.1080/23802359.2016.1186523; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2016, GENOME BIOL EVOL, V8, P2896, DOI 10.1093/gbe/evw195; Lavrov DV, 2013, MOL BIOL EVOL, V30, P865, DOI 10.1093/molbev/mss274; Li YI, 2015, GENOME RES, V25, P1, DOI 10.1101/gr.181990.114; Miyazawa H, 2012, ZOOL SCI, V29, P223, DOI 10.2108/zsj.29.223; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V69, P339, DOI 10.1016/j.ympev.2013.07.016; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V66, P551, DOI 10.1016/j.ympev.2012.05.028; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; SCHIERWATER B, 1991, J EXP ZOOL, V260, P413, DOI 10.1002/jez.1402600316; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schierwater B., 2016, FRONTIERS ECOLOGY EV, V4, P5, DOI [10.3389/fevo.2016.00005, DOI 10.3389/FEVO.2016.00005]; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schuster A, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0928-9; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Xavier BB, 2012, FUNGAL BIOL-UK, V116, P802, DOI 10.1016/j.funbio.2012.04.013	35	0	0	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177959	10.1371/journal.pone.0177959				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EV3PV	WOS:000401672400121	28542197	gold			2018-01-05	
J	Yamazaki, T; Hatano, Y; Handa, T; Kato, S; Hoida, K; Yamamura, R; Fukuyama, T; Uematsu, T; Kobayashi, N; Kimura, H; Yamagata, K				Yamazaki, Taiga; Hatano, Yu; Handa, Tetsuya; Kato, Sakiko; Hoida, Kensuke; Yamamura, Rui; Fukuyama, Takashi; Uematsu, Takayuki; Kobayashi, Noritada; Kimura, Hiroshi; Yamagata, Kazuo			Targeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; MAMMALIAN DEVELOPMENT; CRISPR/CAS SYSTEM; MOUSE; CHROMATIN; DYNAMICS; HETEROCHROMATIN; CANCER; DNMT3A	To study the impact of epigenetic changes on biological functions, the ability to manipulate the epigenetic status of certain genomic regions artificially could be an indispensable technology. "Epigenome editing" techniques have gradually emerged that apply TALE or CRISPR/Cas9 technologies with various effector domains isolated from epigenetic code writers or erasers such as DNA methyltransferase, 5-methylcytosine oxidase, and histone modification enzymes. Here we demonstrate that a TALE recognizing a major satellite, consisting of a repeated sequence in pericentromeres, could be fused with the bacterial CpG methyltransferase, SssI. ChIP-qPCR assays demonstrated that the fusion protein TALMaj-SssI preferentially bound to major chromosomal satellites in cultured cell lines. Then, TALMaj-SssI was expressed in fertilized mouse oocytes with hypomethylated major satellites (10-20% CpG islands). Bisulfite sequencing revealed that the DNA methylation status was increased specifically in major satellites (50-60%), but not in minor satellites or other repeat elements, such as Intracisternal A-particle (IAP) or long interspersed nuclear elements-1 (Line1) when the expression level of TALMaj-SssI is optimized in the cell. At a microscopic level, distal ends of chromosomes at the first mitotic stage were dramatically highlighted by the mCherry-tagged methyl CpG binding domain of human MBD1 (mCherry-MBD-NLS). Moreover, targeted DNA methylation to major satellites did not interfere with kinetochore function during early embryonic cleavages. Co-injection of dCas9 fused with SssI and guide RNA (gRNA) recognizing major satellite sequences enabled increment of the DNA methylation in the satellites, but a few off-target effects were also observed in minor satellites and retrotransposons. Although CRISPR can be applied instead of the TALE system, technical improvements to reduce off-target effects are required. We have demonstrated a new method of introducing DNA methylation without the need of other binding partners using the CpG methyltransferase, SssI.	[Yamazaki, Taiga; Yamamura, Rui; Fukuyama, Takashi; Uematsu, Takayuki; Kobayashi, Noritada] Kitasato Univ, Med Ctr, Div Biomed Res, Kitamoto, Saitama, Japan; [Hatano, Yu; Kato, Sakiko; Hoida, Kensuke; Yamagata, Kazuo] KINDAI Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan; [Handa, Tetsuya; Kimura, Hiroshi] Tokyo Inst Technol, Inst Innovat Res, Cell Biol Unit, Midori Ku, Yokohama, Kanagawa, Japan	Yamazaki, T (reprint author), Kitasato Univ, Med Ctr, Div Biomed Res, Kitamoto, Saitama, Japan.; Yamagata, K (reprint author), KINDAI Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan.	tyamazak@insti.kitasato-u.ac.jp; yamagata@waka.kindai.ac.jp		UEMATSU, TAKAYUKI/0000-0002-3680-7231	JSPS KAKENHI [JP24700954, JP15K14924, JP25116005, JP25712035, JP26660250]; Kitasato University Medical Center; Kitasato University Research Grant	This work was supported by JSPS KAKENHI Grant Numbers JP24700954 (TY), JP15K14924 (TY), JP25116005 (HK and KY), JP25712035 (KY) and JP26660250 (KY). This work was also supported by Grant-in-Aid for Research from Kitasato University Medical Center (TY), and Kitasato University Research Grant for Young Researchers (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2005, BRIT J CANCER, V92, P1934, DOI 10.1038/sj.bjc.6602560; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bernstein DL, 2015, J CLIN INVEST, V125, P1998, DOI 10.1172/JCI77321; Bollati V, 2009, CARCINOGENESIS, V30, P1330, DOI 10.1093/carcin/bgp149; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Chaikind B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096931; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hori T, 2014, DEV CELL, V29, P740, DOI 10.1016/j.devcel.2014.05.001; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kawasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03658; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kungulovski G, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0002-z; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl035; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lo CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42047; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Molina O, 2016, CHROMOSOME RES, V24, P495, DOI 10.1007/s10577-016-9539-3; Morita S, 2016, NAT BIOTECHNOL; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Ueda J, 2014, STEM CELL REP, V2, P910, DOI 10.1016/j.stemcr.2014.05.008; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yamazaki T, 2007, J REPROD DEVELOP, V53, P1035, DOI 10.1262/jrd.19059; Yamazaki T, 2007, DEV BIOL, V304, P409, DOI 10.1016/j.ydbio.2006.12.046	53	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177764	10.1371/journal.pone.0177764				18	Multidisciplinary Sciences	Science & Technology - Other Topics	EV3PV	WOS:000401672400079	28542388	gold			2018-01-05	
J	Chen, YC; Yu, JH; Niu, YY; Qin, DD; Liu, HL; Li, G; Hu, YZ; Wang, JJ; Lu, Y; Kang, Y; Jiang, Y; Wu, KH; Li, SG; Wei, JK; He, J; Wang, JB; Liu, XJ; Luo, YP; Si, CY; Bai, RX; Zhang, KS; Liu, J; Huang, SY; Chen, ZZ; Wang, S; Chen, XY; Bao, XH; Zhang, QP; Li, FX; Geng, R; Liang, AB; Shen, DG; Jiang, TZ; Hu, XT; Ma, YY; Ji, WZ; Sun, YE				Chen, Yongchang; Yu, Juehua; Niu, Yuyu; Qin, Dongdong; Liu, Hailiang; Li, Gang; Hu, Yingzhou; Wang, Jiaojian; Lu, Yi; Kang, Yu; Jiang, Yong; Wu, Kunhua; Li, Siguang; Wei, Jingkuan; He, Jing; Wang, Junbang; Liu, Xiaojing; Luo, Yuping; Si, Chenyang; Bai, Raoxian; Zhang, Kunshan; Liu, Jie; Huang, Shaoyong; Chen, Zhenzhen; Wang, Shuang; Chen, Xiaoying; Bao, Xinhua; Zhang, Qingping; Li, Fuxing; Geng, Rui; Liang, Aibin; Shen, Dinggang; Jiang, Tianzi; Hu, Xintian; Ma, Yuanye; Ji, Weizhi; Sun, Yi Eve			Modeling Rett Syndrome Using TALEN-Edited MECP2 Mutant Cynomolgus Monkeys	CELL			English	Article							CPG-BINDING PROTEIN-2; NETWORK ANALYSIS; MICE; PRIMATES; AUTISM; GIRLS; ABNORMALITIES; NEUROANATOMY; DEFICIENCY; REGRESSION	Gene-editing technologies have made it feasible to create nonhuman primate models for human genetic disorders. Here, we report detailed genotypes and phenotypes of TALEN-edited MECP2 mutant cynomolgus monkeys serving as a model for a neurodevelopmental disorder, Rett syndrome (RTT), which is caused by loss-of-function mutations in the human MECP2 gene. Male mutant monkeys were embryonic lethal, reiterating that RTT is a disease of females. Through a battery of behavioral analyses, including primate-unique eye-tracking tests, in combination with brain imaging via MRI, we found a series of physiological, behavioral, and structural abnormalities resembling clinical manifestations of RTT. Moreover, blood transcriptome profiling revealed that mutant monkeys resembled RTT patients in immune gene dysregulation. Taken together, the stark similarity in phenotype and/or endophenotype between monkeys and patients suggested that gene-edited RTT founder monkeys would be of value for disease mechanistic studies as well as development of potential therapeutic interventions for RTT.	[Chen, Yongchang; Niu, Yuyu; Kang, Yu; Wei, Jingkuan; He, Jing; Si, Chenyang; Bai, Raoxian; Huang, Shaoyong; Chen, Zhenzhen; Wang, Shuang; Ma, Yuanye; Ji, Weizhi] Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming 650500, Peoples R China; [Yu, Juehua; Liu, Hailiang; Li, Siguang; Wang, Junbang; Liu, Xiaojing; Luo, Yuping; Zhang, Kunshan; Liu, Jie; Chen, Xiaoying; Li, Fuxing; Geng, Rui; Liang, Aibin; Sun, Yi Eve] Tongji Univ, Sch Med, Tongji Hosp, Translat Stem Cell Res Ctr, Shanghai 200065, Peoples R China; [Chen, Yongchang; Niu, Yuyu; Kang, Yu; Wei, Jingkuan; He, Jing; Si, Chenyang; Bai, Raoxian; Huang, Shaoyong; Chen, Zhenzhen; Wang, Shuang; Ma, Yuanye; Ji, Weizhi] Yunnan Prov Acad Sci & Technol, Kunming 650051, Peoples R China; [Sun, Yi Eve] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Qin, Dongdong; Hu, Yingzhou; Hu, Xintian] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China; [Li, Gang; Shen, Dinggang] Univ North Carolina Chapel Hill, Dept Radiol, Chapel Hill, NC 27599 USA; [Li, Gang; Shen, Dinggang] Univ North Carolina Chapel Hill, BRIC, Chapel Hill, NC 27599 USA; [Wang, Jiaojian; Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 625014, Peoples R China; [Lu, Yi] Kunming Med Univ, Affiliated Hosp 1, Dept Med Imaging, Kunming 650032, Peoples R China; [Jiang, Yong; Wu, Kunhua] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Kunming 650032, Peoples R China; [Jiang, Yong; Wu, Kunhua] Kunming Univ Sci & Technol, Affiliated Hosp, Kunming 650032, Peoples R China; [Bao, Xinhua; Zhang, Qingping] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China; [Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Natl Lab Pattern Recognit, Beijing 100190, Peoples R China; [Chen, Yongchang; Niu, Yuyu; Kang, Yu; Si, Chenyang; Ji, Weizhi] Kunming Enovate Inst Biosci, Kunming 650000, Peoples R China	Chen, YC; Ji, WZ (reprint author), Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming 650500, Peoples R China.; Sun, YE (reprint author), Tongji Univ, Sch Med, Tongji Hosp, Translat Stem Cell Res Ctr, Shanghai 200065, Peoples R China.; Chen, YC; Ji, WZ (reprint author), Yunnan Prov Acad Sci & Technol, Kunming 650051, Peoples R China.; Sun, YE (reprint author), Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.; Chen, YC; Ji, WZ (reprint author), Kunming Enovate Inst Biosci, Kunming 650000, Peoples R China.	chenyc@lpbr.cn; wji@lpbr.cn; ysun@mednet.ucla.edu		Ji, Weizhi/0000-0003-2550-4224	National Key Research and Development Program [2016YFA0101401, 2016YFA0100800]; National & Provincial Natural Science Foundation of China [U1602224, U1302227, 31571534, 2015FA037, 91319309, 31450110428, 31620103904, 2013HB133, 13JC1407102]; National Institute of Child Health Development of the NIH [U54HD087101-01]	This work was supported by the National Key Research and Development Program (2016YFA0101401 and 2016YFA0100800), the National & Provincial Natural Science Foundation of China (U1602224, U1302227, 31571534, 2015FA037, 91319309, 31450110428, 31620103904, 2013HB133, and 13JC1407102), and the National Institute of Child Health Development of the NIH (U54HD087101-01).	Alshahrani S., 2012, J VIS EXP; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amir RE, 1999, NAT GENET, V23, P185; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bjure J, 1997, EUR CHILD ADOLES PSY, V6, P64; Carter JC, 2008, AM J NEURORADIOL, V29, P436, DOI 10.3174/ajnr.A0857; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Djukic A, 2012, PEDIATR NEUROL, V46, P240, DOI 10.1016/j.pediatrneurol.2012.01.011; Glaze DG, 2004, MENT RETARD DEV D R, V10, P154, DOI 10.1002/mrdd.20030; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899                                                                   ; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412                                                           ; Hagberg Bengt, 2002, Eur J Paediatr Neurol, V6, P293, DOI 10.1053/ejpn.2002.0612; Hetzroni OE, 2006, AUGMENT ALTERN COMM, V22, P48, DOI 10.1080/17461390500387320; Jennings C, 2016, NAT NEUROSCI, V19, P1123, DOI 10.1038/nn.4362; Katz DM, 2016, TRENDS NEUROSCI, V39, P100, DOI 10.1016/j.tins.2015.12.008; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li G, 2014, NEUROIMAGE, V90, P266, DOI 10.1016/j.neuroimage.2013.12.038; Liu H, 2014, STEM CELLS, V14, P323; Liu Z, 2016, NATURE, V530, P98, DOI 10.1038/nature16533; Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167; Naidu S, 2001, BRAIN DEV-JPN, V23, pS62, DOI 10.1016/S0387-7604(01)00381-3                                                   ; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Noser R, 2003, BEHAV BRAIN RES, V147, P9, DOI 10.1016/S0166-4328(03)00111-6; Patterson KC, 2016, HUM MOL GENET, V25, P3303, DOI 10.1093/hmg/ddw179; Qin DD, 2015, BEHAV BRAIN RES, V278, P280, DOI 10.1016/j.bbr.2014.10.001; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; Rett A, 1966, Wien Med Wochenschr, V116, P723; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Rohlfing T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00027; Schanen NC, 1998, J CHILD NEUROL, V13, P229, DOI 10.1177/088307389801300507                                                      ; Shah RR, 2002, BRIT J CLIN PHARMACO, V54, P188, DOI 10.1046/j.1365-2125.2002.01627.x; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Simpson EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19669; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Subramaniam B, 1997, NEUROLOGY, V48, P399, DOI 10.1212/WNL.48.2.399                                                            ; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Veeraragavan S, 2016, HUM MOL GENET, V25, P3284, DOI 10.1093/hmg/ddw178; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wang L, 2015, NEUROIMAGE, V108, P160, DOI 10.1016/j.neuroimage.2014.12.042; Winslow JT, 2002, BIOL PSYCHIAT, V51, P859, DOI 10.1016/S0006-3223(02)01345-8; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang B, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1128	44	2	2	16	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2017	169	5					945	+		10.1016/j.cell.2017.04.035				21	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV1OM	WOS:000401515900018	28525759	green_accepted			2018-01-05	
J	Satomura, A; Nishioka, R; Mori, H; Sato, K; Kuroda, K; Ueda, M				Satomura, Atsushi; Nishioka, Ryosuke; Mori, Hitoshi; Sato, Kosuke; Kuroda, Kouichi; Ueda, Mitsuyoshi			Precise genome-wide base editing by the CRISPR Nickase system in yeast	SCIENTIFIC REPORTS			English	Article							STRAND BREAK REPAIR; NUCLEOTIDE EXCISION-REPAIR; INDUCED DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; ENDONUCLEASE; SPECIFICITY; GENE; RECONSTRUCTION; GENERATION	The CRISPR/Cas9 system has been applied to efficient genome editing in many eukaryotic cells. However, the bases that can be edited by this system have been limited to those within the protospacer adjacent motif (PAM) and guide RNA-targeting sequences. In this study, we developed a genome-wide base editing technology, "CRISPR Nickase system" that utilizes a single Cas9 nickase. This system was free from the limitation of editable bases that was observed in the CRISPR/Cas9 system, and was able to precisely edit bases up to 53 bp from the nicking site. In addition, this system showed no off-target editing, in contrast to the CRISPR/Cas9 system. Coupling the CRISPR Nickase system with yeast gap repair cloning enabled the construction of yeast mutants within only five days. The CRISPR Nickase system provides a versatile and powerful technology for rapid, site-specific, and precise base editing in yeast.	[Satomura, Atsushi; Nishioka, Ryosuke; Mori, Hitoshi; Sato, Kosuke; Kuroda, Kouichi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Satomura, Atsushi] Japan Soc Promot Sci, Sakyo Ku, Kyoto, Japan	Ueda, M (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [26-1413]; JST-CREST [JPMJCR16G2]	This work was supported by a Grant-in-Aid for JSPS Fellows (No. 26-1413) from Japan Society for the Promotion of Science and, JST-CREST (No. JPMJCR16G2).	AHMAD M, 1986, CURR GENET, V10, P587, DOI 10.1007/BF00418125; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bosco G, 1998, GENETICS, V150, P1037; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; DiCarlo JE, 2013, ACS SYNTH BIOL, V2, P741, DOI 10.1021/sb400117c; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Eckert-Boulet N, 2012, YEAST, V29, P323, DOI 10.1002/yea.2912; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Folch-Mallol JL, 2004, MICROBIOL-SGM, V150, P2865, DOI 10.1099/mic.0.27144-0; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawahata M, 1999, YEAST, V15, P1, DOI 10.1002/(SICI)1097-0061(19990115)15:1<1::AID-YEA335>3.0.CO;2-9; Khan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041778; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SS, 2015, DNA REPAIR, V36, P43, DOI 10.1016/j.dnarep.2015.09.006; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; MANIVASAKAM P, 1995, NUCLEIC ACIDS RES, V23, P2799, DOI 10.1093/nar/23.14.2799; Mapelli V, 2011, METAB ENG, V13, P282, DOI 10.1016/j.ymben.2011.03.001; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Matsui K, 2008, APPL ENVIRON MICROB, V74, P4222, DOI 10.1128/AEM.02874-07; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mott C, 2011, DNA REPAIR, V10, P408, DOI 10.1016/j.dnarep.2011.01.007; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Satomura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23157; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603                                                           ; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Standage-Beier K, 2015, ACS SYNTH BIOL, V4, P1217, DOI 10.1021/acssynbio.5b00132; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Steyer B, 2016, ACTA BIOMATER, V34, P143, DOI 10.1016/j.actbio.2015.12.036; Swanson RL, 1999, MOL CELL BIOL, V19, P2929; Tajima M, 1985, Yeast, V1, P67, DOI 10.1002/yea.320010108; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wera S, 1999, BIOCHEM J, V343, P621, DOI 10.1042/0264-6021:3430621                                                       ; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	52	1	1	52	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2017	7								2095	10.1038/s41598-017-02013-7				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EV1SH	WOS:000401526200034	28522803	gold			2018-01-05	
J	Xu, KL; Jin, L; Xiong, MM				Xu, Kelin; Jin, Li; Xiong, Momiao			Functional regression method for whole genome eQTL epistasis analysis with sequencing data	BMC GENOMICS			English	Article						Gene-gene interaction; Multivariate functional regression; Functional regression models; RNA-seq; Next-generation sequencing; Association studies; eQTL	RNA-SEQ; MESSENGER-RNA; GENES; TRANSCRIPTOME; CHALLENGES; EXPRESSION; EVOLUTION; DISEASE; HUMANS	Background: Epistasis plays an essential rule in understanding the regulation mechanisms and is an essential component of the genetic architecture of the gene expressions. However, interaction analysis of gene expressions remains fundamentally unexplored due to great computational challenges and data availability. Due to variation in splicing, transcription start sites, polyadenylation sites, post-transcriptional RNA editing across the entire gene, and transcription rates of the cells, RNA-seq measurements generate large expression variability and collectively create the observed position level read count curves. A single number for measuring gene expression which is widely used for microarray measured gene expression analysis is highly unlikely to sufficiently account for large expression variation across the gene. Simultaneously analyzing epistatic architecture using the RNA-seq and whole genome sequencing (WGS) data poses enormous challenges. Methods: We develop a nonlinear functional regression model (FRGM) with functional responses where the position-level read counts within a gene are taken as a function of genomic position, and functional predictors where genotype profiles are viewed as a function of genomic position, for epistasis analysis with RNA-seq data. Instead of testing the interaction of all possible pair-wises SNPs, the FRGM takes a gene as a basic unit for epistasis analysis, which tests for the interaction of all possible pairs of genes and use all the information that can be accessed to collectively test interaction between all possible pairs of SNPs within two genome regions. Results: By large-scale simulations, we demonstrate that the proposed FRGM for epistasis analysis can achieve the correct type 1 error and has higher power to detect the interactions between genes than the existing methods. The proposed methods are applied to the RNA-seq and WGS data from the 1000 Genome Project. The numbers of pairs of significantly interacting genes after Bonferroni correction identified using FRGM, RPKM and DESeq were 16,2361, 260 and 51, respectively, from the 350 European samples. Conclusions: The proposed FRGM for epistasis analysis of RNA-seq can capture isoform and position-level information and will have a broad application. Both simulations and real data analysis highlight the potential for the FRGM to be a good choice of the epistatic analysis with sequencing data.	[Xu, Kelin; Jin, Li; Xiong, Momiao] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Xu, Kelin; Jin, Li; Xiong, Momiao] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Minist Educ,Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China; [Xu, Kelin] Fudan Univ, Sch Data Sci, Shanghai 200433, Peoples R China; [Xu, Kelin] Fudan Univ, Inst Big Data, Shanghai 200433, Peoples R China; [Xiong, Momiao] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Dept Biostat, Houston, TX 77030 USA; [Xiong, Momiao] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, POB 20186, Houston, TX 77225 USA	Xiong, MM (reprint author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.; Xiong, MM (reprint author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Minist Educ,Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China.; Xiong, MM (reprint author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Dept Biostat, Houston, TX 77030 USA.; Xiong, MM (reprint author), Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, POB 20186, Houston, TX 77225 USA.	momiao.xiong@uth.tmc.edu	Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Institutes of Health [1R01AR057120-01, 1R01HL106034-01]; NHLBI; National Natural Science Foundation of China [31330038, 31521003]; National Basic Research Program [2014CB541801]; 111 Project [B13016]	Mr. Xiong was supported by Grant 1R01AR057120-01 and 1R01HL106034-01, from the National Institutes of Health and NHLBI. Ms. Xu and Mr. Jin were supported by research grants from the National Natural Science Foundation of China (31330038, 31521003), National Basic Research Program (2014CB541801), and 111 Project (B13016). The funders had no role in the design of the study, data collection, analysis, or manuscript preparation.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Csardi G, 2006, INT J COMPLEX SYST, V1695, P1; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Finotello F, 2015, BRIEF FUNCT GENOMICS, V14, P130, DOI 10.1093/bfgp/elu035; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gosik K, 2017, BRIEF BIOINFORM, V18, P250, DOI 10.1093/bib/bbw014; Graffelman J, 2013, STAT APPL GENET MOL, V12, P433, DOI 10.1515/sagmb-2012-0039; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Huang Yang, 2013, Frontiers in Genetics, V4, P51, DOI 10.3389/fgene.2013.00051; Kang HP, 2012, DIABETOLOGIA, V55, P2205, DOI 10.1007/s00125-012-2568-3; Kang MG, 2015, BIOINFORMATICS, V31, P656, DOI 10.1093/bioinformatics/btu727; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Lee J, 2011, CANCER INFORM, V10, P205, DOI 10.4137/CIN.S7473; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li JJ, 2011, P NATL ACAD SCI USA, V108, P19867, DOI 10.1073/pnas.1113972108; Li QH, 2002, J MOL BIOL, V316, P887, DOI 10.1006/jmbi.2001.5318; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Shang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-475; Sun XQ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00106; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang FT, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005965; Zhang FT, 2014, GENOME RES, V24, P989, DOI 10.1101/gr.161760.113; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	27	0	0	2	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 18	2017	18								385	10.1186/s12864-017-3777-4				19	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EV2IK	WOS:000401578600002	28521784	gold			2018-01-05	
J	Dorighi, KM; Swigut, T; Henriques, T; Bhanu, NV; Scruggs, BS; Nady, N; Still, CD; Garcia, BA; Adelman, K; Wysocka, J				Dorighi, Kristel M.; Swigut, Tomek; Henriques, Telmo; Bhanu, Natarajan V.; Scruggs, Benjamin S.; Nady, Nataliya; Still, Christopher D., II; Garcia, Benjamin A.; Adelman, Karen; Wysocka, Joanna			Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation	MOLECULAR CELL			English	Article							POISED ENHANCERS; FACTOR-BINDING; MASS-SPECTRA; SEQ DATA; CHROMATIN; POLYMERASE; GENOME; DROSOPHILA; TRANSITION; SIGNATURES	Monomethylation of histone H3 at lysine 4 (H3K4me1) and acetylation of histone H3 at lysine 27 (H3K27ac) are correlated with transcriptionally engaged enhancer elements, but the functional impact of these modifications on enhancer activity is not well understood. Here we used CRISPR/Cas9 genome editing to separate catalytic activity-dependent and independent functions of Mll3 (Kmt2c) and Mll4 (Kmt2d, Mll2), the major enhancer H3K4 monomethyltransferases. Loss of H3K4me1 from enhancers in Mll3/4 catalytically deficient cells causes partial reduction of H3K27ac, but has surprisingly minor effects on transcription from either enhancers or promoters. In contrast, loss of Mll3/4 proteins leads to strong depletion of enhancer Pol II occupancy and eRNA synthesis, concomitant with downregulation of target genes. Interestingly, downregulated genes exhibit reduced polymerase levels in gene bodies, but not at promoters, suggestive of pause-releasedefects. Altogether, our results suggest that enhancer H3K4me1 provides only a minor contribution to the long-range coactivator functionof Mll3/4.	[Dorighi, Kristel M.; Swigut, Tomek; Nady, Nataliya; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Henriques, Telmo; Scruggs, Benjamin S.; Adelman, Karen] NIEHS, Epigenet & Stem Cell Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Bhanu, Natarajan V.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Still, Christopher D., II] Stanford Univ, Sch Med, Grad Program Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Henriques, Telmo; Adelman, Karen] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Wysocka, J (reprint author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Wysocka, J (reprint author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.; Wysocka, J (reprint author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	wysocka@stanford.edu		Adelman, Karen/0000-0001-5364-334X	Howard Hughes Medical Institute; NIH [R01 GM112720, GM110174, CA196539]; March of Dimes Foundation [1-FY15-312]; NIGMS IRACDA K12 award; NIH, National Institute of Environmental Health Sciences [Z01 ES101987]; Leukemia and Lymphoma Society Robert Arceci Scholar award	We thank Wysocka lab members for comments on the manuscript. We thank Elijah Montgomery for excellent timing and patience during revision. This research was supported in part by Howard Hughes Medical Institute, NIH R01 GM112720 and March of Dimes Foundation 1-FY15-312 (J.W.), NIGMS IRACDA K12 award to K.M.D., the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences to K.A. (Z01 ES101987), and NIH grants GM110174 and CA196539 and a Leukemia and Lymphoma Society Robert Arceci Scholar award to B.A.G.	Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cruz-Molina S., 2017, CELL STEM CELL; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Henriques T, 2013, MOL CELL, V52, P517, DOI 10.1016/j.molcel.2013.10.001; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hodl M, 2012, CURR BIOL, V22, P2253, DOI 10.1016/j.cub.2012.10.008; Hu DQ, 2017, MOL CELL, V65, P460, DOI 10.1016/j.molcel.2017.01.013; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Jang Y., 2016, J MOL BIOL; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Koenecke N, 2017, GENOME RES, V27, P64, DOI 10.1101/gr.209486.116; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Quinlan AR, 2014, CURR PROTOC BIOINFOR, V47, DOI DOI 10.1002/0471250953.BI1112S47; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sidoli S., 2016, JOVE-J VIS EXP, V17, P2; Sidoli S, 2015, MOL CELL PROTEOMICS, V14, P2420, DOI 10.1074/mcp.O114.046102; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang CC, 2016, P NATL ACAD SCI USA, V113, P11871, DOI 10.1073/pnas.1606857113; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2015, STRUCTURE, V23, P1921, DOI 10.1016/j.str.2015.07.018	48	9	9	5	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	MAY 18	2017	66	4					568	+		10.1016/j.molcel.2017.04.018				13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EV1ND	WOS:000401512200014	28483418				2018-01-05	
J	Tammela, T; Sanchez-Rivera, FJ; Cetinbas, NM; Wu, K; Joshi, NS; Helenius, K; Park, Y; Azimi, R; Kerper, NR; Wesselhoeft, RAL; Gu, X; Schmidt, L; Cornwall-Brady, M; Yilmaz, OH; Xue, W; Katajisto, P; Bhutkar, A; Jacks, T				Tammela, Tuomas; Sanchez-Rivera, Francisco J.; Cetinbas, Naniye Malli; Wu, Katherine; Joshi, Nikhil S.; Helenius, Katja; Park, Yoona; Azimi, Roxana; Kerper, Natanya R.; Wesselhoeft, R. A. Lexander; Gu, Xin; Schmidt, Leah; Cornwall-Brady, Milton; Yilmaz, Omer H.; Xue, Wen; Katajisto, Pekka; Bhutkar, Arjun; Jacks, Tyler			A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma	NATURE			English	Article							BETA-CATENIN; MOUSE LUNG; TRANSCRIPTIONAL ACTIVATION; TUMOR INITIATION; CANCER; CELL; CRISPR-CAS9; GENERATION; COMPLEX; IDENTIFICATION	The heterogeneity of cellular states in cancer has been linked to drug resistance, cancer progression and the presence of cancer cells with properties of normal tissue stem cells(1,2). Secreted Wnt signals maintain stem cells in various epithelial tissues, including in lung development and regeneration(3-5). Here we show that mouse and human lung adenocarcinomas display hierarchical features with two distinct subpopulations, one with high Wnt signalling activity and another forming a niche that provides the Wnt ligand. The Wnt responder cells showed increased tumour propagation ability, suggesting that these cells have features of normal tissue stem cells. Genetic perturbation of Wnt production or signalling suppressed tumour progression. Small-molecule inhibitors targeting essential posttranslational modification of Wnt reduced tumour growth and markedly decreased the proliferative potential of lung cancer cells, leading to improved survival of tumour-bearing mice. These results indicate that strategies for disrupting pathways that maintain stem-like and niche cell phenotypes can translate into effective anti-cancer therapies.	[Tammela, Tuomas; Sanchez-Rivera, Francisco J.; Cetinbas, Naniye Malli; Wu, Katherine; Joshi, Nikhil S.; Helenius, Katja; Park, Yoona; Azimi, Roxana; Kerper, Natanya R.; Wesselhoeft, R. A. Lexander; Gu, Xin; Schmidt, Leah; Cornwall-Brady, Milton; Yilmaz, Omer H.; Xue, Wen; Bhutkar, Arjun; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Xue, Wen] Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Katajisto, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Katajisto, Pekka] Karolinska Inst, Dept Biosci & Nutr, S-14183 Stockholm, Sweden; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Jacks, T (reprint author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.; Jacks, T (reprint author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	tjacks@mit.edu		Sanchez-Rivera, Francisco J./0000-0002-8466-8563	Transcend Program; Janssen Pharmaceuticals; Lung Cancer Research Foundation; Howard Hughes Medical Institute; Cancer Center from the National Cancer Institute [P30-CA14051]; National Cancer Institute [K99 CA187317]; Sigrid Juselius Foundation; Hope Funds for Cancer Research; Maud Kuistila Foundation	We thank D. McFadden and P. Sharp for critical reading of the manuscript and T. Papagiannakopoulos for helpful discussions; H. Clevers for Lgr5<SUP>CreER/+</SUP> mice; Janssen Pharmaceuticals for human tissue; J. Roper for mouse colon adenoma tissue; R. T. Bronson for expertise in animal pathology; Y. Soto-Feliciano and S. Levine for massively parallel sequencing expertise; L. Gilbert, M. Horlbeck and J. Weissman for Lgr5 CRISPR gene activation sgRNA sequences; A. Li for help with generation of TCGA data catalogues; M. Griffin, M. Jennings and G. Paradis for FACS support; E. Vasile for microscopy support; K. Cormier and the Hope Babette Tang (1983) Histology Facility for histology support; S. Bajpay, D. Canner, D. Garcia-Gali, R. Kohn, N. Marjanovich, K. Mercer, J. Replogle and R. Romero for help with experiments; K. Anderson, I. Baptista, A. Deconinck, J. Teixeira and K. Yee for administrative support; and the Swanson Biotechnology Center for excellent core facilities. This work was financially supported by the Transcend Program and Janssen Pharmaceuticals, the Lung Cancer Research Foundation, the Howard Hughes Medical Institute and, in part, by the Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.T. is supported by the National Cancer Institute (K99 CA187317), the Sigrid Juselius Foundation, the Hope Funds for Cancer Research and the Maud Kuistila Foundation. T.J. is a Howard Hughes Medical Institute Investigator, a David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Akama-Garren EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep16836; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Cumming G., 2012, UNDERSTANDING NEW ST; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Ilmer M, 2015, CANCER RES, V75, P1883, DOI 10.1158/0008-5472.CAN-14-1327; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Juan J, 2014, GENE DEV, V28, P561, DOI 10.1101/gad.233627.113; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784                                                   ; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marino S, 2000, GENE DEV, V14, P994; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5                                                    ; Stewart DJ, 2014, JNCI-J NATL CANCER I, P106, DOI DOI 10.1093/JNCI/DJT356; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ603; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yeddula N, 2015, P NATL ACAD SCI USA, V112, pE6476, DOI 10.1073/pnas.1520110112; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhao MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082138; Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	62	8	8	9	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					355	+		10.1038/nature22334				24	Multidisciplinary Sciences	Science & Technology - Other Topics	EV0WF	WOS:000401466500064	28489818				2018-01-05	
J	Xu, YB; Li, P; Zou, C; Lu, YL; Xie, CX; Zhang, XC; Prasanna, BM; Olsen, MS				Xu, Yunbi; Li, Ping; Zou, Cheng; Lu, Yanli; Xie, Chuanxiao; Zhang, Xuecai; Prasanna, Boddupalli M.; Olsen, Michael S.			Enhancing genetic gain in the era of molecular breeding	JOURNAL OF EXPERIMENTAL BOTANY			English	Review						Breeding cycle time; doubled haploids; envirotyping; genetic gain; genetic variation; genotyping; heritability; marker-assisted selection; phenotyping; selection intensity	MARKER-ASSISTED SELECTION; GENOME-WIDE ASSOCIATION; CRISPR-CAS SYSTEM; X ENVIRONMENT INTERACTION; QUANTITATIVE TRAIT LOCI; MAIZE PAN-GENOME; TARGETED MUTAGENESIS; CROP IMPROVEMENT; SEGREGATION DISTORTION; MEIOTIC RECOMBINATION	As one of the important concepts in conventional quantitative genetics and breeding, genetic gain can be defined as the amount of increase in performance that is achieved annually through artificial selection. To develop products that meet the increasing demand of mankind, especially for food and feed, in addition to various industrial uses, breeders are challenged to enhance the potential of genetic gain continuously, at ever higher rates, while they close the gaps that remain between the yield potential in breeders' demonstration trials and the actual yield in farmers' fields. Factors affecting genetic gain include genetic variation available in breeding materials, heritability for traits of interest, selection intensity, and the time required to complete a breeding cycle. Genetic gain can be improved through enhancing the potential and closing the gaps, which has been evolving and complemented with modern breeding techniques and platforms, mainly driven by molecular and genomic tools, combined with improved agronomic practice. Several key strategies are reviewed in this article. Favorable genetic variation can be unlocked and created through molecular and genomic approaches including mutation, gene mapping and discovery, and transgene and genome editing. Estimation of heritability can be improved by refining field experiments through well-controlled and precisely assayed environmental factors or envirotyping, particularly for understanding and controlling spatial heterogeneity at the field level. Selection intensity can be significantly heightened through improvements in the scale and precision of genotyping and phenotyping. The breeding cycle time can be shortened by accelerating breeding procedures through integrated breeding approaches such as marker-assisted selection and doubled haploid development. All the strategies can be integrated with other widely used conventional approaches in breeding programs to enhance genetic gain. More transdisciplinary approaches, team breeding, will be required to address the challenge of maintaining a plentiful and safe food supply for future generations. New opportunities for enhancing genetic gain, a high efficiency breeding pipeline, and broad-sense genetic gain are also discussed prospectively.	[Xu, Yunbi; Zou, Cheng; Xie, Chuanxiao] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Xu, Yunbi; Zhang, Xuecai] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan 56130, Texcoco, Mexico; [Li, Ping] Nantong Xinhe Biotechnol, Nantong 226019, Peoples R China; [Lu, Yanli] Sichuan Agr Univ, Maize Res Inst, Wenjiang 611130, Sichuan, Peoples R China; [Prasanna, Boddupalli M.; Olsen, Michael S.] CIMMYT Int Maize & Wheat Improvement Ctr, ICRAF Campus,UN Ave, Nairobi, Kenya	Xu, YB (reprint author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China.; Xu, YB (reprint author), Int Maize & Wheat Improvement Ctr CIMMYT, El Batan 56130, Texcoco, Mexico.	y.xu@cgiar.org			National Key Research and Development Program of China [2016YFD0101803]; National Key Basic Research Program of China [2014 CB138206]; National Natural Science Foundation of China-CGIAR International Collaborative Program [31361140364]; National Natural Science Foundation of China [31271736]; Ministry of Science and Technology of China [KY201402017]; Agricultural Science and Technology Innovation Program (ASTIP) of CAAS; Bill and Melinda Gates Foundation; CGIAR Research Program MAIZE; Science and Technology Partnership Program	The senior author's research activities were supported by the National Key Research and Development Program of China (2016YFD0101803), the National Key Basic Research Program of China (2014 CB138206), the National Natural Science Foundation of China-CGIAR International Collaborative Program (31361140364), the National Natural Science Foundation of China (31271736), Science and Technology Partnership Program, the Ministry of Science and Technology of China (KY201402017), and the Agricultural Science and Technology Innovation Program (ASTIP) of CAAS. Research activities of CIMMYT staff were supported by the Bill and Melinda Gates Foundation and the CGIAR Research Program MAIZE. We thank CIMMYT colleagues for useful discussion on genetic gain-related issues.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Allwright MR, 2016, TRENDS PLANT SCI, V21, P43, DOI 10.1016/j.tplants.2015.10.002; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anacleto R, 2015, THEOR APPL GENET, V128, P1449, DOI 10.1007/s00122-015-2537-6; Asaro A, 2017, G3-GENES GENOM GENET, V6, P4175; Bassi FM, 2016, PLANT SCI, V242, P23, DOI 10.1016/j.plantsci.2015.08.021; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Bernardo R, 2014, CROP SCI, V54, P68, DOI 10.2135/cropsci2013.05.0315; Betti M, 2016, J EXP BOT, V67, P2977, DOI 10.1093/jxb/erw076; Bevan MW, 2017, NATURE, V543, P346, DOI 10.1038/nature22011; Beyene Y, 2016, EUPHYTICA, V208, P285, DOI 10.1007/s10681-015-1590-1; Beyene Y, 2015, CROP SCI, V55, P154, DOI 10.2135/cropsci2014.07.0460; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Brummer EC, 2011, FRONT ECOL ENVIRON, V9, P561, DOI 10.1890/100225; Buckler ES, 2016, RAMPSEQ REPETITIVE S; Bukowski R., 2015, CONSTRUCTION 3 GENER; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Castillo-Juarez H, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00093; Ceballos H, 2013, CROP SCI, V53, P2342, DOI 10.2135/cropsci2013.02.0123; Chen L, 2014, J INTEGR PLANT BIOL, V56, P425, DOI 10.1111/jipb.12192; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.1365-313X.2003.01999.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper M, 2016, CROP SCI, V56, P2141, DOI 10.2135/cropsci2015.08.0512; Cooper M, 2014, CROP PASTURE SCI, V65, P311, DOI 10.1071/CP14007; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Crossa J, 2013, G3-GENES GENOM GENET, V3, P1903, DOI 10.1534/g3.113.008227; Crossa J, 2012, CURR GENOMICS, V13, P225, DOI 10.2174/138920212800543066; Daetwyler HD, 2015, GENETICS, V200, P1341, DOI 10.1534/genetics.115.178038; De La Fuente GN, 2013, TRENDS PLANT SCI, V18, P667, DOI 10.1016/j.tplants.2013.09.001; DOEBLEY J, 1995, GENETICS, V141, P333; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dong X, 2014, MOL BREEDING, V34, P1147, DOI 10.1007/s11032-014-0106-3; Dreisigacker S, 2016, SUSTAIN DEV BIODIVER, V11, P421, DOI 10.1007/978-3-319-27090-6_16; Duangjit J, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0453-3; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Dwivedi SL, 2016, TRENDS PLANT SCI, V21, P31, DOI 10.1016/j.tplants.2015.10.012; Eathington SR, 2007, CROP SCI, V47, pS154, DOI 10.2135/cropsci2007.04.0015IPBS; Ghanem ME, 2015, TRENDS PLANT SCI, V20, P139, DOI 10.1016/j.tplants.2014.11.006; El-Soda M, 2014, TRENDS PLANT SCI, V19, P390, DOI 10.1016/j.tplants.2014.01.001; Endelman JB, 2014, CROP SCI, V54, P48, DOI 10.2135/cropsci2013.03.0154; Fahlgren N, 2015, CURR OPIN PLANT BIOL, V24, P93, DOI 10.1016/j.pbi.2015.02.006; FALCONER DS, 1996, INTRO QUANTITATIVE G; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Food and Agricultural Organization (FAO), 2011, STAT WORLDS LAND WAT; Farkhari M, 2011, PLANT BREEDING, V130, P533, DOI 10.1111/j.1439-0523.2011.01866.x; Fermont AM, 2009, FIELD CROP RES, V112, P24, DOI 10.1016/j.fcr.2009.01.009; Fischer RAT, 2010, CROP SCI, V50, pS85, DOI 10.2135/cropsci2009.10.0564; Fischer T, 2014, ACIAR MONOGR SER, V158, P1; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gao SB, 2008, MOL BREEDING, V22, P477, DOI 10.1007/s11032-008-9192-4; Gauffier C, 2016, PLANT J, V85, P717, DOI 10.1111/tpj.13136; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Golicz AA, 2016, PLANT BIOTECHNOL J, V14, P1099, DOI 10.1111/pbi.12499; Gomez K.A., 1977, CONSTRAINTS HIGH YIE, P1; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gowda M, 2015, THEOR APPL GENET, V128, P1957, DOI 10.1007/s00122-015-2559-0; Greene EA, 2003, GENETICS, V164, P731; Habyarimana E., 2016, Australian Journal of Crop Science, V10, P127; Hall AJ, 2013, FIELD CROP RES, V143, P18, DOI 10.1016/j.fcr.2012.05.014; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Hasegawa Y, 2009, NEW PHYTOL, V182, P994, DOI 10.1111/j.1469-8137.2009.02806.x; He S, 2016, THEOR APPL GENET, V129, P641, DOI 10.1007/s00122-015-2655-1; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Henderson IR, 2012, CURR OPIN PLANT BIOL, V15, P556, DOI 10.1016/j.pbi.2012.09.002; Henry RJ, 2016, CURR OPIN PLANT BIOL, V30, P11, DOI 10.1016/j.pbi.2015.12.008; Heslot N, 2015, CROP SCI, V55, P1, DOI 10.2135/cropsci2014.03.0249; Hirsch CN, 2014, GENETICS, V198, P409, DOI 10.1534/genetics.114.167155; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jacobson A, 2014, CROP SCI, V54, P895, DOI 10.2135/cropsci2013.11.0774; JAMES J. W., 1958, JOUR GENETICS, V56, P55, DOI 10.1007/BF02984720; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Jia YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095882; Jiang Y, 2015, GENETICS, V201, P759, DOI 10.1534/genetics.115.177907; Jin ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep18936; Johnson T, 2005, PHILOS T ROY SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Jonas E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00049; Kainer D, 2015, THEOR APPL GENET, V128, P2351, DOI 10.1007/s00122-015-2591-0; Kelliher T, 2017, NATURE, V542, P105, DOI 10.1038/nature20827; Kitney R, 2012, FEBS LETT, V586, P2029, DOI 10.1016/j.febslet.2012.06.002; Klukas C, 2014, PLANT PHYSIOL, V165, P506, DOI 10.1104/pp.113.233932; Knol E. F., 2016, Animal Frontiers, V6, P15, DOI 10.2527/af.2016-0003; Koning NBJ, 2008, NJAS-WAGEN J LIFE SC, V55, P229, DOI 10.1016/S1573-5214(08)80001-2                                                   ; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Kumar APK, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0620-1; Kumar V, 2016, PLANT BIOTECHNOL J, V14, P1673, DOI 10.1111/pbi.12528; Laborte AG, 2012, EUR J AGRON, V36, P9, DOI 10.1016/j.eja.2011.08.005; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lakew B, 2013, EUPHYTICA, V191, P231, DOI 10.1007/s10681-012-0795-9; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Laviola BG, 2013, IND CROP PROD, V51, P70, DOI 10.1016/j.indcrop.2013.08.016; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Li ZT, 2015, TRENDS PLANT SCI, V20, P822, DOI 10.1016/j.tplants.2015.08.012; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-250; Liu CX, 2017, MOL PLANT, V10, P520, DOI 10.1016/j.molp.2017.01.011; Liu HM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0101-0; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Lu C, 1996, THEOR APPL GENET, V93, P1211, DOI 10.1007/BF00223452; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7914; Lu J, 2015, GENES GENOM, V37, P503; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malosetti M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00044; Massman JM, 2013, CROP SCI, V53, P58, DOI 10.2135/cropsci2012.02.0112; Masuka B, 2012, J INTEGR PLANT BIOL, V54, P238, DOI 10.1111/j.1744-7909.2012.01118.x; McNally K, 2014, 4 INT WORKSH NEXT GE; Melamed-Bessudo C, 2016, CURR OPIN PLANT BIOL, V30, P82, DOI 10.1016/j.pbi.2016.02.003; Melchinger AE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02129; Meuwissen T., 2016, Animal Frontiers, V6, P6, DOI 10.2527/af.2016-0002; Meuwissen T, 2003, MARKER ASSISTED SELE, P54; Meuwissen THE, 2001, GENETICS, V157, P1819; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Myrold DD, 2014, SOIL SCI SOC AM J, V78, P3, DOI 10.2136/sssaj2013.07.0287dgs; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Oakey H, 2016, G3-GENES GENOM GENET, V6, P1313, DOI 10.1534/g3.116.027524; Odegard J, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-3; Oury FX, 2012, EUR J AGRON, V40, P28, DOI 10.1016/j.eja.2012.02.007; Ow DW, 2016, PLANT BIOTECHNOL J, V14, P441, DOI 10.1111/pbi.12472; Palmer CED, 2005, BIOTECHNOL AGRIC FOR, V56, P3; Pardey PG, 2014, AUST J AGR RESOUR EC, V58, P571, DOI 10.1111/1467-8489.12072; Petolino JF, 2016, PLANT BIOTECHNOL J, V14, P435, DOI 10.1111/pbi.12542; Petolino JF, 2016, PLANT BIOTECHNOL J, V14, P503, DOI 10.1111/pbi.12457; Podlich DW, 2004, CROP SCI, V44, P1560, DOI 10.2135/cropsci2004.1560                                                        ; Poland J, 2016, ANNU REV PHYTOPATHOL, V54, P79, DOI 10.1146/annurev-phyto-080615-100056; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Prasanna BM, 2016, SUSTAIN DEV BIODIVER, V11, P61, DOI 10.1007/978-3-319-27090-6_3; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Rawat N, 2016, NAT GENET, V48, P1576, DOI 10.1038/ng.3706; Rebetzke GJ, 2013, FUNCT PLANT BIOL, V40, P1, DOI 10.1071/FP12180; Renaut S, 2015, MOL BIOL EVOL, V32, P2273, DOI 10.1093/molbev/msv106; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Reynolds MP, 2012, PHYSL BREEDING; Robbins K, 2016, PLANT ANIM GEN C 24, pW440; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Ronceret A, 2009, P NATL ACAD SCI USA, V106, P20121, DOI 10.1073/pnas.0906273106; Ruiter R., 2017, PLANT AN GEN C 25, pW697; Rupp R., 2016, Animal Frontiers, V6, P39, DOI 10.2527/af.2016-0006; Rutkoski J., 2016, AAAS 2016 ANN M FEB; Rutkoski JE, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.02.0006; Rutkoski JE, 2011, EUPHYTICA, V179, P161, DOI 10.1007/s10681-010-0301-1; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Saidou AA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-3; Sallam AH, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.05.0020; Salvi S, 2005, TRENDS PLANT SCI, V10, P297, DOI 10.1016/j.tplants.2005.04.008; Salvi S, 2007, GENOMICS ASSISTED CR, P207; Salvi S, 2015, CURR OPIN BIOTECH, V32, P179, DOI 10.1016/j.copbio.2015.01.001; Samayoa LF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0403-3; Sauer NJ, 2016, PLANT BIOTECHNOL J, V14, P496, DOI 10.1111/pbi.12496; Schatz MC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0506-z; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Schopp P, 2015, THEOR APPL GENET, V128, P2189, DOI 10.1007/s00122-015-2577-y; Semagn K, 2015, CROP SCI, V55, P1449, DOI 10.2135/cropsci2014.09.0646; Servin B, 2004, GENETICS, V168, P513, DOI 10.1534/genetics.103.023358; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shen X, 2015, THEOR APPL GENET, V128, P623, DOI 10.1007/s00122-015-2458-4; Sikora P., 2011, International Journal of Plant Genomics, V2011, P314829, DOI 10.1155/2011/314829; Singh A, 2016, TRENDS PLANT SCI, V21, P110, DOI 10.1016/j.tplants.2015.10.015; Snowdon RJ, 2015, TRENDS PLANT SCI, V20, P410, DOI 10.1016/j.tplants.2015.04.013; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Srivastava V, 2016, PLANT BIOTECHNOL J, V14, P471, DOI 10.1111/pbi.12459; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley S. D., 1989, NAT BIOTECHNOL, V7, P257, DOI DOI 10.1038/NBT0389-257; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Technow F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130855; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; TILL BJ, 2007, GENOMICS ASSISTED CR, V1, P333; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Uauy C, 2013, PLANT AN GEN 21 C; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; USDA-National Agricultural Statistics Service, 2013, FIELD CROPS STAT; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; Varshney RK, 2016, TRENDS PLANT SCI, V21, P354, DOI 10.1016/j.tplants.2015.10.018; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Vivek BS, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.07.0070; Voss-Fels K, 2016, PLANT BIOTECHNOL J, V14, P1086, DOI 10.1111/pbi.12456; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Warr A, 2015, G3-GENES GENOM GENET, V5, P1543, DOI 10.1534/g3.115.018564; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Weil CF, 2009, PLANT PHYSIOL, V149, P158, DOI 10.1104/pp.108.128785; Wenzel P, 2014, 4 INT WORKSH NEXT GE; Whelan B, 2013, PRECISION AGRICULTURE FOR GRAIN PRODUCTION SYSTEMS, P1; Wilde H. D., 2012, Emirates Journal of Food and Agriculture, V24, P31; Windhausen VS, 2012, G3-GENES GENOM GENET, V2, P1427, DOI 10.1534/g3.112.003699; Wong CK, 2008, THEOR APPL GENET, V116, P815, DOI 10.1007/s00122-008-0715-5; Woolliams JA, 2015, J ANIM BREED GENET, V132, P89, DOI 10.1111/jbg.12148; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355                                                           ; Xu Y, 2010, MOLECULAR PLANT BREEDING, P1, DOI 10.1079/9781845933920.0000; Xu Y., 2012, MARKER ASSISTED SELE; Xu Y., 2014, 4 INT WORKSH NEXT GE; Xu Y., 2013, CEREAL GENOMICS, P375; Xu Y., 2011, 1 C CER BIOT BREED M; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Xu YB, 2016, THEOR APPL GENET, V129, P653, DOI 10.1007/s00122-016-2691-5; Xu YB, 2012, MOL BREEDING, V29, P833, DOI 10.1007/s11032-012-9699-6; Yang JL, 2015, PLANT J, V84, P587, DOI 10.1111/tpj.13029; Yang SS, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.2; Yin Y, 2016, ANIMAL FRONTIERS, V6, P65; Yu XQ, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.150, 10.1038/NPLANTS.2016.150]; Zeng DL, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.31; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang JP, 2016, THEOR APPL GENET, V129, P117, DOI 10.1007/s00122-015-2614-x; Zhang X, 2015, HEREDITY, V114, P291, DOI 10.1038/hdy.2014.99; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; ZIVY M, 1992, THEOR APPL GENET, V83, P919, DOI 10.1007/BF00226716; Zou C, 2016, PLANT BIOTECHNOL J, V14, P1941, DOI 10.1111/pbi.12559; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	239	2	2	50	50	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAY 17	2017	68	11					2641	2666		10.1093/jxb/erx135				26	Plant Sciences	Plant Sciences	FA6UF	WOS:000405579100003	28830098				2018-01-05	
J	Petersen, G; Cuenca, A; Zervas, A; Ross, GT; Graham, SW; Barrett, CF; Davis, JI; Seberg, O				Petersen, Gitte; Cuenca, Argelia; Zervas, Athanasios; Ross, Gregory T.; Graham, Sean W.; Barrett, Craig F.; Davis, Jerrold I.; Seberg, Ole			Mitochondrial genome evolution in Alismatales: Size reduction and extensive loss of ribosomal protein genes	PLOS ONE			English	Article							PLANT-MITOCHONDRIA; REPAIR MECHANISMS; TRANSFER-RNAS; WEB SERVERS; NUCLEUS; GENERATION; SEQUENCES; RATES; RECOMBINATION; ANGIOSPERMS	The order Alismatales is a hotspot for evolution of plant mitochondrial genomes characterized by remarkable differences in genome size, substitution rates, RNA editing, retrotranscription, gene loss and intron loss. Here we have sequenced the complete mitogenomes of Zostera marina and Stratiotes aloides, which together with previously sequenced mitogenomes from Butomus and Spirodela, provide new evolutionary evidence of genome size reduction, gene loss and transfer to the nucleus. The Zostera mitogenome includes a large portion of DNA transferred from the plastome, yet it is the smallest known mitogenome from a non-parasitic plant. Using a broad sample of the Alismatales, the evolutionary history of ribosomal protein gene loss is analyzed. In Zostera almost all ribosomal protein genes are lost from the mitogenome, but only some can be found in the nucleus.	[Petersen, Gitte; Cuenca, Argelia; Zervas, Athanasios; Seberg, Ole] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Ross, Gregory T.; Graham, Sean W.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Ross, Gregory T.; Graham, Sean W.] Univ British Columbia, UBC Bot Garden, Vancouver, BC, Canada; [Ross, Gregory T.; Graham, Sean W.] Univ British Columbia, Ctr Plant Res, Vancouver, BC, Canada; [Barrett, Craig F.; Davis, Jerrold I.] Cornell Univ, LH Bailey Hortorium & Plant Biol Sect, Ithaca, NY USA; [Cuenca, Argelia] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Barrett, Craig F.] West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	Petersen, G (reprint author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark.	gittep@snm.ku.dk	Graham, Sean/L-3944-2014; Petersen, Gitte/H-1903-2011	Graham, Sean/0000-0001-8209-5231; Petersen, Gitte/0000-0002-2325-0059	Danish Council for Independent Research \ Natural Sciences [12-126713]; NSERC (Natural Sciences and Engineering Research Council of Canada); US National Science Foundation [DEB 0830036, DEB 0830020]	This work was funded by the Danish Council for Independent Research vertical bar Natural Sciences (grant no. 12-126713 to OS and GP), NSERC (Natural Sciences and Engineering Research Council of Canada) Discovery Grant to SWG, and US National Science Foundation (grants DEB 0830036 to SWG and DEB 0830020 to JID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Adams KL, 2001, MOL BIOL EVOL, V18, P2289, DOI 10.1093/oxfordjournals.molbev.a003775                                           ; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Christensen AC, 2014, GENOME BIOL EVOL, V6, P1448, DOI 10.1093/gbe/evu115; Christensen AC, 2013, GENOME BIOL EVOL, V5, P1079, DOI 10.1093/gbe/evt069; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cuenca A, 2016, GENOME BIOL EVOL, V8, P2176, DOI 10.1093/gbe/evw148; Cuenca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061552; Cuenca A, 2012, J MOL EVOL, V74, P158, DOI 10.1007/s00239-012-9496-1; Cuenca A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-349; Doyle JJ, 1987, PHYTOCHEMISTRY B, V19, P11; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Grewe F, 2014, MITOCHONDRION, V19, P135, DOI 10.1016/j.mito.2014.05.008; Guo WH, 2016, MOL BIOL EVOL, V33, P1448, DOI 10.1093/molbev/msw024; Guo WH, 2013, J MOL EVOL, V77, P43, DOI 10.1007/s00239-013-9579-7; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Iorizzo M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-61; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Knoop V, 2012, GENOMICS CHLOROPLAST, P175, DOI DOI 10.1007/978-94-007-2920-9_; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Liu SL, 2009, MOL BIOL EVOL, V26, P875, DOI 10.1093/molbev/msp011; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; MARECHALDROUARD L, 1988, NUCLEIC ACIDS RES, V16, P4777, DOI 10.1093/nar/16.11.4777; Mower JP, 2012, GENOME BIOL EVOL, V4, P670, DOI 10.1093/gbe/evs042; Mower JP, 2012, PLANT GENOME DIVERSI, V1, P123, DOI DOI 10.1007/978-3-7091-1130-7_; Olsen JL, 2016, NATURE, V530, P331, DOI 10.1038/nature16548; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Park S, 2015, NEW PHYTOL, V208, P570, DOI 10.1111/nph.13467; Park S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-405; Petersen G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17588; Petersen G, 2006, TAXON, V55, P871, DOI 10.2307/25065682                                                                ; Petersen G, 2016, CLADISTICS, V32, P141, DOI 10.1111/cla.12120; Qiu YL, 2004, J MOL EVOL, V59, P722, DOI 10.1007/s00239-004-5951-y; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Ross TG, 2016, CLADISTICS, V32, P160, DOI 10.1111/cla.12133; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Skippington E, 2015, P NATL ACAD SCI USA, V112, pE3515, DOI 10.1073/pnas.1504491112; Sloan DB, 2014, GENOME BIOL EVOL, V6, P3210, DOI 10.1093/gbe/evu253; Sloan DB, 2013, NEW PHYTOL, V200, P978, DOI 10.1111/nph.12395; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tang MY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1988-0; Wang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046747; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029774; Zhu AD, 2014, MOL BIOL EVOL, V31, P1228, DOI 10.1093/molbev/msu079	59	0	0	9	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177606	10.1371/journal.pone.0177606				21	Multidisciplinary Sciences	Science & Technology - Other Topics	EV1DX	WOS:000401487700057	28545148	gold			2018-01-05	
J	Mirra, A; Rossi, S; Scaricamazza, S; Di Salvio, M; Salvatori, I; Valle, C; Rusmini, P; Poletti, A; Cestra, G; Carri, MT; Cozzolino, M				Mirra, Alessia; Rossi, Simona; Scaricamazza, Silvia; Di Salvio, Michela; Salvatori, Illari; Valle, Cristiana; Rusmini, Paola; Poletti, Angelo; Cestra, Gianluca; Carri, Maria Teresa; Cozzolino, Mauro			Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice	SCIENTIFIC REPORTS			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; ALS-ASSOCIATED MUTATIONS; EDITING ENZYME ADAR2; SPLICEOSOMAL SNRNPS; TOXIC GAIN; SURVIVAL; MODEL; DEFECTS	Several of the identified genetic factors in Amyotrophic Lateral Sclerosis (ALS) point to dysfunction in RNA processing as a major pathogenic mechanism. However, whether a precise RNA pathway is particularly affected remains unknown. Evidence suggests that FUS, that is mutated in familial ALS, and SMN, the causative factor in Spinal Muscular Atrophy (SMA), cooperate to the same molecular pathway, i.e. regulation of alternative splicing, and that disturbances in SMN-regulated functions, either caused by depletion of SMN protein (as in the case of SMA) or by pathogenic interactions between FUS and SMN (as in the case of ALS) might be a common theme in both diseases. In this work, we followed these leads and tested their pathogenic relevance in vivo. FUS-associated ALS recapitulates, in transgenic mice, crucial molecular features that characterise mouse models of SMA, including defects in snRNPs distribution and in the alternative splicing of genes important for motor neurons. Notably, altering SMN levels by haploinsufficiency or overexpression does not impact the phenotypes of mouse or Drosophila models of FUS-mediated toxicity. Overall, these findings suggest that FUS and SMN functionally interact and that FUS may act downstream of SMN-regulated snRNP assembly in the regulation of alternative splicing and gene expression.	[Mirra, Alessia; Scaricamazza, Silvia; Salvatori, Illari; Valle, Cristiana; Carri, Maria Teresa] IRCCS, Fdn Santa Lucia, I-00143 Rome, Italy; [Mirra, Alessia; Scaricamazza, Silvia; Carri, Maria Teresa] Univ Roma Tor Vergata, Dipartimento Biol, Rome, Italy; [Rossi, Simona; Cozzolino, Mauro] CNR, Ist Farmacol Traslaz IFT, I-00133 Rome, Italy; [Di Salvio, Michela; Cestra, Gianluca] CNR, IBPM, I-00185 Rome, Italy; [Di Salvio, Michela; Cestra, Gianluca] Univ Roma Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Valle, Cristiana] CNR, Ist Biol Cellulare & Neurobiol IBCN, I-00143 Rome, Italy; [Rusmini, Paola; Poletti, Angelo] Univ Milan, Ctr Eccellenza Malattie Neurodegenerat, Dipartimento Sci Farmacol & Biomol DiSFeB, I-20133 Milan, Italy	Cozzolino, M (reprint author), CNR, Ist Farmacol Traslaz IFT, I-00133 Rome, Italy.	mauro.cozzolino@ift.cnr.it	Poletti, Angelo/A-9016-2011	Poletti, Angelo/0000-0002-8883-0468; Carri, Maria Teresa/0000-0002-1789-1546	ARiSLA Foundation; Fondazione Umberto Veronesi; Ministero dell'Economia, FaReBio di Qualita; Ministero degli Affari Esteri e della Cooperazione, CHEMCHAP; Ministero dell'Istruzione, Universita e Ricerca	This project was funded by ARiSLA Foundation, project "FUSMALS" to M.C. S.R. is recipient of a fellowship from Fondazione Umberto Veronesi. The following grants are gratefully acknowledged: Ministero dell'Economia, FaReBio di Qualita (G.C.); Ministero degli Affari Esteri e della Cooperazione, CHEMCHAP (G.C.); Ministero dell'Istruzione, Universita e Ricerca, PRIN 2015LFPNMN (M.C, M.T.C and A.P). We are extremely grateful to Tilmann Achsel and Valeria Gerbino for inspiring scientific discussions and advice, to Maurizio Guasconi for technical help, and to Maria Teresa Viscomi who provided key expertise with histochemistry analysis.	Achsel T, 2013, BIOCHEM SOC T, V41, P1593, DOI 10.1042/BST20130142; Aizawa H, 2016, J CLIN NEUROSCI, V32, P128, DOI [10.1016/j.jocn.2015.12.033, 10.1016/j.jocn.2015.12.039]; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Brahms H, 1997, ARTHRITIS RHEUM, V40, P672, DOI 10.1002/art.1780400412                                                          ; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Di Salvio M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.295; Doktor TK, 2017, NUCLEIC ACIDS RES, V45, P395, DOI 10.1093/nar/gkw731; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gerbino V, 2013, NEUROBIOL DIS, V55, P120, DOI 10.1016/j.nbd.2013.03.003; Groen EJN, 2013, HUM MOL GENET, V22, P3690, DOI 10.1093/hmg/ddt222; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Huo Q, 2014, RNA BIOL, V11, P1430, DOI 10.1080/15476286.2014.996494; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Kariya S, 2012, HUM MOL GENET, V21, P3421, DOI 10.1093/hmg/dds174; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Mihevc S. Prpar, 2016, BRAIN J NEUROL, DOI [10.1093/brain/aww197, DOI 10.1093/BRAIN/AWW197]; Mitchell JC, 2013, ACTA NEUROPATHOL, V125, P273, DOI 10.1007/s00401-012-1043-z; Nolan M, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0358-8; Pesaresi MG, 2011, HUM MOL GENET, V20, P4196, DOI 10.1093/hmg/ddr347; Reber S, 2016, EMBO J, V35, P1504, DOI 10.15252/embj.201593791; Rossi S, 2016, BRAIN PATHOL, V26, P276, DOI 10.1111/bpa.12355; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Scekic-Zahirovic J, 2016, EMBO J, V35, P1077, DOI 10.15252/embj.201592559; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sharma A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10465; Sleigh JN, 2014, HUM MOL GENET, V23, P855, DOI 10.1093/hmg/ddt477; Sun SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7171; Turner BJ, 2014, NEUROBIOL AGING, V35, P906, DOI 10.1016/j.neurobiolaging.2013.09.030; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Yu Y, 2015, NUCLEIC ACIDS RES, V43, P3208, DOI 10.1093/nar/gkv157; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110	36	1	1	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 17	2017	7								2033	10.1038/s41598-017-02195-0				14	Multidisciplinary Sciences	Science & Technology - Other Topics	EV1MS	WOS:000401511100040	28515487	gold			2018-01-05	
J	Sugimoto, K; Hui, SP; Sheng, DZ; Kikuchi, K				Sugimoto, Kotaro; Hui, Subhra P.; Sheng, Delicia Z.; Kikuchi, Kazu			Dissection of zebrafish shha function using site-specific targeting with a Cre-dependent genetic switch	ELIFE			English	Article							RETINOIC ACID; IN-VIVO; HOMOLOGOUS RECOMBINATION; HEART REGENERATION; CRISPR/CAS9 SYSTEM; SONIC-HEDGEHOG; KNOCK-IN; GENOME; EFFICIENT; MOUSE	Despite the extensive use of zebrafish as a model organism in developmental biology and regeneration research, genetic techniques enabling conditional analysis of gene function are limited. In this study, we generated Zwitch, a Cre-dependent invertible gene-trap cassette, enabling the establishment of conditional alleles in zebrafish by generating intronic insertions via in vivo homologous recombination. To demonstrate the utility of Zwitch, we generated a conditional sonic hedgehog a (shha) allele. Homozygous shha mutants developed normally; however, shha mutant embryos globally expressing Cre exhibited strong reductions in endogenous shha and shha target gene mRNA levels and developmental defects associated with null shha mutations. Analyzing a conditional shha mutant generated using an epicardium-specific inducible Cre driver revealed unique roles for epicardium-derived Shha in myocardial proliferation during heart development and regeneration. Zwitch will extend the utility of zebrafish in organ development and regeneration research and might be applicable to other model organisms.	[Sugimoto, Kotaro; Hui, Subhra P.; Sheng, Delicia Z.; Kikuchi, Kazu] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Darlinghurst, NSW, Australia; [Kikuchi, Kazu] Univ New South Wales, St Vincents Clin Sch, Kensington, NSW, Australia	Kikuchi, K (reprint author), Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Darlinghurst, NSW, Australia.; Kikuchi, K (reprint author), Univ New South Wales, St Vincents Clin Sch, Kensington, NSW, Australia.	k.kikuchi@victorchang.edu.au		Sugimoto, Kotaro/0000-0002-5299-7610	National Health and Medical Research Council [APP1032522]; Australian Research Council [APP1046469]; Japan Society for the Promotion of Science	National Health and Medical Research Council APP1032522 Kazu Kikuchi; Australian Research Council APP1046469 Kazu Kikuchi; Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad Kotaro Sugimoto	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Begemann G, 2001, DEVELOPMENT, V128, P3081; Brade T, 2011, DEVELOPMENT, V138, P139, DOI 10.1242/dev.054239; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Burns CG, 2006, BIOTECHNIQUES, V40, P274, DOI 10.2141/000112135; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cermak T, 2011, NUCLEIC ACIDS RES, V39, P7879, DOI 10.1093/nar/gkr739; Choi WY, 2013, DEVELOPMENT, V140, P660, DOI 10.1242/dev.088526; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Gupta V, 2013, CURR BIOL, V23, P1221, DOI 10.1016/j.cub.2013.05.028; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Jungke P, 2016, GENESIS, V54, P19, DOI 10.1002/dvg.22909; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; KOLLER BH, 1992, ANNU REV IMMUNOL, V10, P705, DOI 10.1146/annurev.iy.10.040192.003421; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Graham M, 2011, GENE DEV, V25, P2306, DOI [10.1101/gad.174037.111, DOI 10.1101/GAD.174037.111]; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lobe CG, 1998, BIOESSAYS, V20, P200, DOI 10.1002/(SICI)1521-1878(199803)20:3<200::AID-BIES3>3.0.CO;2-V; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Ni TT, 2012, P NATL ACAD SCI USA, V109, P15389, DOI 10.1073/pnas.1206131109; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Plavicki JS, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-18; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rossant J, 1999, GENE DEV, V13, P142, DOI 10.1101/gad.13.2.142                                                            ; Rudat C, 2013, CARDIOVASC RES, V100, P411, DOI 10.1093/cvr/cvt210; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schnutgen F, 2007, TRANSGENIC RES, V16, P405, DOI 10.1007/s11248-007-9089-8; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Serluca FC, 2008, DEV BIOL, V315, P18, DOI 10.1016/j.ydbio.2007.10.007; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; SUCOV HM, 1995, MOL NEUROBIOL, V10, P169, DOI 10.1007/BF02740674                                                              ; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Thomas KR, 1987, CELL, V51, P503, DOI [10.1016/0092-8674(87)90646-5, DOI 10.1016/0092-8674(87)90646-5]; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JH, 2015, NATURE, V522, P226, DOI 10.1038/nature14325; Wang YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16273; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	55	0	0	2	6	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAY 17	2017	6								e24635	10.7554/eLife.24635				20	Biology	Life Sciences & Biomedicine - Other Topics	EV0DU	WOS:000401409400001		gold			2018-01-05	
J	Quadros, RM; Miura, H; Harms, DW; Akatsuka, H; Sato, T; Aida, T; Redder, R; Richardson, GP; Inagaki, Y; Sakai, D; Buckley, SM; Seshacharyulu, P; Batra, SK; Behlke, MA; Zeiner, SA; Jacobi, AM; Izu, Y; Thoreson, WB; Urness, LD; Mansour, SL; Ohtsuka, M; Gurumurthy, CB				Quadros, Rolen M.; Miura, Hiromi; Harms, Donald W.; Akatsuka, Hisako; Sato, Takehito; Aida, Tomomi; Redder, Ronald; Richardson, Guy P.; Inagaki, Yutaka; Sakai, Daisuke; Buckley, Shannon M.; Seshacharyulu, Parthasarathy; Batra, Surinder K.; Behlke, Mark A.; Zeiner, Sarah A.; Jacobi, Ashley M.; Izu, Yayoi; Thoreson, Wallace B.; Urness, Lisa D.; Mansour, Suzanne L.; Ohtsuka, Masato; Gurumurthy, Channabasavaiah B.			Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins	GENOME BIOLOGY			English	Article						CRISPR/Cas9; Homology directed repair; Easi-CRISPR; long ssDNA donors; CRISPR ribonucleoproteins; Cre-LoxP; Conditional knockout; Reporter and recombinase knock-in	DOUBLE-STRAND BREAK; CELL-CYCLE; DNA; KNOCKOUT; EFFICIENCY; ZYGOTES; SYSTEM; REPAIR; ELECTROPORATION; RECOMBINATION	Background: Conditional knockout mice and transgenic mice expressing recombinases, reporters, and inducible transcriptional activators are key for many genetic studies and comprise over 90% of mouse models created. Conditional knockout mice are generated using labor-intensive methods of homologous recombination in embryonic stem cells and are available for only similar to 25% of all mouse genes. Transgenic mice generated by random genomic insertion approaches pose problems of unreliable expression, and thus there is a need for targeted-insertion models. Although CRISPR-based strategies were reported to create conditional and targeted-insertion alleles via one-step delivery of targeting components directly to zygotes, these strategies are quite inefficient. Results: Here we describe Easi-CRISPR (Efficient additions with ssDNA inserts-CRISPR), a targeting strategy in which long single-stranded DNA donors are injected with pre-assembled crRNA + tracrRNA + Cas9 ribonucleoprotein (ctRNP) complexes into mouse zygotes. We show for over a dozen loci that Easi-CRISPR generates correctly targeted conditional and insertion alleles in 8.5-100% of the resulting live offspring. Conclusions: Easi-CRISPR solves the major problem of animal genome engineering, namely the inefficiency of targeted DNA cassette insertion. The approach is robust, succeeding for all tested loci. It is versatile, generating both conditional and targeted insertion alleles. Finally, it is highly efficient, as treating an average of only 50 zygotes is sufficient to produce a correctly targeted allele in up to 100% of live offspring. Thus, Easi-CRISPR offers a comprehensive means of building large-scale Cre-LoxP animal resources.	[Quadros, Rolen M.; Harms, Donald W.; Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Mouse Genome Engn Core Facil, Res Off, Omaha, NE 68198 USA; [Miura, Hiromi; Akatsuka, Hisako; Ohtsuka, Masato] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Miura, Hiromi; Inagaki, Yutaka; Ohtsuka, Masato] Tokai Univ, Ctr Matrix Biol & Med, Grad Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Akatsuka, Hisako; Sato, Takehito] Tokai Univ, Sch Med, Dept Host Def Mech, Div Basic Med Sci & Mol Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Aida, Tomomi] TMDU, Lab Mol Neurosci, MRI, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan; [Aida, Tomomi] TMDU, MRI, Lab Recombinant Anim, Chiyoda Ku, 2-3-10,2-3-10 Surugadai, Tokyo 1010062, Japan; [Aida, Tomomi] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Redder, Ronald] Univ Nebraska Med Ctr, High Throughput DNA Sequencing & Genotyping Core, Res Off, Omaha, NE USA; [Richardson, Guy P.] Univ Sussex, Sussex Neurosci, Brighton BN1 9QG, E Sussex, England; [Inagaki, Yutaka; Sakai, Daisuke; Ohtsuka, Masato] Tokai Univ, Inst Med Sci, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Inagaki, Yutaka] Tokai Univ, Dept Regenerat Med, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Sakai, Daisuke] Tokai Univ, Sch Med, Dept Orthopaed Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Buckley, Shannon M.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE USA; [Seshacharyulu, Parthasarathy; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Buckley, Shannon M.; Batra, Surinder K.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Behlke, Mark A.; Zeiner, Sarah A.; Jacobi, Ashley M.] Integrated DNA Technol Inc, Coralville, IA 52241 USA; [Izu, Yayoi] Chiba Inst Sci, Dept Anim Risk Management, 3 Shiomi Cho, Choshi, Chiba 2880025, Japan; [Thoreson, Wallace B.] Univ Nebraska Med Ctr, Truhlsen Eye Inst, Omaha, NE 68198 USA; [Thoreson, Wallace B.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Urness, Lisa D.; Mansour, Suzanne L.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Dev Neurosci, Munroe Meyer Inst Genet & Rehabil, Omaha, NE USA	Gurumurthy, CB (reprint author), Univ Nebraska Med Ctr, Mouse Genome Engn Core Facil, Res Off, Omaha, NE 68198 USA.; Ohtsuka, M (reprint author), Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.; Mansour, SL (reprint author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	suzi.mansour@genetics.utah.edu; masato@is.icc.u-tokai.ac.jp; cgurumurthy@unmc.edu		Behlke, Mark/0000-0002-4218-857X; Seshacharyulu, Parthasarathy/0000-0002-2348-3901	Institutional Development Award [P20GM103471]; NIGMS [1P30GM110768-01, P30CA036727]; NIH [R21DC014779, EY10542]; KAKENHI from JSPS [26830131, 16 K07085]; MEXT grants from Nakatani Foundation; SENSHIN Medical Research Foundation; Mochida Memorial Foundation; Takeda Science Foundation; MRI; CNSI/NINS [BS281001]; JSPS [KAKENHI 15 K19988]; Nakatomi Foundation; Ichiro; Kanehara Foundation; Research and Study Project of Tokai University General Research Organization; Tokai University School of Medicine; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16 K18821]; MEXT; Wellcome Trust [087377]; Fred and Pamela Buffet Cancer Center's ACS Institutional Research Grant; Research to Prevent Blindness	This work was supported in part by an Institutional Development Award (PI: Shelley Smith) P20GM103471 (to CBG, RMQ, DWH, and RR), by NIGMS 1P30GM110768-01 and P30CA036727 to RR (as part of support to University of Nebraska DNA Sequencing Core), by NIH R21DC014779 (to SLM) and by KAKENHI (26830131, 16 K07085, Comprehensive Brain Science Network and Adaptive Circuit Shift) from JSPS and MEXT, grants from Nakatani Foundation, SENSHIN Medical Research Foundation, Mochida Memorial Foundation, Takeda Science Foundation, MRI, and CNSI/NINS (BS281001) to TA, KAKENHI 15 K19988 from JSPS and grants from the Nakatomi Foundation, the Ichiro, Kanehara Foundation, and Takeda Science Foundation to Y. Izu, and by Research and Study Project of Tokai University General Research Organization, 2016-2017 Tokai University School of Medicine Project Research to MO, and by Grant-in-Aid for Young Scientists (B) (16 K18821) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to HM, and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2015-2019 to Tokai University, and the Wellcome Trust (grant 087377) to GPR, Fred and Pamela Buffet Cancer Center's ACS Institutional Research Grant to SMB, by NIH grant EY10542 and Senior Scientific Investigator Award Research from Research to Prevent Blindness (to WBT).	Aida T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3331-9; Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Aitman T, 2016, DIS MODEL MECH, V9, P1069, DOI 10.1242/dmm.027706; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bhargava R, 2016, TRENDS GENET, V32, P566, DOI 10.1016/j.tig.2016.06.007; Bishop KA, 2016, G3-GENES GENOM GENET, V6, P2051, DOI 10.1534/g3.116.030601; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cohen J, 2016, SCIENCE, DOI [10.1126/science.aal0334, DOI 10.1126/SCIENCE.AAL0334]; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Fielder TJ, 2011, ADV PROTOCOLS ANIMAL, P81; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Gurumurthy CB, 2016, CURR PROTOC HUM GENE, V88; Gurumurthy CB, 2016, GENOME EDINTING, P65; Gurumurthy CB, 2016, HUM GENET, V135, P971, DOI 10.1007/s00439-016-1704-4; Harms DW, 2014, CURR PROTOC HUM GENE, V83, P1; Horii T, 2016, J REPROD DEVELOP, V62, P7, DOI 10.1262/jrd.2015-151; Inui M, 2014, SCI REP, V4; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Jacobi AM, 2017, METHODS, DOI [10.1016/j.ymeth.2017.03.021, DOI 10.1016/J.YMETH.2017.03.021]; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jung CJ, 2017, TRANSGENIC RES, V26, P263, DOI 10.1007/s11248-016-9998-5; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Lee AYF, 2014, FEBS OPEN BIO, V4, P637, DOI 10.1016/j.fob.2014.06.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19675; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miano JM, 2016, ARTERIOSCL THROM VAS, V36, P1058, DOI 10.1161/ATVBAHA.116.304790; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakao H, 2016, GENESIS, V54, P65, DOI 10.1002/dvg.22914; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; Plummer NW, 2015, DEVELOPMENT, V142, P4385, DOI 10.1242/dev.129981; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sato M, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0115-8; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smalley E, 2016, NAT BIOTECHNOL, V34, P893, DOI 10.1038/nbt0916-893; Takahashi G, 2015, SCI REP-UK, V5, DOI 10.1038/srep11406; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431	57	7	7	10	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	MAY 17	2017	18								92	10.1186/s13059-017-1220-4				15	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EU8XU	WOS:000401322600001	28511701	gold			2018-01-05	
J	Liu, Y; Conlon, DM; Bi, X; Slovik, KJ; Shi, JT; Edelstein, HI; Millar, JS; Javaheri, A; Cuchel, M; Pashos, EE; Iqbal, J; Hussain, MM; Hegele, RA; Yang, WL; Duncan, SA; Rader, DJ; Morrisey, EE				Liu, Ying; Conlon, Donna M.; Bi, Xin; Slovik, Katherine J.; Shi, Jianting; Edelstein, Hailey I.; Millar, John S.; Javaheri, Ali; Cuchel, Marina; Pashos, Evanthia E.; Iqbal, Jahangir; Hussain, M. Mahmood; Hegele, Robert A.; Yang, Wenli; Duncan, Stephen A.; Rader, Daniel J.; Morrisey, Edward E.			Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress	CELL REPORTS			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; APOLIPOPROTEIN-B; LIPOTOXIC CARDIOMYOPATHY; DISULFIDE-ISOMERASE; KINASE INHIBITORS; KNOCKOUT MICE; ABETALIPOPROTEINEMIA; HEART; MOUSE	Abetalipoproteinemia (ABL) is an inherited disorder of lipoprotein metabolism resulting from mutations in microsomal triglyceride transfer protein (MTTP). In addition to expression in the liver and intestine, MTTP is expressed in cardiomyocytes, and cardiomyopathy has been reported in several ABL cases. Using induced pluripotent stem cells (iPSCs) generated from an ABL patient homozygous for a missense mutation (MTTP R46G), we show that human hepatocytes and cardiomyocytes exhibit defects associated with ABL disease, including loss of apolipoprotein B (apoB) secretion and intracellular accumulation of lipids. MTTP R46G iPSC-derived cardiomyocytes failed to secrete apoB, accumulated intracellular lipids, and displayed increased cell death, suggesting intrinsic defects in lipid metabolism due to loss of MTTP function. Importantly, these phenotypes were reversed after the correction of the MTTP R46G mutation by CRISPR/Cas9 gene editing. Together, these data reveal clear cellular defects in iPSC-derived hepatocytes and cardiomyocytes lacking MTTP activity, including a cardiomyocyte-specific regulated stress response to elevated lipids.	[Liu, Ying; Conlon, Donna M.; Bi, Xin; Millar, John S.; Cuchel, Marina; Pashos, Evanthia E.; Rader, Daniel J.; Morrisey, Edward E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Millar, John S.; Pashos, Evanthia E.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Liu, Ying; Slovik, Katherine J.; Shi, Jianting; Edelstein, Hailey I.; Yang, Wenli; Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Cuchel, Marina] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Duncan, Stephen A.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Javaheri, Ali] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol & Pediat, Brooklyn, NY 11203 USA; [Hegele, Robert A.] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	Rader, DJ; Morrisey, EE (reprint author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Rader, DJ (reprint author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.; Morrisey, EE (reprint author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Morrisey, EE (reprint author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.; Rader, DJ; Morrisey, EE (reprint author), Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu; emorrise@mail.med.upenn.edu	Hegele, Robert/G-3301-2011	Duncan, Stephen/0000-0002-2507-7827	Induced Pluripotent Stem Cell Core Facility of the Institute for Regenerative Medicine at the University of Pennsylvania; NIH [U01-HG006398]; AHA Postdoctoral Fellowship [15POST25160019]	We thank the study participants and administrative personnel at the Smilow Center for Translational Research. We also thank the support from the Induced Pluripotent Stem Cell Core Facility of the Institute for Regenerative Medicine at the University of Pennsylvania. This work was supported by NIH grant U01-HG006398. X.B. is supported by AHA Postdoctoral Fellowship 15POST25160019.	Al-Shali K, 2003, CLIN GENET, V63, P135, DOI 10.1046/j.0009-9163.2002.00175.x                                                ; Aminoff A, 2010, J LIPID RES, V51, P103, DOI 10.1194/jlr.M900195-JLR200; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bartels ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005300; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Bi X, 2014, ARTERIOSCL THROM VAS, V34, P1888, DOI 10.1161/ATVBAHA.114.303791; Bjorkegren J, 2001, J BIOL CHEM, V276, P38511, DOI 10.1074/jbc.M106839200; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Cai J., 2008, STEMBOOK; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Chung S., 2010, J BIOL CHEM, V285, P12197, DOI 10.1074/jbc.M109.096933; DISCHE MR, 1970, AM J MED, V49, P568, DOI 10.1016/S0002-9343(70)80053-5; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Gregg Richard E., 1994, Current Opinion in Lipidology, V5, P81, DOI 10.1097/00041433-199404000-00003; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Kohan AB, 2012, AM J PHYSIOL-GASTR L, V302, pG628, DOI 10.1152/ajpgi.00225.2011; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101828; Mallanna S.K., 2013, CURR PROTOC STEM CEL, V26; Miller SA, 2014, BIOCHIM BIOPHYS ACTA, V1842, P1548, DOI [10.1016/j.bbalip.2014.08.001, DOI 10.1016/J.BBALIP.2014.08.001]; Nielsen LB, 1998, CIRCULATION, V98, P13; Nielsen LB, 2002, ARTERIOSCL THROM VAS, V22, P1489, DOI 10.1161/01.ATV.0000030199.06252.26; Nielsen LB, 1999, J MOL CELL CARDIOL, V31, P695, DOI 10.1006/jmcc.1998.0918; Ohashi K, 2000, J LIPID RES, V41, P1199; Orphanos GS, 2009, ACTA ONCOL, V48, P964, DOI 10.1080/02841860903229124; Pons V, 2011, HUM MUTAT, V32, P751, DOI 10.1002/humu.21494; Portal L, 2013, J CARDIOVASC PHARM T, V18, P367, DOI 10.1177/1074248412475158; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakata N, 1999, BBA-MOL CELL BIOL L, V1437, P71, DOI 10.1016/S1388-1981(98)00006-7                                                   ; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Si-Tayeb K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-81; SOBREVILLA LA, 1964, AM J MED, V37, P821, DOI 10.1016/0002-9343(64)90030-0; Tietge UJF, 1999, J LIPID RES, V40, P2134; Walsh MT, 2015, CIRC-CARDIOVASC GENE, V8, P677, DOI 10.1161/CIRCGENETICS.115.001106; Wang J, 2000, Hum Mutat, V15, P294, DOI 10.1002/(SICI)1098-1004(200003)15:3<294::AID-HUMU14>3.3.CO;2-5; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; Yamaguchi J, 2006, J BIOL CHEM, V281, P27063, DOI 10.1074/jbc.M606809200; Yang W, 2012, STEMBOOK; Yang WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134995; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Yokoyama M, 2004, J BIOL CHEM, V279, P4204, DOI 10.1074/jbc.M311995200; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574                                                        ; Zamel R, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-19; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	51	1	1	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	MAY 16	2017	19	7					1456	1466		10.1016/j.celrep.2017.04.064				11	Cell Biology	Cell Biology	EV9SG	WOS:000402125100016	28514664	gold			2018-01-05	
J	Ranjan, A; Srivastava, SK				Ranjan, Alok; Srivastava, Sanjay K.			Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1	ONCOTARGET			English	Article						antipsychotic drug; glioblastoma; neurosphere; in vivo; intracranial	PANCREATIC-CANCER CELLS; IN-VIVO; BREAST-CANCER; TRANSCRIPTION FACTORS; VITRO; ACTIVATION; EXPRESSION; MUTATIONS; APOPTOSIS; GLIOMA	Glioblastoma (GBM) is the most common brain tumor with poor survival rate. Our results show that penfluridol, an antipsychotic drug significantly reduced the survival of ten adult and pediatric glioblastoma cell lines with IC50 ranging 2-5 mu M after 72 hours of treatment and induced apoptosis. Penfluridol treatment suppressed the phosphorylation of Akt at Ser473 and reduced the expression of GLI1, OCT4, Nanog and Sox2 in several glioblastoma cell lines in a concentration-dependent manner. Inhibiting Akt with LY294002 and siRNA, or inhibiting GLI1 using GANT61, cyclopamine, siRNA and CRISPR/Cas9 resulted in enhanced cell growth suppressive effects of penfluridol. On the other hand, overexpression of GLI1 significantly attenuated the effects of penfluridol. Our results further demonstrated that penfluridol treatment inhibited the growth of U87MG tumors by 65% and 72% in subcutaneous and intracranial in vivo glioblastoma tumor models respectively. Immunohistochemical and western blot analysis of tumors revealed reduced pAkt (Ser 473), GLI1, OCT4 and increase in caspase-3 cleavage and TUNEL staining, confirming in vitro findings. Taken together, our results indicate that overall glioblastoma tumor growth suppression by penfluridol was associated with Akt-mediated inhibition of GLI1.	[Ranjan, Alok; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; [Ranjan, Alok; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX 79106 USA; [Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Immunotherapeut & Biotechnol, Abilene, TX 79601 USA	Srivastava, SK (reprint author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA.; Srivastava, SK (reprint author), Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX 79106 USA.; Srivastava, SK (reprint author), Texas Tech Univ, Hlth Sci Ctr, Dept Immunotherapeut & Biotechnol, Abilene, TX 79601 USA.	sanjay.srivastava@ttuhsc.edu			R01 grant - National Cancer Institute, NIH [CA129038]	Supported in part by R01 grant CA129038 (to S.K.S) awarded by the National Cancer Institute, NIH.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Carlson BL, 2011, CURR PROTOC PHARM, V14, P16, DOI DOI 10.1002/0471141755.PH1416S52; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088386; Cheng HW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.77; Chien WW, 2015, MOL ONCOL, V9, P889, DOI 10.1016/j.molonc.2015.01.002; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dalton SO, 2006, BRIT J CANCER, V95, P934, DOI 10.1038/sj.bjc.6603259; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fofaria NM, 2015, CARCINOGENESIS, V36, P142, DOI 10.1093/carcin/bgu233; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Gupta P, 2014, ONCOTARGET, V5, P1812, DOI 10.18632/oncotarget.1743                                                        ; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067278; Gupta P, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-80; HEATH A, 1985, VET HUM TOXICOL, V27, P100; Hedrick E, 2017, MOL CANCER THER, V16, P205, DOI 10.1158/1535-7163.MCT-16-0451; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Ju B, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.10; Kandala PK, 2012, J BIOL CHEM, V287, P28745, DOI 10.1074/jbc.M112.351379; Kandala PK, 2012, ONCOTARGET, V3, P435; Kern D, 2015, ONCOGENE, V34, P5341, DOI 10.1038/onc.2014.450; Liu AF, 2013, CHIN J CANCER, V32, P483, DOI 10.5732/cjc.012.10282; MacDonald TJ, 2011, NEURO-ONCOLOGY, V13, P1049, DOI 10.1093/neuonc/nor092; Pramanik KC, 2015, ONCOTARGET, V6, P11561, DOI 10.18632/oncotarget.3427                                                        ; Pramanik KC, 2014, MOL CANCER THER, V13, P687, DOI 10.1158/1535-7163.MCT-13-0863; Pramanik KC, 2012, ANTIOXID REDOX SIGN, V17, P1417, DOI 10.1089/ars.2011.4369; Queiroz KCS, 2010, ONCOGENE, V29, P6314, DOI 10.1038/onc.2010.375; Ramirez YP, 2015, MOL CANCER THER, V14, P111, DOI 10.1158/1535-7163.MCT-14-0113; Ranjan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26165; Ranjan A, 2016, CANCER RES, V76, P877, DOI 10.1158/0008-5472.CAN-15-1233; Robinson JP, 2011, AM J CANCER RES, V1, P155; Sahu RP, 2009, J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Santoni M, 2013, CURR PROTEIN PEPT SC, V14, P133, DOI 10.2174/1389203711314020005                                                     ; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Wu L, 2014, ASIAN PAC J CANCER P, V15, P489, DOI 10.7314/APJCP.2014.15.1.489; Zhou JC, 2016, CANCER LETT, V370, P313, DOI 10.1016/j.canlet.2015.11.006	38	1	1	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 16	2017	8	20					32960	32976		10.18632/oncotarget.16515				17	Oncology; Cell Biology	Oncology; Cell Biology	EV4XS	WOS:000401767700048	28380428	gold			2018-01-05	
J	Hussmann, D; Madsen, AT; Jakobsen, KR; Luo, Y; Sorensen, BS; Nielsen, AL				Hussmann, Dianna; Madsen, Anne Tranberg; Jakobsen, Kristine Raaby; Luo, Yonglun; Sorensen, Boe Sandahl; Nielsen, Anders Lade			IGF1R depletion facilitates MET-amplification as mechanism of acquired resistance to erlotinib in HCC827 NSCLC cells	ONCOTARGET			English	Article						NSCLC; IGF1R; EGFR-TKI; EMT; MET	GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; LUNG-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EGFR-MUTANT NSCLC; DRUG-RESISTANCE; T790M MUTATION; GEFITINIB; PATHWAY; EMT	EGFR-mutated non-small cell lung cancer patients experience relapse within 1-2 years of treatment with EGFR-inhibitors, such as erlotinib. Multiple resistance mechanisms have been identified including secondary EGFR-mutations, MET-amplification, and epithelial-mesenchymal transition (EMT). Previous studies have indicated a role of Insulin-like growth factor 1 receptor (IGF1R) in acquired resistance to EGFR-directed drugs as well as in EMT. In the present study, we have investigated the involvement of IGF1R in acquired high-dose erlotinib resistance in the EGFR-mutated lung adenocarcinoma cell line HCC827. We observed that IGF1R was upregulated in the immediate response to erlotinib and hyperactivated in erlotinib resistant HCC827 cells. Resistant cells additionally acquired features of EMT, whereas MET-amplification and secondary EGFR-mutations were absent. Using CRISPR/Cas9, we generated a HCC827(IGFR1-/-) cell line and subsequently investigated resistance development in response to high-dose erlotinib. Interestingly, HCC827(IGFR1-/-) cells were now observed to specifically amplify the MET gene. Additionally, we observed a reduced level of mesenchymal markers in HCC827(IGFR1-/-) indicating an intrinsic enhanced epithelial signature compared to HCC827 cells. In conclusion, our data show that IGF1R have an important role in defining selected resistance mechanisms in response to high doses of erlotinib.	[Hussmann, Dianna; Jakobsen, Kristine Raaby; Luo, Yonglun; Nielsen, Anders Lade] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Madsen, Anne Tranberg; Jakobsen, Kristine Raaby; Sorensen, Boe Sandahl] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Nielsen, AL (reprint author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	aln@biomed.au.dk	Luo, Yonglun/C-4708-2013	Luo, Yonglun/0000-0002-0007-7759; Sorensen, Boe/0000-0002-9472-8099; Nielsen, Anders Lade/0000-0003-4372-9961; Jakobsen, Kristine Raaby/0000-0002-5334-7767	Fonden til Laegevidenskabens Fremme; Harboe Fonden; Arvid Nilssons Fond; Else og Mogens Wedell-Wedellsborgs Fond; Krista og Viggo Petersens Fond; Familien Hede Nielsens Fond; Direktor Jacob Madsen & Hustru Olga Madsens Fond; Fabrikant Einar Willumsens Mindelegat; Marie og Borge Kroghs Fond; The Graduate School of Health, Aarhus University, DK	This work was supported by Fonden til Laegevidenskabens Fremme, Harboe Fonden, Arvid Nilssons Fond, Else og Mogens Wedell-Wedellsborgs Fond, Krista og Viggo Petersens Fond, Familien Hede Nielsens Fond, Direktor Jacob Madsen & Hustru Olga Madsens Fond, Fabrikant Einar Willumsens Mindelegat, Marie og Borge Kroghs Fond, and The Graduate School of Health, Aarhus University, DK.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077; Chung JH, 2011, LUNG CANCER, V73, P176, DOI 10.1016/j.lungcan.2010.11.011; Cortot AB, 2013, CANCER RES, V73, P834, DOI 10.1158/0008-5472.CAN-12-2066; Denduluri SK, 2015, GENES DIS, V2, P13, DOI 10.1016/j.gendis.2014.10.004; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI [10.1016/j.apsb.2015.07.001, 10.1016/j.spdn.2015.07.001]; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Jakobsen KR, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.17; Jakobsen KR, 2016, TRANSL LUNG CANCER R, V5, P172, DOI 10.21037/tlcr.2016.04.07; Kuwano M, 2016, PHARMACOL THERAPEUT, V161, P97, DOI 10.1016/j.pharmthera.2016.03.002; Lee Y, 2016, MOL CARCINOGEN, V55, P991, DOI 10.1002/mc.22342; Leighl NB, 2017, CLIN LUNG CANCER, V18, P34, DOI 10.1016/j.cllc.2016.07.007; Morgillo F, 2011, BRIT J CANCER, V105, P382, DOI 10.1038/bjc.2011.244; Murakami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086459; Nurwidya F, 2014, BIOCHEM BIOPH RES CO, V455, P332, DOI 10.1016/j.bbrc.2014.11.014; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Park E, 2015, J PATHOL TRANSL MED, V49, P382, DOI 10.4132/jptm.2015.07.10; Park JH, 2016, ONCOTARGET, V7, P22005, DOI 10.18632/oncotarget.8013; Peled N, 2013, CELL ONCOL, V36, P277, DOI 10.1007/s13402-013-0133-9; Presutti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143333; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Robinson KW, 2013, ONCOLOGIST, V18, P115, DOI 10.1634/theoncologist.2012-0262; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sesumi Y, 2017, LUNG CANCER, V104, P85, DOI 10.1016/j.lungcan.2016.12.012; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Soucheray M, 2015, CANCER RES, V75, P4372, DOI 10.1158/0008-5472.CAN-15-0377; Suda K, 2014, INT J CANCER, V135, P1002, DOI 10.1002/ijc.28737; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Taliaferro-Smith L, 2015, ONCOTARGET, V6, P4757, DOI 10.18632/oncotarget.3023                                                        ; Tetsu O, 2015, CHEMOTHERAPY, V61, P223, DOI 10.1159/000443368; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vazquez-Martin A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02560; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Wilson C, 2014, ONCOTARGET, V5, P7328, DOI 10.18632/oncotarget.2397                                                        ; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yeo CD, 2015, LUNG CANCER, V87, P311, DOI 10.1016/j.lungcan.2015.01.004; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhou J, 2015, ONCOTARGET, V6, P44332, DOI 10.18632/oncotarget.6293; Zhou Y, 2016, CELL MOL LIFE SCI, V73, P2543, DOI 10.1007/s00018-015-2128-3	51	1	1	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 16	2017	8	20					33300	33315		10.18632/oncotarget.16350				16	Oncology; Cell Biology	Oncology; Cell Biology	EV4XS	WOS:000401767700075	28418902	gold			2018-01-05	
J	Hajrah, NH; Obaid, AY; Atef, A; Ramadan, AM; Arasappan, D; Nelson, CA; Edris, S; Mutwakil, MZ; Alhebshi, A; Gadalla, NO; Makki, RM; Al-Kordy, MA; El-Domyati, FM; Sabir, JSM; Khiyami, MA; Hall, N; Bahieldin, A; Jansen, RK				Hajrah, Nahid H.; Obaid, Abdullah Y.; Atef, Ahmed; Ramadan, Ahmed M.; Arasappan, Dhivya; Nelson, Charllotte A.; Edris, Sherif; Mutwakil, Mohammed Z.; Alhebshi, Alawia; Gadalla, Nour O.; Makki, Rania M.; Al-Kordy, Madgy A.; El-Domyati, Fotouh M.; Sabir, Jamal S. M.; Khiyami, Mohammad A.; Hall, Neil; Bahieldin, Ahmed; Jansen, Robert K.			Transcriptomic analysis of salt stress responsive genes in Rhazya stricta	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; MITOCHONDRIAL ELECTRON-TRANSPORT; GENOME-WIDE ANALYSIS; ABIOTIC STRESS; SIGNAL-TRANSDUCTION; ARABIDOPSIS MITOCHONDRIA; OXIDATIVE STRESS; MESSENGER-RNAS; HIGHER-PLANTS; CHLOROPLASTS	Rhazya stricta is an evergreen shrub that is widely distributed across Western and South Asia, and like many other members of the Apocynaceae produces monoterpene indole alkaloids that have anti-cancer properties. This species is adapted to very harsh desert conditions making it an excellent system for studying tolerance to high temperatures and salinity. RNA-Seq analysis was performed on R. stricta exposed to severe salt stress (500 mM NaCl) across four time intervals (0, 2, 12 and 24 h) to examine mechanisms of salt tolerance. A large number of transcripts including genes encoding tetrapyrroles and pentatricopeptide repeat (PPR) proteins were regulated only after 12 h of stress of seedlings grown in controlled greenhouse conditions. Mechanisms of salt tolerance in R. stricta may involve the upregulation of genes encoding chaperone protein Dnaj6, UDP-glucosyl transferase 85a2, protein transparent testa 12 and respiratory burst oxidase homolog protein b. Many of the highly-expressed genes act on protecting protein folding during salt stress and the production of flavonoids, key secondary metabolites in stress tolerance. Other regulated genes encode enzymes in the porphyrin and chlorophyll metabolic pathway with important roles during plant growth, photosynthesis, hormone signaling and abiotic responses. Heme biosynthesis in R. stricta leaves might add to the level of salt stress tolerance by maintaining appropriate levels of photosynthesis and normal plant growth as well as by the participation in reactive oxygen species (ROS) production under stress. We speculate that the high expression levels of PPR genes may be dependent on expression levels of their targeted editing genes. Although the results of PPR gene family indicated regulation of a large number of transcripts under salt stress, PPR actions were independent of the salt stress because their RNA editing patterns were unchanged.	[Hajrah, Nahid H.; Atef, Ahmed; Ramadan, Ahmed M.; Edris, Sherif; Mutwakil, Mohammed Z.; Alhebshi, Alawia; Makki, Rania M.; Sabir, Jamal S. M.; Hall, Neil; Bahieldin, Ahmed; Jansen, Robert K.] KAU, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah, Saudi Arabia; [Obaid, Abdullah Y.] KAU, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Ramadan, Ahmed M.] ARC, AGERI, Giza, Egypt; [Arasappan, Dhivya; Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Nelson, Charllotte A.] Inst Integrat Biol, Ctr Genom Res, Crown St, Liverpool, Merseyside, England; [Edris, Sherif; El-Domyati, Fotouh M.; Bahieldin, Ahmed] Ain Shams Univ, Fac Agr, Dept Genet, Cairo, Egypt; [Edris, Sherif] KAU, Fac Med, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Gadalla, Nour O.] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, Jeddah, Saudi Arabia; [Gadalla, Nour O.; Al-Kordy, Madgy A.] Natl Res Ctr, Genet Engn & Biotechnol Div, Genet & Cytol Dept, Dokki, Egypt; [Khiyami, Mohammad A.] KACST, Riyadh, Saudi Arabia; [Hall, Neil] Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England	Jansen, RK (reprint author), KAU, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah, Saudi Arabia.; Jansen, RK (reprint author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	jansen@austin.utexas.edu	Ramadan, Ahmed/I-8241-2012	Ramadan, Ahmed/0000-0002-2502-9921	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [I-008-31]	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no.I-008-31.; This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. I-008-31. The authors, therefore, acknowledge with thanks DSR technical and financial support. The authors also gratefully acknowledge the support from President of King Abdulaziz University. Prof. Dr. Abdulrahman O. Alyoubi.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arenas A, 2014, MITOCHONDRION, V19, P126, DOI 10.1016/j.mito.2014.08.006; Bahieldin A, 2015, CR BIOL, V338, P285, DOI 10.1016/j.crvi.2015.03.010; Blanco-Herrera F, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0525-2; Brehme N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140680; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Cao ZL, 2011, J INTEGR PLANT BIOL, V53, P258, DOI 10.1111/j.1744-7909.2011.01030.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng CX, 2013, INT J MOL SCI, V14, P24169, DOI 10.3390/ijms141224169; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-6; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; FREYER R, 1993, PLANT J, V4, P621, DOI 10.1046/j.1365-313X.1993.04040621.x                                             ; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Goyal E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27752; Grimm B, 1998, CURR OPIN PLANT BIOL, V1, P245, DOI 10.1016/S1369-5266(98)80112-X; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hammani K, 2011, PLANT CELL, V23, P730, DOI 10.1105/tpc.110.081638; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hasan SS, 2013, P NATL ACAD SCI USA, V110, P4297, DOI 10.1073/pnas.1222248110; HIROSE T, 1994, PLANT MOL BIOL, V26, P509, DOI 10.1007/BF00039562                                                              ; Jiang SC, 2015, PLANT MOL BIOL, V88, P369, DOI 10.1007/s11103-015-0327-9; JOHANNINGMEIER U, 1984, J BIOL CHEM, V259, P3541; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; Khan N.A., 2014, J PLANT BIOCH PHYSL, V2, P120, DOI DOI 10.4172/2329-9029.1000120; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu Y, 2010, J BUS RES, V63, P3, DOI 10.1016/j.jbusres.2009.01.005; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Lv HX, 2014, J PLANT BIOL, V57, P291, DOI 10.1007/s12374-014-0041-1; Martin M, 2009, BBA-BIOENERGETICS, V1787, P920, DOI 10.1016/j.bbabio.2009.03.001; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Murayama M, 2012, J EXP BOT, V63, P5301, DOI 10.1093/jxb/ers188; Obaid AY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0938-6; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294                                                            ; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sabir JSM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33782; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Turan S, 2015, PHYSIOL PLANTARUM, V153, P477, DOI 10.1111/ppl.12250; Vierling E, 1991, PLANT MOL BIOL, V42, P579, DOI DOI 10.1146/ANNUREV.PP.42.060191.003051; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; Wahid A, 2006, J PLANT PHYSIOL, V163, P723, DOI 10.1016/j.jplph.2005.07.007; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Wu DZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055431; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zhang J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-228; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu Q, 2014, MOL PLANT, V7, P290, DOI 10.1093/mp/sst102; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260	63	0	0	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177589	10.1371/journal.pone.0177589				18	Multidisciplinary Sciences	Science & Technology - Other Topics	EV1DC	WOS:000401485500041	28520766	gold			2018-01-05	
J	Sheng, JY; Flick, H; Feng, XY				Sheng, Jiayuan; Flick, Hunter; Feng, Xueyang			Systematic Optimization of Protein Secretory Pathways in Saccharomyces cerevisiae to Increase Expression of Hepatitis B Small Antigen	FRONTIERS IN MICROBIOLOGY			English	Article						yeast knockout; HBsAg; protein express pathway; synergy; CRISPR	SEQUENCE-SPECIFIC CONTROL; HOST PICHIA-PASTORIS; UNFOLDED PROTEIN; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; QUALITY-CONTROL; ER STRESS; YEAST; GENOME; OVEREXPRESSION	Hepatitis B is a major disease that chronically infects millions of people in the world, especially in developing countries. Currently, one of the effective vaccines to prevent Hepatitis B is the Hepatitis B Small Antigen (HBsAg), which is mainly produced by the recombinant yeast Saccharomyces cerevisiae. In order to bring down the price, which is still too high for people in developing countries to afford, it is important to understand key cellular processes that limit protein expression. In this study, we took advantage of yeast knockout collection (YKO) and screened 194 S. cerevisiae strains with single gene knocked out in four major steps of the protein secretory pathway, i.e., endoplasmic-reticulum (ER)-associated protein degradation, protein folding, unfolded protein response (UPR), and translocation and exocytosis. The screening showed that the single deletion of YPT32, SBH1, and HSP42 led to the most significant increase of HBsAg expression over the wild type while the deletion of IRE1 led to a profound decrease of HBsAg expression. The synergistic effects of gene knockout and gene overexpression were next tested. We found that simultaneously deleting YPT32 and overexpressing IRE1 led to a 2.12-fold increase in HBsAg expression over the wild type strain. The results of this study revealed novel genetic targets of protein secretory pathways that could potentially improve the manufacturing of broad scope vaccines in a cost-effective way using recombinant S. cerevisiae.	[Sheng, Jiayuan; Feng, Xueyang] Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Flick, Hunter] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA	Feng, XY (reprint author), Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	xueyang@vt.edu			ICTAS Junior Faculty Award from Virginia Tech;  [175323]	This study was supported by a start-up fund (#175323) and the ICTAS Junior Faculty Award from Virginia Tech.	Ahn JO, 2004, APPL MICROBIOL BIOT, V64, P833, DOI 10.1007/s00253-003-1547-5; ALTER HJ, 1966, BLOOD-J HEMATOL, V27, P297; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Benli M, 1996, EMBO J, V15, P6460; Bergkessel M, 2013, METHOD ENZYMOL, V529, P311, DOI 10.1016/B978-0-12-418687-3.00026-4; BOORSTEIN WR, 1990, J BIOL CHEM, V265, P18912; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Ciplys E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-37; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Ferreira T, 2002, J BIOL CHEM, V277, P21027, DOI 10.1074/jbc.M112281200; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gleeson MAG, 1998, METH MOL B, V103, P81; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Harmsen MM, 1996, APPL MICROBIOL BIOT, V46, P365, DOI 10.1007/s002530050831; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Hollinger F. B., 2001, HEPATITIS B VIRUS FI; Hou J, 2012, FEMS YEAST RES, V12, P491, DOI 10.1111/j.1567-1364.2012.00810.x; Hou J, 2012, METAB ENG, V14, P120, DOI 10.1016/j.ymben.2012.01.002; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Iwata Y, 2012, TRENDS PLANT SCI, V17, P720, DOI 10.1016/j.tplants.2012.06.014; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kim B, 2013, APPL ENVIRON MICROB, V79, P931, DOI 10.1128/AEM.02736-12; KLAUSNER R D, 1989, New Biologist, V1, P3; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lazar C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00433; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liu L, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-73; Love KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037915; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Mattanovich D, 2004, J BIOTECHNOL, V113, P121, DOI 10.1016/j.jbiotec.2004.04.035; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Mattia A., 2008, CLIN INFECT DIS   S2, V46, pS144, DOI DOI 10.1086/523329; Mattia A, 2008, CLIN INFECT DIS, V46, pS115, DOI 10.1086/523329; Mulder HJ, 2004, MOL GENET GENOMICS, V271, P130, DOI 10.1007/s00438-003-0965-5; Nielsen J, 2013, BIOENGINEERED, V4, P207, DOI 10.4161/bioe.22856; Palomares Laura A, 2004, Methods Mol Biol, V267, P15; Park SK, 2014, MOL GENET GENOMICS, V289, P125, DOI 10.1007/s00438-013-0794-0; Payne T, 2008, APPL ENVIRON MICROB, V74, P7759, DOI 10.1128/AEM.01178-08; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Resina D, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-21; ROBINSON AS, 1994, BIO-TECHNOL, V12, P381, DOI 10.1038/nbt0494-381; Robson G. D., 2007, EXPLOITATION FUNGI; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosochacki Stanislaw Jozef, 2002, Acta Microbiol Pol, V51, P205; Schekman R, 2010, MOL BIOL CELL, V21, P3781, DOI 10.1091/mbc.E10-05-0416; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shetty R, 2011, METHOD ENZYMOL, V498, P311, DOI 10.1016/B978-0-12-385120-8.00013-9; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; Soromani C, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-34; Stadlmayr G, 2010, BIOTECHNOL BIOENG, V105, P543, DOI 10.1002/bit.22573; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315                                                          ; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1                                                   ; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972                                                        ; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Ye CM, 2011, PLANT PHYSIOL, V156, P741, DOI 10.1104/pp.111.174110; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zhang BY, 2001, J CELL BIOL, V153, P1187, DOI 10.1083/jcb.153.6.1187; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293	75	1	1	6	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	MAY 16	2017	8								875	10.3389/fmicb.2017.00875				10	Microbiology	Microbiology	EV2HO	WOS:000401576400001	28559891	gold			2018-01-05	
J	Van Sinay, E; Mirabeau, O; Depuydt, G; Van Hiel, MB; Peymen, K; Watteyne, J; Zels, S; Schoofs, L; Beets, I				Van Sinay, Elien; Mirabeau, Olivier; Depuydt, Geert; Van Hiel, Matthias Boris; Peymen, Katleen; Watteyne, Jan; Zels, Sven; Schoofs, Liliane; Beets, Isabel			Evolutionarily conserved TRH neuropeptide pathway regulates growth in Caenorhabditis elegans	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						thyrotropin-releasing hormone; C. elegans; neuropeptide; molecular evolution; growth regulation	THYROTROPIN-RELEASING-HORMONE; MULTIPLE SEQUENCE ALIGNMENT; C-ELEGANS; PHYLOGENETIC TREES; THYROID-HORMONES; ACHATINA-FULICA; NERVOUS-SYSTEM; BODY LENGTH; GENE; RECEPTOR	In vertebrates thyrotropin-releasing hormone (TRH) is a highly conserved neuropeptide that exerts the hormonal control of thyroid-stimulating hormone (TSH) levels as well as neuromodulatory functions. However, a functional equivalent in protostomian animals remains unknown, although TRH receptors are conserved in proto-and deuterostomians. Here we identify a TRH-like neuropeptide precursor in Caenorhabditis elegans that belongs to a bilaterian family of TRH precursors. Using CRISPR/Cas9 and RNAi reverse genetics, we show that TRH-like neuropeptides, through the activation of their receptor TRHR-1, promote growth in C. elegans. TRH-like peptides from pharyngeal motor neurons are required for normal body size, and knockdown of their receptor in pharyngeal muscle cells reduces growth. Mutants deficient for TRH signaling have no defects in pharyngeal pumping or isthmus peristalsis rates, but their growth defect depends on the bacterial diet. In addition to the decrease in growth, trh-1 mutants have a reduced number of offspring. Our study suggests that TRH is an evolutionarily ancient neuropeptide, having its origin before the divergence of protostomes and deuterostomes, and may ancestrally have been involved in the control of postembryonic growth and reproduction.	[Van Sinay, Elien; Depuydt, Geert; Van Hiel, Matthias Boris; Peymen, Katleen; Watteyne, Jan; Zels, Sven; Schoofs, Liliane; Beets, Isabel] Katholieke Univ Leuven, Dept Biol, Funct Genom & Proteom Grp, B-3000 Leuven, Belgium; [Mirabeau, Olivier] Paris Sci & Lettres Res Univ, INSERM U830, Inst Curie, Genet & Biol Canc Unit, F-75005 Paris, France	Schoofs, L; Beets, I (reprint author), Katholieke Univ Leuven, Dept Biol, Funct Genom & Proteom Grp, B-3000 Leuven, Belgium.	liliane.schoofs@kuleuven.be; isabel.beets@kuleuven.be		Van Sinay, Elien/0000-0001-7887-6967	NIH Office of Research Infrastructure Programs [P40 OD010440]; European Research Council [340318]; FWO [G069713N]	We thank the Caenorhabditis Genetics Center, funded by NIH Office of Research Infrastructure Programs Grant P40 OD010440, for providing the wild-type and dbl-1(nk3) C. elegans strains; the TransGeneOme project for the trhr-1 fosmid-based reporter construct; W. De Haes for advice on statistics; F. J. Naranjo-Galindo and E. Vandeweyer for technical assistance; B. Braeckman for advice and use of equipment; and C. Bargmann, G. Jekely, and J. Moller-Jensen for reagents. E.V.S., K.P., J. W., and I. B. are fellows of the Research Foundation - Flanders (FWO). This research was supported by European Research Council Grant 340318 and FWO Grant G069713N.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Altun ZF, 2009, ALIMENTARY SYSTEM PH, DOI [10.3908/wormatlas.1.3, DOI 10.3908/WORMATLAS.1.3]; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery L., 2012, C ELEGANS FEEDING, DOI [10.1895/wormbook.1.150.1, DOI 10.1895/WORMBOOK.1.150.1]; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; BOLER J, 1969, BIOCHEM BIOPH RES CO, V37, P705, DOI 10.1016/0006-291X(69)90868-7                                                    ; Brockie PJ, 2001, J NEUROSCI, V21, P1510; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; BURGUS R, 1969, CR ACAD SCI D NAT, V269, P1870; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cho S, 2007, CURR BIOL, V17, P203, DOI 10.1016/j.cub.2006.12.027; DANFORTH E, 1984, CLIN ENDOCRINOL META, V13, P581, DOI 10.1016/S0300-595X(84)80039-0                                                   ; De Groef B, 2006, GEN COMP ENDOCR, V146, P62, DOI 10.1016/j.ygcen.2005.10.014; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; De Loof A, 2012, GEN COMP ENDOCR, V177, P18, DOI 10.1016/j.ygcen.2012.02.002; Dieterich C, 2007, NUCLEIC ACIDS RES, V35, pD498, DOI 10.1093/nar/gkl804; DUTHIE SM, 1993, MOL CELL ENDOCRINOL, V95, pR11, DOI 10.1016/0303-7207(93)90043-J; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421                                             ; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Fujisawa Y, 2000, PEPTIDES, V21, P1203, DOI 10.1016/S0196-9781(00)00260-6; Galas L, 2009, GEN COMP ENDOCR, V164, P40, DOI 10.1016/j.ygcen.2009.05.003; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; George-Raizen JB, 2014, BIOL OPEN, V3, P1139, DOI 10.1242/bio.20147500; HALL TR, 1986, COMP BIOCHEM PHYS A, V84, P231, DOI 10.1016/0300-9629(86)90608-0                                                    ; HARRIS GW, 1950, BRIT MED BULL, V6, P345, DOI 10.1093/oxfordjournals.bmb.a073628                                              ; HARVEY S, 1990, J ENDOCRINOL, V125, P345, DOI 10.1677/joe.0.1250345                                                           ; Hodin J, 2006, INTEGR COMP BIOL, V46, P719, DOI 10.1093/icb/icl038; Hollenberg AN, 2008, THYROID, V18, P131, DOI 10.1089/thy.2007.0251; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Huang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144991; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Husson S. J., 2014, EUPA OPEN PROTEOMICS, V3, P280; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; KALIVAS PW, 1987, NEUROPHARMACOLOGY, V26, P33, DOI 10.1016/0028-3908(87)90041-4; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelly WG, 1997, GENETICS, V146, P227; Laron Z, 1996, MODERN ENDOCRINOLOGY; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Liu K, 2009, SCIENCE, V324, P392, DOI [10.1126/science.1170540, 10.1126/science.1171243]; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159                                                         ; Miller EV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137403; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; MIYAMOTO M, 1977, EUR J PHARMACOL, V44, P143, DOI 10.1016/0014-2999(77)90100-5; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Morita K, 1999, DEVELOPMENT, V126, P1337; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Nystrom J, 2002, GENETICS, V161, P83; OHTA N, 1991, BIOCHEM BIOPH RES CO, V178, P486, DOI 10.1016/0006-291X(91)90133-R                                                    ; Oishi A, 2009, GENES CELLS, V14, P1141, DOI 10.1111/j.1365-2443.2009.01341.x; Paris M, 2008, GENESIS, V46, P657, DOI 10.1002/dvg.20443; Paris M, 2008, DEV GENES EVOL, V218, P667, DOI 10.1007/s00427-008-0255-7; Patricolo E, 2001, J EXP ZOOL, V290, P426, DOI 10.1002/jez.1084; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raharjo WH, 2011, GENETICS, V189, P885, DOI 10.1534/genetics.111.132449; Ray P, 2008, DEV NEUROBIOL, V68, P421, DOI 10.1002/dneu.20599; Roller L, 2010, PEPTIDES, V31, P429, DOI 10.1016/j.peptides.2009.11.022; Rowe ML, 2014, GEN COMP ENDOCR, V197, P43, DOI 10.1016/j.ygcen.2013.12.002; Rowe ML, 2012, GEN COMP ENDOCR, V179, P331, DOI 10.1016/j.ygcen.2012.09.009; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Savage-Dunn C, 2000, DEV BIOL, V223, P70, DOI 10.1006/dbio.2000.9713; Semmens DC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150224; SHARP T, 1984, REGUL PEPTIDES, V9, P305, DOI 10.1016/0167-0115(84)90083-1; Shibusawa N, 2008, CEREBELLUM, V7, P84, DOI 10.1007/s12311-008-0033-0; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; So SH, 2011, GENES CELLS, V16, P639, DOI 10.1111/j.1365-2443.2011.01514.x; Song BM, 2012, J NEUROSCI, V32, P1920, DOI 10.1523/JNEUROSCI.2064-11.2012; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Tanaka Y, 2014, PEPTIDES, V53, P125, DOI 10.1016/j.peptides.2013.07.027; TAYLOR JA, 1991, HORM BEHAV, V25, P128, DOI 10.1016/0018-506X(91)90046-K; Van Rompay L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16381; Vaudry H, 1999, ANN NY ACAD SCI, V885, P41; Wu W, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-150; YasudaKamatani Y, 1997, PEPTIDES, V18, P347, DOI 10.1016/S0196-9781(96)00343-9	85	0	0	7	9	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 16	2017	114	20					E4065	E4074		10.1073/pnas.1617392114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EU8UT	WOS:000401314700025	28461507				2018-01-05	
J	Butler, JR; Santos, RMN; Martens, GR; Ladowski, JM; Wang, ZY; Li, P; Tector, M; Tector, AJ				Butler, James R.; Santos, Rafael M. N.; Martens, Gregory R.; Ladowski, Joseph M.; Wang, Zheng-Yu; Li, Ping; Tector, Matthew; Tector, A. Joseph			Efficient generation of targeted and controlled mutational events in porcine cells using nuclease-directed homologous recombination	JOURNAL OF SURGICAL RESEARCH			English	Article						CRISPR/Cas9; Nuclease; Xenotransplantation	GENOME; PIGS; XENOTRANSPLANTATION; REPAIR; GENES; ENDONUCLEASE; CRISPR-CAS9; MODEL	Background: Nuclease-based genome editing has rapidly sped the creation of new models of human disease. These techniques also hold great promise for the future of clinical xeno-transplantation and cell-based therapies for cancer or immunodeficient pathology. However, to fully realize the potential of nuclease editing tools, the efficiency and precision of their application must be optimized. The object of this study was to use nonintegrating selection and nuclease-directed homologous recombination to efficiently control the genetic modification of the porcine genome. Methods: Clustered randomly integrating spaced palindromic repeats and associated Cas9 protein (CRISPR/Cas9)-directed mutagenesis with a single-guide RNA target was designed to target the alpha-1,3-galactosyltransferase locus (GGTA1) of the porcine genome. A vector expressing a single-guide RNA, Cas9 protein, and green fluorescent protein was used to increase plasmid-delivered mutational efficiency when coupled with fluorescence sorting. Single and double-strand DNA oligonucleotides with a restriction site replacing the start codon were created with variable homology lengths surrounding the mutational event site. Finally, a transgene construct was flanked with 50 base pairs of homology directed immediately 50 to a nuclease cut site. These products were introduced to cells with a constant concentration of CRISPR/cas9 vector. Phenotype-specific mutational efficiency was measured by flow cytometer. Controlled homologous insertion was measured by Sanger sequence, restriction enzyme digest and flow cytometry. Results: Expression of a fluorescence protein on the Cas9 vector functioned as a nonintegrating selection marker. Selection by this marker increased phenotype-silencing mutation rates from 3.5% to 82% (P = 0.0002). Insertion or deletion mutation increased from 11% to 96% (P = 0.0007). Co-transfection with homologous DNA oligonucleotides increased the aggregate phenotype-silencing mutation rates up to 22% and increased biallelic events. Single-strand DNA was twice as efficient as double-strand DNA. Furthermore, nuclease-mediated insertion by homology-directed repair successfully drove locus-specific transgene expression in the porcine genome. Conclusions: A nonintegrating selection strategy based on fluorescence expression can increase the mutational efficiency of the CRISPR/Cas9 system. The precision of this system can be increased by the addition of a very short homologous template sequence and can serve as a method for locus-specific transgene delivery. Together these strategies may be used to efficiently control mutational events. This system may be used to better use the potential of nuclease-mediated genomic editing. (C) 2017 Elsevier Inc. All rights reserved.	[Butler, James R.; Santos, Rafael M. N.; Martens, Gregory R.; Li, Ping] Indiana Univ, Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Martens, Gregory R.; Ladowski, Joseph M.; Wang, Zheng-Yu; Tector, Matthew; Tector, A. Joseph] Univ Alabama Birmingham, Dept Surg, LHRB 752,701 19th St S, Birmingham, AL 35233 USA	Tector, AJ (reprint author), Univ Alabama Birmingham, Dept Surg, LHRB 752,701 19th St S, Birmingham, AL 35233 USA.	jtector@uab.edu			Association of Academic Surgery Foundation; American Society of Transplant Surgeons	The first author is supported by a Research Fellowship Award from the Association of Academic Surgery Foundation and a grant from the American Society of Transplant Surgeons.	Butler JR, 2016, TRANSGENIC RES, V25, P751, DOI 10.1007/s11248-016-9958-0; Butler JR, 2015, INT J SURG, V23, P217, DOI 10.1016/j.ijsu.2015.07.684; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Critser John K, 2009, ILAR J, V50, P89; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Estrada JL, 2015, XENOTRANSPLANTATION, V22, P194, DOI 10.1111/xen.12161; Higginbotham L, 2015, XENOTRANSPLANTATION, V22, P221, DOI 10.1111/xen.12166; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; KIM JW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018556; Kime C, 2016, CURR PROTOC HUM GENE, V88; Li P, 2015, XENOTRANSPLANTATION, V22, P20, DOI 10.1111/xen.12131; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Perkel JM, 2016, NAT BIOTECHNOL, V34, P3, DOI 10.1038/nbt0116-3; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; REARDON S, 2015, NATURE, V527, P152; Reyes LM, 2014, J IMMUNOL, V193, P5751, DOI 10.4049/jimmunol.1402059; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang KK, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.101; Wang ZY, 2012, XENOTRANSPLANTATION, V19, P249, DOI 10.1111/j.1399-3089.2012.00715.x; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang Y, 2016, J MOL CELL BIOL, V8, P174, DOI 10.1093/jmcb/mjw008	26	2	2	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY 15	2017	212						238	245		10.1016/j.jss.2017.01.025				8	Surgery	Surgery	FA3RS	WOS:000405362700030	28550913				2018-01-05	
J	Karvelis, T; Gasiunas, G; Siksnys, V				Karvelis, Tautvydas; Gasiunas, Giedrius; Siksnys, Virginijus			Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview	METHODS			English	Article						Genome editing; CRISPR; Cas9; High-throughput methods; PAM library	RNA-GUIDED ENDONUCLEASE; STAPHYLOCOCCUS-AUREUS CAS9; ENGINEERED CRISPR-CAS9; STRUCTURAL BASIS; DUAL-RNA; SYSTEMS; SPECIFICITIES; RECOGNITION; DIVERSITY; BACTERIAL	Recently the Cas9, an RNA guided DNA endonuclease, emerged as a powerful tool for targeted genome manipulations. Cas9 protein can be reprogrammed to cleave, bind or nick any DNA target by simply changing crRNA sequence, however a short nucleotide sequence, termed PAM, is required to initiate crRNA hybridization to the DNA target. PAM sequence is recognized by Cas9 protein and must be determined experimentally for each Cas9 variant. Exploration of Cas9 orthologs could offer a diversity of PAM sequences and novel biochemical properties that may be beneficial for genome editing applications. Here we briefly review and compare Cas9 PAM identification assays that can be adopted for other PAM dependent CRISPR-Cas systems. (C) 2017 Elsevier Inc. All rights reserved.	[Karvelis, Tautvydas; Gasiunas, Giedrius; Siksnys, Virginijus] Vilnius Univ, Inst Biotechnol, Sauletekio Av 7, LT-10257 Vilnius, Lithuania	Siksnys, V (reprint author), Vilnius Univ, Inst Biotechnol, Sauletekio Av 7, LT-10257 Vilnius, Lithuania.	siksnys@ibt.lt			Lithuanian Agency for Science, Innovation and Technology (MITA) [31v-107]	This work was supported by the Lithuanian Agency for Science, Innovation and Technology (MITA) Grant #31v-107.	Amitai G., 2016, NAT REV MICROBIOL, P1; Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beisel CL, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0516-x; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Chen HF, 2014, J BIOL CHEM, V289, P13284, DOI 10.1074/jbc.M113.539726; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144970; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Siksnys V, 2016, MOL CELL, V61, P793, DOI 10.1016/j.molcel.2016.03.002; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	53	3	3	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						3	8		10.1016/j.ymeth.2017.03.006				6	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500002	28344037				2018-01-05	
J	DeWitt, MA; Corn, JE; Carroll, D				DeWitt, Mark A.; Corn, Jacob E.; Carroll, Dana			Genome editing via delivery of Cas9 ribonucleoprotein	METHODS			English	Article							STEM-CELLS; IN-VIVO; CAENORHABDITIS-ELEGANS; GENE KNOCKOUT; GUIDE RNAS; DONOR DNA; MOUSE; CRISPR-CAS9; PROTEIN; ELECTROPORATION	The CRISPR-Cas genome editing system is very powerful. The format of the CRISPR reagents and the means of delivery are often important factors in targeting efficiency. Delivery of recombinant Cas9 protein and guide RNA (gRNA) as a preformed ribonucleoprotein (RNP) complex has recently emerged as a powerful and general approach to genome editing. Here we outline methods to produce and deliver Cas9 RNPs. A donor DNA carrying desired sequence changes can also be included to program precise sequence introduction or replacement. RNP delivery limits exposure to genome editing reagents, reduces off-target events, drives high rates of homology-dependent repair, and can be applied to embryos to rapidly generate animal models. RNP delivery thus minimizes some of the pitfalls of alternative editing modalities and is rapidly being adopted by the genome editing community. (C) 2017 Elsevier Inc. All rights reserved.	[DeWitt, Mark A.; Corn, Jacob E.; Carroll, Dana] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Carroll, Dana] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Carroll, D (reprint author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.				NIH [R01 GM078571]; Siebel Scholars Fund; California Institute for Regenerative Medicine; Heritage Medical Research Institute; Li Ka Shing Foundation	We are grateful to people who contributed to the experiments described, including Julia Wang, Nick Bray, Wendy Magis and David Martin. Emily Lingeman and Amos Liang helped in testing the protocols for the 2016 IGI CRISPR Workshop. Funding was provided by NIH grant R01 GM078571 (DC), the Siebel Scholars Fund (DC and MD), a California Institute for Regenerative Medicine postdoctoral fellowship (The CIRM fellowship was awarded to Mark A DeWitt (MD)), the Li Ka Shing Foundation (MD, DC, JEC) and the Heritage Medical Research Institute (JEC).	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cong L., 2013, SCIENCE, P339; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban M.D., 2015, BLOOD; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kouranova E, 2016, HUM GENE THER, V27, P464, DOI 10.1089/hum.2016.009; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Schumann K., 2015, P NATL ACAD SCI USA, V112; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Wu WB, 2017, P NATL ACAD SCI USA, V114, P1660, DOI 10.1073/pnas.1614775114; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	31	4	4	21	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						9	15		10.1016/j.ymeth.2017.04.003				7	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500003	28410976				2018-01-05	
J	Jacobi, AM; Rettig, GR; Turk, R; Collingwood, MA; Zeiner, SA; Quadros, RM; Harms, DW; Bonthuis, PJ; Gregg, C; Ohtsuka, M; Gurumurthy, CB; Behlke, MA				Jacobi, Ashley M.; Rettig, Garrett R.; Turk, Rolf; Collingwood, Michael A.; Zeiner, Sarah A.; Quadros, Rolen M.; Harms, Donald W.; Bonthuis, Paul J.; Gregg, Christopher; Ohtsuka, Masato; Gurumurthy, Channabasavaiah B.; Behlke, Mark A.			Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes	METHODS			English	Article						Genome editing; CRISPR; Cas9; crRNA-tracrRNA; Ribonucleoprotein (RNP) complex; Homology directed repair (HDR)	ONE-STEP GENERATION; KNOCK-IN; CAS9 RIBONUCLEOPROTEINS; ENGINEERED NUCLEASES; GENE DISRUPTION; MODIFIED MICE; DNA; MUTATIONS; SYSTEM; GUIDE	Genome editing using the CRISPR/Cas9 system requires the presence of guide RNAs bound to the Cas9 endonuclease as a ribonucleoprotein (RNP) complex in cells, which cleaves the host cell genome at sites specified by the guide RNAs. New genetic material may be introduced during repair of the double stranded break via homology dependent repair (HDR) if suitable DNA templates are delivered with the CRISPR components. Early methods used plasmid or viral vectors to make these components in the host cell, however newer approaches using recombinant Cas9 protein with synthetic guide RNAs introduced directly as an RNP complex into cells shows faster onset of action with fewer off-target effects. This approach also enables use of chemically modified synthetic guide RNAs that have improved nuclease stability and reduces the risk of triggering an innate immune response in the host cell. This article provides detailed methods for genome editing using the RNP approach with synthetic guide RNAs using lipofection or electroporation in mammalian cells or using microinjection in murine zygotes, with or without addition of a single-stranded HDR template DNA. (C) 2017 The Authors. Published by Elsevier Inc.	[Jacobi, Ashley M.; Rettig, Garrett R.; Turk, Rolf; Collingwood, Michael A.; Zeiner, Sarah A.; Behlke, Mark A.] Integrated DNA Technol Inc, Coralville, IA 52241 USA; [Quadros, Rolen M.; Harms, Donald W.; Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Vice Chancellor Res Off, Mouse Genome Engn Core Facil, Omaha, NE 68198 USA; [Bonthuis, Paul J.; Gregg, Christopher] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Gregg, Christopher] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Ohtsuka, Masato] Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Dept Mol Life Sci, Isehara, Kanagawa 2591193, Japan; [Ohtsuka, Masato] Tokai Univ, Grad Sch Med, Ctr Matrix Biol & Med, Isehara, Kanagawa 2591193, Japan; [Ohtsuka, Masato] Tokai Univ, Inst Med Sci, Isehara, Kanagawa 2591193, Japan; [Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Munroe Meyer Inst Genet & Rehabil, Dev Neurosci, Omaha, NE 68198 USA	Behlke, MA (reprint author), Integrated DNA Technol Inc, Coralville, IA 52241 USA.; Gurumurthy, CB (reprint author), Univ Nebraska Med Ctr, Omaha, NE 68198 USA.	cgurumurthy@unmc.edu; mbehlke@idtdna.com	Turk, Rolf/E-7832-2010	Turk, Rolf/0000-0003-1283-9594; Behlke, Mark/0000-0002-4218-857X	NIH [1R01MH109577-01]; New York Stem Cell Foundation - Robertson Investigator award;  [P20GM103471]	This work was supported in part by an Institutional Development Award (PI: Shelley Smith) P20GM103471 (to CBG, DWH and RMQ), by NIH 1R01MH109577-01 and by New York Stem Cell Foundation - Robertson Investigator award (to C.G.). The authors thank Matt McNeill for assistance with bioinformatics analysis of the NGS experiments.	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujihara Y, 2014, METHOD ENZYMOL, V546, P319, DOI 10.1016/B978-0-12-801185-0.00015-5; Gurumurthy C.B., 2016, ENOME EDITING, P65; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Mean RJ, 2004, BIOTECHNIQUES, V36, P758; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Quadros R.M., 2017, GENOME BIOL; Quadros RM, 2015, FEBS OPEN BIO, V5, P191, DOI 10.1016/j.fob.2015.03.003; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Richardson CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12463; Rivera-Torres N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169350; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sung YH, 2014, METHODS, V69, P85, DOI 10.1016/j.ymeth.2014.02.009; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	36	1	1	24	24	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						16	28		10.1016/j.ymeth.2017.03.021				13	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500004	28351759	gold			2018-01-05	
J	Yumlu, S; Stumm, J; Bashir, S; Dreyer, AK; Lisowski, P; Danner, E; Kuhn, R				Yumlu, Saniye; Stumm, Juergen; Bashir, Sanum; Dreyer, Anne-Kathrin; Lisowski, Pawel; Danner, Eric; Kuehn, Ralf			Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9	METHODS			English	Article						Pluripotent stem cells; Gene editing; CRISPR; Cas9; Knockout; Knockin	HUMAN IPS CELLS; CRISPR-CAS9 NUCLEASES; GENOME; MUTATIONS; SPECIFICITY; EXPRESSION; EFFICIENCY; TALENS; CAS9; DNA	Human induced pluripotent stem cells (hiPSCs) represent an ideal in vitro platform to study human genetics and biology. The recent advent of programmable nucleases makes also the human genome amenable to experimental genetics through either the correction of mutations in patient-derived iPSC lines or the de novo introduction of mutations into otherwise healthy iPSCs. The production of specific and sometimes complex genotypes in multiple cell lines requires efficient and streamlined gene editing technologies. In this article we provide protocols for gene editing in hiPSCs. We presently achieve high rates of gene editing at up to three loci using a modified iCRISPR system. This system includes a doxycydine inducible Cas9 and sgRNA/reporter plasmids for the enrichment of transfected cells by fluorescence activated cell sorting (FACS). Here we cover the selection of target sites, vector construction, transfection, and isolation and genotyping of modified hiPSC clones. (C) 2017 Elsevier Inc. All rights reserved.	[Yumlu, Saniye; Stumm, Juergen; Bashir, Sanum; Dreyer, Anne-Kathrin; Lisowski, Pawel; Danner, Eric; Kuehn, Ralf] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Yumlu, Saniye; Bashir, Sanum; Dreyer, Anne-Kathrin; Kuehn, Ralf] Berlin Inst Hlth, Kapelle Ufer 2, D-10117 Berlin, Germany; [Stumm, Juergen] Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Lisowski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, PL-05552 Magdalenka, Poland	Kuhn, R (reprint author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.	saniye.yumlu@mdc-berlin.de; juergen.stumm@mdc-berlin.de; sanum.bashir@mdc-berlin.de; anne-kathrin.dreyer@mdc-berlin.de; pawel.lisowski@mdc-berlin.de; eric.danner@mdc-berlin.de; ralf.kuehn@mdc-berlin.de	Kuhn, Ralf/U-1278-2017	Kuhn, Ralf/0000-0003-1694-9803; , Eric/0000-0003-3277-5727	National Science Center, Poland [2016/22/M/NZ2/00548]	We thank Dr Harald Stachelscheid (Berlin-Brandenburg Center for Regenerative Therapies) for kindly providing us the iPSC line BCRT#1 and Dr Heiko Lickert (Helmholtz Center Munich) for kindly providing the iPSC line XM001. We also thank Dr Sebastian Diecke who performed karyotyping and SNP analysis (iPSC Core Facility, Max-Delbrtick-Center, Berlin). PL was supported by National Science Center, Poland Grant No. 2016/22/M/NZ2/00548.	Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI [10.1146/annurev.biochern.77.061306.125255, 10.1146/annurev.biochem.77.061306.125255]; Glaser A, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.48; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hasty P, 2000, GENE TARGETING PRACT, P1; Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hotta A, 2015, ANNU REV GENET, V49, P47, DOI 10.1146/annurev-genet-112414-054926; Kim HS, 2014, STEM CELLS DEV, V23, P2673, DOI 10.1089/scd.2014.0167; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Makino S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39608; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Park CY, 2016, NAT PROTOC, V11, P2154, DOI 10.1038/nprot.2016.129; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Pedersen AG, 1997, ISMB, V5, P226; Peters Derek, 2014, STEMBOOK, DOI [10.3824/stembook.1.94.1, DOI 10.3824/STEMBOOK.1.94.1]; Priori SG, 2013, J CLIN INVEST, V123, P84, DOI 10.1172/JCI62838; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Schick JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32326; Shin J.W., 2016, HUM MOL GENET, DOI DOI 10.1093/HMG/DDW286; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Streeter I, 2017, NUCLEIC ACIDS RES, V45, pD691, DOI 10.1093/nar/gkw928; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Turan S, 2016, MOL THER, V24, P685, DOI 10.1038/mt.2016.40; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wefers B., 2011, CURR PROTOC MOUSE BI, P199; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	48	2	2	8	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						29	44		10.1016/j.ymeth.2017.05.009				16	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500005	28522326				2018-01-05	
J	Wassef, M; Luscan, A; Battistella, A; Le Corre, S; Li, H; Wallace, MR; Vidaud, M; Margueron, R				Wassef, M.; Luscan, A.; Battistella, A.; Le Corre, S.; Li, H.; Wallace, M. R.; Vidaud, M.; Margueron, R.			Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines	METHODS			English	Article						Genome editing; CRISPR/CAS9; Targeting vector; Reversible knockout; Constitutive knockout; Point mutation	EMBRYONIC STEM-CELLS; NERVE SHEATH TUMORS; SF3B1 MUTATIONS; GENOME; CANCER; SUZ12; PRC2; MICE	The advent of programmable nucleases such as ZFNs, TALENs and CRISPR/Cas9 has brought the power of genetic manipulation to widely used model systems. In mammalian cells, nuclease-mediated DNA double strand break is mainly repaired through the error-prone non-homologous end joining (NHEJ) repair pathway, eventually leading to accumulation of small deletions or insertions (indels) that can inactivate gene function. However, due to the variable size of the indels and the polyploid status of many cell lines (e.g., cancer-derived cells), obtaining a knockout usually requires lengthy screening and characterization procedures. Given the more precise type of modifications that can be introduced upon homology-directed repair (HDR), we have developed HDR-based gene-targeting strategies that greatly facilitate the process of knockout generation in cell lines. To generate reversible knockouts (R-KO), a selectable promoter-less STOP cassette is inserted in an intron, interrupting transcription. Loss-of-function can be validated by RT-qPCR and is removable, enabling subsequent restoration of gene function. A variant of the R-KO procedure can be used to introduce point mutations. To generate constitutive knockouts (C-KO), an exon is targeted, which makes use of HDR-based gene disruption together with NHEJ-induced indels on nonHDR targeted allele(s). Hence the C-KO procedure greatly facilitates simultaneous inactivation of multiple alleles. Overall these genome-editing tools offer superior precision and efficiency for functional genetic approaches. We provide detailed protocols guiding in the design of targeting vectors and in the analysis and validation of gene targeting experiments. (C) 2017 Elsevier Inc. All rights reserved.	[Wassef, M.; Battistella, A.; Le Corre, S.; Margueron, R.] PSL Res Univ, Inst Curie, F-75005 Paris, France; [Wassef, M.; Battistella, A.; Le Corre, S.; Margueron, R.] INSERM, U934, Paris, France; [Wassef, M.; Battistella, A.; Le Corre, S.; Margueron, R.] CNRS, UMR3215, Paris, France; [Luscan, A.; Vidaud, M.] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, INSERM UMR S745, F-75006 Paris, France; [Luscan, A.; Vidaud, M.] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA7331, F-75006 Paris, France; [Luscan, A.; Vidaud, M.] Hop Cochin, AP HP, Serv Biochim & Genet Mol, F-75014 Paris, France; [Li, H.; Wallace, M. R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Wallace, M. R.] Univ Florida, Hlth Canc Ctr, Gainesville, FL USA; [Wallace, M. R.] Univ Florida, Genet Inst, Gainesville, FL USA	Wassef, M (reprint author), PSL Res Univ, Inst Curie, F-75005 Paris, France.	michel.wassef@curie.fr	Vidaud, Michel/O-7346-2017		EpiUM grant; EpiNF1 grant; ERC-StG REPODDID grant; Labex DEEP	Work in R.M. lab was supported by the EpiUM and EpiNF1 grants, the ERC-StG REPODDID grant and the Labex DEEP. The authors thank M. Charruel for her technical support and I. Vassilev for extracting RNA-seq data.	Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330; Fusi N., 2015, BIORXIV; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Li H, 2016, LAB INVEST, V96, P1105, DOI 10.1038/labinvest.2016.88; Nakatake Y, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-64; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548                                                                ; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116; Zhang Y, 2014, METHODS, V69, P171, DOI 10.1016/j.ymeth.2014.05.003	25	1	1	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						45	54		10.1016/j.ymeth.2017.05.003				10	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500006	28499832				2018-01-05	
J	Wefers, B; Bashir, S; Rossius, J; Wurst, W; Kuhn, R				Wefers, Benedikt; Bashir, Sanum; Rossius, Jana; Wurst, Wolfgang; Kuehn, Ralf			Gene editing in mouse zygotes using the CRISPR/Cas9 system	METHODS			English	Article						CRISPR; Cas9; Mouse; Zygotes; Gene editing	OFF-TARGET SITES; HUMAN-CELLS; CRISPR-CAS9 NUCLEASES; CAS9 NUCLEASES; MUTANT MICE; GUIDE RNAS; GENOME; GENERATION; SPECIFICITY; TOOL	The generation of targeted mouse mutants is a key technology for biomedical research. Using the CRISPR/Cas9 system for induction of targeted double-strand breaks, gene editing can be performed in a single step directly in mouse zygotes. This article covers the design of knockout and knockin alleles, preparation of reagents, microinjection or electroporation of zygotes and the genotyping of pups derived from gene editing projects. In addition we include a section for the control of experimental settings by targeting the Rosa26 locus and PCR based genotyping of blastocysts. (C) 2017 Elsevier Inc. All rights reserved.	[Wefers, Benedikt; Wurst, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Feodor Lynen Str 17, D-81377 Munich, Germany; [Wefers, Benedikt; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm Hlth, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Bashir, Sanum; Rossius, Jana; Kuehn, Ralf] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Bashir, Sanum; Kuehn, Ralf] Berlin Inst Hlth, Kapelle Ufer 2, D-10117 Berlin, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Chair Dev Genet, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] Munich Cluster Syst Neurol SyNergy, Feodor Lynen Str 17, D-81377 Munich, Germany	Kuhn, R (reprint author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	benedikt.wefers@dzne.de; sanum.bashir@mdc-berlin.de; jana.rossius@mdc-berlin.de; wurst@helmholtz-muenchen.de; ralf.kuehn@mdc-berlin.de	Kuhn, Ralf/U-1278-2017	Kuhn, Ralf/0000-0003-1694-9803	German Ministry of Education and Research within the VIP program	This work was supported by the German Ministry of Education and Research within the VIP program.	Aouida M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133373; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujii W, 2016, BIOCHEM BIOPH RES CO, V477, P473, DOI 10.1016/j.bbrc.2016.06.070; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hall B, 2009, CURR PROTOC CELL BIO, P19, DOI DOI 10.1002/0471143030.CB1912S44; Hara S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11221; Hasty P, 2000, GENE TARGETING PRACT, P1; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Terao M, 2016, EXP ANIM TOKYO, V65, P275, DOI 10.1538/expanim.15-0116; Wefers B, 2016, METHODS MOL BIOL, V1338, P229, DOI 10.1007/978-1-4939-2932-0_17; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32565	50	1	1	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						55	67		10.1016/j.ymeth.2017.02.008				13	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500007	28263886				2018-01-05	
J	Mianne, J; Codner, GF; Caulder, A; Fell, R; Hutchison, M; King, R; Stewart, ME; Wells, S; Teboul, L				Mianne, Joffrey; Codner, Gemma F.; Caulder, Adam; Fell, Rachel; Hutchison, Marie; King, Ruairidh; Stewart, Michelle E.; Wells, Sara; Teboul, Lydia			Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control	METHODS			English	Article						CRISPR; Cas9; Genome editing; Screening; Genotyping; Mouse; Mutant; QC	HOMOLOGY-DIRECTED REPAIR; ONE-STEP GENERATION; OFF-TARGET; C57BL/6N MICE; DNA; MUTATIONS; NUCLEASES; ENDONUCLEASE; MUTAGENESIS; PHENOTYPE	The application of CRISPR/Cas9 technology has revolutionised genetics by greatly enhancing the efficacy of genome editing in the early embryo. Furthermore, the system has enabled the generation of allele types previously incompatible with in vivo mutagenesis. Despite its versatility and ease of implementation, CRISPR/Cas9 editing outcome is unpredictable and can generate mosaic founders. Therefore, careful genotyping and characterisation of new mutants is proving essential. The literature presents a wide range of protocols for molecular characterisation, each representing different levels of investment. We present strategies and protocols for designing, producing and screening CRISPR/Cas9 edited founders and genotyping their offspring according to desired allele type (indel, point mutation and deletion). (C) 2017 The Authors. Published by Elsevier Inc.	[Mianne, Joffrey; Codner, Gemma F.; Caulder, Adam; Fell, Rachel; Hutchison, Marie; King, Ruairidh; Stewart, Michelle E.; Wells, Sara; Teboul, Lydia] MRC, Harwell Inst, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England	Teboul, L (reprint author), MRC, Harwell Inst, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England.	l.teboul@har.mrc.ac.uk		Mianne, Joffrey/0000-0003-0893-9947	Medical Research Council IMPC Strategic Award [53658]; National Institute for Health [U42OD011174]	The authors would like to thank the staff of the Mary Lyon Centre for providing excellent animal husbandry and microinjection services. This work was supported by a Medical Research Council IMPC Strategic Award (53658 to SW and LT) and a National Institute for Health (Supplement to Grant U42OD011174 to SW). The authors thank all colleagues of the involved in mouse production in the International Mouse Phenotyping Consortium for helpful discussions.	Bassett AR, 2014, BIOL OPEN, V3, P42, DOI 10.1242/bio.20137120; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Codner GF, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0108-6; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gardiner Wendy J K, 2009, Methods Mol Biol, V561, P111, DOI 10.1007/978-1-60327-019-9_8; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Low BE, 2014, INVEST OPHTH VIS SCI, V55, P387, DOI 10.1167/iovs.13-13278; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126	22	3	3	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						68	76		10.1016/j.ymeth.2017.03.016				9	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500008	28363792	gold			2018-01-05	
J	Albadri, S; Del Bene, F; Revenu, C				Albadri, Shahad; Del Bene, Filippo; Revenu, Celine			Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish	METHODS			English	Article						Knock-in; CRISPR/Cas9; Genome editing; Homologous recombination; Non-homologous-end-joining; Zebrafish	DOUBLE-STRAND BREAKS; ONE-STEP GENERATION; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; OFF-TARGET; CELL-CYCLE; EFFICIENT; CRISPR-CAS9; INTEGRATION; SYSTEM	With its variety of applications, the CRISPR/Cas9 genome editing technology has been rapidly evolving in the last few years. In the zebrafish community, knock-out reports are constantly increasing but insertion studies have been so far more challenging. With this review, we aim at giving an overview of the homologous directed repair (HDR)-based knock-in generation in zebrafish. We address the critical points and limitations of the procedure such as cutting efficiency of the chosen single guide RNA, use of cas9 mRNA or Cas9 protein, homology arm size etc. but also ways to circumvent encountered issues with HDR insertions by the development of non-homologous dependent strategies. While imprecise, these homology-independent mechanisms based on non-homologous-end-joining (NHEJ) repair have been employed in zebrafish to generate reporter lines or to accurately edit an open reading frame by the use of intron-targeting modifications. Therefore, with higher efficiency and insertion rate, NHEJ-based knock-in seems to be a promising approach to target endogenous loci and to circumvent the limitations of HDR whenever it is possible and appropriate. In this perspective, we propose new strategies to generate cDNA edited or tagged insertions, which once established will constitute a new and versatile toolbox for CRISPR/Cas9-based knock-ins in zebrafish. (C) 2017 Elsevier Inc. All rights reserved.	[Albadri, Shahad; Del Bene, Filippo; Revenu, Celine] PSL Res Univ, Inst Curie, INSERM U934, CNRS UMR3215, F-75248 Paris 05, France	Del Bene, F (reprint author), PSL Res Univ, Inst Curie, INSERM U934, CNRS UMR3215, F-75248 Paris 05, France.	filippo.del-bene@curie.fr		del bene, filippo/0000-0001-8551-2846	ATIP/AVENIR program, ERC-StG [311159-Zebratectum]; EU H Marie Sklodowska-Curie Action fellowship (H-MSCA-IF) [661527]; Fondation Berthe Fouassier (Fondation de France) [2015-00060246]	We are grateful to J-P Concordet, Museum National d'Histoire Naturelle Paris, and H. Besir, European Molecular Biology Laboratory Heidelberg, for providing us with Cas9 protein samples. The Del Bene team "Neural Circuit Development" is part of the Laboratoire d'Excellence (LABEX) entitled DEEP (ANR-11-LABX-0044), and of the Ecole des Neurosciences de Paris Ile-de-France network. This work has been supported by an ATIP/AVENIR program starting grant, ERC-StG #311159-Zebratectum (F.D.B.), CNRS, INSERM, Institut Curie. CR is supported by a EU H2020 Marie Sklodowska-Curie Action fellowship (H2020-MSCA-IF-2014 #661527). SA is supported by the Fondation Berthe Fouassier (Fondation de France #2015-00060246).	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188; Auer TO, 2015, ELIFE, V4, DOI 10.7554/eLife.05061; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Dai J, 2010, INT J BIOL SCI, V6, P756; Di Donato V, 2016, GENOME RES, V26, P681, DOI 10.1101/gr.196170.115; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gilbert S.F., 2000, EARLY DEV FISH; Grainger S, 2016, ZEBRAFISH; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hagmann M, 1998, BIOL CHEM, V379, P673, DOI 10.1515/bchm.1998.379.6.673; He MD, 2015, MUTAT RES-FUND MOL M, V780, P86, DOI 10.1016/j.mrfmmm.2015.08.004; Hiom K, 2010, DNA REPAIR, V9, P1256, DOI 10.1016/j.dnarep.2010.09.018; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Horstick EJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv035; Hoshijima K, 2016, METHOD CELL BIOL, V135, P121, DOI 10.1016/bs.mcb.2016.04.008; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hwang Woong Y, 2015, Methods Mol Biol, V1311, P317, DOI 10.1007/978-1-4939-2687-9_21; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Li J, 2015, ONCOTARGET, V6, P17891, DOI 10.18632/oncotarget.4547                                                        ; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Ota S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34991; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Siefert JC, 2015, COMP BIOCHEM PHYS C, V178, P8, DOI 10.1016/j.cbpc.2015.10.003; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Thyme S. B., 2016, CELL REP; Trion U., 2014, DEVELOPMENT, V141, P4827; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917; Zhang Y, 2016, METHOD CELL BIOL, V135, P107, DOI 10.1016/bs.mcb.2016.03.005; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	46	4	4	13	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						77	85		10.1016/j.ymeth.2017.03.005				9	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500009	28300641				2018-01-05	
J	Paix, A; Folkmann, A; Seydoux, G				Paix, Alexandre; Folkmann, Andrew; Seydoux, Geraldine			Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans	METHODS			English	Article						Genome editing; CRISPR; C. elegans; Cas9 RNP; Linear repair templates; Short homology; Gene conversion; Homology-dependent repair (HDR)	CAENORHABDITIS-ELEGANS; BACTERIAL IMMUNITY; INACTIVATION; CRISPR/CAS9; EFFICIENCY; NUCLEASES; DESIGN	The ability to introduce targeted edits in the genome of model organisms is revolutionizing the field of genetics. State-of-the-art methods for precision genome editing use RNA-guided endonucleases to create double-strand breaks (DSBs) and DNA templates containing the edits to repair the DSBs. Following this strategy, we have developed a protocol to create precise edits in the C. elegans genome. The protocol takes advantage of two innovations to improve editing efficiency: direct injection of CRISPR-Cas9 ribonucleoprotein complexes and use of linear DNAs with short homology arms as repair templates. The protocol requires no cloning or selection, and can be used to generate base and gene-size edits in just 4 days. Point mutations, insertions, deletions and gene replacements can all be created using the same experimental pipeline. (C) 2017 The Authors. Published by Elsevier Inc.	[Paix, Alexandre; Folkmann, Andrew; Seydoux, Geraldine] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA	Paix, A; Folkmann, A (reprint author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	apaix1@jhmi.edu; afolkma1@jhu.edu	Paix, Alexandre/E-9137-2011	Paix, Alexandre/0000-0002-8080-7546; Seydoux, Geraldine/0000-0001-8257-0493	National Institutes of Health (NIH) [R01HD37047]	This work was supported by National Institutes of Health (NIH) [Grant No. R01HD37047]. G.S. is an investigator of the Howard Hughes Medical Institute.	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Heppert JK, 2016, MOL BIOL CELL, V27, P3385, DOI 10.1091/mbc.E16-01-0063; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H.M., 2016, CURR PROTOC MOL BIOL, V115, P3171, DOI 10.1002/cpmb.7; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; McVey M, 2016, ANNU REV GENET, V50, P393, DOI 10.1146/annurev-genet-120215-035243; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Paix A., 2016, NUCL ACIDS RES; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Schwartz M.L., 2016, GENETICS; Smith J, 2016, ELIFE, V5, DOI 10.7554/eLife.21337; Ward JD, 2015, GENETICS, V199, P363, DOI 10.1534/genetics.114.172361; Xu SH, 2015, J GENET GENOMICS, V42, P413, DOI 10.1016/j.jgg.2015.06.005	23	3	3	6	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						86	93		10.1016/j.ymeth.2017.03.023				8	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500010	28392263	gold			2018-01-05	
J	Liu, XJ; Xie, CX; Si, HJ; Yang, JX				Liu, Xuejun; Xie, Chuanxiao; Si, Huaijun; Yang, Jinxiao			CRISPR/Cas9-mediated genome editing in plants	METHODS			English	Article							RNA-GUIDED ENDONUCLEASE; CRISPR-CAS SYSTEM; TARGETED MUTAGENESIS; HOMOLOGOUS RECOMBINATION; GENE-EXPRESSION; HUMAN-CELLS; TRANSCRIPTIONAL ACTIVATION; ENGINEERED CRISPR-CAS9; NEISSERIA-MENINGITIDIS; NUCLEASE SPECIFICITY	The increasing burden of the world's population on agriculture necessitates the development of more robust crops. As the amount of information from sequenced crop genomes increases, technology can be used to investigate the function of genes in detail and to design improved crops at the molecular level. Recently, an RNA-programmed genome-editing system composed of a clustered regularly interspaced short palindromic repeats (CRISPR)-encoded guide RNA and the nuclease Cas9 has provided a powerful platform to achieve these goals. By combining versatile tools to study and modify plants at different molecular levels, the CRISPR/Cas9 system is paving the way towards a new horizon for basic research and crop development. In this review, the accomplishments, problems and improvements of this technology in plants, including target sequence cleavage, knock-in/gene replacement, transcriptional regulation, epigenetic modification, off-target effects, delivery system and potential applications, will be highlighted. (C) 2017 Elsevier Inc. All rights reserved.	[Liu, Xuejun] Tianjin Crops Res Inst, Tianjin, Peoples R China; [Xie, Chuanxiao] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Si, Huaijun] GanSu Agr Univ, Coll Life Sci & Technol, Lanzhou, Gansu, Peoples R China; [Yang, Jinxiao] Beijing DaBeiNong Technol Grp, Beijing, Peoples R China	Yang, JX (reprint author), Beijing DaBeiNong Technol Grp, Beijing, Peoples R China.	sdlxj818@163.com; xiechuarociao@caas.cn; hjsi@gsau.edu.cn; jinxiao.yang@dbn.com.cn			Beijing Municipal Science & Technology Commission Fund [Z151100001015002]	This work was supported by grants from Beijing Municipal Science & Technology Commission Fund. The funding number is Z151100001015002.	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Ali Z, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1044191; Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barakate A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00765; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen KL, 2014, PLANT CELL REP, V33, P575, DOI 10.1007/s00299-013-1539-6; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chilton MDM, 2003, PLANT PHYSIOL, V133, P956, DOI 10.1104/pp.103.026104; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gao XQ, 2015, PLANT PHYSIOL, V167, P11, DOI 10.1104/pp.114.246173; Gao Y., 2016, NAT METHODS; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Go DE, 2016, CURR MOL MED, V16, P343, DOI 10.2174/1566524016666160316150847; Hara S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11221; Hiei Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00628; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; JEANNOTTE L, 1991, MOL CELL BIOL, V11, P5578, DOI 10.1128/MCB.11.11.5578                                                          ; Jia HG, 2006, TRANSGENIC RES, V15, P375, DOI 10.1007/s11248-006-0011-6; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kerbach S, 2005, THEOR APPL GENET, V111, P1608, DOI 10.1007/s00122-005-0092-2; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kuzma J, 2016, NATURE, V531, P165, DOI 10.1038/531165a; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Ledford H, 2016, NATURE, V532, P158, DOI 10.1038/532158a; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34531; [刘婷婷 Liu Tingting], 2015, [遗传, Hereditas(Beijing)], V37, P1044, DOI 10.16288/j.yczz.15-303; Liu WS, 2013, NAT REV GENET, V14, P781, DOI 10.1038/nrg3583; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Lozano-Juste J, 2014, TRENDS PLANT SCI, V19, P284, DOI 10.1016/j.tplants.2014.02.014; Ma X., 2016, CURR PROTOC MOL BIOL, V115; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maruyama T, 2016, NAT BIOTECHNOL, V34, P210, DOI 10.1038/nbt0216-210c; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; MCCARRICK JW, 1993, TRANSGENIC RES, V2, P183, DOI 10.1007/BF01977348; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishida K., 2016, SCIENCE, P353; Nishizawa-Yokoi A, 2015, PLANT PHYSIOL, V169, P362, DOI 10.1104/pp.15.00638; Nishizawa-Yokoi A, 2014, PLANT J, V77, P454, DOI 10.1111/tpj.12367; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Perkel Jeffrey M, 2014, Nature, V514, P395; Petolino JF, 2013, PLANT SCI, V201, P128, DOI 10.1016/j.plantsci.2012.12.006; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Pradhan S, 2016, PLANTA, V244, P789, DOI 10.1007/s00425-016-2535-1; Puchta H, 2002, PLANT MOL BIOL, V48, P173, DOI 10.1023/A:1013761821763; Gutierrez C, 2015, PLANT J, V83, P1, DOI [10.1111/tpj.12909, 10.1111/tpj.13100]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qi WW, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0289-2; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Rastogi A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1143-1; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Selle K, 2015, J FOOD SCI, V80, pR2367, DOI 10.1111/1750-3841.13094; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Snell-Rood E, 2016, NATURE, V529, P277, DOI 10.1038/529277a; Subburaj S, 2016, PLANT CELL REP, V35, P1535, DOI 10.1007/s00299-016-1937-7; Sun YW, 2016, MOL PLANT, V9, P628, DOI 10.1016/j.molp.2016.01.001; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tiwari SB, 2012, PLANT J, V70, P855, DOI 10.1111/j.1365-313X.2012.04935.x; Tsai CS, 2015, BIOTECHNOL BIOENG, V112, P2406, DOI 10.1002/bit.25632; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XHW, 2001, GENE, V272, P249, DOI 10.1016/S0378-1119(01)00532-7; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; [韦余达 Wei Yuda], 2015, [遗传, Hereditas(Beijing)], V37, P983, DOI 10.16288/j.yczz.15-239; Weinthal DM, 2013, PLANT PHYSIOL, V162, P390, DOI 10.1104/pp.112.212910; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yamamoto Y, 2015, G3-GENES GENOM GENET, V5, P1843, DOI 10.1534/g3.115.019901; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Yuan M, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.35; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20315; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838	134	2	2	47	47	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						94	102		10.1016/j.ymeth.2017.03.009				9	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500011	28315486				2018-01-05	
J	Collonnier, C; Guyon-Debast, A; Maclot, F; Mara, K; Chariot, F; Nogue, F				Collonnier, Cecile; Guyon-Debast, Anouchka; Maclot, Francois; Mara, Kostlend; Chariot, Florence; Nogue, Fabien			Towards mastering CRISPR-induced gene knock-in in plants: Survey of key features and focus on the model Physcomitrella patens	METHODS			English	Article						CRISPR-Cas9 system; Gene knock-in; Genome editing; Gene targeting; Physcomitrella patens	DOUBLE-STRAND BREAKS; HOMOLOGY-DIRECTED REPAIR; PLURIPOTENT STEM-CELLS; TARGETED MUTAGENESIS; MAMMALIAN-CELLS; GUIDE RNA; TRANSCRIPTIONAL REGULATION; ARABIDOPSIS-THALIANA; GENOME MODIFICATION; DNA REPLICONS	Beyond its predominant role in human and animal therapy, the CRISPR-Cas9 system has also become an essential tool for plant research and plant breeding. Agronomic applications rely on the mastery of gene inactivation and gene modification. However, if the knock-out of genes by non-homologous end joining (NHEJ)-mediated repair of the targeted double-strand breaks (DSBs) induced by the CRISPR-Cas9 system is rather well mastered, the knock-in of genes by homology-driven repair or end joining remains difficult to perform efficiently in higher plants. In this review, we describe the different approaches that can be tested to improve the efficiency of CRISPR-induced gene modification in plants, which include the use of optimal transformation and regeneration protocols, the design of appropriate guide RNAs and donor templates and the choice of nucleases and means of delivery. We also present what can be done to orient DNA repair pathways in the target cells, and we show how the moss Physcomitrella patens can be used as a model plant to better understand what DNA repair mechanisms are involved, and how this knowledge could eventually be used to define more performant strategies of CRISPR-induced gene knock-in. (C) 2017 Elsevier Inc. All rights reserved.	[Collonnier, Cecile; Guyon-Debast, Anouchka; Maclot, Francois; Mara, Kostlend; Chariot, Florence; Nogue, Fabien] INRA, Ctr Versailles Grignon, IJPB, UMR1318, Route St Cyr, F-78026 Versailles, France	Collonnier, C; Nogue, F (reprint author), INRA, Ctr Versailles Grignon, IJPB, UMR1318, Route St Cyr, F-78026 Versailles, France.	cecile.collonnier@inra.fr; fabien.nogue@inra.fr			French government through the programme "Investissements d'Avenir"; French National Research Agency, in the research project called "GENIUS" (Genome ENgineering Improvement for Useful plants of a Sustainable agriculture) [ANR11-BTBR-0001-GENIUS]	This work was supported by the French government through the programme "Investissements d'Avenir" and by the French National Research Agency, in the frame of the research project called "GENIUS" (Genome ENgineering Improvement for Useful plants of a Sustainable agriculture), ref # ANR11-BTBR-0001-GENIUS.	Alagoz Y., 2016, NAT PUBL GR, P1; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Burstein D., 2016, NATURE, P1; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Charlot F, 2014, NUCLEIC ACIDS RES, V42, P11965, DOI 10.1093/nar/gku890; Collonnier C., 2016, PLANT BIOTECHNOL J, P1; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; Ding YD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00703; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Haeussler M, 2016, J GENET GENOMICS, V43, P239, DOI 10.1016/j.jgg.2016.04.008; Hahn F, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00039; Hanin M, 2003, CURR OPIN PLANT BIOL, V6, P157, DOI 10.1016/S1369-5266(03)00016-5; HE XJ, 2016, NUCL ACIDS RES, V44; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Hu X., 2016, J GENET GENOMICS, V44, P2016; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Iwase A, 2015, J PLANT RES, V128, P389, DOI 10.1007/s10265-015-0714-y; Jiang W., 2013, NUCL ACIDS RES, V41; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamisugi Y, 2012, NUCLEIC ACIDS RES, V40, P3496, DOI 10.1093/nar/gkr1272; Kamisugi Y, 2006, NUCLEIC ACIDS RES, V34, P6205, DOI 10.1093/nar/gkl832; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Komor AC, 2016, NATURE, V61, P5985, DOI DOI 10.1038/NATUREL7946; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Larsen JS, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-21; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li H, 2014, PLANT CELL, V26, P195, DOI 10.1105/tpc.113.116491; Li JY, 2017, MOL PLANT, V10, P526, DOI 10.1016/j.molp.2016.12.001; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li QL, 2016, J GENET GENOMICS, V43, P415, DOI 10.1016/j.jgg.2016.04.011; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21451; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Liang Z., 2017, NAT PUBL GR, V8, P1; Lopez-Obando M, 2016, G3-GENES GENOM GENET, V6, P3647, DOI 10.1534/g3.116.033266; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mayavan S, 2015, PLANT CELL REP, V34, P1835, DOI 10.1007/s00299-015-1831-8; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Morineau C., 2016, PLANT BIOTECHNOL J; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Osakabe Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26685; Parry G, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0104-z; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Puchta H, 2013, INT J DEV BIOL, V57, P629, DOI 10.1387/ijdb.130194hp; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Ren C., 2016, SCI REP, V6, P1; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Schaefer DG, 2010, DNA REPAIR, V9, P526, DOI 10.1016/j.dnarep.2010.02.001; Schaefer DG, 2002, ANNU REV PLANT BIOL, V53, P477, DOI 10.1146/annurev.arplant.53.100301.135202; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi J., 2016, PLANT BIOTECHNOL J; Shimatani Z., 2017, NAT BIOTECHNOL, P3; Shimatani Z, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00748; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Sovova T, 2017, CURR ISSUES MOL BIOL, V21, P41, DOI 10.21775/cimb.021.041; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Subburaj S, 2016, PLANT CELL REP, V35, P1535, DOI 10.1007/s00299-016-1937-7; Subramanyam S, 2013, NUCLEIC ACIDS RES, V41, P9020, DOI 10.1093/nar/gkt691; Sun YW, 2016, MOL PLANT, V9, P628, DOI 10.1016/j.molp.2016.01.001; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737; Trouiller B, 2006, NUCLEIC ACIDS RES, V34, P232, DOI 10.1093/nar/gkj423; Trouiller B, 2007, BIOTECHNOL LETT, V29, P1591, DOI 10.1007/s10529-007-9423-5; Vad-Nielsen J, 2016, CELL MOL LIFE SCI, V73, P4315, DOI 10.1007/s00018-016-2271-5; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Waltz E, 2016, NAT BIOTECHNOL, V34, P582, DOI 10.1038/nbt0616-582; Wang LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01333; Wang W., 2016, OPTIMIZING MUL UNPUB, DOI [10.1101/051342, DOI 10.1101/051342]; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Xu RF, 2016, J GENET GENOMICS, V43, P529, DOI 10.1016/j.jgg.2016.07.003; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang Y, 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS12617; Zong Y., 2017, PRECISE BASE EDITING, P4, DOI [10.1038/nbt.3811, DOI 10.1038/NBT.3811]	121	2	2	19	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						103	117		10.1016/j.ymeth.2017.04.024				15	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500012	28478103				2018-01-05	
J	Canver, MC; Bauer, DE; Orkin, SH				Canver, Matthew C.; Bauer, Daniel E.; Orkin, Stuart H.			Functional interrogation of non-coding DNA through CRISPR genome editing	METHODS			English	Article							HOMOLOGY-DIRECTED REPAIR; ONE-STEP GENERATION; SEQUENCE-SPECIFIC CONTROL; MEDIATED KNOCK-IN; HUMAN-CELLS; MAMMALIAN-CELLS; OFF-TARGET; HIGH-THROUGHPUT; REGULATORY DNA; CHROMOSOMAL REARRANGEMENTS	Methodologies to interrogate non-coding regions have lagged behind coding regions despite comprising the vast majority of the genome. However, the rapid evolution of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing has provided a multitude of novel techniques for laboratory investigation including significant contributions to the toolbox for studying non-coding DNA. CRISPR-mediated loss-of-function strategies rely on direct disruption of the underlying sequence or repression of transcription without modifying the targeted DNA sequence. CRISPR-mediated gain of -function approaches similarly benefit from methods to alter the targeted sequence through integration of customized sequence into the genome as well as methods to activate transcription. Here we review CRISPR-based loss-and gain-of-function techniques for the interrogation of non-coding DNA. (C) 2017 Elsevier Inc. All rights reserved.	[Canver, Matthew C.; Bauer, Daniel E.; Orkin, Stuart H.] Harvard Med Sch, Boston, MA 02115 USA; [Bauer, Daniel E.; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Bauer, DE; Orkin, SH (reprint author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	Daniel.Bauer@childrens.harvard.edu; Stuart_Orkin@dfci.harvard.edu		Canver, Matthew/0000-0002-8146-3992	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [F30DK103359-01A1]; NIDDK [K08DK093705, R03DK109232, P30DK049216]; NHLBI [DP2OD022716, P01HL032262]; Burroughs Wellcome Fund; Doris Duke Charitable Foundation Innovations in Clinical Research Award; ASH Scholar Award; Charles H. Hood Foundation Child Health Research Award; Cooley's Anemia Foundation fellowship	M.C.C. is supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Award (F30DK103359-01A1). D.E.B. is supported by NIDDK (K08DK093705, R03DK109232), NHLBI (DP2OD022716), Burroughs Wellcome Fund, Doris Duke Charitable Foundation Innovations in Clinical Research Award, ASH Scholar Award, Charles H. Hood Foundation Child Health Research Award, and Cooley's Anemia Foundation fellowship. S.H.O. is supported by an award from the NHLBI award (P01HL032262) and an award from the NIDDK (P30DK049216, Center of Excellence in Molecular Hematology).	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Aguirre A.J., 2016, CANCER DISCOV, V2641, P617; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Andrey G, 2015, CELL REPORTS, V10, P833; Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; Arroyo J.D., 2016, CELL METAB, V1550-4131, P30433; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bandopadhayay P, 2016, NAT GENET, V48, P273, DOI 10.1038/ng.3500; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bauer D.E., 2015, JOVE-J VIS EXP, V95, P1; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Brandl C, 2015, FEBS OPEN BIO, V5, P26, DOI 10.1016/j.fob.2014.11.009; Canver MC, 2016, BLOOD, V127, P2536, DOI 10.1182/blood-2016-01-678128; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Canver M.C., 2017, NAT GENET; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chi KR, 2016, NATURE, V538, P275, DOI 10.1038/538275a; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Chu V.T., 2016, EFFICIENT CRISPR MED; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Cross BCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31782; DeJesus R, 2016, ELIFE, V5, DOI 10.7554/elife.17290; Dever D.P., 2016, NATURE; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Drier Y, 2016, NAT GENET, V48, P265, DOI 10.1038/ng.3502; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fusi N., 2015, BIORXIV; Gao X., 2014, NUCL ACIDS RES, V42; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Ge XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.100; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guilinger J. P., 2014, NAT BIOTECHNOL; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Haeussler M, 2011, DEV BIOL, V350, P239, DOI 10.1016/j.ydbio.2010.11.026; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hashimoto T, 2016, GENOME RES, V26, P1430, DOI 10.1101/gr.199778.115; HE XJ, 2016, NUCL ACIDS RES, V44; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Housden BE, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3729; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kiessling MK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3042-2; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H.K., 2016, NAT METHODS; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koike-Yusa H., 2013, NAT BIOTECHNOL; Komor A.C., 2017, CELL, P1; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lekomtsev S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3084-5; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Li YX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0680-7; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu K.I., 2016, NAT CHEM BIOL; Liu S.J., 2016, SCIENCE; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lopes R, 2016, NAT REV MOL CELL BIO, V17, P597, DOI 10.1038/nrm.2016.79; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maji B., 2016, NAT CHEM BIOL, V5; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0                                                                ; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Miles LA, 2016, FEBS J, V283, P3170, DOI 10.1111/febs.13770; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34703; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nishida K, 2016, SCIENCE, V102, P553; Nowak C.M., 2016, NUCL ACIDS RES; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Parikh BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116484; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Raghavan A., 2016, BIORXIV; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson C.D., 2016, NAT BIOTECHNOL; Ruiz S, 2016, MOL CELL, V62, P307, DOI 10.1016/j.molcel.2016.03.006; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana N.E., 2016, ANAL BIOCH; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Sen D.R., 2016, SCIENCE; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; Shalem O., 2015, NAT REV GENET; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Simeonov D. R., 2016, BIORXIV; Singh P, 2015, P NATL ACAD SCI USA, V112, P10431, DOI 10.1073/pnas.1506974112; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Smith E, 2016, BLOOD, V128; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Steinhart Z., 2016, NAT MED; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vejnar C.E., 2016, COLD SPRING HARB PRO, V2016, P829; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wallace J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153689; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.95; Wettstein R., 2015, METHODS MOL BIOL; Wolfs J.M., 2016, P NATL ACAD SCI; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Wright JB, 2016, TRENDS GENET, V32, P526, DOI 10.1016/j.tig.2016.06.004; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B., 2016, NAT BIOTECHNOL; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhang X., 2015, NAT GENET, V48, P1, DOI DOI 10.1038/NG.3470; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	210	1	1	6	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						118	129		10.1016/j.ymeth.2017.03.008				12	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500013	28288828				2018-01-05	
J	Guernet, A; Grumolato, L				Guernet, Alexis; Grumolato, Luca			CRISPR/Cas9 editing of the genome for cancer modeling	METHODS			English	Article						CRISPR/Cas9; Cancer model; Tumor suppressor; Oncogene; Tumor heterogeneity; CRISPR-barcoding	CHROMOSOMAL REARRANGEMENTS; TUMOR HETEROGENEITY; STEM-CELLS; CRISPR-CAS9; DNA; THERAPY; SYSTEM; GROWTH; TECHNOLOGY; DISRUPTION	The CRISPR/Cas9 revolution has democratized access to genome editing in many biological fields, including cancer research. Cancer results from the multistep accumulation of mutations that confer to the transformed cells certain biological hallmarks typical of the malignant phenotype. One of the major goals in cancer research is to characterize such mutations and assess their implication in the oncogenic process. Through CRISPR/Cas9 technology, genetic aberrations identified in a patient's tumor can now be easily recreated in experimental models, which can then be used for basic research or for more translational applications. Here we review the different CRISPR/Cas9 strategies that have been implemented to recapitulate oncogenic mutations in both in vitro and in vivo systems, including novel strategies to model tumor evolution and genetic heterogeneity. (C) 2017 Elsevier Inc. All rights reserved.	[Grumolato, Luca] Normandie Univ, UNIROUEN, INSERM, DC2N, Rouen, France; IRIB, Rouen, France	Grumolato, L (reprint author), Normandie Univ, UNIROUEN, INSERM, DC2N, Rouen, France.	luca.grumolato@univ-rouen.fr		grumolato, luca/0000-0001-8231-3032	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Rouen Normandie; Ligue Contre le Cancer de Normandie; Normandy Region; Chair of Excellence program from INSERM	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite de Rouen Normandie and the Ligue Contre le Cancer de Normandie. A.G is recipient of a doctoral fellowship from the Normandy Region. L. G. was supported by a Chair of Excellence program from INSERM and Universite de Rouen Normandie.	Albers J, 2015, J CLIN INVEST, V125, P1603, DOI 10.1172/JCI79743; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Annunziato S, 2016, GENE DEV, V30, P1470, DOI 10.1101/gad.279190.116; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guernet A, 2016, MOL CELL, V63, P526; Harrod A., 2016, ONCOGENE; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Kleppe M, 2014, NAT MED, V20, P342, DOI 10.1038/nm.3522; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Neggers JE, 2015, CHEM BIOL, V22, P107, DOI 10.1016/j.chembiol.2014.11.015; Nguyen LV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6871; Nguyen L.V., 2015, NATURE; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	51	4	4	12	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						130	137		10.1016/j.ymeth.2017.03.007				8	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500014	28288827				2018-01-05	
J	Vanoli, F; Jasin, M				Vanoli, Fabio; Jasin, Maria			Generation of chromosomal translocations that lead to conditional fusion protein expression using CRISPR-Cas9 and homology-directed repair	METHODS			English	Article						Double-strand break; HDR; Chromosomal translocation; CRISPR-Cas9; EWSR1-WT1	DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; ZINC-FINGER; CANCER TRANSLOCATIONS; TALE NUCLEASES; PAIRED NICKS; STEM-CELLS; CAS9; GENE; REARRANGEMENTS	Recurrent chromosomal translocations often lead to expression of fusion proteins associated with oncogenic transformation. To study translocations and downstream events, genome editing techniques have been developed to generate chromosomal translocations through non-homologous end joining of DNA double-strand breaks introduced at the two participating endogenous loci. However, the frequencies at which these events occur is usually too low to efficiently clone cells carrying the translocation. This article provides a detailed method using CRISPR-Cas9 technology and homology-directed repair to efficiently isolate cells harboring a chromosomal translocation. For an additional level of control, the resulting fusion protein is conditionally expressed to allow early events in oncogenic transformation to be studied. We focus on the generation of the EWSR1-WT1 fusion using human mesenchymal cells, which is associated with the translocation found in desmoplastic small round cell tumors. (C) 2017 Elsevier Inc. All rights reserved.	[Vanoli, Fabio; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA	Jasin, M (reprint author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	m-jasin@ski.mskcc.org			NIH/NCI Cancer Center support grant [P30 CA008748]; Alex's Lemonade Stand Innovation Award [NIH R01CA185660, R35GM118175]	The authors wish to thank Travis White for critical reading of the manuscript, and Marc Ladanyi and Lee Spraggon for initial discussions and reagents. MSK research is supported by NIH/NCI Cancer Center support grant P30 CA008748. This work was supported by an Alex's Lemonade Stand Innovation Award, NIH R01CA185660 and R35GM118175 (M.J.).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; GERALD W L, 1989, Pediatric Pathology, V9, P177; Gerald William L., 1993, Zentralblatt fuer Pathologie, V139, P141; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lieber MR, 2016, NAT REV CANCER, V16, P387, DOI 10.1038/nrc.2016.40; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Perez AR, 2017, NAT BIOTECHNOL, V35, P347, DOI 10.1038/nbt.3804; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renouf B, 2014, METHOD ENZYMOL, V546, P251, DOI 10.1016/B978-0-12-801185-0.00012-X; Richardson C, 2000, NATURE, V405, P697; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Spraggon L, 2017, J PATHOL, V242, P102, DOI 10.1002/path.4883; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vanoli F, 2017, P NATL ACAD SCI USA, V114, P3696, DOI 10.1073/pnas.1700622114; Vriend LEM, 2016, NUCLEIC ACIDS RES, V44, P5204, DOI 10.1093/nar/gkw179; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Zhang Y, 2014, METHODS, V69, P171, DOI 10.1016/j.ymeth.2014.05.003	41	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 15	2017	121						138	145		10.1016/j.ymeth.2017.05.006				8	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EZ6AJ	WOS:000404800500015	28522325				2018-01-05	
J	Soto-Feliciano, YM; Bartlebaugh, JME; Liu, YP; Sanchez-Rivera, FJ; Bhutkar, A; Weintraub, AS; Buenrostro, JD; Cheng, CS; Regev, A; Jacks, TE; Young, RA; Hemann, MT				Soto-Feliciano, Yadira M.; Bartlebaugh, Jordan M. E.; Liu, Yunpeng; Sanchez-Rivera, Francisco J.; Bhutkar, Arjun; Weintraub, Abraham S.; Buenrostro, Jason D.; Cheng, Christine S.; Regev, Aviv; Jacks, Tyler E.; Young, Richard A.; Hemann, Michael T.			PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genes	GENES & DEVELOPMENT			English	Article						PHF6; phenotypic plasticity; chromatin regulation; leukemia; lineage maintenance; nucleosome positioning	ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL DEVELOPMENT; FORSSMAN-LEHMANN-SYNDROME; RNA-SEQ EXPERIMENTS; TRANSCRIPTION FACTOR; T-CELLS; ANTIANDROGEN RESISTANCE; EXPRESSION PROFILES; ACQUIRED-RESISTANCE; CRISPR-CAS9 SYSTEM	Developmental and lineage plasticity have been observed in numerous malignancies and have been correlated with tumor progression and drug resistance. However, little is known about the molecular mechanisms that enable such plasticity to occur. Here, we describe the function of the plant homeodomain finger protein 6 (PHF6) in leukemia and define its role in regulating chromatin accessibility to lineage-specific transcription factors. We show that loss of Phf6 in B-cell leukemia results in systematic changes in gene expression via alteration of the chromatin landscape at the transcriptional start sites of B-cell-and T-cell-specific factors. Additionally, Phf6(KO) cells show significant down-regulation of genes involved in the development and function of normal B cells, show up-regulation of genes involved in T-cell signaling, and give rise to mixed-lineage lymphoma in vivo. Engagement of divergent transcriptional programs results in phenotypic plasticity that leads to altered disease presentation in vivo, tolerance of aberrant oncogenic signaling, and differential sensitivity to frontline and targeted therapies. These findings suggest that active maintenance of a precise chromatin landscape is essential for sustaining proper leukemia cell identity and that loss of a single factor (PHF6) can cause focal changes in chromatin accessibility and nucleosome positioning that render cells susceptible to lineage transition.	[Soto-Feliciano, Yadira M.; Bartlebaugh, Jordan M. E.; Liu, Yunpeng; Sanchez-Rivera, Francisco J.; Bhutkar, Arjun; Jacks, Tyler E.; Hemann, Michael T.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Soto-Feliciano, Yadira M.; Bartlebaugh, Jordan M. E.; Liu, Yunpeng; Sanchez-Rivera, Francisco J.; Weintraub, Abraham S.; Regev, Aviv; Jacks, Tyler E.; Young, Richard A.; Hemann, Michael T.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Weintraub, Abraham S.; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Buenrostro, Jason D.; Cheng, Christine S.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Regev, Aviv; Jacks, Tyler E.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Hemann, MT (reprint author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.; Hemann, MT (reprint author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	hemann@mit.edu		Sanchez-Rivera, Francisco J./0000-0002-8466-8563	Koch Institute's Robert A. Swanson (1969) Biotechnology Center; National Cancer Institute (NCI) of the National Institutes of Health (NIH) [F31-CA183405]; National Science Foundation Graduate Research Fellowship [1122374]; MIT Department of Biology training grant; Ludwig Center for Molecular Oncology at Massachusetts Institute of Technology; Koch Institute; Dana-Farber/Harvard Cancer Center; Koch Institute Support (core) grant from the NCI [P30-CA14051]	We thank Alexey Soshnev (Allis laboratory) for help in the preparation of the model figure. We thank S. Levine and S. Motola for RNA-seq support, and T. Volkert and S. Gupta for ChIP-seq support. This work was performed with the support of the Koch Institute's Robert A. Swanson (1969) Biotechnology Center. We thank K. Cormier from the Hope Babette Tang (1983) Histology Facility, and G. Paradis, M.Griffin, M. Jennings, and M. Saturno-Condon from the Flow Cytometry Core Facility. Y.M.S.-F. was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award number F31-CA183405. J.M.E.B. was supported by the National Science Foundation Graduate Research Fellowship under award number 1122374. Y.L. was supported by the MIT Department of Biology training grant. This work was supported in part by the Ludwig Center for Molecular Oncology at Massachusetts Institute of Technology, the Bridge Project (a collaboration between the Koch Institute and the Dana-Farber/Harvard Cancer Center), and Koch Institute Support (core) grant P30-CA14051 from the NCI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or National Science Foundation.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Arenzana TL, 2009, BLOOD, V113, P5857, DOI 10.1182/blood-2008-11-188888; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barrett T, 2012, NUCLEIC ACIDS RES, V41, pD991, DOI DOI 10.1093/NAR/GKS1193; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Belver L, 2016, NAT REV CANCER, V16, P494, DOI 10.1038/nrc.2016.63; BORST J, 1987, NATURE, V325, P683, DOI 10.1038/325683a0; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cooley M, 2015, PHARMACOGENOMICS, V16, P1763, DOI 10.2217/pgs.15.130; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068                                                     ; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eyquem S, 2004, P NATL ACAD SCI USA, V101, P15712, DOI 10.1073/pnas.0405546101; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hahtola S, 2006, CLIN CANCER RES, V12, P4812, DOI 10.1158/1078-0432.CCR-06-0532; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jacoby E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12320; JANEWAY CA, 1988, IMMUNOL REV, V101, P39, DOI 10.1111/j.1600-065X.1988.tb00732.x; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kiaii S, 2013, J CLIN ONCOL, V31, P2654, DOI 10.1200/JCO.2012.44.2137; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot2006.98; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li M, 2016, BIOMARKERS, V6, P1; Litzow MR, 2015, BLOOD, V126, P833, DOI 10.1182/blood-2014-10-551895; Liu ZH, 2014, J BIOL CHEM, V289, P10069, DOI 10.1074/jbc.M113.535351; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Luo Q, 2004, J BIOL CHEM, V279, P18451, DOI 10.1074/jbc.M400320200; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI DOI 10.1093/NAR/GKT997; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meacham CE, 2015, GENE DEV, V29, P483, DOI 10.1101/gad.254151.114; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miyazaki M, 2015, GENE DEV, V29, P409, DOI 10.1101/gad.255331.114; Mori S, 2008, CANCER RES, V68, P8525, DOI 10.1158/0008-5472.CAN-08-1329; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Niebuhr B, 2013, BLOOD, V122, P413, DOI 10.1182/blood-2013-01-480244; Nutt SL, 1999, NATURE, V401, P556; Oser MG, 2015, LANCET ONCOL, V16, pE165, DOI 10.1016/S1470-2045(14)71180-5; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Rutledge DN, 2013, TRAC-TREND ANAL CHEM, V50, P22, DOI 10.1016/j.trac.2013.03.013; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Schep AN, 2017, BIORXIV, DOI [10.1101/110346, DOI 10.1101/110346]; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shamroe CL, 2013, ANN PHARMACOTHER, V47, P1540, DOI 10.1177/1060028013501144; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Smeets MFMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062346; Somasundaram R, 2015, BLOOD, V126, P144, DOI 10.1182/blood-2014-12-575688; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang E, 2015, ELIFE, V4, DOI 10.7554/eLife.06377; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wang Q, 2011, HAEMATOL-HEMATOL J, V96, P1808, DOI 10.3324/haematol.2011.043083; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405                                                     ; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	92	0	0	4	4	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	MAY 15	2017	31	10					973	989		10.1101/gad.295857.117				17	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	EY2VS	WOS:000403831200004	28607179				2018-01-05	
J	Ali, A; Raja, R; Farooqui, SR; Ahmad, S; Banerjea, AC				Ali, Amjad; Raja, Rameez; Farooqui, Sabihur Rahman; Ahmad, Shaista; Banerjea, Akhil C.			USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein	BIOCHEMICAL JOURNAL			English	Article							VIRAL REPLICATION; UBIQUITIN; P53; TRANSCRIPTION; MODULATION; INFECTION; APOPTOSIS; BREAKING; BIOLOGY; RNA	Deubiquitinases (DUBs) are key regulators of complex cellular processes. HIV-1 Tat is synthesized early after infection and is mainly responsible for enhancing viral production. Here, we report that one of the DUBs, USP7, stabilized the HIV-1 Tat protein through its deubiquitination. Treatment with either a general DUB inhibitor (PR-619) or USP7-specific inhibitor (P5091) resulted in Tat protein degradation. The USP7-specific inhibitor reduced virus production in a latently infected T-lymphocytic cell line J1.1, which produces large amounts of HIV-1 upon stimulation. A potent increase in Tat-mediated HIV-1 production was observed with USP7 in a dose-dependent manner. As expected, deletion of the USP7 gene using the CRISPR-Cas9 method reduced the Tat protein and supported less virus production. Interestingly, the levels of endogenous USP7 increased after HIV-1 infection in human T-cells (MOLT-3) and in mammalian cells transfected with HIV-1 proviral DNA. Thus, HIV-1 Tat is stabilized by the host cell deubiquitinase USP7, leading to enhanced viral production, and HIV-1 in turn up-regulates the USP7 protein level.	[Ali, Amjad; Raja, Rameez; Farooqui, Sabihur Rahman; Ahmad, Shaista; Banerjea, Akhil C.] Natl Inst Immunol, Lab Virol, New Delhi, India	Banerjea, AC (reprint author), Natl Inst Immunol, Lab Virol, New Delhi, India.	akhil@nii.res.in			Department of Biotechnology, Government of India [BT/PR8322/Med/14/1245/2006]; Indian Council of Medical Research, Government of India [HIV/50/142/9/2011-ECD-II]	This work was supported by the Department of Biotechnology [grant no. BT/PR8322/Med/14/1245/2006] and the Indian Council of Medical Research [grant no. HIV/50/142/9/2011-ECD-II], Government of India.	Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023                                                                 ; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1                                                  ; Hetzer C, 2005, MICROBES INFECT, V7, P1364, DOI 10.1016/j.micinf.2005.06.003; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Jin YJ, 2008, J IMMUNOL, V180, P7878, DOI 10.4049/jimmunol.180.12.7878                                                    ; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8244; Lecona E, 2016, NAT STRUCT MOL BIOL, V23, P270, DOI 10.1038/nsmb.3185; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Sagnier S, 2015, J VIROL, V89, P615, DOI 10.1128/JVI.02174-14; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Seo T, 2001, J VIROL, V75, P6193, DOI 10.1128/JVI.75.13.6193-6198.2001                                                ; Sette P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-79; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shojania S, 2010, PROTEIN PEPTIDE LETT, V17, P999, DOI 10.2174/092986610791498993                                                      ; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Verhoef K, 1997, VIROLOGY, V237, P228, DOI 10.1006/viro.1997.8786; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Zhang LL, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-61; Zlatanou A, 2016, ONCOGENE, V35, P965, DOI 10.1038/onc.2015.149	34	1	1	10	12	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0264-6021	1470-8728		BIOCHEM J	Biochem. J.	MAY 15	2017	474	10					1653	1668		10.1042/BCJ20160304				16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV9ZC	WOS:000402145500007	28280111				2018-01-05	
J	Kelu, JJ; Webb, SE; Parrington, J; Galione, A; Miller, AL				Kelu, Jeffrey J.; Webb, Sarah E.; Parrington, John; Galione, Antony; Miller, Andrew L.			Ca2+ release via two-pore channel type 2 (TPC2) is required for slow muscle cell myofibrillogenesis and myotomal patterning in intact zebrafish embryos	DEVELOPMENTAL BIOLOGY			English	Article						Two-pore channel 2; Slow skeletal muscle cell differentiation; Myofibrillogenesis; Zebrafish; Morpholino oligonucleotides; CRISPR/Cas9; STED super-resolution microscopy; Ca2+ signaling	ADENINE-DINUCLEOTIDE PHOSPHATE; CALCIUM TRANSIENTS; ACIDIC ORGANELLES; SMOOTH-MUSCLE; MYOBLAST DIFFERENTIATION; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; MYOGENIN EXPRESSION; XENOPUS MYOCYTES; SOMITE FORMATION	We recently demonstrated a critical role for two-pore channel type 2 (TPC2)-mediated Ca2+ release during the differentiation of slow (skeletal) muscle cells (SMC) in intact zebrafish embryos, via the introduction of a translational-blocking morpholino antisense oligonucleotide (MO). Here, we extend our study and demonstrate that knockdown of TPC2 with a non-overlapping splice-blocking MO, knockout of TPC2 (via the generation of a tpcn2(dhkzla) mutant line of zebrafish using CRISPR/Cas9 gene-editing), or the pharmacological inhibition of TPC2 action with bafilomycin Al or trans-ned-19, also lead to a significant attenuation of SMC differentiation, characterized by a disruption of SMC myofibrillogenesis and gross morphological changes in the trunk musculature. When the morphants were injected with tpcn2-mRNA or were treated with IP3/BM or caffeine (agonists of the inositol 1,4,5-trisphosphate receptor (IP3R) and ryanodine receptor (RyR), respectively), many aspects of myofibrillogenesis and myotomal patterning (and in the case of the pharmacological treatments, the Ca2+ signals generated in the SMCs), were rescued. STED super-resolution microscopy revealed a close physical relationship between clusters of RyR in the terminal cisternae of the sarcoplasmic reticulum (SR), and TPC2 in lysosomes, with a mean estimated separation of similar to 52-87 nm. Our data therefore add to the increasing body of evidence, which indicate that localized Ca2+ release via TPC2 might trigger the generation of more global Ca2+ release from the SR via Ca2+-induced Ca2+ release.	[Kelu, Jeffrey J.; Webb, Sarah E.; Miller, Andrew L.] HKUST, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Kelu, Jeffrey J.; Webb, Sarah E.; Miller, Andrew L.] HKUST, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford, England; [Miller, Andrew L.] Marine Biol Lab, Woods Hole, MA 02543 USA	Miller, AL (reprint author), HKUST, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	almiller@ust.hk		Kelu, Jeffrey Jenkin/0000-0002-1577-7854	Hong Kong Research Grants Council (RGC) [662113, 16101714, 16100115]; ANR/RGC [AHKUST601/13]; Hong Kong Theme-based Research Scheme award [T13-706/11-1]; Hong Kong Innovation and Technology Commission [ITCPD/17-9]; HKUST Overseas Research Award	This work was funded by the Hong Kong Research Grants Council (RGC) General Research Fund awards 662113, 16101714 and 16100115; the ANR/RGC Joint Research Scheme award AHKUST601/13 and the Hong Kong Theme-based Research Scheme award T13-706/11-1. We also acknowledge funding support from the Hong Kong Innovation and Technology Commission (ITCPD/17-9), and an HKUST Overseas Research Award 2015/2016 for JJK to work in the University of Oxford with AG for 6 months. We thank Prof. Han Wang and Dr Guodong Huang (Soochow University, Suzhou, China), for training JJK in the CRISPR/Cas9 genome-editing technique, and for providing the Cas9 and gRNA scaffold constructs. We also thank Mr Bob Tang, Application Specialist, Leica Microsystems Ltd., Hong Kong, for providing the opportunity to use the Leica TCS SP8 STED 3X microscope system at the Leica facility in Shanghai, China.	Aley PK, 2013, J BIOL CHEM, V288, P10986, DOI 10.1074/jbc.M113.458620; Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Andersen Soren S. L., 2001, Methods in Cell Science, V23, P205, DOI 10.1023/A:1016349232389; Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Blum M, 2015, DEV CELL, V35, P145, DOI 10.1016/j.devcel.2015.09.017; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M40876200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu GC, 2016, ADV EXP MED BIOL, V898, P423, DOI 10.1007/978-3-319-26974-0_18; Brennan C, 2005, J CELL SCI, V118, P5181, DOI 10.1242/jcs.02625; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Campbell NR, 2006, DEV BIOL, V292, P253, DOI 10.1016/j.ydbio.2005.11.040; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Capel RA, 2015, J BIOL CHEM, V290, P30087, DOI 10.1074/jbc.M115.684076; Cardenas C, 2005, J CELL SCI, V118, P3131, DOI 10.1242/jcs.02446; Carrasco MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1438, DOI 10.1152/ajpcell.00117.2002; Chan CM, 2015, INT J DEV BIOL, V59, P289, DOI 10.1387/ijdb.150209sw; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen YH, 2008, NEUROTOXICOL TERATOL, V30, P440, DOI 10.1016/j.ntt.2008.04.003; Cheung CY, 2011, INT J DEV BIOL, V55, P153, DOI 10.1387/ijdb.103160cc; Collins TP, 2011, CELL CALCIUM, V50, P449, DOI 10.1016/j.ceca.2011.07.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DAVID JD, 1981, DEV BIOL, V82, P297, DOI 10.1016/0012-1606(81)90453-X                                                    ; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fameli Nicola, 2014, F1000Res, V3, P93, DOI 10.12688/f1000research.3720.1; Favia A, 2014, P NATL ACAD SCI USA, V111, pE4706, DOI 10.1073/pnas.1406029111; Ferrari MB, 1999, DEV BIOL, V213, P269, DOI 10.1006/dbio.1999.9387; Ferrari MB, 1996, DEV BIOL, V178, P484, DOI 10.1006/dbio.1996.0233; Ferrari MB, 1998, J CELL BIOL, V141, P1349, DOI 10.1083/jcb.141.6.1349                                                          ; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hao BX, 2016, CELL CALCIUM, V59, P67, DOI 10.1016/j.ceca.2016.01.004; Harris BN, 2005, CELL MOTIL CYTOSKEL, V60, P129, DOI 10.1002/cm.20054; Hein B, 2008, P NATL ACAD SCI USA, V105, P14271, DOI 10.1073/pnas.0807705105; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horstick EJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50259; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jaimovich E, 2000, AM J PHYSIOL-CELL PH, V278, pC998; Jain RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026510; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jentsch TJ, 2015, EMBO J, V34, P1737, DOI 10.15252/embj.201591884; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388                                                            ; Kelu JJ, 2015, INT J DEV BIOL, V59, P313, DOI 10.1387/ijdb.150206am; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Lanner J.T., 2010, COLD SPRING HARB PER, V2; LEE HC, 1993, J BIOL CHEM, V268, P293; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Leung CF, 1998, DEV GROWTH DIFFER, V40, P313; Li HY, 2004, DEV DYNAM, V229, P231, DOI 10.1002/dvdy.10428; Li WH, 1997, TETRAHEDRON, V53, P12017, DOI 10.1016/S0040-4020(97)00714-X; Lin PH, 2015, J BIOL CHEM, V290, P3377, DOI 10.1074/jbc.M114.608471; Lin-Moshier Y, 2014, P NATL ACAD SCI USA, V111, P13087, DOI 10.1073/pnas.1407004111; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Lindsey CC., 1978, FISH PHYSIOL, VVII, P1, DOI DOI 10.1016/S1546-5098(08)60163-6; LIU DWC, 1990, J NEUROSCI, V10, P3947; Lobbardi R, 2011, DEVELOPMENT, V138, P1783, DOI 10.1242/dev.059121; Lopez-Sanjurjo CI, 2013, J CELL SCI, V126, P289, DOI 10.1242/jcs.116103; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Marieb EN, 2012, HUMAN ANATOMY PHYSL; McDonald J. H., 2014, HDB BIOL STAT; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Morgan AJ, 2014, BIOESSAYS, V36, P173, DOI 10.1002/bies.201300118; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Notomi T, 2012, J BIOL CHEM, V287, P35057, DOI 10.1074/jbc.M111.328930; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Orciani M, 2008, J CELL BIOCHEM, V105, P905, DOI 10.1002/jcb.21887; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Park KH, 2015, J INVEST DERMATOL, V135, P1692, DOI 10.1038/jid.2015.43; Parrington J, 2014, ACTA PHYSIOL, V211, P285, DOI 10.1111/apha.12298; Parrington J, 2015, INT J DEV BIOL, V59, P341, DOI 10.1387/ijdb.150211jp; Patel S, 2004, BIOL CELL, V96, P19, DOI 10.1016/j.biolcel.2003.12.001; Patel S, 2012, BIOCHEM SOC T, V40, P153, DOI 10.1042/BST20110693; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pereira GJS, 2014, CELL CALCIUM, V56, P51, DOI 10.1016/j.ceca.2014.04.005; Pisaniello A, 2003, J CELL SCI, V116, P1589, DOI 10.1242/jcs.00358; Pitt S.J., 2016, J PHYSL; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Rost F, 2014, J EXP BIOL, V217, P3870, DOI 10.1242/jeb.102202; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Ruas M, 2014, MOL CELL BIOL, V34, P3981, DOI 10.1128/MCB.00113-14; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sun L, 2003, FASEB J, V17, P369, DOI 10.1096/fj.02-0205com                                                           ; Tomasini AJ, 2009, GENESIS, V47, P736, DOI 10.1002/dvg.20554; Tu MK, 2016, CELL CALCIUM, V59, P91, DOI 10.1016/j.ceca.2016.02.005; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Videler J.J., 1993, FISH SWIMMING, P23; Walseth Timothy F, 2012, Messenger (Los Angel), V1, P86; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; WALTON WH, 1948, NATURE, V162, P329, DOI 10.1038/162329b0                                                                ; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Webb SE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004325; Webb SE, 2010, METHOD CELL BIOL, V99, P263, DOI [10.1016/S0091-679X(10)99010-9, 10.1016/B978-0-12-374841-6.00010-4]; Webb SE, 1997, DEV BIOL, V192, P78, DOI 10.1006/dbio.1997.8724; Webb S.E., 2013, COLD SPRING HARB PRO; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Weisstein E.W., 2015, GAUSSIAN FUNCTION MA; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Wu HJ, 2015, J APPL TOXICOL, V35, P287, DOI 10.1002/jat.3057; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; Yamasaki M, 2005, FEBS J, V272, P4598, DOI 10.1111/j.1742-4658.2005.04860.x; Yeh CH, 2012, DRUG CHEM TOXICOL, V35, P361, DOI 10.3109/01480545.2011.627864; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066077; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	133	0	0	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	MAY 15	2017	425	2					109	129		10.1016/j.ydbio.2017.03.031				21	Developmental Biology	Developmental Biology	EU8PW	WOS:000401302000002	28390800				2018-01-05	
J	Nakagawa, Y; Sakuma, T; Nishimichi, N; Yokosaki, Y; Takeo, T; Nakagata, N; Yamamoto, T				Nakagawa, Yoshiko; Sakuma, Tetsushi; Nishimichi, Norihisa; Yokosaki, Yasuyuki; Takeo, Toru; Nakagata, Naomi; Yamamoto, Takashi			Culture time of vitrified/warmed zygotes before microinjection affects the production efficiency of CRISPR-Cas9-mediated knock-in mice	BIOLOGY OPEN			English	Article						Knock-in; Microinjection; CRISPR-Cas9; Zygote; Culture time; Single-stranded oligodeoxynucleotide (ssODN)	ONE-STEP GENERATION; CRISPR/CAS9 SYSTEM; MOUSE EMBRYOS; VITRO FERTILIZATION; MAMMALIAN-CELLS; GENE-EXPRESSION; GENOME; DNA; INTEGRATION; CAS9	Robust reproductive engineering techniques are required for the efficient and rapid production of genetically modified mice. We have reported the efficient production of genome-edited mice using reproductive engineering techniques, such as ultra-superovulation, in vitro fertilization (IVF) and vitrification/warming of zygotes. We usually use vitrified/warmed fertilized oocytes created by IVF for microinjection because of work efficiency and flexible scheduling. Here, we investigated whether the culture time of zygotes before microinjection influences the efficiency of producing knock-in mice. Knock-in mice were generated using clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) system and single-stranded oligodeoxynucleotide (ssODN) or PITCh (Precise Integration into Target Chromosome) system, a method of integrating a donor vector assisted by microhomology-mediated end-joining. The cryopreserved fertilized oocytes were warmed, cultured for several hours and microinjected at different timings. Microinjection was performed with Cas9 protein, guide RNA(s), and an ssODN or PITCh donor plasmid for the ssODN knock-in and the PITCh knock-in, respectively. Different production efficiencies of knock-in mice were observed by changing the timing of microinjection. Our study provides useful information for the CRISPR-Cas9-based generation of knock-in mice.	[Nakagawa, Yoshiko; Takeo, Toru; Nakagata, Naomi] Kumamoto Univ, Ctr Anim Resources & Dev, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan; [Nishimichi, Norihisa; Yokosaki, Yasuyuki] Hiroshima Univ, Hlth Adm Ctr, Cell Matrix Frontier Lab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan; [Yokosaki, Yasuyuki] Hiroshima Univ Hosp, Clin Genet, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan	Sakuma, T (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.	tetsushi-sakuma@hiroshima-u.ac.jp	Yamamoto, Takashi/U-4790-2017; Sakuma, Tetsushi/A-7615-2013	Yamamoto, Takashi/0000-0002-6516-2903; Takeo, Toru/0000-0002-8103-651X	Japan Society for the Promotion of Science (JSPS) [15H04606]; Japan Agency for Medical Research and Development (AMED) [16769865]	This work was supported by Grants-in-Aid for Scientific Research B, grant number 15H04606 (to N.Na.), from the Japan Society for the Promotion of Science (JSPS) and by a grant for Research on Development of New Drugs (16769865, to T.T.), from the Japan Agency for Medical Research and Development (AMED).	Aida T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3331-9; Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Aida T, 2014, DEV GROWTH DIFFER, V56, P34, DOI 10.1111/dgd.12101; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Fujii W, 2014, BIOCHEM BIOPH RES CO, V445, P791, DOI 10.1016/j.bbrc.2014.01.141; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380                                                         ; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; HOWLETT SK, 1986, CELL, V45, P387, DOI 10.1016/0092-8674(86)90324-7; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260                                                          ; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623                                                         ; Kato T, 2017, BRIEF FUNCT GENOMICS, V16, P13, DOI 10.1093/bfgp/elw031; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; LIN TP, 1966, SCIENCE, V151, P333, DOI 10.1126/science.151.3708.333                                                    ; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Moore GD, 1996, MOL REPROD DEV, V45, P264, DOI 10.1002/(SICI)1098-2795(199611)45:3<264::AID-MRD2>3.0.CO;2-Q; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakagata N, 2013, CRYOBIOLOGY, V67, P188, DOI 10.1016/j.cryobiol.2013.06.011; Nakagawa Y, 2016, BIOL OPEN, V5, P1142, DOI 10.1242/bio.019349; Nakagawa Y, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0144-x; Nakagawa Y, 2014, EXP ANIM TOKYO, V63, P349, DOI 10.1538/expanim.63.349                                                          ; Nakao H, 2016, GENESIS, V54, P65, DOI 10.1002/dvg.22914; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; Nishimichi N, 2011, J BIOL CHEM, V286, P11170, DOI 10.1074/jbc.M110.189258; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2017, METHODS MOL BIOL, V1498, P41, DOI 10.1007/978-1-4939-6472-7_4; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sakuma T, 2015, INT J MOL SCI, V16, P23849, DOI 10.3390/ijms161023849; Sakurai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20011; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Takeo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128330; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Tsuchiya Y, 2015, GENES CELLS, V20, P992, DOI 10.1111/gtc.12305; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	43	1	1	2	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	2046-6390			BIOL OPEN	Biol. Open	MAY 15	2017	6	5					706	713		10.1242/bio.025122				8	Biology	Life Sciences & Biomedicine - Other Topics	EU7ZD	WOS:000401254600020	28396487	gold			2018-01-05	
J	Zhu, LHJ; Lawrence, M; Gupta, A; Pages, H; Kucukural, A; Garber, M; Wolfe, SA				Zhu, Lihua Julie; Lawrence, Michael; Gupta, Ankit; Pages, Herve; Kucukural, Alper; Garber, Manuel; Wolfe, Scot A.			GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases	BMC GENOMICS			English	Article						Genome editing; CRISPR; GUIDE-seq; Off-targets analysis; Bioconductor	OFF-TARGET CLEAVAGE; HUMAN-CELLS; CHROMOSOMAL TRANSLOCATIONS; NEISSERIA-MENINGITIDIS; GENOME MODIFICATION; MAMMALIAN-CELLS; CHIP-CHIP; IN-VIVO; SPECIFICITY; DNA	Background: Genome editing technologies developed around the CRISPR-Cas9 nuclease system have facilitated the investigation of a broad range of biological questions. These nucleases also hold tremendous promise for treating a variety of genetic disorders. In the context of their therapeutic application, it is important to identify the spectrum of genomic sequences that are cleaved by a candidate nuclease when programmed with a particular guide RNA, as well as the cleavage efficiency of these sites. Powerful new experimental approaches, such as GUIDE-seq, facilitate the sensitive, unbiased genome-wide detection of nuclease cleavage sites within the genome. Flexible bioinformatics analysis tools for processing GUIDE-seq data are needed. Results: Here, we describe an open source, open development software suite, GUIDEseq, for GUIDE-seq data analysis and annotation as a Bioconductor package in R. The GUIDEseq package provides a flexible platform with more than 60 adjustable parameters for the analysis of datasets associated with custom nuclease applications. These parameters allow data analysis to be tailored to different nuclease platforms with different length and complexity in their guide and PAM recognition sequences or their DNA cleavage position. They also enable users to customize sequence aggregation criteria, and vary peak calling thresholds that can influence the number of potential off-target sites recovered. GUIDEseq also annotates potential off-target sites that overlap with genes based on genome annotation information, as these may be the most important off-target sites for further characterization. In addition, GUIDEseq enables the comparison and visualization of off-target site overlap between different datasets for a rapid comparison of different nuclease configurations or experimental conditions. For each identified off-target, the GUIDEseq package outputs mapped GUIDE-Seq read count as well as cleavage score from a user specified off-target cleavage score prediction algorithm permitting the identification of genomic sequences with unexpected cleavage activity. Conclusion: The GUIDEseq package enables analysis of GUIDE-data from various nuclease platforms for any species with a defined genomic sequence. This software package has been used successfully to analyze several GUIDE-seq datasets. The software, source code and documentation are freely available at http://www.bioconductor.org/ packages/release/bioc/html/GUIDEseq. html.	[Zhu, Lihua Julie; Gupta, Ankit; Wolfe, Scot A.] Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Zhu, Lihua Julie; Garber, Manuel] Univ Massachusetts, Med Sch, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zhu, Lihua Julie; Kucukural, Alper; Garber, Manuel] Univ Massachusetts, Med Sch, Dept Mol Med, Worcester, MA 01605 USA; [Lawrence, Michael] Genentech Inc, San Francisco, CA USA; [Pages, Herve] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98109 USA; [Wolfe, Scot A.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Zhu, LHJ (reprint author), Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.; Zhu, LHJ (reprint author), Univ Massachusetts, Med Sch, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.; Zhu, LHJ (reprint author), Univ Massachusetts, Med Sch, Dept Mol Med, Worcester, MA 01605 USA.	julie.zhu@umassmed.edu		Zhu, Lihua/0000-0001-7416-0590	NIH [R01AI117839, R01HL093766]	This work was supported by NIH grant R01AI117839 & R01HL093766 to S.A.W.	Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tsai SQ, 2016, NAT BIOTECHNOL, V34, P483, DOI 10.1038/nbt.3534; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhu Lihua Julie, 2015, [Frontiers in Biology, 生物学前沿], V10, P289; Zhu LJ, 2013, METHODS MOL BIOL, V1067, P105, DOI 10.1007/978-1-62703-607-8_8	51	1	1	14	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 15	2017	18								379	10.1186/s12864-017-3746-y				10	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EV2HX	WOS:000401577300002	28506212	gold			2018-01-05	
J	Galuschka, C; Proynova, R; Roth, B; Augustin, HG; Muller-Decker, K				Galuschka, Claudia; Proynova, Rumyana; Roth, Benjamin; Augustin, Hellmut G.; Mueller-Decker, Karin			Models in Translational Oncology: A Public Resource Database for Preclinical Cancer Research	CANCER RESEARCH			English	Review							MOUSE MODELS; XENOGRAFT MODELS; CELL-LINE; MICE; METASTASIS; CARCINOGENESIS; GENERATION; GENES; THERAPEUTICS; CRISPR-CAS9	The devastating diseases of human cancer are mimicked in basic and translational cancer research by a steadily increasing number of tumor models, a situation requiring a platform with standardized reports to share model data. Models in Translational Oncology (MiTO) database was developed as a unique Web platform aiming for a comprehensive overview of preclinical models covering genetically engineered organisms, models of transplantation, chemical/physical induction, or spontaneous development, reviewed here. MiTO serves data entry for metastasis profiles and interventions. Moreover, cell lines and animal lines including tool strains can be recorded. Hyperlinks for connection with other databases and file uploads as supplementary information are supported. Several communication tools are offered to facilitate exchange of information. Notably, intellectual property can be protected prior to publication by inventor-defined accessibility of any given model. Data recall is via a highly configurable keyword search. Genome editing is expected to result in changes of the spectrum of model organisms, a reason to open MiTO for species-independent data. Registered users may deposit own model fact sheets (FS). MiTO experts check them for plausibility. Independently, manually curated FS are provided to principle investigators for revision and publication. Importantly, noneditable versions of reviewed FS can be cited in peer-reviewed journals. (C) 2017 AACR.	[Galuschka, Claudia; Proynova, Rumyana; Roth, Benjamin] German Canc Res Ctr, Informat Technol, Heidelberg, Germany; [Proynova, Rumyana; Roth, Benjamin; Mueller-Decker, Karin] German Canc Res Ctr Heidelberg, Tumor Models, Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr, Vasc Oncol & Metastasis, Heidelberg, Germany; [Augustin, Hellmut G.] Heidelberg Univ Heidelberg, Med Fac Mannheim, Vasc Biol & Tumor Angiogenesis, Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Consortium, Heidelberg, Germany	Muller-Decker, K (reprint author), German Canc Res Ctr Heidelberg, Tumor Models, Heidelberg, Germany.; Muller-Decker, K (reprint author), Deutsch Krebsforschungszentrum DKFZ, INF 280, D-69120 Heidelberg, Germany.	k.mueller-decker@dkfz.de		Augustin, Hellmut/0000-0002-7173-4242	German Cancer Consortium (DKTK)	The MiTO database is supported by the German Cancer Research Center Heidelberg with additional financial support from the German Cancer Consortium (DKTK).	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Brown KM, 2016, ONCOTARGET, V7, P66212, DOI 10.18632/oncotarget.11184; Carpecchi MR, 1989, TRENDS GENET, V5, P70; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cressey D., 2016, NATURE, DOI [10.1038/nature.2016.19274, DOI 10.1038/NATURE.2016.19274]; Damsky WE, 2010, PIGM CELL MELANOMA R, V23, P853, DOI 10.1111/j.1755-148X.2010.00777.x; Daphu I, 2013, CLIN EXP METASTAS, V30, P695, DOI 10.1007/s10585-013-9566-9; de Jong M, 2014, NAT REV CANCER, V14, P481, DOI 10.1038/nrc3751; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546                                                    ; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Hanahan D, 2007, GENE DEV, V21, P2258, DOI 10.1101/gad.1583307; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Huijbers IJ, 2011, BIOESSAYS, V33, P701, DOI 10.1002/bies.201100018; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jacks T, 1996, ANNU REV GENET, V30, P603, DOI 10.1146/annurev.genet.30.1.603; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; Karin M, 2016, CARCINOGENESIS, V37, P541, DOI 10.1093/carcin/bgw060; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; Moriarity BS, 2015, CURR OPIN GENET DEV, V30, P66, DOI 10.1016/j.gde.2015.04.007; Morton JJ, 2016, CANCER RES, V76, P6153, DOI 10.1158/0008-5472.CAN-16-1260; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Nutt LK, 2012, SEMIN CELL DEV BIOL, V23, P412, DOI 10.1016/j.semcdb.2012.03.015; Porter A, 1998, TRENDS GENET, V14, P73, DOI 10.1016/S0168-9525(97)01326-7                                                   ; Potts MB, 2011, NAT REV CANCER, V11, P50, DOI 10.1038/nrc2984; Rad R, 2015, NAT GENET, V47, P47, DOI 10.1038/ng.3164; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Srivastava K, 2014, CANCER CELL, V26, P880, DOI 10.1016/j.ccell.2014.11.005; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391; [Anonymous], 2010, OFFICIAL J EUROPEAN, V267/ 33	50	1	1	2	7	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	MAY 15	2017	77	10					2557	2563		10.1158/0008-5472.CAN-16-3099				7	Oncology	Oncology	EU7YO	WOS:000401252900001	28507049	gold			2018-01-05	
J	Vercruysse, T; De Bie, J; Neggers, JE; Jacquemyn, M; Vanstreels, E; Schmid-Burgk, JL; Hornung, V; Baloglu, E; Landesman, Y; Senapedis, W; Shacham, S; Dagklis, A; Cools, J; Daelemans, D				Vercruysse, Thomas; De Bie, Jolien; Neggers, Jasper E.; Jacquemyn, Maarten; Vanstreels, Els; Schmid-Burgk, Jonathan L.; Hornung, Veit; Baloglu, Erkan; Landesman, Yosef; Senapedis, William; Shacham, Sharon; Dagklis, Antonis; Cools, Jan; Daelemans, Dirk			The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia	CLINICAL CANCER RESEARCH			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NUCLEAR EXPORT; SELECTIVE INHIBITOR; CRM1; EXPRESSION; CANCER; PROGNOSIS; MECHANISM; CRM1/XPO1; PROTEIN	Purpose: Human exportin-1 (XPO1) is the key nuclear-cytoplasmic transport protein that exports different cargo proteins out of the nucleus. Inducing nuclear accumulation of these proteins by inhibiting XPO1 causes cancer cell death. First clinical validation of pharmacological inhibition of XPO1 was obtained with the Selective Inhibitor of Nuclear Export (SINE) compound selinexor (KPT-330) demonstrating activity in phase-II/IIb clinical trials when dosed 1 to 3 times weekly. The second-generation SINE compound KPT-8602 shows improved tolerability and can be dosed daily. Here, we investigate and validate the drug-target interaction of KPT-8602 and explore its activity against acute lymphoblastic leukemia (ALL). Experimental Design: We examined the effect of KPT-8602 on XPO1 function and XPO1-cargo as well as on a panel of leukemia cell lines. Mutant XPO1 leukemia cells were designed to validate KPT-86020s drug-target interaction. In vivo, anti-ALL activity was measured in a mouse ALL model and patient-derived ALL xenograft models. Results: KPT-8602 induced caspase-dependent apoptosis in a panel of leukemic cell lines in vitro. Using CRISPR/Cas9 genome editing, we demonstrated the specificity of KPT-8602 for cysteine 528 in the cargo-binding groove of XPO1 and validated the drug target interaction. In vivo, KPT-8602 showed potent anti-leukemia activity in a mouse ALL model as well as in patient-derived T-and B-ALL xenograft models without affecting normal hematopoiesis. Conclusions: KPT-8602 is highly specific for XPO1 inhibition and demonstrates potent anti-leukemic activity supporting clinical application of the second-generation SINE compound for the treatment of ALL. (C) 2016 AACR.	[Vercruysse, Thomas; Neggers, Jasper E.; Jacquemyn, Maarten; Vanstreels, Els; Daelemans, Dirk] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Rega Inst Med Res, Leuven, Belgium; [De Bie, Jolien; Dagklis, Antonis; Cools, Jan] Katholieke Univ Leuven, Dept Human Genet, Lab Mol Biol Leukemia, Leuven, Belgium; [De Bie, Jolien; Dagklis, Antonis; Cools, Jan] VIB Ctr Biol Dis, Leuven, Belgium; [Schmid-Burgk, Jonathan L.; Hornung, Veit] Univ Bonn, Inst Mol Med, Univ Hosp, Bonn, Germany; [Baloglu, Erkan; Landesman, Yosef; Senapedis, William; Shacham, Sharon] Karyopharm Therapeut Inc, Newton, MA USA	Daelemans, D (reprint author), Katholieke Univ Leuven, Rega Inst Med Res, Herestr 49, B-3000 Leuven, Belgium.	dirk.daelemans@kuleuven.be	Neggers, Jasper/T-5857-2017; Jacquemyn, Maarten/T-6437-2017; Daelemans, Dirk/P-7923-2017	Neggers, Jasper/0000-0002-7267-179X; Jacquemyn, Maarten/0000-0003-2626-4189; Daelemans, Dirk/0000-0001-7092-1153	Kom op Tegen Kanker; Stichting Tegen Kanker; European Research Council; IAP network; Hercules Foundation [ZW13-02]; Rega Foundation; KU Leuven; FWO-Vlaanderen	This work was supported by grants from Kom op Tegen Kanker (to J. Cools), Stichting Tegen Kanker (to J. Cools), the European Research Council (to J. Cools) and the IAP network (to J. Cools). Part of this research work was performed using the "Caps-It" research infrastructure (project ZW13-02, to P. Leyssen and J. Neyts) financially supported by the Hercules Foundation and Rega Foundation, KU Leuven; J. De Bie is supported by FWO-Vlaanderen, A. Dagklis is supported by Kom op Tegen Kanker.	Abdul Razak AR, 2016, J CLIN ONCOL; Chen C, 2014, HAEMATOLOGICA, V99, P359; Crochiere ML, 2016, ONCOTARGET, V7, P1863, DOI 10.18632/oncotarget.6495; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; Degryse S, 2014, BLOOD, V124, P3092, DOI 10.1182/blood-2014-04-566687; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Hing ZA, 2016, LEUKEMIA, V30, P2364, DOI 10.1038/leu.2016.136; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Kuruvilla J, 2013, ASH ANN M NEW ORL LA; Lapalombella R, 2012, BLOOD, V120, P4621, DOI 10.1182/blood-2012-05-429506; Luthra R, 2014, HAEMATOLOGICA, V99, P465, DOI 10.3324/haematol.2013.093765; Neggers JE, 2015, CHEM BIOL, V22, P107, DOI 10.1016/j.chembiol.2014.11.015; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415                                                            ; Noske A, 2008, CANCER, V112, P1733, DOI 10.1002/cncr.23354; Peterson LF, 2011, LEUKEMIA, V25, P761, DOI 10.1038/leu.2011.7; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Robison LL, 2003, BRIT J HAEMATOL, V122, P345, DOI 10.1046/j.1365-2141.2003.04499.x; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; te Winkel ML, 2014, HAEMATOLOGICA, V99, P430, DOI 10.3324/haematol.2013.095562; Van der Watt PJ, 2014, ONCOL REP, V32, P730, DOI 10.3892/or.2014.3231; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Yao Y, 2009, ONCOL REP, V21, P229, DOI 10.3892/or_00000213	26	1	1	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	MAY 15	2017	23	10					2528	2541		10.1158/1078-0432.CCR-16-1580				14	Oncology	Oncology	EU7ZA	WOS:000401254300017	27780859				2018-01-05	
J	Cheng, X; Liu, G; Ke, WT; Zhao, LJ; Lv, B; Ma, XC; Xu, NN; Xia, XL; Deng, X; Zheng, CL; Huang, KY				Cheng, Xi; Liu, Gai; Ke, Wenting; Zhao, Lijuan; Lv, Bo; Ma, Xiaocui; Xu, Nannan; Xia, Xiaoling; Deng, Xuan; Zheng, Chunlei; Huang, Kaiyao			Building a multipurpose insertional mutant library for forward and reverse genetics in Chlamydomonas	PLANT METHODS			English	Article						Chlamydomonas; Insertional mutants; Mutant library; Flagella; Intraflagellar transport; Oil droplet	NUCLEAR TRANSFORMATION; SELECTABLE MARKER; GREEN-ALGA; REINHARDTII; EXPRESSION; MODEL; RESISTANCE; PROTEINS; DNA; COMPLEMENTATION	Background: The unicellular green alga, Chlamydomonas reinhardtii, is a classic model for studying flagella and biofuel. However, precise gene editing, such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas9) system, is not widely used in this organism. Screening of random insertional mutant libraries by polymerase chain reaction provides an alternate strategy to obtain null mutants of individual gene. But building, screening, and maintaining such a library was time-consuming and expensive. Results: By selecting a suitable parental strain, keeping individual mutants using the agar plate, and designing an insertion cassette-specific primer for library screening, we successfully generated and maintained similar to 150,000 insertional mutants of Chlamydomonas, which was used for both reverse and forward genetics analysis. We obtained 26 individual mutants corresponding to 20 genes and identified 967 motility-defect mutants including 10 mutants with defective accumulation of intraflagellar transport complex at the basal body. We also obtained 929 mutants defective in oil droplet assembly after nitrogen deprivation. Furthermore, a new insertion cassette with splicing donor sequences at both ends was also constructed, which increased the efficiency of gene interruption. Conclusion: In summary, this library provides a multifunctional platform both for obtaining mutants of interested genes and for screening of mutants with specific phenotype.	[Cheng, Xi; Liu, Gai; Ke, Wenting; Zhao, Lijuan; Lv, Bo; Ma, Xiaocui; Xu, Nannan; Xia, Xiaoling; Deng, Xuan; Huang, Kaiyao] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan 430072, Peoples R China; [Zhao, Lijuan; Lv, Bo; Ma, Xiaocui; Xu, Nannan] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Zheng, Chunlei] Hubei Univ, Coll Life Sci, Wuhan 430062, Peoples R China	Huang, KY (reprint author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan 430072, Peoples R China.	huangky@ihb.ac.cn		Lv, Bo/0000-0002-3448-8986	National Natural Science Foundation of China [31371354, 31400654]	This project was supported by the National Natural Science Foundation of China (31371354 to Dr. Kaiyao Huang and 31400654 to Dr. Gai Liu).	Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Barahimipour R, 2016, PLANT MOL BIOL, V90, P403, DOI 10.1007/s11103-015-0425-8; Barahimipour R, 2015, PLANT J, V84, P704, DOI 10.1111/tpj.13033; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Bruggeman AJ, 2014, PLANT BIOTECHNOL J, V12, P894, DOI 10.1111/pbi.12192; Cao MQ, 2009, PROTOPLASMA, V235, P107, DOI 10.1007/s00709-009-0036-9; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; DAVIES DR, 1971, GENET RES, V17, P33, DOI 10.1017/S0016672300012015                                                       ; DEBUCHY R, 1989, EMBO J, V8, P2803; Dent RM, 2015, PLANT J, V82, P337, DOI 10.1111/tpj.12806; Dutcher SK, 2012, G3-GENES GENOM GENET, V2, P15, DOI 10.1534/g3.111.000919; Ferrante P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-22; FORK DC, 1965, P NATL ACAD SCI USA, V53, P1307, DOI 10.1073/pnas.53.6.1307; Garcia-Echauri SA, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0064-8; Gonzalez-Ballester D, 2005, ANAL BIOCHEM, V340, P330, DOI 10.1016/j.ab.2005.01.031; Gonzalez-Ballester D, 2005, PLANT PHYSIOL, V137, P522, DOI 10.1104/pp.104.050914; Gonzalez-Ballester D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-24; Goodenough U, 2015, PLANT J, V82, P365, DOI 10.1111/tpj.12794; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363                                                ; Hochmal AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11847; Hu JL, 2014, PLANT J, V79, P1052, DOI 10.1111/tpj.12606; HUANG B, 1977, J CELL BIOL, V72, P67, DOI 10.1083/jcb.72.1.67                                                             ; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069                                                           ; Huang KY, 2002, PHYSIOL PLANTARUM, V115, P613, DOI 10.1034/j.1399-3054.2002.1150416.x; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228                                                          ; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; LEVINE RP, 1960, NATURE, V188, P339, DOI 10.1038/188339b0                                                                ; Li XB, 2016, PLANT CELL, V28, P367, DOI 10.1105/tpc.15.00465; Long H, 2013, METHOD ENZYMOL, V524, P59, DOI 10.1016/B978-0-12-397945-2.00004-4; LOPPES R, 1968, MOL GEN GENET, V102, P229, DOI 10.1007/BF00385978; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Ohresser M, 1997, CURR GENET, V31, P264, DOI 10.1007/s002940050204; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Randall J., 1969, P ROY SOC LOND B BIO, V1030, P31; RANDOLPHANDERSON BL, 1993, MOL GEN GENET, V236, P235, DOI 10.1007/BF00277118; Rasala BA, 2013, PLANT J, V74, P545, DOI 10.1111/tpj.12165; Rasala Beth A, 2011, Bioeng Bugs, V2, P50, DOI 10.4161/bbug.2.1.13423; Richey EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043118; Rymarquis LA, 2005, PLANT PHYSIOL, V137, P557, DOI 10.1104/pp.104.054221; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443; Schroda M, 2006, CURR GENET, V49, P69, DOI 10.1007/s00294-005-0042-1; Scranton MA, 2015, PLANT J, V82, P523, DOI 10.1111/tpj.12780; Shimogawara K, 1998, GENETICS, V148, P1821; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3                                                   ; Sizova I, 2013, PLANT J, V73, P873, DOI 10.1111/tpj.12066; Smith GM, 1916, MONOGRAPH ALGAL GENU; Stevens DR, 1996, MOL GEN GENET, V251, P23; Terashima M, 2015, PLANT J, V81, P147, DOI 10.1111/tpj.12682; Zhang R, 2014, PLANT CELL, V26, P1398, DOI 10.1105/tpc.114.124099; Zorin B, 2009, GENE, V432, P91, DOI 10.1016/j.gene.2008.11.028	61	1	1	9	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1746-4811			PLANT METHODS	Plant Methods	MAY 15	2017	13									10.1186/s13007-017-0183-5				16	Biochemical Research Methods; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	EU6YH	WOS:000401181400001	28515773	gold			2018-01-05	
J	Rothblum, LI; Rothblum, K; Chang, E				Rothblum, Lawrence I.; Rothblum, Katrina; Chang, Eugenie			PAF53 is essential in mammalian cells: CRISPR/Cas9 fails to eliminate PAF53 expression	GENE			English	Article						Ribosomal RNA; Nucleolus; RNA polymerase I; rDNA; PAF53; A49; CRISPR/Cas9; Transcription	RNA-POLYMERASE-I; FACTOR-TIF-IA; RIBOSOMAL DNA-TRANSCRIPTION; GROWTH-DEPENDENT REGULATION; NUCLEOLAR DISRUPTION; HORMONAL-REGULATION; RDNA TRANSCRIPTION; GENE PROMOTER; FISSION YEAST; DEGRON SYSTEM	When mammalian cells are nutrient and/or growth factor deprived, exposed to inhibitors of protein synthesis, stressed by heat shock or grown to confluence, rDNA transcription is essentially shut off. Various mechanisms are available to accomplish this downshift in ribosome biogenesis. Muramatsu's laboratory (Hanada et al., 1996) first demonstrated that mammalian PAF53 was essential for specific rDNA transcription and that PAF53 levels were regulated in response to growth factors. While S. cerevisae A49, the homologue of vertebrate PAF53, is not essential for viability (Liljelund et al., 1992), deletion of yA49 results in colonies that grow at 6% of the wild type rate at 25 degrees C. Experiments described by Wang et al. (2015) identified PAF53 as a gene "essential for optimal proliferation". However, they did not discriminate genes essential for viability. Hence, in order to resolve this question, we designed a series of experiments to determine if PAF53 was essential for cell survival. We set out to delete the gene product from mammalian cells using CRISPR/CAS9 technology. Human 293 cells were transfected with lentiCRISPR v2 carrying genes for various sgRNA that targeted PAF53. In some experiments, the cells were cotransfected in parallel with plasmids encoding FLAG-tagged mouse PAF53. After treating the transfected cells with puromycin (to select for the IentiCRISPR backbone), cells were cloned and analyzed by western blots for PAF53 expression. Genomic DNA was amplified across the "CRISPRd" exon, cloned and sequenced to identify mutated PAF53 genes. We obtained cell lines in Which the endogenous PAF53 gene was "knocked out" only when we rescued with FLAG-PAF53. DNA sequencing demonstrated that in the absence of ectopic PAF53 expression, cells demonstrated unique means of surviving; including recombination or the utilization of alternative reading frames. We never observed a clone in which one PAF53 gene is expressed, unless there was also ectopic expression In the absence of ectopic gene expression, the gene products of both endogenous genes were expressed, irrespective of whether they were partially mutant proteins or not. (C) 2016 Elsevier B.V. All rights reserved.	[Rothblum, Lawrence I.; Rothblum, Katrina; Chang, Eugenie] Univ Oklahoma, Coll Med, Depoartment Cell Biol, Oklahoma City, OK 73104 USA	Rothblum, LI (reprint author), Univ Oklahoma, Coll Med, Depoartment Cell Biol, Oklahoma City, OK 73104 USA.	Lawrence-rothblum@ouhsc.edu			NIH [GM069841, HL077814]; OCAST [HR15-166]; University of Oklahoma; OK-INBRE from the NIH/NIGMS [GM103447]	This work was supported by GM069841 and HL077814 from NIH and HR15-166 from OCAST awarded to L.I. Rothblum and funds from the University of Oklahoma. Eugenie Chang was supported in part by OK-INBRE grant award GM103447 from the NIH/NIGMS.	BATEMAN E, 1986, CELL, V47, P445, DOI 10.1016/0092-8674(86)90601-X; BRUN RP, 1994, MOL CELL BIOL, V14, P5010, DOI 10.1128/MCB.14.7.5010                                                           ; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165                                                          ; Cavanaugh AH, 2002, J BIOL CHEM, V277, P27423, DOI 10.1074/jbc.M201232200; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398                                                          ; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787                                                           ; GOKAL PK, 1990, J BIOL CHEM, V265, P16234; Green M.R., 2012, MOL CLONING LAB MANU; Hanada K, 1996, EMBO J, V15, P2217; Hannan KM, 1998, AM J PHYSIOL-CELL PH, V275, pC130; Hannan RD, 1998, J BIOL CHEM, V273, P1257, DOI 10.1074/jbc.273.2.1257; Hirschler-Laszkiewicz I, 2003, J BIOL CHEM, V278, P18953, DOI 10.1074/jbc.M301093200; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; HUET J, 1975, P NATL ACAD SCI USA, V72, P3034, DOI 10.1073/pnas.72.8.3034                                                          ; Iadevaia V, 2010, ONCOGENE, V29, P5490, DOI 10.1038/onc.2010.279; Kanke M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-8; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; MAHAJAN PB, 1990, J BIOL CHEM, V265, P16244; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373                                                         ; Moorefield B, 2000, P NATL ACAD SCI USA, V97, P4724, DOI 10.1073/pnas.080063997; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Morgado-Palacin L, 2012, CELL CYCLE, V11, P503, DOI 10.4161/cc.11.3.19002; Nakagawa K, 2003, GENES GENET SYST, V78, P199, DOI 10.1266/ggs.78.199                                                              ; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Panov KI, 2006, MOL CELL BIOL, V26, P5436, DOI 10.1128/MCB.00230-06; Penrod Y, 2015, GENE, V556, P61, DOI 10.1016/j.gene.2014.09.022; Penrod Y, 2012, BIOCHEMISTRY-US, V51, P6519, DOI 10.1021/bi300408q; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Rothblum K, 2014, MOL CANCER RES, V12, P1586, DOI 10.1158/1541-7786.MCR-14-0229; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sambrook J., 2006, CONDENSED PROTOCOLS; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; SCHNAPP A, 1990, EMBO J, V9, P2857; SCHNAPP A, 1993, MOL CELL BIOL, V13, P6723, DOI 10.1128/MCB.13.11.6723                                                          ; Seither P, 1997, CHROMOSOMA, V106, P216, DOI 10.1007/s004120050242                                                           ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stepanchick A, 2013, J BIOL CHEM, V288, P9135, DOI 10.1074/jbc.M112.444265; Suzuki A, 2012, CANCER SCI, V103, P632, DOI 10.1111/j.1349-7006.2012.02219.x; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Yamamoto K, 2004, MOL CELL BIOL, V24, P6338, DOI 10.1128/MCB.24.14.6338-6349.2004                                                ; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635	49	0	0	2	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	MAY 15	2017	612						55	60		10.1016/j.gene.2016.12.023				6	Genetics & Heredity	Genetics & Heredity	ET3YY	WOS:000400217100009	28042089				2018-01-05	
J	Lertsuwan, K; Choe, LH; Marwa, IR; Lee, K; Sikes, RA				Lertsuwan, Kornkamon; Choe, Leila H.; Marwa, Irene R.; Lee, Kelvin; Sikes, Robert A.			Identification of Fibulin-1 as a Human Bone Marrow Stromal (HS-5) Cell-Derived Factor That Induces Human Prostate Cancer Cell Death	PROSTATE			English	Article						fibulin-1; HS-5; prostate cancer; bone metastasis; bone marrow stromal cells	NEUROENDOCRINE DIFFERENTIATION; TRANSFORMING GROWTH-FACTOR-BETA-1; PROMOTER HYPERMETHYLATION; EXTRACELLULAR-MATRIX; ELEVATED EXPRESSION; BREAST-CANCER; TUMOR-CELLS; LNCAP MODEL; GROWTH; PROGRESSION	BACKGROUND. Previous studies showed that human bone marrow stromal HS-5 cells secreted unidentified factor(s) inducing PCa cell death. Herein, the HS-5-derived factor (HS-5 DF) was characterized and identified. METHODS. Conditioned media from confluent HS-5 cells were collected and modified for biochemical characteristic testing of HS-5 DF. Cell survival was measured by apoptosis assay and live/dead assay. Fibulin-1 was identified from gel electrophoresis and mass spectrometry. The validation of Fibulin-1 as a HS-5 DF was done by immunoprecipitation (IP) and genetic knockdown by CRISPR/Cas9 system. RESULTS. HS-5 DF was trypsin and heat sensitive, but pH stable. The tentative size of the factor fell between 30 kDa and 100 kDa. TGF-beta 1 treatment led to a suppression of HS-5 DF activity, a property consistent with bone metastasis in prostate cancer. Examination of TGF-beta 1 down regulated proteins led to identification of fibulin-1 as a candidate for the DF. IP of Fibulin-1 from HS-5 CM and CRISPR knockdown of Fibulin-1 showed a significant reduction of HS-5 CM-derived PCa cell death. These results strongly support a role for fibulin-1 in HS-5 bone marrow stromal cell induction of PCa cell death. CONCLUSION. Our data indicate that Fibulin-1 functions as a HS-5 bone marrow stromal cell-derived factor inducing prostate cancer cell death. (C) 2017 Wiley Periodicals, Inc.	[Lertsuwan, Kornkamon; Marwa, Irene R.; Sikes, Robert A.] Univ Delaware, Dept Biol Sci, Ctr Translat Canc Res, Newark, DE USA; [Lertsuwan, Kornkamon; Marwa, Irene R.; Sikes, Robert A.] Univ Delaware, Dept Biol Sci, Lab Canc Ontogeny & Therapeut, Newark, DE USA; [Choe, Leila H.; Lee, Kelvin] Delaware Biotechnol Inst, Newark, DE USA	Sikes, RA (reprint author), Univ Delaware, Ctr Translat Canc Res, Dept Biol Sci, Lab Canc Ontogeny & Therapeut, Wolf Hall,Rm 326,105 Green, Newark, DE 19716 USA.	rasikes@udel.edu			Department of Biological Sciences Center for Translational Cancer Research University of Delaware	Grant sponsor: Department of Biological Sciences Center for Translational Cancer Research University of Delaware.	Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155                                                          ; Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; BONKHOFF H, 1993, VIRCHOWS ARCH A, V423, P291, DOI 10.1007/BF01606893; BONKHOFF H, 1995, HUM PATHOL, V26, P167, DOI 10.1016/0046-8177(95)90033-0; Cheng YY, 2008, BRIT J CANCER, V99, P2083, DOI 10.1038/sj.bjc.6604760; Chung L W, 1997, Hinyokika Kiyo, V43, P815; Cook LM, 2014, CANCER METAST REV, V33, P511, DOI 10.1007/s10555-014-9494-4; Du MJ, 2002, BIOCHEM BIOPH RES CO, V296, P962, DOI 10.1016/S0006-291X(02)02041-7; Finehout EJ, 2003, ELECTROPHORESIS, V24, P3508, DOI 10.1002/elps.200305615; Forti S, 2002, BREAST CANCER RES TR, V73, P245, DOI 10.1023/A:1015854415746                                                         ; Gater A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-88; Gomes RR, 2009, CLIN EXP METASTAS, V26, P641, DOI 10.1007/s10585-009-9263-x; Graf L, 2002, BLOOD, V100, P1509, DOI 10.1182/blood-2002-03-0844; Greene LM, 2003, BRIT J CANCER, V88, P871, DOI 10.1038/sj.bjc.6600802; Gruber R, 2012, WIEN MED WOCHENSCHR, V162, P370, DOI 10.1007/s10354-012-0110-3; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Israeli Ron S, 2008, Rev Urol, V10, P99; Kakehi Y, 1996, Urol Oncol, V2, P131, DOI 10.1016/S1078-1439(96)00078-6; Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Knerr K, 2004, INT J CANCER, V111, P152, DOI 10.1002/ijc.20223; Matei DV, 2012, CLIN GENITOURIN CANC, V10, P164, DOI 10.1016/j.clgc.2011.12.004; Miles FL, 2015, PROSTATE, V75, P1802, DOI 10.1002/pros.23060; Mishra A, 2011, CANCER MICROENVIRON, V4, P221, DOI 10.1007/s12307-011-0083-6; O'Connor JC, 2007, MOL CANCER RES, V5, P585, DOI 10.1158/1541-7786.MCR-06-0408; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; PAGET S, 1989, CANCER METAST REV, V8, P98; Pedersen EA, 2012, ASIAN J ANDROL, V14, P423, DOI 10.1038/aja.2011.164; Perk H, 2008, UROL ONCOL-SEMIN ORI, V26, P250, DOI 10.1016/j.urolonc.2007.05.027; Pienta KJ, 2008, TRANSL ONCOL, V1, P158, DOI 10.1593/tlo.08178; Qing J, 1997, ONCOGENE, V15, P2159, DOI 10.1038/sj.onc.1201385; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROECKLEIN BA, 1995, BLOOD, V85, P997; Santoni M, 2014, BBA-REV CANCER, V1846, P630, DOI 10.1016/j.bbcan.2014.10.008; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; THALMANN GN, 1994, CANCER RES, V54, P2577; Thalmann GN, 2000, PROSTATE, V44, P91; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Torok-Storb B, 1999, ANN NY ACAD SCI, V872, P164, DOI 10.1111/j.1749-6632.1999.tb08461.x                                              ; WALSH PC, 2001, PATRICK WALSHS GIUDE; Wikstrom P, 2000, SCAND J UROL NEPHROL, V34, P85, DOI 10.1080/003655900750016689                                                      ; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Xiao W, 2013, J UROLOGY, V190, P291, DOI 10.1016/j.juro.2013.01.098; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Zhang C, 2011, PROSTATE, V71, P157, DOI 10.1002/pros.21231; Zhang ZG, 2012, J HUAZHONG U SCI-MED, V32, P364, DOI 10.1007/s11596-012-0063-1	49	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-4137	1097-0045		PROSTATE	Prostate	MAY 15	2017	77	7					729	742		10.1002/pros.23303				14	Endocrinology & Metabolism; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	ER1SP	WOS:000398573800004	28168724				2018-01-05	
J	Attayek, PJ; Waugh, JP; Hunsucker, SA; Grayeski, PJ; Sims, CE; Armistead, PM; Allbritton, NL				Attayek, Peter J.; Waugh, Jennifer P.; Hunsucker, Sally A.; Grayeski, Philip J.; Sims, Christopher E.; Armistead, Paul M.; Allbritton, Nancy L.			Automated microraft platform to identify and collect non-adherent cells successfully gene-edited with CRISPR-Cas9	BIOSENSORS & BIOELECTRONICS			English	Article						Microraft; Cell array; CRISPR-Cas9; Cytometry; Cell sorting	MICROSCOPY; IMAGES; LINES	Microraft arrays have been used to screen and then isolate adherent and non-adherent cells with very high efficiency and excellent viability; however, manual screening and isolation limits the throughput and utility of the technology. In this work, novel hardware and software were developed to automate the microraft array platform. The developed analysis software identified microrafts on the array with greater than 99% sensitivity and cells on the microrafts with 100% sensitivity. The software enabled time-lapse imaging and the use of temporally varying characteristics as sort criteria. The automated hardware released microrafts with 98% efficiency and collected released microrafts with 100% efficiency. The automated system was used to examine the temporal variation in EGFP expression in cells transfected with CRISPR-Cas9 components for gene editing. Of 11,499 microrafts possessing a single cell, 220 microrafts were identified as possessing temporally varying EGFP-expression. Candidate cells (n=172) were released and collected from the microraft array and screened for the targeted gene mutation. Two cell colonies were successfully gene edited demonstrating the desired mutation.	[Attayek, Peter J.; Allbritton, Nancy L.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Attayek, Peter J.; Allbritton, Nancy L.] North Carolina State Univ, Raleigh, NC 27695 USA; [Waugh, Jennifer P.; Grayeski, Philip J.; Sims, Christopher E.; Armistead, Paul M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hunsucker, Sally A.; Armistead, Paul M.; Allbritton, Nancy L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sims, Christopher E.; Allbritton, Nancy L.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	Allbritton, NL (reprint author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	nlallbri@unc.edu		Armistead, Paul/0000-0003-3983-5534; Attayek, Peter/0000-0001-7572-6381	NIH [R42GM106421, EY024556, R01 CA201225]; Cell Microsystems, Inc.	This research was supported by grants from the NIH (R42GM106421 and EY024556 to N.L.A. and R01 CA201225 to P.M.A.) The authors declare the following competing financial interest(s): N.L.A and C.E.S. are inventors (patent application no.: 20130066031) and have financial interest in Cell Microsystems, Inc.	Attayek PJ, 2015, ANAL CHEM, V87, P12281, DOI 10.1021/acs.analchem.5b03579; BRIGHT DS, 1987, J MICROSC-OXFORD, V146, P191, DOI 10.1111/j.1365-2818.1987.tb01340.x                                              ; Esendagli G, 2009, CYTOTECHNOLOGY, V61, P45, DOI 10.1007/s10616-009-9241-9; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Leong FJWM, 2003, J CLIN PATHOL, V56, P619, DOI 10.1136/jcp.56.8.619; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Merouane A, 2015, BIOINFORMATICS, V31, P3189, DOI 10.1093/bioinformatics/btv355; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4                                                    ; Otsu N., 1975, AUTOMATICA, V11, P23, DOI DOI 10.1109/TSMC.1979.4310076; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shah PK, 2014, CYTOM PART A, V85A, P642, DOI 10.1002/cyto.a.22480; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Uchida E, 2002, BIOL PHARM BULL, V25, P891, DOI 10.1248/bpb.25.891                                                              ; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Wang YL, 2010, LAB CHIP, V10, P2917, DOI [10.1039/c01c00186d, 10.1039/c0lc00186d]; Wilding JL, 2014, CANCER RES, V74, P2377, DOI 10.1158/0008-5472.CAN-13-2971	17	0	0	9	38	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	MAY 15	2017	91						175	182		10.1016/j.bios.2016.12.019				8	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	EM8YX	WOS:000395599000027	28006686				2018-01-05	
J	Shen, P; Fan, JZ; Guo, LH; Li, JH; Li, A; Zhang, J; Ying, CQ; Ji, JR; Xu, H; Zheng, BW; Xiao, YH				Shen, Ping; Fan, Jianzhong; Guo, Lihua; Li, Jiahua; Li, Ang; Zhang, Jing; Ying, Chaoqun; Ji, Jinru; Xu, Hao; Zheng, Beiwen; Xiao, Yonghong			Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum beta-lactamase (ESBL)	ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS			English	Article						Shigella flexneri; Extended-spectrum beta-lactamase; vertical bar ncF vertical bar vertical bar 2; Comparative genomic analysis	ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; RNA GENES; RESISTANCE; CHINA; PLASMID; SPP.; IDENTIFICATION; EXPRESSION; EVOLUTION	Background: Shigellosis is the most common cause of gastrointestinal infections in developing countries. In China, the species most frequently responsible for shigellosis is Shigella flexneri. S. flexneri remains largely unexplored from a genomic standpoint and is still described using a vocabulary based on biochemical and serological properties. Moreover, increasing numbers of ESBL-producing Shigella strains have been isolated from clinical samples. Despite this, only a few cases of ESBL-producing Shigella have been described in China. Therefore, a better understanding of ESBL-producing Shigella from a genomic standpoint is required. In this study, a S. flexneri type 1a isolate SP1 harboring bla(CTX-M-14), which was recovered from the patient with diarrhea, was subjected to whole genome sequencing. Results: The draft genome assembly of S. flexneri strain SP1 consisted of 4,592,345 bp with a G+C content of 50.46%. RAST analysis revealed the genome contained 4798 coding sequences (CDSs) and 100 RNA-encoding genes. We detected one incomplete prophage and six candidate CRISPR loci in the genome. In vitro antimicrobial susceptibility testing demonstrated that strain SP1 is resistant to ampicillin, amoxicillin/clavulanic acid, cefazolin, ceftriaxone and trimethoprim. In silico analysis detected genes mediating resistance to aminoglycosides, beta-lactams, phenicol, tetracycline, sulphonamides, and trimethoprim. The blaCTX-M-14 gene was located on an vertical bar ncF vertical bar vertical bar 2 plasmid. A series of virulence factors were identified in the genome. Conclusions: In this study, we report the whole genome sequence of a bla(CTX-M-14)-encoding S. flexneri strain SP1. Dozens of resistance determinants were detected in the genome and may be responsible for the multidrug-resistance of this strain, although further confirmation studies are warranted. Numerous virulence factors identified in the strain suggest that isolate SP1 is potential pathogenic. The availability of the genome sequence and comparative analysis with other S. flexneri strains provides the basis to further address the evolution of drug resistance mechanisms and pathogenicity in S. flexneri.	[Shen, Ping; Guo, Lihua; Li, Ang; Zhang, Jing; Ying, Chaoqun; Ji, Jinru; Xu, Hao; Zheng, Beiwen; Xiao, Yonghong] Zhejiang Univ, Sch Med, Affiliated Hosp 1,State Key Lab Diag & Treatment, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Jianzhong] Hangzhou First Peoples Hosp, Dept Clin Lab, Hangzhou 310006, Zhejiang, Peoples R China; [Li, Jiahua] Zhucheng Peoples Hosp, Dept Hosp Infect Control, Zhucheng 252300, Peoples R China	Zheng, BW (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 1,State Key Lab Diag & Treatment, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	zhengbw@zju.edu.cn			National Natural Science Foundation of China [81301460, 81301461]; National Key Research and Development Program of China [2016YFD0501105]	This work was supported by the National Natural Science Foundation of China (Nos. 81301460 and 81301461); National Key Research and Development Program of China (No. 2016YFD0501105).	Al-Hasani K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008223; Antipov D, 2016, BIOINFORMATICS, V32, P3380, DOI 10.1093/bioinformatics/btw493; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Ashton PM, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-7; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BENNISH ML, 1991, REV INFECT DIS, V13, pS245; Bhagwat AA, 2004, FEMS MICROBIOL LETT, V234, P139, DOI 10.1016/j.femsle.2004.03.020; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; CLSI (Clinical and Laboratory Standards Institute), 2013, M100S23 CLSI; Connor TR, 2015, ELIFE, V4, DOI 10.7554/eLife.07335; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kleinheinz K. A., 2014, BACTERIOPHAGE, V4, DOI DOI 10.4161/BACT.27943; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lam F, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1281-5; Li J, 2015, EUR J CLIN MICROBIOL, V34, P447, DOI 10.1007/s10096-014-2244-2; Li P., 2014, INT APPL SCI TECHNOL, V4, P2; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Natale DA, 2000, GENOME BIOL, V1; Poirel L, 2003, ANTIMICROB AGENTS CH, V47, P2938, DOI 10.1128/AAC.47.9.2938-2945.2003; Riccobono E, 2014, INT J ANTIMICROB AG, V44, P374, DOI 10.1016/j.ijantimicag.2014.06.019; Rossi O, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0061-5; Ruiz-Perez F, 2011, P NATL ACAD SCI USA, V108, P12881, DOI 10.1073/pnas.1101006108; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Siguier P, 2012, Methods Mol Biol, V859, P91, DOI 10.1007/978-1-61779-603-6_5; Tajbakhsh M, 2012, J ANTIMICROB CHEMOTH, V67, P1128, DOI 10.1093/jac/dks023; Taneja N, 2012, J ANTIMICROB CHEMOTH, V67, P1347, DOI 10.1093/jac/dks061; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; Valat C, 2016, VET MICROBIOL, V192, P163, DOI 10.1016/j.vetmic.2016.07.011; Wang F, 2013, CELL MICROBIOL, V15, P474, DOI 10.1111/cmi.12052; Wang TT, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0130-4; Wang YF, 2013, INT J ANTIMICROB AG, V42, P507, DOI 10.1016/j.ijantimicag.2013.08.009; Xia SL, 2011, J CLIN MICROBIOL, V49, P232, DOI 10.1128/JCM.01508-10; Xu Y, 2016, EUR J CLIN MICROBIOL, V35, P1347, DOI 10.1007/s10096-016-2671-3; Yang CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29124; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang CL, 2014, BMC INFECT DIS, V14, DOI [10.1186/1471-2334-14-260, 10.1186/14/1-2334-14-260]; Zhang N, 2014, J CLIN MICROBIOL, V52, P1119, DOI 10.1128/JCM.02669-13; Zhang R, 2011, DIAGN MICR INFEC DIS, V69, P98, DOI 10.1016/j.diagmicrobio.2010.08.027; Zhang WL, 2011, J ANTIMICROB CHEMOTH, V66, P2527, DOI 10.1093/jac/dkr341; Zheng BW, 2016, CLIN INFECT DIS, V63, P1393, DOI 10.1093/cid/ciw553; Zheng BW, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0040-2	48	0	0	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-0711			ANN CLIN MICROB ANTI	Ann. Clin. Microbiol. Antimicrob.	MAY 12	2017	16								37	10.1186/s12941-017-0212-2				8	Microbiology	Microbiology	EV6JD	WOS:000401874800001	28499446	gold			2018-01-05	
J	Zhang, J; Liu, SY; Li, RM; Hong, W; Xiao, Y; Feng, YG; Cui, Q; Liu, YJ				Zhang, Jie; Liu, Shiyue; Li, Renmin; Hong, Wei; Xiao, Yan; Feng, Yingang; Cui, Qiu; Liu, Ya-Jun			Efficient whole-cell-catalyzing cellulose saccharification using engineered Clostridium thermocellum	BIOTECHNOLOGY FOR BIOFUELS			English	Article						beta-Glucosidase; Cellulosome; CelS; Fermentable sugar; Genome editing; Lignocellulose	TARGETED GENE DELETION; BETA-GLUCOSIDASE; THERMOANAEROBACTER-BROCKII; DEGRADATION; PROTEIN; MICROBES; ENZYME; POLYSACCHARIDES; SOLUBILIZATION; INTEGRATION	Background: Cost-efficient saccharification is one of the main bottlenecks for industrial lignocellulose conversion. Clostridium thermocellum naturally degrades lignocellulose efficiently using the cellulosome, a multiprotein supermolecular complex, and thus can be potentially used as a low-cost catalyst for lignocellulose saccharification. The industrial use of C. thermocellum is restrained due largely to the inhibition of the hydrolysate cellobiose to its cellulosome. Although the supplementation of beta-glucosidase may solve the problem, the production of the enzymes greatly complicates the process and may also increase the cost of saccharification. Results: To conquer the feedback inhibition and establish an efficient whole-cell catalyst for highly efficient cellulose saccharification, we constructed a recombinant strain of C. thermocellum Delta pyrF:: CaBglA which produced a secretory exoglucanase CelS-bearing heterologous BGL using a newly developed seamless genome editing system. Without the extra addition of enzymes, the relative saccharification level of Delta pyrF:: CaBglA was stimulated by over twofolds compared to its parent strain Delta pyrF through a two-stage saccharification process with 100 g/L Avicel as the carbon source. The production of reducing sugars and the relative saccharification level were further enhanced to 490 mM and 79.4%, respectively, with increased cell density. Conclusions: The high cellulose-degrading ability and sugar productivity suggested that the whole-cell-catalysis strategy for cellulose saccharification is promising, and the C. thermocellum strain Delta pyrF:: CaBglA could be potentially used as an efficient whole-cell catalyst for industrial cellulose saccharification.	[Zhang, Jie; Liu, Shiyue; Li, Renmin; Xiao, Yan; Feng, Yingang; Cui, Qiu; Liu, Ya-Jun] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Qingdao 266101, Peoples R China; [Zhang, Jie; Liu, Shiyue; Li, Renmin; Xiao, Yan; Feng, Yingang; Cui, Qiu; Liu, Ya-Jun] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao 266101, Peoples R China; [Zhang, Jie; Liu, Shiyue; Li, Renmin; Xiao, Yan; Feng, Yingang; Cui, Qiu; Liu, Ya-Jun] Chinese Acad Sci, Qingdao Engn Lab Single Cell Oil, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Peoples R China; [Zhang, Jie; Liu, Shiyue; Li, Renmin] Univ Chinese Acad Sci, Chinese Acad Sci, Beijing 100049, Peoples R China; [Hong, Wei] Guizhou Med Univ, Minist Educ, Key Lab Endem & Ethn Dis, Guiyang 550000, Peoples R China	Cui, Q; Liu, YJ (reprint author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Qingdao 266101, Peoples R China.; Cui, Q; Liu, YJ (reprint author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao 266101, Peoples R China.; Cui, Q; Liu, YJ (reprint author), Chinese Acad Sci, Qingdao Engn Lab Single Cell Oil, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Peoples R China.	cuiqiu@qibebt.ac.cn; liuyj@qibebt.ac.cn	Feng, Yingang/B-6304-2008	Feng, Yingang/0000-0002-0879-1316	National Natural Science Foundation of China [31300035, 31470210, 31560318, 31570029, 31570787]; National Key Technology Research and Development Program of China [2015BAD15B05]; Shandong Province Key Laboratory Union of Carbohydrate Industry Science and Technology	This work was supported by the National Natural Science Foundation of China (Grant Numbers 31300035, 31470210 and 31560318), the National Key Technology Research and Development Program of China (Grant Number 2015BAD15B05), and the Shandong Province Key Laboratory Union of Carbohydrate Industry Science and Technology, partially supported by the National Natural Science Foundation of China (Grant Numbers 31570029, and 31570787).	Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x; Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Breves R, 1997, APPL ENVIRON MICROB, V63, P3902; Cui GZ, 2012, J MICROBIOL METH, V89, P201, DOI 10.1016/j.mimet.2012.02.015; Cui ZL, 2013, BIOMOL NMR ASSIGN, V7, P73, DOI 10.1007/s12104-012-9381-2; Demain AL, 2009, J IND MICROBIOL BIOT, V36, P319, DOI 10.1007/s10295-008-0521-8; Englaender JA, 2017, ACS SYNTH BIOL, V6, P710, DOI 10.1021/acssynbio.6b00350; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; FREIER D, 1988, APPL ENVIRON MICROB, V54, P204; GARCIAMARTINEZ DV, 1980, EUR J APPL MICROBIOL, V9, P189, DOI 10.1007/BF00504485                                                              ; Gefen G, 2012, P NATL ACAD SCI USA, V109, P10298, DOI 10.1073/pnas.1202747109; Gowen CM, 2010, CHEM BIODIVERS, V7, P1086, DOI 10.1002/cbdv.200900314; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Hong W, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-80; Jabbour D, 2012, APPL MICROBIOL BIOT, V93, P1947, DOI 10.1007/s00253-011-3406-0; JOHNSON EA, 1981, APPL ENVIRON MICROB, V41, P1060; JOHNSON EA, 1984, ARCH MICROBIOL, V137, P135, DOI 10.1007/BF00414454                                                              ; Johnson E., 1982, J APPL BIOCHEM, V4, P64; KATAYEVA IA, 1992, ENZYME MICROB TECH, V14, P407, DOI 10.1016/0141-0229(92)90011-C; Kruus K, 1995, APPL MICROBIOL BIOT, V44, P399, DOI 10.1007/s002530050573; LAMED R, 1985, ENZYME MICROB TECH, V7, P37, DOI 10.1016/0141-0229(85)90008-0                                                    ; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Meng DD, 2015, MOL BIOSYST, V11, P3164, DOI 10.1039/c5mb00409h; Mohr G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069032; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; NG TK, 1977, ARCH MICROBIOL, V114, P1, DOI 10.1007/BF00429622; Olson Daniel G., 2015, Metabolic Engineering Communications, V2, P23, DOI 10.1016/j.meteno.2015.03.002; Olson DG, 2013, J BACTERIOL, V195, P733, DOI 10.1128/JB.02014-12; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; Olson DG, 2012, METHOD ENZYMOL, V510, P317, DOI 10.1016/B978-0-12-415931-0.00017-3; Olson DG, 2010, P NATL ACAD SCI USA, V107, P17727, DOI 10.1073/pnas.1003584107; Paye JMD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-015-0412-y; Pei JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-31; Prawitwong P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-184; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Resch MG, 2013, ENERG ENVIRON SCI, V6, P1858, DOI 10.1039/c3ee00019b; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Smith SP, 2013, CURR OPIN STRUC BIOL, V23, P686, DOI 10.1016/j.sbi.2013.09.002; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-105; Tian L, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0528-8; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Waeonukul R, 2013, BIORESOURCE TECHNOL, V130, P424, DOI 10.1016/j.biortech.2012.12.059; Waeonukul R, 2012, BIORESOURCE TECHNOL, V107, P352, DOI 10.1016/j.biortech.2011.12.126; WU JHD, 1988, BIOCHEMISTRY-US, V27, P1703, DOI 10.1021/bi00405a048                                                             ; Xu Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501254; Yi ZL, 2013, BIORESOURCE TECHNOL, V129, P629, DOI 10.1016/j.biortech.2012.12.098; Zhang JX, 2015, INT J DIGIT EARTH, V8, P36, DOI 10.1080/17538947.2013.846418	53	0	0	8	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-6834			BIOTECHNOL BIOFUELS	Biotechnol. Biofuels	MAY 12	2017	10								124	10.1186/s13068-017-0796-y				14	Biotechnology & Applied Microbiology; Energy & Fuels	Biotechnology & Applied Microbiology; Energy & Fuels	EV2XS	WOS:000401620700001	28507596	gold			2018-01-05	
J	Murphy, G				Murphy, Gillian			Riding the metalloproteinase roller coaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKIN FIBROBLAST COLLAGENASE; MATRIX METALLOPROTEINASES; RABBIT BONE; TUMOR MICROENVIRONMENT; TADPOLE COLLAGENASE; TISSUE INHIBITORS; RAT UTERUS; IN-VIVO; PURIFICATION; FAMILY	To many of us in the field, working on matrix metalloproteinases (MMPs) has felt like riding a roller coaster, traveling through times of both excitement and despair. I was fortunate to join the ride when it was a mere carousel of three activities thought to target the proteins that comprise the extracellular matrix (ECM). Newtechnologies brought the thrills of discovery as we uncovered specific proteinase genes and defined specialized activities in different cellular processes. The MMPs and the sister families of "a disintegrin and metalloproteinase" (ADAMs), ADAMs with thrombospondin domains (ADAM-TS), and Astacins are now recognized as key signaling "scissors" that drive rapid changes in a plethora of cellular pathways. My many excellent colleagues and collaborators and I were enthused to contribute to the early development of the field and continue to be amazed at its growth and sophistication. In contrast, the hype and failure of early inhibitor discovery have dogged our standing with the pharmaceutical industry and grant-giving bodies. However, the true believers have kept going, and knowledge of particular functions of MMPs and their contributions to disease progression has progressed. Recognition of the strategic importance of proteinase function should inspire more work harnessing new technologies such as imaging, proteomics, and gene editing to generate a more precise understanding of individual situations. New approaches to inhibitor design and assessment are possible, and the consequent ability to precisely abrogate specific MMP activity could contribute to the fight against a number of pathologies with unmet needs. What a ride it could be!	[Murphy, Gillian] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England	Murphy, G (reprint author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England.	gm290@cam.ac.uk			Medical Research Council, UK; Wellcome Trust; Arthritis Research UK; Cancer Research UK; European Union Framework Programmes	I am exceedingly grateful to my colleagues and students for working so hard and sharing the thrill of discovery with me. I am also grateful to all in the MMP community across the world for sharing the excitements and disappointments of research in this field and for such valuable collaborations. I thank the Medical Research Council, UK, the Wellcome Trust, Arthritis Research UK, Cancer Research UK and the European Union Framework Programmes for supporting our research from 1975 to 2014. Thanks to Hideaki Nagase for critical comments on the manuscript.	Aiken A, 2010, BBA-MOL CELL RES, V1803, P121, DOI 10.1016/j.bbamcr.2009.07.002; Amar S, 2015, EXPERT REV PROTEOMIC, V12, P445, DOI 10.1586/14789450.2015.1069190; Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Basu B, 2012, INT J BIOCHEM CELL B, V44, P393, DOI 10.1016/j.biocel.2011.11.015; Botkjaer KA, 2016, ONCOTARGET, V7, P16773, DOI 10.18632/oncotarget.7780; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brown PD, 1995, ANN ONCOL, V6, P967, DOI 10.1093/oxfordjournals.annonc.a059091                                           ; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; CAWSTON TE, 1981, BIOCHEM J, V195, P159, DOI 10.1042/bj1950159                                                               ; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EISEN AZ, 1968, BIOCHIM BIOPHYS ACTA, V151, P637, DOI 10.1016/0005-2744(68)90010-7                                                    ; EVANSON JOHN M., 1967, SCIENCE, V158, P499, DOI 10.1126/science.158.3800.499; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hall LA, 1996, MED HIST, V40, P231, DOI 10.1017/S0025727300061020                                                       ; HARPER E, 1971, BIOCHEMISTRY-US, V10, P3035, DOI 10.1021/bi00792a008; Iyer RP, 2012, AM J PHYSIOL-HEART C, V303, pH919, DOI 10.1152/ajpheart.00577.2012; JEFFREY JJ, 1970, BIOCHEMISTRY-US, V9, P268, DOI 10.1021/bi00804a012                                                             ; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Matusiak N, 2013, CURR PHARM DESIGN, V19, P4647, DOI 10.2174/1381612811319250011                                                     ; Murphy G, 2003, BIOCHEM SOC SYMP, V70, P65, DOI 10.1042/bss0700065                                                              ; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; NAGAI Y, 1966, BIOCHEMISTRY-US, V5, P3123, DOI 10.1021/bi00874a007                                                             ; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; OKADA Y, 1986, J BIOL CHEM, V261, P14245; Pavlaki M, 2003, CANCER METAST REV, V22, P177, DOI 10.1023/A:1023047431869                                                         ; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Schlage P, 2015, MATRIX BIOL, V44-46, P232, DOI 10.1016/j.matbio.2015.01.003; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; SELLERS A, 1978, BIOCHEM J, V171, P493, DOI 10.1042/bj1710493                                                               ; SELLERS A, 1977, BIOCHEM J, V167, P353, DOI 10.1042/bj1670353                                                               ; SELLERS A, 1977, BIOCHEM J, V163, P303, DOI 10.1042/bj1630303                                                               ; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; STRICKLIN GP, 1983, J BIOL CHEM, V258, P2252; STRICKLIN GP, 1978, BIOCHEMISTRY-US, V17, P2331, DOI 10.1021/bi00605a012; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578                                                         ; Waschkau B, 2013, CONTRAST MEDIA MOL I, V8, P1, DOI 10.1002/cmmi.1486; Watson SA, 1996, BRIT J CANCER, V74, P1354, DOI 10.1038/bjc.1996.549; WOESSNER JF, 1962, BIOCHEM J, V83, P304, DOI 10.1042/bj0830304                                                               ; Yamamoto K, 2015, MATRIX BIOL, V44-46, P255, DOI 10.1016/j.matbio.2015.02.007; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	53	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7708	+		10.1074/jbc.X117.785295				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EU6OU	WOS:000401154100001	28298437	gold			2018-01-05	
J	Bourens, M; Barrientos, A				Bourens, Myriam; Barrientos, Antoni			Human mitochondrial cytochrome c oxidase assembly factor COX18 acts transiently as a membrane insertase within the subunit 2 maturation module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAL EFFECTOR NUCLEASES; ESCHERICHIA-COLI YIDC; SACCHAROMYCES-CEREVISIAE; INNER-MEMBRANE; INTERMEMBRANE SPACE; HUMAN SCO1; GENE; BIOGENESIS; MUTATIONS; DEFICIENCY	Defects in mitochondrial cytochrome c oxidase or respiratory chain complex IV (CIV) assembly are a frequent cause of human mitochondrial disorders. Specifically, mutations in four conserved assembly factors impinging the biogenesis of the mitochondrion-encoded catalytic core subunit 2 (COX2) result in myopathies. These factors afford stability of newly synthesized COX2(the dystonia-ataxia syndrome protein COX20), a protein with two transmembrane domains, and maturation of its copper center, Cu-A (cardiomyopathy proteins SCO1, SCO2, and COA6). COX18 is an additional COX2 assembly factor that belongs to the Oxa1 family of membrane protein insertases. Here, we used a gene-editing approach to generate a human COX18 knock-out HEK293T cell line that displays isolated complete CIV deficiency. We demonstrate that COX20 stabilizes COX2 during insertion of its N-proximal transmembrane domain, and subsequently, COX18 transiently interacts with COX2 to promote translocation across the inner membrane of the COX2 C-tail that contains the apo-CuA site. The release of COX18 from this complex coincides with the binding of the SCO1-SCO2-COA6 copper metallation module to COX2-COX20 to finalize COX2 biogenesis. Therefore, COX18 is a new candidate when screening for mitochondrial disorders associated with isolated CIV deficiency.	[Bourens, Myriam; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA	Barrientos, A (reprint author), Univ Miami, Miller Sch Med, Dept Neurol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA.; Barrientos, A (reprint author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA.	abarrientos@med.miami.edu			NIGMS; National Institutes of Health [GM071775, GM105781, GM112179, R35GM118141]; Muscular Dystrophy Association Grant [381828]; American Heart Association fellowship	This work was supported by NIGMS, National Institutes of Health Grants GM071775, GM105781, GM112179, and R35GM118141 (to A. B.), Muscular Dystrophy Association Grant 381828 (to A. B.), and an American Heart Association fellowship (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baertling F, 2015, HUM MUTAT, V36, P34, DOI 10.1002/humu.22715; Barrientos A, 2009, CURR PROTOC HUM GENE, V19, P3; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Bourens M, 2017, EMBO REP, V18, P477, DOI 10.15252/embr.201643103; Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003; Broadley SA, 2001, MOL CELL BIOL, V21, P7663, DOI 10.1128/MCB.21.22.7663-7672.2001; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Fiumera HL, 2007, MOL CELL BIOL, V27, P4664, DOI 10.1128/MCB.01955-06; Fontanesi F., 2013, MITOCHOND IN PRESS 3, P239; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.E03-11-0789; Gaisne M, 2006, FEMS YEAST RES, V6, P869, DOI 10.1111/j.1567-1364.2006.00083.x; Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069; Haque ME, 2010, J BIOL CHEM, V285, P34991, DOI 10.1074/jbc.M110.163808; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Morgada MN, 2015, P NATL ACAD SCI USA, V112, P11771, DOI 10.1073/pnas.1505056112; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012; Papadopoulou LC, 1999, NAT GENET, V23, P333; POUTRE CG, 1987, GENETICS, V115, P637; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Richter-Dennerlein R., 2016, CELL, V167, p[471, e10]; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; Valnot I, 2000, AM J HUM GENET, V67, P1104; van Bloois E, 2007, FEBS J, V274, P5704, DOI 10.1111/j.1742-4658.2007.06094.x; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200	39	2	2	3	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7774	+		10.1074/jbc.M117.778514				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EU6OU	WOS:000401154100008	28330871				2018-01-05	
J	Kwon, DY; Zhao, YT; Lamonica, JM; Zhou, Z				Kwon, Deborah Y.; Zhao, Ying-Tao; Lamonica, Janine M.; Zhou, Zhaolan			Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC	NATURE COMMUNICATIONS			English	Article							GENE-EXPRESSION; DNA METHYLATION; IN-VIVO; GENOME; CRISPR; MECP2; TRANSCRIPTION; ACTIVATION; ENHANCERS; REPRESSION	Efforts to manipulate locus-specific histone acetylation to assess their causal role in gene expression and cellular and behavioural phenotypes have been impeded by a lack of experimental tools. The Cas9 nuclease has been adapted to target epigenomic modifications, but a detailed description of the parameters of such synthetic epigenome remodellers is still lacking. Here we describe a Cas9-based histone deacetylase (HDAC) and the design principles required to achieve locus-specific histone deacetylation. We assess its range of activity and specificity, and analyse target gene expression in two different cell types to investigate cellular context-dependent effects. Our findings demonstrate that the chromatin environment is an important element to consider when utilizing this synthetic HDAC.	[Kwon, Deborah Y.; Zhao, Ying-Tao; Lamonica, Janine M.; Zhou, Zhaolan] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Zhou, Z (reprint author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	zhaolan@mail.med.upenn.edu			Brain Research Foundation; NIH [R01MH091850]; University of Pennsylvania; T32 Training Programme in Neurodevelopmental Disabilities [T32NS007413]	We thank the Flow Cytometry & Cell Sorting Facility at the University of Pennsylvania Perelman School of Medicine for their FACS services. We also thank the Next Generation Sequencing Core at the Perelman School of Medicine for their high-throughput sequencing services. This work is partially supported by the Brain Research Foundation, NIH R01MH091850, and a start-up fund from the University of Pennsylvania (Z.Z.). D.Y.K. is supported by the T32 Training Programme in Neurodevelopmental Disabilities (T32NS007413). Z.Z. is a Pew Scholar in biomedical science.	Adachi M, 2005, HUM MOL GENET, V14, P3709, DOI 10.1093/hmg/ddi402; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Amir RE, 1999, NAT GENET, V23, P185; Arrar M, 2013, PROTEIN SCI, V22, P1306, DOI 10.1002/pro.2317; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Greer CB, 2015, CELL REP, V13, P1444, DOI 10.1016/j.celrep.2015.10.013; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Heller EA, 2016, J NEUROSCI, V36, P4690, DOI 10.1523/JNEUROSCI.0013-16.2016; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Liu J, 2006, HUM MOL GENET, V15, P1769, DOI 10.1093/hmg/ddl099; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Magklara A, 2013, TRENDS CELL BIOL, V23, P449, DOI 10.1016/j.tcb.2013.04.005; Mahgoub M, 2014, LEARN MEMORY, V21, P564, DOI 10.1101/lm.036012.114; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Nott A, 2016, NAT NEUROSCI, V19, P1497, DOI 10.1038/nn.4347; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476	34	2	2	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 12	2017	8								15315	10.1038/ncomms15315				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EU7OF	WOS:000401223400001	28497787	gold			2018-01-05	
J	Yan, WX; Mirzazadeh, R; Garnerone, S; Scott, D; Schneider, MW; Kallas, T; Custodio, J; Wernersson, E; Li, YQ; Gao, LY; Federova, Y; Zetsche, B; Zhang, F; Bienko, M; Crosetto, N				Yan, Winston X.; Mirzazadeh, Reza; Garnerone, Silvano; Scott, David; Schneider, Martin W.; Kallas, Tomasz; Custodio, Joaquin; Wernersson, Erik; Li, Yinqing; Gao, Linyi; Federova, Yana; Zetsche, Bernd; Zhang, Feng; Bienko, Magda; Crosetto, Nicola			BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks	NATURE COMMUNICATIONS			English	Article							OFF-TARGET CLEAVAGE; HUMAN-CELLS; CAS9 NUCLEASES; CRISPR-CAS9; CPF1; SEQ; RECOMBINATION; SPECIFICITIES; ENDONUCLEASES; GAMMA-H2AX	Precisely measuring the location and frequency of DNA double-strand breaks (DSBs) along the genome is instrumental to understanding genomic fragility, but current methods are limited in versatility, sensitivity or practicality. Here we present Breaks Labeling In Situ and Sequencing (BLISS), featuring the following: (1) direct labelling of DSBs in fixed cells or tissue sections on a solid surface; (2) low-input requirement by linear amplification of tagged DSBs by in vitro transcription; (3) quantification of DSBs through unique molecular identifiers; and (4) easy scalability and multiplexing. We apply BLISS to profile endogenous and exogenous DSBs in low-input samples of cancer cells, embryonic stem cells and liver tissue. We demonstrate the sensitivity of BLISS by assessing the genome-wide off-target activity of two CRISPR-associated RNA-guided endonucleases, Cas9 and Cpf1, observing that Cpf1 has higher specificity than Cas9. Our results establish BLISS as a versatile, sensitive and efficient method for genome-wide DSB mapping in many applications.	[Yan, Winston X.; Scott, David; Schneider, Martin W.; Li, Yinqing; Gao, Linyi; Federova, Yana; Zetsche, Bernd; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yan, Winston X.] Harvard Med Sch, Grad Program Biophys, Boston, MA 02115 USA; [Yan, Winston X.] Harvard Med Sch, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Mirzazadeh, Reza; Garnerone, Silvano; Kallas, Tomasz; Custodio, Joaquin; Wernersson, Erik; Bienko, Magda; Crosetto, Nicola] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, SE-17165 Stockholm, Sweden; [Scott, David; Li, Yinqing; Gao, Linyi; Federova, Yana; Zetsche, Bernd; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Scott, David; Li, Yinqing; Federova, Yana; Zetsche, Bernd; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Gao, Linyi; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Zhang, F (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Bienko, M; Crosetto, N (reprint author), Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, SE-17165 Stockholm, Sweden.; Zhang, F (reprint author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org; magda.bienko@ki.se; nicola.crosetto@ki.se		garnerone, silvano/0000-0002-0252-6108; Gao, Linyi/0000-0002-3579-0327	National Institute of General Medical Sciences [T32GM007753]; Paul and Daisy Soros Fellowship; Swedish Society for Medical Research (SSMF) Postdoctoral Fellowship; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NSF; New York Stem Cell Foundation; Howard Hughes Medical Institute; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Skoltech-MIT Next Generation Program; Science for Life Laboratory; Swedish Research Council [621-2014-5503, 521-2014-2866]; Ragnar Soderberg Foundation; Karolinska Institutet; Karolinska Institutet Strategic Programme in Cancer; Swedish Cancer Research Foundation [CAN 2015/585]	We thank R. Belliveau for overall research support; R. Macrae for critical reading of the manuscript; and the entire Zhang laboratory for support and advice. We also thank the T. Helleday group at Karolinska Institutet for providing reagents and support with confocal microscopy. W.X.Y. is supported by T32GM007753 from the National Institute of General Medical Sciences and a Paul and Daisy Soros Fellowship. E.W. is a recipient of a Swedish Society for Medical Research (SSMF) Postdoctoral Fellowship. F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049); NSF; the New York Stem Cell Foundation; the Howard Hughes Medical Institute; the Simons, Paul G. Allen Family and Vallee Foundations; the Skoltech-MIT Next Generation Program; James and Patricia Poitras; Robert Metcalfe; and David Cheng. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. M.B. is supported by the Science for Life Laboratory, the Swedish Research Council (621-2014-5503) and the Ragnar Soderberg Foundation. N.C. is supported by the Karolinska Institutet, the Karolinska Institutet Strategic Programme in Cancer, the Swedish Research Council (521-2014-2866), the Swedish Cancer Research Foundation (CAN 2015/585) and the Ragnar Soderberg Foundation.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Canela A, 2016, MOL CELL, V63, P898, DOI 10.1016/j.molcel.2016.06.034; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Hashimshony T, 2012, CELL REPORTS, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Lensing SV, 2016, NAT METHODS, V13, P855, DOI 10.1038/nmeth.3960; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schwer B, 2016, P NATL ACAD SCI USA, V113, P2258, DOI 10.1073/pnas.1525564113; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663                                                          ; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Winston X. Y., 2017, PROTOCOL EXCHANGE, DOI [10.1038/protex.2017.018, DOI 10.1038/PROTEX.2017.018]; Yang F, 2015, MUTAT RES-FUND MOL M, V773, P9, DOI 10.1016/j.mrfmmm.2015.01.007; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	27	7	7	5	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 12	2017	8								15058	10.1038/ncomms15058				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EU7NS	WOS:000401222100001	28497783	gold			2018-01-05	
J	Karakikes, I; Termglinchan, V; Cepeda, DA; Lee, J; Diecke, S; Hendel, A; Itzhaki, I; Ameen, M; Shrestha, R; Wu, HD; Ma, N; Shao, NY; Seeger, T; Woo, N; Wilson, KD; Matsa, E; Porteus, MH; Sebastiano, V; Wu, JC				Karakikes, Ioannis; Termglinchan, Vittavat; Cepeda, Diana A.; Lee, Jaecheol; Diecke, Sebastian; Hendel, Ayal; Itzhaki, Ilanit; Ameen, Mohamed; Shrestha, Rajani; Wu, Haodi; Ma, Ning; Shao, Ning-Yi; Seeger, Timon; Woo, Nicole; Wilson, Kitchener D.; Matsa, Elena; Porteus, Matthew H.; Sebastiano, Vittorio; Wu, Joseph C.			A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell-Based Models for Cardiovascular Diseases	CIRCULATION RESEARCH			English	Article						dilated cardiomyopathy; gene knockout; gene targeting; genome editing; stem cell	HOLT-ORAM-SYNDROME; HEART-DISEASE; NUCLEASES; MOUSE; GENE; MUTANT; CARDIOMYOPATHY; CARDIOMYOCYTES; MORPHOGENESIS; SPECIFICITY	Rationale: Targeted genetic engineering using programmable nucleases such as transcription activator-like effector nucleases (TALENs) is a valuable tool for precise, site-specific genetic modification in the human genome. Objective: The emergence of novel technologies such as human induced pluripotent stem cells (iPSCs) and nuclease-mediated genome editing represent a unique opportunity for studying cardiovascular diseases in vitro. Methods and Results: By incorporating extensive literature and database searches, we designed a collection of TALEN constructs to knockout 88 human genes that are associated with cardiomyopathies and congenital heart diseases. The TALEN pairs were designed to induce double-strand DNA break near the starting codon of each gene that either disrupted the start codon or introduced a frameshift mutation in the early coding region, ensuring faithful gene knockout. We observed that all the constructs were active and disrupted the target locus at high frequencies. To illustrate the utility of the TALEN-mediated knockout technique, 6 individual genes (TNNT2, LMNA/ C, TBX5, MYH7, ANKRD1, and NKX2.5) were knocked out with high efficiency and specificity in human iPSCs. By selectively targeting a pathogenic mutation (TNNT2 p. R173W) in patient-specific iPSC-derived cardiac myocytes, we demonstrated that the knockout strategy ameliorates the dilated cardiomyopathy phenotype in vitro. In addition, we modeled the Holt-Oram syndrome in iPSC-cardiac myocytes in vitro and uncovered novel pathways regulated by TBX5 in human cardiac myocyte development. Conclusions: Collectively, our study illustrates the powerful combination of iPSCs and genome editing technologies for understanding the biological function of genes, and the pathological significance of genetic variants in human cardiovascular diseases. The methods, strategies, constructs, and iPSC lines developed in this study provide a validated, readily available resource for cardiovascular research.	[Karakikes, Ioannis; Termglinchan, Vittavat; Lee, Jaecheol; Diecke, Sebastian; Itzhaki, Ilanit; Ameen, Mohamed; Shrestha, Rajani; Wu, Haodi; Ma, Ning; Shao, Ning-Yi; Seeger, Timon; Woo, Nicole; Wilson, Kitchener D.; Matsa, Elena; Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Karakikes, Ioannis] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Termglinchan, Vittavat; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Cepeda, Diana A.; Sebastiano, Vittorio; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Hendel, Ayal; Porteus, Matthew H.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Wilson, Kitchener D.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Sebastiano, Vittorio] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Diecke, Sebastian] Berlin Inst Hlth, Berlin, Germany; [Diecke, Sebastian] Max Delbrueck Ctr, Berlin, Germany	Wu, JC (reprint author), 265 Campus Dr G1120B, Stanford, CA 94305 USA.; Sebastiano, V (reprint author), 265 Campus Dr G1167, Stanford, CA 94305 USA.	vsebast@stanford.edu; joewu@stanford.edu	Ma, Nan/L-1282-2013	Ma, Nan/0000-0003-4006-1003; SHAO, Ning-Yi/0000-0003-4231-828X	National Institutes of Health (NIH) [4R00 HL104002-03]; AHA [15BGIA22730027, 13EIA14420025]; Stanford CVI Seed Grant; Prince Mahidol Award Foundation, Thailand; German Research Foundation; California Institute of Regenerative Medicine (CIRM) [U54 DH068158-01, RB3-2209]; NIH [R01 HL126527, R01 HL130020, R01 HL123968, R01 HL132875, R01 HL133272, R24 HL117756]	This study was funded by the National Institutes of Health (NIH) 4R00 HL104002-03, AHA 15BGIA22730027, and Stanford CVI Seed Grant (I. Karakikes); Prince Mahidol Award Foundation, Thailand (V. Termglinchan); the German Research Foundation (T. Seeger); U54 DH068158-01 (Pilot Project) (V. Sebastiano), California Institute of Regenerative Medicine (CIRM) RB3-2209 (V. Sebastiano); and AHA 13EIA14420025, NIH R01 HL126527, NIH R01 HL130020, NIH R01 HL123968, NIH R01 HL132875, NIH R01 HL133272, and NIH R24 HL117756 (J.C. Wu).	Adams WJ, 2013, STEM CELL REP, V1, P105, DOI 10.1016/j.stemcr.2013.06.007; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30                                                               ; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7                                                   ; Cooley MA, 2008, DEV BIOL, V319, P336, DOI 10.1016/j.ydbio.2008.04.029; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Epstein JA, 2010, NEW ENGL J MED, V363, P1638, DOI 10.1056/NEJMra1003941; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GeorgesLabouesse EN, 1996, DEV DYNAM, V207, P145, DOI 10.1002/(SICI)1097-0177(199610)207:2<145::AID-AJA3>3.0.CO;2-H; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Henderson DJ, 1998, CIRC RES, V83, P523; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Karakikes I, 2015, CIRC RES, V117, P80, DOI 10.1161/CIRCRESAHA.117.305365; Karakikes I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7955; Karakikes I, 2014, STEM CELL TRANSL MED, V3, P18, DOI 10.5966/sctm.2013-0110; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lee TH, 2010, CIRC RES, V106, P120, DOI 10.1161/CIRCRESAHA.109.207902; Maze I, 2014, NAT NEUROSCI, V17, P1476, DOI 10.1038/nn.3816; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nadadur RD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4891; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769                                                                   ; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Tao G, 2012, J MOL CELL CARDIOL, V53, P626, DOI 10.1016/j.yjmcc.2012.08.002; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1016/S0012-1606(97)98559-6	47	4	4	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7330	1524-4571		CIRC RES	Circ.Res.	MAY 12	2017	120	10					1561	+		10.1161/CIRCRESAHA.116.309948				46	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	EU3UW	WOS:000400957500017	28246128				2018-01-05	
J	Ma, YJ; Walsh, MJ; Bernhardt, K; Ashbaugh, CW; Trudeau, SJ; Ashbaugh, IY; Jiang, SZ; Jiang, C; Zhao, B; Root, DE; Doench, JG; Gewurz, BE				Ma, Yijie; Walsh, Michael J.; Bernhardt, Katharina; Ashbaugh, Camille W.; Trudeau, Stephen J.; Ashbaugh, Isabelle Y.; Jiang, Sizun; Jiang, Chang; Zhao, Bo; Root, David E.; Doench, John G.; Gewurz, Benjamin E.			CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors	CELL HOST & MICROBE			English	Article							NF-KAPPA-B; BURKITT-LYMPHOMA CELLS; LATENT MEMBRANE-PROTEIN-1; ENRICHMENT ANALYSIS; SUPER-ENHANCERS; GENE-EXPRESSION; GENOME-WIDE; 3C BINDS; C-MYC; EBV	Epstein-Barr virus (EBV) causes endemic Burkitt lymphoma (BL) and immunosuppression-related lymphomas. These B cell malignancies arise by distinct transformation pathways and have divergent viral and host expression programs. To identify host dependency factors resulting from these EBV+, B cell-transformed cell states, we performed parallel genome-wide CRISPR/Cas9 loss-of-function screens in BL and lymphoblastoid cell lines (LCLs). These highlighted 57 BL and 87 LCL genes uniquely important for their growth and survival. LCL hits were enriched for EBV-induced genes, including viral super-enhancer targets. Our systematic approach uncovered key mechanisms by which EBV oncoproteins activate the PI3K/AKT pathway and evade tumor suppressor responses. LMP1-induced cFLIP was found to be critical for LCL defense against TNF alpha-mediated programmed cell death, whereas EBV-induced BATF/IRF4 were critical for BIM suppression and MYC induction in LCLs. Finally, EBV super-enhancer-targeted IRF2 protected LCLs against Blimp1-mediated tumor suppression. Our results identify viral transformation-driven synthetic lethal targets for therapeutic intervention.	[Ma, Yijie; Walsh, Michael J.; Bernhardt, Katharina; Ashbaugh, Camille W.; Trudeau, Stephen J.; Ashbaugh, Isabelle Y.; Jiang, Sizun; Jiang, Chang; Zhao, Bo; Gewurz, Benjamin E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Walsh, Michael J.; Jiang, Sizun; Gewurz, Benjamin E.] Harvard Med Sch, Program Virol, Boston, MA 02115 USA; [Root, David E.; Doench, John G.; Gewurz, Benjamin E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Gewurz, BE (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA.; Gewurz, BE (reprint author), Harvard Med Sch, Program Virol, Boston, MA 02115 USA.; Gewurz, BE (reprint author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	bgewurz@bwh.harvard.edu		Jiang, Sizun/0000-0001-6149-3142	Burroughs Wellcome Fund; NCI [K08 CA140780, RO1 CA085180, CA AI123420]; Next Generation Fund at the Broad Institute	B.E.G. is a recipient of a Burroughs Wellcome Fund Career Award in Medical Sciences. This work was also supported by institutional funds NCI K08 CA140780, NCI RO1 CA085180, and CA AI123420. J.G.D. is supported by the Next Generation Fund at the Broad Institute. S.J. is a Howard Hughes Medical Institute predoctoral fellow. We thank Dr. Elliott Kieff for reagents and helpful discussions, Emma Vaimberg and Dr. Glenn Cowley for technical assistance, Dr. Jeff Sample for the KEM and MUTU BL cell lines, Dr. Jaap Middeldorp for the EBNA1 antibody, and Dr. Richard Longnecker for the LMP2A antibody.	Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Banerjee S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003314; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Bernhardt K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005405; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8                                                   ; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Cen O, 2015, CURR TOP MICROBIOL, V391, P151, DOI 10.1007/978-3-319-22834-1_5; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cohen J. I., 2011, SCI TRANSL MED, V3; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farrell CJ, 2004, P NATL ACAD SCI USA, V101, P4625, DOI 10.1073/pnas.0306482101; Feederle R, 2011, J VIROL, V85, P9801, DOI 10.1128/JVI.05100-11; Forte E, 2009, J VIROL, V83, P2491, DOI 10.1128/JVI.01681-08; Greenfeld H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004890; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Jha HC, 2015, ONCOTARGET, V6, P30115, DOI 10.18632/oncotarget.5002; Jiang SZ, 2014, P NATL ACAD SCI USA, V111, P421, DOI 10.1073/pnas.1321704111; Johansen LM, 2003, J VIROL, V77, P6029, DOI 10.1128/JVI.77.10.6029-6040.2003; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Kieff E, 2007, FIELDS VIROLOGY, V2, P2603; Kuo TC, 2004, J IMMUNOL, V173, P5556, DOI 10.4049/jimmunol.173.9.5556                                                     ; LaCasce AS, 2006, ONCOLOGIST, V11, P674, DOI 10.1634/theoncologist.11-6-674                                                  ; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lieberman PM, 2014, SCIENCE, V343, P1323, DOI 10.1126/science.1252786; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Meckes DG, 2013, J VIROL, V87, P1301, DOI 10.1128/JVI.02519-12; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Minamitani T, 2015, P NATL ACAD SCI USA, V112, P11612, DOI 10.1073/pnas.1514484112; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Nonkwelo C, 1996, J VIROL, V70, P623; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Paschos K, 2012, NUCLEIC ACIDS RES, V40, P7233, DOI 10.1093/nar/gks391; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Powles J, 2009, INT J EPIDEMIOL, V38, P1141, DOI 10.1093/ije/dyp247; Price AM, 2012, J VIROL, V86, P11096, DOI 10.1128/JVI.01069-12; Reusch JA, 2015, J VIROL, V89, P1731, DOI 10.1128/JVI.02781-14; Rickinson AB, 2014, SEMIN CANCER BIOL, V26, P99, DOI 10.1016/j.semcancer.2014.04.004; Robertson ES, 1996, J VIROL, V70, P3068; ROWE M, 1987, EMBO J, V6, P2743; Saha A, 2009, J VIROL, V83, P4652, DOI 10.1128/JVI.02408-08; Schmidt SCS, 2015, P NATL ACAD SCI USA, V112, P554, DOI 10.1073/pnas.1422580112; Schmitz R., 2014, COLD SPRING HARB PER, V4; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Shoham T, 2003, J IMMUNOL, V171, P4062, DOI 10.4049/jimmunol.171.8.4062                                                     ; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Snow AL, 2006, J IMMUNOL, V177, P3283, DOI 10.4049/jimmunol.177.5.3283                                                     ; Song YJ, 2008, P NATL ACAD SCI USA, V105, P18448, DOI 10.1073/pnas.0809933105; Spender LC, 2001, J VIROL, V75, P3537, DOI 10.1128/JVI.75.8.3537-3546.2001                                                 ; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugden B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001939; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Tepper CG, 1999, BLOOD, V94, P1727; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Vrzalikova K, 2011, BLOOD, V117, P5907, DOI 10.1182/blood-2010-09-307710; Weniger MA, 2016, SEMIN CANCER BIOL, V39, P32, DOI 10.1016/j.semcancer.2016.05.001; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wood CD, 2016, ELIFE, V5, DOI 10.7554/eLife.18270; Zhao B, 1996, J VIROL, V70, P4228; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037; Zhou HF, 2015, CELL HOST MICROBE, V17, P205, DOI 10.1016/j.chom.2014.12.013	77	2	2	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1931-3128	1934-6069		CELL HOST MICROBE	Cell Host Microbe	MAY 10	2017	21	5					580	+		10.1016/j.chom.2017.04.005				19	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	EU2XF	WOS:000400892500009	28494239				2018-01-05	
J	Germain, DP				Germain, Dominique P.			Pseudoxanthoma elasticum	ORPHANET JOURNAL OF RARE DISEASES			English	Review						Pseudoxanthoma elasticum; Metabolic disease; Ectopic mineralization; Skin; Angioid streak; Choroidal neovascularization; Peripheral arterial disease; ABCC6	ECTOPIC MINERALIZATION DISORDERS; SOFT-TISSUE MINERALIZATION; DISEASE-CAUSING MUTATIONS; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; MATRIX GLA-PROTEIN; ABCC6 GENE; VITAMIN-K; MOUSE MODEL; BETA-THALASSEMIA	Pseudoxanthoma elasticum (PXE) is a genetic metabolic disease with autosomal recessive inheritance caused by mutations in the ABCC6 gene. The lack of functional ABCC6 protein leads to ectopic mineralization that is most apparent in the elastic tissues of the skin, eyes and blood vessels. The clinical prevalence of PXE has been estimated at between 1 per 100,000 and 1 per 25,000, with slight female predominance. The first clinical sign of PXE is almost always small yellow papules on the nape and sides of the neck and in flexural areas. The papules coalesce, and the skin becomes loose and wrinkled. The mid-dermal elastic fibers are short, fragmented, clumped and calcified. Dystrophic calcification of Bruch's membrane, revealed by angioid streaks, may trigger choroidal neovascularization and, ultimately, loss of central vision and blindness in late-stage disease. Lesions in small and medium-sized artery walls may result in intermittent claudication and peripheral artery disease. Cardiac complications (myocardial infarction, angina pectoris) are thought to be relatively rare but merit thorough investigation. Ischemic strokes have been reported. PXE is a metabolic disease in which circulating levels of an anti-mineralization factor are low. There is good evidence to suggest that the factor is inorganic pyrophosphate (PPi), and that the circulating low levels of PPi and decreased PPi/Pi ratio result from the lack of ATP release by hepatocytes harboring the mutant ABCC6 protein. However, the substrate(s) bound, transported or modulated by the ABCC6 protein remain unknown. More than 300 sequence variants of the ABCC6 gene have been identified. There is no cure for PXE; the main symptomatic treatments are vascular endothelial growth factor inhibitor therapy (for ophthalmic manifestations), lifestyle, lipid-lowering and dietary measures (for reducing vascular risk factors), and vascular surgery (for severe cardiovascular manifestations). Future treatment options may include gene therapy/editing and pharmacologic chaperone therapy.	[Germain, Dominique P.] Univ Versailles St Quentin Yvelines, Div Med Genet, Paris Saclay Univ, 2 Ave Source Bievre, F-78180 Montigny, France	Germain, DP (reprint author), Univ Versailles St Quentin Yvelines, Div Med Genet, Paris Saclay Univ, 2 Ave Source Bievre, F-78180 Montigny, France.	dominique.germain@uvsq.fr		GERMAIN, Dominique/0000-0002-8355-007X	French Ministry of Health	"Plan National Maladies Rare", from the French Ministry of Health.	Aherrahrou Z, 2008, J BIOL CHEM, V283, P7608, DOI 10.1074/jbc.M708290200; Akoglu G, 2014, INT J DERMATOL, V53, P692, DOI 10.1111/ijd.12008; Aranyi Tamas, 2013, Frontiers in Genetics, V4, P27, DOI 10.3389/fgene.2013.00027; Aravalli RN, 2016, EXPERT OPIN BIOL TH, V16, P595, DOI 10.1517/14712598.2016.1158808; Baccarani-Contri M, 2001, J AM ACAD DERMATOL, V44, P33, DOI 10.1067/mjd.2001.110045; Belinsky MG, 2002, CANCER RES, V62, P6172; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109                                                                   ; Boutouyrie P, 2001, HYPERTENSION, V38, P1181, DOI 10.1161/hy1101.096108                                                           ; Brampton C, 2014, AM J PATHOL, V184, P159, DOI 10.1016/j.ajpath.2013.09.015; Brampton C, 2011, CELL CYCLE, V10, P1810, DOI 10.4161/cc.10.11.15681; Brenner B, 2009, SEMIN THROMB HEMOST, V35, P439, DOI 10.1055/s-0029-1225766; Brown SJ, 2007, BRIT J DERMATOL, V157, P748, DOI 10.1111/j.1365-2133.2007.08076.x; Chassaing N, 2005, J MED GENET, V42, P881, DOI 10.1136/jmg.2004.030171; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Christen-Zach S, 2006, BRIT J DERMATOL, V155, P89, DOI 10.1111/j.1365-2133.2006.07278.x; Chuah MK, 2014, MOL THER, V22, P1605, DOI 10.1038/mt.2014.114; Cianciulli P, 2002, EUR J CLIN INVEST, V32, P700, DOI 10.1046/j.1365-2362.2002.01032.x; Contri MB, 1996, AM J PATHOL, V148, P569; Darier J, 1896, MONATSSCHR PRAKT DER, V23, P609; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; De Vilder EYG, 2015, WORLD J CLIN CASES, V3, P556, DOI 10.12998/wjcc.v3.i7.556; Debette Stephanie, 2014, Handb Clin Neurol, V119, P565, DOI 10.1016/B978-0-7020-4086-3.00037-0; Fabbri Elena, 2009, Dermatol Online J, V15, P7; Finger RP, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-113; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Gambichler T, 2010, ARCH DERMATOL RES, V302, P85, DOI 10.1007/s00403-009-1004-0; Georgalas Ilias, 2009, Ther Clin Risk Manag, V5, P81; Georgalas I, 2011, CLIN EXP OPTOM, V94, P169, DOI 10.1111/j.1444-0938.2010.00559.x; Germain DP, 2016, NEW ENGL J MED, V375, P545, DOI 10.1056/NEJMoa1510198; Germain DP, 2009, INT J CLIN PHARM TH, V47, pS111; Germain DP, 2000, BIOCHEM BIOPH RES CO, V274, P297, DOI 10.1006/bbrc.2000.3101; Germain DP, 2003, ARTERIOSCL THROM VAS, V23, P836, DOI 10.1161/01.ATV.0000067428.19031.28; Germain DP, 2001, J MED GENET, V38, P457, DOI 10.1136/jmg.38.7.457; Germain DP, 2017, TXB TREATABLE NEUROM; Gheduzzi D, 2003, ULTRASTRUCT PATHOL, V27, P375, DOI 10.1080/01913120390248584; Goral V, 2007, WORLD J GASTROENTERO, V13, P3897; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Gorgels TGMF, 2011, J MOL MED, V89, P1125, DOI 10.1007/s00109-011-0782-y; Gronblad E, 1929, ACTA OPHTHALMOL, V7, P329, DOI DOI 10.1111/J.1755-3768.1929.TB07934.X; Guo HT, 2013, J MOL MED, V91, P1177, DOI 10.1007/s00109-013-1066-5; Hamlin N, 2003, BRIT J HAEMATOL, V122, P852, DOI 10.1046/j.1365-2141.2003.04484.x                                                ; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Hendig Doris, 2013, Frontiers in Genetics, V4, P114, DOI 10.3389/fgene.2013.00114; Hendig D, 2008, LAB INVEST, V88, P1303, DOI 10.1038/labinvest.2008.96; HESTON WE, 1971, INT J CANCER, V7, P141, DOI 10.1002/ijc.2910070116                                                          ; Hornstrup LS, 2011, CIRC-CARDIOVASC GENE, V4, P534, DOI 10.1161/CIRCGENETICS.110.958801; Hosen M. J., 2012, SCI CAIRO, V2012; Hosen MJ, 2015, J INVEST DERMATOL, V135, P992, DOI 10.1038/jid.2014.421; Hosen MJ, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-66; Hu XF, 2003, SURV OPHTHALMOL, V48, P424, DOI 10.1016/S0039-6257(03)00053-5; Ibanez-Samaniego L, 2015, REV ESP ENFERM DIG, V107, P190; Iliopoulos J, 2002, ANN THORAC SURG, V73, P652, DOI 10.1016/S0003-4975(01)03011-9                                                   ; Garcia-Fernandez MI, 2008, BBA-MOL BASIS DIS, V1782, P474, DOI 10.1016/j.bbadis.2008.05.001; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; JENSEN OA, 1977, A GRAEF ARCH KLIN EX, V203, P311, DOI 10.1007/BF00409836; Jiang QJ, 2006, J INVEST DERMATOL, V126, P1440, DOI 10.1038/sj.jid.5700267; Jiang QJ, 2011, CELL CYCLE, V10, P701, DOI 10.4161/cc.10.4.14862; Jiang QJ, 2010, AM J PATHOL, V176, P1855, DOI 10.2353/ajpath.2010.090983; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Jin L, 2015, J INVEST DERMATOL, V135, P1294, DOI 10.1038/jid.2015.10; Kalal Iravathy Goud, 2012, J Cardiovasc Dis Res, V3, P150, DOI 10.4103/0975-3583.95373; Karam C, 2015, J CARDIOVASC COMPUT, V9, P238, DOI 10.1016/j.jcct.2015.02.004; Kariminejad A, 2014, J INVEST DERMATOL, V134, P2331, DOI 10.1038/jid.2014.191; Kauffenstein G, 2014, ARTERIOSCL THROM VAS, V34, P1045, DOI 10.1161/ATVBAHA.113.302943; KAZAKIS AM, 1988, J AM ACAD DERMATOL, V19, P384, DOI 10.1016/S0190-9622(88)70183-8; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; Koblos G, 2010, GENET TEST MOL BIOMA, V14, P75, DOI 10.1089/gtmb.2009.0094; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Kool M, 1999, CANCER RES, V59, P175; Kringen MK, 2015, MOL GENET GENOM MED, V3, P233, DOI 10.1002/mgg3.137; Kringen Marianne K, 2012, BMC Res Notes, V5, P425, DOI 10.1186/1756-0500-5-425; Kuzaj P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108336; LaRusso J, 2010, CTS-CLIN TRANSL SCI, V3, P295, DOI 10.1111/j.1752-8062.2010.00243.x; Lau WL, 2014, AM J NEPHROL, V40, P51, DOI 10.1159/000365014; Le Saux O, 2001, AM J HUM GENET, V69, P749, DOI 10.1086/323704; Le Saux O, 2000, NAT GENET, V25, P223; Le Saux Olivier, 2012, Frontiers in Genetics, V3, P289, DOI 10.3389/fgene.2012.00289; Le Saux O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024738; Lebwohl M, 2003, J AM ACAD DERMATOL, V48, P620, DOI 10.1067/mjd.2003.195; LEBWOHL M, 1993, ARCH DERMATOL RES, V285, P121, DOI 10.1007/BF01112912; LEBWOHL M, 1994, J AM ACAD DERMATOL, V30, P103, DOI 10.1016/S0190-9622(08)81894-4                                                   ; Leftheriotis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096003; Leftheriotis Georges, 2013, Frontiers in Genetics, V4, P4, DOI 10.3389/fgene.2013.00004; Leftheriotis G, 2011, J VASC SURG, V54, P1390, DOI 10.1016/j.jvs.2011.04.041; Lewis KG, 2004, J AM ACAD DERMATOL, V51, P1, DOI 10.1016/j.jaad.2004.03.013; Li QL, 2008, J INVEST DERMATOL, V128, P1160, DOI 10.1038/sj.jid.5701145; Li QL, 2016, J INVEST DERMATOL, V136, P550, DOI 10.1016/j.jid.2015.10.065; Li QL, 2016, J INVEST DERMATOL, V136, P275, DOI 10.1038/JID.2015.377; Li QL, 2015, CELL CYCLE, V14, P3184, DOI 10.1080/15384101.2015.1068473; Li QL, 2015, CELL CYCLE, V14, P1082, DOI 10.1080/15384101.2015.1007809; Li QL, 2014, CELL CYCLE, V13, P2609, DOI 10.4161/15384101.2014.943567; Li QL, 2014, MATRIX BIOL, V33, P23, DOI 10.1016/j.matbio.2013.06.003; Li QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089268; Li QL, 2011, J INVEST DERMATOL, V131, P565, DOI 10.1038/jid.2010.388; Li QL, 2011, J INVEST DERMATOL, V131, P782, DOI 10.1038/jid.2010.384; Li QL, 2010, J INVEST DERMATOL, V130, P2561, DOI 10.1038/jid.2010.174; Li QL, 2010, J MOL MED, V88, P173, DOI 10.1007/s00109-009-0522-8; Li QL, 2009, CTS-CLIN TRANSL SCI, V2, P398, DOI 10.1111/j.1752-8062.2009.00161.x; Li QL, 2009, J INVEST DERMATOL, V129, P553, DOI 10.1038/jid.2008.271; Li QL, 2009, AM J PATHOL, V174, P534, DOI 10.2353/ajpath.2009.080865; Liew G, 2013, JAMA INTERN MED, V173, P258, DOI 10.1001/jamainternmed.2013.1583; Lodge AJ, 2005, TEX HEART I J, V32, P576; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mackay EW, 2015, DEVELOPMENT, V142, P1095, DOI 10.1242/dev.113811; Marconi B, 2015, INTRACTABLE RARE DIS, V4, P113, DOI 10.5582/irdr.2015.01014; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; Martin LJ, 2012, CIRC RES, V111, P516, DOI 10.1161/CIRCRESAHA.112.276667; Martin L, 2011, AM J PATHOL, V178, P774, DOI 10.1016/j.ajpath.2010.10.004; Marwah Manjot, 2012, J Cutan Aesthet Surg, V5, P212, DOI 10.4103/0974-2077.101390; Miksch S, 2005, HUM MUTAT, V26, P235, DOI 10.1002/humu.20206; Myung JS, 2010, RETINA-J RET VIT DIS, V30, P748, DOI 10.1097/IAE.0b013e3181c596b1; NELDNER KH, 1988, CLIN DERMATOL, V6, pR8; Neri P, 2009, BRIT J OPHTHALMOL, V93, P155, DOI 10.1136/bjo.2008.145896; Ng ABY, 1999, BRIT J PLAST SURG, V52, P594, DOI 10.1054/bjps.1999.3139; Nitschke Y, 2012, AM J HUM GENET, V90, P25, DOI 10.1016/j.ajhg.2011.11.020; Orssaud C, 2015, OPHTHALMIC GENET, V36, P327, DOI 10.3109/13816810.2014.886268; Perdu J, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<74::AID-HUMU14>3.0.CO;2-F; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Pingel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162337; Pisciotta L, 2010, ATHEROSCLEROSIS, V210, P173, DOI 10.1016/j.atherosclerosis.2009.11.028; Plomp AS, 2010, AM J MED GENET A, V152A, P1049, DOI 10.1002/ajmg.a.33329; Pomozi V, 2017, J INVEST DERMATOL, V137, P595, DOI 10.1016/j.jid.2016.10.035; Pomozi V, 2014, J INVEST DERMATOL, V134, P946, DOI 10.1038/jid.2013.482; Pomozi V, 2013, CIRC RES, V112, pE148, DOI 10.1161/CIRCRESAHA.111.300194; Pulkkinen L, 2001, HUM GENET, V109, P356, DOI 10.1007/s004390100582                                                           ; Rasmussen MR, 2016, J PROTEOME RES, V15, P4591, DOI 10.1021/acs.jproteome.6b00669; Rasmussen MR, 2013, EXPERT REV ENDOCRINO, V8, P37, DOI 10.1586/EEM.12.72; Ratajewski M, 2012, J INVEST DERMATOL, V132, P2709, DOI 10.1038/jid.2012.218; Rigal D., 1881, ANN DERMATOL SYPHIL, V2, P491; Ringpfeil F, 2000, P NATL ACAD SCI USA, V97, P6001, DOI 10.1073/pnas.100041297                                                          ; Rothe M, 2014, CURR GENE THER, V14, P429, DOI 10.2174/1566523214666140918110905                                               ; Sato N, 2009, BIOCHEM BIOPH RES CO, V380, P548, DOI 10.1016/j.bbrc.2009.01.117; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/bse0500179, 10.1042/BSE0500179]; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI 10.1056/NEJMoa0912923; Strandberg J., 1929, Z HAUT GESCHLECHTSKR, V31, P689; Struk B, 2000, J MOL MED-JMM, V78, P282, DOI 10.1007/s001090000114                                                           ; Struk B, 1997, HUM MOL GENET, V6, P1823, DOI 10.1093/hmg/6.11.1823                                                           ; Suliman ME, 2008, ADV CLIN CHEM, V46, P217, DOI 10.1016/S0065-2423(08)00406-X; Szabo Z, 2011, MOL GENET METAB, V104, P421, DOI 10.1016/j.ymgme.2011.07.013; Terry Sharon F., 2013, Frontiers in Genetics, V4, P101, DOI 10.3389/fgene.2013.00101; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Uitto J, 2017, J INVEST DERMATOL, V137, P790, DOI 10.1016/j.jid.2016.12.014; Val-Bernal JF, 2017, AM J DERMATOPATH, V39, P150, DOI 10.1097/DAD.0000000000000653; van den Berg JSP, 2000, CEREBROVASC DIS, V10, P315, DOI 10.1159/000016076                                                               ; Vanakker OM, 2007, J INVEST DERMATOL, V127, P581, DOI 10.1038/sj.jid.5700610; Vanakker Olivier M, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9514; Van Loey S, 2013, B SOC BELGE OPHTALMO, V322, P83; Vasseur M, 2011, EUR J VASC ENDOVASC, V42, P292, DOI 10.1016/j.ejvs.2011.05.007; Verbraak FD, 2010, DEV OPHTHALMOL, V46, P96, DOI 10.1159/000320012; VILJOEN DL, 1990, PLAST RECONSTR SURG, V85, P233, DOI 10.1097/00006534-199002000-00011                                                ; Voskou S, 2015, REDOX BIOL, V6, P226, DOI 10.1016/j.redox.2015.07.018; WALKER ER, 1989, ARCH DERMATOL, V125, P70, DOI 10.1001/archderm.125.1.70; Wang AR, 2012, J CUTAN PATHOL, V39, P957, DOI 10.1111/j.1600-0560.2012.01979.x; Weston BW, 2008, HAEMOPHILIA, V14, P1209, DOI 10.1111/j.1365-2516.2008.01853.x; Yokoo T, 2016, WORLD J GASTROENTERO, V22, P8862, DOI 10.3748/wjg.v22.i40.8862; Yoo JY, 2011, J AM ACAD DERMATOL, V65, P341, DOI 10.1016/j.jaad.2010.05.023; Zhou Y, 2013, J INVEST DERMATOL, V133, P2672, DOI 10.1038/jid.2013.234; Zimmo L, 2013, J VASC SURG, V57, P842, DOI 10.1016/j.jvs.2012.09.016	160	1	1	2	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1750-1172			ORPHANET J RARE DIS	Orphanet J. Rare Dis.	MAY 10	2017	12								85	10.1186/s13023-017-0639-8				13	Genetics & Heredity; Medicine, Research & Experimental	Genetics & Heredity; Research & Experimental Medicine	EU3NU	WOS:000400939100001	28486967	gold			2018-01-05	
J	Yang, YP; Ma, HT; Starchenko, A; Huh, WJ; Li, W; Hickman, FE; Zhang, Q; Franklin, JL; Mortlock, DP; Fuhrmann, S; Carter, BD; Ihrie, RA; Coffey, RJ				Yang, Yu-Ping; Ma, Haiting; Starchenko, Alina; Huh, Won Jae; Li, Wei; Hickman, F. Edward; Zhang, Qin; Franklin, Jeffrey L.; Mortlock, Douglas P.; Fuhrmann, Sabine; Carter, Bruce D.; Ihrie, Rebecca A.; Coffey, Robert J.			A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo	CELL REPORTS			English	Article							EPIDERMAL-GROWTH-FACTOR; NEURAL STEM-CELLS; ERBB NEGATIVE REGULATOR; FACTOR RECEPTOR; TUMOR-SUPPRESSOR; PROGENITOR CELLS; TGF-ALPHA; TYROSINE PHOSPHORYLATION; VASCULAR NICHE; ADULT BRAIN	EGF receptor (EGFR) is a critical signaling node throughout life. However, it has not been possible to directly visualize endogenous Egfr in mice. Using CRISPR/Cas9 genome editing, we appended a fluorescent reporter to the C terminus of the Egfr. Homozygous reporter mice appear normal and EGFR signaling is intact in vitro and in vivo. We detect distinct patterns of Egfr expression in progenitor and differentiated compartments in embryonic and adult mice. Systemic delivery of EGF or amphiregulin results in markedly different patterns of Egfr internalization and trafficking in hepatocytes. In the normal intestine, Egfr localizes to the crypt rather than villus compartment, expression is higher in adjacent epithelium than in intestinal tumors, and following colonic injury expression appears in distinct cell populations in the stroma. This reporter, under control of its endogenous regulatory elements, enables in vivo monitoring of the dynamics of Egfr localization and trafficking in normal and disease states.	[Yang, Yu-Ping; Ma, Haiting; Li, Wei; Zhang, Qin; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Yang, Yu-Ping; Ma, Haiting; Starchenko, Alina; Huh, Won Jae; Li, Wei; Zhang, Qin; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, Nashville, TN 37232 USA; [Starchenko, Alina; Franklin, Jeffrey L.; Fuhrmann, Sabine; Ihrie, Rebecca A.; Coffey, Robert J.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Huh, Won Jae] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hickman, F. Edward; Carter, Bruce D.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Mortlock, Douglas P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Fuhrmann, Sabine] Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, Nashville, TN 37232 USA; [Ihrie, Rebecca A.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Ihrie, Rebecca A.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA; [Franklin, Jeffrey L.; Coffey, Robert J.] Dept Vet Affairs, Med Ctr, Nashville, TN 37232 USA	Coffey, RJ (reprint author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA.; Coffey, RJ (reprint author), Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, Nashville, TN 37232 USA.; Coffey, RJ (reprint author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA.; Coffey, RJ (reprint author), Dept Vet Affairs, Med Ctr, Nashville, TN 37232 USA.	robert.coffey@vanderbilt.edu			NIH [R01 CA046413, R01 CA151566, R01 CA163563, R01 CA174377]; GI Special Programs of Research Excellence [P50 CA095103, R01 EY024373, P30 EY008126, R01 NS096238]; Department of Defense/Tuberous Sclerosis Complex Research Program [TS150037]; Research to Prevent Blindness; Vanderbilt-Ingram Cancer Center	We thank G. Carpenter for critical reading of our manuscript, and the Coffey lab members for helpful discussions. This work was supported by the NIH (grants R01 CA046413, R01 CA151566, R01 CA163563, and R01 CA174377) and GI Special Programs of Research Excellence (P50 CA095103 to R.J.C., R01 EY024373 and P30 EY008126 to S.F., and R01 NS096238 to R.A.I.). It was also supported by an unrestricted grant from Research to Prevent Blindness to S.F., Department of Defense/Tuberous Sclerosis Complex Research Program Idea Development Award TS150037, and two Discovery Grants from the Vanderbilt-Ingram Cancer Center to R.A.I., one of which was a gift from the Michael David Greene Brain Cancer Fund. We acknowledge the Vanderbilt Transgenic Mouse/ES Cell Shared Resource, which is supported in part by the Vanderbilt-Ingram Cancer Center.	Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CHABOT JG, 1986, AM J PHYSIOL, V250, pG760; Chung EK, 2005, EXP CELL RES, V309, P149, DOI 10.1016/j.yexcr.2005.05.012; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; COHEN S, 1982, P NATL ACAD SCI-BIOL, V79, P6237, DOI 10.1073/pnas.79.20.6237; COHEN S, 1962, J BIOL CHEM, V237, P1555; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9                                                   ; DONALDSON RW, 1992, P NATL ACAD SCI USA, V89, P8477, DOI 10.1073/pnas.89.18.8477; Dube PE, 2012, J CLIN INVEST, V122, P2780, DOI 10.1172/JCI62888; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; GRANT MB, 1992, INVEST OPHTH VIS SCI, V33, P3292; Hardbower DM, 2016, J CLIN INVEST, V126, P3296, DOI 10.1172/JCI83585; Iino S, 2009, HISTOCHEM CELL BIOL, V131, P691, DOI 10.1007/s00418-009-0580-6; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; Kondo J, 2015, GASTROENTEROLOGY, V149, P407, DOI 10.1053/j.gastro.2015.04.018; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lillien L, 1998, MOL CELL NEUROSCI, V10, P296, DOI 10.1006/mcne.1997.0659                                                          ; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; OKEEFE E, 1974, ARCH BIOCHEM BIOPHYS, V164, P518, DOI 10.1016/0003-9861(74)90062-9; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Powell AE, 2014, AM J PHYSIOL-GASTR L, V307, pG16, DOI 10.1152/ajpgi.00358.2013; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Reneker LW, 2000, DEVELOPMENT, V127, P533; RENEKER LXW, 1995, DEVELOPMENT, V121, P1669; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; RUFFJAMISON S, 1993, J BIOL CHEM, V268, P7610; RUFFJAMISON S, 1994, J BIOL CHEM, V269, P21933; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schlessinger J., 2014, COLD SPRING HARB PER, V6, P6; Schneider MR, 2016, ONCOGENE, V35, P2949, DOI 10.1038/onc.2015.372; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Strunk KE, 2004, GENETICS, V167, P1821, DOI 10.1534/genetics.103.020495; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wang Y, 2013, BRIT J CANCER, V108, P1765, DOI 10.1038/bjc.2013.138; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Xia Y, 2004, BIOCHEM PHARMACOL, V68, P997, DOI 10.1016/j.bcp.2004.05.028; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346	56	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	MAY 9	2017	19	6					1257	1267		10.1016/j.celrep.2017.04.048				11	Cell Biology	Cell Biology	EV9SC	WOS:000402124700016	28494873	gold			2018-01-05	
J	Takei, Y; Shah, S; Harvey, S; Qi, LS; Cai, L				Takei, Yodai; Shah, Sheet; Harvey, Sho; Qi, Lei S.; Cai, Long			Multiplexed Dynamic Imaging of Genomic Loci by Combined CRISPR Imaging and DNA Sequential FISH	BIOPHYSICAL JOURNAL			English	Article							EMBRYONIC STEM-CELLS; SINGLE CELLS; SYSTEM; HYBRIDIZATION; SEQUENCES; TRACKING	Visualization of chromosome dynamics allows the investigation of spatiotemporal chromatin organization and its role in gene regulation and other cellular processes. However, current approaches to label multiple genomic loci in live cells have a fundamental limitation in the number of loci that can be labeled and uniquely identified. Here we describe an approach we call "track first and identify later" for multiplexed visualization of chromosome dynamics by combining two techniques: CRISPR imaging and DNA sequential fluorescence in situ hybridization. Our approach first labels and tracks chromosomal loci in live cells with the CRISPR-Cas9 system, then barcodes those loci, by DNA sequential fluorescence in situ hybridization in fixed cells and resolves their identities. We demonstrate our approach by tracking telomere dynamics, identifying 12 unique subtelomeric regions with variable detection efficiencies, and tracking back the telomere dynamics of respective chromosomes in mouse embryonic stem cells.	[Takei, Yodai; Shah, Sheet] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Shah, Sheet] Univ Calif Los Angeles, David Geffen Sch Med, Caltech Med Sci Training Program, Los Angeles, CA 90095 USA; [Harvey, Sho; Cai, Long] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Qi, Lei S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, ChEM H, Stanford, CA 94305 USA	Cai, L (reprint author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	lcai@caltech.edu			Nakajima Foundation; Allen Distinguished Investigator Award; NIH [U01-EB 021240-01]	Y.T. is supported by a Graduate Fellowship from the Nakajima Foundation. L.C. is supported by the Allen Distinguished Investigator Award, and NIH grant No. U01-EB 021240-01.	Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Bustin M, 2016, SCIENCE, V352, DOI 10.1126/science.aad6933; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Fu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11707; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Guan J, 2017, BIOPHYS J, V112, P1077, DOI 10.1016/j.bpj.2017.01.032; Letsou W, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005089; Li VC, 2012, P NATL ACAD SCI USA, V109, P12550, DOI 10.1073/pnas.1206740109; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Shah S, 2016, DEVELOPMENT, V143, P2862, DOI 10.1242/dev.138560; Shao SP, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw066; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Wang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26857; Zhou YX, 2017, CELL RES, V27, P298, DOI 10.1038/cr.2017.9	22	3	3	10	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	MAY 9	2017	112	9					1773	1776		10.1016/j.bpj.2017.03.024				4	Biophysics	Biophysics	EU8PS	WOS:000401301600006	28427715	gold			2018-01-05	
J	Funkhouser, SA; Steibel, JP; Bates, RO; Raney, NE; Schenk, D; Ernst, CW				Funkhouser, Scott A.; Steibel, Juan P.; Bates, Ronald O.; Raney, Nancy E.; Schenk, Darius; Ernst, Catherine W.			Evidence for transcriptome-wide RNA editing among Sus scrofa PRE-1 SINE elements	BMC GENOMICS			English	Article						PRE-1; RNA editing; Swine; Bioinformatics	DNA-SEQUENCE DIFFERENCES; WIDESPREAD RNA; SITES; ALU; IDENTIFICATION; POPULATION; MUTATION; DATABASE; GENOME; GENE	Background: RNA editing by ADAR (adenosine deaminase acting on RNA) proteins is a form of transcriptional regulation that is widespread among humans and other primates. Based on high-throughput scans used to identify putative RNA editing sites, ADAR appears to catalyze a substantial number of adenosine to inosine transitions within repetitive regions of the primate transcriptome, thereby dramatically enhancing genetic variation beyond what is encoded in the genome. Results: Here, we demonstrate the editing potential of the pig transcriptome by utilizing DNA and RNA sequence data from the same pig. We identified a total of 8550 mismatches between DNA and RNA sequences across three tissues, with 75% of these exhibiting an A-to-G (DNA to RNA) discrepancy, indicative of a canonical ADAR-catalyzed RNA editing event. When we consider only mismatches within repetitive regions of the genome, the A-to-G percentage increases to 94%, with the majority of these located within the swine specific SINE retrotransposon PRE-1. We also observe evidence of A-to-G editing within coding regions that were previously verified in primates. Conclusions: Thus, our high-throughput evidence suggests that pervasive RNA editing by ADAR can exist outside of the primate lineage to dramatically enhance genetic variation in pigs.	[Funkhouser, Scott A.] Michigan State Univ, Genet Grad Program, E Lansing, MI 48824 USA; [Steibel, Juan P.; Bates, Ronald O.; Raney, Nancy E.; Schenk, Darius; Ernst, Catherine W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Schenk, Darius] Heinrich Heine Univ, Dusseldorf, Germany	Ernst, CW (reprint author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	ernstc@msu.edu			USDA National Institute of Food and Agriculture; MSU AgBioResearch; College of Natural Science at Michigan State University	This project is supported by Agriculture and Food Research Initiative Competitive Grant no. 2014-67015-21619 from the USDA National Institute of Food and Agriculture, and by MSU AgBioResearch and the College of Natural Science at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Daniel C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r28; Deffit SN, 2015, WILEY INTERDISCIP RE, V7, P113; Edwards DB, 2008, J ANIM SCI, V86, P241, DOI 10.2527/jas.2006-625; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Higuchi M, 2000, NATURE, V406, P78; Hu XD, 2015, CANCER LETT, V357, P510, DOI 10.1016/j.canlet.2014.12.006; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Smit A., 2013, REPEATMASKER OPEN 4; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vassetzky NS, 2013, NUCLEIC ACIDS RES, V41, pD83, DOI 10.1093/nar/gks1263; Veno MT, 2012, RNA BIOL, V9, P1054, DOI 10.4161/rna.21082; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	32	0	0	7	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 9	2017	18								360	10.1186/s12864-017-3766-7				9	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EV2HC	WOS:000401575200001	28486975	gold			2018-01-05	
J	Ni, YX; Cao, B; Ma, T; Niu, G; Huo, YD; Huang, JD; Chen, DN; Liu, Y; Yu, B; Zhang, MQ; Niu, HB				Ni, Yanxiang; Cao, Bo; Ma, Tszshan; Niu, Gang; Huo, Yingdong; Huang, Jiandong; Chen, Danni; Liu, Yi; Yu, Bin; Zhang, Michael Q.; Niu, Hanben			Super-resolution imaging of a 2.5 kb non-repetitive DNA in situ in the nuclear genome using molecular beacon probes	ELIFE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; EMBRYONIC STEM-CELLS; OLIGOPAINT FISH PROBES; FLUORESCENT-PROBES; OLIGONUCLEOTIDE PROBES; CRISPR/CAS SYSTEM; ARCHITECTURE; RESOLUTION; HYBRIDIZATION; VISUALIZATION	High-resolution visualization of short non-repetitive DNA in situ in the nuclear genome is essential for studying looping interactions and chromatin organization in single cells. Recent advances in fluorescence in situ hybridization (FISH) using Oligopaint probes have enabled super resolution imaging of genomic domains with a resolution limit of 4.9 kb. To target shorter elements, we developed a simple FISH method that uses molecular beacon (MB) probes to facilitate the probe-target binding, while minimizing non-specific fluorescence. We used three-dimensional stochastic optical reconstruction microscopy (3D-STORM) with optimized imaging conditions to efficiently distinguish sparsely distributed Alexa-647 from background cellular autofluorescence. Utilizing 3D-STORM and only 29-34 individual MB probes, we observed 3D fine scale nanostructures of 2.5 kb integrated or endogenous unique DNA in situ in human or mouse genome, respectively. We demonstrated our MB-based FISH method was capable of visualizing the so far shortest non-repetitive genomic sequence in 3D at super-resolution.	[Ni, Yanxiang; Cao, Bo; Niu, Gang; Huo, Yingdong; Chen, Danni; Liu, Yi; Yu, Bin; Niu, Hanben] Shenzhen Univ, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Coll Optoelect Engn, Shenzhen, Peoples R China; [Ni, Yanxiang; Ma, Tszshan; Zhang, Michael Q.] Tsinghua Univ, MOE Key Lab Bioinformat Bioinformat Div, Beijing, Peoples R China; [Ni, Yanxiang; Ma, Tszshan; Zhang, Michael Q.] Tsinghua Univ, Sch Med, Ctr Synthet & Syst Biol, TNLIST, Beijing, Peoples R China; [Ni, Yanxiang; Huang, Jiandong] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Niu, Gang] LemonData Biotech, Shenzhen, Peoples R China; [Niu, Gang] Phil Rivers Technol, Beijing, Peoples R China; [Zhang, Michael Q.] Univ Texas Dallas, Dept Biol Sci, Ctr Syst Biol, Dallas, TX 75080 USA	Ni, YX; Niu, HB (reprint author), Shenzhen Univ, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Coll Optoelect Engn, Shenzhen, Peoples R China.; Ni, YX; Zhang, MQ (reprint author), Tsinghua Univ, MOE Key Lab Bioinformat Bioinformat Div, Beijing, Peoples R China.; Ni, YX; Zhang, MQ (reprint author), Tsinghua Univ, Sch Med, Ctr Synthet & Syst Biol, TNLIST, Beijing, Peoples R China.; Ni, YX (reprint author), Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.; Zhang, MQ (reprint author), Univ Texas Dallas, Dept Biol Sci, Ctr Syst Biol, Dallas, TX 75080 USA.	niyanxiang0000@gmail.com; michaelzhang@tsinghua.edu.cn; hbniu@szu.edu.cn			National Basic Research Program of China [2012CB825802, 2012CB316503, 2015CB352005]; National Natural Science Foundation of China [61235012, 31401146, 31361163004, 91019016, 31671384, 61178080, 61335001]; Special-Funded Program on National Key Scientific Instruments and Equipment Development [2012YQ150092]; Shenzhen Science and Technology Planning Project [JCYJ20150324141711698]	National Basic Research Program of China 2012CB825802 Hanben Niu; National Natural Science Foundation of China 61235012 Hanben Niu; National Natural Science Foundation of China 31401146 Yanxiang Ni; National Natural Science Foundation of China 31361163004 Michael Q Zhang; National Natural Science Foundation of China 91019016 Michael Q Zhang; National Natural Science Foundation of China 31671384 Michael Q Zhang; Special-Funded Program on National Key Scientific Instruments and Equipment Development 2012YQ150092 Hanben Niu; National Basic Research Program of China 2012CB316503 Michael Q Zhang; National Basic Research Program of China 2015CB352005 Danni Chen; National Natural Science Foundation of China 61178080 Bin Yu; National Natural Science Foundation of China 61335001 Danni Chen; Shenzhen Science and Technology Planning Project JCYJ20150324141711698 Bin Yu	Ahuja AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10660; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Blinka S, 2016, CELL REP, V17, P19, DOI 10.1016/j.celrep.2016.09.002; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Branco MR, 2008, CHROMOSOME RES, V16, P413, DOI 10.1007/s10577-008-1230-x; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Dekker J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019356; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Didenko VV, 2001, BIOTECHNIQUES, V31, P1106; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Hogan MS, 2015, CELL STEM CELL, V16, P275, DOI 10.1016/j.stem.2015.02.001; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huo YD, 2015, ACTA PHYS SIN-CH ED, V64, DOI 10.7498/aps.64.028701; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/nmeth.1605, 10.1038/NMETH.1605]; Kelley SO, 1999, SCIENCE, V283, P375, DOI 10.1126/science.283.5400.375; Kennedy-Darling J, 2014, ANAL CHEM, V86, P5678, DOI 10.1021/ac501354y; Lehmann M, 2015, ANGEW CHEM INT EDIT, V54, P13230, DOI 10.1002/anie.201505138; Luger K, 1997, NATURE, V389, P251; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Markaki Y, 2013, METHOD MOL BIOL, V950, P43, DOI [10.1007/978-1-62703-137-0_4, DOI 10.1007/978-1-62703-137-0_4]; Markaki Y, 2012, BIOESSAYS, V34, P412, DOI 10.1002/bies.201100176; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schmitt AD, 2016, NAT REV MOL CELL BIO, V17, P743, DOI 10.1038/nrm.2016.104; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Seidel CAM, 1996, J PHYS CHEM-US, V100, P5541, DOI 10.1021/jp951507c                                                               ; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Smith EM, 2016, AM J HUM GENET, V98, P185, DOI 10.1016/j.ajhg.2015.12.002; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X                                                   ; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/NMETH.1171; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yamada NA, 2011, CYTOGENET GENOME RES, V132, P248, DOI 10.1159/000322717; Yang XS, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.134; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Zufferey R, 1998, J VIROL, V72, P3	66	1	1	71	75	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAY 9	2017	6								e21660	10.7554/eLife.21660				23	Biology	Life Sciences & Biomedicine - Other Topics	EU8XG	WOS:000401321200001		gold			2018-01-05	
J	Goto, T; Hirotsu, Y; Mochizuki, H; Nakagomi, T; Shikata, D; Yokoyama, Y; Oyama, T; Amemiya, K; Okimoto, K; Omata, M				Goto, Taichiro; Hirotsu, Yosuke; Mochizuki, Hitoshi; Nakagomi, Takahiro; Shikata, Daichi; Yokoyama, Yujiro; Oyama, Toshio; Amemiya, Kenji; Okimoto, Kenichiro; Omata, Masao			Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile	ONCOTARGET			English	Article						lung cancer; multiple cancers; metastasis; mutation; next-generation sequencing	FORTHCOMING 8TH EDITION; INTRAPULMONARY METASTASIS; INTRATUMOR HETEROGENEITY; TNM CLASSIFICATION; EVOLUTION; TUMORS; GENE; P53; ADENOCARCINOMA; CLONALITY	In cases of multiple lung cancers, individual tumors may represent either a primary lung cancer or both primary and metastatic lung cancers. Treatment selection varies depending on such features, and this discrimination is critically important in predicting prognosis. The present study was undertaken to determine the efficacy and validity of mutation analysis as a means of determining whether multiple lung cancers are primary or metastatic in nature. The study involved 12 patients who underwent surgery in our department for multiple lung cancers between July 2014 and March 2016. Tumor cells were collected from formalin-fixed paraffin-embedded tissues of the primary lesions by using laser capture microdissection, and targeted sequencing of 53 lung cancer-related genes was performed. In surgically treated patients with multiple lung cancers, the driver mutation profile differed among the individual tumors. Meanwhile, in a case of a solitary lung tumor that appeared after surgery for double primary lung cancers, gene mutation analysis using a bronchoscopic biopsy sample revealed a gene mutation profile consistent with the surgically resected specimen, thus demonstrating that the tumor in this case was metastatic. In cases of multiple lung cancers, the comparison of driver mutation profiles clarifies the clonal origin of the tumors and enables discrimination between primary and metastatic tumors.	[Goto, Taichiro; Nakagomi, Takahiro; Shikata, Daichi; Yokoyama, Yujiro] Yamanashi Cent Hosp, Lung Canc & Resp Dis Ctr, Yamanashi, Japan; [Hirotsu, Yosuke; Mochizuki, Hitoshi; Amemiya, Kenji; Okimoto, Kenichiro; Omata, Masao] Yamanashi Cent Hosp, Genome Anal Ctr, Yamanashi, Japan; [Oyama, Toshio] Yamanashi Cent Hosp, Dept Pathol, Yamanashi, Japan; [Omata, Masao] Univ Tokyo, Tokyo, Japan	Goto, T (reprint author), Yamanashi Cent Hosp, Lung Canc & Resp Dis Ctr, Yamanashi, Japan.	taichiro@1997.jukuin.keio.ac.jp			Yamanashi Prefecture; YASUDA Medical Foundation	This study was supported by a Grant-in-Aid for Genome Research Project from Yamanashi Prefecture (Y.H. and M.O.) and the grant from The YASUDA Medical Foundation (Y.H.).	Cancer Genome Atlas Research Network, 2014, NATURE, V511, P543, DOI DOI 10.1038/NATURE13385; Chang YL, 2007, CLIN CANCER RES, V13, P52, DOI 10.1158/1078-0432.CCR-06-1743; Chung JH, 2009, J THORAC ONCOL, V4, P1490, DOI 10.1097/JTO.0b013e3181bc9731; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Detterbeck FC, 2016, J THORAC ONCOL, V11, P651, DOI 10.1016/j.jtho.2016.01.025; Detterbeck FC, 2016, J THORAC ONCOL, V11, P639, DOI 10.1016/j.jtho.2016.01.024; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Girard N, 2010, CHEST, V137, P46, DOI 10.1378/chest.09-0325; Goto T, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3059-1; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hirotsu Y, 2015, MOL GENET GENOM MED, V3, P459, DOI 10.1002/mgg3.157; Hirotsu Y, 2015, MOL GENET GENOM MED, V3, P121, DOI 10.1002/mgg3.120; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Matsuzoe D, 1999, BRIT J CANCER, V79, P1549, DOI 10.1038/sj.bjc.6690247; Mitsudomi T, 1997, J THORAC CARDIOV SUR, V114, P354, DOI 10.1016/S0022-5223(97)70180-6; Nakajima J, 1996, ANN THORAC SURG, V61, P158, DOI 10.1016/0003-4975(95)00705-9                                                    ; Ono K, 2009, CANCER, V115, P3489, DOI 10.1002/cncr.24382; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Shimizu S, 2000, CLIN CANCER RES, V6, P3994; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Takamochi K, 2012, LUNG CANCER, V75, P313, DOI 10.1016/j.lungcan.2011.08.007; van der Sijp JRM, 2002, J CLIN ONCOL, V20, P1105, DOI 10.1200/JCO.20.4.1105; van Oijen MGCT, 2000, CANCER, V88, P884, DOI 10.1002/(SICI)1097-0142(20000215)88:4<884::AID-CNCR20>3.0.CO;2-S                ; Wang XY, 2009, J NATL CANCER I, V101, P560, DOI 10.1093/jnci/djp054; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	30	1	1	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 9	2017	8	19					31133	31143		10.18632/oncotarget.16096				11	Oncology; Cell Biology	Oncology; Cell Biology	EU4MH	WOS:000401003200041	28415711	gold			2018-01-05	
J	Garasia, S; Samaan, Z; Gerstein, HC; Engert, JC; Mohan, V; Diaz, R; Anand, SS; Meyre, D				Garasia, Sophiya; Samaan, Zainab; Gerstein, Hertzel C.; Engert, James C.; Mohan, Viswanathan; Diaz, Rafael; Anand, Sonia S.; Meyre, David			Influence of depression on genetic predisposition to type 2 diabetes in a multiethnic longitudinal study	SCIENTIFIC REPORTS			English	Article							TEST-RETEST RELIABILITY; MAJOR DEPRESSION; METAANALYSIS; ASSOCIATION; OBESITY; INDIVIDUALS; POPULATION; PREVALENCE; DISORDER; DESIGN	We assessed the association between depression status and prevalent and incident type 2 diabetes (T2D) as well as the interaction between depression and a genetic risk score (GS) based on 20 T2D single-nucleotide polymorphisms (SNPs) in a multi-ethnic longitudinal study. We studied 17,375 participants at risk for dysglycemia. All participants had genotypic and phenotypic data collected at baseline and 9,930 participants were followed-up for a median of 3.3 years. Normal glucose tolerance (NGT), impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) and T2D statuses were determined using an oral glucose tolerance test and the 2003 American Diabetes Association criteria. Depression was diagnosed at baseline using Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM IV). Multivariate logistic regression models were adjusted for age, sex, ethnicity and body-mass index and an interaction term GS X depression was added to the model. After appropriate Bonferroni correction, no significant association between depression and T2D-related traits (IFG/IGT, T2D and dysglycemia), and no significant interaction between the GS and depression status was observed at baseline or follow-up. Our longitudinal data do not support an association between depression and abnormal glycemic status. Moreover, depression does not modify the effect of T2D predisposing gene variants.	[Garasia, Sophiya; Samaan, Zainab; Gerstein, Hertzel C.; Anand, Sonia S.; Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Samaan, Zainab] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Samaan, Zainab; Gerstein, Hertzel C.; Anand, Sonia S.; Meyre, David] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Samaan, Zainab; Gerstein, Hertzel C.; Anand, Sonia S.; Meyre, David] Hamilton Gen Hosp, Hamilton Hlth Sci, Hamilton, ON, Canada; [Gerstein, Hertzel C.; Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Diaz, Rafael] ECLA Acad Res Org, Rosario, Argentina; [Meyre, David] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Meyre, D (reprint author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Meyre, D (reprint author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.; Meyre, D (reprint author), Hamilton Gen Hosp, Hamilton Hlth Sci, Hamilton, ON, Canada.; Meyre, D (reprint author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	meyred@mcmaster.ca	Meyre, David/D-7315-2011	Gerstein, Hertzel/0000-0001-8072-2836			*ADA, 2004, DIABETES CARE, V27, pS5, DOI DOI 10.2337/DIACARE.27.2007.S5.PUBMED:14693921; Afari N, 2010, DEPRESS ANXIETY, V27, P799, DOI 10.1002/da.20704; Alyass A, 2015, DIABETOLOGIA, V58, P87, DOI 10.1007/s00125-014-3390-x; Anand SS, 2012, EUR J PREV CARDIOL, V19, P755, DOI 10.1177/1741826711409327; APA, 2000, DIAGN STAT MAN MENT, P1; Blumenthal SR, 2014, JAMA PSYCHIAT, V71, P889, DOI 10.1001/jamapsychiatry.2014.414; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Christensen L, 1996, INT J EAT DISORDER, V20, P105; Dream I., 2004, DIABETOLOGIA, V47, P1519; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Gerstein HC, 2004, DIABETOLOGIA, V47, P1519, DOI 10.1007/s00125-004-1485-5; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kan C, 2016, MOL PSYCHIATR, V21, P903, DOI 10.1038/mp.2016.28; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Karam JG, 2011, CURR DIABETES REP, V11, P56, DOI 10.1007/s11892-010-0163-x; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; McIntyre Roger S, 2007, Ann Clin Psychiatry, V19, P257, DOI 10.1080/10401230701653377; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Rivera M, 2012, MOL PSYCHIATR, V17, P604, DOI 10.1038/mp.2011.45; Robiou-du-Pont S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118925; Samaan Z, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.113; Samaan Z, 2013, MOL PSYCHIATR, V18, P1281, DOI 10.1038/mp.2012.160; Samaan Z, 2015, J CLIN PSYCHIAT, V76, pE1611, DOI 10.4088/JCP.14m09720; Steptoe A, 1997, PREV MED, V26, P845, DOI 10.1006/pmed.1997.0224; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Zahn D, 2015, PSYCHOSOM MED, V77, P145, DOI 10.1097/PSY.0000000000000145	31	0	0	6	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 9	2017	7								1629	10.1038/s41598-017-01406-y				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EU2PD	WOS:000400870500019	28487510	gold			2018-01-05	
J	Marin, MA; Fonseca, E; Encinas, F; Freitas, F; Camargo, DA; Coimbra, RS; de Filippis, I; Vicente, AC				Marin, Michel Abanto; Fonseca, Erica; Encinas, Fernando; Freitas, Fernanda; Camargo, Dhian Almeida; Coimbra, Roney Santos; de Filippis, Ivano; Vicente, Ana Carolina			The invasive Neisseria meningitidis MenC CC103 from Brazil is characterized by an accessory gene repertoire	SCIENTIFIC REPORTS			English	Article							SEROGROUP C; NATURAL TRANSFORMATION; MENINGOCOCCAL DISEASE; ESCHERICHIA-COLI; CHROMOSOMAL DNA; IV SECRETION; GENOME; GONORRHOEAE; PROTEIN; ISLAND	Neisseria meningitidis infections are a major issue for global health. The invasive MenC ST-103 clonal complex (CC103) has been the most prevalent in meningococcal outbreaks in Brazil, occurring also in several countries worldwide. Here we have analysed the population structure and accessory genome of MenC CC103 strains from a global perspective. An in-depth phylogenomic analysis revealed a lineage of N. meningitidis causing meningitis in Brazil and the United Kingdom. This lineage was also characterized as harbouring a particular accessory genome composed of CRISPR/Cas and restriction modification systems. This lineage was also characterized by a genomic island resembling an integrative and conjugative element. This island carried genes potentially associated with virulence and fitness. We propose this accessory gene repertoire could be contributing to the spatial-temporal persistence of the invasive MenC CC103 lineage.	[Marin, Michel Abanto; Fonseca, Erica; Encinas, Fernando; Freitas, Fernanda; Vicente, Ana Carolina] Fundacao Oswaldo Cruz, IOC, Lab Genet Mol Microrganismos, FIOCRUZ, Av Brasil 4365, Rio De Janeiro, Brazil; [Camargo, Dhian Almeida] Fundacao Ezequiel Dias FUNED, Belo Horizonte, MG, Brazil; [Coimbra, Roney Santos] Fundacao Oswaldo Cruz, Neurogen Ctr Pesquisas Rene Rachou CPqRR, FIOCRUZ, Belo Horizonte, MG, Brazil; [de Filippis, Ivano] Fundacao Oswaldo Cruz, INCQS, FIOCRUZ, Rio De Janeiro, RJ, Brazil	Marin, MA (reprint author), Fundacao Oswaldo Cruz, IOC, Lab Genet Mol Microrganismos, FIOCRUZ, Av Brasil 4365, Rio De Janeiro, Brazil.	mfabanto@gmail.com		de Filippis, Ivano/0000-0003-0610-8648	Programa Nacional de Pos Doutorado/Capes (PNPD/CAPES); Brasil Sem Miseria (BSM/CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FNS/SVS [25030001256201331]; Instituto Oswaldo Cruz, IOC/FIOCRUZ; Wellcome Trust; European Union	This work was supported by the Programa Nacional de Pos Doutorado/Capes (PNPD/CAPES); Brasil Sem Miseria (BSM/CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FNS/SVS (25030001256201331) and the Instituto Oswaldo Cruz, IOC/FIOCRUZ. This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford<SUP>53</SUP>. The development of this site has been funded by the Wellcome Trust and European Union. We thank Dr. Lee Crainey for the English revision.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Carraro N., 2014, MICROBIOLOGY SPECTRU, V2; Crum-Cianflone N, 2016, INFECT DIS THER, V5, P89, DOI 10.1007/s40121-016-0107-0; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324                                                             ; de Filippis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033016; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dominguez NM, 2011, J BACTERIOL, V193, P377, DOI 10.1128/JB.00948-10; Drees JC, 2006, J BIOL CHEM, V281, P4708, DOI 10.1074/jbc.M513592200; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Gorla MCO, 2012, ENFERM INFEC MICR CL, V30, P56, DOI 10.1016/j.eimc.2011.07.022; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Harrison OB, 2015, EBIOMEDICINE, V2, P234, DOI 10.1016/j.ebiom.2015.01.004; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Huson DH, 2004, BIOINFORMATICS, V20, P2044, DOI 10.1093/bioinformatics/bth198; Ibarz-Pavon AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044102; Jamet A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004592; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Kedzierska B., 2016, MOL BASEL SWITZERLAN, V21; Kohler PL, 2013, J BACTERIOL, V195, P1666, DOI 10.1128/JB.02098-12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mehr IJ, 2000, GENETICS, V154, P523; Nair DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083961; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Obergfell K. P., 2015, MICROBIOLOGY SPECTRU, V3; Pachulec E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109613; Safadi MAP, 2014, EMERG INFECT DIS, V20, P806, DOI 10.3201/eid2005.130948; R Core Team, 2016, R LANG ENV STAT COMP; Ramsey ME, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00061; Rotman E, 2014, ANNU REV GENET, V48, P405, DOI 10.1146/annurev-genet-120213-092007; Sahl JW, 2014, PEERJ, V2, DOI 10.7717/peerj.332; Sardinha G, 2013, DIAGN MICR INFEC DIS, V76, P524, DOI 10.1016/j.diagmicrobio.2013.04.008; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sims GE, 2011, P NATL ACAD SCI USA, V108, P8329, DOI 10.1073/pnas.1105168108; South A, 2011, R J, V3, P35; Stefanelli P, 2016, J INFECTION, V73, P136, DOI 10.1016/j.jinf.2016.05.003; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479                                                  ; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Woodhams KL, 2012, J BACTERIOL, V194, P2275, DOI 10.1128/JB.00094-12; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zola TA, 2010, INFECT IMMUN, V78, P2429, DOI 10.1128/IAI.00228-10; Zweig M, 2014, ENVIRON MICROBIOL, V16, P1040, DOI 10.1111/1462-2920.12291	58	0	0	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 9	2017	7								1617	10.1038/s41598-017-01671-x				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EU2PD	WOS:000400870500007	28487566	gold			2018-01-05	
J	Brunger, JM; Zutshi, A; Willard, VP; Gersbach, CA; Guilak, F				Brunger, Jonathan M.; Zutshi, Ananya; Willard, Vincent P.; Gersbach, Charles A.; Guilak, Farshid			Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs	STEM CELL REPORTS			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TNF-ALPHA; GENE-EXPRESSION; POSTTRAUMATIC ARTHRITIS; TRANSCRIPTION FACTORS; EPITHELIAL-CELLS; SKELETAL-MUSCLE; TOGGLE SWITCH; INFLAMMATION	Chronic inflammatory diseases such as arthritis are characterized by dysregulated responses to pro-inflammatory cytokines such as interleukin- 1 (IL-1) and tumor necrosis factor alpha (TNF-alpha). Pharmacologic anti-cytokine therapies are often effective at diminishing this inflammatory response but have significant side effects and are used at high, constant doses that do not reflect the dynamic nature of disease activity. Using the CRISPR/Cas9 genome-engineering system, we created stem cells that antagonize IL-1- or TNF-alpha-mediated inflammation in an autoregulated, feedback-controlled manner. Our results show that genome engineering can be used successfully to rewire endogenous cell circuits to allow for prescribed input/output relationships between inflammatory mediators and their antagonists, providing a foundation for cell-based drug delivery or cell-based vaccines via a rapidly responsive, autoregulated system. The customization of intrinsic cellular signaling pathways in stem cells, as demonstrated here, opens innovative possibilities for safer and more effective therapeutic approaches for a wide variety of diseases.	[Brunger, Jonathan M.; Zutshi, Ananya; Gersbach, Charles A.; Guilak, Farshid] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Willard, Vincent P.; Guilak, Farshid] Cytex Therapeut Inc, Durham, NC 27705 USA; [Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Guilak, Farshid] Shriners Hosp Children St Louis, St Louis, MO 63110 USA	Guilak, F (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.; Guilak, F (reprint author), Cytex Therapeut Inc, Durham, NC 27705 USA.; Guilak, F (reprint author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.; Guilak, F (reprint author), Shriners Hosp Children St Louis, St Louis, MO 63110 USA.	guilak@wustl.edu			Nancy Taylor Foundation for Chronic Diseases; Arthritis Foundation; NIH [AR061042, AR50245, AR48852, AG15768, AR48182, AR067467, AR065956, OD008586]; NSF CAREER [CBET-1151035]; Collaborative Research Center of the AO Foundation, Davos, Switzerland	The authors would like to thank Dr. David Pisetsky for important discussions on this project and Sameer Chervu for technical assistance. Supported by the Nancy Taylor Foundation for Chronic Diseases, the Arthritis Foundation, NIH grants AR061042, AR50245, AR48852, AG15768, AR48182, AR067467, AR065956, OD008586, NSF CAREER Award CBET-1151035, and the Collaborative Research Center of the AO Foundation, Davos, Switzerland.	Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bloquel C, 2004, HUM GENE THER, V15, P189, DOI 10.1089/104303404772679995                                                      ; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139                                                     ; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Furman BD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4591; Garaulet G, 2013, MOL THER, V21, P119, DOI 10.1038/mt.2012.131; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131                                                                ; Georgopoulos S, 1996, J INFLAMM, V46, P86; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Grant TD, 2000, DEV DYNAM, V218, P394, DOI 10.1002/(SICI)1097-0177(200006)218:2<394::AID-DVDY12>3.0.CO;2-I                 ; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khoury M, 2007, J GENE MED, V9, P596, DOI 10.1002/jgm.1053; Kimmerling KA, 2015, EUR CELLS MATER, V29, P124, DOI 10.22203/eCM.v029a10                                                            ; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002; Li YP, 2001, FASEB J, V15, P1413, DOI 10.1096/fj.00-0632fje; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Mozzetta C, 2009, INT J BIOCHEM CELL B, V41, P701, DOI 10.1016/j.biocel.2008.08.033; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Ping DS, 1999, J IMMUNOL, V162, P727; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rachakonda PS, 2008, ARTHRITIS RHEUM-US, V58, P2088, DOI 10.1002/art.23598; Ramos-Casals M, 2008, BEST PRACT RES CL RH, V22, P847, DOI 10.1016/j.berh.2008.09.008; Rebel VI, 1999, J EXP MED, V190, P1493, DOI 10.1084/jem.190.10.1493                                                         ; Reid MB, 2001, RESPIR RES, V2, P269, DOI 10.1186/rr67                                                                    ; Rezzoug F, 2008, J IMMUNOL, V180, P49, DOI 10.4049/jimmunol.180.1.49                                                       ; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; Soler AP, 1996, AM J PHYSIOL-RENAL, V270, pF869; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; van de Loo FAJ, 2004, GENE THER, V11, P581, DOI 10.1038/sj.gt.3302182; Wang YP, 2000, KIDNEY INT, V57, P2011, DOI 10.1046/j.1523-1755.2000.00051.x; Wroblewska L, 2015, NAT BIOTECHNOL, V33, P839, DOI 10.1038/nbt.3301; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	46	3	3	7	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	MAY 9	2017	8	5					1202	1213		10.1016/j.stemcr.2017.03.022				12	Cell & Tissue Engineering; Cell Biology	Cell Biology	EU6FM	WOS:000401129400009	28457885	gold			2018-01-05	
J	Avior, Y; Lezmi, E; Yanuka, D; Benvenisty, N				Avior, Yishai; Lezmi, Elyad; Yanuka, Dorit; Benvenisty, Nissim			Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells	STEM CELL REPORTS			English	Article							TUMOR-SUPPRESSOR; GENE-EXPRESSION; IN-VIVO; PROTEIN; CANCER; E2F1; DIFFERENTIATION; CYCLE; IDENTIFICATION; PROLIFERATION	Human embryonic stem cells (hESCs) provide a platform for studying human development and understanding mechanisms underlying diseases. Retinoblastoma-1 (RB1) is a key regulator of cell cycling, of which biallelic inactivation initiates retinoblastoma, the most common congenital intraocular malignancy. We developed a model to study the role of RB1 in early development and tumor formation by generating RB1-null hESCs using CRISPR/Cas9. RB1(-/-) hESCs initiated extremely large teratomas, with neural expansions similar to those of trilateral retinoblastoma tumors, in which retinoblastoma is accompanied by intracranial neural tumors. Teratoma analysis further revealed a role for the transcription factor ZEB1 in RB1-mediated ectoderm differentiation. Furthermore, RB1(-/-) cells displayed mitochondrial dysfunction similar to poorly differentiated retinoblastomas. Screening more than 100 chemotherapies revealed an RB1(-/-)-specific cell sensitivity to carboplatin, exploiting their mitochondrial dysfunction. Together, our work provides a human pluripotent cell model for retinoblastoma and sheds light on developmental and tumorigenic roles of RB1.	[Avior, Yishai; Lezmi, Elyad; Yanuka, Dorit; Benvenisty, Nissim] Hebrew Univ Jerusalem, Inst Life Sci, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel	Benvenisty, N (reprint author), Hebrew Univ Jerusalem, Inst Life Sci, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel.	nissimb@mail.huji.ac.il			Israel Science Foundation [269/12]; Azrieli Foundation; Rosetrees Trust	The authors would like to thank Gahl Levy for his help in mitochondria-related assays, Dr. Yael Friedman and Chava Gliksmn from the Bio-Imaging unit for their work with the transmission electron microscope, and Prof. Eran Meshorer for critically reading the manuscript. Y.A. is a Clore Fellow. N.B. is the Herbert Cohn Chair in Cancer Research. This work was partially supported by the Israel Science Foundation (grant number 269/12), by The Rosetrees Trust, and by The Azrieli Foundation.	Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Avior Y, 2015, STEM CELL REP, V4, P967, DOI 10.1016/j.stemcr.2015.05.006; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Benavente CA, 2015, ANNU REV PATHOL-MECH, V10, P547, DOI 10.1146/annurev-pathol-012414-040259; Biancotti JC, 2010, STEM CELLS, V28, P1530, DOI 10.1002/stem.483; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Carta A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1441; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; De Jong MC, 2015, AM J OPHTHALMOL, V160, P1116, DOI 10.1016/j.ajo.2015.09.009; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Duband JL, 2010, CELL ADHES MIGR, V4, P458, DOI 10.4161/cam.4.3.12501; Dunkel IJ, 2010, PEDIATR BLOOD CANCER, V54, P384, DOI 10.1002/pbc.22336; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Ferecatu I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-50; Ghanem N, 2012, J NEUROSCI, V32, P8219, DOI 10.1523/JNEUROSCI.1344-12.2012; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514                                                           ; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; Kopper O, 2010, STEM CELLS, V28, P75, DOI 10.1002/stem.260; Koziczak M, 2000, MOL CELL BIOL, V20, P2014, DOI 10.1128/MCB.20.6.2014-2022.2000                                                 ; Leng Theodore, 2010, Retina, V30, pS66; Li R., 2011, CURR PROTOC CYTOM; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Lumbroso-Le Rouic L, 2016, EYE, V30, P46, DOI 10.1038/eye.2015.179; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Mitter D, 2011, EUR J HUM GENET, V19, P947, DOI 10.1038/ejhg.2011.58; Miyake S, 2000, MOL CELL BIOL, V20, P8889, DOI 10.1128/MCB.20.23.8889-8902.2000; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Ozolek J.A, 2011, EMBRYONIC STEM CELLS; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prost S, 2007, ONCOGENE, V26, P3572, DOI 10.1038/sj.onc.1210151; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richter S, 2003, AM J HUM GENET, V72, P253, DOI 10.1086/345651; Rodjan F, 2010, AM J NEURORADIOL, V31, P1385, DOI 10.3174/ajnr.A2102; Siebzehnrubl FA, 2013, EMBO MOL MED, V5, P1196, DOI 10.1002/emmm.201302827; Singh L, 2016, TUMOR BIOL, V37, P5797, DOI 10.1007/s13277-015-4120-9; Singh S, 2016, ELIFE, V5, DOI 10.7554/elife.12717; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859                                                           ; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235                                                             ; Vance KW, 2010, MOL BIOL CELL, V21, P2770, DOI 10.1091/mbc.E09-12-1029; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wright KD, 2010, PEDIATR BLOOD CANCER, V55, P570, DOI 10.1002/pbc.22545; Xing JL, 2008, J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213	64	2	2	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	MAY 9	2017	8	5					1354	1365		10.1016/j.stemcr.2017.03.005				12	Cell & Tissue Engineering; Cell Biology	Cell Biology	EU6FM	WOS:000401129400020	28392220	gold			2018-01-05	
J	Torres-Ruiz, R; Martinez-Lage, M; Martin, MC; Garcia, A; Bueno, C; Castano, J; Ramirez, JC; Menendez, P; Cigudosa, JC; Rodriguez-Perales, S				Torres-Ruiz, Raul; Martinez-Lage, Marta; Martin, Maria C.; Garcia, Aida; Bueno, Clara; Castano, Julio; Ramirez, Juan C.; Menendez, Pablo; Cigudosa, Juan C.; Rodriguez-Perales, Sandra			Efficient Recreation of t(11;22) EWSR1-FLI1(+) in Human Stem Cells Using CRISPR/Cas9	STEM CELL REPORTS			English	Article							DOUBLE-STRAND BREAKS; FINGER NUCLEASE PROTEINS; END-JOINING REPAIR; ZINC-FINGER; CHROMOSOMAL TRANSLOCATIONS; CANCER TRANSLOCATIONS; MEDIATED DELIVERY; GENE DISRUPTION; CAS9 PROTEIN; HUMAN GENOME	Efficient methodologies for recreating cancer-associated chromosome translocations are in high demand as tools for investigating how such events initiate cancer. The CRISPR/Cas9 system has been used to reconstruct the genetics of these complex rearrangements at native loci while maintaining the architecture and regulatory elements. However, the CRISPR system remains inefficient in human stem cells. Here, we compared three strategies aimed at enhancing the efficiency of the CRISPR-mediated t(11;22) translocation in human stem cells, including mesenchymal and induced pluripotent stem cells: (1) using end-joining DNA processing factors involved in repair mechanisms, or (2) ssODNs to guide the ligation of the double-strand break ends generated by CRISPR/Cas9; and (3) all-in-one plasmid or ribonucleoprotein complex-based approaches. We report that the generation of targeted t(11;22) is significantly increased by using a combination of ribonucleoprotein complexes and ssODNs. The CRISPR/Cas9-mediated generation of targeted t(11;22) in human stem cells opens up new avenues in modeling Ewing sarcoma.	[Torres-Ruiz, Raul; Martinez-Lage, Marta; Martin, Maria C.; Cigudosa, Juan C.; Rodriguez-Perales, Sandra] CNIO, Human Canc Genet Program, Mol Cytogenet Grp, Madrid 28029, Spain; [Garcia, Aida] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Ctr Invest Energet Medioambientales & Tecnol CIEM, Hematopoiet Innovat Therapies Div, Madrid 28040, Spain; [Torres-Ruiz, Raul; Bueno, Clara; Castano, Julio; Menendez, Pablo] Univ Barcelona, Sch Med, Josep Carreras Leukemia Res Inst, Dept Biomed, E-08036 Barcelona, Spain; [Ramirez, Juan C.] VIVEBioTECH, San Sebastian 20009, Spain; [Menendez, Pablo] ICREA, Barcelona 08010, Spain; [Menendez, Pablo] ISCIII, Ctr Invest Biomed Red Canc CIBER ONC, Barcelona 08010, Spain	Torres-Ruiz, R (reprint author), CNIO, Human Canc Genet Program, Mol Cytogenet Grp, Madrid 28029, Spain.; Torres-Ruiz, R (reprint author), Univ Barcelona, Sch Med, Josep Carreras Leukemia Res Inst, Dept Biomed, E-08036 Barcelona, Spain.	rtorresr@cnio.es; srodriguezp@cnio.es		Martinez-Lage Garcia, Marta/0000-0001-5535-025X; Torres, Raul/0000-0001-9606-0398	Spanish National Research and Development Plan; Instituto de Salud Carlos III; FEDER [PI14/01884, PI12/00425]; Lady Tata Memorial Trust; ICREA	This work was supported by funds from the Spanish National Research and Development Plan, Instituto de Salud Carlos III, and FEDER (PI14/01884 to S.R.-P. and PI12/00425 to J.C.C.). R.T.-R. was supported by an international fellowship from Lady Tata Memorial Trust during 2016-2017.	Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Bueno C, 2011, LEUKEMIA, V25, P400, DOI 10.1038/leu.2010.284; Castano J, 2016, ONCOTARGET, V7, P30440, DOI 10.18632/oncotarget.8938; Certo MT, 2012, NAT METHODS, V9, P973, DOI [10.1038/NMETH.2177, 10.1038/nmeth.2177]; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen JM, 2010, SEMIN CANCER BIOL, V20, P222, DOI 10.1016/j.semcancer.2010.05.007; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503                                                     ; Forster A, 2005, COLD SH Q B, V70, P275, DOI 10.1101/sqb.2005.70.008                                                         ; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Guryanova OA, 2013, SEMIN HEMATOL, V50, P145, DOI 10.1053/j.seminhematol.2013.03.027; Howard SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004943; Iliakis G, 2015, MUTAT RES-GEN TOX EN, V793, P166, DOI 10.1016/j.mrgentox.2015.07.001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kovar H, 2016, ONCOTARGET, V7, P8613, DOI 10.18632/oncotarget.6937; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liu J, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.6; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McVey M, 2004, GENETICS, V168, P2067, DOI 10.1534/genetics.104.033902; Menendez P, 2006, CYTOTHERAPY, V8, P530, DOI 10.1080/14653240601026654; Minas T.Z., 2016, ONCOTARGET, V9, P422; Munoz-Lopez A, 2016, STEM CELL REP, V7, P602, DOI 10.1016/j.stemcr.2016.08.013; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Renouf B, 2014, METHOD ENZYMOL, V546, P251, DOI 10.1016/B978-0-12-801185-0.00012-X; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Rodriguez-Perales S, 2016, ONCOGENE, V35, P125, DOI 10.1038/onc.2015.70; Sancho-Martinez I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10743; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Torres R, 2014, GENE THER, V21, P343, DOI 10.1038/gt.2014.1; Torres R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019794; Torres R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007570; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Wray J, 2013, BLOOD, V121, P4359, DOI 10.1182/blood-2012-10-460527; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431	45	1	1	4	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	MAY 9	2017	8	5					1408	1420		10.1016/j.stemcr.2017.04.014				13	Cell & Tissue Engineering; Cell Biology	Cell Biology	EU6FM	WOS:000401129400024	28494941	gold			2018-01-05	
J	Nakano, Y; Aso, H; Soper, A; Yamada, E; Moriwaki, M; Juarez-Fernandez, G; Koyanagi, Y; Sato, K				Nakano, Yusuke; Aso, Hirofumi; Soper, Andrew; Yamada, Eri; Moriwaki, Miyu; Juarez-Fernandez, Guillermo; Koyanagi, Yoshio; Sato, Kei			A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif	RETROVIROLOGY			English	Review						Vif; APOBEC3; Lentivirus; Mammal; Evolutionary arms race	FELINE IMMUNODEFICIENCY VIRUS; CAPRINE ARTHRITIS-ENCEPHALITIS; CROSS-SPECIES TRANSMISSION; DEFICIENCY-SYNDROME AIDS; T-LYMPHOTROPIC VIRUS; RESTRICTION FACTORS; JEMBRANA-DISEASE; SEROLOGICAL SURVEY; DOMESTIC CATS; ENDOGENOUS LENTIVIRUS	Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins are mammalian-specific cellular deaminases and have a robust ability to restrain lentivirus replication. To antagonize APOBEC3-mediated antiviral action, lentiviruses have acquired viral infectivity factor (Vif) as an accessory gene. Mammalian APOBEC3 proteins inhibit lentiviral replication by enzymatically inserting G-to-A hypermutations in the viral genome, whereas lentiviral Vif proteins degrade host APOBEC3 via the ubiquitin/proteasome-dependent pathway. Recent investigations provide evidence that lentiviral vif genes evolved to combat mammalian APOBEC3 proteins. In corollary, mammalian APOBEC3 genes are under Darwinian selective pressure to escape from antagonism by Vif. Based on these observations, it is widely accepted that lentiviral Vif and mammalian APOBEC3 have co-evolved and this concept is called an "evolutionary arms race."This review provides a comprehensive summary of current knowledge with respect to the evolutionary dynamics occurring at this pivotal host-virus interface.	[Nakano, Yusuke; Aso, Hirofumi; Soper, Andrew; Yamada, Eri; Moriwaki, Miyu; Juarez-Fernandez, Guillermo; Koyanagi, Yoshio; Sato, Kei] Kyoto Univ, Lab Syst Virol, Dept Biosyst Sci, Inst Frontier Life & Med Sci,Sakyo Ku, 53 Shogoinkawara Cho, Kyoto 6068507, Japan; [Aso, Hirofumi] Kyoto Univ, Fac Pharmaceut Sci, Kyoto, Japan; [Moriwaki, Miyu] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama, Japan	Sato, K (reprint author), Kyoto Univ, Lab Syst Virol, Dept Biosyst Sci, Inst Frontier Life & Med Sci,Sakyo Ku, 53 Shogoinkawara Cho, Kyoto 6068507, Japan.	ksato@virus.kyoto-u.ac.jp	Juarez-Fernandez, Guillermo/O-2370-2017	Juarez-Fernandez, Guillermo/0000-0002-2871-9637; Sato, Kei/0000-0003-4431-1380	CREST; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Salt Science Research Foundation; Smoking Research Foundation; JSPS [17H05813, 24115008]; AMED; JSPS Core-to-Core program, A. Advanced Research Networks; AMED [HIV/AIDS 16fk0410203h0002]; JST;  [15K07166];  [16KT0111]	This study was supported in part by CREST, JST (to KS); Takeda Science Foundation (to KS); Mochida Memorial Foundation for Medical and Pharmaceutical Research (to KS); Salt Science Research Foundation (to KS); Smoking Research Foundation (to KS); Grants-in-Aid for Scientific Research C 15K07166 (to KS), Scientific Research B (Generative Research Fields) 16KT0111 (to KS), and Scientific Research on Innovative Areas 17H05813 (to KS) and 24115008 (to YK) from JSPS; the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from AMED (to EY); and the JSPS Core-to-Core program, A. Advanced Research Networks (to YK); and Research on HIV/AIDS 16fk0410203h0002 from AMED (to YK).	ADAMS DS, 1980, AM J PATHOL, V99, P257; ADAMS DS, 1980, INFECT IMMUN, V28, P421; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Barr MC, 1997, VIROLOGY, V228, P84, DOI 10.1006/viro.1996.8358; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bibi F, 2009, PALAEONTOL ELECTRON, V12; Binka M, 2012, J VIROL, V86, P49, DOI 10.1128/JVI.06082-11; Carpenter MA, 1996, J VIROL, V70, P6682; Cavirani S, 1998, PREV VET MED, V37, P147, DOI 10.1016/S0167-5877(98)00099-3; CLAVEL F, 1986, NATURE, V324, P691, DOI 10.1038/324691a0; Compton AA, 2013, PHILOS TRANS R SOC L, V368; Compton AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003135; Compton AA, 2012, CELL HOST MICROBE, V11, P91, DOI 10.1016/j.chom.2011.11.010; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cui J, 2012, J VIROL, V86, P3383, DOI 10.1128/JVI.06652-11; D'arc M, 2015, P NATL ACAD SCI USA, V112, pE1343, DOI 10.1073/pnas.1502022112; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; de Castro FL, 2014, INFECT GENET EVOL, V27, P389, DOI 10.1016/j.meegid.2014.08.024; Desport M, 2007, VIRUS RES, V126, P233, DOI 10.1016/j.virusres.2007.03.005; Desport M, 2010, CURR HIV RES, V8, P53, DOI 10.2174/157016210790416370                                                      ; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Etienne L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005149; Evans DT, 2013, FIELDS VIROLOGY, V2, P1584; Freed EO, 2013, FIELDS VIROLOGY, V2, P1502; Fujino T, 1999, NUCLEIC ACIDS RES, V27, P2662, DOI 10.1093/nar/27.13.2662                                                          ; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823                                                         ; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; Gilbert C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000425; Gonzalez ET, 2008, RES VET SCI, V85, P353, DOI 10.1016/j.rvsc.2007.10.008; HAASE AT, 1973, NATURE-NEW BIOL, V245, P237; HAASE AT, 1974, VIROLOGY, V57, P251, DOI 10.1016/0042-6822(74)90125-1; Han GZ, 2012, MOL BIOL EVOL, V29, P2905, DOI 10.1093/molbev/mss126; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hassanin A, 2004, MOL PHYLOGENET EVOL, V33, P896, DOI 10.1016/j.ympev.2004.08.009; Hatziioannou T, 2006, SCIENCE, V314, P95, DOI 10.1126/science.1130994; HIRAI N, 1994, MICROBIOL IMMUNOL, V38, P943, DOI 10.1111/j.1348-0421.1994.tb02151.x                                              ; HORZINEK M, 1991, J GEN VIROL, V72, P2923, DOI 10.1099/0022-1317-72-12-2923; Hultquist JF, 2012, J VIROL, V86, P2874, DOI 10.1128/JVI.06950-11; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Ikeda T, 2017, SCI REP-UK, V7, DOI 10.1038/srep46719; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Kane JR, 2015, CELL REP, V11, P1236, DOI 10.1016/j.celrep.2015.04.038; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.070041104; KERTAYADNYA G, 1993, J GEN VIROL, V74, P1765, DOI 10.1099/0022-1317-74-9-1765; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kitamura S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00258; Klatt NR, 2012, COLD SPRING HARB PER, V2; Koito A., 2011, MOB GENET ELEMENTS, V1, P197; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Krisko JF, 2016, J VIROL, V90, P4681, DOI 10.1128/JVI.03275-15; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Krupp A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003641; Kuritzkes DR, 2013, FIELDS VIROLOGY, V2, P1561; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lee J, 2017, J VIROL, V91, DOI 10.1128/JVI.02134-16; Lee JS, 2014, J VIROL, V88, P7727, DOI 10.1128/JVI.00473-14; Locatelli S, 2012, AIDS, V26, P659, DOI 10.1097/QAD.0b013e328350fb68; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4                                                   ; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; McCarthy KR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005085; MCNAB WB, 1994, CAN J VET RES, V58, P36; Meas S, 2004, JPN J VET RES, V52, P3; Meas S, 2001, ARCH VIROL, V146, P1037, DOI 10.1007/s007050170134; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; da Cruz JCM, 2013, VIRUSES-BASEL, V5, P1867, DOI 10.3390/v5071867; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; OLMSTED RA, 1992, J VIROL, V66, P6008; ONUMA M, 1992, J ACQ IMMUN DEF SYND, V5, P1009; Ooms M, 2013, CELL HOST MICROBE, V14, P411, DOI 10.1016/j.chom.2013.09.006; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Pecon-Slattery J, 2008, VET IMMUNOL IMMUNOP, V123, P32, DOI 10.1016/j.vetimm.2008.01.010; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Polack B, 1996, VET MICROBIOL, V48, P165, DOI 10.1016/0378-1135(95)00138-7; Ramirez H, 2013, VIRUSES-BASEL, V5, P1175, DOI 10.3390/v5041175; Refsland EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004761; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sato K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004453; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sharp PM, 2011, COLD SPRING HARB PER, V1; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; SIGURDSSON B, 1957, J NEUROPATH EXP NEUR, V16, P389, DOI 10.1097/00005072-195707000-00010                                                ; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Starrett GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12918; Stern MA, 2010, J VIROL, V84, P7378, DOI 10.1128/JVI.00584-10; Sutton CA, 2005, VIROLOGY, V332, P519, DOI 10.1016/j.virol.2004.11.042; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; Troyer RM, 2013, J VIROL, V87, P7940, DOI 10.1128/JVI.00752-13; Valas S, 1997, VIROLOGY, V237, P307, DOI 10.1006/viro.1997.8800; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; VANDERMAATEN MJ, 1972, JNCI-J NATL CANCER I, V49, P1649, DOI 10.1093/jnci/49.6.1649                                                          ; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; VandeWoude S, 2010, VET IMMUNOL IMMUNOP, V134, P25, DOI 10.1016/j.vetimm.2009.10.005; Wang JW, 2011, J VIROL, V85, P12482, DOI 10.1128/JVI.05218-11; Wang XJ, 2011, J VIROL, V85, P3142, DOI 10.1128/JVI.02049-10; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377; Wilcox GE, 1997, AUST VET J, V75, P492, DOI 10.1111/j.1751-0813.1997.tb14379.x; Wittkopp CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005865; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yamada E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33988; Yoshikawa R, 2017, J VIROL, V91, DOI 10.1128/JVI.00250-17; Yoshikawa R, 2016, MICROBIOL IMMUNOL, V60, P427, DOI 10.1111/1348-0421.12387; Yoshikawa R, 2016, MICROBIOL IMMUNOL, V60, P272, DOI 10.1111/1348-0421.12371; Yoshikawa R, 2016, J VIROL, V90, P474, DOI 10.1128/JVI.02612-15; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zielonka J, 2010, J VIROL, V84, P7312, DOI 10.1128/JVI.00209-10; Zielonka J, 2009, J VIROL, V83, P7547, DOI 10.1128/JVI.00015-09	125	0	0	6	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-4690			RETROVIROLOGY	Retrovirology	MAY 8	2017	14								31	10.1186/s12977-017-0355-4				12	Virology	Virology	EV4WQ	WOS:000401764800001	28482907	gold			2018-01-05	
J	Okada, M; Kanamori, M; Someya, K; Nakatsukasa, H; Yoshimura, A				Okada, Masahiro; Kanamori, Mitsuhiro; Someya, Kazue; Nakatsukasa, Hiroko; Yoshimura, Akihiko			Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells	EPIGENETICS & CHROMATIN			English	Article						Treg; Foxp3; CRISPR; dCas9; TET1; p300; Epigenome editing	TRANSCRIPTION FACTOR FOXP3; TARGETED DNA DEMETHYLATION; STAPHYLOCOCCUS-AUREUS CAS9; GENE-EXPRESSION; TGF-BETA; IN-VIVO; EPIGENETIC CHANGES; ENDOGENOUS GENES; DIFFERENTIATION; ENHANCER	Background: Epigenome editing is expected to manipulate transcription and cell fates and to elucidate the gene expression mechanisms in various cell types. For functional epigenome editing, assessing the chromatin context-dependent activity of artificial epigenetic modifier is required. Results: In this study, we applied clustered regularly interspaced short palindromic repeats (CRISPR)-dCas9-based epigenome editing to mouse primary T cells, focusing on the Forkhead box P3 (Foxp3) gene locus, a master transcription factor of regulatory T cells (Tregs). The Foxp3 gene locus is regulated by combinatorial epigenetic modifications, which determine the Foxp3 expression. Foxp3 expression is unstable in transforming growth factor beta (TGF-beta)-induced Tregs (iTregs), while stable in thymus-derived Tregs (tTregs). To stabilize Foxp3 expression in iTregs, we introduced dCas9-TET1CD (dCas9 fused to the catalytic domain (CD) of ten-eleven translocation dioxygenase 1 (TET1), methylcytosine dioxygenase) and dCas9-p300CD (dCas9 fused to the CD of p300, histone acetyltransferase) with guide RNAs (gRNAs) targeted to the Foxp3 gene locus. Although dCas9-TET1CD induced partial demethylation in enhancer region called conserved non-coding DNA sequences 2 (CNS2), robust Foxp3 stabilization was not observed. In contrast, dCas9-p300CD targeted to the promoter locus partly maintained Foxp3 transcription in cultured and primary T cells even under inflammatory conditions in vitro. Furthermore, dCas9-p300CD promoted expression of Treg signature genes and enhanced suppression activity in vitro. Conclusions: Our results showed that artificial epigenome editing modified the epigenetic status and gene expression of the targeted loci, and engineered cellular functions in conjunction with endogenous epigenetic modification, suggesting effective usage of these technologies, which help elucidate the relationship between chromatin states and gene expression.	[Okada, Masahiro; Kanamori, Mitsuhiro; Someya, Kazue; Nakatsukasa, Hiroko; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan	Okada, M; Yoshimura, A (reprint author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	okada@z5.keio.jp; yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013		Ministry of Education, Culture, Sports, Science and Technology of Japan [25221305]; Takeda Science Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; Kanae Foundation; Senshin Medical Research Foundation Keio Gijuku Academic Developmental Funds;  [17K15451]	This work was supported by special Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25221305), Grant-in- Aid for Young Scientists (B) (No. 17K15451), Advanced Research & Development Programs for Medical Innovation (AMED-CREST), the Takeda Science Foundation, Uehara Memorial Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Kanae Foundation, and Senshin Medical Research Foundation Keio Gijuku Academic Developmental Funds.	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Bennett CL, 2001, NAT GENET, V27, P20; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bothur E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9576; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hibino S, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.17; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; KUBO M, 1994, INT IMMUNOL, V6, P179, DOI 10.1093/intimm/6.2.179                                                          ; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259                                                      ; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nair VS, 2016, MOL CELLS, V39, P888, DOI 10.14348/molcells.2016.0276; Nair VS, 2016, J IMMUNOL, V196, P2119, DOI 10.4049/jimmunol.1502352; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Park M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1046-5; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x                                                ; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sekiya T, 2015, J EXP MED, V212, P1623, DOI 10.1084/jem.20142088; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725                                                    ; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	69	4	4	4	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-8935			EPIGENET CHROMATIN	Epigenetics Chromatin	MAY 8	2017	10								24	10.1186/s13072-017-0129-1				17	Genetics & Heredity	Genetics & Heredity	EU1BC	WOS:000400746300002	28503202	gold			2018-01-05	
J	Song, YN; Xu, YX; Deng, JC; Chen, M; Lu, Y; Wang, Y; Yao, HB; Zhou, L; Liu, ZQ; Lai, LX; Li, ZJ				Song, Yuning; Xu, Yuxin; Deng, Jichao; Chen, Mao; Lu, Yi; Wang, Yong; Yao, Haobin; Zhou, Lina; Liu, Zhiquan; Lai, Liangxue; Li, Zhanjun			CRISPR/Cas9-mediated mutation of tyrosinase (Tyr) 3 ' UTR induce graying in rabbit	SCIENTIFIC REPORTS			English	Article							GREATER-THAN-AATA; HB H DISEASE; MESSENGER-RNA; POLYADENYLATION SIGNAL; GENE; ALBINISM; TRANSCRIPTION; HOMOZYGOSITY; SEQUENCE; MOUSE	The 3' untranslated regions (UTRs), located at the end of mRNA molecules, are believed to play a role in RNA replication and/or protein translation. Mutations in the tyrosinase (Tyr) gene are known to cause recessive albinism in humans and other species. In this study, to test whether the CRISPR/Cas9 system works on the mutation of the UTRs regulatory region in rabbit, the 3' UTR of the rabbit Tyr gene was deleted by a dual sgRNA directed CRISPR/Cas9 system. As expected, gray coat color and reduced melanin in hair follicles and irises was found in the mutated rabbit, thus increasing confidence in the association of the mutation of the Tyr 3' UTR with graying in rabbit. The graying phenotype was also found in the F1 generation, suggesting that the mutated allele can be stably inherited by the offspring. Thus, we provide the first evidence that reduced melanin and graying can be caused by deletion of the Tyr 3' UTR in rabbits. Additionally, CRISPR/Cas9-mediated large fragment deletions can facilitate genotype to phenotype studies of UTRs or non-coding RNAs in future.	[Song, Yuning; Xu, Yuxin; Deng, Jichao; Chen, Mao; Lu, Yi; Wang, Yong; Yao, Haobin; Zhou, Lina; Liu, Zhiquan; Lai, Liangxue; Li, Zhanjun] Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130062, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, CAS Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China	Lai, LX; Li, ZJ (reprint author), Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130062, Peoples R China.; Lai, LX (reprint author), Chinese Acad Sci, CAS Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China.	lai_liangxue@gibh.ac.cn; lizj_1998@jlu.edu.cn			National Natural Science Foundation of China [31201080, 31272394]	We thank Peiran Hu at the Embryo Engineering Center for the critical technical assistance. This work was financially supported by the National Natural Science Foundation of China (Grant Nos 31201080 and 31272394).	Aigner B, 2000, MAMM GENOME, V11, P700, DOI 10.1007/s003350010120; Anistoroaei R, 2008, ANIM GENET, V39, P645, DOI 10.1111/j.1365-2052.2008.01788.x; Beermann F, 2004, MAMM GENOME, V15, P749, DOI [10.1007/s00335-004-4002-8, 10.1007/s00335-04-4002-8]; Brown JT, 2001, RNA, V7, P1566; Cui TT, 2015, ARCH DERMATOL RES, V307, P683, DOI 10.1007/s00403-015-1563-1; Deshpande P, 2015, HEMOGLOBIN, V39, P415, DOI 10.3109/03630269.2015.1079785; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; Farashi S, 2015, HEMOGLOBIN, V39, P355, DOI 10.3109/03630269.2015.1059850; Geissler R, 2016, RNA BIOL, V13, P1075, DOI 10.1080/15476286.2016.1225645; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Jiang ZS, 2016, MOL MED REP, V14, P4415, DOI 10.3892/mmr.2016.5755; Livny J, 2010, NUCLEIC ACIDS RES, V38, P1504, DOI [10.1093/nar/gkp1121, 10.1093/nar/gkq190]; MARTIN G, 1996, THE EMBO JOURNAL, V15, P2593; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0                                                   ; Nair SB, 2013, HEMOGLOBIN, V37, P277, DOI 10.3109/03630269.2013.774284; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Schmutz SM, 2004, MAMM GENOME, V15, P62, DOI 10.1007/s00335-002-2249-5; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Utzeri VJ, 2014, ANIM GENET, V45, P600, DOI 10.1111/age.12171; Wang Yu, 2014, Cell Regen (Lond), V3, P3, DOI 10.1186/2045-9769-3-3; YU X, 2016, THE JOURNAL, V42, P983, DOI DOI 10.1111/J0G.12989; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	25	1	1	4	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 8	2017	7								1569	10.1038/s41598-017-01727-y				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EU2QR	WOS:000400874500009	28484254	gold			2018-01-05	
J	Si, FW; Li, DY; Cox, SE; Sauls, JT; Azizi, O; Sou, C; Schwartz, AB; Erickstad, MJ; Jun, YG; Li, XT; Jun, S				Si, Fangwei; Li, Dongyang; Cox, Sarah E.; Sauls, John T.; Azizi, Omid; Sou, Cindy; Schwartz, Amy B.; Erickstad, Michael J.; Jun, Yonggun; Li, Xintian; Jun, Suckjoon			Invariance of Initiation Mass and Predictability of Cell Size in Escherichia coli	CURRENT BIOLOGY			English	Article							GENE-EXPRESSION; BACTERIAL-CELL; DNAA PROTEIN; GROWTH-RATE; SALMONELLA-TYPHIMURIUM; CHROMOSOME-REPLICATION; DIVISION; CYCLE; TIME; SYNCHRONIZATION	It is generally assumed that the allocation and synthesis of total cellular resources in microorganisms are uniquely determined by the growth conditions. Adaptation to a new physiological state leads to a change in cell size via reallocation of cellular resources. However, it has not been understood how cell size is coordinated with biosynthesis and robustly adapts to physiological states. We show that cell size in Escherichia coli can be predicted for any steady-state condition by projecting all biosynthesis into three measurable variables representing replication initiation, replication-division cycle, and the global biosynthesis rate. These variables can be decoupled by selectively controlling their respective core biosynthesis using CRISPR interference and antibiotics, verifying our predictions that different physiological states can result in the same cell size. We performed extensive growth inhibition experiments, and we discovered that cell size at replication initiation per origin, namely the initiation mass or unit cell, is remarkably invariant under perturbations targeting transcription, translation, ribosome content, replication kinetics, fatty acid and cell wall synthesis, cell division, and cell shape. Based on this invariance and balanced resource allocation, we explain why the total cell size is the sum of all unit cells. These results provide an overarching framework with quantitative predictive power over cell size in bacteria.	[Si, Fangwei; Cox, Sarah E.; Sauls, John T.; Schwartz, Amy B.; Erickstad, Michael J.; Jun, Yonggun; Li, Xintian; Jun, Suckjoon] Univ Calif San Diego, Dept Phys, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Li, Dongyang; Jun, Suckjoon] Univ Calif San Diego, Div Biol, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Azizi, Omid] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Sou, Cindy] Univ Calif San Diego, Eleanor Roosevelt Coll, 9500 Gilman Dr, La Jolla, CA 92093 USA	Jun, S (reprint author), Univ Calif San Diego, Dept Phys, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Jun, S (reprint author), Univ Calif San Diego, Div Biol, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	suckjoon.jun@gmail.com			Paul G. Allen Family Foundation; Pew Charitable Trust; NSF [MCB-1253843]; NIH [R01 GM118565-01]	This work was supported by the Paul G. Allen Family Foundation, Pew Charitable Trust, NSF CAREER grant MCB-1253843, and NIH grant R01 GM118565-01 (to S.J.). We are deeply grateful to Arshad Desai, Johan Paulsson, James Pelletier, Matt Scott, Terry Hwa, Tsutomu Katayama, Petra Levin, Kirsten Skarstad, Massimo Vergassola, and all members of the Jun lab for critical reading and invaluable discussions. We give special thanks to Tony Hui (Princeton) for help with RNA/protein measurements in the initial stage of this work and to Don Court for helpful experimental suggestions.	Basan M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156178; Bremer H., 2008, ECOSAL PLUS, V3; Brown S. D., 2015, GENOME ANNOUNC, V3; CAMPBELL A, 1957, BACTERIOL REV, V21, P263; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; DONACHIE WD, 1970, NATURE, V227, P1220, DOI 10.1038/2271220a0; FANTES PA, 1975, J THEOR BIOL, V50, P213, DOI 10.1016/0022-5193(75)90034-X                                                    ; HANSEN FG, 1991, RES MICROBIOL, V142, P161, DOI 10.1016/0923-2508(91)90025-6; HANSEN FG, 1991, J BACTERIOL, V173, P5194, DOI 10.1128/jb.173.16.5194-5199.1991                                                ; Harris LK, 2016, CELL, V165, P1479, DOI 10.1016/j.cell.2016.05.045; Hashimoto M, 2016, P NATL ACAD SCI USA, V113, P3251, DOI 10.1073/pnas.1519412113; HELMSTETTER C, 1968, COLD SPRING HARB SYM, V33, P809, DOI 10.1101/SQB.1968.033.01.093                                                     ; HELMSTETTER CE, 1968, J MOL BIOL, V31, P507, DOI 10.1016/0022-2836(68)90424-5; Helmstetter C. E., 1996, ESCHERICHIA COLI SAL, V2, P1627; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Jun S, 2015, TRENDS MICROBIOL, V23, P4, DOI 10.1016/j.tim.2014.12.001; Kennard AS, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.012408; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; LANE HED, 1975, J MOL BIOL, V97, P99; Li XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep39076; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7                                                    ; Mitchison JM, 1971, BIOL CELL CYCLE; Neidhardt FC, 1999, J BACTERIOL, V181, P7405; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; PRITCHARD RH, 1970, NATURE, V226, P126, DOI 10.1038/226126a0; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592                                                       ; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; SOMPAYRAC L, 1973, NATURE-NEW BIOL, V241, P133; Stokke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030981; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.nprot.2013.021, 10.1038/nprot.2013.021]; Vischer NOE, 1999, J MICROSC-OXFORD, V196, P61; Wallden M, 2016, CELL, V166, P729, DOI 10.1016/j.cell.2016.06.052; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wiktor J, 2016, NUCLEIC ACIDS RES, V44, P3801, DOI 10.1093/nar/gkw214; Youngren B, 2014, GENE DEV, V28, P71, DOI 10.1101/gad.231050.113; ZARITSKY A, 1973, J BACTERIOL, V114, P824; Zheng H, 2016, P NATL ACAD SCI USA, V113, P15000, DOI 10.1073/pnas.1617932114	48	9	9	11	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	MAY 8	2017	27	9					1278	1287		10.1016/j.cub.2017.03.022				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EU0ZO	WOS:000400741700018	28416114				2018-01-05	
J	Zhu, QY; Xu, YN; Qiu, L; Ma, CC; Yu, BW; Song, Q; Jin, W; Jin, QH; Liu, JY; Mu, Y				Zhu, Qiangyuan; Xu, Yanan; Qiu, Lin; Ma, Congcong; Yu, Bingwen; Song, Qi; Jin, Wei; Jin, Qinhan; Liu, Jinyu; Mu, Ying			A scalable self-priming fractal branching microchannel net chip for digital PCR	LAB ON A CHIP			English	Article							POLYMERASE-CHAIN-REACTION; ABSOLUTE COPY NUMBER; REAL-TIME; NONINVASIVE DIAGNOSIS; MICROFLUIDIC CHIP; SINGLE CELLS; GENOME; QUANTIFICATION; PLASMA; DNA	As an absolute quantification method at the single-molecule level, digital PCR has been widely used in many bioresearch fields, such as next generation sequencing, single cell analysis, gene editing detection and so on. However, existing digital PCR methods still have some disadvantages, including high cost, sample loss, and complicated operation. In this work, we develop an exquisite scalable self-priming fractal branching microchannel net digital PCR chip. This chip with a special design inspired by natural fractal-tree systems has an even distribution and 100% compartmentalization of the sample without any sample loss, which is not available in existing chip-based digital PCR methods. A special 10 nm nano-waterproof layer was created to prevent the solution from evaporating. A vacuum pre-packaging method called self-priming reagent introduction is used to passively drive the reagent flow into the microchannel nets, so that this chip can realize sequential reagent loading and isolation within a couple of minutes, which is very suitable for point-of-care detection. When the number of positive microwells stays in the range of 100 to 4000, the relative uncertainty is below 5%, which means that one panel can detect an average of 101 to 15 374 molecules by the Poisson distribution. This chip is proved to have an excellent ability for single molecule detection and quantification of low expression of hHF-MSC stem cell markers. Due to its potential for high throughput, high density, low cost, lack of sample and reagent loss, self-priming even compartmentalization and simple operation, we envision that this device will significantly expand and extend the application range of digital PCR involving rare samples, liquid biopsy detection and point-of-care detection with higher sensitivity and accuracy.	[Zhu, Qiangyuan; Qiu, Lin; Yu, Bingwen; Song, Qi; Jin, Wei; Jin, Qinhan; Mu, Ying] Zhejiang Univ, State Key Lab Ind Control Technol, Inst Cyber Syst & Control, Res Ctr Analyt Instrumentat, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Yanan; Ma, Congcong] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Jinyu] Jilin Univ, Sch Publ Hlth, Changchun 130021, Jilin, Peoples R China	Mu, Y (reprint author), Zhejiang Univ, State Key Lab Ind Control Technol, Inst Cyber Syst & Control, Res Ctr Analyt Instrumentat, Hangzhou 310058, Zhejiang, Peoples R China.	muying@zju.edu.cn			National Natural Science Foundation of China [31400728, 31270907]; China Postdoctoral Science Foundation [2014M561749]; National Key Foundation for Exploring Scientific Instruments [2013YQ470781]; Autonomous Research Project of State Key Laboratory of Industrial Control Technology, China [ICT1601]	This work was supported by the National Natural Science Foundation of China (31400728, 31270907), China Postdoctoral Science Foundation (2014M561749), National Key Foundation for Exploring Scientific Instruments (2013YQ470781), and the Autonomous Research Project of State Key Laboratory of Industrial Control Technology, China (No. ICT1601).	Barrett AN, 2014, METHODS MOL BIOL, V1160, P215, DOI 10.1007/978-1-4939-0733-5_17; Beer NR, 2007, ANAL CHEM, V79, P8471, DOI 10.1021/ac701809w; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Bian XJ, 2015, BIOSENS BIOELECTRON, V74, P770, DOI 10.1016/j.bios.2015.07.016; Bizouarn F, 2014, METHODS MOL BIOL, V1160, P189, DOI 10.1007/978-1-4939-0733-5_16; Bizouarn F, 2014, METHODS MOL BIOL, V1160, P27, DOI 10.1007/978-1-4939-0733-5_4; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boizeau L, 2014, J CLIN MICROBIOL, V52, P3497, DOI 10.1128/JCM.01306-14; Cohen DE, 2010, ANAL CHEM, V82, P5707, DOI 10.1021/ac100713u; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Eastburn DJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv297; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fu YS, 2015, P NATL ACAD SCI USA, V112, P11923, DOI 10.1073/pnas.1513988112; Gao J, 2004, LAB CHIP, V4, P47, DOI 10.1039/b310552k; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; Heyries KA, 2011, NAT METHODS, V8, P649, DOI [10.1038/NMETH.1640, 10.1038/nmeth.1640]; Jacobs BKM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-283; Jeong HH, 2015, LAB CHIP, V15, P4387, DOI 10.1039/c5lc01025j; Kaitu'u-Lino TJ, 2014, PLACENTA, V35, P1106, DOI 10.1016/j.placenta.2014.10.003; Le Gac S, 2010, TRENDS BIOTECHNOL, V28, P55, DOI 10.1016/j.tibtech.2009.10.005; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2010, PRENATAL DIAG, V30, P702, DOI 10.1002/pd.2516; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Marques FZ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-44; Mazaika E., 2014, CURR PROTOC HUM GENE, V82, P24; Mazutis L, 2009, ANAL CHEM, V81, P4813, DOI 10.1021/ac900403z; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Roberts CH, 2014, GENOME MED, V6, DOI 10.1186/gm537; Sanmamed MF, 2015, CLIN CHEM, V61, P297, DOI 10.1373/clinchem.2014.230235; Schuler F, 2015, LAB CHIP, V15, P2759, DOI 10.1039/c5lc00291e; Seki Y, 2016, ONCOLOGIST, V21, P156, DOI 10.1634/theoncologist.2015-0288; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Shen F, 2010, LAB CHIP, V10, P2666, DOI 10.1039/c004521g; Song Q, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9970-9; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Sun YN, 2014, LAB CHIP, V14, P3603, DOI 10.1039/c4lc00598h; Sundberg SO, 2010, ANAL CHEM, V82, P1546, DOI 10.1021/ac902398c; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Thompson AM, 2014, ANAL CHEM, V86, P12308, DOI 10.1021/ac5035924; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973; Wang YZ, 2016, ANALYST, V141, P3821, DOI 10.1039/c6an00164e; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; WEIBEL ER, 1991, AM J PHYSIOL, V261, pL361; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; White AK, 2013, ANAL CHEM, V85, P7182, DOI 10.1021/ac400896j; Witters D, 2014, LAB CHIP, V14, P3225, DOI 10.1039/c4lc00248b; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhang P, 2016, LAB CHIP, V16, P3033, DOI 10.1039/c6lc00279j; Zhu QY, 2014, LAB CHIP, V14, P1176, DOI 10.1039/c3lc51327k; Zhu QY, 2012, LAB CHIP, V12, P4755, DOI 10.1039/c2lc40774d; Zonta E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159094	55	1	1	10	20	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1473-0197	1473-0189		LAB CHIP	Lab Chip	MAY 7	2017	17	9					1655	1665		10.1039/c7lc00267j				11	Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience & Nanotechnology	Biochemistry & Molecular Biology; Chemistry; Science & Technology - Other Topics	ET9UW	WOS:000400655300013	28418438				2018-01-05	
J	Zhang, H; Cheng, QX; Liu, AM; Zhao, GP; Wang, J				Zhang, Hong; Cheng, Qiu-Xiang; Liu, Ai-Min; Zhao, Guo-Ping; Wang, Jin			A Novel and Efficient Method for Bacteria Genome Editing Employing both CRISPR/Cas9 and an Antibiotic Resistance Cassette	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR/Cas9; protospacer adjacent motif; genome editing; antibiotic resistance cassette; sequence-independent	ESCHERICHIA-COLI; CRISPR-CAS9; DELETION; MUTAGENESIS; INTEGRATION; SYSTEMS	As Cas9-mediated cleavage requires both protospacer and protospacer adjacent motif (PAM) sequences, it is impossible to employ the CRISPR/Cas9 system to directly edit genomic sites without available PAM sequences nearby. Here, we optimized the CRISPR/Cas9 system and developed an innovative two-step strategy for efficient genome editing of any sites, which did not rely on the availability of PAM sequences. An antibiotic resistance cassette was employed as both a positive and a negative selection marker. By integrating the optimized two-plasmid CRISPR/Cas system and donor DNA, we achieved gene insertion and point mutation with high efficiency in Escherichia coli, and importantly, obtained clean mutants with no other unwanted mutations. Moreover, genome editing of essential genes was successfully achieved using this approach with a few modifications. Therefore, our newly developed method is PAM-independent and can be used to edit any genomic loci, and we hope this method can also be used for efficient genome editing in other organisms.	[Zhang, Hong; Zhao, Guo-Ping; Wang, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai, Peoples R China; [Zhang, Hong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Cheng, Qiu-Xiang] Shanghai Tolo Biotechnol Co Ltd, Shanghai, Peoples R China; [Liu, Ai-Min] Anhui Normal Univ, Coll Life Sci, Prov Key Labs Conservat & Utilizat Important Biol, Wuhu, Peoples R China	Wang, J (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai, Peoples R China.; Liu, AM (reprint author), Anhui Normal Univ, Coll Life Sci, Prov Key Labs Conservat & Utilizat Important Biol, Wuhu, Peoples R China.	amliu9393@163.com; wangj01@hotmail.com			Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]; National Natural Science Foundation of China [31430004, 31421061]; National High Technology Research and Development Program ("863" Program) of China [2014AA021501]	This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB19040200), the National Natural Science Foundation of China (31430004 and 31421061) and the National High Technology Research and Development Program ("863" Program) of China (Grant No. 2014AA021501). We thank Xiao-Yan Li in Tolo Biotech. for her assistance in editing the frr gene in MG1655.	Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Biot-Pelletier D, 2016, J BIOL ENG, V10, DOI 10.1186/s13036-016-0028-1; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; [Anonymous], ACS SYNTH BIOL, V4, P585, DOI [10.1021/sb500255k, DOI 10.1021/SB500255K]; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y., 2015, ICIC EL, V9, P81, DOI DOI 10.1128/AEM.04023-14; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kostner D, 2013, APPL MICROBIOL BIOT, V97, P8341, DOI 10.1007/s00253-013-5164-7; Li SY, 2016, ACS SYNTH BIOL, V5, P1383, DOI 10.1021/acssynbio.6b00114; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Peters B, 2013, APPL MICROBIOL BIOT, V97, P2521, DOI 10.1007/s00253-012-4354-z; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Wang HL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1339; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359; Zhao DD, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0605-5	24	0	0	8	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	MAY 5	2017	8								812	10.3389/fmicb.2017.00812				11	Microbiology	Microbiology	ET9QA	WOS:000400641200001	28529507	gold			2018-01-05	
J	Morgens, DW; Wainberg, M; Boyle, EA; Ursu, O; Araya, CL; Tsui, CK; Haney, MS; Hess, GT; Han, K; Jeng, EE; Li, A; Snyder, MP; Greenleaf, WJ; Kundaje, A; Bassik, MC				Morgens, David W.; Wainberg, Michael; Boyle, Evan A.; Ursu, Oana; Araya, Carlos L.; Tsui, C. Kimberly; Haney, Michael S.; Hess, Gaelen T.; Han, Kyuho; Jeng, Edwin E.; Li, Amy; Snyder, Michael P.; Greenleaf, William J.; Kundaje, Anshul; Bassik, Michael C.			Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens	NATURE COMMUNICATIONS			English	Article							HUMAN-CELLS; CRISPR-CAS9 NUCLEASES; FUNCTIONAL GENOMICS; RNA INTERFERENCE; CRISPR/CAS9 SYSTEMS; ENDONUCLEASE CAS9; MAMMALIAN-CELLS; ESSENTIAL GENES; DIGENOME-SEQ; REVEALS	CRISPR-Cas9 screens are powerful tools for high-throughput interrogation of genome function, but can be confounded by nuclease-induced toxicity at both on-and off-target sites, likely due to DNA damage. Here, to test potential solutions to this issue, we design and analyse a CRISPR-Cas9 library with 10 variable-length guides per gene and thousands of negative controls targeting non-functional, non-genic regions (termed safe-targeting guides), in addition to non-targeting controls. We find this library has excellent performance in identifying genes affecting growth and sensitivity to the ricin toxin. The safe-targeting guides allow for proper control of toxicity from on-target DNA damage. Using this toxicity as a proxy to measure off-target cutting, we demonstrate with tens of thousands of guides both the nucleotide position-dependent sensitivity to single mismatches and the reduction of off-target cutting using truncated guides. Our results demonstrate a simple strategy for high-throughput evaluation of target specificity and nuclease toxicity in Cas9 screens.	[Morgens, David W.; Boyle, Evan A.; Ursu, Oana; Araya, Carlos L.; Tsui, C. Kimberly; Haney, Michael S.; Hess, Gaelen T.; Han, Kyuho; Jeng, Edwin E.; Li, Amy; Snyder, Michael P.; Greenleaf, William J.; Kundaje, Anshul; Bassik, Michael C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Wainberg, Michael; Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Jeng, Edwin E.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Bassik, Michael C.] Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA	Bassik, MC (reprint author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Bassik, MC (reprint author), Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.	bassik@stanford.edu		Ursu, Oana/0000-0001-8743-4730; Boyle, Evan/0000-0003-4494-9771	NIH [1DP2HD084069-01]; NIH/NHGRI [T32 HG000044]; Stanford ChEM-H; Stanford Neuroscience Institute; National Science Foundation (NSF) [DGE-114747]; Natural Sciences and Engineering Research Council of Canada (NSERC) [PGSD3-476082-2015]	We thank M. Dubreuil, R.M. Deans, C.H. Lee, J.D. Smith, J.M. Geisinger, B.X.H. Fu, members of the Bassik lab, Doug Vollrath, Max Horlbeck, Luke Gilbert, Martin Kampmann and Jonathan Weissman for technical expertise and helpful discussions. We thank Laurakay Bruhn, Steven Altschuler, Marc Valer, Ben Borgo, Peter Sheffield and Carsten Carstens of Agilent Inc. for oligonucleotide synthesis and helpful discussions. This work was funded by the NIH Director's New Innovator Award Program (project no 1DP2HD084069-01) NIH/NHGRI (training grant T32 HG000044 to D.W.M. and G.T.H.), and seed grants from Stanford ChEM-H and Stanford Neuroscience Institute. This material is based on work supported by the National Science Foundation (NSF) Graduate Research Fellowship (grant DGE-114747 to D.W.M.) and by the Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship-Doctoral (grant PGSD3-476082-2015 to M.W.). Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF or NSERC.	Acosta-Alvear D, 2015, ELIFE, V4, DOI 10.7554/eLife.08153; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Crispin M, 2009, J BIOL CHEM, V284, P21684, DOI 10.1074/jbc.M109.006254; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Cummings R. D., 2009, R TYPE LECTINS ESSEN; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fu BXH, 2016, NUCLEIC ACIDS RES, V44, P5365, DOI 10.1093/nar/gkw417; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Roadmap Epigenome Consortium, 2015, NATURE, V518, P317; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	58	5	5	8	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 5	2017	8								15178	10.1038/ncomms15178				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EU2IG	WOS:000400851300001	28474669	gold			2018-01-05	
J	Takahashi, Y; Wu, J; Suzuki, K; Martinez-Redondo, P; Li, M; Liao, HK; Wu, MZ; Hernandez-Benitez, R; Hishida, T; Shokhirev, MN; Esteban, CR; Sancho-Martinez, I; Belmonte, JCI				Takahashi, Yuta; Wu, Jun; Suzuki, Keiichiro; Martinez-Redondo, Paloma; Li, Mo; Liao, Hsin-Kai; Wu, Min-Zu; Hernandez-Benitez, Reyna; Hishida, Tomoaki; Shokhirev, Maxim Nikolaievich; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua			Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells	SCIENCE			English	Article							ANGELMAN-SYNDROME; COLORECTAL-CANCER; UBIQUITIN LIGASE; UBE3A; DIFFERENTIATION; SPECIFICATION; TRANSCRIPT; CONVERSION; PROMOTERS; MUTATION	CpG islands (CGIs) are primarily promoter-associated genomic regions and are mostly unmethylated within highly methylated mammalian genomes. The mechanisms by which CGIs are protected from de novo methylation remain elusive. Here we show that insertion of CpG-free DNA into targeted CGIs induces de novo methylation of the entire CGI in human pluripotent stem cells (PSCs). The methylation status is stably maintained even after CpG-free DNA removal, extensive passaging, and differentiation. By targeting the DNA mismatch repair gene MLH1 CGI, we could generate a PSC model of a cancer-related epimutation. Furthermore, we successfully corrected aberrant imprinting in induced PSCs derived from an Angelman syndrome patient. Our results provide insights into how CpG-free DNA induces de novo CGI methylation and broaden the application of targeted epigenome editing for a better understanding of human development and disease.	[Takahashi, Yuta; Wu, Jun; Suzuki, Keiichiro; Li, Mo; Liao, Hsin-Kai; Wu, Min-Zu; Hernandez-Benitez, Reyna; Hishida, Tomoaki; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Takahashi, Yuta] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan; [Wu, Jun; Wu, Min-Zu] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos 135, Murcia 30107, Spain; [Li, Mo; Hernandez-Benitez, Reyna] King Abdullah Univ Sci & Technol, Thuwal 239556900, Saudi Arabia; [Shokhirev, Maxim Nikolaievich] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Sancho-Martinez, Ignacio] Novartis Fdn GNF, Genom Inst, Dept Pharmacol C128, 10675 John Jay Hopkins Dr, La Jolla, CA 92121 USA	Belmonte, JCI (reprint author), Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu		Suzuki, Keiichiro/0000-0001-5603-9105; Li, Mo/0000-0003-0827-8907	Astellas Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; California Institute for Regenerative Medicine (CIRM); Fundacion Alfonso Martin Escudero; Razavi Newman Integrative Genomics and Bioinformatics Core Facility; Next Generation Sequencing (NGS) Core Facility at the Salk Institute; NIH-National Cancer Institute (NCI) Cancer Center Support Grant (CCSG) [P30 014195]; Chapman Foundation; Leona M. and Harry B. Helmsley Charitable Trust; UCAM (iPSC); G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation	We thank M. C. Ku and T. Nguyen for next-generation sequencing; I. Dubova and K. McIntyre for teratoma analysis; D. O'Keefe for critical reading of the manuscript; C. J. Chang, A. Goebl, E. Aizawa, N. Y. Kim, Y. Hishida, R. D. Soligalla, and M. Morales Valencia for experimental help; M. Schwarz and P. Schwarz for administrative help; and A. Fukamizu for scientific discussion. Y. T. was partially supported by Astellas Foundation, Uehara Memorial Foundation, and Mochida Memorial Foundation research fellowships. K.S. and M.L. were supported by a California Institute for Regenerative Medicine (CIRM) Training Grant fellowship. P.M.-R. was partially supported by the Fundacion Alfonso Martin Escudero. This work was supported by the Razavi Newman Integrative Genomics and Bioinformatics Core Facility and the Next Generation Sequencing (NGS) Core Facility at the Salk Institute, with funding from NIH-National Cancer Institute (NCI) Cancer Center Support Grant (CCSG) no. P30 014195, the Chapman Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust. Work in the laboratory of J.C.I.B. was supported by UCAM (iPSC work), The G. Harold and Leila Y. Mathers Charitable Foundation, The Moxie Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust.	BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Egawa K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004655; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Harbord M, 2001, J CLIN NEUROSCI, V8, P421, DOI 10.1054/jocn.2000.0753; Herzing LBK, 2002, HUM MOL GENET, V11, P1707, DOI 10.1093/hmg/11.15.1707; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W                                                    ; Mercer AA, 2016, ELIFE, V5, DOI 10.7554/eLife.07596; Mulherkar SA, 2009, J NEUROCHEM, V110, P1955, DOI 10.1111/j.1471-4159.2009.06293.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15                                                               ; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Runte M, 2004, HUM GENET, V114, P553, DOI 10.1007/s00439-004-1104-z; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022	34	1	1	11	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					503	+		10.1126/science.aag3260				6	Multidisciplinary Sciences	Science & Technology - Other Topics	ET8JM	WOS:000400545700030	28473583				2018-01-05	
J	Lee, HK; Willi, M; Wang, CC; Yang, CM; Smith, HE; Liu, CY; Hennighausen, L				Lee, Hye Kyung; Willi, Michaela; Wang, Chaochen; Yang, Chul Min; Smith, Harold E.; Liu, Chengyu; Hennighausen, Lothar			Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in mice	NUCLEIC ACIDS RESEARCH			English	Article							CHROMOSOME CONFORMATION CAPTURE; RANGE CHROMATIN INTERACTIONS; V(D)J RECOMBINATION; BINDING-SITE; INSULATED NEIGHBORHOODS; GENOME TOPOLOGY; EXPRESSION; DOMAINS; TRANSCRIPTION; LOCUS	The zinc finger protein CTCF has been invoked in establishing boundaries between genes, thereby controlling spatial and temporal enhancer activities. However, there is limited genetic evidence to support the concept that these boundaries restrict the search space of enhancers. We have addressed this question in the casein locus containing five mammary and two non-mammary genes under the control of at least seven putative enhancers. We have identified two CTCF binding sites flanking the locus and two associated with a super-enhancer. Individual deletion of these sites from the mouse genome did not alter expression of any of the genes. However, deletion of the border CTCF site separating the Csn1s1 mammary enhancer from neighboring genes resulted in the activation of Sult1d1 at a distance of more than 95 kb but not the more proximal and silent Sult1e1 gene. Loss of this CTCF site led to de novo interactions between the Sult1d1 promoter and several enhancers in the casein locus. Our study demonstrates that only one out of the four CTCF sites in the casein locus had a measurable in vivo activity. Studies on additional loci are needed to determine the biological role of CTCF sites associated with enhancers.	[Lee, Hye Kyung; Willi, Michaela; Wang, Chaochen; Yang, Chul Min; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Lee, Hye Kyung] Seoul Natl Univ, Dept Cell & Dev Biol, Seoul 110749, South Korea; [Lee, Hye Kyung] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Willi, Michaela] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Smith, Harold E.] NIDDK, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA	Hennighausen, L (reprint author), NIDDK, Lab Genet & Physiol, US Natl Inst Hlth, Bethesda, MD 20892 USA.	lotharh@mail.nih.gov		Willi, Michaela/0000-0002-2248-1998	IPR of the NIDDK/NIH; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1184]	IPR of the NIDDK/NIH; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1184 to H.K.L.]. Funding for open access charge: IPR of the NIDDK/NIH.	Andrey G, 2017, GENOME RES, V27, P223, DOI 10.1101/gr.213066.116; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Blinka S, 2016, CELL REP, V17, P19, DOI 10.1016/j.celrep.2016.09.002; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; Chen L, 2016, J IMMUNOL, V197, P3188, DOI 10.4049/jimmunol.1601124; Chen L, 2015, NAT IMMUNOL, V16, P1085, DOI 10.1038/ni.3232; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Doyle B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003867; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; Faucon F, 2009, PHYSIOL GENOMICS, V40, P61, DOI 10.1152/physiolgenomics.00032.2009; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; Fitzpatrick GV, 2007, MOL CELL BIOL, V27, P2636, DOI 10.1128/MCB.02036-06; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Gomez-Marin C, 2015, P NATL ACAD SCI USA, V112, P7542, DOI 10.1073/pnas.1505463112; Gosalia N, 2014, NUCLEIC ACIDS RES, V42, P9612, DOI 10.1093/nar/gku648; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Herz HM, 2016, BIOESSAYS, V38, P1003, DOI 10.1002/bies.201600106; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kang K, 2014, MOL CELL BIOL, V34, P464, DOI 10.1128/MCB.00988-13; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kim S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.33; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lee HK, 2012, GENE EXPR PATTERNS, V12, P102, DOI 10.1016/j.gep.2012.02.002; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Liu MD, 2015, NAT BIOTECHNOL, V33, P198, DOI 10.1038/nbt.3062; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lu YM, 2016, NUCLEIC ACIDS RES, V44, P6200, DOI 10.1093/nar/gkw249; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Magbanua JP, 2015, MOL CELL BIOL, V35, P318, DOI 10.1128/MCB.01061-14; Metser G, 2016, NUCLEIC ACIDS RES, V44, P1052, DOI 10.1093/nar/gkv999; Narendra V, 2016, GENE DEV, V30, P2657, DOI 10.1101/gad.288324.116; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Naumova N, 2012, METHODS, V58, P192, DOI 10.1016/j.ymeth.2012.07.022; Nikolic T, 2014, CELL MOL IMMUNOL, V11, P58, DOI 10.1038/cmi.2013.41; Oki M, 2002, CURR OPIN CELL BIOL, V14, P299, DOI 10.1016/S0955-0674(02)00327-7; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Plasschaert RN, 2014, NUCLEIC ACIDS RES, V42, P774, DOI 10.1093/nar/gkt910; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Raviram R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004780; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Shore AN, 2014, INT J BIOCHEM CELL B, V54, P318, DOI 10.1016/j.biocel.2014.03.012; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Vietri Rudan M, 2015, CELL REP, V10, P1297, DOI [10.1016/j.celrep.2015.02.004, DOI 10.1016/J.CELREP.2015.02.004]; Willi M, 2016, NUCLEIC ACIDS RES, V44, P10277, DOI 10.1093/nar/gkw844; Xu M, 2014, MOL CELL BIOL, V34, P3867, DOI 10.1128/MCB.00567-14; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358; Zhao LJ, 2016, J EXP MED, V213, P1921, DOI 10.1084/jem.20160670	70	2	2	1	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 5	2017	45	8					4606	4618		10.1093/nar/gkx185				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ET8UO	WOS:000400578600034	28334928	gold			2018-01-05	
J	Li, M; Gong, LY; Zhao, DH; Zhou, J; Xiang, H				Li, Ming; Gong, Luyao; Zhao, Dahe; Zhou, Jian; Xiang, Hua			The spacer size of I-B CRISPR is modulated by the terminal sequence of the protospacer	NUCLEIC ACIDS RESEARCH			English	Article							ADAPTIVE IMMUNE-SYSTEMS; CAS SYSTEM; ESCHERICHIA-COLI; HALOARCULA-HISPANICA; FOREIGN DNA; HALOFERAX-MEDITERRANEI; PRIMED ADAPTATION; RNA SPACERS; ACQUISITION; INTERFERENCE	Prokaryotes memorize invader information by incorporating alien DNA as spacers into CRISPR arrays. Although the spacer size has been suggested to be predefined by the architecture of the acquisition complex, there is usually an unexpected heterogeneity. Here, we explored the causes of this heterogeneity in Haloarcula hispanica I-B CRISPR. High-throughput sequencing following adaptation assays demonstrated significant size variation among 37 957 new spacers, which appeared to be sequence-dependent. Consistently, the third nucleotide at the spacer 3'-end (PAM-distal end) showed an evident bias for cytosine and mutating this cytosine in the protospacer sequence could change the final spacer size. In addition, slippage of the 5'-end (PAM-end), which contributed to most of the observed PAM (protospacer adjacent motif) inaccuracy, also tended to change the spacer size. We propose that both ends of the PAM-protospacer sequence should exhibit nucleotide selectivity (with different stringencies), which fine-tunes the structural ruler, to a certain extent, to specify the spacer size.	[Li, Ming; Gong, Luyao; Zhao, Dahe; Zhou, Jian; Xiang, Hua] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Gong, Luyao; Xiang, Hua] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Xiang, H (reprint author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.; Xiang, H (reprint author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.	xiangh@im.ac.cn			National Natural Science Foundation of China [31571283, 31271334]; CAS/SAFEA International Partnership Program for Creative Research Teams	National Natural Science Foundation of China [31571283, 31271334]; CAS/SAFEA International Partnership Program for Creative Research Teams. Funding for open access charge: National Natural Science Foundation of China [31571283].	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Garrett Roger A., 2015, Life-Basel, V5, P783, DOI 10.3390/life5010783; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Kuznedelov K, 2016, NUCLEIC ACIDS RES, V44, P10849, DOI 10.1093/nar/gkw914; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Li M, 2013, J BACTERIOL, V195, P867, DOI 10.1128/JB.01688-12; Liu HL, 2011, J GENET GENOMICS, V38, P261, DOI 10.1016/j.jgg.2011.05.003; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Strotskaya A, 2017, NUCLEIC ACIDS RES, V45, P1946, DOI 10.1093/nar/gkx042; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Wang HN, 2015, MICROBIOL MOL BIOL R, V79, P117, DOI 10.1128/MMBR.00042-14; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Zhang J, 2013, BIOCHEM SOC T, V41, P1422, DOI 10.1042/BST20130031	40	2	2	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 5	2017	45	8					4642	4654		10.1093/nar/gkx229				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ET8UO	WOS:000400578600037	28379481	gold			2018-01-05	
J	Haag, S; Schindler, M; Berndt, L; Brennicke, A; Takenaka, M; Weber, G				Haag, Sascha; Schindler, Magdalena; Berndt, Leona; Brennicke, Axel; Takenaka, Mizuki; Weber, Gert			Crystal structures of the Arabidopsis thaliana organellar RNA editing factors MORF1 and MORF9	NUCLEIC ACIDS RESEARCH			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; MOTIF-CONTAINING PROTEIN; STRUCTURE REFINEMENT; PLANT ORGANELLES; GENE-EXPRESSION; MESSENGER-RNAS; DOMAIN; COMPLEX; BINDING; 4-THIOURIDINE	In flowering plant plastids and mitochondria, multiple organellar RNA editing factor (MORF/RIP) proteins are required at most sites for efficient C to U RNA editing catalyzed by the RNA editosome. MORF proteins harbor a conserved stretch of residues (MORF-box), form homo-and heteromers and interact with selected PPR (pentatricopeptide repeat) proteins, which recognize each editing site. The molecular function of the MORF-box remains elusive since it shares no sequence similarity with known domains. We determined structures of the A. thaliana mitochondrial MORF1 and chloroplast MORF9 MORF-boxes which both adopt a novel globular fold (MORF domain). Our structures state a paradigmatic model for MORF domains and their specific dimerization via a hydrophobic interface. We cross-validate the interface by yeast two-hybrid studies and pulldown assays employing structure-based mutants. We find a structural similarity of the MORF domain to an N-terminal ferredoxin-like domain (NFLD), which confers RNA substrate positioning in bacterial 4-thiouracil tRNA synthetases, implying direct RNA contacts of MORF proteins during RNA editing. With the MORF1 and MORF9 structures we elucidate a yet unknown fold, corroborate MORF interaction studies, validate the mechanism of MORF multimerization by structure-based mutants and pave the way towards a complete structural characterization of the plant RNA editosome.	[Haag, Sascha; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, Mol Bot, D-89069 Ulm, Germany; [Schindler, Magdalena; Weber, Gert] Free Univ Berlin, Inst Chem & Biochem, Strukt Biochem, Takustr 6, D-14195 Berlin, Germany; [Berndt, Leona; Weber, Gert] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Mol Strukt Biol, Felix Hausdorff Str 4, D-17487 Greifswald, Germany	Takenaka, M (reprint author), Univ Ulm, Mol Bot, D-89069 Ulm, Germany.; Weber, G (reprint author), Free Univ Berlin, Inst Chem & Biochem, Strukt Biochem, Takustr 6, D-14195 Berlin, Germany.; Weber, G (reprint author), Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Mol Strukt Biol, Felix Hausdorff Str 4, D-17487 Greifswald, Germany.	mizuki.takenaka@uni-ulm.de; gweber@posteo.de	Weber, Gert/I-1800-2013		Deutsche Forschungsgemeinschaft [TA642/10-1, TA 642/6-1, TA 642/3-1, BR726/11-2]; Heisenberg fellowship from Deutsche Forschungsgemeinschaft [TA642/4-2]; Ulm University; Greifswald University	Deutsche Forschungsgemeinschaft [TA642/10-1, TA 642/6-1, TA 642/3-1 to M.T.; BR726/11-2 to A.B.]; Heisenberg fellowship from Deutsche Forschungsgemeinschaft [TA642/4-2 to M.T.]. Funding for open access charge: Ulm University and Greifswald University budget.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P215, DOI 10.1016/S0968-0004(01)01826-6                                                   ; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Braun P, 2012, PROTEOMICS, V12, P1499, DOI 10.1002/pmic.201100598; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Dehouck Y, 2003, J MOL BIOL, V330, P1215, DOI 10.1016/S0022-2836(03)00614-4; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAVRE A, 1971, J MOL BIOL, V58, P367, DOI 10.1016/0022-2836(71)90252-X                                                    ; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Glass F, 2015, MOL PLANT, V8, P1466, DOI 10.1016/j.molp.2015.05.008; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Neumann P, 2014, NUCLEIC ACIDS RES, V42, P6673, DOI 10.1093/nar/gku249; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaxco KW, 2009, CURR BIOL, V19, pR25, DOI 10.1016/j.cub.2008.11.004; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2014, MOL PLANT, V7, P582, DOI 10.1093/mp/sst170; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Vermel M, 2002, P NATL ACAD SCI USA, V99, P5866, DOI 10.1073/pnas.092019599; Vonrhein C, 2007, METHOD MOL BIOL, V364, P215, DOI DOI 10.1385/1-59745-266-1:215; Waterman DG, 2006, J MOL BIOL, V356, P97, DOI 10.1016/j.jmb.2005.11.013; Zehrmann A, 2015, J BIOL CHEM, V290, P6445, DOI 10.1074/jbc.M114.602086; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535	47	1	1	6	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 5	2017	45	8					4915	4928		10.1093/nar/gkx099				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ET8UO	WOS:000400578600058	28201607	gold			2018-01-05	
J	Craske, MG; Stein, MB; Eley, TC; Milad, MR; Holmes, A; Rapee, RM; Wittchen, HU				Craske, Michelle G.; Stein, Murray B.; Eley, Thalia C.; Milad, Mohammed R.; Holmes, Andrew; Rapee, Ronald M.; Wittchen, Hans-Ulrich			Anxiety disorders	NATURE REVIEWS DISEASE PRIMERS			English	Article							COGNITIVE-BEHAVIORAL THERAPY; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; MENTAL-HEALTH SURVEY; CHILDHOOD EMOTIONAL MALTREATMENT; GENE-ENVIRONMENT INTERACTIONS; CLINICAL-PRACTICE GUIDELINES; NATIONAL COMORBIDITY SURVEY; RESEARCH DOMAIN CRITERIA; PRESCHOOL-AGED CHILDREN	Anxiety disorders constitute the largest group of mental disorders in most western societies and are a leading cause of disability. The essential features of anxiety disorders are excessive and enduring fear, anxiety or avoidance of perceived threats, and can also include panic attacks. Although the neurobiology of individual anxiety disorders is largely unknown, some generalizations have been identified for most disorders, such as alterations in the limbic system, dysfunction of the hypothalamic-pituitary-adrenal axis and genetic factors. In addition, general risk factors for anxiety disorders include female sex and a family history of anxiety, although disorder-specific risk factors have also been identified. The diagnostic criteria for anxiety disorders varies for the individual disorders, but are generally similar across the two most common classification systems: the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and the International Classification of Diseases, Tenth Edition (ICD-10). Despite their public health significance, the vast majority of anxiety disorders remain undetected and untreated by health care systems, even in economically advanced countries. If untreated, these disorders are usually chronic with waxing and waning symptoms. Impairments associated with anxiety disorders range from limitations in role functioning to severe disabilities, such as the patient being unable to leave their home.	[Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychol, 405 Hilgard Ave, Los Angeles, CA 90095 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Eley, Thalia C.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Milad, Mohammed R.] Harvard Univ, Dept Psychiat, Harvard Med Sch, Boston, MA 02115 USA; [Milad, Mohammed R.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, Rockville, MD 20852 USA; [Rapee, Ronald M.] Macquarie Univ, Dept Psychol, Ctr Emot Hlth, Sydney, NSW, Australia; [Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Fac Sci, Dresden, Germany	Craske, MG (reprint author), Univ Calif Los Angeles, Dept Psychol, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	craske@psych.ucla.edu	Wittchen, Hans-Ulrich/A-8507-2014	Rapee, Ronald/0000-0002-1724-1076			Afifi TO, 2012, PEDIATRICS, V130, P184, DOI 10.1542/peds.2011-2947; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Arloth J, 2015, NEURON, V86, P1189, DOI 10.1016/j.neuron.2015.05.034; Baldwin DS, 2014, J PSYCHOPHARMACOL, V28, P403, DOI 10.1177/0269881114525674; Bale TL, 2017, NEUROPSYCHOPHARMACOL, V42, P386, DOI 10.1038/npp.2016.215; Bale TL, 2014, DIALOGUES CLIN NEURO, V16, P297; Bandelow B, 2016, WORLD J BIOL PSYCHIA, V17, P321, DOI 10.1080/15622975.2016.1181783; Bandelow B, 2015, EUR ARCH PSY CLIN N, V265, P363, DOI 10.1007/s00406-014-0563-z; Batelaan NM, 2014, J CLIN PSYCHIAT, V75, P985, DOI 10.4088/JCP.13m08837; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903                                                       ; Beesdo K, 2010, ARCH GEN PSYCHIAT, V67, P47, DOI 10.1001/archgenpsychiatry.2009.177; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bittner A, 2004, J CLIN PSYCHIAT, V65, P618; Bogels SM, 2013, CLIN PSYCHOL REV, V33, P663, DOI 10.1016/j.cpr.2013.03.006; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Campbell-Sills L, 2009, J AFFECT DISORDERS, V112, P92, DOI 10.1016/j.jad.2008.03.014; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Chattarji S, 2015, NAT NEUROSCI, V18, P1364, DOI 10.1038/nn.4115; Christensen H, 2014, CURR OPIN PSYCHIATR, V27, P7, DOI 10.1097/YCO.0000000000000019; Christopher P., 2016, LANCET, V388, P1659; Coleman JRI, 2016, BRIT J PSYCHIAT, V209, P236, DOI 10.1192/bjp.bp.115.168229; Cover KK, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.67; Craske M. G., 2010, COGNITIVE BEHAV THER; Craske MG, 2006, BEHAV THER, V37, P112, DOI 10.1016/j.beth.2005.05.003; Craske MG, 2016, LANCET, V388, P3048, DOI 10.1016/S0140-6736(16)30381-6; Craske MG, 2014, BEHAV RES THER, V58, P10, DOI 10.1016/j.brat.2014.04.006; Craske MG, 2011, ARCH GEN PSYCHIAT, V68, P378, DOI 10.1001/archgenpsychiatry.2011.25; Cremers HR, 2015, PSYCHOL MED, V45, P1521, DOI 10.1017/S0033291714002657; Cristea IA, 2015, BRIT J PSYCHIAT, V206, P7, DOI 10.1192/bjp.bp.114.146761; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cuijpers P, 2016, WORLD PSYCHIATRY, V15, P245, DOI 10.1002/wps.20346; Cuijpers P, 2016, AM J PSYCHIAT, V173, P680, DOI 10.1176/appi.ajp.2015.15091141; Cuijpers P, 2014, WORLD PSYCHIATRY, V13, P56, DOI 10.1002/wps.20089; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Daskalakis NP, 2016, EXP NEUROL, V284, P133, DOI 10.1016/j.expneurol.2016.07.024; Dias BG, 2015, TRENDS NEUROSCI, V38, P96, DOI 10.1016/j.tins.2014.12.003; Donovan MR, 2010, J AFFECT DISORDERS, V123, P9, DOI 10.1016/j.jad.2009.06.021; Dunsmoor JE, 2015, BIOL PSYCHIAT, V78, P336, DOI 10.1016/j.biopsych.2015.04.010; Edwards SL, 2010, J CLIN CHILD ADOLESC, V39, P400, DOI 10.1080/15374411003691701; Eley TC, 2007, J CHILD PSYCHOL PSYC, V48, P1184, DOI 10.1111/j.1469-7610.2007.01838.x; Eley TC, 2015, AM J PSYCHIAT, V172, P630, DOI 10.1176/appi.ajp.2015.14070818; Eley TC, 2010, J CHILD PSYCHOL PSYC, V51, P772, DOI 10.1111/j.1469-7610.2010.02227.x; Emmrich A, 2012, PSYCHOTHER PSYCHOSOM, V81, P161, DOI 10.1159/000335246; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Faravelli C, 2012, CURR PHARM DESIGN, V18, P5663, DOI 10.2174/138161212803530907                                                      ; Fernandes V, 2015, EUR PSYCHIAT, V30, P756, DOI 10.1016/j.eurpsy.2015.06.004; First MB, 2014, J NERV MENT DIS, V202, P841, DOI 10.1097/NMD.0000000000000210; First MJ, 2016, STRUCTURED CLIN INTE; Fisak BJ, 2011, PREV SCI, V12, P255, DOI 10.1007/s11121-011-0210-0; Fonzo GA, 2016, PSYCHOL MED, V46, P1037, DOI 10.1017/S0033291715002603; Fonzo GA, 2015, BRIT J PSYCHIAT, V206, P206, DOI 10.1192/bjp.bp.114.149880; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Garcia-Campayo J, 2015, PREV MED, V76, pS12, DOI 10.1016/j.ypmed.2014.10.015; Gardenswartz CA, 2001, BEHAV THER, V32, P725, DOI 10.1016/S0005-7894(01)80017-4; Gilmartin MR, 2014, TRENDS NEUROSCI, V37, P455, DOI 10.1016/j.tins.2014.05.004; Ginsburg GS, 2015, AM J PSYCHIAT, V172, P1207, DOI 10.1176/appi.ajp.2015.14091178; Ginsburg GS, 2014, JAMA PSYCHIAT, V71, P310, DOI 10.1001/jamapsychiatry.2013.4186; Glover EM, 2013, J PSYCHIATR NEUROSCI, V38, P341, DOI 10.1503/jpn.120129; Gommoll C, 2015, DEPRESS ANXIETY, V32, P451, DOI 10.1002/da.22365; Gray SL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i90; Greco LA, 2005, BEHAV THER, V36, P197, DOI 10.1016/S0005-7894(05)80068-1                                                   ; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Gunduz-Cinar O, 2013, MOL PSYCHIATR, V18, P813, DOI 10.1038/mp.2012.72; Hankin BL, 2004, COGNITIVE THER RES, V28, P309, DOI 10.1023/B:COTR.0000031805.60529.0d; Hardwicke TE, 2016, P NATL ACAD SCI USA, V113, P5206, DOI 10.1073/pnas.1601440113; Hariri AR, 2015, NAT NEUROSCI, V18, P1347, DOI 10.1038/nn.4111; Harris AZ, 2015, ANNU REV NEUROSCI, V38, P171, DOI 10.1146/annurev-neuro-071714-034111; Heeren A, 2015, CLIN PSYCHOL REV, V40, P76, DOI 10.1016/j.cpr.2015.06.001; Heldt E, 2011, REV BRAS PSIQUIATR, V33, P23, DOI 10.1590/S1516-44462010005000005                                                 ; Higa-McMillan CK, 2016, J CLIN CHILD ADOLESC, V45, P91, DOI 10.1080/15374416.2015.1046177; Higgins E, 2015, EDUC PSYCHOL PRACT, V31, P424, DOI 10.1080/02667363.2015.1086977; Hoagwood K, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00006                                                ; Hodes GE, 2015, NAT NEUROSCI, V18, P1386, DOI 10.1038/nn.4113; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621; Hofmann SG, 2014, J CONSULT CLIN PSYCH, V82, P375, DOI 10.1037/a0035491; Hofmann SG, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0450-3; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Holmes A, 2013, TRENDS NEUROSCI, V36, P23, DOI 10.1016/j.tins.2012.11.003; Holmes EA, 2014, NATURE, V511, P287, DOI 10.1038/511287a; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Howe AS, 2016, MOL PSYCHIATR, V21, P665, DOI 10.1038/mp.2015.138; Hudson JL, 2015, J AM ACAD CHILD PSY, V54, P454, DOI 10.1016/j.jaac.2015.03.018; Hwang MJ, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0673-9; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Inslicht SS, 2013, J PSYCHIATR RES, V47, P64, DOI 10.1016/j.jpsychires.2012.08.027; Ishikawa S, 2007, CHILD ADOLESCENT MEN, V12, P164, DOI DOI 10.1111/J.1475-3588.2006.00433.X; James G., 2013, COCHRANE DB SYST REV, V3; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Katzman MA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-S1-S1; Keefe JR, 2014, CLIN PSYCHOL REV, V34, P309, DOI 10.1016/j.cpr.2014.03.004; Keers R, 2016, PSYCHOTHER PSYCHOSOM, V85, P146, DOI 10.1159/000444023; Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524; Kendler KS, 2011, AM J PSYCHIAT, V168, P29, DOI 10.1176/appi.ajp.2010.10030340; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kendler KS, 2002, ARCH GEN PSYCHIAT, V59, P242, DOI 10.1001/archpsyc.59.3.242; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P1005, DOI 10.1001/archpsyc.58.11.1005; Kessler RC, 1999, AM J PSYCHIAT, V156, P115, DOI 10.1176/ajp.156.1.115                                                           ; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617                                                       ; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kessler RC, 2010, CURR TOP BEHAV NEURO, V2, P21, DOI 10.1007/7854_2009_9; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421                                                       ; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Kobak KA, 2013, PSYCHOTHERAPY, V50, P235, DOI 10.1037/a0030568; Kredlow MA, 2016, PSYCHOL BULL, V142, P314, DOI 10.1037/bul0000034; Kreys TJM, 2015, PHARMACOTHERAPY, V35, P175, DOI 10.1002/phar.1529; Lanius RA, 2006, J PSYCHIAT RES, V40, P709, DOI 10.1016/j.jpyschires.2005.07.007; Lau JYF, 2007, DEV PSYCHOPATHOL, V19, P1129, DOI 10.1017/S0954579407000582; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-3; LeDoux JE, 2016, AM J PSYCHIAT, V173, P1083, DOI 10.1176/appi.ajp.2016.16030353; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lewis-Fernandez R, 2010, DEPRESS ANXIETY, V27, P212, DOI 10.1002/da.20647; Lieb R, 2002, ARCH GEN PSYCHIAT, V59, P365, DOI 10.1001/archpsyc.59.4.365                                                       ; Lim L, 2015, SINGAP MED J, V56, P310, DOI 10.11622/smedj.2015088; Loerinc AG, 2015, CLIN PSYCHOL REV, V42, P72, DOI 10.1016/j.cpr.2015.08.004; Hudson J. L, 2014, WILEY HDB ANXIETY DI, P623; Maeng LY, 2015, HORM BEHAV, V76, P106, DOI 10.1016/j.yhbeh.2015.04.002; Manassis K, 2014, J CONSULT CLIN PSYCH, V82, P1163, DOI 10.1037/a0036969; Marchesi C, 2016, J AFFECT DISORDERS, V190, P543, DOI 10.1016/j.jad.2015.11.004; Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180; Haro JM, 2014, INT J METH PSYCH RES, V23, P1, DOI 10.1002/mpr.1406; Marin MF, 2016, AM J PSYCHIAT, V173, P930, DOI 10.1176/appi.ajp.2015.14111460; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P227, DOI 10.1016/j.neubiorev.2004.04.001; Mendoza-Garces L, 2011, ANAT REC, V294, P1913, DOI 10.1002/ar.21247; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Mirza SS, 2015, WORLD PSYCHIATRY, V14, P103, DOI 10.1002/wps.20192; Mohatt J, 2014, AM J PSYCHIAT, V171, P741, DOI 10.1176/appi.ajp.2014.13101337; Moylan S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-123; Muris P, 1999, PERS INDIV DIFFER, V26, P99; Murray L, 2009, PSYCHOL MED, V39, P1413, DOI 10.1017/S0033291709005157; Murrough JW, 2015, EXPERT OPIN EMERG DR, V20, P393, DOI 10.1517/14728214.2015.1049996; Myers B, 2014, FRONT NEUROENDOCRIN, V35, P180, DOI 10.1016/j.yfrne.2013.12.003; Nauta MH, 2004, BEHAV RES THER, V42, P813, DOI 10.1016/S0005-7967(03)00200-6; Olthuis J. V., 2016, COCHRANE DB SYST REV, V12; Ori R, 2015, COCHRANE DB SYST REV, V10; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Otowa T, 2014, PSYCHIAT RES, V220, P404, DOI 10.1016/j.psychres.2014.07.053; Pennant ME, 2015, BEHAV RES THER, V67, P1, DOI 10.1016/j.brat.2015.01.009; Perez-Edgar K, 2005, CHILD ADOL PSYCH CL, V14, P681, DOI 10.1016/j.chc.2005.05.008; Perna G, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0668-3; Phan K, 2014, ANN THORAC SURG, V98, P1499, DOI 10.1016/j.athoracsur.2014.05.060; Piacentini J, 2014, J AM ACAD CHILD PSY, V53, P297, DOI 10.1016/j.jaac.2013.11.010; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Rapee R. M., 2010, COOL LITTLE KIDS ANX; Rapee RM, 2013, J CHILD PSYCHOL PSYC, V54, P780, DOI 10.1111/jcpp.12048; Rapee RM, 2010, AM J PSYCHIAT, V167, P1518, DOI 10.1176/appi.ajp.2010.09111619; Rapee RM, 2009, ANNU REV CLIN PSYCHO, V5, P311, DOI 10.1146/annurev.clinpsy.032408.153628; Ravindran LN, 2010, J CLIN PSYCHIAT, V71, P839, DOI 10.4088/JCP.10r06218blu; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Robinson OJ, 2014, LANCET PSYCHIAT, V1, P294, DOI 10.1016/S2215-0366(14)70305-0; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Sadock BJ, 2017, KAPLAN SADOCKS COMPR, V1; Sanislow CA, 2010, J ABNORM PSYCHOL, V119, P631, DOI 10.1037/a0020909; Sareen J, 2013, PSYCHOL MED, V43, P73, DOI 10.1017/S003329171200102X; Schneider RL, 2015, CLIN PSYCHOL REV, V38, P39, DOI 10.1016/j.cpr.2015.02.004; Schniering CA, 2000, CLIN PSYCHOL REV, V20, P453, DOI 10.1016/S0272-7358(99)00037-9                                                   ; Scholten WD, 2013, PSYCHOTHER PSYCHOSOM, V82, P399, DOI 10.1159/000350450; Selzam S, 2017, MOL PSYCHIATR, V22, P267, DOI 10.1038/mp.2016.107; Sharpley CF, 2014, BEHAV BRAIN RES, V273, P89, DOI 10.1016/j.bbr.2014.07.030; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shimada-Sugimoto M, 2015, PSYCHIAT CLIN NEUROS, V69, P388, DOI 10.1111/pcn.12291; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shvil E, 2014, NEUROBIOL LEARN MEM, V113, P101, DOI 10.1016/j.nlm.2014.02.003; Silove D, 2015, AM J PSYCHIAT, V172, P647, DOI 10.1176/appi.ajp.2015.1409118.5; Singewald N, 2015, PHARMACOL THERAPEUT, V149, P150, DOI 10.1016/j.pharmthera.2014.12.004; Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spinhoven P, 2016, J ANXIETY DISORD, V44, P92, DOI 10.1016/j.janxdis.2016.10.011; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steenen SA, 2016, J PSYCHOPHARMACOL, V30, P128, DOI 10.1177/0269881115612236; Stein DJ, 2014, J CLIN PSYCHIAT, V75, P362, DOI 10.4088/JCP.13m08433; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251                                                       ; Stein MB, 2008, NEUROPSYCHOPHARMACOL, V33, P312, DOI 10.1038/sj.npp.1301422; Stevens JS, 2014, P NATL ACAD SCI USA, V111, P3158, DOI 10.1073/pnas.1318954111; Swartz JR, 2015, NEURON, V85, P505, DOI 10.1016/j.neuron.2014.12.055; Taillieu TL, 2016, CHILD ABUSE NEGLECT, V59, P1, DOI 10.1016/j.chiabu.2016.07.005; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Teubert D, 2011, J ANXIETY DISORD, V25, P1046, DOI 10.1016/j.janxdis.2011.07.001; Turecki G, 2016, BIOL PSYCHIAT, V79, P87, DOI 10.1016/j.biopsych.2014.11.022; Uliaszek AA, 2012, J ABNORM PSYCHOL, V121, P4, DOI 10.1037/a0025835; van Apeldoorn FJ, 2010, J CLIN PSYCHIAT, V71, P574, DOI 10.4088/JCP.08m04681blu; van de Water T, 2016, CNS SPECTRUMS, V21, P334, DOI 10.1017/S1092852916000122; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; van Ginneken N, 2013, COCHRANE DB SYST REV, V19; Vermani M, 2011, PRIM CARE COMPANION, V13, pe1, DOI DOI 10.4088/PCC.10M01013; Vollestad J, 2012, BRIT J CLIN PSYCHOL, V51, P239, DOI 10.1111/j.2044-8260.2011.02024.x; Vos SPF, 2012, PSYCHOL MED, V42, P2661, DOI 10.1017/S0033291712000876; Vrshek-Schallhorn S, 2014, PSYCHOL ASSESSMENT, V26, P730, DOI 10.1037/a0036842; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Waszczuk MA, 2014, JAMA PSYCHIAT, V71, P905, DOI 10.1001/jamapsychiatry.2014.655; Waters AM, 2016, CLIN PSYCHOL REV, V50, P50, DOI 10.1016/j.cpr.2016.09.008; Weber H, 2016, MOL PSYCHIATR, V21, P813, DOI 10.1038/mp.2015.125; Wehry AM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0591-z; White KS, 2013, J CONSULT CLIN PSYCH, V81, P47, DOI 10.1037/a0030666; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2014, INT J METH PSYCH RES, V23, P28, DOI 10.1002/mpr.1409; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24; Wittchen HU, 2000, ACTA PSYCHIAT SCAND, V102, P14, DOI 10.1111/j.0065-1591.2000.acp29[dash]03.x; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Ye XB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-313; Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011; Zhang XB, 2015, J AFFECT DISORDERS, V172, P24, DOI 10.1016/j.jad.2014.09.036; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmerman M, 2010, J CLIN PSYCHIAT, V71, P235, DOI 10.4088/JCP.08m04940blu; Zimmerman M, 2008, J CLIN PSYCHIAT, V69, P1916, DOI 10.4088/JCP.v69n1209                                                            ; Zimmermann P, 2003, PSYCHOL MED, V33, P1211, DOI 10.1017/S0033291703008158; Zorn JV, 2017, PSYCHONEUROENDOCRINO, V77, P25, DOI 10.1016/j.psyneuen.2016.11.036	225	3	3	23	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2056-676X			NAT REV DIS PRIMERS	Nat. Rev. Dis. Primers	MAY 4	2017	3								17024	10.1038/nrdp.2017.24				18	Medicine, General & Internal	General & Internal Medicine	ET8AJ	WOS:000400520300001	28470168				2018-01-05	
J	Shi, ZD; Lee, K; Yang, DP; Amin, S; Verma, N; Li, QV; Zhu, ZR; Soh, CL; Kumar, R; Evans, T; Chen, SB; Huangfu, DW				Shi, Zhong-Dong; Lee, Kihyun; Yang, Dapeng; Amin, Sadaf; Verma, Nipun; Li, Qing V.; Zhu, Zengrong; Soh, Chew-Li; Kumar, Ritu; Evans, Todd; Chen, Shuibing; Huangfu, Danwei			Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CONGENITAL HEART-DISEASE; TRANSCRIPTION FACTOR; BETA-CELLS; IN-VITRO; DEFINITIVE ENDODERM; AGENESIS; MOUSE; MUTATIONS; DIFFERENTIATION	Human disease phenotypes associated with haploinsufficient gene requirements are often not recapitulated well in animal models. Here, we have investigated the association between human GATA6 haploinsufficiency and a wide range of clinical phenotypes that include neonatal and adult-onset diabetes using CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9-mediated genome editing coupled with human pluripotent stem cell (hPSC) directed differentiation. We found that loss of one GATA6 allele specifically affects the differentiation of human pancreatic progenitors from the early PDX1+ stage to the more mature PDX1+NKX6.1+ stage, leading to impaired formation of glucose-responsive beta-like cells. In addition to this GATA6 haploinsufficiency, we also identified dosage-sensitive requirements for GATA6 and GATA4 in the formation of both definitive endoderm and pancreatic progenitor cells. Our work expands the application of hPSCs from studying the impact of individual gene loci to investigation of multigenic human traits, and it establishes an approach for identifying genetic modifiers of human disease.	[Shi, Zhong-Dong; Lee, Kihyun; Yang, Dapeng; Verma, Nipun; Li, Qing V.; Zhu, Zengrong; Soh, Chew-Li; Huangfu, Danwei] Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA; [Lee, Kihyun; Amin, Sadaf] Cornell Univ, Weill Grad Sch Med Sci, 1300 York Ave, New York, NY 10065 USA; [Verma, Nipun] Rockefeller Univ, Cornell Univ, Weill Grad Sch Med Sci, Sloan Kettering Inst,Triinst MD PhD Program, 1300 York Ave, New York, NY 10065 USA; [Li, Qing V.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10065 USA; [Kumar, Ritu; Evans, Todd; Chen, Shuibing] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA	Huangfu, DW (reprint author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.; Chen, SB (reprint author), Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA.	shc2034@med.cornell.edu; huangfud@mskcc.org		Huangfu, Danwei/0000-0002-1145-6199	New York State Stem Cell Science Program (NYSTEM) [C029567, C029156]; NIH/NIDDK [R01DK096239, DP3DK111907, DP2DK098093-01]; Tri-Institutional Stem Cell Initiative [2016-004]; MSKCC Cancer Center Support grant [P30 CA008748]; Korean Government Scholarship Program for Study Overseas; Mogam Science Scholarship Foundation; Howard Hughes Medical Institute (HHMI) Medical Research Fellowship; NYSTEM postdoctoral fellowship from the Center for Stem Cell Biology of the Sloan Kettering Institute [C026879]	We thank Drs. Licia Selleri and Wenjun Guo and members of the D.H. laboratory for insightful discussions and critical reading of the manuscript. The mouse anti-NKX6.1 and rat anti-C-Peptide antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242, USA. This study was funded in part by the New York State Stem Cell Science Program (NYSTEM) (C029567 and C029156), the NIH/NIDDK (R01DK096239, DP3DK111907 and DP2DK098093-01), the Tri-Institutional Stem Cell Initiative (#2016-004), and a MSKCC Cancer Center Support grant (P30 CA008748). K.L. was supported by the Korean Government Scholarship Program for Study Overseas and Mogam Science Scholarship Foundation. N.V. was supported by the Howard Hughes Medical Institute (HHMI) Medical Research Fellowship. Z.Z. was supported by a NYSTEM postdoctoral fellowship (C026879) from the Center for Stem Cell Biology of the Sloan Kettering Institute.	Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033; Bates DL, 2008, J MOL BIOL, V381, P1292, DOI 10.1016/j.jmb.2008.06.072; Bonnefond A, 2012, DIABETOLOGIA, V55, P2845, DOI 10.1007/s00125-012-2645-7; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bui PH, 2013, AM J MED GENET A, V161A, P1773, DOI 10.1002/ajmg.a.35974; Carrasco M, 2012, J CLIN INVEST, V122, P3504, DOI 10.1172/JCI63240; Catli G, 2013, DIABETES METAB, V39, P370, DOI 10.1016/j.diabet.2013.01.005; Chao CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118449; D'Amato E, 2010, DIABETIC MED, V27, P1195, DOI 10.1111/j.1464-5491.2010.03046.x; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dang VT, 2008, EUR J HUM GENET, V16, P1350, DOI 10.1038/ejhg.2008.111; De Franco E, 2013, DIABETES, V62, P993, DOI [10.2337/db12-0885, 10.2337/db12-0885/-/DC1]; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; Eifes S, 2013, CLIN CASE REP, V1, P86, DOI 10.1002/ccr3.33; Gong ML, 2013, HORM RES PAEDIAT, V79, P250, DOI 10.1159/000348844; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; Kang MJ, 2013, DEVELOPMENT, V140, P267, DOI 10.1242/dev.084996; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Nostro MC, 2015, STEM CELL REP, V4, P591, DOI 10.1016/j.stemcr.2015.02.017; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pan YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017536; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shaw-Smith C, 2014, DIABETES, V63, P2888, DOI 10.2337/db14-0061; Stanescu DE, 2015, PEDIATR DIABETES, V16, P67, DOI 10.1111/pedi.12111; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Suzuki S, 2014, AM J MED GENET A, V164, P476, DOI 10.1002/ajmg.a.36275; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035; Tiyaboonchai A, 2017, STEM CELL REP, V8, P589, DOI 10.1016/j.stemcr.2016.12.026; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Walker EM, 2014, DEV BIOL, V392, P283, DOI 10.1016/j.ydbio.2014.05.017; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; Wilkie AOM, 2003, J ANAT, V202, P27, DOI 10.1046/j.1469-7580.2003.00130.x; Xuan SH, 2016, DEVELOPMENT, V143, P780, DOI 10.1242/dev.127217; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Yorifuji T, 2012, J MED GENET, V49, P642, DOI 10.1136/jmedgenet-2012-101161; Yu L, 2014, J MED GENET, V51, P197, DOI 10.1136/jmedgenet-2013-101989; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhu ZR, 2016, CELL STEM CELL, V18, P755, DOI 10.1016/j.stem.2016.03.015; Zhu ZR, 2015, STEM CELL REP, V4, P1103, DOI 10.1016/j.stemcr.2015.04.016	57	4	4	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2017	20	5					675	+		10.1016/j.stem.2017.01.001				20	Cell & Tissue Engineering; Cell Biology	Cell Biology	ET8QP	WOS:000400565700016	28196600				2018-01-05	
J	Cruz-Molina, S; Respuela, P; Tebartz, C; Kolovos, P; Nikolic, M; Fueyo, R; van Ijcken, WFJ; Grosveld, F; Frommolt, P; Bazzi, H; Rada-Iglesias, A				Cruz-Molina, Sara; Respuela, Patricia; Tebartz, Christina; Kolovos, Petros; Nikolic, Milos; Fueyo, Raquel; van Ijcken, Wilfred F. J.; Grosveld, Frank; Frommolt, Peter; Bazzi, Hisham; Rada-Iglesias, Alvaro			PRC2 Facilitates the Regulatory Topology Required for Poised Enhancer Function during Pluripotent Stem Cell Differentiation	CELL STEM CELL			English	Article							CHROMOSOME CONFORMATION CAPTURE; GENERATION SEQUENCING DATA; REPRESSIVE COMPLEX 2; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; GENOME-WIDE; CHROMATIN INTERACTIONS; DEVELOPMENTAL GENES; POLYCOMB PROTEINS; NEURAL INDUCTION	Poised enhancers marked by H3K27me3 in pluripotent stem cells have been implicated in the establishment of somatic expression programs during embryonic stem cell (ESC) differentiation. However, the functional relevance and mechanism of action of poised enhancers remain unknown. Using CRISPR/Cas9 technology to engineer precise genetic deletions, we demonstrate that poised enhancers are necessary for the induction of major anterior neural regulators. Interestingly, circularized chromosome conformation capture sequencing (4C-seq) shows that poised enhancers already establish physical interactions with their target genes in ESCs in a polycomb repressive complex 2 (PRC2)-dependent manner. Loss of PRC2 does not activate poised enhancers or induce their putative target genes in undifferentiated ESCs; however, loss of PRC2 in differentiating ESCs severely and specifically compromises the induction of major anterior neural genes representing poised enhancer targets. Overall, our work illuminates an unexpected function for polycomb proteins in facilitating neural induction by endowing major anterior neural loci with a permissive regulatory topology.	[Cruz-Molina, Sara; Respuela, Patricia; Tebartz, Christina; Nikolic, Milos; Rada-Iglesias, Alvaro] Univ Cologne, CMMC, Robert Koch Str 21, D-50931 Cologne, Germany; [Nikolic, Milos; Frommolt, Peter; Bazzi, Hisham; Rada-Iglesias, Alvaro] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respos, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Kolovos, Petros; Grosveld, Frank] Erasmus MC, Dept Cell Biol, NL-3015 CN Rotterdam, Netherlands; [Fueyo, Raquel] Inst Biol Mol Barcelona, CSIC, Barcelona 08028, Spain; [van Ijcken, Wilfred F. J.] Erasmus MC, Ctr Biom, NL-3015 CN Rotterdam, Netherlands	Rada-Iglesias, A (reprint author), Univ Cologne, CMMC, Robert Koch Str 21, D-50931 Cologne, Germany.; Rada-Iglesias, A (reprint author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respos, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.	aradaigl@uni-koeln.de	Kolovos, Petros/K-1126-2017; Frommolt, Peter/L-9656-2016	Kolovos, Petros/0000-0002-0787-6158; Frommolt, Peter/0000-0002-1966-8014	CMMC; DFG [RA 2547/1-1, RA 2547/2-1, TE 1007/3-1]; UoC Advanced Researcher Group Grant; CECAD	We thank the Rada-Iglesias lab members for insightful comments and critical reading of the manuscript, Peter Nurnberg and Janine Altmuller for technical assistance with next-generation sequencing, and the Argyris Papantonis laboratory for technical assistance with 4C-seq experiments. We also thank Anton Wutz and Diego Pasini for generously providing us with the EED<SUP>-/-</SUP> and SUZ12<SUP>-/-</SUP> mESC lines and Leo Kurian and Stefan Frank for sharing with us the pX330-U6-Chimeric_BB-CBh-hSpCas9 vector. Work in the Rada-Iglesias laboratory is supported by CMMC intramural funding, the DFG (research grants RA 2547/1-1, RA 2547/2-1, and TE 1007/3-1), a UoC Advanced Researcher Group Grant, and a CECAD grant.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Attanasio C, 2014, GENOME RES, V24, P920, DOI 10.1101/gr.168930.113; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creppe C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004851; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Entrevan M, 2016, TRENDS CELL BIOL, V26, P511, DOI 10.1016/j.tcb.2016.04.009; Faust C, 1998, DEVELOPMENT, V125, P4495; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Gaspard N, 2010, CURR OPIN NEUROBIOL, V20, P37, DOI 10.1016/j.conb.2009.12.001; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Guo GJ, 2016, CELL REP, V14, P956, DOI 10.1016/j.celrep.2015.12.089; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joshi O, 2015, CELL STEM CELL, V17, P748, DOI 10.1016/j.stem.2015.11.010; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalkan T., 2014, PHILOS T R SOC LON B, V369; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondo T, 2016, TRENDS BIOCHEM SCI, V41, P9, DOI 10.1016/j.tibs.2015.11.005; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Livyatan I, 2015, CELL STEM CELL, V17, P647, DOI 10.1016/j.stem.2015.11.015; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matsuda K, 2014, GENES CELLS, V19, P374, DOI 10.1111/gtc.12136; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Morey L, 2015, CELL STEM CELL, V17, P300, DOI 10.1016/j.stem.2015.08.009; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rehimi R, 2016, CELL REP, V17, P3062, DOI 10.1016/j.celrep.2016.11.046; Respuela P, 2016, CELL STEM CELL, V18, P118, DOI 10.1016/j.stem.2015.09.010; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Sharma J, 2013, J BIOL CHEM, V288, P9482, DOI 10.1074/jbc.M112.416180; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Thongjuea S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt373; Tie F, 2016, P NATL ACAD SCI USA, V113, pE744, DOI 10.1073/pnas.1515465113; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vernimmen D, 2011, GENE DEV, V25, P1583, DOI 10.1101/gad.16985411; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wagle P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1695-x; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	81	6	6	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2017	20	5					689	+		10.1016/j.stem.2017.02.004				26	Cell & Tissue Engineering; Cell Biology	Cell Biology	ET8QP	WOS:000400565700017	28285903				2018-01-05	
J	East-Seletsky, A; O'Connell, MR; Burstein, D; Knott, GJ; Doudna, JA				East-Seletsky, Alexandra; O'Connell, Mitchell R.; Burstein, David; Knott, Gavin J.; Doudna, Jennifer A.			RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes	MOLECULAR CELL			English	Article							SYSTEMS; EVOLUTION; IMMUNITY; DEFENSE; COMPLEX; CLASSIFICATION; PROKARYOTES; MECHANISM; TOOL; DNA	CRISPR adaptive immunity pathways protect prokaryotic cells against foreign nucleic acids using CRISPR RNA (crRNA)-guided nucleases. In type VI-A CRISPR-Cas systems, the signature protein Cas13a (formerly C2c2) contains two separate ribonuclease activities that catalyze crRNA maturation and ssRNA degradation. The Cas13a protein family occurs across different bacterial phyla and varies widely in both protein sequence and corresponding crRNA sequence conservation. Although grouped phylogenetically together, we show that the Cas13a enzyme family comprises two distinct functional groups that recognize orthogonal sets of crRNAs and possess different ssRNA cleavage specificities. These functional distinctions could not be bioinformatically predicted, suggesting more subtle co-evolution of Cas13a enzymes. Additionally, we find that Cas13a pre-crRNA processing is not essential for ssRNA cleavage, although it enhances ssRNA targeting for crRNAs encoded internally within the CRISPR array. We define two Cas13a protein subfamilies that can operate in parallel for RNA detection both in bacteria and for diagnostic applications.	[East-Seletsky, Alexandra; O'Connell, Mitchell R.; Knott, Gavin J.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Burstein, David] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA	Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Burstein, David/0000-0002-6219-1880; O'Connell, Mitchell/0000-0002-8642-3973; Seletsky, Alexandra/0000-0001-6673-5817; Knott, Gavin J./0000-0002-9007-6273	National Health and Medical Research Council of Australia; Frontiers Science award from the Paul Allen Institute; National Science Foundation [MCB-1244557]	We thank the QB3 MacroLab for assistance with cloning of Cas13a constructs, Nan Ma and Kaihong Zhou for technical assistance, S.C. Knight for contributions during initial project conception, Tina Liu and Addison Wright for critical reading of the manuscript, and members of the Doudna laboratory for helpful discussions. M.R.O. is a recipient of a C.J. Martin Overseas Early Career Fellowship from the National Health and Medical Research Council of Australia. This work was supported in part by a Frontiers Science award from the Paul Allen Institute to J.A.D. and by the National Science Foundation (MCB-1244557 to J.A.D.), and J.A.D. is an Investigator of the Howard Hughes Medical Institute. J.A.D. is a co-founder of Caribou Biosciences, Inc., Editas Medicine, and Intellia Therapeutics. The authors have submitted a patent related to this work.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Nickel L, 2013, RNA BIOL, V10, P779, DOI 10.4161/rna.23928; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Semenova E, 2015, NUCLEIC ACIDS RES, V43, P6049, DOI 10.1093/nar/gkv546; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Sokolowski RD, 2014, NUCLEIC ACIDS RES, V42, P6532, DOI 10.1093/nar/gku308; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	33	8	8	31	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	MAY 4	2017	66	3					373	+		10.1016/j.molcel.2017.04.008				14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ET8QC	WOS:000400564100008	28475872				2018-01-05	
J	Jiang, Y; Qian, FH; Yang, JJ; Liu, YM; Dong, F; Xu, CM; Sun, BB; Chen, B; Xu, XS; Li, Y; Wang, RX; Yang, S				Jiang, Yu; Qian, Fenghui; Yang, Junjie; Liu, Yingmiao; Dong, Feng; Xu, Chongmao; Sun, Bingbing; Chen, Biao; Xu, Xiaoshu; Li, Yan; Wang, Renxiao; Yang, Sheng			CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum	NATURE COMMUNICATIONS			English	Article							LACTOBACILLUS-REUTERI; ACCURATE DOCKING; GENE-EXPRESSION; CAS SYSTEMS; PROTEIN; MODEL; GLIDE; REPLACEMENT; GENERATION; PARAMETERS	Corynebacterium glutamicum is an important industrial metabolite producer that is difficult to genetically engineer. Although the Streptococcus pyogenes (Sp) CRISPR-Cas9 system has been adapted for genome editing of multiple bacteria, it cannot be introduced into C. glutamicum. Here we report a Francisella novicida (Fn) CRISPR-Cpf1-based genome-editing method for C. glutamicum. CRISPR-Cpf1, combined with single-stranded DNA (ssDNA) recombineering, precisely introduces small changes into the bacterial genome at efficiencies of 86-100%. Large gene deletions and insertions are also obtained using an all-in-one plasmid consisting of FnCpf1, CRISPR RNA, and homologous arms. The two CRISPR-Cpf1-assisted systems enable N iterative rounds of genome editing in 3N+4 or 3N+2 days. A proof-of-concept, codon saturation mutagenesis at G149 of gamma-glutamyl kinase relieves L-proline inhibition using Cpf1-assisted ssDNA recombineering. Thus, CRISPR-Cpf1-based genome editing provides a highly efficient tool for genetic engineering of Corynebacterium and other bacteria that cannot utilize the Sp CRISPR-Cas9 system.	[Jiang, Yu; Qian, Fenghui; Yang, Junjie; Liu, Yingmiao; Dong, Feng; Xu, Chongmao; Sun, Bingbing; Chen, Biao; Xu, Xiaoshu; Yang, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Jiang, Yu; Qian, Fenghui; Yang, Junjie; Liu, Yingmiao; Dong, Feng; Xu, Chongmao; Sun, Bingbing; Chen, Biao; Yang, Sheng] Shanghai Res & Dev Ctr Ind Biotechnol, Shanghai 201201, Peoples R China; [Liu, Yingmiao; Yang, Sheng] Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing 200237, Jiangsu, Peoples R China; [Liu, Yingmiao] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing 211816, Jiangsu, Peoples R China; [Sun, Bingbing] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Li, Yan; Wang, Renxiao] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Yang, S (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.; Yang, S (reprint author), Shanghai Res & Dev Ctr Ind Biotechnol, Shanghai 201201, Peoples R China.; Yang, S (reprint author), Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing 200237, Jiangsu, Peoples R China.	syang@sibs.ac.cn			National basic research program of China [973: 2014CB745101]; Shanghai scientific research project [14XD1424900]	We thank Drs Xilin Zhao and Karl Drlica for critical comments on the manuscript, and Dr Liuyang Diao and Ms. Xiaoxue Chen for technical support. This work was supported in part by the National basic research program of China (973: 2014CB745101) and Shanghai scientific research project (14XD1424900).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Binder S, 2013, NUCLEIC ACIDS RES, V41, P6360, DOI 10.1093/nar/gkt312; Chen T, 2014, BIORESOURCE TECHNOL, V151, P411, DOI 10.1016/j.biortech.2013.10.017; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; DANDEKAR AM, 1988, J BACTERIOL, V170, P5943, DOI 10.1128/jb.170.12.5943-5945.1988                                                ; Eggeling L, 2015, APPL MICROBIOL BIOT, V99, P3387, DOI 10.1007/s00253-015-6508-2; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Heider SAE, 2015, BIOTECHNOL J, V10, P1170, DOI 10.1002/biot.201400590; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3128.2006; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Lee JY, 2016, J MICROBIOL BIOTECHN, V26, P807, DOI 10.4014/jmb.1601.01053; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li Q, 2016, BIOTECHNOL J, V11, P961, DOI 10.1002/biot.201600053; Ma WW, 2015, BIOTECHNOL LETT, V37, P609, DOI 10.1007/s10529-014-1718-8; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; Nakamura J, 2006, PLASMID, V56, P179, DOI 10.1016/j.plasmid.2006.05.003; Nesvera J, 1997, J BACTERIOL, V179, P1525, DOI 10.1128/jb.179.5.1525-1532.1997                                                 ; Nesvera J, 2011, APPL MICROBIOL BIOT, V90, P1641, DOI 10.1007/s00253-011-3272-9; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Okibe N, 2011, J MICROBIOL METH, V85, P155, DOI 10.1016/j.mimet.2011.02.012; Perez-Arellano I, 2006, FEBS LETT, V580, P6247, DOI 10.1016/j.febslet.2006.10.031; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHWARZER A, 1991, BIO-TECHNOL, V9, P84, DOI 10.1038/nbt0191-84; Tan YZ, 2012, PLASMID, V67, P44, DOI 10.1016/j.plasmid.2011.11.001; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI [10.4161/bioe.2104, 10.4161/bioe.21049]; Wendisch VF, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2060-1; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Nakanishi T., 1989, EP Patent, Patent No. [0,098,122B1, 0098122B1]	45	8	8	33	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 4	2017	8								15179	10.1038/ncomms15179				11	Multidisciplinary Sciences	Science & Technology - Other Topics	ET8PE	WOS:000400561100001	28469274	gold			2018-01-05	
J	Si, T; Chao, R; Min, YH; Wu, YY; Ren, W; Zhao, HM				Si, Tong; Chao, Ran; Min, Yuhao; Wu, Yuying; Ren, Wen; Zhao, Huimin			Automated multiplex genome-scale engineering in yeast	NATURE COMMUNICATIONS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; ESCHERICHIA-COLI; GENE-EXPRESSION; HUMAN-CELLS; STRATEGY; INTEGRATION; EFFICIENCY; SEQUENCE; SYSTEM; CDNA	Genome-scale engineering is indispensable in understanding and engineering microorganisms, but the current tools are mainly limited to bacterial systems. Here we report an automated platform for multiplex genome-scale engineering in Saccharomyces cerevisiae, an important eukaryotic model and widely used microbial cell factory. Standardized genetic parts encoding overexpression and knockdown mutations of 490% yeast genes are created in a single step from a full-length cDNA library. With the aid of CRISPR-Cas, these genetic parts are iteratively integrated into the repetitive genomic sequences in a modular manner using robotic automation. This system allows functional mapping and multiplex optimization on a genome scale for diverse phenotypes including cellulase expression, isobutanol production, glycerol utilization and acetic acid tolerance, and may greatly accelerate future genome-scale engineering endeavours in yeast.	[Si, Tong; Chao, Ran; Zhao, Huimin] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Si, Tong; Chao, Ran; Wu, Yuying; Ren, Wen; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Min, Yuhao; Zhao, Huimin] Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	Zhao, HM (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	zhao5@illinois.edu		Si, Tong/0000-0003-2985-9014	Roy J. Carver Charitable Trust; Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign (UIUC); Defence Advanced Research Program Agency; National Academies Keck Futures Initiative on Synthetic Biology; Carl R. Woese Institute for Genomic Biology (UIUC); 3M Corporation	This work was supported by the Roy J. Carver Charitable Trust, Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign (UIUC), Defence Advanced Research Program Agency and National Academies Keck Futures Initiative on Synthetic Biology. T.S. acknowledges postdoctoral fellowship support from Carl R. Woese Institute for Genomic Biology (UIUC). R.C. acknowledges fellowship support from 3M Corporation. We also thank Alvaro G. Hernandez and Chris L. Wright for help with NGS, Barbara Pilas for help with FACS, and Alexander Ulanov for help with GC at Roy J. Carver Biotechnology Center (UIUC). We acknowledge Christopher J. Fields, Jenny Drnevich, Ravi Kiran Donthu and Gloria Rendon at High-Performance Biological Computing Center (UIUC) for their help with computational analysis with the NGS data.	Andrews S., QUALITY CONTROL TOOL; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Bogdanova EA, 2008, MOL BIOSYST, V4, P205, DOI 10.1039/b715110c; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Chao R, 2017, ACS SYNTH BIOL, V6, P678, DOI 10.1021/acssynbio.6b00293; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DiCarlo JE, 2013, ACS SYNTH BIOL, V2, P741, DOI 10.1021/sb400117c; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898                                                          ; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464                                                              ; King BC, 2009, BIOTECHNOL BIOENG, V102, P1033, DOI 10.1002/bit.22151; Lee FWF, 1997, APPL MICROBIOL BIOT, V48, P339, DOI 10.1007/s002530051059; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Martinez-Gomez K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-46; Mira NP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-79; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3; Parekh RN, 1996, BIOTECHNOL PROGR, V12, P16, DOI 10.1021/bp9500627                                                               ; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SAKAI A, 1990, APPL MICROBIOL BIOT, V33, P302, DOI 10.1007/BF00164526; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Shi SB, 2016, METAB ENG, V33, P19, DOI 10.1016/j.ymben.2015.10.011; Shimoi H, 1998, J BACTERIOL, V180, P3381; Si T, 2015, BIOTECHNOL ADV, V33, P1420, DOI 10.1016/j.biotechadv.2014.11.007; Si T, 2015, ACS SYNTH BIOL, V4, P283, DOI 10.1021/sb500074a; Si T, 2014, METAB ENG, V22, P60, DOI 10.1016/j.ymben.2014.01.002; Smith KM, 2011, METAB ENG, V13, P674, DOI 10.1016/j.ymben.2011.08.004; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Voordeckers K, 2015, CURR OPIN MICROBIOL, V28, P1, DOI 10.1016/j.mib.2015.06.018; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Wen F, 2010, APPL ENVIRON MICROB, V76, P1251, DOI 10.1128/AEM.01687-09; Wentz AE, 2007, APPL ENVIRON MICROB, V73, P1189, DOI 10.1128/AEM.02427-06; Yazdani SS, 2007, CURR OPIN BIOTECH, V18, P213, DOI 10.1016/j.copbio.2007.05.002; Zhu YY, 2001, BIOTECHNIQUES, V30, P892; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Dundon C. A., 2013, US patent, Patent No. [13701247 A2, 13701247]	60	6	6	26	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY 4	2017	8								15187	10.1038/ncomms15187				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET8PF	WOS:000400561200001	28469255	gold			2018-01-05	
J	Cavazzana, M; Antoniani, C; Miccio, A				Cavazzana, Marina; Antoniani, Chiara; Miccio, Annarita			Gene Therapy for beta-Hemoglobinopathies	MOLECULAR THERAPY			English	Review							SICKLE-CELL-DISEASE; LOCUS-CONTROL REGION; HEMATOPOIETIC STEM-CELLS; ORPHAN NUCLEAR RECEPTORS; FETAL-HEMOGLOBIN; GLOBIN GENE; LENTIVIRAL VECTOR; THALASSEMIA MAJOR; GAMMA-GLOBIN; CD34(+) CELLS	beta-Thalassemia and sickle cell disease (SCD) are the world's two most widely disseminated hereditary hemoglobinopathies. beta-Thalassemia originated in the Mediterranean, Middle Eastern, and Asian regions, and SCD originated in central Africa. However, subsequent population migration means that these two diseases are now global and thus constitute a growing health problem in many countries. Despite remarkable improvements in medical care for patients with beta-hemoglobinopathies, there is still only one definitive treatment option: allogeneic hematopoietic stem cell (HSC) transplantation. The development of gene therapy for beta-hemoglobinopathies has been justified by (1) the limited availability of human leukocyte antigen (HLA)-identical donors, (2) the narrow window of application of HSC transplantation to the youngest patients, and (3) recent advances in HSC-based gene therapy. The huge ongoing efforts in translational medicine and the high number of related publications show that gene therapy has the potential to become the treatment of choice for patients who lack either an HLA genoidentical sibling or an alternative, medically acceptable donor. In this dynamic scientific context, we first summarize the main steps toward clinical translation of this therapeutic approach and then discuss novel lentiviraland genome editing-based treatment strategies for beta-hemoglobinopathies.	[Cavazzana, Marina] Necker Childrens Hosp, AP HP, Biotherapy Dept, F-75015 Paris, France; [Cavazzana, Marina] Grp Hosp Univ Ouest, AP HP, INSERM, Biotherapy Clin Invest Ctr, F-75015 Paris, France; [Cavazzana, Marina] INSERM, Lab Human Lymphohematopoiesis, UMR 1163, F-75015 Paris, France; [Antoniani, Chiara; Miccio, Annarita] Sorbonne Paris Cite Univ, Imagine Inst, Paris Descartes, F-75015 Paris, France; [Antoniani, Chiara; Miccio, Annarita] INSERM, Lab Chromatin & Gene Regulat, UMR 1163, F-75015 Paris, France	Miccio, A (reprint author), INSERM, Lab Chromatin & Gene Regulat, UMR 1163, F-75015 Paris, France.; Cavazzana, M (reprint author), AP HP, Dept Biotherapy, 149 Rue Sevres, F-75015 Paris, France.	m.cavazzana@aphp.fr; annarita.miccio@institutimagine.org			AFM-Telethon [17224]; European Research Council (ERC-AdG, GENEFORCURE); Agence nationale de la recherche [ANR-16-CE18-0004]	This work was supported by grants from AFM-Telethon (17224), the European Research Council (ERC 2015-AdG, GENEFORCURE), and Agence nationale de la recherche (ANR-16-CE18-0004).	ADACHI K, 1994, J BIOL CHEM, V269, P9562; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Altrock PM, 2016, AM J HEMATOL, V91, P931, DOI 10.1002/ajh.24449; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Basak A, 2015, J CLIN INVEST, V125, P2363, DOI 10.1172/JCI81163; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bernardo ME, 2012, BLOOD, V120, P473, DOI 10.1182/blood-2012-04-423822; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Boulad F, 2014, BLOOD, V123, P1483, DOI 10.1182/blood-2013-06-507178; Breda L, 2016, BLOOD, V128, P1139, DOI 10.1182/blood-2016-01-691089; Brendel C, 2016, J CLIN INVEST, V126, P3868, DOI 10.1172/JCI87885; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cavazzana M., 2016, BLOOD, V128, pSCI; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; Costa FC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003155; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597                                                          ; Filipe A, 1999, EMBO J, V18, P687, DOI 10.1093/emboj/18.3.687; Fitzhugh CD, 2009, CYTOTHERAPY, V11, P464, DOI 10.1080/14653240902849788; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; Gaziev J, 2003, CURR OPIN PEDIATR, V15, P24, DOI 10.1097/00008480-200302000-00005; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Abina Hacein-Bey, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI DOI 10.1001/JAMA.2015.3253; Hanawa H, 2004, BLOOD, V104, P2281, DOI 10.1182/blood-2004-03-0863; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Kanter J, 2016, BLOOD, V128; Karponi G, 2015, BLOOD, V126, P616, DOI 10.1182/blood-2015-03-629618; LEBOULCH P, 1994, EMBO J, V13, P3065; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Lidonnici M.R., 2016, HAEMATOLOGICA; Liu MD, 2015, NAT BIOTECHNOL, V33, P198, DOI 10.1038/nbt.3062; Madigan Catherine, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010659; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; Mansilla-Soto J, 2016, HUM GENE THER, V27, P295, DOI 10.1089/hum.2016.037; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; May C, 2002, BLOOD, V99, P1902, DOI 10.1182/blood.V99.6.1902                                                        ; Miccio A, 2008, P NATL ACAD SCI USA, V105, P10547, DOI 10.1073/pnas.0711666105; Miccio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027955; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Negre O, 2015, CURR GENE THER, V15, P64; Ngo S, 2014, BLOOD, V124; O'Neill D, 1999, P NATL ACAD SCI USA, V96, P349, DOI 10.1073/pnas.96.2.349; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806                                                         ; Perumbeti A, 2009, BLOOD, V114, P1174, DOI 10.1182/blood-2009-01-201863; POWARS DR, 1984, BLOOD, V63, P921; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Renneville A, 2015, BLOOD, V126, P1930, DOI 10.1182/blood-2015-06-649087; Ribeil JA, 2013, SCI WORLD J, V2013, DOI DOI 10.1155/2013/394295; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Romero Z, 2013, J CLIN INVEST, V123, P3317, DOI 10.1172/JCI67930; Roselli EA, 2010, EMBO MOL MED, V2, P315, DOI 10.1002/emmm.201000083; SADELAIN M, 1995, P NATL ACAD SCI USA, V92, P6728, DOI 10.1073/pnas.92.15.6728; Samakoglu S, 2006, NAT BIOTECHNOL, V24, P89, DOI 10.1038/nbt1176; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; Tanabe O, 2007, GENE DEV, V21, P2832, DOI 10.1101/gad.1593307; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Thompson AA, 2016, BLOOD, V128; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Tsang JCH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0739-5; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Walters MC, 2001, BIOL BLOOD MARROW TR, V7, P665, DOI 10.1053/bbmt.2001.v7.pm11787529                                                 ; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yannaki E, 2013, HUM GENE THER, V24, P852, DOI 10.1089/hum.2013.163; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538; Zhou WL, 2004, J BIOL CHEM, V279, P26227, DOI 10.1074/jbc.M402191200	88	5	5	10	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	MAY 3	2017	25	5					1142	1154		10.1016/j.ymthe.2017.03.024				13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	EU5OT	WOS:000401082600012	28377044				2018-01-05	
J	Yin, CR; Zhang, T; Qu, XY; Zhang, YG; Putatunda, R; Xiao, X; Li, F; Xiao, WD; Zhao, HQ; Dai, S; Qin, XB; Mo, XM; Young, WB; Khalili, K; Hu, WH				Yin, Chaoran; Zhang, Ting; Qu, Xiying; Zhang, Yonggang; Putatunda, Raj; Xiao, Xiao; Li, Fang; Xiao, Weidong; Zhao, Huaqing; Dai, Shen; Qin, Xuebin; Mo, Xianming; Young, Won-Bin; Khalili, Kamel; Hu, Wenhui			In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models	MOLECULAR THERAPY			English	Article							ADENOASSOCIATED VIRAL VECTORS; STAPHYLOCOCCUS-AUREUS CAS9; GENE EDITING TECHNOLOGIES; NEURAL PRECURSOR CELLS; CRISPR/CAS9 SYSTEM; MODULATES PROLIFERATION; CRISPR-CAS9 NUCLEASES; EFFICIENT DELIVERY; LENTIVIRAL VECTORS; PACKAGING CAPACITY	CRISPR-associated protein 9 (Cas9)-mediated genome editing provides a promising cure for HIV-1/AIDS; however, gene delivery efficiency in vivo remains an obstacle to overcome. Here, we demonstrate the feasibility and efficiency of excising the HIV-1 provirus in three different animal models using an all-in-one adeno-associated virus (AAV) vector to deliver multiplex single-guide RNAs (sgRNAs) plus Staphylococcus aureus Cas9 (saCas9). The quadruplex sgRNAs/saCas9 vector outperformed the duplex vector in excising the integrated HIV-1 genome in cultured neural stem/progenitor cells from HIV-1 Tg26 transgenic mice. Intravenously injected quadruplex sgRNAs/saCas9 AAV-DJ/8 excised HIV-1 proviral DNA and significantly reduced viral RNA expression in several organs/tissues of Tg26 mice. In EcoHIV acutely infected mice, intravenously injected quadruplex sgRNAs/saCas9 AAV-DJ/8 reduced systemic EcoHIV infection, as determined by live bioluminescence imaging. Additionally, this quadruplex vector induced efficient proviral excision, as determined by PCR genotyping in the liver, lungs, brain, and spleen. Finally, in humanized bone marrow/liver/thymus (BLT) mice with chronic HIV-1 infection, successful proviral excision was detected by PCR genotyping in the spleen, lungs, heart, colon, and brain after a single intravenous injection of quadruplex sgRNAs/saCas9 AAV-DJ/8. In conclusion, in vivo excision of HIV-1 proviral DNA by sgRNAs/saCas9 in solid tissues/organs can be achieved via AAV delivery, a significant step toward human clinical trials.	[Yin, Chaoran; Zhang, Ting; Zhang, Yonggang; Putatunda, Raj; Xiao, Xiao; Li, Fang; Dai, Shen; Qin, Xuebin; Khalili, Kamel; Hu, Wenhui] Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, Dept Neurosci, 3500 N Broad St, Philadelphia, PA 19140 USA; [Yin, Chaoran; Zhang, Ting; Zhang, Yonggang; Putatunda, Raj; Xiao, Xiao; Li, Fang; Dai, Shen; Qin, Xuebin; Khalili, Kamel; Hu, Wenhui] Temple Univ, Lewis Katz Sch Med, Comprehens NeuroAIDS Ctr, 3500 N Broad St, Philadelphia, PA 19140 USA; [Qu, Xiying; Young, Won-Bin] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15219 USA; [Xiao, Weidong] Temple Univ, Lewis Katz Sch Med, Dept Microbiol & Immunol, 3500 N Broad St, Philadelphia, PA 19140 USA; [Zhao, Huaqing] Temple Univ, Lewis Katz Sch Med, Dept Clin Sci, 3500 N Broad St, Philadelphia, PA 19140 USA; [Mo, Xianming] Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy,Lab Stem Cell Biol, Chengdu 610041, Peoples R China	Khalili, K; Hu, WH (reprint author), Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, Dept Neurosci, 3500 N Broad St, Philadelphia, PA 19140 USA.; Khalili, K; Hu, WH (reprint author), Temple Univ, Lewis Katz Sch Med, Comprehens NeuroAIDS Ctr, 3500 N Broad St, Philadelphia, PA 19140 USA.; Young, WB (reprint author), Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15219 USA.	bioimaging@mail.com; kamel.khalili@temple.edu; whu@temple.edu			NIH [R01NS087971, P30MH092177, R21MH100949, R21NS094084, 5T32MH079785]	We thank Dr. Jennifer Gordon for expertise, advice, and support of the studies with Tg26 transgenic mice, as well as Jessica Otte for assistance with Tg26 mice. This work was supported by NIH grants R01NS087971 (to W.H. and K.K.), P30MH092177 (to K.K.), and R21MH100949 and R21NS094084 (to W.-B.Y.). R.P. was supported by NIH grant 5T32MH079785. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC) (NIH grant P30MH092177) at Temple University Lewis Katz School of Medicine.	Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Balinang JM, 2017, AIDS, V31, P753, DOI 10.1097/QAD.0000000000001398; Bartel M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00204; Bauer D.E., 2015, JOVE-J VIS EXP, V95; Brady JM, 2017, IMMUNOL REV, V275, P324, DOI 10.1111/imr.12478; Cheung JY, 2015, CTS-CLIN TRANSL SCI, V8, P305, DOI 10.1111/cts.12331; Das S, 2011, NEUROCHEM INT, V59, P357, DOI 10.1016/j.neuint.2011.02.020; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5                                                    ; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Fatima M, 2016, CELL DEATH DIFFER, V23, P776, DOI 10.1038/cdd.2015.138; Fine EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10777; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fuchs SP, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.68; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Hahn YK, 2012, GLIA, V60, P1871, DOI 10.1002/glia.22403; Haque S, 2016, AM J PATHOL, V186, P347, DOI 10.1016/j.ajpath.2015.10.002; Hastie E, 2015, HUM GENE THER, V26, P257, DOI 10.1089/hum.2015.025; Holehonnur R, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-28; Howes R, 2015, METHODS MOL BIOL, V1239, P75, DOI 10.1007/978-1-4939-1862-1_5; Hu PR, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.25; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kelschenbach JL, 2012, J NEUROIMMUNE PHARM, V7, P380, DOI 10.1007/s11481-011-9316-1; Khalili K, 2015, J NEUROVIROL, V21, P310, DOI 10.1007/s13365-014-0308-9; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Manjunath N, 2013, VIRUSES-BASEL, V5, P2748, DOI 10.3390/v5112748; Mao YY, 2016, BMC BIOTECHNOL, V16; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mishra M, 2010, J NEUROVIROL, V16, P355, DOI 10.3109/13550284.2010.513028; Moser RJ, 2016, CURR GENE THER, V16, P207, DOI 10.2174/1566523216666160602213738; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rothe M, 2014, CURR GENE THER, V14, P429, DOI 10.2174/1566523214666140918110905                                               ; Rothenaigner I, 2007, AIDS, V21, P2271, DOI 10.1097/QAD.0b013e3282f12f27                                                    ; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schneider M, 2015, AIDS, V29, P1147, DOI 10.1097/QAD.0000000000000691; Schwartz L, 2007, J NEUROVIROL, V13, P274, DOI 10.1080/13550280701344975; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Song JS, 2015, J GEN VIROL, V96, P3131, DOI 10.1099/jgv.0.000245; Stone D, 2013, CURR OPIN HIV AIDS, V8, P217, DOI 10.1097/COH.0b013e32835f736c; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wu JQ, 2007, HUM GENE THER, V18, P171, DOI 10.1089/hum.2006.088; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yang YM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5564; Yin CR, 2016, AIDS, V30, P1163, DOI 10.1097/QAD.0000000000001079; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yu X, 2016, BIOTECHNOL LETT, V38, P919, DOI 10.1007/s10529-016-2064-9; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	85	10	11	17	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	MAY 3	2017	25	5					1168	1186		10.1016/j.ymthe.2017.03.012				19	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	EU5OT	WOS:000401082600015	28366764				2018-01-05	
J	Zou, Z; Huang, K; Wei, YM; Chen, HC; Liu, ZD; Jin, ML				Zou, Zhong; Huang, Kun; Wei, Yanmin; Chen, Huanchun; Liu, Ziduo; Jin, Meilin			Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection	SCIENTIFIC REPORTS			English	Article							LIVE ATTENUATED VACCINE; ONE-STEP GENERATION; CRISPR-CAS9 SYSTEM; HUMAN-CELLS; GENOME; CHICKENS; CHINA; GENE; PROTECTION; STRATEGY	Duck enteritis virus (DEV), duck tembusu virus (DTMUV), and highly pathogenic avian influenza virus (HPAIV) H5N1 are the most important viral pathogens in ducks, as they cause significant economic losses in the duck industry. Development of a novel vaccine simultaneously effective against these three viruses is the most economical method for reducing losses. In the present study, by utilizing a clustered regularly interspaced short palindromic repeats (CRISPR)/associated 9 (Cas9)-mediated gene editing strategy, we efficiently generated DEV recombinants (C-KCE-HA/PrM-E) that simultaneously encode the hemagglutinin (HA) gene of HPAIV H5N1 and pre-membrane proteins (PrM), as well as the envelope glycoprotein (E) gene of DTMUV, and its potential as a trivalent vaccine was also evaluated. Ducks immunized with C-KCE-HA/PrM-E enhanced both humoral and cell-mediated immune responses to H5N1 and DTMUV. Importantly, a single-dose of C-KCE-HA/PrM-E conferred solid protection against virulent H5N1, DTMUV, and DEV challenges. In conclusion, these results demonstrated for the first time that the CRISPR/Cas9 system can be applied for modification of the DEV genome rapidly and efficiently, and that recombinant C-KCE-HA/PrM-E can serve as a potential candidate trivalent vaccine to prevent H5N1, DTMUV, and DEV infections in ducks.	[Zou, Zhong; Huang, Kun; Wei, Yanmin; Chen, Huanchun; Liu, Ziduo; Jin, Meilin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Zou, Zhong; Huang, Kun; Wei, Yanmin; Chen, Huanchun; Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Wuhan 430070, Peoples R China; [Liu, Ziduo] Huazhong Agr Univ, Coll Life Sci, Wuhan 430070, Peoples R China; [Zou, Zhong; Wei, Yanmin; Chen, Huanchun; Jin, Meilin] Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan, Hubei, Peoples R China	Jin, ML (reprint author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.; Jin, ML (reprint author), Huazhong Agr Univ, Coll Vet Med, Wuhan 430070, Peoples R China.; Jin, ML (reprint author), Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan, Hubei, Peoples R China.	jml8328@126.com			National Key Research and Development Program of China [2016YFD0501600]	This research was supported by the National Key Research and Development Program of China (2016YFD0501600). We should like to thank Dr. Gang Cao (College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, P.R. China.) for kindly donating plasmids pX330. Special acknowledgments go to Prof. Yanxiu Liu (College of Foreign Languages, Huazhong Agricultural University, Wuhan 430070, P.R. China.) for editing the manuscript.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000                                                ; Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; Bierle CJ, 2016, J VIROL, V90, P6989, DOI 10.1128/JVI.00139-16; Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen PC, 2014, VACCINE, V32, P5271, DOI 10.1016/j.vaccine.2014.07.082; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kanda T, 2016, J VIROL, V90, P4383, DOI 10.1128/JVI.00060-16; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; Li GX, 2014, VIROLOGY, V450, P233, DOI 10.1016/j.virol.2013.12.028; Li H, 2016, ANTIVIR RES, V130, P19, DOI 10.1016/j.antiviral.2016.03.003; Li N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00581; Li YF, 2009, VIROLOGY, V391, P151, DOI 10.1016/j.virol.2009.06.018; Liang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19176; Lin CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34531; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Liu JX, 2013, ANTIVIR RES, V97, P329, DOI 10.1016/j.antiviral.2012.12.015; Liu JX, 2011, J VIROL, V85, P10989, DOI 10.1128/JVI.05420-11; Liu M, 2012, J CLIN MICROBIOL, V50, P2807, DOI 10.1128/JCM.00655-12; Liu XM, 2013, VACCINE, V31, P5953, DOI 10.1016/j.vaccine.2013.10.035; Lu XH, 1999, J VIROL, V73, P5903; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEWCOMB SS, 1968, J AM VET MED ASSOC, V153, P1897; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; Sun L, 2014, CLIN VACCINE IMMUNOL, V21, P1046, DOI 10.1128/CVI.00154-14; Sun Y, 2017, ARCH VIROL, V162, P171, DOI 10.1007/s00705-016-3077-3; Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P193, DOI 10.1111/tbed.12085; Thontiravong A, 2015, EMERG INFECT DIS, V21, P2164, DOI 10.3201/eid2112.150600; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JC, 2011, VIRUS RES, V159, P23, DOI 10.1016/j.virusres.2011.04.013; Wang XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.95; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhao W, 2014, J VIROL, V88, P8397, DOI 10.1128/JVI.01321-14; Zou Z, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01613; Zou Z, 2015, VET RES, V46, DOI 10.1186/s13567-015-0174-3; Zou Z, 2014, VIRUSES-BASEL, V6, P2428, DOI 10.3390/v6062428	51	0	0	11	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 3	2017	7								1478	10.1038/s41598-017-01554-1				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET7QN	WOS:000400492400009	28469192	gold			2018-01-05	
J	Raghuram, V; Weber, S; Raber, J; Chen, DH; Bird, TD; Maylie, J; Adelman, JP				Raghuram, Vijeta; Weber, Sydney; Raber, Jacob; Chen, Dong-Hui; Bird, Thomas D.; Maylie, James; Adelman, John P.			Assessment of mutations in KCNN2 and ZNF135 to patient neurological symptoms	NEUROREPORT			English	Article						apamin; ataxia; CRISPR-Cas system; human exome sequencing; neuroscience; SK potassium channel; transgenic mice; ZNF135	CA2+-ACTIVATED K+ CHANNELS; CONDUCTANCE	Exome sequencing from a patient with neurological and developmental symptoms revealed two mutations in separate genes. One was a homozygous transition mutation that results in an in-frame, premature translational stop codon in the ZNF135 gene predicted to encode a transcriptional repressor. Another mutation was heterozygous, a single nucleotide duplication in the KCNN2 gene that encodes a Ca2+ -activated K+ channel, SK2, and leads to a translational frame shift and a premature stop codon. Heterologous expression studies, brain slice recordings, and coordination tests from a transgenic mouse line carrying the SK2 mutation suggest that it does not contribute to the patient's symptoms. ZNF135 is expressed in human brain and it is likely that the homozygous mutation underlies the human phenotype. Copyright (C) 2017 The Author(s). Published by Wolters Kluwer Health, Inc.	[Raghuram, Vijeta; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA; [Weber, Sydney; Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Chen, Dong-Hui; Bird, Thomas D.] Univ Washington, Geriatr Res GRECC, Dept Neurol, VA Puget Sound Healthcare Syst, Seattle, WA 98195 USA	Adelman, JP (reprint author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	adelman@ohsu.edu			NIH	This work was supported by NIH grants to J.M. and J.P.A.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Liu Y, 2014, LECT NOTES COMPUT SC, V8404, P1, DOI 10.1007/978-3-642-54903-8_1; Xia XM, 1998, NATURE, V395, P503	7	0	0	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAY 3	2017	28	7					375	379		10.1097/WNR.0000000000000754				5	Neurosciences	Neurosciences & Neurology	ES2CI	WOS:000399333000002	28240725				2018-01-05	
J	Li, WT; Luo, R; He, QG; van Kuppeveld, FJM; Rottier, PJM; Bosch, BJ				Li, Wentao; Luo, Rui; He, Qigai; van Kuppeveld, Frank J. M.; Rottier, Peter J. M.; Bosch, Berend-Jan			Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry	VIRUS RESEARCH			English	Article						Porcine epidemic diarrhea virus; Aminopeptidase N; Receptor; Coronavirus; Virus cell entry	RECEPTOR-BINDING DOMAIN; HUMAN CORONAVIRUS 229E; FUNCTIONAL RECEPTOR; SIALIC-ACID; VERO CELLS; INFECTION; PROTEIN; PROPAGATION; OUTBREAK; CULTURE	Porcine epidemic diarrhea virus (PEDV) is an emerging pathogenic coronavirus that causes a significant economic burden to the swine industry. The virus infects the intestinal epithelium and causes villous atrophy, resulting in diarrhea and dehydration. Interaction of the viral spike (S) surface glycoprotein - through its Si subunit - with the host cell receptor is the first step in infection and the main determinant for virus tropism. As for several other alphacoronaviruses including the porcine transmissible gastroenteritis virus (TGEV) and the human coronavirus 229E (HCoV-229E), the aminopeptidase N (APN) protein was reported to be a functional receptor for PEDV. In this study we examined the role of APN as a receptor. We show that overexpression of porcine APN renders MDCK cells susceptible to TGEV, but not to PEDV. Consistently, unlike TGEV-S1, PEDV-S1 exhibited no binding to cell-surface expressed APN or to a soluble version of APN. Moreover, preincubation of these viruses with soluble APN or pretreatment of APN expressing ST cells with soluble TGEV-S1 blocked TGEV infection, but had no effect on infection by PEDV. The combined observations indicated that APN is not required for PEDV infection. To definitively prove this conclusion, we applied CRISPR/Cas9 genome engineering to knock out APN expression in PEDV-susceptible porcine (ST) and human cell lines (Huh7 and HeLa). As a consequence these cells no longer bound TGEV-S1 and HCoV-229E-S1 at their surface and were resistant to infection by the corresponding viruses. However, genetic ablation of APN expression had no effect on their infectability by PEDV, demonstrating that APN is not essential for PEDV cell entry.	[Li, Wentao; van Kuppeveld, Frank J. M.; Rottier, Peter J. M.; Bosch, Berend-Jan] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands; [Luo, Rui; He, Qigai] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China	Bosch, BJ (reprint author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands.	b.j.bosch@uu.nl			Natural Science Foundation of China [31272572]	We thank Bas Kolpa and Gilbert van Hagen from the veterinary practice De Oosthof for their help in acquiring the Dutch PEDV-UU isolate and Dr. Qigai He for the PEDV-GDU and PEDV-FJ9 isolate. This study was supported by a grant from the Natural Science Foundation of China (31272572) provided to Qigai He.	Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; CHASEY D, 1978, RES VET SCI, V25, P255; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Cima Greg, 2013, J Am Vet Med Assoc, V243, P30; Cong YY, 2015, VIROLOGY, V478, P1, DOI 10.1016/j.virol.2015.01.020; DEBOUCK P, 1980, AM J VET RES, V41, P219; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0                                                                ; Deng F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030055; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Guo DH, 2014, DNA CELL BIOL, V33, P20, DOI 10.1089/dna.2013.2193; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huan CC, 2015, ARCH VIROL, V160, P1621, DOI 10.1007/s00705-015-2408-0; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Khatri M, 2015, EMERG INFECT DIS, V21, P549, DOI 10.3201/eid2103.141658; KUSANAGI K, 1992, J VET MED SCI, V54, P313, DOI 10.1292/jvms.54.313                                                             ; Langereis MA, 2015, J VIROL, V89, P11169, DOI 10.1128/JVI.01781-15; Li BX, 2007, VIROLOGY, V365, P166, DOI 10.1016/j.virol.2007.03.031; Li B.X., 2009, BING DU XUE BAO, V25, P220; Li CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069997; Li WT, 2016, VIRUS RES, V226, P117, DOI 10.1016/j.virusres.2016.05.031; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; Ma RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110647; Meng FD, 2014, VIROLOGY, V456, P20, DOI 10.1016/j.virol.2014.01.010; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Nam E, 2010, VET MICROBIOL, V144, P41, DOI 10.1016/j.vetmic.2009.12.024; Oh Jin Sik, 2003, J Vet Sci, V4, P269; Park JE, 2015, VIRUS RES, V197, P108, DOI 10.1016/j.virusres.2014.12.024; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Truong QL, 2013, J VET MED SCI, V75, P1647, DOI 10.1292/jvms.12-0568; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; SCHULTZE B, 1991, J VIROL, V65, P6232; Shirato K, 2016, J GEN VIROL, V97, P2528, DOI 10.1099/jgv.0.000563; Shirato K, 2011, J VIROL, V85, P7872, DOI 10.1128/JVI.00464-11; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Tang BSF, 2005, J VIROL, V79, P6180, DOI 10.1128/JVI.79.10.6180-6193.2005; Tresnan DB, 1996, J VIROL, V70, P8669; TURGEON DC, 1980, CAN VET J, V21, P100; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; Wicht O, 2014, J VIROL, V88, P7952, DOI 10.1128/JVI.00297-14; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Xu L, 2016, VIROL SIN, V31, P69, DOI 10.1007/s12250-016-3727-3; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zeng SL, 2015, PROTEOMICS, V15, P1819, DOI 10.1002/pmic.201400458	49	2	2	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1702	1872-7492		VIRUS RES	Virus Res.	MAY 2	2017	235				SI		6	13		10.1016/j.virusres.2017.03.018				8	Virology	Virology	EZ9MP	WOS:000405054800002	28363778				2018-01-05	
J	Nordin, F; Ahmad, RNR; Farzaneh, F				Nordin, Fazlina; Ahmad, Raja Norazireen Raja; Farzaneh, Farzin			Transactivator protein: An alternative for delivery of recombinant proteins for safer reprogramming of induced Pluripotent Stem Cell	VIRUS RESEARCH			English	Review						TAT protein; iPSC; Reprogramming somatic cell; Protein transduction	HIV-1 TAT PROTEIN; INSULIN-PRODUCING CELLS; ARGININE-RICH PEPTIDES; HUMAN SOMATIC-CELLS; MAMMALIAN-CELLS; IN-VIVO; DEFINED FACTORS; FUSION PROTEIN; BASIC DOMAIN; TRANSDUCTION TECHNOLOGY	Induced pluripotent stem cells (iPSC) are somatic cells reprogrammed to pluripotency by forced expression of pluripotency factors. These cells are shown to have the same pluripotent potential as embryonic stem cells (ESC) and considered as an alternative to the much controversial usage of ESC which involved human embryos. However, the traditional method in reprogramming cells into iPSC using genome-integrating retro- or lentiviruses remains an obstacle for its application in clinical setting. Although numerous studies have been conducted for a safer DNA-based reprogramming, reprogramming of iPSC by genetic modifications may raise the possibility of malignant transformation and has been a major limitation for its usage in clinical applications. Therefore, there is a need for an alternative method to reprogram the cells without the use of gene editing and a much safer way to deliver transcription factors to induce pluripotency on target cells. Using protein transduction approach, a number of studies have demonstrated the generation of human iPSCs from human fibroblasts and mouse embryonic fibroblasts by direct delivery of reprogramming proteins. In this review, the definition and mechanism of HIV-TAT protein (a type of protein transduction domain) in delivering recombinant proteins, including the potential of protein-based delivery to induce iPSC were further discussed.	[Nordin, Fazlina; Ahmad, Raja Norazireen Raja] UKMMC, CTC, 12th Floor,Clin Block, Kuala Lumpur 56000, Wilayah Perseku, Malaysia; [Farzaneh, Farzin] Kings Coll London, Dept Mol Med, Immunol Grp, London, England	Nordin, F (reprint author), UKMMC, CTC, 12th Floor,Clin Block, Kuala Lumpur 56000, Wilayah Perseku, Malaysia.	nordinf@ppukm.ukm.edu.my					Aksoy I, 2013, STEM CELLS, V31, P2632, DOI 10.1002/stem.1522; Barka T, 2000, J HISTOCHEM CYTOCHEM, V48, P1453, DOI 10.1177/002215540004801102                                                      ; Barka T, 1996, HUM GENE THER, V7, P613, DOI 10.1089/hum.1996.7.5-613                                                        ; Beerens A. M. J., 2003, Current Gene Therapy, V3, P486, DOI 10.2174/1566523034578258; Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; BONIFACI N, 1995, AIDS, V9, P995, DOI 10.1097/00002030-199509000-00003; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Bru T, 2008, EXP CELL RES, V314, P2634, DOI 10.1016/j.yexcr.2008.05,009; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Dai Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109856; Denault JB, 1996, FEBS LETT, V379, P113, DOI 10.1016/0014-5793(95)01487-X; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Flinterman M, 2009, MOL THER, V17, P334, DOI 10.1038/mt.2008.256; Ford KG, 2001, GENE THER, V8, P1, DOI 10.1038/sj.gt.3301383; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200                                                          ; Goh P. A., 2013, PLOS ONE, V26; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Harreither E., 2014, CELL REGEN LOND, V31, P2; Hartley JL, 2012, METHODS MOL BIOL, V801, P1, DOI 10.1007/978-1-61779-352-3_1; Hidema S, 2012, J BIOSCI BIOENG, V113, P5, DOI 10.1016/j.jbiosc.2011.08.025; Ho A, 2001, CANCER RES, V61, P474; Hu QR, 2014, STEM CELL TRANSL MED, V3, P1526, DOI 10.5966/sctm.2014-0038; HUANGFU D, 2008, P NATL ACAD SCI USA, V26, P795, DOI [10.1038/ nbt1418., DOI 10.1038/NBT1418]; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kaitsuka T, 2014, STEM CELL TRANSL MED, V3, P114, DOI 10.5966/sctm.2013-0075; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Kwon HY, 2000, FEBS LETT, V485, P163, DOI 10.1016/S0014-5793(00)02215-8; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li QQ, 2008, METHOD CELL BIOL, V90, P287, DOI 10.1016/S0091-679X(08)00814-5; Li SP, 2017, STEM CELL TRANSL MED, V6, P340, DOI 10.5966/sctm.2015-0390; Li W, 2009, TRENDS PHARMACOL SCI, V31, P36; Li XH, 2015, STEM CELL TRANSL MED, V4, P1415, DOI 10.5966/sctm.2015-0136; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lord JM, 1998, J CELL BIOL, V140, P733; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; MANN DA, 1991, EMBO J, V10, P1733; Mi ZB, 2000, MOL THER, V2, P339, DOI 10.1006/mthe.2000.0137; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nemes C, 2014, TISSUE ENG PART C-ME, V20, P383, DOI [10.1089/ten.TEC.2013.0026, 10.1089/ten.tec.2013.0026]; Noguchi H, 2006, ACTA MED OKAYAMA, V60, P1; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Noguchi H, 2006, J HEPATO-BILIARY-PAN, V13, P306, DOI 10.1007/s00534-005-1038-4; Nordin F, 2014, J CELL SCI THER, V5, P158; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ostensen CG, 2002, BIOCHEM BIOPH RES CO, V291, P945, DOI 10.1006/bbrc.2002.6536; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prakash O, 2000, J NATL CANCER I, V92, P721, DOI 10.1093/jnci/92.9.721; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2                                                   ; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.E05-06-0572; Their M., 2012, STEM CELLS INT; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Thier M, 2010, INT J DEV BIOL, V54, P1713, DOI 10.1387/ijdb.103193mt; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010                                                        ; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289                                                        ; Wang Y, 2011, STEM CELL REV REP, V7, P331, DOI 10.1007/s12015-010-9209-3; L Warren, 2010, J IMMUNOTHER, V7, P618, DOI DOI 10.1016/J.STEM.2010.08.012; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xu C, 2009, BIOCHEM BIOPH RES CO, V379, P771, DOI 10.1016/j.bbrc.2008.12.125; Xu HM, 2013, CELL TRANSPLANT, V22, P147, DOI 10.3727/096368912X653057; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Zhang H, 2012, BIOMATERIALS, V33, P5047, DOI 10.1016/j.biomaterials.2012.03.061; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	93	1	1	4	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1702	1872-7492		VIRUS RES	Virus Res.	MAY 2	2017	235				SI		106	114		10.1016/j.virusres.2017.04.007				9	Virology	Virology	EZ9MP	WOS:000405054800015	28408207				2018-01-05	
J	Hinze, SJ; Jackson, MR; Lie, S; Jolly, L; Field, M; Barry, SC; Harvey, RJ; Shoubridge, C				Hinze, S. J.; Jackson, M. R.; Lie, S.; Jolly, L.; Field, M.; Barry, S. C.; Harvey, R. J.; Shoubridge, C.			Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis	TRANSLATIONAL PSYCHIATRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; LINKED MENTAL-RETARDATION; NEURODEVELOPMENTAL DISORDERS; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; MOLECULAR DIAGNOSIS; RHO GTPASES; MUTATIONS; PROTEIN	There is considerable genetic and phenotypic heterogeneity associated with intellectual disability (ID), specific learning disabilities, attention-deficit hyperactivity disorder, autism and epilepsy. The intelligence quotient (IQ) motif and SEC7 domain containing protein 2 gene (IQSEC2) is located on the X-chromosome and harbors mutations that contribute to non-syndromic ID with and without early-onset seizure phenotypes in both sexes. Although IQ and Sec7 domain mutations lead to partial loss of IQSEC2 enzymatic activity, the in vivo pathogenesis resulting from these mutations is not known. Here we reveal that IQSEC2 has a key role in dendritic spine morphology. Partial loss-of-function mutations were modeled using a lentiviral short hairpin RNA (shRNA) approach, which achieved a 57% knockdown of Iqsec2 expression in primary hippocampal cell cultures from mice. Investigating gross morphological parameters after 8 days of in vitro culture (8DIV) identified a 32% reduction in primary axon length, in contrast to a 27% and 31% increase in the number and complexity of dendrites protruding from the cell body, respectively. This increase in dendritic complexity and spread was carried through dendritic spine development, with a 34% increase in the number of protrusions per dendritic segment compared with controls at 15DIV. Although the number of dendritic spines had normalized by 21DIV, a reduction was noted in the number of immature spines. In contrast, when modeling increased dosage, overexpression of wild-type IQSEC2 led to neurons with shorter axons that were more compact and displayed simpler dendritic branching. Disturbances to dendritic morphology due to knockdown of Iqsec2 were recapitulated in neurons from Iqsec2 knockout mice generated in our laboratory using CRISPR/Cas9 technology. These observations provide evidence of dosage sensitivity for IQSEC2, which normally escapes X-inactivation in females, and links these disturbances in expression to alterations in the morphology of developing neurons.	[Hinze, S. J.; Jackson, M. R.; Lie, S.; Jolly, L.; Shoubridge, C.] Univ Adelaide, Adelaide Sch Med, Dept Paediat, Adelaide, SA, Australia; [Hinze, S. J.; Jackson, M. R.; Jolly, L.; Barry, S. C.; Shoubridge, C.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Field, M.] Genet Learning Disabil Serv, Waratah, NSW, Australia; [Harvey, R. J.] UCL Sch Pharm, Dept Pharmacol, London, England; Univ Adelaide, Robinson Res Inst, Sch Med, Intellectual Disabil Res,Discipline Paediat,Fac H, Adelaide, SA 5005, Australia	Shoubridge, C (reprint author), Univ Adelaide, Robinson Res Inst, Sch Med, Intellectual Disabil Res,Discipline Paediat,Fac H, Adelaide, SA 5005, Australia.	cheryl.shoubridge@adelaide.edu.au		Shoubridge, Cheryl/0000-0002-0157-3084	Australian National Health and Medical Research Council (NHMRC) [1006586]; Channel 7 Children's Research Foundation [161263]; Australian Research Council [FT120100086]	The full-length IQSEC2 cDNA in pCAGGS were a kind gift from Dr Randall Walikonis (University of Connecticut, USA). The Intellectual Disability research program in the Department of Paediatrics, University of Adelaide, Australia was funded by the Australian National Health and Medical Research Council (NHMRC) (Grant No. 1006586), and the Channel 7 Children's Research Foundation (Grant No. 161263). CS is supported by the Australian Research Council (Future Fellowship FT120100086).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Allou L, 2017, CLIN GENET, V91, P431, DOI 10.1111/cge.12784; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Brown JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11080; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4185-05.2006; Epi K.C.E.e., 2016, AM J HUM GENET, V99, P287; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Gandomi SK, 2014, J GENET COUNS, V23, P289, DOI 10.1007/s10897-013-9671-6; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grillo FW, 2013, P NATL ACAD SCI USA, V110, pE1514, DOI 10.1073/pnas.1218731110; Helbig KL, 2016, GENET MED, V18, P898, DOI 10.1038/gim.2015.186; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kalscheuer Vera M, 2015, Front Mol Neurosci, V8, P85, DOI 10.3389/fnmol.2015.00085; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002                                                                   ; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lebel RR, 2002, CLIN GENET, V61, P139, DOI 10.1034/j.1399-0004.2002.610209.x                                               ; Meredith RM, 2012, TRENDS NEUROSCI, V35, P335, DOI 10.1016/j.tins.2012.03.005; Moey C, 2016, EUR J HUM GENET, V24, P373, DOI 10.1038/ejhg.2015.123; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Olson HE, 2015, AM J MED GENET A, V167, P2017, DOI 10.1002/ajmg.a.37132; PAPA M, 1995, J NEUROSCI, V15, P1; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Sanda M, 2009, BRAIN RES, V1251, P7, DOI 10.1016/j.brainres.2008.11.061; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; Shoubridge C, 2007, GENOMICS, V90, P59, DOI 10.1016/j.ygeno.2007.03.005; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Tzschach A, 2015, EUR J HUM GENET, V23, P1513, DOI 10.1038/ejhg.2015.5; Um JW, 2017, NEUROSCI RES, V116, P54, DOI 10.1016/j.neures.2016.06.007; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Zerem A, 2016, EPILEPSIA, V57, P1858, DOI 10.1111/epi.13560	39	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	MAY 2	2017	7								e1110	10.1038/tp.2017.81				11	Psychiatry	Psychiatry	EW2MU	WOS:000402331500001	28463240	gold			2018-01-05	
J	Al-Jaff, M; Sandstrom, E; Grabherr, M				Al-Jaff, Mohammed; Sandstrom, Eric; Grabherr, Manfred			microTaboo: a general and practical solution to the k-disjoint problem	BMC BIOINFORMATICS			English	Article						k-disjoint problem; Software; Sequence mining	COMPLETE GENOME SEQUENCE; ALGORITHMS; K-12; DNA	Background: A common challenge in bioinformatics is to identify short sub-sequences that are unique in a set of genomes or reference sequences, which can efficiently be achieved by k-mer (k consecutive nucleotides) counting. However, there are several areas that would benefit from a more stringent definition of "unique", requiring that these sub-sequences of length W differ by more than k mismatches (i.e. a Hamming distance greater than k) from any other sub-sequence, which we term the k-disjoint problem. Examples include finding sequences unique to a pathogen for probe-based infection diagnostics; reducing off-target hits for re-sequencing or genome editing; detecting sequence (e.g. phage or viral) insertions; and multiple substitution mutations. Since both sensitivity and specificity are critical, an exhaustive, yet efficient solution is desirable. Results: We present microTaboo, a method that allows for efficient and extensive sequence mining of unique (k-disjoint) sequences of up to 100 nucleotides in length. On a number of simulated and real data sets ranging from microbe-to mammalian-size genomes, we show that microTaboo is able to efficiently find all sub-sequences of a specified length W that do not occur within a threshold of k mismatches in any other sub-sequence. We exemplify that microTaboo has many practical applications, including point substitution detection, sequence insertion detection, padlock probe target search, and candidate CRISPR target mining. Conclusions: microTaboo implements a solution to the k-disjoint problem in an alignment-and assembly free manner. microTaboo is available for Windows, Mac OS X, and Linux, running Java 7 and higher, under the GNU GPLv3 license, at:https://MohammedAlJaff.github.io/microTaboo	[Al-Jaff, Mohammed; Sandstrom, Eric; Grabherr, Manfred] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Grabherr, Manfred] Uppsala Univ, Bioinformat Infrastruct Life Sci, S-75123 Uppsala, Sweden	Grabherr, M (reprint author), Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden.; Grabherr, M (reprint author), Uppsala Univ, Bioinformat Infrastruct Life Sci, S-75123 Uppsala, Sweden.	manfred.grabherr@imbim.uu.se		Grabherr, Manfred/0000-0001-8792-6508	Swedish Research Council Formas; Bioinformatics Infrastructure for Life Sciences (BILS); Science for Life Laboratory	This work was in part supported by the Swedish Research Council Formas, the Bioinformatics Infrastructure for Life Sciences (BILS), and the Science for Life Laboratory. No funding body played any role in the design, execution and conclusions of this study.	Andrews S, FASTQC QUALITY CONTR; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOYER RS, 1977, COMMUN ACM, V20, P762, DOI 10.1145/359842.359859; Brown JK, 2002, PHYTOPATHOLOGY, V92, P734, DOI 10.1094/PHYTO.2002.92.7.734; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gusfield D., 1997, ALGORITHMS STRINGS T; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11                                                           ; KARP RM, 1987, IBM J RES DEV, V31, P249, DOI 10.1147/rd.312.0249                                                             ; Knuth D. E., 1977, SIAM Journal on Computing, V6, P323, DOI 10.1137/0206024; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Leggett ML, 2013, FRONT GENET, V4, P288; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mattisson J., 2016, FRAMTAGNING UNIKA GE; Mielczarek M, 2016, J APPL GENET, V57, P71, DOI 10.1007/s13353-015-0292-7; Mohr SE, 2016, FEBS J, V283, P3232, DOI 10.1111/febs.13777; Pavankumar AR, 2016, ANAL CHEM, V88, P4277, DOI 10.1021/acs.analchem.5b04312; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Stothard P, 2000, BIOTECHNIQUES, V28, P1102; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WU R, 1971, J MOL BIOL, V57, P491, DOI 10.1016/0022-2836(71)90105-7; Zamani N, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-12	23	0	0	2	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	MAY 2	2017	18								228	10.1186/s12859-017-1644-6				7	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	ET9GN	WOS:000400615500001	28464826	gold			2018-01-05	
J	Liao, YF; Chen, LL; Feng, Y; Shen, J; Gao, Y; Cote, G; Choy, E; Harmon, D; Mankin, H; Hornicek, F; Duan, ZF				Liao, Yunfei; Chen, Lulu; Feng, Yong; Shen, Jacson; Gao, Yan; Cote, Gregory; Choy, Edwin; Harmon, David; Mankin, Henry; Hornicek, Francis; Duan, Zhenfeng			Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells	ONCOTARGET			English	Article						programmed cell death ligand 1; osteosarcoma; CRISPR/Cas9; metastasis	TUMOR-INFILTRATING LYMPHOCYTES; PD-L1 EXPRESSION; BREAST-CANCER; SYSTEM; IMMUNOTHERAPY; CHECKPOINT; THERAPY; STATE; TOOL	Programmed cell death ligand 1 (PD-L1) is a transmembrane protein that is expressed on tumor cells that suppresses the T cell-mediated immune response. Therapies targeting the PD-L1 pathway promote anti-tumor immunity and have shown promising results in some types of cancers. However, the functional and therapeutic roles of PD-L1 in osteosarcoma remain largely unknown. In this study, we found that PD-L1 protein was expressed in osteosarcoma cell lines and tissue microarray of patient tumors. Tissue microarray immunohistochemistry analysis showed that the overall and five-year survival rates of patients with high levels of PD-L1 expression were significantly shorter than patients with low levels. High levels of PD-L1 expression were also associated with metastasis in osteosarcoma patients. Furthermore, we applied the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system to target PD-L1 gene at the DNA level in osteosarcoma cell lines. We found that the expression of PD-L1 could be efficiently disrupted by CRISPR/Cas9 system and PD-L1 knockdown increased drug sensitivities for doxorubicin and paclitaxel. These results suggest that PD-L1 is an independent prognostic factor in osteosarcoma and that PD-L1 knockout by CRISPR/Cas9 may be a therapeutic approach for the treatment of osteosarcoma.	[Liao, Yunfei; Chen, Lulu] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan Union Hosp, Dept Endocrinol, Wuhan 430022, Peoples R China; [Liao, Yunfei; Feng, Yong; Shen, Jacson; Gao, Yan; Mankin, Henry; Hornicek, Francis; Duan, Zhenfeng] Massachusetts Gen Hosp, Dept Orthopaed Surg, Sarcoma Biol Lab, Boston, MA 02114 USA; [Liao, Yunfei; Feng, Yong; Shen, Jacson; Gao, Yan; Cote, Gregory; Choy, Edwin; Harmon, David; Mankin, Henry; Hornicek, Francis; Duan, Zhenfeng] Harvard Med Sch, Boston, MA 02114 USA; [Feng, Yong] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan Union Hosp, Dept Orthopaed Surg, Wuhan 430022, Peoples R China; [Cote, Gregory; Choy, Edwin; Harmon, David] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA	Duan, ZF (reprint author), Massachusetts Gen Hosp, Dept Orthopaed Surg, Sarcoma Biol Lab, Boston, MA 02114 USA.; Duan, ZF (reprint author), Harvard Med Sch, Boston, MA 02114 USA.	zduan@mgh.harvard.edu			Sarcoma Foundation of America (SFA); National Cancer Institute (NCI)/National Institutes of Health (NIH), UO1 [CA 151452-01]; Sarcoma SPORE/NIH; Academic Enrichment Fund of MGH Orthopaedics; Gattegno fund; Wechsler fund; Kenneth Stanton Fund	This work was supported, in part, by the Gattegno and Wechsler funds, the Kenneth Stanton Fund. Dr. Duan is supported, in part, through a grant from the Sarcoma Foundation of America (SFA), a grant from the National Cancer Institute (NCI)/National Institutes of Health (NIH), UO1, CA 151452-01, a pilot grant from Sarcoma SPORE/NIH, and a grant from an Academic Enrichment Fund of MGH Orthopaedics.	Bustamante Alvarez Jean G, 2015, [Cancer Biology and Medicine, 癌症生物学与医学], V12, P209, DOI 10.7497/j.issn.2095-3941.2015.0032; Castro NP, 2015, ONCOTARGET, V6, P11910, DOI 10.18632/oncotarget.4182                                                        ; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Duan ZF, 2008, MOL CANCER THER, V7, P2377, DOI 10.1158/1535-7163.MCT-08-0316; Feng Y, 2015, ONCOTARGET, V6, P11139, DOI 10.18632/oncotarget.3576                                                        ; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11365; Grobarczyk B, 2015, STEM CELL REV REP, V11, P774, DOI 10.1007/s12015-015-9600-1; Jo YI, 2015, BBA-REV CANCER, V1856, P234, DOI 10.1016/j.bbcan.2015.09.003; Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; LI YM, 2013, IEEE INT CONF CON AU, P21; Liao YF, 2016, J ORTHOP RES, V34, P1185, DOI 10.1002/jor.23134; Lin YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142656; Liu B, 2015, J NANOSCI NANOTECHNO, V15, P1946, DOI 10.1166/jnn.2015.9832; Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006; Meng XJ, 2015, CANCER TREAT REV, V41, P868, DOI 10.1016/j.ctrv.2015.11.001; Moore Drew D, 2014, Cancer Treat Res, V162, P65, DOI 10.1007/978-3-319-07323-1_4; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Pellagatti A, 2015, ARCH TOXICOL, V89, P1023, DOI 10.1007/s00204-015-1504-y; Qing Y, 2015, DRUG DES DEV THER, V9, P901, DOI 10.2147/DDDT.S75152; Raedler Lisa A, 2015, Am Health Drug Benefits, V8, P180; Romano E, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0059-z; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Savic N, 2015, TRANSL RES; Shen JK, 2014, CANCER IMMUNOL RES, V2, P690, DOI 10.1158/2326-6066.CIR-13-0224; Sheridan C, 2017, NAT BIOTECHNOL, V35, P3, DOI 10.1038/nbt0117-3; Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076012; Swaika A, 2015, MOL IMMUNOL, V67, P4, DOI 10.1016/j.molimm.2015.02.009; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Torres-Ruiz R, 2015, INT J MOL SCI, V16, P22151, DOI 10.3390/ijms160922151; Wimberly H, 2015, CANCER IMMUNOL RES, V3, P326, DOI 10.1158/2326-6066.CIR-14-0133; Zhang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075851; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2	35	0	0	4	7	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 2	2017	8	18					30276	30287		10.18632/oncotarget.16326				12	Oncology; Cell Biology	Oncology; Cell Biology	ET7EG	WOS:000400456200059	28415820	gold			2018-01-05	
J	Yang, L; Liu, YN; Zhang, N; Ding, XY; Zhang, W; Shen, KF; Huang, L; Zhou, JF; Cui, S; Zhu, ZM; Hu, Z; Xiao, M				Yang, Li; Liu, Ya'Nan; Zhang, Na; Ding, Xiao'Yi; Zhang, Wei; Shen, Ke'Feng; Huang, Liang; Zhou, Jian'Feng; Cui, Sen; Zhu, Zun'Min; Hu, Zheng; Xiao, Min			Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs	ONCOTARGET			English	Article						DNMT3A R882H mutation; TALENs; K562; GSH; SLC7A11	ACUTE MYELOID-LEUKEMIA; MAMMALIAN DNA METHYLTRANSFERASES; X(C)(-) CYSTINE/GLUTAMATE ANTIPORTER; CHRONIC MYELOMONOCYTIC LEUKEMIA; THERAPEUTIC TARGET; POOR-PROGNOSIS; CANCER-CELLS; GROWTH; SULFASALAZINE; INHIBITION	DNA methyltransferase 3A (DNMT3A) mutations occurred in 18%similar to 23% of acute myeloid leukemia (AML) patients, and were considered to be an adverse prognostic factor for adult de novo AML cases. However, the relevant molecular mechanism of the mutation in AML pathogenesis remains obscure. In this study, we established K562 and SKM1 cell model carrying the DNMT3A R882H mutation via transcription activator-like effector nuclease (TALEN) and Clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) technology, and discovered that mutated DNMT3A could promote the proliferative capability of malignant cell clones. Further RNA microarray analysis revealed that some genes crucial for glutathione (GSH) synthesis, including CTH, PSPH, PSAT1 and especially SLC7A11 (the cysteine/glutamate transporter) were significantly upregulated, which resulted in significant elevation of intracellular GSH levels. A subsequent experiment demonstrated that the mutant clones are resistant to chemotherapy as well as SLC7A11-inhibitors By shRNA induced SLC7A11 silencing, we discovered profoundly decreased cellular GSH and cell proliferative ability of DNMT3A mutated clones. Our results provided novel insight into the role of the DNMT3A R882H mutation in AML pathogenesis and suggested that targeting the cellular GSH synthetic pathway could enhance the current therapy for AML patients with the DNMT3A R882H mutation.	[Yang, Li; Ding, Xiao'Yi; Zhang, Wei; Shen, Ke'Feng; Huang, Liang; Zhou, Jian'Feng; Xiao, Min] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China; [Liu, Ya'Nan] Wuhan Univ, Zhongnan Hosp, Dept Hematol, Wuhan, Hubei Province, Peoples R China; [Zhang, Na] FMMU, Xijing Hosp, Dept Hematol, Xian, Shanxi Province, Peoples R China; [Hu, Zheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China; [Hu, Zheng] Sun Yat Sen 14 Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Zhou, Jian'Feng] Qinghai Univ, Xining, Qinghai Provinc, Peoples R China; [Cui, Sen] Qinghai Univ, Affiliated Hosp, Dept Hematol, Xining, Qinghai Provinc, Peoples R China; [Zhu, Zun'Min] Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Henan Province, Peoples R China	Xiao, M (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China.; Hu, Z (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China.; Hu, Z (reprint author), Sun Yat Sen 14 Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	Huzheng1998@163.com; Xiaomin@tjh.tjmu.edu.cn		Huang, Liang/0000-0002-8370-3232	National Science Foundation of China [81200382, 2012AA020801, 81025011, 81090414]	The study were supported by the grant National Science Foundation of China (No. 81200382, 2012AA020801, 81025011, 81090414).	Abdel-Wahab O, 2011, LEUKEMIA, V25, P1219, DOI 10.1038/leu.2011.82; Brandl C, 2015, FEBS OPEN BIO, V5, P26, DOI 10.1016/j.fob.2014.11.009; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814; DNA methyltransferase is essential for self-renewal, 2007, J EXP MED, V204, P715, DOI [10.1084/jem.20060750, DOI 10.1084/JEM.20060750]; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Guan J, 2009, CANCER CHEMOTH PHARM, V64, P463, DOI 10.1007/s00280-008-0894-4; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; ISHII T, 1981, J CELL PHYSIOL, V107, P283, DOI 10.1002/jcp.1041070215; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Neumann M, 2013, ONCOTARGET, V4, P954, DOI 10.18632/oncotarget.1106                                                        ; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pham AN, 2010, J PHARMACOL EXP THER, V332, P949, DOI 10.1124/jpet.109.162248; Polet F, 2016, ONCOTARGET, V7, P1765, DOI 10.18632/oncotarget.6426; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Rodriguez-Osorio N, 2010, REPROD BIOMED ONLINE, V20, P243, DOI 10.1016/j.rbmo.2009.11.006; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Thiede C, 2001, BLOOD, V98, p717A; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Traverso N, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/972913; Truett GE, 2000, BIOTECHNIQUES, V29, P52; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang L, 2014, ONCOL REP, V31, P2079, DOI 10.3892/or.2014.3067; Wu X, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.32; Xu J, 2014, P NATL ACAD SCI USA, V111, P2620, DOI 10.1073/pnas.1400150111; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	45	0	0	3	4	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 2	2017	8	18					30395	30409		10.18632/oncotarget.16449				15	Oncology; Cell Biology	Oncology; Cell Biology	ET7EG	WOS:000400456200068	28418922	gold			2018-01-05	
J	Hill, VK; Kim, JS; James, CD; Waldman, T				Hill, Victoria K.; Kim, Jung-Sik; James, C. David; Waldman, Todd			Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing	PLOS ONE			English	Article							RICTOR-MTOR COMPLEX; TUMOR-SUPPRESSOR; GERMLINE MUTATIONS; CANCER SUSCEPTIBILITY; COWDEN DISEASE; PHOSPHATASE; PHOSPHORYLATION; PTEN/MMAC1; IDENTIFICATION; SPECIFICITY	PTEN is among the most commonly mutated tumor suppressor genes in human cancer. However, studying the role of PTEN in the pathogenesis of cancer has been limited, in part, by the paucity of human cell-based isogenic systems that faithfully model PTEN loss. In an effort to remedy this problem, gene editing was used to correct an endogenous mutant allele of PTEN in two human glioblastoma multiforme (GBM) cell lines-42MGBA and T98G. PTEN correction resulted in reduced cellular proliferation that was Akt-dependent in 42MGBA cells and Akt-independent in T98G cells. This is the first report of human cancer cell lines in which mutant PTEN has been corrected by gene editing. The isogenic sets of gene edited cell lines reported here will likely prove useful for further study of PTEN mutations in the pathogenesis of cancer, and for the discovery and validation of novel therapeutics targeting the PTEN pathway.	[Hill, Victoria K.; Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [James, C. David] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA	Waldman, T (reprint author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	waldmant@georgetown.edu			NIH [R01CA115699, R01CA159467]	This study was funded by NIH grants R01CA115699 and R01CA159467. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Han SY, 2000, CANCER RES, V60, P3147; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033                                                      ; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim JS, 2011, MOL CELL BIOL, V31, P2756, DOI 10.1128/MCB.01323-10; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333                                                              ; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Mounir Z, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000389; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513                                                        ; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Perzelova A, 1998, NEOPLASMA, V45, P25; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356                                                              ; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang SI, 1997, CANCER RES, V57, P4183; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	38	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176683	10.1371/journal.pone.0176683				11	Multidisciplinary Sciences	Science & Technology - Other Topics	ET9RV	WOS:000400646300042	28464039	gold			2018-01-05	
J	Lee, K; Mackley, VA; Rao, A; Chong, AT; Dewitt, MA; Corn, JE; Murthy, N				Lee, Kunwoo; Mackley, Vanessa A.; Rao, Anirudh; Chong, Anthony T.; Dewitt, Mark A.; Corn, Jacob E.; Murthy, Niren			Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering	ELIFE			English	Article							HUMAN-CELLS; MUSCULAR-DYSTROPHY; MOUSE MODEL; IN-VIVO; GENOME; CAS9; ENDONUCLEASE; NUCLEASES; SYSTEM; DELIVERY	Chemical modification of the gRNA and donor DNA has great potential for improving the gene editing efficiency of Cas9 and Cpf1, but has not been investigated extensively. In this report, we demonstrate that the gRNAs of Cas9 and Cpf1, and donor DNA can be chemically modified at their terminal positions without losing activity. Moreover, we show that 5' fluorescently labeled donor DNA can be used as a marker to enrich HDR edited cells by a factor of two through cell sorting. In addition, we demonstrate that the gRNA and donor DNA can be directly conjugated together into one molecule, and show that this gRNA-donor DNA conjugate is three times better at transfecting cells and inducing HDR, with cationic polymers, than unconjugated gRNA and donor DNA. The tolerance of the gRNA and donor DNA to chemical modifications has the potential to enable new strategies for genome engineering.	[Lee, Kunwoo; Mackley, Vanessa A.] GenEdit Inc, Berkeley, CA 94720 USA; [Rao, Anirudh; Chong, Anthony T.; Murthy, Niren] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dewitt, Mark A.; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dewitt, Mark A.; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA	Lee, K (reprint author), GenEdit Inc, Berkeley, CA 94720 USA.; Murthy, N (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	lee@genedit.com; nmurthy@berkeley.edu		Corn, Jacob/0000-0002-7798-5309			Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Conboy MJ, 2010, METHODS MOL BIOL, V621, P149, DOI 10.1007/978-1-60761-063-2_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Guell M, 2014, BIOINFORMATICS, V30, P2968, DOI 10.1093/bioinformatics/btu427; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056476; Kim HJ, 2014, ACS NANO, V8, P8979, DOI 10.1021/nn502125h; Kim HJ, 2010, J CONTROL RELEASE, V145, P141, DOI 10.1016/j.jconrel.2010.03.019; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Lee JS, 2016, BIOTECHNOL BIOENG, V113, P2518, DOI 10.1002/bit.26002; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	37	1	1	11	16	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAY 2	2017	6								e25312	10.7554/eLife.25312				17	Biology	Life Sciences & Biomedicine - Other Topics	ET6WO	WOS:000400434000001		gold			2018-01-05	
J	Li, B; Ding, SY; Feng, NG; Mooney, N; Ooi, YS; Ren, LL; Diep, J; Kelly, MR; Yasukawa, LL; Patton, JT; Yamazaki, H; Shirao, T; Jackson, PK; Greenberg, HB				Li, Bin; Ding, Siyuan; Feng, Ningguo; Mooney, Nancie; Ooi, Yaw Shin; Ren, Lili; Diep, Jonathan; Kelly, Marcus R.; Yasukawa, Linda L.; Patton, John T.; Yamazaki, Hiroyuki; Shirao, Tomoaki; Jackson, Peter K.; Greenberg, Harry B.			Drebrin restricts rotavirus entry by inhibiting dynamin-mediated endocytosis	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						drebrin; rotavirus; endocytosis	ACTIN-BINDING; VIRUS ENTRY; PROTEIN; CELLS; INFECTION; REVEALS; PATHWAY; GLYCOPROTEIN; EXPRESSION; PARTICLES	Despite the wide administration of several effective vaccines, rotavirus (RV) remains the single most important etiological agent of severe diarrhea in infants and young children worldwide, with an annual mortality of over 200,000 people. RV attachment and internalization into target cells is mediated by its outer capsid protein VP4. To better understand the molecular details of RV entry, we performed tandem affinity purification coupled with high-resolution mass spectrometry to map the host proteins that interact with VP4. We identified an actin-binding protein, drebrin (DBN1), that coprecipitates and colocalizes with VP4 during RV infection. Importantly, blocking DBN1 function by siRNA silencing, CRISPR knockout (KO), or chemical inhibition significantly increased host cell susceptibility to RV infection. Dbn1 KO mice exhibited higher incidence of diarrhea and more viral antigen shedding in their stool samples compared with the wild-type littermates. In addition, we found that uptake of other dynamin-dependent cargos, including transferrin, cholera toxin, and multiple viruses, was also enhanced in DBN1-deficient cells. Inhibition of cortactin or dynamin-2 abrogated the increased virus entry observed in DBN1-deficient cells, suggesting that DBN1 suppresses dynamin-mediated endocytosis via interaction with cortactin. Our study unveiled an unexpected role of DBN1 in restricting the entry of RV and other viruses into host cells and more broadly to function as a crucial negative regulator of diverse dynamin-dependent endocytic pathways.	[Li, Bin; Ding, Siyuan; Feng, Ningguo; Mooney, Nancie; Ooi, Yaw Shin; Diep, Jonathan; Kelly, Marcus R.; Yasukawa, Linda L.; Jackson, Peter K.; Greenberg, Harry B.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Li, Bin; Ding, Siyuan; Feng, Ningguo; Yasukawa, Linda L.; Greenberg, Harry B.] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Li, Bin; Ding, Siyuan; Feng, Ningguo; Yasukawa, Linda L.; Greenberg, Harry B.] VA Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA; [Li, Bin] Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing 210014, Jiangsu, Peoples R China; [Mooney, Nancie; Kelly, Marcus R.; Jackson, Peter K.] Stanford Univ, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Ren, Lili] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211816, Jiangsu, Peoples R China; [Patton, John T.] Univ Maryland, Dept Vet Med, College Pk, MD 20740 USA; [Yamazaki, Hiroyuki; Shirao, Tomoaki] Gunma Univ, Dept Neurobiol & Behav, Maebashi, Gumma 3718511, Japan	Ding, SY; Greenberg, HB (reprint author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Ding, SY; Greenberg, HB (reprint author), Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.; Ding, SY; Greenberg, HB (reprint author), VA Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA.	syding@stanford.edu; hbgreen@stanford.edu	Ding, Siyuan/G-2718-2017		NIH [R01 AI021362, R56 AI021362, U19 AI116484]; US Department of Veterans Affairs Merit Review Grant [GRH0022]; Walter V. and Idun Berry Postdoctoral Fellowship Program; Stanford Institute for Immunity, Transplantation, and Infection Young Investigator Award; Early Career Award from the Thrasher Research Fund	We thank all members of the H.B.G. laboratory for their support; Dr. Jan E. Carette (Stanford University), Dr. Xin Wang (Cleveland Clinic), and Dr. Stefan Linder (University of Hamburg) for kindly providing valuable reagents and useful suggestions; and Drs. Chris Adams and Ryan Leib (Stanford Mass Spectrometry core facility) for their assistance. This work is supported by NIH Grants R01 AI021362, R56 AI021362, U19 AI116484, and by US Department of Veterans Affairs Merit Review Grant GRH0022 (to H.B.G.). S.D. is supported by the Walter V. and Idun Berry Postdoctoral Fellowship Program; the Stanford Institute for Immunity, Transplantation, and Infection Young Investigator Award; and an Early Career Award from the Thrasher Research Fund.	Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101                                                    ; BASS DM, 1992, J CLIN INVEST, V90, P2313, DOI 10.1172/JCI116119; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Porta DC, 2016, VIROLOGY, V499, P65, DOI [10.1016/j.virol.2016.09.010, 10.1016/j.viro1.2016.09.010]; Cossart P, 2014, COLD SPRING HARB PER, V6, P6; Dalton KP, 2001, VIROLOGY, V279, P414, DOI 10.1006/viro.2000.0736; Diaz-Salinas MA, 2013, J VIROL, V87, P1658, DOI 10.1128/JVI.02086-12; Ding SY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005929; Ding SY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001758; Duan DS, 1999, J VIROL, V73, P10371; Estes MK, 2013, ROTAVIRUSES; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12; Green VA, 2016, CELL HOST MICROBE, V20, P107, DOI 10.1016/j.chom.2016.06.005; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; HOSHINO Y, 1984, J INFECT DIS, V149, P694, DOI 10.1093/infdis/149.5.694                                                        ; Irving AT, 2012, IMMUNITY, V36, P795, DOI 10.1016/j.immuni.2012.02.020; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Keon BH, 2000, J CELL SCI, V113, P325; Kessels MM, 2005, NAT CELL BIOL, V7, P448, DOI 10.1038/ncb0505-448; Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Ludert JE, 1996, J VIROL, V70, P487; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mancini A, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-36; Marsh M, 2001, FRONTIERS MOL BIOL; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mendez E, 1999, VIROLOGY, V263, P450, DOI 10.1006/viro.1999.9976; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Nonnenmacher M, 2011, CELL HOST MICROBE, V10, P563, DOI 10.1016/j.chom.2011.10.014; Parr RD, 2006, J VIROL, V80, P2842, DOI 10.1128/JVI.80.6.2842-2854.2006; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Rehm K, 2013, J CELL SCI, V126, P3756, DOI 10.1242/jcs.129437; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Wolf M, 2011, J VIROL, V85, P2492, DOI 10.1128/JVI.02082-10; Xu SQ, 2015, ONCOTARGET, V6, P10825, DOI 10.18632/oncotarget.3424                                                        	45	0	0	4	6	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 2	2017	114	18					E3642	E3651		10.1073/pnas.1619266114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	ET5VV	WOS:000400358000009	28416666	gold			2018-01-05	
J	Verdon, Q; Boonen, M; Ribes, C; Jadot, M; Gasnier, B; Sagne, C				Verdon, Quentin; Boonen, Marielle; Ribes, Christopher; Jadot, Michel; Gasnier, Bruno; Sagne, Corinne			SNAT7 is the primary lysosomal glutamine exporter required for extracellular protein-dependent growth of cancer cells	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						lysosome; transporter; glutamine; cell nutrition; cancer	AMINO-ACIDS; VITAMIN-B-12 METABOLISM; TRANSCRIPTIONAL CONTROL; TRANSPORTER; MTORC1; TFEB; IDENTIFICATION; FIBROBLASTS; MECHANISMS; RAS	Lysosomes degrade cellular components sequestered by autophagy or extracellular material internalized by endocytosis and phagocytosis. The macromolecule building blocks released by lysosomal hydrolysis are then exported to the cytosol by lysosomal transporters, which remain undercharacterized. In this study, we designed an in situ assay of lysosomal amino acid export based on the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis that detects lysosomal storage. This assay was used to screen candidate lysosomal transporters, leading to the identification of sodium-coupled neutral amino acid transporter 7 (SNAT7), encoded by the SLC38A7 gene, as a lysosomal transporter highly selective for glutamine and asparagine. Cell fractionation confirmed the lysosomal localization of SNAT7, and flux measurements confirmed its substrate selectivity and showed a strong activation by the lysosomal pH gradient. Interestingly, gene silencing or editing experiments revealed that SNAT7 is the primary permeation pathway for glutamine across the lysosomal membrane and it is required for growth of cancer cells in a low free-glutamine environment, when macropinocytosis and lysosomal degradation of extracellular proteins are used as an alternative source of amino acids. SNAT7 may, thus, represent a novel target for glutamine-related anticancer therapies.	[Verdon, Quentin; Ribes, Christopher; Gasnier, Bruno; Sagne, Corinne] Paris Descartes Univ, Sorbonne Paris Cite, CNRS UMR 8250, Neurophoton Lab, Paris, France; [Boonen, Marielle; Jadot, Michel] Univ Namur, Lab Chim Physiol Narilis, Unite Rech Physiol Mol URPhyM, B-5000 Namur, Belgium	Gasnier, B; Sagne, C (reprint author), Paris Descartes Univ, Sorbonne Paris Cite, CNRS UMR 8250, Neurophoton Lab, Paris, France.	bruno.gasnier@parisdescartes.fr; corinne.sagne@parisdescartes.fr	Sagne, Corinne/K-7601-2017	Gasnier, Bruno/0000-0003-4458-6296	Ligue contre le Cancer, Comite de Paris [RS15/75-82, RS16/75-101]; CNRS; Ministere de l'enseignement superieur et de la recherche (Doctoral School BIOSIGNE at Paris-Sud University); charity Vaincre les Maladies Lysosomales	We thank Francois Darchen for comments on the manuscript. We are grateful to Cecile Debacker, Stephanie Dupuy, and Virginie Tevel for technical help in cell culture, flow cytometry, and fractionation experiments, respectively. This study was supported by Ligue contre le Cancer, Comite de Paris Grants RS15/75-82 and RS16/75-101 (to B.G.) and the CNRS. Q.V. was supported by PhD fellowships from the Ministere de l'enseignement superieur et de la recherche (Doctoral School BIOSIGNE at Paris-Sud University) and from the charity Vaincre les Maladies Lysosomales. C.S. is a scientist from the Institut National de la Sante et de la Recherche Medicale.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Broer S, 2009, J BIOL CHEM, V284, P25823, DOI 10.1074/jbc.M109.031013; Broer S, 2014, PFLUGERS ARCH, V466, P155, DOI DOI 10.1007/S00424-013-1393-Y; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DE DUVE C., 1955, BIOCHEM JOUR, V60, P604; Della Valle MC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006403; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; GOLDMAN R, 1973, BIOCHIM BIOPHYS ACTA, V318, P205, DOI 10.1016/0005-2736(73)90114-4; Hagglund MGA, 2015, J MOL BIOL, V427, P1495, DOI 10.1016/j.jmb.2014.10.016; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; HARMS E, 1980, P NATL ACAD SCI-BIOL, V77, P6139, DOI 10.1073/pnas.77.10.6139; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; Jadot M, 2017, MOL CELL PROTEOMICS, V16, P194, DOI 10.1074/mcp.M116.064527; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kawaguchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30183; Liu B, 2012, ADV OPTOELECTRON, DOI 10.1155/2012/895723; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; PISONI RL, 1991, BIOCHIM BIOPHYS ACTA, V1071, P351, DOI 10.1016/0304-4157(91)90002-E                                                    ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; REEVES JP, 1979, J BIOL CHEM, V254, P8914; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498                                                          ; Samraj AN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00033; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Veithen A, 1996, J CELL SCI, V109, P2005; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200	47	1	1	6	10	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 2	2017	114	18					E3602	E3611		10.1073/pnas.1617066114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	ET5VV	WOS:000400358000005	28416685	green_published			2018-01-05	
J	Liu, X; Wu, SR; Xu, J; Sui, C; Wei, JH				Liu, Xuan; Wu, Surui; Xu, Jiao; Sui, Chun; Wei, Jianhe			Application of CRISPR/Cas9 in plant biology	ACTA PHARMACEUTICA SINICA B			English	Review						CRISPRiCas system; Gene editing technology; Gene modification; Plant biology; Transcriptional regulation	EFFICIENT TARGETED MUTAGENESIS; RNA-GUIDED ENDONUCLEASE; ZINC-FINGER NUCLEASES; CAS SYSTEM; GENOME MODIFICATION; TRANSCRIPTIONAL REGULATION; STAPHYLOCOCCUS-AUREUS; ARABIDOPSIS-THALIANA; DIRECTED MUTAGENESIS; NICOTIANA-TABACUM	The CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system was first identified in bacteria and archaea and can degrade exogenous substrates. It was developed as a gene editing technology in 2013. Over the subsequent years, it has received extensive attention owing to its easy manipulation, high efficiency, and wide application in gene mutation and transcriptional regulation in mammals and plants. The process of CRISPR/Cas is optimized constantly and its application has also expanded dramatically. Therefore, CRISPR/Cas is considered a revolutionary technology in plant biology. Here, we introduce the mechanism of the type II CRISPR/Cas called CRISPR/Cas9, update its recent advances in various applications in plants, and discuss its future prospects to provide an argument for its use in the study of medicinal plants. (C) 2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license	[Liu, Xuan; Wu, Surui; Xu, Jiao; Sui, Chun; Wei, Jianhe] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100193, Peoples R China	Sui, C (reprint author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100193, Peoples R China.	csui@implad.ac.cn					Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cai YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136064; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; [常振仪 Chang Zhenyi], 2015, [农业生物技术学报, Journol of Agricultural Biotechnology], V23, P1196; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Endo M, 2016, PLANT PHYSIOL, V170, P667, DOI 10.1104/pp.15.01663; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng C, 2016, J GENET GENOMICS, V43, P37, DOI 10.1016/j.jgg.2015.10.002; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Geng YJ, 2016, RSC ADV, V6, P33514, DOI 10.1039/c6ra02774a; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jia LJ., 2014, CHINA MED HERALD, V11, P154; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RA, 2015, PLANT MOL BIOL, V87, P143, DOI 10.1007/s11103-014-0266-x; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; McGlew K, 2015, PLANT CELL REP, V34, P519, DOI 10.1007/s00299-014-1710-8; Mercx S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00040; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Michno JM, 2015, GM CROPS FOOD, V6, P243, DOI 10.1080/21645698.2015.1106063; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin YY, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Ul Ain Q, 2015, J CONTROL RELEASE, V205, P120, DOI 10.1016/j.jconrel.2014.12.036; Upadhyay SK, 2014, BIOMED RES INT, DOI 10.1155/2014/742482; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yan L, 2015, MOL PLANT, V8, P922, DOI 10.1016/j.molp.2014.12.011; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20315; Zhang GH, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0104-3; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; [赵海卫(综述) Zhao HaiWei], 2015, [中国病原生物学杂志, Journal of Pathogen Biology], V10, P281; Zheng XL, 2016, PLANT CELL REP, V35, P1545, DOI 10.1007/s00299-016-1967-1; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu JJ, 2016, J GENET GENOMICS, V43, P25, DOI 10.1016/j.jgg.2015.10.006	103	1	1	3	3	INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES	BEIJING	C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, 100050, PEOPLES R CHINA	2211-3835	2211-3843		ACTA PHARM SIN B	Acta Pharm. Sin. B	MAY	2017	7	3					292	302		10.1016/j.apsb.2017.01.002				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FO9DJ	WOS:000417187900004	28589077	gold			2018-01-05	
J	Ganem, NS; Ben-Asher, N; Lamm, AT				Ganem, Nabeel S.; Ben-Asher, Noa; Lamm, Ayelet T.			In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic	DRUG RESISTANCE UPDATES			English	Review						ADAR; Chemotherapeutic drug sensitivity; Cancer biomarkers; Gene therapy	PRE-MESSENGER-RNA; ADENOSINE-DEAMINASE; HEPATOCELLULAR-CARCINOMA; ENZYME ADAR1; INOSINE RNA; GENE; EXPRESSION; MUTATIONS; MICE; GLIOBLASTOMA	In recent years, A-to-I RNA modifications performed by the Adenosine Deaminase Acting on RNA (ADAR) protein family were found to be expressed at altered levels in multiple human malignancies. A-to-I RNA editing changes adenosine to inosine on double stranded RNA, thereby changing transcript sequence and structure. Although A-to-I RNA editing have the potential to change essential mRNA transcripts, affecting their corresponding protein structures, most of the human editing sites identified to date reside in non-coding repetitive transcripts such as Alu elements. Therefore, the impact of the hypo- or hyper-editing found in specific cancers remains unknown. Moreover, it is yet unclear whether or not changes in RNA editing and ADAR expression levels facilitate or even drive cancer progression or are just a byproduct of other affected pathways. In both cases, however, the levels of RNA editing and ADAR enzymes can possibly be used as specific biomarkers, as their levels change differently in specific malignancies. More significantly, recent studies suggest that ADAR enzymes can be used to reverse the oncogenic process, suggesting a potential for gene therapies. This review focuses on new findings that suggest that RNA editing by ADARs can affect cancer progression and even formation. We also discuss new possibilities of using ADAR enzymes and RNA editing as cancer biomarkers, indicators of chemotherapeutic drug sensitivity, and even to be themselves potential therapeutic tools.	[Ganem, Nabeel S.; Ben-Asher, Noa; Lamm, Ayelet T.] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel	Lamm, AT (reprint author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	ayeletla@technion.ac.il			Israel Cancer Research Fund (ICRF); Israeli Centers of Research Excellence (I-CORE) program [1796/12]; Binational Israel-USA Science Foundation [2015091]	We thank Alla Fishman for critical reading of the manuscript and discussions. This work was funded by The Israeli Centers of Research Excellence (I-CORE) program, (Center No. 1796/12 to ATL), Israel Cancer Research Fund (ICRF), and the Binational Israel-USA Science Foundation (grant no. 2015091).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738                                                  ; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Cho CJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040799; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Eran A, 2013, MOL PSYCHIATR, V18, P1041, DOI 10.1038/mp.2012.118; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; Fukuda M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41478; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Gaisler-Salomon I, 2014, NEUROBIOL AGING, V35, P1785, DOI 10.1016/j.neurobiolaging.2014.02.018; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Ganem N.S., 2017, RNA BIOL; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Goldstein B, 2017, GENOME RES, V27, P462, DOI 10.1101/gr.211169.116; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hanswillemenke A, 2015, J AM CHEM SOC, V137, P15875, DOI 10.1021/jacs.5b10216; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Heep M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010034; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421                                                         ; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Higuchi M, 2000, NATURE, V406, P78; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Liddicoat BJ, 2016, WIRES RNA, V7, P157, DOI 10.1002/wrna.1322; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004225; Mehta Sunali, 2010, Ther Adv Med Oncol, V2, P125, DOI 10.1177/1758834009360519; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; MONTIELGONZALEZ MF, 2016, NUCL ACIDS RES, V44; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nimmich ML, 2009, NEUROSCI RES, V63, P288, DOI 10.1016/j.neures.2009.01.003; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Oakes E, 2017, J BIOL CHEM, V292, P4326, DOI 10.1074/jbc.M117.779868; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Samuel CE, 2012, CURR TOP MICROBIOL, V353, P163, DOI 10.1007/82_2011_148; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Schmidt HD, 2015, MOL PSYCHIATR, V20, P1460, DOI 10.1038/mp.2014.134; SCHUMACHER JM, 1995, BIOL REPROD, V52, P1274, DOI 10.1095/biolreprod52.6.1274; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stafforst T, 2012, ANGEW CHEM INT EDIT, V51, P11166, DOI 10.1002/anie.201206489; Steinman RA, 2013, INT J CANCER, V132, P1741, DOI 10.1002/ijc.27851; Streit AK, 2011, EPILEPSIA, V52, P645, DOI 10.1111/j.1528-1167.2011.02986.x; Thomas JM, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600187; Tomaselli S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0575-z; Vogel P, 2014, ANGEW CHEM INT EDIT, V53, P6267, DOI 10.1002/anie.201402634; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang YM, 2017, GENOME RES, V27, P1112, DOI 10.1101/gr.219741.116; Wettengel J, 2017, NUCLEIC ACIDS RES, V45, P2797, DOI 10.1093/nar/gkw911; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang XJ, 2004, HUM MUTAT, V23, P629, DOI 10.1002/humu.9246	72	0	0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1368-7646	1532-2084		DRUG RESIST UPDATE	Drug Resist. Update	MAY	2017	32						16	22		10.1016/j.drup.2017.09.001				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FN8UA	WOS:000416299800002	29145975				2018-01-05	
J	DiCarlo, JE; Sengillo, JD; Justus, S; Cabral, T; Tsang, SH; Mahajan, VB				DiCarlo, James E.; Sengillo, Jesse D.; Justus, Sally; Cabral, Thiago; Tsang, Stephen H.; Mahajan, Vinit B.			CRISPR-Cas Genome Surgery in Ophthalmology	TRANSLATIONAL VISION SCIENCE & TECHNOLOGY			English	Review						CRISPR-Cas; genome engineering; gene therapy; synthetic biology; precision medicine	PLURIPOTENT STEM-CELLS; LEBERS CONGENITAL AMAUROSIS; RETINAL GANGLION-CELLS; DOUBLE-STRAND BREAKS; HUMAN IPS CELLS; IN-VIVO; GENE-THERAPY; RETINITIS-PIGMENTOSA; HOMOLOGOUS RECOMBINATION; RESTRICTION ENZYMES	Genetic disease affecting vision can significantly impact patient quality of life. Gene therapy seeks to slow the progression of these diseases by treating the underlying etiology at the level of the genome. Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated systems (Cas) represent powerful tools for studying diseases through the creation of model organisms generated by targeted modification and by the correction of disease mutations for therapeutic purposes. CRISPR-Cas systems have been applied successfully to the visual sciences and study of ophthalmic disease -from the modification of zebrafish and mammalian models of eye development and disease, to the correction of pathogenic mutations in patientderived stem cells. Recent advances in CRISPR-Cas delivery and optimization boast improved functionality that continues to enhance genome-engineering applications in the eye. This review provides a synopsis of the recent implementations of CRISPRCas tools in the field of ophthalmology.	[DiCarlo, James E.; Sengillo, Jesse D.; Justus, Sally; Cabral, Thiago; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Jonas Childrens Vis Care, New York, NY 10027 USA; [DiCarlo, James E.; Sengillo, Jesse D.; Justus, Sally; Cabral, Thiago; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10027 USA; [DiCarlo, James E.; Sengillo, Jesse D.; Justus, Sally; Cabral, Thiago; Tsang, Stephen H.] New York Presbyterian Hosp, Edward S Harkness Eye Inst, New York, NY 10032 USA; [Sengillo, Jesse D.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Cabral, Thiago] Univ Fed Espirito Santo, Dept Ophthalmol, Vitoria, Brazil; [Cabral, Thiago] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Tsang, Stephen H.] Columbia Univ, Coll Phys & Surg, Inst Human Nutr, Dept Pathol & Cell Biol, New York, NY USA; [Mahajan, Vinit B.] Stanford Univ, Dept Ophthalmol, Byers Eye Inst, Omics Lab, Palo Alto, CA 94304 USA; [Mahajan, Vinit B.] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA	Tsang, SH (reprint author), New York Presbyterian Hosp, Edward S Harkness Eye Inst, New York, NY 10032 USA.; Mahajan, VB (reprint author), Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA.	sht2@columbia.edu; vinit.mahajan@stanford.com			National Institutes of Health (NIH; Bethesda, MD) [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437]; NIH [R01EY024698, R21AG050437, 5P30EY019007, R01EY018213, \1R01EY026682]; National Cancer Institute Core [5P30CA013696]; Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB, New York, NY, USA; RPB medical student fellowship (JDS); Tistou and Charlotte Kerstan Foundation; Schneeweiss Stem Cell Fund, New York State [C029572]; Foundation Fighting Blindness New York Regional Research Center [C-NY05-0705-0312]; Gebroe Family Foundation; ICO-Retina Research Foundation Helmerich Fellowships; Retina Research Foundation in cooperation with the ICO Foundation	Supported by National Institutes of Health (NIH; Bethesda, MD) Grants R01EY026682, R01EY024665, R01EY025225, R01EY024698, and R21AG050437 (VBM). The Jonas Children's Vision Project and Bernard & Shirlee Brown Glaucoma Laboratory are supported by the NIH (5P30EY019007, R01EY018213, R01EY024698, 1R01EY026682, R21AG050437), National Cancer Institute Core (5P30CA013696), the Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB, New York, NY, USA, and the RPB medical student fellowship (JDS). SHT is a member of the RD-CURE Consortium and is supported by the Tistou and Charlotte Kerstan Foundation, the Schneeweiss Stem Cell Fund, New York State (C029572), the Foundation Fighting Blindness New York Regional Research Center Grant (C-NY05-0705-0312), and the Gebroe Family Foundation. T. C. is supported by the ICO-Retina Research Foundation Helmerich Fellowships, which is sponsored by the Retina Research Foundation in cooperation with the ICO Foundation.	Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103                                                             ; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Collery RF, 2016, INVEST OPHTH VIS SCI, V57, P6805, DOI 10.1167/iovs.16-19593; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Duan YJ, 2016, J BIOL CHEM, V291, P16339, DOI 10.1074/jbc.M116.729467; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garg A, 2017, CELL, V6, P4, DOI [10.3390/cells6010004, DOI 10.3390/CELLS6010004]; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879                                                       ; Hayashi R, 2016, NATURE, V531, P376, DOI 10.1038/nature17000; Huang Xionggao, 2017, Invest Ophthalmol Vis Sci, V58, P1228, DOI 10.1167/iovs.16-20537; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Hung SSC, 2017, PHARMACOL THERAPEUT, DOI [10.1016/j.pharmthera.2017.02.026, DOI 10.1016/J.PHARMTHERA.2017.02.026]; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; JASIN M, 1988, GENE DEV, V2, P1353, DOI 10.1101/gad.2.11.1353                                                           ; JASIN M, 1985, CELL, V43, P695, DOI 10.1016/0092-8674(85)90242-9; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jun AS, 2003, EYE, V17, P906, DOI 10.1038/sj.eye.6700565; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Keeler CE, 1928, J GEN PHYSIOL, V11, P361, DOI 10.1085/jgp.11.4.361                                                            ; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; KIM E, 2017, NAT COMMUN, V8; Kim K, 2017, GENOME RES, V27, P419, DOI 10.1101/gr.219089.116; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kim YG, 1997, GENE, V203, P43, DOI 10.1016/S0378-1119(97)00489-7; Kitazawa K, 2017, EXP EYE RES, V154, P30, DOI 10.1016/j.exer.2016.11.005; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Latella MC, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.92; Li Y, 2016, METHOD MOL BIOL, V1353, P77; Lv JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep43062; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Partridge M, 1996, ANTISENSE NUCLEIC A, V6, P169, DOI 10.1089/oli.1.1996.6.169; Pearl JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005090; Priglinger CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146887; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Reichman S, 2017, STEM CELLS, V35, P1176, DOI 10.1002/stem.2586; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399; Richardson R, 2017, EYE, V31, P68, DOI 10.1038/eye.2016.198; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Ruan GX, 2017, MOL THER, V25, P331, DOI 10.1016/j.ymthe.2016.12.006; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Saraiva J, 2016, J CONTROL RELEASE, V241, P94, DOI 10.1016/j.jconrel.2016.09.011; Schierling B, 2012, NUCLEIC ACIDS RES, V40, P2623, DOI 10.1093/nar/gkr1112; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Schorderet D, 2015, PROG MOL BIOL TRANSL, V134, P73, DOI 10.1016/bs.pmbts.2015.04.004; Sengillo JD, 2017, GENES, V8; Sengillo JD, 2016, AM J MED GENET C, V172, P349, DOI 10.1002/ajmg.c.31534; Serifi I, 2016, BIOCHEM J, V473, P4609, DOI 10.1042/BCJ20160523; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Sluch VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16595; Sluch VM, 2014, DEV OPHTHALMOL, V53, P111, DOI 10.1159/000358409; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Sundin OH, 2005, P NATL ACAD SCI USA, V102, P9553, DOI 10.1073/pnas.0501451102; Sundin Olof H, 2005, Ophthalmic Genet, V26, P153, DOI 10.1080/13816810500374359; Swart JF, 2017, NAT REV RHEUMATOL, V13, P244, DOI 10.1038/nrrheum.2017.7; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor SM, 2015, INVEST OPHTH VIS SCI, V56, P7496, DOI 10.1167/iovs.15-17616; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vandenberghe LH, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017442; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wiley LA, 2015, PROG RETIN EYE RES, V44, P15, DOI 10.1016/j.preteyeres.2014.10.002; Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yanik M, 2017, PROG RETIN EYE RES, V56, P1, DOI 10.1016/j.preteyeres.2016.09.001; Yasue A, 2017, SCI REP, V7, P53, DOI 10.1038/s41598-017-00088-w; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; ZHONG H, 2015, SCI REP UK, V5	100	0	0	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	2164-2591			TRANSL VIS SCI TECHN	Transl. Vis. Sci. Technol.	MAY	2017	6	3							13	10.1167/tvst.6.3.13				13	Ophthalmology	Ophthalmology	FH2GT	WOS:000410957800013	28573077	gold			2018-01-05	
J	Pacher, M; Puchta, H				Pacher, Michael; Puchta, Holger			From classical mutagenesis to nuclease-based breeding - directing natural DNA repair for a natural end-product	PLANT JOURNAL			English	Article						genome engineering; synthetic DNA nucleases; gene editing; non-homologous end-joining	DOUBLE-STRAND BREAKS; CHIMERIC RNA/DNA OLIGONUCLEOTIDES; SEQUENCE-SPECIFIC NUCLEASES; ZINC-FINGER NUCLEASES; SOMATIC PLANT-CELLS; ONE-SIDED INVASION; HOMOLOGOUS RECOMBINATION; TARGETED MUTAGENESIS; CRISPR/CAS9 SYSTEM; STAPHYLOCOCCUS-AUREUS	Production of mutants of crop plants by the use of chemical or physical genotoxins has a long tradition. These factors induce the natural DNA repair machinery to repair damage in an error-prone way. In the case of radiation, multiple double-strand breaks (DSBs) are induced randomly in the genome, leading in very rare cases to a desirable phenotype. In recent years the use of synthetic, site-directed nucleases (SDNs) - also referred to as sequence-specific nucleases - like the CRISPR/Cas system has enabled scientists to use exactly the same naturally occurring DNA repair mechanisms for the controlled induction of genomic changes at pre-defined sites in plant genomes. As these changes are not necessarily associated with the permanent integration of foreign DNA, the obtained organisms per se cannot be regarded as genetically modified as there is no way to distinguish them from natural variants. This applies to changes induced by DSBs as well as single-strand breaks, and involves repair by non-homologous end-joining and homologous recombination. The recent development of SDN-based 'DNA-free' approaches makes mutagenesis strategies in classical breeding indistinguishable from SDN-derived targeted genome modifications, even in regard to current regulatory rules. With the advent of new SDN technologies, much faster and more precise genome editing becomes available at reasonable cost, and potentially without requiring time-consuming deregulation of newly created phenotypes. This review will focus on classical mutagenesis breeding and the application of newly developed SDNs in order to emphasize similarities in the context of the regulatory situation for genetically modified crop plants.	[Pacher, Michael; Puchta, Holger] Karlsruhe Inst Technol, Bot Inst, Mol Biol & Biochem, PO 6980, D-76049 Karlsruhe, Germany	Puchta, H (reprint author), Karlsruhe Inst Technol, Bot Inst, Mol Biol & Biochem, PO 6980, D-76049 Karlsruhe, Germany.	holger.puchta@kit.edu		Puchta, Holger/0000-0003-1073-8546	European Research Council (ERC)	We would like to express our apologies to all our dedicated colleagues whose exciting work couldn't be cited due to space limitations. Due to the broad spectrum of this review we had to limit our references to a minimum of the amazing work published so far in this area. Furthermore, we would like to thank our group for sharing their enthusiasm for working with the CRISPR/Cas system, and express our special thanks to Amy Whitbread for critically reading the manuscript and the European Research Council (ERC) for generously funding this research on genome engineering.	Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; AUERBACH C, 1946, NATURE, V157, P302, DOI 10.1038/157302a0; Auerbach C, 1941, J GENET, V41, P255, DOI 10.1007/BF02983022; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; BEALE G, 1993, GENETICS, V134, P393; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; BELMAAZA A, 1994, MUTAT RES, V314, P199, DOI 10.1016/0921-8777(94)90065-5; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Breyer Didier, 2009, Environmental Biosafety Research, V8, P57, DOI 10.1051/ebr/2009007; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Halluin K, 2013, PLANT BIOTECHNOL J, V11, P933, DOI 10.1111/pbi.12085; de Vries H., 1901, DIE MUTATIONSTHEORIE, VI; de Vries H., 1903, DIE MUTATIONSTHEORIE, VII; de Vries Hugo, 1909, MUTATION THEORY EXPT; de Vries H, 1905, SPECIES VARIETIES TH; Dhaliwal AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145227; Dong CM, 2006, PLANT CELL REP, V25, P457, DOI 10.1007/s00299-005-0098-x; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2012, EFSA J, V10, P2603, DOI DOI 10.2903/J.EFSA.2012.2943; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; European Commission JRC, 2011, IPTS IHCP NEW PLANT; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Freisleben R., 1942, NATURWISSENSCHAFTEN, V30, P608; Gepts P, 2002, CROP SCI, V42, P1780, DOI 10.2135/cropsci2002.1780                                                        ; Gepts P., 2001, OUR FRAGILE WORLD CH, P629; GUSTAFSSON A, 1948, HEREDITAS, V34, P371; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Hilscher J., 2016, BIOTECHNOL J, V11, P1; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kanchiswamy CN, 2016, TRENDS BIOTECHNOL, V34, P562, DOI 10.1016/j.tibtech.2016.03.007; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kharkwal MC, 2004, PLANT BREEDING: MENDELIAN TO MOLECULAR APPROACHES, P601; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kochevenko A, 2003, PLANT PHYSIOL, V132, P174, DOI 10.1104/pp.102.016857; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Lundqvist U., 2009, Induced plant mutations in the genomics era. Proceedings of an International Joint FAO/IAEA Symposium, 2008, P39; Luo S, 2015, MOL PLANT, V8, P1425, DOI 10.1016/j.molp.2015.05.012; Lusser M, 2013, NEW BIOTECHNOL, V30, P437, DOI 10.1016/j.nbt.2013.02.004; Ma X., 2016, CURR PROTOC MOL BIOL, V1, P115, DOI [10.1002/cpmb.10, DOI 10.1002/CPMB.10]; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McHughen A, 2008, PLANT BIOTECHNOL J, V6, P2, DOI 10.1111/j.1467-7652.2007.00300.x; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; Nakagawa H., 2009, INDUCED PLANT MUTATI; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Oehlker F., 1943, MUTATION RES PROBLEM; Okuzaki A, 2004, PLANT CELL REP, V22, P509, DOI 10.1007/s00299-003-0698-2; Osman K, 2011, NEW PHYTOL, V190, P523, DOI 10.1111/j.1469-8137.2011.03665.x; Pacher M, 2007, GENETICS, V175, P21, DOI 10.1534/genetics.106.065185; Pauwels K, 2014, NEW BIOTECHNOL, V31, P18, DOI 10.1016/j.nbt.2013.07.001; Petolino JF, 2010, PLANT MOL BIOL, V73, P617, DOI 10.1007/s11103-010-9641-4; Podevin N, 2013, TRENDS BIOTECHNOL, V31, P375, DOI 10.1016/j.tibtech.2013.03.004; Podevin N, 2012, EMBO REP, V13, P1057, DOI 10.1038/embor.2012.168; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; Puchta H, 1998, PLANT J, V13, P331, DOI 10.1046/j.1365-313X.1998.00035.x                                                ; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; PUCHTA H, 1991, MOL GEN GENET, V230, P1, DOI 10.1007/BF00290641; Puchta H., 2015, ADV NEW TECHNOLOGY T, P1; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Gutierrez C, 2015, PLANT J, V83, P1, DOI [10.1111/tpj.12909, 10.1111/tpj.13100]; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Puchta H, 2013, INT J DEV BIOL, V57, P629, DOI 10.1387/ijdb.130194hp; Quetier F, 2016, PLANT SCI, V242, P65, DOI 10.1016/j.plantsci.2015.09.003; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rapoport I. A., 1948, CR DOKLADY ACAD SCI, V59, P1183; Rapoport I.A., 1946, CR HEBD ACAD SCI, V54, P65; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Ruiter R, 2003, PLANT MOL BIOL, V53, P715, DOI 10.1023/B:PLAN.0000019111.96107.01                                              ; Salomon S, 1998, EMBO J, V17, P6086, DOI 10.1093/emboj/17.20.6086                                                        ; Samanta MK, 2016, TRANSGENIC RES, V25, P561, DOI 10.1007/s11248-016-9953-5; Sapehin A. A., 1930, ZUCHTER, V2, P257; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Sauer NJ, 2016, PLANT BIOTECHNOL J, V14, P496, DOI 10.1111/pbi.12496; Schaeffer SM, 2015, PLANT SCI, V240, P130, DOI 10.1016/j.plantsci.2015.09.011; Schiml S, 2016, P NATL ACAD SCI USA, V113, P7266, DOI 10.1073/pnas.1603823113; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shu Q. Y., 2011, PLANT BREEDING GENET, P1; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Siebert R, 2002, PLANT CELL, V14, P1121, DOI 10.1105/tpc.001727; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Sprink T, 2016, PLANT CELL REP, V35, P1493, DOI 10.1007/s00299-016-1990-2; Stadler LJ, 1928, P NATL ACAD SCI USA, V14, P69, DOI 10.1073/pnas.14.1.69; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; STERN MJ, 1984, CELL, V37, P1015, DOI 10.1016/0092-8674(84)90436-7; Steuer S, 2004, CHEMBIOCHEM, V5, P206, DOI 10.1002/cbic.200300718; Stoddard TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154634; STUBBE H., 1934, Zuchter, V6, P299, DOI 10.1007/BF01813299; Subburaj S, 2016, PLANT CELL REP, V35, P1535, DOI 10.1007/s00299-016-1937-7; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; TINLAND B, 1994, P NATL ACAD SCI USA, V91, P8000, DOI 10.1073/pnas.91.17.8000; TOLLENAAR D., 1934, GENETICA, V16, P111, DOI 10.1007/BF01837860; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; US Office of Science and Technology Policy (OSTP), 1986, FED REGISTER, V51, P23302; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Waigmann E, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.s1008; Waltz E, 2016, NAT BIOTECHNOL, V34, P582, DOI 10.1038/nbt0616-582; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Waltz E, 2015, NAT BIOTECHNOL, V33, P12, DOI 10.1038/nbt0115-12; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weinthal DM, 2013, PLANT PHYSIOL, V162, P390, DOI 10.1104/pp.112.212910; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wolt JD, 2016, PLANT BIOTECHNOL J, V14, P510, DOI 10.1111/pbi.12444; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Zhang F., 2015, ADV NEW TECHNOLOGY T; Zhang YM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11649; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768; Zhu T, 2000, NAT BIOTECHNOL, V18, P555	138	6	6	15	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	MAY	2017	90	4			SI		819	833		10.1111/tpj.13469				15	Plant Sciences	Plant Sciences	FE3RY	WOS:000408134600014	28027431				2018-01-05	
J	Yang, J; Harding, T; Kamikawa, R; Simpson, AGB; Roger, AJ				Yang, Jiwon; Harding, Tommy; Kamikawa, Ryoma; Simpson, Alastair G. B.; Roger, Andrew J.			Mitochondrial Genome Evolution and a Novel RNA Editing System in Deep-Branching Heteroloboseids	GENOME BIOLOGY AND EVOLUTION			English	Article						protist; phylogenomics; eukaryote; amoeba "BB2"; Pharyngomonas; transcription	PHYSARUM-POLYCEPHALUM; EUGLENA-GRACILIS; RIBOSOMAL-RNA; GENE CONTENT; DNA; SEQUENCE; PROTISTS; TRANSCRIPTOME; PROTEINS; KINETOPLASTIDS	Discoba (Excavata) is an evolutionarily important group of eukaryotes that includes Jakobida, with the most bacterial-like mitochondrial genomes known, and Euglenozoa, many of which have extensively fragmented mitochondrial genomes. However, little is known about the mitochondrial genomes of Heterolobosea, the third main group of Discoba. Here, we studied two heteroloboseids-an undescribed amoeba "BB2" and Pharyngomonas kirbyi. Phylogenomic analysis revealed that they form a clade that is a sister group to all other Heterolobosea. We characterized the mitochondrial genomes of BB2 and P. kirbyi, which encoded 44 and 48 putative protein-coding genes respectively. Their gene contents were similar to that of Naegleria. In BB2, mitochondrially encoded RNAs were heavily edited, with similar to 500 mononucleotide insertion events, mostly guanosines. These insertions always have the same identity as an adjacent nucleotide. Editing occurs in all ribosomal RNAs and protein-coding transcripts except one, and half of the transfer RNAs. Analysis of Illumina deep-sequencing data suggested that this RNA editing is very accurate and efficient, and most likely co-transcriptional. The dissimilarity of this editing process to other RNA editing phenomena in discobids, as well as its apparent absence in P. kirbyi, suggest that this remarkably extensive system of insertional editing evolved independently in the BB2 lineage, after its divergence from the P. kirbyi lineage.	[Yang, Jiwon; Harding, Tommy; Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada; [Kamikawa, Ryoma] Kyoto Univ, Grad Sch Human & Environm Studies, Grad Sch Global Environm Studies, Kyoto, Japan; [Simpson, Alastair G. B.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada; [Simpson, Alastair G. B.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Simpson, Alastair G. B.; Roger, Andrew J.] Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Toronto, ON, Canada	Roger, AJ (reprint author), Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada.; Roger, AJ (reprint author), Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Toronto, ON, Canada.	andrew.roger@dal.ca			Natural Sciences and Engineering Research Council of Canada [2016-06792]; Tula Foundation; Canadian Institute for Advanced Research (CIfAR)	We thank Dr Matt Brown for providing a pipeline for phylogenomic tree construction and Dr Michael Gray, Dr John Archibald and Dr Claudio Slamovits for useful discussions. This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (grant number 2016-06792 to AJR) as well as the Tula Foundation and the Canadian Institute for Advanced Research (CIfAR).	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Antes T, 1998, MOL CELL BIOL, V18, P7521, DOI 10.1128/MCB.18.12.7521                                                          ; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bundschuh R, 2011, NUCLEIC ACIDS RES, V39, P6044, DOI 10.1093/nar/gkr180; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Byrne EM, 2002, EMBO J, V21, P6154, DOI 10.1093/emboj/cdf610                                                            ; Chateigner-Boutin AL, 2011, WIRES RNA, V2, P493, DOI 10.1002/wrna.72; Cheng YW, 2001, EMBO J, V20, P1405, DOI 10.1093/emboj/20.6.1405                                                         ; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225                                                           ; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; David V, 2015, MBIO, V6, DOI 10.1128/mBio.01498-15; Derelle R, 2015, P NATL ACAD SCI USA, V112, pE693, DOI 10.1073/pnas.1420657112; Dobakova E, 2015, GENOME BIOL EVOL, V7, P3358, DOI 10.1093/gbe/evv229; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Flegontov P, 2011, CURR GENET, V57, P225, DOI 10.1007/s00294-011-0340-8; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Fu CJ, 2014, GENOME BIOL EVOL, V6, P2240, DOI 10.1093/gbe/evu180; Garrison E, 2012, GENOMICS, V1207, P3907; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harding T, 2016, GENOME BIOL EVOL, V8, P2241, DOI 10.1093/gbe/evw152; Harding T, 2013, PROTIST, V164, P272, DOI 10.1016/j.protis.2012.08.002; Herman EK, 2013, J EUKARYOT MICROBIOL, V60, P179, DOI 10.1111/jeu.12022; Horton TL, 2002, CURR OPIN MICROBIOL, V5, P620, DOI 10.1016/S1369-5274(02)00379-X; JACQUES JP, 1994, EMBO J, V13, P5496; Janouskovec J, 2013, CURR BIOL, V23, P2546, DOI 10.1016/j.cub.2013.10.062; Kamikawa R, 2016, GENOME BIOL EVOL, V8, P458, DOI 10.1093/gbe/evw011; Kamikawa R, 2014, GENOME BIOL EVOL, V6, P306, DOI 10.1093/gbe/evu015; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kiethega GN, 2013, RNA BIOL, V10, P301, DOI 10.4161/rna.23340; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leger MM, 2016, MOL BIOL EVOL, V33, P2318, DOI 10.1093/molbev/msw103; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; MAHENDRAN R, 1994, EMBO J, V13, P232; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Moreira S, 2016, NUCLEIC ACIDS RES, V44, P4907, DOI 10.1093/nar/gkw188; Nishimura Y, 2016, GENOME BIOL EVOL, V8, P3090, DOI 10.1093/gbe/evw217; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Park JS, 2011, PROTIST, V162, P691, DOI 10.1016/j.protis.2011.05.004; Perez-Brocal V, 2010, GENOME BIOL EVOL, V2, P257, DOI 10.1093/gbe/evq015; Rio DC, 2010, COLD SPRING HARB PRO, V2010, P5439, DOI DOI 10.1101/PDB.PR0T5439; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Spencer DF, 2011, MOL GENET GENOMICS, V285, P19, DOI 10.1007/s00438-010-0585-9; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196                                                         ; Tikhonenkov, 2014, PLOS ONE, V9; VISOMIRSKIROBIC LM, 1995, RNA, V1, P681; Yabuki A, 2016, GENOME BIOL EVOL, DOI [10.1093/gbe/evw207, DOI 10.1093/GBE/EVW207]; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908	64	1	1	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1759-6653			GENOME BIOL EVOL	Genome Biol. Evol.	MAY	2017	9	5					1161	1174		10.1093/gbe/evx086				14	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	FC3SW	WOS:000406760400004	28453770	gold			2018-01-05	
J	Grahl, N; Demers, EG; Crocker, AW; Hogan, DA				Grahl, Nora; Demers, Elora G.; Crocker, Alex W.; Hogan, Deborah A.			Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species	MSPHERE			English	Article						CRISPR; Candida; auris; genome editing; glabrata; lusitaniae; molecular methods	GUIDE RNA; RESISTANCE; LUSITANIAE; CRISPR-CAS9; ELECTROPORATION; TRANSFORMATION; CRISPR/CAS9; GLABRATA; CELLS	Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 genome modification systems have greatly facilitated the genetic analysis of fungal pathogens. In CRISPR-Cas9 genome editing methods designed for use in Candida albicans, DNAs that encode the necessary components are expressed in the target cells. Unfortunately, expression constructs that work efficiently in C. albicans are not necessarily expressed well in other pathogenic species within the genus Candida or the related genus Clavispora. To circumvent the need for species-specific expression constructs, we implemented an expression-free CRISPR genome editing system and demonstrated its successful use in three different non-albicans Candida species: Candida (Clavispora) lusitaniae, Candida glabrata, and Candida auris. In CRISPR-Cas9-mediated genome editing methods, a targeted double-stranded DNA break can be repaired by homologous recombination to a template designed by the investigator. In this protocol, the DNA cleavage is induced upon transformation of purified Cas9 protein in complex with gene-specific and scaffold RNAs, referred to as RNA-protein complexes (RNPs). In all three species, the use of RNPs increased both the number of transformants and the percentage of transformants in which the target gene was successfully replaced with a selectable marker. We constructed mutants defective in known or putative catalase genes in C. lusitaniae, C. glabrata, and C. auris and demonstrated that, in all three species, mutants were more susceptible to hydrogen peroxide than the parental strain. This method, which circumvents the need for expression of CRISPR-Cas9 components, may be broadly useful in the study of diverse Candida species and emergent pathogens for which there are limited genetic tools. IMPORTANCE Existing CRISPR-Cas9 genome modification systems for use in Candida albicans, which rely on constructs to endogenously express the Cas9 protein and guide RNA, do not work efficiently in other Candida species due to inefficient promoter activity. Here, we present an expression-free method that uses RNA-protein complexes and demonstrate its use in three Candida species known for their drug resistance profiles. We propose that this system will aid the genetic analysis of fungi that lack established genetic systems.	[Grahl, Nora; Demers, Elora G.; Crocker, Alex W.; Hogan, Deborah A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Grahl, Nora] Twincore GmbH, Ctr Clin & Expt Res, Inst Mol Bacteriol, Hannover, Germany	Hogan, DA (reprint author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	dhogan@dartmouth.edu			National Institutes of Health [R01 GM108492, T32GM008704]	Research reported in this publication was supported by grants from the National Institutes of Health to D.A.H. (R01 GM108492 to D.A.H.) and E.G.D. (NIH NIGMS award number T32GM008704). N.G. was a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asner SA, 2015, ANTIMICROB AGENTS CH, V59, P7715, DOI 10.1128/AAC.02204-15; Atkinson BJ, 2008, MED MYCOL, V46, P541, DOI 10.1080/13693780801968571; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; Chowdhary A, 2016, J HOSP INFECT, V94, P209, DOI 10.1016/j.jhin.2016.08.004; Cuellar-Cruz M, 2008, EUKARYOT CELL, V7, P814, DOI 10.1128/EC.00011-08; De Backer MD, 1999, YEAST, V15, P1609, DOI 10.1002/(SICI)1097-0061(199911)15:15<1609::AID-YEA485>3.3.CO;2-P; Desnos-Ollivier M, 2011, J CLIN MICROBIOL, V49, P2304, DOI 10.1128/JCM.00325-11; Enkler L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35766; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Kick L, 2017, BIOENGINEERED, V8, P280, DOI 10.1080/21655979.2017.1299834; Krappmann S, 2017, MED MYCOL, V55, P16, DOI 10.1093/mmy/myw097; Lockhart SR, 2016, DIAGN MICR INFEC DIS, V84, P52, DOI 10.1016/j.diagmicrobio.2015.08.012; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; Mitchell AP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006209; Norton EL, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00217-17, 10.1128/msphere.00217-17]; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schelenz S, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0132-5; Sharma C., 2016, New Microbes and New Infections, V13, P77, DOI 10.1016/j.nmni.2016.07.003; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sun C, 2014, CHEM COMMUN, V50, P11536, DOI 10.1039/c4cc04730c; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389	32	4	4	6	6	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	MAY-JUN	2017	2	3							e00218-17	10.1128/mSphere.00218-17				9	Microbiology	Microbiology	FB9ZG	WOS:000406497300029					2018-01-05	
J	Masroori, N; Cherry, P; Merindol, N; Li, JX; Dufour, C; Poulain, L; Plourde, MB; Berthoux, L				Masroori, Nasser; Cherry, Pearl; Merindol, Natacha; Li, Jia-xin; Dufour, Caroline; Poulain, Lina; Plourde, Melodie B.; Berthoux, Lionel			Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines	MSPHERE			English	Article						HIV-1; PML; TRIM19; TRIM5 alpha; innate immunity; interferon; restriction factors	PROMYELOCYTIC LEUKEMIA PROTEIN; IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR-BODIES; ANTIVIRAL DEFENSE; TRIM5-ALPHA; INTERFERON; RESISTANCE; EXPRESSION; REPLICATION; RETROVIRUS	The PML (promyelocytic leukemia) protein is a member of the TRIM family, a large group of proteins that show high diversity in functions but possess a common tripartite motif giving the family its name. We and others recently reported that both murine PML (mPML) and human PML (hPML) strongly restrict the early stages of infection by HIV-1 and other lentiviruses when expressed in mouse embryonic fibroblasts (MEFs). This restriction activity was found to contribute to the type I interferon (IFN-I)-mediated inhibition of HIV-1 in MEFs. Additionally, PML caused transcriptional repression of the HIV-1 promoter in MEFs. In contrast, the modulation of the early stages of HIV-1 infection of human cells by PML has been investigated by RNA interference, with unclear results. In order to conclusively determine whether PML restricts HIV-1 or not in human cells, we used the clustered regularly interspaced short palindromic repeat with Cas9 (CRISPR-Cas9) system to knock out its gene in epithelial, lymphoid, and monocytic human cell lines. Infection challenges showed that PML knockout had no effect on the permissiveness of these cells to HIV-1 infection. IFN-I treatments inhibited HIV-1 equally whether PML was expressed or not. Overexpression of individual hPML isoforms, or of mPML, in a human T cell line did not restrict HIV-1. The presence of PML was not required for the restriction of nonhuman retroviruses by TRIM5 alpha (another human TRIM protein), and TRIM5 alpha was inhibited by arsenic trioxide through a PML-independent mechanism. We conclude that PML is not a restriction factor for HIV-1 in human cell lines representing diverse lineages. IMPORTANCE PML is involved in innate immune mechanisms against both DNA and RNA viruses. Although the mechanism by which PML inhibits highly divergent viruses is unclear, it was recently found that it can increase the transcription of interferon-stimulated genes (ISGs). However, whether human PML inhibits HIV-1 has been debated. Here we provide unambiguous, knockout-based evidence that PML does not restrict the early postentry stages of HIV-1 infection in a variety of human cell types and does not participate in the inhibition of HIV-1 by IFN-I. Although this study does not exclude the possibility of other mechanisms by which PML may interfere with HIV-1, we nonetheless demonstrate that PML does not generally act as an HIV-1 restriction factor in human cells and that its presence is not required for IFN-I to stimulate the expression of anti-HIV-1 genes. These results contribute to uncovering the landscape of HIV-1 inhibition by ISGs in human cells.	[Berthoux, Lionel] Univ Quebec Trois Rivieres, Lab Antiviral Immun, Dept Med Biol, Trois Rivieres, PQ, Canada; Univ Quebec Trois Rivieres, BioMed Res Grp, Trois Rivieres, PQ, Canada	Berthoux, L (reprint author), Univ Quebec Trois Rivieres, Lab Antiviral Immun, Dept Med Biol, Trois Rivieres, PQ, Canada.	berthoux@uqtr.ca					Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI 10.1089/ARS.2008.2270; Bell P, 2001, J VIROL, V75, P7683, DOI 10.1128/JVI.75.16.7683-7691.2001; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Berthoux L, 2004, J VIROL, V78, P11739, DOI 10.1128/JVI.78.21.11739-11750.2004; Berthoux L, 2003, J VIROL, V77, P3167, DOI 10.1128/JVI.77.5.3167-3180.2003; Blondel D, 2002, ONCOGENE, V21, P7957, DOI 10.1038/sj.onc.1205931; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Chelbi-Alix MK, 1998, J VIROL, V72, P1043; Cuchet D, 2011, J CELL SCI, V124, P280, DOI 10.1242/jcs.075390; Diaz-Griffero F, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-38; Dutrieux J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005280; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Grotzinger T, 1996, EUR J BIOCHEM, V238, P554, DOI 10.1111/j.1432-1033.1996.0554z.x; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kahle T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010002; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kim YE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004785; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lusic M, 2013, CELL HOST MICROBE, V13, P665, DOI 10.1016/j.chom.2013.05.006; Maroui MA, 2011, J VIROL, V85, P13164, DOI 10.1128/JVI.05808-11; Masroori N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0253-1; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; Mitchell AM, 2014, J VIROL, V88, P925, DOI 10.1128/JVI.02922-13; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nepveu-Traversy ME, 2016, HELIYON, V2; Pacheco B, 2016, SCI REP-UK, V6, DOI 10.1038/srep37489; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/orlagh.00031-06; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pham QT, 2010, GENE THER, V17, P859, DOI 10.1038/gt.2010.40; Pizzato M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005050; Plourde MB, 2013, INT J BIOCHEM CELL B, V45, P826, DOI 10.1016/j.biocel.2013.01.013; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Regad T, 2001, EMBO J, V20, P3495, DOI 10.1093/emboj/20.13.3495; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roberts RM, 1998, J INTERF CYTOK RES, V18, P805, DOI 10.1089/jir.1998.18.805; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sebastian S, 2006, J VIROL, V80, P2051, DOI 10.1128/JVI.80.4.2051-2054.2006; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimoda K, 2002, J IMMUNOL, V169, P4707, DOI 10.4049/jimmunol.169.9.4707                                                     ; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Wang ZG, 1998, NAT GENET, V20, P266; Woodhall DL, 2006, J BIOL CHEM, V281, P37652, DOI 10.1074/jbc.M604273200; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	61	0	0	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	MAY-JUN	2017	2	3							e00233-17	10.1128/mSphereDirect.00233-17				20	Microbiology	Microbiology	FB9ZG	WOS:000406497300031		gold			2018-01-05	
J	Norton, EL; Sherwood, RK; Bennett, RJ				Norton, Emily L.; Sherwood, Racquel K.; Bennett, Richard J.			Development of a CRISPR-Cas9 System for Efficient Genome Editing of Candida lusitaniae	MSPHERE			English	Article						CRISPR; DNA double-strand break; homology-directed repair; nonhomologous end joining	CANCER-PATIENTS; EVOLUTION; PATHOGEN; FUNGEMIA; SEX	Candida lusitaniae is a member of the Candida clade that includes a diverse group of fungal species relevant to both human health and biotechnology. This species exhibits a full sexual cycle to undergo interconversion between haploid and diploid forms. C. lusitaniae is also an emerging opportunistic pathogen that can cause serious bloodstream infections in the clinic and yet has often proven to be refractory to facile genetic manipulations. In this work, we develop a clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated gene 9 (Cas9) system to enable genome editing of C. lusitaniae. We demonstrate that expression of CRISPR-Cas9 components under species-specific promoters is necessary for efficient gene targeting and can be successfully applied to multiple genes in both haploid and diploid isolates. Gene deletion efficiencies with CRISPR-Cas9 were further enhanced in C. lusitaniae strains lacking the established nonhomologous end joining (NHEJ) factors Ku70 and DNA ligase 4. These results indicate that NHEJ plays an important role in directing the repair of DNA double-strand breaks (DSBs) in C. lusitaniae and that removal of this pathway increases integration of gene deletion templates by homologous recombination. The described approaches significantly enhance the ability to perform genetic studies in, and promote understanding of, this emerging human pathogen and model sexual species. IMPORTANCE The ability to perform efficient genome editing is a key development for detailed mechanistic studies of a species. Candida lusitaniae is an important member of the Candida clade and is relevant both as an emerging human pathogen and as a model for understanding mechanisms of sexual reproduction. We highlight the development of a CRISPR-Cas9 system for efficient genome manipulation in C. lusitaniae and demonstrate the importance of species-specific promoters for expression of CRISPR components. We also demonstrate that the NHEJ pathway contributes to non-template-mediated repair of DNA DSBs and that removal of this pathway enhances efficiencies of gene targeting by CRISPR-Cas9. These results therefore establish important genetic tools for further exploration of C. lusitaniae biology.	[Norton, Emily L.; Sherwood, Racquel K.; Bennett, Richard J.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Bennett, RJ (reprint author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Richard_Bennett@brown.edu			National Science Foundation [MCB1516651]	This work was supported by National Science Foundation grant MCB1516651 to R.J.B.	Asner SA, 2015, ANTIMICROB AGENTS CH, V59, P7715, DOI 10.1128/AAC.02204-15; Atkinson BJ, 2008, MED MYCOL, V46, P541, DOI 10.1080/13693780801968571; BLINKHORN RJ, 1989, J CLIN MICROBIOL, V27, P236; Bloomfield G, 2016, SEMIN CELL DEV BIOL, V54, P158, DOI 10.1016/j.semcdb.2016.01.026; Breuer U, 2006, YEAST, V23, P415, DOI 10.1002/yea.1374; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Centers for Disease Control and Prevention, 2016, GLOB EM INV INF CAUS; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; CHRISTENSON JC, 1987, PEDIATR INFECT DIS J, V6, P755, DOI 10.1097/00006454-198708000-00013; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Ene IV, 2014, NAT REV MICROBIOL, V12, P239, DOI 10.1038/nrmicro3236; Fell VL, 2015, MUTAT RES-REV MUTAT, V763, P15, DOI 10.1016/j.mrrev.2014.06.002; Foureau E, 2013, BIOTECHNOL LETT, V35, P1035, DOI 10.1007/s10529-013-1169-7; Giri S, 2012, INDIAN J MED MICROBI, V30, P270, DOI 10.4103/0255-0857.99484; Grahl N, 2017, MSPHERE, V2, DOI [10.1128/msphere.00218-17, 10.1128/mSphere.00218-17]; Hawkins JL, 2003, CLIN INFECT DIS, V36, pE14, DOI 10.1086/344651; Hogan DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149998; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Krappmann Sven, 2007, Fungal Biology Reviews, V21, P25, DOI 10.1016/j.fbr.2007.02.004; Lam I., 2014, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A016634; Larkin E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.02396-16, 10.1128/AAC.02396-16]; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; Minari A, 2001, CLIN INFECT DIS, V32, P186, DOI 10.1086/318473; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ng H., 2017, mSphere, V2, pe00385, DOI 10.1128/msphere.00385-16; Papon N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003550; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Sherwood RK, 2014, NATURE, V506, P387, DOI 10.1038/nature12891; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; STRATI F, 2016, FRONT MICROBIOL, V7, DOI DOI 10.3389/FMICB.2016; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248	35	3	3	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	MAY-JUN	2017	2	3							e00217-17	10.1128/mSphere.00217-17				10	Microbiology	Microbiology	FB9ZG	WOS:000406497300028					2018-01-05	
J	Jordan, B				Jordan, Bertrand			A new milestone in human embryo editing	M S-MEDECINE SCIENCES			English	Article							CRISPR	Viable human embryos carrying a disease mutation have now been corrected by CRISPR-Cas9 editing. Although the correction is not perfect, and the embryos have not been implanted, this brings us closer to human germline editing and to the associated ethical questions.	[Jordan, Bertrand] Univ EFS CNRS, Marseille, France	Jordan, B (reprint author), Univ EFS CNRS, Marseille, France.	bertrand.jordan@univ-amu.fr					Hohmann S, 2017, MOL GENET GENOMICS, V292, P535, DOI 10.1007/s00438-017-1300-x; Jordan B, 2016, M S-MED SCI, V32, P1035, DOI 10.1051/medsci/20163211024; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Ledford H, 2017, NATURE, V542, P401, DOI 10.1038/nature.2017.21502; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z	6	0	0	7	7	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0767-0974			M S-MED SCI	M S-Med. Sci.	MAY	2017	33	5					549	551		10.1051/medsci/20173305021                                                      				3	Medicine, Research & Experimental	Research & Experimental Medicine	FB0ZB	WOS:000405872400021	28612733				2018-01-05	
J	Huang, LD; Fernandes, H; Zia, H; Tavassoli, P; Rennert, H; Pisapia, D; Imielinski, M; Sboner, A; Rubin, MA; Kluk, M; Elemento, O				Huang, Linda; Fernandes, Helen; Zia, Hamid; Tavassoli, Peyman; Rennert, Hanna; Pisapia, David; Imielinski, Marcin; Sboner, Andrea; Rubin, Mark A.; Kluk, Michael; Elemento, Olivier			The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations	JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION			English	Article						precision medicine; database; cancer genomics; clinical reporting; pathology; application-programming interface	VARIANTS	Objective: This paper describes the Precision Medicine Knowledge Base (PMKB; https://pmkb.weill.cornell.edu), an interactive online application for collaborative editing, maintenance, and sharing of structured clinical-grade cancer mutation interpretations. Materials and Methods: PMKB was built using the Ruby on Rails Web application framework. Leveraging existing standards such as the Human Genome Variation Society variant description format, we implemented a data model that links variants to tumor-specific and tissue-specific interpretations. Key features of PMKB include support for all major variant types, standardized authentication, distinct user roles including high-level approvers, and detailed activity history. A REpresentational State Transfer (REST) application-programming interface (API) was implemented to query the PMKB programmatically. Results: At the time of writing, PMKB contains 457 variant descriptions with 281 clinical-grade interpretations. The EGFR, BRAF, KRAS, and KIT genes are associated with the largest numbers of interpretable variants. PMKB's interpretations have been used in over 1500 AmpliSeq tests and 750 whole-exome sequencing tests. The interpretations are accessed either directly via the Web interface or programmatically via the existing API. Discussion: An accurate and up-to-date knowledge base of genomic alterations of clinical significance is critical to the success of precision medicine programs. The open-access, programmatically accessible PMKB represents an important attempt at creating such a resource in the field of oncology. Conclusion: The PMKB was designed to help collect and maintain clinical-grade mutation interpretations and facilitate reporting for clinical cancer genomic testing. The PMKB was also designed to enable the creation of clinical cancer genomics automated reporting pipelines via an API.	[Huang, Linda; Fernandes, Helen; Zia, Hamid; Tavassoli, Peyman; Pisapia, David; Imielinski, Marcin; Sboner, Andrea; Rubin, Mark A.; Kluk, Michael; Elemento, Olivier] Weill Cornell Med, Inst Precis Med, New York, NY 10065 USA; [Huang, Linda; Sboner, Andrea; Elemento, Olivier] Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA; [Fernandes, Helen; Zia, Hamid; Tavassoli, Peyman; Rennert, Hanna; Pisapia, David; Imielinski, Marcin; Sboner, Andrea; Rubin, Mark A.; Kluk, Michael] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA	Rubin, MA; Kluk, M; Elemento, O (reprint author), Weill Cornell Med, Inst Precis Med, New York, NY 10065 USA.; Elemento, O (reprint author), Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA.; Rubin, MA; Kluk, M (reprint author), Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA.	rubinma@med.cornell.edu; mik9095@med.cornell.edu; ole2001@med.cornell.edu			National Science Foundation [DB1054964]; National Institutes of Health [R01CA194547]; Hirschl Trust	This work was supported by a CAREER grant from the National Science Foundation (DB1054964), National Institutes of Health grant R01CA194547, and the Hirschl Trust.	Beltran H, 2015, JAMA ONCOL, V1, P466, DOI 10.1001/jamaoncol.2015.1313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ603; Yates A, 2015, BIOINFORMATICS, V31, P143, DOI 10.1093/bioinformatics/btu613	11	2	2	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1067-5027	1527-974X		J AM MED INFORM ASSN	J. Am. Med. Inf. Assoc.	MAY	2017	24	3					513	519		10.1093/jamia/ocw148				7	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	Computer Science; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	FA7HP	WOS:000405616900007	27789569	gold			2018-01-05	
J	Chipman, AD				Chipman, Ariel D.			Oncopeltus fasciatus as an evo-devo research organism	GENESIS			English	Review						appendages; arthropod; comparative embryology; extraembryonic membranes; model organism; segmentation	MILKWEED BUG-ONCOPELTUS; INTERMEDIATE GERMBAND INSECT; HEMIMETABOLOUS INSECT; FUNCTIONAL ANALYSES; GAP GENE; HEMIPTERA-LYGAEIDAE; CELL SPECIFICATION; RNAI ANALYSIS; SEGMENTATION; EVOLUTION	The large milkweed bug Oncopeltus fasciatus was one of the main study insects for a range of biological questions throughout much of the 20th century. Its importance waned with the introduction of Drosophila melanogaster as a genetic model organism. The evo-devo revolution of the turn of the century re-introduced Oncopeltus into the scientific community, and it has proved increasingly useful, mostly within a comparative context for evolution driven research. The last few years have seen a number of significant contributions to our understanding of the evolution of developmental processes in insects, and in arthropods in general, arise from work on Oncopeltus. This review presents some of the key studies and shows how they have provided new insights into evolutionary questions. The advent of whole genome sequencing and genome editing techniques is reducing the gap between Drosophila and (re-)emerging systems such as Oncopeltus. We expect that the ease of work on Oncopeltus and its pivotal phylogenetic position will contribute to the expansion of its use within the evo-devo community and more broadly in arthropod research.	[Chipman, Ariel D.] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Edmond J Safra Campus, IL-91904 Jerusalem, Israel	Chipman, AD (reprint author), Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	Ariel.chipman@huji.ac.il		Chipman, Ariel/0000-0001-6696-840X			Abzhanov A, 2000, DEV BIOL, V227, P673, DOI 10.1006/dbio.2000.9904; AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; Akam M, 2000, P NATL ACAD SCI USA, V97, P4438, DOI 10.1073/pnas.97.9.4438; ANDRE FLOYD, 1934, IOWA STATE COLL JOUR SCI, V9, P73; Angelini DR, 2005, DEV BIOL, V286, P57, DOI 10.1016/j.ydbio.2005.07.006; Angelini DR, 2005, DEV BIOL, V283, P409, DOI 10.1016/j.ydbio.2005.04.034; Angelini DR, 2004, DEV BIOL, V271, P306, DOI 10.1016/j.ydbio.2004.04.005; Ben-David J, 2010, DEV BIOL, V346, P140, DOI 10.1016/j.ydbio.2010.07.010; Benton MA, 2016, CURR BIOL, V26, P1609, DOI 10.1016/j.cub.2016.04.055; Birkan M, 2011, EVOL DEV, V13, P436, DOI 10.1111/j.1525-142X.2011.00497.x; Butt F. H., 1949, CORNELL EXPT STATION, V283, P3; CAVE MD, 1975, J CELL BIOL, V66, P461, DOI 10.1083/jcb.66.3.461                                                            ; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Chipman AD, 2008, EVOLVING PATHWAYS KE, P339; Duncan EJ, 2013, DEV BIOL, V377, P245, DOI 10.1016/j.ydbio.2013.02.010; El-Sherif E, 2012, DEVELOPMENT, V139, P4341, DOI 10.1242/dev.085126; Ellango R, 2016, APPL BIOCHEM BIOTECH, V179, P1393, DOI 10.1007/s12010-016-2072-1; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; Ewen-Campen B, 2013, BIOL OPEN, V2, P556, DOI 10.1242/bio.20134390; Ewen-Campen B, 2013, CURR BIOL, V23, P835, DOI 10.1016/j.cub.2013.03.063; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; FEIR D, 1974, ANNU REV ENTOMOL, V19, P81, DOI 10.1146/annurev.en.19.010174.000501                                             ; Francischetti IMB, 2007, INSECT BIOCHEM MOLEC, V37, P903, DOI 10.1016/j.ibmb.2007.04.007; French V, 2001, CURR BIOL, V11, pR910, DOI 10.1016/S0960-9822(01)00552-8; Grimaldi David, 2005, pi; Herke SW, 2005, DEVELOPMENT, V132, P27, DOI 10.1242/dev.01561; Horn T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00303; Hrycaj S, 2008, EVOL DEV, V10, P705, DOI 10.1111/j.1525-142X.2008.00284.x; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; Jockusch E. L., 2015, EVOLUTIONARY DEV BIO, V5, P111; LAWRENCE PA, 1973, J EMBRYOL EXP MORPH, V30, P681; LAWRENCE PA, 1966, J EXP BIOL, V44, P607; LAWRENCE PA, 1970, GENET RES, V15, P347, DOI 10.1017/S0016672300001713                                                       ; LAWRENCE PA, 1966, J CELL SCI, V1, P475; LAWRENCE PA, 1969, DEV BIOL, V19, P12, DOI 10.1016/0012-1606(69)90068-2; LAWRENCE PA, 1975, J CELL BIOL, V65, P373; Liu J, 2016, GENETICS, V203, P403, DOI 10.1534/genetics.115.186684; Liu J, 2014, EVOL DEV, V16, P270, DOI 10.1111/ede.12090; Liu PZ, 2010, DEVELOPMENT, V137, P835, DOI 10.1242/dev.045948; Liu PZ, 2005, EVOL DEV, V7, P629, DOI 10.1111/j.1525-142X.2005.05066.x                                                ; Liu PZ, 2005, DEVELOPMENT, V132, P2081, DOI 10.1242/dev.01807; Liu PZ, 2004, DEVELOPMENT, V131, P4567, DOI 10.1242/dev.01311; Liu PZ, 2004, DEVELOPMENT, V131, P1515, DOI 10.1242/dev.01046; Lynch JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002029; MCDOWELL RE, 1974, INSECT BIOCHEM, V4, P295, DOI 10.1016/0020-1790(74)90052-3; Medved V, 2015, P NATL ACAD SCI USA, V112, P15946, DOI 10.1073/pnas.1509517112; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Panfilio KA, 2006, DEV BIOL, V292, P226, DOI 10.1016/j.ydbio.2005.12.028; Panfilio KA, 2008, DEV BIOL, V313, P471, DOI 10.1016/j.ydbio.2007.11.004; Panfilio KA, 2010, DEV BIOL, V340, P100, DOI 10.1016/j.ydbio.2009.12.034; Panfilio KA, 2009, DEV BIOL, V333, P297, DOI 10.1016/j.ydbio.2009.06.036; PATEL NH, 1994, DEVELOPMENT, P201; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Posnien N, 2010, ARTHROPOD STRUCT DEV, V39, P399, DOI 10.1016/j.asd.2010.08.002; Posnien N, 2010, DEV BIOL, V338, P107, DOI 10.1016/j.ydbio.2009.11.010; Posnien N, 2009, EVOL DEV, V11, P480, DOI 10.1111/j.1525-142X.2009.00356.x; Prpic NM, 2003, DEV BIOL, V264, P119, DOI 10.1016/j.ydbio.2003.08.002; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Rogers BT, 2002, EVOL DEV, V4, P96, DOI 10.1046/j.1525-142X.2002.01065.x                                                ; Schaeper ND, 2013, DEV GENES EVOL, V223, P341, DOI 10.1007/s00427-013-0449-5; Schinko JB, 2008, DEV BIOL, V317, P600, DOI 10.1016/j.ydbio.2008.03.005; Schmidt-Ott U, 2016, CURR OPIN INSECT SCI, V13, P86, DOI 10.1016/j.cois.2016.01.009; Sharma AI, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0053-7; SHELTON PMJ, 1974, J EMBRYOL EXP MORPH, V32, P337; Simon S, 2012, GENOME BIOL EVOL, V4, P1295, DOI 10.1093/gbe/evs104; Stahi R, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1745; TAUTZ D, 1995, TRENDS GENET, V11, P23, DOI 10.1016/S0168-9525(00)88982-9; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Weisbrod A, 2013, DEV BIOL, V380, P125, DOI 10.1016/j.ydbio.2013.04.030; WRIGHT DA, 1981, DEV BIOL, V85, P317, DOI 10.1016/0012-1606(81)90263-3	72	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	MAY	2017	55	5			SI				e23020	10.1002/dvg.23020				10	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	EX6OQ	WOS:000403362000004					2018-01-05	
J	Cinpolat, O; Unal, ZN; Ismi, O; Gorur, A; Unal, M				Cinpolat, Ovgu; Unal, Zeynep Nil; Ismi, Onur; Gorur, Aysegul; Unal, Murat			Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: a prospective, case-control study	BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY			English	Article						Salivary gland tumor; MicroRNA; miR-21; miR-30e; Pathogenesis	SQUAMOUS-CELL CARCINOMA; ORAL-CANCER; PAROTID-GLAND; EXPRESSION; HEAD; METASTASIS; FREQUENT; CLUSTER; GENES	Introduction: Salivary gland tumors (SGTs) are rare head and neck malignancies consisting of a spectrum of tumors with different biological behaviors. Objective: In this study we aimed to find out differential expression of microRNA profiles between benign and malignant SGTs. Methods: We investigated the possible role of 95 microRNAs in the 20 patients with salivary gland tumors with comparison of 17 patients without malignancy or salivary gland diseases. Sixteen of the tumors were benign (seven pleomorphic adenomas, nine Warthin tumors), four of them were malignant (two squamous cell carcinomas, one high grade mucoepidermoid carcinoma, one adenocarcinoma). Serum and saliva samples were collected from both patients and control group. Tissue samples of tumor masses were also collected from patient group. Results: Among studied microRNAs miR-21, miR-23a, miR-27a, miR-223, miR-125b, miR-126, miR-146a, miR-30e were down regulated in the benign group compared to control group in the serum samples (p-values are 0.04, 0.00005, 0.00005, 0.0022, 0.031, 0.00008, 0.044, and 0.0007, respectively). When tissue samples were studied miR-21, miR-31, miR-199a-5p, miR-146b, miR-345 were up-regulated in the malignant group compared to benign group (p-values are 0.006, 0.02, 0.013, 0.013, 0.041, respectively). miR-30e showed statistically significant up-regulation in malignant tumor group's plasma samples compared to benign group (p = 0.034). There was no statistically significant difference in saliva samples between groups. Conclusion: Our results showed that different microRNAs may play role in salivary tumor pathogenesis according to biological behavior. Although there was no difference in saliva samples between groups, according to tissue and serum samples miR-21 and 30e may have an important role; since they were down-regulated in benign tumors whereas up-regulated in malignant ones. (C) 2016 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.	[Cinpolat, Ovgu] Gaziantep State Hosp, Gaziantep, Turkey; [Unal, Zeynep Nil] Mersin Univ, Fac Pharm, Dept Biochem, Mersin, Turkey; [Ismi, Onur; Unal, Murat] Mersin Univ, Fac Med, Dept Otorhinolaryngol, Mersin, Turkey; [Gorur, Aysegul] Mersin Univ, Dept Med Biochem, Fac Med, Mersin, Turkey	Ismi, O (reprint author), Mersin Univ, Fac Med, Dept Otorhinolaryngol, Mersin, Turkey.	dronurismi@outlook.com			Mersin University Academic Research Project Unit	Funding of this study was maintained by Mersin University Academic Research Project Unit.	Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chen W, 2014, ONCOL LETT, V7, P2029, DOI 10.3892/ol.2014.1975; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chou CK, 2013, J CLIN ENDOCR METAB, V98, pE196, DOI 10.1210/jc.2012-2666; Clauditz TS, 2012, DIAGN MOL PATHOL, V21, P134, DOI 10.1097/PDM.0b013e318255552c; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; El-Halawany MS, 2015, BIOMED RES INT, DOI 10.1155/2015/649750; Eveson JW, 2005, WHO CLASSIFICATION T, P221; Fuziwara CS, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/743450; GAUGHAN RK, 1992, ARCH OTOLARYNGOL, V118, P798; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; He QT, 2013, BBA-GEN SUBJECTS, V1830, P5258, DOI 10.1016/j.bbagen.2013.07.028; Hebrant A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103871; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Jevnaker AM, 2008, ARCH ORAL BIOL, V53, P629, DOI 10.1016/j.archoralbio.2008.01.014; Kim BK, 2015, BMB REP; Kiss O, 2015, VIRCHOWS ARCH; Kiss O, 2015, PATHOL ONCOL RES, V21, P29, DOI 10.1007/s12253-014-9770-1; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SW, 2001, AM J OTOLARYNG, V22, P400, DOI 10.1053/ajot.2001.28068; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu L, 2013, J ORAL PATHOL MED, V42, P140, DOI 10.1111/j.1600-0714.2012.01189.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066778; Muscat JE, 1998, OTOLARYNG HEAD NECK, V118, P195, DOI 10.1016/S0194-5998(98)80013-2; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Peng FS, 2015, ONCOL REP, V33, P942, DOI 10.3892/or.2014.3664; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schou JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099886; Speight PM, 2002, ORAL DIS, V8, P229, DOI 10.1034/j.1601-0825.2002.02870.x                                                ; Veit JA, 2015, ANTICANCER RES, V35, P1271; Wang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098597; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298; Zhou JD, 2014, INT J CLIN EXP PATHO, V7, P7182	41	1	1	3	3	ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL	SAO PAULO	AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL	1808-8694	1808-8686		BRAZ J OTORHINOLAR	Braz. J. Otorhinolaryngol.	MAY-JUN	2017	83	3					276	284		10.1016/j.bjorl.2016.03.013				9	Otorhinolaryngology	Otorhinolaryngology	EZ1JM	WOS:000404467200007	27184509	gold			2018-01-05	
J	Chiurillo, MA; Lander, N; Bertolini, MS; Storey, M; Vercesi, AE; Docampo, R				Chiurillo, Miguel A.; Lander, Noelia; Bertolini, Mayara S.; Storey, Melissa; Vercesi, Anibal E.; Docampo, Roberto			Different Roles of Mitochondrial Calcium Uniporter Complex Subunits in Growth and Infectivity of Trypanosoma cruzi	MBIO			English	Article						calcium signaling; mitochondria; Trypanosoma; uniporter	IN-SITU; CA2+ UPTAKE; ESSENTIAL COMPONENT; CELL BIOENERGETICS; LIPID-COMPOSITION; CA-2+ TRANSPORT; CULTURE FORMS; METABOLISM; AUTOPHAGY; EXPRESSION	Trypanosoma cruzi is the agent of Chagas disease, and the finding that this parasite possesses a mitochondrial calcium uniporter (TcMCU) with characteristics similar to that of mammalian mitochondria was fundamental for the discovery of the molecular nature of MCU in eukaryotes. We report here that ablation of TcMCU, or its paralog TcMCUb, by clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 led to a marked decrease in mitochondrial Ca2+ uptake without affecting the membrane potential of these cells, whereas overexpression of each gene caused a significant increase in the ability of mitochondria to accumulate Ca2+. While TcMCU-knockout (KO) epimastigotes were viable and able to differentiate into trypomastigotes, infect host cells, and replicate normally, ablation of TcMCUb resulted in epimastigotes having an important growth defect, lower rates of respiration and metacyclogenesis, more pronounced autophagy changes under starvation, and significantly reduced infectivity. Overexpression of TcMCUb, in contrast to what was proposed for its mammalian ortholog, did not result in a dominant negative effect on TcMCU. IMPORTANCE The finding of a mitochondrial calcium uniporter (MCU) in Trypanosoma cruzi was essential for the discovery of the molecular nature of this transporter in mammals. In this work, we used the CRISPR/Cas9 technique that we recently developed for T. cruzi to knock out two components of the uniporter: MCU, the pore subunit, and MCUb, which was proposed as a negative regulator of MCU in human cells. In contrast to what occurs in human cells, MCU is not essential, while MCUb is essential for growth, differentiation, and infectivity; has a bioenergetic role; and does not act as a dominant negative subunit of MCU.	[Chiurillo, Miguel A.; Lander, Noelia; Bertolini, Mayara S.; Vercesi, Anibal E.; Docampo, Roberto] Univ Estadual Campinas, Dept Patol Clin, Campinas, SP, Brazil; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Chiurillo, MA; Docampo, R (reprint author), Univ Estadual Campinas, Dept Patol Clin, Campinas, SP, Brazil.; Docampo, R (reprint author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	mchiurillo@yahoo.com; rdocampo@uga.edu			Sao Paulo Research Foundation (FAPESP), Brazil [2013/50624-0]; U.S. National Institutes of Health [AI107663]; FAPESP [2014/08995-4, 2014/13148-9, 2015/25709-8]	Funding for this work was provided by the Sao Paulo Research Foundation (FAPESP), Brazil (2013/50624-0), and the U.S. National Institutes of Health (grant AI107663). N.L. and M.A.C. are postdoctoral fellows of FAPESP (grants 2014/08995-4 and 2014/13148-9, respectively). M.S.B. is a Master's fellow of FAPESP (grant 2015/25709-8).	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Bourguignon SC, 1998, HISTOCHEM CELL BIOL, V110, P527, DOI 10.1007/s004180050314; Brennand Ana, 2012, Cells, V1, P346, DOI 10.3390/cells1030346; CARAFOLI E, 1970, BIOCHIM BIOPHYS ACTA, V205, P18, DOI 10.1016/0005-2728(70)90057-5; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; DOCAMPO R, 1978, BIOCHIM BIOPHYS ACTA, V502, P466, DOI 10.1016/0005-2728(78)90079-8                                                    ; DOCAMPO R, 1989, ARCH BIOCHEM BIOPHYS, V272, P122, DOI 10.1016/0003-9861(89)90202-6; Docampo R, 2014, MOL BIOCHEM PARASIT, V196, P108, DOI 10.1016/j.molbiopara.2014.09.001; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Irigoin F, 2009, BIOCHEM J, V418, P595, DOI 10.1042/BJ20081981; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Kovacs-Bogdan E, 2014, P NATL ACAD SCI USA, V111, P8985, DOI 10.1073/pnas.1400514111; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li FJ, 2017, AUTOPHAGY, V13, P715, DOI 10.1080/15548627.2017.1280218; Li FJ, 2012, CELL MICROBIOL, V14, P1242, DOI 10.1111/j.1462-5822.2012.01795.x; Lorenzi HA, 2003, GENE, V310, P91, DOI 10.1016/S0378-1119(03)00502-X; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Maugeri DA, 2011, ESSAYS BIOCHEM, V51, P15, DOI [10.1042/bse0510015, 10.1042/BSE0510015]; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; OLIVEIRA MM, 1977, COMP BIOCHEM PHYS B, V58, P195, DOI 10.1016/0305-0491(77)90109-2                                                    ; Oxenoid K, 2016, NATURE, V533, P269, DOI 10.1038/nature17656; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; ROGERSON GW, 1980, INT J PARASITOL, V10, P131, DOI 10.1016/0020-7519(80)90024-7; ROGERSON GW, 1979, INT J BIOCHEM, V10, P1019, DOI 10.1016/0020-711X(79)90083-1; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; RYLEY JF, 1956, BIOCHEM J, V62, P215, DOI 10.1042/bj0620215                                                               ; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202                                                       ; Smaili SS, 2013, CURR MOL MED, V13, P252; Tomar D, 2016, CELL REP, V15, P1673, DOI 10.1016/j.celrep.2016.04.050; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499	49	0	0	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	MAY-JUN	2017	8	3							e00574-17	10.1128/mBio.00574-17				16	Microbiology	Microbiology	EZ5DU	WOS:000404733300035		gold			2018-01-05	
J	Dhingra, SK; Redhi, D; Combrinck, JM; Yeo, T; Okombo, J; Henrich, PP; Cowell, AN; Gupta, P; Stegman, ML; Hoke, JM; Cooper, RA; Winzeler, E; Mok, S; Egan, TJ; Fidock, DA				Dhingra, Satish K.; Redhi, Devasha; Combrinck, Jill M.; Yeo, Tomas; Okombo, John; Henrich, Philipp P.; Cowell, Annie N.; Gupta, Purva; Stegman, Matthew L.; Hoke, Jonathan M.; Cooper, Roland A.; Winzeler, Elizabeth; Mok, Sachel; Egan, Timothy J.; Fidock, David A.			A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug Piperaquine	MBIO			English	Article						malaria; PfCRT; Plasmodium falciparum; artemisinin-based combination therapies; digestive vacuole; genome editing; heme detoxification; piperaquine resistance	PFMDR1 COPY NUMBER; IN-VITRO SENSITIVITIES; DNA-SEQUENCING DATA; SUB-SAHARAN AFRICA; CHLOROQUINE RESISTANCE; DIHYDROARTEMISININ-PIPERAQUINE; ARTEMISININ RESISTANCE; COMBINATION THERAPIES; WESTERN CAMBODIA; DIGESTIVE VACUOLE	Current efforts to reduce the global burden of malaria are threatened by the rapid spread throughout Asia of Plasmodium falciparum resistance to artemisinin-based combination therapies, which includes increasing rates of clinical failure with dihydroartemisinin plus piperaquine (PPQ) in Cambodia. Using zinc finger nuclease-based gene editing, we report that addition of the C101F mutation to the chloroquine (CQ) resistance-conferring PfCRT Dd2 isoform common to Asia can confer PPQ resistance to cultured parasites. Resistance was demonstrated as significantly higher PPQ concentrations causing 90% inhibition of parasite growth (IC90) or 50% parasite killing (50% lethal dose [LD50]). This mutation also reversed Dd2-mediated CQ resistance, sensitized parasites to amodiaquine, quinine, and artemisinin, and conferred amantadine and blasticidin resistance. Using heme fractionation assays, we demonstrate that PPQ causes a buildup of reactive free heme and inhibits the formation of chemically inert hemozoin crystals. Our data evoke inhibition of heme detoxification in the parasite's acidic digestive vacuole as the primary mode of both the bis-aminoquinoline PPQ and the related 4-aminoquinoline CQ. Both drugs also inhibit hemoglobin proteolysis at elevated concentrations, suggesting an additional mode of action. Isogenic lines differing in their pfmdr1 copy number showed equivalent PPQ susceptibilities. We propose that mutations in PfCRT could contribute to a multifactorial basis of PPQ resistance in field isolates. IMPORTANCE The global agenda to eliminate malaria depends on the continued success of artemisinin-based combination therapies (ACTs), which target the asexual blood stages of the intracellular parasite Plasmodium. Partial resistance to artemisinin, however, is now established in Southeast Asia, exposing the partner drugs to increased selective pressure. Plasmodium falciparum resistance to the first-line partner piperaquine (PPQ) is now spreading rapidly in Cambodia, resulting in clinical treatment failures. Here, we report that a variant form of the Plasmodium falciparum chloroquine resistance transporter, harboring a C101F mutation edited into the chloroquine (CQ)-resistant Dd2 isoform prevalent in Asia, can confer PPQ resistance in cultured parasites. This was accompanied by a loss of CQ resistance. Biochemical assays showed that PPQ, like CQ, inhibits the detoxification of reactive heme that is formed by parasite-mediated catabolism of host hemoglobin. We propose that novel PfCRT variants emerging in the field could contribute to a multigenic basis of PPQ resistance.	[Dhingra, Satish K.; Yeo, Tomas; Henrich, Philipp P.; Mok, Sachel; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA; [Redhi, Devasha; Combrinck, Jill M.] Univ Cape Town, Div Pharmacol, Dept Med, Cape Town, South Africa; [Okombo, John; Egan, Timothy J.] Univ Cape Town, Dept Chem, Cape Town, South Africa; [Cowell, Annie N.] Univ Calif San Diego, Dept Internal Med, Div Infect Dis, San Diego, CA 92103 USA; [Gupta, Purva; Winzeler, Elizabeth] Univ Calif San Diego, Dept Pediat, Div Host Microbe Syst & Therapeut, San Diego, CA 92103 USA; [Stegman, Matthew L.; Cooper, Roland A.] Dominican Univ Calif San Rafael, Dept Nat Sci & Math, San Rafael, CA USA; [Hoke, Jonathan M.; Cooper, Roland A.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Fidock, David A.] Columbia Univ, Dept Med, Div Infect Dis, New York, NY 10027 USA	Fidock, DA (reprint author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA.; Fidock, DA (reprint author), Columbia Univ, Dept Med, Div Infect Dis, New York, NY 10027 USA.	df2260@cumc.columbia.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI50234, R01 AI124678, R01 AI71121, R01 AI110329, R01 AI103058]; National Research Foundation South Africa	This research was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award no. R01 AI50234 and R01 AI124678 to D.A.F., R01 AI71121 to J.M.H. and R.A.C., R01 AI110329 to T.J.E., and R01 AI103058 to E.A.W. and D.A.F. Devasha Redhi and Jill Combrinck thank the National Research Foundation South Africa for scholarship support. We also thank Tree Star, Inc., for their donation of a 1-year subscription to FloJo version 10 analysis software. The authors declare they have no conflicts of interest.	Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/s1473-3099(16)30409-1, 10.1016/S1473-3099(16)30409-1]; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Boni MF, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001984; Bray PG, 1998, MOL PHARMACOL, V54, P170; Breman Joel G., 2009, Science Progress, V92, P1, DOI 10.3184/003685009X440290; Bustos Maria D, 2013, Southeast Asian J Trop Med Public Health, V44 Suppl 1, P201; Chaorattanakawee S, 2015, ANTIMICROB AGENTS CH, V59, P4631, DOI 10.1128/AAC.00366-15; Chenet SM, 2016, J INFECT DIS, V213, P1472, DOI 10.1093/infdis/jiv752; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Combrinck JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0729-9; Combrinck JM, 2013, ACS CHEM BIOL, V8, P133, DOI 10.1021/cb300454t; Conrad MD, 2014, J INFECT DIS, V210, P344, DOI 10.1093/infdis/jiu141; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duru V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0539-5; Eastman RT, 2011, ANTIMICROB AGENTS CH, V55, P3908, DOI 10.1128/AAC.01793-10; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; EVANS SG, 1993, BIOCHEM PHARMACOL, V45, P1168, DOI 10.1016/0006-2952(93)90264-W; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(00)00084-8; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; Griffin CE, 2012, ANTIMICROB AGENTS CH, V56, P5356, DOI 10.1128/AAC.05667-11; Hao MM, 2013, ANTIMICROB AGENTS CH, V57, P1723, DOI 10.1128/AAC.02306-12; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; Hrycyna CA, 2014, ACS CHEM BIOL, V9, P722, DOI 10.1021/cb4008953; Huang F, 2015, J INFECT DIS, V212, P1629, DOI 10.1093/infdis/jiv249; Imwong M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17412; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Klonis N, 2013, CURR OPIN MICROBIOL, V16, P722, DOI 10.1016/j.mib.2013.07.005; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Lekostaj JK, 2008, BIOCHEMISTRY-US, V47, P10394, DOI 10.1021/bi8010658; Lewis IA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004085; Lim P, 2015, ANTIMICROB AGENTS CH, V59, P2934, DOI 10.1128/AAC.05163-14; Lukens AK, 2014, P NATL ACAD SCI USA, V111, P799, DOI 10.1073/pnas.1320886110; Makler MT, 1998, PARASITOL TODAY, V14, P376, DOI 10.1016/S0169-4758(98)01284-8; MalariaGEN Plasmodium falciparum Community Project, 2016, ELIFE, V5; Manary MJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-63; Maxmen A, 2016, NAT MED, V22, P220, DOI 10.1038/nm0316-220; Mbah MLN, 2015, AM J TROP MED HYG, V92, P555, DOI 10.4269/ajtmh.14-0490; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Nankabirwa JI, 2016, ANTIMICROB AGENTS CH, V60, P5649, DOI 10.1128/AAC.00920-16; Ngalah BS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08308; Nguyen TD, 2015, LANCET GLOB HEALTH, V3, pE758, DOI 10.1016/S2214-109X(15)00162-X; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Olafson KN, 2015, P NATL ACAD SCI USA, V112, P4946, DOI 10.1073/pnas.1501023112; Ouattara A, 2015, AM J TROP MED HYG, V92, P1202, DOI 10.4269/ajtmh.14-0605; Paguio MF, 2011, MOL BIOCHEM PARASIT, V178, P1, DOI 10.1016/j.molbiopara.2011.03.003; Papakrivos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039569; Pascual A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-431; Patil CY, 2014, ANN MED HEALTH SCI R, V4, P466, DOI 10.4103/2141-9248.139270; Pelleau S, 2015, P NATL ACAD SCI USA, V112, P11672, DOI 10.1073/pnas.1507142112; Petersen I, 2015, MOL MICROBIOL, V97, P381, DOI 10.1111/mmi.13035; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-89; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Pulcini S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14552; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Richards SN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005725; Roberts L, 2008, ANTIMICROB AGENTS CH, V52, P1840, DOI 10.1128/AAC.01478-07; Sa JM, 2011, ESSAYS BIOCHEM, V51, P137, DOI [10.1042/BSE0510137, 10.1042/bse0510137]; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Saunders DL, 2016, ANTIMICROB AGENTS CH, V60, P1896, DOI 10.1128/AAC.02302-15; Saunders DL, 2014, NEW ENGL J MED, V371, P484, DOI 10.1056/NEJMc1403007; Semenov A, 1998, ANTIMICROB AGENTS CH, V42, P2254; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Takala-Harrison S, 2015, ANN NY ACAD SCI, V1342, P62, DOI 10.1111/nyas.12766; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI [10.10164/j.pt.2016.05.010, 10.1016/j.pt.2016.05.010]; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Veiga MI, 2012, ANTIMICROB AGENTS CH, V56, P3615, DOI 10.1128/AAC.06350-11; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; Warhurst DC, 2007, BIOCHEM PHARMACOL, V73, P1910, DOI 10.1016/j.bcp.2007.03.011; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; World Health Organization (WHO), 2016, WORLD MALARIA REPORT; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI 10.1016/S1473-3099(16)30415-7; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; YAYON A, 1984, EMBO J, V3, P2695; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216	105	3	3	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	MAY-JUN	2017	8	3							e00303-17	10.1128/mBio.00303-17				19	Microbiology	Microbiology	EZ5DU	WOS:000404733300005		gold			2018-01-05	
J	Smollett, K; Blombach, F; Reichelt, R; Thomm, M; Werner, F				Smollett, Katherine; Blombach, Fabian; Reichelt, Robert; Thomm, Michael; Werner, Finn			A global analysis of transcription reveals two modes of Spt4/5 recruitment to archaeal RNA polymerase	NATURE MICROBIOLOGY			English	Article							METHANOCALDOCOCCUS METHANOCOCCUS JANNASCHII; MOLECULAR-MECHANISMS; PYROCOCCUS-FURIOSUS; FACTOR REQUIREMENTS; INITIATION-FACTOR; ESCHERICHIA-COLI; OPEN COMPLEX; START SITES; 3 DOMAINS; FACTOR-B	The archaeal transcription apparatus is closely related to the eukaryotic RNA polymerase (RNAP) II system, while archaeal genomes are more similar to bacteria with densely packed genes organized in operons. This makes understanding transcription in archaea vital, both in terms of molecular mechanisms and evolution. Very little is known about how archaeal cells orchestrate transcription on a systems level. We have characterized the genome-wide occupancy of the Methanocaldococcus jannaschii transcription machinery and its transcriptome. Our data reveal how the TATA and BRE promoter elements facilitate recruitment of the essential initiation factors TATA-binding protein and transcription factor B, respectively, which in turn are responsible for the loading of RNAP into the transcription units. The occupancies of RNAP and Spt4/5 strongly correlate with each other and with RNA levels. Our results show that Spt4/5 is a general elongation factor in archaea as its presence on all genes matches RNAP. Spt4/5 is recruited proximal to the transcription start site on the majority of transcription units, while on a subset of genes, including rRNA and CRISPR loci, Spt4/5 is recruited to the transcription elongation complex during early elongation within 500 base pairs of the transcription start site and akin to its bacterial homologue NusG.	[Smollett, Katherine; Blombach, Fabian; Werner, Finn] UCL, Inst Struct & Mol Biol, Gower St, London WC1E 6BT, England; [Reichelt, Robert; Thomm, Michael] Univ Regensburg, Inst Microbiol & Archaea Ctr, D-93053 Regensburg, Germany	Werner, F (reprint author), UCL, Inst Struct & Mol Biol, Gower St, London WC1E 6BT, England.	f.werner@ucl.ac.uk		Blombach, Fabian/0000-0001-5337-8662	Wellcome Trust Investigator Award [WT096553MA]	The authors thank J. Bahler and D. Bitton for advice throughout this project. The authors also thank T. Arnvig, D. Grohman and other members of the RNAP laboratory for encouragement and critical reading of the manuscript. Research in the RNAP laboratory at University College London is funded by Wellcome Trust Investigator Award WT096553MA (to F.W.).	Andrews S., 2010, FASTQC QUALITY CONTR; Arnvig KB, 2008, J BACTERIOL, V190, P7251, DOI 10.1128/JB.00760-08; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Babski J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2920-y; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Bell SD, 2000, J BIOL CHEM, V275, P12934, DOI 10.1074/jbc.275.17.12934; Bell SD, 1998, P NATL ACAD SCI USA, V95, P15218, DOI 10.1073/pnas.95.26.15218; Blombach F, 2016, J MOL BIOL, V428, P2592, DOI 10.1016/j.jmb.2016.04.016; Blombach F, 2015, ELIFE, V4, DOI 10.7554/eLife.08378; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Churchman L. S., 2012, CURR PROTOC MOL BIOL, V4, P1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diamant G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11547; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; French SL, 2007, MOL BIOL EVOL, V24, P893, DOI 10.1093/molbev/msm007; Gietl A, 2014, NUCLEIC ACIDS RES, V42, P6219, DOI 10.1093/nar/gku273; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P585, DOI 10.1093/nar/gkp928; Jager D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-684; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; JENSEN KF, 1990, MICROBIOL REV, V54, P89; Jones W.J., 1983, MICROBIOLOGY, V136, P254; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Li EH, 2008, NUCLEIC ACIDS RES, V36, P6948, DOI 10.1093/nar/gkm499; Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09209; Liu W, 2007, J MOL BIOL, V369, P474, DOI 10.1016/j.jmb.2007.03.044; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Micorescu M, 2008, J BACTERIOL, V190, P157, DOI 10.1128/JB.01498-07; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Nagy J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7161; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Ouhammouch M, 2003, P NATL ACAD SCI USA, V100, P5097, DOI 10.1073/pnas.0837150100; Peeters E, 2015, NAT REV MICROBIOL, V13, P333, DOI 10.1038/nrmicro3467; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Qureshi SA, 2006, CAN J MICROBIOL, V52, P1136, DOI 10.1139/W06-073; R Core Team, 2014, R LANG ENV STAT COMP; Reichelt R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2360-0; Schulz S, 2016, P NATL ACAD SCI USA, V113, pE1816, DOI 10.1073/pnas.1515817113; Seitzer P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-317; Sevostyanova A, 2008, P NATL ACAD SCI USA, V105, P865, DOI 10.1073/pnas.0708432105; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Smollett Katherine, 2015, Methods Mol Biol, V1276, P291, DOI 10.1007/978-1-4939-2392-2_17; Smollett Katherine, 2015, Methods Mol Biol, V1276, P305, DOI 10.1007/978-1-4939-2392-2_18; Toffano-Nioche C, 2013, RNA BIOL, V10, P1211, DOI 10.4161/rna.25567; Torarinsson E, 2005, ENVIRON MICROBIOL, V7, P47, DOI 10.1111/j.1462-2920.2004.00674.x; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9                                                   ; Werner F, 2008, TRENDS MICROBIOL, V16, P247, DOI 10.1016/j.tim.2008.03.008; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zhang J, 2009, NUCLEIC ACIDS RES, V37, P3588, DOI 10.1093/nar/gkp213	63	1	1	3	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2058-5276			NAT MICROBIOL	NAT. MICROBIOL	MAY	2017	2	5							17021	10.1038/nmicrobiol.2017.21				11	Microbiology	Microbiology	EZ7HV	WOS:000404894200007	28248297				2018-01-05	
J	Chuery, ACS; da Silva, IDCG; Ribalta, JCL; Speck, NMD				Silva Chuery, Ana Carolina; Cotrim Guerreiro da Silva, Ismael Dale; Lascasas Ribalta, Julisa Chamorro; de Gois Speck, Neila Maria			Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						Human papillomavirus; Oncoproteins; Genetic polymorphisms; p53 gene; Argininea	CERVICAL-CANCER DEVELOPMENT; POLYMORPHISM; RISK; METAANALYSIS; MUTATIONS; WOMEN; TP53; POPULATION; NEOPLASIA; VARIANTS	Objective: To evaluate the association between p53 polymorphisms and human papillomavirus (HPV) E6/E7 mRNA expression. Methods: We analyzed 175 cervical samples from women aged 16-69 years old who were tested for HPV E6/E7 mRNA expression (NucliSENS (R) EasyQ (R) HPV). The samples were divided into three groups: positive (n = 75) those with positive HPV E6/E7 mRNA expression and positive high-risk HPV Hybrid Capture (HR-HC) test; negative (n = 52) those with negative HPV E6/E7 mRNA expression and positive HR-HC; and control (n = 48) those with negative HPV E6/E7 mRNA expression and negative HR-HC. The p53 polymorphisms at codons 11, 72, and 248 were evaluated through polymerase chain reaction-restriction fragment length polymorphism( PCR-RFLP). Results: The frequency of the arginine/arginine homozygous genotype at codon 72 was significantly higher in the positive (49.3%) than in the negative (32.7%) and control groups (20.8%, p = 0.002*). The frequency of the arginine allele was also significantly higher in the positive (67.3%) than in the negative (53.8%) and control groups (38.5%, p < 0.001*). The arginine/arginine homozygous genotype was significantly associated with positive HPV E6/E7 mRNA expression (positive group) compared with negative and control groups (odds ratio: 2.633; 95% CI, 1.399-4.954, p = 0.003). The frequency of arginine/arginine homozygous genotype at codon 72 remained significantly more frequent in the positive group of women aged >= 30 years than in the other two groups. Conclusion: The presence of the p53 arginine/arginine homozygous genotype at codon 72 was significantly associated with the positive HPV E6/E7 mRNA expression. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[Silva Chuery, Ana Carolina; Lascasas Ribalta, Julisa Chamorro; de Gois Speck, Neila Maria] Univ Fed Sao Paulo Unifesp, Dept Ginecol, Nucleo Prevencao Doencas Ginecol, Sao Paulo, SP, Brazil; [Cotrim Guerreiro da Silva, Ismael Dale] Univ Fed Sao Paulo Unifesp, Dept Ginecol, Escola Paulista Med, Sao Paulo, SP, Brazil	Chuery, ACS (reprint author), Univ Fed Sao Paulo Unifesp, Dept Ginecol, Nucleo Prevencao Doencas Ginecol, Sao Paulo, SP, Brazil.	acchuery@hotmail.com					Agresti A., 1990, CATEGORICAL DATA ANA; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bertuccio MP, 2011, EUR J GYNAECOL ONCOL, V32, P62; Burroni E, 2013, J MED VIROL, V85, P83, DOI 10.1002/jmv.23417; Castellsague X, 2009, GYNECOL ONCOL, V115, pS15, DOI 10.1016/j.ygyno.2009.09.021; Ciotti M, 2006, ANTICANCER RES, V26, P3745; Hu XX, 2010, CANCER EPIDEM BIOMAR, V19, P755, DOI 10.1158/1055-9965.EPI-09-0886; Hussain SP, 2001, CANCER RES, V61, P6350; Jaiswal PK, 2011, BIOSCI TRENDS, V5, P205, DOI 10.5582/bst.2011.v5.5.205; Jee SH, 2004, INT J GYNECOL OBSTET, V85, P301, DOI 10.1016/j.ijgo.2003.08.017; Jiang P, 2010, ACTA BIOCH BIOPH SIN, V42, P671, DOI 10.1093/abbs/gmq069; Josefsson AM, 1998, NATURE, V396, P531, DOI 10.1038/25037                                                                   ; Kawamura M, 1996, ONCOGENE, V12, P2361; Kim JW, 2001, AM J OBSTET GYNECOL, V184, P55, DOI 10.1067/mob.2001.108329; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Koshiol J, 2009, CANCER EPIDEM BIOMAR, V18, P1631, DOI 10.1158/1055-9965.EPI-08-0830; Koushik A, 2004, CANCER EPIDEM BIOMAR, V13, P11, DOI 10.1158/1055-9965.EPI-083-3                                                     ; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lie AK, 2005, GYNECOL ONCOL, V97, P908, DOI 10.1016/j.ygyno.2005.02.026; Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011; Makin H, 2000, INT J CANCER, V87, P528; Manahan KJ, 2001, INT J ONCOL, V19, P387; Molden T, 2006, GYNECOL ONCOL, V100, P95, DOI 10.1016/j.ygyno.2005.07.108; Oliveira S, 2008, J MED VIROL, V80, P424, DOI 10.1002/jmv.21103; Settheetham-Ishida Wannapa, 2006, Asian Pac J Cancer Prev, V7, P113; Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153; Sousa H, 2007, INT J MOL MED, V20, P731; Storey A, 1998, NATURE LUND, V393, P279; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Vieira JO, 2008, EUR J GYNAECOL ONCOL, V29, P364; Wang JY, 2001, ANTICANCER RES, V21, P513; Zhou XY, 2009, GYNECOL ONCOL, V114, P327, DOI [10.1016/j.ygyno.2009.05.011, 10.1016/j.ygyna.2009.05.011]; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	33	0	0	0	0	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	MAY-JUN	2017	21	3					248	254		10.1016/j.bjid.2017.03.002				7	Infectious Diseases	Infectious Diseases	EZ1ET	WOS:000404453600006	28347732	gold			2018-01-05	
J	de Almeida, RM; Barbosa, AV; Lisboa, RD; Santos, AFD; Hofer, E; Vallim, DC; Hofer, CB				de Almeida, Rosana Macedo; Barbosa, Andre Victor; Lisboa, Rodrigo de Castro; das Merces Santos, Andre Felipe; Hofer, Ernesto; Vallim, Deyse Christina; Hofer, Cristina Barroso			Virulence genes and genetic relationship of L. monocytogenes isolated from human and food sources in Brazil	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						Listeria monocytogenes; Listeriosis; Virulence; Food; PFGE; Brazila	FIELD GEL-ELECTROPHORESIS; LISTERIA-MONOCYTOGENES; PROCESSING PLANTS; MULTIPLEX PCR; SAO-PAULO; SEROVARS; SURVEILLANCE; INFECTIONS; PREVALENCE; PATTERNS	This herein presented assay provided a bacteriological and molecular characterization of 100 samples of L. monocytogenes isolated from human (43) and food (57) sources, from several regions of Brazil, and collected between 1975 and 2013. Antigenic characterization defined 49% of serotype 4b samples, followed by 28% of serotype 1/2b, 14% of serotype 1/2c, 8% of serotype 1/2a, and 1% of serotype 3b. Both type of samples from human and food origin express the same serotype distribution. Multiplex PCR analysis showed 13 strains of type 4b with the amplification profile 4b- VI (Variant I). Virulence genes hly, inlA, inlB, inlC, inlJ, actA, plcA, and prfA were detected in all samples, highlighting a deletion of 105pb on the actA gene in 23% of serotype 4b samples. Macrorestriction profile with ApaI at PFGE showed 55 pulsotypes, with the occurrence of the same pulsotype in hospitalized patients in Sao Paulo in 1992 and 1997, and two other highly related pulsotypes in patients hospitalized in Rio de Janeiro in 2008. Recognized pulsotypes in listeriosis cases have also been detected in food. Thus, the prevalence of a serotype and the persistence of certain pulsotypes herald future problems. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[de Almeida, Rosana Macedo; Barbosa, Andre Victor; Lisboa, Rodrigo de Castro; Hofer, Ernesto; Vallim, Deyse Christina] Inst Oswaldo Cruz Fiocruz, Lab Zoonoses Bacterianas, Rio De Janeiro, RJ, Brazil; [de Almeida, Rosana Macedo; Hofer, Cristina Barroso] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Doencas Infecciosas & Parasitari, Rio de Janeiro, RJ, Brazil; [Barbosa, Andre Victor] Univ Fed Fluminense, Inst Biomed, Lab Enteropatogenos Bacterianos Microbiol Vet & A, Niteroi, RJ, Brazil; [das Merces Santos, Andre Felipe] Inst Oswaldo Cruz Fiocruz, Lab Enterobacterias, Rio De Janeiro, RJ, Brazil	de Almeida, RM (reprint author), Inst Oswaldo Cruz Fiocruz, Lab Zoonoses Bacterianas, Rio De Janeiro, RJ, Brazil.; de Almeida, RM (reprint author), Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Doencas Infecciosas & Parasitari, Rio de Janeiro, RJ, Brazil.	rosanaalmeida1301@hotmail.com			Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for financial support.	Almeida G, 2010, EUR J CLIN MICROBIOL, V29, P1219, DOI 10.1007/s10096-010-0988-x; Barancelli GV, 2014, INT J FOOD MICROBIOL, V173, P21, DOI 10.1016/j.ijfoodmicro.2013.12.018; Barbosa AV, 2015, J INFECT DEV COUNTR, V9, P962, DOI 10.3855/jidc.5639; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Brito JRF, 2008, APPL ENVIRON MICROB, V74, P4954, DOI 10.1128/AEM.01828-07; Bueno VF, 2010, INT J ENVIRON HEAL R, V20, P43, DOI 10.1080/09603120903281283; Camargo AC, 2015, FOODBORNE PATHOG DIS, V12, P323, DOI 10.1089/fpd.2014.1875; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; Chen JS, 2009, FOOD MICROBIOL, V26, P103, DOI 10.1016/j.fm.2008.08.003; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI [10.1128/JCM.42.8.3819-3822.2004, 10.1128/JCM.42.3819-3822.2004]; FARBER JM, 1991, MICROBIOL REV, V55, P476; Hofer E, 2000, MEM I OSWALDO CRUZ, V95, P615, DOI 10.1590/S0074-02762000000500005; Hudson JA, 2001, J APPL MICROBIOL, V90, P614, DOI 10.1046/j.1365-2672.2001.01287.x; Munoz AI, 2012, BIOMEDICA, V32, P408, DOI [10.7705/biomedica.v32i3.709, 10.1590/S0120-41572012000300011]; Johnson J, 2004, APPL ENVIRON MICROB, V70, P4256, DOI 10.1128/AEM.70.7.4256-4266.2004; Kerouanton A, 2010, J MICROBIOL METH, V80, P134, DOI 10.1016/j.mimet.2009.11.008; Lambertz ST, 2013, INT J FOOD MICROBIOL, V166, P186, DOI 10.1016/j.ijfoodmicro.2013.06.008; Leclercq A, 2011, INT J FOOD MICROBIOL, V147, P74, DOI 10.1016/j.ijfoodmicro.2011.03.010; Liu D, 2007, J MICROBIOL METH, V71, P133, DOI 10.1016/j.mimet.2007.08.007; Lukinmaa S, 2003, J CLIN MICROBIOL, V41, P1694, DOI 10.1128/JCM.41.4.1694-1700.2003; Magalhaes R, 2014, FOODBORNE PATHOG DIS, V11, P907, DOI 10.1089/fpd.2014.1806; Martins IS, 2010, AM J INFECT CONTROL, V38, pE31, DOI 10.1016/j.ajic.2010.02.014; Meloni D, 2014, MEAT SCI, V97, P443, DOI 10.1016/j.meatsci.2014.02.012; Brasil. Ministerio da Sande, 2014, PORT 1 271; NOTERMANS SHW, 1991, APPL ENVIRON MICROB, V57, P2666; Ragon M, 2008, PLOS PATHOG; ROCOURT J, 1983, ANN INST PASTEUR MIC, VA134, P359, DOI 10.1016/S0769-2609(83)80061-1; Sant'Ana AS, 2012, INT J FOOD MICROBIOL, V155, P1, DOI 10.1016/j.ijfoodmicro.2011.12.036; Seeliger HP, 1979, METHOD MICROBIOL, P31; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233	32	0	0	1	1	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	MAY-JUN	2017	21	3					282	289		10.1016/j.bjid.2017.01.004				8	Infectious Diseases	Infectious Diseases	EZ1ET	WOS:000404453600011	28274807	gold			2018-01-05	
J	Fontalvo, MC; Favacho, ARD; Araujo, AD; dos Santos, NM; de Oliveira, GMB; Aguiar, DM; de Lemos, ERS; Horta, MC				Fontalvo, Mariana Campos; de Mendonca Favacho, Alexsandra Rodrigues; Araujo, Andreina de Carvalho; dos Santos, Naylla Mayana; Barboza de Oliveira, Glauber Meneses; Aguiar, Daniel Moura; Sampaio de Lemos, Elba Regina; Horta, Mauricio Claudio			Bartonella species pathogenic for humans infect pets, free-ranging wild mammals and their ectoparasites in the Caatinga biome, Northeastern Brazil: a serological and molecular study	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						Bartonella; Flea; Tick; Lice; Brazila	ARTHROPOD-BORNE PATHOGENS; NORTH-EASTERN BRAZIL; DOMESTIC CATS; SYNTHASE GENE; MATO-GROSSO; PREVALENCE; HENSELAE; RODENTS; STATE; DIVERSITY	This study verified the occurrence of Bartonella spp. in dogs, cats, wild mammals and their ectoparasites in Petrolina and Lagoa Grande Counties, Pernambuco, located in a semi-arid region in Northeastern Brazil. Anti-Bartonella spp. antibodies were detected by indirect immunofluorescence assay (IFA) in 24.8% of dogs (27/109) and in 15% of cats (6/40). Bartonella sp. DNA was identified by PCR performed on DNA extracted from blood and ectoparasites using primers targeting Bartonella sp. gltA and ribC genes in 100% (9/9) of Pulex irritans from Cerdocyon thous, 57.4% (35/61) of P. irritans from dogs, 2.3% (1/43) of Ctenocephalides felis felis from dogs, 53.3% (24/45) of C. felis felis from cats, and 10% (1/10) of Polyplax spp. from Thrichomys apereoides. DNA sequencing identified Bartonella clarridgeiae and Bartonella henselae in C. felis felis from cats, Bartonella rochalimae in P. irritans from dog and C. thous, and Bartonella vinsoni berkhofii in P. irritans from dog. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[Fontalvo, Mariana Campos; Araujo, Andreina de Carvalho; dos Santos, Naylla Mayana; Barboza de Oliveira, Glauber Meneses; Horta, Mauricio Claudio] Univ Fed Vale do Sao Francisco Univasf, Lab Doencas Parasitarias, Petrolina, PE, Brazil; [de Mendonca Favacho, Alexsandra Rodrigues; Sampaio de Lemos, Elba Regina] Inst Oswaldo Cruz FIOCRUZ, Lab Hantaviroses & Rickettsioses, Rio De Janeiro, RJ, Brazil; [Aguiar, Daniel Moura] Univ Fed Mato Grosso, Lab Virol & Rickettsioses, Cuiaba, MT, Brazil	Horta, MC (reprint author), Univ Fed Vale do Sao Francisco Univasf, Lab Doencas Parasitarias, Petrolina, PE, Brazil.	horta.mc@hotmail.com		Meneses Barboza de Oliveira, Glauber/0000-0002-2426-6626	Brazilian Research Funding Agency (CNPq)	The thank Ana Isabel A. Santos, Lais F. Santos, Josenilton R. Santos, Ivo W. G. da Silva, and Dalia M. R. Machado for their valuable help during the field work and laboratory tests and the Centro de Conservacao e Manejo de Fauna (Cema-Fauna) for confirmation of the identification of wild mammalian species. This work was supported by the Brazilian Research Funding Agency (CNPq).	Akane A, 1994, FORENSIC SCI, V39, P367; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andre MR, 2016, J FELINE MED SURG, V18, P783, DOI 10.1177/1098612X15593787; Andre MR, 2014, TICKS TICK-BORNE DIS, V5, P545, DOI 10.1016/j.ttbdis.2014.03.011; Barbosa A. D., 2011, Ciencia Veterinaria nos Tropicos, V14, P1; Barros-Battesti D, 2006, CARRAPATOS IMPORTANC, P223; BIRTLES RJ, 1994, ANN TROP MED PARASIT, V88, P317, DOI 10.1080/00034983.1994.11812872                                                  ; Bortoli CP, 2012, REV BRAS PARASITOL V, V21, P219; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Braga IA, 2015, BRAZ J INFECT DIS, V19, P451, DOI 10.1016/j.bjid.2015.05.002; Breitschwerdt EB, 2008, VET IMMUNOL IMMUNOP, V123, P167, DOI 10.1016/j.vetimm.2008.01.025; Brenner EC, 2013, EPIDEMIOL INFECT, V141, P54, DOI 10.1017/S0950268812000519; Buffet JP, 2013, FUTURE MICROBIOL, V8, P1117, DOI 10.2217/fmb.13.77; Chomel BB, 2005, B ACAD NAT MED PARIS, V189, P465; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952; Braga MDCD, 2012, MEM I OSWALDO CRUZ, V107, P772, DOI 10.1590/S0074-02762012000600011; Crissiuma A, 2011, J FELINE MED SURG, V13, P149, DOI 10.1016/j.jfms.2010.08.010; Dantas-Torres F, 2012, PARASITOLOGY, V139, P83, DOI 10.1017/S0031182011001740; Favacho ARD, 2015, MICROBES INFECT, V17, P889, DOI 10.1016/j.micinf.2015.08.014; Diniz PPPV, 2013, PLONEGL TROP DIS, V5, pe2393; Fonseca MT, 1997, THESIS, P60; Guimaraes MF., 2014, THESIS, P91; Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11; Horta MC, 2007, BRAZIL MEM I OSVALDO, V107, P793; IBGE (Institute Brasileiro de Geografia e Estatistica), 2012, MAN TECN VEG BRAS, P272; INMET, 2015, PEC AB; Johnson G, 2003, J CLIN MICROBIOL, V41, P1069, DOI 10.1128/JCM.41.3.1069-1072.2003; Kim Chul-Min, 2005, Journal of Veterinary Science, V6, P327; Kitada AAB, 2014, J FELINE MED SURG, V16, P308, DOI 10.1177/1098612X13508193; La Scola B, 2002, CLIN MICROBIOL INFEC, V8, P345, DOI 10.1046/j.1469-0691.2002.00434.x; Lamas CC, 2010, ACTA TROP, V115, P137, DOI 10.1016/j.actatropica.2010.02.015; Linardi PM, 2000, SIFONAPTEROS BRASIL, P291; Loureiro VL, 2007, REV BRAS CIENC VET, V14, P39; Mares-Guia MAMM, 2014, TRABALHO CAMPO CORN, P95; Meheretu Y, 2013, VECTOR-BORNE ZOONOT, V13, P164, DOI 10.1089/vbz.2012.1004; Merhej V, 2012, J BACTERIOL, V194, P7012, DOI 10.1128/JB.01924-12; Miceli NG, 2013, REV BRAS PARASITOL V, V22, P385, DOI 10.1590/S1984-29612013000300011; Ministerio da Integragdo National, 2005, REL FIN; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797; Oliveira IA, 2003, ECOLOGIA CONSERVACAO; Pereira JS, 1839, REV BRAS HIG SAN AN, V9, P105; Pretorius AM, 1999, J S AFR VET ASSOC, V70, P154; Reis C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001186; Rubio AV, 2014, VECTOR-BORNE ZOONOT, V14, P838, DOI 10.1089/vbz.2014.1673; Silva CS, 2008, REV SET CIENC AGR AM, V4, P473; Souza A.M., 2010, REV BRAS CIE VET, V17, P7; Staggemeier R, 2010, MEM I O CRUZ, V200, P873; Tsai YL, 2010, AM J TROP MED HYG, V83, P917, DOI 10.4269/ajtmh.2010.10-0083; Diniz PPVD, 2007, VET RES, V38, P697, DOI 10.1051/vetres:2007023; Yamamoto K, 1998, J WILDLIFE DIS, V34, P56, DOI 10.7589/0090-3558-34.1.56                                                       	50	0	0	2	2	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	MAY-JUN	2017	21	3					290	296		10.1016/j.bjid.2017.02.002				7	Infectious Diseases	Infectious Diseases	EZ1ET	WOS:000404453600012	28249707	gold			2018-01-05	
J	Xie, XL; Hu, YC; Xu, YH; Yin, KQ; Li, Y; Chen, Y; Xia, J; Xu, LJ; Liu, ZJ; Geng, SZ; Li, QC; Jiao, XN; Chen, X; Pan, ZM				Xie, Xiaolei; Hu, Yachen; Xu, Yaohui; Yin, Kequan; Li, Yang; Chen, Yun; Xia, Jie; Xu, Lijuan; Liu, Zijian; Geng, Shizhong; Li, Qiuchun; Jiao, Xinan; Chen, Xiang; Pan, Zhiming			Genetic analysis of Salmonella enterica serovar Gallinarum biovar Pullorum based on characterization and evolution of CRISPR sequence	VETERINARY MICROBIOLOGY			English	Article						CRISPR; Salmonella enterica serovar Gallinarum biovar Pullorum (S. Pullorum); SNP; Whole-genome single-nucleotide polymorphism typing (WGST)	FRAGMENT LENGTH POLYMORPHISM; FIELD GEL-ELECTROPHORESIS; TANDEM-REPEAT ANALYSIS; SEROTYPE ENTERITIDIS; VARIABLE-NUMBER; OUTBREAK; EPIDEMIOLOGY; MVLST; TYPHIMURIUM; DIVERSITY	Salmonella enterica serovar Gallinarum biovar Pullorum (S. Pullorum) is the cause of pullorum disease, characterized by white diarrhea, which leads to high mortality in poultry. In this study, we aimed to assess the genetic diversity of 655 S. Pullorum strains from 1962 to 2015 in China, Europe, and South America. A sequence typing scheme based on clustered regularly interspaced short palindromic repeats (CRISPR) was used to reveal the genetic relationships among these strains in this study. Overall, a total of 20 Pullorum sequence types (PSTs) of CRISPR were identified in the 655 isolates with PST7 (74%, 486/655) and PST3 (13%, 86/655) to be the most two frequent PSTs belonging to two different lineages, which confirmed the genetic conservation of S. Pullorum strains isolated from six provinces and two direct controlled municipalities (Beijing and Shanghai) in China. However, the identification of seven new PSTs distributed in strains isolated since 2001 implied that genetic variation continues to develop in S. Pullorum. Interestingly, the whole-genome single-nucleotide polymorphism typing (WGST) of 96 strains out of the 655 isolates divided them into four lineages based on SNP analysis of core genomic sequence and exhibit good correspondence with the CRISPR subtyping method. Notably, 22 out of 26 isolates from Europe and South America were distributed in five distinctive PSTs (with no Chinese strains). Additionally, CRISPR data of spacers and their arrangement exhibit subtle but distinct specificity between different strains, and the dynamic adaptive nature of CRISPR loci provides critical insights into the evolution of S. Pullorum as the bacteria are influenced by their environment. (C) 2017 Elsevier B.V. All rights reserved.	[Xie, Xiaolei; Hu, Yachen; Yin, Kequan; Li, Yang; Chen, Yun; Xia, Jie; Xu, Lijuan; Liu, Zijian; Geng, Shizhong; Li, Qiuchun; Jiao, Xinan; Chen, Xiang; Pan, Zhiming] Yangzhou Univ, Jiangsu Key Lab Zoonosis, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Xu, Yaohui] Henan Univ Anim Husb & Econ, Coll Vet Med, Zhengzhou, Henan, Peoples R China; [Jiao, Xinan] Yangzhou Univ, Minist Agr China, Key Lab Prevent & Control Biol Hazard Factors Ani, Yangzhou, Jiangsu, Peoples R China	Li, QC; Jiao, XN (reprint author), Yangzhou Univ, Jiangsu Key Lab Zoonosis, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Jiao, XN (reprint author), Yangzhou Univ, Minist Agr China, Key Lab Prevent & Control Biol Hazard Factors Ani, Yangzhou, Jiangsu, Peoples R China.	qcli@yzu.edu.cn; jiao@yzu.edu.cn		Li, Qiuchun/0000-0003-0923-9758	National Natural Science Foundation of China [31230070, 31320103907]; National Key Research and Development Program of China [2017YFD0500100, 2017YFNC020029]; Special Fund for Agro-scientific Research in the Public Interest [201403054]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Student Research and Innovation Project of Jiangsu Province [KYLX16_1404]	This work was supported by the National Natural Science Foundation of China (31230070, 31320103907), National Key Research and Development Program of China (2017YFD0500100, 2017YFNC020029), Special Fund for Agro-scientific Research in the Public Interest (201403054), The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Graduate Student Research and Innovation Project of Jiangsu Province (KYLX16_1404).	Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beranek A, 2009, INT J MED MICROBIOL, V299, P43, DOI 10.1016/j.ijmm.2008.06.002; Berchieri A, 2001, AVIAN PATHOL, V30, P221, DOI 10.1080/03079450120054631; Deng XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Giammanco GM, 2007, RES MICROBIOL, V158, P10, DOI 10.1016/j.resmic.2006.10.004; Graham RMA, 2014, EPIDEMIOL INFECT, V142, P2347, DOI 10.1017/S0950268814000375; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Larsson JT, 2009, EUROSURVEILLANCE, V14, P6; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Lindstedt BA, 2000, J CLIN MICROBIOL, V38, P1623; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Shariat N, 2015, MICROBIOL-SGM, V161, P374, DOI 10.1099/mic.0.000005; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shariat N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-254; Shariat N, 2013, J CLIN MICROBIOL, V51, P2328, DOI 10.1128/JCM.00608-13; Shariat N, 2013, FOOD MICROBIOL, V34, P164, DOI 10.1016/j.fm.2012.11.012; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222                                                          ; Torpdahl M, 2005, J MICROBIOL METH, V63, P173, DOI 10.1016/j.mimet.2005.03.006; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; [查华 Zha Hua], 2012, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V34, P996	31	2	2	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1135	1873-2542		VET MICROBIOL	Vet. Microbiol.	MAY	2017	203						81	87		10.1016/j.vetmic.2017.02.010				7	Microbiology; Veterinary Sciences	Microbiology; Veterinary Sciences	EZ4VJ	WOS:000404710300012	28619172				2018-01-05	
J	Dempewolf, H; Baute, G; Anderson, J; Kilian, B; Smith, C; Guarino, L				Dempewolf, Hannes; Baute, Gregory; Anderson, Justin; Kilian, Benjamin; Smith, Chelsea; Guarino, Luigi			Past and Future Use of Wild Relatives in Crop Breeding	CROP SCIENCE			English	Review							PRIMARY GENE POOL; WHEAT IMPROVEMENT; TRANSGRESSIVE SEGREGATION; ENVIRONMENTAL ADAPTATION; SOMATIC HYBRIDIZATION; CRISPR/CAS9 SYSTEM; CULTIVATED BARLEY; CLIMATE-CHANGE; RICE GENOMES; PLANTS	Wild species related to agricultural crops (crop wild relatives, or CWR) can increase the adaptive capacity of agricultural systems around the world. They represent a large pool of genetic diversity from which to draw new allelic variation required in breeding programs. Crop wild relatives have been extremely valuable in adapting crop varieties to changing disease pressures, farming practices, market demands, and climatic conditions. Unfortunately, CWR are a threatened resource and measures need to be taken to protect them, both in the wild and in genebanks. Here, we review how wild species have contributed to the development of improved crop varieties and where efforts must be concentrated to harness their value in the future. Drawing on the results of an extensive literature search, a series of 14 expert consultation meetings, and in-depth interview with experts on 24 crops, we document the role that CWR play in modern crop breeding. We discuss (i) their past and current use, (ii) advanced breeding methods and technologies that promise to facilitate the continued use of CWR, and (iii) what constraints continue to hinder increased use of CWR in breeding.	[Dempewolf, Hannes; Kilian, Benjamin; Guarino, Luigi] Global Crop Divers Trust, Pl Vereinten Nationen 7, D-53113 Bonn, Germany; [Dempewolf, Hannes; Baute, Gregory] Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC, Canada; [Anderson, Justin] Univ Hawaii Manoa, Dept Trop Plant & Soil Sci, 3190 Maile Way, Honolulu, HI 96822 USA; [Smith, Chelsea] Univ Waterloo, Dept Environm & Resource Studies, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada	Dempewolf, H (reprint author), Global Crop Divers Trust, Pl Vereinten Nationen 7, D-53113 Bonn, Germany.; Dempewolf, H (reprint author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC, Canada.	hannes.dempewolf@croptrust.org			Government of Norway	This work was undertaken as part of the initiative "Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives" which is supported by the Government of Norway. The project is managed by the Global Crop Diversity Trust with the Millennium Seed Bank of the Royal Botanic Gardens, Kew, and implemented in partnership with national and international genebanks and plant breeding institutes around the world. For further information, see the project website: http://www.cwrdiversity.org/. We thank Holly Vincent who contributed to an early version of the reference list for "breeding uses," as well as John Wiersema and Blanca Leon for curating the CWR database in GRIN, which was a further source of information on "breeding uses." We thank all the experts who have contributed to the consultation meetings and, in particular, the following scientists who participated in the interviews: Clair Hersey, Eva Weltzien-Raltunde, Ruaraidh Sackville Hamilton, Meredith Bonierbale, Hans-Joachim Braun, Santosh Deshpande, K.K. Jena, Antonio Lopez-Montes, Rony Swennen, and Peter Hanson.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Alercia A., 2015, FAO BIOVERSITY MULTI; Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Anderson JE, 2016, G3-GENES GENOM GENET, V6, P835, DOI 10.1534/g3.116.026914; Andersson M.S., 2010, EVOL APPL, V3, P402, DOI [10.1111/j.1752-4571.2010.00138.x, DOI 10.1111/J.1752-4571.2010.00138.X]; Araki M, 2015, TRENDS PLANT SCI, V20, P145, DOI 10.1016/j.tplants.2015.01.010; Baute GJ, 2015, NEW PHYTOL, V206, P830, DOI 10.1111/nph.13255; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Breithaupt H, 2008, EMBO REP, V9, P832, DOI 10.1038/embor.2008.157; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Brummer EC, 2011, FRONT ECOL ENVIRON, V9, P561, DOI 10.1890/100225; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.22, 10.1038/nplants.2016.22]; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Commission on Genetic Resources for Food and Agriculture, 2010, 2 REP STAT WORLDS PL; Cooper H. D., 2001, BROADENING GENETIC B; Dempewolf H, 2014, AGROECOL SUST FOOD, V38, P369, DOI 10.1080/21683565.2013.870629; Dempewolf H, 2012, PLANT CELL, V24, P2710, DOI 10.1105/tpc.112.100115; DEVICENTE MC, 1993, GENETICS, V134, P585; Dreisigacker S, 2008, AUST J AGR RES, V59, P413, DOI 10.1071/AR07225; Dwivedi SL, 2008, PL BRED RE, V30, P179; EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2012, EFSA J, V10, P2603, DOI DOI 10.2903/J.EFSA.2012.2943; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; GLIMELIUS K, 1991, TRENDS BIOTECHNOL, V9, P24, DOI 10.1016/0167-7799(91)90008-6; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HAMMER K, 1984, Kulturpflanze, V32, P11; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; HARLAN JR, 1976, CROP SCI, V16, P329, DOI 10.2135/cropsci1976.0011183X001600030004x                                       ; Haussmann B. I. G., 2004, Plant Genetic Resources Characterization and Utilization, V2, P3, DOI 10.1079/PGR200430; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Hein L, 2006, ECOL ECON, V60, P176, DOI 10.1016/j.ecolecon.2005.11.022; Hoyt E., 1988, CONSERVING WILD RELA; Hu XX, 2016, MOL PLANT, V9, P943, DOI 10.1016/j.molp.2016.03.003; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Hulse-Kemp AM, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.36; Hunter D., 2011, CROP WILD RELATIVES; Iftekharuddaula KM, 2011, EUPHYTICA, V178, P83, DOI 10.1007/s10681-010-0272-2; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee,2008.01.013; Jha UC, 2014, PLANT BREEDING, V133, P679, DOI 10.1111/pbr.12217; Khatodia S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00506, 10.3389/fpls.2016.00506]; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Kilian B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P1, DOI 10.1007/978-3-642-14228-4_1; Kilian B, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P137, DOI 10.1007/978-3-642-12425-9_8; Kole C., 2011, WILD CROP RELATIVES; Li JY, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-8; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Liu JH, 2005, PLANT CELL TISS ORG, V82, P19, DOI 10.1007/s11240-004-6015-0; Livaja M, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0444-4; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Maxted N., 2009, ESTABLISHMENT GLOBAL; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Moore G, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.18, 10.1038/nplants.2015.18]; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Nemeth C, 2015, GENOME, V58, P71, DOI 10.1139/gen-2015-0002; Nice LM, 2016, GENETICS, V203, P1453, DOI 10.1534/genetics.116.190736; Nogue F, 2016, PLANT CELL REP, V35, P1475, DOI 10.1007/s00299-016-1993-z; Ogbonnaya FC, 2013, PL BRED RE, V37, P35; Pimentel D, 1997, BIOSCIENCE, V47, P747, DOI 10.2307/1313097                                                                 ; Porch TG, 2013, AGRONOMY-BASEL, V3, P433, DOI 10.3390/agronomy3020433; Prescott-Allen C., 1986, 1 RESOURCE WILD SPEC; Prescott-Allen R., 1981, SITU CONSERVATION CR; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Russell J, 2016, NAT GENET, V48, P1024, DOI 10.1038/ng.3612; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sawler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080791; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132112; Sharma S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00309; Shaw PD, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-259; Song QJ, 2015, G3-GENES GENOM GENET, V5, P1999, DOI 10.1534/g3.115.019000; Spindel JE, 2016, NEW PHYTOL, V212, P814, DOI 10.1111/nph.14174; Stalker H. T., 1980, Advances in Agronomy, V33, P111, DOI 10.1016/S0065-2113(08)60165-0; Stander J.R., 1993, J SUGAR BEET RES, V30, P197, DOI [10.5274/jsbr.30.4.197, DOI 10.5274/JSBR.30.4.197]; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thormann I., 2014, PREDICTIVE CHARACTER; Valkoun J, 2001, TRADITIONAL PLANT BR, P699; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; van de Wiel C., 2010, 338 WAG UR PLANT BRE; Varshney RK, 2016, PLANT SCI, V242, P98, DOI 10.1016/j.plantsci.2015.09.009; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Warr A, 2015, G3-GENES GENOM GENET, V5, P1543, DOI 10.1534/g3.115.018564; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; Wendler N, 2015, MOL PLANT, V8, P1507, DOI 10.1016/j.molp.2015.05.004; Wright EM, 2011, EUPHYTICA, V179, P471, DOI 10.1007/s10681-011-0369-2; Xu JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-656; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu YB, 1998, CROP SCI, V38, P12, DOI 10.2135/cropsci1998.0011183X003800010002x                                       ; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	98	4	4	34	34	CROP SCIENCE SOC AMER	MADISON	677 S SEGOE ROAD, MADISON, WI 53711 USA	0011-183X	1435-0653		CROP SCI	Crop Sci.	MAY-JUN	2017	57	3					1070	1082		10.2135/cropsci2016.10.0885				13	Agronomy	Agriculture	EZ1PO	WOS:000404483500004					2018-01-05	
J	Yuan, L; Yao, HB; Xu, YX; Chen, M; Deng, JC; Song, YN; Sui, TT; Wang, Y; Huang, YY; Li, ZJ; Lai, LX				Yuan, Lin; Yao, Haobin; Xu, Yuxin; Chen, Mao; Deng, Jichao; Song, Yuning; Sui, Tingting; Wang, Yong; Huang, Yongye; Li, Zhanjun; Lai, Liangxue			CRISPR/Cas9-Mediated Mutation of alpha A-Crystallin Gene Induces Congenital Cataracts in Rabbits	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						rabbits; alpha A-crystallin; congenital cataracts; CRISPR/Cas9; animal model	MISSENSE MUTATION; MOUSE MODELS; LENS; MICE; CRYAA; DISRUPTION; GENERATION; DISEASES; EYE	PURPOSE. The present study aimed to investigate the role of the alpha A-crystallin gene in inducing congenital cataracts in rabbits and to construct a novel animal model for characterization and pathologic analysis of congenital cataracts for future research. METHODS. We generated alpha A-crystallin gene knockout rabbits with congenital cataracts by coinjection of Cas9 mRNA and sgRNA into zygotes. Cataract phenotypes were investigated in a repeated study of 19 F0-generation and 11 F1-generation rabbits with alpha A-crystallin gene mutations. Heritability was analyzed by PCR, sequencing, slim lamp, hematoxylin eosin staining, immunohistochemistry, and Western blot. RESULTS. We found alpha A-crystallin gene mutations in all 19 F0-generation pups (100%) with indel mutations in the alpha A-crystallin gene ranging from 3 to 52 bp. Off-target assay revealed that none of the potential off-target sites exhibited mutations, demonstrating that off-target mutagenesis was not induced by cytoplasmic microinjection of in vitro-transcribed Cas9 mRNA. Slim lamp assay revealed that 15 of 19 live pups (78.9%) exhibited typical phenotypes, including congenital cataracts, microphthalmia, obscurity, and early atrophy of the lens, and failed differentiation of lens fibers. Histologic hematoxylin and eosin staining showed that alpha A-crystallin gene knockout rabbits exhibited smaller lenses. Production of the alpha A-crystallin protein was determined to be dramatically reduced in alpha A-crystallin gene knockout rabbits. We induced alpha A-crystallin gene mutations and phenotypes in F1-generation rabbits. CONCLUSIONS. Our data suggest that CRISPR/Cas9-mediated mutation of the alpha A-crystallin gene in rabbits recapitulates phenotypes of congenital cataracts, microphthalmia, obscurity, and early atrophy of the lens, and failed differentiation of lens fibers. These findings suggest the possibility of a new animal model of congenital cataracts, which should be used to further investigate the association between mutations in alpha A-crystallin gene and congenital cataracts in humans.	[Yuan, Lin; Yao, Haobin; Xu, Yuxin; Chen, Mao; Deng, Jichao; Song, Yuning; Sui, Tingting; Wang, Yong; Huang, Yongye; Li, Zhanjun; Lai, Liangxue] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Inst Zoonosis, Changchun, Peoples R China; [Huang, Yongye] Northeastern Univ, Coll Life Sci & Hlth, Shenyang, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	Li, ZJ; Lai, LX (reprint author), Jilin Prov Key Lab Anim Embryo Engn, 5333 Xian Rd, Changchun 130062, Peoples R China.	lizj_1998@jlu.edu.cn; lai_liangxue@gibh.ac.cn			National Natural Science Foundation of China [31201080, 31272394]	Supported by the National Natural Science Foundation of China (Grant No. 31201080 and 31272394).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Arora A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034108; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Cobb BA, 2002, BIOCHEMISTRY-US, V41, P483, DOI 10.1021/bi0112457; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; Devi RR, 2006, MOL VIS, V12, P190; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2                                                       ; HAMAI Y, 1974, EXP EYE RES, V18, P537, DOI 10.1016/0014-4835(74)90060-8                                                    ; Jiaox X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137973; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; Li XJ, 2012, J GENET GENOMICS, V39, P237, DOI 10.1016/j.jgg.2012.05.006; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Pendergrass W, 2005, INVEST OPHTH VIS SCI, V46, P4661, DOI 10.1167/iovs.05-0808; Rong P, 2002, DEVELOPMENT, V129, P167; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Su DM, 2012, MOL VIS, V18, P3057; Wride MA, 1996, DIFFERENTIATION, V61, P77, DOI 10.1046/j.1432-0436.1996.6120077.x; Xia CH, 2006, DEVELOPMENT, V133, P2033, DOI 10.1242/dev.02361; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024; Zhang L, 2011, MOL VIS, V17, P2693	26	0	0	3	3	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	MAY	2017	58	6			SI		BIO34	BIO41		10.1167/iovs.16-21287				8	Ophthalmology	Ophthalmology	EZ3EI	WOS:000404593000005	28475701				2018-01-05	
J	Park, C; Han, MH; Park, SH; Hong, SH; Kim, GY; Moon, SK; Kim, WJ; Choi, YH				Park, Cheol; Han, Min-Ho; Park, Shin-Hyung; Hong, Su-Hyun; Kim, Gi-Young; Moon, Sung-Kwon; Kim, Wun-Jae; Choi, Yung Hyun			Induction of apoptosis by Moutan Cortex Radicis in human gastric cancer cells through the activation of caspases and the AMPK signaling pathway	REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY			English	Article						Moutan Cortex Radicis; Gastric cancer; Apoptosis; Caspase; AMPK	PROTEIN-KINASE AMPK; PAEONIA-SUFFRUTICOSA; GENE-EXPRESSION; ETHANOL EXTRACT; ROOT BARK; GROWTH; DEATH; OXYGEN; MITOCHONDRIA; INHIBITION	Moutan Cortex Radicis, the root bark of Paeonia x suffruticosa Andrews, Paeoniaceae, has been widely used in traditional medicine therapy. Although it has been shown to possess many pharmacological activities, the molecular mechanisms of its anti-cancer activity have not been clearly elucidated. In the present study, we investigated the pro-apoptotic effects of the ethanol extract of Moutan Cortex Radicis in human gastric cancer AGS cells. Moutan Cortex Radicis treatment inhibited the cell viability of AGS cells in a concentration-dependent manner, which was associated with apoptotic cell death. Moutan Cortex Radicis's induction of apoptosis was connected with the upregulation of death receptor 4, death receptor 5, tumor necrosis factor-related apoptosis-inducing ligand, Fas ligand, and Bax, and the downregulation of Bcl-2 and Bid. Moutan Cortex Radicis treatment also induced the loss of mitochondrial membrane potential (Delta psi m), the proteolytic activation of caspases (-3, -8, and -9), and the degradation of poly(ADPribose) polymerase, an activated caspase-3 substrate protein. However, the pre-treatment of a caspase-3 inhibitor significantly attenuated Moutan Cortex Radicis-induced apoptosis and cell viability reduction. In addition, Moutan Cortex Radicis treatment effectively activated the adenosine monophosphate-activated protein kinase signaling pathway; however, a specific inhibitor of AMPK significantly reduced Moutan Cortex Radicis-induced apoptosis. Overall, the results suggest that the apoptotic activity of Moutan Cortex Radicis may be associated with a caspase-dependent cascade through the activation of both extrinsic and intrinsic signaling pathways connected with adenosine monophosphate-activated protein kinase activation, and Moutan Cortex Radicis as an activator of adenosine monophosphate-activated protein kinase could be a prospective application to treat human cancers. (C) 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda.	[Park, Cheol] Dong Eui Univ, Dept Mol Biol, Coll Nat Sci & Human Ecol, Busan, South Korea; [Han, Min-Ho] Marine Biodivers Inst Korea, Nat Prod Res Team, Seocheon, South Korea; [Park, Shin-Hyung] Dongeui Univ Coll Korean Med, Dept Pathol, Busan, South Korea; [Hong, Su-Hyun] Dongeui Univ Coll Korean Med, Dept Biochem, Busan, South Korea; [Kim, Gi-Young] Jeju Natl Univ, Sch Marine Biomed Sci, Dept Marine Life Sci, Jeju, South Africa; [Moon, Sung-Kwon] Chungbuk Natl Univ, Dept Urol, Coll Med & Inst Tumor Res, Cheongju, South Korea; [Kim, Wun-Jae] Chung Ang Univ, Sch Food Sci & Technol, Ansung, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Anti Aging Res Ctr Blue Bio Ind RIC, Busan, South Korea	Kim, WJ (reprint author), Chung Ang Univ, Sch Food Sci & Technol, Ansung, South Korea.; Choi, YH (reprint author), Dong Eui Univ, Anti Aging Res Ctr Blue Bio Ind RIC, Busan, South Korea.	wjkim@chungbuk.ac.kr; choiyh@deu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) grant - Korea government [2015R1A2A2A01004633, 2014R1A1A1008460]; Functional Districts of the Science Belt support program, Ministry of Science, ICT and Future Planning, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (2015R1A2A2A01004633 and 2014R1A1A1008460) and the Functional Districts of the Science Belt support program, Ministry of Science, ICT and Future Planning, Republic of Korea.	Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cai JX, 2014, PHYTOMEDICINE, V21, P984, DOI 10.1016/j.phymed.2014.02.012; Chen HY, 2015, APOPTOSIS, V20, P821, DOI 10.1007/s10495-015-1111-7; Chiang PC, 2010, BIOCHEM PHARMACOL, V79, P162, DOI 10.1016/j.bcp.2009.08.022; Choi HS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-82; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Eom DW, 2015, BMB REP, V48, P461, DOI 10.5483/BMBRep.2015.48.8.216; Fan LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062627; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Figarola JL, 2015, J BIOL CHEM, V290, P30321, DOI 10.1074/jbc.M115.686352; Fu PK, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/837513; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gao Y, 2015, J ETHNOPHARMACOL, V169, P24, DOI 10.1016/j.jep.2015.03.074; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hensley P, 2013, BIOL CHEM, V394, P831, DOI 10.1515/hsz-2013-0128; HIRAI A, 1983, THROMB RES, V31, P29, DOI 10.1016/0049-3848(83)90005-1; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kim HG, 2014, FOOD CHEM TOXICOL, V65, P293, DOI 10.1016/j.fct.2013.12.037; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620                                                                ; Li M, 2014, ONCOL REP, V32, P2845, DOI 10.3892/or.2014.3543; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; Monteverde T, 2015, FEBS J, V282, P4658, DOI 10.1111/febs.13534; Mukudai Y, 2013, ONCOL REP, V30, P2665, DOI 10.3892/or.2013.2744; Nieminen AI, 2013, P NATL ACAD SCI USA, V110, pE1839, DOI 10.1073/pnas.1208530110; Pan DJ, 2004, TRENDS CELL BIOL, V14, P78, DOI 10.1016/j.tcb.2003.12.006; Park J, 2011, AFR J TRADIT COMPLEM, V8, P220, DOI 10.4314/ajtcam.v8i5S.2; Peng LH, 2013, PHYTOMEDICINE, V20, P1082, DOI 10.1016/j.phymed.2013.04.015; Poon TYC, 2011, J DIABETES, V3, P184, DOI 10.1111/j.1753-0407.2011.00130.x; Rho S, 2005, BIOL PHARM BULL, V28, P661, DOI 10.1248/bpb.28.661; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sauer H, 2012, INT J ONCOL, V40, P501, DOI 10.3892/ijo.2011.1230; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sui XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097781; Tran Quangdon, 2016, Toxicol Res, V32, P177, DOI 10.5487/TR.2016.32.3.177; Wang SC, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/409823; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; You MK, 2016, NUTR RES PRACT, V10, P139, DOI 10.4162/nrp.2016.10.2.139; Yun CS, 2013, J NAT MED-TOKYO, V67, P576, DOI 10.1007/s11418-012-0714-3; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500	48	0	0	3	3	SOC BRASILEIRA FARMACOGNOSIA	CURITIBA-PR	C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL	0102-695X			REV BRAS FARMACOGN	Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.	MAY-JUN	2017	27	3					315	323		10.1016/j.bjp.2016.11.003				9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	EZ1ZO	WOS:000404509500007		gold			2018-01-05	
J	Fasolino, M; Zhou, ZL				Fasolino, Maria; Zhou, Zhaolan			The Crucial Role of DNA Methylation and MeCP2 in Neuronal Function	GENES			English	Review						DNA methylation; 5-methylcytosine (5mC); 5-hydroxymethylcytosine (5hmC); methyl-CpG-binding protein 2 (MeCP2); Rett Syndrome (RTT); DNA methyltransferase (DNMT); ten-eleven translocation (TET) methylcytosine dioxygenase; neuroplasticity; long-term potentiation (LTP)	LONG-TERM POTENTIATION; CPG-BINDING PROTEIN-2; SYNAPTIC CIRCUIT ABNORMALITIES; GENE-EXPRESSION CHANGES; 2/3 PYRAMIDAL NEURONS; X-LINKED INHERITANCE; EMBRYONIC STEM-CELLS; RETT-SYNDROME; NERVOUS-SYSTEM; MOUSE MODEL	A neuron is unique in its ability to dynamically modify its transcriptional output in response to synaptic activity while maintaining a core gene expression program that preserves cellular identity throughout a lifetime that is longer than almost every other cell type in the body. A contributing factor to the immense adaptability of a neuron is its unique epigenetic landscape that elicits locus-specific alterations in chromatin architecture, which in turn influences gene expression. One such epigenetic modification that is sensitive to changes in synaptic activity, as well as essential for maintaining cellular identity, is DNA methylation. The focus of this article is on the importance of DNA methylation in neuronal function, summarizing recent studies on critical players in the establishment of (the "writing"), the modification or erasure of (the "editing"), and the mediation of (the "reading") DNA methylation in neurodevelopment and neuroplasticity. One "reader" of DNA methylation in particular, methyl-CpG-binding protein 2 (MeCP2), is highlighted, given its undisputed importance in neuronal function.	[Fasolino, Maria; Zhou, Zhaolan] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Zhou, ZL (reprint author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	fasolino@mail.med.upenn.edu; zhaolan@mail.med.upenn.edu			U.S. National Institute of Health [R01 MH091850, R01 NS081054]	This work was supported by the U.S. National Institute of Health grant R01 MH091850 and R01 NS081054 to Z.Z., who is a Pew Scholar in the biomedical sciences.	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; ALLAN J, 1984, J CELL BIOL, V98, P1320, DOI 10.1083/jcb.98.4.1320; Amir RE, 1999, NAT GENET, V23, P185; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bird A., 2002, GENES DEV; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Brooks PJ, 1996, J NEUROSCI, V16, P939; Brown GP, 2000, J NEUROSCI, V20, P7880; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen L, 2015, P NATL ACAD SCI USA, V112, P5509, DOI 10.1073/pnas.1505909112; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446                                                         ; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Delepine C, 2016, HUM MOL GENET, V25, P146, DOI 10.1093/hmg/ddv464; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; ELLISON KA, 1992, AM J HUM GENET, V50, P278; Fan GP, 2001, J NEUROSCI, V21, P788; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Filion G. J. P., 2005, MOL CELL BIOL, P26; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Golshani P., 2007, THL, V3, P227; Gonzales ML, 2012, MOL CELL BIOL, V32, P2894, DOI 10.1128/MCB.06728-11; Goto K., 1994, DIFFERENTIATION; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899                                                                   ; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538                                                          ; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ishibashi T, 2008, FEBS LETT, V582, P1157, DOI 10.1016/j.febslet.2008.03.005; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeffrey LN, 2010, ANN NEUROL, V68, P944; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Khrapunov S, 2014, BIOCHEMISTRY-US, V53, P3379, DOI 10.1021/bi500424z; Kinde B, 2015, P NATL ACAD SCI USA, V112, P6800, DOI 10.1073/pnas.1411269112; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200                                                          ; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Lagger S., BIORXIV; Lehnertz B., 2003, CURR BIOL; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li X, 2014, P NATL ACAD SCI USA, V111, P7120, DOI 10.1073/pnas.1318906111; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Linhoff MW, 2015, CELL, V163, P246, DOI 10.1016/j.cell.2015.09.002; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lisman J., 2012, NAT REV NEUROSCI; Lister R., 2013, SCIENCE; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI [10.1523/JNEUROSCI.0324-09.2009, 10.1523/JNEUROSCI.324-09.2009]; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012                                                    ; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842                                                         ; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mo A., 2015, NEURON; Morris M. J., 2016, NEUROBIOL LEARN MEM; Morris M. J., 2014, NEUROBIOL LEARN MEM; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nguyen Minh Vu Chuong, 2012, J Neurosci, V32, P10021, DOI 10.1523/JNEUROSCI.1316-12.2012; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; PEARSON EC, 1984, EUR J BIOCHEM, V144, P353, DOI 10.1111/j.1432-1033.1984.tb08471.x; Percy AK, 2010, ANN NEUROL, V68, P951, DOI 10.1002/ana.22154; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Prokhortchouk A., GENES DEV, V15, P1613; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Roberts R, 1998, NATURE, V393, P358, DOI 10.1038/30718                                                                   ; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932                                                                  ; Schanen NC, 1997, AM J HUM GENET, V61, P634, DOI 10.1086/515525; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tai DJC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10552; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Varley K. E., 2013, GENOME; Wang ITJ, 2013, NEUROBIOL DIS, V58, P3, DOI 10.1016/j.nbd.2013.04.020; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Wood L, 2010, NEUROBIOL DIS, V38, P281, DOI 10.1016/j.nbd.2010.01.018; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Xie W., 2012, CELL; Xu GL, 1999, NATURE, V402, P187; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Ying SW, 2002, J NEUROSCI, V22, P1532; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhao YT, 2013, NEUROBIOL DIS, V59, P257, DOI 10.1016/j.nbd.2013.08.001; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X                                                   	142	1	1	7	7	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2073-4425			GENES-BASEL	Genes	MAY	2017	8	5							141	10.3390/genes8050141				19	Genetics & Heredity	Genetics & Heredity	EZ1FS	WOS:000404456100014		gold			2018-01-05	
J	Tian, XZ; Wang, F; Zhang, L; Ji, PY; Wang, J; Lv, DY; Li, GD; Chai, ML; Lian, ZX; Liu, GS				Tian, Xiuzhi; Wang, Feng; Zhang, Lu; Ji, Pengyun; Wang, Jing; Lv, Dongying; Li, Guangdong; Chai, Menglong; Lian, Zhengxing; Liu, Guoshi			Melatonin Promotes the In Vitro Development of Microinjected Pronuclear Mouse Embryos via Its Anti-Oxidative and Anti-Apoptotic Effects	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						melatonin; mouse; pronuclear embryo; microinjection; anti-oxidation; anti-apoptosis	PORCINE OOCYTES; 2-CELL EMBRYOS; MATURATION; CELLS; IMPLANTATION; EXPRESSION; EFFICIENCY	CRISPR/Cas9 (Clustered regularly interspaced short palindromic repeats) combined with pronuclear microinjection has become the most effective method for producing transgenic animals. However, the relatively low embryo developmental rate limits its application. In the current study, it was observed that 10(-7) M melatonin is considered an optimum concentration and significantly promoted the in vitro development of murine microinjected pronuclear embryos, as indicated by the increased blastocyst rate, hatching blastocyst rate and blastocyst cell number. When these blastocysts were implanted into recipient mice, the pregnancy rate and birth rate were significantly higher than those of the microinjected control, respectively. Mechanistic studies revealed that melatonin treatment reduced reactive oxygen species (ROS) production and cellular apoptosis during in vitro embryo development and improved the quality of the blastocysts. The implantation of quality-improved blastocysts led to elevated pregnancy and birth rates. In conclusion, the results revealed that the anti-oxidative and anti-apoptotic activities of melatonin improved the quality of microinjected pronuclear embryos and subsequently increased both the efficiency of embryo implantation and the birth rate of the pups. Therefore, the melatonin supplementation may provide a novel alternative method for generating large numbers of transgenic mice and this method can probably be used in human-assisted reproduction and genome editing.	[Tian, Xiuzhi; Wang, Feng; Zhang, Lu; Ji, Pengyun; Wang, Jing; Lv, Dongying; Li, Guangdong; Chai, Menglong; Lian, Zhengxing; Liu, Guoshi] China Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Anim Genet Improvement, Minist Agr,Natl Engn Lab Anim Breeding,Key Lab An, Beijing 100193, Peoples R China	Liu, GS (reprint author), China Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Anim Genet Improvement, Minist Agr,Natl Engn Lab Anim Breeding,Key Lab An, Beijing 100193, Peoples R China.	tian7550@163.com; vicent007@126.com; df765@sina.com; jipengyun1989@gmail.com; caylajingjing@gmail.com; suxingdemogu@icloud.com; 15600911225@163.com; cml313@163.com; lianzhx@cau.edu.cn; gshliu@cau.edu.cn			Key State Science and Technology Projects [2014ZX08008020B, 2016ZX08008-003]	This research was supported by the Key State Science and Technology Projects (2014ZX08008020B, 2016ZX08008-003).	Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034; Agarwal A, 2006, FERTIL STERIL, V86, P503, DOI 10.1016/j.fertnstert.2006.02.088; Barrett P, 2012, J PINEAL RES, V52, P376, DOI 10.1111/j.1600-079X.2011.00963.x; Buyukavci M, 2006, FUND CLIN PHARMACOL, V20, P73, DOI 10.1111/j.1472-8206.2005.00389.x; Cheuqueman C, 2015, ANDROLOGIA, V47, P604, DOI 10.1111/and.12308; Choi J, 2008, MOL REPROD DEV, V75, P1127, DOI 10.1002/mrd.20861; Dair EL, 2008, FERTIL STERIL, V89, P1299, DOI 10.1016/j.fertnstert.2007.03.050; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380                                                         ; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Hogan B., 1986, MANIPULATING MOUSE E, V101, P223; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Korkmaz A, 2012, GENE, V503, P1, DOI 10.1016/j.gene.2012.04.040; Mohseni M, 2012, MUTAT RES-FUND MOL M, V738, P19, DOI 10.1016/j.mrfmmm.2012.08.006; Nakano M, 2012, ZYGOTE, V20, P199, DOI 10.1017/S0967199411000190; Nanassy L, 2008, ANIM REPROD SCI, V104, P264, DOI 10.1016/j.anireprosci.2007.01.019; Orly W., 2003, ANN NY ACAD SCI, V993, P351; Pang YW, 2013, J PINEAL RES, V54, P389, DOI 10.1111/jpi.12024; Papis K, 2007, J PINEAL RES, V43, P321, DOI 10.1111/j.1600-079X.2007.00479.x; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rodriguez-Osorio N, 2007, J PINEAL RES, V43, P283, DOI 10.1111/j.1600-079X.2007.00475.x; Rose C, 2012, THERIOGENOLOGY, V77, P1883, DOI 10.1016/j.theriogenology.2012.01.005; Sampaio RV, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-103; Shi JM, 2009, J PINEAL RES, V47, P318, DOI 10.1111/j.1600-079X.2009.00717.x; Siu AW, 2006, J PINEAL RES, V40, P101, DOI 10.1111/j.1600-079X.2005.00304.x; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Tamura H, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-5; Tian XZ, 2010, ENDOCR RES, V35, P17, DOI 10.3109/07435800903539607; Tian XZ, 2014, J PINEAL RES, V57, P239, DOI 10.1111/jpi.12163; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093641; Wang F, 2014, J PINEAL RES, V56, P333, DOI 10.1111/jpi.12126; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19071; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162	39	0	0	4	4	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAY	2017	18	5							988	10.3390/ijms18050988				10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	EY6SQ	WOS:000404113900095					2018-01-05	
J	Bautista, MA; Black, JA; Youngblut, ND; Whitaker, RJ				Bautista, Maria A.; Black, Jesse A.; Youngblut, Nicholas D.; Whitaker, Rachel J.			Differentiation and Structure in Sulfolobus islandicus Rod-Shaped Virus Populations	VIRUSES-BASEL			English	Article						host-virus interactions; Sulfolobus islandicus rod-shaped virus; archaeal virus	TURRETED ICOSAHEDRAL VIRUS; ARCHAEAL VIRUSES; HOST INTERACTIONS; HOT-SPRINGS; GENOMICS; SYSTEM; RUDIVIRUSES; BACTERIAL; PROTEINS; DNA	In the past decade, molecular surveys of viral diversity have revealed that viruses are the most diverse and abundant biological entities on Earth. In culture, however, most viral isolates that infect microbes are represented by a few variants isolated on type strains, limiting our ability to study how natural variation affects virus-host interactions in the laboratory. We screened a set of 137 hot spring samples for viruses that infect a geographically diverse panel of the hyperthemophilic crenarchaeon Sulfolobus islandicus. We isolated and characterized eight SIRVs (Sulfolobus islandicus rod-shaped viruses) from two different regions within Yellowstone National Park (USA). Comparative genomics revealed that all SIRV sequenced isolates share 30 core genes that represent 50-60% of the genome. The core genome phylogeny, as well as the distribution of variable genes (shared by some but not all SIRVs) and the signatures of host-virus interactions recorded on the CRISPR (clustered regularly interspaced short palindromic repeats) repeat-spacer arrays of S. islandicus hosts, identify different SIRV lineages, each associated with a different geographic location. Moreover, our studies reveal that SIRV core genes do not appear to be under diversifying selection and thus we predict that the abundant and diverse variable genes govern the coevolutionary arms race between SIRVs and their hosts.	[Bautista, Maria A.; Whitaker, Rachel J.] Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA; [Black, Jesse A.] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA; [Youngblut, Nicholas D.] Max Planck Inst Dev Biol, Dept Microbiome Sci, Spemannstr 35, D-72076 Tubingen, Germany; [Whitaker, Rachel J.] Univ Illinois, Carl R Woese Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA	Whitaker, RJ (reprint author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA.; Whitaker, RJ (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	bautist2@illinois.edu; black2@uchicago.edu; youngblut@tuebingen.mpg.de; rwhitaker@life.illinois.edu			NSF DEB [0816885]; NSF Dimensions of Diversity DEB [1342876]; NASA [NNX09AM92G]	This work was supported by NSF DEB 0816885 and NSF Dimensions of Diversity DEB 1342876 and NASA NNX09AM92G. We acknowledge past and current Whitaker Lab members for sample collection efforts in Yellowstone National Park, especially P. Diebold. We acknowledge A. Herrera, J. Kremer, and B. Lee for experimental assistance. We thank S. J. Robinson at the Imaging Technology Group at the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign for his assistance imaging the viruses under TEM. We thank C. L Wright and A. Hernandez at the W. M. Keck Center for Comparative and Functional Genomics at the University of Illinois at Urbana-Champaign for their assistance with Next-generation sequencing. We thank W. England, T. Kim, and P. Degnan for their assistance with bioinformatics.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bautista MA, 2015, MBIO, V6, DOI 10.1128/mBio.02565-14; Bolduc B, 2015, ISME J, V9, P2162, DOI 10.1038/ismej.2015.28; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brum JR, 2015, NAT REV MICROBIOL, V13, P147, DOI 10.1038/nrmicro3404; Brumfield SK, 2009, J VIROL, V83, P5964, DOI 10.1128/JVI.02668-08; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; Coil D., 2014, ARXIV14015130 Q BIO; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Daum B, 2014, P NATL ACAD SCI USA, V111, P3829, DOI 10.1073/pnas.1319245111; Deng L, 2014, J VIROL, V88, P10264, DOI 10.1128/JVI.01495-14; DiMaio F, 2015, SCIENCE, V348, P914, DOI 10.1126/science.aaa4181; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fulton J., 2009, BACTERIOPHAGES, V501, P43; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guilliere F, 2009, J BIOL CHEM, V284, P22222, DOI 10.1074/jbc.M109.029850; Guo Y, 2015, J MOL BIOL, V427, P2179, DOI 10.1016/j.jmb.2015.03.013; Held NL, 2013, ENVIRON MICROBIOL, V15, P3065, DOI 10.1111/1462-2920.12146; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39                                                             ; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Korber B., 2000, HIV SIGNATURE SEQUEN, P55; Krupovic M, 2012, ADV VIRUS RES, V82, P33, DOI 10.1016/B978-0-12-394621-8.00012-1; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Lefkowitz EJ, 2006, VIRUS RES, V117, P105, DOI 10.1016/j.virusres.2006.01.016; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.000019; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Menzel P, 2015, MICROB ECOL, V70, P411, DOI 10.1007/s00248-015-0576-9; Oke M, 2011, J VIROL, V85, P925, DOI 10.1128/JVI.01467-10; Ortmann AC, 2006, NAT REV MICROBIOL, V4, P520, DOI 10.1038/nrmicro1444; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Peng X, 2001, VIROLOGY, V291, P226, DOI 10.1006/viro.2001.1190; Pina M, 2011, FEMS MICROBIOL REV, V35, P1035, DOI 10.1111/j.1574-6976.2011.00280.x; Prangishvili D, 1999, GENETICS, V152, P1387; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Prangishvili D, 2013, ANNU REV MICROBIOL, V67, P565, DOI 10.1146/annurev-micro-092412-155633; Prangishvili D, 2013, BIOCHEM SOC T, V41, P443, DOI 10.1042/BST20120313; Quax TEF, 2011, P NATL ACAD SCI USA, V108, P3354, DOI 10.1073/pnas.1018052108; Quax TEF, 2010, VIROLOGY, V404, P1, DOI 10.1016/j.virol.2010.04.020; Rachel R, 2002, ARCH VIROL, V147, P2419, DOI 10.1007/s00705-002-0895-2; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rodriguez-Valera F., 2014, BACTERIOPHAGE, V4; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; SCHLEPER C, 1992, P NATL ACAD SCI USA, V89, P7645, DOI 10.1073/pnas.89.16.7645; Snyder JC, 2007, P NATL ACAD SCI USA, V104, P19102, DOI 10.1073/pnas.0709445104; Snyder JC, 2011, J VIROL, V85, P6287, DOI 10.1128/JVI.00379-11; Szymczyna BR, 2009, STRUCTURE, V17, P499, DOI 10.1016/j.str.2009.03.001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	61	2	2	1	1	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	MAY	2017	9	5							120	10.3390/v9050120				15	Virology	Virology	EY8DY	WOS:000404226000027		gold			2018-01-05	
J	Kalatzis, PG; Rorbo, N; Castillo, D; Mauritzen, JJ; Jorgensen, J; Kokkari, C; Zhang, FX; Katharios, P; Middelboe, M				Kalatzis, Panos G.; Rorbo, Nanna; Castillo, Daniel; Mauritzen, Jesper Juel; Jorgensen, Johanna; Kokkari, Constantina; Zhang, Faxing; Katharios, Pantelis; Middelboe, Mathias			Stumbling across the Same Phage: Comparative Genomics of Widespread Temperate Phages Infecting the Fish Pathogen Vibrio anguillarum	VIRUSES-BASEL			English	Article						bacteriophages; temperate; Vibrio anguillarum; Siphovirus; genetic similarity; omnipresent; lysogenic conversion	HARVEYI MYOVIRUS-LIKE; TAPE MEASURE PROTEIN; FLAVOBACTERIUM-PSYCHROPHILUM; ADENINE METHYLTRANSFERASE; LYSOGENIC CONVERSION; BACTERIAL VIRULENCE; MEMBRANE-PROTEIN; GENETIC RICHNESS; GADUS-MORHUA; BACTERIOPHAGE	Nineteen Vibrio anguillarum-specific temperate bacteriophages isolated across Europe and Chile from aquaculture and environmental sites were genome sequenced and analyzed for host range, morphology and life cycle characteristics. The phages were classified as Siphoviridae with genome sizes between 46,006 and 54,201 bp. All 19 phages showed high genetic similarity, and 13 phages were genetically identical. Apart from sporadically distributed single nucleotide polymorphisms (SNPs), genetic diversifications were located in three variable regions (VR1, VR2 and VR3) in six of the phage genomes. Identification of specific genes, such as N6-adenine methyltransferase and lambda like repressor, as well as the presence of a tRNAArg, suggested a both mutualistic and parasitic interaction between phages and hosts. During short term phage exposure experiments, 28% of a V. anguillarum host population was lysogenized by the temperate phages and a genomic analysis of a collection of 31 virulent V. anguillarum showed that the isolated phages were present as prophages in >50% of the strains covering large geographical distances. Further, phage sequences were widely distributed among CRISPR-Cas arrays of publicly available sequenced Vibrios. The observed distribution of these specific temperate Vibriophages across large geographical scales may be explained by efficient dispersal of phages and bacteria in the marine environment combined with a mutualistic interaction between temperate phages and their hosts which selects for co-existence rather than arms race dynamics.	[Kalatzis, Panos G.; Rorbo, Nanna; Castillo, Daniel; Mauritzen, Jesper Juel; Jorgensen, Johanna; Middelboe, Mathias] Univ Copenhagen, Marine Biol Sect, DK-3000 Helsingor, Denmark; [Kalatzis, Panos G.; Kokkari, Constantina; Katharios, Pantelis] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion 71500, Greece; [Zhang, Faxing] Beijing Genom Inst BGI Pk,21 Hongan 3rd St,Bldg 7, Shenzhen 518083, Peoples R China	Middelboe, M (reprint author), Univ Copenhagen, Marine Biol Sect, DK-3000 Helsingor, Denmark.	panos.kalatzis@bio.ku.dk; nanna.rorbo@bio.ku.dk; danielcastillobq@gmail.com; kcq442@alumni.ku.dk; johannajorgensen88@gmail.com; dkok@hcmr.gr; jason.zhang@genomics.cn; katharios@hcmr.gr; mmiddelboe@bio.ku.dk	Middelboe, Mathias/B-9995-2009	Middelboe, Mathias/0000-0002-9587-9171; Katharios, Pantelis/0000-0001-9905-5068	Danish Council for Strategic Research (ProAqua project) [12-132390]; Danish Agency for Science, Technology and Innovation (INP) [5132-00014B]; Greek National Strategic Reference Framework; European Social Fund; Greek National Funds; FISHPHAGE [131]	The study was supported by the Danish Council for Strategic Research (ProAqua project 12-132390), the Danish Agency for Science, Technology and Innovation (INP Grant#5132-00014B) and by the Greek National Strategic Reference Framework 2007-2013 (co-funded by European Social Fund and Greek National Funds) FISHPHAGE project 131, www.gsrt.gr. We would like to thank the staff of Venosund and Sogndal aquaculture units for providing us water samples and George Chalepakis and the staff of the Laboratory of Electron Microscopy of the University of Crete for the TEM work.	ACTIS LA, 1986, J BACTERIOL, V167, P57, DOI 10.1128/jb.167.1.57-65.1986                                                     ; Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290; Alonso Guillermina, 2000, International Microbiology, V3, P81; AUSTIN B, 1995, SYST APPL MICROBIOL, V18, P285, DOI 10.1016/S0723-2020(11)80400-5                                                   ; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berngruber TW, 2010, J VIROL, V84, P10200, DOI 10.1128/JVI.00865-10; Bochow S, 2012, J APPL MICROBIOL, V113, P1001, DOI 10.1111/j.1365-2672.2012.05358.x; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Castillo D., 2017, MSYSTEMS, V2; Castillo D, 2015, APPL ENVIRON MICROB, V81, P1157, DOI 10.1128/AEM.03699-14; Clokie M. R. J., 2011, BACTERIOPHAGE, V1, P31, DOI DOI 10.4161/BACT.1.1.14942; Comeau AM, 2006, ENVIRON MICROBIOL, V8, P1164, DOI 10.1111/j.1462-2920.2006.01006.x; Comeau AM, 2007, ENVIRON MICROBIOL, V9, P1790, DOI 10.1111/j.1462-2920.2007.01299.x; Cumby N, 2015, MOL MICROBIOL, V96, P437, DOI 10.1111/mmi.12918; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davies EV, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw015; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Frans I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070477; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hasan NA, 2015, P NATL ACAD SCI USA, V112, pE2813, DOI 10.1073/pnas.1503928112; Higuera G, 2013, AQUACULTURE, V392, P128, DOI 10.1016/j.aquaculture.2013.02.013; Holm KO, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0060-7; Hyman P, 2009, BACTERIOPHAGES METHO, V1, P175; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KELLOGG CA, 1995, MAR ECOL PROG SER, V120, P89, DOI 10.3354/meps120089; Kim YC, 2014, BBA-MOL CELL RES, V1843, P1717, DOI 10.1016/j.bbamcr.2014.04.010; KOSTER WL, 1991, J BIOL CHEM, V266, P23829; Laslett D., 2004, PLOS ONE, V32, P11, DOI DOI 10.1093/NAR/GKH152; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; LURIA SE, 1953, COLD SPRING HARB SYM, V18, P237, DOI 10.1101/SQB.1953.018.01.034                                                     ; MACDONELL MT, 1985, SYST APPL MICROBIOL, V6, P171, DOI 10.1016/S0723-2020(85)80051-5                                                   ; Mateus L, 2014, AQUACULTURE, V424, P167, DOI 10.1016/j.aquaculture.2014.01.001; Mikkelsen H, 2004, AQUACULTURE, V242, P81, DOI 10.1016/j.aquaculture.2004.09.004; Munro J, 2003, DIS AQUAT ORGAN, V54, P187, DOI 10.3354/dao054187; Murphy J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-831; Murphy J, 2013, APPL ENVIRON MICROB, V79, P7547, DOI 10.1128/AEM.02229-13; Naka H, 2011, FISH PATHOL, V46, P1, DOI 10.3147/jsfp.46.1                                                               ; Napolitano MG, 2016, P NATL ACAD SCI USA, V113, pE5588, DOI 10.1073/pnas.1605856113; NATHANS D, 1975, ANNU REV BIOCHEM, V44, P273, DOI 10.1146/annurev.bi.44.070175.001421                                             ; Oakey HJ, 2000, J APPL MICROBIOL, V89, P702, DOI 10.1046/j.1365-2672.2000.01169.x; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; Obeng N, 2016, TRENDS MICROBIOL, V24, P440, DOI 10.1016/j.tim.2015.12.009; Oliveira J, 2012, AQUACULT INT, V20, P879, DOI 10.1007/s10499-012-9515-7; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Park Y, 2007, VIRUS GENES, V34, P177, DOI 10.1007/s11262-006-0059-7; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pedersen K, 1997, J APPL MICROBIOL, V82, P365, DOI 10.1046/j.1365-2672.1997.00373.x; Penfold CN, 2012, BIOCHEM SOC T, V40, P1433, DOI 10.1042/BST20120253; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Garcia-Del Portillo F., 1999, P NATL ACAD SCI USA, V96, P11578; REHNSTAM AS, 1989, APPL ENVIRON MICROB, V55, P1907; Rodkhum C, 2006, J FISH DIS, V29, P157, DOI 10.1111/j.1365-2761.2006.00692.x; Rodriguez-Rubio L, 2012, APPL ENVIRON MICROB, V78, P6369, DOI 10.1128/AEM.01236-12; Romero J., 2014, GENOME ANNOUNC, V2, P2013; Ronneseth A., 2017, J FISH DIS; Samuelsen OB, 2004, AQUACULTURE, V235, P27, DOI 10.1016/S0044-8486(03)00446-0; Sano E, 2004, APPL ENVIRON MICROB, V70, P5842, DOI 10.1128/AEM.70.10.5842-5846.2004; Silva-Rubio A, 2008, J FISH DIS, V31, P235, DOI 10.1111/j.1365-2761.2007.00878.x; SKOV MN, 1995, APPL ENVIRON MICROB, V61, P1540; Sonnenschein EC, 2017, ISME J, V11, P569, DOI 10.1038/ismej.2016.111; SPENCER R, 1960, J BACTERIOL, V79, P614; Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; Tan DM, 2014, APPL ENVIRON MICROB, V80, P3128, DOI 10.1128/AEM.03544-13; Thompson FL, 2006, J BACTERIOL, V188, P4592, DOI 10.1128/JB.00141-06; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thompson JR, 2006, BIOLOGY OF VIBRIOS, P190; Thurber RV, 2009, CURR OPIN MICROBIOL, V12, P582, DOI 10.1016/j.mib.2009.08.008; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; Vidgen M, 2006, J APPL MICROBIOL, V100, P481, DOI 10.1111/j.1365-2672.2005.02829.x; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910                                                   ; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049; Weynberg KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep17889; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Williamson SJ, 2006, MICROB ECOL, V52, P217, DOI 10.1007/s00248-006-9113-1; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Williamson SJ, 2001, APPL ENVIRON MICROB, V67, P1682, DOI 10.1128/AEM.67.4.1682-1688.2001; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Zahn K, 1996, MOL MICROBIOL, V21, P69, DOI 10.1046/j.1365-2958.1996.6201335.x; Zhou Y., 2011, NUCLEIC ACIDS RES, V39, P1, DOI DOI 10.1093/NAR/GKQ742	87	1	1	3	3	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	MAY	2017	9	5							122	10.3390/v9050122				19	Virology	Virology	EY8DY	WOS:000404226000029		gold			2018-01-05	
J	Fan, XR; Naz, M; Fan, XR; Xuan, W; Miller, AJ; Xu, GH				Fan, Xiaorong; Naz, Misbah; Fan, Xiaoru; Xuan, Wei; Miller, Anthony J.; Xu, Guohua			Plant nitrate transporters: from gene function to application	JOURNAL OF EXPERIMENTAL BOTANY			English	Review						Crop; gene function; nitrate transporter; nitrogen use efficiency	NITROGEN-USE EFFICIENCY; PARTNER PROTEIN OSNAR2.1; LONG-DISTANCE TRANSPORT; ANION CHANNEL SLAC1; ORYZA-SATIVA L.; ARABIDOPSIS NITRATE; ROOT ARCHITECTURE; PLASMA-MEMBRANE; MEDICAGO-TRUNCATULA; FAMILY-MEMBERS	Plant nitrate transporters were first identified and functionally characterized more than 20 years ago. They are encoded at least by four gene families, NRT1 (NPF), NRT2, CLC, and SLAC1/SLAH. In this review, we overview the functions of the nitrate transporters in relation to their potential use as targets for improving crop nitrogen use efficiency. These functions include their roles in root architecture and nutrient acquisition; vacuole nitrate and protein storage; nutrient allocation from source to sink; sensing both abiotic and biotic stresses; the ionic balance of nitrate with potassium, chloride and cellular pH; and the circadian clock-regulated carbon and nitrogen balance. We provide and discuss some examples of the use of nitrate transporter genes and their regulators in improving plant growth and development, nitrogen use efficiency, and resistance to some abiotic stresses. We propose several strategies for effectively using nitrate transporters to achieve higher crop yields and nitrogen use efficiency by using gene transformation or genome editing or molecular marker-assisted breeding.	[Fan, Xiaorong; Naz, Misbah; Fan, Xiaoru; Xu, Guohua] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Fan, Xiaorong; Fan, Xiaoru; Xuan, Wei; Xu, Guohua] Nanjing Agr Univ, Minist Agr, Key Lab Plant Nutr & Fertilizat Lower Middle Reac, Nanjing 210095, Jiangsu, Peoples R China; [Miller, Anthony J.] John Innes Inst, Metab Biol Dept, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	Xu, GH (reprint author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.; Xu, GH (reprint author), Nanjing Agr Univ, Minist Agr, Key Lab Plant Nutr & Fertilizat Lower Middle Reac, Nanjing 210095, Jiangsu, Peoples R China.	ghxu@njau.edu.cn	xu, guohua/J-1840-2012; Miller, Anthony/B-5139-2008	xu, guohua/0000-0002-3283-2392; Miller, Anthony/0000-0003-0572-7607	China National Key Program for Research and Development [2016YFD0100700]; National Natural Science Foundation [31372122]; Transgenic Project [2016ZX08001003-008]; 111 Project [12009]; Innovative Research Team Development Plan Ministry of Education of China; Priority Academic Program Development of the Jiangsu Higher Education Institutions; Jiangsu Science Fund for Distinguished Young Scholars [BK20160030]; Biotechnology and Biological Sciences Research Council [BB/JJ004553/1, BB/L010305/1]; John Innes Foundation	Work in GX's laboratory is supported by the China National Key Program for Research and Development (2016YFD0100700), the National Natural Science Foundation (grant 31372122), the Transgenic Project (grant 2016ZX08001003-008), the 111 Project (grant 12009), the Innovative Research Team Development Plan of the Ministry of Education of China, and the Priority Academic Program Development of the Jiangsu Higher Education Institutions project. XF is supported by the Jiangsu Science Fund for Distinguished Young Scholars (grant BK20160030). AJM is supported by grant funding (BB/JJ004553/1 and BB/L010305/1) from the Biotechnology and Biological Sciences Research Council and the John Innes Foundation.	Abenavoli MR, 2016, PLANT PHYSIOL BIOCH, V107, P21, DOI 10.1016/j.plaphy.2016.04.021; Alboresi A, 2005, PLANT CELL ENVIRON, V28, P500, DOI 10.1111/j.1365-3040.2005.01292.x; Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Alvarez JM, 2014, PLANT J, V80, P1, DOI 10.1111/tpj.12618; Araus V, 2016, PLANT PHYSIOL, V171, P1523, DOI 10.1104/pp.15.01731; Bagchi R, 2012, PLANT PHYSIOL, V160, P906, DOI 10.1104/pp.112.196444; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Bouguyon E, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.15, 10.1038/nplants.2015.15]; Camanes G, 2012, PLANT SIGNAL BEHAV, V7, P619, DOI 10.4161/psb.20430; Castaings L, 2011, J EXP BOT, V62, P1391, DOI 10.1093/jxb/erq375; Chen CZ, 2012, PLANT PHYSIOL, V159, P1582, DOI 10.1104/pp.112.199257; Chen JG, 2016, PLANT BIOTECHNOL J, V14, P1705, DOI 10.1111/pbi.12531; Chen XB, 2016, CURR BIOL, V26, P640, DOI 10.1016/j.cub.2015.12.066; Chiba Y, 2015, J PLANT RES, V128, P679, DOI 10.1007/s10265-015-0710-2; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Coskun D, 2016, PLANT CELL ENVIRON, DOI [10.1111/pce.12671, DOI 10.1111/PCE.12671.]; Cubero-Font P, 2016, CURR BIOL, V26, P2213, DOI 10.1016/j.cub.2016.06.045; David LC, 2016, PLANTA, V244, P1315, DOI 10.1007/s00425-016-2588-1; David LC, 2014, J EXP BOT, V65, P885, DOI 10.1093/jxb/ert481; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dechorgnat J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042491; Drechsler N, 2015, PLANT PHYSIOL, V169, P2832, DOI 10.1104/pp.15.01152; Fagard M, 2014, J EXP BOT, V65, P5643, DOI 10.1093/jxb/eru323; Falhof J, 2016, MOL PLANT, V9, P323, DOI 10.1016/j.molp.2015.11.002; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Fan XR, 2007, J EXP BOT, V58, P1729, DOI 10.1093/jxb/erm033; Fan XR, 2016, P NATL ACAD SCI USA, V113, P7118, DOI 10.1073/pnas.1525184113; Fan XR, 2016, J INTEGR PLANT BIOL, V58, P590, DOI 10.1111/jipb.12382; Fan XR, 2005, SCI CHINA SER C, V48, P897, DOI [10.1360/062005-281, 10.1007/BF03187128]; Fang XZ, 2016, NEW PHYTOL, V211, P149, DOI 10.1111/nph.13892; Fang ZM, 2013, PLANT BIOTECHNOL J, V11, P446, DOI 10.1111/pbi.12031; Feng HM, 2011, J EXP BOT, V62, P2319, DOI 10.1093/jxb/erq403; Fu YL, 2015, FEBS LETT, V589, P1072, DOI 10.1016/j.febslet.2015.03.016; Gamir J, 2014, PLANT J, V78, P227, DOI 10.1111/tpj.12465; Gangappa SN, 2016, MOL PLANT, V9, P1353, DOI 10.1016/j.molp.2016.07.002; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Geiger D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001346; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Giehl RFH, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.21, 10.1038/nplants.2015.21]; Goel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143645; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Good AG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001124; Gu CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23462; Guo S, 2007, PLANT BIOLOGY, V9, P21, DOI 10.1055/s-2006-924541; Gutierrez RA, 2012, SCIENCE, V336, P1673, DOI 10.1126/science.1217620; Hachiya T, 2011, J PLANT RES, V124, P425, DOI 10.1007/s10265-010-0385-7; Han YL, 2016, PLANT PHYSIOL, V170, P1684, DOI 10.1104/pp.15.01377; He X, 2015, PLANT PHYSIOL, V169, P1991, DOI 10.1104/pp.15.00568; Ho CH, 2010, CURR OPIN PLANT BIOL, V13, P604, DOI 10.1016/j.pbi.2010.08.005; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hsu PK, 2013, PLANT PHYSIOL, V163, P844, DOI 10.1104/pp.113.226563; Hu B, 2015, NAT GENET, V47, P834, DOI 10.1038/ng.3337; Huang SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18192; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jin Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep14222; Jonassen EM, 2009, J PLANT PHYSIOL, V166, P2071, DOI 10.1016/j.jplph.2009.05.010; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Kechid M, 2013, NEW PHYTOL, V198, P514, DOI 10.1111/nph.12158; Kiba T, 2016, PLANT CELL PHYSIOL, V57, P707, DOI 10.1093/pcp/pcw052; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; Kotur Z, 2015, PLANT CELL ENVIRON, V38, P1490, DOI 10.1111/pce.12496; Kotur Z, 2012, NEW PHYTOL, V194, P724, DOI 10.1111/j.1469-8137.2012.04094.x; Krapp A, 2015, CURR OPIN PLANT BIOL, V25, P115, DOI 10.1016/j.pbi.2015.05.010; Krapp A, 2014, J EXP BOT, V65, P789, DOI 10.1093/jxb/eru001; Krapp A, 2011, PLANT PHYSIOL, V157, P1255, DOI 10.1104/pp.111.179838; Krouk G, 2016, PLANT MOL BIOL, V91, P599, DOI 10.1007/s11103-016-0463-x; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Le Deunff E, 2016, ANN BOT-LONDON, V118, P607, DOI 10.1093/aob/mcw123; Lejay L, 1999, PLANT J, V18, P509, DOI 10.1046/j.1365-313X.1999.00480.x; Leran S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07962; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Lezhneva L, 2014, PLANT J, V80, P230, DOI 10.1111/tpj.12626; Li B, 2016, PLANT PHYSIOL, V170, P1014, DOI 10.1104/pp.15.01163; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Li GW, 2016, PLANT CELL PHYSIOL, V57, P733, DOI 10.1093/pcp/pcw022; Li JY, 2010, PLANT CELL, V22, P1633, DOI 10.1105/tpc.110.075242; Li YL, 2008, PLANT CELL ENVIRON, V31, P73, DOI 10.1111/j.1365-3040.2007.01737.x; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu XQ, 2014, NEW PHYTOL, V204, P74, DOI 10.1111/nph.12986; Liu ZY, 2016, FUNCT INTEGR GENOMIC, V16, P323, DOI 10.1007/s10142-016-0486-z; Lupini A, 2016, PLANT PHYSIOL BIOCH, V102, P107, DOI [10.1016/j.plaphy2016.02.022, 10.1016/j.plaphy.2016.02.022]; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Ma JF, 2015, TRENDS PLANT SCI, V20, P435, DOI 10.1016/j.tplants.2015.04.007; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Maierhofer T, 2014, PLANT CELL, V26, P2554, DOI 10.1105/tpc.114.125849; Mao QQ, 2014, PLANT PHYSIOL, V166, P934, DOI 10.1104/pp.114.243766; Marin IC, 2011, PLANTA, V233, P539, DOI 10.1007/s00425-010-1316-5; Matakiadis T, 2009, PLANT PHYSIOL, V149, P949, DOI 10.1104/pp.108.126938; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Medici A, 2014, J EXP BOT, V65, P5567, DOI 10.1093/jxb/eru245; Meng SA, 2016, MOL PLANT, V9, P461, DOI 10.1016/j.molp.2015.12.015; Migocka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073972; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Monachello D, 2009, NEW PHYTOL, V183, P88, DOI 10.1111/j.1469-8137.2009.02837.x; Morere-Le Paven MC, 2011, J EXP BOT, V62, P5595, DOI 10.1093/jxb/err243; Mounier E, 2014, PLANT CELL ENVIRON, V37, P162, DOI 10.1111/pce.12143; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; O'Brien JA, 2016, MOL PLANT, V9, P837, DOI 10.1016/j.molp.2016.05.004; Ouyang J, 2015, SCI REPORTS, V5, P9635; Pal'ove-Balang P, 2015, PLANT BIOLOGY, V17, P16, DOI 10.1111/plb.12169; Pellizzaro A, 2015, PHYSIOL PLANTARUM, V154, P256, DOI 10.1111/ppl.12314; Pike S, 2014, PLANT CELL PHYSIOL, V55, P162, DOI 10.1093/pcp/pct167; Pires MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135234; QUESADA A, 1994, PLANT J, V5, P407, DOI 10.1111/j.1365-313X.1994.00407.x; Rahayu YS, 2005, J EXP BOT, V56, P1143, DOI 10.1093/jxb/eri107; RAVEN JA, 1976, J THEOR BIOL, V57, P301, DOI 10.1016/0022-5193(76)90003-5; Remans T, 2006, PLANT PHYSIOL, V140, P909, DOI 10.1104/pp.105.075721; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Saito H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7095; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Segonzac C, 2007, PLANT CELL, V19, P3760, DOI 10.1105/tpc.106.048173; SIDDIQI MY, 1990, PLANT PHYSIOL, V93, P1426, DOI 10.1104/pp.93.4.1426; Sugiura M, 2007, PLANT CELL PHYSIOL, V48, P1022, DOI 10.1093/pcp/pcm073; Tal I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11486; Tang Z, 2012, PLANT PHYSIOL, V160, P2052, DOI 10.1104/pp.112.204461; Taochy Christelle, 2015, Plant J, V83, P466, DOI 10.1111/tpj.12901; Taulemesse F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120291; Tnani H, 2013, PLANT SCI, V207, P140, DOI 10.1016/j.plantsci.2013.03.005; Tong Y, 2005, PLANT J, V41, P442, DOI 10.1111/j.1365-313X.2004.02310.x; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; van der Leij M, 1998, PLANTA, V205, P64, DOI 10.1007/s004250050297                                                           ; von Wittgenstein NJJB, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-11; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; Weichert A, 2012, PLANTA, V235, P311, DOI 10.1007/s00425-011-1508-7; Xia XD, 2015, J EXP BOT, V66, P317, DOI 10.1093/jxb/eru425; Xie WB, 2015, P NATL ACAD SCI USA, V112, pE5411, DOI 10.1073/pnas.1515919112; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yan M, 2011, PLANT CELL ENVIRON, V34, P1360, DOI 10.1111/j.1365-3040.2011.02335.x; Yu LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27795; Zarabi M, 2012, ENVIRON MONIT ASSESS, V184, P7607, DOI 10.1007/s10661-012-2522-3; Zhang GB, 2014, PLANT CELL, V26, P3984, DOI 10.1105/tpc.114.129296; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407                                                    ; Zheng Y, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1176819; Zhou JJ, 1998, J BIOL CHEM, V273, P12017, DOI 10.1074/jbc.273.20.12017; Zhu GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21049; Zhu JW, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv131; Zifarelli G, 2010, FEBS LETT, V584, P2122, DOI 10.1016/j.febslet.2009.12.042	146	2	2	37	37	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAY 1	2017	68	10			SI		2463	2475		10.1093/jxb/erx011				13	Plant Sciences	Plant Sciences	EY6YO	WOS:000404131000002	28158856				2018-01-05	
J	Coskunoglu, A; Orenay-Boyacioglu, S; Deveci, A; Bayam, M; Onur, E; Onan, A; Cam, FS				Coskunoglu, Aysun; Orenay-Boyacioglu, Seda; Deveci, Artuner; Bayam, Mustafa; Onur, Ece; Onan, Arzu; Cam, Fethi S.			Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus	NOISE & HEALTH			English	Article						BDNF gene polymorphism; neurotrophic factor; serum BDNF level; tinnitus	VAL66MET POLYMORPHISM; TREATMENT RESPONSE; MAJOR DEPRESSION; AUDITORY-CORTEX; DISORDER; TRAUMA; DISEASE; LOCUS; RISK	Background: Brain-derived neurotrophic factor (BDNF) gene polymorphisms are associated with abnormalities in regulation of BDNF secretion. Studies also linked BDNF polymorphisms with changes in brainstem auditory-evoked response test results. Furthermore, BDNF levels are reduced in tinnitus, psychiatric disorders, depression, dysthymic disorder that may be associated with stress, conversion disorder, and suicide attempts due to crises of life. For this purpose, we investigated whether there is any role of BDNF changes in the pathophysiology of tinnitus. Materials and Methods: In this study, we examined the possible effects of BDNF variants in individuals diagnosed with tinnitus for more than 3 months. Fifty-two tinnitus subjects between the ages of 18 and 55, and 42 years healthy control subjects in the same age group, who were free of any otorhinolaryngology and systemic disease, were selected for examination. The intensity of tinnitus and depression was measured using the tinnitus handicap inventory, and the differential diagnosis of psychiatric diagnoses made using the Structured Clinical Interview for Fourth Edition of Mental Disorders. BDNF gene polymorphism was analyzed in the genomic deoxyribonucleic acid (DNA) samples extracted from the venous blood, and the serum levels of BDNF were measured. One-way analysis of variance and Chi-squared tests were applied. Results: Serum BDNF level was found lower in the tinnitus patients than controls, and it appeared that there is no correlation between BDNF gene polymorphism and tinnitus. Conclusions: This study suggests neurotrophic factors such as BDNF may have a role in tinnitus etiology. Future studies with larger sample size may be required to further confirm our results.	[Coskunoglu, Aysun; Cam, Fethi S.] Celal Bayar Univ, Fac Med, Dept Med Genet, Manisa, Turkey; [Orenay-Boyacioglu, Seda] Adnan Menderes Univ, Fac Med, Dept Med Genet, Efeler, Aydin, Turkey; [Deveci, Artuner] Celal Bayar Univ, Fac Med, Dept Psychiat, Manisa, Turkey; [Bayam, Mustafa] Celal Bayar Univ, Fac Med, Dept Otorhinolaryngol, Manisa, Turkey; [Onur, Ece; Onan, Arzu] Celal Bayar Univ, Fac Med, Dept Med Biochem, Manisa, Turkey	Orenay-Boyacioglu, S (reprint author), Adnan Menderes Univ, Fac Med, Dept Med Genet, Efeler, Aydin, Turkey.	sorenay@adu.edu.tr			Celal Bayar University Scientific Research Projects	This study was supported by Celal Bayar University Scientific Research Projects.	Aydemir O, 2009, TURKISH J PSYCHIAT, V20, P381; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Bhang S, 2011, J AFFECT DISORDERS, V128, P299, DOI 10.1016/j.jad.2010.07.008; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Deveci A, 2007, PSYCHIAT CLIN NEUROS, V61, P571, DOI 10.1111/j.1440-1819.2007.01710.x; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Eggermont JJ, 2000, TINNITUS HDB, P85121; Eggermont JJ, 2012, FRONT SYST NEUROSCI, V6, P1; Eker C, 2005, B CLIN PSYCHOPHARMAC, V15, P104; Folmer Robert L, 2004, Ear Nose Throat J, V83, P107; Foltynie T, 2005, J NEUROL, V252, P833, DOI 10.1007/s00415-005-0756-5; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410                                                       ; GALL C, 1991, EPILEPSY RES, P225; Goto F, 2012, NEUROSCI LETT, V510, P73, DOI 10.1016/j.neulet.2012.01.001; Guerini FR, 2009, EUR J NEUROL, V16, P1240, DOI 10.1111/j.1468-1331.2009.02706.x; Hegerl U, 1998, EUR ARCH PSY CLIN N, V248, P96, DOI 10.1007/s004060050024; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Jastreboff PJ, 2005, TINNITUS RETRAINING; Jastreboff PJ, 1998, OTOLARYNGOLOGY HEAD, P3198; Juckel G, 2010, J PSYCHIATR RES, V44, P541, DOI 10.1016/j.jpsychires.2009.11.006; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Koester M, 2004, MMW-FORTSCH MEDIZIN, V146, P29; Kotan Z., 2009, CURR APPROACH PSYCHI, V1, P22; Lang UE, 2005, NEUROPSYCHOPHARMACOL, V30, P1148, DOI 10.1038/sj.npp.1300666; Langguth B, 2007, PROGR BRAIN RES; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Licinio J, 2009, ARCH GEN PSYCHIAT, V66, P488, DOI 10.1001/archgenpsychiatry.2009.38; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Moller AR, 2011, TEXTBOOK OF TINNITUS, P1; Noell CA, 2003, GERIATRICS, V58, P28; Nondahl DM, 2010, INT J AUDIOL, V49, P580, DOI 10.3109/14992021003753508; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Orenay-Boyacioglu S, 2016, BIOCHEM GENET, V54, P552, DOI 10.1007/s10528-016-9741-1; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Pantev C, 2012, ANN NY ACAD SCI, V1252, P253, DOI 10.1111/j.1749-6632.2012.06452.x; Park YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060340; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pivac N, 2011, PROG NEURO-PSYCHOPH, V35, P356, DOI 10.1016/j.pnpbp.2010.10.020; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Qian L, 2007, BIOCHEM BIOPH RES CO, V353, P738, DOI 10.1016/j.bbrc.2006.12.121; Real E, 2009, BIOL PSYCHIAT, V66, P674, DOI 10.1016/j.biopsych.2009.05.017; Ribeiro L, 2007, NEUROREPORT, V18, P1291, DOI 10.1097/WNR.0b013e328273bcb0; Roberts LE, 2006, ACTA OTO-LARYNGOL, V126, P27, DOI 10.1080/03655230600895358; Sand PG, 2007, PROG BRAIN RES, V166, P159, DOI 10.1016/S0079-6123(07)66014-2; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Sheikh HI, 2010, PSYCHIAT GENET, V20, P109, DOI 10.1097/YPG.0b013e32833a2038; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Sozeri-Varma G, 2011, NEUROL PSYCHIAT BR, V17, P84, DOI 10.1016/j.npbr.2011.09.001; Tinnitus Patient Survey, 1986, INF AM TINN ASS ATA; Tuncer U, 2010, TURKIYE KLIN J ENT S, V3, P6; Yilmaz I, 2002, OTOSKOP, V3, P49; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	57	0	0	1	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1463-1741	1998-4030		NOISE HEALTH	Noise Health	MAY-JUN	2017	19	88					140	148		10.4103/nah.NAH_74_16				9	Audiology & Speech-Language Pathology; Public, Environmental & Occupational Health	Audiology & Speech-Language Pathology; Public, Environmental & Occupational Health	EY6VC	WOS:000404120500004	28615544	gold			2018-01-05	
J	Pinto, B; Rusciano, G; D'Errico, S; Borbone, N; Sasso, A; Piccialli, V; Mayol, L; Oliviero, G; Piccialli, G				Pinto, Brunella; Rusciano, Giulia; D'Errico, Stefano; Borbone, Nicola; Sasso, Antonio; Piccialli, Vincenzo; Mayol, Luciano; Oliviero, Giorgia; Piccialli, Gennaro			Synthesis and label free characterization of a bimolecular PNA homo quadruplex	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						PNA; G-quadruplex; Surface enhanced Raman scattering; SERS; Label free monitoring	PEPTIDE NUCLEIC-ACID; THROMBIN-BINDING APTAMER; SURFACE-ENHANCED RAMAN; DOUBLE-STRANDED DNA; CIRCULAR-DICHROISM; GENE-EXPRESSION; HUMAN GENOME; SEQUENCE; OLIGONUCLEOTIDES; SPECTROSCOPY	Background: G-quadruplex DNA is involved in many physiological and pathological processes. Both clinical and experimental studies on DNA G-quadruplexes are slowed down by their enzymatic instability. In this frame, more stable chemically modified analogs are needed. Methods: The bis-end-linked-(gggt)2 PNA molecule (BEL-PNA) was synthesized using in solution and solid phase synthetic approaches. Quadruplex formation was assessed by circular dichroism (CD) and surface enhanced Raman scattering (SERS). Results: An unprecedented bimolecular PNA homo quadruplex is here reported. To achieve this goal, we developed a bifunctional linker that once functionalized with gggt PNA strands and annealed in K+ buffer allowed the obtainment of a PNA homo quadruplex. The identification of the strong SERS band at similar to 1481 cm(-1), attributable to vibrations involving the quadruplex diagnostic Hoogsteen type hydrogen bonds, confirmed the formation of the PNA homo quadruplex. Conclusions: By tethering two G-rich PNA strands to the two ends of a suitable bifunctional linker it is possible to obtain bimolecular PNA homo quadruplexes after annealing in K+-containing buffers. The formation of such CD unfriendly complexes can be monitored, even at low concentrations, by using the SERS technique. General significance: Given the importance of DNA G-quadruplexes in medicine and nanotechnology, the obtainment of G-quadruplex analogs provided with enhanced enzymatic stability, and their monitoring by highly sensitive label-free techniques are of the highest importance. This article is part of a Special Issue entitled "Gquadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. (C) 2016 Elsevier B.V. All rights reserved.	[Pinto, Brunella; D'Errico, Stefano; Borbone, Nicola; Mayol, Luciano; Piccialli, Gennaro] Univ Napoli Federico II, Dipartimento Farm, I-80131 Naples, Italy; [Rusciano, Giulia; Sasso, Antonio] Univ Napoli Federico II, Dipartimento Sci Fis, I-80126 Naples, Italy; [Piccialli, Vincenzo] Univ Napoli Federico II, Dipartimento Sci Chim, I-80126 Naples, Italy; [Oliviero, Giorgia] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Piccialli, Gennaro] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Piccialli, G (reprint author), Univ Napoli Federico II, Dipartimento Farm, I-80131 Naples, Italy.; Oliviero, G (reprint author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy.	giorgia.oliviero@unina.it; gennaro.piccialli@unina.it					Agarwal T, 2014, BIOCHEMISTRY-US, V53, P3711, DOI 10.1021/bi401451q; Amato F, 2014, BIOMED RES INT, DOI 10.1155/2014/610718; Amato F, 2014, MEDCHEMCOMM, V5, P68, DOI 10.1039/c3md00257h; Armitage B, 1998, NUCLEIC ACIDS RES, V26, P715, DOI 10.1093/nar/26.3.715; Arrondo JLR, 1998, CHEM PHYS LIPIDS, V96, P53, DOI 10.1016/S0009-3084(98)00080-2; Avino A, 2012, CURR PHARM DESIGN, V18, P2036, DOI 10.2174/138161212799958387                                                      ; Balasubramanian S, 2006, RSC BIOMOL SCI, pV; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; BETTS L, 1995, SCIENCE, V270, P1838, DOI 10.1126/science.270.5243.1838; Bidzinska J, 2013, MOLECULES, V18, P12368, DOI 10.3390/molecules181012368; Borbone N, 2012, J MED CHEM, V55, P10716, DOI 10.1021/jm301414f; Borbone N, 2011, NUCLEIC ACIDS RES, V39, P7848, DOI 10.1093/nar/gkr489; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Briones C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.208103; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cogoi S, 2016, BBA-GENE REGUL MECH, V1859, P663, DOI 10.1016/j.bbagrm.2016.02.002; COLAIANNI SEM, 1995, VIB SPECTROSC, V9, P111; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Cree SL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00160; Crestey F, 2008, TETRAHEDRON LETT, V49, P5890, DOI 10.1016/j.tetlet.2008.07.130; D'Atri V, 2012, CHEM COMMUN, V48, P9516, DOI 10.1039/c2cc34399a; Datta B, 2005, J AM CHEM SOC, V127, P4199, DOI 10.1021/ja0446202; Davis J. T., 2004, CHEM INT ED, V43, P668, DOI http://dx.doi.org/10.1002/anie.200300589; De Stefano L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0160; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Esposito V, 2009, BIOORGAN MED CHEM, V17, P1997, DOI 10.1016/j.bmc.2009.01.027; Griffin TJ, 1998, ANAL BIOCHEM, V260, P56, DOI 10.1006/abio.1998.2686                                                          ; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Grossmann TN, 2008, BIOORGAN MED CHEM, V16, P34, DOI 10.1016/j.bmc.2007.04.066; Holder IT, 2014, CHEM BIOL, V21, P1511, DOI 10.1016/j.chembiol.2014.09.014; Ishizuka T, 2012, ANGEW CHEM INT EDIT, V51, P7198, DOI 10.1002/anie.201201176; Knauert MP, 2001, HUM MOL GENET, V10, P2243, DOI 10.1093/hmg/10.20.2243; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r                                                               ; Kormuth KA, 2016, BIOCHEMISTRY-US, V55, P1749, DOI 10.1021/acs.biochem.6b00026; Krafft C, 2002, NUCLEIC ACIDS RES, V30, P3981, DOI 10.1093/nar/gkf517                                                              ; Krishnan-Ghosh Y, 2004, J AM CHEM SOC, V126, P5944, DOI 10.1021/ja031508f                                                               ; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lech CJ, 2011, BIOPHYS J, V101, P1987, DOI 10.1016/j.bpj.2011.08.049; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025                                                             ; Livshits GI, 2014, NAT NANOTECHNOL, V9, P1040, DOI [10.1038/nnano.2014.246, 10.1038/NNANO.2014.246]; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Mateo-Marti E, 2007, BIOSENS BIOELECTRON, V22, P1926, DOI 10.1016/j.bios.2006.08.012; MIURA T, 1994, BIOCHEMISTRY-US, V33, P7848, DOI 10.1021/bi00191a012                                                             ; Moggio L, 2006, ORG LETT, V8, P2015, DOI 10.1021/ol0603559; Murphy CT, 2014, BIOCHEMISTRY-US, V53, P5315, DOI 10.1021/bi5006859; Nagatoishi S, 2007, BIOCHEM BIOPH RES CO, V352, P812, DOI 10.1016/j.bbrc.2006.11.088; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Oliviero G, 2004, TETRAHEDRON LETT, V45, P4869, DOI 10.1016/j.tetlet.2004.04.149; Oliviero G, 2009, BIOPOLYMERS, V91, P466, DOI 10.1002/bip.21153; Onyshchenko MI, 2009, NUCLEIC ACIDS RES, V37, P7570, DOI 10.1093/nar/gkp840; Pagba CV, 2010, J RAMAN SPECTROSC, V41, P241, DOI 10.1002/jrs.2428; Parker F.S., 1983, APPL INFRARED PLENUM; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Roviello GN, 2011, MOL BIOSYST, V7, P1773, DOI 10.1039/c1mb05007a; Roviello GN, 2010, MOL BIOSYST, V6, P199, DOI 10.1039/b910278g; Rusciano G, 2016, BBA-GEN SUBJECTS, V1860, P795, DOI 10.1016/j.bbagen.2016.01.010; Rusciano G, 2011, ANAL CHEM, V83, P6849, DOI 10.1021/ac201783h; Sagi J, 2014, J BIOMOL STRUCT DYN, V32, P477, DOI 10.1080/07391102.2013.775074; Shin YJ, 2015, ONCOGENE, V34, P1292, DOI 10.1038/onc.2014.65; Sugimoto N, 2001, BIOCHEMISTRY-US, V40, P8444, DOI 10.1021/bi010480m; Thomas GJ, 1999, ANNU REV BIOPH BIOM, V28, P1, DOI 10.1146/annurev.biophys.28.1.1                                                  ; Wittung P, 1996, J AM CHEM SOC, V118, P7049, DOI 10.1021/ja960521f                                                               ; Wittung P, 1997, BIOCHEMISTRY-US, V36, P7973, DOI 10.1021/bi963136b	64	1	1	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	MAY	2017	1861	5	B		SI		1222	1228		10.1016/j.bbagen.2016.11.037				7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EY1NX	WOS:000403733700004	27913190				2018-01-05	
J	Marusic, M; Hosnjak, L; Krafcikova, P; Poljak, M; Viglasky, V; Plavec, J				Marusic, Maja; Hosnjak, Lea; Krafcikova, Petra; Poljak, Mario; Viglasky, Viktor; Plavec, Janez			The effect of single nucleotide polymorphisms in G-rich regions of high-risk human papillomaviruses on structural diversity of DNA	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						G-quadruplex; Hairpin; HPV; Nucleic acids structures; NMR; Single nucleotide polymorphism	G-QUADRUPLEX STRUCTURES; HUMAN GENOME; SMALL-MOLECULE; MESSENGER-RNA; GENE; MOTIFS; ACID; REPLICATION; TRANSLATION; SECONDARY	Background: Infection with high-risk human papillomaviruses (HPVs) can lead to development of cancer of the head and neck and anogenital regions. G-rich sequences found in genomes of high-risk HPVs can fold into non-canonical secondary structures that could serve as 3D motifs distinct from double-stranded DNA and present recognition sites for ligands and opportunity for gene expression modulation. Methods: Combination of UV, CD and NMR spectroscopy and PAGE electrophoresis were used as they offer complementary insights into structural changes of G-rich oligonucleotides. Results: G-rich region of HPV16 is shown to preferentially form hairpin structures, while regions of HPV18, HPV52 and HPV58 fold into four-stranded DNA structures called G-quadruplexes. Single nucleotide polymorphisms found in G-rich sequences have been found to promote formation of hairpin structures of HPV16 and have affected number of species formed in G-rich region of HPV52, whereas they have exhibited minimal effect on the formation of HPV18 and HPV58 G-quadruplex structures. These structural changes were reflected in differences in apparent thermal stabilities. Conclusions: Potential of G-rich sequences as drug targets was evaluated based on the results of the current study. HPV16 and HPV18 are considered less appropriate targets due to several single nucleotide polymorphisms and low stability, respectively. On the other hand, HPV52 and HPV58 could be used for small-molecule mediated stabilization. General significance: G-rich sequences occurring in high-risk HPVs can fold into hairpin and G-quadruplex structures that could be potentially utilized as drug targets. This article is part of a Special Issue entitled "Gquadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. (C) 2016 Elsevier B.V. All rights reserved.	[Marusic, Maja; Plavec, Janez] Slovenian NMR Inst, Natl Inst Chem, Hajdrihova 19, SI-1000 Ljubljana, Slovenia; [Hosnjak, Lea; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, SI-1000 Ljubljana, Slovenia; [Krafcikova, Petra; Viglasky, Viktor] Safarik Univ, Fac Sci, Inst Chem, Dept Biochem, Kosice 04001, Slovakia; [Plavec, Janez] EN FIST Ctr Excellence, SI-1000 Ljubljana, Slovenia; [Plavec, Janez] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Plavec, J (reprint author), Slovenian NMR Inst, Natl Inst Chem, Hajdrihova 19, SI-1000 Ljubljana, Slovenia.	janez.plavec@ki.si	Viglasky, Viktor/B-9592-2017	Viglasky, Viktor/0000-0001-9811-2278; Plavec, Janez/0000-0003-1570-8602	Slovenian Research Agency [ARRS] [P1-242, J1-6733]; Slovak Research and Development Agency [APVV-0280-11]; Slovak Grant Agency [1/0131/16]	Authors acknowledge financial support of Slovenian Research Agency [ARRS, grant nos. P1-242 and J1-6733], Slovak Research and Development Agency [contract No. APVV-0280-11], and Slovak Grant Agency [1/0131/16]. We would like to thank Dr. Bo tjan J. Kocjan for his valuable assistance at the study initiation, Dr. Robert D. Burk and Dr. Zigui Chen for providing non-published nucleotide sequences of 130 isolates of HPV16, 37 isolates of HPV18, 70 isolates of HPV52 and 29 isolates of HPV58. We would also like to thank Dr. Antonio Carlos de Freitas, Dr. Paul K.S. Chan, Dr. Roberto Filho and Dr. Yong Poovorawan who kindly provided clinical status data of isolates.	Artusi S, 2015, ANTIVIR RES, V118, P123, DOI 10.1016/j.antiviral.2015.03.016; Baran N, 1997, NUCLEIC ACIDS RES, V25, P297, DOI 10.1093/nar/25.2.297; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chan P.K.S., 2014, PLOS ONE, V9; CHRISTIANSEN J, 1994, NUCLEIC ACIDS RES, V22, P5709, DOI 10.1093/nar/22.25.5709; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013                                                         ; GLOBOCAN, 2012, GLOBOCAN V1 0 CANC I; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jelen MM, 2014, J VIROL, V88, P7307, DOI 10.1128/JVI.00621-14; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Madireddy A, 2016, NUCLEIC ACIDS RES, V44, P3675, DOI 10.1093/nar/gkw038; Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r; Piazza A, 2015, EMBO J, V34, P1718, DOI 10.15252/embj.201490702; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/NCHEMBIO.780, 10.1038/nchembio.780]; Saini N, 2013, BIOCHIMIE, V95, P117, DOI 10.1016/j.biochi.2012.10.005; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tellam JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004423; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Wang SR, 2016, CELL CHEM BIOL, V23, P1113, DOI 10.1016/j.chembiol.2016.07.019; Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	1	1	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	MAY	2017	1861	5	B		SI		1229	1236		10.1016/j.bbagen.2016.11.007				8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EY1NX	WOS:000403733700005	27836759				2018-01-05	
J	Brcic, J; Plavec, J				Brcic, Jasna; Plavec, Janez			ALS and FTD linked GGGGCC-repeat containing DNA oligonucleotide folds into two distinct G-quadruplexes	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						ALS/FTD; GGGGCC repeat; Folding; pH; Cooling rate; NMR	AMYOTROPHIC-LATERAL-SCLEROSIS; G-TRACT LENGTH; HEXANUCLEOTIDE REPEAT; HUMAN TELOMERE; C9ORF72 GENE; SEQUENCE; TOPOLOGY; FORMS; STABILITY; PROTEINS	Background: The most common genetic cause of neurological disorders ALS and FTD is a largely increased number of GGGGCC repeats in C9orf72 gene. Non-canonical structures including G-quadruplexes adopted by expanded repeats are hypothesized to be crucial in pathogenesis. Recently, we have shown that structural polymorphism of oligonucleotide d(G(4)C(2))(3)G(4) is reduced by dG to 8Br-dG substitution. High-resolution structure of one of the two major G-quadruplexes adopts antiparallel topology comprising of four G-quartets. Herein, we describe the topology of the second major G-quadruplex structure and influence of folding conditions on relative populations of the two folds. Methods: Influence of folding conditions was explored by 1H D-1 NMR. Determination of topology was achieved by 2D NMR complemented with PAGE and CD. UV melting experiment was used to explore thermal stability of structures. Results: Two structures adopted by oligonucleotide d(G(4)C(2))(3)GG(Br)GG denoted AQU and NAN coexist in solution and ratio of their populations is determined by pH and rate of cooling when folding from thermally denatured state in the presence of K+ ions. Conclusions: AQU is kinetically favored and forms by folding at low pH, while NAN is favored thermodynamically and at neutral pH. AQU and NAN share similar antiparallel topology with four G-quartets and three edgewise loops, however they exhibit distinct structural and dynamic properties. General significance: Novel G-quadruplex topology adds insight into diverse polymorphism of DNA sequences comprising potentially pathological GGGGCC repeat. Relative populations of the two structures and their dependence on folding conditions contribute to understanding of factors that govern G-quadruplex folding. This article is part of a Special Issue entitled "Gquadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. (C) 2016 Elsevier B.V. All rights reserved.	[Brcic, Jasna; Plavec, Janez] Slovenian NMR Ctr, Natl Inst Chem, Ljubljana, Slovenia; [Plavec, Janez] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Plavec, Janez] EN FIST Ctr Excellence, Ljubljana, Slovenia	Plavec, J (reprint author), Slovenian NMR Ctr, Natl Inst Chem, Ljubljana, Slovenia.	janez.plavec@ki.si		Plavec, Janez/0000-0003-1570-8602	Slovenian Research Agency (ARRS) [P1-0242, J1-6733]	This work was supported by the Slovenian Research Agency (ARRS, grants P1-0242 and J1-6733).	Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003; Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c; Amrane S, 2009, NUCLEIC ACIDS RES, V37, P931, DOI 10.1093/nar/gkn990; Boeynaems S, 2016, ACTA NEUROPATHOL, V132, P159, DOI 10.1007/s00401-016-1586-5; Brcic J, 2016, FRONT CHEM SCI ENG, V10, P222, DOI 10.1007/s11705-016-1556-4; Brcic J, 2015, NUCLEIC ACIDS RES, V43, P8590, DOI 10.1093/nar/gkv815; Brown NM, 2005, ORG BIOMOL CHEM, V3, P4153, DOI 10.1039/b511706b; Cang XH, 2011, NUCLEIC ACIDS RES, V39, P4499, DOI 10.1093/nar/gkr031; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; Webba Da Silva M, 2007, CHEM-EUR J, V13, P9738; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dodd DW, 2016, BIOCHEMISTRY-US, V55, P1283, DOI 10.1021/acs.biochem.6b00136; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Galer P, 2016, ANGEW CHEM INT EDIT, V55, P1993, DOI 10.1002/anie.201507569; Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z; Gitler AD, 2016, BRAIN RES, V1647, P19, DOI 10.1016/j.brainres.2016.04.004; Haeusler AR, 2016, NAT REV NEUROSCI, V17, P383, DOI 10.1038/nrn.2016.38; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hazel P, 2006, NUCLEIC ACIDS RES, V34, P2117, DOI 10.1093/nar/gkl182; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Karsisiotis AI, 2013, METHODS, V64, P28, DOI 10.1016/j.ymeth.2013.06.004; Kovanda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17944; Lannan FM, 2012, J AM CHEM SOC, V134, P15324, DOI 10.1021/ja303499m; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Marusic M, 2015, ANGEW CHEM INT EDIT, V54, P11716, DOI 10.1002/anie.201505348; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; Mirkin EV, 2014, MOL CELL, V53, P1, DOI 10.1016/j.molcel.2013.12.021; Mirkin SM, 2002, NAT GENET, V31, P5, DOI 10.1038/ng0502-5; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Petraccone L, 2004, BIOCHEMISTRY-US, V43, P4877, DOI 10.1021/bi0300985; Phan AT, 2004, J MOL BIOL, V338, P93, DOI 10.1016/j.jmb.2004.02.042; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; Randazzo A, 2002, NUCLEOS NUCLEOT NUCL, V21, P535, DOI 10.1081/NCN-120015067; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Risitano A, 2004, NUCLEIC ACIDS RES, V32, P2598, DOI 10.1093/nar/gkh598; Rutherford NJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.005; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Sket P, 2015, NEUROBIOL AGING, V36, P1091, DOI 10.1016/j.neurobiolaging.2014.09.012; Tang CF, 2006, J AM CHEM SOC, V128, P5966, DOI 10.1021/ja0603958; Thys RG, 2015, J BIOL CHEM, V290, P28953, DOI 10.1074/jbc.M115.660324; Tong XT, 2011, NUCLEIC ACIDS RES, V39, P6753, DOI 10.1093/nar/gkr233; Vatovec S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.015; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yan YY, 2013, BBA-GEN SUBJECTS, V1830, P4935, DOI 10.1016/j.bbagen.2013.06.019; Zamiri B, 2015, NUCLEIC ACIDS RES, V43, P10055, DOI 10.1093/nar/gkv1008; Zhou B, 2015, SCI REP-UK, V5, DOI 10.1038/srep16673	52	1	1	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	MAY	2017	1861	5	B		SI		1237	1245		10.1016/j.bbagen.2016.11.018				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EY1NX	WOS:000403733700006	27856299				2018-01-05	
J	Lecours, MJ; Marchand, A; Anwar, A; Guetta, C; Hopkins, WS; Gabelica, V				Lecours, Michael J.; Marchand, Adrien; Anwar, Ahdia; Guetta, Corinne; Hopkins, W. Scott; Gabelica, Valerie			What stoichiometries determined by mass spectrometry reveal about the ligand binding mode to G-quadruplex nucleic acids	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						G-quadruplex; Mass spectrometry; Ligand; PhenDC3; 360A; Pyridostatin; Conformation; Ligand-induced isomerization	HUMAN TELOMERIC DNA; K+ SOLUTION; SEQUENCE; STABILITY; TETRAPLEX; KINETICS; PARALLEL	G-quadruplexes (G4s) have become important drug targets to regulate gene expression and telomere maintenance. Many studies on G4 ligand binding focus on determining the ligand binding affinities and selectivities. Ligands, however, can also affect the G4 conformation. Here we explain how to use electrospray ionization mass spectrometry (ESI-MS) to monitor simultaneously ligand binding and cation binding stoichiometries. The changes in potassium binding stoichiometry upon ligand binding hint at ligand-induced conformational changes involving a modification of the number of G-quartets. We investigated the interaction of three quadruplex ligands (PhenDC3, 360A and Pyridostatin) with a variety of G4s. Electrospray mass spectrometry makes it easy to detect K+ displacement (interpreted as quartet disruption) upon ligand binding, and to determine how many ligand molecules must be bound for the quartet opening to occur. The reasons for ligand-induced conversion to antiparallel structures with fewer quartets are discussed. Conversely, K+ intalce (hence quartet formation) was detected upon ligand binding to G-rich sequences that did not form quadruplexes in 1 mM K+ alone. This demonstrates the value of mass spectrometry for assessing not only ligand binding, but also ligand-induced rearrangements in the target sequence. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. (C) 2017 Elsevier B.V. All rights reserved.	[Lecours, Michael J.; Anwar, Ahdia; Hopkins, W. Scott] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Marchand, Adrien; Gabelica, Valerie] Univ Bordeaux, INSERM, U1212,UMR5320,CNRS,IECB, Lab Acides Nucle Regulat Nat & Artificielle ARNA, 2 Rue Robert Escarpit, F-33607 Pessac, France; [Guetta, Corinne] Univ Paris 11, INSERM, U1196,UMR9187,CNRS, Inst Curie,Lab Chim Modelisat & Imagerie Biol CMI, Orsay, France	Gabelica, V (reprint author), Univ Bordeaux, INSERM, U1212,UMR5320,CNRS,IECB, Lab Acides Nucle Regulat Nat & Artificielle ARNA, 2 Rue Robert Escarpit, F-33607 Pessac, France.	v.gabelica@iecb.u-bordeaux.fr	Gabelica, Valerie/E-9417-2011; Marchand, Adrien/A-5920-2013	Gabelica, Valerie/0000-0001-9496-0165; Marchand, Adrien/0000-0002-2061-3408	University of Waterloo (Bordeaux-Waterloo research grants); Inserm [ATIP-Avenir Grant] [R12086GS]; Conseil Regional Aquitaine [20121304005]; EU Seventh Framework Programme [FP7-PEOPLE-2012-CIG-333611]; NSERC; Michael Smith Foundation for Health Research	This work was financially supported by the University of Waterloo (Bordeaux-Waterloo research grants), the Inserm [ATIP-Avenir Grant no. R12086GS], the Conseil Regional Aquitaine [Grant no. 20121304005], the EU Seventh Framework Programme [FP7-PEOPLE-2012-CIG-333611] and NSERC. M.L. benefited from a CGS-MSFSS scholarship and a fellowship from the Michael Smith Foundation for Health Research to fund his research stay in Bordeaux.	Amrane S, 2012, J AM CHEM SOC, V134, P5807, DOI 10.1021/ja208993r; Balthasart F, 2013, J AM SOC MASS SPECTR, V24, P1, DOI 10.1007/s13361-012-0499-3; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Buscaglia R, 2013, BIOPOLYMERS, V99, P1006, DOI 10.1002/bip.22247; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Chung WJ, 2014, ANGEW CHEM INT EDIT, V53, P999, DOI 10.1002/anie.201308063; Cian A. D., 2007, NUCLEIC ACIDS RES, V35, P2483; Davis J. T., 2004, CHEM INT ED, V43, P668, DOI http://dx.doi.org/10.1002/anie.200300589; De Cian A, 2007, J AM CHEM SOC, V129, P1856, DOI 10.1021/ja067352b; Gabelica V, 2009, ANAL CHEM, V81, P6708, DOI 10.1021/ac900785m; Granotier C, 2005, NUCLEIC ACIDS RES, V33, P4182, DOI 10.1093/nar/gki722; Gray RD, 2010, BIOCHEMISTRY-US, V49, P179, DOI 10.1021/bi901357r; Gray RD, 2009, J PHYS CHEM B, V113, P2676, DOI 10.1021/jp809578f; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Koirala D, 2011, NAT CHEM, V3, P782, DOI [10.1038/nchem.1126, 10.1038/NCHEM.1126]; Largy E, 2016, J AM CHEM SOC, V138, P2780, DOI 10.1021/jacs.5b13130; Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Marchand A., NUCL ACIDS RES; Marchand A, 2016, CHEM-EUR J, V22, P9551, DOI 10.1002/chem.201601937; Marchand A, 2015, J AM CHEM SOC, V137, P750, DOI 10.1021/ja5099403; Marchand A, 2014, J AM SOC MASS SPECTR, V25, P1146, DOI 10.1007/s13361-014-0890-3; Miller MC, 2010, J AM CHEM SOC, V132, P17105, DOI 10.1021/ja105259m; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Neidle S, 2016, J MED CHEM, V59, P5987, DOI 10.1021/acs.jmedchem.5b01835; Nicoludis JM, 2012, NUCLEIC ACIDS RES, V40, P5432, DOI 10.1093/nar/gks152; Ou TM, 2008, CHEMMEDCHEM, V3, P690, DOI 10.1002/cmdc.200700300; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292; SCHULTZE P, 1994, STRUCTURE, V2, P221, DOI 10.1016/S0969-2126(00)00023-X; Sket P, 2004, BIOORGAN MED CHEM, V12, P5735, DOI 10.1016/j.bmc.2004.08.009; Sponer J, 2017, BBA-GEN SUBJECTS, V1861, P1246, DOI 10.1016/j.bbagen.2016.12.008; Stadlbauer P, 2013, NUCLEIC ACIDS RES, V41, P7128, DOI 10.1093/nar/gkt412; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029; Zhou J, 2013, ANGEW CHEM INT EDIT, V52, P7742, DOI 10.1002/anie.201301278	42	0	0	7	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	MAY	2017	1861	5	B		SI		1353	1361		10.1016/j.bbagen.2017.01.010				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EY1NX	WOS:000403733700017	28087374				2018-01-05	
J	Cogoi, S; Rapozzi, V; Cauci, S; Xodo, LE				Cogoi, Susanna; Rapozzi, Valentina; Cauci, Sabina; Xodo, Luigi E.			Critical role of hnRNP Al in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Review						G-quadruplex; KRAS oncogene; Pancreatic cancer; hnRNP Al; Transcription regulation; G4 unfolding	NUCLEAR RIBONUCLEOPROTEIN A1; INTEGRIN-LINKED KINASE; G-QUADRUPLEX STRUCTURES; RNA-RECOGNITION MOTIF; PRE-MESSENGER-RNA; KI-RAS PROMOTER; C-MYC PROMOTER; CRYSTAL-STRUCTURE; BINDING PROTEINS; MESENCHYMAL TRANSITION	KRAS is one of the most mutated genes in human cancer. Its crucial role in the tumourigenesis of pancreatic ductal adenocarcinoma (PDAC) has been widely demonstrated. As this deadly cancer does not sufficiently respond to conventional chemotherapies, it is important to increase our knowledge of pancreatic cancer biology, in particular how oncogenic KRAS is regulated. The promoter of ICRAS contains a GA-element composed of runs of guanines that fold into a G4 structure. This unusual DNA conformation is recognized by several nuclear proteins, including MAZ and hnRNP Al. Recent data have revealed that KRAS is interconnected to ILK and hnRNP Al in a circuitry that enables pancreatic cancer cells to maintain an aggressive phenotype. The present review illustrates recent advances on how KRAS is regulated in pancreatic cancer cells, focusing on the formation of G4 structures in the KRAS promoter and their interaction with hnRNP Al. The newly discovered ICRAS-ILK-hnRNP Al regulatory loop is discussed, emphasizing its potential as a therapeutic target for PDAC-specific molecules. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. (C) 2016 Elsevier B.V. All rights reserved.	[Cogoi, Susanna; Rapozzi, Valentina; Cauci, Sabina; Xodo, Luigi E.] Univ Udine, Dept Med & Biol Sci, Ple Kolke 4, I-33100 Udine, Italy	Xodo, LE (reprint author), Dept Med & Biol Sci, Ple Kolbe 4, I-33100 Udine, Italy.	luigi.xodo@uniud.it		Cauci, Sabina/0000-0001-7443-1899; XODO, Luigi/0000-0003-3344-7207	AIRC (Italian association for cancer research) [14301]	This work has been financed by AIRC (Italian association for cancer research), IG2013, project Code 14301.	Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Barraud P, 2013, J BIOMOL NMR, V55, P119, DOI 10.1007/s10858-012-9696-4; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Brito H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126891; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P3063, DOI 10.1093/nar/gkg435; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Chu PC, 2016, ONCOGENE, V35, P3897, DOI 10.1038/onc.2015.458; Cogoi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38468; Cogoi S, 2004, BIOCHEMISTRY-US, V43, P2512, DOI 10.1021/bi035754f; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Cogoi S, 2014, NUCLEIC ACIDS RES, V42, P8379, DOI 10.1093/nar/gku574; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Cogoi S, 2009, J MED CHEM, V52, P564, DOI 10.1021/jm800874t; Collins MA, 2014, GASTROENTEROLOGY, V146, P822, DOI 10.1053/j.gastro.2013.11.052; Damiano F, 2013, BIOCHEM J, V449, P543, DOI 10.1042/BJ20120906; Das S, 2004, J BIOL CHEM, V279, P7313, DOI 10.1074/jbc.M312585200; David C.J., 2010, CANC LETT, V463, P364; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102                                                           ; Eser S., 2003, BRIT J CANCER, V4, P437; Faudale M, 2012, CHEM COMMUN, V48, P874, DOI 10.1039/c1cc15850c; Ford LP, 2002, ONCOGENE, V21, P580, DOI 10.1038/sj.onc.1205086; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; HOFFMAN EK, 1987, MOL CELL BIOL, V7, P2592, DOI 10.1128/MCB.7.7.2592                                                            ; HOFFMAN EK, 1990, P NATL ACAD SCI USA, V87, P2705, DOI 10.1073/pnas.87.7.2705; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; JORDANO J, 1986, NUCLEIC ACIDS RES, V14, P7361, DOI 10.1093/nar/14.18.7361; KAHN S, 1987, ANTICANCER RES, V7, P639; Kaufhold S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0062-0; Kruger AC, 2010, EUR BIOPHYS J BIOPHY, V39, P1343, DOI 10.1007/s00249-010-0587-x; Kwok CK, 2016, NAT METHODS, V13, P841, DOI 10.1038/nmeth.3965; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Lavrado J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09696; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Martinez-Salas E, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/391546; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T                                                    ; Membrino A, 2010, CHEM COMMUN, V46, P625, DOI 10.1039/b918964e; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Meng P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.326; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.3.CO;2-C; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001                                                ; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Morgan RK, 2016, BBA-GENE REGUL MECH, V1859, P235, DOI 10.1016/j.bbagrm.2015.11.004; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Myers JC, 2004, J MOL BIOL, V342, P743, DOI 10.1016/j.jmb.2004.07.029; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Paramasivam M, 2011, CHEM COMMUN, V47, P4965, DOI 10.1039/c1cc10269a; Paramasivam M, 2009, NUCLEIC ACIDS RES, V37, P2841, DOI 10.1093/nar/gkp138; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Podbevsek P, 2016, NUCLEIC ACIDS RES, V44, P917, DOI 10.1093/nar/gkv1359; Rapozzi V, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-75; Salgado G. F., 2016, ADV NONCANONICAL NUC; Schaeffer DF, 2010, VIRCHOWS ARCH, V456, P261, DOI 10.1007/s00428-009-0866-z; Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Shamoo Y, 1997, NAT STRUCT BIOL, V4, P215, DOI 10.1038/nsb0397-215; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Svitkin YV, 1996, EMBO J, V15, P7147; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Vitali J, 2002, NUCLEIC ACIDS RES, V30, P1531, DOI 10.1093/nar/30.7.1531; Xanthoulis A., 2013, CELL SIGNAL, V19, P3189; Xia H, 2005, J BIOL CHEM, V280, P13171, DOI 10.1074/jbc.M414120200; Xu RM, 1997, STRUCTURE, V5, P559, DOI 10.1016/S0969-2126(97)00211-6; Xu W, 2015, CANCER LETT, V356, P613, DOI 10.1016/j.canlet.2014.10.008; Zhou ZJ, 2013, INT J CANCER, V132, P1080, DOI 10.1002/ijc.27742; Zhu XY, 2012, GENET MOL BIOL, V35, P538, DOI 10.1590/S1415-47572012005000028	81	3	3	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	MAY	2017	1861	5	B		SI		1389	1398		10.1016/j.bbagen.2016.11.031				10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EY1NX	WOS:000403733700021	27888145				2018-01-05	
J	Rigo, R; Palumbo, M; Sissi, C				Rigo, Riccardo; Palumbo, Manlio; Sissi, Claudia			G-quadruplexes in human promoters: A challenge for therapeutic applications	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Review						G-quadruplex; gene promoter; gene expression; DNA structures	C-MYC PROMOTER; DNA G-QUADRUPLEX; PARALLEL G-QUADRUPLEXES; GENE-EXPRESSION; TOPOISOMERASE-I; SMALL-MOLECULE; P1 PROMOTER; DUPLEX DNA; SECONDARY STRUCTURES; GENOME INSTABILITY	Background: G-rich sequences undergo unique structural equilibria to form G-quadruplexes (G4) both in vitro and in cell systems. Several pathologies emerged to be directly related to G4 occurrence at defined genomic portions. Additionally, G-rich sequences are significantly represented around transcription start sites (TSS) thus leading to the hypothesis of a gene regulatory function for G4. Thus, the tuning of G4 formation has been proposed as a new powerful tool to regulate gene expression to treat related pathologies. However, up-to date this approach did not provide any new really efficient treatment. Scope of review: Here, we summarize the most recent advances on the correlation between the structural features of G4 in human promoters and the role these systems physiologically exert. In particular we focus on the effect of G4 localization among cell compartments and along the promoters in correlation with protein interaction networks and epigenetic state. Finally the intrinsic structural features of G4 at promoters are discussed to unveil the contribution of different G4 structural modules in this complex architecture. Major conclusions: It emerges that G4s play several roles in the intriguing and complex mechanism of gene expression, being able to produce opposite effects on the same target This reflects the occurrence of a highly variegate network of several components working simultaneously. General significance: The resulting picture is still fuzzy but some points of strength are definitely emerging, which prompts all of us to strengthen our efforts in view of a selective control of gene expression through G4 modulation. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. (C) 2016 Elsevier B.V. All rights reserved.	[Rigo, Riccardo; Palumbo, Manlio; Sissi, Claudia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, V Marzolo 5, I-35131 Padua, Italy	Sissi, C (reprint author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, V Marzolo 5, I-35131 Padua, Italy.	claudia.sissi@unipd.it		Rigo, Riccardo/0000-0002-6394-1583; Palumbo, Manlio/0000-0002-3163-1564	University of Padova [CPDA147272/14]; PhD studentship	This work was supported by University of Padova grant (CPDA147272/14) and PhD studentship (RR).	Abe H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-900; Agarwal T, 2014, BIOCHEMISTRY-US, V53, P3711, DOI 10.1021/bi401451q; Agrawal P, 2014, J AM CHEM SOC, V136, P1750, DOI 10.1021/ja4118945; Agrawal P, 2013, NUCLEIC ACIDS RES, V41, P10584, DOI 10.1093/nar/gkt784; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c; An N, 2016, ACS CHEM BIOL, V11, P500, DOI 10.1021/acschembio.5b00844; Arcovito A, 2014, J BIOL CHEM, V289, P21230, DOI 10.1074/jbc.M114.565010; Arimondo PB, 2000, NUCLEIC ACIDS RES, V28, P4832, DOI 10.1093/nar/28.24.4832                                                          ; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Baranello L, 2012, BBA-GENE REGUL MECH, V1819, P632, DOI 10.1016/j.bbagrm.2011.12.007; Bauer L, 2011, BIOCHEMISTRY-US, V50, P7484, DOI 10.1021/bi2003235; Benabou S, 2014, BBA-GEN SUBJECTS, V1840, P41, DOI 10.1016/j.bbagen.2013.08.028; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; BOLES TC, 1987, BIOCHEMISTRY-US, V26, P367, DOI 10.1021/bi00376a006; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Broxson C, 2011, BIOCHEMISTRY-US, V50, P4162, DOI 10.1021/bi2002136; Buckley L, 2016, EPIGENOMICS-UK, V8, P13, DOI 10.2217/epi.15.104; Cayrou C, 2015, GENOME RES, V25, P1873, DOI 10.1101/gr.192799.115; Cea V, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00209; Chaires JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115580; Chen YI, 2016, AM J TRANSL RES, V8, P1626; Chiarella S, 2013, NUCLEIC ACIDS RES, V41, P3228, DOI 10.1093/nar/gkt001; Chu P.C, 2015, ONCOGENE; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Cogoi S, 2016, BBA-GENE REGUL MECH, V1859, P663, DOI 10.1016/j.bbagrm.2016.02.002; Cogoi S, 2014, NUCLEIC ACIDS RES, V42, P8379, DOI 10.1093/nar/gku574; Cogoi S, 2009, J MED CHEM, V52, P564, DOI 10.1021/jm800874t; Cousins ARO, 2014, CHEM COMMUN, V50, P15202, DOI 10.1039/c4cc07487d; Cree SL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00160; Cui YX, 2016, BIOCHEMISTRY-US, V55, P2291, DOI 10.1021/acs.biochem.6b00016; Cummaro A, 2011, BIOCHIMIE, V93, P1392, DOI 10.1016/j.biochi.2011.04.005; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Dettler JM, 2011, BIOPHYS J, V100, P1517, DOI 10.1016/j.bpj.2011.01.068; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008; Eddy S, 2015, BIOCHEMISTRY-US, V54, P3218, DOI 10.1021/acs.biochem.5b00060; Farhath MM, 2015, BIOCHEMISTRY-US, V54, P5533, DOI 10.1021/acs.biochem.5b00209; Fleming AM, 2015, ACS CENTRAL SCI, V1, P226, DOI 10.1021/acscentsci.5b00202; Fotticchia I, 2013, CHEM COMMUN, V49, P9488, DOI 10.1039/c3cc44560g; Nguyen GH, 2014, P NATL ACAD SCI USA, V111, P9905, DOI 10.1073/pnas.1404807111; Ginisty H, 1999, J CELL SCI, V112, P761; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Greco ML, 2015, FEBS LETT, V589, P2117, DOI 10.1016/j.febslet.2015.06.025; Grummt I, 2013, BBA-GENE REGUL MECH, V1829, P393, DOI 10.1016/j.bbagrm.2012.10.004; Gu HP, 2012, ENDOCRINOLOGY, V153, P3692, DOI 10.1210/en.2012-1114; Guedin A, 2008, BIOCHIMIE, V90, P686, DOI 10.1016/j.biochi.2008.01.009; Guerrero-Bosagna C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100194; Haider R., 2010, MOL BIOSYST, V6, P2439; Haider S, 2008, BIOPHYS J, V95, P296, DOI 10.1529/biophysj.107.120501; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Hegyi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep09165; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hoffmann RF, 2016, NUCLEIC ACIDS RES, V44, P152, DOI 10.1093/nar/gkv900; Holder IT, 2014, CHEM BIOL, V21, P1511, DOI 10.1016/j.chembiol.2014.09.014; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kim M, 2016, NUCLEIC ACIDS RES, V44, P4807, DOI 10.1093/nar/gkw272; Kumar N, 2008, NUCLEIC ACIDS RES, V36, P5610, DOI 10.1093/nar/gkn543; Kuo MHJ, 2015, J AM CHEM SOC, V137, P210, DOI 10.1021/ja5089327; Laguerre A, 2015, J AM CHEM SOC, V137, P8521, DOI 10.1021/jacs.5b03413; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Le HT, 2012, ORG BIOMOL CHEM, V10, P9393, DOI 10.1039/c2ob26504d; Lech CJ, 2011, BIOPHYS J, V101, P1987, DOI 10.1016/j.bpj.2011.08.049; Levy MA, 2015, HUM MOL GENET, V24, P1824, DOI 10.1093/hmg/ddu596; Li Y, 2016, CHEMBIOCHEM, V17, P928, DOI 10.1002/cbic.201500655; Lim KW, 2015, NUCLEIC ACIDS RES, V43, P5630, DOI 10.1093/nar/gkv355; Lim KW, 2014, BIOCHEMISTRY-US, V53, P247, DOI 10.1021/bi401161a; Lin J, 2013, BIOCHEM BIOPH RES CO, V433, P368, DOI 10.1016/j.bbrc.2012.12.040; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Marchand C, 2002, J BIOL CHEM, V277, P8906, DOI 10.1074/jbc.M106372200; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Matsugami A, 2003, J BIOL CHEM, V278, P28147, DOI 10.1074/jbc.M303694200; Mekmaysy CS, 2008, J AM CHEM SOC, V130, P6710, DOI 10.1021/ja801976h; Membrino A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024421; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mendoza O, 2015, BIOCHIMIE, V118, P225, DOI 10.1016/j.biochi.2015.09.031; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494                                                         ; Miller MC, 2011, ORG BIOMOL CHEM, V9, P7633, DOI 10.1039/c1ob05891f; Morgan RK, 2016, BBA-GENE REGUL MECH, V1859, P235, DOI 10.1016/j.bbagrm.2015.11.004; Neidle S, 2016, J MED CHEM, V59, P5987, DOI 10.1021/acs.jmedchem.5b01835; Neidle S, 2015, CHEM REC, V15, P691, DOI 10.1002/tcr.201500011; Ogloblina AM, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1026, DOI 10.1134/S0006297915080088; Onel B, 2016, J AM CHEM SOC, V138, P2563, DOI 10.1021/jacs.5b08596; Onyshchenko MI, 2011, NUCLEIC ACIDS RES, V39, P7114, DOI 10.1093/nar/gkr259; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Pagano B, 2013, METHODS, V64, P43, DOI 10.1016/j.ymeth.2013.02.018; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Payet L, 2012, BIOCHEMISTRY-US, V51, P3154, DOI 10.1021/bi201750g; Petraccone L, 2013, TOP CURR CHEM, V330, P23, DOI 10.1007/128_2012_350; Petraccone L, 2011, J AM CHEM SOC, V133, P20951, DOI 10.1021/ja209192a; Petraccone L, 2008, J AM CHEM SOC, V130, P16530, DOI 10.1021/ja8075567; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Rangan A, 2001, J BIOL CHEM, V276, P4640, DOI 10.1074/jbc.M005962200; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u                                                               ; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ros S. Da, 2014, PLOS ONE, V9; Salvati E, 2014, NUCLEIC ACIDS RES, V42, P2945, DOI 10.1093/nar/gkt1289; Schonhoft JD, 2009, NUCLEIC ACIDS RES, V37, P3310, DOI 10.1093/nar/gkp181; Scognamiglio PL, 2014, BBA-GEN SUBJECTS, V1840, P2050, DOI [10.1016/j.bbagen2014.02.017, 10.1016/j.bbagen.2014.02.017]; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Selvam S, 2016, NUCLEIC ACIDS RES, V44, P45, DOI 10.1093/nar/gkv1326; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4                                                    ; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Smestad JA, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0236-4; Smith Steven S., 2010, Cancer Genomics & Proteomics, V7, P207; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Sun HX, 2014, BBA-GEN SUBJECTS, V1840, P3052, DOI 10.1016/j.bbagen.2014.07.014; Szalai VA, 2002, J AM CHEM SOC, V124, P1625, DOI 10.1021/ja0119651; Tran PLT, 2011, BIOCHIMIE, V93, P1288, DOI 10.1016/j.biochi.2011.05.011; Tsumagari K, 2008, NUCLEIC ACIDS RES, V36, P2196, DOI 10.1093/nar/gkn055; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Cheong VV, 2016, ANGEW CHEM INT EDIT, V55, P160, DOI 10.1002/anie.201507034; Cheong VV, 2015, NUCLEIC ACIDS RES, V43, P10506, DOI 10.1093/nar/gkv826; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Wei DG, 2013, J AM CHEM SOC, V135, P19319, DOI 10.1021/ja4101358; Wei PC, 2013, NUCLEIC ACIDS RES, V41, P1533, DOI 10.1093/nar/gks1232; Wickramasinghe CM, 2015, DNA REPAIR, V29, P83, DOI 10.1016/j.dnarep.2015.01.004; Yadav P, 2016, NUCLEIC ACIDS RES, V44, P718, DOI 10.1093/nar/gkv1152; You HJ, 2015, J AM CHEM SOC, V137, P2424, DOI 10.1021/ja511680u; Yu ZB, 2012, J AM CHEM SOC, V134, P5157, DOI 10.1021/ja210399h; Zamiri B, 2015, NUCLEIC ACIDS RES, V43, P10055, DOI 10.1093/nar/gkv1008	140	3	3	15	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	MAY	2017	1861	5	B		SI		1399	1413		10.1016/j.bbagen.2016.12.024				15	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EY1NX	WOS:000403733700022	28025083				2018-01-05	
J	Jaiswal, MK				Jaiswal, Manoj Kumar			Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease	NEURAL REGENERATION RESEARCH			English	Review						iPSCs; stem cells; human patients; ALS; mitochondria; motor neuron disease; disease modeling; neurodegeneration; gene editing; transplantation; drug screening	SPINAL MUSCULAR-ATROPHY; MUTANT SOD1; DRUG DISCOVERY; ALS; PATIENT; MITOCHONDRIA; GENERATION; MODELS; MICE; PATHOGENESIS	Amyotrophic lateral sclerosis (ALS) and motor neuron diseases (MNDs) are progressive neurodegenerative diseases that affect nerve cells in the brain affecting upper and lower motor neurons (UMNs/LMNs), brain stem and spinal cord. The clinical phenotype is characterized by loss of motor neurons (MNs), muscular weakness and atrophy eventually leading to paralysis and death due to respiratory failure within 3-5 years after disease onset. No effective treatment or cure is currently available that halts or reverses ALS and MND except FDA approved drug riluzole that only modestly slows the progression of ALS in some patients. Recent advances in human derived induced pluripotent stem cells have made it possible for the first time to obtain substantial amounts of human cells to recapitulate in vitro "disease in dish" and test some of the underlying pathogenetic mechanisms involved in ALS and MNDs. In this review, I discussed the opportunities and challenges of induced pluropotent stem cells-derived motor neurons for treatment of ALS and MND patients with special emphasis on their implications in finding a cure for ALS and MNDs.	[Jaiswal, Manoj Kumar] Columbia Univ, New York State Psychiat Inst, Mol Imaging & Neuropathol Div, New York, NY 10027 USA; [Jaiswal, Manoj Kumar] Columbia Univ, Dept Psychiat, New York, NY 10027 USA	Jaiswal, MK (reprint author), Columbia Univ, New York State Psychiat Inst, Mol Imaging & Neuropathol Div, New York, NY 10027 USA.; Jaiswal, MK (reprint author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	mj2750@cumc.columbia.edu					Adami Raffaella, 2014, Front Cell Dev Biol, V2, P17, DOI 10.3389/fcell.2014.00017; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Alves CJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00332; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Beal MF, 2000, BRAIN, V123, P1291, DOI 10.1093/brain/123.7.1291                                                        ; Bedlack RS, 2015, NEUROL CLIN, V33, P909, DOI 10.1016/j.ncl.2015.07.008; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; Benkler C, 2013, GLIA, V61, P312, DOI 10.1002/glia.22428; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Cetin H, 2015, NEUROEPIDEMIOLOGY, V44, P6, DOI 10.1159/000369813; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Chipman PH, 2012, PROG BRAIN RES, V201, P313, DOI 10.1016/B978-0-444-59544-7.00015-9; Corti S, 2008, J CLIN INVEST, V118, P3316, DOI 10.1172/JCI35432; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Garbes L, 2013, HUM MOL GENET, V22, P398, DOI 10.1093/hmg/dds437; Giri S, 2015, DRUG DISCOV TODAY, V20, P37, DOI 10.1016/j.drudis.2014.10.011; Goos M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-131; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Hermann A, 2013, J NEURAL TRANSM, V120, pS19, DOI 10.1007/s00702-013-1042-9; Higelin J, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00290; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Jaiswal Manoj Kumar, 2014, Mol Cell Ther, V2, P26, DOI 10.1186/2052-8426-2-26; Jaiswal MK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00199; Jaiswal MK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-64; Jaiswal MK, 2009, MOL PHARMACOL, V75, P478, DOI 10.1124/mol.108.050831; Jaiswal MK, 2012, MOTOR NEURON DIS CAU, P87; Jaiswal MK, 2017, ROLE MITOCHONDRIA OX; Japtok J, 2015, NEUROBIOL DIS, V82, P420, DOI 10.1016/j.nbd.2015.07.017; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Kondo T, 2014, STEM CELL REP, V3, P242, DOI 10.1016/j.stemcr.2014.05.017; Kong JM, 1998, J NEUROSCI, V18, P3241; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Lenzi J, 2015, DIS MODEL MECH, V8, P755, DOI 10.1242/dmm.020099; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Liu XX, 2015, NEUROGENETICS, V16, P223, DOI 10.1007/s10048-015-0448-y; Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013; Lorson CL, 2010, HUM MOL GENET, V19, pR111, DOI 10.1093/hmg/ddq147; Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546; Magrane J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528; Manuel M, 2009, J NEUROSCI, V29, P11246, DOI 10.1523/JNEUROSCI.3260-09.2009; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; McDermott CJ, 2008, BRIT MED J, V336, P658, DOI 10.1136/bmj.39493.511759.BE; McGivern JV, 2013, GLIA, V61, P1418, DOI 10.1002/glia.22522; McNeish J, 2015, CELL STEM CELL, V17, P8, DOI 10.1016/j.stem.2015.06.013; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Nizzardo M, 2014, HUM MOL GENET, V23, P342, DOI 10.1093/hmg/ddt425; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Paine A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00219; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Patten SA, 2014, DIS MODEL MECH, V7, P799, DOI 10.1242/dmm.015719; Pepper JP, 2017, JAMA FACIAL PLAST SU, V19, P197, DOI 10.1001/jamafacial.2016.1544; Philippidou P, 2012, NAT NEUROSCI, V15, P1636, DOI 10.1038/nn.3242; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sareen D, 2014, J COMP NEUROL, V522, P2707, DOI 10.1002/cne.23578; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sareen D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039113; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Son MJ, 2015, CELL DEATH DIFFER, V22, P1957, DOI 10.1038/cdd.2015.43; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Su HX, 2013, STEM CELL RES, V11, P529, DOI 10.1016/j.scr.2013.02.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Vaskova EA, 2013, ACTA NATURAE, V5, P15; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xu CC, 2016, DIS MODEL MECH, V9, P39, DOI 10.1242/dmm.021766; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	81	0	0	9	9	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2017	12	5					723	736		10.4103/1673-5374.206635				14	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	EX6UY	WOS:000403378800008	28616022	gold			2018-01-05	
J	Shaikh, MH; Clarke, DTW; Johnson, NW; McMillan, NAJ				Shaikh, Mushfiq H.; Clarke, Daniel T. W.; Johnson, Newell W.; McMillan, Nigel A. J.			Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?	ORAL ONCOLOGY			English	Review						RNA interference; CRISPR/Cas; Short interfering RNA; Head and neck squamous cell carcinoma; Human papillomavirus; Nanoparticles and lipoplex	SQUAMOUS-CELL CARCINOMA; SMALL INTERFERING RNA; FACTOR RECEPTOR EGFR; NF-KAPPA-B; IN-VIVO; HUMAN-PAPILLOMAVIRUS; DRUG-DELIVERY; PHOTODYNAMIC THERAPY; CERVICAL-CARCINOMA; SYSTEMIC DELIVERY	Conventional treatment strategies have done little to improve the prognosis or disease-free survival in head and neck cancer (HNC) patients. Recent progress in our understanding of molecular aspects of head and neck squamous cell carcinoma (HNSCC) has provided insights into the potential use of molecular targeted therapies in combination with current treatment strategies. Here we review the current understanding of treatment modalities for both HPV-positive and HPV-negative HNSCCs with the potential to use gene editing and silencing technologies therapeutically. The development of sequence-specific RNA interference (RNAi) with its strong gene-specific silencing ability, high target specificity, greater potency and reduced side effects, has shown it to be a promising therapeutic candidate for treating cancers. CRISPR/Cas gene editing is the newest technology with the ability to delete, mutate or replace genes of interest and has great potential for treating HNSCCs. We also discuss the major challenge in using these approaches in HNSCC; that being the choice of target and the ability to deliver the payload. Finally, we highlight the potential combination of RNAi or CRIPSR/Cas with current treatment strategies and outline the possible path to the clinic. Crown Copyright (C) 2017 Published by Elsevier Ltd. All rights reserved.	[Shaikh, Mushfiq H.; Johnson, Newell W.] Griffith Univ, Sch Dent & Oral Hlth, Gold Coast Campus, Southport, Qld 4222, Australia; [Shaikh, Mushfiq H.; Clarke, Daniel T. W.; McMillan, Nigel A. J.] Griffith Univ, Sch Med Sci, Gold Coast Campus, Southport, Qld 4222, Australia; [Shaikh, Mushfiq H.; Clarke, Daniel T. W.; Johnson, Newell W.; McMillan, Nigel A. J.] Menzies Hlth Inst Queensland, Understanding Chron Condit Program, Southport, Qld, Australia	McMillan, NAJ (reprint author), Griffith Univ, Menzies Hlth Inst Queensland, Sch Med Sci, Room 3-37,Bldg G05,Gold Coast Campus, Southport, Qld 4222, Australia.	mushfiq.shaikh@griffithuni.edu.au; daniel.clarke@griffith.edu.au; n.johnson@griffith.edu.au; n.mcmillan@griffith.edu.au		Johnson, Newell/0000-0001-5866-262X	Griffith University, Australia; Cancer Council of Queensland; National Health and Medical Research Council of Australia	MHS is funded by Griffith University, Australia. NAJM has received funding from the Cancer Council of Queensland and the National Health and Medical Research Council of Australia.	Adhim Z, 2013, ACTA OTO-LARYNGOL, V133, P761, DOI 10.3109/00016489.2013.773405; Asokan A, 2002, J PHARM SCI, V91, P903, DOI 10.1002/jps.10095; Barata P, 2016, CANCER TREAT REV, V50, P35, DOI 10.1016/j.ctrv.2016.08.004; Bhadra D, 2002, PHARMAZIE, V57, P5; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Bousarghin L, 2009, MOL CANCER THER, V8, P357, DOI 10.1158/1535-7163.MCT-08-0626; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999                                                         ; Burtness B, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-469; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carson AR, 2012, CANCER RES, V72, P6191, DOI 10.1158/0008-5472.CAN-11-4079; Chang RS, 2011, BIOMATERIALS, V32, P9785, DOI 10.1016/j.biomaterials.2011.09.017; Chaudhary SA, 2010, EXPERT OPIN DRUG DEL, V7, P871, DOI 10.1517/17425247.2010.493554; Chen SM, 2008, CANCER BIOL THER, V7, P734, DOI 10.4161/cbt.7.5.5722                                                            ; Chen WH, 2015, CANCER LETT, V359, P65, DOI 10.1016/j.canlet.2014.12.052; Chen X, 2011, J CONTROL RELEASE, V152, P349, DOI 10.1016/j.jconrel.2011.02.026; Cho HJ, 2012, PHARM RES-DORDR, V29, P1007, DOI 10.1007/s11095-011-0642-z; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chong RHE, 2013, J CONTROL RELEASE, V166, P211, DOI 10.1016/j.jconrel.2012.12.030; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conway C, 2015, ONCOTARGET, V6, P40186, DOI 10.18632/oncotarget.5529; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497                                                            ; Ding Z, 2011, PHARM RES-DORDR, V28, P145, DOI 10.1007/s11095-010-0093-y; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duan JM, 2007, MOL CANCER THER, V6, P37, DOI 10.1158/1535-7163.MCT-05-0285; Dudek H, 2014, MOL THER, V22, P92, DOI 10.1038/mt.2013.233; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301                                                              ; FARHOOD H, 1995, BBA-BIOMEMBRANES, V1235, P289, DOI 10.1016/0005-2736(95)80016-9; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferris RL, 2007, CLIN CANCER RES, V13, P5663, DOI 10.1158/1078-0432.CCR-07-1544; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gao ZB, 2012, J CONTROL RELEASE, V162, P45, DOI 10.1016/j.jconrel.2012.05.051; Gardlik R, 2005, MED SCI MONITOR, V11, pRA110; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Grimm D, 2005, METHOD ENZYMOL, V392, P381, DOI 10.1016/S0076-6879(04)92023-X                                                   ; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gu W, 2006, CANCER GENE THER, V13, P1023, DOI 10.1038/sj.cgt.7700971; Guzman LA, 1996, CIRCULATION, V94, P1441; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Haigh O, 2014, J CONTROL RELEASE, V194, P148, DOI 10.1016/j.jconrel.2014.08.021; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023                                                         ; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Hoffmann EM, 2011, EXPERT OPIN DRUG DEL, V8, P299, DOI 10.1517/17425247.2011.553217; Hsin CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113129; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hyakusoku H, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0284-4; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Keck MK, 2015, CLIN CANCER RES, V21, P870, DOI 10.1158/1078-0432.CCR-14-2481; Kedmi R, 2010, BIOMATERIALS, V31, P6867, DOI 10.1016/j.biomaterials.2010.05.027; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kimple RJ, 2013, CANCER RES, V73, P4791, DOI 10.1158/0008-5472.CAN-13-0587; Kindt N, 2014, J CANCER RES CLIN, V140, P937, DOI 10.1007/s00432-014-1648-9; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Kothari V, 2012, ANTICANCER RES, V32, P121; Lalonde ES, 2002, HEAD NECK-J SCI SPEC, V24, P1038, DOI 10.1002/hed.10148; Landesman-Milo D, 2015, CANCER METAST REV, V34, P291, DOI 10.1007/s10555-015-9554-4; Lara MF, 2012, HUM GENE THER, V23, P816, DOI 10.1089/hum.2011.211; Lea JS, 2007, REPROD SCI, V14, P20, DOI 10.1177/1933719106298189; Lecaros RLG, 2016, MOL THER, V24, P106, DOI 10.1038/mt.2015.169; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2                                                   ; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu Dan, 2006, Ai Zheng, V25, P11; Liu WL, 2009, CANCER GENE THER, V16, P764, DOI 10.1038/cgt.2009.24; Lun MY, 2005, ANN CLIN LAB SCI, V35, P251; Maeda H, 2010, BIOCONJUGATE CHEM, V21, P797, DOI 10.1021/bc100070g; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martinez-Useros J, 2015, ORAL ONCOL, V51, P423, DOI 10.1016/j.oraloncology.2015.02.092; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3                                                   ; Mazumdar A, 2009, HEAD NECK-J SCI SPEC, V31, P625, DOI 10.1002/hed.21007; Mehra NK, 2013, THER DELIV, V4, P369, DOI [10.4155/TDE.13.6, 10.4155/tde.13.6]; Messager L, 2014, CURR OPIN PHARMACOL, V18, P104, DOI 10.1016/j.coph.2014.09.017; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Murphy BA, 2007, EXPERT REV ANTICANC, V7, P1043, DOI 10.1586/14737140.7.7.1043; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/ch700110z; Niu XY, 2006, INT J GYNECOL CANCER, V16, P743, DOI 10.1111/j.1525-1438.2006.00384.x                                                ; Nozawa H, 2006, CANCER SCI, V97, P1115, DOI 10.1111/j.1349-7006.2006.00287; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Psyrri A, 2013, AM SOC CLIN ONCOL ED, V2013, P246, DOI [DOI 10.1200/EDBOOK_AM.2013.33.246, 10.1200/EdBook_AM.2013.33.246]; Putral LN, 2005, MOL PHARMACOL, V68, P1311, DOI 10.1124/mol.105.014191; Rahman MA, 2012, J CONTROL RELEASE, V159, P384, DOI 10.1016/j.jconrel.2012.01.045; Ramqvist T, 2011, ANTICANCER RES, V31, P1515; Redhead HM, 2001, J CONTROL RELEASE, V70, P353, DOI 10.1016/S0168-3659(00)00367-9                                                   ; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwartz GJ, 2000, HEAD NECK-J SCI SPEC, V22, P34, DOI 10.1002/(SICI)1097-0347(200001)22:1<34::AID-HED6>3.3.CO;2-V; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharpe LA, 2014, EXPERT OPIN DRUG DEL, V11, P901, DOI 10.1517/17425247.2014.902047; Sobral LM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-32; Son S, 2012, ACCOUNTS CHEM RES, V45, P1100, DOI 10.1021/ar200248u; Sosnik A, 2014, ISRN PHARM, V2014, DOI DOI 10.1155/2014/926157; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x; Tong M, 2008, J CELL BIOCHEM, V105, P1202, DOI 10.1002/jcb.21920; Wu SY, 2011, GENE THER, V18, P14, DOI 10.1038/gt.2010.113; Wu SY, 2011, J CONTROL RELEASE, V155, P418, DOI 10.1016/j.jconrel.2011.02.002; Xu HL, 2015, J CONTROL RELEASE, V199, P84, DOI 10.1016/j.jconrel.2014.12.012; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891; Yao SH, 2015, HUM GENE THER, V26, P463, DOI 10.1089/hum.2015.067; Yi L, 2016, BBA-REV CANCER, V1866, P197, DOI 10.1016/j.bbcan.2016.09.002; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang YJ, 2006, MOL THER, V14, P336, DOI 10.1016/j.ymthe.2006.04.001; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11; Zufferey R, 1998, J VIROL, V72, P9873; [Anonymous], 2015, NATURE, V517, P576, DOI DOI 10.1038/NATURE14129	117	0	0	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1368-8375	1879-0593		ORAL ONCOL	Oral Oncol.	MAY	2017	68						9	19		10.1016/j.oraloncology.2017.02.016				11	Oncology; Dentistry, Oral Surgery & Medicine	Oncology; Dentistry, Oral Surgery & Medicine	EW4JZ	WOS:000402469100003	28438299				2018-01-05	
J	Oegema, R; Baillat, D; Schot, R; van Unen, LM; Brooks, A; Kia, SK; Hoogeboom, AJM; Xia, Z; Li, W; Cesaroni, M; Lequin, MH; van Slegtenhorst, M; Dobyns, WB; de Coo, IFM; Verheijen, FW; Kremer, A; van der Spek, PJ; Heijsman, D; Wagner, EJ; Fornerod, M; Mancini, GMS				Oegema, Renske; Baillat, David; Schot, Rachel; van Unen, Leontine M.; Brooks, Alice; Kia, Sima Kheradmand; Hoogeboom, A. Jeannette M.; Xia, Zheng; Li, Wei; Cesaroni, Matteo; Lequin, Maarten H.; van Slegtenhorst, Marjon; Dobyns, William B.; de Coo, Irenaeus F. M.; Verheijen, Frans W.; Kremer, Andreas; van der Spek, Peter J.; Heijsman, Daphne; Wagner, Eric J.; Fornerod, Maarten; Mancini, Grazia M. S.			Human mutations in integrator complex subunits link transcriptome integrity to brain development	PLOS GENETICS			English	Article							RNA-POLYMERASE-II; 3' END FORMATION; CORTICAL DEVELOPMENT; NEURONAL DEVELOPMENT; SPLICING REGULATION; GENE-EXPRESSION; U4ATAC SNRNA; MALFORMATIONS; PROTEIN; EMBRYO	Integrator is an RNA polymerase II (RNAPII)-associated complex that was recently identified to have a broad role in both RNA processing and transcription regulation. Importantly, its role in human development and disease is so far largely unexplored. Here, we provide evidence that biallelic Integrator Complex Subunit 1 (INTS1) and Subunit 8 (INTS8) gene mutations are associated with rare recessive human neurodevelopmental syndromes. Three unrelated individuals of Dutch ancestry showed the same homozygous truncating INTS1 mutation. Three siblings harboured compound heterozygous INTS8 mutations. Shared features by these six individuals are severe neurodevelopmental delay and a distinctive appearance. The INTS8 family in addition presented with neuronal migration defects (periventricular nodular heterotopia). We show that the first INTS8 mutation, a nine base-pair deletion, leads to a protein that disrupts INT complex stability, while the second missense mutation introduces an alternative splice site leading to an unstable messenger. Cells from patients with INTS8 mutations show increased levels of unprocessed UsnRNA, compatible with the INT function in the 3'-end maturation of UsnRNA, and display significant disruptions in gene expression and RNA processing. Finally, the introduction of the INTS8 deletion mutation in P19 cells using genome editing alters gene expression throughout the course of retinoic acid-induced neural differentiation. Altogether, our results confirm the essential role of Integrator to transcriptome integrity and point to the requirement of the Integrator complex in human brain development.	[Oegema, Renske; Schot, Rachel; van Unen, Leontine M.; Brooks, Alice; Kia, Sima Kheradmand; Hoogeboom, A. Jeannette M.; van Slegtenhorst, Marjon; Verheijen, Frans W.; Heijsman, Daphne; Mancini, Grazia M. S.] Erasmus MC Univ Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Baillat, David; Wagner, Eric J.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Xia, Zheng; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Xia, Zheng; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cesaroni, Matteo] Temple Univ, Sch Med, Fels Inst, Philadelphia, PA 19122 USA; [Lequin, Maarten H.] Univ Med Ctr Rotterdam, Erasmus MC Sophia, Dept Pediat Radiol, Rotterdam, Netherlands; [Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [de Coo, Irenaeus F. M.] Univ Med Ctr Rotterdam, Erasmus MC Sophia, Dept Neurol, Rotterdam, Netherlands; [Kremer, Andreas; van der Spek, Peter J.; Heijsman, Daphne] Univ Med Ctr, Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Fornerod, Maarten] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat Oncol & Biochem, Rotterdam, Netherlands; [Oegema, Renske; Lequin, Maarten H.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Mancini, GMS (reprint author), Erasmus MC Univ Med Ctr, Dept Clin Genet, Rotterdam, Netherlands.; Wagner, EJ (reprint author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	ejwagner@utmb.edu; g.mancini@erasmusmc.nl		Xia, Zheng/0000-0003-3364-8324; van Unen, Leontine/0000-0003-1174-9140	Welch Foundation [H-1889]; Erasmus MC [104673]; CTMM; Lygature	Work in the Wagner laboratory is funded from the Welch Foundation (H-1889). Work in the Mancini laboratory was supported by the Erasmus MC grant (Mrace nr. 104673 to GMSM). Work in the Erasmus MC Bioinformatics department was supported by CTMM and Lygature grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht TR, 2012, MOL CELL BIOL, V32, P1112, DOI 10.1128/MCB.06511-11; Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Baillat D, 2016, PROTEIN EXPRES PURIF, V128, P101, DOI 10.1016/j.pep.2016.08.011; Baillat D, 2015, TRENDS BIOCHEM SCI, V40, P257, DOI 10.1016/j.tibs.2015.03.005; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bonano VI, 2007, NAT PROTOC, V2, P2166, DOI 10.1038/nprot.2007.292; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Elsaid MF, 2017, ANN NEUROL, V81, P68, DOI 10.1002/ana.24826; Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10; Gaertner B, 2014, DEVELOPMENT, V141, P1179, DOI 10.1242/dev.088492; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Grabowski P, 2011, CURR OPIN GENET DEV, V21, P388, DOI 10.1016/j.gde.2011.03.005; Gripp KW, 2011, AM J MED GENET A, V155A, P2516, DOI 10.1002/ajmg.a.34190; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7; Han SM, 2006, DEVELOPMENT, V133, P3597, DOI 10.1242/dev.02534; Hata T, 2007, BBA-MOL CELL RES, V1773, P1039, DOI 10.1016/j.bbamcr.2007.04.010; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Hennekam RCM, 2011, EUR J MED GENET, V54, P220, DOI 10.1016/j.ejmg.2010.12.001; Hunter A, 1993, HUMAN MALFORMATIONS, V2, P1; Jacobs MP, 2001, NEUROLOGY, V57, P1536, DOI 10.1212/WNL.57.9.1536                                                           ; Jia YC, 2012, CELL, V148, P296, DOI 10.1016/j.cell.2011.11.057; Kapp LD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003822; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; KUZNIECKY R, 1993, NEUROLOGY, V43, P681, DOI 10.1212/WNL.43.4.681                                                            ; Lagha M, 2013, CELL, V153, P976, DOI 10.1016/j.cell.2013.04.045; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Lardelli RM, 2017, NAT GENET, V49, P457, DOI 10.1038/ng.3762; Latos PA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8776; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Negraes PD, 2012, CURR PROTOC STEM CEL; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099                                                                   ; Norris AD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00122; Oegema R, 2016, MALFORMATIONS CORTIC; Papayannis CE, 2012, SEIZURE-EUR J EPILEP, V21, P377, DOI 10.1016/j.seizure.2012.03.009; Peart N, 2013, WIRES RNA, V4, P491, DOI 10.1002/wrna.1174; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Richardson L, 2010, NUCLEIC ACIDS RES, V38, pD703, DOI 10.1093/nar/gkp763; Rutkowski RJ, 2009, DEV DYNAM, V238, P1131, DOI 10.1002/dvdy.21922; Saha RN, 2013, NEUROSCIENCE, V247, P175, DOI 10.1016/j.neuroscience.2013.04.064; Singh RK, 2014, MOL CELL, V55, P592, DOI 10.1016/j.molcel.2014.06.035; Skaar JR, 2015, CELL RES, V25, P288, DOI 10.1038/cr.2015.19; Srour M, 2011, EPILEPSIA, V52, P728, DOI 10.1111/j.1528-1167.2010.02975.x; Stadelmayer B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6531; Tao SJ, 2009, DEVELOPMENT, V136, P2757, DOI 10.1242/dev.034959; Tohyama J, 2015, J HUM GENET, V60, P167, DOI 10.1038/jhg.2015.5; van den Berg DLC, 2017, NEURON, V93, P348, DOI 10.1016/j.neuron.2016.11.047; West A. E., 2011, COLD SPRING HARB PER, V3; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Wu Y, 2017, P NATL ACAD SCI USA, V114, P4394, DOI 10.1073/pnas.1616605114; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	61	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	MAY	2017	13	5							e1006809	10.1371/journal.pgen.1006809				20	Genetics & Heredity	Genetics & Heredity	EX0CD	WOS:000402884800052	28542170	gold			2018-01-05	
J	Ma, L; Zhang, DC; Miao, QS; Yang, J; Xuan, YH; Hu, YB				Ma, Lai; Zhang, Dechun; Miao, Qisong; Yang, Jing; Xuan, Yuanhu; Hu, Yibing			Essential Role of Sugar Transporter OsSWEET11 During the Early Stage of Rice Grain Filling	PLANT AND CELL PHYSIOLOGY			English	Article						Caryopsis; Development; Maternal-filial interface; OsSWEET11; Rice; Sugar transporter	ORYZA-SATIVA L.; DISEASE-SUSCEPTIBILITY GENE; SIEVE ELEMENT TRANSPORT; POST-PHLOEM TRANSPORT; DEVELOPING SEEDS; DEVELOPING CARYOPSIS; BACTERIAL-BLIGHT; WHEAT GRAINS; SUCROSE; EXPRESSION	This study investigated the role of the sugar transporter OsSWEET11 during the early stage of rice caryopsis development using beta-glucoronidase (GUS) to represent its expression, together with clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9)-mediated knockout, cross-fertilization and RNA sequencing (RNA-seq) analyses. The results showed that OsSWEET11 was expressed strongly in developing caryopsis, particularly in the ovular vascular trace, nucellar epidermis and cross cells. The knockout of OsSWEET11 significantly decreased the sucrose concentration in the mutant embryo sacs and led to defective grain filling compared with that of the wild-type (WT) plant. Moreover, the expression of 2,549 genes in the mutant caryopsis was affected. The grain weight and seed setting percentage were also decreased in the mutants. The cross-fertilization of the mutant and WT rice revealed that the mutated maternal donor induced defective grain filling. These results strongly suggested that OsSWEET11 played an important role in sucrose release from maternal tissue to the maternal-filial interface during the early stage of caryopsis development. It might also induce sucrose release from the ovular vascular trace and cross cells of developing caryopsis. These findings bridge the gap in the understanding of post-phloem sugar transport during the early stage of rice caryopsis development.	[Ma, Lai; Yang, Jing; Hu, Yibing] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China; [Zhang, Dechun] China Three Gorges Univ, Biotechnol Res Ctr, Yichang 443002, Peoples R China; [Miao, Qisong] HoHai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing 210098, Jiangsu, Peoples R China; [Xuan, Yuanhu] Shenyang Agr Univ, Coll Plant Protect, Shenyang 110866, Peoples R China; [Hu, Yibing] State Key Lab Soil & Sustainable Agr, Nanjing 210008, Peoples R China	Hu, YB (reprint author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.; Hu, YB (reprint author), State Key Lab Soil & Sustainable Agr, Nanjing 210008, Peoples R China.	huyb@njau.edu.cn		, Yuanhu/0000-0002-4704-8090	Natural Science Foundation of China [31371596]; State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences [Y412201445]; Natural Science Foundation of Jiangsu Province, China [BK20151424]	This work was supported by the Natural Science Foundation of China [31371596]; the State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences [Y412201445]; and the Natural Science Foundation of Jiangsu Province, China [BK20151424].	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Bai A. N., 2015, CELL RES, V25, P1; Braun DM, 2014, J EXP BOT, V65, P1713, DOI 10.1093/jxb/ert416; CERNINGBEROARD J, 1975, CEREAL CHEM, V52, P857; Chen LQ, 2015, PLANT CELL, V27, P607, DOI 10.1105/tpc.114.134585; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; COULTER HD, 1967, J ULTRA MOL STRUCT R, V20, P346, DOI 10.1016/S0022-5320(67)80104-7; Crafts A. S., 1971, FREEMAN; ELLIS JR, 1987, ANN BOT-LONDON, V60, P671, DOI 10.1093/oxfordjournals.aob.a087498                                              ; Furbank RT, 2001, AUST J PLANT PHYSIOL, V28, P1187, DOI 10.1071/PP01111; HANSEN J, 1975, ANAL BIOCHEM, V68, P87, DOI 10.1016/0003-2697(75)90682-X; Hirose T, 2002, PLANT CELL PHYSIOL, V43, P452, DOI 10.1093/pcp/pcf055; HOLM J, 1986, STARCH-STARKE, V38, P224, DOI 10.1002/star.19860380704; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimura K, 2001, PLANT CELL PHYSIOL, V42, P1181, DOI 10.1093/pcp/pce148; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Jenner C. F., 1976, WHEAT GRAINS SPINACH; Jenner C. F., 1974, FACTORS GRAIN REGULA; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lalonde S, 2003, PLANT CELL ENVIRON, V26, P37, DOI 10.1046/j.1365-3040.2003.00847.x; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; OPARKA KJ, 1981, PLANTA, V152, P388, DOI 10.1007/BF00385354; OPARKA KJ, 1981, PLANTA, V151, P561, DOI 10.1007/BF00387436; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191                                                ; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; PATRICK JW, 1995, AUST J PLANT PHYSIOL, V22, P681, DOI 10.1071/PP9950681                                                               ; Ruan YL, 1997, PLANT CELL ENVIRON, V20, P341, DOI 10.1046/j.1365-3040.1997.d01-73.x; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; SAUER N, 1993, PLANT J, V4, P601, DOI 10.1046/j.1365-313X.1993.04040601.x                                             ; Scofield GN, 2002, FUNCT PLANT BIOL, V29, P815, DOI 10.1071/PP01204; SINGH R, 1977, PLANT PHYSIOL, V59, P417, DOI 10.1104/pp.59.3.417; Sosso D, 2015, NAT GENET, V47, P1489, DOI 10.1038/ng.3422; Stadler R, 2005, PLANT PHYSIOL, V139, P701, DOI 10.1104/pp.105.065607; Tang Z, 2012, PLANT PHYSIOL, V160, P2052, DOI 10.1104/pp.112.204461; Turgeon R, 2009, ANNU REV PLANT BIOL, V60, P207, DOI 10.1146/annurev.arplant.043008.092045; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; WANG N, 1995, PLANT PHYSIOL, V109, P579, DOI 10.1104/pp.109.2.579                                                            ; WANG N, 1994, PLANT PHYSIOL, V104, P7, DOI 10.1104/pp.104.1.7                                                              ; WARDLAW IF, 1974, ANNU REV PLANT PHYS, V25, P515, DOI 10.1146/annurev.pp.25.060174.002503                                             ; Weber H, 1996, PLANT J, V10, P823, DOI 10.1046/j.1365-313X.1996.10050823.x; Wu XB, 2016, J INTEGR PLANT BIOL, V58, P772, DOI 10.1111/jipb.12440; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253                                             ; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhang WH, 2007, FUNCT PLANT BIOL, V34, P314, DOI 10.1071/FP06271	52	1	2	29	29	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2017	58	5					863	873		10.1093/pcp/pcx040				11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	EW9QD	WOS:000402853400001	28371825				2018-01-05	
J	Yasui, Y; Tanaka, W; Sakamoto, T; Kurata, T; Hirano, HY				Yasui, Yukiko; Tanaka, Wakana; Sakamoto, Tomoaki; Kurata, Tetsuya; Hirano, Hiro-Yuki			Genetic Enhancer Analysis Reveals that FLORAL ORGAN NUMBER2 and OsMADS3 Co-operatively Regulate Maintenance and Determinacy of the Flower Meristem in Rice	PLANT AND CELL PHYSIOLOGY			English	Article						Determinacy; Flower development; FON2; MADS-box gene; Meristem; Stem cell	STEM-CELL MAINTENANCE; FLORAL MERISTEM; ORYZA-SATIVA; RECEPTOR KINASE; ARABIDOPSIS; SHOOT; CLAVATA1; WUSCHEL; SIZE; DIVERSIFICATION	Meristems such as the shoot apical meristem and flower meristem (FM) act as a reservoir of stem cells, which reproduce themselves and supply daughter cells for the differentiation of lateral organs. In Oryza sativa (rice), the FLORAL ORGAN NUMBER2 (FON2) gene, which is similar to Arabidopsis CLAVATA3, is involved in meristem maintenance. In fon2 mutants, the numbers of floral organs are increased due to an enlargement of the FM. To identify new factors regulating meristem maintenance in rice, we performed a genetic screening of mutants that enhanced the fon2 mutation, and found a mutant line (2B-424) in which pistil number was dramatically increased. By using a map-based approach and next-generation sequencing, we found that the line 2B-424 had a complete loss-of-function mutation (a large deletion) in OsMADS3, a class C MADS-box gene that is known to be involved in stamen specification. Disruption of OsMADS3 in the fon2 mutant by CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9) technology caused a flower phenotype similar to that of 2B-424, confirming that the gene responsible for enhancement of fon2 was OsMADS3. Morphological analysis showed that the fon2 and osmads3 mutations synergistically affected pistil development and FM determinacy. We also found that whorl 3 was duplicated in mature flowers and the FM was enlarged at an early developmental stage in severe osmads3 single mutants. These findings suggest that OsMADS3 is involved not only in FM determinacy in late flower development but also in FM activity in early flower development.	[Yasui, Yukiko; Tanaka, Wakana; Hirano, Hiro-Yuki] Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo 1138654, Japan; [Sakamoto, Tomoaki; Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Ikoma 6300192, Japan; [Sakamoto, Tomoaki] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Kurata, Tetsuya] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Hirano, HY (reprint author), Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo 1138654, Japan.	hyhirano@bs.s.u-tokyo.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [25113008]; National Institute of Genetics [NIG-JOINT] [2015-A160, 2016-A164]; Japan Society for the Promotion of Science [15J06957, 201506957]	This work was supported by the Ministry of Education, Science, Sports, and Culture of Japan [a Grant-in-Aid for Scientific Research (grant 25113008) to H.-Y.H.]; the National Institute of Genetics [NIG-JOINT (2015-A160, 2016-A164) to H.-Y.H.]; and the Japan Society for the Promotion of Science [grant 15J06957, a Research Fellowship for Young Scientists (201506957) to Y.Y.].	Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Chu HW, 2006, PLANT PHYSIOL, V142, P1039, DOI 10.1104/pp.106.086736; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Dreni L, 2011, PLANT CELL, V23, P2850, DOI 10.1105/tpc.111.087007; Durfee T, 2003, P NATL ACAD SCI USA, V100, P8571, DOI 10.1073/pnas.1033043100; Fletcher LC, 1999, SCIENCE, V283, P1911; Ha CM, 2010, CURR TOP DEV BIOL, V91, P103, DOI 10.1016/S0070-2153(10)91004-1; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano H.-Y., 2014, FLOWER DEV METHODS P, P57; Itoh JI, 2000, PLANT CELL, V12, P2161, DOI 10.1105/tpc.12.11.2161; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; KOUCHI H, 1993, MOL GEN GENET, V238, P106; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Li HF, 2011, PLANT PHYSIOL, V156, P263, DOI 10.1104/pp.111.172080; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3                                                   ; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Ohmori Y, 2013, PLANT CELL, V25, P229, DOI 10.1105/tpc.112.103432; Pautler M, 2013, PLANT CELL PHYSIOL, V54, P302, DOI 10.1093/pcp/pct025; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Satoh H, 2010, BREEDING SCI, V60, P475, DOI 10.1270/jsbbs.60.475; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Suzaki T, 2004, DEVELOPMENT, V131, P5649, DOI 10.1242/dev.01441; Suzaki T, 2006, PLANT CELL PHYSIOL, V47, P1591, DOI 10.1093/pcp/pcl025; Tanaka W, 2015, PLANT CELL, V27, P1173, DOI 10.1105/tpc.15.00074; Tanaka W, 2014, ADV BOT RES, V72, P221, DOI 10.1016/B978-0-12-417162-6.00008-0; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yamaguchi T., 2004, YABBY GENE DROOPING	34	0	0	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2017	58	5					893	903		10.1093/pcp/pcx038				11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	EW9QD	WOS:000402853400004	28371923				2018-01-05	
J	Men, K; Duan, XM; He, ZY; Yang, Y; Yao, SH; Wei, YQ				Men, Ke; Duan, Xingmei; He, Zhiyao; Yang, Yang; Yao, Shaohua; Wei, Yuquan			CRISPR/Cas9-mediated correction of human genetic disease	SCIENCE CHINA-LIFE SCIENCES			English	Review						CRISPR/Cas9; genome editing; genetic disease; gene therapy	PLURIPOTENT STEM-CELLS; DUCHENNE MUSCULAR-DYSTROPHY; ZINC-FINGER NUCLEASES; IN-VIVO; FACTOR-IX; CHROMOSOMAL REARRANGEMENTS; EFFICIENT TRANSDUCTION; CYSTIC-FIBROSIS; HEMOPHILIA-B; MOUSE MODEL	The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) protein 9 system (CRISPR/Cas9) provides a powerful tool for targeted genetic editing. Directed by programmable sequence-specific RNAs, this system introduces cleavage and double-stranded breaks at target sites precisely. Compared to previously developed targeted nucleases, the CRISPR/Cas9 system demonstrates several promising advantages, including simplicity, high specificity, and efficiency. Several broad genome-editing studies with the CRISPR/Cas9 system in different species in vivo and ex vivo have indicated its strong potential, raising hopes for therapeutic genome editing in clinical settings. Taking advantage of non-homologous end-joining (NHEJ) and homology directed repair (HDR)-mediated DNA repair, several studies have recently reported the use of CRISPR/Cas9 to successfully correct disease-causing alleles ranging from single base mutations to large insertions. In this review, we summarize and discuss recent preclinical studies involving the CRISPR/Cas9-mediated correction of human genetic diseases.	[Men, Ke; Yang, Yang; Yao, Shaohua; Wei, Yuquan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Men, Ke; Yang, Yang; Yao, Shaohua; Wei, Yuquan] Sichuan Univ, West China Hosp, Canc Ctr, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Duan, Xingmei] Univ Elect Sci & Technol China, Dept Pharm, Individualized Medicat Key Lab Sichuan Prov, Chengdu 610072, Peoples R China; [Duan, Xingmei] Sichuan Translat Med Hosp, Sichuan Prov Peoples Hosp, Chengdu 610072, Peoples R China; [He, Zhiyao] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Pharm, Chengdu 610041, Peoples R China	Men, K (reprint author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.	mendingbob@hotmail.com			National Natural Science Foundation [NSFC81502677, NSFC81602699, NSFC81123003]; National Key Research and Development Program of China [2016YFA0201402]; Key Technologies R & D program of Sichuan Province [2015FZ0040]	This work was supported by the National Natural Science Foundation (NSFC81502677, NSFC81602699, NSFC81123003), the National Key Research and Development Program of China (2016YFA0201402), and the Key Technologies R & D program of Sichuan Province (2015FZ0040).	Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Aoki Y, 2012, P NATL ACAD SCI USA, V109, P13763, DOI 10.1073/pnas.1204638109; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615                                                             ; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Chang CW, 2015, CELL REP, V12, P1668, DOI 10.1016/j.celrep.2015.08.013; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen ZG, 2015, SCI CHINA LIFE SCI, V58, P119, DOI 10.1007/s11427-014-4791-2; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidoff AM, 2005, MOL THER, V11, P875, DOI 10.1016/j.ymthe.2004.12.022; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550; Flynn R, 2015, EXP HEMATOL, V43, P838, DOI 10.1016/j.exphem.2015.06.002; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gao X, 2015, SCI CHINA LIFE SCI, V58, P319, DOI 10.1007/s11427-015-4842-3; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Kimbrel EA, 2015, NAT REV DRUG DISCOV, V14, P681, DOI 10.1038/nrd4738; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Mukherjee S, 2011, MOL THER, V19, P1188, DOI 10.1038/mt.2011.116; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Okada Takashi, 2013, Pharmaceuticals (Basel), V6, P813, DOI 10.3390/ph6070813; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Piras BA, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.15; Pirazzoli V, 2014, CELL REP, V7, P999, DOI 10.1016/j.celrep.2014.04.014; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Porteus MH, 2015, MOL THER, V23, P979, DOI 10.1038/mt.2015.83; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shinmyo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20611; Smith KR, 2004, INT J MED SCI, V1, P76; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weiner A, 2009, NAT REV MICROBIOL, V7, P748, DOI 10.1038/nrmicro2206; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yang YY, 2016, STEM CELL TRANSL MED, V5, P8, DOI 10.5966/sctm.2015-0157; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhang DD, 2016, SCI CHINA LIFE SCI, V59, P854, DOI 10.1007/s11427-016-0192-5; Zhang DD, 2016, SCI CHINA LIFE SCI, V59, P740, DOI 10.1007/s11427-016-0128-8; Zhang XX, 2016, SCI CHINA LIFE SCI, V59, P1341, DOI 10.1007/s11427-016-0358-3; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	98	1	1	20	21	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2017	60	5			SI		447	457		10.1007/s11427-017-9032-4				11	Biology	Life Sciences & Biomedicine - Other Topics	EW8EI	WOS:000402750800002	28534256				2018-01-05	
J	He, ZY; Men, K; Qin, Z; Yang, Y; Xu, T; Wei, YQ				He, Zhi-Yao; Men, Ke; Qin, Zhou; Yang, Yang; Xu, Ting; Wei, Yu-Quan			Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field	SCIENCE CHINA-LIFE SCIENCES			English	Review						genome editing; CRISPR; Cas9; viral vector; non-viral vector; gene therapy	PEPTIDE-MEDIATED DELIVERY; HEPATITIS-B-VIRUS; IN-VIVO; GUIDE RNA; CAS9 PROTEIN; HUMAN-CELLS; MUSCULAR-DYSTROPHY; MOUSE-LIVER; TARGET DNA; T-CELLS	The clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (CRISPR-Cas9) system provides a novel genome editing technology that can precisely target a genomic site to disrupt or repair a specific gene. Some CRISPR-Cas9 systems from different bacteria or artificial variants have been discovered or constructed by biologists, and Cas9 nucleases and single guide RNAs (sgRNA) are the major components of the CRISPR-Cas9 system. These Cas9 systems have been extensively applied for identifying therapeutic targets, identifying gene functions, generating animal models, and developing gene therapies. Moreover, CRISPR-Cas9 systems have been used to partially or completely alleviate disease symptoms by mutating or correcting related genes. However, the efficient transfer of CRISPR-Cas9 system into cells and target organs remains a challenge that affects the robust and precise genome editing activity. The current review focuses on delivery systems for Cas9 mRNA, Cas9 protein, or vectors encoding the Cas9 gene and corresponding sgRNA. Non-viral delivery of Cas9 appears to help Cas9 maintain its on-target effect and reduce off-target effects, and viral vectors for sgRNA and donor template can improve the efficacy of genome editing and homology-directed repair. Safe, efficient, and producible delivery systems will promote the application of CRISPR-Cas9 technology in human gene therapy.	[He, Zhi-Yao; Qin, Zhou; Xu, Ting] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Peoples R China; [He, Zhi-Yao; Men, Ke; Qin, Zhou; Yang, Yang; Xu, Ting; Wei, Yu-Quan] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [He, Zhi-Yao; Men, Ke; Qin, Zhou; Yang, Yang; Xu, Ting; Wei, Yu-Quan] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Men, Ke; Yang, Yang; Wei, Yu-Quan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China	Xu, T (reprint author), Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Peoples R China.; Xu, T (reprint author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.; Xu, T (reprint author), Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.	tingx2009@163.com			National Natural and Scientific Foundation of China [81602699, 81502677, 81402302]; National High Technology Research and Development Program of China [2015AA020309]; China Postdoctoral Science Foundation [2015M570791]	This work was supported by the National Natural and Scientific Foundation of China (81602699 to Zhi-Yao He, 81502677 to Ke Men, 81402302 to Yang Yang), the National High Technology Research and Development Program of China (2015AA020309 to Zhi-Yao He), and the China Postdoctoral Science Foundation Funded Project (2015M570791 to Zhi-Yao He).	Adler AF, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.25; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Blinka S, 2016, CELL REP, V17, P19, DOI 10.1016/j.celrep.2016.09.002; Chen YY, 2017, SCI CHINA LIFE SCI, V60, P520, DOI 10.1007/s11427-017-9021-5; Cheong TC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10934; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Croce C.M., 2016, SIG TRANSDUCT TARGET, V1, P15006; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Deng HX, 2016, SCI CHINA LIFE SCI, V59, P1055, DOI 10.1007/s11427-015-4863-y; Feng Y, 2015, J ORTHOP RES, V33, P199, DOI 10.1002/jor.22745; FRICANOKUGLER CJ, 2016, JOVE J VIS EXP MAY, DOI DOI 10.3791/53783; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Harel Itamar, 2016, Nat Protoc, V11, P2010, DOI 10.1038/nprot.2016.103; He ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23764; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li H., 2016, SIG TRANSDUCT TARGET, V1, P16018; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu J, 2016, J CONTROL RELEASE, V244, P83, DOI 10.1016/j.jconrel.2016.11.014; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mentis AF, 2016, NEUROSCI BIOBEHAV R, V71, P323, DOI 10.1016/j.neubiorev.2016.09.012; Munshi NV, 2016, CIRCULATION, V134, P777, DOI 10.1161/CIRCULATIONAHA.116.024007; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Osakabe Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26685; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Reardon S., 2016, NATURE IN PRESS, DOI [10.1038/nature.2016.20137, DOI 10.1038/NATURE.2016.20137]; Sakuma T, 2016, GENES CELLS, V21, P1253, DOI 10.1111/gtc.12437; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Sessions J.W., 2016, CRISPR CAS9 DIRECTED, V5, P1521; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Suenaga T, 2014, MICROBIOL IMMUNOL, V58, P513, DOI 10.1111/1348-0421.12180; Suresh B, 2017, METHODS MOL BIOL, V1507, P81, DOI 10.1007/978-1-4939-6518-2_7; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tanihara F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600803; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valletta S, 2015, ONCOTARGET, V6, P44061, DOI 10.18632/oncotarget.6392; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Williams MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25611; Xie SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34555; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yao SH, 2015, HUM GENE THER, V26, P463, DOI 10.1089/hum.2015.067; Yi L, 2016, BBA-REV CANCER, V1866, P197, DOI 10.1016/j.bbcan.2016.09.002; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yuan M, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.35; Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15; Zhang DD, 2016, SCI CHINA LIFE SCI, V59, P740, DOI 10.1007/s11427-016-0128-8; Zhang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163551; Zhang XX, 2016, SCI CHINA LIFE SCI, V59, P1341, DOI 10.1007/s11427-016-0358-3; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	82	1	1	20	23	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2017	60	5			SI		458	467		10.1007/s11427-017-9033-0				10	Biology	Life Sciences & Biomedicine - Other Topics	EW8EI	WOS:000402750800003	28527117				2018-01-05	
J	Zhang, XH; Wang, LR; Liu, MY; Li, DL				Zhang, Xiaohui; Wang, Liren; Liu, Mingyao; Li, Dali			CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy	SCIENCE CHINA-LIFE SCIENCES			English	Review						CRISPR/Cas9; gene therapy; in vivo; ex vivo	DUCHENNE MUSCULAR-DYSTROPHY; HEMATOPOIETIC STEM-CELLS; MOUSE MODEL; CAS NUCLEASES; GENOME; CRISPR-CAS9; MICE; HEMOPHILIA; DISEASE; MUSCLE	CRISPR/Cas9 is a versatile genome-editing tool which is widely used for modifying the genome of both prokaryotic and eukaryotic organisms for basic research and applications. An increasing number of reports have demonstrated that CRISPR/Cas9-mediated genome editing is a powerful technology for gene therapy. Here, we review the recent advances in CRISPR/Cas9-mediated gene therapy in animal models via different strategies and discuss the challenges as well as future prospects.	[Liu, Mingyao; Li, Dali] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	Liu, MY; Li, DL (reprint author), East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.	myliu@bio.ecnu.edu.cn; dlli@bio.ecnu.edu.cn			National Natural Science Foundation of China [31371455, 31171318, 81330049]; Science and Technology Commission of Shanghai Municipality [14140900300]	This work was supported by the National Natural Science Foundation of China (31371455, 31171318 to Dali Li, 81330049 to Mingyao Liu), the Science and Technology Commission of Shanghai Municipality (14140900300 to Dali Li).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949                                                    ; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim K, 2017, GENOME RES, V27, P419, DOI 10.1101/gr.219089.116; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nygaard S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8166; Ou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32463; Pankowicz FP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12642; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Prakash V, 2016, MOL THER, V24, P465, DOI 10.1038/mt.2016.5; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Nguyen TH, 2016, EMBO MOL MED, V8, P439, DOI 10.15252/emmm.201606325; Wang CX, 2014, BLOOD, V124, P913, DOI 10.1182/blood-2013-12-546218; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xie C, 2016, CELL RES, V26, P1099, DOI 10.1038/cr.2016.101; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	51	2	2	12	13	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2017	60	5			SI		468	475		10.1007/s11427-017-9057-2				8	Biology	Life Sciences & Biomedicine - Other Topics	EW8EI	WOS:000402750800004	28534255				2018-01-05	
J	Ren, XJ; Holsteens, K; Li, HY; Sun, J; Zhang, YF; Liu, LP; Liu, QF; Ni, JQ				Ren, Xingjie; Holsteens, Kristof; Li, Haiyi; Sun, Jin; Zhang, Yifan; Liu, Lu-Ping; Liu, Qingfei; Ni, Jian-Quan			Genome editing in Drosophila melanogaster: from basic genome engineering to the multipurpose CRISPR-Cas9 system	SCIENCE CHINA-LIFE SCIENCES			English	Review						genome editing; Drosophila melanogaster; mutagenesis; transgenesis; CRISPR-Cas9	ZINC-FINGER NUCLEASES; SITE-SPECIFIC RECOMBINATION; GUIDED ENDONUCLEASE CAS9; P-ELEMENT TRANSPOSITION; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA-RECOGNITION; TRANSCRIPTIONAL ACTIVATION; INSERTIONAL MUTAGENESIS; RESTRICTION ENZYMES	Nowadays, genome editing tools are indispensable for studying gene function in order to increase our knowledge of biochemical processes and disease mechanisms. The extensive availability of mutagenesis and transgenesis tools make Drosophila melanogaster an excellent model organism for geneticists. Early mutagenesis tools relied on chemical or physical methods, ethyl methane sulfonate (EMS) and X-rays respectively, to randomly alter DNA at a nucleotide or chromosomal level. Since the discovery of transposable elements and the availability of the complete fly genome, specific genome editing tools, such as P-elements, zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), have undergone rapid development. Currently, one of the leading and most effective contemporary tools is the CRISPR-cas9 system made popular because of its low cost, effectiveness, specificity and simplicity of use. This review briefly addresses the most commonly used mutagenesis and transgenesis tools in Drosophila, followed by an in-depth review of the multipurpose CRISPR-Cas9 system and its current applications.	[Ren, Xingjie; Holsteens, Kristof; Sun, Jin; Liu, Lu-Ping; Ni, Jian-Quan] Tsinghua Univ, Sch Med, Gene Regulatory Lab, Beijing 100084, Peoples R China; [Li, Haiyi] French Int Sch Hong Kong, Hong Kong 999000, Hong Kong, Peoples R China; [Zhang, Yifan] Univ Calif San Diego, Dept Biol, San Diego, CA 92093 USA; [Liu, Qingfei] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China	Ni, JQ (reprint author), Tsinghua Univ, Sch Med, Gene Regulatory Lab, Beijing 100084, Peoples R China.; Liu, QF (reprint author), Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China.	liuqf@biomed.tsinghua.edu.cn; nijq@mail.tsinghua.edu.cn			National Key Technology Research and Development Program of the Ministry of Science and Technology of the People's Republic of China [2015BAI09B03, 2016YFE0113700]; National Natural Science Foundation of China [31371496, 31571320]; National Basic Research Program [2013CB35102]	We thank members of the Ni lab for their critical comments on the manuscript. This work was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of the People's Republic of China (2015BAI09B03, 2016YFE0113700), the National Natural Science Foundation of China (31371496, 31571320), the National Basic Research Program (2013CB35102).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Antosh M, 2014, DOSE-RESPONSE, V12, P551, DOI 10.2203/dose-response.13-047.Antosh; Ashburner M, 1989, DROSOPHILA LAB HDB; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P1717, DOI 10.1534/g3.113.007260; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bottcher R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku289; Bokel C., 2008, METHODS PROTOCOLS, P119; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Chen YY, 2017, SCI CHINA LIFE SCI, V60, P520, DOI 10.1007/s11427-017-9021-5; Choi CM, 2009, SCIENCE, V324, P54, DOI 10.1126/science.1168275; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COOLEY L, 1988, TRENDS GENET, V4, P254, DOI 10.1016/0168-9525(88)90032-7                                                    ; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Dodson MW, 2014, DIS MODEL MECH, V7, P1351, DOI 10.1242/dmm.017020; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; EEKEN JCJ, 1994, MUTAT RES, V307, P201, DOI 10.1016/0027-5107(94)90293-3; Engels WR, 1996, CURR TOP MICROBIOL, V204, P103; ENGELS WR, 1992, BIOESSAYS, V14, P681, DOI 10.1002/bies.950141007; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gebler C, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw183; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gokcezade J., 2014, G3, VG3, P2279; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; Gorski MM, 2003, GENETICS, V165, P1929; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gray YHM, 1996, GENETICS, V144, P1601; Greenspan R. J., 2004, FLY PUSHING THEORY P; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Josephs EA, 2015, NUCLEIC ACIDS RES, V43, P8924, DOI 10.1093/nar/gkv892; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31527; Katsuyama T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt638; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koana T, 2007, RADIAT RES, V167, P217, DOI 10.1667/RR0705.1; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lewis E. B., 1968, DROS INFORM SERV, V43, P193; LI L, 1992, P NATL ACAD SCI USA, V89, P4275, DOI 10.1073/pnas.89.10.4275; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin SL, 2015, GENETICS, V201, P433, DOI 10.1534/genetics.115.181065; Liu JY, 2016, METHODS MOL BIOL, V1338, P179, DOI 10.1007/978-1-4939-2932-0_14; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; MAHMOUD J, 1991, ENVIRON MOL MUTAGEN, V18, P157, DOI 10.1002/em.2850180303; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin SG, 2001, GENOME BIOL, V2; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McVey M, 2004, GENETICS, V168, P2067, DOI 10.1534/genetics.104.033902; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Mglinets V A, 1973, Sov Genet, V7, P1036; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mohr SE, 2002, GENETICS, V162, P165; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Moscou MJ, 2009, CHINESE J BIOCH MOL, V326, P1501, DOI DOI 10.1126/SCIENCE.1178817; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; Nairz K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r83; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; PATTON JS, 1992, NUCLEIC ACIDS RES, V20, P5859, DOI 10.1093/nar/20.21.5859; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PEABODY DS, 1993, EMBO J, V12, P595; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pirrotta V, 1988, Biotechnology, V10, P437; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ren B, 2017, SCI CHINA LIFE SCI, V60, P516, DOI 10.1007/s11427-016-0406-x; Ren X., 2014, G3, VG3, P1955; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; RIO DC, 1990, ANNU REV GENET, V24, P543; RIO DC, 1986, CELL, V44, P21, DOI 10.1016/0092-8674(86)90481-2; ROBERTS DB, 1987, AM J OBSTET GYNECOL, V157, P568, DOI 10.1016/S0002-9378(87)80008-X                                                   ; ROBERTSON HM, 1988, GENETICS, V118, P461; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sebo ZL, 2014, FLY, V8, P52, DOI 10.4161/fly.26828; Sepp KJ, 1999, GENETICS, V151, P1093; Shen L., 2017, SCI CHINA LIFE SCI, V309, DOI [10.1007/s11427-017-9008-8, DOI 10.1007/S11427-017-9008-8]; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435                                                         ; Spradling AC, 2011, P NATL ACAD SCI USA, V108, P15948, DOI 10.1073/pnas.1112960108; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497                                                        ; Vazquez J, 2002, CURR BIOL, V12, P1473, DOI 10.1016/S0960-9822(02)01090-4; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wen KJ, 2016, GENOME RES, V26, P1233, DOI 10.1101/gr.199547.115; Xu J, 2015, J GENET GENOMICS, V42, P141, DOI 10.1016/j.jgg.2015.02.007; Xue Z., 2014, G3, VG3, P2167; Yu ZS, 2014, BIOL OPEN, V3, P271, DOI 10.1242/bio.20147682; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; ZHANG P, 1993, GENETICS, V133, P361	135	1	1	10	11	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2017	60	5			SI		476	489		10.1007/s11427-017-9029-9				14	Biology	Life Sciences & Biomedicine - Other Topics	EW8EI	WOS:000402750800005	28527116				2018-01-05	
J	Ran, YD; Liang, Z; Gao, CX				Ran, Yidong; Liang, Zhen; Gao, Caixia			Current and future editing reagent delivery systems for plant genome editing	SCIENCE CHINA-LIFE SCIENCES			English	Review						genome editing; DNA; RNA; RNP and virus delivery; Agrobacterium-mediated transformation; biolistic method; protoplast transfection; ttransgene-free genome edited plant	ZINC-FINGER NUCLEASES; EFFICIENT TARGETED MUTAGENESIS; CHIMERIC RNA/DNA OLIGONUCLEOTIDES; CRISPR-CAS SYSTEM; MESOPOROUS SILICA NANOPARTICLES; FLORAL DIP TRANSFORMATION; SITE-SPECIFIC MUTAGENESIS; EFFECTOR NUCLEASES; HOMOLOGOUS RECOMBINATION; NICOTIANA-BENTHAMIANA	Many genome editing tools have been developed and new ones are anticipated; some have been extensively applied in plant genetics, biotechnology and breeding, especially the CRISPR/Cas9 system. These technologies have opened up a new era for crop improvement due to their precise editing of user-specified sequences related to agronomic traits. In this review, we will focus on an update of recent developments in the methodologies of editing reagent delivery, and consider the pros and cons of current delivery systems. Finally, we will reflect on possible future directions.	[Ran, Yidong] Genovo Biotechnol Co Ltd, Tianjin 301700, Peoples R China; [Liang, Zhen; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Liang, Zhen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Ran, YD (reprint author), Genovo Biotechnol Co Ltd, Tianjin 301700, Peoples R China.; Gao, CX (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China.	yidongran@genovo.org; cxgao@genetics.ac.cn					Ainley WM, 2013, PLANT BIOTECHNOL J, V11, P1126, DOI 10.1111/pbi.12107; Alagoz Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30910; Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Andersson M, 2017, PLANT CELL REP, V36, P117, DOI 10.1007/s00299-016-2062-3; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Cai YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136064; Cao MX, 2006, MOL BIOTECHNOL, V32, P55, DOI 10.1385/MB:32:1:055; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Char SN, 2015, PLANT BIOTECHNOL J, V13, P1002, DOI 10.1111/pbi.12344; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040; de Pater S, 2009, PLANT BIOTECHNOL J, V7, P821, DOI 10.1111/j.1467-7652.2009.00446.x; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Dong CM, 2006, PLANT CELL REP, V25, P457, DOI 10.1007/s00299-005-0098-x; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Du JJ, 2012, CURR DRUG METAB, V13, P82, DOI 10.2174/138920012798356862                                                      ; English JJ, 1997, PLANT J, V12, P597, DOI 10.1046/j.1365-313X.1997.00597.x; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Forsyth A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2015.01572; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Gupta M, 2012, PLANT BIOTECHNOL J, V10, P783, DOI 10.1111/j.1467-7652.2012.00695.x; Gurushidze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092046; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Huang YW, 2015, BIOMED RES INT, DOI 10.1155/2015/834079; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jensen S. P., 2014, J CITRUS PATHOL, V1, P10; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Jia HG, 2014, PLANT CELL REP, V33, P1993, DOI 10.1007/s00299-014-1673-9; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Jung JH, 2016, PLANT MOL BIOL, V92, P131, DOI 10.1007/s11103-016-0499-y; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679                                                          ; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li J, 2016, PLANT BIOTECHNOL J, V14, P533, DOI 10.1111/pbi.12403; Li T, 2016, J GENET GENOMICS, V43, P297, DOI 10.1016/j.jgg.2016.03.005; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lor VS, 2014, PLANT PHYSIOL, V166, P1288, DOI 10.1104/pp.114.247593; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Luo S, 2015, MOL PLANT, V8, P1425, DOI 10.1016/j.molp.2015.05.012; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Martin-Ortigosa S, 2014, PLANT PHYSIOL, V164, P537, DOI 10.1104/pp.113.233650; Martin-Ortigosa S, 2012, ADV FUNCT MATER, V22, P3576, DOI 10.1002/adfm.201200359; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nicolia A, 2015, J BIOTECHNOL, V204, P17, DOI 10.1016/j.jbiotec.2015.03.021; Okuzaki A, 2004, PLANT CELL REP, V22, P509, DOI 10.1007/s00299-003-0698-2; Osakabe K, 2010, P NATL ACAD SCI USA, V107, P12034, DOI 10.1073/pnas.1000234107; Paul JW, 2016, PLANT CELL REP, V35, P1417, DOI 10.1007/s00299-016-1985-z; Peer R, 2015, PLANTA, V241, P941, DOI 10.1007/s00425-014-2224-x; Petolino JF, 2015, IN VITRO CELL DEV-PL, V51, P1, DOI 10.1007/s11627-015-9663-3; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Popat A, 2011, NANOSCALE, V3, P2801, DOI 10.1039/c1nr10224a; Pratt S, 2012, W PRODUCER      0528; Qi YP, 2013, G3-GENES GENOM GENET, V3, P1707, DOI 10.1534/g3.113.006270; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Raitskin O, 2016, CURR OPIN BIOTECH, V37, P69, DOI 10.1016/j.copbio.2015.11.008; Rakoczy-Trojanowska M, 2002, CELL MOL BIOL LETT, V7, P849; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; Rinaldo AR, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0210-z; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Schaeffer SM, 2015, PLANT SCI, V240, P130, DOI 10.1016/j.plantsci.2015.09.011; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Stoddard TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154634; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Torney F, 2007, NAT NANOTECHNOL, V2, P295, DOI 10.1038/nnano.2007.108; Tovkach A, 2009, PLANT J, V57, P747, DOI 10.1111/j.1365-313X.2008.03718.x; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vainstein A, 2011, TRENDS BIOTECHNOL, V29, P363, DOI 10.1016/j.tibtech.2011.03.007; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Weinthal D, 2010, TRENDS PLANT SCI, V15, P308, DOI 10.1016/j.tplants.2010.03.001; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768; Zhu T, 2000, NAT BIOTECHNOL, V18, P555	136	1	1	38	44	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2017	60	5			SI		490	505		10.1007/s11427-017-9022-1				16	Biology	Life Sciences & Biomedicine - Other Topics	EW8EI	WOS:000402750800006	28527114				2018-01-05	
J	Shen, L; Hua, YF; Fu, YP; Li, J; Liu, Q; Jiao, XZ; Xin, GW; Wang, JJ; Wang, XC; Yan, CJ; Wang, KJ				Shen, Lan; Hua, Yufeng; Fu, Yaping; Li, Jian; Liu, Qing; Jiao, Xiaozhen; Xin, Gaowei; Wang, Junjie; Wang, Xingchun; Yan, Changjie; Wang, Kejian			Rapid generation of genetic diversity by multiplex CRISPR/Cas9 genome editing in rice	SCIENCE CHINA-LIFE SCIENCES			English	Article						CRISPR/Cas9; genome editing; agronomic genes; rice	ORYZA-SATIVA L; NATURAL VARIATION; GRAIN WIDTH; SYSTEM; PLANTS; ENCODES; PROTEIN; YIELD; SD-1; GS3	The clustered regularly interspaced short palindromic repeats (CRISPR)-associated endonuclease 9 (CRISPR/Cas9) system has emerged as a promising technology for specific genome editing in many species. Here we constructed one vector targeting eight agronomic genes in rice using the CRISPR/Cas9 multiplex genome editing system. By subsequent genetic transformation and DNA sequencing, we found that the eight target genes have high mutation efficiencies in the T-0 generation. Both heterozygous and homozygous mutations of all editing genes were obtained in T-0 plants. In addition, homozygous sextuple, septuple, and octuple mutants were identified. As the abundant genotypes in T-0 transgenic plants, various phenotypes related to the editing genes were observed. The findings demonstrate the potential of the CRISPR/Cas9 system for rapid introduction of genetic diversity during crop breeding.	[Shen, Lan; Hua, Yufeng; Fu, Yaping; Liu, Qing; Jiao, Xiaozhen; Wang, Junjie; Wang, Kejian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Shen, Lan; Yan, Changjie] Yangzhou Univ, Key Lab Plant Funct Genom, Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China; [Li, Jian] Lianyungang Acad Agr Sci, Lianyungang 222006, Peoples R China; [Xin, Gaowei; Wang, Xingchun] Shanxi Agr Univ, Coll Life Sci, Taigu 030801, Peoples R China	Wang, KJ (reprint author), Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.; Yan, CJ (reprint author), Yangzhou Univ, Key Lab Plant Funct Genom, Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China.	cjyan@yzu.edu.cn; wangkejian@caas.cn		Wang, Kejian/0000-0002-8385-6714	National Natural Science Foundation of China [31271681, 3140101312]; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences; Jiangsu Agriculture Science and Technology Innovation Fund [CX(13)5075]	This work was supported by the National Natural Science Foundation of China (31271681, 3140101312), the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences, and Jiangsu Agriculture Science and Technology Innovation Fund (CX(13)5075).	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Chen SH, 2008, PLANT CELL, V20, P1850, DOI 10.1105/tpc.108.058917; CHO YG, 1994, THEOR APPL GENET, V89, P54, DOI 10.1007/BF00226982; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fukuma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153338; Generoso WC, 2016, J MICROBIOL METH, V127, P203, DOI 10.1016/j.mimet.2016.06.020; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu XX, 2016, MOL PLANT, V9, P943, DOI 10.1016/j.molp.2016.03.003; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Ma X., 2016, CURR PROTOC MOL BIOL, V115; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mitsuda SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161288; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11                                                           ; Patron NJ, 2014, CURR OPIN PLANT BIOL, V19, P14, DOI 10.1016/j.pbi.2014.02.004; Piao R, 2009, THEOR APPL GENET, V119, P1497, DOI 10.1007/s00122-009-1151-x; Qi WW, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0289-2; Sakuma T, 2016, GENES CELLS, V21, P1253, DOI 10.1111/gtc.12437; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen L., 2016, J INTEGR PLANT BIOL, DOI [10.1111/jipb.12501, DOI 10.1111/JIPB.12501]; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; SOOD BC, 1978, INDIAN J GENET PL BR, V38, P268; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32271; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu XR, 2013, PLANT PHYSIOL, V161, P317, DOI 10.1104/pp.112.208496; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu HY, 2015, J EXP BOT, V66, P1543, DOI 10.1093/jxb/eru525; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681	44	2	2	11	11	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2017	60	5			SI		506	515		10.1007/s11427-017-9008-8				10	Biology	Life Sciences & Biomedicine - Other Topics	EW8EI	WOS:000402750800007	28349304	gold			2018-01-05	
J	Stracy, M; Kapanidis, AN				Stracy, Mathew; Kapanidis, Achillefs N.			Single-molecule and super-resolution imaging of transcription in living bacteria	METHODS			English	Article						Super-resolution imaging; Transcription; Quantitative microscopy; PALM; Single-particle tracking; Live cells	ESCHERICHIA-COLI CHROMOSOME; PHOTOACTIVATED LOCALIZATION MICROSCOPY; CRISPR-MEDIATED CONTROL; RNA-POLYMERASE-II; FLUORESCENT PROTEIN; INITIAL TRANSCRIPTION; SPATIAL-ORGANIZATION; LABELED PROTEINS; HIGH-THROUGHPUT; GENE-REGULATION	In vivo single-molecule and super-resolution techniques are transforming our ability to study transcription as it takes place in its native environment in living cells. This review will detail the methods for imaging single molecules in cells, and the data-analysis tools which can be used to extract quantitative information on the spatial organization, mobility, and kinetics of the transcription machinery from these experiments. Furthermore, we will highlight studies which have applied these techniques to shed new light on bacterial transcription. (C) 2017 The Authors. Published by Elsevier Inc.	[Stracy, Mathew; Kapanidis, Achillefs N.] Univ Oxford, Clarendon Lab, Biol Phys Res Grp, Dept Phys, Oxford OX1 3PU, England	Stracy, M; Kapanidis, AN (reprint author), Univ Oxford, Clarendon Lab, Biol Phys Res Grp, Dept Phys, Oxford OX1 3PU, England.	mathew.stracy@physics.ox.ac.uk; kapanidis@physics.ox.ac.uk		Stracy, Mathew/0000-0001-5685-0352	UK EPSRC (through the University of Oxford LSI-DTC); BBSRC [BB/N018656/1]; European Research Council [261227]; UK BBSRC [BB/N018656/1, BB/J00054X/1]; Wellcome Trust [110164/Z/15/Z]	We thank Stephan Uphoff, Federico Garza de Leon, Pawel Zawadzki, Christian Lesterlin, and David Sherratt for their contributions in the development of high-resolution and sptPALM approaches in the Kapanidis laboratory. M.S. was supported by the UK EPSRC (through the University of Oxford LSI-DTC) and BBSRC (grant BB/N018656/1). A.N.K. was supported by the European Research Council (Starter grant 261227), the UK BBSRC (grants BB/J00054X/1 and BB/N018656/1), and the Wellcome Trust (Investigator award 110164/Z/15/Z).	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bakshi S, 2013, BIOPHYS J, V105, P2676, DOI 10.1016/j.bpj.2013.10.024; Bakshi S, 2012, MOL MICROBIOL, V85, P21, DOI 10.1111/j.1365-2958.2012.08081.x; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Bratton BP, 2011, J BACTERIOL, V193, P5138, DOI 10.1128/JB.00198-11; Bremer H., 1996, ESCHERICHIA COLI SAL; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5                                                   ; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Cisse II, 2013, SCIENCE, V341, P664, DOI 10.1126/science.1239053; Crawford R, 2013, BIOPHYS J, V105, P2439, DOI 10.1016/j.bpj.2013.09.057; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duchi D, 2016, MOL CELL, V63, P939, DOI 10.1016/j.molcel.2016.08.011; Durisic N, 2014, NAT METHODS, V11, P156, DOI [10.1038/NMETH.2784, 10.1038/nmeth.2784]; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elmore S, 2005, J STRUCT BIOL, V151, P275, DOI 10.1016/j.jsb.2005.06.004; Endesfelder U, 2013, BIOPHYS J, V105, P172, DOI 10.1016/j.bpj.2013.05.048; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Ester M., 1996, 2 INT C KNOWL DISC D, P226; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Gahlmann A, 2014, NAT REV MICROBIOL, V12, P9, DOI 10.1038/nrmicro3154; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/NMETH.2411, 10.1038/nmeth.2411]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0                                                   ; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Harden TT, 2016, P NATL ACAD SCI USA, V113, P602, DOI 10.1073/pnas.1513899113; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Hensel Z, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001591; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; Hohlbein J, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/031001; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Holden S.J., 2014, P NATL ACAD SCI USA; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Jin DJ, 2006, J STRUCT BIOL, V156, P284, DOI 10.1016/j.jsb.2006.07.005; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Ke N, 2016, J BACTERIOL, V198, P1035, DOI 10.1128/JB.00864-15; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Leisle L, 2016, ELIFE, V5, DOI 10.7554/eLife.19088; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/nmeth.3579, 10.1038/NMETH.3579]; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Mangiameli SM, 2017, ELIFE, V6, DOI 10.7554/eLife.19848; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Michalet X, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061916; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nienhaus K, 2014, CHEM SOC REV, V43, P1088, DOI 10.1039/c3cs60171d; Paige MF, 2001, SINGLE MOL, V2, P191, DOI 10.1002/1438-5171(200110)2:3<191::AID-SIMO191>3.0.CO;2-K; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Rosenbloom AB, 2014, P NATL ACAD SCI USA, V111, P13093, DOI 10.1073/pnas.1320044111; Rubin-Delanchy P, 2015, NAT METHODS, V12, P1072, DOI [10.1038/NMETH.3612, 10.1038/nmeth.3612]; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Sage D, 2015, NAT METHODS, V12, P717, DOI [10.1038/NMETH.3442, 10.1038/nmeth.3442]; Sanamrad A, 2014, P NATL ACAD SCI USA, V111, P11413, DOI 10.1073/pnas.1411558111; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0                                                                ; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6                                                   ; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/NMETH.1704, 10.1038/nmeth.1704]; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Spahn C, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/1/014005; Stracy M., 2015, P NATL ACAD SCI USA, V112; Stracy M., 2016, NAT COMMUN IN PRESS; Stracy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12568; Stracy M, 2014, FEBS LETT, V588, P3585, DOI 10.1016/j.febslet.2014.05.026; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/NMETH.1298, 10.1038/nmeth.1298]; Sustarsic M, 2014, HISTOCHEM CELL BIOL, V142, P113, DOI 10.1007/s00418-014-1213-2; Thomason L.C., 2007, CURRENT PROTOCOLS MO; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X                                                   ; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/NMETH.1171; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0                                                                ; Uphoff S, 2013, P NATL ACAD SCI USA, V110, P8063, DOI 10.1073/pnas.1301804110; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6                                                   ; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902                                                    ; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; Wang XD, 2010, J BACTERIOL, V192, P6143, DOI 10.1128/JB.00861-10; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Wiktor J, 2016, NUCLEIC ACIDS RES, V44, P3801, DOI 10.1093/nar/gkw214; Wu FB, 2016, CHEM SOC REV, V45, P268, DOI 10.1039/c5cs00514k; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Zawadzki P, 2015, CELL REP, V13, P2587, DOI 10.1016/j.celrep.2015.11.034; Zhao ZQW, 2014, P NATL ACAD SCI USA, V111, P681, DOI 10.1073/pnas.1318496111	98	1	1	22	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	MAY 1	2017	120						103	114		10.1016/j.ymeth.2017.04.001				12	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW9OU	WOS:000402849900012	28414097				2018-01-05	
J	Bart, RS; Taylor, NJ				Bart, Rebecca S.; Taylor, Nigel J.			New opportunities and challenges to engineer disease resistance in cassava, a staple food of African small-holder farmers	PLOS PATHOGENS			English	Article							BROWN STREAK DISEASE; BACTERIAL-BLIGHT; MOSAIC GEMINIVIRUSES; TRANSGENIC CASSAVA; VIRUS; GENOME; PLANTS; GENE; ACTIVATOR; NIGERIA	The storage root crop cassava (Manihot esculenta) is the most important source of dietary calories in the tropics after rice and maize [1]. It plays a central role in food and economic security for small-holder farmers and holds unrealized potential as a cash and commodity crop. In Africa, cassava production is constrained by three major diseases: cassava mosaic disease (CMD), cassava brown streak disease (CBSD), and cassava bacterial blight (CBB) [2]. Strong inbreeding depression and heterozygosity present challenges to conventional cassava breeding programs. While important advances are being made with genotype-by-sequencing technologies and marker-assisted breeding, these techniques alone will not unlock the crop's full potential. Historically, cassava has received less research investment than other major crops. Over the last decade, however, multiple genomic platforms and diverse germplasm collections have been developed, along with effective genetic transformation protocols. As a result, numerous reports of genetically engineered cassava have now been published (see Chavarriaga-Aguirre and colleagues) [3]. Here, we briefly summarize previous efforts with an emphasis on technologies relevant to small-holder farmers in Africa. In addition, we discuss new opportunities for using genome-editing technologies to create disease-resistant cassava plants. We conclude by highlighting additional challenges that must be overcome prior to delivering biotechnology-improved cassava varieties to small-holder farmers in Africa.	[Bart, Rebecca S.; Taylor, Nigel J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Bart, RS (reprint author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	rbart@danforthcenter.org	Taylor, Nigel/M-2851-2013; Bart, Rebecca/M-2838-2013		Bill and Melinda Gates Foundation [N003988801, OPP1088642, OPP1125410, OPPGD1485]; USAID [AID-EDH-A-00-09-00010]	This work was supported in part by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). N003988801 and OPP1088642 to RSB and NJT, OPP1125410 to RSB, and OPPGD1485 to NJT. Additional support from USAID (AID-EDH-A-00-09-00010) to NJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Bart R, 2012, P NATL ACAD SCI USA, V109, pE1972, DOI 10.1073/pnas.1208003109; Beyene G, 2016, MOL PLANT PATHOL, V17, P1095, DOI 10.1111/mpp.12353; Boher B., 1994, African Crop Science Journal, V2, P505; Bredeson JV, 2016, NAT BIOTECHNOL; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Castiblanco LF, 2013, MOL PLANT PATHOL, V14, P84, DOI 10.1111/j.1364-3703.2012.00830.x; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Chavarriaga-Aguirre P, 2016, IN VITRO CELL DEV-PL, V52, P461, DOI 10.1007/s11627-016-9776-3; Cohn M, 2014, MOL PLANT MICROBE IN, V27, P1186, DOI 10.1094/MPMI-06-14-0161-R; Emily AM, 2016, AFRICAN J AGR RES, V11, P2064; Howeler R, 2013, SAVE GROW CASSAVA D; Howeler RH, 2012, CASSAVA HDB REFERENC, P1; Ilardi Vincenza, 2011, GM Crops, V2, P24, DOI 10.4161/gmcr.2.1.15096; Legg JP, 2004, PLANT MOL BIOL, V56, P585, DOI 10.1007/s11103-004-1651-7; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lopez CE, 2012, TROP PLANT BIOL, V5, P117, DOI 10.1007/s12042-011-9092-3; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mutka AM, 2016, PLANT PHYSIOL, V172, P650, DOI 10.1104/pp.16.00984; Nicaise V, 2003, PLANT PHYSIOL, V132, P1272, DOI 10.1104/pp.102.017855; Nyaboga E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00526; Odipio John, 2014, GM Crops Food, V5, P16, DOI 10.4161/gmcr.26408; Ogwok E, 2012, MOL PLANT PATHOL, V13, P1019, DOI 10.1111/j.1364-3703.2012.00812.x; Okogbenin E, 2012, CROP SCI, V52, P2576, DOI 10.2135/cropsci2011.11.0586; Onyeka TJ, 2008, AFR J AGRIC RES, V3, P297; Pati BL, 2015, J GEN VIROL, V96, P956, DOI 10.1099/vir.0.000014; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/J.1364-3703.2009.00559.X, 10.1111/j.1364-3703.2009.00559.x]; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Rabbi IY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0273-1; Rabbi IY, 2013, VIRUS RES; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Taha O, 2016, INT J GENOMICS, V2016; Taylor N, 2012, TROP PLANT BIOL, V5, P127, DOI 10.1007/s12042-012-9099-4; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Wagaba Henry, 2016, Front Plant Sci, V7, P2060, DOI 10.3389/fpls.2016.02060; Wang HF, 2015, P NATL ACAD SCI USA, V112, P13729, DOI 10.1073/pnas.1519067112; Wang WQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6110; Wilson MC, 2017, NEW PHYTOL, V213, P1632, DOI 10.1111/nph.14443; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Wolfe MD, 2016, PLANT GENOME, V9; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617	43	2	2	12	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	MAY	2017	13	5							e1006287	10.1371/journal.ppat.1006287				7	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	EW9ZK	WOS:000402877700005	28493983	gold			2018-01-05	
J	Long, S; Brown, KM; Drewry, LL; Anthony, B; Phan, IQH; Sibley, LD				Long, Shaojun; Brown, Kevin M.; Drewry, Lisa L.; Anthony, Bryan; Phan, Isabelle Q. H.; Sibley, L. David			Calmodulin-like proteins localized to the conoid regulate motility and cell invasion by Toxoplasma gondii	PLOS PATHOGENS			English	Article							APICOMPLEXAN PARASITES; MAMMALIAN-CELLS; MYOSIN-A; HOST-CELLS; SYSTEM; GENE; SECRETION; MOTOR; CYTOSKELETON; DEGRADATION	Toxoplasma gondii contains an expanded number of calmodulin (CaM)-like proteins whose functions are poorly understood. Using a combination of CRISPR/Cas9-mediated gene editing and a plant-like auxin-induced degron (AID) system, we examined the roles of three apically localized CaMs. CaM1 and CaM2 were individually dispensable, but loss of both resulted in a synthetic lethal phenotype. CaM3 was refractory to deletion, suggesting it is essential. Consistent with this prediction auxin-induced degradation of CaM3 blocked growth. Phenotypic analysis revealed that all three CaMs contribute to parasite motility, invasion, and egress from host cells, and that they act downstream of microneme and rhoptry secretion. Super-resolution microscopy localized all three CaMs to the conoid where they overlap with myosin H (MyoH), a motor protein that is required for invasion. Biotinylation using BirA fusions with the CaMs labeled a number of apical proteins including MyoH and its light chain MLC7, suggesting they may interact. Consistent with this hypothesis, disruption of MyoH led to degradation of CaM3, or redistribution of CaM1 and CaM2. Collectively, our findings suggest these CaMs may interact with MyoH to control motility and cell invasion.	[Long, Shaojun; Brown, Kevin M.; Drewry, Lisa L.; Anthony, Bryan; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Phan, Isabelle Q. H.] Ctr Infect Dis Res, Seattle, WA USA; [Phan, Isabelle Q. H.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA USA	Sibley, LD (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	sibley@wustl.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI034036]; American Heart Association [15POST22130001]; National Science Foundation [DGE-1143954]	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) grant AI034036. KMB was partially supported by a grant from the American Heart Association (http://www.heart.org) (15POST22130001). LLD was supported by a grant from the National Science Foundation (https://www.nsf.gov/) (DGE-1143954). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaganan A, 2013, PNAS, V111, P1126, DOI DOI 10.1073/PNAS.1313501111; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Andenmatten N, 2012, NAT METHODS; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Brown KM, 2016, J BIOL CHEM, V291, P9554, DOI 10.1074/jbc.M115.700518; Brown KM, 2017, AUXIN BASED IN PRESS; BURG JL, 1988, J IMMUNOL, V141, P3584; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 2008, V47, P33; Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14; Delbac F, 2001, J CELL BIOL, V155, P613, DOI 10.1083/jcb.200012116; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Drewry LL, 2015, MBIO, V6, DOI 10.1128/mBio.00557-15; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004504; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaji RY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005268; Garcia C. R., 2017, CURR TOP MED CHEM; Del Carmen MG, 2009, CELL MICROBIOL, V11, P967, DOI 10.1111/j.1462-5822.2009.01304.x; Graindorge A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005388; Heaslip AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002201; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Hu K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040010; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jacot D, 2016, CELL HOST MICROBE, V20, P731, DOI 10.1016/j.chom.2016.10.020; Jacot D, 2013, EMBO J, V32, P1702, DOI 10.1038/emboj.2013.113; Katris NJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004074; Kreidenweiss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078661; Kursula P, 2014, AMINO ACIDS, V46, P2295, DOI 10.1007/s00726-014-1795-y; Long S, 2001, EMBO J, V20, P3132; Long SJ, 2016, INFECT IMMUN, V84, P1262, DOI [10.1128/IAI.01173-15, 10.1128/IAI.00175-16]; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Meissner M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.22.e115                                                          ; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Nagayasu E, 2017, MOL BIOL CELL, V28, P411, DOI 10.1091/mbc.E16-08-0587; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Paul AS, 2015, CELL HOST MICROBE, V18, P49, DOI 10.1016/j.chom.2015.06.003; Peng J, 2011, PROTEINS, V79, P161, DOI 10.1002/prot.23175; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philip N, 2015, CELL HOST MICROBE, V18, P122, DOI 10.1016/j.chom.2015.05.018; Polonais V, 2011, TRAFFIC, V12, P287, DOI 10.1111/j.1600-0854.2010.01148.x; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; SAFFER LD, 1992, J PROTOZOOL, V39, P526, DOI 10.1111/j.1550-7408.1992.tb04844.x; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; Sidik SM, 2016, J BIOL CHEM, V291, P9566, DOI 10.1074/jbc.M115.703546; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Skillman KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3285; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; Wernimont AK, 2011, PROTEINS, V79, P803, DOI 10.1002/prot.22919; Wichroski MJ, 2002, INFECT IMMUN, V70, P4353, DOI 10.1128/IAI.70.8.4353-4361.2002; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350	75	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	MAY	2017	13	5							e1006379	10.1371/journal.ppat.1006379				28	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	EW9ZK	WOS:000402877700033	28475612	gold			2018-01-05	
J	Ahn, J; Lee, J; Park, JY; Oh, KB; Hwang, S; Lee, CW; Lee, K				Ahn, Jinsoo; Lee, Joonbum; Park, Ju Yeon; Oh, Keon Bong; Hwang, Seongsoo; Lee, Chang-Won; Lee, Kichoon			Targeted genome editing in a quail cell line using a customized CRISPR/Cas9 system	POULTRY SCIENCE			English	Article						CRISPR/Cas9; 7SK promoter; CBh promoter; QM7 (quail muscle clone 7) cell line; melanophilin (MLPH) locus	MUTATIONS; GENERATION; EXPRESSION; PROMOTERS; VECTORS; GENES	Soon after RNA-guided Cas9 (CRISPRassociated protein 9) endonuclease opened a new era of targeted genome editing, the CRISPR/Cas9 platform began to be extensively used to modify genes in various types of cells and organisms. However, successful CRISPR/Cas9-mediated insertion/deletion (indel) mutation remains to be demonstrated in avian cell lines. The objective of this study was to design a poultry specific CRISPR/Cas9 system to efficiently introduce targeted deletion mutation in chromosomes of the quail muscle clone 7 (QM7) cell line using a customized quail CRISPR vector. In this study, two avian-specific promoters, quail 7SK (q7SK) promoter and CBh promoter, the hybrid form of cytomegalovirus and chicken /3-actin promoters, were cloned into a CRISPR vector for the expression of guide RNA and Cas9 protein, respectively. Then, guide RNA, which was designed to target 20-base pair (bp) nucleotides in the quail melanophilin (MLPH) locus, was ligated to the modified CRISPR vector and transfected to QM7 cells. Our results showed multiple indel mutations in the quail MLPH locus in nearly half of the alleles being tested, suggesting the high efficiency of the system for targeted gene modification. The new CRISPR vector developed from this study has the potential application to generate knockout avian cell lines and knockout poultry.	[Ahn, Jinsoo; Lee, Joonbum; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Park, Ju Yeon] Ohio State Univ, Dept Biol Sci, Columbus, OH 43210 USA; [Oh, Keon Bong; Hwang, Seongsoo] RDA, Natl Inst Anim Sci, Anim Biotechnol Div, Jeonbuk 55365, South Korea; [Lee, Chang-Won] Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Food Anim Hlth Res Program, 1680 Madison Ave, Wooster, OH 44691 USA	Lee, K (reprint author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu			Ohio Agricultural Research and Development Center; Cooperative Research Program for Animal Science & Technology Development [PJ01095601]	This work was partially carried out with the support of the Ohio Agricultural Research and Development Center Interdisciplinary Research SEEDS funding (K. Lee and C. Lee) and the Cooperative Research Program for Animal Science & Technology Development (Project No. PJ01095601). We acknowledge the Addgene company and Dr. Feng Zhang for supplying us with the lentiCRISPRv2 (#52961) plasmid.	Ahn J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124768; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bannister SC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-79; Bed'hom B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-442; Chen PR, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030384; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shin SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100905; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	18	2	2	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-5791	1525-3171		POULTRY SCI	Poult. Sci.	MAY	2017	96	5					1445	1450		10.3382/ps/pew435				6	Agriculture, Dairy & Animal Science	Agriculture	EW8TY	WOS:000402792200049	27965404				2018-01-05	
